PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Li, YY; Cao, MH; Goetz, B; Chen, CQ; Feng, YJ; Chen, CJ; Kasparek, MS; Sibaev, A; Storr, M; Kreis, ME				Li, Yong-yu; Cao, Ming-hua; Goetz, Brigitte; Chen, Chun-qiu; Feng, Ya-jing; Chen, Chang-Jie; Kasparek, Michael S.; Sibaev, Andrej; Storr, Martin; Kreis, Martin E.			The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NEURONAL PATHWAYS; MYENTERIC PLEXUS; CB1 RECEPTORS; GUINEA-PIG; MICE; MOUSE; COLON; EXPRESSION; SYSTEM	Introduction: Intestinal inflammatory responses play a critical role in the pathogenesis of postoperative ileus (POI). As cannabinoid receptor-1 (CB1) is involved in inhibiting gastrointestinal (GI) motility and anti-inflammation, we aimed to explore its contribution to POI. Methods: Experimental POI was induced in adult female CB1-deficient (CB1-/-) mice and wild-type littermates (C57BL/6N) by standardized small bowel manipulation. Twenty-four hours after surgery, GI transit was assessed by charcoal transport. FITC avidin, F4/80, and myeloperoxidase immunohistochemistry techniques were used to evaluate the inflammatory response in the muscularis of ileum and colon. Expressions of p38MAPK and its phosphorylated form (pp38) in the intestine were determined. Plasma levels of proinflammatory cytokines and chemokines were measured by ELISA as well. Results: POI was characterized by decreased GI transit (p<0.01) and accompanied by a marked intestinal and systematic inflammatory response in wild-type and CB1-/- mice. Increased numbers of inflammatory cells, including macrophages, neutrophils, and mast cells were observed in the muscularis of ileum and colon (p<0.01, or p<0.05). Plasma levels of interleukin-6 (IL-6), cytokine-induced neutrophil chemoattractant-1 (CINC-1/KC), and monocyte chemoattractant protein-1 (MCP-1) were elevated (p<0.01, or p<0.05). Expression of p38 and pp38 increased in the intestine (p<0.01, or p<0.05). CB1-/- mice showed an increased inflammatory response during POI, especially the systemic inflammatory markers, such as IL-6, KC, CINC1, and pp38 expression were increased as compared to those in WT mice (p<0.05). Conclusions: Intestinal motility was inhibited during POI. In this condition, inhibition of motility did not seem to be altered by the absence of CB1 receptors, however, an increased inflammatory response was observed in CB1-/- mice. Hence, CB1 receptor activation rather than inhibition may reduce the inflammatory response in POI, which has a remote potential to relate into reduced inhibition of intestinal motility during POI.	[Li, Yong-yu; Cao, Ming-hua; Chen, Chun-qiu; Feng, Ya-jing; Chen, Chang-Jie] Tongji Univ, Sch Med, Inst Digest Dis, Dept Pathophysiol, Shanghai 200092, Peoples R China; [Goetz, Brigitte; Kasparek, Michael S.] Univ Munich, Dept Surg, Hosp Grosshadern, Munich, Germany; [Sibaev, Andrej; Storr, Martin] Univ Munich, Dept Internal Med 2, Hosp Grosshadern, Munich, Germany; [Kreis, Martin E.] Charite, Dept Gen Visceral & Vasc Surg, D-13353 Berlin, Germany	Tongji University; University of Munich; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Li, YY (corresponding author), Tongji Univ, Sch Med, Inst Digest Dis, Dept Pathophysiol, Shanghai 200092, Peoples R China.	liyongyu@tongji.edu.cn		Kreis, Martin E./0000-0002-9312-4840	National Natural Science Foundation of China [81270477, 81170345]; Deutsche Forschungs-gemeinschaft [DFG KA 2329/5-1]; Deutsche Akademische Austauschdienst (DAAD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungs-gemeinschaft(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by the National Natural Science Foundation of China (grants 81270477 to Dr. Yong-yu Li, and 81170345 to Dr. Chun-qiu Chen), and the Deutsche Forschungs-gemeinschaft (DFG KA 2329/5-1 to Dr. Michael S. Kasparek), and a travel grant by the Deutsche Akademische Austauschdienst (DAAD) to Dr. Yong-yu Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami M, 2002, BRIT J PHARMACOL, V135, P1598, DOI 10.1038/sj.bjp.0704625; Barquist E, 1996, AM J PHYSIOL-REG I, V270, pR888, DOI 10.1152/ajpregu.1996.270.4.R888; Bauer AJ, 2004, NEUROGASTROENT MOTIL, V16, P54, DOI 10.1111/j.1743-3150.2004.00558.x; Cao MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052921; Casu MA, 2003, EUR J PHARMACOL, V459, P97, DOI 10.1016/S0014-2999(02)02830-3; Coutts AA, 1998, CAN J PHYSIOL PHARM, V76, P340, DOI 10.1139/cjpp-76-3-340; Coutts AA, 2002, J COMP NEUROL, V448, P410, DOI 10.1002/cne.10270; De Jonge WJ, 2004, GASTROENTEROLOGY, V127, P535, DOI 10.1053/j.gastro.2004.04.017; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; DeWinter BY, 1997, BRIT J PHARMACOL, V120, P464, DOI 10.1038/sj.bjp.0700913; Di Marzo V, 2006, GUT, V55, P1373, DOI 10.1136/gut.2005.090472; Gao ZR, 2010, LANGENBECK ARCH SURG, V395, P407, DOI 10.1007/s00423-010-0594-5; Hornby PJ, 2004, BRIT J PHARMACOL, V141, P1335, DOI 10.1038/sj.bjp.0705783; Kalff JC, 1999, GASTROENTEROLOGY, V117, P378, DOI 10.1053/gast.1999.0029900378; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kathmann M, 2001, BRIT J PHARMACOL, V132, P1169, DOI 10.1038/sj.bjp.0703987; Kirkup AJ, 2001, AM J PHYSIOL-GASTR L, V280, pG787, DOI 10.1152/ajpgi.2001.280.5.G787; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Kreis ME, 2003, ZBL CHIR, V128, P320, DOI 10.1055/s-2003-38797; Landi M, 2002, EUR J PHARMACOL, V450, P77, DOI 10.1016/S0014-2999(02)02053-8; Li YY, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01419.x; LIVINGSTON EH, 1990, DIGEST DIS SCI, V35, P121, DOI 10.1007/BF01537233; Manara L, 2002, DIGEST LIVER DIS, V34, P262, DOI 10.1016/S1590-8658(02)80146-3; Mancinelli R, 2001, LIFE SCI, V69, P101, DOI 10.1016/S0024-3205(01)01110-9; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Marzo VD, 2008, NAT REV DRUG DISCOV, V7, P438; Mascolo N, 2002, FASEB J, V16, P1973, DOI 10.1096/fj.02-0338fje; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mueller MH, 2008, ANN SURG, V247, P791, DOI 10.1097/SLA.0b013e31816a9d97; Mueller MH, 2011, J GASTROINTEST SURG, V15, P891, DOI 10.1007/s11605-011-1481-2; Ohama Takashi, 2007, Journal of Smooth Muscle Research, V43, P43, DOI 10.1540/jsmr.43.43; Pinto L, 2002, GASTROENTEROLOGY, V123, P227, DOI 10.1053/gast.2002.34242; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Scaldaferri F, 2009, EUR J IMMUNOL, V39, P290, DOI 10.1002/eji.200838316; Snoek SA, 2012, NEUROGASTROENT MOTIL, V24, P172, DOI 10.1111/j.1365-2982.2011.01820.x; Spiller RC, 2003, CURR OPIN GASTROEN, V19, P103, DOI 10.1097/00001574-200303000-00001; Storr M, 2004, AM J PHYSIOL-GASTR L, V286, pG110, DOI 10.1152/ajpgi.00148.2003; Storr M, 2008, GASTROENTEROLOGY, V134, pA430; The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022; Tsuchida Y, 2011, GUT, V60, P638, DOI 10.1136/gut.2010.227546; Wright K, 2005, GASTROENTEROLOGY, V129, P437, DOI 10.1053/j.gastro.2005.05.026	42	7	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67427	10.1371/journal.pone.0067427	http://dx.doi.org/10.1371/journal.pone.0067427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844009	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000071
J	Mattioni, M; Le Novere, N				Mattioni, Michele; Le Novere, Nicolas			Integration of Biochemical and Electrical Signaling-Multiscale Model of the Medium Spiny Neuron of the Striatum	PLOS ONE			English	Article							DENDRITIC SPINES; SYNAPTIC PLASTICITY; COMPUTATIONAL MODEL; AMPA RECEPTORS; ACTIVATION; MODULATION; MECHANISMS; SYSTEMS; BRAIN; OSCILLATIONS	Neuron behavior results from the interplay between networks of biochemical processes and electrical signaling. Synaptic plasticity is one of the neuronal properties emerging from such an interaction. One of the current approaches to study plasticity is to model either its electrical aspects or its biochemical components. Among the chief reasons are the different time scales involved, electrical events happening in milliseconds while biochemical cascades respond in minutes or hours. In order to create multiscale models taking in consideration both aspects simultaneously, one needs to synchronize the two models, and exchange relevant variable values. We present a new event-driven algorithm to synchronize different neuronal models, which decreases computational time and avoids superfluous synchronizations. The algorithm is implemented in the TimeScales framework. We demonstrate its use by simulating a new multiscale model of the Medium Spiny Neuron of the Neostriatum. The model comprises over a thousand dendritic spines, where the electrical model interacts with the respective instances of a biochemical model. Our results show that a multiscale model is able to exhibit changes of synaptic plasticity as a result of the interaction between electrical and biochemical signaling. Our synchronization strategy is general enough to be used in simulations of other models with similar synchronization issues, such as networks of neurons. Moreover, the integration between the electrical and the biochemical models opens up the possibility to investigate multiscale process, like synaptic plasticity, in a more global manner, while taking into account a more realistic description of the underlying mechanisms.	[Mattioni, Michele; Le Novere, Nicolas] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Le Novere, Nicolas] Babraham Inst, Cambridge, England	European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Le Novere, N (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Cambridge, England.	n.lenovere@gmail.com						ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Araya R, 2007, P NATL ACAD SCI USA, V104, P12347, DOI 10.1073/pnas.0705282104; Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; Araya R, 2006, P NATL ACAD SCI USA, V103, P18799, DOI 10.1073/pnas.0609225103; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Arendt KL, 2010, NAT NEUROSCI, V13, P36, DOI 10.1038/nn.2462; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bhalla U, 2011, NEURAL NETW IN PRESS; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Bower JM, 1998, BOOK GENESIS EXPLORI; Brunel N, 2007, BIOL CYBERN, V97, P337, DOI 10.1007/s00422-007-0190-0; Burger SK, 2011, J CHEM INF MODEL, V51, P93, DOI 10.1021/ci100329z; Cao Y, 2012, TUNN UNDERGR SP TECH, V28, P124, DOI 10.1016/j.tust.2011.10.004; Carnevale NT, 2006, NEURON BOOK; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Cvijovic M, 2008, GENOME INFORM SER, V21, P114; Davison AP, 2012, COMPUT SCI ENG, V14, P48, DOI 10.1109/MCSE.2012.41; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; DESDOUITS F, 1995, BIOCHEM BIOPH RES CO, V206, P652, DOI 10.1006/bbrc.1995.1092; DESTEXHE A, 1993, BIOPHYS J, V65, P1538, DOI 10.1016/S0006-3495(93)81190-1; Djurfeldt M, 2010, NEUROINFORMATICS, V8, P43, DOI 10.1007/s12021-010-9064-z; Ekeberg O, 2008, NAT PRECED; Engquist B., 2003, NOT AM MATH SOC, V50, P1062; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gabriel E, 2004, LECT NOTES COMPUT SC, V3241, P97; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI DOI 10.4249/SCH0LARPEDIA.1430; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Gropp W., 2002, P 9 EUR PVM MPI US G; Gruber AJ, 2009, SYNAPSE, V63, P173, DOI 10.1002/syn.20593; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hayer A, 2005, PLOS COMPUT BIOL, V1, P137, DOI 10.1371/journal.pcbi.0010020; HEMMINGS HC, 1984, J BIOL CHEM, V259, P4491; Hines Michael L, 2009, Front Neuroinform, V3, P1, DOI 10.3389/neuro.11.001.2009; Holbro N, 2010, P NATL ACAD SCI USA, V107, P15975, DOI 10.1073/pnas.1004562107; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P297, DOI 10.1111/j.1432-1033.1983.tb07362.x; Ingram GD, 2004, CHEM ENG SCI, V59, P2171, DOI 10.1016/j.ces.2004.02.010; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jackson MB, 2003, J NEUROSCI, V23, P1612; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; KING MM, 1984, J BIOL CHEM, V259, P8080; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Le Novere N, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S11; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lee Seok-Jin R, 2009, Open Neurosci J, V3, P117; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043810; Li Lu, 2010, THESIS U CAMBRIDGE; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Lucic V, 2008, EUR BIOPHYS J BIOPHY, V38, P83, DOI 10.1007/s00249-008-0362-4; Machne R, 2006, BIOINFORMATICS, V22, P1406, DOI 10.1093/bioinformatics/btl086; Majda AJ, 2000, MATH FRONTIERS PERSP; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mattioni M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00020; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Moyer JT, 2007, J NEUROPHYSIOL, V98, P3731, DOI 10.1152/jn.00335.2007; Olivier BG, 2005, BIOINFORMATICS, V21, P560, DOI 10.1093/bioinformatics/bti046; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Perrino BA, 2002, EUR J BIOCHEM, V269, P3540, DOI 10.1046/j.1432-1033.2002.03040.x; Petersen JD, 2003, J NEUROSCI, V23, P11270; Pitt-Francis J, 2009, COMPUT PHYS COMMUN, V180, P2452, DOI 10.1016/j.cpc.2009.07.019; Quintana AR, 2005, BIOCHEM BIOPH RES CO, V334, P674, DOI 10.1016/j.bbrc.2005.06.152; Ray Subhasis, 2008, Front Neuroinform, V2, P6, DOI 10.3389/neuro.11.006.2008; Schulz Marvin, 2006, Genome Inform, V17, P62; SEGEV I, 1998, METHODS NEURONAL MOD; Shen HW, 2008, BRAIN STRUCT FUNCT, V213, P149, DOI 10.1007/s00429-008-0184-2; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Surmeier DJ, 2010, PROG BRAIN RES, V183, P149, DOI 10.1016/S0079-6123(10)83008-0; Takahashi K, 2004, BIOINFORMATICS, V20, P538, DOI 10.1093/bioinformatics/btg442; Tolle DP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-25; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; Vayttaden S, 2004, SCI STKE, P14; Vervaeke K, 2010, NEURON, V67, P435, DOI 10.1016/j.neuron.2010.06.028; Wils Stefan, 2009, Front Neuroinform, V3, P15, DOI 10.3389/neuro.11.015.2009; Wilson C. J., 1992, SINGLE NEURON COMPUT, P141, DOI [10.1016/B978-0-12-484815-3.50012-8, DOI 10.1016/B978-0-12-484815-3.50012-8]; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1	95	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66811	10.1371/journal.pone.0066811	http://dx.doi.org/10.1371/journal.pone.0066811			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843966	Green Published, gold			2022-12-27	WOS:000321733000053
J	Mos, M; Esparza-Franco, MA; Godfrey, EL; Richardson, K; Davey, J; Ladds, G				Mos, Magdalena; Esparza-Franco, Manuel A.; Godfrey, Emma L.; Richardson, Kathryn; Davey, John; Ladds, Graham			The Role of the RACK1 Ortholog Cpc2p in Modulating Pheromone-Induced Cell Cycle Arrest in Fission Yeast (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							G-ALPHA-SUBUNIT; SCHIZOSACCHAROMYCES-POMBE; SEXUAL-DIFFERENTIATION; NEGATIVE REGULATOR; ADENYLATE-CYCLASE; SRC ACTIVITY; PAT1 KINASE; S-PHASE; PROTEIN; RECEPTOR	The detection and amplification of extracellular signals requires the involvement of multiple protein components. In mammalian cells the receptor of activated C kinase (RACK1) is an important scaffolding protein for signal transduction networks. Further, it also performs a critical function in regulating the cell cycle by modulating the G(1)/S transition. Many eukaryotic cells express RACK1 orthologs, with one example being Cpc2p in the fission yeast Schizosaccharomyces pombe. In contrast to RACK1, Cpc2p has been described to positively regulate, at the ribosomal level, cells entry into M phase. In addition, Cpc2p controls the stress response pathways through an interaction with Msa2p, and sexual development by modulating Ran1p/Pat1p. Here we describe investigations into the role, which Cpc2p performs in controlling the G protein-mediated mating response pathway. Despite structural similarity to G beta-like subunits, Cpc2p appears not to function at the G protein level. However, upon pheromone stimulation, cells overexpressing Cpc2p display substantial cell morphology defects, disorientation of septum formation and a significantly protracted G(1) arrest. Cpc2p has the potential to function at multiple positions within the pheromone response pathway. We provide a mechanistic interpretation of this novel data by linking Cpc2p function, during the mating response, with its previous described interactions with Ran1p/Pat1p. We suggest that overexpressing Cpc2p prolongs the stimulated state of pheromone-induced cells by increasing ste11 gene expression. These data indicate that Cpc2p regulates the pheromone-induced cell cycle arrest in fission yeast by delaying cells entry into S phase.	[Mos, Magdalena; Godfrey, Emma L.; Davey, John; Ladds, Graham] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Esparza-Franco, Manuel A.; Richardson, Kathryn] Univ Warwick, Syst Biol Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Mos, M (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England.	m.mos@warwick.ac.uk		Ladds, Graham/0000-0001-7320-9612	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G01227X/1]; University Hospitals of Coventry; Warwickshire NHS Trust; Birmingham Science City Research Alliance; BBSRC pre-doctoral traineeship; National Council on Science and Technology of Mexico (CONACYT); BBSRC [BB/G01227X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G01227X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University Hospitals of Coventry; Warwickshire NHS Trust; Birmingham Science City Research Alliance; BBSRC pre-doctoral traineeship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Council on Science and Technology of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (grant BB/G01227X/1 to MM and GL), University Hospitals of Coventry and Warwickshire NHS Trust (GL), Birmingham Science City Research Alliance (GL), a BBSRC pre-doctoral traineeship (KR), and the National Council on Science and Technology of Mexico (CONACYT) (MAE-F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian MK, 1998, GENETICS, V149, P1265; Batlle M, 2003, J CELL SCI, V116, P701, DOI 10.1242/jcs.00266; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; DAVEY J, 1992, EMBO J, V11, P951, DOI 10.1002/j.1460-2075.1992.tb05134.x; Davey J, 1998, YEAST, V14, P1529, DOI 10.1002/(SICI)1097-0061(199812)14:16<1529::AID-YEA357>3.0.CO;2-0; Davey J, 1995, METHODS MOL GENETICS; Didmon M, 2002, CURR GENET, V41, P241, DOI 10.1007/s00294-002-0301-3; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; EGEL R, 1994, YEAST, V10, P1347, DOI 10.1002/yea.320101012; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goddard A, 2006, FUNGAL GENET BIOL, V43, P840, DOI 10.1016/j.fgb.2006.06.005; HANNIG G, 1994, P NATL ACAD SCI USA, V91, P10084, DOI 10.1073/pnas.91.21.10084; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Hill C, 2009, CELL PHYSIOL BIOCHEM, V23, P1, DOI 10.1159/000204075; Hiskens R, 2005, BIOCHEM BIOPH RES CO, V337, P1038, DOI 10.1016/j.bbrc.2005.09.149; IMAI Y, 1992, MOL CELL BIOL, V12, P1827, DOI 10.1128/MCB.12.4.1827; Jeong HT, 2004, BIOSCI BIOTECH BIOCH, V68, P1621, DOI 10.1271/bbb.68.1621; JIN M, 1995, GENETICS, V140, P457; JOHNSON DR, 1994, J CELL BIOL, V127, P751, DOI 10.1083/jcb.127.3.751; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kim DU, 1996, MOL GEN GENET, V252, P20, DOI 10.1007/BF02173201; Kitamura K, 2001, DEV CELL, V1, P389, DOI 10.1016/S1534-5807(01)00037-5; Kjaerulff S, 2005, MOL CELL BIOL, V25, P2045, DOI 10.1128/MCB.25.5.2045-2059.2005; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; Ladds G, 1996, MOL MICROBIOL, V20, P35, DOI 10.1111/j.1365-2958.1996.tb02486.x; Ladds G, 2003, MOL MICROBIOL, V47, P781, DOI 10.1046/j.1365-2958.2003.03336.x; Ladds G, 2000, MOL MICROBIOL, V38, P839, DOI 10.1046/j.1365-2958.2000.02180.x; Ladds G, 2007, CELL SIGNAL, V19, P103, DOI 10.1016/j.cellsig.2006.05.027; Landry S, 2000, GENETICS, V154, P1463; Li P, 1996, CELL, V87, P869, DOI 10.1016/S0092-8674(00)81994-7; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MAEDA T, 1990, P NATL ACAD SCI USA, V87, P7814, DOI 10.1073/pnas.87.20.7814; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Mamidipudi V, 2007, BIOCHEM BIOPH RES CO, V352, P423, DOI 10.1016/j.bbrc.2006.11.034; Martin-Castellanos C, 1996, EMBO J, V15, P839, DOI 10.1002/j.1460-2075.1996.tb00419.x; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McLeod M, 2000, MOL CELL BIOL, V20, P4016, DOI 10.1128/MCB.20.11.4016-4027.2000; MORENO S, 1994, NATURE, V367, P236, DOI 10.1038/367236a0; MORENO S, 1994, J CELL SCI, P63; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Niranjan T, 2007, J BIOL CHEM, V282, P24231, DOI 10.1074/jbc.M702595200; Nunez A, 2010, J BIOL CHEM, V285, P41366, DOI 10.1074/jbc.M110.173815; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; Oowatari Y, 2011, CURR GENET, V57, P191, DOI 10.1007/s00294-011-0335-5; Paul SK, 2009, FEBS J, V276, P5076, DOI 10.1111/j.1742-4658.2009.07204.x; Peeters T, 2006, P NATL ACAD SCI USA, V103, P13034, DOI 10.1073/pnas.0509644103; Shor B, 2003, J BIOL CHEM, V278, P49119, DOI 10.1074/jbc.M303968200; Tsukahara K, 1998, MOL CELL BIOL, V18, P4488, DOI 10.1128/MCB.18.8.4488; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Watson P, 1999, MOL MICROBIOL, V33, P623, DOI 10.1046/j.1365-2958.1999.01510.x; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	57	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e65927	10.1371/journal.pone.0065927	http://dx.doi.org/10.1371/journal.pone.0065927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843946	Green Published, gold			2022-12-27	WOS:000321733000045
J	Samygina, VR; Sokolov, AV; Bourenkov, G; Petoukhov, MV; Pulina, MO; Zakharova, ET; Vasilyev, VB; Bartunik, H; Svergun, DI				Samygina, Valeriya R.; Sokolov, Alexey V.; Bourenkov, Gleb; Petoukhov, Maxim V.; Pulina, Maria O.; Zakharova, Elena T.; Vasilyev, Vadim B.; Bartunik, Hans; Svergun, Dmitri I.			Ceruloplasmin: Macromolecular Assemblies with Iron-Containing Acute Phase Proteins	PLOS ONE			English	Article							X-RAY-DIFFRACTION; HUMAN LACTOFERRIN; STRUCTURAL-CHARACTERIZATION; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; OXIDASE ACTIVITY; MYELOPEROXIDASE; BINDING; IDENTIFICATION; COMPLEX	Copper-containing ferroxidase ceruloplasmin (Cp) forms binary and ternary complexes with cationic proteins lactoferrin (Lf) and myeloperoxidase (Mpo) during inflammation. We present an X-ray crystal structure of a 2Cp-Mpo complex at 4.7 angstrom resolution. This structure allows one to identify major protein-protein interaction areas and provides an explanation for a competitive inhibition of Mpo by Cp and for the activation of p-phenylenediamine oxidation by Mpo. Small angle X-ray scattering was employed to construct low-resolution models of the Cp-Lf complex and, for the first time, of the ternary 2Cp-2Lf-Mpo complex in solution. The SAXS-based model of Cp-Lf supports the predicted 1:1 stoichiometry of the complex and demonstrates that both lobes of Lf contact domains 1 and 6 of Cp. The 2Cp-2Lf-Mpo SAXS model reveals the absence of interaction between Mpo and Lf in the ternary complex, so Cp can serve as a mediator of protein interactions in complex architecture. Mpo protects antioxidant properties of Cp by isolating its sensitive loop from proteases. The latter is important for incorporation of Fe3+ into Lf, which activates ferroxidase activity of Cp and precludes oxidation of Cp substrates. Our models provide the structural basis for possible regulatory role of these complexes in preventing iron-induced oxidative damage.	[Samygina, Valeriya R.] Russian Acad Sci, Inst Crystallog, Moscow, Russia; [Samygina, Valeriya R.] CICbioGUNE, Struct Biol Unit, Derio, Spain; [Sokolov, Alexey V.; Pulina, Maria O.; Zakharova, Elena T.; Vasilyev, Vadim B.] Inst Expt Med NWB RAMS, St Petersburg, Russia; [Bourenkov, Gleb; Petoukhov, Maxim V.; Svergun, Dmitri I.] EMBL Hamburg, Hamburg, Germany; [Bartunik, Hans] Max Planck Inst, Res Unit Struct Mol Biol, Hamburg, Germany	Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Institute of Experimental Medicine; European Molecular Biology Laboratory (EMBL); Max Planck Society	Samygina, VR (corresponding author), Russian Acad Sci, Inst Crystallog, Moscow, Russia.	vsamygina@cicbiogune.es; svergun@embl-hamburg.de	Zakharova, Elena T/E-3956-2014; Bourenkov, Gleb P/C-7794-2017; Vasilyev, Vadim/G-4297-2015; Petoukhov, Maxim V/R-7371-2016; Samygina, Valeriya R/A-9069-2014; Sokolov, Alexey V/G-4335-2015; Samygina, Valeriya/GQR-0852-2022	Zakharova, Elena T/0000-0003-4232-8824; Bourenkov, Gleb P/0000-0002-2617-5920; Petoukhov, Maxim V/0000-0001-6760-4595; Sokolov, Alexey V/0000-0001-9033-0537; Samygina, Valeriya/0000-0002-1528-5972; Svergun, Dmitri/0000-0003-0830-5696	RAS Presidium program; European Community's Seventh Framework Programme (FP7) [227764]; RAS Presidium program "Basic science for Medicine"; RFBR [12-04-00301, 13-04-01186, MK 1484.2012.4]; German Ministry of Education and Science ( BMBF) project BIOSCAT [05K20912]	RAS Presidium program(Russian Academy of Sciences); European Community's Seventh Framework Programme (FP7); RAS Presidium program "Basic science for Medicine"; RFBR(Russian Foundation for Basic Research (RFBR)); German Ministry of Education and Science ( BMBF) project BIOSCAT(Federal Ministry of Education & Research (BMBF))	The study was supported by RAS Presidium program. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 227764, supported by RAS Presidium program "Basic science for Medicine" and RFBR grant Nos. 12-04-00301, 13-04-01186, and MK 1484.2012.4 and performed within the Program of Russian-German scientific cooperation. DIS and MVP acknowledge support from the German Ministry of Education and Science ( BMBF) project BIOSCAT, contract 05K20912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento I, 2007, ACTA CRYSTALLOGR D, V63, P240, DOI 10.1107/S090744490604947X; Bielli P, 2001, J BIOL CHEM, V276, P2678, DOI 10.1074/jbc.M007176200; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Brock JH, 2002, BIOCHEM CELL BIOL, V80, P1, DOI 10.1139/o01-212; Brunger AT, 2005, STRUCTURE, V13, P171, DOI 10.1016/j.str.2005.01.002; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Griffin SV, 1999, KIDNEY INT, V55, P917, DOI 10.1046/j.1523-1755.1999.055003917.x; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Ha-Duong NT, 2010, BIOCHEMISTRY-US, V49, P10261, DOI 10.1021/bi1014503; Kim RH, 2000, FREE RADICAL RES, V33, P81, DOI 10.1080/10715760000300641; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KOKRYAKOV VN, 1990, VOP MED KHIM, V36, P13; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Maio N, 2010, J BIOL CHEM, V285, P20507, DOI 10.1074/jbc.M109.090027; Meyer-Siegler KL, 2006, J UROLOGY, V175, P1523, DOI 10.1016/S0022-5347(05)00650-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura M, 2006, DNA CELL BIOL, V25, P491, DOI 10.1089/dna.2006.25.491; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nozaki A, 2003, J BIOL CHEM, V278, P10162, DOI 10.1074/jbc.M207879200; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panasenko O. M., 2008, Biofizika, V53, P573; Park YS, 2000, FREE RADICAL RES, V33, P261, DOI 10.1080/10715760000301421; Park YS, 1999, FEBS LETT, V458, P133, DOI 10.1016/S0014-5793(99)01142-4; Patel BN, 2002, J NEUROSCI, V22, P6578; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Prokopowicz Z, 2012, ARCH IMMUNOL THER EX, V60, P43, DOI 10.1007/s00005-011-0156-8; Pulina MO, 2002, BIOCHEM CELL BIOL, V80, P35, DOI 10.1139/o01-206; Sabatucci A, 2007, J MOL BIOL, V371, P1038, DOI 10.1016/j.jmb.2007.05.089; Samygina VR, 2008, CRYSTALLOGR REP+, V53, P655, DOI 10.1134/S1063774508040172; Segelmark M, 1997, CLIN EXP IMMUNOL, V108, P167, DOI 10.1046/j.1365-2249.1997.d01-992.x; Senkovich O, 2007, J MOL BIOL, V370, P701, DOI 10.1016/j.jmb.2007.04.075; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Sokolov AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P872, DOI 10.1134/S0006297907080093; Sokolov AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P409, DOI 10.1134/S0006297907040074; Sokolov AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1225, DOI 10.1134/S0006297909110078; Sokolov AV, 2009, BIOMETALS, V22, P521, DOI 10.1007/s10534-009-9209-4; Sokolov AV, 2008, FREE RADICAL RES, V42, P989, DOI 10.1080/10715760802566574; Sokolov AV, 2012, BIOCHEM CELL BIOL, V90, P397, DOI [10.1139/O2012-004, 10.1139/o2012-004]; Sokolov AV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P160, DOI 10.1134/S0006297906020076; Stoj C, 2003, FEBS LETT, V554, P422, DOI 10.1016/S0014-5793(03)01218-3; Sun XL, 1999, ACTA CRYSTALLOGR D, V55, P403, DOI 10.1107/S0907444998011226; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tams JW, 1999, BIOCHEM J, V341, P271, DOI 10.1042/0264-6021:3410271; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Eden ME, 2000, ARCH BIOCHEM BIOPHYS, V381, P119, DOI 10.1006/abbi.2000.1952; vanBerkel PHC, 1996, BIOCHEM J, V319, P117, DOI 10.1042/bj3190117; vanDalen CJ, 1997, BIOCHEM J, V327, P487; VASIL'EV V B, 1988, Biokhimiya, V53, P2051; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WALKER FJ, 1990, J BIOL CHEM, V265, P1834; YOUNG SN, 1972, BIOCHEM J, V129, P273, DOI 10.1042/bj1290273; Zaitsev VN, 1999, J BIOL INORG CHEM, V4, P579, DOI 10.1007/s007750050380; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	59	66	70	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67145	10.1371/journal.pone.0067145	http://dx.doi.org/10.1371/journal.pone.0067145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843990	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000063
J	Titov, N; Dear, BF; Johnston, L; Lorian, C; Zou, J; Wootton, B; Spence, J; McEvoy, PM; Rapee, RM				Titov, Nickolai; Dear, Blake F.; Johnston, Luke; Lorian, Carolyn; Zou, Judy; Wootton, Bethany; Spence, Jay; McEvoy, Peter M.; Rapee, Ronald M.			Improving Adherence and Clinical Outcomes in Self-Guided Internet Treatment for Anxiety and Depression: Randomised Controlled Trial	PLOS ONE			English	Article							MENTAL-HEALTH; HELP INTERVENTIONS; SOCIAL PHOBIA; DISORDERS; PSYCHOTHERAPY; METAANALYSIS; PROGRAMS; EFFICACY	Background: Depression and anxiety are common, disabling and chronic. Self-guided internet-delivered treatments are popular, but few people complete them. New strategies are required to realise their potential. Aims: To evaluate the effect of automated emails on the effectiveness, safety, and acceptability of a new automated transdiagnostic self-guided internet-delivered treatment, the Wellbeing Course, for people with depression and anxiety. Method: A randomised controlled trial was conducted through the website: www.ecentreclinic.org. Two hundred and fifty seven people with elevated symptoms were randomly allocated to the 8 week course either with or without automated emails, or to a waitlist control group. Primary outcome measures were the Patient Health Questionnaire 9-Item (PHQ-9) and the Generalized Anxiety Disorder 7-Item (GAD-7). Results: Participants in the treatment groups had lower PHQ-9 and GAD-7 scores at post-treatment than controls. Automated emails increased rates of course completion (58% vs. 35%), and improved outcomes in a subsample with elevated symptoms. Conclusions: The new self-guided course was beneficial, and automated emails facilitated outcomes. Further attention to strategies that facilitate adherence, learning, and safety will help realise the potential of self-guided interventions.	[Titov, Nickolai; Dear, Blake F.; Johnston, Luke; Lorian, Carolyn; Zou, Judy; Wootton, Bethany; Spence, Jay; Rapee, Ronald M.] Macquarie Univ, Dept Psychol, Ctr Emot Hlth, Sydney, NSW 2109, Australia; [McEvoy, Peter M.] Univ Western Australia, Ctr Clin Intervent, Perth, WA 6009, Australia; [McEvoy, Peter M.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia	Macquarie University; University of Western Australia; University of Western Australia	Titov, N (corresponding author), Macquarie Univ, Dept Psychol, Ctr Emot Hlth, Sydney, NSW 2109, Australia.	nick.titov@mq.edu.au		Woottonb, Bethany/0000-0002-0751-8529; Titov, Nickolai/0000-0002-7268-729X; Wootton, Bethany/0000-0001-9036-0699; Rapee, Ronald/0000-0002-1724-1076; Dear, Blake/0000-0001-9324-3092; McEvoy, Peter/0000-0003-2924-6760	Australian National Health and Medical Research Council Project [630560]; Australian Government	Australian National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR)	This research was enabled by funding from the Australian National Health and Medical Research Council Project Grant No. #630560. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r NT and BFD are authors and developers of the Wellbeing Course, but derive no personal or financial benefit from it. NT, BFD, and RR have developed and operate a national telephone and online treatment service, the MindSpot Clinic (www.mindspot.org.au), for people with anxiety and depression, funded by the Australian Government. This service uses a version of the Wellbeing treatment course.	Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Bandura A., 1986, SOCIAL FDN THOUGHT A; Berger Thomas, 2011, Cognitive Behaviour Therapy, V40, P251, DOI 10.1080/16506073.2011.616531; Cavanagh K., 2010, OXFORD GUIDE LOW INT, P227, DOI DOI 10.1093/MED:PSYCH/9780199590117.003.0021; Chang CC, 2008, J HEALTH COMMUN, V13, P37, DOI 10.1080/10810730701807027; Christensen H, 2006, PSYCHOL MED, V36, P1737, DOI 10.1017/S0033291706008695; Christensen H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1194; Clark DM, 2009, BEHAV RES THER, V47, P910, DOI 10.1016/j.brat.2009.07.010; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Clarke G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.3.e14; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Dear BF, 2011, BEHAV RES THER, V49, P830, DOI 10.1016/j.brat.2011.09.007; Farvolden P, 2009, J TECHNOL HUMAN SERV, V27, P5, DOI 10.1080/15228830802458889; Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996; Gellatly J, 2007, PSYCHOL MED, V37, P1217, DOI 10.1017/S0033291707000062; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Hinyard LJ, 2007, HEALTH EDUC BEHAV, V34, P777, DOI 10.1177/1090198106291963; Johnston L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028079; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Klein B, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1918; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lewis C, 2012, BRIT J PSYCHIAT, V200, P15, DOI 10.1192/bjp.bp.110.084756; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; McEvoy PM, 2009, J COGN PSYCHOTHER, V23, P20, DOI 10.1891/0889-8391.23.1.20; Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151; Morgan AJ, 2012, BRIT J PSYCHIAT, V200, P412, DOI 10.1192/bjp.bp.111.101394; Richards DA, 2009, BRIT J CLIN PSYCHOL, V48, P377, DOI 10.1348/014466509X405178; Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Seeley-Wait Elizabeth, 2009, Prim Care Companion J Clin Psychiatry, V11, P231, DOI 10.4088/PCC.07m00576; Stein MB, 1999, PSYCHOSOM MED, V61, P359, DOI 10.1097/00006842-199905000-00016; Titov N, 2011, BEHAV RES THER, V49, P441, DOI 10.1016/j.brat.2011.03.007; Titov N, 2011, CURR OPIN PSYCHIATR, V24, P18, DOI 10.1097/YCO.0b013e32833ed18f; Titov N, 2010, AUST NZ J PSYCHIAT, V44, P938, DOI 10.3109/00048674.2010.493859; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010885; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P913, DOI 10.1080/00048670903179160; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P1030, DOI 10.1080/00048670802512107; van Dulmen S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-55; Wilson E.J., 1993, J ACAD MARKET SCI, V21, P101, DOI [10.1007/BF02894421, DOI 10.1007/BF02894421, https://doi.org/10.1007/BF02894421]	44	152	152	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e62873	10.1371/journal.pone.0062873	http://dx.doi.org/10.1371/journal.pone.0062873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23843932	Green Published, gold			2022-12-27	WOS:000321733000038
J	Eggert, M; Aichinger, E; Pfaffl, MW; Steinlein, OK; Pfob, M				Eggert, Marlene; Aichinger, Eric; Pfaffl, Michael W.; Steinlein, Ortrud K.; Pfob, Martina			Nicotinic Acetylcholine Receptor Subunits alpha 4 and alpha 5 Associated with Smoking Behaviour and Lung Cancer Are Regulated by Upstream Open Reading Frames	PLOS ONE			English	Article							MESSENGER-RNA; SUSCEPTIBILITY LOCUS; DEPENDENCE; TRANSLATION; CHRNA4; GENES; PROKARYOTES; EUKARYOTES; ADDICTION; TOBACCO	Nicotinic acetylcholine receptor subunits (nAChR) are associated with different aspects of smoking behaviour as well as with smoking related disorders. Several of these subunits have been found to be upregulated in smokers or differentially expressed in lung tumor cells. The mechanisms behind these observations are not known but assumed to be mainly post-transcriptional. Many post-transcriptional mechanisms are initiated by functionally relevant sequence motifs within untranslated gene regions, such as upstream open reading frames (uORFs). We performed a systematic search in all smoking-associated neuronal nAChR subunits and identified functionally relevant uORFs in CHRNA4 and CHRNA5. Luciferase experiments showed that these uORFs are able to significantly decrease protein expression. Our quantitative real-time PCR (qPCR) results strongly suggest that the observed effects originate at the translation rather than at the transcription level. Interestingly, the CHRNA4 uORF was only functionally relevant when expressed in the shorter isoform of this gene. Therefore, the data presented in this study strongly points towards an important role of uORFs within the 5'UTR of CHRNA4-isoform 1 and CHRNA5 as regulators of protein translation. Moreover, the shared uORF of CHRNA4-isoform 1/isoform 2 represents the first example of a sequence context-dependent uORF.	[Eggert, Marlene; Aichinger, Eric; Steinlein, Ortrud K.; Pfob, Martina] Univ Munich, Univ Hosp, Inst Human Genet, Munich, Germany; [Pfaffl, Michael W.] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany	University of Munich; Technical University of Munich	Eggert, M (corresponding author), Univ Munich, Univ Hosp, Inst Human Genet, Munich, Germany.	Marlene.Eggert@med.uni-muenchen.de	Pfaffl, Michael/G-6622-2013	Pfaffl, Michael/0000-0002-3192-1019; Eggert, Marlene/0000-0002-9113-9643	Deutsche Forschungsgemeinschaft [STE16511-2]; Friedrich-Baur-Stiftung [57/12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Baur-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft [STE16511-2] and the Friedrich-Baur-Stiftung [ No 57/12]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Briggs CA, 2006, MOL PHARMACOL, V70, P227, DOI 10.1124/mol.105.020198; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; De Biasi M, 2011, J ADDICT RES THER S, VS1; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Han SZ, 2011, AM J MED GENET B, V156B, P421, DOI 10.1002/ajmg.b.31177; Han SZ, 2010, BIOL PSYCHIAT, V67, P12, DOI 10.1016/j.biopsych.2009.08.028; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hutchison KE, 2007, ARCH GEN PSYCHIAT, V64, P1078, DOI 10.1001/archpsyc.64.9.1078; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Li MD, 2005, HUM MOL GENET, V14, P1211, DOI 10.1093/hmg/ddi132; Maouche K, 2009, AM J PATHOL, V175, P1868, DOI 10.2353/ajpath.2009.090212; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mize GJ, 1998, J BIOL CHEM, V273, P32500, DOI 10.1074/jbc.273.49.32500; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sachs MS, 2006, GENE DEV, V20, P915, DOI 10.1101/gad.1427006; Steinlein OK, 2012, CHEM REV; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Tournier JM, 2011, CURR OPIN ONCOL, V23, P83, DOI 10.1097/CCO.0b013e3283412ea1; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Zeiger JS, 2008, HUM MOL GENET, V17, P724, DOI 10.1093/hmg/ddm344	27	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66157	10.1371/journal.pone.0066157	http://dx.doi.org/10.1371/journal.pone.0066157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843950	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000011
J	Rapanoel, HA; Mazandu, GK; Mulder, NJ				Rapanoel, Holifidy A.; Mazandu, Gaston K.; Mulder, Nicola J.			Predicting and Analyzing Interactions between Mycobacterium tuberculosis and Its Human Host	PLOS ONE			English	Article							GENE ONTOLOGY; IN-VITRO; PROTEIN; IDENTIFICATION; BINDING; TOOL	The outcome of infection by Mycobacterium tuberculosis (Mtb) depends greatly on how the host responds to the bacteria and how the bacteria manipulates the host, which is facilitated by protein-protein interactions. Thus, to understand this process, there is a need for elucidating protein interactions between human and Mtb, which may enable us to characterize specific molecular mechanisms allowing the bacteria to persist and survive under different environmental conditions. In this work, we used the interologs method based on experimentally verified intra-species and inter-species interactions to predict human-Mtb functional interactions. These interactions were further filtered using known human-Mtb interactions and genes that are differentially expressed during infection, producing 190 interactions. Further analysis of the subcellular location of proteins involved in these human-Mtb interactions confirms feasibility of these interactions. We also conducted functional analysis of human and Mtb proteins involved in these interactions, checking whether these proteins play a role in infection and/or disease, and enriching Mtb proteins in a previously predicted list of drug targets. We found that the biological processes of the human interacting proteins suggested their involvement in apoptosis and production of nitric oxide, whereas those of the Mtb interacting proteins were relevant to the intracellular environment of Mtb in the host. Mapping these proteins onto KEGG pathways highlighted proteins belonging to the tuberculosis pathway and also suggested that Mtb proteins might use the host to acquire nutrients, which is in agreement with the intracellular lifestyle of Mtb. This indicates that these interactions can shed light on the interplay between Mtb and its human host and thus, contribute to the process of designing novel drugs with new biological mechanisms of action.	[Rapanoel, Holifidy A.; Mazandu, Gaston K.; Mulder, Nicola J.] Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Cape Town	Mulder, NJ (corresponding author), Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Nicola.Mulder@uct.ac.za	Mazandu, Gaston/AAH-6401-2019	Mazandu, Gaston/0000-0002-6441-8006; Mulder, Nicola J/0000-0003-4905-0941	National Research Foundation (NRF); Claude Leon Foundation	National Research Foundation (NRF); Claude Leon Foundation	This work has been supported by the National Research Foundation (NRF) and the Claude Leon Foundation Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Chen L, 2011, AFR J MICROBIOL RES, V5, P394; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Forst CV, 2006, DRUG DISCOV TODAY, V11, P220, DOI 10.1016/S1359-6446(05)03735-9; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kumar R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S16; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Luo MK, 2005, NAT CHEM BIOL, V1, P149, DOI 10.1038/nchembio717; Mazandu GK, 2012, INT J MOL SCI, V13, P7283, DOI 10.3390/ijms13067283; Mazandu Gaston K., 2011, Advances in Bioinformatics, V2011, P801478, DOI 10.1155/2011/801478; Mazandu GK, 2012, INFECT GENET EVOL, V12, P922, DOI 10.1016/j.meegid.2011.10.027; Mazandu GK, 2011, INFECT GENET EVOL, V11, P725, DOI 10.1016/j.meegid.2011.04.012; Mazandu GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018607; Mazandu GK, 2012, TUBERCULOSIS RISK FA; Mustafa AS, 2009, EXPERT REV VACCINES, V8, P1309, DOI [10.1586/erv.09.93, 10.1586/ERV.09.93]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Pruess Manuela, 2005, In Silico Biology, V5, P179; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; Song CH, 2003, J CLIN IMMUNOL, V23, P194, DOI 10.1023/A:1023309928879; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Takahashi K, 2004, BIOCHEM BIOPH RES CO, V325, P203, DOI 10.1016/j.bbrc.2004.10.021; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	39	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67472	10.1371/journal.pone.0067472	http://dx.doi.org/10.1371/journal.pone.0067472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844013	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000047
J	Wang, SJ; Zhou, CG; Fu, XL				Wang, Su-Jing; Zhou, Chun-Guang; Fu, Xiaolan			Fusion Tensor Subspace Transformation Framework	PLOS ONE			English	Article							DISCRIMINANT-ANALYSIS; COMPONENT ANALYSIS; EIGENFACES; PCA	Tensor subspace transformation, a commonly used subspace transformation technique, has gained more and more popularity over the past few years because many objects in the real world can be naturally represented as multidimensional arrays, i.e. tensors. For example, a RGB facial image can be represented as a three-dimensional array (or 3rd-order tensor). The first two dimensionalities (or modes) represent the facial spatial information and the third dimensionality (or mode) represents the color space information. Each mode of the tensor may express a different semantic meaning. Thus different transformation strategies should be applied to different modes of the tensor according to their semantic meanings to obtain the best performance. To the best of our knowledge, there are no existing tensor subspace transformation algorithm which implements different transformation strategies on different modes of a tensor accordingly. In this paper, we propose a fusion tensor subspace transformation framework, a novel idea where different transformation strategies are implemented on separate modes of a tensor. Under the framework, we propose the Fusion Tensor Color Space (FTCS) model for face recognition.	[Wang, Su-Jing; Fu, Xiaolan] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Wang, Su-Jing; Zhou, Chun-Guang] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China; [Wang, Su-Jing] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Jilin, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Jilin University; Jilin University	Wang, SJ (corresponding author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	wangsujing@psych.cn.cn		Wang, Su-Jing/0000-0002-8774-6328	973 Program [2011CB302201]; National Natural Science Foundation of China [61075042, 61175023]; China Postdoctoral Science Foundation [2012M520428]; Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University [93K172013K04]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University	This work was supported in part by grants from 973 Program (2011CB302201), the National Natural Science Foundation of China (61075042, 61175023), China Postdoctoral Science Foundation funded project (2012M520428) and the open project program (93K172013K04) of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education, Jilin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Tao DC, 2007, KNOWL INF SYST, V13, P1, DOI 10.1007/s10115-006-0050-6; Fukunaga K., 2013, INTRO STAT PATTERN R; He X, 2005, ADV NEURAL INF PROCE, P18; He XF, 2004, ADV NEUR IN, V16, P153; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Liu CJ, 2008, IEEE T INF FOREN SEC, V3, P213, DOI 10.1109/TIFS.2008.923824; Lu HP, 2008, IEEE T NEURAL NETWOR, V19, P18, DOI 10.1109/TNN.2007.901277; Lu HP, 2011, PATTERN RECOGN, V44, P1540, DOI 10.1016/j.patcog.2011.01.004; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Song FX, 2007, IEEE T SYST MAN CY B, V37, P1599, DOI 10.1109/TSMCB.2007.906579; Sun J., 2008, ACM T KNOWL DISCOV D, V2, P1, DOI [10.1145/1409620.1409621, DOI 10.1145/1409620.1409621]; Tao DC, 2008, IEEE T CIRC SYST VID, V18, P1397, DOI 10.1109/TCSVT.2008.2002825; Tao DC, 2008, NEUROCOMPUTING, V71, P1866, DOI 10.1016/j.neucom.2007.08.036; Tao DC, 2007, IEEE T PATTERN ANAL, V29, P1700, DOI 10.1109/TPAMI.2007.1096; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wang SJ, 2012, IEEE T NEUR NET LEAR, V23, P876, DOI 10.1109/TNNLS.2012.2191620; Wang SJ, 2011, NEUROCOMPUTING, V74, P2142, DOI 10.1016/j.neucom.2011.01.024; Wang SJ, 2011, IEEE T IMAGE PROCESS, V20, P2490, DOI 10.1109/TIP.2011.2121084; Wang XG, 2004, IEEE T PATTERN ANAL, V26, P1222, DOI 10.1109/TPAMI.2004.57; Yan S, 2005, CVPR 2005, P11; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yang J, 2008, IEEE T NEURAL NETWOR, V19, P2088, DOI 10.1109/TNN.2008.2003187; Ye J., 2004, P ADV NEUR INF PROC, P1569; Yu WW, 2006, IMAGE VISION COMPUT, V24, P239, DOI 10.1016/j.imavis.2005.11.006; Zhang LF, 2011, IEEE GEOSCI REMOTE S, V8, P374, DOI 10.1109/LGRS.2010.2077272	27	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e66647	10.1371/journal.pone.0066647	http://dx.doi.org/10.1371/journal.pone.0066647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840864	gold, Green Published, Green Submitted			2022-12-27	WOS:000321271900003
J	Cross, BM; Hack, A; Reinhardt, TA; Rao, R				Cross, Brandie M.; Hack, Anniesha; Reinhardt, Timothy A.; Rao, Rajini			SPCA2 Regulates Orai1 Trafficking and Store Independent Ca2+ Entry in a Model of Lactation	PLOS ONE			English	Article							MAMMARY-GLAND; CALCIUM-TRANSPORT; PLASMA-MEMBRANE; EXPRESSION; CELLS; LOCALIZATION; CA2+-ATPASES; TISSUE; TUMORS; MILK	An unconventional interaction between SPCA2, an isoform of the Golgi secretory pathway Ca2+-ATPase, and the Ca2+ influx channel Orai1, has previously been shown to contribute to elevated Ca2+ influx in breast cancer derived cells. In order to investigate the physiological role of this interaction, we examined expression and localization of SPCA2 and Orai1 in mouse lactating mammary glands. We observed co-induction and co-immunoprecipitation of both proteins, and isoform-specific differences in the localization of SPCA1 and SPCA2. Three-dimensional cultures of normal mouse mammary epithelial cells were established using lactogenic hormones and basement membrane. The mammospheres displayed elevated Ca2+ influx by store independent mechanisms, consistent with upregulation of both SPCA2 and Orai1. Knockdown of either SPCA2 or Orai1 severely depleted Ca2+ influx and interfered with mammosphere differentiation. We show that SPCA2 is required for plasma membrane trafficking of Orai1 in mouse mammary epithelial cells and that this function can be replaced, at least in part, by a membrane-anchored C-terminal domain of SPCA2. These findings clearly show that SPCA2 and Orai1 function together to regulate Store-independent Ca2+ entry (SICE), which mediates the massive basolateral Ca2+ influx into mammary epithelia to support the large calcium transport requirements for milk secretion.	[Cross, Brandie M.; Hack, Anniesha; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Reinhardt, Timothy A.] ARS, USDA, Natl Anim Dis Ctr, Ames, IA USA	Johns Hopkins University; United States Department of Agriculture (USDA)	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rrao@jhmi.edu	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509	National Institutes of Health [GM62142]; United States Department of Agriculture Agricultural Research Service intramural funding CRIS [3625-32000-102-00D]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062142, T32GM008752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Agricultural Research Service intramural funding CRIS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health GM62142 (to RR) and United States Department of Agriculture Agricultural Research Service intramural funding CRIS 3625-32000-102-00D to (TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantamongkol U, 2009, NAT CELL BIOL INT, V34, P67; Anantamongkol U, 2007, BIOCHEM BIOPH RES CO, V352, P537, DOI 10.1016/j.bbrc.2006.11.055; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Garside VC, 2010, EXP CELL RES, V316, P2859, DOI 10.1016/j.yexcr.2010.06.014; Hong JH, 2011, TRAFFIC, V12, P232, DOI 10.1111/j.1600-0854.2010.01138.x; Ji J, 2011, AM J PHYSIOL-ENDOC M, V301, pE889, DOI 10.1152/ajpendo.00173.2011; Lur G, 2011, BIOCHEM J, V436, P231, DOI 10.1042/BJ20110083; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Neville MC, 2005, J MAMMARY GLAND BIOL, V10, P119, DOI 10.1007/s10911-005-5395-z; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Putney JW, 2011, NEUROCHEM RES, V36, P1157, DOI 10.1007/s11064-010-0383-0; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Reinhardt TA, 1999, AM J PHYSIOL-CELL PH, V276, pC796, DOI 10.1152/ajpcell.1999.276.4.C796; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; VanHouten JN, 2007, J MAMMARY GLAND BIOL, V12, P223, DOI 10.1007/s10911-007-9057-1; Vanoevelen J, 2005, J BIOL CHEM, V280, P22800, DOI 10.1074/jbc.M501026200; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200	22	53	55	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67348	10.1371/journal.pone.0067348	http://dx.doi.org/10.1371/journal.pone.0067348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840669	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400060
J	Martiny, K; Refsgaard, E; Lund, V; Lunde, M; Sorensen, L; Thougaard, B; Lindberg, L; Bech, P				Martiny, Klaus; Refsgaard, Else; Lund, Vibeke; Lunde, Marianne; Sorensen, Lene; Thougaard, Britta; Lindberg, Lone; Bech, Per			The Day-to-Day Acute Effect of Wake Therapy in Patients with Major Depression Using the HAM-D-6 as Primary Outcome Measure: Results from a Randomised Controlled Trial	PLOS ONE			English	Article							TOTAL SLEEP-DEPRIVATION; LIGHT THERAPY; BIPOLAR DEPRESSION; MOOD	Background: This paper reports day-to-day data for from a one-week intervention phase, part of a 9-weeks randomised parallel study with patient having major depression (data from weekly visits have been reported). Wake therapy (sleep deprivation) has an established antidepressant effect with onset of action within hours. Deterioration on the following night's sleep is, however, common, and we used daily light therapy and sleep time stabilisation as a preventive measure. In particular, we evaluated the day-to-day acute effect of and tolerance to sleep deprivation and examined predictors of response. Methods: Patients were assessed at psychiatric inpatient wards. In the wake group (n = 36), patients did three wake therapies in combination with light therapy each morning together with sleep time stabilisation. In the exercise group (n = 38), patients did daily exercise. Hamilton subscale scores were primary outcome (not blinded), secondary outcome was self-assessment data from the Preskorn scale and sleep. Results: Patients in the wake therapy group had an immediate, large, stable, and statistically significant better antidepressant effect than patients in the exercise group with response rates at day5 of 75.0%/25.1% and remission rates of 58.6%/6.0%, respectively. The response and remission rates were diminished at day8 with response rates of 41.9%/10.1% and remission rates of 19.4%/4.7%, respectively. Patients and ward personnel found the method applicable with few side effects. Positive diurnal variation (mood better in the evening) predicted a larger response to wake therapy. In the wake group napping on days after intervention predicted greater deterioration on day8. Conclusions: The intervention induced an acute antidepressant response without relapse between wake nights but with a diminishing effect after intervention. Development is still needed to secure maintenance of response. Avoiding napping in the days after wake therapy is important.	[Martiny, Klaus] Copenhagen Univ Hosp, Rigshosp, Psychiat Ctr Copenhagen, Copenhagen, Denmark; [Refsgaard, Else; Lund, Vibeke; Lunde, Marianne; Sorensen, Lene; Lindberg, Lone; Bech, Per] Copenhagen Univ Hosp, Mental Hlth Ctr North Zealand, Psychiat Res Unit, Copenhagen, Denmark; [Thougaard, Britta] Copenhagen Univ Hosp, Bispebjerg, Child & Adolescent Psychiat Ctr, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Martiny, K (corresponding author), Copenhagen Univ Hosp, Rigshosp, Psychiat Ctr Copenhagen, Copenhagen, Denmark.	klaus.martiny@regionh.dk	Martiny, Klaus/M-2567-2015	Martiny, Klaus/0000-0002-7317-5958; Bech, Per/0000-0002-4948-6115	Eli Lilly, Copenhagen Denmark; Danish Agency for Science, Technology and Innovation, Denmark; Danish Medical Research Council, Eastern Region Research Foundation; Olga Bryde Nielsen Foundation, Denmark; Frederiksborg General Hospital Research Grant, Denmark; AstraZeneca, Copenhagen, Denmark	Eli Lilly, Copenhagen Denmark; Danish Agency for Science, Technology and Innovation, Denmark; Danish Medical Research Council, Eastern Region Research Foundation; Olga Bryde Nielsen Foundation, Denmark; Frederiksborg General Hospital Research Grant, Denmark; AstraZeneca, Copenhagen, Denmark(AstraZeneca)	The authors acknowledge financial support and the receipt of duloxetine from Eli Lilly, Copenhagen Denmark (https://www.eli-lilly.dk/); The Danish Agency for Science, Technology and Innovation, Denmark (http://www.fi.dk/); The Danish Medical Research Council, Eastern Region Research Foundation (no website); The Olga Bryde Nielsen Foundation, Denmark (http://www.hillerodhospital.dk); and The Frederiksborg General Hospital Research Grant, Denmark (http://www.hillerodhospital.dk/topmenu/Kontakt/). AstraZeneca, Copenhagen, Denmark provided funding for a travel grant (http://www.astrazeneca.dk/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CLIN PSYCHOMETRICS; BECH P, 1986, ACTA PSYCHIAT SCAND, V73, P1; BECH P, 1981, ACTA PSYCHIAT SCAND, V63, P290, DOI 10.1111/j.1600-0447.1981.tb00676.x; Bech P, 2005, KOMPENDIUM RATING SC; Bech P, 2012, ACTA PSYCHIAT SCAND, V125, P423, DOI 10.1111/j.1600-0447.2011.01817.x; Boivin DB, 1997, ARCH GEN PSYCHIAT, V54, P145; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brown H., 1999, APPL MIXED MODELS ME; Colombo C, 2000, PSYCHIAT RES, V95, P43, DOI 10.1016/S0165-1781(00)00164-5; EMEA, 1997, CPMPICH13595 EMEA; Giedke H, 2002, SLEEP MED REV, V6, P361, DOI 10.1053/smrv.2002.0235; Glenville M, 1978, Adv Biosci, V21, P235; GORDIJN MCM, 1994, J AFFECT DISORDERS, V31, P261, DOI 10.1016/0165-0327(94)90102-3; Hedges LV, 1985, STAT METHODS METAANA, P78; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Kreuzer PM, 2012, BRAIN STIMUL, V5, P141, DOI 10.1016/j.brs.2011.02.005; Kryger, 2010, PRINCIPLES PRACTICE, P1682; KUHS H, 1991, BIOL PSYCHIAT, V29, P1129, DOI 10.1016/0006-3223(91)90255-K; MacLean, 1992, J Sleep Res, V1, P35; Martiny K, 2012, J CLIN PSYCHIAT, V73, P1234, DOI 10.4088/JCP.11m07625; Neumeister A, 1996, BIOL PSYCHIAT, V39, P16, DOI 10.1016/0006-3223(95)00086-0; OSullivan RL, 1997, ACTA PSYCHIAT SCAND, V95, P379, DOI 10.1111/j.1600-0447.1997.tb09649.x; RIEMANN D, 1993, PSYCHIAT RES, V49, P109, DOI 10.1016/0165-1781(93)90099-3; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Smeraldi E, 1999, NEUROPSYCHOPHARMACOL, V20, P380, DOI 10.1016/S0893-133X(98)00129-8; Voderholzer U, 2003, EUR ARCH PSY CLIN N, V253, P68, DOI 10.1007/s00406-003-0408-7; Wirz-Justice A, 2005, PSYCHOL MED, V35, P939, DOI 10.1017/S003329170500437X; Wirz-Justice A, 1999, BIOL PSYCHIAT, V46, P445, DOI 10.1016/S0006-3223(99)00125-0; Wirz-Justice A, 2009, CHRONOTHERAPEUTICS A; Wirz-Justice A, 2012, HAND CLINIC, V106, P697, DOI 10.1016/B978-0-444-52002-9.00042-5; Wirz-Justice Anna, 2008, Dialogues Clin Neurosci, V10, P337; WU JC, 1990, AM J PSYCHIAT, V147, P14; Wu JC, 2009, BIOL PSYCHIAT, V66, P298, DOI 10.1016/j.biopsych.2009.02.018	33	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67264	10.1371/journal.pone.0067264	http://dx.doi.org/10.1371/journal.pone.0067264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840645	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400051
J	Tanner, RA; Varia, S; Eschen, R; Wood, S; Murphy, ST; Gange, AC				Tanner, Robert A.; Varia, Sonal; Eschen, Rene; Wood, Suzy; Murphy, Sean T.; Gange, Alan C.			Impacts of an Invasive Non-Native Annual Weed, Impatiens glandulifera, on Above- and Below-Ground Invertebrate Communities in the United Kingdom	PLOS ONE			English	Article							PRINCIPAL RESPONSE CURVES; DIFFERENT TROPHIC LEVELS; SALIX X RUBENS; ARTHROPOD ABUNDANCE; PLANT; ASSEMBLAGES; DIVERSITY; VEGETATION; HERBIVORES; HABITATS	Vegetation community composition and the above-and below-ground invertebrate communities are linked intrinsically, though few studies have assessed the impact of non-native plants on both these parts of the community together. We evaluated the differences in the above- (foliage- and ground-dwelling) and below-ground invertebrate communities in nine uninvaded plots and nine plots invaded by the annual invasive species Impatiens glandulifera, in the UK during 2007 and 2008. Over 139,000 invertebrates were identified into distinct taxa and categorised into functional feeding groups. The impact of I. glandulifera on the vegetation and invertebrate community composition was evaluated using multivariate statistics including principal response curves (PRC) and redundancy analysis (RDA). In the foliage-dwelling community, all functional feeding groups were less abundant in the invaded plots, and the species richness of Coleoptera and Heteroptera was significantly reduced. In the ground-dwelling community, herbivores, detritivores, and predators were all significantly less abundant in the invaded plots. In contrast, these functional groups in the below-ground community appeared to be largely unaffected, and even positively associated with the presence of I. glandulifera. Although the cover of I. glandulifera decreased in the invaded plots in the second year of the study, only the below-ground invertebrate community showed a significant response. These results indicate that the above-and below-ground invertebrate communities respond differently to the presence of I. glandulifera, and these community shifts can potentially lead to a habitat less biologically diverse than surrounding native communities; which could have negative impacts on higher trophic levels and ecosystem functioning.	[Tanner, Robert A.; Varia, Sonal; Wood, Suzy; Murphy, Sean T.] CABI, Egham, Surrey, England; [Eschen, Rene] CABI, Delemont, Switzerland; [Gange, Alan C.] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England	University of London; Royal Holloway University London	Tanner, RA (corresponding author), CABI, Egham, Surrey, England.	r.tanner@cabi.org		Varia, Sonal/0000-0001-7244-9286	Royal Entomological Society, United Kingdom	Royal Entomological Society, United Kingdom	This study was supported by the Royal Entomological Society, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Beerling David J., 1993, Entomologist, V112, P127; BEERLING DJ, 1993, J ECOL, V81, P367, DOI 10.2307/2261507; Belnap J, 2001, ECOL APPL, V11, P1261; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Brook AJ, 2008, J APPL ECOL, V45, P1357, DOI 10.1111/j.1365-2664.2008.01530.x; Brown VK, 1990, ADV ECOL RES; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Castano-Meneses Gabriela, 2004, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V75, P135; Clewley GD, 2012, J APPL ECOL, V49, P1287, DOI 10.1111/j.1365-2664.2012.02209.x; Cockel CP, 2011, HDB GLOBAL FRESHWAER, P67; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; de Groot M, 2007, BIOL CONSERV, V136, P612, DOI 10.1016/j.biocon.2007.01.005; Eisenhauer N, 2011, J ECOL, V99, P572, DOI 10.1111/j.1365-2745.2010.01783.x; Environment Agency, 2010, OUR RIV HAB STAT RIV; Eschen R, 2012, AGR ECOSYST ENVIRON, V151, P53, DOI 10.1016/j.agee.2012.01.017; Eviner VT, 2008, RESTOR ECOL, V16, P713, DOI 10.1111/j.1526-100X.2008.00482.x; Gerber E, 2008, BIOL CONSERV, V141, P646, DOI 10.1016/j.biocon.2007.12.009; Greenwood H, 2004, DIVERS DISTRIB, V10, P485, DOI 10.1111/j.1366-9516.2004.00104.x; Hejda M, 2006, BIOL CONSERV, V132, P143, DOI 10.1016/j.biocon.2006.03.025; Hejda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039571; Herrera AM, 2003, BIOL INVASIONS, V5, P167, DOI 10.1023/A:1026190115521; Holland-Clift S, 2011, AUSTRAL ECOL, V36, P511, DOI 10.1111/j.1442-9993.2010.02178.x; Hulme PE, 2006, J APPL ECOL, V43, P43, DOI 10.1111/j.1365-2664.2005.01102.x; Hulme PE, 2013, TRENDS ECOL EVOL, V28, P212, DOI 10.1016/j.tree.2012.10.010; Kappes H, 2007, ECOSYSTEMS, V10, P734, DOI 10.1007/s10021-007-9052-9; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Kasperek G., 2004, NEOBIOTA, V3, P27; Kettenring KM, 2011, J APPL ECOL, V48, P970, DOI 10.1111/j.1365-2664.2011.01979.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Masters GJ, 2004, ECOL STU AN, V173, P93; Maule H., 2000, Aspects of Applied Biology, P31; Moser T, 2007, ECOTOXICOLOGY, V16, P573, DOI 10.1007/s10646-007-0169-6; Murrell C, 2011, AM J BOT, V98, P38, DOI 10.3732/ajb.1000135; Neet Cornelis R., 1996, Revue Suisse de Zoologie Volume Hors Serie, V2, P501; Oksanen J., 2016, R PACKAG; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Perner J, 2005, ECOGRAPHY, V28, P429, DOI 10.1111/j.0906-7590.2005.04119.x; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; R Development Core Team, 2011, R LANG ENV STAT COMP; Rudd K., 2009, THESIS U NOTRE DAME; Scheiman DM, 2003, J WILDLIFE MANAGE, V67, P115, DOI 10.2307/3803067; Scherber C, 2010, OECOLOGIA, V163, P707, DOI 10.1007/s00442-010-1625-1; Schmidt MH, 2005, AGR ECOSYST ENVIRON, V105, P235, DOI 10.1016/j.agee.2004.03.009; Sheppard AW, 2006, WEED RES, V46, P93, DOI 10.1111/j.1365-3180.2006.00497.x; Skorka P, 2010, BIOL CONSERV, V143, P856, DOI 10.1016/j.biocon.2009.12.030; St John MG, 2006, ECOLOGY, V87, P1314, DOI 10.1890/0012-9658(2006)87[1314:ASMASB]2.0.CO;2; STEWART AJA, 1995, ECOL ENTOMOL, V20, P98, DOI 10.1111/j.1365-2311.1995.tb00434.x; Stiling P, 2005, OECOLOGIA, V142, P413, DOI 10.1007/s00442-004-1739-4; Talley TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042460; Tanner RA, 2013, PLANT ECOL, V214, P423, DOI 10.1007/s11258-013-0179-9; Tickner DP, 2001, PLANT INVASIONS: SPECIES ECOLOGY AND ECOSYSTEM MANAGEMENT, P159; Topp W, 2008, BIOL INVASIONS, V10, P381, DOI 10.1007/s10530-007-9137-6; van den Brink PJ, 2009, ENVIRON MONIT ASSESS, V152, P271, DOI 10.1007/s10661-008-0314-6; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; van Ruijven J, 2005, ECOL LETT, V8, P30, DOI 10.1111/j.1461-0248.2004.00688.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2	63	53	55	6	167	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67271	10.1371/journal.pone.0067271	http://dx.doi.org/10.1371/journal.pone.0067271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840648	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400053
J	Alisi, A; Ceccarelli, S; Panera, N; Prono, F; Petrini, S; De Stefanis, C; Pezzullo, M; Tozzi, A; Villani, A; Bedogni, G; Nobili, V				Alisi, Anna; Ceccarelli, Sara; Panera, Nadia; Prono, Federica; Petrini, Stefania; De Stefanis, Cristiano; Pezzullo, Marco; Tozzi, Alberto; Villani, Alberto; Bedogni, Giorgio; Nobili, Valerio			Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							METABOLIC SYNDROME; KLOTHO EXPRESSION; OBESITY; CHILDREN; FGF21; AUTOPHAGY; FIBROSIS	Atypical fibroblast growth factors (FGF) 21 and 19 play a central role in energy metabolism through the mediation of Klotho coreceptor. Contradictory findings are available about the association of FGF21 and FGF19 with nonalcoholic fatty liver disease (NAFLD) in humans. We investigated the association of serum FGF21, FGF19 and liver Klotho coreceptor with nonalcoholic steatohepatitis (NASH) and fibrosis in children with NAFLD. Serum FGF21 and FGF19 were measured in 84 children with biopsy-proven NAFLD and 23 controls (CTRL). The hepatic expression of Klotho coreceptor was measured in 7 CTRL, 9 patients with NASH (NASH+) and 11 patients without NASH (NASH-). FGF21 and FGF19 showed a tendency to decrease from CTRL (median FGF21 = 196 pg/mL; median FGF19 = 201 pg/mL) to NASH- (FGF21 = 89 pg/mL; FGF19 = 81 pg/mL) to NASH+ patients (FGF21 = 54 pg/mL; FGF19 = 41 pg/mL) (p<0.001 for all comparisons) and were inversely associated with the probability of NASH and fibrosis in children with NAFLD. The hepatic expression of Klotho coreceptor was inversely associated with NASH (R-2 = 0.87, p<0.0001) and directly associated with serum FGF21 (R-2 = 0.57, p<0.0001) and FGF19 (R-2 = 0.67, p<0.0001). In conclusion, serum FGF19 and FGF21 and hepatic Klotho expression are inversely associated with hepatic damage in children with NAFLD and these findings may have important implications for understanding the mechanisms of NAFLD progression.	[Alisi, Anna; Ceccarelli, Sara; Panera, Nadia; Prono, Federica; De Stefanis, Cristiano; Nobili, Valerio] IRCCS, Bambino Gesu Childrens Hosp, Hepatometab Dis Unit, Rome, Italy; [Alisi, Anna; Ceccarelli, Sara; Panera, Nadia; Prono, Federica; De Stefanis, Cristiano; Nobili, Valerio] IRCCS, Bambino Gesu Childrens Hosp, Liver Res Unit, Rome, Italy; [Petrini, Stefania] IRCCS, Bambino Gesu Childrens Hosp, Microscopy Unit, Rome, Italy; [Pezzullo, Marco] IRCCS, Bambino Gesu Childrens Hosp, Core Facil, Rome, Italy; [Tozzi, Alberto] IRCCS, Bambino Gesu Childrens Hosp, Epidemiol Unit, Rome, Italy; [Villani, Alberto] IRCCS, Bambino Gesu Childrens Hosp, Pediat & Infect Dis Unit, Rome, Italy; [Bedogni, Giorgio] Liver Res Ctr, Clin Epidemiol Unit, Trieste, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Alisi, A (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Hepatometab Dis Unit, Rome, Italy.	anna.alisi@opbg.net	Bedogni, Giorgio/K-1911-2018; De Stefanis, Cristiano/K-8592-2018; Pezzullo, Marco/AAI-2404-2019; Nobili, Valerio/K-8670-2018; Petrini, Stefania/I-1464-2018; Ceccarelli, Sara/X-5822-2019; Tozzi, Alberto Eugenio/F-9494-2012; De Stefanis, Cristiano/AAA-1524-2020; panera, nadia/I-2087-2018; Villani, Alberto/K-9844-2018; Alisi, Anna/A-6469-2010	Bedogni, Giorgio/0000-0002-1495-9306; De Stefanis, Cristiano/0000-0001-5898-9518; Petrini, Stefania/0000-0002-3249-0003; Ceccarelli, Sara/0000-0001-6313-3247; Tozzi, Alberto Eugenio/0000-0002-6884-984X; De Stefanis, Cristiano/0000-0001-5898-9518; panera, nadia/0000-0002-5365-3123; Alisi, Anna/0000-0001-7241-6329; nobili, valerio/0000-0002-4570-3979	Bambino Gesu Children's Hospital and Research Institute; Associazione Italiana Ricerca sul Cancro (AIRC)	Bambino Gesu Children's Hospital and Research Institute; Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	V. Nobili was supported by a research grant from Bambino Gesu Children's Hospital and Research Institute. A. Alisi was supported by a research grant (MFAG) from Associazione Italiana Ricerca sul Cancro (AIRC). The authors also thank Nicolo Valenti Onlus (Italy) for generous donation of Envision plate reader (Perkin Elmer, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Alisi A, 2012, ANN MED, V44, P29, DOI 10.3109/07853890.2010.547869; Alisi A, 2010, CURR OPIN CLIN NUTR, V13, P397, DOI 10.1097/MCO.0b013e32833aae84; Alisi A, 2009, J PEDIATR-US, V155, P469, DOI 10.1016/j.jpeds.2009.06.014; Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Barutcuoglu B, 2011, ANN CLIN LAB SCI, V41, P390; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Cacciari E, 2002, EUR J CLIN NUTR, V56, P171, DOI 10.1038/sj.ejcn.1601314; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053949; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Diaz-Delfin J, 2012, ENDOCRINOLOGY, V153, P4238, DOI 10.1210/en.2012-1193; Eren F, 2012, CLIN BIOCHEM, V45, P655, DOI 10.1016/j.clinbiochem.2012.03.019; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Huang CL, 2012, ADV EXP MED BIOL, V728, P100, DOI 10.1007/978-1-4614-0887-1_7; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Jones SA, 2012, ADV EXP MED BIOL, V728, P171, DOI 10.1007/978-1-4614-0887-1_11; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Latasa MU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052711; Lohman TG, 1988, ANTHROPOMETRIC STAND, P55; LONG JS, 2008, REGRESSION MODELS CA; Manco M, 2008, GUT, V57, P1283, DOI 10.1136/gut.2007.142919; Morris-Stiff G, 2010, J HEPATOL, V53, P795, DOI 10.1016/j.jhep.2010.07.003; Pacifico L, 2011, WORLD J GASTROENTERO, V17, P3082, DOI 10.3748/wjg.v17.i26.3082; Reinehr T, 2012, J CLIN ENDOCR METAB, V97, P2143, DOI 10.1210/jc.2012-1221; Royston P., 2008, MULTIVARIABLE MODEL; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Shu GS, 2013, CELL ONCOL, V36, P121, DOI 10.1007/s13402-012-0118-0; Vajro P, 2012, J PEDIATR GASTR NUTR, V54, P700, DOI 10.1097/MPG.0b013e318252a13f; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895; Yang CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033870	40	70	72	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67160	10.1371/journal.pone.0067160	http://dx.doi.org/10.1371/journal.pone.0067160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840612	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400077
J	Basafa, E; Murphy, RJ; Kutzer, MD; Otake, Y; Armand, M				Basafa, Ehsan; Murphy, Ryan J.; Kutzer, Michael D.; Otake, Yoshito; Armand, Mehran			A Particle Model for Prediction of Cement Infiltration of Cancellous Bone in Osteoporotic Bone Augmentation	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; PROXIMAL FEMUR; FLOW; POLYMETHYLMETHACRYLATE; FEMOROPLASTY; FLUID; SPH; HYDRODYNAMICS; INJECTION; PERMEABILITY	Femoroplasty is a potential preventive treatment for osteoporotic hip fractures. It involves augmenting mechanical properties of the femur by injecting Polymethylmethacrylate (PMMA) bone cement. To reduce the risks involved and maximize the outcome, however, the procedure needs to be carefully planned and executed. An important part of the planning system is predicting infiltration of cement into the porous medium of cancellous bone. We used the method of Smoothed Particle Hydrodynamics (SPH) to model the flow of PMMA inside porous media. We modified the standard formulation of SPH to incorporate the extreme viscosities associated with bone cement. Darcy creeping flow of fluids through isotropic porous media was simulated and the results were compared with those reported in the literature. Further validation involved injecting PMMA cement inside porous foam blocks - osteoporotic cancellous bone surrogates - and simulating the injections using our proposed SPH model. Millimeter accuracy was obtained in comparing the simulated and actual cement shapes. Also, strong correlations were found between the simulated and the experimental data of spreading distance (R-2=0.86) and normalized pressure (R-2=0.90). Results suggest that the proposed model is suitable for use in an osteoporotic femoral augmentation planning framework.	[Basafa, Ehsan; Murphy, Ryan J.; Armand, Mehran] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Basafa, Ehsan; Murphy, Ryan J.; Otake, Yoshito; Armand, Mehran] Johns Hopkins Univ, Lab Computat Sensing & Robot, Baltimore, MD USA; [Murphy, Ryan J.; Kutzer, Michael D.; Armand, Mehran] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Armand, Mehran] Johns Hopkins Univ, Dept Orthopaed Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University	Basafa, E (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	basafa@jhu.edu		Murphy, Ryan/0000-0003-3065-7700	National Institutes of Health (NIH/NIBIB) [5R21EB0077747-03]; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063815] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grant no. 5R21EB0077747-03 from the National Institutes of Health (NIH/NIBIB), URL:http://www.nih.gov/. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroud G, 2004, P I MECH ENG H, V218, P331, DOI 10.1243/0954411041932827; Baroud G, 2003, MED ENG PHYS, V25, P283, DOI 10.1016/S1350-4533(02)00223-0; Basafa E, 2013, MED ENG PHYS, V35, P860, DOI 10.1016/j.medengphy.2013.01.003; BEAUDOIN AJ, 1991, J BIOMECH, V24, P127, DOI 10.1016/0021-9290(91)90357-S; Becker M, 2007, SYMPOSIUM ON COMPUTER ANIMATION 2007: ACM SIGGRAPH/ EUROGRAPHICS SYMPOSIUM PROCEEDINGS, P209; Beckmann J, 2007, MED ENG PHYS, V29, P755, DOI 10.1016/j.medengphy.2006.08.006; Beckmann J, 2011, J ORTHOP RES, V29, P1753, DOI 10.1002/jor.21410; Bohner M, 2003, BIOMATERIALS, V24, P2721, DOI 10.1016/S0142-9612(03)00086-3; Bryant J D, 1989, Proc Inst Mech Eng H, V203, P71, DOI 10.1243/PIME_PROC_1989_203_013_01; Clavet S., 2005, P 2005 ACM SIGGRAPH, P219, DOI [DOI 10.1145/1073368.1073400, DOI 10.1145/1073368]; Desbrun M., 1996, Computer Animation and Simulation '96. Proceedings of the Eurographics Workshop, P61; Dragomir-Daescu D, 2011, ANN BIOMED ENG, V39, P742, DOI 10.1007/s10439-010-0196-y; Ferrari A, 2010, HIGH PERFORMANCE COMPUTING ON VECTOR SYSTEMS 2009, P179, DOI 10.1007/978-3-642-03913-3_14; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Heini PF, 2004, CLIN BIOMECH, V19, P506, DOI 10.1016/j.clinbiomech.2004.01.014; Holmes DW, 2011, INT J NUMER ANAL MET, V35, P419, DOI 10.1002/nag.898; Jiang FM, 2007, COMPUT PHYS COMMUN, V176, P471, DOI 10.1016/j.cpc.2006.12.003; Koponen A, 1997, PHYS REV E, V56, P3319, DOI 10.1103/PhysRevE.56.3319; Kutzer MD, 2011, ASME 2011 INT DES EN, P821; Lane JM, 2000, CLIN ORTHOP RELAT R, P139; Lenaerts T, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360648; Lian Z, 2008, COMPUT BIOL MED, V38, P304, DOI 10.1016/j.compbiomed.2007.10.009; Liu MB, 2007, P ANN INT IEEE EMBS, P1152, DOI 10.1109/IEMBS.2007.4352500; Loeffel M, 2008, SPINE, V33, P1352, DOI 10.1097/BRS.0b013e3181732aa9; Lucas BC, 2012, IEEE T MED IMAGING, V31, P860, DOI 10.1109/TMI.2011.2171498; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; MONAGHAN JJ, 1992, ANNU REV ASTRON ASTR, V30, P543, DOI 10.1146/annurev.aa.30.090192.002551; Morris JP, 1997, J COMPUT PHYS, V136, P214, DOI 10.1006/jcph.1997.5776; Muller M., 2003, ACM SIGGRAPH/Eurographics Symposium on Computer Animation, P154; Otake Y, 2009, P 9 ANN M CAOS INT B, P177; Otake Y, 2012, IEEE T MED IMAGING, V31, P948, DOI 10.1109/TMI.2011.2176555; Ovaysi S, 2010, J COMPUT PHYS, V229, P7456, DOI 10.1016/j.jcp.2010.06.028; Paiva A, 2006, SIBGRAPI, P78; Paiva A, 2009, COMPUT AIDED DESIGN, V41, P306, DOI 10.1016/j.cad.2008.10.004; Pereira GG, 2011, APPL MATH MODEL, V35, P1666, DOI 10.1016/j.apm.2010.09.043; Pnueli D, 1997, FLUID MECH; Randles PW, 1996, COMPUT METHOD APPL M, V139, P375, DOI 10.1016/S0045-7825(96)01090-0; SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411; Shao SD, 2003, ADV WATER RESOUR, V26, P787, DOI 10.1016/S0309-1708(03)00030-7; Sousa ACM, 2007, MATER SCI FORUM, V553, P171, DOI 10.4028/www.scientific.net/MSF.553.171; Steele K, 2004, COMPUT ANIMAT VIRT W, V15, P183, DOI 10.1002/cav.20; Sutter EG, 2010, GERIATR ORTHOP SURG, V1, P22, DOI 10.1177/2151458510378406; Sutter EG, 2010, J ORTHOP TRAUMA, V24, P95, DOI 10.1097/BOT.0b013e3181b5c0c6; Tartakovsky AM, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004770; Zhong ZC, 2008, I C COMP AID DES CON, P523, DOI 10.1109/CAIDCD.2008.4730624; Zhong ZW, 2011, BIORHEOLOGY, V48, P89, DOI 10.3233/BIR-2011-0587; Zhu Y, 1999, INT J NUMER ANAL MET, V23, P881; Zhu YN, 2005, ACM T GRAPHIC, V24, P965, DOI 10.1145/1073204.1073298	48	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67958	10.1371/journal.pone.0067958	http://dx.doi.org/10.1371/journal.pone.0067958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840794	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400124
J	Bryngelson, A; Asberg, M; Nygren, A; Jensen, I; Mittendorfer-Rutz, E				Bryngelson, Anna; Asberg, Marie; Nygren, Ake; Jensen, Irene; Mittendorfer-Rutz, Ellenor			All-Cause and Cause-Specific Mortality after Long-Term Sickness Absence for Psychiatric Disorders: A Prospective Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PSYCHOSOCIAL RISK-FACTORS; EXCESS CANCER-MORTALITY; DEPRESSION; MECHANISMS; ANXIETY; PEOPLE	Objective: The aim was to examine if long-term psychiatric sickness absence was associated with all-cause and diagnosis-specific (cardiovascular disease (CVD), cancer and suicide) mortality for the period 1990-2007. An additional aim was to examine these associations for psychiatric sickness absence in 1990 and 2000, with follow-up on mortality during 19911997 and 2001-2007, separately. Methods: Employees within municipalities and county councils, 244,990 individuals in 1990 and 764,137 individuals in 2000, were followed up to 2007 through register linkages. Analyses were conducted with flexible parametric survival models comparing sickness absentees due to psychiatric diagnoses (>90 days) with those not receiving sick leave benefit. Results: Long-term sickness absence for psychiatric disorders was associated with an increased risk of mortality due to all causes; CVD; cancer (smoking and non-smoking related); and suicide during the period 1990-2007. After full adjustment for socio-demographic covariates and previous inpatient care due to somatic and psychiatric diagnoses, these associations remained significant for all-cause mortality (Hazard ratios (HR) and 95% confidence interval (CI)): HR 1.56, 95% CI 1.3-1.8; CVD: HR 1.35, 95% CI 1.0-1.9, and suicide: HR 3.84, 95% CI 2.4-6.1. For both cohorts 1990 and 2000 estimates point in the same direction. For the time-period 2000-2007, we found increased risks of mortality in the fully adjusted model due to all causes: HR 1.47, 95% CI 1.2-1.7; CVD: HR 1.83, 95% CI 1.2-2.7; overall cancer: HR 1.33, 95% CI 1.0-1.7; and suicide: HR 2.15, 95% CI 1.3-3.7. Conclusion: Long-term sickness absence for psychiatric disorders predicted premature mortality from all-causes, cardiovascular disease, cancer, and suicide.	[Bryngelson, Anna; Asberg, Marie; Nygren, Ake] Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Jensen, Irene] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Mittendorfer-Rutz, Ellenor] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Bryngelson, A (corresponding author), Karolinska Inst, Dept Clin Sci, Stockholm, Sweden.	anna.bryngelson@ki.se	Jensen, Irene B/B-6012-2012	Jensen, Irene B/0000-0003-1745-866X	AFA Insurance; Swedish Research Council [A0268301]	AFA Insurance; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was financially supported by AFA Insurance. EMR is the recipient of an Assistant Professorship grant of the Swedish Research Council (A0268301). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript. However, the used data on sickness absence came from AFA Insurance.; The study was financially supported by AFA Insurance. This does not alter the authors' adherence to all PLOS ONE policies of sharing data and materials.	Bunker SJ, 2003, MED J AUSTRALIA, V178, P272, DOI 10.5694/j.1326-5377.2003.tb05193.x; Ferrie JE, 2009, J EPIDEMIOL COMMUN H, V63, P50, DOI 10.1136/jech.2008.074369; Floderus B, 2005, J REHABIL MED, V37, P291, DOI 10.1080/16501970510034422; Gjesdal S, 2008, EUR J PUBLIC HEALTH, V18, P517, DOI 10.1093/eurpub/ckn010; Godard C, 2006, EUR PSYCHIAT, V21, P451, DOI 10.1016/j.eurpsy.2006.03.001; Goldston K, 2008, CLIN PSYCHOL REV, V28, P288, DOI 10.1016/j.cpr.2007.05.005; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Head J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1469; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Jarvisalo J, 2005, GERMANY NETHERLANDS; Kapusta ND, 2009, ACTA PSYCHIAT SCAND, V119, P236, DOI 10.1111/j.1600-0447.2008.01314.x; Karolinska Institutet School of Public Health, 2010, SJALVM STOCKH SVER 1; Kisely S, 2008, CAN J PSYCHIAT, V53, P753, DOI 10.1177/070674370805301107; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Lauber C, 2008, EPIDEMIOL PSICHIAT S, V17, P10, DOI 10.1017/S1121189X0000261X; Lawrence D, 2000, ACTA PSYCHIAT SCAND, V101, P382, DOI 10.1034/j.1600-0447.2000.101005382.x; Lawrence D, 2010, CAN J PSYCHIAT, V55, P752, DOI 10.1177/070674371005501202; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Lidwall U, 2010, THESIS KAROLINSKA I; LJUNGDAHL LO, 1991, SCAND J SOC MED, V19, P148, DOI 10.1177/140349489101900302; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; Melchior M, 2010, AM J EPIDEMIOL, V172, P700, DOI 10.1093/aje/kwq186; Mittendorfer-Rutz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045788; Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862; Nathell L, 2002, THESIS CAROLINSKA ME; Niederkrotenthaler T, 2012, EUR J EPIDEMIOL, V27, P729, DOI 10.1007/s10654-012-9724-4; Ockander M, 2001, INT J SOC WELF, V10, P74, DOI 10.1111/1468-2397.00154; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; The Swedish National Board of Health and Welfare, 2010, DODS; The Swedish National Board of Health and Welfare, 2009, QUAL CONT INP CAR RE; The Swedish Social Insurance Agency, 2004, WOM MEN SICKN ABS; The Swedish Social Insurance Agency, 2010, 201016 SWED SOC INS, P16; The Swedish Social Insurance Agency, 2005, FORS HUV FORS IN SOC; The Swedish Social Insurance Agency, 2002, REV AN, P4; Whang W, 2009, J AM COLL CARDIOLOGY, V53	37	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67887	10.1371/journal.pone.0067887	http://dx.doi.org/10.1371/journal.pone.0067887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840784	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400121
J	Majima, T; Takeuchi, K; Sano, K; Hirashima, M; Zankov, DP; Tanaka-Okamoto, M; Ishizaki, H; Miyoshi, J; Ogita, H				Majima, Takashi; Takeuchi, Keisuke; Sano, Keigo; Hirashima, Masanori; Zankov, Dimitar P.; Tanaka-Okamoto, Miki; Ishizaki, Hiroyoshi; Miyoshi, Jun; Ogita, Hisakazu			An Adaptor Molecule Afadin Regulates Lymphangiogenesis by Modulating RhoA Activity in the Developing Mouse Embryo	PLOS ONE			English	Article							CELL-CELL JUNCTIONS; GROWTH-FACTOR; VASCULAR DEVELOPMENT; LYMPHATIC-SYSTEM; TIGHT JUNCTIONS; PROTEIN; NECTIN; ADHESION; ANGIOGENESIS; INVOLVEMENT	Afadin is an intracellular binding partner of nectins, cell-cell adhesion molecules, and plays important roles in the formation of cell-cell junctions. Afadin-knockout mice show early embryonic lethality, therefore little is known about the function of afadin during organ development. In this study, we generated mice lacking afadin expression in endothelial cells, and found that the majority of these mice were embryonically lethal as a result of severe subcutaneous edema. Defects in the lymphatic vessels of the skin were observed, although the morphology in the blood vessels was almost normal. Severe disruption of VE-cadherin-mediated cell-cell junctions occurred only in lymphatic endothelial cells, but not in blood endothelial cells. Knockout of afadin did not affect the differentiation and proliferation of lymphatic endothelial cells. Using in vitro assays with blood and lymphatic microvascular endothelial cells ( BMVECs and LMVECs, respectively), knockdown of afadin caused elongated cell shapes and disruption of cell-cell junctions among LMVECs, but not BMVECs. In afadin-knockdown LMVECs, enhanced F-actin bundles at the cell periphery and reduced VE-cadherin immunostaining were found, and activation of RhoA was strongly increased compared with that in afadin-knockdown BMVECs. Conversely, inhibition of RhoA activation in afadin-knockdown LMVECs restored the cell morphology. These results indicate that afadin has different effects on blood and lymphatic endothelial cells by controlling the levels of RhoA activation, which may critically regulate the lymphangiogenesis of mouse embryos.	[Majima, Takashi; Tanaka-Okamoto, Miki; Ishizaki, Hiroyoshi; Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan; [Takeuchi, Keisuke; Zankov, Dimitar P.; Ogita, Hisakazu] Shiga Univ Med Sci, Div Mol Med Biochem, Dept Biochem & Mol Biol, Shiga, Japan; [Sano, Keigo; Hirashima, Masanori] Kobe Univ, Grad Sch Med, Div Vasc Biol, Dept Physiol & Cell Biol, Kobe, Hyogo, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Shiga University of Medical Science; Kobe University	Ogita, H (corresponding author), Shiga Univ Med Sci, Div Mol Med Biochem, Dept Biochem & Mol Biol, Shiga, Japan.	hogita@belle.shiga-med.ac.jp	Hirashima, Masanori/ABC-9204-2021; Ogita, Hisakazu/AAE-4416-2020	Hirashima, Masanori/0000-0002-0190-4381; Tanaka-Okamoto, Miki/0000-0002-6429-7662; Ogita, Hisakazu/0000-0001-6750-1668	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Mochida Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23590335] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-aid for Scientific Research, KAKENHI. from the Japan Society for the Promotion of Science (JSPS) and The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Mochida Foundation for Medical and Pharmaceutical Research, Suzuken Memorial Foundation, Daiichi-Sankyo Foundation of Life Science, SENSHIN Medical Research Foundation, The Uehara Memorial Foundation, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; Birukova AA, 2012, J CELL PHYSIOL, V227, P1883, DOI 10.1002/jcp.22916; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fukumoto Y, 2011, J BIOL CHEM, V286, P43537, DOI 10.1074/jbc.M111.308858; Gorovoy M, 2009, CIRC RES, V105, P549, DOI 10.1161/CIRCRESAHA.109.195883; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hammerling B, 2006, CELL TISSUE RES, V324, P55, DOI 10.1007/s00441-005-0090-3; Hirashima M, 2004, BLOOD, V104, P711, DOI 10.1182/blood-2004-01-0254; Hirashima M, 2008, DEV BIOL, V316, P149, DOI 10.1016/j.ydbio.2008.01.023; Hosking B, 2007, BIOESSAYS, V29, P1192, DOI 10.1002/bies.20672; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Komura H, 2008, GENES CELLS, V13, P79, DOI 10.1111/j.1365-2443.2007.01150.x; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Miyata M, 2009, J BIOL CHEM, V284, P24595, DOI 10.1074/jbc.M109.016436; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Ogita H, 2008, INT REV CYTOL, V265, P1, DOI 10.1016/S0074-7696(07)65001-3; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Severs NJ, 2001, MICROSC RES TECHNIQ, V52, P301, DOI 10.1002/1097-0029(20010201)52:3<301::AID-JEMT1015>3.0.CO;2-Q; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Wakamatsu K, 2007, J BIOL CHEM, V282, P18173, DOI 10.1074/jbc.M611159200; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Waschke J, 2005, AM J PHYSIOL-HEART C, V288, pH1296, DOI 10.1152/ajpheart.00687.2004; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yagi T, 2000, GENE DEV, V14, P1169; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	47	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e68134	10.1371/journal.pone.0068134	http://dx.doi.org/10.1371/journal.pone.0068134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840823	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400132
J	Nolan-Stevaux, O; Tedesco, D; Ragan, S; Makhanov, M; Chenchik, A; Ruefli-Brasse, A; Quon, K; Kassner, PD				Nolan-Stevaux, Olivier; Tedesco, Donato; Ragan, Seamus; Makhanov, Mikhail; Chenchik, Alex; Ruefli-Brasse, Astrid; Quon, Kim; Kassner, Paul D.			Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment	PLOS ONE			English	Article							STEM-CELLS; BREAST-CANCER; RNAI; TARGET; TRANSDUCTION; DYNAMICS; LINES	Advances in the fields of cancer initiating cells and high-throughput in vivo shRNA screens have highlighted a need to observe the growth of tumor cells in cancer models at the clonal level. While in vivo cancer cell growth heterogeneity in xenografts has been described, it has yet to be measured. Here, we tested an approach to quantify the clonal growth heterogeneity of cancer cells in subcutaneous xenograft mouse models. Using a high-throughput sequencing method, we followed the fate in vitro and in vivo of ten thousand HCT-116 cells individually tagged with a unique barcode delivered by lentiviral transduction. While growth in vitro was less homogeneous than anticipated, we still find that 95% of the final cells derived from 80% of the original cells. In xenografts, however, 95% of the retrieved barcoded cells originated from only 6% of the initially injected cells, an effect we term "clonal dominance''. We observed this clonal dominance in two additional xenograft models (MDA-MB-468 and A2780(cis)) and in two different host strains (NSG and Nude). By precisely and reproducibly quantifying clonal cancer cell growth in vivo, we find that a small subset of clones accounts for the vast majority of the descendant cells, even with HCT-116, a cell line reported to lack a tumor-initiating compartment. The stochastic in vivo selection process we describe has important implications for the fields of in vivo shRNA screening and tumor initiating cells.	[Nolan-Stevaux, Olivier; Ruefli-Brasse, Astrid] Amgen Inc, Oncol Res, San Francisco, CA USA; [Tedesco, Donato; Makhanov, Mikhail; Chenchik, Alex] Cellecta Inc, Mountain View, CA USA; [Ragan, Seamus; Kassner, Paul D.] Amgen Inc, Genome Anal Unit, San Francisco, CA USA; [Quon, Kim] Amgen Inc, Therapeut Innovat Unit, Seattle, WA USA	Amgen; Amgen; Amgen	Nolan-Stevaux, O (corresponding author), Amgen Inc, Oncol Res, San Francisco, CA USA.	oliviern@amgen.com; dtedesco@cellecta.com		Kassner, Paul/0000-0002-1471-1191; Nolan-Stevaux, Olivier/0000-0002-5934-4786	Amgen Inc.	Amgen Inc.(Amgen)	Cellecta, Inc. was a provider of lentiviral shRNA libraries for this study and is the employer of Donato Tedesco, Mikhail Makhanov and Alex Chenchik. Olivier Nolan-Stevaux, Seamus Ragan, Astrid Ruefli-Brasse, Kim Quon and Paul D. Kassner are employed by Amgen. This study was funded by Amgen Inc. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arai T, 1999, VIROLOGY, V260, P109, DOI 10.1006/viro.1999.9773; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fehse B, 2004, GENE THER, V11, P879, DOI 10.1038/sj.gt.3302270; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Kreso A, 2012, SCIENCE; Luria S., 1978, GEN VIROLOGY, V3rd; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; MORGAN JR, 1995, J VIROL, V69, P6994, DOI 10.1128/JVI.69.11.6994-7000.1995; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Serganova I, 2004, CANCER RES, V64, P6101, DOI 10.1158/0008-5472.CAN-04-0842; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	24	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67316	10.1371/journal.pone.0067316	http://dx.doi.org/10.1371/journal.pone.0067316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840661	gold, Green Submitted, Green Published			2022-12-27	WOS:000321424400094
J	Zhao, KJ; Fang, YB; Huang, QH; Xu, Y; Hong, B; Li, Q; Liu, JM; Zhao, WY; Deng, BQ				Zhao, Kai-Jun; Fang, Yi-Bin; Huang, Qing-Hai; Xu, Yi; Hong, Bo; Li, Qiang; Liu, Jian-Min; Zhao, Wen-Yuan; Deng, Ben-Qiang			Reconstructive Treatment of Ruptured Intracranial Spontaneous Vertebral Artery Dissection Aneurysms: Long-Term Results and Predictors of Unfavorable Outcomes	PLOS ONE			English	Article							INFERIOR CEREBELLAR ARTERY; ENDOVASCULAR TREATMENT; VERTEBROBASILAR DISSECTION; FOLLOW-UP; SUBARACHNOID HEMORRHAGE; HEMODYNAMICS; MANAGEMENT; OCCLUSION; STENTS	Introduction: Few studies focused on predictors of unfavorable outcomes (modified Rankin Scale, 2-6) after reconstructive treatment of the ruptured intracranial spontaneous vertebral artery dissection aneurysms (ris-VADAs), which was evaluated based on 57 reconstructed lesions in this study. Methods: Results of 57 consecutive patients (M: F = 29: 28; median age, 48 years; range, 27 to 69 years) harboring 57 ris-VADAs, which were treated with coils combined with single stents (n = 32), double overlapping stents (n = 16), and triple overlapping stents (n = 9) between October 2000 to March 2011, were retrospectively reviewed and analyzed. Results: The available (n = 54) mean durations of angiographic and clinical follow-ups were 27 months (range, 12 to 78) and 62 months (range, 12 to 132), respectively. The involvement of PICA (p = 0.004), size of lesions (p = 0.000), quantity of stent (p = 0.001), and coil type (p = 0.002) affected the immediate obliteration grade, which was only risk factor for angiographic recurrences (p = 0.031). Although the post-treatment outcomes did not differ between single stent and multiple stents (p = 0.434), 5 angiographic recurrences, 1 rebleeding and 1 suspected rebleeding, all occurred in partial obliteration after single-stent-assisted coiling. Progressive thrombosis and in-stent obliteration were not detected on follow-up angiograms. Older age (odds ratio [OR] = 1.090; 95% confidence interval [CI], 1.004-1.184; p = 0.040) and unfavorable Hunt-Hess scale (OR = 4.289; 95% CI, 1.232-14.933; p = 0.022) were independent predictors of unfavorable outcomes in the reconstructed ris-VADAs. Conclusions: Immediate obliteration grade was only risk factor for angiographic recurrence after reconstructive treatment. Unfavorable Hunt-Hess grade and older age were independent predictors of unfavorable outcomes in ris-VADAs.	[Zhao, Kai-Jun; Fang, Yi-Bin; Huang, Qing-Hai; Xu, Yi; Hong, Bo; Li, Qiang; Liu, Jian-Min; Zhao, Wen-Yuan] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Deng, Ben-Qiang] Second Mil Med Univ, Changhai Hosp, Dept Neurol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Liu, JM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	chstroke@163.com; doczhaowy@163.com; xiaocalf@medmail.com.cn	Li, Qiang/T-3538-2019	Fang, Yi-Bin/0000-0002-6773-4733	National Natural Science Foundation of China [81171093, 81271271, 30973102, 81101906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant No. 81171093, 81271271, 30973102, and 81101906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SS, 2012, RADIOLOGY, V264, P196, DOI 10.1148/radiol.12112331; Arauz A, 2010, STROKE, V41, P717, DOI 10.1161/STROKEAHA.109.568790; Arnold M, 2006, STROKE, V37, P2499, DOI 10.1161/01.STR.0000240493.88473.39; Guilbert F, 2008, RADIOLOGY, V246, P643, DOI 10.1148/radiol.2462070743; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Kim BM, 2011, NEUROLOGY, V76, P1735, DOI 10.1212/WNL.0b013e31821a7d94; Kim BM, 2011, STROKE, V42, P2425, DOI 10.1161/STROKEAHA.111.617381; Kim MJ, 2012, AM J NEURORADIOL, V33, P348, DOI 10.3174/ajnr.A2741; Kim M, 2007, NEUROSURGERY, V61, P1305, DOI 10.1227/01.NEU.0000280168.25968.49; Krischek O, 2011, MINIM INVAS NEUROSUR, V54, P21, DOI 10.1055/s-0031-1271681; Kurata A, 2001, AM J NEURORADIOL, V22, P11; Lee JM, 2010, ACTA NEUROCHIR, V152, P1455, DOI 10.1007/s00701-010-0683-9; Lieber BB, 1997, ANN BIOMED ENG, V25, P460, DOI 10.1007/BF02684187; Meng H, 2006, AM J NEURORADIOL, V27, P1861; MIZUTANI T, 1995, NEUROSURGERY, V36, P905, DOI 10.1227/00006123-199505000-00003; Park SI, 2009, AM J NEURORADIOL, V30, P1351, DOI 10.3174/ajnr.A1561; Peluso JP, 2008, AM J NEURORADIOL, V29, P86, DOI 10.3174/ajnr.A0758; Peluso JPP, 2008, AM J NEURORADIOL, V29, P102, DOI 10.3174/ajnr.A0771; Ro A, 2009, J NEUROSURG, V110, P948, DOI 10.3171/2008.11.JNS08951; Sedat J, 2007, CEREBROVASC DIS, V24, P183, DOI 10.1159/000104475; Shin YS, 2007, NEURORADIOLOGY, V49, P149, DOI 10.1007/s00234-006-0169-x; Tahtinen OI, 2009, RADIOLOGY, V253, P199, DOI 10.1148/radiol.2531081923; Takagi T, 2007, NEUROSURG REV, V30, P32, DOI 10.1007/s10143-006-0049-1; White PM, 2011, LANCET, V377, P1655, DOI 10.1016/S0140-6736(11)60408-X; YAMAURA A, 1990, J NEUROSURG, V72, P183, DOI 10.3171/jns.1990.72.2.0183; Yasui T, 2000, NEUROL SURG TOKYO, V28, P345; Zenteno MA, 2008, J NEUROSURG, V108, P1104, DOI 10.3171/JNS/2008/108/6/1104; Zhao WY, 2007, ACTA NEUROCHIR, V149, P585, DOI 10.1007/s00701-007-1161-x	28	38	50	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67169	10.1371/journal.pone.0067169	http://dx.doi.org/10.1371/journal.pone.0067169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840616	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400079
J	Kitagawa, H; Kawano, M; Yamanaka, K; Kakeda, M; Tsuda, K; Inada, H; Yoneda, M; Sakaguchi, T; Nigi, A; Nishimura, K; Komada, H; Tsurudome, M; Yasutomi, Y; Nosaka, T; Mizutani, H				Kitagawa, Hiroshi; Kawano, Mitsuo; Yamanaka, Keiichi; Kakeda, Masato; Tsuda, Kenshiro; Inada, Hiroyasu; Yoneda, Misao; Sakaguchi, Tadashi; Nigi, Akina; Nishimura, Koumei; Komada, Hiroshi; Tsurudome, Masato; Yasutomi, Yasuhiro; Nosaka, Tetsuya; Mizutani, Hitoshi			Intranasally Administered Antigen 85B Gene Vaccine in Non-Replicating Human Parainfluenza Type 2 Virus Vector Ameliorates Mouse Atopic Dermatitis	PLOS ONE			English	Article							REGULATORY T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN; SEQUENCE; CDNA; TH1; EXPRESSION; IMMUNITY; CULTURE; REGION	Atopic dermatitis (AD) is a refractory and recurrent inflammatory skin disease. Various factors including heredity, environmental agent, innate and acquired immunity, and skin barrier function participate in the pathogenesis of AD. T - helper (Th) 2-dominant immunological milieu has been suggested in the acute phase of AD. Antigen 85B (Ag85B) is a 30-kDa secretory protein well conserved in Mycobacterium species. Ag85B has strong Th1-type cytokine inducing activity, and is expected to ameliorate Th2 condition in allergic disease. To perform Ag85B function in vivo, effective and less invasive vaccination method is required. Recently, we have established a novel functional virus vector; recombinant human parainfluenza type 2 virus vector (rhPIV2): highly expressive, replication-deficient, and very low-pathogenic vector. In this study, we investigated the efficacy of rhPIV2 engineered to express Ag85B (rhPIV2/Ag85B) in a mouse AD model induced by repeated oxazolone (OX) challenge. Ear swelling, dermal cell infiltrations and serum IgE level were significantly suppressed in the rhPIV2/Ag85B treated mouse group accompanied with elevated IFN-gamma and IL-10 mRNA expressions, and suppressed IL-4, TNF-alpha and MIP-2 mRNA expressions. The treated mice showed no clinical symptom of croup or systemic adverse reactions. The respiratory tract epithelium captured rhPIV2 effectively without remarkable cytotoxic effects. These results suggested that rhPIV2/Ag85B might be a potent therapeutic tool to control allergic disorders.	[Kitagawa, Hiroshi; Yamanaka, Keiichi; Kakeda, Masato; Tsuda, Kenshiro; Mizutani, Hitoshi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan; [Kawano, Mitsuo; Sakaguchi, Tadashi; Nigi, Akina; Nishimura, Koumei; Tsurudome, Masato; Nosaka, Tetsuya] Mie Univ, Grad Sch Med, Dept Microbiol & Mol Genet, Tsu, Mie 514, Japan; [Inada, Hiroyasu] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Dept Pathol, Suzuka, Mie, Japan; [Yoneda, Misao; Komada, Hiroshi] Suzuka Univ Med Sci, Grad Sch, Dept Clin Nutr, Suzuka, Mie, Japan; [Yasutomi, Yasuhiro] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Lab Immunoregulat & Vaccine Res, Tsukuba, Ibaraki, Japan	Mie University; Mie University; National Institute of Health Sciences - Japan	Mizutani, H (corresponding author), Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan.	h-mizuta@clin.medic.mie-u.ac.jp		Kakeda, Masato/0000-0001-9011-3655	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591643, 24591647]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	K. Yamanaka (23591643) and H. Mizutani (24591647) received grants for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Other authors did not receive any financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Bukreyev A, 2004, LANCET, V363, P2122, DOI 10.1016/S0140-6736(04)16501-X; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Ito Y, 2009, ANN ALLERG ASTHMA IM, V103, P160, DOI 10.1016/S1081-1206(10)60170-6; JUNG T, 1995, J ALLERGY CLIN IMMUN, V96, P515, DOI 10.1016/S0091-6749(95)70296-2; Kakeda M, BR J DERMATOL, V166, P953; KAWANO M, 1991, NUCLEIC ACIDS RES, V19, P2739, DOI 10.1093/nar/19.10.2739; Kawano M, 2001, VIROLOGY, V284, P99, DOI 10.1006/viro.2001.0864; KAWANO M, 1990, VIROLOGY, V178, P289, DOI 10.1016/0042-6822(90)90406-H; KAWANO M, 1990, VIROLOGY, V179, P857, DOI 10.1016/0042-6822(90)90155-K; Kitagaki H, 1997, J IMMUNOL, V159, P2484; Kondo H, 1998, EUR J IMMUNOL, V28, P769, DOI 10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Matsuyama T, 1999, CLIN EXP ALLERGY, V29, P687; Mori H, 2009, ARCH DERMATOL RES, V301, P151, DOI 10.1007/s00403-008-0873-y; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OHGIMOTO S, 1990, VIROLOGY, V177, P116, DOI 10.1016/0042-6822(90)90465-4; Ou LS, 2004, J ALLERGY CLIN IMMUN, V113, P756, DOI 10.1016/j.jaci.2004.01.772; REINHOLD U, 1990, CLIN EXP IMMUNOL, V79, P374; Russo DM, 2000, INFECT IMMUN, V68, P6826, DOI 10.1128/IAI.68.12.6826-6832.2000; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Takatsu K, 2003, INT IMMUNOPHARMACOL, V3, P783, DOI 10.1016/S01567-5769(02)00209-6; Tompkins SM, 2007, VIROLOGY, V362, P139, DOI 10.1016/j.virol.2006.12.005; Wu J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-51; Yamanaka K, 2011, CURR PROBL DERMATOL, V41, P80, DOI 10.1159/000323299; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	28	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66614	10.1371/journal.pone.0066614	http://dx.doi.org/10.1371/journal.pone.0066614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843958	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000049
J	Delgado, FF; Cermak, N; Hecht, VC; Son, S; Li, YZ; Knudsen, SM; Olcum, S; Higgins, JM; Chen, JZ; Grover, WH; Manalis, SR				Delgado, Francisco Feijo; Cermak, Nathan; Hecht, Vivian C.; Son, Sungmin; Li, Yingzhong; Knudsen, Scott M.; Olcum, Selim; Higgins, John M.; Chen, Jianzhu; Grover, William H.; Manalis, Scott R.			Intracellular Water Exchange for Measuring the Dry Mass, Water Mass and Changes in Chemical Composition of Living Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HUMAN ERYTHROCYTES; RIBONUCLEIC-ACID; BUOYANT DENSITY; SINGLE CELLS; GROWTH-RATE; PROTEIN; MICROSCOPY; VOLUME; CYCLE	We present a method for direct non-optical quantification of dry mass, dry density and water mass of single living cells in suspension. Dry mass and dry density are obtained simultaneously by measuring a cell's buoyant mass sequentially in an H2O-based fluid and a D2O-based fluid. Rapid exchange of intracellular H2O for D2O renders the cell's water content neutrally buoyant in both measurements, and thus the paired measurements yield the mass and density of the cell's dry material alone. Utilizing this same property of rapid water exchange, we also demonstrate the quantification of intracellular water mass. In a population of E. coli, we paired these measurements to estimate the percent dry weight by mass and volume. We then focused on cellular dry density - the average density of all cellular biomolecules, weighted by their relative abundances. Given that densities vary across biomolecule types (RNA, DNA, protein), we investigated whether we could detect changes in biomolecular composition in bacteria, fungi, and mammalian cells. In E. coli, and S. cerevisiae, dry density increases from stationary to exponential phase, consistent with previously known increases in the RNA/protein ratio from up-regulated ribosome production. For mammalian cells, changes in growth conditions cause substantial shifts in dry density, suggesting concurrent changes in the protein, nucleic acid and lipid content of the cell.	[Delgado, Francisco Feijo; Hecht, Vivian C.; Knudsen, Scott M.; Olcum, Selim; Grover, William H.; Manalis, Scott R.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Cermak, Nathan; Manalis, Scott R.] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Son, Sungmin; Manalis, Scott R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Li, Yingzhong; Chen, Jianzhu; Grover, William H.; Manalis, Scott R.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Higgins, John M.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Higgins, John M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Higgins, John M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Manalis, SR (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	scottm@media.mit.edu	Olcum, Selim/I-8523-2012	Olcum, Selim/0000-0002-6417-1007; Feijo Delgado, Francisco/0000-0001-9528-3389; Grover, William/0000-0001-6854-8951; Cermak, Nathan/0000-0002-8389-8236	Physical Sciences Oncology Center at the Massachusetts Institute of Technology from the United States National Cancer Institute [U54CA143874]; United States National Institutes of Health [P50GM68762, R01CA170592]; Institute for Collaborative Biotechnologies from the United States Army Research Office [W911NF-09-D-0001]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/47736/2008]; Directorate For Geosciences [1129359] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA014051, U54CA143874, R01CA170592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK098087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	Physical Sciences Oncology Center at the Massachusetts Institute of Technology from the United States National Cancer Institute; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Collaborative Biotechnologies from the United States Army Research Office; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Physical Sciences Oncology Center at the Massachusetts Institute of Technology (U54CA143874) from the United States National Cancer Institute. Center for Cell Decision Process Grant (P50GM68762) and contract R01CA170592, both from the United States National Institutes of Health. Institute for Collaborative Biotechnologies through contract number W911NF-09-D-0001 from the United States Army Research Office. F. F. D. acknowledges support from Fundacao para a Ciencia e a Tecnologia, Portugal, through a graduate fellowship (SFRH/BD/47736/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON N. G., 1966, NAT CANCER INST MONOGR, V21, P253; BARER R, 1953, NATURE, V171, P720, DOI 10.1038/171720a0; BEAMAN TC, 1982, J BACTERIOL, V150, P870, DOI 10.1128/JB.150.2.870-877.1982; BOEHLKE KW, 1975, J BACTERIOL, V121, P429, DOI 10.1128/JB.121.2.429-433.1975; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BRATBAK G, 1984, APPL ENVIRON MICROB, V48, P755, DOI 10.1128/AEM.48.4.755-757.1984; Bremer H, 2008, ECOSAL ESCHERICHIA C, P1553, DOI [10.1128/ecosal.5.2.3., DOI 10.1128/EC0SAL.5.2.3]; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bryan AK, 2010, P NATL ACAD SCI USA, V107, P999, DOI 10.1073/pnas.0901851107; Carrera M, 2008, J APPL MICROBIOL, V105, P68, DOI 10.1111/j.1365-2672.2008.03758.x; DENNIS PP, 1974, J BACTERIOL, V119, P270, DOI 10.1128/JB.119.1.270-281.1974; ENGELHARD HH, 1991, CYTOMETRY, V12, P68, DOI 10.1002/cyto.990120110; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; GAMBLE CN, 1960, J BIOPHYS BIOCHEM CY, V8, P53, DOI 10.1083/jcb.8.1.53; GREGERSEN MI, 1967, SCIENCE, V157, P825, DOI 10.1126/science.157.3790.825; Grover WH, 2011, P NATL ACAD SCI USA, V108, P10992, DOI 10.1073/pnas.1104651108; Halasz A, 1991, CHEM COMPOSITION BIO, P319; Harz A, 2009, CYTOM PART A, V75A, P104, DOI 10.1002/cyto.a.20682; Jang Y, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009673; KUBITSCHEK HE, 1983, J BACTERIOL, V155, P1027, DOI 10.1128/JB.155.3.1027-1032.1983; Lee J, 2011, SPACE, P82; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; MITCHISON JM, 1958, EXP CELL RES, V15, P214, DOI 10.1016/0014-4827(58)90077-6; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; PANIJPAN B, 1977, J CHEM EDUC, V54, P172, DOI 10.1021/ed054p172; POLAKIS ES, 1966, BIOCHEM J, V98, P883, DOI 10.1042/bj0980883; Potma EO, 2001, P NATL ACAD SCI USA, V98, P1577, DOI 10.1073/pnas.031575698; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Sherman F, 1998, ENCY MOL BIOL MOL ME, P302; Short KW, 2005, BIOPHYS J, V88, P4274, DOI 10.1529/biophysj.103.038604; THOMSON JF, 1974, ARCH BIOCHEM BIOPHYS, V160, P130, DOI 10.1016/S0003-9861(74)80017-2; TISA LS, 1982, APPL ENVIRON MICROB, V43, P1307, DOI 10.1128/AEM.43.6.1307-1310.1982; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Watson JD, 1972, MOL BIOL GENE; WEED RI, 1963, J CLIN INVEST, V42, P581, DOI 10.1172/JCI104747; Weng YC, 2011, LAB CHIP, V11, P4174, DOI 10.1039/c1lc20736a; Yamada EA, 2005, J AGR FOOD CHEM, V53, P3931, DOI 10.1021/jf0400821	40	89	92	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67590	10.1371/journal.pone.0067590	http://dx.doi.org/10.1371/journal.pone.0067590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844039	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000062
J	Liu, F; Shen, J; Zhao, J; Zeng, H; Li, LX; Zhao, JG; Lu, FD; Bao, YQ; Jia, WP				Liu, Fang; Shen, Jing; Zhao, Jun; Zeng, Hui; Li, Lianxi; Zhao, Jungong; Lu, Fengdi; Bao, Yuqian; Jia, Weiping			Cystatin C: A Strong Marker for Lower Limb Ischemia in Chinese Type 2 Diabetic Patients?	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; NUTRITION EXAMINATION SURVEY; GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; NATIONAL-HEALTH; CARDIOVASCULAR EVENTS; UNITED-STATES; RISK-FACTORS; ATHEROSCLEROSIS	Objective: Cystatin C is growing to be an ideal indicator for renal function and cardiovascular events. The aim of this study was to investigate the relationship between serum cystatin C levels and peripheral arterial disease and to explore its diagnostic value for lower limb ischemia (LLI) in type 2 diabetic population. Methods: A total of 1609 T2DM patients were included in this cross-sectional study. Their clinical and biochemical characteristics, ankle-brachial index (ABI), carotid and lower extremity arterial ultrasound were detected. LLI was defined by ABI <0.9 and lower extremity arterial stenosis >50% by ultrasound examination. Patients were divided to two groups: with LLI and without. The risk factors of LLI were explored by binary logistic regression analysis. Results: The serum concentrations of cystatin C were 1.53 +/- 0.60 and 1.08 +/- 0.30 mg/L in patients with and without LLI, respectively. Binary logistic regression analysis showed that the significant risk factors were cystatin C (P = 0.007, OR = 5.081), the presence of hypertension (P = 0.011, OR = 3.527), age (P<0.001, OR = 1.181), GA (P = 0.002, OR = 1.089) and diabetes duration (P = 0.008, OR = 1.074). The prevalence of coronary artery disease, cerebral infarction and LLI increased with cystatin C (P<0.01), and the prevalence of LLI in patients with cystatin C>1.2 mg/L was much higher than other three quartile groups. Receiver operating characteristic curve analysis revealed the cut point of cystatin C for LLI was 1.2 mg/L. The risk of LLI dramatically increased in patients with cystatin C>1.2 mg/L (OR = 21.793, 95% confidence interval 10.046-47.280, P<0.001). After adjusting for sex, age, duration, HbA1c, GA and hypertension, its OR still remained 3.395 (95% confidence interval 1.335-8.634). Conclusions: There was a strong and independent association between cystatin C and limb arterial disease in diabetic population, and cystatin C>1.2 mg/L indicated a great increased risk of LLI.	[Liu, Fang; Shen, Jing; Zhao, Jun; Zeng, Hui; Li, Lianxi; Zhao, Jungong; Lu, Fengdi; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab,Affiliated Peoples Hosp 6, Shanghai Key Clin Ctr Metab Dis,Shanghai Key Lab, Shanghai Clin Ctr Diabet,Shanghai Diabet Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, F (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrinol & Metab,Affiliated Peoples Hosp 6, Shanghai Key Clin Ctr Metab Dis,Shanghai Key Lab, Shanghai Clin Ctr Diabet,Shanghai Diabet Inst, Shanghai 200030, Peoples R China.	liufangstar@163.com; wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012		Research Fund for the National Natural Science Funding of China [81270397, 81070650]	Research Fund for the National Natural Science Funding of China	This work was supported by grants from the Research Fund for the National Natural Science Funding of China (No. 81270397 and 81070650). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE S1, V35, pS11; [Anonymous], 2003, DIABETES CARE, V26, P3333; Arpegard J, 2008, ATHEROSCLEROSIS, V199, P397, DOI 10.1016/j.atherosclerosis.2007.11.025; Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Bokenkamp A, 2006, PEDIATR NEPHROL, V21, P1223, DOI 10.1007/s00467-006-0192-5; Chen J, 2012, AM J CARDIOL, V110, P136, DOI 10.1016/j.amjcard.2012.02.061; Chen JH, 2009, KAOHSIUNG J MED SCI, V25, P366, DOI 10.1016/S1607-551X(09)70529-7; Cheung BMY, 2009, INT J CARDIOL, V135, P156, DOI 10.1016/j.ijcard.2008.03.039; Deo Rajet, 2009, Clin Cardiol, V32, pE18, DOI 10.1002/clc.20465; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Dijk JM, 2006, ATHEROSCLEROSIS, V188, P444, DOI 10.1016/j.atherosclerosis.2005.11.010; Eriksson P, 2004, ARTERIOSCL THROM VAS, V24, P551, DOI 10.1161/01.ATV.0000117180.57731.36; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Ishizaka N, 2007, ATHEROSCLEROSIS, V193, P373, DOI 10.1016/j.atherosclerosis.2006.06.031; Ix JH, 2007, CIRCULATION, V115, P173, DOI 10.1161/CIRCULATIONAHA.106.644286; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Koenig W, 2005, CLIN CHEM, V51, P321, DOI 10.1373/clinchem.2004.041889; Laterza OF, 2002, CLIN CHEM, V48, P699; Lee SH, 2010, METABOLISM, V59, P241, DOI 10.1016/j.metabol.2009.07.019; O'Hare AM, 2005, ARCH INTERN MED, V165, P2666, DOI 10.1001/archinte.165.22.2666; O'Hare AM, 2004, CIRCULATION, V109, P320, DOI 10.1161/01.CIR.0000114519.75433.DD; Ridker PM, 1998, CIRCULATION, V97, P425; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Selvin E, 2009, EUR HEART J, V30, P1918, DOI 10.1093/eurheartj/ehp195; Sheen YJ, 2012, ANGIOLOGY, V63, P55, DOI 10.1177/0003319711406709; Shi GP, 1999, J CLIN INVEST, V104, P1191, DOI 10.1172/JCI7709; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Shlipak MG, 2006, ANN INTERN MED, V145, P237, DOI 10.7326/0003-4819-145-4-200608150-00003; Singh D, 2007, NEPHROL DIAL TRANSPL, V22, P1087, DOI 10.1093/ndt/gfl744; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V216, P440, DOI 10.1016/j.atherosclerosis.2011.02.016; Wattanakit K, 2007, J AM SOC NEPHROL, V18, P629, DOI 10.1681/ASN.2005111204; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138	32	14	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66907	10.1371/journal.pone.0066907	http://dx.doi.org/10.1371/journal.pone.0066907			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843968	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000020
J	Makedonov, I; Black, SE; MacIntosh, BJ				Makedonov, Ilia; Black, Sandra E.; MacIntosh, Bradley J.			BOLD fMRI in the White Matter as a Marker of Aging and Small Vessel Disease	PLOS ONE			English	Article							DIFFUSION TENSOR MRI; ALZHEIMERS-DISEASE; FUNCTIONAL MRI; ISCHEMIC LEUKOARAIOSIS; PHYSIOLOGICAL NOISE; BRAIN IMAGES; HYPERINTENSITIES; LESIONS; DYSFUNCTION; ROBUST	Purpose: Determine whether white matter signal fluctuation on T2* weighted BOLD contrast images are associated with aging and cerebral small vessel disease (SVD). Methodology: Resting state BOLD data were collected with a 250 ms repetition time (TR) to achieve unaliased, ungated cardiac sampled BOLD (cs-BOLD) images on 11 young adult controls, 10 healthy older adult controls and 7 adults with extensive white matter hyperintensities (WMH) from SVD. Tissue classes (WM and GM) were segmented on T1 images. WMH were identified on FLAIR images in the SVD group. Raw physiological noise (sigma(physio)) and cardiac pulsatility (i.e. fluctuations at the cardiac frequency) were calculated voxel wise and group differences were tested by ANOVA. It was also possible to calculate sigma(physio) in 2s TR cardiac aliased whole-brain BOLD (wb-BOLD) data (N = 84) obtained from the International Consortium for Brain Mapping. Results: CS-BOLD metrics showed an aging and SVD effects (p<0.0005). Covariates such as thermal noise, WM volume and partial volume did not influence the significant aging effect seen on the cardiac pulsatility metric (p<0.017) but did influence the sigma(physio) (p = 0.184). As a verification of the cs-BOLD findings, the wb-BOLD also showed a linear aging effect of sigma(physio) in WM. In the SVD adults, cardiac pulsatility and sigma(physio) were lower in WMH regions compared to normal appearing white matter (NAWM) regions (p<0.0013 and p<0.002, respectively). Cardiac pulsatility was better able to distinguish WMH regions from NAWM than sigma(physio) as measured by effect size (Cohen's d 2.2 and 0.88, respectively). Conclusion: NAWM was found to have graded increases in cardiac pulsations due to age and SVD, independently. Within SVD participants, WMH lesions had reduced physiological noise compared to NAWM. Cardiac pulsatility in resting BOLD data may provide a complementary dynamic measure of WM integrity to add to static FLAIR anatomical images.	[Makedonov, Ilia; Black, Sandra E.; MacIntosh, Bradley J.] Sunnybrook Hlth Sci Ctr, Heart & Stroke Fdn Ctr Stroke Recovery, Toronto, ON M4N 3M5, Canada; [Makedonov, Ilia; Black, Sandra E.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Black, Sandra E.] Sunnybrook Hlth Sci Ctr, Dept Med Neurol, Toronto, ON M4N 3M5, Canada; [Black, Sandra E.] Univ Toronto, Toronto, ON, Canada; [Makedonov, Ilia; Black, Sandra E.; MacIntosh, Bradley J.] Sunnybrook Res Inst, Brain Sci Res Program, Toronto, ON, Canada; [MacIntosh, Bradley J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Makedonov, I (corresponding author), Sunnybrook Hlth Sci Ctr, Heart & Stroke Fdn Ctr Stroke Recovery, Toronto, ON M4N 3M5, Canada.	i.makedonov@utoronto.ca		Black, Sandra/0000-0001-7093-8289; MacIntosh, Bradley/0000-0001-7300-2355	Canadian Institutes of Health Research Institute of Aging Catalyst Grant [211653]; Canadian Institutes of Health Research [MT12139]; Natural Science & Engineering Research Council Discovery Grant; Heart and Stroke Foundation Centre for Stroke Recovery	Canadian Institutes of Health Research Institute of Aging Catalyst Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science & Engineering Research Council Discovery Grant; Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada)	Canadian Institutes of Health Research Institute of Aging Catalyst Grant 211653, Canadian Institutes of Health Research MT12139, Natural Science & Engineering Research Council Discovery Grant, Heart and Stroke Foundation Centre for Stroke Recovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AWAD IA, 1986, STROKE, V17, P1090, DOI 10.1161/01.STR.17.6.1090; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Biswal B, 1996, MAGNET RESON MED, V35, P107, DOI 10.1002/mrm.1910350114; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brickman AM, 2009, PSYCHIAT RES-NEUROIM, V172, P117, DOI 10.1016/j.pscychresns.2008.11.006; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brown WR, 2007, J NEUROL SCI, V257, P62, DOI 10.1016/j.jns.2007.01.015; Carmichael O, 2012, NEUROBIOL AGING, V33, P83, DOI 10.1016/j.neurobiolaging.2010.01.021; Chung CP, 2010, MED HYPOTHESES, V75, P85, DOI 10.1016/j.mehy.2010.01.042; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; de Groot JC, 2000, ANN NEUROL, V47, P145; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DUYN JH, 1994, NMR BIOMED, V7, P83, DOI 10.1002/nbm.1940070113; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Gao FQ, 2012, ALZH ASS INT C; Gao JH, 2012, NEUROIMAGE, V62, P1035, DOI 10.1016/j.neuroimage.2011.09.088; Gibson E, 2010, J MAGN RESON IMAGING, V31, P1311, DOI 10.1002/jmri.22004; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Henry-Feugeas MC, 2008, MED HYPOTHESES, V70, P866, DOI 10.1016/j.mehy.2007.07.027; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Hickie I, 1997, BIOL PSYCHIAT, V42, P367, DOI 10.1016/S0006-3223(96)00363-0; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Joutel A., 2002, Journal de la Societe de Biologie, V196, P109; Kidwell CS, 2001, J NEUROIMAGING, V11, P229, DOI 10.1111/j.1552-6569.2001.tb00039.x; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Makedonov I, 2013, EUR J NEUROL, V20, P243, DOI 10.1111/j.1468-1331.2012.03785.x; Marstrand JR, 2002, STROKE, V33, P972, DOI 10.1161/01.STR.0000012808.81667.4B; MOODY DM, 1995, RADIOLOGY, V194, P469, DOI 10.1148/radiology.194.2.7824728; Mungas D, 2001, NEUROLOGY, V57, P2229, DOI 10.1212/WNL.57.12.2229; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Resnick SM, 2003, J NEUROSCI, V23, P3295; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Sakakibara R, 1999, J NEUROL NEUROSUR PS, V67, P658, DOI 10.1136/jnnp.67.5.658; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P670, DOI 10.1111/j.1365-2990.2007.00890.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Speck O, 1998, MAGNET RESON MED, V40, P243, DOI 10.1002/mrm.1910400210; Wang HH, 2008, J MAGN RESON IMAGING, V27, P866, DOI 10.1002/jmri.21007; Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837; Whitman GT, 2001, NEUROLOGY, V57, P990, DOI 10.1212/WNL.57.6.990; Wowk B, 1997, MAGNET RESON MED, V38, P1029, DOI 10.1002/mrm.1910380625; Yacoub E, 2005, NEUROIMAGE, V24, P738, DOI 10.1016/j.neuroimage.2004.09.002; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	50	48	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67652	10.1371/journal.pone.0067652	http://dx.doi.org/10.1371/journal.pone.0067652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844047	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000067
J	Rinsky, JL; Nadimpalli, M; Wing, S; Hall, D; Baron, D; Price, LB; Larsen, J; Stegger, M; Stewart, J; Heaney, CD				Rinsky, Jessica L.; Nadimpalli, Maya; Wing, Steve; Hall, Devon; Baron, Dothula; Price, Lance B.; Larsen, Jesper; Stegger, Marc; Stewart, Jill; Heaney, Christopher D.			Livestock-Associated Methicillin and Multidrug Resistant Staphylococcus aureus Is Present among Industrial, Not Antibiotic-Free Livestock Operation Workers in North Carolina	PLOS ONE			English	Article							UNITED-STATES; MRSA; ST398; COLONIZATION; TRANSMISSION; INFECTIONS; PREVALENCE; ANIMALS	Objectives: Administration of antibiotics to food animals may select for drug-resistant pathogens of clinical significance, such as methicillin-resistant Staphylococcus aureus (MRSA). In the United States, studies have examined prevalence of MRSA carriage among individuals exposed to livestock, but prevalence of multidrug-resistant S. aureus (MDRSA) carriage and the association with livestock raised with versus without antibiotic selective pressure remains unclear. We aimed to examine prevalence, antibiotic susceptibility, and molecular characteristics of S. aureus among industrial livestock operation (ILO) and antibiotic-free livestock operation (AFLO) workers and household members in North Carolina. Methods: Participants in this cross-sectional study were interviewed and provided a nasal swab for S. aureus analysis. Resulting S. aureus isolates were assessed for antibiotic susceptibility, multi-locus sequence type, and absence of the scn gene (a marker of livestock association). Results: Among 99 ILO and 105 AFLO participants, S. aureus nasal carriage prevalence was 41% and 40%, respectively. Among ILO and AFLO S. aureus carriers, MRSA was detected in 7% (3/41) and 7% (3/42), respectively. Thirty seven percent of 41 ILO versus 19% of 42 AFLO S. aureus-positive participants carried MDRSA. S. aureus clonal complex (CC) 398 was observed only among workers and predominated among ILO (13/34) compared with AFLO (1/35) S. aureus-positive workers. Only ILO workers carried scn-negative MRSA CC398 (2/34) and scn-negative MDRSA CC398 (6/34), and all of these isolates were tetracycline resistant. Conclusions: Despite similar S. aureus and MRSA prevalence among ILO and AFLO-exposed individuals, livestock-associated MRSA and MDRSA (tetracycline-resistant, CC398, scn-negative) were only present among ILO-exposed individuals. These findings support growing concern about antibiotics use and confinement in livestock production, raising questions about the potential for occupational exposure to an opportunistic and drug-resistant pathogen, which in other settings including hospitals and the community is of broad public health importance.	[Rinsky, Jessica L.; Wing, Steve] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Nadimpalli, Maya; Stewart, Jill] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Hall, Devon; Baron, Dothula] REACH, Warsaw, NC USA; [Price, Lance B.] George Washington Univ, Dept Environm & Occupat Hlth, Washington, DC USA; [Larsen, Jesper; Stegger, Marc] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Heaney, Christopher D.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Heaney, Christopher D.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; George Washington University; Statens Serum Institut; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Heaney, CD (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	cheaney@jhsph.edu	Stewart, Jill/T-6862-2018; Larsen, Jesper/AAJ-3161-2021	Stewart, Jill/0000-0002-3474-5233; Larsen, Jesper/0000-0003-0582-0457; Stegger, Marc/0000-0003-0321-1180; Nadimpalli, Maya/0000-0002-6526-116X	North Carolina Translational and Clinical Sciences Institute; North Carolina Occupational Safety and Health Education and Research Center; W.K. Kellogg Health Scholars Program - Community Track; Gillings Innovation Laboratory award from the UNC Gillings School of Global Public Health; National Institute of Environmental Health Sciences (NIEHS) [T32ES007018]; Royster Society fellowship; EPA Science to Achieve Results fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007018] Funding Source: NIH RePORTER	North Carolina Translational and Clinical Sciences Institute; North Carolina Occupational Safety and Health Education and Research Center; W.K. Kellogg Health Scholars Program - Community Track; Gillings Innovation Laboratory award from the UNC Gillings School of Global Public Health; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Royster Society fellowship; EPA Science to Achieve Results fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this study was provided by the North Carolina Translational and Clinical Sciences Institute, North Carolina Occupational Safety and Health Education and Research Center, the W.K. Kellogg Health Scholars Program - Community Track, and a Gillings Innovation Laboratory award from the UNC Gillings School of Global Public Health. CDH was supported by the W.K. Kellogg Health Scholars Program - Community Track, JLR by the National Institute of Environmental Health Sciences (NIEHS; award no. T32ES007018), and MN by a Royster Society fellowship and an EPA Science to Achieve Results fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Baptiste KE, 2005, EMERG INFECT DIS, V11, P1942, DOI 10.3201/eid1112.050241; Bramble M, 2011, VECTOR-BORNE ZOONOT, V11, P617, DOI 10.1089/vbz.2010.0025; Casey JA, 2013, EPIDEMIOL INFECT, V141, P1166, DOI 10.1017/S0950268812001872; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clinical and Laboratory Standards Institute, 2012, M7A9 CLIN LAB STAND, V11th; Clinical and Laboratory Standards Institute, 2010, M100S200 CLIN LAB ST; Cromwell G.L., 2001, SWINE NUTR, V2, P401; Cuny C, 2012, APPL ENVIRON MICROB, V78, P1296, DOI 10.1128/AEM.07260-11; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feinman S.E., 1978, DRAFT ENV IMPACT STA; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Larsen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031245; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lowder BV, 2010, VIRULENCE, V1, P283, DOI 10.4161/viru.1.4.11838; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Osadebe LU, 2013, ZOONOSES PUBLIC HLTH, V60, P234, DOI 10.1111/j.1863-2378.2012.01527.x; Poulsen AB, 2003, J ANTIMICROB CHEMOTH, V51, P419, DOI 10.1093/jac/dkg084; Rafee Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-45; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Silbergeld EK, 2008, MED CLIN N AM, V92, P1391, DOI 10.1016/j.mcna.2008.07.003; Smith TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063704; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith Tara C, 2009, PLoS One, V4, pe4258, DOI 10.1371/journal.pone.0004258; Statens Serum Institut Danish Medicines Agency National Veterinary Insitute National Food Institute, 2010, DANMAP 2010 US ANT A; Steward CD, 2005, J CLIN MICROBIOL, V43, P1716, DOI 10.1128/JCM.43.4.1716-1721.2005; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; United States Food and Drug Administration, 2011, SUMM REP ANT SOLD DI; USDA, 2010, US DEP AGR 2010 NAT; USDA, 2007, US DEP AGR CENS AGR; USDOC, 2010, US DEP COMM 2010 CUR; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P343, DOI 10.1111/j.1469-0691.2010.03227.x; Werner G, 2012, VET MICROBIOL, V160, P162, DOI [10.1016/j.vetmic.2012.05.019, 10.1016/j.vetmic.2012.05.005]; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wing S, 2002, ENVIRON HEALTH PERSP, V110, P437, DOI 10.1289/ehp.02110437; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P225, DOI 10.2307/3454438; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	61	105	106	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67641	10.1371/journal.pone.0067641	http://dx.doi.org/10.1371/journal.pone.0067641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844044	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000065
J	Nakano, T; Ohki, I; Yokota, A; Ashida, H				Nakano, Toshihiro; Ohki, Izuru; Yokota, Akiho; Ashida, Hiroki			MtnBD Is a Multifunctional Fusion Enzyme in the Methionine Salvage Pathway of Tetrahymena thermophila	PLOS ONE			English	Article							RUBISCO-LIKE PROTEIN; 5-METHYLTHIORIBOSE 1-PHOSPHATE ISOMERASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ACIREDUCTONE DIOXYGENASE; PHOTOSYNTHETIC RUBISCO; KLEBSIELLA-PNEUMONIAE; EVOLUTIONARY RELATIONSHIPS; RHODOSPIRILLUM-RUBRUM; MECHANISTIC DIVERSITY	To recycle reduced sulfur to methionine in the methionine salvage pathway (MSP), 5-methylthioribulose-1-phosphate is converted to 2-keto-4-methylthiobutyrate, the methionine precursor, by four steps; dehydratase, enolase, phosphatase, and dioxygenase reactions (catalyzed by MtnB, MtnW, MtnX and MtnD, respectively, in Bacillus subtilis). It has been proposed that the MtnBD fusion enzyme in Tetrahymena thermophila catalyzes four sequential reactions from the dehydratase to dioxygenase steps, based on the results of molecular biological analyses of mutant yeast strains with knocked-out MSP genes, suggesting that new catalytic function can be acquired by fusion of enzymes. This result raises the question of how the MtnBD fusion enzyme can catalyze four very different reactions, especially since there are no homologous domains for enolase and phosphatase (MtnW and MtnX, respectively, in B. subtilis) in the peptide. Here, we tried to identify the domains responsible for catalyzing the four reactions using recombinant proteins of full-length MtnBD and each domain alone. UV-visible and H-1-NMR spectral analyses of reaction products revealed that the MtnB domain catalyzes dehydration and enolization and the MtnD domain catalyzes dioxygenation. Contrary to a previous report, conversion of 5-methylthioribulose-1-phosphate to 2-keto-4-methylthiobutyrate was dependent on addition of an exogenous phosphatase from B. subtilis. This was observed for both the MtnB domain and full-length MtnBD, suggesting that MtnBD does not catalyze the phosphatase reaction. Our results suggest that the MtnB domain of T. thermophila MtnBD acquired the new function to catalyze both the dehydratase and enolase reactions through evolutionary gene mutations, rather than fusion of MSP genes.	[Nakano, Toshihiro; Ohki, Izuru; Yokota, Akiho; Ashida, Hiroki] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Ikoma, Nara, Japan; [Ashida, Hiroki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Ashida, H (corresponding author), Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Ikoma, Nara, Japan.	ashida@bs.naist.jp	Ohki, Izuru/O-4816-2019	Ohki, Izuru/0000-0002-0667-5936	Japanese Society for the Promotion of Science [21688024, 18688021]; Nissan Science Foundation; Global COE Program at NAIST; JST, PRESTO	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nissan Science Foundation; Global COE Program at NAIST; JST, PRESTO(Japan Science & Technology Agency (JST))	This research was supported by the Japanese Society for the Promotion of Science (Grant nos. 21688024 and 18688021 for Scientific Research), by the Nissan Science Foundation, by the Global COE Program at NAIST and the JST, PRESTO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli E, 2010, AMINO ACIDS, V38, P393, DOI 10.1007/s00726-009-0396-7; Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Ashida H, 2005, RES MICROBIOL, V156, P611, DOI 10.1016/j.resmic.2005.01.014; Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Ashida H, 2008, BIOSCI BIOTECH BIOCH, V72, P959, DOI 10.1271/bbb.70651; Ashida H, 2008, J EXP BOT, V59, P1543, DOI 10.1093/jxb/ern104; Avigad G, 1975, Methods Enzymol, V41, P27; Berger BJ, 2003, J BACTERIOL, V185, P2418, DOI 10.1128/JB.185.8.2418-2431.2003; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Doolittle RF, 1999, NAT GENET, V23, P6, DOI 10.1038/12597; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Eisenbeis S, 2010, J PEPT SCI, V16, P538, DOI 10.1002/psc.1233; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Enright AJ, 2001, GENOME BIOL, V2; Fani R, 2009, PHYS LIFE REV, V6, P23, DOI 10.1016/j.plrev.2008.12.003; FURFINE ES, 1988, J BIOL CHEM, V263, P9598; Gupta RS, 2002, THEOR POPUL BIOL, V61, P423, DOI 10.1006/tpbi.2002.1589; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Gupta RS, 1999, MOL MICROBIOL, V32, P893, DOI 10.1046/j.1365-2958.1999.01417.x; HOROWITZ S, 1985, P NATL ACAD SCI USA, V82, P2452, DOI 10.1073/pnas.82.8.2452; Imker HJ, 2008, BIOCHEMISTRY-US, V47, P11171, DOI 10.1021/bi801685f; Ku SY, 2007, J BIOL CHEM, V282, P22195, DOI 10.1074/jbc.M611045200; Ku SY, 2004, ACTA CRYSTALLOGR D, V60, P116, DOI 10.1107/S0907444903022042; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; MYERS RW, 1993, J BIOL CHEM, V268, P24785; Nakano T, 2013, BIOCHEM BIOPH RES CO, V431, P176, DOI 10.1016/j.bbrc.2012.12.142; Nakano T, 2010, BIOCHEM BIOPH RES CO, V392, P212, DOI 10.1016/j.bbrc.2010.01.017; Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x; Pochapsky TC, 2006, J BIOMOL NMR, V34, P117, DOI 10.1007/s10858-005-5735-8; Pochapsky TC, 2002, NAT STRUCT BIOL, V9, P966, DOI 10.1038/nsb863; Pommerrenig B, 2011, PLANT CELL, V23, P1904, DOI 10.1105/tpc.110.079657; Saito Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2021, DOI 10.1271/bbb.70209; Saito Y, 2009, J BIOL CHEM, V284, P13256, DOI 10.1074/jbc.M807095200; Sali A, 1999, NATURE, V402, P23, DOI 10.1038/46915; Salim HMW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-279; Salim HMW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000701; Sauter M, 2005, PLANT J, V44, P718, DOI 10.1111/j.1365-313X.2005.02564.x; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2001, BMC Microbiol, V1, P15, DOI 10.1186/1471-2180-1-15; Sekowska A, 1999, DNA Res, V6, P255, DOI 10.1093/dnares/6.5.255; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Tamura H, 2008, PROTEIN SCI, V17, P126, DOI 10.1110/ps.073169008; Tamura H, 2009, ACTA CRYSTALLOGR D, V65, P942, DOI 10.1107/S0907444909022422; Wang H, 2005, ACTA CRYSTALLOGR F, V61, P521, DOI 10.1107/S174430910501184X; Wang H, 2005, J MOL BIOL, V348, P917, DOI 10.1016/j.jmb.2005.01.072; Warlick BPE, 2012, BIOCHEMISTRY-US, V51, P9470, DOI 10.1021/bi301311t; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147; Xu QP, 2007, PROTEINS, V69, P433, DOI 10.1002/prot.21602; Xu QP, 2006, PROTEINS, V64, P808, DOI 10.1002/prot.20947; Zhang YL, 2004, BIOORGAN MED CHEM, V12, P3847, DOI 10.1016/j.bmc.2004.05.002	56	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67385	10.1371/journal.pone.0067385	http://dx.doi.org/10.1371/journal.pone.0067385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840871	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900010
J	Bertani, S; Pineau, P; Loli, S; Moura, J; Zimic, M; Deharo, E; Ruiz, E				Bertani, Stephane; Pineau, Pascal; Loli, Sebastian; Moura, Julien; Zimic, Mirko; Deharo, Eric; Ruiz, Eloy			An Atypical Age-Specific Pattern of Hepatocellular Carcinoma in Peru: A Threat for Andean Populations	PLOS ONE			English	Article							GENE-EXPRESSION; GLOBAL BURDEN; STEM-CELLS; CANCER; RESECTION; BIMODALITY	Background: In South America, the highest incidence of primary liver cancer is observed in Peru. However, national estimations on hepatocellular carcinoma incidence and mortality are approximated using aggregated data from surrounding countries. Thus, there is a lack of tangible information from Peru that impairs an accurate description of the local incidence, presentation, and outcomes of hepatocellular carcinoma. The present study attempts to fill this gap and assesses the clinical epidemiology of hepatocellular carcinoma in this country. Methods: A retrospective cohort study was conducted by analysing the medical charts of 1,541 patients with hepatocellular carcinoma admitted between 1997 and 2010 at the Peruvian national institute for cancer. The medical records including liver function, serologic status, and tumor pathology and stage were monitored. Statistical analyses were performed in order to characterize tumor presentation according to demographic features, risk factors, and regional origin. Results: Surprisingly, the age distribution of the patient population displayed bimodality corresponding to two distinct age-based subpopulations. While an older group was in keeping with the age range observed for hepatocellular carcinoma around the world, a younger population displayed an abnormally juvenile mean age of 25.5 years old. In addition, each subpopulation displayed age-specific pathophysiological and clinical characteristics. Conclusions: The analysis suggests two different age-specific natural histories of hepatocellular carcinoma in the Peruvian patient population. This otherwise unusual tumor process that is ongoing in younger patients leads to the hypothesis that there may be a Peru-endemic risk factor driving hepatocarcinogenesis in the local population.	[Bertani, Stephane; Deharo, Eric] Univ Toulouse 3, Unite Pharmacochim & Pharmacol Dev, UMR152, F-31062 Toulouse, France; [Bertani, Stephane; Deharo, Eric] Inst Rech Dev, Unite Pharmacochim & Pharmacol Dev, UMR152, Lima, Peru; [Pineau, Pascal] Inst Pasteur, INSERM, Nucl Org & Oncogenesis Unit, U993, F-75724 Paris, France; [Loli, Sebastian; Zimic, Mirko] Univ Peruana Cayetano Heredia, Fac Ciencias, Labs Invest & Desarrollo, Unidad Bioinformat & Biol Mol, Lima, Peru; [Moura, Julien] Inst Rech Dev, Programme Andin Rech & Format Vulnerabilite & Ris, Lima, Peru; [Ruiz, Eloy] Inst Nacl Enfermedades Neoplas, Dept Cirugia Abdomen, Lima, Peru	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidad Peruana Cayetano Heredia; Institut de Recherche pour le Developpement (IRD); Instituto Nacional de Enfermedades Neoplasicas	Bertani, S (corresponding author), Univ Toulouse 3, Unite Pharmacochim & Pharmacol Dev, UMR152, F-31062 Toulouse, France.	stephane.bertani@ird.fr	Pineau, Pascal/AAP-5614-2020; Loli, Sebastian/ABD-8263-2020; Bertani, Stephane/B-1250-2013; Deharo, Eric/I-6026-2015	Pineau, Pascal/0000-0002-9407-1592; Loli, Sebastian/0000-0001-8656-332X; Bertani, Stephane/0000-0002-0398-9745; Deharo, Eric/0000-0002-5664-9517				Ahmed SE, 2008, COMMUN STAT-THEOR M, V37, P1147, DOI 10.1080/03610920701713286; Allemann P, 2012, WORLD J SURG, V36, P2684; Averhoff FM, 2012, CLIN INFECT DIS   S1, P10; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Choi GH, 2009, AM J SURG, V198, P693, DOI 10.1016/j.amjsurg.2008.09.019; COX DR, 1972, J R STAT SOC B, V34, P187; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DZIADEK MA, 1983, EMBO J, V2, P549, DOI 10.1002/j.1460-2075.1983.tb01461.x; Edge SB, 2002, AJCC CANC STAGING MA; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; HADI AS, 1993, J AM STAT ASSOC, V88, P1264, DOI 10.2307/2291266; Hasegawa K, 2007, SAUDI MED J, V28, P1171; Hiotis Spiros P, 2012, BMC Gastroenterol, V12, P64, DOI 10.1186/1471-230X-12-64; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Mack TM, 2001, LANCET, V357, P1638, DOI 10.1016/S0140-6736(00)04860-1; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marrero JA, 2006, J HEPATOL, V44, P630, DOI 10.1016/j.jhep.2006.02.003; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Robinson Helen M, 2012, Pac Health Dialog, V18, P179; Schneider PD, 2004, SURG CLIN N AM, V84, P355, DOI 10.1016/S0039-6109(03)00224-X; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Sherman M, 2010, J HEPATOL, V52, P939, DOI 10.1016/j.jhep.2010.02.006; SHIOJIRI N, 1991, CANCER RES, V51, P2611; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Tabuse M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-60; Tang YH, 2012, HEPATO-GASTROENTEROL, V59, P1393, DOI 10.5754/hge10600; Teschendorff AE, 2006, BIOINFORMATICS, V22, P2269, DOI 10.1093/bioinformatics/btl174; TYNER AL, 1990, J CELL BIOL, V110, P915, DOI 10.1083/jcb.110.4.915; Van Thiel David H, 2011, J Gastrointest Cancer, V42, P191, DOI 10.1007/s12029-010-9195-3; VANRENSBURG SJ, 1985, BRIT J CANCER, V51, P713, DOI 10.1038/bjc.1985.107; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; von Meltzer M, 2008, VIRUS GENES, V37, P225, DOI 10.1007/s11262-008-0261-x; Wang J, 2009, CANCER INFORM, V7, P199; Waniez P, 2011, U BORDEAUX SEGALEN; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yamashita YI, 2011, J SURG ONCOL, V104, P292, DOI 10.1002/jso.21931; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang SH, 2007, SURGERY, V141, P598, DOI 10.1016/j.surg.2006.11.006	51	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67756	10.1371/journal.pone.0067756	http://dx.doi.org/10.1371/journal.pone.0067756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840771	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400132
J	Gaspar, JG; Neider, MB; Simons, DJ; McCarley, JS; Kramer, AF				Gaspar, John G.; Neider, Mark B.; Simons, Daniel J.; McCarley, Jason S.; Kramer, Arthur F.			Change Detection: Training and Transfer	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; CHANGE BLINDNESS; CHESS PLAYERS; OLDER-ADULTS; DISCRIMINATION; CONJUNCTIONS; SPECIFICITY; RECOGNITION; ORIENTATION	Observers often fail to notice even dramatic changes to their environment, a phenomenon known as change blindness. If training could enhance change detection performance in general, then it might help to remedy some real-world consequences of change blindness (e.g. failing to detect hazards while driving). We examined whether adaptive training on a simple change detection task could improve the ability to detect changes in untrained tasks for young and older adults. Consistent with an effective training procedure, both young and older adults were better able to detect changes to trained objects following training. However, neither group showed differential improvement on untrained change detection tasks when compared to active control groups. Change detection training led to improvements on the trained task but did not generalize to other change detection tasks.	[Gaspar, John G.; Simons, Daniel J.; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Gaspar, John G.; Simons, Daniel J.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; [Neider, Mark B.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA; [McCarley, Jason S.] Flinders Univ S Australia, Dept Psychol, Adelaide, SA 5001, Australia	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; State University System of Florida; University of Central Florida; Flinders University South Australia	Gaspar, JG (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	jgaspar2@illinois.edu	Simons, Daniel J./P-3625-2019; McCarley, Jason S./J-1100-2019; Kramer, Arthur/AAB-2937-2019	McCarley, Jason S./0000-0002-8824-7491; Kramer, Arthur/0000-0001-5870-2724	Office of Naval Research [N000140710903]	Office of Naval Research(Office of Naval Research)	The Office of Naval Research supported this project (grant number N000140710903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMOWICZ JK, 1976, J GERONTOL, V31, P39, DOI 10.1093/geronj/31.1.39; Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Ahissar M, 1996, PERCEPTUAL CONSTANCI; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Beck MR, HUM FACTORS; Boot WR, 2009, ATTEN PERCEPT PSYCHO, V71, P950, DOI 10.3758/APP.71.4.950; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; CHARNESS N, 1981, J GERONTOL, V36, P615, DOI 10.1093/geronj/36.5.615; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Fahle M, 1996, CURR BIOL, V6, P292, DOI 10.1016/S0960-9822(02)00479-7; FIORENTINI A, 1981, VISION RES, V21, P1149, DOI 10.1016/0042-6989(81)90017-1; Furmanski CS, 2000, VISION RES, V40, P473, DOI 10.1016/S0042-6989(99)00134-0; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; Hoffman L, 2005, PSYCHOL AGING, V20, P610, DOI 10.1037/0882-7974.20.4.610; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Kramer A.F, 1999, ATTENTION PERFORMANC; Loh WY, 1997, STAT SINICA, V7, P815; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; McCarley JS, 2004, PSYCHOL SCI, V15, P302, DOI 10.1111/j.0956-7976.2004.00673.x; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Neider MB, 2010, ACTA PSYCHOL, V134, P29, DOI 10.1016/j.actpsy.2009.12.001; Owens M, 2013, PSYCHOPHYS, V10, P1; Pringle HL, 2001, PSYCHON B REV, V8, P89, DOI 10.3758/BF03196143; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; SHEPARD RN, 1967, J VERB LEARN VERB BE, V6, P156, DOI 10.1016/S0022-5371(67)80067-7; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Simons DJ, 2000, VIS COGN, V7, P1, DOI 10.1080/135062800394658; Smith JD, 2005, J EXP PSYCHOL GEN, V134, P443, DOI 10.1037/0096-3445.134.4.443; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Werner S, 2000, VIS COGN, V7, P163, DOI 10.1080/135062800394748	38	18	18	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67781	10.1371/journal.pone.0067781	http://dx.doi.org/10.1371/journal.pone.0067781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840775	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400135
J	Hsu, TC; Tsai, CC; Chiu, CC; Hsu, JD; Tzang, BS				Hsu, Tsai-Ching; Tsai, Chun-Chou; Chiu, Chun-Ching; Hsu, Jeng-Dong; Tzang, Bor-Show			Exacerbating Effects of Human Parvovirus B19 NS1 on Liver Fibrosis in NZB/W F1 Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR-ALPHA; PROTEIN; DISEASE; INTERLEUKIN-6; ASSOCIATION; EXPRESSION; APOPTOSIS; MECHANISMS; ANTIBODIES	Systemic lupus erythematosus (SLE) is an autoimmune disorder with unknown etiology that impacts various organs including liver. Recently, human parvovirus B19 (B19) is recognized to exacerbate SLE. However, the effects of B19 on liver in SLE are still unclear. Herein we aimed to investigate the effects of B19 on liver in NZB/W F1 mice by injecting subcutaneously with PBS, recombinant B19 NS1, VP1u or VP2, respectively. Our experimental results revealed that B19 NS1 protein significantly enhanced the TGF-beta/Smad fibrotic signaling by increasing the expressions of TGF-beta, Smad2/3, phosphorylated Smad2/3, Smad4 and Sp1. The consequent fibrosis-related proteins, PAI-1 and alpha-SMA, were also significantly induced in livers of NZB/W F1 mice receiving B19 NS1 protein. Accordingly, markedly increased collagen deposition was also observed in livers of NZB/W F1 mice receiving B19 NS1 protein. However, no significant difference was observed in livers of NZB/W F1 mice receiving B19 VP1u or VP2 as compared to the controls. These findings indicate that B19 NS1 plays a crucial role in exacerbating liver fibrosis in NZB/W F1 mice through enhancing the TGF-(a) over cap /Smad fibrotic signaling.	[Hsu, Tsai-Ching; Tsai, Chun-Chou; Chiu, Chun-Ching] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Hsu, Tsai-Ching; Tzang, Bor-Show] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan; [Hsu, Tsai-Ching] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Hsu, Tsai-Ching; Tzang, Bor-Show] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Chiu, Chun-Ching] Chunghua Christian Hosp, Dept Neurol, Chunghua, Taiwan; [Chiu, Chun-Ching] Chunghua Christian Hosp, Dept Med Intens Care Unit, Chunghua, Taiwan; [Hsu, Jeng-Dong] Chung Shan Med Univ, Sch Med, Dept Pathol, Taichung, Taiwan; [Hsu, Jeng-Dong] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; Asia University Taiwan; Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Tzang, BS (corresponding author), Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan.	bstzang@csmu.edu.tw		Bor-Show, Tzang/0000-0003-0140-9943	National Science Council, Taiwan, Republic of China [NSC 97-2314-B040-009, NSC 98-2314-B-040-008-MY3, NSC-99-2320-B-040-004-MY3, NSC 101-2314-B-040-008, NSC 99-2320-B-040-007-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by NSC 97-2314-B040-009, NSC 98-2314-B-040-008-MY3, NSC-99-2320-B-040-004-MY3, NSC 101-2314-B-040-008 and NSC 99-2320-B-040-007-MY3 from the National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abraham S, 2004, ANN RHEUM DIS, V63, P123, DOI 10.1136/ard.2002.001826; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen DY, 2010, CLIN CHIM ACTA, V411, P1084, DOI 10.1016/j.cca.2010.04.004; Chowdhary VR, 2008, J RHEUMATOL, V35, P2159, DOI 10.3899/jrheum.080336; Dixon JB, 2003, J HEPATOL, V39, P967, DOI 10.1016/S0168-8278(03)00459-8; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Fu Y, 2002, J VIROL, V76, P5395, DOI 10.1128/JVI.76.11.5395-5403.2002; Hahn BH, 1993, DUBOIS LUPUS ERYTHEM, P69; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hsu TC, 2006, CLIN EXP IMMUNOL, V144, P152, DOI 10.1111/j.1365-2249.2006.03023.x; Hsu TC, 2008, J AGR FOOD CHEM, V56, P9685, DOI 10.1021/jf8020255; Hsu TC, 2010, FOOD CHEM, V119, P62, DOI 10.1016/j.foodchem.2009.05.088; KAJIGAYA S, 1991, P NATL ACAD SCI USA, V88, P4646, DOI 10.1073/pnas.88.11.4646; Lehmann HW, 2003, AUTOIMMUN REV, V2, P218, DOI 10.1016/S1568-9972(03)00014-4; MACKAY IR, 1959, LANCET, V1, P65; Magro CM, 2006, APPL IMMUNOHISTO M M, V14, P208, DOI 10.1097/01.pai.0000160730.54062.6d; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; MEIJER C, 1993, LUPUS, V2, P359, DOI 10.1177/096120339300200605; Mitchell LA, 2002, J MED VIROL, V67, P267, DOI 10.1002/jmv.2217; Mukai M, 2000, LUPUS, V9, P74, DOI 10.1177/096120330000900115; NEUNER P, 1994, IMMUNOLOGY, V83, P262; Piek E, 1999, INT J CANCER, V80, P756, DOI 10.1002/(SICI)1097-0215(19990301)80:5<756::AID-IJC21>3.0.CO;2-N; RUNYON BA, 1980, AM J MED, V69, P187, DOI 10.1016/0002-9343(80)90378-2; Seve P, 2005, SEMIN ARTHRITIS RHEU, V34, P642, DOI 10.1016/j.semarthrit.2004.07.008; Shek FW, 2004, EUR J GASTROEN HEPAT, V16, P123, DOI 10.1097/00042737-200402000-00001; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Tsai CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059724; Tzang BS, 2008, INT IMMUNOPHARMACOL, V8, P589, DOI 10.1016/j.intimp.2008.01.010; Tzang BS, 2007, CLIN CHIM ACTA, V378, P59, DOI 10.1016/j.cca.2006.10.016; Tzang BS, 2011, MOL IMMUNOL, V48, P1518, DOI 10.1016/j.molimm.2011.04.013; Tzang BS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-40; Tzang BS, 2009, CLIN CHIM ACTA, V405, P76, DOI 10.1016/j.cca.2009.04.002; von Landenberg P, 2003, ARTHRITIS RHEUM-US, V48, P1939, DOI 10.1002/art.11038; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Xu RA, 2012, CELL MOL IMMUNOL, V9, P296, DOI 10.1038/cmi.2011.53; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840	38	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68393	10.1371/journal.pone.0068393	http://dx.doi.org/10.1371/journal.pone.0068393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840852	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400193
J	Myers, CE; Bermudez-Hernandez, K; Scharfman, HE				Myers, Catherine E.; Bermudez-Hernandez, Keria; Scharfman, Helen E.			The Influence of Ectopic Migration of Granule Cells into the Hilus on Dentate Gyrus-CA3 Function	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SEIZURE-INDUCED NEUROGENESIS; CA3 PYRAMIDAL CELLS; RAT HIPPOCAMPAL SLICES; PILOCARPINE-INDUCED SEIZURES; INDUCED STATUS EPILEPTICUS; ENHANCED SYNAPTIC PLASTICITY; HILAR MOSSY CELLS; KNOCK-OUT MICE; NEUROPEPTIDE-Y	Postnatal neurogenesis of granule cells (GCs) in the dentate gyrus (DG) produces GCs that normally migrate from the subgranular zone to the GC layer. However, GCs can mismigrate into the hilus, the opposite direction. Previous descriptions of these hilar ectopic GCs (hEGCs) suggest that they are rare unless there are severe seizures. However, it is not clear if severe seizures are required, and it also is unclear if severe seizures are responsible for the abnormalities of hEGCs, which include atypical dendrites and electrophysiological properties. Here we show that large numbers of hEGCs develop in a transgenic mouse without severe seizures. The mice have a deletion of BAX, which normally regulates apoptosis. Surprisingly, we show that hEGCs in the BAX(-/-)mouse have similar abnormalities as hEGCs that arise after severe seizures. We next asked if there are selective effects of hEGCs, i.e., whether a robust population of hEGCs would have any effect on the DG if they were induced without severe seizures. Indeed, this appears to be true, because it has been reported that BAX(-/-)mice have defects in a behavior that tests pattern separation, which depends on the DG. However, inferring functional effects of hEGCs is difficult in mice with a constitutive BAX deletion because there is decreased apoptosis in and outside the DG. Therefore, a computational model of the normal DG and hippocampal subfield CA3 was used. Adding a small population of hEGCs (5% of all GCs), with characteristics defined empirically, was sufficient to disrupt a simulation of pattern separation and completion. Modeling results also showed that effects of hEGCs were due primarily to "backprojections" of CA3 pyramidal cell axons to the hilus. The results suggest that hEGCs can develop for diverse reasons, do not depend on severe seizures, and a small population of hEGCs may impair DG-dependent function.	[Myers, Catherine E.] New Jersey Healthcare Syst, NeuroBehav Res Lab, Vet Affairs Med Ctr, E Orange, NJ USA; [Myers, Catherine E.] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Myers, Catherine E.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [Bermudez-Hernandez, Keria] NYU, Sackler Program Biomed Sci, Langone Med Ctr, New York, NY USA; [Bermudez-Hernandez, Keria; Scharfman, Helen E.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Scharfman, Helen E.] NYU, Langone Med Ctr, New York, NY USA	New Jersey Department of Health & Senior Services; US Department of Veterans Affairs; Veterans Health Administration (VHA); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center	Scharfman, HE (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA.	hscharfman@nki.rfmh.org	Myers, Catherine E./AAU-5804-2020	Myers, Catherine E./0000-0002-2776-4823	NIH [MH-090606]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH090606] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by NIH MH-090606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2011, EUR J NEUROSCI, V33, P1160, DOI 10.1111/j.1460-9568.2011.07615.x; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; Baram T. Z., 2001, FEBRILE SEIZURES; Barkas L, 2012, BRAIN, V135, P2358, DOI 10.1093/brain/aws176; Becker S, 2009, BRAIN RES, V1299, P45, DOI 10.1016/j.brainres.2009.07.095; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Bering R, 1997, EXP BRAIN RES, V115, P423, DOI 10.1007/PL00005712; Blaabjerg M, 2007, PROG BRAIN RES, V163, P85, DOI 10.1016/S0079-6123(07)63005-2; BlascoIbanez JM, 1997, HIPPOCAMPUS, V7, P307, DOI 10.1002/(SICI)1098-1063(1997)7:3<307::AID-HIPO6>3.0.CO;2-H; Boyett JM, 2001, HIPPOCAMPUS, V11, P418, DOI 10.1002/hipo.1056; Brooks-Kayal A., EPILEPSIA IN PRESS; Buckmaster P, 2012, JASPERS BASIC MECH E; Cameron MC, 2011, J COMP NEUROL, V519, P2175, DOI 10.1002/cne.22623; Chambers RA, 2007, J COGNITIVE NEUROSCI, V19, P1, DOI 10.1162/jocn.2007.19.1.1; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Dashtipour K, 2001, BRAIN RES, V890, P261, DOI 10.1016/S0006-8993(00)03119-X; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DELLER T, 1990, J COMP NEUROL, V300, P433, DOI 10.1002/cne.903000312; DELLER T, 1995, J COMP NEUROL, V352, P55, DOI 10.1002/cne.903520105; DELLER T, 1994, J COMP NEUROL, V350, P612, DOI 10.1002/cne.903500408; Derrick BE, 2007, PROG BRAIN RES, V163, P417, DOI 10.1016/S0079-6123(07)63024-6; Fournier NM, 2013, EXP NEUROL, V244, P96, DOI 10.1016/j.expneurol.2012.11.031; Frotscher M, 2006, CELL TISSUE RES, V326, P361, DOI 10.1007/s00441-006-0269-2; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; GOODMAN JH, 1992, HIPPOCAMPUS, V2, P13, DOI 10.1002/hipo.450020103; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Houser CR, 2007, PROG BRAIN RES, V163, P217, DOI 10.1016/S0079-6123(07)63013-1; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jessberger S, 2007, J NEUROSCI, V27, P5967, DOI 10.1523/JNEUROSCI.0110-07.2007; Jinde S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00014; Jung AR, 2008, J NEUROSCI, V28, P2941, DOI 10.1523/JNEUROSCI.3897-07.2008; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007; Kim WR, 2009, EUR J NEUROSCI, V29, P1408, DOI 10.1111/j.1460-9568.2009.06693.x; KNEISLER TB, 1995, J PHYSIOL-LONDON, V487, P125, DOI 10.1113/jphysiol.1995.sp020866; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Kuruba Ramkumar, 2007, CNS & Neurological Disorders-Drug Targets, V6, P342, DOI 10.2174/187152707783220884; Lacefield CO, 2012, HIPPOCAMPUS, V22, P106, DOI 10.1002/hipo.20860; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; LEVY WB, 1983, NEUROSCIENCE, V8, P799, DOI 10.1016/0306-4522(83)90011-8; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; LUBBERS K, 1987, ANAT EMBRYOL, V177, P1, DOI 10.1007/BF00325285; Lubke J, 1998, J NEUROPHYSIOL, V79, P1518, DOI 10.1152/jn.1998.79.3.1518; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; McCloskey DP, 2006, EUR J NEUROSCI, V24, P2203, DOI 10.1111/j.1460-9568.2006.05101.x; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILNER TA, 1992, HIPPOCAMPUS, V2, P107, DOI 10.1002/hipo.450020204; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mohapel P, 2004, NEUROBIOL DIS, V15, P196, DOI 10.1016/j.nbd.2003.11.010; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Myers CE, 2011, HIPPOCAMPUS, V21, P1190, DOI 10.1002/hipo.20828; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; Neunuebel JP, 2012, J NEUROSCI, V32, P3848, DOI 10.1523/JNEUROSCI.6038-11.2012; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 2002, PROG BRAIN RES, V135, P121; Parent JM, 1997, J NEUROSCI, V17, P3727; Pierce JP, 2007, NEUROSCI LETT, V422, P136, DOI 10.1016/j.neulet.2007.06.016; Pierce JP, 2011, J COMP NEUROL, V519, P1196, DOI 10.1002/cne.22568; Pierce JP, 2005, EXP NEUROL, V196, P316, DOI 10.1016/j.expneurol.2005.08.007; Ribak CE, 2007, PROG BRAIN RES, V163, P155, DOI 10.1016/S0079-6123(07)63009-X; Rutten A, 2002, EUR J NEUROSCI, V16, P501, DOI 10.1046/j.1460-9568.2002.02103.x; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; SCHARFMAN HE, 1993, HIPPOCAMPUS, V3, P9, DOI 10.1002/hipo.450030103; SCHARFMAN HE, 1995, HIPPOCAMPUS, V5, P287, DOI 10.1002/hipo.450050403; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; Scharfman HE, 2003, NEUROSCIENCE, V121, P1017, DOI 10.1016/S0306-4522(03)00481-0; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; SCHARFMAN HE, 1994, J NEUROSCI, V14, P6041; Scharfman HE, 2002, J COMP NEUROL, V454, P424, DOI 10.1002/cne.10449; Scharfman HE, 2002, EXP NEUROL, V174, P201, DOI 10.1006/exnr.2002.7869; SCHARFMAN HE, 1994, NEUROSCIENCE, V59, P245, DOI 10.1016/0306-4522(94)90593-2; SCHARFMAN HE, 1994, J NEUROPHYSIOL, V72, P2167, DOI 10.1152/jn.1994.72.5.2167; SCHARFMAN HE, 1992, EPILEPSY RES, P93; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Scharfman HE, 2007, SCIENCE, V315, P336, DOI 10.1126/science.1138711; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Scharfman HE, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00106; Scharfman HE, 2012, EPILEPSIA, V53, P98, DOI 10.1111/j.1528-1167.2012.03480.x; Scharfman HE, 2009, EPILEPSY RES, V85, P150, DOI 10.1016/j.eplepsyres.2009.03.006; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Scott BW, 1998, NEUROSCI LETT, V248, P73, DOI 10.1016/S0304-3940(98)00355-3; SERESS L, 1992, BRAIN RES, V569, P353, DOI 10.1016/0006-8993(92)90651-O; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Sperk G, 2007, PROG BRAIN RES, V163, P285, DOI 10.1016/S0079-6123(07)63017-9; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Takahashi Y, 2000, NEUROSCI LETT, V287, P105, DOI 10.1016/S0304-3940(00)01133-2; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Urban NN, 2001, HIPPOCAMPUS, V11, P408, DOI 10.1002/hipo.1055.abs; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vezzani A, 1996, EPILEPSY RES, V26, P267, DOI 10.1016/S0920-1211(96)00059-9; Weisz VI, 2012, COGNITION, V125, P13, DOI 10.1016/j.cognition.2012.07.002; Williamson A, 2007, PROG BRAIN RES, V163, P183, DOI 10.1016/S0079-6123(07)63011-8; Winawer MR, 2007, NEUROSCIENCE, V149, P465, DOI 10.1016/j.neuroscience.2007.06.009; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Wong R K, 1986, Adv Neurol, V44, P583; Zhan RZ, 2010, J NEUROPHYSIOL, V104, P3293, DOI 10.1152/jn.00663.2010; Zhan RZ, 2009, J NEUROPHYSIOL, V102, P670, DOI 10.1152/jn.00147.2009	115	50	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68208	10.1371/journal.pone.0068208	http://dx.doi.org/10.1371/journal.pone.0068208			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840835	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400177
J	Song, MH; Kwon, TJ; Kim, HR; Jeon, JH; Baek, JI; Lee, WS; Kim, UK; Choi, JY				Song, Mee Hyun; Kwon, Tae-Jun; Kim, Hui Ram; Jeon, Ju Hyun; Baek, Jeong-In; Lee, Won-Sang; Kim, Un-Kyung; Choi, Jae Young			Mutational Analysis of EYA1, SIX1 and SIX5 Genes and Strategies for Management of Hearing Loss in Patients with BOR/BO Syndrome	PLOS ONE			English	Article							BRANCHIOOTORENAL SYNDROME; VESTIBULAR AQUEDUCT; PHENOTYPIC CONSEQUENCES; KOREAN FAMILY; MECHANISM; CHILDREN; EAR	Background: Branchio-oto-renal (BOR) or branchio-otic (BO) syndrome is one of the most common forms of autosomal dominant syndromic hearing loss. Mutations in EYA1, SIX1 and SIX5 genes have been associated with BOR syndrome. In this study, clinical and genetic analyses were performed in patients with BOR/BO syndrome focusing on auditory manifestations and rehabilitation. Methods: The audiologic manifestations were reviewed in 10 patients with BOR/BO syndrome. The operative findings and hearing outcome were analyzed in patients who underwent middle ear surgeries. The modality and outcome of auditory rehabilitation were evaluated. Genetic analysis was performed for EYA1, SIX1, and SIX5 genes. Results: All patients presented with mixed hearing loss. Five patients underwent middle ear surgeries without successful hearing gain. Cochlear implantation performed in two patients resulted in significant hearing improvement. Genetic analysis revealed four novel EYA1 mutations and a large deletion encompassing the EYA1 gene. Conclusions: Auditory rehabilitation in BOR/BO syndrome should be individually tailored keeping in mind the high failure rate after middle ear surgeries. Successful outcome can be expected with cochlear implantations in patients with BOR/BO syndrome who cannot benefit from hearing aids. The novel EYA1 mutations may add to the genotypic and phenotypic spectrum of BOR syndrome in the East Asian population.	[Song, Mee Hyun] Kwandong Univ, Coll Med, Dept Otorhinolaryngol, Myongji Hosp, Goyang, South Korea; [Kwon, Tae-Jun; Kim, Hui Ram; Baek, Jeong-In; Kim, Un-Kyung] Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Taegu, South Korea; [Jeon, Ju Hyun] Inje Univ, Dept Otorhinolaryngol, Coll Med, Goyang, South Korea; [Lee, Won-Sang; Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea	Catholic Kwandong University; Myongji Hospital; Kyungpook National University; Inje University; Yonsei University; Yonsei University Health System	Kim, UK (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Taegu, South Korea.	kimuk@knu.ac.kr; jychoi@yuhs.ac		choi, jae young/0000-0001-9493-3458	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A1015761, 2011-0028066]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1015761) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0028066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Bajaj Yogesh, 2012, Cochlear Implants Int, V13, P163, DOI 10.1179/1754762811Y.0000000020; Buchman CA, 2004, LARYNGOSCOPE, V114, P309, DOI 10.1097/00005537-200402000-00025; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; CHEN A, 1995, AM J MED GENET, V58, P365, DOI 10.1002/ajmg.1320580413; CREMERS CWRJ, 1981, ORL J OTO-RHINO-LARY, V43, P223, DOI 10.1159/000275541; FRASER FC, 1980, AM J MED GENET, V7, P341, DOI 10.1002/ajmg.1320070316; Hoskins BE, 2007, AM J HUM GENET, V80, P800, DOI 10.1086/513322; Ito T, 2006, LARYNGOSCOPE, V116, P796, DOI 10.1097/01.mlg.0000209096.40400.96; Kalatzis V, 1998, DEV DYNAM, V213, P486, DOI 10.1002/(SICI)1097-0177(199812)213:4<486::AID-AJA13>3.0.CO;2-L; Kemperman MH, 2001, OTOL NEUROTOL, V22, P637, DOI 10.1097/00129492-200109000-00014; Kim SC, 2011, OTOLARYNG HEAD NECK, V145, P303, DOI 10.1177/0194599811403076; Kim SH, 2005, INT J PEDIATR OTORHI, V69, P1123, DOI 10.1016/j.ijporl.2005.03.003; Kochhar A, 2007, AM J MED GENET A, V143A, P1671, DOI 10.1002/ajmg.a.31561; Krug P, 2011, HUM MUTAT, V32, P183, DOI 10.1002/humu.21402; Kwon MJ, 2009, ACTA OTO-LARYNGOL, V129, P688, DOI 10.1080/00016480802342432; Lee KY, 2007, INT J PEDIATR OTORHI, V71, P169, DOI 10.1016/j.ijporl.2006.08.023; Matsunaga T, 2007, ACTA OTO-LARYNGOL, V127, P98, DOI 10.1080/00016480500527185; Merchant SN, 2007, ANN OTO RHINOL LARYN, V116, P532, DOI 10.1177/000348940711600709; Morisada N, 2010, PEDIATR NEPHROL, V25, P1343, DOI 10.1007/s00467-010-1445-x; Mosrati MA, 2011, EUR J MED GENET, V54, pE484, DOI 10.1016/j.ejmg.2011.06.001; Orten DJ, 2008, HUM MUTAT, V29, P537, DOI 10.1002/humu.20691; Ozaki H, 2002, J HUM GENET, V47, P107, DOI 10.1007/s100380200011; Propst EJ, 2005, LARYNGOSCOPE, V115, P1855, DOI 10.1097/01.mlg.0000177032.98386.20; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Sanggaard KM, 2007, EUR J HUM GENET, V15, P1121, DOI 10.1038/sj.ejhg.5201900; Sennaroglu Levent, 2010, Cochlear Implants Int, V11, P4, DOI 10.1002/cii.416; Song MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024511; Stockley TL, 2009, AM J MED GENET A, V149A, P322, DOI 10.1002/ajmg.a.32679; Wang SH, 2012, LARYNGOSCOPE, V122, P1130, DOI 10.1002/lary.23217	30	21	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67236	10.1371/journal.pone.0067236	http://dx.doi.org/10.1371/journal.pone.0067236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840632	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400044
J	Grundemann, C; Thell, K; Lengen, K; Garcia-Kaufer, M; Huang, YH; Huber, R; Craik, DJ; Schabbauer, G; Gruber, CW				Gruendemann, Carsten; Thell, Kathrin; Lengen, Karin; Garcia-Kaeufer, Manuel; Huang, Yen-Hua; Huber, Roman; Craik, David J.; Schabbauer, Gernot; Gruber, Christian W.			Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; KV1.3 POTASSIUM CHANNELS; PLANT CYCLOTIDES; IMMUNOSUPPRESSIVE PEPTIDE; CIRCULAR MINIPROTEINS; SCANNING MUTAGENESIS; CYCLOSPORINE-A; KALATA B1; KNOT; EXPRESSION	Cyclotides are a diverse and abundant group of ribosomally synthesized plant peptides containing a unique cyclic cystine-knotted topology that confers them with remarkable stability. Kalata B1, a representative member of this family of mini-proteins, has been found to inhibit the proliferation of human peripheral blood mononuclear cells. Analysis of T-cell proliferation upon treatment with chemically synthesized kalata B1 mutants revealed a region comprising inter-cysteine loops 1 and 2 of the cyclotide framework to be important for biological activity. Cytokine signaling analysis using an 'active' kalata B1 mutant [T20K], and the reference drug cyclosporin A (CsA) demonstrated that treatment of activated T-lymphocytes with these compounds decreased the expression of the interleukin-2 (IL-2) surface receptor as well as IL-2 cytokine secretion and IL-2 gene expression, whereas the 'inactive' kalata B1 mutant [V10K] did not cause any effects. The anti-proliferative activity of [T20K] kalata B1 was antagonized by addition of exogenous IL-2. Furthermore, treatment with [T20K] kalata B1 led to an initial reduction of the effector function, as indicated by the reduced IFN-gamma and TNF-alpha production, but the levels of both cytokines stabilized over time and returned to their normal levels. On the other hand, the degranulation activity remained reduced. This indicated that cyclotides interfere with T-cell polyfunctionality and arrest the proliferation of immune-competent cells through inhibiting IL-2 biology at more than one site. The results open new avenues to utilize native and synthetically-optimized cyclotides for applications in immune-related disorders and as immunosuppressant peptides.	[Gruendemann, Carsten; Thell, Kathrin; Schabbauer, Gernot; Gruber, Christian W.] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Gruendemann, Carsten; Lengen, Karin; Garcia-Kaeufer, Manuel; Huber, Roman] Univ Med Ctr Freiburg, Ctr Complementary Med, Dept Environm Hlth Sci, Freiburg, Germany; [Huang, Yen-Hua; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Medical University of Vienna; University of Freiburg; University of Queensland	Gruber, CW (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria.	christian.w.gruber@meduniwien.ac.at	Gruber, Christian/C-4406-2011; Garcia-Käufer, Manuel/AAF-8340-2020; Huang, Yen-Hua/J-9056-2014; Craik, David/B-1695-2010	Huang, Yen-Hua/0000-0001-6937-2660; Craik, David/0000-0003-0007-6796; Gruber, Christian/0000-0001-6060-7048; Schabbauer, Gernot/0000-0002-7490-8009	Austrian Science Fund (FWF) [P24743-B21, P22889-B11]; Software AG foundation/DAMUS-Donata [DO-P 9383]; Austrian Science Fund (FWF) [P 24743, P 22889] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Software AG foundation/DAMUS-Donata; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financially supported by the Austrian Science Fund (FWF): P24743-B21 and P22889-B11 and the Software AG foundation/DAMUS-Donata (DO-P 9383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboye TL, 2012, J BIOL CHEM, V287, P27026, DOI 10.1074/jbc.R111.305508; Assinger A, 2008, FEBS LETT, V582, P778, DOI 10.1016/j.febslet.2008.02.001; BETTENS F, 1985, IMMUNOBIOLOGY, V170, P434, DOI 10.1016/S0171-2985(85)80067-X; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Colgrave ML, 2010, ANTIMICROB AGENTS CH, V54, P2160, DOI 10.1128/AAC.01306-09; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2007, CURR OPIN DRUG DISC, V10, P176; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Craik DJ, 2001, TOXICON, V39, P1809, DOI 10.1016/S0041-0101(01)00129-5; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Fuhrmann S, 2012, IMMUNOLOGY, V136, P408, DOI 10.1111/j.1365-2567.2012.03594.x; Giang KTN, 2013, J BIOL CHEM, V288, P3370, DOI 10.1074/jbc.M112.415356; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gruber CW, 2007, J BIOL CHEM, V282, P20435, DOI 10.1074/jbc.M700018200; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Gruber CW, 2010, CURR PHARM DESIGN, V16, P3071; Gruber CW, 2010, BIOPOLYMERS, V94, P565, DOI 10.1002/bip.21414; Grundemann C, 2012, J NAT PROD, V75, P167, DOI 10.1021/np200722w; Gurrola GB, 2012, BIOCHEMISTRY-US, V51, P4049, DOI 10.1021/bi300060n; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Hashempour H, 2013, AMINO ACIDS, V44, P581, DOI 10.1007/s00726-012-1376-x; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Jagadish K, 2013, ANGEW CHEM INT EDIT, V52, P3126, DOI 10.1002/anie.201209219; Katarzynska J, 2011, EUR J MED CHEM, V46, P4608, DOI 10.1016/j.ejmech.2011.07.040; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Mulvenna JP, 2006, PLANT CELL, V18, P2134, DOI 10.1105/tpc.106.042812; Poth AG, 2012, J BIOL CHEM, V287, P27033, DOI 10.1074/jbc.M112.370841; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Ren YH, 2008, MICROBIOL-SGM, V154, P1973, DOI 10.1099/mic.0.2008/017954-0; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schoepke T., 1993, SCI PHARM, V61, P145; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Shah K, 2003, CELL IMMUNOL, V221, P100, DOI 10.1016/S0008-8749(03)00063-7; SHEVACH EM, 1985, ANNU REV IMMUNOL, V3, P397; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; SOLBACH W, 1985, CLIN EXP IMMUNOL, V60, P501; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Trabi M, 2004, J NAT PROD, V67, P806, DOI 10.1021/np034068e; Varga Z, 2012, MOL PHARMACOL, V82, P372, DOI 10.1124/mol.112.078006; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984	53	54	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e68016	10.1371/journal.pone.0068016	http://dx.doi.org/10.1371/journal.pone.0068016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840803	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400127
J	Jansson, A; Norkko, J; Norkko, A				Jansson, Anna; Norkko, Joanna; Norkko, Alf			Effects of Reduced pH on Macoma balthica Larvae from a System with Naturally Fluctuating pH-Dynamics	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; OCEAN ACIDIFICATION; BALTIC SEA; MYTILUS-EDULIS; BLUE MUSSELS; GROWTH; IMPACTS; SIZE; CO2; SURVIVAL	Ocean acidification is causing severe changes in the inorganic carbon balance of the oceans. The pH conditions predicted for the future oceans are, however, already regularly occurring in the Baltic Sea, and the system might thus work as an analogue for future ocean acidification scenarios. The characteristics of the Baltic Sea with low buffering capacity and large natural pH fluctuations, in combination with multiple other stressors, suggest that OA effects may be severe, but remain largely unexplored. A calcifying species potentially affected by low pH conditions is the bivalve Macoma balthica (L.). We investigated larval survival and development of M. balthica by exposing the larvae to a range of pH levels: 7.2, 7.4, 7.7 and 8.1 during 20 days in order to learn what the effects of reduced pH are on the larval biology and thus also potentially for the population dynamics of this key species. We found that even a slight pH decrease causes significant negative changes during the larval phase, both by slowing growth and by decreasing survival. The growth was slower in all reduced pH treatments compared to the control treatment. The size of 250 mm that is considered indicative to imminent settling in our system was reached by 22% of the larvae grown in control conditions after 20 days, whereas in all reduced pH treatments the size of 250 mm was reached by only 7-14%. The strong impact of ocean acidification on larvae is alarming as slowly growing individuals are exposed to higher predation risk in response to the longer time they are required to spend in the plankton, further decreasing the ecological competence of the species.	[Jansson, Anna] Abo Akad Univ, Turku, Finland; [Jansson, Anna; Norkko, Joanna; Norkko, Alf] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Jansson, Anna] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland	Abo Akademi University; University of Helsinki; Finnish Environment Institute	Jansson, A (corresponding author), Abo Akad Univ, Turku, Finland.	jansson.anna.e@gmail.com	Norkko, Alf/A-1856-2012; Norkko, Alf/K-2341-2019; Norkko, Alf/L-8736-2019	Norkko, Alf/0000-0002-9741-4458; Norkko, Alf/0000-0002-9741-4458; Norkko, Joanna/0000-0001-9885-8408	Walter and Andree de Nottbeck Foundation	Walter and Andree de Nottbeck Foundation	This work was funded by the Walter and Andree de Nottbeck Foundation (www.nottbeck.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKAR S, 1980, OPHELIA, P31; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Bonsdorff E, 2006, J EXP MAR BIOL ECOL, V330, P383, DOI 10.1016/j.jembe.2005.12.041; Bonsdorff E, 1995, OLSEN INT S, P253; Brutemark A, 2011, OCEANOL HYDROBIOL ST, V40, P91, DOI 10.2478/s13545-011-0034-3; CADDY JF, 1967, CAN J ZOOLOG, V45, P955, DOI 10.1139/z67-105; CADDY JF, 1969, CAN J ZOOLOG, V47, P609, DOI 10.1139/z69-105; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Crim RN, 2011, J EXP MAR BIOL ECOL, V400, P272, DOI 10.1016/j.jembe.2011.02.002; ELMGREN R, 1986, ECOLOGY, V67, P827, DOI 10.2307/1939805; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Havenhand JN, 2012, AMBIO, V41, P637, DOI 10.1007/s13280-012-0326-x; Hjalmarsson S, 2008, CONT SHELF RES, V28, P593, DOI 10.1016/j.csr.2007.11.010; KAUTSKY N, 1982, MAR BIOL, V68, P117, DOI 10.1007/BF00397599; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Laine AO, 2003, ESTUAR COAST SHELF S, V57, P87, DOI 10.1016/S0272-7714(02)00333-5; Lepparanta M, 2009, SPRINGER-PRAX BOOKS, pXI; Lewis E., 1998, ORNLCDIAC105; Lischka S, 2010, BIOGEOSCIENCES, V7, P8177, DOI DOI 10.5194/BGD-7-8177-2010; Meier HEM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049929; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Michaud E, 2006, J EXP MAR BIOL ECOL, V337, P178, DOI 10.1016/j.jembe.2006.06.025; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Omstedt A, 2010, TELLUS B, V62, P280, DOI 10.1111/j.1600-0889.2010.00463.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pedersen TM, 2008, J MARINE SYST, V73, P185, DOI 10.1016/j.jmarsys.2007.10.008; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Ross PM, 2011, WATER-SUI, V3, P1005, DOI 10.3390/w3041005; Rousi H, 2011, BOREAL ENVIRON RES, V16, P521; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SALONEN K, 1979, LIMNOL OCEANOGR, V24, P177, DOI 10.4319/lo.1979.24.1.0177; Schneider B, 2003, J MARINE SYST, V42, P53, DOI 10.1016/S0924-7963(03)00064-2; Segerstrale S.G, 1962, SOCIETAS SCIENTIARUM, V24, P1; SEGERSTRALE SVEN G., 1960, SOC SCI FENNICA COMMENTAT BIOL, V23, P1; STURESSON U, 1971, OIKOS, V22, P414, DOI 10.2307/3543868; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; TEDENGREN M, 1986, OPHELIA, V25, P147, DOI 10.1080/00785326.1986.10429746; Thomas H, 1999, J MARINE SYST, V22, P53, DOI 10.1016/S0924-7963(99)00030-5; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Timmermann K, 2012, J MARINE SYST, V105, P60, DOI 10.1016/j.jmarsys.2012.06.001; Valanko S, 2010, MAR ECOL PROG SER, V416, P145, DOI 10.3354/meps08796; Valanko S, 2010, J EXP MAR BIOL ECOL, V384, P51, DOI 10.1016/j.jembe.2009.12.012; Van Colen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049795; Van Colen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044655; Villas A, 2011, ECOL APPL, V21, P2172, DOI 10.1890/10-1473.1; Villnas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044920; Westerbom M, 2002, MAR BIOL, V140, P991, DOI 10.1007/s00227-001-0765-6	57	29	30	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e68198	10.1371/journal.pone.0068198	http://dx.doi.org/10.1371/journal.pone.0068198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840833	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400133
J	Hicks, SL; Wilson, I; Muhammed, L; Worsfold, J; Downes, SM; Kennard, C				Hicks, Stephen L.; Wilson, Iain; Muhammed, Louwai; Worsfold, John; Downes, Susan M.; Kennard, Christopher			A Depth-Based Head-Mounted Visual Display to Aid Navigation in Partially Sighted Individuals	PLOS ONE			English	Article							SENSORY SUBSTITUTION; VISION; ENHANCEMENT; BLIND	Independent navigation for blind individuals can be extremely difficult due to the inability to recognise and avoid obstacles. Assistive techniques such as white canes, guide dogs, and sensory substitution provide a degree of situational awareness by relying on touch or hearing but as yet there are no techniques that attempt to make use of any residual vision that the individual is likely to retain. Residual vision can restricted to the awareness of the orientation of a light source, and hence any information presented on a wearable display would have to limited and unambiguous. For improved situational awareness, i.e. for the detection of obstacles, displaying the size and position of nearby objects, rather than including finer surface details may be sufficient. To test whether a depth-based display could be used to navigate a small obstacle course, we built a real-time head-mounted display with a depth camera and software to detect the distance to nearby objects. Distance was represented as brightness on a low-resolution display positioned close to the eyes without the benefit focussing optics. A set of sighted participants were monitored as they learned to use this display to navigate the course. All were able to do so, and time and velocity rapidly improved with practise with no increase in the number of collisions. In a second experiment a cohort of severely sight-impaired individuals of varying aetiologies performed a search task using a similar low-resolution head-mounted display. The majority of participants were able to use the display to respond to objects in their central and peripheral fields at a similar rate to sighted controls. We conclude that the skill to use a depth-based display for obstacle avoidance can be rapidly acquired and the simplified nature of the display may appropriate for the development of an aid for sight-impaired individuals.	[Hicks, Stephen L.; Wilson, Iain; Muhammed, Louwai; Kennard, Christopher] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Worsfold, John] Royal Natl Inst Blind People, London, England; [Downes, Susan M.] Oxford Univ Hosp NHS Trust, Oxford, England; [Downes, Susan M.] Univ Oxford, Nuffield Lab Ophthalmol, Oxford OX2 6AW, England; [Downes, Susan M.; Kennard, Christopher] NIHR Biomed Res Ctr, Oxford, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Hicks, SL (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	stephen.hicks@ndcn.ox.ac.uk		Muhammed, Louwai/0000-0002-2262-4063	National Institute for Health Research (NIHR); NIHR Biomedical Research Centre, Oxford; National Institute for Health Research [II-LB-1111-20005] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the National Institute for Health Research (NIHR) under the i4i programme. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. CK and SD are supported by the NIHR Biomedical Research Centre, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Atabany WI, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-27; Alexander MS, 2011, J NEUROPHYSIOL, V106, P860, DOI 10.1152/jn.01040.2010; Apfelbaum HL, 2008, OPHTHAL PHYSL OPT, V28, P204, DOI 10.1111/j.1475-1313.2008.00537.x; Bach-Y-Rita P, 2004, ANN NY ACAD SCI, V1013, P83, DOI 10.1196/annals.1305.006; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bourbakis N, 2008, IEEE ENG MED BIOL, V27, P49, DOI 10.1109/MEMB.2007.901780; Cupples ME, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e542; Everingham MR, 2003, INT J HUM-COMPUT INT, V15, P231, DOI 10.1207/S15327590IJHC1502_3; Federation of Ophthalmic and Dispensing Opticians, 2012, FUND RIGHT SIGHT; GIBSON JJ, 1950, AM J PSYCHOL, V63, P367, DOI 10.2307/1418003; Hart PM, 2005, BRIT J OPHTHALMOL, V89, P1127, DOI 10.1136/bjo.2004.059683; Hart PM, 1999, BRIT J OPHTHALMOL, V83, P1115, DOI 10.1136/bjo.83.10.1115; Johnson LA, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P869; Luo G, 2009, INVEST OPHTH VIS SCI, V50, P4509, DOI 10.1167/iovs.08-2916; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; MASSOF RW, 1992, OPTOMETRY VISION SCI, V69, P32, DOI 10.1097/00006324-199201000-00005; OSHEA RP, 1994, VISION RES, V34, P1595, DOI 10.1016/0042-6989(94)90116-3; PELI E, 1991, INVEST OPHTH VIS SCI, V32, P2337; Proulx MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001840; Ruch T.C., 1960, MED PHYSL BIOPHYSICS MED PHYSL BIOPHYSICS, V18th; Sampaio E, 2001, BRAIN RES, V908, P204, DOI 10.1016/S0006-8993(01)02667-1; Striem-Amit E, 2012, NEURON, V76, P640, DOI 10.1016/j.neuron.2012.08.026; Striem-Amit E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033136; Tu ZW, 2005, INT J COMPUT VISION, V63, P113, DOI 10.1007/s11263-005-6642-x; World Health Organization, 2010, NEW EST VIS IMP BLIN	25	60	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67695	10.1371/journal.pone.0067695	http://dx.doi.org/10.1371/journal.pone.0067695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844067	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000094
J	Tavares, G; Faisal, A				Tavares, Gabriela; Faisal, Aldo			Scaling-Laws of Human Broadcast Communication Enable Distinction between Human, Corporate and Robot Twitter Users	PLOS ONE			English	Article							HUMAN DYNAMICS; PATTERNS	Human behaviour is highly individual by nature, yet statistical structures are emerging which seem to govern the actions of human beings collectively. Here we search for universal statistical laws dictating the timing of human actions in communication decisions. We focus on the distribution of the time interval between messages in human broadcast communication, as documented in Twitter, and study a collection of over 160,000 tweets for three user categories: personal (controlled by one person), managed (typically PR agency controlled) and bot-controlled (automated system). To test our hypothesis, we investigate whether it is possible to differentiate between user types based on tweet timing behaviour, independently of the content in messages. For this purpose, we developed a system to process a large amount of tweets for reality mining and implemented two simple probabilistic inference algorithms: 1. a naive Bayes classifier, which distinguishes between two and three account categories with classification performance of 84.6% and 75.8%, respectively and 2. a prediction algorithm to estimate the time of a user's next tweet with an R-2 approximate to 0.7. Our results show that we can reliably distinguish between the three user categories as well as predict the distribution of a user's inter-message time with reasonable accuracy. More importantly, we identify a characteristic power-law decrease in the tail of inter-message time distribution by human users which is different from that obtained for managed and automated accounts. This result is evidence of a universal law that permeates the timing of human decisions in broadcast communication and extends the findings of several previous studies of peer-to-peer communication.	[Tavares, Gabriela; Faisal, Aldo] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England; [Faisal, Aldo] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Faisal, Aldo] Univ London Imperial Coll Sci Technol & Med, Fac Med, Med Res Council Clin Sci Ctr, London, England	Imperial College London; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Faisal, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England.	aldo.faisal@imperial.ac.uk	Faisal, Aldo/A-2367-2009	Faisal, Aldo/0000-0003-0813-7207	Human Frontiers in Science Program [HFSP RGP0022/2012]	Human Frontiers in Science Program(Human Frontier Science Program)	AAF acknowledges the support of the Human Frontiers in Science Program (grant number HFSP RGP0022/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Bishop C. M, 2006, PATTERN RECOGNITION; Bollen J., 2009, MODELING PUBLIC MOOD; Chu Z., 2010, P 26 ANN COMP SEC AP, P21, DOI DOI 10.1145/1920261.1920265; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DEGROOT MH, 1975, PROBABILITY STAT; Dezso Z, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066132; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Kleban S., 2003, SUP 2003 ACM IEEE C, P28; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lumezanu C, 2012, P 6 INT AAAI C WEBL, P210; Masoliver J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021112; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Paul Michael J, 2011, 5 INT AAAI C WEBL SO; PAXSON V, 1995, IEEE ACM T NETWORK, V3, P226, DOI 10.1109/90.392383; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309	22	29	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e65774	10.1371/journal.pone.0065774	http://dx.doi.org/10.1371/journal.pone.0065774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843945	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000044
J	Zhang, ZF; Shively, JE				Zhang, Zhifang; Shively, John E.			Acceleration of Bone Repair in NOD/SCID Mice by Human Monoosteophils, Novel LL-37-Activated Monocytes	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; OSTEOBLAST-LINEAGE CELLS; OSTEOCLAST DIFFERENTIATION; ALPHA-3-BETA-1 INTEGRIN; REGULATORY MECHANISMS; PRECURSOR CELLS; MATRIX; ATHEROSCLEROSIS; VASCULOGENESIS; OSTEOACTIVIN	Background: An incomplete understanding of bone forming cells during wound healing and ectopic calcification has led to a search for circulating cells that may fulfill this function. Previously, we showed that monoosteophils, a novel lineage of calcifying/bone-forming cells generated by treatment of monocytes with the natural peptide LL-37, are candidates. In this study, we have analyzed their gene expression profile and bone repair function. Methods and Findings: Human monoosteophils can be distinguished from monocytes, macrophages and osteoclasts by their unique up-regulation of integrin alpha 3 and down-regulation of CD14 and CD16. Monoosteophils express high mRNA and protein levels of SPP1 (osteopontin), GPNMB (osteoactivin), CHI3L1 (cartilage glycoprotein-39), CHIT1 (Chitinase 1), MMP-7, CCL22 and MAPK13 (p38MAPK delta). Monocytes from wild type, but not MAPK13 KO mice are also capable of monoosteophil differentiation, suggesting that MAPK13 regulates this process. When human monoosteophils were implanted in a freshly drilled hole in mid-diaphyseal femurs of NOD/SCID mice, significant bone repair required only 14 days compared to at least 24 days in control treated injuries. Conclusion: Human derived monoosteophils, characterized as CD45(+) alpha 3(+) alpha 3 beta(+) CD34(-) CD14(-)BAP (bone alkaline phosphatase)(-) cells, can function in an animal model of bone injury.	[Zhang, Zhifang; Shively, John E.] City Hope Natl Med Ctr, Dept Immunol, Beckman Res Inst, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Dept Immunol, Beckman Res Inst, Duarte, CA USA.	jshively@coh.org			City of Hope; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	City of Hope funded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x; Benjamin M, 2004, INT REV CYTOL, V233, P1, DOI 10.1016/S0074-7696(04)33001-9; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Choi YH, 2010, INT J BIOCHEM CELL B, V42, P662, DOI 10.1016/j.biocel.2009.12.011; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Eghbali-Fatourechi GZ, 2007, BONE, V40, P1370, DOI 10.1016/j.bone.2006.12.064; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Fadini GP, 2012, CIRCULATION, V125, P2772, DOI 10.1161/CIRCULATIONAHA.112.090860; Fadini GP, 2011, CIRC RES, V108, P1112, DOI 10.1161/CIRCRESAHA.110.234088; Gossl M, 2010, EUR HEART J, V31, P2909, DOI 10.1093/eurheartj/ehq373; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Johansen JS, 1999, RHEUMATOLOGY, V38, P618, DOI 10.1093/rheumatology/38.7.618; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Khan AN, 2010, ANN THORAC MED, V5, P67, DOI 10.4103/1817-1737.62469; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Laguna JC, 2012, PHARMACOGENOMICS, V13, P477, DOI [10.2217/PGS.12.9, 10.2217/pgs.12.9]; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Lundstrom A, 1998, BIOCHEM BIOPH RES CO, V250, P735, DOI 10.1006/bbrc.1998.9389; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y; NAKAI M, 1992, CANCER RES, V52, P5395; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Pignolo RJ, 2011, J BONE MINER RES, V26, P1685, DOI 10.1002/jbmr.370; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Seta Noriyuki, 2007, Keio Journal of Medicine, V56, P41, DOI 10.2302/kjm.56.41; Shalhoub V, 2010, J CELL BIOCHEM, V111, P911, DOI 10.1002/jcb.22779; Standal T, 2004, EXP ONCOL, V26, P179; Suda RK, 2009, STEM CELLS, V27, P2209, DOI 10.1002/stem.150; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zhang ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013985; Zuo C, 2012, OSTEOPOROSIS INT, V23, P1653, DOI 10.1007/s00198-012-1909-x	45	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67649	10.1371/journal.pone.0067649	http://dx.doi.org/10.1371/journal.pone.0067649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844045	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000087
J	Amancio, DR; Altmann, EG; Rybski, D; Oliveira, ON; Costa, LD				Amancio, Diego R.; Altmann, Eduardo G.; Rybski, Diego; Oliveira, Osvaldo N., Jr.; Costa, Luciano da F.			Probing the Statistical Properties of Unknown Texts: Application to the Voynich Manuscript	PLOS ONE			English	Article							KEYWORD DETECTION; DISTRIBUTIONS; NETWORKS; LAW	While the use of statistical physics methods to analyze large corpora has been useful to unveil many patterns in texts, no comprehensive investigation has been performed on the interdependence between syntactic and semantic factors. In this study we propose a framework for determining whether a text (e.g., written in an unknown alphabet) is compatible with a natural language and to which language it could belong. The approach is based on three types of statistical measurements, i.e. obtained from first-order statistics of word properties in a text, from the topology of complex networks representing texts, and from intermittency concepts where text is treated as a time series. Comparative experiments were performed with the New Testament in 15 different languages and with distinct books in English and Portuguese in order to quantify the dependency of the different measurements on the language and on the story being told in the book. The metrics found to be informative in distinguishing real texts from their shuffled versions include assortativity, degree and selectivity of words. As an illustration, we analyze an undeciphered medieval manuscript known as the Voynich Manuscript. We show that it is mostly compatible with natural languages and incompatible with random texts. We also obtain candidates for keywords of the Voynich Manuscript which could be helpful in the effort of deciphering it. Because we were able to identify statistical measurements that are more dependent on the syntax than on the semantics, the framework may also serve for text analysis in language-dependent applications.	[Amancio, Diego R.; Oliveira, Osvaldo N., Jr.; Costa, Luciano da F.] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Paulo, Brazil; [Altmann, Eduardo G.] Max Planck Inst Phys Complex Syst MPIPKS, Dresden, Germany; [Rybski, Diego] Potsdam Inst Climate Impact Res PIK, Potsdam, Germany	Universidade de Sao Paulo; Max Planck Society; Potsdam Institut fur Klimafolgenforschung	Amancio, DR (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Sao Paulo, Brazil.	diego.amancio@usp.br	Oliveira, Osvaldo N./A-1714-2008; Amancio, Diego Raphael/I-1071-2012; da F. Costa, Luciano/H-5475-2011; Altmann, Eduardo/A-3320-2009; Altmann, Eduardo G./ABD-2012-2020	Oliveira, Osvaldo N./0000-0002-5399-5860; da F. Costa, Luciano/0000-0001-5203-4366; Altmann, Eduardo/0000-0002-1932-3710; Altmann, Eduardo G./0000-0002-1932-3710; Rybski, Diego/0000-0001-6125-7705	CNPq; Sao Paulo Brazilian Foundation (FAPESP) [2010/00927-9, 2011/50761-2]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Brazilian Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful to CNPq and Sao Paulo Brazilian Foundation (FAPESP, www.fapesp.br) (grant numbers 2010/00927-9 and 2011/50761-2) for the financial support. DRA acknowledges support from the Max Planck Institute for the Physics of Complex Systems during his one-month visit to Dresden (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann EG, 2012, P NATL ACAD SCI USA, V109, P11582, DOI 10.1073/pnas.1117723109; Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Amancio DR, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/01/P01004; Amancio DR, 2008, INT J MOD PHYS C, V19, P583, DOI 10.1142/S0129183108012285; Amancio DR, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043029; Amancio DR, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123024; Amit S., 2001, IEEE DATA ENG B, V24, P35; Serrano MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005372; Belfield R, 2007, 6 UNSOLVED CIPHERS; Cancho RFI, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051915; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Carretero-Campos C, 2013, PHYSICA A, V392, P1481, DOI 10.1016/j.physa.2012.11.052; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Croft B., 2009, SEARCH ENGINES INFOR; da F. Costa L., 2009, Europhysics Letters, V87, DOI 10.1209/0295-5075/87/18008; Echtermeyer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015765; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Herrera JP, 2008, EPJ B, V63, P824; Klimek P, 2011, PHYSICA A, V390, P3870, DOI 10.1016/j.physa.2011.05.033; Koehn Philipp, 2010, STAT MACHINE TRANSLA; Manning C.D., 1999, FDN STAT NATURAL LAN; Masucci AP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026102; Masucci AP, 2009, ADV COMPLEX SYST, V12, P113, DOI 10.1142/S0219525909002039; McKay AT, 1932, J R STAT SOC, V95, P695, DOI 10.2307/2342041; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Montemurro MA, 2001, ADV COMPLEX SYST, V5; Nirenburg S., 1989, Machine Translation, V4, P5, DOI 10.1007/BF00367750; Ortuno M, 2002, EUROPHYS LETT, V57, P759, DOI 10.1209/epl/i2002-00528-3; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Petersen A.M., 2012, SCI REP, V2; Ross S.M., 2009, INTRO PROBABILITY MO, V10th; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Sano Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012805; Schinner A, 2007, CRYPTOLOGIA, V31, P95, DOI 10.1080/01611190601133539; Yatsko VA, 2010, AUTOM DOC MATH LINGU, V44, P111, DOI 10.3103/S0005105510030027	36	39	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67310	10.1371/journal.pone.0067310	http://dx.doi.org/10.1371/journal.pone.0067310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844002	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000040
J	Forghani, P; Harris, W; Giver, CR; Mirshafiey, A; Galipeau, J; Waller, EK				Forghani, Parvin; Harris, Wayne; Giver, Cynthia R.; Mirshafiey, Abbas; Galipeau, Jacques; Waller, Edmund K.			Properties of Immature Myeloid Progenitors with Nitric-Oxide-Dependent Immunosuppressive Activity Isolated from Bone Marrow of Tumor-Free Mice	PLOS ONE			English	Article							NATURAL SUPPRESSOR-CELLS; T-CELLS; IMMUNE SUPPRESSION; BEARING MICE; CANCER; TOLERANCE; MODEL; SUBPOPULATIONS; INFLAMMATION; METASTASIS	Myeloid derived suppressor cells (MDSCs) from tumor-bearing mice are important negative regulators of anti-cancer immune responses, but the role for immature myeloid cells (IMCs) in non-tumor-bearing mice in the regulation of immune responses are poorly described. We studied the immune-suppressive activity of IMCs from the bone marrow (BM) of C57Bl/6 mice and the mechanism(s) by which they inhibit T-cell activation and proliferation. IMCs, isolated from BM by high-speed FACS, inhibited mitogen-induced proliferation of CD4(+) and CD8(+) T-cells in vitro. Cell-to-cell contact of T-cells with viable IMCs was required for suppression. Neither neutralizing antibodies to TGF beta 1, nor genetic disruption of indolamine 2,3-dioxygenase, abrogated IMC-mediated suppressive activity. In contrast, suppression of T-cell proliferation was absent in cultures containing IMCs from interferon-gamma (IFN-gamma) receptor KO mice or T-cells from IFN-gamma KO mice (on the C57Bl/6 background). The addition of NO inhibitors to co-cultures of T-cells and IMC significantly reduced the suppressive activity of IMCs. IFN-gamma signaling between T-cells and IMCs induced paracrine Nitric Oxide (NO) release in culture, and the degree of inhibition of T-cell proliferation was proportional to NO levels. The suppressive activity of IMCs from the bone marrow of tumor-free mice was comparable with MDSCs from BALB/c bearing mice 4T1 mammary tumors. These results indicate that IMCs have a role in regulating T-cell activation and proliferation in the BM microenvironment.	[Forghani, Parvin; Mirshafiey, Abbas] Univ Tehran Med Sci, Sch Publ Hlth, Dept Pathobiol, Tehran, Iran; [Forghani, Parvin; Harris, Wayne; Giver, Cynthia R.; Galipeau, Jacques; Waller, Edmund K.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Tehran University of Medical Sciences; Emory University	Waller, EK (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	ewaller@emory.edu	Waller, Edmund K/AAP-3055-2020; Galipeau, Jacques/R-9909-2019	Galipeau, Jacques/0000-0002-9374-1996; Forghani, Parvin/0000-0001-9727-3344; Mirshafiey, Abbas/0000-0003-1996-2747	Winship Cancer Institute	Winship Cancer Institute	This research project was supported, in part, by the Winship Cancer Institute. The authors would like to thank Dr. Taofeek K Owonikoko MD, PhD and Dr. Ian Copland, PhD for useful critiques of the manuscript.	Belyaev NN, 2008, KOREAN J PHYSIOL PHA, V12, P193, DOI 10.4196/kjpp.2008.12.4.193; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Bronte V, 2009, EUR J IMMUNOL, V39, P2670, DOI 10.1002/eji.200939892; Bronte V, 2009, J IMMUNOTHER, V32, P1, DOI 10.1097/CJI.0b013e3181837276; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dolcetti L., 2010, CURR PROTOC IMMUNOL; Dolcetti L, 2008, CANCER LETT, V267, P216, DOI 10.1016/j.canlet.2008.03.012; Enioutina EY, 2011, J IMMUNOL, V186, P697, DOI 10.4049/jimmunol.1002987; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; GILLIS S, 1981, P NATL ACAD SCI-BIOL, V78, P1133, DOI 10.1073/pnas.78.2.1133; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Hossain MS, 2007, BLOOD, V109, P4548, DOI 10.1182/blood-2006-04-017442; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Jia WT, 2010, J NEUROIMMUNOL, V223, P20, DOI 10.1016/j.jneuroim.2010.03.011; Kajino K, 2007, IMMUNOLOGY, V120, P28, DOI 10.1111/j.1365-2567.2006.02474.x; Kallberg E, 2010, PROSTATE, V70, P1461, DOI 10.1002/pros.21181; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Medina-Echeverz J, 2011, J IMMUNOL, V186, P807, DOI 10.4049/jimmunol.1001483; Moline-Velazquez V, 2011, BRAIN PATHOL; MOORE SC, 1992, CELL IMMUNOL, V141, P398, DOI 10.1016/0008-8749(92)90158-L; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj Srinivas, 2009, Cancer Res, V69, P7503, DOI 10.1158/0008-5472.CAN-09-2152; Rossner S, 2005, EUR J IMMUNOL, V35, P3533, DOI 10.1002/eji.200526172; Saio M, 2001, J IMMUNOL, V167, P5583, DOI 10.4049/jimmunol.167.10.5583; Saleem SJ, 2011, INT IMMUNOPHARMACOL, V11, P808, DOI 10.1016/j.intimp.2011.03.010; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Slaney CY, 2011, IMMUNOL CELL BIOL, V89, P7, DOI 10.1038/icb.2010.110; Steding CE, 2011, IMMUNOLOGY, V133, P221, DOI 10.1111/j.1365-2567.2011.03429.x; STROBER S, 1989, J IMMUNOL, V143, P1118; STROBER S, 1984, ANNU REV IMMUNOL, V2, P219, DOI 10.1146/annurev.iy.02.040184.001251; STROBER S, 1984, FED PROC, V43, P263; SUGIURA K, 1990, CANCER RES, V50, P2582; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Wallace Paul K, 2007, Immunol Invest, V36, P527; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	43	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e64837	10.1371/journal.pone.0064837	http://dx.doi.org/10.1371/journal.pone.0064837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843936	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000003
J	Wang, QQ; Zhou, YB; Li, SL; Zhuo, C; Xu, SQ; Huang, LX; Yang, L; Liao, K				Wang, Qinqin; Zhou, Yanbin; Li, Shaoli; Zhuo, Chao; Xu, Siqi; Huang, Lixia; Yang, Ling; Liao, Kang			Real-Time Fluorescence Loop Mediated Isothermal Amplification for the Detection of Acinetobacter baumannii	PLOS ONE			English	Article							MULTIPLEX PCR; RAPID IDENTIFICATION; CALCOACETICUS; DIFFERENTIATE; STRAINS; COMPLEX; SPACER; SYSTEM	Background: Detection of Acinetobacter baumannii has been relying primarily on bacterial culture that often fails to return useful results in time. Although DNA-based assays are more sensitive than bacterial culture in detecting the pathogen, the molecular results are often inconsistent and challenged by doubts on false positives, such as those due to system-and environment-derived contaminations. In addition, these molecular tools require expensive laboratory instruments. Therefore, establishing molecular tools for field use require simpler molecular platforms. The loop-mediated isothermal amplification method is relatively simple and can be improved for better use in a routine clinical bacteriology laboratory. A simple and portable device capable of performing both the amplification and detection (by fluorescence) of LAMP in the same platform has been developed in recent years. This method is referred to as real-time loop-mediated isothermal amplification. In this study, we attempted to utilize this method for rapid detection of A. baumannii. Methodology and Significant Findings: Species-specific primers were designed to test the utility of this method. Clinical samples of A. baumannii were used to determine the sensitivity and specificity of this system compared to bacterial culture and a polymerase chain reaction method. All positive samples isolated from sputum were confirmed to be the species of Acinetobacter by 16S rRNA gene sequencing. The RealAmp method was found to be simpler and allowed real-time detection of DNA amplification, and could distinguish A. baumannii from Acinetobacter calcoaceticus and Acinetobacter genomic species 3. DNA was extracted by simple boiling method. Compared to bacterial culture, the sensitivity and specificity of RealAmp in detecting A. baumannii was 98.9% and 75.0%, respectively. Conclusion: The RealAmp assay only requires a single unit, and the assay positivity can be verified by visual inspection. Therefore, this assay has great potential of field use as a molecular tool for detection of A. baumannii.	[Wang, Qinqin; Zhou, Yanbin; Li, Shaoli; Xu, Siqi; Huang, Lixia] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Resp Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Qinqin; Zhou, Yanbin; Li, Shaoli; Xu, Siqi; Huang, Lixia] Sun Yat Sen Univ, Inst Resp Dis, Guangzhou 510275, Guangdong, Peoples R China; [Zhuo, Chao; Yang, Ling] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Liao, Kang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Clin Lab, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Sun Yat Sen University	Zhou, YB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Resp Med, Guangzhou 510275, Guangdong, Peoples R China.	sysuzyb@yahoo.cn		Zhou, Yanbin/0000-0002-0099-4258	National Natural Science foundation of China [81071931]; Natural Science Foundation of Guangdong Province of China [S2011010004703, S2012010008393]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China [2010-609]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work is supported by grants from the National Natural Science foundation of China (81071931, Yanbin Zhou), the Natural Science Foundation of Guangdong Province of China (S2011010004703, Yanbin Zhou and S2012010008393, Yanbin Zhou), and Scientific Research Foundation for Returned Scholars, Ministry of Education of China (2010-609, Yanbin Zhou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chen TL, 2007, CLIN MICROBIOL INFEC, V13, P801, DOI 10.1111/j.1469-0691.2007.01744.x; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Funke G, 1998, J CLIN MICROBIOL, V36, P1948, DOI 10.1128/JCM.36.7.1948-1952.1998; Garcia-Arata MI, 1997, RES MICROBIOL, V148, P777, DOI 10.1016/S0923-2508(97)82453-9; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Higgins PG, 2007, CLIN MICROBIOL INFEC, V13, P1199, DOI 10.1111/j.1469-0691.2007.01819.x; Higgins PG, 2010, J CLIN MICROBIOL, V48, P4592, DOI 10.1128/JCM.01765-10; Hu ZX, 2011, PEDIATR INT, V53, P867, DOI 10.1111/j.1442-200X.2011.03397.x; Joyanes P, 2001, J CLIN MICROBIOL, V39, P3247, DOI 10.1128/JCM.39.9.3247-3253.2001; KOCAGOZ T, 1993, J CLIN MICROBIOL, V31, P1435; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Meng S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041978; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Njiru ZK, 2012, J CLIN MICROBIOL, V50, P1737, DOI 10.1128/JCM.06460-11; Patel JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054986; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Podnecky NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058032; Soo PC, 2013, J MICROBIOL METH, V92, P197, DOI 10.1016/j.mimet.2012.11.020; Visca P, 2011, IUBMB LIFE, V63, P1048, DOI 10.1002/iub.534; Zander E, 2013, INT J MED MICROBIOL, V303, P88, DOI 10.1016/j.ijmm.2012.12.007	25	21	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66406	10.1371/journal.pone.0066406	http://dx.doi.org/10.1371/journal.pone.0066406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843955	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000014
J	Alsop, EB; Raymond, J				Alsop, Eric B.; Raymond, Jason			Resolving Prokaryotic Taxonomy without rRNA: Longer Oligonucleotide Word Lengths Improve Genome and Metagenome Taxonomic Classification	PLOS ONE			English	Article							EVOLUTIONARY IMPLICATIONS; SEQUENCES; SIGNATURES; DINUCLEOTIDE; FREQUENCIES; FRAGMENTS; BIASES	Oligonucleotide signatures, especially tetranucleotide signatures, have been used as method for homology binning by exploiting an organism's inherent biases towards the use of specific oligonucleotide words. Tetranucleotide signatures have been especially useful in environmental metagenomics samples as many of these samples contain organisms from poorly classified phyla which cannot be easily identified using traditional homology methods, including NCBI BLAST. This study examines oligonucleotide signatures across 1,424 completed genomes from across the tree of life, substantially expanding upon previous work. A comprehensive analysis of mononucleotide through nonanucleotide word lengths suggests that longer word lengths substantially improve the classification of DNA fragments across a range of sizes of relevance to high throughput sequencing. We find that, at present, heptanucleotide signatures represent an optimal balance between prediction accuracy and computational time for resolving taxonomy using both genomic and metagenomic fragments. We directly compare the ability of tetranucleotide and heptanucleotide world lengths (tetranucleotide signatures are the current standard for oligonucleotide word usage analyses) for taxonomic binning of metagenome reads. We present evidence that heptanucleotide word lengths consistently provide more taxonomic resolving power, particularly in distinguishing between closely related organisms that are often present in metagenomic samples. This implies that longer oligonucleotide word lengths should replace tetranucleotide signatures for most analyses. Finally, we show that the application of longer word lengths to metagenomic datasets leads to more accurate taxonomic binning of DNA scaffolds and have the potential to substantially improve taxonomic assignment and assembly of metagenomic data.	[Alsop, Eric B.; Raymond, Jason] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Alsop, EB (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	ealsop@asu.edu			NASA Exobiology and Evolutionary Biology Program [NNX08AP61G]; NASA Astrobiology Institute at ASU [08-NAI5-0018]	NASA Exobiology and Evolutionary Biology Program(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute at ASU	EBA and JR acknowledge support from the NASA Exobiology and Evolutionary Biology Program (NNX08AP61G) as well as support from the NASA Astrobiology Institute at ASU (08-NAI5-0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, GENE, V365, P27, DOI 10.1016/j.gene.2005.09.040; Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Bohlin J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-487; Chatterji S, 2007, COMPOSTBM DNA COMPOS; Deschavanne P, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P161, DOI 10.1109/BIBE.2000.889603; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Fadiel Ahmed, 2003, Archaea, V1, P185, DOI 10.1155/2003/458235; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gatherer D, 2007, EVOL BIOINFORM, V3, P211; GOLDMAN N, 1993, NUCLEIC ACIDS RES, V21, P2487, DOI 10.1093/nar/21.10.2487; Grigoriev IV, 2011, NUCLEIC ACIDS RES; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12837, DOI 10.1073/pnas.91.26.12837; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Lightfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017677; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; McHardy AC, 2007, CURR OPIN MICROBIOL, V10, P499, DOI 10.1016/j.mib.2007.08.004; Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41; Perry SC, 2010, GENOME BIOL EVOL, V2, P117, DOI 10.1093/gbe/evq004; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rocha EPC, 1998, NUCLEIC ACIDS RES, V26, P2971, DOI 10.1093/nar/26.12.2971; Rosen Gail, 2008, Advances in Bioinformatics, V2008, P205969, DOI 10.1155/2008/205969; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Swingley WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038108; Takahashi M, 2009, GENOMICS, V93, P525, DOI 10.1016/j.ygeno.2009.01.009; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Willenbrock H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r114; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x	35	6	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67337	10.1371/journal.pone.0067337	http://dx.doi.org/10.1371/journal.pone.0067337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840870	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900009
J	Costa, AMS; Pereira-Castro, I; Ricardo, E; Spencer, F; Fisher, S; da Costa, LT				Sousa Costa, Angela M.; Pereira-Castro, Isabel; Ricardo, Elisabete; Spencer, Forrest; Fisher, Shannon; da Costa, Luis Teixeira			GRG5/AES Interacts with T-Cell Factor 4 (TCF4) and Downregulates Wnt Signaling in Human Cells and Zebrafish Embryos	PLOS ONE			English	Article							AMINO-TERMINAL ENHANCER; APC TUMOR-SUPPRESSOR; GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTOR LEF-1; C-ELEGANS EMBRYOS; HELIX-LOOP-HELIX; BETA-CATENIN; HMG-BOX; MEDIATED TRANSCRIPTION; XENOPUS EMBRYOS	Transcriptional control by TCF/LEF proteins is crucial in key developmental processes such as embryo polarity, tissue architecture and cell fate determination. TCFs associate with beta-catenin to activate transcription in the presence of Wnt signaling, but in its absence act as repressors together with Groucho-family proteins (GRGs). TCF4 is critical in vertebrate intestinal epithelium, where TCF4-beta-catenin complexes are necessary for the maintenance of a proliferative compartment, and their abnormal formation initiates tumorigenesis. However, the extent of TCF4-GRG complexes' roles in development and the mechanisms by which they repress transcription are not completely understood. Here we characterize the interaction between TCF4 and GRG5/AES, a Groucho family member whose functional relationship with TCFs has been controversial. We map the core GRG interaction region in TCF4 to a 111-amino acid fragment and show that, in contrast to other GRGs, GRG5/AES-binding specifically depends on a 4-amino acid motif (LVPQ) present only in TCF3 and some TCF4 isoforms. We further demonstrate that GRG5/AES represses Wnt-mediated transcription both in human cells and zebrafish embryos. Importantly, we provide the first evidence of an inherent repressive function of GRG5/AES in dorsal-ventral patterning during early zebrafish embryogenesis. These results improve our understanding of TCF-GRG interactions, have significant implications for models of transcriptional repression by TCF-GRG complexes, and lay the groundwork for in depth direct assessment of the potential role of Groucho-family proteins in both normal and abnormal development.	[Sousa Costa, Angela M.; Pereira-Castro, Isabel; Ricardo, Elisabete; da Costa, Luis Teixeira] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Sousa Costa, Angela M.; Pereira-Castro, Isabel; Ricardo, Elisabete; da Costa, Luis Teixeira] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Spencer, Forrest] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Fisher, Shannon] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [da Costa, Luis Teixeira] Univ Evora, ICAAM Inst Agr & Environm Mediterranean Sci, Evora, Portugal	Universidade do Porto; Universidade do Porto; Johns Hopkins University; University of Pennsylvania; University of Evora	Fisher, S (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	sfisher4@upenn.edu; ltcosta@uevora.pt	Pereira-Castro, Isabel/F-6487-2010; Ricardo, Elisabete/B-3801-2015; Costa, Ângela/GRR-9421-2022; Ricardo, Elisabete/K-2205-2013; Goncalves Rodrigues, Acacio/K-1467-2013	Pereira-Castro, Isabel/0000-0003-4149-4310; Ricardo, Elisabete/0000-0002-6797-8607; Goncalves Rodrigues, Acacio/0000-0003-4246-5212	Fundacao para a Ciencia e a Tecnologia [POCTI/41854/MGI/2001, Ciencia2008-ICAAM, SFRH/BD/24402/2005, SFRH/BD/44264/2008, PEst-C/AGR/UI0115/2011]; FEDER through the COMPETE programme; FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER through the COMPETE programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (through grants POCTI/41854/MGI/2001 and Ciencia2008-ICAAM to L. T. C., SFRH/BD/24402/2005 to A. M. S. C. and SFRH/BD/44264/2008 to I. P.-C. and Strategic Project PEst-C/AGR/UI0115/2011) as well as FEDER Funds through the COMPETE programme. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Andrioli LP, 2012, DEV BIOL, V361, P177, DOI 10.1016/j.ydbio.2011.10.016; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; Ashyraliyev M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000548; Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Barker N, 1999, AM J PATHOL, V154, P29, DOI 10.1016/S0002-9440(10)65247-9; Beagle B, 2010, DEV DYNAM, V239, P2795, DOI 10.1002/dvdy.22439; Beagle B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011821; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brannon M, 1999, DEVELOPMENT, V126, P3159; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Brinkmeier ML, 2003, MOL ENDOCRINOL, V17, P2152, DOI 10.1210/me.2003-0225; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; CASTROP J, 1992, NUCLEIC ACIDS RES, V20, P611, DOI 10.1093/nar/20.3.611; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cho EA, 1998, MECH DEVELOP, V77, P9; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; De Iaco R, 2006, EMBO J, V25, P244, DOI 10.1038/sj.emboj.7600907; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Dorsky RI, 1999, MECH DEVELOP, V86, P147, DOI 10.1016/S0925-4773(99)00101-X; Douglas KR, 2001, MAMM GENOME, V12, P843, DOI 10.1007/s00335-001-2076-0; Duval A, 2000, CANCER RES, V60, P3872; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Flowers EB, 2010, DEVELOPMENT, V137, P1799, DOI 10.1242/dev.046219; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Galceran J, 2000, DEVELOPMENT, V127, P469; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Giebel B, 1997, P NATL ACAD SCI USA, V94, P6250, DOI 10.1073/pnas.94.12.6250; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIESE K, 1993, EMBO J, V12, P4667, DOI 10.1002/j.1460-2075.1993.tb06155.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein RE, 1999, DEVELOPMENT, V126, P3747; Gradl D, 2002, J BIOL CHEM, V277, P14159, DOI 10.1074/jbc.M107055200; GUGER KA, 1995, DEV BIOL, V172, P115, DOI 10.1006/dbio.1995.0009; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Holland LZ, 2002, DEV BIOL, V241, P209, DOI 10.1006/dbio.2001.0503; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jennings BH, 2008, EMBO REP, V9, P76, DOI 10.1038/sj.embor.7401122; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Kelly C, 2000, DEVELOPMENT, V127, P3899; KELLY GM, 1995, MECH DEVELOP, V53, P261, DOI 10.1016/0925-4773(95)00442-4; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kunz M, 2004, DEV BIOL, V273, P390, DOI 10.1016/j.ydbio.2004.06.015; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Lepourcelet M, 2002, J BIOL CHEM, V277, P47732, DOI 10.1074/jbc.M208154200; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mariadason JM, 2001, CANCER RES, V61, P3465; MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Molenaar M, 2000, MECH DEVELOP, V91, P311, DOI 10.1016/S0925-4773(99)00259-2; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2007, EMBO REP, V8, P966, DOI 10.1038/sj.embor.7401071; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Pukrop T, 2001, J BIOL CHEM, V276, P8968, DOI 10.1074/jbc.M007533200; Range RC, 2005, DEV BIOL, V279, P252, DOI 10.1016/j.ydbio.2004.12.023; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Sarma NJ, 2011, J BIOL CHEM, V286, P38989, DOI 10.1074/jbc.M111.297952; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Shimeld S, 2008, DEV GENES EVOL, V218, P639, DOI 10.1007/s00427-008-0248-6; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; Standley HJ, 2006, DEV BIOL, V289, P318, DOI 10.1016/j.ydbio.2005.10.012; Struewing I, 2010, BIOCHEM BIOPH RES CO, V399, P245, DOI 10.1016/j.bbrc.2010.07.062; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Sumoy L, 1999, DEV GENES EVOL, V209, P48, DOI 10.1007/s004270050226; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Tsuji S, 2005, DEV GENES EVOL, V215, P275, DOI 10.1007/s00427-005-0474-0; UM M, 1995, MOL CELL BIOL, V15, P5007; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Verkade Heather, 2008, V469, P225, DOI 10.1007/978-1-60327-469-2_17; Vonica A, 2000, DEV BIOL, V217, P230, DOI 10.1006/dbio.1999.9551; WAINWRIGHT SM, 1992, MOL CELL BIOL, V12, P2475, DOI 10.1128/MCB.12.6.2475; Wang H, 2011, DEVELOPMENT, V138, P3711, DOI 10.1242/dev.068270; Wang WF, 2004, DEV BIOL, V270, P364, DOI 10.1016/j.ydbio.2004.03.003; WANG ZY, 1995, ONCOGENE, V10, P1243; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Yang J, 2002, DEVELOPMENT, V129, P5743, DOI 10.1242/dev.00150; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Young RM, 2002, MECH DEVELOP, V117, P269, DOI 10.1016/S0925-4773(02)00180-6; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang YM, 2010, BIOCHEM J, V427, P499, DOI 10.1042/BJ20091631; Zhao J, 2003, EMBO J, V22, P6078, DOI 10.1093/emboj/cdg593	135	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67694	10.1371/journal.pone.0067694	http://dx.doi.org/10.1371/journal.pone.0067694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840876	gold, Green Submitted, Green Published			2022-12-27	WOS:000321271900015
J	Debiais-Thibaud, M; Metcalfe, CJ; Pollack, J; Germon, I; Ekker, M; Depew, M; Laurenti, P; Borday-Birraux, V; Casane, D				Debiais-Thibaud, Melanie; Metcalfe, Cushla J.; Pollack, Jacob; Germon, Isabelle; Ekker, Marc; Depew, Michael; Laurenti, Patrick; Borday-Birraux, Veronique; Casane, Didier			Heterogeneous Conservation of Dlx Paralog Co-Expression in Jawed Vertebrates	PLOS ONE			English	Article							DISTAL-LESS GENE; EXPRESSION PATTERNS; HOMEOBOX GENES; DEVELOPMENTAL EXPRESSION; GNATHOSTOMES INSIGHTS; SCYLIORHINUS-CANICULA; EVOLUTIONARY ORIGIN; REGULATORY ELEMENTS; CIONA-INTESTINALIS; BRANCHIAL ARCHES	Background: The Dlx gene family encodes transcription factors involved in the development of a wide variety of morphological innovations that first evolved at the origins of vertebrates or of the jawed vertebrates. This gene family expanded with the two rounds of genome duplications that occurred before jawed vertebrates diversified. It includes at least three bigene pairs sharing conserved regulatory sequences in tetrapods and teleost fish, but has been only partially characterized in chondrichthyans, the third major group of jawed vertebrates. Here we take advantage of developmental and molecular tools applied to the shark Scyliorhinus canicula to fill in the gap and provide an overview of the evolution of the Dlx family in the jawed vertebrates. These results are analyzed in the theoretical framework of the DDC (Duplication-Degeneration- Complementation) model. Results: The genomic organisation of the catshark Dlx genes is similar to that previously described for tetrapods. Conserved non-coding elements identified in bony fish were also identified in catshark Dlx clusters and showed regulatory activity in transgenic zebrafish. Gene expression patterns in the catshark showed that there are some expression sites with high conservation of the expressed paralog(s) and other expression sites with events of paralog sub-functionalization during jawed vertebrate diversification, resulting in a wide variety of evolutionary scenarios within this gene family. Conclusion: Dlx gene expression patterns in the catshark show that there has been little neo-functionalization in Dlx genes over gnathostome evolution. In most cases, one tandem duplication and two rounds of vertebrate genome duplication have led to at least six Dlx coding sequences with redundant expression patterns followed by some instances of paralog sub-functionalization. Regulatory constraints such as shared enhancers, and functional constraints including gene pleiotropy, may have contributed to the evolutionary inertia leading to high redundancy between gene expression patterns.	[Debiais-Thibaud, Melanie] Univ Montpellier 2, Inst Sci Evolut, UMR5554, Montpellier, France; [Metcalfe, Cushla J.; Germon, Isabelle; Laurenti, Patrick; Borday-Birraux, Veronique; Casane, Didier] CNRS, Lab Evolut Genome & Speciat, Gif Sur Yvette, France; [Pollack, Jacob; Ekker, Marc] Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Depew, Michael] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Laurenti, Patrick; Borday-Birraux, Veronique; Casane, Didier] Univ Paris Diderot, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Ottawa; University of California System; University of California San Francisco; UDICE-French Research Universities; Universite Paris Cite	Debiais-Thibaud, M (corresponding author), Univ Montpellier 2, Inst Sci Evolut, UMR5554, Montpellier, France.	Melanie.Debiais-Thibaud@univ-montp2.fr	Metcalfe, Cushla/AAE-4078-2019; Metcalfe, Cushla/D-2476-2013; Metcalfe, Cushla/GSI-8011-2022; Laurenti, Patrick/I-8785-2012	Metcalfe, Cushla/0000-0001-9375-3332; Metcalfe, Cushla/0000-0001-9375-3332; Laurenti, Patrick/0000-0002-2903-1148; Debiais-Thibaud, Melanie/0000-0002-1377-2515	Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by a grant from the Natural Sciences and Engineering Research Council to ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Avaron F, 2003, EVOL DEV, V5, P145, DOI 10.1046/j.1525-142X.2003.03021.x; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Blentic A, 2008, DEV DYNAM, V237, P592, DOI 10.1002/dvdy.21439; Borday-Birraux V, 2006, EVOL DEV, V8, P130, DOI 10.1111/j.1525-142X.2006.00084.x; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; Caracciolo A, 2000, MECH DEVELOP, V99, P173, DOI 10.1016/S0925-4773(00)00474-3; Cobb J, 2005, DEVELOPMENT, V132, P3055, DOI 10.1242/dev.01885; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Compagnucci C, 2013, DEV BIOL, V377, P428, DOI 10.1016/j.ydbio.2013.02.022; Coubrough ML, 2006, EXP CELL RES, V312, P3880, DOI 10.1016/j.yexcr.2006.08.023; de Melo J, 2005, DEVELOPMENT, V132, P311, DOI 10.1242/dev.01560; Debiais-Thibaud M, 2008, EVOL DEV, V10, P464, DOI 10.1111/j.1525-142X.2008.00257.x; Debiais-Thibaud M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-307; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Finger JH, 2011, NUCLEIC ACIDS RES, V39, pD835, DOI 10.1093/nar/gkq1132; Force A, 1999, GENETICS, V151, P1531; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Freitas R, 2004, DEV GENES EVOL, V214, P466, DOI 10.1007/s00427-004-0426-0; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Fujimoto S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-15; Ghanem N, 2008, DEV BIOL, V322, P415, DOI 10.1016/j.ydbio.2008.07.029; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Ghoul-Mazgar S, 2005, BONE, V37, P799, DOI 10.1016/j.bone.2005.03.020; Gillis JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2429; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Holland ND, 1996, DEVELOPMENT, V122, P2911; Irvine SQ, 2007, J EXP ZOOL PART B, V308B, P428, DOI 10.1002/jez.b.21169; Irvine SQ, 2011, DEV BIOL, V353, P432, DOI 10.1016/j.ydbio.2011.02.009; Janvier P., 1996, EARLY VERTEBRATES; Jeffery WR, 2008, DEV BIOL, V324, P152, DOI 10.1016/j.ydbio.2008.08.022; Kaji T, 2004, DEV BIOL, V276, P523, DOI 10.1016/j.ydbio.2004.09.020; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Kuraku S, 2010, DEV BIOL, V341, P315, DOI 10.1016/j.ydbio.2010.02.013; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Li H, 2008, DEV BIOL, V316, P458, DOI 10.1016/j.ydbio.2008.01.001; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; Long JE, 2003, J NEUROSCI, V23, P568, DOI 10.1523/JNEUROSCI.23-02-00568.2003; Luo T, 2001, MOL REPROD DEV, V60, P331, DOI 10.1002/mrd.1095; MacDonald RB, 2010, DEV DYNAM, V239, P2298, DOI 10.1002/dvdy.22365; MacDonald RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-157; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; McDougall C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-241; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Meulemans D, 2007, INT J BIOL SCI, V3, P356; Morasso MI, 1996, J CELL BIOL, V135, P1879, DOI 10.1083/jcb.135.6.1879; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; MORASSO MI, 1995, P NATL ACAD SCI USA, V92, P3968, DOI 10.1073/pnas.92.9.3968; Neidert AH, 2001, P NATL ACAD SCI USA, V98, P1665, DOI 10.1073/pnas.98.4.1665; Oulion S, 2010, MOL BIOL EVOL, V27, P2829, DOI 10.1093/molbev/msq172; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Park BK, 2004, DEV BIOL, V268, P532, DOI 10.1016/j.ydbio.2004.01.010; Poitras L, 2007, DEVELOPMENT, V134, P1755, DOI 10.1242/dev.02845; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Quinn LM, 2000, PLACENTA, V21, pS50, DOI 10.1053/plac.1999.0514; Quint E, 2000, J EXP ZOOL, V288, P235, DOI 10.1002/1097-010X(20001015)288:3&lt;235::AID-JEZ4&gt;3.0.CO;2-J; Renz AJ, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-1; ROBINSON GW, 1994, MECH DEVELOP, V48, P199, DOI 10.1016/0925-4773(94)90060-4; Rouzankina I, 2004, DEV BIOL, V265, P219, DOI 10.1016/j.ydbio.2003.09.023; SIMEONE A, 1994, P NATL ACAD SCI USA, V91, P2250, DOI 10.1073/pnas.91.6.2250; Solomon KS, 2002, DEVELOPMENT, V129, P3127; Stock DW, 2005, GENETICS, V169, P807, DOI 10.1534/genetics.104.031831; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Thisse C, 2005, ZFIN DIRECT DATA SUB; Venkatesh TV, 1999, DEV GENES EVOL, V209, P254; Verreijdt L, 2006, DEV DYNAM, V235, P1371, DOI 10.1002/dvdy.20734; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Woda JM, 2003, DEVELOPMENT, V130, P331, DOI 10.1242/dev.00212; Yang L, 1998, J NEUROSCI, V18, P8322; Yu M, 2011, INT J DEV NEUROSCI, V29, P681, DOI 10.1016/j.ijdevneu.2011.06.005; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008097	80	12	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68182	10.1371/journal.pone.0068182	http://dx.doi.org/10.1371/journal.pone.0068182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840829	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400172
J	Dyer, GA; Lopez-Feldman, A				Dyer, George A.; Lopez-Feldman, Alejandro			Inexplicable or Simply Unexplained? The Management of Maize Seed in Mexico	PLOS ONE			English	Article							IN-SITU CONSERVATION; CENTRAL VALLEYS; SOUTHEASTERN GUANAJUATO; POPULATION-STRUCTURE; GENETIC DIVERSITY; ISOZYME VARIATION; FARMERS; CHIAPAS; LANDRACES; SYSTEMS	Farmer management of plant germplasm pre-dates crop domestication, but humans' role in crop evolution and diversity remains largely undocumented and often contested. Seemingly inexplicable practices observed throughout agricultural history, such as exchanging or replacing seed, continue to structure crop populations across the developing world. Seed management practices can be construed as events in the life history of crops and management data used to model crop demography, but this requires suitable quantitative data. As a prerequisite to addressing the causes and implications of maize seed management, we describe its patterns of variation across Mexico by drawing from the literature and new analysis. We find that rates of seed replacement, introduction and diffusion differ significantly across regions and altitudinal zones, but interactions among explanatory factors can obscure patterns of variation. The type, source, geographic origin and ownership of seed help explain observed rates. Yet, controlling for the characteristics of germplasm barely reduces interregional differences vastly exceeding variation across elevations. With few exceptions, monotonic altitudinal trends are absent. Causal relationships between management practices and the physical environment could determine farmers' wellbeing and crop conservation in the face of climate change. Scarce and inconsistent data on management nevertheless could prevent an understanding of these relationships. Current conceptions on the management and dynamics of maize diversity are founded on a patchwork of observations in surprisingly few and dissimilar environments. Our estimates of management practices should shed light on differences in maize population dynamics across Mexico. Consistency with previous studies spanning over a decade suggests that common sets of forces are present within large areas, but causal associations remain unknown. The next step in explaining crop diversity should address variation in seed management across space and time simultaneously while identifying farmers' values and motivations as underlying forces.	[Dyer, George A.] Colegio Mexico, Ctr Estudios Econ, Mexico City, DF, Mexico; [Dyer, George A.] ABT Associates Inc, Mexico City, DF, Mexico; [Dyer, George A.] Inst Nacl Ecol & Cambio Climat, Mexico City, DF, Mexico; [Lopez-Feldman, Alejandro] Ctr Invest & Docencia Econ, Div Econ, Mexico City, DF, Mexico	Colegio de Mexico; ABT Associates; Instituto de Ecologia - Mexico; Centro de Investigacion y Docencia Economicas A.C. (CIDE)	Dyer, GA (corresponding author), Colegio Mexico, Ctr Estudios Econ, Mexico City, DF, Mexico.	georgie.dyer@gmail.com	Lopez-Feldman, Alejandro/AAI-2918-2020	Lopez-Feldman, Alejandro/0000-0002-9194-2612	Comision Intersecretarial de Bioseguridad de Organismos Genetica mente Modificados (CIBIOGEM), Mexico, through the Fondo CIBIOGEM Project [164357]	Comision Intersecretarial de Bioseguridad de Organismos Genetica mente Modificados (CIBIOGEM), Mexico, through the Fondo CIBIOGEM Project	Financial support for this work was provided by Comision Intersecretarial de Bioseguridad de Organismos Genetica mente Modificados (CIBIOGEM), Mexico, through the Fondo CIBIOGEM Project 164357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias LM, 2007, CAMBIOS RECIENTES DI, V23, P69; Astier M, 2010, J MAPS, DOI [10.4113/jom.2010.1101, DOI 10.4113/J0M.2010.1101]; Badstue LB, 2006, HUM ECOL, V34, P249, DOI 10.1007/s10745-006-9016-2; Bellon MR, 2011, P NATL ACAD SCI USA, V108, P13432, DOI 10.1073/pnas.1103373108; Bellon MR, 2006, WORLD DEV, V34, P113, DOI 10.1016/j.worlddev.2005.05.012; BELLON MR, 1994, ECON BOT, V48, P196, DOI 10.1007/BF02908218; Bellon MR, 2003, GENET RESOUR CROP EV, V50, P401, DOI 10.1023/A:1023967611495; Bellon MR, 2001, WORLD DEV, V29, P799, DOI 10.1016/S0305-750X(01)00013-4; BELLON MR, 2011, WORLD DEV, V39, P1434, DOI DOI 10.1016/j.worlddev.2010.12.010; Benz B, 2007, CURR ANTHROPOL, V48, P289, DOI 10.1086/512986; Birol E, 2009, ENVIRON DEV ECON, V14, P521, DOI 10.1017/S1355770X08004944; BRETTING PK, 1990, AM J BOT, V77, P211, DOI 10.2307/2444643; Brush SB, 2007, AGR ECOSYST ENVIRON, V121, P211, DOI 10.1016/j.agee.2006.12.018; BRUSH SB, 1988, HUM ECOL, V16, P307, DOI 10.1007/BF00888449; Brush SB., 2004, FARMERS BOUNTY LOCAT; Chambers KJ, 2007, ECON BOT, V61, P60, DOI 10.1663/0013-0001(2007)61[60:DMZMLL]2.0.CO;2; De Boef WS, 2012, J SUSTAIN AGR, V34, P504; DOEBLEY JF, 1985, AM J BOT, V72, P629, DOI 10.2307/2443674; DYER G, 2002, THESIS U CALIFORNIA; Dyer GA, 2005, M SMALE VALUING CROP, P1; Dyer GA, 2008, P NATL ACAD SCI USA, V105, P470, DOI 10.1073/pnas.0706321105; Dyer GA, 2011, WORLD DEV, V39, P1878, DOI 10.1016/j.worlddev.2011.04.032; Dyer GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005734; ESCOBAR MDA, 2006, THESIS U AUTONOMA BA; Gil-Munoz A, 2002, P S MAN CROP DIV TRA, P5; Gomez JAA, 2000, ECON BOT, V54, P60, DOI 10.1007/BF02866600; GOODMAN MM, 1983, MAYDICA, V28, P169; Hart JP, 2008, STATE MUSEUM B, V512, P87; HILLMAN GC, 1990, BIOL J LINN SOC, V39, P39, DOI 10.1111/j.1095-8312.1990.tb01611.x; Hodgkin T., 2007, Managing biodiversity in agricultural ecosystems, P77; Jarvis DI, 2008, P NATL ACAD SCI USA, V105, P5326, DOI 10.1073/pnas.0800607105; Keleman A, 2009, GEOGR J, V175, P52, DOI 10.1111/j.1475-4959.2008.00314.x; Moreno LL, 2006, BIODIVERS CONSERV, V15, P1771, DOI 10.1007/s10531-004-6679-0; Lazos Chavero Elena, 2008, Nueva antropol, V21, P9; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mercer K, 2008, EVOL APPL, V1, P489, DOI 10.1111/j.1752-4571.2008.00038.x; Mercer KL, 2010, EVOL APPL, V3, P480, DOI 10.1111/j.1752-4571.2010.00137.x; Pautasso M, 2013, AGRON SUSTAIN DEV, V33, P151, DOI 10.1007/s13593-012-0089-6; Perales H, 2003, ECON BOT, V57, P21, DOI 10.1663/0013-0001(2003)057[0007:LOMICM]2.0.CO;2; Perales H., 2008, CAPITAL NATURAL MEXI, VI, P565; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Pita Duque A, 2010, THESIS U CALIFORNIA; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Rice E, 1998, WORLD DEV, V26, P1625, DOI 10.1016/S0305-750X(98)00079-5; Rice E, 2007, GENET RESOUR CROP EV, V54, P701, DOI 10.1007/s10722-006-0023-3; Corral JAR, 2008, CROP SCI, V48, P1502, DOI 10.2135/cropsci2007.09.0518; SANCHEZ GJJ, 1992, ECON BOT, V46, P72, DOI 10.1007/BF02985256; Smale M, 2001, ECON DEV CULT CHANGE, V50, P201, DOI 10.1086/340010; Smale M, 1999, 9909 CIMMYT INT MAIZ; Snively-Martinez AE, 2009, THESIS WASHINGTON ST; Sokal RR, 1995, BIOMETRY; Stromberg PM, 2010, HUM ECOL, V38, P539, DOI 10.1007/s10745-010-9333-3; Thomas M, 2011, GENET RESOUR CROP EV, V58, P321, DOI 10.1007/s10722-011-9662-0; Van Dusen ME, 2005, ENVIRON DEV ECON, V10, P513, DOI 10.1017/S1355770X05002317; van Etten Jacob, 2007, Plant Genetic Resources Characterization and Utilization, V5, P57, DOI 10.1017/S147926210767230X; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wellhausen E.J., 1952, RACES MAIZE MEXICO T; Zeven AC, 1999, EUPHYTICA, V110, P181, DOI 10.1023/A:1003701529155	59	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68320	10.1371/journal.pone.0068320	http://dx.doi.org/10.1371/journal.pone.0068320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840847	Green Published, gold			2022-12-27	WOS:000321148400189
J	Ferrandez-Ayela, A; Alonso-Peral, MM; Sanchez-Garcia, AB; Micol-Ponce, R; Perez-Perez, JM; Micol, JL; Ponce, MR				Ferrandez-Ayela, Almudena; Magdalena Alonso-Peral, Maria; Belen Sanchez-Garcia, Ana; Micol-Ponce, Rosa; Manuel Perez-Perez, Jose; Micol, Jose Luis; Ponce, Maria Rosa			Arabidopsis TRANSCURVATA1 Encodes NUP58, a Component of the Nucleopore Central Channel	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; MESSENGER-RNA EXPORT; AUXIN RESPONSE; NUCLEOCYTOPLASMIC TRANSPORT; LEAF MORPHOGENESIS; GENETIC-ANALYSIS; FLOWERING-TIME; UBIQUITIN LIGASES; PLANT DEVELOPMENT; SHADE AVOIDANCE	The selective trafficking of proteins and RNAs through the nuclear envelope regulates nuclear-cytoplasmic segregation of macromolecules and is mediated by nucleopore complexes (NPCs), which consist of about 400 nucleoporins (Nups) of about 30 types. Extensive studies of nucleoporin function in yeast and vertebrates showed that Nups function in nucleocytoplasmic trafficking and other processes. However, limited studies of plant Nups have identified only a few mutations, which cause pleiotropic phenotypes including reduced growth and early flowering. Here, we describe loss-of-function alleles of Arabidopsis TRANSCURVATA1 (TCU1); these mutations cause increased hypocotyl and petiole length, reticulate and asymmetrically epinastic leaf laminae of reduced size, and early flowering. TCU1 is transcribed in all of the organs and tissues examined, and encodes the putative ortholog of yeast and vertebrate Nup58, a nucleoporin of the Nup62 subcomplex. Nup58 forms the central channel of the NPC and acts directly in translocation of proteins through the nuclear envelope in yeast and vertebrates. Yeast two-hybrid (Y2H) assays identified physical interactions between TCU1/NUP58 and 34 proteins, including nucleoporins, SCF (Skp1/Cul1/F-box) ubiquitin ligase complex components and other nucleoplasm proteins. Genetic interactions were also found between TCU1 and genes encoding nucleoporins, soluble nuclear transport receptors and components of the ubiquitin-proteasome and auxin signaling pathways. These genetic and physical interactions indicate that TCU1/NUP58 is a member of the Nup62 subcomplex of the Arabidopsis NPC. Our findings also suggest regulatory roles for TCU1/NUP58 beyond its function in nucleocytoplasmic trafficking, a hypothesis that is supported by the Y2H and genetic interactions that we observed.	[Ferrandez-Ayela, Almudena; Magdalena Alonso-Peral, Maria; Belen Sanchez-Garcia, Ana; Micol-Ponce, Rosa; Manuel Perez-Perez, Jose; Micol, Jose Luis; Ponce, Maria Rosa] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain	Universidad Miguel Hernandez de Elche	Ponce, MR (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Campus Elche, Elche, Spain.	mrponce@umh.es	Alonso Peral, Maria/C-5123-2011; Ponce, María Rosa/C-8203-2014; Perez-Perez, Jose Manuel/B-4247-2011; Micol-Ponce, Rosa/T-9815-2017; Micol, José Luis/B-4832-2010	Ponce, María Rosa/0000-0003-0770-4230; Perez-Perez, Jose Manuel/0000-0003-2848-4919; Micol-Ponce, Rosa/0000-0001-9389-2906; Micol, José Luis/0000-0002-0396-1750; Sanchez-Garcia, Ana Belen/0000-0002-1315-8400	Ministerio de Ciencia e Innovacion of Spain [BIO2008-01900]; Generalitat Valenciana [PROMETEO/2009/112]; Ministerio de Ciencia e Innovacion of Spain	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by grants from the Ministerio de Ciencia e Innovacion of Spain (BIO2008-01900 to M.R.P.) and the Generalitat Valenciana (PROMETEO/2009/112 to M.R.P. and J.L.M.). A.F.-A. and M.M.A.-P. hold fellowships from the Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alabadi D, 2009, PLANT MOL BIOL, V69, P409, DOI 10.1007/s11103-008-9400-y; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Bermejo R, 2012, TRENDS CELL BIOL, V22, P465, DOI 10.1016/j.tcb.2012.05.007; Berna G, 1999, GENETICS, V152, P729; Candela H, 1999, DEV BIOL, V205, P205, DOI 10.1006/dbio.1998.9111; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Carabelli M, 2007, GENE DEV, V21, P1863, DOI 10.1101/gad.432607; Casal JJ, 2012, ARABIDOPSIS BOOK, pe0157; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Cernac A, 1997, DEVELOPMENT, V124, P1583; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; del Pozo JC, 1999, TRENDS PLANT SCI, V4, P107, DOI 10.1016/S1360-1385(99)01382-5; Devlin PF, 2003, PLANT PHYSIOL, V133, P1617, DOI 10.1104/pp.103.034397; Dong CH, 2006, MOL CELL BIOL, V26, P9533, DOI 10.1128/MCB.01063-06; Esteve-Bruna D, 2013, PLANT PHYSIOL, V161, P1303, DOI 10.1104/pp.112.207779; Faria AMC, 2006, IMMUNITY, V24, P295, DOI 10.1016/j.immuni.2006.01.014; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Gonzalez-Bayon R, 2006, J EXP BOT, V57, P3019, DOI 10.1093/jxb/erl063; Grunwald D, 2012, CURR OPIN CELL BIOL, V24, P100, DOI 10.1016/j.ceb.2011.11.011; Heilmann M, 2013, PLANT PHYSIOL, V161, P547, DOI 10.1104/pp.112.206805; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kandasamy MK, 2001, PLANT CELL, V13, P1541, DOI 10.1105/tpc.13.7.1541; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Merkle T, 2003, CURR GENET, V44, P231, DOI 10.1007/s00294-003-0444-x; Merkle T, 2001, PLANTA, V213, P499, DOI 10.1007/s004250100621; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Molla-Morales A, 2011, PLANT J, V65, P335, DOI 10.1111/j.1365-313X.2010.04425.x; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Murtas G, 2003, PLANT CELL, V15, P2308, DOI 10.1105/tpc.015487; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Parry G, 2004, SEMIN CELL DEV BIOL, V15, P221, DOI 10.1016/j.semcdb.2003.12.003; Parry G, 2006, PLANT CELL, V18, P1590, DOI 10.1105/tpc.106.041566; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Perez-Perez JM, 2004, PLANT PHYSIOL, V134, P101, DOI 10.1104/pp.103.032524; Ponce M. Rosa, 2006, V323, P105; Ponce MR, 1999, MOL GEN GENET, V261, P408, DOI 10.1007/s004380050982; Ponce MR, 1998, PLANT J, V14, P497, DOI 10.1046/j.1365-313X.1998.00146.x; Quesada V, 1999, FEBS LETT, V461, P101, DOI 10.1016/S0014-5793(99)01426-X; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Reeves PH, 2002, DEVELOPMENT, V129, P5349, DOI 10.1242/dev.00113; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rose A, 2004, EXPTL BIOL REV, P69; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Rubio-Diaz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036500; Serrano-Cartagena J, 1999, MOL GEN GENET, V261, P725, DOI 10.1007/s004380050016; Serrano-Cartagena J, 2000, GENETICS, V156, P1363; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Sistla S, 2007, MOL BIOL CELL, V18, P3692, DOI 10.1091/mbc.E06-12-1062; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; Stamm P, 2010, J EXP BOT, V61, P2889, DOI 10.1093/jxb/erq147; Stone SL, 2007, CURR OPIN PLANT BIOL, V10, P624, DOI 10.1016/j.pbi.2007.07.010; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Tian Q, 1999, DEVELOPMENT, V126, P711; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Wiermer M, 2012, PLANT J, V70, P796, DOI 10.1111/j.1365-313X.2012.04928.x; Xu XM, 2007, CURR BIOL, V17, P1157, DOI 10.1016/j.cub.2007.05.076; Xu XM, 2007, PLANT CELL, V19, P1537, DOI 10.1105/tpc.106.049239; Xu XM, 2007, PLANT SIGNAL BEHAV, V2, P553, DOI 10.4161/psb.2.6.4836; Zhang YL, 2005, PLANT CELL, V17, P1306, DOI 10.1105/tpc.104.029926; Zhao DZ, 2003, PLANT PHYSIOL, V133, P203, DOI 10.1104/pp.103.024703; Zhao Q, 2011, PLANT SIGNAL BEHAV, V6, P330, DOI 10.4161/psb.6.3.13402; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	81	17	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67661	10.1371/journal.pone.0067661	http://dx.doi.org/10.1371/journal.pone.0067661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840761	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400124
J	Harries, LW; McCulloch, LJ; Holley, JE; Rawling, TJ; Welters, HJ; Kos, K				Harries, Lorna W.; McCulloch, Laura J.; Holley, Janet E.; Rawling, Thomas J.; Welters, Hannah J.; Kos, Katarina			A Role for SPARC in the Moderation of Human Insulin Secretion	PLOS ONE			English	Article							ADIPOSE-TISSUE; BETA-CELLS; MATRICELLULAR PROTEINS; DIABETES-MELLITUS; EXPRESSION; PATHWAY; DISEASE; DIFFERENTIATION; ASSOCIATION; OSTEONECTIN	Aims/Hypothesis: We have previously shown the implication of the multifunctional protein SPARC (Secreted protein acidic and rich in cysteine)/osteonectin in insulin resistance but potential effects on beta-cell function have not been assessed. We therefore aimed to characterise the effect of SPARC on beta-cell function and features of diabetes. Methods: We measured SPARC expression by qRT-PCR in human primary pancreatic islets, adipose tissue, liver and muscle. We then examined the relation of SPARC with glucose stimulated insulin secretion (GSIS) in primary human islets and the effect of SPARC overexpression on GSIS in beta cell lines. Results: SPARC was expressed at measurable levels in human islets, adipose tissue, liver and skeletal muscle, and demonstrated reduced expression in primary islets from subjects with diabetes compared with controls (p<= 0.05). SPARC levels were positively correlated with GSIS in islets from control donors (p<= 0.01). Overexpression of SPARC in cultured beta-cells resulted in a 2.4-fold increase in insulin secretion in high glucose conditions (p<= 0.01). Conclusions: Our data suggest that levels of SPARC are reduced in islets from donors with diabetes and that it has a role in insulin secretion, an effect which appears independent of SPARC's modulation of obesity-induced insulin resistance in adipose tissue.	[Harries, Lorna W.; McCulloch, Laura J.; Holley, Janet E.; Rawling, Thomas J.; Welters, Hannah J.; Kos, Katarina] Univ Exeter, Inst Biomed & Clin Sci, Exeter Med Sch, Exeter, Devon, England	University of Exeter	Harries, LW (corresponding author), Univ Exeter, Inst Biomed & Clin Sci, Exeter Med Sch, Exeter, Devon, England.	L.W.Harries@exeter.ac.uk	Kos, Katarina/G-6772-2014; Harries, Lorna/D-2241-2014	Harries, Lorna/0000-0001-7791-8061; Kos, Katarina/0000-0003-3761-2249	Diabetes Research Wellness Foundation; Peninsula NIHR Clinical Research Facility	Diabetes Research Wellness Foundation; Peninsula NIHR Clinical Research Facility	This study was funded by the Diabetes Research Wellness Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Omental fat samples were provided by the NIHR Peninsula Research Bank and the study was supported by the Peninsula NIHR Clinical Research Facility. We thank Jonathan Locke of the Exeter Medical School, Exeter, UK, for technical assistance. LWH is the guarantor of this study. We thank David Allard for provision of the SPARC construct.	Aye T, 2010, J HISTOCHEM CYTOCHEM, V58, P369, DOI 10.1369/jhc.2009.954909; Bhoopathi P, 2011, CANCER RES, V71, P4908, DOI 10.1158/0008-5472.CAN-10-3395; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bradshaw AD, 2012, INT J BIOCHEM CELL B, V44, P480, DOI 10.1016/j.biocel.2011.12.021; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Chavey C, 2006, OBESITY, V14, P1890, DOI 10.1038/oby.2006.220; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clark A, 2001, DIABETES, V50, pS169, DOI 10.2337/diabetes.50.2007.S169; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Delany AM, 2008, OSTEOPOROSIS INT, V19, P969, DOI 10.1007/s00198-007-0523-9; Fenouille N, 2011, ONCOGENE, V30, P4887, DOI 10.1038/onc.2011.198; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Ihm SH, 2006, DIABETES, V55, P1361, DOI 10.2337/db05-1333; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Kos K, 2009, DIABETES, V58, P1780, DOI 10.2337/db09-0211; Kotani K, 2011, J INT MED RES, V39, P528, DOI 10.1177/147323001103900221; Landsman L, 2011, P NATL ACAD SCI USA, V108, P17010, DOI 10.1073/pnas.1105404108; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Nakamura S, 1996, ARTHRITIS RHEUM, V39, P539, DOI 10.1002/art.1780390402; Nanba Y, 1997, ACTA MED OKAYAMA, V51, P239; Nie J, 2011, CONNECT TISSUE RES, V52, P99, DOI 10.3109/03008207.2010.483747; Nie J, 2009, J BIOL CHEM, V284, P1279, DOI 10.1074/jbc.M808285200; Perez SE, 2005, DIABETES, V54, P694, DOI 10.2337/diabetes.54.3.694; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portela M, 2010, DEV CELL, V19, P562, DOI 10.1016/j.devcel.2010.09.004; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Llera AS, 2010, CYTOKINE GROWTH F R, V21, P67, DOI 10.1016/j.cytogfr.2009.11.010; Song HY, 2010, BIOCHEM BIOPH RES CO, V396, P961, DOI 10.1016/j.bbrc.2010.05.033; Szabat M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.119; Takahashi M, 2001, OBES RES, V9, P388, DOI 10.1038/oby.2001.50; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Wu DD, 2011, EUR J ENDOCRINOL, V165, P597, DOI 10.1530/EJE-11-0131; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187	43	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68253	10.1371/journal.pone.0068253	http://dx.doi.org/10.1371/journal.pone.0068253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840838	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400180
J	Lemmon, G; Meiler, J				Lemmon, Gordon; Meiler, Jens			Towards Ligand Docking Including Explicit Interface Water Molecules	PLOS ONE			English	Article							HIV-1 PROTEASE; DRUG DESIGN; BINDING; PREDICTION; COMPLEXES; RECOGNITION; CHALLENGES; DYNAMICS	Small molecule docking predicts the interaction of a small molecule ligand with a protein at atomic-detail accuracy including position and conformation the ligand but also conformational changes of the protein upon ligand binding. While successful in the majority of cases, docking algorithms including RosettaLigand fail in some cases to predict the correct protein/ligand complex structure. In this study we show that simultaneous docking of explicit interface water molecules greatly improves Rosetta's ability to distinguish correct from incorrect ligand poses. This result holds true for both protein-centric water docking wherein waters are located relative to the protein binding site and ligand-centric water docking wherein waters move with the ligand during docking. Protein-centric docking is used to model 99 HIV-1 protease/protease inhibitor structures. We find protease inhibitor placement improving at a ratio of 9:1 when one critical interface water molecule is included in the docking simulation. Ligand-centric docking is applied to 341 structures from the CSAR benchmark of diverse protein/ligand complexes [1]. Across this diverse dataset we see up to 56% recovery of failed docking studies, when waters are included in the docking simulation.	[Lemmon, Gordon; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA; [Lemmon, Gordon; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	jens.meiler@vanderbilt.edu	Lemmon, Gordon H/O-2199-2015	Lemmon, Gordon H/0000-0002-8381-205X; Meiler, Jens/0000-0001-8945-193X	National institute of health (NIH) [R01 GM080403, R01 MH090192, R01 GM099842]; national science foundation (NSF) [0742762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R01GM080403, R01GM099842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER	National institute of health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); national science foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work in the Meiler laboratory is supported through National institute of health (NIH) (R01 GM080403, R01 MH090192, R01 GM099842) and national science foundation (NSF) (Career 0742762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; Bronowska A. K., 2011, THERMODYNAMICS INTER; Cameron IL, 2007, CELL BIOL INT, V31, P531, DOI 10.1016/j.cellbi.2006.11.020; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; de Graaf C, 2005, J MED CHEM, V48, P2308, DOI 10.1021/jm049650u; Deng YQ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2842080; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2036, DOI 10.1021/ci200082t; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hornak V, 2006, J AM CHEM SOC, V128, P2812, DOI 10.1021/ja058211x; Huang SY, 2010, INT J MOL SCI, V11, P3016, DOI 10.3390/ijms11083016; Ikura T, 2004, CHEM PHYS, V307, P111, DOI 10.1016/j.chemphys.2004.05.010; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; Kim R, 2008, J COMPUT CHEM, V29, P1316, DOI 10.1002/jcc.20893; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Lie MA, 2011, J CHEM INF MODEL, V51, P909, DOI 10.1021/ci100510m; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Ni HH, 2001, J MED CHEM, V44, P3043, DOI 10.1021/jm010205y; Poornima CS, 1995, J COMPUT AID MOL DES, V9, P500, DOI 10.1007/BF00124321; Rarey M, 1999, PROTEINS, V34, P17, DOI 10.1002/(SICI)1097-0134(19990101)34:1<17::AID-PROT3>3.0.CO;2-1; Roberts BC, 2008, J CHEM INF MODEL, V48, P397, DOI 10.1021/ci700285e; Sarkhel S, 2004, PROTEINS, V54, P247, DOI 10.1002/prot.10567; Schneider G, 2005, NAT REV DRUG DISCOV, V4, P649, DOI 10.1038/nrd1799; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Thilagavathi R, 2010, J CHEM INF MODEL, V50, P415, DOI 10.1021/ci900345h; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; Young T, 2007, P NATL ACAD SCI USA, V104, P808, DOI 10.1073/pnas.0610202104	31	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67536	10.1371/journal.pone.0067536	http://dx.doi.org/10.1371/journal.pone.0067536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840735	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400102
J	Zappala, S; Helliwell, JR; Tracy, SR; Mairhofer, S; Sturrock, CJ; Pridmore, T; Bennett, M; Mooney, SJ				Zappala, Susan; Helliwell, Jonathan R.; Tracy, Saoirse R.; Mairhofer, Stefan; Sturrock, Craig J.; Pridmore, Tony; Bennett, Malcolm; Mooney, Sacha J.			Effects of X-Ray Dose On Rhizosphere Studies Using X-Ray Computed Tomography	PLOS ONE			English	Article							SOIL PORE CHARACTERISTICS; GAMMA-IRRADIATION; MICROBIAL BIOMASS; COMPACTION; RADIATION; SEEDLINGS; ROOTS; CT	X-ray Computed Tomography (CT) is a non-destructive imaging technique originally designed for diagnostic medicine, which was adopted for rhizosphere and soil science applications in the early 1980s. X-ray CT enables researchers to simultaneously visualise and quantify the heterogeneous soil matrix of mineral grains, organic matter, air-filled pores and water-filled pores. Additionally, X-ray CT allows visualisation of plant roots in situ without the need for traditional invasive methods such as root washing. However, one routinely unreported aspect of X-ray CT is the potential effect of X-ray dose on the soil-borne microorganisms and plants in rhizosphere investigations. Here we aimed to i) highlight the need for more consistent reporting of X-ray CT parameters for dose to sample, ii) to provide an overview of previously reported impacts of X-rays on soil microorganisms and plant roots and iii) present new data investigating the response of plant roots and microbial communities to X-ray exposure. Fewer than 5% of the 126 publications included in the literature review contained sufficient information to calculate dose and only 2.4% of the publications explicitly state an estimate of dose received by each sample. We conducted a study involving rice roots growing in soil, observing no significant difference between the numbers of root tips, root volume and total root length in scanned versus unscanned samples. In parallel, a soil microbe experiment scanning samples over a total of 24 weeks observed no significant difference between the scanned and unscanned microbial biomass values. We conclude from the literature review and our own experiments that X-ray CT does not impact plant growth or soil microbial populations when employing a low level of dose (<30 Gy). However, the call for higher throughput X-ray CT means that doses that biological samples receive are likely to increase and thus should be closely monitored.	[Zappala, Susan; Helliwell, Jonathan R.; Tracy, Saoirse R.; Sturrock, Craig J.; Mooney, Sacha J.] Univ Nottingham, Div Agr & Environm Sci, Sutton, Bonington, England; [Mairhofer, Stefan; Pridmore, Tony] Univ Nottingham, Sch Comp Sci, Nottingham NG7 2RD, England; [Bennett, Malcolm] Univ Nottingham, Div Plant & Crop Sci, Sutton, Bonington, England	University of Nottingham; University of Nottingham; University of Nottingham	Zappala, S (corresponding author), Univ Nottingham, Div Agr & Environm Sci, Sutton, Bonington, England.	plxsz3@nottingham.ac.uk	Sturrock, Craig/N-6422-2017; Mooney, Sacha J/G-4020-2010; Bennett, Malcolm/G-4004-2010	Sturrock, Craig/0000-0002-5333-8502; Bennett, Malcolm/0000-0003-0475-390X; Pridmore, Tony/0000-0002-9485-1978; tracy, saoirse/0000-0002-0251-6751; Mooney, Sacha/0000-0002-9314-8113	Engineering and Physical Sciences Research Council Doctoral Training Award; BBSRC [BB/G023972/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023972/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council Doctoral Training Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funders include University of Nottingham (http://www.nottingham.ac.uk/), Lawe's agricultural trust (http://www.rothamsted.ac.uk/Content. php? Section = AboutUs&Page = LawesAgriculturalTrust) and the Engineering and Physical Sciences Research Council Doctoral Training Award(http://www.epsrc.ac.uk) The funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Enezi NA, 2012, INT J AGRIC BIOL, V14, P329; Al-Khayri J, 2012, EMIRATES J FOOD AGR, V24; Als-Nielsen J., 2011, ELEMENTS MODERN XRAY, DOI 10.1002/9781119998365; Bouckaert L, 2012, SOIL BIOL BIOCH; Cattell W, 1931, SCIENCE, V73, P531, DOI 10.1126/science.73.1898.531; Dhondt S, 2010, TRENDS PLANT SCI, V15, P419, DOI 10.1016/j.tplants.2010.05.002; Dutilleul P, 2005, TRENDS PLANT SCI, V10, P411, DOI 10.1016/j.tplants.2005.06.004; Flavel RJ, 2012, J EXPT BOT; Genter CF, 1941, J HERED, V32, P39, DOI 10.1093/oxfordjournals.jhered.a104951; Goodspeed TH, 1929, J HERED, V20, P243, DOI 10.1093/oxfordjournals.jhered.a103193; Gregory PJ, 2003, PLANT SOIL, V255, P351, DOI 10.1023/A:1026179919689; HOUNDSFIELD GN, 1972, Patent No. 1283915; JACKSON NE, 1967, SOIL SCI SOC AM PRO, V31, P491, DOI 10.2136/sssaj1967.03615995003100040021x; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; Jenneson PM, 2003, APPL RADIAT ISOTOPES, V58, P177, DOI 10.1016/S0969-8043(02)00310-X; Johnson EL, 1936, PLANT PHYSIOL, V11, P319, DOI 10.1104/pp.11.2.319; Johnson EL, 1937, PLANT PHYSIOL, V12, P547, DOI 10.1104/pp.12.2.547; Johnson EL, 1936, EFFECTS XRAYS GREEN, P961; Karahara I, 2012, ANN BOT-LONDON, V110, P503, DOI 10.1093/aob/mcs075; Kauffman J.M., 2003, J SCI EXPLORATION, V17, P389; Kravchenko A, 2011, ECOL APPL, V21, P1202, DOI 10.1890/10-0525.1; Martin SL, 2012, SOIL BIOL BIOCHEM, V49, P167, DOI 10.1016/j.soilbio.2012.02.036; McGinnis R., 2009, RAD PRO XRAY DEVICE; McNamara NP, 2003, APPL SOIL ECOL, V24, P117, DOI 10.1016/S0929-1393(03)00073-8; Mooney SJ, 2012, PLANT SOIL, V352, P1, DOI 10.1007/s11104-011-1039-9; Mori I, 2012, RADIOLOGICAL PHYS TE, P1; Munkholm LJ, 2012, GEODERMA, V181, P22, DOI 10.1016/j.geoderma.2012.02.024; Nunan N, 2006, GEODERMA, V133, P398, DOI 10.1016/j.geoderma.2005.08.004; Pang W, 2011, PLANT DIS, V95, P1308, DOI 10.1094/PDIS-01-11-0026; Stupian GW, 2007, TR200785553 SEG CA E; Stuppy WH, 2003, TRENDS PLANT SCI, V8, P2, DOI 10.1016/S1360-1385(02)00004-3; Tracy SR, 2012, ANN BOT-LONDON, V110, P511, DOI 10.1093/aob/mcs031; Tracy SR, 2012, PLANT SOIL, V353, P195, DOI 10.1007/s11104-011-1022-5; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wildenschild D, 2002, J HYDROL, V267, P285, DOI 10.1016/S0022-1694(02)00157-9; Yang WN, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3531980; Yardin MR, 2000, RADIAT PHYS CHEM, V57, P565, DOI 10.1016/S0969-806X(99)00480-6	37	54	55	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67250	10.1371/journal.pone.0067250	http://dx.doi.org/10.1371/journal.pone.0067250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840640	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321424400087
J	Markhus, MW; Skotheim, S; Graff, IE; Froyland, L; Braarud, HC; Stormark, KM; Malde, MK				Markhus, Maria Wik; Skotheim, Siv; Graff, Ingvild Eide; Froyland, Livar; Braarud, Hanne Cecilie; Stormark, Kjell Morten; Malde, Marian Kjellevold			Low Omega-3 Index in Pregnancy Is a Possible Biological Risk Factor for Postpartum Depression	PLOS ONE			English	Article							ESSENTIAL FATTY-ACIDS; EDINBURGH POSTNATAL DEPRESSION; FISH CONSUMPTION; MATERNAL DEPRESSION; DOUBLE-BLIND; PERINATAL DEPRESSION; SYMPTOMS; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; PREVALENCE	Background: Depression is a common disorder affecting 10-15% women in the postpartum period. Postpartum depression can disrupt early mother-infant interaction, and constitutes a risk factor for early child development. Recently, attention has been drawn to the hypothesis that a low intake of seafood in pregnancy can be a risk factor for postpartum depression. Seafood is a unique dietary source of the marine omega-3 fatty acids and is a natural part of a healthy balanced diet that is especially important during pregnancy. Methods: In a community based prospective cohort in a municipality in Western Norway, we investigated both nutritional and psychological risk factors for postpartum depression. The source population was all women who were pregnant within the period November 2009 - June 2011. The fatty acid status in red blood cells was assessed in the 28th gestation week and participants were screened for postpartum depression using the Edinburgh Postnatal Depression Scale (EPDS) three months after delivery. The aim of the present study was to investigate if a low omega-3 index in pregnancy is a possible risk factor for postpartum depression. Results: In a simple regression model, the omega-3 index was associated with the EPDS score in a nonlinear inverse manner with an R square of 19. Thus, the low omega-3 index explained 19% of the variance in the EPDS score. The DPA content, DHA content, omega-3 index, omega-3/omega-6 ratio, total HUFA score, and the omega-3 HUFA score were all inversely correlated with the EPDS score. The EPDS scores of participants in the lowest omega-3 index quartile were significantly different to the three other omega-3 index quartiles. Conclusion: In this study population, a low omega-3 index in late pregnancy was associated with higher depression score three months postpartum.	[Markhus, Maria Wik; Graff, Ingvild Eide; Froyland, Livar; Malde, Marian Kjellevold] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Skotheim, Siv; Braarud, Hanne Cecilie; Stormark, Kjell Morten] Uni Res, Reg Ctr Child & Youth Mental Hlth & Child Welf, Uni Hlth, Bergen, Norway; [Markhus, Maria Wik; Froyland, Livar] Univ Bergen, Fac Med & Dent, Dept Biomed, Bergen, Norway; [Stormark, Kjell Morten] Univ Bergen, Dept Clin Psychol, Fac Psychol, Bergen, Norway	University of Bergen; University of Bergen	Markhus, MW (corresponding author), Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway.	maria.wik.markhus@nifes.no	Kjellevold, Marian/Q-6334-2019; Markhus, Maria Wik/AAL-9055-2021; Kjellevold, Marian/C-2973-2012	Kjellevold, Marian/0000-0001-7070-5784; Markhus, Maria Wik/0000-0002-0196-5387; Kjellevold, Marian/0000-0001-7070-5784				AL MDM, 1995, BRIT J NUTR, V74, P55, DOI 10.1079/BJN19950106; Araujo P, 2008, J CHROMATOGR A, V1212, P106, DOI 10.1016/j.chroma.2008.10.006; Assies J, 2004, PROSTAG LEUKOTR ESS, V70, P349, DOI 10.1016/j.plefa.2003.12.009; Assies J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010635; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Becker W, 2007, FISKKONSUMTION RISK; Berle JO, 2003, J AFFECT DISORDERS, V76, P151, DOI 10.1016/S0165-0327(02)00082-4; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Blum JS, 1999, J PERS, V67, P93, DOI 10.1111/1467-6494.00049; CODDINGTON RD, 1972, J PSYCHOSOM RES, V16, P205, DOI 10.1016/0022-3999(72)90045-1; Cohen J.E., 1988, STAT POWER ANAL BEHA; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; COX JL, 1993, BRIT J PSYCHIAT, V163, P27, DOI 10.1192/bjp.163.1.27; da Rocha CMM, 2012, MATERN CHILD NUTR, V8, P36, DOI 10.1111/j.1740-8709.2010.00256.x; Dahl Lisbeth, 2006, Tidsskr Nor Laegeforen, V126, P309; Dahl L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-127; de Groot RHM, 2012, PROSTAG LEUKOTR ESS, V86, P113, DOI 10.1016/j.plefa.2012.01.002; De Vriese SR, 2003, LIFE SCI, V73, P3181, DOI 10.1016/j.lfs.2003.02.001; Eberhard-Gran M, 2003, SOC PSYCH PSYCH EPID, V38, P551, DOI 10.1007/s00127-003-0679-3; *EFSA, 2005, EFSA J, V236, P1, DOI DOI 10.2903/J.EFSA.2005.236; EFSA, 2009, EFSA J, V1176, P11; FAO, 1997, REV STAT WORLD AQ; FAO/WHO, 2011, REP JOINT EXP CONS R; Fodevaredirektoratet, 2003, HELH FISK FISK; Freeman MP, 2008, J AFFECT DISORDERS, V110, P142, DOI 10.1016/j.jad.2007.12.228; Freeman MP, 2006, ACTA PSYCHIAT SCAND, V113, P31, DOI 10.1111/j.1600-0447.2005.00660.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Golding J, 2009, EPIDEMIOLOGY, V20, P598, DOI 10.1097/EDE.0b013e31819d6a57; Harris William S, 2010, Curr Cardiol Rep, V12, P503, DOI 10.1007/s11886-010-0141-6; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Helsedirektoratet, 2011, UTV NORSK KOSTH; HIBBELN JR, 1995, AM J CLIN NUTR, V62, P1; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hibbeln JR, 2002, J AFFECT DISORDERS, V69, P15, DOI 10.1016/S0165-0327(01)00374-3; HORNSTRA G, 1995, EUR J OBSTET GYN R B, V61, P57, DOI 10.1016/0028-2243(95)02153-J; Jacka FN, 2013, BRIT J NUTR, V109, P2059, DOI 10.1017/S0007114512004102; Judge MP, 2011, FASEB J, V25; Kang JX, 1996, CIRCULATION, V94, P1774, DOI 10.1161/01.CIR.94.7.1774; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Koletzko B, 2008, NESTLE NUTR WORKS SE, V62, P35, DOI 10.1159/000146246; Koletzko B, 2007, BRIT J NUTR, V98, P873, DOI 10.1017/S0007114507764747; LANDS WEM, 1995, AM J CLIN NUTR, V61, p721S, DOI 10.1093/ajcn/61.3.721S; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Makrides M, 2003, ASIA PAC J CLIN NU S, V12, pS37; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Malde M, 2012, INT J NURSING MIDWIF, V4, P4; Markhus M, 2013, FOOD NUTR R IN PRESS; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Mathiesen KS, 1999, SOC PSYCH PSYCH EPID, V34, P61, DOI 10.1007/s001270050113; McNamara RK, 2009, PROSTAG LEUKOTR ESS, V81, P223, DOI 10.1016/j.plefa.2009.05.017; Miles EA, 2011, AM J CLIN NUTR, V94, p1986S, DOI 10.3945/ajcn.110.001636; Miller LJ, 2011, PSYCHIAT CLIN N AM, V34, P53, DOI 10.1016/j.psc.2010.11.010; Milte CM, 2009, NUTR REV, V67, P573, DOI 10.1111/j.1753-4887.2009.00229.x; Montgomery C, 2003, BRIT J NUTR, V90, P135, DOI 10.1079/BJN2003888; Moser DK, 2000, NURS RES, V49, P109, DOI 10.1097/00006199-200003000-00008; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nesheim MC., 2007, SEAFOOD CHOICES BALA, DOI 10.17226/11762; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Oken E, 2005, ENVIRON HEALTH PERSP, V113, P1376, DOI 10.1289/ehp.8041; Otto SJ, 2003, PROSTAG LEUKOTR ESS, V69, P237, DOI 10.1016/S0952-3278(03)00090-5; Peet M, 1998, BIOL PSYCHIAT, V43, P315, DOI 10.1016/S0006-3223(97)00206-0; Popa T A, 2012, J Med Life, V5, P414; Pottala JV, 2012, PROSTAG LEUKOTR ESS, V86, P161, DOI 10.1016/j.plefa.2012.03.002; Raeder MB, 2007, J AFFECT DISORDERS, V101, P245, DOI 10.1016/j.jad.2006.11.006; Redshaw M., 2007, RECORDED DELIVERY NA; Rees AM, 2008, AUST NZ J PSYCHIAT, V42, P199, DOI 10.1080/00048670701827267; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Russell FD, 2012, MAR DRUGS, V10, P2535, DOI 10.3390/md10112535; SACN, 2004, ADV FISH CONS BEN RI; Savitz DA, 1999, PAEDIATR PERINAT EP, V13, P114; Schotte CKW, 2006, DEPRESS ANXIETY, V23, P312, DOI 10.1002/da.20177; Shapiro GD, 2012, CAN J PSYCHIAT, V57, P704, DOI 10.1177/070674371205701108; Shelton RC, 2010, CNS DRUGS, V24, P131, DOI 10.2165/11530280-000000000-00000; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos Artemis P., 2009, V99, P1, DOI 10.1159/000192755; Skotheim S, 2013, INFANT BEHAV DEV, V36, P419, DOI 10.1016/j.infbeh.2013.03.009; Sontrop J, 2008, PAEDIATR PERINAT EP, V22, P389, DOI 10.1111/j.1365-3016.2008.00941.x; Stark KD, 2008, LIPIDS, V43, P45, DOI 10.1007/s11745-007-3128-3; Strom M, 2012, HYPERTENSION, V59, P36, DOI 10.1161/HYPERTENSIONAHA.111.179382; Strom M, 2009, AM J CLIN NUTR, V90, P149, DOI 10.3945/ajcn.2009.27552; Su KP, 2008, J CLIN PSYCHIAT, V69, P644, DOI 10.4088/JCP.v69n0418; Sublette ME, 2011, J CLIN PSYCHIAT, V72, P1577, DOI 10.4088/JCP.10m06634; TREVARTHEN C., 1979, SPEECH BEGINNINGS HU, P321; *VKM, 2007, COMPR ASS FISH OTH S; WHIFFEN VE, 1992, CLIN PSYCHOL REV, V12, P485, DOI 10.1016/0272-7358(92)90068-J; WHO, 2012, MAT MENT HLTH CHILD; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	91	62	66	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67617	10.1371/journal.pone.0067617	http://dx.doi.org/10.1371/journal.pone.0067617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844041	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000086
J	Miwa, K; Lee, JK; Takagishi, Y; Opthof, T; Fu, XM; Hirabayashi, M; Watabe, K; Jimbo, Y; Kodama, I; Komuro, I				Miwa, Keiko; Lee, Jong-Kook; Takagishi, Yoshiko; Opthof, Tobias; Fu, Xianming; Hirabayashi, Masumi; Watabe, Kazuhiko; Jimbo, Yasuhiko; Kodama, Itsuo; Komuro, Issei			Axon Guidance of Sympathetic Neurons to Cardiomyocytes by Glial Cell Line-Derived Neurotrophic Factor (GDNF)	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; VENTRICULAR-ARRHYTHMIA; MYOCARDIAL-INFARCTION; RAT; INNERVATION; EXPRESSION; MECHANISMS; ARTEMIN; SYSTEM; DEATH	Molecular signaling of cardiac autonomic innervation is an unresolved issue. Here, we show that glial cell line-derived neurotrophic factor (GDNF) promotes cardiac sympathetic innervation in vitro and in vivo. In vitro, ventricular myocytes (VMs) and sympathetic neurons (SNs) isolated from neonatal rat ventricles and superior cervical ganglia were cultured at a close distance. Then, morphological and functional coupling between SNs and VMs was assessed in response to GDNF (10 ng/ml) or nerve growth factor (50 ng/ml). As a result, fractions of neurofilament-M-positive axons and synapsin-I-positive area over the surface of VMs were markedly increased with GDNF by 9-fold and 25-fold, respectively, compared to control without neurotrophic factors. Pre- and post-synaptic stimulation of beta(1)-adrenergic receptors (BAR) with nicotine and noradrenaline, respectively, resulted in an increase of the spontaneous beating rate of VMs co-cultured with SNs in the presence of GDNF. GDNF overexpressing VMs by adenovirus vector (AdGDNF-VMs) attracted more axons from SNs compared with mock-transfected VMs. In vivo, axon outgrowth toward the denervated myocardium in adult rat hearts after cryoinjury was also enhanced significantly by adenovirus-mediated GDNF overexpression. GDNF acts as a potent chemoattractant for sympathetic innervation of ventricular myocytes, and is a promising molecular target for regulation of cardiac function in diseased hearts.	[Miwa, Keiko; Lee, Jong-Kook; Kodama, Itsuo] Nagoya Univ, Environm Med Res Inst, Dept Cardiovasc Res, Nagoya, Aichi 464, Japan; [Takagishi, Yoshiko] Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 464, Japan; [Miwa, Keiko] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan; [Lee, Jong-Kook] Osaka Univ, Grad Sch Med, Dept Cardiovasc Regenerat Med, Suita, Osaka, Japan; [Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Opthof, Tobias] Univ Amsterdam, Acad Med Ctr, Ctr Heart Failure Res, Expt Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands; [Opthof, Tobias] Univ Med Ctr Utrecht, Dept Med Physiol, Utrecht, Netherlands; [Fu, Xianming] Nagoya Univ, Grad Sch Med, Dept Cardiovasc Surg, Nagoya, Aichi 4648601, Japan; [Hirabayashi, Masumi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi 444, Japan; [Watabe, Kazuhiko] Tokyo Metropolitan Inst Med Sci, Lab Neurodegenerat Pathol ALS, Tokyo 113, Japan; [Jimbo, Yasuhiko] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan	Nagoya University; Nagoya University; Hokkaido University; Osaka University; Osaka University; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tokyo Metropolitan Institute of Medical Science; University of Tokyo; University of Tokyo	Komuro, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan.	komuro-tky@umin.ac.jp	Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Watabe, Kazuhiko/0000-0002-0245-3834; Fu, Xian-ming/0000-0001-8030-9830	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; Suzuken Memorial Foundation; TERUMO Research Fellowship	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Suzuken Memorial Foundation; TERUMO Research Fellowship	This work was supported in part by: 1. Japan Society for the Promotion of Science (1) (http://www.jsps.go.jp/english/e-grants/index.html) 2. The Ministry of Education, Culture, Sports, Science and Technology, Japan (1) (http://www.mext.go.jp/english/) 3. The Suzuken Memorial Foundation (1) (http://www.suzukenzaidan.or.jp/index.html) 4. The TERUMO Research Fellowship (1) (https://www.terumozaidan.or.jp/english/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Boivin B, 2006, CARDIOVASC RES, V71, P69, DOI 10.1016/j.cardiores.2006.03.015; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Chen PS, 2001, CARDIOVASC RES, V50, P409, DOI 10.1016/S0008-6363(00)00308-4; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Damon DH, 2007, AM J PHYSIOL-HEART C, V293, pH266, DOI 10.1152/ajpheart.00859.2006; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Esler M, 2000, Heart Fail Rev, V5, P17; Hakamata Y, 2001, BIOCHEM BIOPH RES CO, V286, P779, DOI 10.1006/bbrc.2001.5452; Hakuba N, 2003, GENE THER, V10, P426, DOI 10.1038/sj.gt.3301917; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Ieda M, 2004, J CLIN INVEST, V113, P876, DOI 10.1172/JCI200419480; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Martinelli PM, 2006, AUTON NEUROSCI-BASIC, V130, P32, DOI 10.1016/j.autneu.2006.05.004; Martinelli PM, 2002, HISTOCHEM CELL BIOL, V118, P337, DOI 10.1007/s00418-002-0452-9; Miwa K, 2010, BIOMED RES-TOKYO, V31, P353, DOI 10.2220/biomedres.31.353; Oh YS, 2006, HEART RHYTHM, V3, P728, DOI 10.1016/j.hrthm.2006.02.005; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PODRID PJ, 1990, CIRCULATION, V82, P103; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Takeuchi A, 2001, LAB CHIP, V13, P2268; Takeuchi A, 2012, INTEGR BIOL-UK, V4, P1532, DOI 10.1039/c2ib20060k; Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3	26	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e65202	10.1371/journal.pone.0065202	http://dx.doi.org/10.1371/journal.pone.0065202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843937	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000040
J	Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Rief, P; Hackl, G; Pilger, E; Brodmann, M				Gary, Thomas; Pichler, Martin; Belaj, Klara; Hafner, Franz; Gerger, Armin; Froehlich, Harald; Eller, Philipp; Rief, Peter; Hackl, Gerald; Pilger, Ernst; Brodmann, Marianne			Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease Patients	PLOS ONE			English	Article							INFLAMMATION; NEUTROPHIL	Background: Platelet-to-Lymphocyte Ratio (PLR) is an easily applicable blood test. An elevated PLR has been associated with poor prognosis in patients with different oncologic disorder. As platelets play a key role in atherosclerosis and atherothrombosis, we investigated PLR and its association with critical limb ischemia (CLI) and other vascular endpoints in peripheral arterial occlusive disease (PAOD) patients. Methods and Findings: We evaluated 2121 PAOD patients treated at our institution from 2005 to 2010. PLR was calculated and the cohort was categorized into tertiles according to the PLR. An optimal cut-off value for the continuous PLR was calculated by applying a receiver operating curve analysis to discriminate between CLI and non-CLI. In our cohort occurrence of CLI significantly increased with an increase in PLR. As an optimal cut-off value, a PLR of 150 was identified. Two groups were categorized, one containing 1228 patients (PLR <= 150) and a second group with 893 patients (PLR>150). CLI was more frequent in PLR>150 patients (410(45.9%)) compared to PLR <= 150 patients (270(22.0%)) (p<0.001), as was prior myocardial infarction (51(5.7%) vs. 42(3.5%), p=0.02). Regarding inflammatory parameters, C-reactive protein (median 7.0 mg/l (3.0-24.25) vs. median 5.0 mg/l (2.0-10.0)) and fibrinogen (median 457 mg/dl (359.0-583.0) vs. 372 mg/dl (317.25-455.75)) also significantly differed in the two patient groups (both p<0.001). Finally, a PLR>150 was associated with an OR of 1.9 (95% CI 1.7-2.1) for CLI even after adjustment for other well-established vascular risk factors. Conclusions: An increased PLR is significantly associated with patients at high risk for CLI and other cardiovascular endpoints. The PLR is a broadly available and cheap marker, which could be used to highlight patients at high risk for vascular endpoints.	[Gary, Thomas; Belaj, Klara; Hafner, Franz; Froehlich, Harald; Eller, Philipp; Rief, Peter; Hackl, Gerald; Pilger, Ernst; Brodmann, Marianne] Med Univ Graz, Dept Internal Med, Div Vasc Med, Graz, Austria; [Pichler, Martin; Gerger, Armin] Med Univ Graz, Dept Internal Med, Div Oncol, Graz, Austria	Medical University of Graz; Medical University of Graz	Gary, T (corresponding author), Med Univ Graz, Dept Internal Med, Div Vasc Med, Graz, Austria.	thomas.gary@medunigraz.at		Pichler, Martin/0000-0002-8701-9462; Froehlich, Harald/0000-0003-4415-9809				Aerden D, 2011, ANN VASC SURG, V25, P770, DOI 10.1016/j.avsg.2010.12.025; Bertele V, 1999, EUR J VASC ENDOVASC, V18, P401, DOI 10.1053/ejvs.1999.0934; Bertomeu V, 2008, EUR J VASC ENDOVASC, V36, P189, DOI 10.1016/j.ejvs.2008.02.004; Gary T, 2012, ATHEROSCLEROSIS, V225, P517, DOI 10.1016/j.atherosclerosis.2012.10.025; Gary T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056745; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; HIRSCH AT, 2006, CIRCULATION, V113, pE463, DOI [DOI 10.1161/CIRCULATI0NAHA.106.174526, 10.1161/CIRCULATIONAHA.106.174526]; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Iso Y, 2010, ATHEROSCLEROSIS, V209, P167, DOI 10.1016/j.atherosclerosis.2009.08.028; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.656705; Lindemann S, 2007, J THROMB HAEMOST, V5, P203, DOI 10.1111/j.1538-7836.2007.02517.x; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Novo S., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P219, DOI 10.2174/1568006043335989; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Suades R, 2012, THROMB HAEMOSTASIS, V108, P1208, DOI 10.1160/TH12-07-0486; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Tasoglu I, 2013, CLIN APPL THROMB HEM	18	169	175	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67688	10.1371/journal.pone.0067688	http://dx.doi.org/10.1371/journal.pone.0067688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844064	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000078
J	Huang, HC; Chang, TM; Chang, YJ; Wen, HY				Huang, Huey-Chun; Chang, Tsong-Min; Chang, Yu-Jia; Wen, Hsin-Yun			UVB Irradiation Regulates ERK1/2-and p53-Dependent Thrombomodulin Expression in Human Keratinocytes	PLOS ONE			English	Article							FACTOR-KAPPA-B; INDUCED SKIN CARCINOGENESIS; KRUPPEL-LIKE FACTOR-2; TUMOR-NECROSIS-FACTOR; ULTRAVIOLET-RADIATION; DOWN-REGULATION; TRANSCRIPTIONAL REPRESSION; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; P53	Thrombomodulin (TM) is highly expressed in endothelial cells and acts as a natural anticoagulation factor to maintain circulation homeostasis. TM is an interesting molecule with many physiological functions, including anti-inflammation, anti-thrombosis, and carcinogenesis inhibition. TM can also be detected on the spinous layer of epidermal keratinocytes. However, the role of epidermal TM is still under investigation. In this study, we investigated keratinocyte TM expression and regulation in response to sub-cytotoxic ultraviolet B (UVB) irradiation. Oxidative stress was assessed with DCF and the results revealed that UVB irradiation significantly and dose-dependently augmented reactive oxygen species (ROS) production in HaCaT cells. In addition, low-dose UVB irradiation decreased TM mRNA and protein levels. Blocking ROS production and ERK activation prevented UVB-induced TM down-regulation. The nuclear p53 accumulation and TM promoter binding was observed within 3 h after UVB exposure. Small interfering RNA-mediated p53 knockdown disrupted the UVB-mediated TM protein down-regulation. Our study demonstrates that UVB irradiation results in ROS accumulation and ERK activation, which causes the nuclear p53 accumulation and TM promoter binding to inhibit TM expression. This study provides novel evidence demonstrating that p53 serves as a key regulator of keratinocyte TM expression.	[Huang, Huey-Chun; Wen, Hsin-Yun] China Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Care, Taichung, Taiwan; [Chang, Tsong-Min] Hung Kuang Univ, Dept Appl Cosmetol, Taichung, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Dept Surg, Taipei, Taiwan	China Medical University Taiwan; Hungkuang University; Taipei Medical University	Huang, HC (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Care, Taichung, Taiwan.	lchuang@mail.cmu.edu.tw	Huang, Huey-Chun/O-3852-2015	Huang, Huey-Chun/0000-0002-3300-5946; Chang, Yu-Jia/0000-0003-3978-3244	China Medical University [CMU95-320, CMU96-229]; National Science Council [NSC 95-2320-B-039-020, NSC101-2320-B-039-037]	China Medical University(China Medical University); National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported in part by grants from China Medical University CMU95-320, CMU96-229, and grants of National Science Council (NSC 95-2320-B-039-020 and NSC101-2320-B-039-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Ahmed KM, 2009, FREE RADICAL BIO MED, V46, P1543, DOI 10.1016/j.freeradbiomed.2009.03.012; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; Berneburg M, 2000, PHOTODERMATOL PHOTO, V16, P239, DOI 10.1034/j.1600-0781.2000.160601.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brash DE, 2006, BRIT J DERMATOL, V154, P8, DOI 10.1111/j.1365-2133.2006.07230.x; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Cao C, 2008, J CELL PHYSIOL, V215, P506, DOI 10.1002/jcp.21336; Chang H, 2003, FREE RADICAL RES, V37, P655, DOI 10.1080/1071576031000094907; Chang H, 2002, BIOL CHEM, V383, P703, DOI 10.1515/BC.2002.072; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Furuta J, 2005, MELANOMA RES, V15, P15, DOI 10.1097/00008390-200502000-00004; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; ISHII H, 1992, BLOOD, V80, P2556; Iwata M, 2008, BIOCHEM BIOPH RES CO, V377, P642, DOI 10.1016/j.bbrc.2008.10.049; Jackson DE, 1996, PATHOLOGY, V28, P225, DOI 10.1080/00313029600169024; Kang ES, 2011, FREE RADICAL BIO MED, V50, P680, DOI 10.1016/j.freeradbiomed.2010.12.021; Kao YC, 2010, MOL CELL BIOL, V30, P4767, DOI 10.1128/MCB.01021-09; Koutsi A, 2008, INT J BIOCHEM CELL B, V40, P1669, DOI 10.1016/j.biocel.2007.06.024; Kumar A, 2011, ARTERIOSCL THROM VAS, V31, P133, DOI 10.1161/ATVBAHA.110.215061; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Li YP, 2009, J DERMATOL SCI, V54, P143, DOI 10.1016/j.jdermsci.2009.01.009; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; MlZutani H, 1996, BRIT J DERMATOL, V135, P187; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Peterson JJ, 1999, AM J PATHOL, V155, P1569, DOI 10.1016/S0002-9440(10)65473-9; Peus D, 1999, J INVEST DERMATOL, V112, P751, DOI 10.1046/j.1523-1747.1999.00584.x; Raife TJ, 1998, J INVEST MED, V46, P127; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Rong YY, 2010, FEBS LETT, V584, P852, DOI 10.1016/j.febslet.2010.01.048; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Sohn RH, 2005, BLOOD, V105, P3910, DOI 10.1182/blood-2004-03-0928; Song DM, 2009, BLOOD, V114, P2521, DOI 10.1182/blood-2009-02-205914; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Thomas-Ahner JM, 2007, CANCER RES, V67, P3468, DOI 10.1158/0008-5472.CAN-06-3798; Tomita N, 1998, J HYPERTENS, V16, P993, DOI 10.1097/00004872-199816070-00013; Varani J, 2002, J INVEST DERMATOL, V119, P122, DOI 10.1046/j.1523-1747.2002.01810.x; von Bulow S, 2005, BURNS, V31, P459, DOI 10.1016/j.burns.2004.11.021; Wang L, 2005, ONCOGENE, V24, P3020, DOI 10.1038/sj.onc.1208547; Zbytek B, J STEROID B IN PRESS	51	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67632	10.1371/journal.pone.0067632	http://dx.doi.org/10.1371/journal.pone.0067632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844043	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000064
J	Yanez, CO; Morales, AR; Yue, XL; Urakami, T; Komatsu, M; Jarvinen, TAH; Belfield, KD				Yanez, Ciceron O.; Morales, Alma R.; Yue, Xiling; Urakami, Takeo; Komatsu, Masanobu; Jarvinen, Tero A. H.; Belfield, Kevin D.			Deep Vascular Imaging in Wounds by Two-Photon Fluorescence Microscopy	PLOS ONE			English	Article							CYCLIC RGD PEPTIDES; TISSUE; ALPHA(V)BETA(3); RECOGNITION	Deep imaging within tissue (over 300 mu m) at micrometer resolution has become possible with the advent of two-photon fluorescence microscopy (2PFM). The advantages of 2PFM have been used to interrogate endogenous and exogenous fluorophores in the skin. Herein, we employed the integrin (cell-adhesion proteins expressed by invading angiogenic blood vessels) targeting characteristics of a two-photon absorbing fluorescent probe to image new vasculature and fibroblasts up to approximate to 1600 mu m within wound (neodermis)/granulation tissue in lesions made on the skin of mice. Reconstruction revealed three dimensional (3D) architecture of the vascular plexus forming at the regenerating wound tissue and the presence of a fibroblast bed surrounding the capillaries. Biologically crucial events, such as angiogenesis for wound healing, may be illustrated and analyzed in 3D on the whole organ level, providing novel tools for biomedical applications.	[Yanez, Ciceron O.; Morales, Alma R.; Yue, Xiling; Belfield, Kevin D.] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA; [Belfield, Kevin D.] Univ Cent Florida, Coll Opt & Photon, Orlando, FL 32816 USA; [Urakami, Takeo; Komatsu, Masanobu] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL USA; [Jarvinen, Tero A. H.] Univ Tampere, Dept Orthopaed Surg, Tampere City Hosp, FIN-33101 Tampere, Finland; [Jarvinen, Tero A. H.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; Sanford Burnham Prebys Medical Discovery Institute; Tampere University; Tampere University	Belfield, KD (corresponding author), Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA.	belfield@ucf.edu	Komatsu, Masanobu/AAV-3013-2020; Belfield, Kevin D/D-4765-2009	Belfield, Kevin D/0000-0002-7339-2813; Jarvinen, Tero/0000-0002-4027-1759; Komatsu, Masanobu/0000-0001-7548-137X	National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering) [R15 EB008858-01]; National Institutes of Health (National Cancer Institute) [R01 CA125255]; James and Esther King Biomedical Research Program [10KD-11]; National Science Foundation [CHE-0832622]; NATIONAL CANCER INSTITUTE [R01CA125255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R15EB008858] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James and Esther King Biomedical Research Program; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors wish to acknowledge the National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering R15 EB008858-01 to K. D. B., National Cancer Institute R01 CA125255 to M. K.), the James and Esther King Biomedical Research Program (10KD-11) and the National Science Foundation (CHE-0832622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; CAVANI A, 1993, J INVEST DERMATOL, V101, P600, DOI 10.1111/1523-1747.ep12366057; Chen WL, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3247157; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; HIRANO Y, 1991, J BIOMED MATER RES, V25, P1523, DOI 10.1002/jbm.820251209; Jarvinen TAH, 2010, P NATL ACAD SCI USA, V107, P21671, DOI 10.1073/pnas.1016233107; Kobat D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646209; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Morales AR, 2010, ORG BIOMOL CHEM, V8, P2600, DOI 10.1039/b925934a; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Pawlicki M, 2009, ANGEW CHEM INT EDIT, V48, P3244, DOI 10.1002/anie.200805257; PETICOLA.WL, 1967, ANNU REV PHYS CHEM, V18, P233, DOI 10.1146/annurev.pc.18.100167.001313; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; So PTC, 1998, OPT EXPRESS, V3, P339, DOI 10.1364/OE.3.000339; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6	18	24	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67559	10.1371/journal.pone.0067559	http://dx.doi.org/10.1371/journal.pone.0067559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844028	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000056
J	Ayyavoo, A; Derraik, JGB; Hofman, PL; Mathai, S; Biggs, J; Stone, P; Sadler, L; Cutfield, WS				Ayyavoo, Ahila; Derraik, Jose G. B.; Hofman, Paul L.; Mathai, Sarah; Biggs, Janene; Stone, Peter; Sadler, Lynn; Cutfield, Wayne S.			Pre-Pubertal Children Born Post-Term Have Reduced Insulin Sensitivity and Other Markers of the Metabolic Syndrome	PLOS ONE			English	Article							BINDING PROTEIN-1 IGFBP-1; BLOOD-PRESSURE; GLUCOSE-TOLERANCE; CARDIOVASCULAR RISK; MINIMAL-MODEL; BIRTH; RESISTANCE; STANDARDS; ADULTS; ATHEROSCLEROSIS	Background: There are no data on the metabolic consequences of post-term birth (>= 42 weeks gestation). We hypothesized that post-term birth would adversely affect insulin sensitivity, as well as other metabolic parameters and body composition in childhood. Methods: 77 healthy pre-pubertal children, born appropriate-for-gestational-age were studied in Auckland, New Zealand: 36 born post-term (18 boys) and 41 (27 boys) born at term (38-40 weeks gestation). Primary outcome was insulin sensitivity measured using intravenous glucose tolerance tests and Bergman's minimal model. Other assessments included fasting hormone concentrations and lipid profiles, body composition from whole-body dual-energy X-ray absorptiometry, 24-hour ambulatory blood pressure monitoring, and inflammatory markers. Results: Insulin sensitivity was 34% lower in post-term than in term children (7.7 vs. 11.6 x10(-4).min(-1).(mU/l); p<0.0001). There was a compensatory increase in acute insulin response among post-term children (418 vs 304 mU/l; p=0.037), who also displayed lower glucose effectiveness than those born at term (2.25 vs 3.11 x10(-2).min(-1); p=0.047). Post-term children not only had more body fat (p=0.014) and less fat-free mass (p=0.014), but also had increased central adiposity with more truncal fat (p=0.017) and greater android to gynoid fat ratio (p=0.007) compared to term controls. Further, post-term children displayed other markers of the metabolic syndrome: lower normal nocturnal systolic blood pressure dipping (p=0.027), lower adiponectin concentrations (p=0.005), as well as higher leptin (p=0.008) and uric acid (p=0.033) concentrations. Post-term boys (but not girls) also displayed a less favourable lipid profile, with higher total cholesterol (p=0.018) and LDL-C (p=0.006) concentrations, and total cholesterol to HDL-C ratio (p=0.048). Conclusions: Post-term children have reduced insulin sensitivity and display a number of early markers of the metabolic syndrome. These findings could have important implications for the management of prolonged pregnancies. Future studies need to examine potential impacts later in life, as well as possible underlying mechanisms.	[Ayyavoo, Ahila; Derraik, Jose G. B.; Hofman, Paul L.; Mathai, Sarah; Biggs, Janene; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Ayyavoo, Ahila; Hofman, Paul L.; Cutfield, Wayne S.] Gravida Natl Ctr Growth & Dev, Auckland, New Zealand; [Stone, Peter] Univ Auckland, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Sadler, Lynn] Auckland Dist Hlth Board, Natl Womens Hlth, Auckland, New Zealand	University of Auckland; University of Auckland; Auckland District Health Board	Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008; Stone, Peter/L-3677-2019	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; stone, peter/0000-0003-1546-752X	Gravida: National Centre for Growth and Development; Australasian Paediatric Endocrine Group (APEG)	Gravida: National Centre for Growth and Development; Australasian Paediatric Endocrine Group (APEG)	This study was funded by Gravida: National Centre for Growth and Development, the Australasian Paediatric Endocrine Group (APEG), and Maureen Trotter. The funders had any role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Beltrand J, 2012, J PEDIATR-US, V160, P769, DOI 10.1016/j.jpeds.2011.10.030; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; BRISMAR K, 1994, J CLIN ENDOCR METAB, V79, P872, DOI 10.1210/jc.79.3.872; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; CUTFIELD WS, 1990, J CLIN ENDOCR METAB, V70, P1644, DOI 10.1210/jcem-70-6-1644; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; Ehrenstein V, 2007, PEDIATRICS, V119, pE554, DOI 10.1542/peds.2006-1308; Esteghamati A, 2009, METAB SYNDR RELAT D, V7, P447, DOI 10.1089/met.2008.0100; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Heald AH, 2001, DIABETOLOGIA, V44, P333, DOI 10.1007/s001250051623; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; Hulthe J, 2003, METABOLISM, V52, P1612, DOI 10.1016/S0026-0495(03)00313-5; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Kalish RB, 2004, AM J OBSTET GYNECOL, V191, P975, DOI 10.1016/j.ajog.2004.06.053; Lie RT, 2006, OBSTET GYNECOL, V107, P880, DOI 10.1097/01.AOG.0000206797.52832.36; Mandruzzato G, 2010, J PERINAT MED, V38, P111, DOI [10.1515/JPM.2010.057, 10.1515/jpm.2010.057]; Mathai S, 2012, DIABETES, V61, P2479, DOI 10.2337/db11-1672; Mihu CM, 2004, LEONARDO J PRACT TEC, V4, P51; Moster D, 2011, OBSTET GYNECOL SURV, V66, P8, DOI [10.1097/OGX.0b013e3182021dcb, DOI 10.1097/0GX.0B013E3182021DCB]; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Norwitz ER, 2007, CLIN OBSTET GYNECOL, V50, P547, DOI 10.1097/GRF.0b013e31804c9b11; Novotny R, 2007, OBESITY, V15, P1565, DOI 10.1038/oby.2007.185; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; SHEAR CL, 1987, HYPERTENSION, V9, P236, DOI 10.1161/01.HYP.9.3.236; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; Urbina E, 2008, HYPERTENSION, V52, P433, DOI 10.1161/HYPERTENSIONAHA.108.190329; Wassink AMJ, 2008, EUR HEART J, V29, P213, DOI 10.1093/eurheartj/ehm582; Wiklund P, 2008, J CLIN ENDOCR METAB, V93, P4360, DOI 10.1210/jc.2008-0804; Zeitlin J, 2007, BJOG-INT J OBSTET GY, V114, P1097, DOI 10.1111/j.1471-0528.2007.01328.x	39	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67966	10.1371/journal.pone.0067966	http://dx.doi.org/10.1371/journal.pone.0067966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840881	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900020
J	Boutros, R; Mondesert, O; Lorenzo, C; Astuti, P; McArthur, G; Chircop, M; Ducommun, B; Gabrielli, B				Boutros, Rose; Mondesert, Odile; Lorenzo, Corinne; Astuti, Puji; McArthur, Grant; Chircop, Megan; Ducommun, Bernard; Gabrielli, Brian			CDC25B Overexpression Stabilises Centrin 2 and Promotes the Formation of Excess Centriolar Foci	PLOS ONE			English	Article							CENTROSOME DUPLICATION; GAMMA-TUBULIN; CHROMOSOMAL INSTABILITY; MICROTUBULE NUCLEATION; PROTEIN-KINASE; RING COMPLEX; HUMAN-CELLS; DNA-DAMAGE; HELA-CELLS; S-PHASE	CDK-cyclin complexes regulate centriole duplication and microtubule nucleation at specific cell cycle stages, although their exact roles in these processes remain unclear. As the activities of CDK-cyclins are themselves positively regulated by CDC25 phosphatases, we investigated the role of centrosomal CDC25B during interphase. We report that overexpression of CDC25B, as is commonly found in human cancer, results in a significant increase in centrin 2 at the centrosomes of interphase cells. Conversely, CDC25B depletion causes a loss of centrin 2 from the centrosome, which can be rescued by treatment with the proteasome inhibitor MG132. CDC25B overexpression also promotes the formation of excess centrin 2 "foci". These foci can accumulate other centrosome proteins, including gamma-tubulin and PCM-1, and can function as microtubule organising centres, indicating that these represent functional centrosomes. Formation of centrin 2 foci can be blocked by specific inhibition of CDK2 but not CDK1. CDK2-mediated phosphorylation of Monopolar spindle 1 (Mps1) at the G1/S transition is essential for the initiation of centrosome duplication, and Mps1 is reported to phosphorylate centrin 2. Overexpression of wild-type or non-degradable Mps1 exacerbated the formation of excess centrin 2 foci induced by CDC25B overexpression, while kinase-dead Mps1 has a protective effect. Together, our data suggest that CDC25B, through activation of a centrosomal pool of CDK2, stabilises the local pool of Mps1 which in turn regulates the level of centrin 2 at the centrosome. Overexpression of CDC25B may therefore contribute to tumourigenesis by perturbing the natural turnover of centrosome proteins such as Mps1 and centrin 2, thus resulting in the de novo assembly of extra-numerary centrosomes and potentiating chromosome instability.	[Boutros, Rose; Astuti, Puji; Gabrielli, Brian] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Boutros, Rose; Chircop, Megan] Childrens Med Res Inst, Cell Cycle Unit, Sydney, NSW, Australia; [Mondesert, Odile; Lorenzo, Corinne; Ducommun, Bernard] CRT CIV UMS3039, ITAV, Ctr Pierre Potier, Toulouse, France; [Astuti, Puji] Univ Gadjah Mada, Fac Pharm, Yogyakarta, Indonesia; [McArthur, Grant] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Ducommun, Bernard] CNRS, LBCMCP UMR5088, Toulouse, France; [Ducommun, Bernard] CHU Purpan, Serv Hematol, Toulouse, France	University of Queensland; Children's Medical Research Institute - Australia; University of Sydney; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Gadjah Mada University; Peter Maccallum Cancer Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU de Toulouse	Boutros, R (corresponding author), Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia.	rboutros@cmri.org.au	Astuti, Puji/GLV-5075-2022; Gabrielli, Brian G/B-3655-2011	Astuti, Puji/0000-0003-3316-6149; Gabrielli, Brian G/0000-0003-3933-1651; DUCOMMUN, Bernard/0000-0002-7126-8368; Boutros, Rose/0000-0001-9025-2057	National Health and Medical Research Council (NHMRC) Australia; NHMRC Australia; C.N.R.S; l'Universite Paul Sabatier; la Ligue Nationale Contre le Cancer	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); C.N.R.S(Centre National de la Recherche Scientifique (CNRS)European Commission); l'Universite Paul Sabatier; la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	RB was supported by a C.J. Martin post-doctoral training fellowship and a Project Grant from the National Health and Medical Research Council (NHMRC) Australia. Work in the Gabrielli lab is supported by the NHMRC Australia. Work in the Ducommun lab was supported by C.N.R.S, l'Universite Paul Sabatier and la Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldin V, 1997, J BIOL CHEM, V272, P32731, DOI 10.1074/jbc.272.52.32731; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Boutros R, 2008, CELL CYCLE, V7, P401, DOI 10.4161/cc.7.3.5295; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Boutros R, 2011, BIOL CELL, V103, P55, DOI 10.1042/BC20100111; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gillingham AK, 2000, EMBO REP, V1, P524; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hinchcliffe EH, 2002, ONCOGENE, V21, P6154, DOI 10.1038/sj.onc.1205826; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kasbek C, 2009, ENVIRON MOL MUTAGEN, V50, P654, DOI 10.1002/em.20476; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Loffler H, 2013, ONCOGENE, V32, P2963, DOI 10.1038/onc.2012.310; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Mirey G, 2005, CELL CYCLE, V4, P806, DOI 10.4161/cc.4.6.1716; Mogensen MM, 2000, J CELL SCI, V113, P3013; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Paoletti A, 1996, J CELL SCI, V109, P3089; Pihan GA, 2003, CANCER RES, V63, P1398; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Ruiz F, 1999, CURR BIOL, V9, P43, DOI 10.1016/S0960-9822(99)80045-1; Schmitt E, 2006, J CELL SCI, V119, P4269, DOI 10.1242/jcs.03200; Sohn J, 2004, P NATL ACAD SCI USA, V101, P16437, DOI 10.1073/pnas.0407663101; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Theis-Febvre N, 2003, ONCOGENE, V22, P220, DOI 10.1038/sj.onc.1206107; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Yang CH, 2010, MOL BIOL CELL, V21, P4361, DOI 10.1091/mbc.E10-04-0298; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	41	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67822	10.1371/journal.pone.0067822	http://dx.doi.org/10.1371/journal.pone.0067822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840880	Green Published, gold			2022-12-27	WOS:000321271900019
J	Komine, H; Kuhn, L; Matsushita, N; Mule, JJ; Pilon-Thomas, S				Komine, Hiroshi; Kuhn, Lisa; Matsushita, Norimasa; Mule, James J.; Pilon-Thomas, Shari			Examination of MARCO Activity on Dendritic Cell Phenotype and Function Using a Gene Knockout Mouse	PLOS ONE			English	Article							TUMOR-MESSENGER-RNA; RECEPTORS SR-AI/II; SCAVENGER RECEPTORS; MELANOMA PATIENTS; ANTITUMOR IMMUNITY; BINDING-RECEPTOR; IN-VITRO; T-CELLS; MACROPHAGES; VACCINATION	We have reported the upregulation of MARCO, a member of the class A scavenger receptor family, on the surface of murine and human dendritic cells (DCs) pulsed with tumor lysates. Exposure of murine tumor lysate-pulsed DCs to an anti-MARCO antibody led to loss of dendritic-like processes and enhanced migratory capacity. In this study, we have further examined the biological and therapeutic implications of MARCO expression by DCs. DCs generated from the bone marrow (bm) of MARCO knockout (MARCO(-/-)) mice were phenotypically similar to DCs generated from the bm of wild-type mice and produced normal levels of IL-12 and TNF-alpha when exposed to LPS. MARCO(-/-) DCs demonstrated enhanced migratory capacity in response to CCL-21 in vitro. After subcutaneous injection into mice, MARCO(-/-) TP-DCs migrated more efficiently to the draining lymph node leading to enhanced generation of tumor-specific IFN-gamma producing T cells and improved tumor regression and survival in B16 melanoma-bearing mice. These results support targeting MARCO on the surface of DCs to improve trafficking and induction of anti-tumor immunity.	[Komine, Hiroshi; Kuhn, Lisa; Matsushita, Norimasa; Mule, James J.; Pilon-Thomas, Shari] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA; [Mule, James J.; Pilon-Thomas, Shari] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Pilon-Thomas, S (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA.	shari.pilon-thomas@moffitt.org			National Cancer Institute/National Institutes of Health [5 R01 CA071669-10]; NATIONAL CANCER INSTITUTE [R01CA071669, P30CA076292] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute/National Institutes of Health (5 R01 CA071669-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Arredouani MS, 2007, J IMMUNOL, V178, P5912, DOI 10.4049/jimmunol.178.9.5912; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; Asavaroengchai W, 2002, P NATL ACAD SCI USA, V99, P931, DOI 10.1073/pnas.022634999; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Berntsen A, 2008, J IMMUNOTHER, V31, P771, DOI 10.1097/CJI.0b013e3181833818; Chang AE, 2002, CLIN CANCER RES, V8, P1021; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Fields RC, 1998, P NATL ACAD SCI USA, V95, P9482, DOI 10.1073/pnas.95.16.9482; FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0; Geiger JD, 2001, CANCER RES, V61, P8513; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Grolleau A, 2003, J IMMUNOL, V171, P2879, DOI 10.4049/jimmunol.171.6.2879; Guo CQ, 2012, IMMUNOL CELL BIOL, V90, P101, DOI 10.1038/icb.2011.10; HART IR, 1979, AM J PATHOL, V97, P587; Jozefowski S, 2005, J IMMUNOL, V175, P8032, DOI 10.4049/jimmunol.175.12.8032; Kotera Y, 2001, CANCER RES, V61, P8105; Kyte JA, 2006, CANCER GENE THER, V13, P905, DOI 10.1038/sj.cgt.7700961; Kyte JA, 2006, CANCER IMMUNOL IMMUN, V55, P1432, DOI 10.1007/s00262-006-0161-7; Lesterhuis WJ, 2011, CLIN CANCER RES, V17, P5725, DOI 10.1158/1078-0432.CCR-11-1261; Matsushita N, 2010, CANCER IMMUNOL IMMUN, V59, P875, DOI 10.1007/s00262-009-0813-5; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Pikkarainen T, 1999, J BIOL CHEM, V274, P10975, DOI 10.1074/jbc.274.16.10975; Pilon-Thomas S, 2006, CANCER IMMUNOL IMMUN, V55, P1238, DOI 10.1007/s00262-005-0104-8; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Verdijk P, 2009, CLIN CANCER RES, V15, P2531, DOI 10.1158/1078-0432.CCR-08-2729; Wang XY, 2007, CANCER RES, V67, P4996, DOI 10.1158/0008-5472.CAN-06-3138; Yi HF, 2012, J MOL MED, V90, P413, DOI 10.1007/s00109-011-0828-1	31	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67795	10.1371/journal.pone.0067795	http://dx.doi.org/10.1371/journal.pone.0067795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840879	Green Submitted, Green Published, gold			2022-12-27	WOS:000321271900018
J	Lai, MC; Wang, SW; Cheng, L; Tarn, WY; Tsai, SJ; Sun, HS				Lai, Ming-Chih; Wang, Shainn-Wei; Cheng, Lie; Tarn, Woan-Yuh; Tsai, Shaw-Jenq; Sun, H. Sunny			Human DDX3 Interacts with the HIV-1 Tat Protein to Facilitate Viral mRNA Translation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HELICASE DDX3; SECONDARY STRUCTURE; MODULATES TRANSLATION; DEPENDENT TRANSLATION; INITIATION; EXPORT; STRESS; TYPE-1; REGION	Nuclear export and translation of intron-containing viral mRNAs are required for HIV-1 gene expression and replication. In this report, we provide evidence to show that DDX3 regulates the translation of HIV-1 mRNAs. We found that knockdown of DDX3 expression effectively inhibited HIV-1 production. Translation of HIV-1 early regulatory proteins, Tat and rev, was impaired in DDX3-depleted cells. All HIV-1 transcripts share a highly structured 5' untranslated region (UTR) with inhibitory elements on translation of viral mRNAs, yet DDX3 promoted translation of reporter mRNAs containing the HIV-1 5' UTR, especially with the transactivation response (TAR) hairpin. Interestingly, DDX3 directly interacts with HIV-1 Tat, a well-characterized transcriptional activator bound to the TAR hairpin. HIV-1 Tat is partially targeted to cytoplasmic stress granules upon DDX3 overexpression or cell stress conditions, suggesting a potential role of Tat/DDX3 complex in translation. We further demonstrated that HIV-1 Tat remains associated with translating mRNAs and facilitates translation of mRNAs containing the HIV-1 5' UTR. Taken together, these findings indicate that DDX3 is recruited to the TAR hairpin by interaction with viral Tat to facilitate HIV-1 mRNA translation.	[Lai, Ming-Chih; Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Wang, Shainn-Wei; Sun, H. Sunny] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Cheng, Lie] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Academia Sinica - Taiwan	Tsai, SJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan.	seantsai@mail.ncku.edu.tw; hssun@mail.ncku.edu.tw	Tsai, Shaw-Jenq/AAG-6569-2019; Tarn, Woan-Yuh/N-8464-2018; Wang, Shainn-Wei/B-9644-2009	Sun, Sunny/0000-0002-3661-4448; TSAI, SHAW-JENQ/0000-0002-3569-5813; , Lie/0000-0001-5825-6162	National Science Council of Taiwan [NSC100-2320-B-006-021-MY3, NSC100-2627-B-006-022]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants (NSC100-2320-B-006-021-MY3 to MCL and NSC100-2627-B-006-022 to HSS) from the National Science Council of Taiwan (http://web1.nsc.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan LG, 2010, J CELL SCI, V123, P369, DOI 10.1242/jcs.055897; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Berkhout B, 2011, NUCLEIC ACIDS RES, V39, P5232, DOI 10.1093/nar/gkr113; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Charbonneau J, 2012, RNA, V18, P519, DOI 10.1261/rna.030346.111; Charnay N, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-74; Choi YJ, 2012, J CELL BIOCHEM, V113, P985, DOI 10.1002/jcb.23428; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cullen BR, 2005, NATURE, V433, P26, DOI 10.1038/433026a; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; DINGWALL C, 1989, P NATL ACAD SCI USA, V86, P6925, DOI 10.1073/pnas.86.18.6925; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; FISHER AG, 1985, NATURE, V316, P262, DOI 10.1038/316262a0; Garbelli A, 2011, CURR MED CHEM, V18, P3015, DOI 10.2174/092986711796391688; Geissler R, 2012, NUCLEIC ACIDS RES, V40, P4998, DOI 10.1093/nar/gks070; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Grallert B, 2000, J CELL SCI, V113, P1447; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Ishaq M, 2008, MOL BIOTECHNOL, V39, P231, DOI 10.1007/s12033-008-9040-0; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Krishnan Vyjayanthi, 2004, Retrovirology, V1, P42, DOI 10.1186/1742-4690-1-42; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Lai MC, 2010, MOL CELL BIOL, V30, P5444, DOI 10.1128/MCB.00560-10; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Liu JF, 2011, J NEUROIMMUNE PHARM, V6, P308, DOI 10.1007/s11481-011-9265-8; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Marsden S, 2006, J MOL BIOL, V361, P327, DOI 10.1016/j.jmb.2006.06.016; Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897; PARKIN NT, 1988, EMBO J, V7, P2831, DOI 10.1002/j.1460-2075.1988.tb03139.x; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; SENGUPTA DN, 1990, P NATL ACAD SCI USA, V87, P7492, DOI 10.1073/pnas.87.19.7492; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029	56	38	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68665	10.1371/journal.pone.0068665	http://dx.doi.org/10.1371/journal.pone.0068665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840900	gold, Green Submitted, Green Published			2022-12-27	WOS:000321271900039
J	Cui, F; Wang, T; Wang, L; Yang, SX; Zhang, L; Cao, HX; Zhang, Y; Hu, HD; Zhai, SY				Cui, Feng; Wang, Tao; Wang, Ling; Yang, Shuxia; Zhang, Ling; Cao, Haixia; Zhang, Yan; Hu, Haodong; Zhai, Shenyong			Spatial Analysis of Hemorrhagic Fever with Renal Syndrome in Zibo City, China, 2009-2012	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; LIAONING PROVINCE; CANCER CLUSTERS; DISEASE; VIRUS; SURVEILLANCE; TUBERCULOSIS; HANTAVIRUSES	Background: Hemorrhagic fever with renal syndrome (HFRS) is highly endemic in mainland China, where human cases account for 90% of the total global cases. Zibo City is one of the most serious affected areas in Shandong Province China with the HFRS incidence increasing sharply from 2009 to 2012. However, the hotspots of HFRS in Zibo remained unclear. Thus, a spatial analysis was conducted with the aim to explore the spatial, spatial-temporal and seasonal patterns of HFRS in Zibo from 2009 to 2012, and to provide guidance for formulating regional prevention and control strategies. Methods: The study was based on the reported cases of HFRS from the National Notifiable Disease Surveillance System. Annualized incidence maps and seasonal incidence maps were produced to analyze the spatial and seasonal distribution of HFRS in Zibo City. Then spatial scan statistics and space-time scan statistics were conducted to identify clusters of HFRS. Results: There were 200 cases reported in Zibo City during the 4-year study period. One most likely cluster and one secondary cluster for high incidence of HFRS were identified by the space-time analysis. And the most likely cluster was found to exist at Yiyuan County in October to December 2012. The human infections in the fall and winter reflected a seasonal characteristic pattern of Hantaan virus (HTNV) transmission. The secondary cluster was detected at the center of Zibo in May to June 2009, presenting a seasonal characteristic of Seoul virus (SEOV) transmission. Conclusion: To control and prevent HFRS in Zibo city, the comprehensive preventive strategy should be implemented in the southern areas of Zibo in autumn and in the northern areas of Zibo in spring.	[Cui, Feng; Wang, Tao; Wang, Ling; Yang, Shuxia; Zhang, Ling; Cao, Haixia; Zhang, Yan; Hu, Haodong; Zhai, Shenyong] Zibo Municipal Ctr Dis Control & Prevent, Zibo, Shandong, Peoples R China		Zhai, SY (corresponding author), Zibo Municipal Ctr Dis Control & Prevent, Zibo, Shandong, Peoples R China.	zibocdc@163.com			Zibo Municipal Center for Disease Control and Prevention	Zibo Municipal Center for Disease Control and Prevention	This work was supported by Zibo Municipal Center for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2010, PEDIATR BLOOD CANCER, V54, P511, DOI 10.1002/pbc.22403; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; CHEN HX, 1986, J INFECT DIS, V154, P394, DOI 10.1093/infdis/154.3.394; Clement JP, 2003, ANTIVIR RES, V57, P121, DOI 10.1016/S0166-3542(02)00205-X; Cousens S, 2001, LANCET, V357, P1002, DOI 10.1016/S0140-6736(00)04236-7; Fang LQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000789; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Henry KA, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-48; KIM YS, 1995, NEPHRON, V71, P419, DOI 10.1159/000188762; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Lin HL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-207; Liu X, 2012, EPIDEMIOL INFECT, V140, P851, DOI 10.1017/S0950268811001063; Liu YX, 2007, AM J TROP MED HYG, V76, P801, DOI 10.4269/ajtmh.2007.76.801; Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395; Saman DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030532; SCHMALJOHN CS, 1983, VIROLOGY, V131, P482, DOI 10.1016/0042-6822(83)90514-7; Simmons JH, 2002, COMPARATIVE MED, V52, P97; Song G, 1999, CHINESE MED J-PEKING, V112, P472; Sun L, 2011, CHINESE MED J-PEKING, V124, P1639, DOI 10.3760/cma.j.issn.0366-6999.2011.11.007; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; Wu W, 2009, EPIDEMIOL INFECT, V137, P1766, DOI 10.1017/S0950268809002659; Wu W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-229; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Zhang WY, 2009, AM J TROP MED HYG, V80, P678, DOI 10.4269/ajtmh.2009.80.678; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470; Zhang YZ, 2009, EMERG INFECT DIS, V15, P885, DOI 10.3201/eid1506.081126; Zuo SQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000945	34	11	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67490	10.1371/journal.pone.0067490	http://dx.doi.org/10.1371/journal.pone.0067490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840719	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400091
J	Dong, HT; Li, QM; Zhang, Y; Tan, W; Jiang, ZX				Dong, Hongtao; Li, Qiuming; Zhang, Ying; Tan, Wei; Jiang, Zhengxuan			IL23R Gene Confers Susceptibility to Ankylosing Spondylitis Concomitant with Uveitis in a Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTERLEUKIN 23 RECEPTOR; ACUTE ANTERIOR UVEITIS; BEHCETS-DISEASE; LOCI; IL-23R; SPONDYLOARTHRITIS; POLYMORPHISMS; AUTOIMMUNITY; PATHOGENESIS	Purpose: The interleukin-23 receptor (IL-23R) has been shown to be associated with ankylosing spondylitis (AS) in many different populations. This study examined whether IL-23R polymorphisms were associated with susceptibility to this disease in a Chinese Han population. Methods: Three single-nucleotide polymorphisms (SNP), rs7517847, rs11209032, and rs17375018, were genotyped in 291 AS patients and 312 age-, sex-, and ethnically matched healthy controls using a polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP) assay. Results: The genotype and allele frequencies of rs17375018, rs7517847, and rs11209032 were not different between the patients with AS and the healthy controls. On the one hand, stratification analysis indicated that the rs17375018 GG genotype and the G allele were increased in AS patients who were HLA-B27 positive (corrected p = 0.024, odds ratio [OR] 2.35, 95% CI 1.30-4.24; pc = 0.006, OR 1.98, 95% CI 1.28-3.07, respectively). On the other hand, the analysis according to clinical characteristics showed a significantly increased prevalence of the homozygous rs17375018 GG genotype and the G allele in patients with AS and uveitis compared with the controls (p(c) = 0.024 and p(c) = 0.024, respectively). In addition, haplotype analysis performed with the SHEsis platform revealed no significant difference concerning the haplotypes between AS patients and healthy controls. Conclusions: In this study, the results suggested that the rs17375018 of IL23R was positively associated with HLA-B27-positive AS and that the rs17375018 GG of IL-23R was associated with AS concomitant with uveitis. We found no evidence for an association between the other two SNPs of IL-23R and AS.	[Dong, Hongtao; Li, Qiuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, Zhengzhou 450052, Peoples R China; [Zhang, Ying; Tan, Wei] Zunyi Med Univ, Affiliated Hosp 3, Peoples Hosp Zunyi 1, Dept Ophthalmol, Zunyi, Peoples R China; [Jiang, Zhengxuan] Anhui Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Hefei, Peoples R China	Zhengzhou University; Zunyi Medical University; Anhui Medical University	Dong, HT (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, Zhengzhou 450052, Peoples R China.	dhtkidy@126.com; tanwei950118@sina.com; jzx1287@163.com			Foundation for health science and technology innovative talents of Henan province, china [4107]; Governor Foundation of Special Research of Clinical Application in Guizhou Province [131]; Key project of Natural Science Foundation of Higher Educational Bureau of Anhui Province [KJ2013A]; Foundation of Anhui Medical University [2012xkj053]	Foundation for health science and technology innovative talents of Henan province, china; Governor Foundation of Special Research of Clinical Application in Guizhou Province; Key project of Natural Science Foundation of Higher Educational Bureau of Anhui Province; Foundation of Anhui Medical University	This work was supported by the Foundation for health science and technology innovative talents of Henan province, china (4107); the Governor Foundation of Special Research of Clinical Application in Guizhou Province, 2012(131); the Key project of Natural Science Foundation of Higher Educational Bureau of Anhui Province (KJ2013A), the Foundation of Anhui Medical University (2012xkj053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaskas K, 2012, INVEST OPHTH VIS SCI, V53, P6171, DOI 10.1167/iovs.12-10026; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Brown MA, 2006, BEST PRACT RES CL RH, V20, P611, DOI 10.1016/j.berh.2006.03.005; Brown MA, 2009, CURR OPIN RHEUMATOL, V21, P318, DOI 10.1097/BOR.0b013e32832b3795; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; Davidson SI, 2009, ARTHRITIS RHEUM-US, V60, P3263, DOI 10.1002/art.24933; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Hollis-Moffatt JE, 2009, ANN RHEUM DIS, V68, P1340, DOI 10.1136/ard.2008.090142; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Jiang ZX, 2010, HUM IMMUNOL, V71, P414, DOI 10.1016/j.humimm.2010.01.026; Karaderi T, 2009, RHEUMATOLOGY, V48, P386, DOI 10.1093/rheumatology/ken501; Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642; Martin TM, 2011, OCUL IMMUNOL INFLAMM, V19, P108, DOI 10.3109/09273948.2011.559302; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Reveille JD, 2011, ANN RHEUM DIS, V70, pI44, DOI 10.1136/ard.2010.140574; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; ROSENBAUM JT, 1992, RHEUM DIS CLIN N AM, V18, P143; Rueda B, 2008, ANN RHEUM DIS, V67, P1451, DOI 10.1136/ard.2007.080283; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sung IH, 2009, J RHEUMATOL, V36, P1003, DOI 10.3899/jrheum.081121; Tam LS, 2010, NAT REV RHEUMATOL, V6, P399, DOI 10.1038/nrrheum.2010.79; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z; Zhou HY, 2010, MOL VIS, V16, P2585	30	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67505	10.1371/journal.pone.0067505	http://dx.doi.org/10.1371/journal.pone.0067505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840727	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400096
J	Hua, KF; Liao, PC; Fang, ZX; Yang, FL; Yang, YL; Chen, YL; Chiu, YC; Liu, ML; Lam, Y; Wu, SH				Hua, Kuo-Feng; Liao, Pei-Chun; Fang, Zhanxiong; Yang, Feng-Ling; Yang, Yu-Liang; Chen, Yi-Lin; Chiu, Yi-Chich; Liu, May-Lan; Lam, Yulin; Wu, Shih-Hsiung			Generation of Reactive Oxygen Species by Polyenylpyrroles Derivatives Causes DNA Damage Leading to G2/M Arrest and Apoptosis in Human Oral Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; DEATH RECEPTOR; CANCER CELLS; P53; BCL-2; MITOCHONDRIA; EXPRESSION; CYTOCHROME-P450	Oral squamous cell carcinoma (OSCC) accounts for 5.8% of all malignancies in Taiwan and the incidence of OSCC is on the rise. OSCC is also a common malignancy worldwide and the five-year survival rate remains poor. Therefore, new and effective treatments are needed to control OSCC. In the present study we have investigated the efficacy and associated mechanisms of polyenylpyrroles and their analogs in both in vitro cell culture and in vivo nude mice xenografts. Auxarconjugatin B (compound 1a) resulted in cell cycle arrest in the G2/M phase and caspase-dependent apoptosis in OEC-M1 and HSC-3 cells by activating DNA damage and mitochondria dysfunction through the loss of mitochondrial membrane potential, release of cytochrome c, increase in B-cell lymphoma-2-associated X protein level, and decrease in B-cell lymphoma-2 level. Compound 1a-induced generation of intracellular reactive oxygen species through cytochrome P450 1A1 was identified as a major mechanism of its effect for DNA damage, mitochondria dysfunction and apoptosis, which was reversed by antioxidant N-acetylcysteine as well as cytochrome P450 1A1 inhibitor and specific siRNA. Furthermore, compound 1a-treated nude mice showed a reduction in the OEC-M1 xenograft tumor growth and an increase in the caspase-3 activation in xenograft tissue. These results provide promising insights as to how compound 1a mediates cytotoxicity and may prove to be a molecular rationale for its translation into a potential therapeutic against OSCC.	[Hua, Kuo-Feng; Liao, Pei-Chun; Chen, Yi-Lin] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Fang, Zhanxiong; Lam, Yulin] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Yang, Feng-Ling; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Yang, Yu-Liang] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Chiu, Yi-Chich] Natl Ilan Univ, Dept Biomechatron Engn, Ilan, Taiwan; [Liu, May-Lan] Toko Univ, Dept Nutr Sci, Chiayi, Taiwan	National Ilan University; National University of Singapore; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Ilan University	Hua, KF (corresponding author), Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan.	kfhua@niu.edu.tw; chmlamyl@nus.edu.sg; shwu@gate.sinica.edu.tw			National Science Council, Taiwan [100-2313-B-197-002, 100-2325-B-001-021]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan; contract grant number: 100-2313-B-197-002; 100-2325-B-001-021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERESFORD AP, 1993, DRUG METAB REV, V25, P503, DOI 10.3109/03602539308993984; Bose JS, 2009, J MED CHEM, V52, P3184, DOI 10.1021/jm8015766; Brodska B, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/253529; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Canton DA, 2010, MOL CELL, V40, P1, DOI 10.1016/j.molcel.2010.09.020; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031864; Costa C, 2010, TOXICOLOGY, V271, P83, DOI 10.1016/j.tox.2010.02.014; Fang Z, 2010, J MED CHEM, V53, P7967, DOI 10.1021/jm100619x; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hamouchene H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-333; Hsiao JR, 2009, J ORAL PATHOL MED, V38, P188, DOI 10.1111/j.1600-0714.2008.00732.x; Hua KF, 2012, INFLAMM RES, V61, P1107, DOI 10.1007/s00011-012-0503-1; Kopf PG, 2010, TOXICOL SCI, V117, P537, DOI 10.1093/toxsci/kfq218; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Liao PC, 2013, INFLAMM RES, V62, P89, DOI 10.1007/s00011-012-0555-2; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Lin YS, 2012, J ORAL PATHOL MED, V41, P322, DOI 10.1111/j.1600-0714.2011.01103.x; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; McLean L, 2008, INT J CANCER, V122, P1665, DOI 10.1002/ijc.23244; Meshkini A, 2012, EXP TOXICOL PATHOL, V64, P357, DOI 10.1016/j.etp.2010.09.010; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Murugan AK, 2012, ORAL ONCOL, V48, P383, DOI 10.1016/j.oraloncology.2011.12.006; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Ohnishi K, 2002, APOPTOSIS, V7, P367, DOI 10.1023/A:1016131614856; Oliva CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024665; Perez-Cruz I, 2003, BLOOD, V102, P336, DOI 10.1182/blood-2002-11-3559; Petti S, 2007, ORAL ONCOL, V43, P408, DOI 10.1016/j.oraloncology.2006.04.010; Priyadarsini RV, 2012, FREE RADICAL RES, V46, P41, DOI 10.3109/10715762.2011.637204; Qu W, 2011, CHEM-BIOL INTERACT, V193, P88, DOI 10.1016/j.cbi.2011.05.005; Ropke M, 1996, P NATL ACAD SCI USA, V93, P14704, DOI 10.1073/pnas.93.25.14704; Shi ZQ, 2010, INT J CANCER, V127, P2334, DOI 10.1002/ijc.25222; Thirsk C, 2002, J CHEM SOC PERK T 1, P999, DOI 10.1039/b109741p; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Tsantoulis PK, 2007, ORAL ONCOL, V43, P523, DOI 10.1016/j.oraloncology.2006.11.010; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; YANG CY, 1994, J DENT RES, V73, P1407, DOI 10.1177/00220345940730080301; Yang MH, 2012, ONCOGENE, V31, P2401, DOI 10.1038/onc.2011.423; Yeh CC, 2009, MOL CANCER THER, V8, P2718, DOI 10.1158/1535-7163.MCT-09-0211; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Zhuo XL, 2012, TUMOR BIOL, V33, P2079, DOI 10.1007/s13277-012-0467-3	43	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67603	10.1371/journal.pone.0067603	http://dx.doi.org/10.1371/journal.pone.0067603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840748	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400113
J	Ma, X; Zhao, RZ; Ma, ZY; Yao, KH; Yu, SJ; Zheng, YJ; Yang, YH				Ma, Xiang; Zhao, Ruizhen; Ma, Zhuoya; Yao, Kaihu; Yu, Sangjie; Zheng, Yuejie; Yang, Yonghong			Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Invasive Diseases from Shenzhen Children's Hospital	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; UPPER RESPIRATORY-INFECTIONS; MACROLIDE RESISTANCE; ASIAN NETWORK; SURVEILLANCE; MECHANISMS; SUSCEPTIBILITY; COUNTRIES; DETERMINANTS; PREVALENCE	Objective: To provide guidance for clinical disease prevention and treatment, this study examined the epidemiology, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae (S. pneumoniae) associated with invasive pneumococcal diseases (IPDs) among children less than 14 years of age in Shenzhen, China. Materials and Methods: All the clinical strains were isolated from children less than 14 years old from January 2009 to August 2012. The serotypes and antibiotic resistance of strains of S. pneumoniae were determined using the capsular swelling method and the E-test. Results: A total of 89 strains were isolated and 87 isolates were included. The five prevailing serotypes were 19F (28.7%), 14 (16.1%), 23F (11.5%), 19A (9.2%) and 6B (6.9%). The most common sequence types (ST) were ST271 (21.8%), ST876 (18.4%), ST320 (8.0%) and ST81 (6.9%) which were mainly related to 19F, 14, 19A and 23F, respectively. The potential coverage by 7-, 10-, and 13-valent pneumococcal conjugate vaccine were 77.0%, 77.0%, and 89.7%, respectively. Among the 87 isolates investigated, 11.5% were resistant to penicillin, and for meningitis isolates, the resistance rate was 100%. Multi-drug resistance (MDR) was exhibited by 49 (56.3%) isolates. Eighty-four isolates were resistance to erythromycin, among which, 56 (66.7%) carried the ermB gene alone and 28 (33.3%) expressed both the ermB and mefA/E genes. Conclusions: The potential coverage of PCV13 is higher than PCV7 and PCV10 because high rates of serotypes 19A and 6A in Shenzhen. The clinical treatment of IPD needs a higher drug concentration of antibiotics. Continued surveillance of the antimicrobial susceptibility and serotypes distribution of IPD isolates may be necessary.	[Ma, Xiang; Yao, Kaihu; Yu, Sangjie; Yang, Yonghong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China; [Ma, Xiang; Yao, Kaihu; Yu, Sangjie; Yang, Yonghong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China; [Zhao, Ruizhen; Ma, Zhuoya; Zheng, Yuejie] Shenzhen Childrens Hosp, Bacteriol Lab, Shenzhen, Peoples R China; [Zhao, Ruizhen; Ma, Zhuoya; Zheng, Yuejie] Shenzhen Childrens Hosp, Dept Resp Dis, Shenzhen, Peoples R China	Capital Medical University; Capital Medical University	Zheng, YJ (corresponding author), Shenzhen Childrens Hosp, Bacteriol Lab, Shenzhen, Peoples R China.	yuejiez@sina.com; yyh66@vip.sina.com	ma, xiang/GSE-2438-2022	ma, xiang/0000-0001-6139-4355	Ministry of Science and Technology [2008BA166B01]; National Natural Science Funds of the People's Republic of China [30801259]; Beijing Guidance Teacher Technology Item of Excellent Doctorship Thesis [YB20091002502]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Funds of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Beijing Guidance Teacher Technology Item of Excellent Doctorship Thesis	This work was supported by the Ministry of Science and Technology [2008BA166B01], the National Natural Science Funds of the People's Republic of China [30801259], and the Beijing Guidance Teacher Technology Item of Excellent Doctorship Thesis [YB20091002502]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Bae S, 2009, DIAGN MICR INFEC DIS, V63, P213, DOI 10.1016/j.diagmicrobio.2008.10.002; Bharathiraja R., 2005, Indian Journal of Pediatrics, V72, P877, DOI 10.1007/BF02731121; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Cho HJ, 2004, SOC SCI MED, V58, P623, DOI 10.1016/S0277-9536(03)00231-4; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20 CLSI; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fitoussi F, 2001, ANTIMICROB AGENTS CH, V45, P636, DOI 10.1128/AAC.45.2.636-638.2001; Ho PL, 2006, EUR J CLIN MICROBIOL, V25, P323, DOI 10.1007/s10096-006-0139-6; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Johnston NJ, 1998, ANTIMICROB AGENTS CH, V42, P2425, DOI 10.1128/AAC.42.9.2425; Kelly LM, 1999, J CLIN MICROBIOL, V37, P3296, DOI 10.1128/JCM.37.10.3296-3299.1999; Kilgore PE, 2005, 43 ANN M INF DIS SOC, P142; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lee NY, 2001, CLIN INFECT DIS, V32, P1463, DOI 10.1086/320165; Osatakul S, 2007, ANN TROP PAEDIATR, V27, P115, DOI 10.1179/146532807X192480; Phongsamart W, 2007, VACCINE, V25, P1275, DOI 10.1016/j.vaccine.2006.10.001; Reinert RR, 2005, ANTIMICROB AGENTS CH, V49, P2903, DOI 10.1128/AAC.49.7.2903-2913.2005; Sahm DF, 2000, J ANTIMICROB CHEMOTH, V45, P457, DOI 10.1093/jac/45.4.457; Schmitz FJ, 2001, INT J ANTIMICROB AG, V18, P433, DOI 10.1016/S0924-8579(01)00427-7; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P2101, DOI 10.1128/AAC.48.6.2101-2107.2004; Song JH, 2004, J ANTIMICROB CHEMOTH, V53, P457, DOI 10.1093/jac/dkh118; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Srifeungfung S, 2010, VACCINE, V28, P3440, DOI 10.1016/j.vaccine.2010.02.071; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Tait-Kamradt A, 2000, ANTIMICROB AGENTS CH, V44, P3395, DOI 10.1128/AAC.44.12.3395-3401.2000; Toltzis P, 2006, PEDIATR INFECT DIS J, V25, P19, DOI 10.1097/01.inf.0000195784.27503.f0; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027; Yu S, 2008, EUR J CLIN MICROBIOL, V27, P649, DOI 10.1007/s10096-008-0481-y; Zhao CJ, 2012, DIAGN MICR INFEC DIS, V73, P174, DOI 10.1016/j.diagmicrobio.2012.03.003; Zhou L, 2011, VACCINE, V29, P7704, DOI 10.1016/j.vaccine.2011.07.137	35	24	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67507	10.1371/journal.pone.0067507	http://dx.doi.org/10.1371/journal.pone.0067507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840728	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400097
J	Mori, M; Boarbi, S; Michel, P; Bakinahe, R; Rits, K; Wattiau, P; Fretin, D				Mori, Marcella; Boarbi, Samira; Michel, Patrick; Bakinahe, Raissa; Rits, Katleen; Wattiau, Pierre; Fretin, David			In Vitro and In Vivo Infectious Potential of Coxiella burnetii: A Study on Belgian Livestock Isolates	PLOS ONE			English	Article							Q-FEVER; PHASE-I; VIRULENCE; EPIDEMIC; DISEASES; MODEL; LIPOPOLYSACCHARIDE; NETHERLANDS; VARIANTS; CLASSICS	Q-fever is a zoonosis caused by the gram-negative obligate intracellular pathogen Coxiella burnetii. Since its discovery, and particularly following the recent outbreaks in the Netherlands, C. burnetii appeared as a clear public health concern. In the present study, the infectious potential displayed by goat and cattle isolates of C. burnetii was compared to a reference strain (Nine Mile) using both in vitro (human HeLa and bovine macrophage cells) and in vivo (BALB/c mice) models. The isolates had distant genomic profiles with one - the goat isolate - being identical to the predominant strain circulating in the Netherlands during the 2007-2010 outbreaks. Infective doses were established with ethidium monoazide-PCR for the first time here applied to C. burnetii. This method allowed for the preparation of reproducible and characterized inocula thanks to its capacity to discriminate between live and dead cells. Globally, the proliferative capacity of the Nine Mile strain in cell lines and mice was higher compared to the newly isolated field strains. In vitro, the bovine C. burnetii isolate multiplied faster in a bovine macrophage cell line, an observation tentatively explained by the preferential specificity of this strain for allogeneic host cells. In the BALB/c mouse model, however, the goat and bovine isolates multiplied at about the same rate indicating no peculiar hypervirulent behavior in this animal model.	[Mori, Marcella; Boarbi, Samira; Michel, Patrick; Bakinahe, Raissa; Rits, Katleen; Fretin, David] VAR CODA CERVA, Operat Directorate Bacterial Dis, Bacterial Zoonoses Livestock, Vet & Agrochem Res Ctr, Brussels, Belgium; [Wattiau, Pierre] VAR CODA CERVA, Vet & Agrochem Res Ctr, Operat Directorate Bacterial Dis, Brussels, Belgium	Ghent University; Ghent University	Mori, M (corresponding author), VAR CODA CERVA, Operat Directorate Bacterial Dis, Bacterial Zoonoses Livestock, Vet & Agrochem Res Ctr, Brussels, Belgium.	marcella.mori@coda-cerva.be	Mori, Marcella/U-3810-2018	Mori, Marcella/0000-0002-7191-9191	Belgian Federal Public Service for Health, Food Chain Safety and the Environment [DIVACOX RF 10/6228]	Belgian Federal Public Service for Health, Food Chain Safety and the Environment	This work was supported by a Grant from the Belgian Federal Public Service for Health, Food Chain Safety and the Environment (ref. DIVACOX RF 10/6228). (http://www.health.belgium.be/eportal/Aboutus/ourorganisation/Recherchecontractuelle/index.htm?fodnlang=fr) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Arricau-Bouvery N, 2003, ANN NY ACAD SCI, V990, P524, DOI 10.1111/j.1749-6632.2003.tb07422.x; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; BURNET FM, 1983, REV INFECT DIS, V5, P800; Delsing CE, 2010, NETH J MED, V68, P382; DERRICK EH, 1983, REV INFECT DIS, V5, P790; Dijkstra F, 2011, FEMS IMMUNOL MED MIC; Enserink M, 2010, SCIENCE, V327, P266, DOI [10.1126/science.327.5963.266-a, 10.1126/science.327.5963.266-b]; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Guatteo R, 2011, VET MICROBIOL, V149, P1, DOI 10.1016/j.vetmic.2010.10.007; He YP, 2010, FOOD MICROBIOL, V27, P439, DOI 10.1016/j.fm.2009.11.017; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Huijsmans CJJ, 2011, APPL ENVIRON MICROB, V77, P2051, DOI 10.1128/AEM.02293-10; Jager MM, 2011, CLIN VACCINE IMMUNOL, V18, P963, DOI 10.1128/CVI.00009-11; Karagiannis I, 2007, EUROSURVEILLANCE, V12; KAZAR J, 1993, ACTA VIROL, V37, P437; Kersh GJ, 2010, APPL ENVIRON MICROB, V76, P4469, DOI 10.1128/AEM.00042-10; Klaassen CHW, 2009, EMERG INFECT DIS, V15, P613, DOI 10.3201/eid1504.081612; Klee SR, 2006, ANN NY ACAD SCI, V1078, P563, DOI 10.1196/annals.1374.111; Leroy Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025781; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Narasaki CT, 2012, ADV EXP MED BIOL, V984, P65, DOI 10.1007/978-94-007-4315-1_4; Omsland A, 2011, ANNU REV MICROBIOL, V65, P111, DOI 10.1146/annurev-micro-090110-102927; Pholwat S, 2011, J CLIN MICROBIOL, V49, P69, DOI 10.1128/JCM.01500-10; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Rawsthorne H, 2009, INT J FOOD MICROBIOL, V131, P246, DOI 10.1016/j.ijfoodmicro.2009.01.031; Rieder A, 2008, J APPL MICROBIOL, V105, P2035, DOI 10.1111/j.1365-2672.2008.03972.x; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Russell-Lodrigue KE, 2006, INFECT IMMUN, V74, P6085, DOI 10.1128/IAI.00763-06; Shannon Jeffrey G., 2008, V431, P189; Stein A, 2005, INFECT IMMUN, V73, P2469, DOI 10.1128/IAI.73.4.2469-2477.2005; STOKER MGP, 1956, CAN J MICROBIOL, V2, P310, DOI 10.1139/m56-036; Svraka S, 2006, FEMS MICROBIOL LETT, V254, P268, DOI 10.1111/j.1574-6968.2005.00036.x; Tamrakar SB, 2011, RISK ANAL, V31, P120, DOI 10.1111/j.1539-6924.2010.01466.x; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P2156, DOI 10.1128/JCM.06831-11; Tilburg JJHC, 2012, EMERG INFECT DIS, V18, P887, DOI 10.3201/eid1805.111907; Tilburg JJ, 2011, J CLIN MICROBIOL; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; van der Hoek W, 2010, EURO SURVEILL, P15; van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17; Zhang GQ, 2007, J IMMUNOL, V179, P8372, DOI 10.4049/jimmunol.179.12.8372; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030841	45	25	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67622	10.1371/journal.pone.0067622	http://dx.doi.org/10.1371/journal.pone.0067622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840751	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400116
J	Jeon, JH; Paik, SS; Chun, MH; Oh, U; Kim, IB				Jeon, Ji Hyun; Paik, Sun Sook; Chun, Myung-Hoon; Oh, Uhtaek; Kim, In-Beom			Presynaptic Localization and Possible Function of Calcium-Activated Chloride Channel Anoctamin 1 in the Mammalian Retina	PLOS ONE			English	Article							CONE BIPOLAR CELLS; AII AMACRINE CELLS; CL-CHANNELS; ROD; CURRENTS; TMEM16A; EXPRESSION; PROTEIN; RELEASE; SUBTYPES	Calcium (Ca2+)-activated chloride (Cl-) channels (CaCCs) play a role in the modulation of action potentials and synaptic responses in the somatodendritic regions of central neurons. In the vertebrate retina, large Ca2+-activated Cl- currents (I-Cl(Ca)) regulate synaptic transmission at photoreceptor terminals; however, the molecular identity of CaCCs that mediate I-Cl(Ca) remains unclear. The transmembrane protein, TMEM16A, also called anoctamin 1 (ANO1), has been recently validated as a CaCC and is widely expressed in various secretory epithelia and nervous tissues. Despite the fact that tmem16a was first cloned in the retina, there is little information on its cellular localization and function in the mammalian retina. In this study, we found that ANO1 was abundantly expressed as puncta in 2 synaptic layers. More specifically, ANO1 immunoreactivity was observed in the presynaptic terminals of various retinal neurons, including photoreceptors. I-Cl(Ca) was first detected in dissociated rod bipolar cells expressing ANO1. I-Cl(Ca) was abolished by treatment with the Ca2+ channel blocker Co2+, the L-type Ca2+ channel blocker nifedipine, and the Cl- channel blockers 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) and niflumic acid (NFA). More specifically, a recently discovered ANO1-selective inhibitor, T16A(inh)-A01, and a neutralizing antibody against ANO1 inhibited I-Cl(Ca) in rod bipolar cells. Under a current-clamping mode, the suppression of I-Cl(Ca) by using NPPB and T16A(inh)-A01 caused a prolonged Ca2+ spike-like depolarization evoked by current injection in dissociated rod bipolar cells. These results suggest that ANO1 confers I-Cl(Ca) in retinal neurons and acts as an intrinsic regulator of the presynaptic membrane potential during synaptic transmission.	[Jeon, Ji Hyun; Paik, Sun Sook; Chun, Myung-Hoon; Kim, In-Beom] Catholic Univ Korea, Dept Anat, Coll Med, Seoul, South Korea; [Jeon, Ji Hyun; Paik, Sun Sook; Kim, In-Beom] Catholic Univ Korea, Catholic Neurosci Inst, Coll Med, Seoul, South Korea; [Oh, Uhtaek] Seoul Natl Univ, Channel Res Ctr, Coll Pharm, Seoul, South Korea; [Kim, In-Beom] Catholic Univ Korea, Catholic Inst Appl Anat, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul National University (SNU); Catholic University of Korea	Kim, IB (corresponding author), Catholic Univ Korea, Dept Anat, Coll Med, Seoul, South Korea.	ibkimmd@catholic.ac.kr	Kim, In-Beom/A-6728-2011		Basic Science Research Program of the National Research Foundation (NRF) of Korea [2010-0022317]; Ministry of Education, Science, and Technology	Basic Science Research Program of the National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Basic Science Research Program (2010-0022317) of the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babai N, 2010, NEUROSCIENCE, V165, P1447, DOI 10.1016/j.neuroscience.2009.11.032; BARNES S, 1992, J NEUROPHYSIOL, V68, P745, DOI 10.1152/jn.1992.68.3.745; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Bieda MC, 2000, VISUAL NEUROSCI, V17, P243, DOI 10.1017/S0952523800172062; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Bloomfield SA, 2000, J PHYSIOL-LONDON, V523, P771, DOI 10.1111/j.1469-7793.2000.t01-1-00771.x; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carolina V, 2005, VISION RES, V45, P2659, DOI 10.1016/j.visres.2005.03.020; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; DACHEUX RF, 1986, J NEUROSCI, V6, P331; de la Villa P, 1998, EUR J NEUROSCI, V10, P317, DOI 10.1046/j.1460-9568.1998.00051.x; DELAVILLA P, 1995, J NEUROSCI, V15, P3571; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; ELIASOF S, 1993, J NEUROSCI, V13, P402; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jeon JH, 2011, CELL TISSUE RES, V345, P223, DOI 10.1007/s00441-011-1206-6; KANEKO A, 1985, J PHYSIOL-LONDON, V358, P131, DOI 10.1113/jphysiol.1985.sp015544; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Lalonde MR, 2008, CHANNELS, V2, P252, DOI 10.4161/chan.2.4.6704; Ma YP, 2003, VISUAL NEUROSCI, V20, P131, DOI 10.1017/s0952523803202042; MacLeish PR, 2007, J NEUROPHYSIOL, V98, P86, DOI 10.1152/jn.00775.2006; MARICQ AV, 1988, NEURON, V1, P503, DOI 10.1016/0896-6273(88)90181-X; Mercer AJ, 2011, J NEUROPHYSIOL, V105, P321, DOI 10.1152/jn.00332.2010; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; NELSON R, 1982, J NEUROPHYSIOL, V47, P928, DOI 10.1152/jn.1982.47.5.928; OKADA T, 1995, NEUROSCI RES, V23, P297, DOI 10.1016/0168-0102(95)00955-8; Pan ZH, 2000, J NEUROPHYSIOL, V83, P513, DOI 10.1152/jn.2000.83.1.513; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Satoh H, 2001, NEUROSCI LETT, V310, P161, DOI 10.1016/S0304-3940(01)02120-6; Satoh H, 1998, NEUROREPORT, V9, P2161, DOI 10.1097/00001756-199807130-00002; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Singer JH, 2003, J NEUROSCI, V23, P10923; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; SUZUKI S, 1990, VISUAL NEUROSCI, V5, P223, DOI 10.1017/S0952523800000298; TACHIBANA M, 1993, ANN NY ACAD SCI, V707, P359, DOI 10.1111/j.1749-6632.1993.tb38070.x; Thoreson WB, 2000, VISUAL NEUROSCI, V17, P197, DOI 10.1017/S0952523800172025; Thoreson WB, 2003, J NEUROPHYSIOL, V90, P1747, DOI 10.1152/jn.00932.2002; Thoreson WB, 2002, VISUAL NEUROSCI, V19, P235, DOI 10.1017/S0952523802192017; Thoreson WB, 1996, J GEN PHYSIOL, V107, P631, DOI 10.1085/jgp.107.5.631; Trexler EB, 2005, J NEUROPHYSIOL, V93, P1476, DOI 10.1152/jn.00597.2004; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Wan QF, 2011, VISUAL NEUROSCI, V28, P109, DOI 10.1017/S0952523810000453; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	57	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67989	10.1371/journal.pone.0067989	http://dx.doi.org/10.1371/journal.pone.0067989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840801	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400126
J	Murray, JM; Moenne-Loccoz, R; Velay, A; Habersetzer, F; Doffoel, M; Gut, JP; Fofana, I; Zeisel, MB; Stoll-Keller, F; Baumert, TF; Schvoerer, E				Murray, John M.; Moenne-Loccoz, Remy; Velay, Aurelie; Habersetzer, Francois; Doffoel, Michel; Gut, Jean-Pierre; Fofana, Isabel; Zeisel, Mirjam B.; Stoll-Keller, Francoise; Baumert, Thomas F.; Schvoerer, Evelyne			Determine Antiviral Response Assessed through Optimal Covariance Networks	PLOS ONE			English	Article							HEPATITIS-C; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; VIRAL CLEARANCE; VIRUS; ESCAPE; INTERFERON; RESISTANCE; MUTATIONS; THERAPY	The poor response to the combined antiviral therapy of pegylated alfa-interferon and ribavarin for hepatitis C virus (HCV) infection may be linked to mutations in the viral envelope gene E1E2 (env), which can result in escape from the immune response and higher efficacy of viral entry. Mutations that result in failure of therapy most likely require compensatory mutations to achieve sufficient change in envelope structure and function. Compensatory mutations were investigated by determining positions in the E1E2 gene where amino acids (aa) covaried across groups of individuals. We assessed networks of covarying positions in E1E2 sequences that differentiated sustained virological response (SVR) from non-response (NR) in 43 genotype 1a (17 SVR), and 49 genotype 1b (25 SVR) chronically HCV-infected individuals. Binary integer programming over covariance networks was used to extract aa combinations that differed between response groups. Genotype 1a E1E2 sequences exhibited higher degrees of covariance and clustered into 3 main groups while 1b sequences exhibited no clustering. Between 5 and 9 aa pairs were required to separate SVR from NR in each genotype. aa in hypervariable region 1 were 6 times more likely than chance to occur in the optimal networks. The pair 531-626 (EI) appeared frequently in the optimal networks and was present in 6 of 9 NR in one of the 1a clusters. The most frequent pairs representing SVR were 431-481 (EE), 500-522 (QA) in 1a, and 407-434 (AQ) in 1b. Optimal networks based on covarying aa pairs in HCV envelope can indicate features that are associated with failure or success to antiviral therapy.	[Murray, John M.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Murray, John M.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Moenne-Loccoz, Remy; Habersetzer, Francois; Doffoel, Michel; Baumert, Thomas F.] Nouvel Hop Civil, Hop Univ Strasbourg, Strasbourg, France; [Velay, Aurelie; Schvoerer, Evelyne] Univ Lorraine, EA Stress Immunite & Pathogenes, Vandoeuvre Les Nancy, France; [Velay, Aurelie; Schvoerer, Evelyne] CHU Nancy, Pole Lab, Vandoeuvre Les Nancy, France; [Habersetzer, Francois; Doffoel, Michel; Fofana, Isabel; Zeisel, Mirjam B.; Stoll-Keller, Francoise; Baumert, Thomas F.] INSERM, U748, Strasbourg, France; [Habersetzer, Francois; Doffoel, Michel; Gut, Jean-Pierre; Fofana, Isabel; Zeisel, Mirjam B.; Stoll-Keller, Francoise; Baumert, Thomas F.] Univ Strasbourg, Strasbourg, France; [Stoll-Keller, Francoise] Hop Univ Strasbourg, Lab Virol, Strasbourg, France	University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lorraine; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Murray, JM (corresponding author), Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia.	J.Murray@unsw.edu.au	Zeisel, Mirjam B/E-9205-2016; Murray, John/B-5481-2009; Velay, Aurélie/D-3309-2019; Baumert, Thomas/ABF-4718-2020	Zeisel, Mirjam B/0000-0003-1606-0131; Murray, John/0000-0001-9314-2283; Baumert, Thomas/0000-0002-8864-2168; ABRAVANEL, Florence/0000-0002-1753-1065; Velay, Aurelie/0000-0002-9174-8959	European Union [ERC-2008-AdG-233130-HEPCENT]; chair of excellence program of the Agence Nationale de la Recherche France [ANR-05-CEXC-008]; ANRS [2011/132, 2011/154, 2012/239, 319, 2012/318]; DGOS Inserm [A12027MS]; University of Strasbourg; Laboratoire d'excellence LabEx HEPSYS [ANR-10-LAB-28]; Fondation Transplantation (France); Region Alsace (France); Region Lorraine (France); Abbott Molecular (France); Roche (France)	European Union(European Commission); chair of excellence program of the Agence Nationale de la Recherche France(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); DGOS Inserm; University of Strasbourg; Laboratoire d'excellence LabEx HEPSYS; Fondation Transplantation (France); Region Alsace (France)(Region Grand-Est); Region Lorraine (France)(Region Grand-Est); Abbott Molecular (France); Roche (France)(Roche Holding)	This work was supported by the European Union (ERC-2008-AdG-233130-HEPCENT, INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2009), the chair of excellence program of the Agence Nationale de la Recherche France (ANR-05-CEXC-008), ANRS (2011/132, 2011/154, 2012/239&319, 2012/318), DGOS Inserm A12027MS, the University of Strasbourg and Laboratoire d'excellence LabEx HEPSYS (ANR-10-LAB-28). E. Schvoerer thanks the Fondation Transplantation (France), Region Alsace (France), Region Lorraine (France), Abbott Molecular (France) and Roche (France) for unrestricted financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Brown RJP, 2007, J GEN VIROL, V88, P458, DOI 10.1099/vir.0.82357-0; Dubois F, 1997, HEPATOLOGY, V25, P1490, DOI 10.1002/hep.510250630; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Hofmann WP, 2005, J CLIN VIROL, V32, P86, DOI 10.1016/j.jcv.2004.08.004; Keck ZY, 2008, J VIROL, V82, P6067, DOI 10.1128/JVI.00252-08; Keck ZY, 2009, J VIROL, V83, P6149, DOI 10.1128/JVI.00248-09; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lara J, 2011, J VIROL, V85, P3649, DOI 10.1128/JVI.02197-10; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Legrand-Abravanel F, 2009, J MED VIROL, V81, P2029, DOI 10.1002/jmv.21583; Nemhauser GL., 1988, INTEGER COMBINATORIA, DOI [10.1002/9781118627372, DOI 10.1002/9781118627372]; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Pawlotsky JM, 2009, NAT REV GASTRO HEPAT, V6, P383, DOI 10.1038/nrgastro.2009.102; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schvoerer E, 2013, J INFECT DIS, V207, P1306, DOI 10.1093/infdis/jit032; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Troesch M, 2006, VIROLOGY, V352, P357, DOI 10.1016/j.virol.2006.05.015; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67254	10.1371/journal.pone.0067254	http://dx.doi.org/10.1371/journal.pone.0067254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840641	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800126
J	Wang, Y; Jiang, ZB; Jin, ZY; Tan, H; Xu, B				Wang, Yong; Jiang, Zhiben; Jin, Zhenyu; Tan, Hua; Xu, Bing			Risk Factors for Infectious Diseases in Backyard Poultry Farms in the Poyang Lake Area, China	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; A VIRUS; HEMAGGLUTININ SUBTYPE; DOMESTIC DUCKS; CHICKEN FARMS; H5N1; EPIDEMIC; THAILAND; ASIA; MARKETS	Emergence and transmission of infectious diseases have an enormous impact on the poultry industry and present a serious threat to the health of humans and wild birds. Noncommercial poultry operations, such as backyard poultry facilities in China, are potential sources of virus exchange between commercial poultry and wild birds. It is particularly critical in wetland areas where backyard poultry have close contact with commercial poultry and migratory birds, therefore increasing the risk of contracting infectious diseases. To evaluate the transmission risks, a cross-sectional study was undertaken in the Poyang Lake area, China, involving 309 residents in the backyard poultry farms in three counties (Region A, B, and C) of Jiangxi Province. We examined the backyard poultry population, poultry species, presence of poultry deaths from infectious diseases, food sources, and biosecurity practices. Region B ranked highest for biosecurity while region C ranked lowest. The risks of infectious diseases were assessed by adjusted odds ratio based on multivariate logistic regression analysis. Potential risk factors in the three regions of the study site were compared. In Region A, significant factor was contact of poultry with wild birds (OR: 6.573, 95% CI: 2.148-20.115, P=0.001). In Region B, the most significant factor was contact of poultry with neighboring backyard waterfowls (OR: 3.967, 95% CI: 1.555-10.122, P=0.004). In Region C, significant factors were poultry purchase from local live bird markets (OR: 3.740, 95% CI: 1.243-11.255, P=0.019), and contact of poultry with wild birds (OR: 3.379, 95% CI: 1.058-10.791, P=0.040). In summary, backyard poultry was significantly affected by neighboring commercial poultry and close contact with wild birds. The results are expected to improve our understanding of the transmission risks of infectious diseases in a typical backyard poultry environment in rural China, and address the need to improve local farming practices and take preventive measures.	[Wang, Yong; Xu, Bing] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China; [Jiang, Zhiben; Jin, Zhenyu; Tan, Hua; Xu, Bing] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Xu, Bing] Univ Utah, Dept Geog, Salt Lake City, UT USA	Tsinghua University; Beijing Normal University; Utah System of Higher Education; University of Utah	Xu, B (corresponding author), Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China.	bingxu@tsinghua.edu.cn	Xu, Bing/C-7732-2015		Ministry of Science and Technology, China, National Research Program [2010CB530300, 2012CB955501, 2012AA12A407]; National Natural Science Foundation of China [41271099]	Ministry of Science and Technology, China, National Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Ministry of Science and Technology, China, National Research Program (2010CB530300, 2012CB955501, 2012AA12A407), and the National Natural Science Foundation of China (41271099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey BL, 2003, AVIAN DIS, V47, P1099, DOI 10.1637/0005-2086-47.s3.1099; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Biswas PK, 2009, EMERG INFECT DIS, V15, P1931, DOI 10.3201/eid1512.090643; Busani L, 2009, VET J, V181, P171, DOI 10.1016/j.tvjl.2008.02.013; Chen H, 2009, REV SCI TECH OIE, V28, P267, DOI 10.20506/rst.28.1.1860; China Animal Industry Yearbook Editorial Committee, 2011, CHIN AN IND YB; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Ji WT, 2007, NEWS, V11, P37; Jiangxi Yearbook Editorial Committee, 2011, JIANGX YB; Koch G, 2006, NJAS-WAGEN J LIFE SC, V54, P179, DOI 10.1016/S1573-5214(06)80021-7; Kou Z, 2005, J VIROL, V79, P15460, DOI 10.1128/JVI.79.24.15460-15466.2005; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Kung NY, 2007, EMERG INFECT DIS, V13, P412, DOI 10.3201/eid1303.060365; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Liu QF, 2010, VIRUS RES, V147, P25, DOI 10.1016/j.virusres.2009.09.014; Mannelli A, 2006, PREV VET MED, V73, P273, DOI 10.1016/j.prevetmed.2005.09.005; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; National Development and Reform Commission, 2006, NAT AN EP PREV SYST; Nishiguchi A, 2007, ZOONOSES PUBLIC HLTH, V54, P337, DOI 10.1111/j.1863-2378.2007.01074.x; Paul M, 2011, ACTA TROP, V118, P209, DOI 10.1016/j.actatropica.2011.03.009; Paul M, 2010, VET RES, V41, DOI 10.1051/vetres/2009076; Prosser DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017622; Shankman D, 2003, PROF GEOGR, V55, P434, DOI 10.1111/0033-0124.5504003; SIVANANDAN V, 1991, AVIAN DIS, V35, P974, DOI 10.2307/1591638; Songserm T, 2006, EMERG INFECT DIS, V12, P575, DOI 10.3201/eid1204.051614; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Suarez DL, 2000, AVIAN DIS, V44, P356, DOI 10.2307/1592550; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Werner O, 2003, AVIAN DIS, V47, P1104, DOI 10.1637/0005-2086-47.s3.1104; Whiteford A., 2004, P 53 W POULTR DIS C, P81; Zhang HB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-42	40	38	38	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67366	10.1371/journal.pone.0067366	http://dx.doi.org/10.1371/journal.pone.0067366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840680	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800130
J	Michelou, VK; Caporaso, JG; Knight, R; Palumbi, SR				Michelou, Vanessa K.; Caporaso, J. Gregory; Knight, Rob; Palumbi, Stephen R.			The Ecology of Microbial Communities Associated with Macrocystis pyrifera	PLOS ONE			English	Article							MARINE BACTERIAL STRAIN; DIVERSITY; KELP; EXTRACTION; FUCOIDAN; GROWTH; ALGAE; OCEAN; HOST; DNA	Kelp forests are characterized by high biodiversity and productivity, and the cycling of kelp-produced carbon is a vital process in this ecosystem. Although bacteria are assumed to play a major role in kelp forest carbon cycling, knowledge of the composition and diversity of these bacterial communities is lacking. Bacterial communities on the surface of Macrocystis pyrifera and adjacent seawater were sampled at the Hopkins Marine Station in Monterey Bay, CA, and further studied using 454-tag pyrosequencing of 16S RNA genes. Our results suggest that M. pyrifera-dominated kelp forests harbor distinct microbial communities that vary temporally. The distribution of sequence tags assigned to Gammaproteobacteria, Alphaproteobacteria and Bacteriodetes differed between the surface of the kelp and the surrounding water. Several abundant Rhodobacteraceae, uncultivated Gammaproteobacteria and Bacteriodetes-associated tags displayed considerable temporal variation, often with similar trends in the seawater and the surface of the kelp. Bacterial community structure and membership correlated with the kelp surface serving as host, and varied over time. Several kelp-specific taxa were highly similar to other bacteria known to either prevent the colonization of eukaryotic larvae or exhibit antibacterial activities. Some of these kelp-specific bacterial associations might play an important role for M. pyrifera. This study provides the first assessment of the diversity and phylogenetic profile of the bacterial communities associated with M. pyrifera.	[Michelou, Vanessa K.; Palumbi, Stephen R.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Caporaso, J. Gregory] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Stanford University; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Michelou, VK (corresponding author), Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA.	michelou@hawaii.edu	Knight, Rob/D-1299-2010	Caporaso, Greg/0000-0002-8865-1670; Knight, Rob/0000-0002-0975-9019	David and Lucile Packard Foundation; Stanford University; Howard Hughes Medical Institute	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Stanford University(Stanford University); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the David and Lucile Packard Foundation and by Stanford University, and by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarzua S, 1999, BOT MAR, V42, P459, DOI 10.1515/BOT.1999.053; Bengtsson MM, 2011, AQUAT MICROB ECOL, V62, P191, DOI 10.3354/ame01477; Bengtsson MM, 2011, THESIS U BERGEN BERG; Bengtsson MM, 2012, ISME J; Bulleri F, 2002, J EXP MAR BIOL ECOL, V267, P89, DOI 10.1016/S0022-0981(01)00361-6; Burke C, 2010, ISME J; Burke C, 2009, APPL ENVIRON MICROB, V75, P252, DOI 10.1128/AEM.01630-08; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collen J, 2001, J PHYCOL, V37, P474, DOI 10.1046/j.1529-8817.2001.037004474.x; Cunliffe M, 2006, APPL MICROBIOL BIOT, V72, P1083, DOI 10.1007/s00253-006-0374-x; DAVIS CL, 1983, MAR ECOL PROG SER, V13, P115, DOI 10.3354/meps013115; Dempster EL, 1999, BIOTECHNIQUES, V27, P66, DOI 10.2144/99271bm13; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Graham MH, 2007, P NATL ACAD SCI USA, V104, P16576, DOI 10.1073/pnas.0704778104; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Lachnit T, 2009, AQUAT BIOL, V5, P181, DOI 10.3354/ab00149; LINLEY EAS, 1982, ESTUAR COAST SHELF S, V14, P1, DOI 10.1016/S0302-3524(82)80063-7; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Ottesen EA, 2011, ISME J; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Rappe MS, 2000, FEMS MICROBIOL ECOL, V33, P219, DOI 10.1016/S0168-6496(00)00064-7; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reis AMM, 2009, J APPL MICROBIOL, V106, P1378, DOI 10.1111/j.1365-2672.2008.04106.x; Rich VI, 2011, ENVIRON MICROBIOL, V13, P116, DOI 10.1111/j.1462-2920.2010.02314.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sakai T, 2004, MAR BIOTECHNOL, V6, P335, DOI 10.1007/s10126-003-0033-5; Sapp M, 2007, FEMS MICROBIOL ECOL, V59, P622, DOI 10.1111/j.1574-6941.2006.00238.x; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Steinberg PD, 2002, J PHYCOL, V38, P621, DOI 10.1046/j.1529-8817.2002.02042.x; Suzuki MT, 2004, MICROB ECOL, V48, P473, DOI 10.1007/s00248-004-0213-5; Suzuki MT, 2001, AQUAT MICROB ECOL, V24, P117, DOI 10.3354/ame024117; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Woo-Jung K, 2008, J MICROBIOL BIOTECHN, V18, P616; Zheng L, 2005, ANN MICROBIOL, V55, P119; ZIMMERMAN RC, 1986, MAR ECOL PROG SER, V27, P277, DOI 10.3354/meps027277	42	57	58	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67480	10.1371/journal.pone.0067480	http://dx.doi.org/10.1371/journal.pone.0067480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840715	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200136
J	Kouba, M; Bartos, L; Stastny, K				Kouba, Marek; Bartos, Ludek; Stastny, Karel			Differential Movement Patterns of Juvenile Tengmalms Owls (Aegolius funereus) during the Post-Fledging Dependence Period in Two Years with Contrasting Prey Abundance	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; EAGLE HIERAAETUS-FASCIATUS; EASTERN SCREECH-OWLS; TAWNY OWLS; REPRODUCTIVE SUCCESS; STRIX-ALUCO; ACCIPITER-GENTILIS; NORTHERN GOSHAWKS; FOOD ABUNDANCE; DISPERSAL BEHAVIOR	Fledgling behaviour and movement patterns throughout the post-fledging dependence period (PFDP), especially in relation to changing environmental conditions, have been rarely studied, despite the fact that this period is recognized as of crucial significance in terms of high mortality of juveniles. The PFDP can extend over quite a protracted period, particularly in birds of prey, and a knowledge of the movement patterns of individuals is fundamental for understanding mechanisms underlying survival, habitat use and dispersion. We radiotracked 39 fledglings of the Tengmalm's owl (Aegolius funereus) in two years with different availability of prey: 2010 (n = 29) and 2011 (n = 10) and obtained 1455 daily locations. Fledglings reached independence on average in 45 days after fledging in 2010 (n = 22) and 57 days in 2011 (n = 6). Within years, the most important measures influencing the distance moved from the nest box were age of fledglings and number of surviving siblings present. Individual home range size and duration of PFDP in particular were dependent on maximal number of siblings seen outside the nest box. In the season with low prey availability fledglings were observed at greater distances from the nest box than in the year with higher prey availability (mean distance: 350 m in 2010 and 650 m in 2011) and occupied larger home ranges (mean: 30.3 ha in 2010 and 57.7 ha in 2011). The main factor causing these differences between years was probably the different availability of prey in these two years, affecting breeding success and post-fledging survivorship of the Tengmalm's owls.	[Kouba, Marek; Stastny, Karel] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Bartos, Ludek] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Anim Sci & Ethol, Prague, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Research Institute of Animal Science	Kouba, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	marekkouba8@gmail.com	Kouba, Marek/A-1350-2019	Kouba, Marek/0000-0003-2262-5733	Czech University of Life Sciences Prague [IGA FZP 201042110029, CIGA CZU 20104205, MSMT 1321/213205]; Ministry of Agriculture of the Czech Republic [MZe 0002701404]	Czech University of Life Sciences Prague; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work has been supported by grants from the Czech University of Life Sciences Prague (IGA FZP 201042110029, CIGA CZU 20104205, MSMT 1321/213205) and Ministry of Agriculture of the Czech Republic (MZe 0002701404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo BE, 2002, ANIM BEHAV, V63, P235, DOI 10.1006/anbe.2001.1899; Balbontin J, 2005, ARDEA, V93, P189; BELTHOFF JR, 1993, J RAPTOR RES, V27, P8; BELTHOFF JR, 1989, CONDOR, V91, P254, DOI 10.2307/1368302; BENDEL PR, 1993, J FIELD ORNITHOL, V64, P326; Bengtsson G, 2004, J THEOR BIOL, V231, P299, DOI 10.1016/j.jtbi.2004.06.025; Blackwell PG, 1997, ECOL MODEL, V100, P87, DOI 10.1016/S0304-3800(97)00153-1; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Coles CF, 1997, US FOR SERV T R NC, V190, P111; CRAMP S, 1985, BIRDS W PALAEARCTIC, V4; Cushman SA, 2005, OIKOS, V109, P331, DOI 10.1111/j.0030-1299.2005.13538.x; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Delgado MD, 2009, ARDEA, V97, P7, DOI 10.5253/078.097.0102; Drdakova-Zarybnicka M, 2004, ZIVA, V3, P128; Eldegard K, 2012, J ORNITHOL, V153, P385, DOI 10.1007/s10336-011-0753-7; Eldegard K, 2010, BEHAV ECOL SOCIOBIOL, V64, P815, DOI 10.1007/s00265-009-0898-z; Eldegard K, 2009, P ROY SOC B-BIOL SCI, V276, P1713, DOI 10.1098/rspb.2008.1775; Ellsworth EA, 1999, ANIM BEHAV, V57, P883, DOI 10.1006/anbe.1998.1050; Frye GG, 2012, WILSON J ORNITHOL, V124, P199; Ganey JL, 1998, WILSON BULL, V110, P206; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; Gurarie E, 2011, AM NAT, V178, P113, DOI 10.1086/660285; Hakkarainen H, 2003, OIKOS, V100, P162, DOI 10.1034/j.1600-0706.2003.11906.x; Hakkarainen H, 2008, OECOLOGIA, V155, P479, DOI 10.1007/s00442-007-0929-2; HARPER AB, 1986, AM NAT, V128, P99, DOI 10.1086/284542; HAYNE DW, 1949, J MAMMAL, V30, P1, DOI 10.2307/1375189; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Kennedy PL, 2003, OECOLOGIA, V134, P284, DOI 10.1007/s00442-002-1108-0; KENWARD RE, 1993, ANIM BEHAV, V46, P365, DOI 10.1006/anbe.1993.1198; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kloubec B., 1990, TICHODROMA, V3, P103; Konig C, 2008, OWLS WORLD; Konrad PM, 1986, J RAPTOR RES, V20, P35; KORPIMAKI E, 1991, OECOLOGIA, V85, P543, DOI 10.1007/BF00323767; KORPIMAKI E, 1988, ORNIS FENNICA, V65, P21; KORPIMAKI E, 1989, IBIS, V131, P41, DOI 10.1111/j.1474-919X.1989.tb02742.x; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; Korpimaki E, 1981, ACTA U OULUENSIS 118, V13, P1; Korpimaki E, 2011, BEHAV ECOL SOCIOBIOL, V65, P1093, DOI 10.1007/s00265-010-1118-6; Kouba Marek, 2012, Sylvia, V48, P115; McClaren EL, 2005, J RAPTOR RES, V39, P253; McFadzen ME, 1996, CONDOR, V98, P791, DOI 10.2307/1369859; Mikkola H., 2020, OWLS, P97; Miller G. S., 1989, THESIS OREGON STATE; Minguez E, 2001, J RAPTOR RES, V35, P228; Mock D. W., 1997, EVOLUTION SIBLING RI; Mock DW, 1998, ANIM BEHAV, V56, P1, DOI 10.1006/anbe.1998.0842; Newton I., 1979, POPULATION ECOLOGY R; NILSSON JA, 1990, ANIM BEHAV, V40, P1001, DOI 10.1016/S0003-3472(05)81010-3; Overskaug K, 1999, CONDOR, V101, P169, DOI 10.2307/1370460; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; PETTY S J, 1989, Ringing and Migration, V10, P75; Pokorny J., 2000, Buteo, V11, P107; Pykal Jiri, 1994, P537; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; SONERUD G A, 1988, Fauna Norvegica Series C Cinclus, V11, P47; Southern H.N., 1954, Bird Study, V1, P101; Sunde P, 2005, OIKOS, V110, P461, DOI 10.1111/j.0030-1299.2005.14069.x; Sunde P, 2003, OIKOS, V101, P265, DOI 10.1034/j.1600-0706.2003.12203.x; Sunde P, 2008, J AVIAN BIOL, V39, P242, DOI 10.1111/j.2008.0908-8857.04194.x; Tao J., 2002, MIXED MODEL ANAL USI; Todd LD, 2001, J RAPTOR RES, V35, P282; Todd LD, 2003, J WILDLIFE MANAGE, V67, P512, DOI 10.2307/3802709; TRIVERS RL, 1974, AM ZOOL, V14, P249; Vacik R, 1991, SYLVIA, V28, P95; Vasquez RA, 2002, BEHAV ECOL, V13, P182, DOI 10.1093/beheco/13.2.182; Vergara P, 2010, BEHAV ECOL, V21, P507, DOI 10.1093/beheco/arq011; WEATHERS WW, 1989, ECOL MONOGR, V59, P223, DOI 10.2307/1942600; Whitmore S, 2009, THESIS CALIFORNIA ST; Wiens JD, 2006, CONDOR, V108, P253, DOI 10.1093/condor/108.2.253; Wiens JD, 2006, ECOL APPL, V16, P406, DOI 10.1890/04-1915; Withey John C., 2001, P43, DOI 10.1016/B978-012497781-5/50004-9; Wood PB, 1998, J WILDLIFE MANAGE, V62, P333, DOI 10.2307/3802296; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911	75	19	19	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67034	10.1371/journal.pone.0067034	http://dx.doi.org/10.1371/journal.pone.0067034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843981	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000059
J	Rubenstein, R; Chang, BG				Rubenstein, Richard; Chang, Binggong			Re-Assessment of PrPSc Distribution in Sporadic and Variant CJD	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; PATHOLOGICAL PRION PROTEIN; QUAKING-INDUCED CONVERSION; CEREBROSPINAL-FLUID; BLOOD-TRANSFUSION; IMMUNE-SYSTEM; SCRAPIE; INFECTIVITY; TISSUE	Human prion diseases are fatal neurodegenerative disorders associated with an accumulation of PrPSc in the central nervous system (CNS). Of the human prion diseases, sporadic Creutzfeldt-Jakob disease (sCJD), which has no known origin, is the most common form while variant CJD (vCJD) is an acquired human prion disease reported to differ from other human prion diseases in its neurological, neuropathological, and biochemical phenotype. Peripheral tissue involvement in prion disease, as judged by PrPSc accumulation in the tonsil, spleen, and lymph node has been reported in vCJD as well as several animal models of prion diseases. However, this distribution of PrPSc has not been consistently reported for sCJD. We reexamined CNS and non-CNS tissue distribution and levels of PrPSc in both sCJD and vCJD. Using a sensitive immunoassay, termed SOFIA, we also assessed PrPSc levels in human body fluids from sCJD as well as in vCJD-infected humanized transgenic mice (Tg666). Unexpectedly, the levels of PrPSc in non-CNS human tissues (spleens, lymph nodes, tonsils) from both sCJD and vCJD did not differ significantly and, as expected, were several logs lower than in the brain. Using protein misfolding cyclic amplification (PMCA) followed by SOFIA, PrPSc was detected in cerebrospinal fluid (CSF), but not in urine or blood, in sCJD patients. In addition, using PMCA and SOFIA, we demonstrated that blood from vCJD-infected Tg666 mice showing clinical disease contained prion disease-associated seeding activity although the data was not statistically significant likely due to the limited number of samples examined. These studies provide a comparison of PrPSc in sCJD vs. vCJD as well as analysis of body fluids. Further, these studies also provide circumstantial evidence that in human prion diseases, as in the animal prion diseases, a direct comparison and intraspecies correlation cannot be made between the levels of PrPSc and infectivity.	[Rubenstein, Richard] Suny Downstate Med Ctr, Dept Neurol & Physiol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Neurol & Physiol, Brooklyn, NY 11203 USA.	richard.rubenstein@downstate.edu	chang, binggong/F-5043-2014		SUNY Downstate Medical Center; Talecris Biotherapeutics IIT program; Bionosis, Inc.	SUNY Downstate Medical Center; Talecris Biotherapeutics IIT program; Bionosis, Inc.	This work was supported in part by the SUNY Downstate Medical Center, Talecris Biotherapeutics IIT program, and Bionosis, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: The authors have obtained funding from commercial sources (Talecris Biotherapeutics and Bionosis, Inc). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aguzzi A, 2000, HAEMATOLOGICA, V85, P3; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 2001, J LAB CLIN MED, V137, P5, DOI 10.1067/mlc.2001.111951; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 2005, VOX SANG, V89, P63, DOI 10.1111/j.1423-0410.2005.00683.x; CASACCIA P, 1989, ARCH VIROL, V108, P145, DOI 10.1007/BF01313752; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Chang BG, 2009, J VIROL METHODS, V159, P15, DOI 10.1016/j.jviromet.2009.02.019; Chohan G, 2010, TRANSFUSION, V50, P1003, DOI 10.1111/j.1537-2995.2010.02614.x; Coste J, 2009, VOX SANG, V96, P284, DOI 10.1111/j.1423-0410.2009.01161.x; Coulthart MB, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-133; DESLYS JP, 1994, LANCET, V343, P848, DOI 10.1016/S0140-6736(94)92046-X; DIRINGER H, 1984, ARCH VIROL, V82, P105, DOI 10.1007/BF01309373; Fraser H, 1996, J GEN VIROL, V77, P1935, DOI 10.1099/0022-1317-77-8-1935; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Goodall CA, 2006, J NEUROL NEUROSUR PS, V77, P89, DOI 10.1136/jnnp.2005.065755; Green AJE, 2001, J NEUROL NEUROSUR PS, V70, P744, DOI 10.1136/jnnp.70.6.744; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mabbott NA, 1998, IMMUNOL TODAY, V19, P201, DOI 10.1016/S0167-5699(98)01253-5; MANUELIDIS EE, 1985, LANCET, V2, P896; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Miyazawa K, 2011, J CELL BIOCHEM, V112, P3630, DOI 10.1002/jcb.23286; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Ramasamy I, 2003, LANCET INFECT DIS, V3, P214, DOI 10.1016/S1473-3099(03)00578-4; Rubenstein R, 2012, J GEN VIROL, V93, P1375, DOI 10.1099/vir.0.038802-0; Rubenstein R, 2011, J VIROL, V85, P9031, DOI 10.1128/JVI.05111-11; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; TAMAI Y, 1992, NEW ENGL J MED, V327, P649; TATEISHI J, 1985, LANCET, V2, P1074; THOMPSON EJ, 1995, J NEUROL NEUROSUR PS, V59, P349, DOI 10.1136/jnnp.59.4.349; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; World Health Organization, 2006, GUIDELINES TISSUE IN, V14-15, P2005; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	55	31	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66352	10.1371/journal.pone.0066352	http://dx.doi.org/10.1371/journal.pone.0066352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843953	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000046
J	Zanolli, C				Zanolli, Clement			Additional Evidence for Morpho-Dimensional Tooth Crown Variation in a New Indonesian H-erectus Sample from the Sangiran Dome (Central Java)	PLOS ONE			English	Article							HOMO-ERECTUS; PLEISTOCENE HOMINIDS; DENTAL MORPHOLOGY; MANDIBULAR MOLAR; CUSP AREAS; MEGANTHROPUS; REMAINS; LANDSCAPES; DISPERSALS; HISTORY	This contribution reports fifteen human fossil dental remains found during the last two decades in the Sangiran Dome area, in Central Java, Indonesia. Among this sample, only one of the specimens had already been briefly described, with the other fourteen remaining unreported. Seven of the fifteen isolated teeth were found in a secured stratigraphic context in the late Lower-early Middle Pleistocene Kabuh Formation. The remaining elements were surface finds which, based on coincidental sources of information, were inferred as coming from the Kabuh Formation. Mainly constituted of permanent molars, but also including one upper incisor and one upper premolar, this dental sample brings additional evidence for a marked degree of size variation and time-related structural reduction in Javanese H. erectus. This is notably expressed by a significant decrease of the mesiodistal diameter, frequently associated to the reduction or even loss of the lower molar distal cusp (hypoconulid) and to a more square occlusal outline. In addition to the hypoconulid reduction or loss, this new sample also exhibits a low frequency of the occlusal Y-groove pattern, with a dominance of the X and, to a lesser extent, of the+patterns. This combination is rare in the Lower and early Middle Pleistocene paleoanthropological record, including in the early Javanese dental assemblage from the Sangiran Dome. On the other hand, similar dental features are found in Chinese H. erectus and in H. heidelbergensis. As a whole, this new record confirms the complex nature of the intermittent exchanges that occurred between continental and insular Southeast Asia through the Pleistocene.	[Zanolli, Clement] Abdus Salaam Int Ctr Theoret Phys, Multidisciplinary Lab, Trieste, Italy; [Zanolli, Clement] MNHN Paris, Dept Prehist, UMR 7194, Paris, France	Abdus Salam International Centre for Theoretical Physics (ICTP); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Zanolli, C (corresponding author), Abdus Salaam Int Ctr Theoret Phys, Multidisciplinary Lab, Trieste, Italy.	clement.zanolli@gmail.com		Zanolli, Clement/0000-0002-5617-1613	Deutscher Akademischer Austauschdienst Dienst grant; German Deutscher Akademischer Austauschdienst Dienst; French Societe des Amis du Musee de l'Homme; MNHN Paris by the INEE-CNRS; Societe des Amis du Musee de l'Homme	Deutscher Akademischer Austauschdienst Dienst grant(Deutscher Akademischer Austausch Dienst (DAAD)); German Deutscher Akademischer Austauschdienst Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); French Societe des Amis du Musee de l'Homme; MNHN Paris by the INEE-CNRS; Societe des Amis du Musee de l'Homme	This PhD research program was not accompanied by a specific grant covering the three years work. However, during that period the author benefited in 2009 of a Deutscher Akademischer Austauschdienst Dienst grant (total amount of 3,200 euro) to spend three months at the Senckenberg Museum in Frankfurt in order to comparatively examine the locally stored Indonesian fossil hominid dental material, and, in 2011, of the Andre Leroi-Gourhan grant (1,500 euro), provided by the Societe des Amis du Musee de l'Homme as contribution to the microtomographic analysis of orangutan dental material stored at the Senckenberg Museum and to participate the 15th International Symposium on Dental Morphology held the same year in Newcastle. In any case, these two grants had only poor direct impact on the study design, data collection and analysis, decision to publish, or preparation of the manuscript submitted to PLOS.; This contribution summarizes part of a PhD dissertation on dental structural morphology of H. erectus s.s. from Java developed at the Museum National d'Histoire Naturelle (MNHN) of Paris under the scientific direction of R. Macchiarelli and co-directed by D. Grimaud-Herve. It concerns published and unpublished human tooth specimens collected between 1991 and 2009 during field research work jointly developed in the Sangiran Dome area by the Indonesian Archeological Services of Yogyakarta and the French MNHN, and permanently stored at the Balai Pelestarian Situs Manusia Purba of Sangiran, Java. F. Semah, director of the French team, and H. Widianto, curator, have made possible this study within the framework of a long-term scientific collaboration in the fields of geo-prehistory and paleoanthropology between the French MNHN, the Pusat Penelitian Arkeologi of Jakarta, and the Balai Pelestarian Situs Manusia Purba of Sangiran, and D. Grimaud-Herve has kindly assured the temporary transport in 2009-2010 of some specimens in France for analysis. For having granted access to the collections of fossil hominid teeth stored at the Senckenberg Museum of Frankfurt, as well as for scientific collaboration and warm hospitality, the author is deeply indebted to F. Schrenk, O. Kullmer, C. Hertler, V. Volpato, J. Habersetzer, B. Denkel-Oswalt, and E. Pantak-Wein. In France, C. Argot, A. Froment, C. Lefevre, H. Lelievre, and P. Mennecier allowed the comparative analysis of extant and fossil specimens stored at the MNHN, and C. Braquard and D. Bouchon allowed access to the zoological collection at the Univ. of Poitiers. The dental sample has been imaged by high resolution microtomography at the Centre de Microtomographie of the Univ. of Poitiers thanks to the collaboration and under the supervision of A. Mazurier and R. Macchiarelli. For analytical support, thanks are due to F. Bernardini, L. Mancini, P. Sardini, G. Tromba, C. Tuniz, and the NESPOS Society (www.nespos.org). For scientific discussion, the author is sincerely indebted to P. Bayle, L. Bondioli, J. Braga, A. Coppa, M.C. Dean, F. Detroit, F.E. Grine, R. Macchiarelli, B. Maureille, A. Mazurier, P. O'Higgins, L. Puymerail. The author sincerely thanks the academic editor L. Bondioli and three anonymous reviewers for their valuable comments. Research partially granted by the German Deutscher Akademischer Austauschdienst Dienst and the French Societe des Amis du Musee de l'Homme and supported at the MNHN Paris by the INEE-CNRS.	Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Arif J., 2007, RECENT ADV SE ASIAN, P140; Aziz F, 2006, SARTONO DARI HOMINID, P69; Aziz F, 1996, GEOL RES DEV CTR BAN, V8, P47; Aziz F, 2001, SCI LIFE PAPERS HONO, P53; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bailey SE, 2000, DENT ANTHR, V14, P1, DOI DOI 10.26575/DAJ.V14I2.18; Bailey SE, 2010, QUATERN INT, V211, P14, DOI 10.1016/j.quaint.2009.01.008; Bettis EA, 2009, J HUM EVOL, V56, P11, DOI 10.1016/j.jhevol.2008.09.003; Bouteaux A, 2010, QUATERN INT, V223, P220, DOI 10.1016/j.quaint.2009.10.007; Ciochon RL, 2010, VERTEBR PALEOBIOL PA, P111, DOI 10.1007/978-90-481-9036-2_8; Ciochon RL, 2009, NATURE, V459, P910, DOI 10.1038/459910a; CLARK WE, 1964, FOSSIL EVIDENCE HUMA; de Castro JMB, 1999, J HUM EVOL, V37, P523, DOI 10.1006/jhev.1999.0323; Dennell Robin W., 2004, Asian Perspectives, V43, P205, DOI 10.1353/asi.2004.0018; Djubiantono T, 1992, THESIS MNHN PARIS; Djubiantono T., 1991, B INDOPAC PREHIST AS, V11, P7; Dubois E., 1891, PALAEONTOLOGISCHE ON, P12; Franzen J.L., 1985, P255; Franzen J.L., 1985, ANCESTORS HARD EVIDE, P221; Grimaud-Herve D., 2001, ORIGINE PEUPLEMENTS, P331; Grine F.E., 1984, Courier Forschungsinstitut Senckenberg, V69, P69; Grine Frederick E., 2009, P49, DOI 10.1007/978-1-4020-9980-9_6; Grine Frederick Edward, 1994, Courier Forschungsinstitut Senckenberg, V171, P75; Henrich R, 2002, MAR GEOL, V184, P17, DOI 10.1016/S0025-3227(01)00279-1; HYODO M, 1993, ANTHROPOL SCI, V101, P157, DOI 10.1537/ase.101.157; Hyodo M., 2001, SANGIRAN MAN CULTURE, P320; Hyodo M, 2011, P NATL ACAD SCI USA, V108, P19563, DOI 10.1073/pnas.1113106108; Indriati Etty, 2004, National Science Museum Monographs, V24, P163; JACOB T, 1973, J HUM EVOL, V2, P473, DOI 10.1016/0047-2484(73)90125-5; JACOB T, 1980, CURRENT ARGUMENT EAR, P170; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P497, DOI 10.1002/ajpa.10427; Kaifu Y, 2001, GEOLOGICAL RES DEV C, V27, P55; Kaifu Y, 2007, J HUM EVOL, V52, P222, DOI 10.1016/j.jhevol.2006.08.012; Kaifu Y, 2006, ANTHROPOL SCI, V114, P35, DOI 10.1537/ase.040729; Kaifu Y, 2011, J HUM EVOL, V61, P270, DOI 10.1016/j.jhevol.2011.04.002; Kingston JD, 2007, YEARB PHYS ANTHROPOL, V50, P20, DOI 10.1002/ajpa.20733; Kramer A, 1989, THESIS U MICHIGAN AN; Kramer Andrew, 1994, Courier Forschungsinstitut Senckenberg, V171, P105; Krantz G.S., 1975, P361; Krantz Grover S., 1994, Courier Forschungsinstitut Senckenberg, V171, P69; Krantz GS, 1981, PROCESS HUMAN EVOLUT; Langbroek M, 2000, J HUM EVOL, V38, P595, DOI 10.1006/jhev.1999.0394; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lee AYC, 2004, B INDOPAC PREHIST AS, V24, P143; Liu ZF, 2003, MAR GEOL, V201, P133, DOI 10.1016/S0025-3227(03)00213-5; Louys J, 2012, CR PALEVOL, V11, P203, DOI 10.1016/j.crpv.2011.03.003; Martinon-~Torres M, 2006, THESIS U SANTIAGO CO; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2008, J HUM EVOL, V55, P249, DOI 10.1016/j.jhevol.2007.12.008; Maureille B, 2001, PALEO, V13, P183, DOI DOI 10.4000/PALEO.1043; Moigne AM, 2004, LATE NEOGENE QUATERN, V2, P176; MOORREES COENRAAD F. A., 1957, JOUR DENTAL RES, V36, P39, DOI 10.1177/00220345570360011501; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; ORBANSEGEBARTH R, 1983, J HUM EVOL, V12, P711, DOI 10.1016/S0047-2484(83)80126-2; RIGHTMIRE GP, 1993, EVOLUTION HOMO ERECT; Robinson JT, 1953, AM J PHYS ANTHROP-NE, V11, P1, DOI 10.1002/ajpa.1330110112; Robinson JT, 1955, AM J PHYS ANTHROP-NE, V13, P429, DOI 10.1002/ajpa.1330130304; Saleki H, 1997, THESIS MNHN PARIS; Sartono S., 1961, Publikasi Tek Ser Pal, V2, P1; Sartono S, 1980, INT ASS HIST AS 8 C; Schwartz J. H., 2003, HUMAN FOSSIL RECORD, V2; Scolan H., 2012, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V24, P69, DOI 10.1007/s13219-011-0047-x; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Semah A.-M., 2001, ORIGINE PEUPLEMENTS, P251; Semah AM, 1998, SANGIRAN MAN CULTURE, P231; Semah AM, 2010, QUATERN INT, V223, P451, DOI 10.1016/j.quaint.2009.07.017; Semah F, 2000, J ARCHAEOL SCI, V27, P763, DOI 10.1006/jasc.1999.0482; SEMAH F, 1992, J HUM EVOL, V23, P439, DOI 10.1016/0047-2484(92)90092-N; Semah F., 2001, ORIGINE PEUPLEMENTS, P299; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; SUWA G, 1994, AM J PHYS ANTHROPOL, V93, P407, DOI 10.1002/ajpa.1330930402; TOBIAS PV, 1964, NATURE, V204, P515, DOI 10.1038/204515a0; Turner II C. G., 1991, ADV DENT ANTHR, P13; Tyler D.E., 2003, Human Evolution, V18, P229, DOI 10.1007/BF02436289; Tyler D.E., 2001, HUM EVOL, V16, P81; Tyler DE, 2004, QUATERN INT, V117, P125, DOI 10.1016/S1040-6182(03)00122-8; Uchida A, 1998, J HUM EVOL, V34, P55, DOI 10.1006/jhev.1997.0186; Uchida A, 1998, ANTHROPOL SCI, V106, P119, DOI 10.1537/ase.106.Supplement_119; Uchida A, 1998, J HUM EVOL, V34, P71, DOI 10.1006/jhev.1997.0187; VOISIN JL, 2012, PALEOANTHROPOLOGY, P241, DOI DOI 10.4207/PA.2012.ART76; von Koenigswald G.H.R., 1960, C INT ANTHR ETH BRUS, P271; von Koenigswald G.H.R., 1950, INT GEOL C REP 18 9, P59; Von Koenigswald GHR, 1940, WET MEDED K NED NATU, V28, P1; VONKOENI.GH, 1967, J DENT RES, V46, P779; VONKOENIGSWALD GHR, 1954, NATURE, V173, P795, DOI 10.1038/173795a0; Weidenreich F., 1937, Palaeontologia Sinica, Vno. 101, P1; Weidenreich F., 1945, Anthropological Papers of the American Museum of Natural History, V40, P5; Widianto H, 1993, THESIS MNHN PARIS; Widianto H., 1991, B INDOPACIFIC PREHIS, V11, P23; Wolpoff M. H., 1999, PALEOANTHROPOLOGY; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1988, J ANAT, V161, P1; WOOD BA, 1983, J ANAT, V137, P287; Zaim Y, 2011, J HUM EVOL, V61, P363, DOI 10.1016/j.jhevol.2011.04.009; Zanolli C., 2011, THESIS MUSEUM NATL H; Zanolli C, 2012, AM J PHYS ANTHROPOL, V147, P472, DOI 10.1002/ajpa.21657	101	41	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67233	10.1371/journal.pone.0067233	http://dx.doi.org/10.1371/journal.pone.0067233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23843996	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000066
J	Dorajoo, R; Li, RY; Ikram, MK; Liu, JJ; Froguel, P; Lee, J; Sim, X; Ong, RTH; Tay, WT; Peng, C; Young, TL; Blakemore, AIF; Cheng, CY; Aung, T; Mitchell, P; Wang, JJ; Klaver, CC; Boerwinkle, E; Klein, R; Siscovick, DS; Jensen, RA; Gudnason, V; Smith, AV; Teo, YY; Wong, TY; Tai, ES; Heng, CK; Friedlander, Y				Dorajoo, Rajkumar; Li, Ruoying; Ikram, Mohammad Kamran; Liu, Jianjun; Froguel, Philippe; Lee, Jeannette; Sim, Xueling; Ong, Rick Twee-Hee; Tay, Wan Ting; Peng, Chen; Young, Terri L.; Blakemore, Alexandra I. F.; Cheng, Ching Yu; Aung, Tin; Mitchell, Paul; Wang, Jie Jin; Klaver, Caroline C.; Boerwinkle, Eric; Klein, Ronald; Siscovick, David S.; Jensen, Richard A.; Gudnason, Vilmundur; Smith, Albert Vernon; Teo, Yik Ying; Wong, Tien Yin; Tai, E-Shyong; Heng, Chew-Kiat; Friedlander, Yechiel			Are C-Reactive Protein Associated Genetic Variants Associated with Serum Levels and Retinal Markers of Microvascular Pathology in Asian Populations from Singapore?	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; METABOLIC-SYNDROME; VESSEL CALIBER; INFLAMMATION; LOCI; METAANALYSIS; PREVALENCE	Introduction: C-reactive protein (CRP) levels are associated with cardiovascular disease and systemic inflammation. We assessed whether CRP-associated loci were associated with serum CRP and retinal markers of microvascular disease, in Asian populations. Methods: Genome-wide association analysis (GWAS) for serum CRP was performed in East-Asian Chinese (N = 2,434) and Malays (N = 2,542) and South-Asian Indians (N = 2,538) from Singapore. Leveraging on GWAS data, we assessed, in silico, association levels among the Singaporean datasets for 22 recently identified CRP-associated loci. At loci where directional inconsistencies were observed, quantification of inter-ethnic linkage disequilibrium (LD) difference was determined. Next, we assessed association for a variant at CRP and retinal vessel traits [central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE)] in a total of 24,132 subjects of East-Asian, South-Asian and European ancestry. Results: Serum CRP was associated with SNPs in/near APOE, CRP, HNF1A and LEPR (p-values <= 4.7 x 10(-8)) after meta-analysis of Singaporean populations. Using a candidate-SNP approach, we further replicated SNPs at 4 additional loci that had been recently identified to be associated with serum CRP (IL6R, GCKR, IL6 and IL1F10) (p-values <= 0.009), in the Singaporean datasets. SNPs from these 8 loci explained 4.05% of variance in serum CRP. Two SNPs (rs2847281 and rs6901250) were detected to be significant (p-value <= 0.036) but with opposite effect directions in the Singaporean populations as compared to original European studies. At these loci we did not detect significant inter-population LD differences. We further did not observe a significant association between CRP variant and CRVE or CRAE levels after meta-analysis of all Singaporean and European datasets (p-value >0.058). Conclusions: Common variants associated with serum CRP, first detected in primarily European studies, are also associated with CRP levels in East-Asian and South-Asian populations. We did not find a causal link between CRP and retinal measures of microvascular disease.	[Dorajoo, Rajkumar; Liu, Jianjun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Li, Ruoying] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Ikram, Mohammad Kamran; Tay, Wan Ting; Cheng, Ching Yu; Aung, Tin; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Ikram, Mohammad Kamran; Cheng, Ching Yu; Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Ikram, Mohammad Kamran; Cheng, Ching Yu] Duke NUS Grad Med Sch, Ctr Quantitat Med, Off Clin Sci, Singapore, Singapore; [Ikram, Mohammad Kamran; Klaver, Caroline C.] Erasmus MC, Dept Epidemiol & Ophthalmol, Rotterdam, Netherlands; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, Sch Publ Hlth, Hammersmith Hosp, London, England; [Froguel, Philippe] Univ Lille Nord de France, CNRS, UMR 8199, UDSL, Lille, France; [Lee, Jeannette; Ong, Rick Twee-Hee; Peng, Chen; Cheng, Ching Yu; Teo, Yik Ying; Tai, E-Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Sim, Xueling] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Sim, Xueling] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Ong, Rick Twee-Hee] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Young, Terri L.] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore; [Young, Terri L.] Duke Univ, Med Ctr, Duke Ctr Human Genet, Durham, NC USA; [Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Sect Invest Med, Div Diabet Endocrinol & Metab, London, England; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Wang, Jie Jin; Wong, Tien Yin] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Boerwinkle, Eric] Univ Texas Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Houston, Human Genome Sequencing Ctr, Houston, TX USA; [Boerwinkle, Eric] Baylor Coll Med, Houston, TX 77030 USA; [Klein, Ronald] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Siscovick, David S.; Jensen, Richard A.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Siscovick, David S.; Jensen, Richard A.] Univ Washington, Dept Med, Seattle, WA USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Gudnason, Vilmundur] Univ Iceland, Dept Med, Reykjavik, Iceland; [Gudnason, Vilmundur; Smith, Albert Vernon] Iceland Heart Assoc, Kopavogur, Iceland; [Gudnason, Vilmundur; Smith, Albert Vernon] Univ Iceland, Reykjavik, Iceland; [Teo, Yik Ying] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Tai, E-Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tai, E-Shyong] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore; [Heng, Chew-Kiat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore; [Friedlander, Yechiel] Hebrew Univ Hadassah Sch Publ Hlth & Community Me, Epidemiol Unit, Jerusalem, Israel	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; National University of Singapore; National University of Singapore; University of Michigan System; University of Michigan; National University of Singapore; Duke University; Imperial College London; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Iceland; Icelandic Heart Association; University of Iceland; National University of Singapore; National University of Singapore; National University of Singapore	Teo, YY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	statyy@nus.edu.sg; tien_yin_wong@nuhs.edu.sg; e_shyong_tai@nuhs.edu.sg; chew_kiat_heng@nuhs.edu.sg; yechielf@ekmd.huji.ac.il	Sim, Xueling/AAZ-6652-2020; Smith, Albert Vernon/K-5150-2015; Wong, Tien Yin/AAC-9724-2020; Heng, Chew-Kiat/A-5530-2009; Wang, Jie Jin/P-1499-2014; Tai, E Shyong/J-9831-2013; wang, jie/GRS-0942-2022; Klaver, Caroline C.W./A-2013-2016; Gudnason, Vilmundur/AAE-7126-2019; Blakemore, Alexandra I F/D-2253-2009; Liu, Jianjun/AAK-4989-2020; Mitchell, Paul/P-1498-2014; Cheng, Ching-Yu/Y-2229-2019; Cheng, Ching-Yu/K-7017-2013; Gudnason, Vilmundur/K-6885-2015; FROGUEL, Philippe/O-6799-2017; Chen, Peng/E-5546-2015	Sim, Xueling/0000-0002-1233-7642; Smith, Albert Vernon/0000-0003-1942-5845; Wong, Tien Yin/0000-0002-8448-1264; Heng, Chew-Kiat/0000-0002-7309-9473; Wang, Jie Jin/0000-0001-9491-4898; Gudnason, Vilmundur/0000-0001-5696-0084; Blakemore, Alexandra I F/0000-0003-0661-564X; Liu, Jianjun/0000-0002-3255-3019; Cheng, Ching-Yu/0000-0003-0655-885X; Cheng, Ching-Yu/0000-0003-0655-885X; Gudnason, Vilmundur/0000-0001-5696-0084; FROGUEL, Philippe/0000-0003-2972-0784; Chen, Peng/0000-0002-1422-4641; Ikram, Mohammad Kamran/0000-0003-0173-9571; Klein, Ronald/0000-0002-4428-6237; Tai, E Shyong/0000-0003-2929-8966; Klaver, Caroline/0000-0002-2355-5258; Dorajoo, Rajkumar/0000-0001-6608-2051	Biomedical Research Council of Singapore (BMRC) [05/1/36/19/413, 03/1/27/18/216]; National Medical Research Council of Singapore (NMRC) [NMRC/1174/2008]; NMRC [NMRC/0796/2003, NMRC/STaR/0003/2008]; BMRC [09/1/35/19/616]; HUJ-CREATE Programme of the National Research Foundation, Singapore [370062002]; Medical Research Council [G1002084] Funding Source: researchfish; MRC [G1002084] Funding Source: UKRI	Biomedical Research Council of Singapore (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore (NMRC)(National Medical Research Council, Singapore); NMRC(National Medical Research Council, Singapore); BMRC(Agency for Science Technology & Research (A*STAR)); HUJ-CREATE Programme of the National Research Foundation, Singapore(National Research Foundation, Singapore); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Singapore Prospective Study Program (SP2) was funded through grants from the Biomedical Research Council of Singapore (BMRC; 05/1/36/19/413 and 03/1/27/18/216) and the National Medical Research Council of Singapore (NMRC; NMRC/1174/2008). The Singapore Malay Eye Study (SiMES) was funded by the NMRC (NMRC/0796/2003, NMRC/STaR/0003/2008), and the BMRC (09/1/35/19/616). The SINDI hsCRP measurements were funded by the HUJ-CREATE Programme of the National Research Foundation, Singapore (Project Number 370062002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Cheung CYL, 2010, AM J EPIDEMIOL, V171, P206, DOI 10.1093/aje/kwp357; De Silva DA, 2009, STROKE, V40, P3695, DOI 10.1161/STROKEAHA.109.559435; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Diabetic Retinopathy Study Coordinating Center, 1972, DIAB RET STUD MAN OP; Dorajoo R, 2012, INT J OBESITY, V36, P159, DOI 10.1038/ijo.2011.86; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Fox ER, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-1; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hein TW, 2009, ATHEROSCLEROSIS, V206, P61, DOI 10.1016/j.atherosclerosis.2009.02.002; Hong YL, 2009, CLIN CHEM, V55, P1450, DOI 10.1373/clinchem.2009.125369; Hung AM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-65; Ikram MK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001184; Makita S, 2009, ATHEROSCLEROSIS, V204, P234, DOI 10.1016/j.atherosclerosis.2008.07.040; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; Oh J, 2011, DIABETES CARE, V34, pS155, DOI 10.2337/dc11-s211; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Retterstol L, 2003, ATHEROSCLEROSIS, V169, P279, DOI 10.1016/S0021-9150(03)00192-8; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9; Sabanayagam C, 2009, J HYPERTENS, V27, P2209, DOI 10.1097/HJH.0b013e328330141d; Sabanayagam C, 2010, MICROCIRCULATION, V17, P297, DOI 10.1111/j.1549-8719.2010.00021.x; Saraheimo M, 2003, DIABETOLOGIA, V46, P1402, DOI 10.1007/s00125-003-1194-5; Shah T, 2010, CIRC-CARDIOVASC GENE, V3, P436, DOI 10.1161/CIRCGENETICS.110.957431; Singh U, 2008, J LIPID RES, V49, P1015, DOI 10.1194/jlr.M700535-JLR200; St Clair L, 2007, AM J CARDIOL, V99, p80B, DOI 10.1016/j.amjcard.2006.11.008; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	44	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67650	10.1371/journal.pone.0067650	http://dx.doi.org/10.1371/journal.pone.0067650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844046	Green Published, gold			2022-12-27	WOS:000321341000066
J	Li, ZJ; Li, Q; Geng, LL; Chen, XH; Bi, KS				Li, Zuojing; Li, Qing; Geng, Lulu; Chen, Xiaohui; Bi, Kaishun			Use of the Local False Discovery Rate for Identification of Metabolic Biomarkers in Rat Urine Following Genkwa Flos-Induced Hepatotoxicity	PLOS ONE			English	Article							MASS-SPECTROMETRY; METABONOMICS; GENOMICS	Metabolomics is concerned with characterizing the large number of metabolites present in a biological system using nuclear magnetic resonance (NMR) and HPLC/MS (high-performance liquid chromatography with mass spectrometry). Multivariate analysis is one of the most important tools for metabolic biomarker identification in metabolomic studies. However, analyzing the large-scale data sets acquired during metabolic fingerprinting is a major challenge. As a posterior probability that the features of interest are not affected, the local false discovery rate (LFDR) is a good interpretable measure. However, it is rarely used to when interrogating metabolic data to identify biomarkers. In this study, we employed the LFDR method to analyze HPLC/MS data acquired from a metabolomic study of metabolic changes in rat urine during hepatotoxicity induced by Genkwa flos (GF) treatment. The LFDR approach was successfully used to identify important rat urine metabolites altered by GF-stimulated hepatotoxicity. Compared with principle component analysis (PCA), LFDR is an interpretable measure and discovers more important metabolites in an HPLC/MS-based metabolomic study.	[Li, Zuojing] Shenyang Pharmaceut Univ, Sch Med Devices, Shenyang, Peoples R China; [Li, Zuojing; Li, Qing; Geng, Lulu; Chen, Xiaohui; Bi, Kaishun] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Bi, KS (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China.	kaishunbi.syphu@gmail.com.com	Li, Qing/AAD-3286-2022	Li, Qing/0000-0003-3087-4692				Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bottcher C, 2007, ANAL CHEM, V79, P1507, DOI 10.1021/ac061037q; Box G. E. P., 1954, ANN MATH STAT, V25, P33, DOI [DOI 10.1214/A0MS/1177728786, 10.1214/aoms/1177728786]; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Efron B., 2010, LARGE SCALE INFERENC, V1; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Fukushima A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-1; Geng LL, 2013, PHYTOTHER RES, V27, P521, DOI 10.1002/ptr.4748; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Lenz EM, 2004, ANALYST, V129, P535, DOI 10.1039/b400159c; Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; Moco S, 2007, TRAC-TREND ANAL CHEM, V26, P855, DOI 10.1016/j.trac.2007.08.003; Plumb RS, 2003, RAPID COMMUN MASS SP, V17, P2632, DOI 10.1002/rcm.1250; Plumb RS, 2002, RAPID COMMUN MASS SP, V16, P1991, DOI 10.1002/rcm.813; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rousseau R, 2008, CHEMOMETR INTELL LAB, V91, P54, DOI 10.1016/j.chemolab.2007.06.008; Sweetlove LJ, 2005, NEW PHYTOL, V168, P9, DOI 10.1111/j.1469-8137.2005.01513.x; Wall M. E., 2003, PRACTICAL APPROACH M, P91, DOI [10.1007/0-306-47815-3_5, DOI 10.1007/0-306-47815-3_5]; Wilson ID, 2005, J CHROMATOGR B, V817, P67, DOI 10.1016/j.jchromb.2004.07.045; Yang ZY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-87	24	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67451	10.1371/journal.pone.0067451	http://dx.doi.org/10.1371/journal.pone.0067451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844011	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000045
J	Munoz-Moreno, E; Arbat-Plana, A; Batalle, D; Soria, G; Illa, M; Prats-Galino, A; Eixarch, E; Gratacos, E				Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Batalle, Dafnis; Soria, Guadalupe; Illa, Miriam; Prats-Galino, Alberto; Eixarch, Elisenda; Gratacos, Eduard			A Magnetic Resonance Image Based Atlas of the Rabbit Brain for Automatic Parcellation	PLOS ONE			English	Article							3-DIMENSIONAL DIGITAL ATLAS; C57BL/6J MOUSE-BRAIN; MODEL; MRI; DATABASE; AVERAGE; HYPERTONIA; DISTORTION; MOTOR	Rabbit brain has been used in several works for the analysis of neurodevelopment. However, there are not specific digital rabbit brain atlases that allow an automatic identification of brain regions, which is a crucial step for various neuroimage analyses, and, instead, manual delineation of areas of interest must be performed in order to evaluate a specific structure. For this reason, we propose an atlas of the rabbit brain based on magnetic resonance imaging, including both structural and diffusion weighted, that can be used for the automatic parcellation of the rabbit brain. Ten individual atlases, as well as an average template and probabilistic maps of the anatomical regions were built. In addition, an example of automatic segmentation based on this atlas is described.	[Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Batalle, Dafnis; Illa, Miriam; Eixarch, Elisenda; Gratacos, Eduard] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fetal & Perinatal Med Res Grp, Barcelona, Spain; [Soria, Guadalupe] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Expt MRI Unit 7T, Barcelona, Spain; [Illa, Miriam; Eixarch, Elisenda; Gratacos, Eduard] Univ Barcelona, Maternal Fetal Med Dept, ICGON, Hosp Clin, Barcelona, Spain; [Prats-Galino, Alberto] Univ Barcelona, Fac Med, Lab Surg NeuroAnat LSNA, Human Anat & Embryol Unit, Barcelona 7, Spain; [Eixarch, Elisenda; Gratacos, Eduard] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Munoz-Moreno, E (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fetal & Perinatal Med Res Grp, Barcelona, Spain.	emunozm@clinic.ub.es	Muñoz-Moreno, Emma/ABD-6424-2021; Soria, Guadalupe/AAG-4658-2021; Muñoz-Moreno, Emma/A-2363-2016; Soria, Guadalupe/GXH-4792-2022; Prats-Galino, Alberto/J-6319-2013; Batalle, Dafnis/H-7531-2019; Gratacos, Eduard/AAR-4939-2020	Muñoz-Moreno, Emma/0000-0003-2104-7265; Soria, Guadalupe/0000-0002-8344-0479; Muñoz-Moreno, Emma/0000-0003-2104-7265; Prats-Galino, Alberto/0000-0002-2710-6433; Batalle, Dafnis/0000-0003-2097-979X; Gratacos, Eduard/0000-0002-7405-7224; Illa, Miriam/0000-0002-8366-830X; Arbat-Plana, Ariadna/0000-0003-0479-8323; Eixarch, Elisenda/0000-0001-7379-9608	Obra Social "la Caixa," Barcelona, Spain; European Union [217911]; AGAUR [1099]; Carlos III Institute of Health, Spain [CD11/00048, CM11/00032]	Obra Social "la Caixa," Barcelona, Spain(La Caixa Foundation); European Union(European Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Carlos III Institute of Health, Spain(Instituto de Salud Carlos III)	This work was supported by grants: Obra Social "la Caixa," Barcelona, Spain; the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA Grant Agreement no 217911 (u-Volumes); AGAUR 2009 SGR Grant no 1099; and Sara Borrell and Rio Hortega grants from Carlos III Institute of Health, Spain (CD11/00048 to E.M. and CM11/00032 to M.I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardekani S, 2005, MAGN RESON MED, V54, P1163, DOI 10.1002/mrm.20651; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Brodmann K, 1909, VERGLEICHENDE LOKALI; Cabezas M, 2011, COMPUT METH PROG BIO, V104, pE158, DOI 10.1016/j.cmpb.2011.07.015; Cardenes R, 2009, COMPUT METH PROG BIO, V96, P108, DOI 10.1016/j.cmpb.2009.04.009; Chakravarty M. M., 2008, RHESUS MONKEY BRAIN; Chuang N, 2011, NEUROIMAGE, V54, P80, DOI 10.1016/j.neuroimage.2010.07.043; Derrick M, 2004, J NEUROSCI, V24, P24, DOI 10.1523/JNEUROSCI.2816-03.2004; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Drobyshevsky A, 2007, J CEREBR BLOOD F MET, V27, P270, DOI 10.1038/sj.jcbfm.9600333; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Ma Y, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.001.2008; MacKenzie-Graham A, 2004, J ANAT, V204, P93, DOI 10.1111/j.1469-7580.2004.00264.x; Mattes D, 2003, IEEE T MED IMAGING, V22, P120, DOI 10.1109/TMI.2003.809072; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Saadani-Makki F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.090; Salvador R, 2005, HUM BRAIN MAPP, V24, P144, DOI 10.1002/hbm.20076; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Shek JW., 1985, ATLAS RABBIT BRAIN S; Urban I., 1972, STEREOTAXIC ATLAS NZ; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Vellema M, 2011, NEUROIMAGE, V57, P352, DOI 10.1016/j.neuroimage.2011.04.033; Veraart J, 2011, NEUROIMAGE, V58, P975, DOI 10.1016/j.neuroimage.2011.06.063; VOGT BA, 1986, J COMP NEUROL, V248, P74, DOI 10.1002/cne.902480106; Warfield S, 1999, BRAIN WARPING, V4, P67; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zilles K., 1985, RAT NERVOUS SYSTEM F, V1, P375	37	26	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67418	10.1371/journal.pone.0067418	http://dx.doi.org/10.1371/journal.pone.0067418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844007	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000043
J	Braeunig, JH; Schweda, F; Han, PL; Seifert, R				Braeunig, Joerg H.; Schweda, Frank; Han, Pyung-Lim; Seifert, Roland			Similarly Potent Inhibition of Adenylyl Cyclase by P-Site Inhibitors in Hearts from Wild Type and AC5 Knockout Mice	PLOS ONE			English	Article							QUANTITATIVE PCR; SF9 CELLS; DISRUPTION; EXPRESSION; EFFICIENCY; VI; PURINE; BIAS	Adenylyl cyclase type 5 (AC5) was described as major cardiac AC isoform. The knockout of AC5 (AC5KO) exerted cardioprotective effects in heart failure. Our study explored the impact of AC5KO on mouse heart AC activities and evaluated putative AC5-selective inhibitors. In cardiac membranes from AC5KO mice, basal AC activity was decreased, while AC stimulation was intact. The putative AC5-selective P-site inhibitors SQ22,536 [9-(tetra-hydro-2-furanyl)-9H-purin-6-amine], vidarabine (9-beta-D-arabinosyladenine) and NKY80 [2-amino-7-(2-furanyl)-7,8-dihydro-5(6H)-quinazolinone] inhibited recombinant AC5 more potently than AC2 and AC1, but selectivity was only modest (similar to 4-40-fold). These compounds inhibited cardiac AC from WT and AC5KO mice with similar potencies. In conclusion, AC regulation in AC5KO hearts was unimpaired, questioning the supposed dominant role of AC5 in the heart. Moreover, the AC inhibitors SQ22,536, NKY80 and vidarabine lack adequate selectivity for AC5 and, therefore, do not present suitable tools to study AC5-specific functions.	[Braeunig, Joerg H.; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Schweda, Frank] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Han, Pyung-Lim] Ewha Woman Univ, Grad Sch, Dept Brain & Cognit Sci, Seoul, South Korea	Hannover Medical School; University of Regensburg; Ewha Womans University	Seifert, R (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	seifert.roland@mh-hannover.de	Seifert, Roland/G-3189-2013	Han, Pyung-Lim/0000-0002-1735-6746	Deutsche Forschungsgemeinschaft [529/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grant 529/5-2 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldehni F, 2011, HYPERTENSION, V57, P460, DOI 10.1161/HYPERTENSIONAHA.110.167130; Antoni FA, 2006, NEUROCHEM RES, V31, P287, DOI 10.1007/s11064-005-9019-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dessauer CW, 1999, TRENDS PHARMACOL SCI, V20, P205, DOI 10.1016/S0165-6147(99)01310-3; El-Armouche A, 2009, HEART FAIL REV, V14, P225, DOI 10.1007/s10741-008-9132-8; Emery AC, 2013, MOL PHARMACOL, V83, P95, DOI 10.1124/mol.112.081760; ESPINASSE I, 1995, J MOL CELL CARDIOL, V27, P1789, DOI 10.1016/0022-2828(95)90002-0; Gille A, 2003, J BIOL CHEM, V278, P12672, DOI 10.1074/jbc.M211292200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gottle M, 2009, J PHARMACOL EXP THER, V329, P1156, DOI 10.1124/jpet.109.150953; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Ho D, 2010, HEART FAIL REV, V15, P495, DOI 10.1007/s10741-010-9183-5; Houston C, 2002, J NEUROCHEM, V80, P678, DOI 10.1046/j.0022-3042.2001.00746.x; Hu CL, 2009, AM J PHYSIOL-HEART C, V297, pH1776, DOI 10.1152/ajpheart.00050.2009; Iwatsubo K, 2004, J BIOL CHEM, V279, P40938, DOI 10.1074/jbc.M314238200; Iwatsubo K, 2012, AM J PHYSIOL-HEART C, V302, pH2622, DOI 10.1152/ajpheart.00190.2012; Johnson RA, 1997, J BIOL CHEM, V272, P8962; Lee KW, 2002, J NEUROSCI, V22, P7931; Li Y, 2012, J BIOL CHEM, V287, P29815, DOI 10.1074/jbc.M112.380568; Ludwig MG, 2002, J RECEPT SIGNAL TR R, V22, P79, DOI 10.1081/RRS-120014589; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; Mou TC, 2006, MOL PHARMACOL, V70, P878, DOI 10.1124/mol.106.026427; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; Onda T, 2001, J BIOL CHEM, V276, P47785, DOI 10.1074/jbc.M107233200; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P618, DOI 10.1161/01.HYP.0000255172.84842.d2; Pavan B, 2009, DRUG DISCOV TODAY, V14, P982, DOI 10.1016/j.drudis.2009.07.007; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Pinto C, 2011, BIOCHEM PHARMACOL, V82, P358, DOI 10.1016/j.bcp.2011.05.010; Raimundo S, 1999, CLIN CHIM ACTA, V285, P155, DOI 10.1016/S0009-8981(99)00067-4; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Seifert R, 1998, EUR J BIOCHEM, V255, P369, DOI 10.1046/j.1432-1327.1998.2550369.x; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Tang T, 2006, BASIC RES CARDIOL, V101, P117, DOI 10.1007/s00395-005-0559-y; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; TOBISE K, 1994, CIRC RES, V74, P596, DOI 10.1161/01.RES.74.4.596; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Wang T, 2004, MOL CELL ENDOCRINOL, V223, P55, DOI 10.1016/j.mce.2004.05.012; WHITLEY R, 1980, DRUGS, V20, P267, DOI 10.2165/00003495-198020040-00002; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038	47	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68009	10.1371/journal.pone.0068009	http://dx.doi.org/10.1371/journal.pone.0068009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840883	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900022
J	Grant, F; Guille, C; Sen, S				Grant, Faren; Guille, Constance; Sen, Srijan			Well-Being and the Risk of Depression under Stress	PLOS ONE			English	Article							POSITIVE MENTAL-HEALTH; CONTINUUM; COHORT; IMPACT	Improving our ability to accurately predict individual risk for depression would have profound public health benefits. While there has been growing interest in understanding the relation between measures of positive emotion, such as well-being, and depression, it is not clear whether low well-being is an independent predictor of short term depression risk. We assessed whether low well-being is a risk factor for depressive symptoms. Medical internship is a well-established period of stress when levels of depressive symptoms increase dramatically. 1621 individuals beginning medical internship were assessed for well-being, depressive symptoms, and a set of psychological and demographic traits prior to starting internship year and again for depressive symptoms at 3 month intervals during the year. Low subjective well-being significantly predicted increased depression symptom scores during the stress of medical internship and accounted for individual level inter-variability in depression symptom trends across time. Assessing well-being may have utility in predicting future depression risk.	[Grant, Faren] Univ Maryland Baltimore Cty, Dept Psychol, Baltimore, MD 21228 USA; [Guille, Constance] Med Univ S Carolina, Dept Psychiat, Charleston, SC 29425 USA; [Sen, Srijan] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University System of Maryland; University of Maryland Baltimore County; Medical University of South Carolina; University of Michigan System; University of Michigan	Sen, S (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	srijan@umich.edu	Sen, Srijan/J-8053-2013	Sen, Srijan/0000-0003-4495-495X	National Center for Research Resources [UL1RR024986]; National Institute of Mental Health [MH095109]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101459, K23MH095109] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project was supported by the following grants: UL1RR024986 from the National Center for Research Resources (SS) and MH095109 from the National Institute of Mental Health (SS). The funding agencies played no role in the design and conduct of the study; collection management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript.	BUTTERFIELD PS, 1988, ARCH INTERN MED, V148, P1428, DOI 10.1001/archinte.148.6.1428; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Duckworth AL, 2005, ANNU REV CLIN PSYCHO, V1, P629, DOI 10.1146/annurev.clinpsy.1.102803.144154; Dyrbye LN, 2012, ACAD MED, V87, P1024, DOI 10.1097/ACM.0b013e31825cfa35; Fledderus M, 2012, PSYCHOL MED, V42, P485, DOI 10.1017/S0033291711001206; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Holzel L, 2011, J AFFECT DISORDERS, V129, P1, DOI 10.1016/j.jad.2010.03.025; Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P21, DOI 10.1177/1745691610393527; Kessler RC, 2006, AM J PSYCHIAT, V163, P1561, DOI 10.1176/appi.ajp.163.9.1561; Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197; Keyes CLM, 2007, AM PSYCHOL, V62, P95, DOI 10.1037/0003-066X.62.2.95; Keyes CLM, 2010, AM J PUBLIC HEALTH, V100, P2366, DOI 10.2105/AJPH.2010.192245; Koivumaa-Honkanen H, 2004, SOC PSYCH PSYCH EPID, V39, P994, DOI 10.1007/s00127-004-0833-6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamers SMA, 2011, J CLIN PSYCHOL, V67, P99, DOI 10.1002/jclp.20741; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; ROGOSA D, 1982, PSYCHOL BULL, V92, P726, DOI 10.1037/0033-2909.92.3.726; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719; Sen S, 2013, JAMA INTERN MED, V173, P657, DOI 10.1001/jamainternmed.2013.351; Sen S, 2010, ARCH GEN PSYCHIAT, V67, P557, DOI 10.1001/archgenpsychiatry.2010.41; Shanafelt T, 2002, JAMA-J AM MED ASSOC, V288, P1846, DOI 10.1001/jama.288.15.1846; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; Watson D, 2010, CLIN PSYCHOL REV, V30, P839, DOI 10.1016/j.cpr.2009.11.002; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wood AM, 2010, J AFFECT DISORDERS, V122, P213, DOI 10.1016/j.jad.2009.06.032	29	76	80	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67395	10.1371/journal.pone.0067395	http://dx.doi.org/10.1371/journal.pone.0067395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175ZH	23840872	gold, Green Published, Green Submitted			2022-12-27	WOS:000321271900011
J	Carmona, J; Cruz, A; Moreira-Teixeira, L; Sousa, C; Sousa, J; Osorio, NS; Saraiva, AL; Svenson, S; Kallenius, G; Pedrosa, J; Rodrigues, F; Castro, AG; Saraiva, M				Carmona, Jenny; Cruz, Andrea; Moreira-Teixeira, Lucia; Sousa, Carole; Sousa, Jeremy; Osorio, Nuno S.; Saraiva, Ana L.; Svenson, Stefan; Kallenius, Gunilla; Pedrosa, Jorge; Rodrigues, Fernando; Castro, Antonio G.; Saraiva, Margarida			Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PULMONARY TUBERCULOSIS; GENE POLYMORPHISMS; BEIJING GENOTYPE; CELL RESPONSES; LUNG PATHOLOGY; INFECTION; MICE; EXPRESSION; SUSCEPTIBILITY	Tuberculosis associates with a wide spectrum of disease outcomes. The Beijing (Bj) lineage of Mycobacterium tuberculosis (Mtb) is suggested to be more virulent than other Mtb lineages and prone to elicit non-protective immune responses. However, highly heterogeneous immune responses were reported upon infection of innate immune cells with Bj strains or stimulation with their glycolipids. Using both in vitro and in vivo mouse models of infection, we here report that the molecular mechanism for this heterogeneity may be related to distinct TLR activations. Among this Mtb lineage, we found strains that preferentially activate TLR2, and others that also activate TLR4. Recognition of Mtb strains by TLR4 resulted in a distinct cytokine profile in vitro and in vivo, with specific production of type I IFN. We also uncover a novel protective role for TLR4 activation in vivo. Thus, our findings contribute to the knowledge of the molecular basis underlying how host innate immune cells handle different Mtb strains, in particular the intricate host-pathogen interaction with strains of the Mtb Bj lineage.	[Carmona, Jenny; Cruz, Andrea; Moreira-Teixeira, Lucia; Sousa, Carole; Sousa, Jeremy; Osorio, Nuno S.; Pedrosa, Jorge; Rodrigues, Fernando; Castro, Antonio G.; Saraiva, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Carmona, Jenny; Cruz, Andrea; Moreira-Teixeira, Lucia; Sousa, Carole; Sousa, Jeremy; Osorio, Nuno S.; Pedrosa, Jorge; Rodrigues, Fernando; Castro, Antonio G.; Saraiva, Margarida] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Saraiva, Ana L.] EUVG, Coimbra, Portugal; [Svenson, Stefan; Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Universidade do Minho; Karolinska Institutet	Castro, AG (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	acastro@ecsaude.uminho.pt; msaraiva@ecsaude.uminho.pt	Moreira-Teixeira, Lúcia/AAH-4216-2020; Cruz, Andrea/GWQ-5824-2022; Pedrosa, Jorge/H-4877-2011; SOUSA, Carole/AAH-2269-2021; Rodrigues, Fernando/T-5299-2018; Källenius, Gunilla/AGZ-3956-2022; Sousa, Carole/I-2285-2019; Osório, Nuno S./D-4773-2013; Castro, Gil/T-7584-2018; Moreira-Teixeira, Lucia/J-8489-2014; Cruz, Andrea/K-4585-2013; Osório, Nuno S./AAF-4307-2020; Rodrigues, Fernando/A-3123-2011; Saraiva, Margarida/E-8781-2011	Moreira-Teixeira, Lúcia/0000-0002-4817-8196; Pedrosa, Jorge/0000-0002-8204-4888; Rodrigues, Fernando/0000-0001-8436-9398; Sousa, Carole/0000-0002-8707-8796; Osório, Nuno S./0000-0003-0949-5399; Castro, Gil/0000-0002-4684-4183; Moreira-Teixeira, Lucia/0000-0002-4817-8196; Cruz, Andrea/0000-0002-1662-3072; Osório, Nuno S./0000-0003-0949-5399; Saraiva, Margarida/0000-0002-8180-1293; Sousa, Jeremy/0000-0002-1310-1201; Kallenius, Gunilla/0000-0002-8921-0551	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-MII/101977/2008, PTDC/BIA-BCM/102776/2008, SFRH/BD/35981/2007, SFRH/BPD/3306/2007, SFRH/BPD/77399/2011, SFRH/BI/33456/2008, SFRH/BPD/33959/2009]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work has been funded by Fundacao para a Ciencia e Tecnologia, Portugal. Project grants: PTDC/SAU-MII/101977/2008 and PTDC/BIA-BCM/102776/2008. Personal grants: SFRH/BD/35981/2007 to JC; SFRH/BPD/3306/2007 to AC; SFRH/BPD/77399/2011 to LMT; SFRH/BI/33456/2008 to CS; and SFRH/BPD/33959/2009 to NSO. MS is a Ciencia 2007 fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2006, CLIN EXP IMMUNOL, V145, P389, DOI 10.1111/j.1365-2249.2006.03162.x; Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Biswas Debasis, 2009, BMC Res Notes, V2, P162, DOI 10.1186/1756-0500-2-162; Branger J, 2004, INT IMMUNOL, V16, P509, DOI 10.1093/intimm/dxh052; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Kamath AB, 2003, INFECT IMMUN, V71, P4112, DOI 10.1128/IAI.71.7.4112-4118.2003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kirschner DE, 2010, CURR OPIN BIOTECH, V21, P524, DOI 10.1016/j.copbio.2010.06.002; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Ma MJ, 2010, HUM IMMUNOL, V71, P1005, DOI 10.1016/j.humimm.2010.07.009; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Najmi N, 2010, TISSUE ANTIGENS, V76, P102, DOI 10.1111/j.1399-0039.2010.01481.x; Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Scanga CA, 2004, INFECT IMMUN, V72, P2400, DOI 10.1128/IAI.72.4.2400-2404.2004; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Teixeira-Coelho M, 2011, INT IMMUNOL, V23, P89, DOI 10.1093/intimm/dxq459; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; World Health Organization, 2011, GLOB TUB CONTR SURV; Xue Y, 2010, INT J IMMUNOGENET, V37, P135, DOI 10.1111/j.1744-313X.2009.00892.x; Yim JJ, 2006, GENES IMMUN, V7, P150, DOI 10.1038/sj.gene.6364274	57	57	61	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67277	10.1371/journal.pone.0067277	http://dx.doi.org/10.1371/journal.pone.0067277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840651	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400091
J	Van Zyl, GU; Liu, TF; Claassen, M; Engelbrecht, S; de Oliveira, T; Preiser, W; Wood, NT; Travers, S; Shafer, RW				Van Zyl, Gert U.; Liu, Tommy F.; Claassen, Mathilda; Engelbrecht, Susan; de Oliveira, Tulio; Preiser, Wolfgang; Wood, Natasha T.; Travers, Simon; Shafer, Robert W.			Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens	PLOS ONE			English	Article							DRUG-RESISTANCE; NEVIRAPINE; FREQUENCY; INHIBITOR; MUTATION; THERAPY	Objectives: South Africa's national antiretroviral (ARV) treatment program expanded in 2010 to include the nucleoside reverse transcriptase (RT) inhibitors (NRTI) tenofovir (TDF) for adults and abacavir (ABC) for children. We investigated the associated changes in genotypic drug resistance patterns in patients with first-line ARV treatment failure since the introduction of these drugs, and protease inhibitor (PI) resistance patterns in patients who received ritonavir-boosted lopinavir (LPV/r)-containing therapy. Methods: We analysed ARV treatment histories and HIV-1 RT and protease mutations in plasma samples submitted to the Tygerberg Academic Hospital National Health Service Laboratory. Results: Between 2006 and 2012, 1,667 plasma samples from 1,416 ARV-treated patients, including 588 children and infants, were submitted for genotypic resistance testing. Compared with 720 recipients of a d4T or AZT-containing first-line regimen, the 153 recipients of a TDF-containing first-line regimen were more likely to have the RT mutations K65R (46% vs 4.0%; p<0.001), Y115F (10% vs. 0.6%; p<0.001), L74VI (8.5% vs. 1.8%; p<0.001), and K70EGQ (7.8% vs. 0.4%) and recipients of an ABC-containing first-line regimen were more likely to have K65R (17% vs 4.0%; p, <0.001), Y115F (30% vs 0.6%; p<0.001), and L74VI (56% vs 1.8%; p<0.001). Among the 490 LPV/r recipients, 55 (11%) had >= 1 LPV-resistance mutations including 45 (9.6%) with intermediate or high-level LPV resistance. Low (20 patients) and intermediate (3 patients) darunavir (DRV) cross resistance was present in 23 (4.6%) patients. Conclusions: Among patients experiencing virological failure on a first-line regimen containing two NRTI plus one NNRTI, the use of TDF in adults and ABC in children was associated with an increase in four major non-thymidine analogue mutations. In a minority of patients, LPV/r-use was associated with intermediate or high-level LPV resistance with predominantly low-level DRV cross-resistance.	[Van Zyl, Gert U.; Claassen, Mathilda; Engelbrecht, Susan; Preiser, Wolfgang] Natl Hlth Lab Serv, Coastal Branch, Tygerberg, South Africa; [Van Zyl, Gert U.; Claassen, Mathilda; Engelbrecht, Susan; Preiser, Wolfgang] Univ Stellenbosch, Fac Med & Hlth Sci, Div Med Virol, Parow, South Africa; [Liu, Tommy F.; Shafer, Robert W.] Stanford Univ, Med Ctr, Ctr AIDS Res, Div Infect Dis, Stanford, CA 94305 USA; [de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Wood, Natasha T.; Travers, Simon] Univ Western Cape, SANBI, ZA-7535 Bellville, South Africa	Stellenbosch University; Stanford University; University of Kwazulu Natal; South African National Biodiversity Institute; University of the Western Cape	Van Zyl, GU (corresponding author), Natl Hlth Lab Serv, Coastal Branch, Tygerberg, South Africa.	guvz@sun.ac.za	van Zyl, Gert/I-7357-2019; Engelbrecht, Susan/G-7286-2011; Preiser, Wolfgang/J-4875-2016	van Zyl, Gert/0000-0003-3021-5101; Engelbrecht, Susan/0000-0002-1318-5994; Preiser, Wolfgang/0000-0002-0254-7910; Claassen, Mathilda/0000-0002-6308-4438	NIAID NIH HHS [R56 AI068581] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI068581] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber TJ, 2012, J ANTIMICROB CHEMOTH, V67, P995, DOI 10.1093/jac/dkr569; de Oliveira T, 2010, NATURE, V464, P673, DOI 10.1038/464673c; Department of Health (South Africa), 2004, NAT ANT TREATM GUID; Hassani Espili N, 2004, ANTIVIR THER, V9, pS28; Johnson Victoria A, 2003, Top HIV Med, V11, P215; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Morris L, 2003, AIDS, V17, P1698, DOI 10.1097/00002030-200307250-00017; National Department of Health, 2010, CLIN GUID MAN HIV AI; National Department of Health, 2010, GUID MAN HIV CHILDR; Parkin NT, 2003, 12 INT HIV DRUG RES; Pillay V, 2008, AIDS RES HUM RETROV, V24, P1449, DOI 10.1089/aid.2008.0180; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Sunpath H, 2012, 19 C RETR OPP INF 5; Tang MW, 2012, CLIN INFECT DIS, V54, P862, DOI 10.1093/cid/cir1034; Trivedi V, 2008, AIDS RES HUM RETROV, V24, P1291, DOI 10.1089/aid.2007.0244; van Zyl GU, 2008, J MED VIROL, V80, P942, DOI 10.1002/jmv.21157; Wallis CL, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/769627; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b	18	51	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67188	10.1371/journal.pone.0067188	http://dx.doi.org/10.1371/journal.pone.0067188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840622	Green Published, gold			2022-12-27	WOS:000321424400083
J	Anthony, BJ; James, KR; Gobert, GN; Ramm, GA; McManus, DP				Anthony, Barrie J.; James, Kylie R.; Gobert, Geoffrey N.; Ramm, Grant A.; McManus, Donald P.			Schistosoma japonicum Eggs Induce a Proinflammatory, Anti-Fibrogenic Phenotype in Hepatic Stellate Cells	PLOS ONE			English	Article							RNA EXPRESSION PATTERN; GRANULOMA-FORMATION; LIVER FIBROSIS; ACTIVATION; DYNAMICS; MANSONI; IL-13; MICE; IMMUNOPATHOGENESIS; RECRUITMENT	Hepatic fibrosis induced by egg deposition is the most serious pathology associated with chronic schistosomiasis, in which the hepatic stellate cell (HSC) plays a central role. While the effect of Schistosoma mansoni eggs on the fibrogenic phenotype of HSCs has been investigated, studies determining the effect of eggs of S. japonicum on HSCs are lacking. Disease caused by S. japonicum is much more severe than that resulting from S. mansoni infection so it is important to compare the pathologies caused by these two parasites, to determine whether this phenotype is due to the species interacting differently with the mammalian host. Accordingly, we investigated the effect of S. japonicum eggs on the human HSC cell line, LX-2, with and without TGF-beta (Transforming Growth Factor beta) co-treatment, so as to determine the impact on genes associated with fibrogenesis, inflammation and matrix reorganisation. Activation status of HSCs was assessed by aSMA (Alpha Smooth Muscle Actin) immunofluorescence, accumulation of Oil Red O-stained lipid droplets and the relative expression of selected genes associated with activation. The fibrogenic phenotype of HSCs was inhibited by the presence of eggs both with or without TGF-beta treatment, as evidenced by a lack of aSMA staining and reduced gene expression of aSMA and Col1A1 (Collagen 1A1). Unlike S. mansoni-treated cells, however, expression of the quiescent HSC marker PPAR-gamma (Peroxisome Proliferator-Activated Receptor gamma) was not increased, nor was there accumulation of lipid droplets. In contrast, S. japonicum eggs induced the mRNA expression of MMP-9 (Matrix Metalloproteinase 9), CCL2 (Chemokine (C-C motif) Ligand 2) and IL-6 (Interleukin 6) in HSCs indicating that rather than inducing complete HSC quiescence, the eggs induced a proinflammatory phenotype. These results suggest HSCs in close proximity to S. japonicum eggs in the liver may play a role in the proinflammatory regulation of hepatic granuloma formation.	[Anthony, Barrie J.; James, Kylie R.; Gobert, Geoffrey N.; McManus, Donald P.] Queensland Inst Med Res, Mol Parasitol Lab, Brisbane, Qld 4006, Australia; [Ramm, Grant A.] Queensland Inst Med Res, Hepat Fibrosis Grp, Brisbane, Qld 4006, Australia; [Ramm, Grant A.] Univ Queensland, Fac Hlth Sci, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland	Anthony, BJ (corresponding author), Queensland Inst Med Res, Mol Parasitol Lab, Brisbane, Qld 4006, Australia.	Barrie.Anthony@qimr.edu.au	Ramm, Grant A/G-2669-2013; Gobert, Geoffrey/V-2985-2019; McManus, Donald P./G-2678-2013; McManus, Don/AAC-5394-2020	Ramm, Grant A/0000-0001-7058-6201; McManus, Don/0000-0001-6443-1449; James, Kylie/0000-0002-7107-0650; Gobert, Geoffrey/0000-0001-5884-6453	Australian National Health and Medical Research Council (NHMRC)	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	We acknowledge financial support from the Australian National Health and Medical Research Council (NHMRC). DPM is a NHMRC Senior Principal Research Fellow and GR is a NHMRC Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60; Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009; Anthony BJ, 2012, TRENDS PARASITOL, V28, P572, DOI 10.1016/j.pt.2012.09.005; Anthony BJ, 2012, PPAR RES, V2012, DOI 10.1155/2012/128068; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Chang D, 2006, ACTA TROP, V97, P318, DOI 10.1016/j.actatropica.2005.12.006; CHENSUE SW, 1995, AM J PATHOL, V146, P130; Chiu BC, 2002, PARASITE IMMUNOL, V24, P285, DOI 10.1046/j.1365-3024.2002.00466.x; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Hamada T, 2008, HEPATOLOGY, V47, P186, DOI 10.1002/hep.21922; He Y, 2012, CELL SIGNAL, V24, P1923, DOI 10.1016/j.cellsig.2012.06.003; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Khandoga A, 2006, J LEUKOCYTE BIOL, V79, P1295, DOI 10.1189/jlb.0805468; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; La Flamme AC, 2000, J IMMUNOL, V164, P2419, DOI 10.4049/jimmunol.164.5.2419; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Liu Y, 2011, J IMMUNOL, V187, P2814, DOI 10.4049/jimmunol.1003260; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Mentink-Kane MM, 2011, GASTROENTEROLOGY, V141, P2200, DOI 10.1053/j.gastro.2011.08.008; Morales-Montor J, 2004, J PARASITOL, V90, P547, DOI 10.1645/GE-89R1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Perry CR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001178; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramm Grant A, 2009, Hepatology, V50, P1664, DOI 10.1002/hep.23338; Ramm GA, 2009, HEPATOLOGY, V49, P533, DOI 10.1002/hep.22637; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Sugimoto R, 2005, LIVER INT, V25, P420, DOI 10.1111/j.1478-3231.2005.01087.x; Tao Jun, 2003, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V21, P173; Thomas PG, 2005, J IMMUNOL, V175, P2082, DOI 10.4049/jimmunol.175.4.2082; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; Trehanpati N, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.17; Wen XY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001399; Wickert L, 2002, BIOCHEM BIOPH RES CO, V295, P330, DOI 10.1016/S0006-291X(02)00669-1; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	42	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e68479	10.1371/journal.pone.0068479	http://dx.doi.org/10.1371/journal.pone.0068479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840855	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200141
J	Narayanan, T; Subramaniam, S				Narayanan, Tejaswini; Subramaniam, Shankar			Community Structure Analysis of Gene Interaction Networks in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							ACTIN CYTOSKELETON; SKELETAL-MUSCLE; CELL-ADHESION; EXPRESSION; INTEGRATION; COMPLEX; KINASE; BETA; RHOA; KEGG	Duchenne Muscular Dystrophy (DMD) is an important pathology associated with the human skeletal muscle and has been studied extensively. Gene expression measurements on skeletal muscle of patients afflicted with DMD provides the opportunity to understand the underlying mechanisms that lead to the pathology. Community structure analysis is a useful computational technique for understanding and modeling genetic interaction networks. In this paper, we leverage this technique in combination with gene expression measurements from normal and DMD patient skeletal muscle tissue to study the structure of genetic interactions in the context of DMD. We define a novel framework for transforming a raw dataset of gene expression measurements into an interaction network, and subsequently apply algorithms for community structure analysis for the extraction of topological communities. The emergent communities are analyzed from a biological standpoint in terms of their constituent biological pathways, and an interpretation that draws correlations between functional and structural organization of the genetic interactions is presented. We also compare these communities and associated functions in pathology against those in normal human skeletal muscle. In particular, differential enhancements are observed in the following pathways between pathological and normal cases: Metabolic, Focal adhesion, Regulation of actin cytoskeleton and Cell adhesion, and implication of these mechanisms are supported by prior work. Furthermore, our study also includes a gene-level analysis to identify genes that are involved in the coupling between the pathways of interest. We believe that our results serve to highlight important distinguishing features in the structural/functional organization of constituent biological pathways, as it relates to normal and DMD cases, and provide the mechanistic basis for further biological investigations into specific pathways differently regulated between normal and DMD patients. These findings have the potential to serve as fertile ground for therapeutic applications involving targeted drug development for DMD.	[Narayanan, Tejaswini] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Subramaniam, S (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	shankar@ucsd.edu			NSF [0939370, DBI 0835541, DBI 0641037]	NSF(National Science Foundation (NSF))	NSF grant awards Science and Technology Center Grant 0939370, DBI 0835541 and DBI 0641037 which supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bianchi ML, 2008, EUROPEAN MUSCULOSKEL; Carson JA, 2000, J APPL PHYSIOL, V88, P337, DOI 10.1152/jappl.2000.88.1.337; Chen J, 2009, P SIAM DAT MIN C US; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Chinet AE, 1994, EXPERIENTIA; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dinh TN, 2009, IEEE IPCCC, P161, DOI 10.1109/PCCC.2009.5403845; Domin J, 1996, J BIOL CHEM, V271, P21614, DOI 10.1074/jbc.271.35.21614; Dwinell MR, 2009, NUCLEIC ACIDS RES, V37, pD744, DOI 10.1093/nar/gkn842; ENGVALL E, 1994, BRAZ J MED BIOL RES, V27, P2213; Eriksen KA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.148701; Fadic R, 2005, BIOL RES, V38, P375, DOI 10.4067/S0716-97602005000400010; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hofman JM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258701; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irving-Rodgers HF, 2010, CELL TISSUE RES, V339, P613, DOI 10.1007/s00441-009-0905-8; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keep NH, 2000, NEUROL SCI, P929; Leskovec J., 2008, P 17 INT C WORLD WID, P915, DOI [10.1145/1367497.1367620, DOI 10.1145/1367497.1367620]; Narayanan T, 2011, P 3 INT C BIOINF COM; Narayanan Tejaswini, 2011, BMC Res Notes, V4, P569, DOI 10.1186/1756-0500-4-569; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nguyen NP, 2001, P IEEE INT C COMP CO; Nowak Kristen, 2005, V264, P98, DOI 10.1002/0470093765.ch8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Picard F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S17; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; REPASKE DR, 1992, J BIOL CHEM, V267, P18683; Ruan J, 2007, P INT C DAT MIN US; Sakuma K, 2004, ACTA NEUROPATHOL, V108, P241, DOI 10.1007/s00401-004-0884-5; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sorokin LM, 2000, EXP CELL RES, V256, P500, DOI 10.1006/excr.2000.4842; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Steinhaeuser K, 2008, SOCIAL COMPUTING, BEHAVIORAL MODELING AND PREDICTION, P168, DOI 10.1007/978-0-387-77672-9_19; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TINSLEY JM, 1993, CURR OPIN GENET DEV, V3, P484, DOI 10.1016/0959-437X(93)90124-8; Torrente Y, 2003, J CELL BIOL, V162, P511, DOI 10.1083/jcb.200210006; Wang Y, 2012, J APPL PHYSL; Wang Y, 2012, J APPL PHYSIOL, V113, P1902, DOI 10.1152/japplphysiol.01515.2011; Warner LE, 2002, HUM MOL GENET, V11, P1095, DOI 10.1093/hmg/11.9.1095; Wasserman S, 1994, SOCIAL NETW IN PRESS; Wei L, 2000, AM J PHYSIOL-HEART C, V278, pH1736, DOI 10.1152/ajpheart.2000.278.6.H1736; WROGEMANN K, 1976, LANCET, V1, P672; Yan H, 2012, CNS NEUROSCI THER, V18, P729, DOI 10.1111/j.1755-5949.2012.00353.x; Yang QF, 2007, INT J DATA MIN BIOIN, V1, P241, DOI 10.1504/IJDMB.2007.011611	50	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67237	10.1371/journal.pone.0067237	http://dx.doi.org/10.1371/journal.pone.0067237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840633	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200126
J	Cui, YQ; Lindo, J; Hughes, CE; Johnson, JW; Hernandez, AG; Kemp, BM; Ma, J; Cunningham, R; Petzelt, B; Mitchell, J; Archer, D; Cybulski, JS; Malhi, RS				Cui, Yinqiu; Lindo, John; Hughes, Cris E.; Johnson, Jesse W.; Hernandez, Alvaro G.; Kemp, Brian M.; Ma, Jian; Cunningham, Ryan; Petzelt, Barbara; Mitchell, Joycellyn; Archer, David; Cybulski, Jerome S.; Malhi, Ripan S.			Ancient DNA Analysis of Mid-Holocene Individuals from the Northwest Coast of North America Reveals Different Evolutionary Paths for Mitogenomes	PLOS ONE			English	Article							POPULATION HISTORY; MIGRATION HISTORY; GENETIC DIVERSITY; Y-CHROMOSOMES; PATTERNS; SEQUENCES; SINGLE; GENOME; ALASKA; DAMAGE	To gain a better understanding of North American population history, complete mitochondrial genomes (mitogenomes) were generated from four ancient and three living individuals of the northern Northwest Coast of North America, specifically the north coast of British Columbia, Canada, current home to the indigenous Tsimshian, Haida, and Nisga'a. The mitogenomes of all individuals were previously unknown and assigned to new sub-haplogroup designations D4h3a7, A2ag and A2ah. The analysis of mitogenomes allows for more detailed analyses of presumed ancestor-descendant relationships than sequencing only the HVSI region of the mitochondrial genome, a more traditional approach in local population studies. The results of this study provide contrasting examples of the evolution of Native American mitogenomes. Those belonging to sub-haplogroups A2ag and A2ah exhibit temporal continuity in this region for 5000 years up until the present day. Of possible associative significance is that archaeologically identified house structures in this region maintain similar characteristics for this same period of time, demonstrating cultural continuity in residence patterns. The individual dated to 6000 years before present (BP) exhibited a mitogenome belonging to sub-haplogroup D4h3a. This sub-haplogroup was earlier identified in the same general area at 10300 years BP on Prince of Wales Island, Alaska, and may have gone extinct, as it has not been observed in any living individuals of the Northwest Coast. The presented case studies demonstrate the different evolutionary paths of mitogenomes over time on the Northwest Coast.	[Cui, Yinqiu; Lindo, John; Hughes, Cris E.; Malhi, Ripan S.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Cui, Yinqiu] Jilin Univ, Coll Life Sci, Changchun 130023, Jilin, Peoples R China; [Johnson, Jesse W.; Malhi, Ripan S.] Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; [Hernandez, Alvaro G.] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL 61801 USA; [Kemp, Brian M.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Kemp, Brian M.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Ma, Jian] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Ma, Jian; Malhi, Ripan S.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cunningham, Ryan] Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA; [Petzelt, Barbara; Mitchell, Joycellyn] Metlakatla Treaty Off, Metlakatla, BC, Canada; [Archer, David] Northwest Community Coll, Prince Rupert, BC, Canada; [Cybulski, Jerome S.] Canadian Museum Civilizat, Gatineau, PQ, Canada	University of Illinois System; University of Illinois Urbana-Champaign; Jilin University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington State University; Washington State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Malhi, RS (corresponding author), Univ Illinois, Dept Anthropol, 109 Davenport Hall, Urbana, IL 61801 USA.	malhi@illinois.edu	Cui, Yinqiu/I-1846-2019; Ma, Jian/A-9838-2008	Cui, Yinqiu/0000-0003-3702-5773; Ma, Jian/0000-0002-4202-5834; Malhi, Ripan/0000-0002-1484-0292	National Science Foundation grant [BCS-0745459, BCS-1025139]	National Science Foundation grant(National Science Foundation (NSF))	This study was funded by the National Science Foundation grant BCS-0745459 and BCS-1025139 to RSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Archer D, 2011, LUCY ISLAND AR UNPUB; Bolnick DA, 2006, MOL BIOL EVOL, V23, P2161, DOI 10.1093/molbev/msl088; Boyd RT, 1990, HDB N AM INDIANS, P1774; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; CHISHOLM BS, 1983, CURR ANTHROPOL, V24, P396, DOI 10.1086/203018; CROSBY AW, 1976, WILLIAM MARY QUART, V33, P289, DOI 10.2307/1922166; Cybulski J. S., 2010, HUMAN VARIATION AM I, P77; Cybulski J. S., 2007, CANADIAN J ARCHAEOLO, P55; Cybulski Jerome S., 2006, HDB N AM INDIANS, V3, P532; Cybulski JS, 1986, HUMAN REMAINS LUCY I; Cybulski JS, 2012, TSIMSHIAN LANDSCAPES; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; HALPIN M, 1990, HDB N AM INDIANS, V0007, P00267; Hunley K, 2011, AM J PHYS ANTHROPOL, V146, P530, DOI 10.1002/ajpa.21506; Jenkins DL, 2012, SCIENCE, V337, P223, DOI 10.1126/science.1218443; Kaestle FA, 2001, AM J PHYS ANTHROPOL, V115, P1, DOI 10.1002/ajpa.1051; Kemp B. M., 2010, HUMAN VARIATION AM I, P12; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HJ, 2011, J HUM GENET, V56, P815, DOI 10.1038/jhg.2011.102; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; MacDonald George F, 1987, HIST ATLAS CANADA, V1; MACDONALD GF, 1981, B C STUD, V0048, P00037; Malakoff D, 2011, AM ARCHAEOL, V15, P26; Malhi RS, 2007, J ARCHAEOL SCI, V34, P642, DOI 10.1016/j.jas.2006.07.004; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Malhi RS, 2008, AM J PHYS ANTHROPOL, V137, P412, DOI 10.1002/ajpa.20883; Malhi RS, 2004, HUM BIOL, V76, P33, DOI 10.1353/hub.2004.0023; McLaren Duncan., 2008, THESIS U VICTORIA; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; O'Rourke DH, 2000, HUM BIOL, V72, P15; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Powell J.F., 2005, 1 AM RACE EVOLUTION; Raff JA, 2011, AM J PHYS ANTHROPOL, V146, P503, DOI 10.1002/ajpa.21594; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Schurr TG, 2012, AM J PHYS ANTHROPOL, V148, P422, DOI 10.1002/ajpa.22068; Stone Anne C, 1996, ANCIENT BIOMOLECULES, V1, P83; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Trotter M, 1952, AM J PHYS ANTHROP-NE, V10, P463, DOI 10.1002/ajpa.1330100407; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; Wei Z, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr599; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	52	39	39	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66948	10.1371/journal.pone.0066948	http://dx.doi.org/10.1371/journal.pone.0066948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23843972	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000056
J	Ferguson, BD; Liu, R; Rolle, CE; Tan, YHC; Krasnoperov, V; Kanteti, R; Tretiakova, MS; Cervantes, GM; Hasina, R; Hseu, RD; Iafrate, AJ; Karrison, T; Ferguson, MK; Husain, AN; Faoro, L; Vokes, EE; Gill, PS; Salgia, R				Ferguson, Benjamin D.; Liu, Ren; Rolle, Cleo E.; Tan, Yi-Hung Carol; Krasnoperov, Valery; Kanteti, Rajani; Tretiakova, Maria S.; Cervantes, Gustavo M.; Hasina, Rifat; Hseu, Robyn D.; Iafrate, A. John; Karrison, Theodore; Ferguson, Mark K.; Husain, Aliya N.; Faoro, Leonardo; Vokes, Everett E.; Gill, Parkash S.; Salgia, Ravi			The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TOPOISOMERASE-I ACTIVITY; BIOLOGICAL SIGNIFICANCE; TUMOR ADVANCEMENT; EXPRESSION; SURVIVAL; EPHRINB2; INHIBITORS; COMPLEX; HEAD	Despite progress in locoregional and systemic therapies, patient survival from lung cancer remains a challenge. Receptor tyrosine kinases are frequently implicated in lung cancer pathogenesis, and some tyrosine kinase inhibition strategies have been effective clinically. The EphB4 receptor tyrosine kinase has recently emerged as a potential target in several other cancers. We sought to systematically study the role of EphB4 in lung cancer. Here, we demonstrate that EphB4 is overexpressed 3-fold in lung tumors compared to paired normal tissues and frequently exhibits gene copy number increases in lung cancer. We also show that overexpression of EphB4 promotes cellular proliferation, colony formation, and motility, while EphB4 inhibition reduces cellular viability in vitro, halts the growth of established tumors in mouse xenograft models when used as a single-target strategy, and causes near-complete regression of established tumors when used in combination with paclitaxel. Taken together, these data suggest an important role for EphB4 as a potential novel therapeutic target in lung cancer. Clinical trials investigating the efficacy of anti-EphB4 therapies as well as combination therapy involving EphB4 inhibition may be warranted.	[Ferguson, Benjamin D.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Ferguson, Benjamin D.; Rolle, Cleo E.; Tan, Yi-Hung Carol; Kanteti, Rajani; Cervantes, Gustavo M.; Hasina, Rifat; Hseu, Robyn D.; Faoro, Leonardo; Vokes, Everett E.; Salgia, Ravi] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Tretiakova, Maria S.; Husain, Aliya N.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Ferguson, Mark K.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Karrison, Theodore] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ferguson, Mark K.; Salgia, Ravi] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Liu, Ren; Gill, Parkash S.] Univ So Calif, Dept Med, Div Med Oncol, Los Angeles, CA USA; [Krasnoperov, Valery; Gill, Parkash S.] Vasgene Therapeut Inc, Los Angeles, CA USA; [Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Southern California; Harvard University; Massachusetts General Hospital	Salgia, R (corresponding author), Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rsalgia@medicine.bsd.uchicago.edu	Tretiakova, Maria/U-3320-2019; Vokes, Everett/Q-2146-2019; Ferguson, Benjamin/O-3214-2013	Ferguson, Benjamin/0000-0001-8358-3368; Tan, Yi-Hung Carol/0000-0001-7541-007X	NIH/NICHD [T32HD009007]; ASCO Translational Award; NIH/NCI [R01 CA 129501 05]; Janice Lamb McArdle Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA129501] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ASCO Translational Award; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Janice Lamb McArdle Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported in part by NIH/NICHD T32HD009007, "Graduate Training in Growth and Development" (BDF), ASCO Translational Award (EEV), NIH/NCI R01 CA 129501 05 (RS), and Janice Lamb McArdle Cancer Research Foundation (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2008, BRIT J CANCER, V98, P845, DOI 10.1038/sj.bjc.6604216; Alam SM, 2007, ANN ONCOL, V18, P485, DOI 10.1093/annonc/mdl414; Alam SM, 2009, GYNECOL ONCOL, V114, P84, DOI 10.1016/j.ygyno.2009.03.017; Bardelle C, 2008, BIOORG MED CHEM LETT, V18, P5717, DOI 10.1016/j.bmcl.2008.09.087; Bardelle C, 2008, BIOORG MED CHEM LETT, V18, P2776, DOI 10.1016/j.bmcl.2008.04.015; Bardelle C, 2010, BIOORG MED CHEM LETT, V20, P6242, DOI 10.1016/j.bmcl.2010.08.100; Barlaam B, 2011, BIOORG MED CHEM LETT, V21, P2207, DOI 10.1016/j.bmcl.2011.03.009; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Cabezon-Gutierrez L, 2012, LUNG, V190, P381, DOI 10.1007/s00408-012-9391-y; Cheng EH, 2012, NAT MED, V18, P494, DOI 10.1038/nm.2725; Cheng H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-5; Chhatriwala H, 2006, CANCER BIOL THER, V5, P1600, DOI 10.4161/cbt.5.12.3546; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; Cohen EEW, 2010, J CLIN ONCOL, V28, P3336, DOI 10.1200/JCO.2009.27.0397; DASSONVILLE O, 1993, J CLIN ONCOL, V11, P1873, DOI 10.1200/JCO.1993.11.10.1873; Davalos V, 2006, CANCER RES, V66, P8943, DOI 10.1158/0008-5472.CAN-05-4640; DEFFIE AM, 1989, CANCER RES, V49, P58; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Flanagan JG, 1997, CELL, V90, P403; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hasina R, 2013, CANCER RES, V73, P184, DOI 10.1158/0008-5472.CAN-12-0915; Herath NI, 2012, EUR J CANCER, V48, P753, DOI 10.1016/j.ejca.2011.07.003; Hermes A, 2008, J CLIN ONCOL, V26, P4261, DOI 10.1200/JCO.2007.15.7545; HEUSER L, 1979, CANCER, V43, P1888, DOI 10.1002/1097-0142(197905)43:5<1888::AID-CNCR2820430545>3.0.CO;2-M; Ichimura E, 1996, JPN J CANCER RES, V87, P1063, DOI 10.1111/j.1349-7006.1996.tb03111.x; Ishikawa M, 2012, LUNG CANCER, V76, P431, DOI 10.1016/j.lungcan.2011.12.004; Ji XD, 2011, CANCER RES, V71, P1156, DOI 10.1158/0008-5472.CAN-10-0717; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kumar SR, 2007, BRIT J CANCER, V96, P1083, DOI 10.1038/sj.bjc.6603642; Kumar SR, 2006, AM J PATHOL, V169, P279, DOI 10.2353/ajpath.2006.050889; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Lee YC, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-119; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Masood R, 2006, INT J CANCER, V119, P1236, DOI 10.1002/ijc.21926; Maulik G, 2004, J ENVIRON PATHOL TOX, V23, P237, DOI 10.1615/JEnvPathToxOncol.v23.i4.10; Minamiya Y, 2010, LUNG CANCER, V68, P466, DOI 10.1016/j.lungcan.2009.07.015; Oberholzer M, 1996, HISTOCHEM CELL BIOL, V105, P333, DOI 10.1007/BF01463655; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Reynolds CP, 2005, METH MOLEC MED, V111, P335; Rosell R, 2006, CLIN CANCER RES, V12, P7222, DOI 10.1158/1078-0432.CCR-06-0627; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sakai A, 2012, J THORAC ONCOL, V7, P1337, DOI 10.1097/JTO.0b013e31825cca4c; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Spannuth WA, 2010, MOL CANCER THER, V9, P2377, DOI 10.1158/1535-7163.MCT-10-0200; Spano JP, 2004, ANN ONCOL, V15, P613, DOI 10.1093/annonc/mdh136; Stephenson S A, 2001, BMC Mol Biol, V2, P15, DOI 10.1186/1471-2199-2-15; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Xia G, 2006, ONCOGENE, V25, P769, DOI 10.1038/sj.onc.1209108; Xia GB, 2005, CLIN CANCER RES, V11, P4305, DOI 10.1158/1078-0432.CCR-04-2109; Xia GB, 2005, CANCER RES, V65, P4623, DOI 10.1158/0008-5472.CAN-04-2667; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Yavrouian EJ, 2008, ARCH OTOLARYNGOL, V134, P985, DOI 10.1001/archotol.134.9.985; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054674; Zheng MF, 2012, MOL MED REP, V6, P405, DOI 10.3892/mmr.2012.936	62	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67668	10.1371/journal.pone.0067668	http://dx.doi.org/10.1371/journal.pone.0067668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844053	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000071
J	Ibanez-Casas, I; De Portugal, E; Gonzalez, N; McKenney, KA; Haro, JM; Usall, J; Perez-Garcia, M; Cervilla, JA				Ibanez-Casas, Inmaculada; De Portugal, Enrique; Gonzalez, Nieves; McKenney, Kathryn A.; Haro, Josep M.; Usall, Judith; Perez-Garcia, Miguel; Cervilla, Jorge A.			Deficits in Executive and Memory Processes in Delusional Disorder: A Case-Control Study	PLOS ONE			English	Article							SCHIZOPHRENIA; INHIBITION; VALIDATION; PROFILE	Objective: Delusional disorder has been traditionally considered a psychotic syndrome that does not evolve to cognitive deterioration. However, to date, very little empirical research has been done to explore cognitive executive components and memory processes in Delusional Disorder patients. This study will investigate whether patients with delusional disorder are intact in both executive function components (such as flexibility, impulsivity and updating components) and memory processes (such as immediate, short term and long term recall, learning and recognition). Methods: A large sample of patients with delusional disorder (n = 86) and a group of healthy controls (n = 343) were compared with regard to their performance in a broad battery of neuropsychological tests including Trail Making Test, Wisconsin Card Sorting Test, Colour-Word Stroop Test, and Complutense Verbal Learning Test (TAVEC). Results: When compared to controls, cases of delusional disorder showed a significantly poorer performance in most cognitive tests. Thus, we demonstrate deficits in flexibility, impulsivity and updating components of executive functions as well as in memory processes. These findings held significant after taking into account sex, age, educational level and premorbid IQ. Conclusions: Our results do not support the traditional notion of patients with delusional disorder being cognitively intact.	[Ibanez-Casas, Inmaculada; McKenney, Kathryn A.; Perez-Garcia, Miguel; Cervilla, Jorge A.] Univ Granada, Ctr Invest Biomed Red Salud Mental CIBERSAM, Granada, Spain; [Ibanez-Casas, Inmaculada; McKenney, Kathryn A.; Cervilla, Jorge A.] Univ Granada, Federico Oloriz Inst Neurosci, Granada, Spain; [Ibanez-Casas, Inmaculada; McKenney, Kathryn A.; Cervilla, Jorge A.] Univ Granada, Psiquiatria Biol Ambiental PSYBAM Grp, Granada, Spain; [De Portugal, Enrique] Hosp Gen Gregorio Maranon, Dept Psychiat, Madrid, Spain; [Gonzalez, Nieves; Haro, Josep M.; Usall, Judith] St Joan de Deu SSM, Res & Dev Unit, Barcelona 08830, Spain; [Haro, Josep M.; Usall, Judith] San Juan de Dios Fdn, Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona, Spain; [Perez-Garcia, Miguel] Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Cervilla, Jorge A.] Univ Granada, Dept Psychiat & Med Psychol, Granada, Spain; [Cervilla, Jorge A.] San Cecilio Univ Hosp, Psychiat Inpatient Unit, Granada, Spain; [Cervilla, Jorge A.] Kings Coll London, Ctr Global Mental Hlth, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Granada; University of Granada; University of Granada; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Granada; University of Granada; Hospital Universitario San Cecilio; University of London; King's College London	Cervilla, JA (corresponding author), Univ Granada, Ctr Invest Biomed Red Salud Mental CIBERSAM, Granada, Spain.	jacb@ugr.es	García, Miguel Pérez/F-9630-2010; perez, miguel/GXF-5077-2022; Ibanez-Casas, Inmaculada/I-4659-2014; Haro, Josep Maria/D-1423-2011; Cervilla, Jorge A/O-2106-2016	García, Miguel Pérez/0000-0003-4775-7556; Ibanez-Casas, Inmaculada/0000-0002-1007-8966; Haro, Josep Maria/0000-0002-3984-277X; Cervilla, Jorge A/0000-0001-6891-1992	Fondo de Investigaciones Sanitarias Instituto de Salud Carlos III, Ministry of economy and competitivity [FIS PI021813, FIS PF09/01671]; Proyecto de Excelencia, Consejeria de Innovacion, Junta de Andalucia [CTS 1686]	Fondo de Investigaciones Sanitarias Instituto de Salud Carlos III, Ministry of economy and competitivity; Proyecto de Excelencia, Consejeria de Innovacion, Junta de Andalucia(Junta de Andalucia)	This study was partially funded by grants from the Fondo de Investigaciones Sanitarias Instituto de Salud Carlos III, Ministry of economy and competitivity (Project No. FIS PI021813 and FIS PF09/01671), and by Proyecto de Excelencia, Consejeria de Innovacion, Junta de Andalucia (Project No. CTS 1686). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid Mona, 2008, Curr Psychiatry Rep, V10, P229, DOI 10.1007/s11920-008-0038-x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1981, MANUAL WISCONSIN CAR; Army Individual Test Battery, 1944, ARM COMB FITN TEST; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Barnett JH, 2005, PSYCHOL MED, V35, P1031, DOI 10.1017/S0033291704004301; Barona A., 1984, J CLIN NEUROPSYCHOL, V8, P169; Benedet MJ, 1998, MANUAL TEST APRENDIZ; Bilbao-Bilbao A, 2004, REV NEUROLOGIA, V38, P431; Bommer I, 2007, NERVENARZT, V78, P796, DOI 10.1007/s00115-006-2213-9; Bommer Isabel, 2006, Cogn Neuropsychiatry, V11, P493, DOI 10.1080/13546800500359994; Conway CR, 2002, COMPR PSYCHIAT, V43, P175, DOI 10.1053/comp.2002.32358; de Portugal E, 2009, REV PSIQUIATR SALUD, V2, P72, DOI 10.1016/S1888-9891(09)72248-7; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Delis DC., 2000, CALIFORNIA VERBAL LE; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Evans JD, 1996, J NEUROPSYCH CLIN N, V8, P281; Fear C, 1996, BRIT J PSYCHIAT, V168, P61, DOI 10.1192/bjp.168.1.61; First MB, 2001, VERSION ESPANOLA ENT; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Freeman D, 2008, PSYCHOL MED, V38, P1121, DOI 10.1017/S0033291708003589; Fujii DEM, 1999, NEUROPSY NEUROPSY BE, V12, P110; Garety PA, 1999, BRIT J CLIN PSYCHOL, V38, P113, DOI 10.1348/014466599162700; Golden C.J., 1994, STROOP TEST COLORES; Groth-Marnat G., 2000, NEUROPSYCHOLOGICAL A; Heaton R K, 2000, WCST 64 CV COMPTER V; Herlitz A, 1996, ACTA PSYCHIAT SCAND, V93, P355, DOI 10.1111/j.1600-0447.1996.tb10660.x; Ibanez-Casas I, 2012, PSYCHOPATHOLOGY, V45, P78, DOI 10.1159/000327899; JIBIKI I, 1994, NEUROPSYCHOBIOLOGY, V30, P7, DOI 10.1159/000119127; Kraepelin E, 1896, LEHRBUCH PSYCHIAT; Kunert HJ, 2007, PSYCHOPATHOLOGY, V40, P191, DOI 10.1159/000100367; Lapcin S, 2008, INT J NEUROPSYCHOPH, V11, P251; LAPCIN S, 2008, INT J NEUROPSYCHO S1, V11, P251; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Leposavic I, 2009, PSYCHIAT DANUB, V21, P166; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Mazurek I, 2004, EUR NEUROPSYCHOPHARM, V14, pS295, DOI 10.1016/S0924-977X(04)80362-6; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Mraz R, 2004, ARCH CLIN NEUROPSYCH, V19, P905; Munro A., 1999, DELUSIONAL DISORDER; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simon AE, 2003, EUR ARCH PSY CLIN N, V253, P216, DOI 10.1007/s00406-003-0421-x; Steinmetz JP, 2011, CLIN NEUROPSYCHOL, V25, P652, DOI 10.1080/13854046.2011.568525; van Os Jim, 2003, Epidemiol Psichiatr Soc, V12, P242; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Villalta-Gil V, 2006, SCHIZOPHR RES, V87, P246, DOI 10.1016/j.schres.2006.06.013; Walston F, 1998, EVOL HUM BEHAV, V19, P257, DOI 10.1016/S1090-5138(98)00010-5	50	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67341	10.1371/journal.pone.0067341	http://dx.doi.org/10.1371/journal.pone.0067341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844005	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000042
J	Schneikert, J; Chandra, SHV; Ruppert, JG; Ray, S; Wenzel, EM; Behrens, J				Schneikert, Jean; Chandra, Shree Harsha Vijaya; Ruppert, Jan Gustav; Ray, Suparna; Wenzel, Eva Maria; Behrens, Jurgen			Functional Comparison of Human Adenomatous Polyposis Coli (APC) and APC-Like in Targeting Beta-Catenin for Degradation	PLOS ONE			English	Article							MUTATION CLUSTER REGION; WNT SIGNALING PATHWAY; TUMOR-SUPPRESSOR; COLORECTAL TUMORS; SOMATIC MUTATIONS; EPITHELIAL-CELLS; TRUNCATED APC; GENE; IDENTIFICATION; DROSOPHILA	Truncating mutations affect the adenomatous polyposis coli (APC) gene in most cases of colon cancer, resulting in the stabilization of beta-catenin and uncontrolled cell proliferation. We show here that colon cancer cell lines express also the paralog APC-like (APCL or APC2). RNA interference revealed that it controls the level and/or the activity of beta-catenin, but it is less efficient and binds less well to beta-catenin than APC, thereby providing one explanation as to why the gene is not mutated in colon cancer. A further comparison indicates that APCL down-regulates the beta-catenin level despite the lack of the 15R region known to be important in APC. To understand this discrepancy, we performed immunoprecipitation experiments that revealed that phosphorylated beta-catenin displays a preference for binding to the 15 amino acid repeats (15R) rather than the first 20 amino acid repeat of APC. This suggests that the 15R region constitutes a gate connecting the steps of beta-catenin phosphorylation and subsequent ubiquitination/degradation. Using RNA interference and domain swapping experiments, we show that APCL benefits from the 15R of truncated APC to target beta-catenin for degradation, in a process likely involving heterodimerization of the two partners. Our data suggest that the functional complementation of APCL by APC constitutes a substantial facet of tumour development, because the truncating mutations of APC in colorectal tumours from familial adenomatous polyposis (FAP) patients are almost always selected for the retention of at least one 15R.	[Schneikert, Jean; Chandra, Shree Harsha Vijaya; Ruppert, Jan Gustav; Ray, Suparna; Behrens, Jurgen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Wenzel, Eva Maria] Univ Oslo, Norwegian Radium Hosp, Dept Biochem,Inst Canc Res, Oslo Univ Hosp, Oslo, Norway; [Wenzel, Eva Maria] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway	University of Erlangen Nuremberg; University of Oslo; University of Oslo	Schneikert, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany.	jschneik@molmed.uni-erlangen.de	Vijaya Chandra, Shree Harsha/GYA-5830-2022	Wenzel, Eva Maria/0000-0002-5561-3344	Sander Stiftung; Deutsche Forschungsgemeinschaft [SCHN 1189/1-2]	Sander Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the the Sander Stiftung (www.sanst.de) to JB and the Deutsche Forschungsgemeinschaft (www.dfg.de) to JS (grant no SCHN 1189/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; Chandra SHV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034479; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Day CL, 2000, J MOL BIOL, V301, P147, DOI 10.1006/jmbi.2000.3895; Faux MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014127; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Gaujoux S, 2010, CLIN CANCER RES, V16, P5133, DOI 10.1158/1078-0432.CCR-10-1497; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Groves C, 2002, AM J PATHOL, V160, P2055, DOI 10.1016/S0002-9440(10)61155-8; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Jarrett CR, 2001, CANCER RES, V61, P7978; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kohler EM, 2010, ONCOGENE, V29, P1663, DOI 10.1038/onc.2009.447; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Kunttas-Tatli E, 2012, GENETICS, V190, P1059, DOI 10.1534/genetics.111.133280; Kuraguchi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000367; Latchford A, 2007, HUM MOL GENET, V16, P78, DOI 10.1093/hmg/ddl442; Lewis A, 2010, GUT, V59, P1680, DOI 10.1136/gut.2009.193680; Li ZY, 2008, J CELL SCI, V121, P1916, DOI 10.1242/jcs.029470; Liu J, 2006, J MOL BIOL, V360, P133, DOI 10.1016/j.jmb.2006.04.064; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mattie FJ, 2010, CURR BIOL, V20, P2169, DOI 10.1016/j.cub.2010.11.050; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Nakagawa H, 1998, CANCER RES, V58, P5176; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Schneikert J, 2011, HUM MOL GENET, V20, P3554, DOI 10.1093/hmg/ddr273; Shintani T, 2012, J NEUROSCI, V32, P6468, DOI 10.1523/JNEUROSCI.0590-12.2012; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; van Es JH, 1999, CURR BIOL, V9, P105, DOI 10.1016/S0960-9822(99)80024-4; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wacker I, 2009, MOL CELL BIOL, V29, P1707, DOI 10.1128/MCB.01184-07; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Zhou MN, 2011, J CELL SCI, V124, P1589, DOI 10.1242/jcs.073916	49	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68072	10.1371/journal.pone.0068072	http://dx.doi.org/10.1371/journal.pone.0068072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840886	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900025
J	Selvam, K; Duncan, JR; Tanaka, M; Battista, JR				Selvam, Kathiresan; Duncan, Jana R.; Tanaka, Masashi; Battista, John R.			DdrA, DdrD, and PprA: Components of UV and Mitomycin C Resistance in Deinococcus radiodurans R1	PLOS ONE			English	Article							MICROCOCCUS-RADIODURANS; DNA-REPAIR; SCHIZOSACCHAROMYCES-POMBE; EXTREME RADIORESISTANCE; TARGETED MUTAGENESIS; PYRIMIDINE DIMERS; ESCHERICHIA-COLI; CROSS-LINKS; WILD-TYPE; RADIATION	Mutants created by deleting the ddrA, ddrB, ddrC, ddrD, and pprA loci of Deinococcus radiodurans R1alone and in all possible combinations of pairs revealed that the encoded gene products contribute to this species' resistance to UV light and/or mitomycin C. Deleting pprA from an otherwise wild type cell sensitizes the resulting strain to UV irradiation, reducing viability by as much as eight fold relative to R1. If this deletion is introduced into Delta ddrA or Delta ddrD background, the resulting strains become profoundly sensitive to the lethal effects of UV light. At a fluence of 1000 Jm(-2), the Delta ddrA Delta pprA and Delta ddrD Delta pprA strains are 100- and 1000-fold more sensitive to UV relative to the strain that has only lost pprA. Deletion of ddrA results in a 100 fold increase in strain sensitivity to mitomycin C, but in backgrounds that combine a deletion of ddrA with deletions of either ddrC or ddrD, mitomycin resistance is restored to wild type levels. Inactivation of ddrB also increases D. radiodurans sensitivity to mitomycin, but unlike the ddrA mutant deleting ddrC or ddrD from a Delta ddrB background further increases that sensitivity. Despite the effect that loss of these gene products has on DNA damage resistance, none appear to directly affect either excision repair or homologous recombination suggesting that they participate in novel processes that facilitate tolerance to UV light and interstrand crosslinks in this species.	[Selvam, Kathiresan; Duncan, Jana R.; Battista, John R.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Selvam, Kathiresan; Duncan, Jana R.; Battista, John R.] A&M Coll, Baton Rouge, LA USA; [Tanaka, Masashi] Natl Ctr Global Hlth & Med, Dept Mol Immunol & Inflammat, Tokyo, Japan	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; National Center for Global Health & Medicine - Japan	Battista, JR (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jbattis@lsu.edu	, Masashi/AAM-9856-2021	, Masashi/0000-0003-0719-8972	United States Department of Energy [DEFG0201ER63151]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Grant DEFG0201ER63151 from the United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTISTA JR, 2001, BERGEYS MANUAL SYSTE, V1, P395; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; BOLING ME, 1966, BIOCHIM BIOPHYS ACTA, V123, P26, DOI 10.1016/0005-2787(66)90155-9; BOWMAN KK, 1994, NUCLEIC ACIDS RES, V22, P3026, DOI 10.1093/nar/22.15.3026; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; DALY MJ, 1994, J BACTERIOL, V176, P7506, DOI 10.1128/JB.176.24.7506-7515.1994; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Earl AM, 2002, J BACTERIOL, V184, P1003, DOI 10.1128/jb.184.4.1003-1009.2002; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; GUTMAN PD, 1994, GENE, V141, P31, DOI 10.1016/0378-1119(94)90124-4; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; HANSEN MT, 1982, J BACTERIOL, V152, P976; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HOWARDFL.P, 1966, RADIAT RES, VS, P156; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; KITAYAMA S, 1983, J BACTERIOL, V155, P1200, DOI 10.1128/JB.155.3.1200-1207.1983; KITAYAMA S, 1982, BIOCHIM BIOPHYS ACTA, V697, P381, DOI 10.1016/0167-4781(82)90103-8; Kota S, 2006, APPL MICROBIOL BIOT, V72, P790, DOI 10.1007/s00253-006-0340-7; LAWLEY PD, 1968, BIOCHEM J, V109, P433, DOI 10.1042/bj1090433; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; MATTIMORE V, 1995, J BACTERIOL, V177, P5232, DOI 10.1128/jb.177.18.5232-5237.1995; Misra HS, 2006, MOL MICROBIOL, V59, P1308, DOI 10.1111/j.1365-2958.2005.05005.x; Moeller R, 2007, J BACTERIOL, V189, P3306, DOI 10.1128/JB.00018-07; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MOSELEY BEB, 1983, J GEN MICROBIOL, V129, P2437; MOSELEY BEB, 1971, J BACTERIOL, V105, P976, DOI 10.1128/JB.105.3.976-983.1971; MOSELEY BEB, 1978, MOL GEN GENET, V160, P331, DOI 10.1007/BF00332977; MOSELEY BEB, 1975, J BACTERIOL, V121, P422, DOI 10.1128/JB.121.2.422-428.1975; Moseley BEB, 1983, PHOTOCHEM PHOTOBIOL, P223; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; SWEET DM, 1974, MUTAT RES, V23, P311, DOI 10.1016/0165-1218(74)90093-7; Takao M, 1996, NUCLEIC ACIDS RES, V24, P1267, DOI 10.1093/nar/24.7.1267; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; TOMASZ M, 1986, P NATL ACAD SCI USA, V83, P6702, DOI 10.1073/pnas.83.18.6702; TOMASZ M, 1987, BIOCHEMISTRY-US, V26, P2010, DOI 10.1021/bi00381a034; VARGHESE AJ, 1970, PHOTOCHEM PHOTOBIOL, V11, P511, DOI 10.1111/j.1751-1097.1970.tb06022.x; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yuan ML, 2009, INT J SYST EVOL MICR, V59, P1513, DOI 10.1099/ijs.0.004523-0; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	42	41	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e69007	10.1371/journal.pone.0069007	http://dx.doi.org/10.1371/journal.pone.0069007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840905	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900044
J	Awadalla, MS; Thapa, SS; Hewitt, AW; Burdon, KP; Craig, JE				Awadalla, Mona S.; Thapa, Suman S.; Hewitt, Alex W.; Burdon, Kathryn P.; Craig, Jamie E.			Association of Genetic Variants with Primary Angle Closure Glaucoma in Two Different Populations	PLOS ONE			English	Article							ADHERENS JUNCTIONS; STICKLER SYNDROME; PREVALENCE; MUTATIONS; LINKAGE; COL2A1	Purpose: A recent large genome-wide association study (GWAS) identified multiple variants associated with primary angle-closure glaucoma (PACG). The present study investigated the role of these variants in two cohorts with PACG recruited from Australia and Nepal. Method: Patients with PACG and appropriate controls were recruited from eye clinics in Australia (n = 232 cases and n = 288 controls) and Nepal (n = 106 cases and 204 controls). Single nucleotide polymorphisms (SNPs) rs3753841 (COL11A1), rs1015213 (located between PCMTD1 and ST18), rs11024102 (PLEKHA7), and rs3788317 (TXNRD2) were selected and genotyped on the Sequenom. Analyses were conducted using PLINK and METAL. Results: After adjustment for age and sex, SNP rs3753841 was found to be significantly associated with PACG in the Australian cohort (p = 0.017; OR = 1.34). SNPs rs1015213 (p = 0.014; OR 2.35) and rs11024102 (p = 0.039; OR 1.43) were significantly associated with the disease development in the Nepalese cohort. None of these SNPs survived Bonferroni correction (p = 0.05/4 = 0.013). However, in the combined analysis, of both cohorts, rs3753841 and rs1015213 showed significant association with p-values of 0.009 and 0.004, respectively both surviving Bonferroni correction. SNP rs11024102 showed suggestive association with PACG (p-value 0.035) and no association was found with rs3788317. Conclusion: The present results support the initial GWAS findings, and confirm the SNP's contribution to PACG. This is the first study to investigate these loci in both Australian Caucasian and Nepalese populations.	[Awadalla, Mona S.; Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr Adelaide, Adelaide, SA, Australia; [Thapa, Suman S.] Tilganga Inst Ophthalmol, Nepal Glaucoma Eye Clin, Kathmandu, Nepal; [Hewitt, Alex W.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia	Flinders Medical Centre; Flinders University South Australia; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Awadalla, MS (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr Adelaide, Adelaide, SA, Australia.	awad0002@flinders.edu.au	Burdon, Kathryn/AAD-2334-2022; Hewitt, Alex W/D-1936-2013; Burdon, Kathryn/A-5026-2009	Burdon, Kathryn/0000-0001-8217-1249; Hewitt, Alex W/0000-0002-5123-5999; Burdon, Kathryn/0000-0001-8217-1249; Craig, Jamie/0000-0001-9955-9696	Flinders Medical Centre Foundation; National Health and Medical Research Council (NHMRC) of Australia Career Development Award	Flinders Medical Centre Foundation; National Health and Medical Research Council (NHMRC) of Australia Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a grant from the Flinders Medical Centre Foundation. KPB is funded by a National Health and Medical Research Council (NHMRC) of Australia Career Development Award and JEC is an NHMRC Practitioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; Boyles AL, 2011, EPIDEMIOLOGY, V22, P746, DOI 10.1097/EDE.0b013e318225ba48; Day AC, 2012, BRIT J OPHTHALMOL, V96, P1162, DOI 10.1136/bjophthalmol-2011-301189; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Frick KD, 2003, AM J OPHTHALMOL, V135, P471, DOI 10.1016/S0002-9394(02)02110-4; Heimark RL, 2002, CURR EYE RES, V25, P299, DOI 10.1076/ceyr.25.5.299.13495; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Khan AO, 2006, OPHTHALMOLOGY, V113, P718, DOI 10.1016/j.ophtha.2006.01.013; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Richards AJ, 2012, EUR J HUM GENET, V20, P552, DOI 10.1038/ejhg.2011.223; Richards AJ, 2010, HUM MUTAT, V31, pE1461, DOI 10.1002/humu.21257; Salmon JF, 1999, PROG RETIN EYE RES, V18, P121, DOI 10.1016/S1350-9462(98)00007-X; Souzeau E, 2012, CLIN EXP OPHTHALMOL, V40, P569, DOI 10.1111/j.1442-9071.2011.02742.x; Thapa SS, 2012, OPHTHALMOLOGY, V119, P759, DOI 10.1016/j.ophtha.2011.10.021; Thapa SS, 2011, OPTOMETRY VISION SCI, V88, P150, DOI 10.1097/OPX.0b013e318205e320; Thapa SS, 2011, CLIN EXP OPHTHALMOL, V39, P126, DOI 10.1111/j.1442-9071.2010.02429.x; Vithana E.N., 2012, NAT GENET; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yan H, 2006, MOL VIS, V12, P1153	25	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67903	10.1371/journal.pone.0067903	http://dx.doi.org/10.1371/journal.pone.0067903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840785	Green Published, gold			2022-12-27	WOS:000321148400140
J	Cheng, YQ; Xu, J; Nie, BB; Luo, CR; Yang, T; Li, HJ; Lu, J; Xu, L; Shan, BC; Xu, XF				Cheng, Yuqi; Xu, Jian; Nie, Binbin; Luo, Chunrong; Yang, Tao; Li, Haijun; Lu, Jin; Xu, Lin; Shan, Baoci; Xu, Xiufeng			Abnormal Resting-State Activities and Functional Connectivities of the Anterior and the Posterior Cortexes in Medication-Naive Patients with Obsessive-Compulsive Disorder	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CINGULATE CORTEX; PREFRONTAL CORTEX; ANXIETY DISORDER; DECISION-MAKING; FMRI; BRAIN; CONFLICT; SEROTONIN; NETWORKS	Background: Obsessive-compulsive disorder (OCD) is a mental illness characterized by the loss of control. Because the cingulate cortex is believed to be important in executive functions, such as inhibition, we used functional magnetic resonance imaging (fMRI) techniques to examine whether and how activity and functional connectivity (FC) of the cingulate cortex were altered in drug-naive OCD patients. Methods: Twenty-three medication-naive OCD patients and 23 well-matched healthy controls received fMRI scans in a resting state. Functional connectivities of the anterior cingulate (ACC) and the posterior cingulate (PCC) to the whole brain were analyzed using correlation analyses based on regions of interest (ROI) identified by the fractional amplitude of low-frequency fluctuation (fALFF). Independent Component Analysis (ICA) was used to identify the resting-state sub-networks. Results: fALFF analysis found that regional activity was increased in the ACC and decreased in the PCC in OCD patients when compared to controls. FC of the ACC and the PCC also showed different patterns. The ACC and the PCC were found to belong to different resting-state sub-networks in ICA analysis and showed abnormal FC, as well as contrasting correlations with the severity of OCD symptoms. Conclusions: Activity of the ACC and the PCC were increased and decreased, respectively, in the medication-naive OCD patients compared to controls. Different patterns in FC were also found between the ACC and the PCC with respect to these two groups. These findings implied that the cardinal feature of OCD, the loss of control, may be attributed to abnormal activities and FC of the ACC and the PCC.	[Cheng, Yuqi; Yang, Tao; Lu, Jin; Xu, Xiufeng] Kunming Med Univ, Affiliated Hosp 1, Dept Psychiat, Kunming, Yunnan, Peoples R China; [Xu, Jian] Kunming Med Univ, Affiliated Hosp 1, Dept Internal Med, Kunming, Yunnan, Peoples R China; [Nie, Binbin; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal Tech, Beijing, Peoples R China; [Cheng, Yuqi; Xu, Lin] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Cheng, Yuqi; Xu, Lin] Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Luo, Chunrong; Li, Haijun] First Hosp Kunming City, Magnet Resonance Imaging Ctr, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology	Shan, BC (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal Tech, Beijing, Peoples R China.	shanbc@ihep.ac.cn; xfxu2004@sina.com		Nie, Binbin/0000-0002-8038-7772; Xu, Lin/0000-0002-2710-3507; Shan, Baoci/0000-0001-7417-5063	National Natural Science Foundation of China (NSFC) [81101005, 81160379, 81160171]; Ministry of Science and Technology of China [2009CB941302, 2009ZX09501-03, 2009CB522006]; Ministry of Science and Technology of Yunnan Province [2012FB158]; Funding of Yunnan Provincial Health Science and Technology Plan [2010NS016, 2011WS008]; NSFC-Yunnan Joint Foundation [U1032605]; Yunnan Administration of Science & Technology and Kunming Medical College [2011FB167]; State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Science and Technology of Yunnan Province; Funding of Yunnan Provincial Health Science and Technology Plan; NSFC-Yunnan Joint Foundation; Yunnan Administration of Science & Technology and Kunming Medical College; State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University	This work is supported by grants from National Natural Science Foundation of China (NSFC) (81101005, 81160379, and 81160171), the Ministry of Science and Technology of China (2009CB941302, 2009ZX09501-03, and 2009CB522006), the Ministry of Science and Technology of Yunnan Province (2012FB158), the Funding of Yunnan Provincial Health Science and Technology Plan (2010NS016, 2011WS008), the NSFC-Yunnan Joint Foundation (U1032605), the united founding of Yunnan Administration of Science & Technology and Kunming Medical College(2011FB167), and the Funding from State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Barbey AK, 2009, PHILOS T R SOC B, V364, P1291, DOI 10.1098/rstb.2008.0315; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Cavedini P, 2006, NEUROPSYCHOL REV, V16, P3, DOI 10.1007/s11065-006-9001-y; First M.B., 2014, STRUCTURED CLIN INTE; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Fontenelle LF, 2012, J PSYCHIATR NEUROSCI, V37, P231, DOI 10.1503/jpn.110074; Gilbert AR, 2008, J AFFECT DISORDERS, V109, P117, DOI 10.1016/j.jad.2007.12.223; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hasselbalch SG, 2007, ACTA PSYCHIAT SCAND, V115, P388, DOI 10.1111/j.1600-0447.2006.00940.x; Hesse S, 2005, PSYCHIAT RES-NEUROIM, V140, P63, DOI 10.1016/j.pscychresns.2005.07.002; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Maltby N, 2005, NEUROIMAGE, V24, P495, DOI 10.1016/j.neuroimage.2004.08.041; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; Modell J G, 1989, J Neuropsychiatry Clin Neurosci, V1, P27; Morein-Zamir S, 2010, PSYCHOL MED, V40, P263, DOI 10.1017/S003329170999033X; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; PERANI D, 1995, BRIT J PSYCHIAT, V166, P244, DOI 10.1192/bjp.166.2.244; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Saxena S, 2004, AM J PSYCHIAT, V161, P1038, DOI 10.1176/appi.ajp.161.6.1038; Schlosser RGM, 2010, HUM BRAIN MAPP, V31, P1834, DOI 10.1002/hbm.20980; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stein DJ, 2010, DEPRESS ANXIETY, V27, P495, DOI 10.1002/da.20699; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P301, DOI 10.1001/archpsyc.62.3.301; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; van Veen V, 2006, CURR DIR PSYCHOL SCI, V15, P237, DOI 10.1111/j.1467-8721.2006.00443.x; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; VOGT BA, 1979, SCIENCE, V204, P205, DOI 10.1126/science.107587; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Yucel M, 2007, ARCH GEN PSYCHIAT, V64, P946, DOI 10.1001/archpsyc.64.8.946	43	43	46	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67478	10.1371/journal.pone.0067478	http://dx.doi.org/10.1371/journal.pone.0067478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840714	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400089
J	Courtin, A; Richards, FM; Bapiro, TE; Bramhall, JL; Neesse, A; Cook, N; Krippendorff, BF; Tuveson, DA; Jodrell, DI				Courtin, Aurelie; Richards, Frances M.; Bapiro, Tashinga E.; Bramhall, Jo L.; Neesse, Albrecht; Cook, Natalie; Krippendorff, Ben-Fillippo; Tuveson, David A.; Jodrell, Duncan I.			Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer	PLOS ONE			English	Article							ORAL FLUOROPYRIMIDINE CARBAMATE; GEMCITABINE PLUS CAPECITABINE; CYTIDINE DEAMINASE; NUCLEOSIDE TRANSPORTER; CELLULAR PHARMACOLOGY; RANDOMIZED-TRIAL; IN-VITRO; CHEMOTHERAPY; CELLS; XENOGRAFTS	Capecitabine (CAP) is a 5-FU pro-drug approved for the treatment of several cancers and it is used in combination with gemcitabine (GEM) in the treatment of patients with pancreatic adenocarcinoma (PDAC). However, limited pre-clinical data of the effects of CAP in PDAC are available to support the use of the GEMCAP combination in clinic. Therefore, we investigated the pharmacokinetics and the efficacy of CAP as a single agent first and then in combination with GEM to assess the utility of the GEMCAP therapy in clinic. Using a model of spontaneous PDAC occurring in Kras(G12D); p53(R172H); Pdx1-Cre (KPC) mice and subcutaneous allografts of a KPC PDAC-derived cell line (K8484), we showed that CAP achieved tumour concentrations (similar to 25 mu M) of 5-FU in both models, as a single agent, and induced survival similar to GEM in KPC mice, suggesting similar efficacy. In vitro studies performed in K8484 cells as well as in human pancreatic cell lines showed an additive effect of the GEMCAP combination however, it increased toxicity in vivo and no benefit of a tolerable GEMCAP combination was identified in the allograft model when compared to GEM alone. Our work provides pre-clinical evidence of 5-FU delivery to tumours and anti-tumour efficacy following oral CAP administration that was similar to effects of GEM. Nevertheless, the GEMCAP combination does not improve the therapeutic index compared to GEM alone. These data suggest that CAP could be considered as an alternative to GEM in future, rationally designed, combination treatment strategies for advanced pancreatic cancer.	[Courtin, Aurelie; Richards, Frances M.; Bapiro, Tashinga E.; Bramhall, Jo L.; Krippendorff, Ben-Fillippo; Jodrell, Duncan I.] Canc Res UK Cambridge Res Inst, Pharmacol & Drug Dev Grp, Cambridge, England; [Neesse, Albrecht; Cook, Natalie; Tuveson, David A.] Canc Res UK Cambridge Res Inst, Tumour Modelling & Expt Med Grp, Cambridge, England; [Courtin, Aurelie; Richards, Frances M.; Bapiro, Tashinga E.; Bramhall, Jo L.; Neesse, Albrecht; Cook, Natalie; Krippendorff, Ben-Fillippo; Tuveson, David A.; Jodrell, Duncan I.] Univ Cambridge, Dept Oncol, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Richards, FM (corresponding author), Canc Res UK Cambridge Res Inst, Pharmacol & Drug Dev Grp, Cambridge, England.	fran.richards@cruk.cam.ac.uk	Cook, Natalie/O-4871-2015	Cook, Natalie/0000-0003-2606-1082; Bramhall, Jo/0000-0002-0996-1583	Cancer Research UK [C96/A8333]; CRUK Cambridge Institute Group Leader funding; University of Cambridge; Li Ka Shing Foundation; Hutchison-Whampoa Ltd.; NIHR Cambridge Biomedical Research Centre; Cancer Research UK [15678] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); CRUK Cambridge Institute Group Leader funding; University of Cambridge(University of Cambridge); Li Ka Shing Foundation; Hutchison-Whampoa Ltd.; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK (www.cancerresearchuk.org) via Programme Grant C96/A8333 to DJ and via CRUK Cambridge Institute Group Leader funding to DJ and DT. This work was also supported by The University of Cambridge, the Li Ka Shing Foundation and by a charitable donation to the University of Cambridge from Hutchison-Whampoa Ltd. The work was also supported by funding from the NIHR Cambridge Biomedical Research Centre (www.nihr.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Aresvik DM, 2010, ANTICANCER RES, V30, P3879; Blanquicett C, 2005, CLIN CANCER RES, V11, P8773, DOI 10.1158/1078-0432.CCR-05-0627; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cartwright TH, 2002, J CLIN ONCOL, V20, P160, DOI 10.1200/JCO.20.1.160; Ciccolini J, 2010, J CLIN ONCOL, V28, P160, DOI 10.1200/JCO.2009.24.4491; Cook N, 2008, METHOD ENZYMOL, V439, P73, DOI 10.1016/S0076-6879(07)00406-5; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Frese KK, 2012, CANCER DISCOV, V2, P260, DOI 10.1158/2159-8290.CD-11-0242; Guichard SM, 2005, J CHROMATOGR B, V826, P232, DOI 10.1016/j.jchromb.2005.09.010; Guichard SM, 2008, EUR J CANCER, V44, P310, DOI 10.1016/j.ejca.2007.10.023; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Herrmann R, 2007, J CLIN ONCOL, V25, P2212, DOI 10.1200/JCO.2006.09.0886; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hubner RA, 2013, PANCREAS, V42, P511, DOI 10.1097/MPA.0b013e31826c6aee; Hwang IT, 2007, BIOCHEM BIOPH RES CO, V359, P304, DOI 10.1016/j.bbrc.2007.05.088; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Ishikawa T, 1998, BIOCHEM PHARMACOL, V55, P1091, DOI 10.1016/S0006-2952(97)00682-5; Ishitsuka H, 2000, INVEST NEW DRUG, V18, P343, DOI 10.1023/A:1006497231579; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Lin Y, 2012, BRIT J CANCER, V107, P1692, DOI 10.1038/bjc.2012.450; Mackey JR, 1998, CANCER RES, V58, P4349; Mercier C, 2009, CANCER CHEMOTH PHARM, V63, P1177, DOI 10.1007/s00280-008-0889-1; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Miwa M, 1998, EUR J CANCER, V34, P1274, DOI 10.1016/S0959-8049(98)00058-6; Morita T, 2003, ONCOLOGY-BASEL, V65, P267, DOI 10.1159/000074480; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Ninomiya I, 2004, INT J CANCER, V112, P135, DOI 10.1002/ijc.20360; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; PRESSACCO J, 1995, BRIT J CANCER, V72, P939, DOI 10.1038/bjc.1995.437; PRESSACCO J, 1995, CANCER RES, V55, P1505; Quinney SK, 2005, J PHARMACOL EXP THER, V313, P1011, DOI 10.1124/jpet.104.081265; Rauchwerger DR, 2000, CANCER RES, V60, P6075; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reigner B, 2001, CLIN PHARMACOKINET, V40, P85, DOI 10.2165/00003088-200140020-00002; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Shindoh H, 2011, J TOXICOL SCI, V36, P411, DOI 10.2131/jts.36.411; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yoshida T, 2010, DRUG METAB DISPOS, V38, P1814, DOI 10.1124/dmd.110.034397	43	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67330	10.1371/journal.pone.0067330	http://dx.doi.org/10.1371/journal.pone.0067330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840665	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400058
J	Dieye, TN; NDiaye, BP; Dieng, AB; Fall, M; Britain, N; Vermaak, S; Camara, M; Diop-Ndiaye, H; Ngom-Gueye, NF; Diaw, PA; Toure-Kane, C; Sow, PS; Mboup, S; McShane, H				Dieye, Tandakha N.; NDiaye, Birahim P.; Dieng, Alle B.; Fall, Marema; Britain, Nathaniel; Vermaak, Samantha; Camara, Makhtar; Diop-Ndiaye, Halimatou; Ngom-Gueye, Ndeye Fatou; Diaw, Papa A.; Toure-Kane, Coumba; Sow, Papa S.; Mboup, Souleymane; McShane, Helen			Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naive Subjects Gives Comparable Immunogenicity to One Dose in ART plus Subjects	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE RECONSTITUTION; PROTECTIVE EFFICACY; ENHANCED IMMUNOGENICITY; BCG VACCINATION; CELLS; BURDEN; MEMORY; RISK	Tuberculosis (TB) is a global public health problem exacerbated by the HIV epidemic. Here we evaluate a candidate TB vaccine, MVA85A, in a Phase I study in HIV-infected adults in Senegal. 24 patients were enrolled: Group 1:12, antiretroviral therapy (ART) naive, adults, with CD4 counts > 300 and HIV RNA load,100 000 copies/ml. Group 2: 12 adults, stable on ART, with CD4 counts > 300, and an undetectable HIV RNA load. Safety was evaluated by occurrence of local and systemic adverse events (AEs) and by monitoring of CD4 count, HIV RNA load, haematology and biochemistry. Immunogenicity was evaluated by ex-vivo interferon-gamma ELISpot assay. 87.7% of AEs were mild; 11.6% were moderate; and 0.7% were severe. 29.2% of AEs were systemic; 70.8% were expected local AEs. There were no vaccine-related Serious Adverse Events (SAEs) or clinically significant effects on HIV RNA load or CD4 count. In ART naive subjects, the first MVA85A immunisation induced a significant immune response at 1 and 4 weeks post-immunisation, which contracted to baseline by 12 weeks. Durability of immunogenicity in subjects on ART persisted out to 24 weeks post-vaccination. A second dose of MVA85A at 12 months enhanced immunogenicity in ART naive subjects. Subjects on ART had higher responses after the first vaccination compared with ART naive subjects; responses were comparable after 2 immunisations. In conclusion, MVA85A is well-tolerated and immunogenic in HIV-infected subjects in Senegal. A two dose regimen in ART naive subjects is comparable in immunogenicity to a single dose in subjects on ART.	[Dieye, Tandakha N.; NDiaye, Birahim P.; Fall, Marema; Camara, Makhtar; Diop-Ndiaye, Halimatou; Diaw, Papa A.; Toure-Kane, Coumba; Mboup, Souleymane] Ctr Hosp Univ Le Dantec, Lab Bacteriol Virol, Dakar, Senegal; [Dieng, Alle B.; Sow, Papa S.] Ctr Hosp Univ Fann, Ctr Rech Clin, Dakar, Senegal; [Britain, Nathaniel; Vermaak, Samantha; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England; [Ngom-Gueye, Ndeye Fatou] Ctr Hosp Univ Fann, Ctr Traitement Ambulatoire, Dakar, Senegal	University of Oxford; Jenner Institute	McShane, H (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	helen.mcshane@ndm.ox.ac.uk		Vermaak, Samantha/0000-0003-4791-8364; McShane, Helen/0000-0002-2126-5142; DIOP-NDIAYE, Halimatou/0000-0001-5885-5448	EuropeAID [SANTE/2006/105-066]; Wellcome Trust [076943/Z/05/Z]	EuropeAID; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by EuropeAID (SANTE/2006/105-066; http://ec.europa.eu/europeaid/index_en.htm), and Wellcome Trust (076943/Z/05/Z to HM; www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOBAL TUBERCULOSIS; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bekker LG, 2010, CLIN INFECT DIS, V50, pS208, DOI 10.1086/651493; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Breen RAM, 2005, AIDS, V19, P1201, DOI 10.1097/01.aids.0000176221.33237.67; Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cowley SC, 2003, J IMMUNOL, V171, P4689, DOI 10.4049/jimmunol.171.9.4689; de Colombani P, 2004, EUR RESPIR J, V24, P493, DOI 10.1183/09031936.04.00064504; Douek DC, 2002, CYTOTHERAPY, V4, P425, DOI 10.1080/146532402320776035; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2013, LANCET; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Hesseling AC, 2009, SAMJ S AFR MED J, V99, P88; Ibango HB, 2006, LANCET INFECT DIS, V6, P522, DOI 10.1016/S1473-3099(06)70552-7; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223; Notermans DW, 1999, J INFECT DIS, V180, P1050, DOI 10.1086/315013; Ota MOC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002461; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Plana M, 2011, IMMUNOLOGY, V133, P318, DOI 10.1111/j.1365-2567.2011.03442.x; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Schacker TW, 2010, JAIDS-J ACQ IMM DEF, V54, P59, DOI 10.1097/QAI.0b013e3181c96520; Scriba TJ, 2012, AM J RESP CRIT CARE, V185, P769, DOI 10.1164/rccm.201108-1548OC; Sereti I, 2004, BLOOD, V104, P775, DOI 10.1182/blood-2003-12-4355; SHEARER GM, 1991, AIDS, V5, P245, DOI 10.1097/00002030-199103000-00001; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Tameris MD, 2013, LANCET; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Wallis RS, 2003, J INFECT DIS, V187, P270, DOI 10.1086/346053; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832	41	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67177	10.1371/journal.pone.0067177	http://dx.doi.org/10.1371/journal.pone.0067177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840618	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400041
J	Gontikaki, E; Thornton, B; Huvenne, VAI; Witte, U				Gontikaki, Evangelia; Thornton, Barry; Huvenne, Veerle A. I.; Witte, Ursula			Negative Priming Effect on Organic Matter Mineralisation in NE Atlantic Slope Sediments	PLOS ONE			English	Article							IN-SITU EXPERIMENTS; MARINE-SEDIMENTS; MICROBIAL UTILIZATION; BENTHIC RESPONSE; SEA-FLOOR; CARBON; SOIL; PRESERVATION; MECHANISMS; COMMUNITY	The priming effect (PE) is a complex phenomenon which describes a modification (acceleration or retardation) in the mineralisation rate of refractory organic matter (OM) following inputs of labile material. PEs are well-studied in terrestrial ecosystems owing to their potential importance in the evolution of soil carbon stocks but have been largely ignored in aquatic systems despite the fact that the prerequisite for their occurrence, i.e. the co-existence of labile and refractory OM, is also true for sediments. We conducted stable isotope tracer experiments in continental margin sediments from the NE Atlantic (550-950 m) to study PE occurrence and intensity in relation to labile OM input. Sediment slurries were treated with increasing quantities of the C-13-labelled diatom Thalassiosira rotula and PE was quantified after 7, 14 and 21 days. There was a stepwise effect of diatom quantity on its mineralisation although mineralisation efficiency dropped with increasing substrate amounts. The addition of diatomaceous OM yielded a negative PE (i.e. retardation of existing sediment OM mineralisation) at the end of the experiment regardless of diatom quantity. Negative PE is often the result of preferential utilisation of the newly deposited labile material by the microbial community ("preferential substrate utilization'', PSU) which is usually observed at excessive substrate additions. The fact that PSU and the associated negative PE occurred even at low substrate levels in this study could be attributed to limited amounts of OM subject to priming in our study area (similar to 0.2% organic carbon [OC]) which seems to be an exception among continental slopes (typically >0.5% OC). We postulate that PEs will normally be positive in continental slope sediments and that their intensity will be a direct function of sediment OC content. More experiments with varying supply of substrate targeting C-poor vs. C-rich sediments are needed to confirm these hypotheses.	[Gontikaki, Evangelia; Witte, Ursula] Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Aberdeen, Scotland; [Thornton, Barry] James Hutton Inst, Aberdeen, Scotland; [Huvenne, Veerle A. I.] Natl Oceanog Ctr, Southampton, Hants, England	University of Aberdeen; James Hutton Institute; NERC National Oceanography Centre	Gontikaki, E (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Aberdeen, Scotland.	e.gontikaki@abdn.ac.uk	Gontikaki, Evina/C-5559-2017	Gontikaki, Evina/0000-0003-1838-210X; Huvenne, Veerle A.I./0000-0001-7135-6360	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland [HR09011]; European Community [226354]; Natural Environment Research Council (NERC); European Research Council (ERC) [258482]; Joint Nature Conservation Committee (JNCC); Lenfest Ocean Programme (PEW Foundation); Rural and Environment Science and Analytical Services of the Scottish Government; NERC [noc010011] Funding Source: UKRI; Natural Environment Research Council [noc010011] Funding Source: researchfish	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland; European Community(European Commission); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Joint Nature Conservation Committee (JNCC); Lenfest Ocean Programme (PEW Foundation); Rural and Environment Science and Analytical Services of the Scottish Government; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, grant reference HR09011) and the European Community's Seventh Framework Programme (FP7/2007-2013) under the HERMIONE project, grant agreement nu 226354. Cruise JC060 was also funded by the Natural Environment Research Council (NERC, MAREMAP programme), the European Research Council (ERC, CODEMAP project, Starting Grant No 258482), the Joint Nature Conservation Committee (JNCC, http://jncc.defra.gov.uk/), and the Lenfest Ocean Programme (PEW Foundation, http://www.lenfestocean.org/). BT received funding from the Rural and Environment Science and Analytical Services of the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, PRODUCTIVITY ACCUMUL; Aspetsberger F, 2007, MAR BIOL RES, V3, P342, DOI 10.1080/17451000701632885; Beaulieu SE, 2002, OCEANOGR MAR BIOL, V40, P171; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Blagodatskaya EV, 2007, APPL SOIL ECOL, V37, P95, DOI 10.1016/j.apsoil.2007.05.002; BREMER E, 1994, SOIL BIOL BIOCHEM, V26, P511, DOI 10.1016/0038-0717(94)90184-8; Buhring SI, 2006, LIMNOL OCEANOGR, V51, P157; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; CANFIELD DE, 1994, CHEM GEOL, V114, P315, DOI 10.1016/0009-2541(94)90061-2; Canuel EA, 1996, GEOCHIM COSMOCHIM AC, V60, P1793, DOI 10.1016/0016-7037(96)00045-2; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Farjalla VF, 2009, MICROB ECOL, V57, P657, DOI 10.1007/s00248-008-9466-8; Fontaine S, 2005, ECOL LETT, V8, P1075, DOI 10.1111/j.1461-0248.2005.00813.x; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gontikaki E, 2012, GEOMICROBIOL J, V29, P648, DOI 10.1080/01490451.2011.605822; Gontikaki E, 2011, MAR ECOL PROG SER, V421, P39, DOI 10.3354/meps08892; Grutters M, 2002, LIMNOL OCEANOGR, V47, P1521, DOI 10.4319/lo.2002.47.5.1521; Guenet B, 2010, EUR J SOIL SCI, V61, P384, DOI 10.1111/j.1365-2389.2010.01234.x; Guenet B, 2010, APPL SOIL ECOL, V46, P436, DOI 10.1016/j.apsoil.2010.09.006; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; HANSEN LS, 1992, MAR BIOL, V112, P147, DOI 10.1007/BF00349738; HARVEY HR, 1995, GEOCHIM COSMOCHIM AC, V59, P3367; Hee CA, 2001, LIMNOL OCEANOGR, V46, P1908, DOI 10.4319/lo.2001.46.8.1908; Heip CHR, 2001, DEEP-SEA RES PT II, V48, P3223, DOI 10.1016/S0967-0645(01)00038-8; Inthorn M, 2006, GEOLOGY, V34, P205, DOI 10.1130/G22153.1; IOC IHO and BODC, 2003, CENT ED GEBCO DIG AT; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Joos O, 2008, RAPID COMMUN MASS SP, V22, P4029, DOI 10.1002/rcm.3827; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P747, DOI 10.1016/j.soilbio.2005.06.025; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lopez-Urrutia A, 2007, ECOLOGY, V88, P817, DOI 10.1890/06-1641; Luna GM, 2002, APPL ENVIRON MICROB, V68, P3509, DOI 10.1128/AEM.68.7.3509-3513.2002; Masson DG, 2003, MAR GEOL, V194, P159, DOI 10.1016/S0025-3227(02)00704-1; Mayor DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038582; Mayor DJ, 2012, ISME J, V6, P1740, DOI 10.1038/ismej.2012.14; Middelburg JJ, 1997, DEEP-SEA RES PT I, V44, P327, DOI 10.1016/S0967-0637(96)00101-X; Moodley L, 2002, MAR ECOL PROG SER, V236, P23, DOI 10.3354/meps236023; Mook W.G., 2000, ENV ISOTOPES HYDROLO, VI; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Pinheiro J, 2001, MIXED EFFECTS MODELS; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2012, R LANG ENV STAT COMP; Sarkar D., 2019, NLME LINEAR NONLINEA; Sathyendranath S, 1995, DEEP-SEA RES PT I, V42, P1773, DOI 10.1016/0967-0637(95)00059-F; Schluter M, 2000, GLOBAL BIOGEOCHEM CY, V14, P329, DOI 10.1029/1999GB900043; Schneckenberger K, 2008, SOIL BIOL BIOCHEM, V40, P1981, DOI 10.1016/j.soilbio.2008.02.020; Turnewitsch R, 2007, J SEA RES, V57, P270, DOI 10.1016/j.seares.2006.08.001; van Nugteren P, 2009, MAR BIOL, V156, P2277, DOI 10.1007/s00227-009-1255-5; Veuger B, 2006, LIMNOL OCEANOGR, V51, P1572, DOI 10.4319/lo.2006.51.4.1572; Wakeham SG, 2006, HANDB ENVIRON CHEM, V2, P295, DOI 10.1007/698_2_009; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799; Zuur Alain F., 2009, P1	57	40	40	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67722	10.1371/journal.pone.0067722	http://dx.doi.org/10.1371/journal.pone.0067722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840766	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321148400128
J	Janaka, SK; Faurot, J; Johnson, MC				Janaka, Sanath Kumar; Faurot, Jared; Johnson, Marc C.			Functional Complementation of a Model Target to Study Vpu Sensitivity	PLOS ONE			English	Article							LEUKEMIA-VIRUS ENVELOPE; CYTOPLASMIC DOMAIN; PROTEIN; SEQUENCES; ENV; GLYCOPROTEINS; FUSION; VECTOR; TYPE-1; HIV-1	HIV-1 forms infectious particles with Murine Leukemia virus (MLV) Env, but not with the closely related Gibbon ape Leukemia Virus (GaLV) Env. We have determined that the incompatibility between HIV-1 and GaLV Env is primarily caused by the HIV-1 accessory protein Vpu, which prevents GaLV Env from being incorporated into particles. We have characterized the 'Vpu sensitivity sequence' in the cytoplasmic tail domain (CTD) of GaLV Env using a chimeric MLV Env with the GaLV Env CTD (MLV/GaLV Env). Vpu sensitivity is dependent on an alpha helix with a positively charged face containing at least one Lysine. In the present study, we utilized functional complementation to address whether all the three helices in the CTD of an Env trimer have to contain the Vpu sensitivity motif for the trimer to be modulated by Vpu. Taking advantage of the functional complementation of the binding defective (D84K) and fusion defective (L493V) MLV and MLV/GaLV Env mutants, we were able to assay the activity of mixed trimers containing both MLV and GaLV CTDs. Mixed trimers containing both MLV and GaLV CTDs were functionally active and remained sensitive to Vpu. However, trimers containing an Env with the GaLV CTD and an Env with no CTD remained functional but were resistant to Vpu. Together these data suggest that the presence of at least one GaLV CTD is sufficient to make an Env trimer sensitive to Vpu, but only if it is part of a trimeric CTD complex.	[Janaka, Sanath Kumar; Faurot, Jared; Johnson, Marc C.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Johnson, MC (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA.	marcjohnson@missouri.edu	Janaka, Sanath Kumar/AAE-8500-2021	Janaka, Sanath Kumar/0000-0003-2341-1526	U.S. Public Health Service [R21 AI087448, R01 AI73098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073098, R21AI087448] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by U.S. Public Health Service grants R21 AI087448 and R01 AI73098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AL, 2001, P NATL ACAD SCI USA, V98, P4113, DOI 10.1073/pnas.071432398; BATTINI JL, 1995, J VIROL, V69, P713, DOI 10.1128/JVI.69.2.713-719.1995; BATTINI JL, 1992, J VIROL, V66, P1468, DOI 10.1128/JVI.66.3.1468-1475.1992; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Center RJ, 1997, J VIROL, V71, P5706, DOI 10.1128/JVI.71.7.5706-5711.1997; CHAMBERS P, 1990, J GEN VIROL, V71, P3075, DOI 10.1099/0022-1317-71-12-3075; Christodoulopoulos I, 2001, J VIROL, V75, P4129, DOI 10.1128/JVI.75.9.4129-4138.2001; Christodoulopoulos I, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-4; Epand RF, 2008, EXP MOL PATHOL, V84, P9, DOI 10.1016/j.yexmp.2007.11.003; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; FREED EO, 1987, J VIROL, V61, P2852, DOI 10.1128/JVI.61.9.2852-2856.1987; HEARD JM, 1991, J VIROL, V65, P4026, DOI 10.1128/JVI.65.8.4026-4032.1991; Janaka SK, 2011, J VIROL, V85, P11945, DOI 10.1128/JVI.05171-11; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Loving R, 2012, P NATL ACAD SCI USA, V109, P7735, DOI 10.1073/pnas.1118125109; Lucas TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051741; Lucas TM, 2010, VIROLOGY, V405, P548, DOI 10.1016/j.virol.2010.06.017; Lucas TM, 2010, J VIROL, V84, P2666, DOI 10.1128/JVI.01562-09; MacKrell AJ, 1996, J VIROL, V70, P1768, DOI 10.1128/JVI.70.3.1768-1774.1996; NG VL, 1982, J GEN VIROL, V59, P329, DOI 10.1099/0022-1317-59-2-329; OTT D, 1990, J VIROL, V64, P757, DOI 10.1128/JVI.64.2.757-766.1990; SHAPIRO SZ, 1976, J MOL BIOL, V107, P459, DOI 10.1016/S0022-2836(76)80078-2; Stitz J, 2006, J GEN VIROL, V87, P1577, DOI 10.1099/vir.0.81231-0; Taylor GM, 2003, VIROLOGY, V312, P295, DOI 10.1016/S0042-6822(03)00297-6; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; Zhao Y, 1997, J VIROL, V71, P6967, DOI 10.1128/JVI.71.9.6967-6972.1997; Zhao Y, 1998, J VIROL, V72, P5392, DOI 10.1128/JVI.72.7.5392-5398.1998	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68507	10.1371/journal.pone.0068507	http://dx.doi.org/10.1371/journal.pone.0068507			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840857	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400197
J	Stamm, C; Barthelmann, J; Kunz, N; Toellner, KM; Westermann, J; Kalies, K				Stamm, Claudia; Barthelmann, Julia; Kunz, Natalia; Toellner, Kai-Michael; Westermann, Juergen; Kalies, Kathrin			Dose-Dependent Induction of Murine Th1/Th2 Responses to Sheep Red Blood Cells Occurs in Two Steps: Antigen Presentation during Second Encounter Is Decisive	PLOS ONE			English	Article							DELAYED-TYPE HYPERSENSITIVITY; HELPER T-CELLS; B-CELLS; IMMUNE-RESPONSES; MESSENGER-RNA; MARGINAL ZONE; MICE; TH2; RECRUITMENT; SPLEEN	The differentiation of CD4 T cells into Th1 and Th2 cells in vivo is difficult to analyze since it is influenced by many factors such as genetic background of the mice, nature of antigen, and adjuvant. In this study, we used a well-established model, which allows inducing Th1 or Th2 cells simply by low (LD, 10(5)) or high dose (HD, 10(9)) injection of sheep red blood cells (SRBC) into C57BL/6 mice. Signature cytokine mRNA expression was determined in specific splenic compartments after isolation by laser-microdissection. LD immunization with SRBC induced T cell proliferation in the splenic T cell zone but no Th1 differentiation. A second administration of SRBC into the skin rapidly generated Th1 cells. In contrast, HD immunization with SRBC induced both T cell proliferation and immediate Th2 differentiation. In addition, splenic marginal zone and B cell zone were activated indicating B cells as antigen presenting cells. Interestingly, disruption of the splenic architecture, in particular of the marginal zone, abolished Th2 differentiation and led to the generation of Th1 cells, confirming that antigen presentation by B cells directs Th2 polarization. Only in its absence Th1 cells develop. Therefore, B cells might be promising targets in order to therapeutically modulate the T cell response.	[Stamm, Claudia; Barthelmann, Julia; Kunz, Natalia; Westermann, Juergen; Kalies, Kathrin] Med Univ Lubeck, Inst Anat, Ctr Struct & Cell Biol Med, D-23538 Lubeck, Germany; [Toellner, Kai-Michael] Univ Birmingham, Sch Med, MRC Ctr Immune Regulat, Div Immun & Infect, Birmingham, W Midlands, England	University of Lubeck; University of Birmingham	Kalies, K (corresponding author), Med Univ Lubeck, Inst Anat, Ctr Struct & Cell Biol Med, D-23538 Lubeck, Germany.	kalies@anat.uni-luebeck.de	Kalies, Kathrin/A-8114-2014; Toellner, Kai-Michael/F-1519-2011	Toellner, Kai-Michael/0000-0001-8404-645X; Kalies, Kathrin/0000-0002-8929-4249	Deutsche Forschungsgemeinschaft [SFB 654, C4]; Excellence Cluster "Inflammation at Interfaces'' [DFG EXC 306/1]; MRC [G1001390] Funding Source: UKRI; Medical Research Council [G1001390] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster "Inflammation at Interfaces''; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 654, C4) and the Excellence Cluster "Inflammation at Interfaces'' (DFG EXC 306/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon TI, 2012, NATURE; Barthelmann J, 2012, MED MICROBIOL IMMUN, V201, P25, DOI 10.1007/s00430-011-0201-6; Blander JM, 2000, J EXP MED, V191, P2065, DOI 10.1084/jem.191.12.2065; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Corse E, 2011, J IMMUNOL, V186, P5039, DOI 10.4049/jimmunol.1003650; Ghani S, 2009, IMMUNOLOGY, V128, pe870, DOI 10.1111/j.1365-2567.2009.03096.x; Gorham JD, 1997, J MOL MED, V75, P502, DOI 10.1007/s001090050135; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; HURTREL B, 1992, CELL IMMUNOL, V142, P252, DOI 10.1016/0008-8749(92)90287-Y; IGNATIUS R, 1994, CELL IMMUNOL, V156, P262, DOI 10.1006/cimm.1994.1171; Iniesta V, 2008, PARASITOL RES, V102, P887, DOI 10.1007/s00436-007-0844-9; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kalies K, 2006, J IMMUNOL, V176, P741, DOI 10.4049/jimmunol.176.2.741; Kalies K, 2008, J IMMUNOL, V180, P5457, DOI 10.4049/jimmunol.180.8.5457; KAUFMANN SHE, 1979, IMMUNOLOGY, V38, P613; KRAAL G, 1986, IMMUNOLOGY, V58, P665; LAGRANGE PH, 1975, J EXP MED, V141, P82, DOI 10.1084/jem.141.1.82; LAGRANGE PH, 1974, J EXP MED, V139, P528, DOI 10.1084/jem.139.3.528; Liu G, 2010, CLIN EXP IMMUNOL, V160, P168, DOI 10.1111/j.1365-2249.2010.04091.x; Malherbe L, 2008, IMMUNITY, V28, P698, DOI 10.1016/j.immuni.2008.03.014; MARCHAL G, 1982, J IMMUNOL, V129, P954; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Milicevic NM, 2011, J IMMUNOL, V186, P1486, DOI 10.4049/jimmunol.1000740; MILON G, 1983, J IMMUNOL, V130, P1103; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Molesworth-Kenyon S, 2005, VIROLOGY, V333, P1, DOI 10.1016/j.virol.2005.01.005; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Ronet C, 2008, J IMMUNOL, V180, P4825, DOI 10.4049/jimmunol.180.7.4825; Rutemark C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041968; SACKS DL, 1984, J IMMUNOL, V132, P2072; STEVEN WM, 1980, ANAT RECORD, V198, P503, DOI 10.1002/ar.1091980311; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; VANDENEERTWEGH AJM, 1992, CRIT REV IMMUNOL, V11, P337; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	37	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67746	10.1371/journal.pone.0067746	http://dx.doi.org/10.1371/journal.pone.0067746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840769	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400130
J	Valour, F; Trouillet-Assant, S; Rasigade, JP; Lustig, S; Chanard, E; Meugnier, H; Tigaud, S; Vandenesch, F; Etienne, J; Ferry, T; Laurent, F				Valour, Florent; Trouillet-Assant, Sophie; Rasigade, Jean-Philippe; Lustig, Sebastien; Chanard, Emmanuel; Meugnier, Helene; Tigaud, Sylvestre; Vandenesch, Francois; Etienne, Jerome; Ferry, Tristan; Laurent, Frederic		Lyon BJI Study Grp	Staphylococcus epidermidis in Orthopedic Device Infections: The Role of Bacterial Internalization in Human Osteoblasts and Biofilm Formation	PLOS ONE			English	Article							FLOW-CYTOMETRY; INVASION; CELLS; QUANTIFICATION; STRAINS; OSTEOMYELITIS; MECHANISM; VIRULENCE; INSERTION; IS256	Background: Staphylococcus epidermidis orthopedic device infections are caused by direct inoculation of commensal flora during surgery and remain rare, although S. epidermidis carriage is likely universal. We wondered whether S. epidermidis orthopedic device infection strains might constitute a sub-population of commensal isolates with specific virulence ability. Biofilm formation and invasion of osteoblasts by S. aureus contribute to bone and joint infection recurrence by protecting bacteria from the host-immune system and most antibiotics. We aimed to determine whether S. epidermidis orthopedic device infection isolates could be distinguished from commensal strains by their ability to invade osteoblasts and form biofilms. Materials and Methods: Orthopedic device infection S. epidermidis strains (n = 15) were compared to nasal carriage isolates (n = 22). Osteoblast invasion was evaluated in an ex vivo infection model using MG63 osteoblastic cells co-cultured for 2 hours with bacteria. Adhesion of S. epidermidis to osteoblasts was explored by a flow cytometric approach, and internalized bacteria were quantified by plating cell lysates after selective killing of extra-cellular bacteria with gentamicin. Early and mature biofilm formations were evaluated by a crystal violet microtitration plate assay and the Biofilm Ring Test method. Results: No difference was observed between commensal and infective strains in their ability to invade osteoblasts (internalization rate 308+/-631 and 347+/-431 CFU/well, respectively). This low internalization rate correlated with a low ability to adhere to osteoblasts. No difference was observed for biofilm formation between the two groups. Conclusion: Osteoblast invasion and biofilm formation levels failed to distinguish S. epidermidis orthopedic device infection strains from commensal isolates. This study provides the first assessment of the interaction between S. epidermidis strains isolated from orthopedic device infections and osteoblasts, and suggests that bone cell invasion is not a major pathophysiological mechanism in S. epidermidis orthopedic device infections, contrary to what is observed for S. aureus.	[Valour, Florent; Trouillet-Assant, Sophie; Rasigade, Jean-Philippe; Lustig, Sebastien; Vandenesch, Francois; Etienne, Jerome; Ferry, Tristan; Laurent, Frederic] INSERM, U1111, Int Ctr Res Infectiol, F-69008 Lyon, France; [Valour, Florent; Trouillet-Assant, Sophie; Rasigade, Jean-Philippe; Tigaud, Sylvestre; Laurent, Frederic] Hosp Civils Lyon, North Lyon Univ Hosp, Bacteriol Lab, Lyon, France; [Valour, Florent; Ferry, Tristan] Hosp Civils Lyon, Dept Infect Dis, Lyon, France; [Lustig, Sebastien] Hosp Civils Lyon, Dept Orthoped Surg, Lyon, France; [Chanard, Emmanuel] Novecia, Bacteriol Lab, Lyon, France; [Meugnier, Helene; Vandenesch, Francois; Etienne, Jerome] Hosp Civils Lyon, East Lyon Univ Hosp, Bacteriol Lab, Lyon, France; [Lustig, Sebastien; Meugnier, Helene; Vandenesch, Francois; Etienne, Jerome; Ferry, Tristan; Laurent, Frederic] Univ Lyon 1, F-69365 Lyon, France; [Vandenesch, Francois; Etienne, Jerome; Laurent, Frederic] French Natl Reference Ctr Staphylococci, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Valour, F (corresponding author), INSERM, U1111, Int Ctr Res Infectiol, F-69008 Lyon, France.	florent.valour@chu-lyon.fr	LAURENT, Frederic/AGM-0706-2022; Lustig, Sébastien/E-3375-2013; trouillet-assant, sophie/L-9400-2014; Ferry, Tristan/M-5108-2014; Rasigade, Jean-Philippe/L-9320-2014; ETIENNE, Jerome/C-5471-2014; Vandenesch, Francois/C-7209-2014; ADER, Florence/M-7619-2014; Laurent, Frederic/M-4719-2014; Rasigade, Jean-Philippe/AAE-1667-2021	Rasigade, Jean-Philippe/0000-0002-8264-0452; ETIENNE, Jerome/0000-0002-3348-3315; Vandenesch, Francois/0000-0001-9412-7106; ADER, Florence/0000-0002-4778-4338; Janier, Marc/0000-0001-5937-9180; ferry, tristan/0000-0003-3082-7001; laurent, frederic/0000-0003-0609-9091; Valour, Florent/0000-0002-1467-6162	French Ministry of Health; French Ministry of Education; Institut National de la Sante et de la Recherche Medicale (Inserm)	French Ministry of Health; French Ministry of Education; Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the French Ministry of Health, the French Ministry of Education and the Institut National de la Sante et de la Recherche Medicale (Inserm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RA, 2001, MICROB PATHOGENESIS, V31, P205, DOI 10.1006/mpat.2001.0465; Anaya-Lopez JL, 2006, RES VET SCI, V81, P358, DOI 10.1016/j.rvsc.2006.02.002; Bergeron M, 2011, EUR J CLIN MICROBIOL, V30, P343, DOI 10.1007/s10096-010-1091-z; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Ellington JK, 1999, MICROB PATHOGENESIS, V26, P317, DOI 10.1006/mpat.1999.0272; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660; Gu J, 2005, J HOSP INFECT, V61, P342, DOI 10.1016/j.jhin.2005.04.017; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x; Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002; Koskela A, 2009, EUR J CLIN MICROBIOL, V28, P655, DOI 10.1007/s10096-008-0664-6; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Pautke C, 2004, ANTICANCER RES, V24, P3743; Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013; Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004; Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0; Trouillet S, 2011, J MICROBIOL METH, V86, P145, DOI 10.1016/j.mimet.2011.04.012; Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045; Yao YF, 2005, INFECT IMMUN, V73, P1856, DOI 10.1128/IAI.73.3.1856-1860.2005; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	28	47	48	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67240	10.1371/journal.pone.0067240	http://dx.doi.org/10.1371/journal.pone.0067240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840636	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400047
J	Wang, J; Mou, YR; Zhang, QY; Zhang, F; Yang, HC; Zhang, WT; Li, AW				Wang, Jian; Mou, Yaru; Zhang, Qiangye; Zhang, Fan; Yang, Hongchao; Zhang, Wentong; Li, Aiwu			Expression and Significance of Neuroligins in Myenteric Cells of Cajal in Hirschsprung's Disease	PLOS ONE			English	Article							INTERSTITIAL-CELLS; INHIBITORY SYNAPSES; NEUROTRANSMISSION; PACEMAKERS; MEDIATORS; NEUREXIN; MODEL	Purpose: The aim of this study was to investigate the expression and significance of neuroligins in myenteric cells of Cajal (ICC-MY) in Hirschsprung's disease (HSCR). Methods: Longitudinal muscle with adherent myenteric plexus (LMMP) from surgical excision waste colon of HSCR children were prepared by peeling off the mucous layer, sub-mucosal layer and circular muscle. Neuroligins, c-Kit (c-Kit-immunoreactivity representing ICC) and their relationship were assessed by double labeling immunofluorescence staining. ICC-MY were dissociated and cultured from LMMP by enzymolysis method, and were purified and analyzed using a combination of magnetic-activated cell sorting (MACS) and flow cytometry (FCM). Western-blot analysis was applied to compare and evaluate the expression levels of neuroligins in ICC-MY which were dissociated from different segments of HSCR (ganglionic colonic segment, transitional colonic segment and aganglionic colonic segment). Results: Neuroligins and c-Kit were expressed on the same cells (ICC-MY); ICC-MY were dissociated, cultured and purified. For HSCR, neuroligins were expressed significantly in ICC-MY from ganglionic colonic segments, moderately in those from transitional colonic segments and down-regulated significantly in those from aganglionic colonic segments. Conclusions: Neuroligins were expressed in ICC-MY of human beings, and the expression varies from different segments of HSCR. This abnormal expression might play an important role in the pathogenesis of this disease through affecting the synaptic function of ICC-MY.	[Wang, Jian; Zhang, Qiangye; Yang, Hongchao; Zhang, Wentong; Li, Aiwu] Shandong Univ, Dept Pediat Surg, Qilu Hosp, Jinan, Shandong, Peoples R China; [Mou, Yaru] Shandong Univ, Prov Hosp, Dept Cardiol, Jinan 250100, Shandong, Peoples R China; [Zhang, Fan] Shandong Univ, Qilu Hosp, Dept ENT, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, AW (corresponding author), Shandong Univ, Dept Pediat Surg, Qilu Hosp, Jinan, Shandong, Peoples R China.	zisetianxie@163.com			National Natural Science Foundation of China [81270720]; Shandong Provincial Natural Science Foundation, China [ZR2009CM095]; Innovation Fund Projects of Shandong University [2012ZD026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Innovation Fund Projects of Shandong University	This work was supported by the National Natural Science Foundation of China (Project Number: 81270720), Shandong Provincial Natural Science Foundation, China (Project Number: ZR2009CM095), and Innovation Fund Projects of Shandong University (Project Number: 2012ZD026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuzu DT, 2011, NEUROGASTROENT MOTIL, V23, pE309, DOI 10.1111/j.1365-2982.2011.01730.x; Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Biswas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009133; Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Du Peng, 2010, Critical Reviews in Biomedical Engineering, V38, P225, DOI 10.1615/CritRevBiomedEng.v38.i3.10; EDERY P, 1994, J MED GENET, V31, P602, DOI 10.1136/jmg.31.8.602; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Gfroerer S, 2010, WORLD J GASTROENTERO, V16, P5716, DOI 10.3748/wjg.v16.i45.5716; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Huang Y, 2010, TOHOKU J EXP MED, V221, P125, DOI 10.1620/tjem.221.125; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Lorincz A, 2008, GASTROENTEROLOGY, V134, pA534; Mostafa RM, 2010, WORLD J GASTROENTERO, V16, P3239, DOI 10.3748/wjg.v16.i26.3239; Nemeth L, 2000, J PEDIATR SURG, V35, P823, DOI 10.1053/jpsu.2000.6851; Ordog T, 2004, CYTOM PART A, V62A, P139, DOI 10.1002/cyto.a.20078; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Roberts RR, 2008, AM J PHYSIOL-GASTR L, V294, pG996, DOI 10.1152/ajpgi.00558.2007; Rumessen JJ, 2003, INT REV CYTOL, V229, P115, DOI 10.1016/S0074-7696(03)29004-5; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P901, DOI 10.1016/S0016-5085(96)70057-4; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P279, DOI 10.1053/gast.1996.v111.pm8690192; Wang HF, 2009, NEUROSCI LETT, V451, P208, DOI 10.1016/j.neulet.2009.01.015; [王健 WANG Jian], 2010, [中华小儿外科杂志, Chinese Journal of Pediatric Surgery], V31, P132; Ward SM, 2000, J NEUROSCI, V20, P1393; Wouters MM, 2011, NETH J MED, V69, P55	34	1	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67205	10.1371/journal.pone.0067205	http://dx.doi.org/10.1371/journal.pone.0067205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840625	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400042
J	Yao, Y; Chan, AKY; Qin, ZY; Chen, LC; Zhang, X; Pang, JCS; Li, HM; Wang, Y; Mao, Y; Ng, HK; Zhou, LF				Yao, Yu; Chan, Aden Ka-Yin; Qin, Zhi Yong; Chen, Ling Chao; Zhang, Xin; Pang, Jesse Chung-Sean; Li, Hiu Ming; Wang, Yin; Mao, Ying; Ng, Ho-Keung; Zhou, Liang Fu			Mutation Analysis of IDH1 in Paired Gliomas Revealed IDH1 Mutation Was Not Associated with Malignant Progression but Predicted Longer Survival	PLOS ONE			English	Article							CODON 132 MUTATION; LOW-GRADE GLIOMAS; ASTROCYTIC TUMORS; MOLECULAR MARKERS; DIFFUSE GLIOMAS; GLIOBLASTOMAS; BRAIN; 2-HYDROXYGLUTARATE; CLASSIFICATION; TEMOZOLOMIDE	Recurrence and progression to higher grade lesions are characteristic behaviors of gliomas. Though IDH1 mutation frequently occurs and is considered as an early event in gliomagenesis, little is known about its role in the recurrence and progression of gliomas. We therefore analysed IDH1 and IDH2 statusat codon 132 of IDH1 and codon 172 of IDH2 by direct sequencing and anti-IDH1-R132H immunohistochemistry in 53 paired samples and their recurrences, including 29 low-grade gliomas, 16 anaplastic gliomas and 8 Glioblastomas. IDH1/IDH2 mutation was detected in 32 primarytumors, with 25 low-grade gliomas and 6 anaplastic gliomas harboring IDH1 mutation and 1 low-grade glioma harboring IDH2 mutation. All of the paired tumors showed consistent IDH1 and IDH2 status. Patients were analyzed according to IDH1 status and tumor-related factors. Malignant progression at recurrence was noted in 22 gliomas and was not associated with IDH1 mutation. Survival analysis revealed patients with IDH1 mutated gliomas had a significantly longer progression-free survival (PFS) and overall survival (OS). In conclusion, this study demonstrated a strong tendency of IDH1/IDH2 status being consistent during progression of glioma. IDH1 mutation was not a predictive marker for malignant progression and it was a potential prognostic marker for gliomas of Chinese patients.	[Yao, Yu; Qin, Zhi Yong; Chen, Ling Chao; Zhang, Xin; Mao, Ying; Zhou, Liang Fu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Chan, Aden Ka-Yin; Pang, Jesse Chung-Sean; Li, Hiu Ming; Ng, Ho-Keung] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Aden Ka-Yin; Pang, Jesse Chung-Sean; Li, Hiu Ming; Ng, Ho-Keung] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Wang, Yin] Fudan Univ, Huashan Hosp, Dept Neuropathol, Shanghai 200433, Peoples R China	Fudan University; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Fudan University	Ng, HK (corresponding author), Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.	hkng@cuhk.edu; lfzhouc@126.com	Chan, Aden K./I-2535-2015; Ng, Ho Keung/I-3952-2015	Chan, Aden K./0000-0001-9176-963X; Mao, Ying/0000-0001-8055-115X	Project for Science and Technology Commission of Shanghai Municipality Grant [10JC1402200]; National Natural Science Foundation of China [81172412]; Shanghai Talents Development Funds [2011063]; Ministry of Health of China [W2012FZ003]; Wu Jieping medical foundation for clinical research of special fund project [320.6700.1162]; Project for National 985 Engineering of China [985III-YFX0102]; Science and Technology Commission of Shanghai Municipality Grant [10JC1402200]	Project for Science and Technology Commission of Shanghai Municipality Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Talents Development Funds; Ministry of Health of China; Wu Jieping medical foundation for clinical research of special fund project; Project for National 985 Engineering of China; Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by The Project for Science and Technology Commission of Shanghai Municipality Grant (No. 10JC1402200 to L.F.Z.), National Natural Science Foundation of China (81172412 to H.K.N.), Shanghai Talents Development Funds (No. 2011063 to Y.Y.), The Grant from Ministry of Health of China (W2012FZ003 to Z.Y.Q.), Wu Jieping medical foundation for clinical research of special fund project (No. 320.6700.1162 to Y.Y.), The Project for National 985 Engineering of China (No. 985III-YFX0102 to Y.M.). Science and Technology Commission of Shanghai Municipality Grant (No. 10JC1402200 to L.F.Z.) had a role in study design; National Natural Science Foundation of China (81172412 to H.K.N.) had a role in experiment, data collection and analysis; Shanghai Talents Development Funds (No. 2011063 to Y.Y.) have a role in decisions to follow up, publish and prepare the manuscript.	Ahmadi R, 2012, J NEURO-ONCOL, V109, P15, DOI 10.1007/s11060-012-0863-y; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Cheng Y, 1999, J NEUROPATH EXP NEUR, V58, P120, DOI 10.1097/00005072-199902000-00002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Dubbink HJ, 2009, NEUROLOGY, V73, P1792, DOI 10.1212/WNL.0b013e3181c34ace; Hartmann C, 2011, CLIN CANCER RES, V17, P4588, DOI 10.1158/1078-0432.CCR-10-3194; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Ishii N, 1999, ONCOGENE, V18, P5870, DOI 10.1038/sj.onc.1203241; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Lass U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041298; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Masica DL, 2011, CANCER RES, V71, P4550, DOI 10.1158/0008-5472.CAN-11-0180; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Scott JG, 2011, NEURO-ONCOLOGY, V13, P1262, DOI 10.1093/neuonc/nor083; Shibahara I, 2012, INT J CLIN ONCOL, V17, P551, DOI 10.1007/s10147-011-0323-2; Tang JY, 2012, KAOHSIUNG J MED SCI, V28, P138, DOI 10.1016/j.kjms.2011.10.023; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yue WY, 2009, J NEUROSURG, V110, P709, DOI 10.3171/2008.3.JNS17459; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	32	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67421	10.1371/journal.pone.0067421	http://dx.doi.org/10.1371/journal.pone.0067421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840696	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400078
J	Kanahara, N; Yoshida, T; Oda, Y; Yamanaka, H; Moriyama, T; Hayashi, H; Shibuya, T; Nagaushi, Y; Sawa, T; Sekine, Y; Shimizu, E; Asano, M; Iyo, M				Kanahara, Nobuhisa; Yoshida, Taisuke; Oda, Yasunori; Yamanaka, Hiroshi; Moriyama, Toshihiro; Hayashi, Hideaki; Shibuya, Takayuki; Nagaushi, Yasunori; Sawa, Takashi; Sekine, Yoshimoto; Shimizu, Eiji; Asano, Makoto; Iyo, Masaomi			Onset Pattern and Long-Term Prognosis in Schizophrenia: 10-Year Longitudinal Follow-Up Study	PLOS ONE			English	Article							UNTREATED PSYCHOSIS; 1ST-EPISODE PSYCHOSIS; DURATION; CRITERIA; INTERVENTION; PREDICTION; REMISSION; ADMISSION; COHORTS; TRIAL	Background: Although the duration of untreated psychosis (DUP) plays an important role in the short-term prognosis of patients with schizophrenia, their long-term prognosis generally is not determined by DUP alone. It is important to explore how other clinical factors in the early stage are related to DUP and consequent disease courses. Methods: A total of 664 patients with untreated psychosis were surveyed for this study. At the first examination, we divided them into the severe positive symptoms cases (SC) or the less severe cases (NonSC) and compared the prognosis among the two groups after a 10-year follow-up. In all, 113 patients in the SC group and 43 patients in the NonSC group were follow-up completers. Results: Whereas DUP was not different between the two groups, patients with nonacute onset in both groups had significantly longer DUP than those in patients with acute onset. For all clinical measures, there was no difference in prognosis between the two groups or among the four groups classified by mode of onset (MoO) and initial severity of positive symptoms. However, the degree of improvement of global assessment of functioning (GAF) was significantly smaller in the NonSC-nonacute group than in the SC-acute and SC-nonacute groups. Conclusions: These results suggest that neither DUP nor MoO alone necessarily affects the initial severity of positive symptoms. Moreover, it is possible that patients with low impetus of positive symptoms onset within long DUP experience profound pathologic processes. Therefore, the current study results indicated that long DUP and nonacute onset were related to poor long-term prognosis, regardless of initial positive symptoms.	[Kanahara, Nobuhisa; Yoshida, Taisuke; Oda, Yasunori; Yamanaka, Hiroshi; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan; [Oda, Yasunori; Yamanaka, Hiroshi; Moriyama, Toshihiro; Hayashi, Hideaki; Shibuya, Takayuki; Nagaushi, Yasunori; Sawa, Takashi; Asano, Makoto] Chiba Psychiat Med Ctr, Dept Psychiat, Chiba, Japan; [Kanahara, Nobuhisa; Sekine, Yoshimoto] Chiba Univ, Ctr Forens Mental Hlth, Div Med Treatment & Rehabil, Chiba, Japan; [Shimizu, Eiji] Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan	Chiba University; Chiba University; Chiba University	Kanahara, N (corresponding author), Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan.	kanahara@faculty.chiba-u.jp	Shimizu, Eiji/K-4637-2017	Shimizu, Eiji/0000-0002-6741-9338	Mitsubishi Pharma Research Foundation	Mitsubishi Pharma Research Foundation	This study was supported by grants from the Mitsubishi Pharma Research Foundation (http://di.mt-pharma.co.jp/zaidan/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius M, 2010, PSYCHIAT DANUB, V22, P211; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441; Beitinger R, 2008, PROG NEURO-PSYCHOPH, V32, P1643, DOI 10.1016/j.pnpbp.2008.06.008; Bertelsen M, 2009, SCHIZOPHR RES, V107, P173, DOI 10.1016/j.schres.2008.09.018; Birchwood M, 1998, BRIT J PSYCHIAT, V172, P53, DOI 10.1192/S0007125000297663; Bottlender R, 2003, SCHIZOPHR RES, V62, P37, DOI 10.1016/S0920-9964(02)00348-1; Buchanan RW, 2005, AM J PSYCHIAT, V162, P124, DOI 10.1176/appi.ajp.162.1.124; Chang WC, 2012, PSYCHIAT RES, V198, P360, DOI 10.1016/j.psychres.2011.09.006; Freudenreich O, 2007, HARVARD REV PSYCHIAT, V15, P189, DOI 10.1080/10673220701679804; HAAS GL, 1992, SCHIZOPHRENIA BULL, V18, P373, DOI 10.1093/schbul/18.3.373; Kalla O, 2002, ACTA PSYCHIAT SCAND, V106, P265, DOI 10.1034/j.1600-0447.2002.02302.x; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Kolakowska T., 1976, BRIEF PSYCHIATRIC RA; Larsen TK, 2000, SCHIZOPHR RES, V45, P1, DOI 10.1016/S0920-9964(99)00169-3; Liberman RP, 2002, INT REV PSYCHIATR, V14, P256, DOI 10.1080/0954026021000016905; Malla AK, 2002, SCHIZOPHR RES, V54, P231, DOI 10.1016/S0920-9964(01)00254-7; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; MCCREADIE RG, 1992, BRIT J PSYCHIAT, V161, P496, DOI 10.1192/bjp.161.4.496; Melle I, 2004, ARCH GEN PSYCHIAT, V61, P143, DOI 10.1001/archpsyc.61.2.143; Morgan C, 2006, BRIT J PSYCHIAT, V189, P446, DOI 10.1192/bjp.bp.106.021303; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785; Petrakis IL, 2004, AM J PSYCHIAT, V161, P1776, DOI 10.1176/appi.ajp.161.10.1776; Siris SG, 2001, J PSYCHOPHARMACOL, V15, P127, DOI 10.1177/026988110101500209; Verdoux H, 1998, EUR PSYCHIAT, V13, P346, DOI 10.1016/S0924-9338(99)80701-9; White C, 2009, PSYCHOL MED, V39, P1447, DOI 10.1017/S003329170800514X; Wiersma D, 2000, PSYCHOL MED, V30, P1155, DOI 10.1017/S0033291799002627; ZHANG ML, 1994, BRIT J PSYCHIAT, V165, P96, DOI 10.1192/S0007125000293045	28	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67273	10.1371/journal.pone.0067273	http://dx.doi.org/10.1371/journal.pone.0067273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840649	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400089
J	Pliss, L; Hausknecht, KA; Stachowiak, MK; Dlugos, CA; Richards, JB; Patel, MS				Pliss, Lioudmila; Hausknecht, Kathryn A.; Stachowiak, Michal K.; Dlugos, Cynthia A.; Richards, Jerry B.; Patel, Mulchand S.			Cerebral Developmental Abnormalities in a Mouse with Systemic Pyruvate Dehydrogenase Deficiency	PLOS ONE			English	Article							BRAIN IN-VIVO; COMPLEX DEFICIENCY; E1-ALPHA SUBUNIT; LACTIC-ACIDOSIS; RAT-BRAIN; FEMALE MICE; PDHA1 GENE; METABOLISM; GLUCOSE; LOCALIZATION	Pyruvate dehydrogenase (PDH) complex (PDC) deficiency is an inborn error of pyruvate metabolism causing a variety of neurologic manifestations. Systematic analyses of development of affected brain structures and the cellular processes responsible for their impairment have not been performed due to the lack of an animal model for PDC deficiency. METHODS: In the present study we investigated a murine model of systemic PDC deficiency by interrupting the X-linked Pdha1 gene encoding the a subunit of PDH to study its role on brain development and behavioral studies. RESULTS: Male embryos died prenatally but heterozygous females were born. PDC activity was reduced in the brain and other tissues in female progeny compared to age-matched control females. Immunohistochemical analysis of several brain regions showed that approximately 40% of cells were PDH-. The oxidation of glucose to CO2 and incorporation of glucose-carbon into fatty acids were reduced in brain slices from 15 day-old PDC-deficient females. Histological analyses showed alterations in several structures in white and gray matters in 35 day-old PDC-deficient females. Reduction in total cell number and reduced dendritic arbors in Purkinje neurons were observed in PDC-deficient females. Furthermore, cell proliferation, migration and differentiation into neurons by newly generated cells were reduced in the affected females during pre- and postnatal periods. PDC-deficient mice had normal locomotor activity in a novel environment but displayed decreased startle responses to loud noises and there was evidence of abnormal pre-pulse inhibition of the startle reflex. CONCLUSIONS: The results show that a reduction in glucose metabolism resulting in deficit in energy production and fatty acid biosynthesis impairs cellular differentiation and brain development in PDC-deficient mice.	[Pliss, Lioudmila; Patel, Mulchand S.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14260 USA; [Hausknecht, Kathryn A.; Richards, Jerry B.] SUNY Buffalo, Res Inst Addict, Buffalo, NY 14260 USA; [Stachowiak, Michal K.; Dlugos, Cynthia A.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Patel, MS (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14260 USA.	mspatel@buffalo.edu	Hausknecht, Kathryn/G-5018-2017; Hausknecht, Kathryn/AAS-3211-2020; Richards, J Brent/AAF-4225-2019	Hausknecht, Kathryn/0000-0003-2748-364X; Hausknecht, Kathryn/0000-0003-2748-364X; Richards, J Brent/0000-0002-3746-9086	US Public Health Service Grant [DK20478]; Biochemistry Department IFR (Income Fund Reimbursable, The Research Foundation of State University of New York)	US Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Biochemistry Department IFR (Income Fund Reimbursable, The Research Foundation of State University of New York)	This work was supported in part by the US Public Health Service Grant DK20478 and the Biochemistry Department IFR (Income Fund Reimbursable, The Research Foundation of State University of New York) funds (both to MSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnerias C, 2010, DEV MED CHILD NEUROL, V52, pe1, DOI 10.1111/j.1469-8749.2009.03541.x; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; BROWN GK, 1988, EUR J PEDIATR, V147, P10, DOI 10.1007/BF00442603; BROWN RM, 1989, GENOMICS, V4, P174, DOI 10.1016/0888-7543(89)90297-8; CHOW CW, 1987, ACTA NEUROPATHOL, V74, P393, DOI 10.1007/BF00687218; Cremer J E, 1974, Biochem J, V142, P527; CROSS JH, 1994, PEDIATR NEUROL, V10, P276; DAHL HHM, 1992, J INHERIT METAB DIS, V15, P835, DOI 10.1007/BF01800219; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; DeBrosse SD, 2012, MOL GENET METAB, V107, P394, DOI 10.1016/j.ymgme.2012.09.001; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hatta T, 2002, J NEUROSCI, V22, P5516; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Imbard A, 2011, MOL GENET METAB, V104, P507, DOI 10.1016/j.ymgme.2011.08.008; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Johnson MT, 2001, MOL GENET METAB, V74, P293, DOI 10.1006/mgme.2001.3249; Kerr D. S., 1996, ALPHA KETO ACID DEHY, P249; KERR DS, 1987, PEDIATR RES, V22, P312, DOI 10.1203/00006450-198709000-00015; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lib MY, 2002, J HISTOCHEM CYTOCHEM, V50, P877, DOI 10.1177/002215540205000701; Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.0.CO;2-K; MARAGOS C, 1989, J BIOL CHEM, V264, P12294; MICHOTTE A, 1993, ACTA NEUROPATHOL, V85, P674, DOI 10.1007/BF00334680; NOLL F, 1966, BIOCHEM Z, V346, P41; Patel KP, 2012, MOL GENET METAB, V105, P34, DOI 10.1016/j.ymgme.2011.09.032; Patel MS, 2003, BIOCHEM MOL BIOL EDU, V31, P5, DOI 10.1002/bmb.2003.494031010156; PATEL MS, 1974, J NEUROCHEM, V23, P309, DOI 10.1111/j.1471-4159.1974.tb04359.x; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pliss L, 2004, J NEUROCHEM, V91, P1082, DOI 10.1111/j.1471-4159.2004.02790.x; Pliss L, 2007, NEUROCHEM RES, V32, P645, DOI 10.1007/s11064-007-9295-z; PRICK M, 1981, NEUROLOGY, V31, P398; Quintana E, 2010, CLIN GENET, V77, P474, DOI 10.1111/j.1399-0004.2009.01313.x; Robinson B.H., 1995, METABOLIC MOL BASES, P1479; ROBINSON BH, 1987, J PEDIATR-US, V111, P525, DOI 10.1016/S0022-3476(87)80112-9; Schurr A, 2006, J CEREBR BLOOD F MET, V26, P142, DOI 10.1038/sj.jcbfm.9600174; SIESS E, 1971, H-S Z PHYSIOL CHEM, V352, P447, DOI 10.1515/bchm2.1971.352.1.447; SOTELO C, 1994, J NEUROSCI, V14, P124; Takahashi T, 1996, J NEUROSCI, V16, P5762; Takahashi T, 1999, J NEUROSCI, V19, P10357; TAKAKUBO F, 1994, DEV BRAIN RES, V77, P63, DOI 10.1016/0165-3806(94)90214-3; Taylor MR, 2004, P NATL ACAD SCI USA, V101, P4584, DOI 10.1073/pnas.0307074101; WILBUR DO, 1974, J NEUROCHEM, V22, P709, DOI 10.1111/j.1471-4159.1974.tb04284.x; Ye P, 1996, DEV BRAIN RES, V95, P44	45	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67473	10.1371/journal.pone.0067473	http://dx.doi.org/10.1371/journal.pone.0067473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840713	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400104
J	Hwang, LC; Bai, CH; You, SL; Sun, CA; Chen, CJ				Hwang, Lee-Ching; Bai, Chyi-Huey; You, San-Lin; Sun, Chien-An; Chen, Chien-Jen			Description and Prediction of the Development of Metabolic Syndrome: A Longitudinal Analysis Using a Markov Model Approach	PLOS ONE			English	Article							OBESITY; RISK; DISEASE; PRECURSOR; HISTORY	Background: Delineating the natural history of metabolic syndrome (MetS) is prerequisite to prevention. This study aimed to build Markov models to simulate each component's progress and to test the effect of different initial states on the development of MetS. Methods: MetS was defined with revised AHA/NHLBI criteria. Each reversible multistate Markov chain consisted of 8 states (no component, five isolated component states, 2-component state, and MetS state). Yearly transition probabilities were calculated from a five-year population-based follow up studywhich enrolled 2,247 individuals with mean aged 32.4 years at study entry. Results: In men, high BP or a 2-component state was most likely to initiate the progress of MetS. In women, abdominal obesity or low HDL were the most likely initiators. Metabolic components were likely to occur together. The development of MetS was an increasing monotonic function of time. MetS was estimated to develop within 15 years in 12.7% of young men with no component, and 2 components developed in 16.3%. MetS was estimated to develop in 10.6% of women with at the age of 47, and 2 components developed in 14.3%. MetS was estimated to develop in 24.6% of men and 27.6% of women with abdominal obesity, a rate higher than in individuals initiating with no component. Conclusions: This modeling study allows estimation of the natural history of MetS. Men tended to develop this syndrome sooner than women did, i.e., before their fifth decade of life. Individuals with 1 or 2 components showed increased development of MetS.	[Hwang, Lee-Ching] Mackay Mem Hosp, Dept Family Med, Taipei, Taiwan; [Hwang, Lee-Ching] Mackay Med Coll, New Taipei City, Taiwan; [Bai, Chyi-Huey] Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [You, San-Lin; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Sun, Chien-An] Fu Jen Catholic Univ, Dept Publ Hlth, Coll Med, New Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Academia Sinica - Taiwan; Fu Jen Catholic University	Hwang, LC (corresponding author), Mackay Mem Hosp, Dept Family Med, Taipei, Taiwan.	hlc@ms2.mmh.org.tw	Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008	You, San-Lin/0000-0002-3192-3356	Bureau of Health Promotion, Department of Health, Executive Yuan, Taiwan, Republic of China [DOH95-HP-2103]	Bureau of Health Promotion, Department of Health, Executive Yuan, Taiwan, Republic of China	This study was supported by a grant from the Bureau of Health Promotion, Department of Health (DOH95-HP-2103), Executive Yuan, Taiwan, Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; BECK JR, 1988, J CLIN EPIDEMIOL, V41, P619, DOI 10.1016/0895-4356(88)90113-8; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Craig BA, 1999, STAT MED, V18, P1355, DOI 10.1002/(SICI)1097-0258(19990615)18:11<1355::AID-SIM130>3.3.CO;2-B; Denton BT, 2009, MED DECIS MAKING, V29, P351, DOI 10.1177/0272989X08329462; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Grassi A, 2010, STUD HEALTH TECHNOL, V160, P1155, DOI 10.3233/978-1-60750-588-4-1155; Han TS, 2002, OBES RES, V10, P923, DOI 10.1038/oby.2002.126; Haring R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039461; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Kim BJ, 2012, CIRC J, V76, P2363, DOI 10.1253/circj.CJ-12-0315; Macchia A, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.023; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Prabhakaran D, 2004, VASC MED, V9, P55, DOI 10.1191/1358863x04vm515ra; Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8; Rigopoulou EI, 2010, LIVER INT, V30, P637, DOI 10.1111/j.1478-3231.2010.02216.x; Santos AC, 2010, PREV MED, V50, P99, DOI 10.1016/j.ypmed.2009.11.011; Silverstein MD, 1999, GASTROENTEROLOGY, V117, P49, DOI 10.1016/S0016-5085(99)70549-4; SILVERSTEIN MD, 1988, J CLIN EPIDEMIOL, V41, P623, DOI 10.1016/0895-4356(88)90114-X; Sonnenberg A, 2010, LIVER INT, V30, P718, DOI 10.1111/j.1478-3231.2009.02196.x; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Spiegel BMR, 2003, HEPATOLOGY, V37, P366, DOI 10.1053/jhep.2003.50050; Sweeting MJ, 2010, STAT MED, V29, P1161, DOI 10.1002/sim.3812; Tenenbaum A, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-11; Veenstra DL, 2008, ALIMENT PHARM THER, V27, P1240, DOI 10.1111/j.1365-2036.2008.03691.x; Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yang T, 2012, ATHEROSCLEROSIS, V220, P525, DOI 10.1016/j.atherosclerosis.2011.11.014	30	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67436	10.1371/journal.pone.0067436	http://dx.doi.org/10.1371/journal.pone.0067436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840701	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800133
J	Nyberg, ST; Fransson, EI; Heikkila, K; Alfredsson, L; Casini, A; Clays, E; De Bacquer, D; Dragano, N; Erbel, R; Ferrie, JE; Hamer, M; Jockel, KH; Kittel, F; Knutsson, A; Ladwig, KH; Lunau, T; Marmot, MG; Nordin, M; Rugulies, R; Siegrist, J; Steptoe, A; Westerholm, PJM; Westerlund, H; Theorell, T; Brunner, EJ; Singh-Manoux, A; Batty, GD; Kivimaki, M				Nyberg, Solja T.; Fransson, Eleonor I.; Heikkila, Katriina; Alfredsson, Lars; Casini, Annalisa; Clays, Els; De Bacquer, Dirk; Dragano, Nico; Erbel, Raimund; Ferrie, Jane E.; Hamer, Mark; Joeckel, Karl-Heinz; Kittel, France; Knutsson, Anders; Ladwig, Karl-Heinz; Lunau, Thorsten; Marmot, Michael G.; Nordin, Maria; Rugulies, Reiner; Siegrist, Johannes; Steptoe, Andrew; Westerholm, Peter J. M.; Westerlund, Hugo; Theorell, Tores; Brunner, Eric J.; Singh-Manoux, Archana; Batty, G. David; Kivimaki, Mika		IPD-Work Consortium	Job Strain and Cardiovascular Disease Risk Factors: Meta-Analysis of Individual-Participant Data from 47,000 Men and Women	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; AMBULATORY BLOOD-PRESSURE; WORK STRESS; INEQUALITIES; MORTALITY; SWEDISH; PROFILE; REWARD	Background: Job strain is associated with an increased coronary heart disease risk, but few large-scale studies have examined the relationship of this psychosocial characteristic with the biological risk factors that potentially mediate the job strain - heart disease association. Methodology and Principal Findings: We pooled cross-sectional, individual-level data from eight studies comprising 47,045 participants to investigate the association between job strain and the following cardiovascular disease risk factors: diabetes, blood pressure, pulse pressure, lipid fractions, smoking, alcohol consumption, physical inactivity, obesity, and overall cardiovascular disease risk as indexed by the Framingham Risk Score. In age-, sex-, and socioeconomic status-adjusted analyses, compared to those without job strain, people with job strain were more likely to have diabetes (odds ratio 1.29; 95% CI: 1.11-1.51), to smoke (1.14; 1.08-1.20), to be physically inactive (1.34; 1.26-1.41), and to be obese (1.12; 1.04-1.20). The association between job strain and elevated Framingham risk score (1.13; 1.03-1.25) was attributable to the higher prevalence of diabetes, smoking and physical inactivity among those reporting job strain. Conclusions: In this meta-analysis of work-related stress and cardiovascular disease risk factors, job strain was linked to adverse lifestyle and diabetes. No association was observed between job strain, clinic blood pressure or blood lipids.	[Nyberg, Solja T.; Heikkila, Katriina; Kivimaki, Mika] Finnish Inst Occupat Hlth, Helsinki, Finland; [Nyberg, Solja T.; Heikkila, Katriina; Kivimaki, Mika] Finnish Inst Occupat Hlth, Tampere, Finland; [Fransson, Eleonor I.] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [Fransson, Eleonor I.; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Fransson, Eleonor I.; Westerlund, Hugo; Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Alfredsson, Lars] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Casini, Annalisa; Kittel, France] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Clays, Els; De Bacquer, Dirk] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Dragano, Nico; Lunau, Thorsten; Siegrist, Johannes] Univ Dusseldorf, Fac Med, Inst Med Sociol, D-40225 Dusseldorf, Germany; [Erbel, Raimund] Univ Duisburg Essen, Dept Cardiol, West German Heart Ctr Essen, Essen, Germany; [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England; [Ferrie, Jane E.; Hamer, Mark; Marmot, Michael G.; Steptoe, Andrew; Brunner, Eric J.; Singh-Manoux, Archana; Batty, G. David; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Joeckel, Karl-Heinz] Univ Duisburg Essen, Fac Med, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Ladwig, Karl-Heinz] German Res Ctr Environm Hlth, Neuherberg, Germany; [Nordin, Maria] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Rugulies, Reiner] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Westerholm, Peter J. M.] Uppsala Univ, Uppsala, Sweden; [Singh-Manoux, Archana] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Kivimaki, Mika] Univ Helsinki, Inst Behav Sci, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Jonkoping University; Karolinska Institutet; Stockholm University; Stockholm County Council; Universite Libre de Bruxelles; Ghent University; Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of Bristol; University of London; University College London; University of Duisburg Essen; Mid-Sweden University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Umea University; National Research Centre for the Working Environment; University of Copenhagen; University of Copenhagen; Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Edinburgh; University of Helsinki	Nyberg, ST (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	solja.nyberg@ttl.fi	Brunner, Eric/H-2114-2011; Marmot, M G/Y-3920-2019; Siegrist, Johannes/AAL-6814-2021; Kivimaki, Mika/B-3607-2012; Ferrie, Jane/AAZ-2009-2020; Steptoe, Andrew/Y-2440-2019; Rugulies, Reiner/E-8140-2010; De Bacquer, Dirk/HGU-3191-2022; Fransson, Eleonor I/J-7792-2013; Westerlund, Hugo/A-3049-2012; Ladwig, Karl-Heinz/B-5351-2014; Batty, GD/Y-4401-2018; Casini, Annalisa/ABG-2250-2020; Alfredsson, Lars/AAC-9007-2019; Singh-Manoux, Archana/F-6804-2013; Hamer, Mark/C-1602-2008; Hamer, Mark/AAJ-6814-2021	Brunner, Eric/0000-0002-0595-4474; Marmot, M G/0000-0002-2431-6419; Siegrist, Johannes/0000-0002-7530-4178; Kivimaki, Mika/0000-0002-4699-5627; Rugulies, Reiner/0000-0002-7752-131X; Fransson, Eleonor I/0000-0001-9042-4832; Westerlund, Hugo/0000-0002-8806-5698; Ladwig, Karl-Heinz/0000-0003-0710-1720; Batty, GD/0000-0003-1822-5753; Casini, Annalisa/0000-0002-3539-4500; Alfredsson, Lars/0000-0003-1688-6697; Singh-Manoux, Archana/0000-0002-1244-5037; Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; De Bacquer, Dirk/0000-0002-3202-7238; Clays, Els/0000-0002-1092-945X; Steptoe, Andrew/0000-0001-7808-4943; Heikkila, Katriina/0000-0001-6269-6881; Theorell, Tores/0000-0003-1956-7931	European Union New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; Danish National Research Centre for the Working Environment, Denmark; Academy of Finland [132944]; BUPA Foundation [22094477]; British Heart Foundation (BHF), UK; Heinz Nixdorf Foundation, Germany; German Ministry of Education and Science; German Research Foundation; Medical Research Council, UK [K013351]; US National Institutes of Health [R01HL036310, R01AG034454]; Economic and Social Research Council, UK; British Heart Foundation [RG/07/008/23674, RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1, ES/F02679X/1] Funding Source: researchfish; Medical Research Council [MR/K026992/1, G0601647, G0902037, G8802774, G0100222, MR/K013351/1, G19/35, G0701830, G1000616] Funding Source: researchfish; ESRC [ES/J023299/1, ES/F02679X/1] Funding Source: UKRI; MRC [G1000616, MR/K013351/1, G0902037, G0701830, G0601647] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	European Union New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Council for Working Life and Social Research, Sweden(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); German Social Accident Insurance, Germany; Danish National Research Centre for the Working Environment, Denmark; Academy of Finland(Academy of Finland); BUPA Foundation; British Heart Foundation (BHF), UK; Heinz Nixdorf Foundation, Germany; German Ministry of Education and Science; German Research Foundation(German Research Foundation (DFG)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by the European Union New OSH ERA research programme (funded by the Finnish Work Environment Fund, Finland, the Swedish Council for Working Life and Social Research, Sweden, the German Social Accident Insurance, Germany, the Danish National Research Centre for the Working Environment, Denmark), the Academy of Finland (grant number 132944), the BUPA Foundation (grant number 22094477), and the British Heart Foundation (BHF), UK. The HNR was funded by the Heinz Nixdorf Foundation, Germany, German Ministry of Education and Science and the German Research Foundation. The German National Accident Insurance supports analyses in the frame of the OSH ERA project. MK is supported by the Medical Research Council, UK (K013351), and the US National Institutes of Health (R01HL036310, R01AG034454) and a professorial fellowship from the Economic and Social Research Council, UK. GDB was a Wellcome Trust Fellow during the preparation of this manuscript. AS is a BHF professor. Funding bodies for participating cohort studies are listed on their websites. The study was conducted independently of funding agencies. None of the funding agencies played an active role in the preparation, review, or editing of this manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alfredsson L, 2002, SCAND J WORK ENV HEA, V28, P238, DOI 10.5271/sjweh.671; Assaf AR, 2002, J WOMEN HEALTH GEN-B, V11, P899, DOI 10.1089/154099902762203731; Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; Clays E, 2012, J HUM HYPERTENS, V26, P381, DOI 10.1038/jhh.2011.42; Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; De Bacquer D, 2005, AM J EPIDEMIOL, V161, P434, DOI 10.1093/aje/kwi040; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Eaker ED, 2004, AM J EPIDEMIOL, V159, P950, DOI 10.1093/aje/kwh127; Fan LB, 2013, SCAND J WORK ENV HEA, V39, P112, DOI 10.5271/sjweh.3294; Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336; Fransson EI, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-62; Hamer M, 2012, J EPIDEMIOL COMMUN H, V66, P1110, DOI 10.1136/jech-2011-200505; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040101; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035463; Heraclides A, 2009, DIABETES CARE, V32, P2230, DOI 10.2337/dc09-0132; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Kang MG, 2005, PREV MED, V40, P583, DOI 10.1016/j.ypmed.2004.07.018; Karasek R, 1990, HLTH WORK STRESS PRO; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Kivimaki M, 2013, CAN MED ASSOC J, V185, P763, DOI 10.1503/cmaj.121735; Laflamme N, 1998, SCAND J WORK ENV HEA, V24, P334, DOI 10.5271/sjweh.353; LANDSBERGIS PA, 1994, SCAND J WORK ENV HEA, V20, P349, DOI 10.5271/sjweh.1386; Landsbergis PA, 2013, AM J PUBLIC HEALTH, V103, pE61, DOI 10.2105/AJPH.2012.301153; Leynen F., 2003, Archives of Public Health, V61, P75; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Matthews KA, 1998, STROKE, V29, P1525, DOI 10.1161/01.STR.29.8.1525; Mezuk Briana, 2011, Race Soc Probl, V3, P38; Mosca L, 2004, J AM COLL CARDIOL, V43, P900, DOI 10.1016/j.jacc.2004.02.001; NETTERSTROM B, 1991, BRIT J IND MED, V48, P684; Nyberg ST, 2012, J INTERN MED, V272, P65, DOI 10.1111/j.1365-2796.2011.02482.x; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Peter R, 1998, J EPIDEMIOL COMMUN H, V52, P540, DOI 10.1136/jech.52.9.540; Rosenthal T, 2012, J AM SOC HYPERTENS, V6, P2, DOI 10.1016/j.jash.2011.09.002; Schnall PL, 1998, PSYCHOSOM MED, V60, P697, DOI 10.1097/00006842-199811000-00007; SHAPER AG, 1985, ANN CLIN BIOCHEM, V22, P50, DOI 10.1177/000456328502200104; Soderberg M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1102; Stang A, 2005, EUR J EPIDEMIOL, V20, P489, DOI 10.1007/s10654-005-5529-z; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tsutsumi A, 2003, J EPIDEMIOL, V13, P63, DOI 10.2188/jea.13.63	47	131	136	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67323	10.1371/journal.pone.0067323	http://dx.doi.org/10.1371/journal.pone.0067323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840664	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000322342800129
J	Carlin, LE; Guseva, NV; Shey, MR; Ballas, ZK; Heusel, JW				Carlin, Lindsey E.; Guseva, Natalya V.; Shey, Michael R.; Ballas, Zuhair K.; Heusel, Jonathan W.			The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition	PLOS ONE			English	Article							MURINE CYTOMEGALOVIRUS M157; NATURAL-KILLER-CELLS; CLASS-I; SIGNAL-TRANSDUCTION; TUMOR SURVEILLANCE; NKG2D LIGANDS; LIPID RAFTS; NK CELLS; ACTIVATION; PROTEINS	The murine cytomegalovirus-encoded protein m157 is a cognate ligand for both inhibitory and activating receptors expressed by natural killer cells. Additionally, m157 is expressed on the surface of infected cells by a glycophosphatidylinositol (GPI) anchor. Although endogenous GPI-anchored proteins are known to be ligands for the NK cell receptor, NKG2D, the contribution of the GPI anchor for viral m157 ligand function is unknown. To determine whether the GPI anchor for m157 is dispensable for m157 function, we generated m157 variants expressed as transmembrane fusion proteins and tested cells expressing transmembrane m157 for the capacity to activate cognate Ly49 receptors. We found that the GPI anchor is required for high-level cell surface expression of m157, and that the transmembrane m157 ligand retains the capacity to activate reporter cells and NK cells expressing Ly49H, as well as Ly49I(129) reporter cells, but with reduced potency. Importantly, target cells expressing the transmembrane form of m157 were killed less efficiently and failed to mediate Ly49H receptor downregulation on fresh NK cells compared to targets expressing GPI-anchored m157. Taken together, these results show that the GPI anchor for m157 facilitates robust cell surface expression, and that NK cells are sensitive to the altered cell surface expression of this potent viral evasin.	[Carlin, Lindsey E.; Ballas, Zuhair K.; Heusel, Jonathan W.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Carlin, Lindsey E.; Guseva, Natalya V.; Heusel, Jonathan W.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Ballas, Zuhair K.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Shey, Michael R.; Ballas, Zuhair K.] Univ Iowa, Iowa City VA Med Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Heusel, JW (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.	jon-heusel@uiowa.edu	Heusel, Jon/AAC-8050-2021	Knaack, Aaron/0000-0001-7712-1415; Ballas, Zuhair/0000-0001-5569-1230	National Institutes of Health (NIH Office of Extramural Research) [AI076989-01, AI088182-01]	National Institutes of Health (NIH Office of Extramural Research)	This study was funded by the National Institutes of Health (NIH Office of Extramural Research: http://grants.nih.gov/grants/oer.htm), grants AI076989-01 and AI088182-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; Cella M, 2004, J EXP MED, V200, P817, DOI 10.1084/jem.20031847; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chalifour A, 2009, IMMUNITY, V30, P337, DOI 10.1016/j.immuni.2008.12.019; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cheng TP, 2008, IMMUNOGENETICS, V60, P565, DOI 10.1007/s00251-008-0313-3; Chiang EY, 2002, J IMMUNOL, V168, P2200, DOI 10.4049/jimmunol.168.5.2200; Colonna M, 2010, NAT IMMUNOL, V11, P1079, DOI [10.1038/ni1210-1079, 10.1038/ni0211-107]; Corbett AJ, 2011, J IMMUNOL, V186, P1713, DOI 10.4049/jimmunol.1003308; da Silva RB, 2011, CELL MOL LIFE SCI, V68, P3505, DOI 10.1007/s00018-011-0801-8; Davis AH, 2008, J IMMUNOL, V181, P265, DOI 10.4049/jimmunol.181.1.265; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Eriksson M, 1999, J EXP MED, V190, P1005, DOI 10.1084/jem.190.7.1005; Fernandez-Messina L, 2011, J CELL SCI, V124, P321, DOI 10.1242/jcs.076042; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Guseva NV, 2010, EUR J IMMUNOL, V40, P2618, DOI 10.1002/eji.200940134; Hayakawa Y, 2012, EXPERT OPIN THER TAR, V16, P587, DOI 10.1517/14728222.2012.681378; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603; Kaplan A, 2011, J IMMUNOL, V187, P760, DOI 10.4049/jimmunol.1002208; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; Martinez E, 2011, J IMMUNOL, V186, P5538, DOI 10.4049/jimmunol.1002254; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Orr MT, 2011, CURR TOP MICROBIOL, V350, P67, DOI 10.1007/82_2010_85; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Perussia B, 2000, NAT IMMUNOL, V1, P372, DOI 10.1038/80808; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Raulet DH, 1997, IMMUNOL REV, V155, P41, DOI 10.1111/j.1600-065X.1997.tb00938.x; Scalzo AA, 2007, IMMUNOL CELL BIOL, V85, P46, DOI 10.1038/sj.icb.7100013; Shey Michael R., 2008, V447, P259, DOI 10.1007/978-1-59745-242-7_18; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Souza-Fonseca-Guimaraes F, 2012, MOL MED, V18, P270, DOI 10.2119/molmed.2011.00201; Stojanovic A, 2011, J INNATE IMMUN, V3, P355, DOI 10.1159/000325465; Sumaria N, 2009, IMMUNOL CELL BIOL, V87, P559, DOI 10.1038/icb.2009.41; Takada A, 2008, J IMMUNOL, V180, P1678, DOI 10.4049/jimmunol.180.3.1678; Tripathy SK, 2006, J VIROL, V80, P545, DOI 10.1128/JVI.80.1.545-550.2006; Yokoyama WM, 2010, BIOL BLOOD MARROW TR, V16, pS97, DOI 10.1016/j.bbmt.2009.10.009	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67295	10.1371/journal.pone.0067295	http://dx.doi.org/10.1371/journal.pone.0067295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840655	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200129
J	Hart, KM; Lamont, MM; Sartain, AR; Fujisaki, I; Stephens, BS				Hart, Kristen M.; Lamont, Margaret M.; Sartain, Autumn R.; Fujisaki, Ikuko; Stephens, Brail S.			Movements and Habitat-Use of Loggerhead Sea Turtles in the Northern Gulf of Mexico during the Reproductive Period	PLOS ONE			English	Article							STATE-SPACE MODELS; NEST-SITE FIDELITY; CARETTA-CARETTA; SATELLITE-TRACKING; GREEN TURTLE; LEATHERBACK TURTLES; CHELONIA-MYDAS; HOME-RANGE; DIVING BEHAVIOR; PATTERNS	Nesting strategies and use of important in-water habitats for far-ranging marine turtles can be determined using satellite telemetry. Because of a lack of information on habitat-use by marine turtles in the northern Gulf of Mexico, we used satellite transmitters in 2010 through 2012 to track movements of 39 adult female breeding loggerhead turtles (Caretta caretta) tagged on nesting beaches at three sites in Florida and Alabama. During the nesting season, recaptured turtles emerged to nest 1 to 5 times, with mean distance between emergences of 27.5 km; however, several turtles nested on beaches separated by similar to 250 km within a single season. Mean total distances traveled throughout inter-nesting periods for all turtles was 1422.0 +/- 930.8 km. In-water inter-nesting sites, delineated using 50% kernel density estimation (KDE), were located a mean distance of 33.0 km from land, in water with mean depth of -31.6 m; other in-water inter-nesting sites, delineated using minimum convex polygon (MCP) approach, were located a mean 13.8 km from land and in water with a mean depth of -15.8 m. Mean size of in-water inter-nesting habitats were 61.9 km(2) (50% KDEs, n = 10) and 741.4 km(2) (MCPs, n = 30); these areas overlapped significantly with trawling and oil and gas extraction activities. Abundance estimates for this nesting subpopulation may be inaccurate in light of how much spread there is between nests of the same individual. Further, our results also have consequences for critical habitat designations for northern Gulf loggerheads, as protection of one nesting beach would not encompass the entire range used by turtles during breeding seasons.	[Hart, Kristen M.] US Geol Survey, Southeast Ecol Sci Ctr, Davie, FL USA; [Lamont, Margaret M.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL USA; [Sartain, Autumn R.] Cherokee Nation Technol Solut LLC, US Geol Survey, Sci R&D, Southeast Ecol Sci Ctr, Davie, FL USA; [Fujisaki, Ikuko] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Stephens, Brail S.] Univ Florida, US Geol Survey, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Stephens, Brail S.] Univ Florida, Florida Cooperat Fish & Wildlife Res Unit, Gainesville, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida	Hart, KM (corresponding author), US Geol Survey, Southeast Ecol Sci Ctr, Davie, FL USA.	kristen_hart@usgs.gov			U.S. Geological Survey Priority Ecosystem Studies program; Natural Resource Damage Assessment for the Deepwater Horizon oil spill; EAFB Natural Resources Division	U.S. Geological Survey Priority Ecosystem Studies program(United States Geological Survey); Natural Resource Damage Assessment for the Deepwater Horizon oil spill; EAFB Natural Resources Division	Funding for this work was provided by the U.S. Geological Survey Priority Ecosystem Studies program, the Natural Resource Damage Assessment for the Deepwater Horizon oil spill, and EAFB Natural Resources Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; BJORNDAL KA, 1980, COPEIA, P525; Bjorndal KA, 2011, SCIENCE, V331, P537, DOI 10.1126/science.1199935; Blumenthal Janice M., 2006, Endangered Species Research, V7, P1; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Campagna C, 2011, BIOSCIENCE, V61, P393, DOI 10.1525/bio.2011.61.5.8; CLS, 2011, ARG US MAN WORLDW TR; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; Ehrhart LM, 1980, 19761979; Encalada SE, 1998, MAR BIOL, V130, P567, DOI 10.1007/s002270050278; ESRI, 2007, ARCGIS 9 3 GIS; Girard C, 2009, MAR BIOL, V156, P1827, DOI 10.1007/s00227-009-1216-z; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hansson M, 2000, MAR ECOL PROG SER, V198, P191, DOI 10.3354/meps198191; Hart KM, 2012, BIOL CONSERV, V145, P185, DOI 10.1016/j.biocon.2011.10.030; Hart KM, 2010, AQUAT BIOL, V11, P77, DOI 10.3354/ab00296; Hart Kristen M., 2010, Endangered Species Research, V10, P9, DOI 10.3354/esr00238; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hays GC, 2002, MAR BIOL, V141, P985, DOI 10.1007/s00227-002-0885-7; HAYS GC, 1991, J MAR BIOL ASSOC UK, V71, P743, DOI 10.1017/S0025315400053261; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Hochscheid S, 1999, MAR ECOL PROG SER, V185, P101, DOI 10.3354/meps185101; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Hooge P.H. W., 2001, ANIMAL MOVEMENT 2 5; Houghton JDR, 2002, MAR ECOL PROG SER, V227, P63, DOI 10.3354/meps227063; Hughes G. R, 1974, 36 OC RES I; IUCN, 2012, CAR IUCN RED LIST TH; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; King JR, 2005, MOL ECOL, V14, P653, DOI 10.1111/j.1365-294X.2005.02438.x; Lamont MM, 2007, CHELONIAN CONSERV BI, V6, P206, DOI 10.2744/1071-8443(2007)6[206:RONSTT]2.0.CO;2; Lamont MM, 2012, CHELONIAN CONSERV BI, V11, P190, DOI 10.2744/CCB-1006.1; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lazar B, 2011, MAR POLLUT BULL, V62, P43, DOI 10.1016/j.marpolbul.2010.09.013; Limpus CJ, 1985, STUDY LOGGERHEAD TUR; Lund F, 1986, THESIS U FLORIDA GAI; Malarde J, 2011, IMPROVING ARGOS DOPP; Marcovaldi Maria Angela, 2010, Endangered Species Research, V12, P263, DOI 10.3354/esr00308; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; McDaniel CJ, 2000, CONSERV ECOL, V4; Miller J, 2003, ECOLOGY CONSERVATION, P125; Miller JD, 1997, REPROD SEA TURTLES, P51; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Mooney KA, 2006, J ARACHNOL, V34, P241, DOI 10.1636/S03-41.1; MORTIMER JA, 1987, COPEIA, P103, DOI 10.2307/1446043; National Marine Fisheries Service, 2002, ESA BIOL OP SHRIMP T; National Marine Fisheries Service Southeast Fisheries Science Center (NMFS SEFSC), 2008, NOAA TECHNICAL MEMOR; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Phillips K, 2011, BEACH POPULATION TRE; Plotkin PT, 2002, ORYX, V36, P396, DOI 10.1017/S0030605302000753; Rees AF, 2010, MAR ECOL PROG SER, V418, P201, DOI 10.3354/meps08767; Richards Paul M., 2011, Endangered Species Research, V15, P151, DOI 10.3354/esr00379; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; SAKAMOTO W, 1993, NIPPON SUISAN GAKK, V59, P1129; SAKAMOTO W, 1990, NIPPON SUISAN GAKK, V56, P1435; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Schofield Gail, 2010, Endangered Species Research, V10, P191, DOI 10.3354/esr00137; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Schroeder B.A., 2003, LOGGERHEAD SEA TURTL, P114; Schwinghamer P, 1998, CONSERV BIOL, V12, P1215, DOI 10.1046/j.1523-1739.1998.0120061215.x; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Shamblin BM, 2012, MAR ECOL PROG SER, V469, P145, DOI 10.3354/meps09980; Shamblin BM, 2011, MAR BIOL, V158, P571, DOI 10.1007/s00227-010-1582-6; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; Steenhof K, 2009, WILSON J ORNITHOL, V121, P12, DOI 10.1676/07-177.1; STONEBURNER DL, 1982, COPEIA, P400, DOI 10.2307/1444621; Tucker AD, 2001, J HERPETOL, V35, P500, DOI 10.2307/1565970; TUCKER AD, 1991, HERPETOLOGICA, V47, P115; Turtle Expert Working Group, 2009, NMFSSEFSC575 NOAA; U.S. Department of Commerce, 2010, FED REGISTER, V75, P12598; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; White G. C., 1990, ANAL WILDLIFE RADIOT; Williams KL, 2008, SOUTHEAST NAT, V7, P165, DOI 10.1656/1528-7092(2008)7[165:TRFLTF]2.0.CO;2; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3; Zbinden JA, 2007, BIOL CONSERV, V137, P157, DOI 10.1016/j.biocon.2007.01.022	88	30	31	0	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66921	10.1371/journal.pone.0066921	http://dx.doi.org/10.1371/journal.pone.0066921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843971	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000055
J	Muniz, CP; Troncoso, LL; Moreira, MA; Soares, EA; Pissinatti, A; Bonvicino, CR; Seuanez, HN; Sharma, B; Jia, HW; Shankar, A; Switzer, WM; Santos, AF; Soares, MA				Muniz, Claudia P.; Troncoso, Lian L.; Moreira, Miguel A.; Soares, Esmeralda A.; Pissinatti, Alcides; Bonvicino, Cibele R.; Seuanez, Hector N.; Sharma, Bechan; Jia, Hongwei; Shankar, Anupama; Switzer, William M.; Santos, Andre F.; Soares, Marcelo A.			Identification and Characterization of Highly Divergent Simian Foamy Viruses in a Wide Range of New World Primates from Brazil	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; GENETIC DIVERSITY; INFECTION; HUMANS; PREVALENCE; EVOLUTION; MONKEYS; AIDS	Foamy viruses naturally infect a wide range of mammals, including Old World (OWP) and New World primates (NWP), which are collectively called simian foamy viruses (SFV). While NWP species in Central and South America are highly diverse, only SFV from captive marmoset, spider monkey, and squirrel monkey have been genetically characterized and the molecular epidemiology of SFV infection in NWPs remains unknown. We tested a large collection of genomic DNA (n = 332) comprising 14 genera of NWP species for the presence of SFV polymerase (pol) sequences using generic PCR primers. Further molecular characterization of positive samples was carried out by LTR-gag and larger pol sequence analysis. We identified novel SFVs infecting nine NWP genera. Prevalence rates varied between 14-30% in different species for which at least 10 specimens were tested. High SFV genetic diversity among NWP up to 50% in LTR-gag and 40% in pol was revealed by intragenus and intrafamilial comparisons. Two different SFV strains infecting two captive yellow-breasted capuchins did not group in species-specific lineages but rather clustered with SFVs from marmoset and spider monkeys, indicating independent cross-species transmission events. We describe the first SFV epidemiology study of NWP, and the first evidence of SFV infection in wild NWPs. We also document a wide distribution of distinct SFVs in 14 NWP genera, including two novel co-speciating SFVs in capuchins and howler monkeys, suggestive of an ancient evolutionary history in NWPs for at least 28 million years. A high SFV genetic diversity was seen among NWP, yet these viruses seem able to jump between NWP species and even genera. Our results raise concerns for the risk of zoonotic transmission of NWP SFV to humans as these primates are regularly hunted for food or kept as pets in forest regions of South America.	[Muniz, Claudia P.; Troncoso, Lian L.; Seuanez, Hector N.; Santos, Andre F.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Moreira, Miguel A.; Soares, Esmeralda A.; Bonvicino, Cibele R.; Seuanez, Hector N.; Soares, Marcelo A.] Inst Nacl Canc, Programa Genet, Rio De Janeiro, Brazil; [Pissinatti, Alcides] Ctr Primatol Rio de Janeiro, Rio De Janeiro, Brazil; [Bonvicino, Cibele R.] Inst Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil; [Sharma, Bechan] Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India; [Jia, Hongwei; Shankar, Anupama; Switzer, William M.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca); Fundacao Oswaldo Cruz; University of Allahabad; Centers for Disease Control & Prevention - USA	Soares, MA (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	masoares@biologia.ufrj.br	Ferreira, Miguel/HHZ-6251-2022; Bonvicino, Cibele/O-3390-2014; Santos, Andre FA/I-5734-2016; Sharma, Bechan/G-6836-2015; Soares, Marcelo A/G-5662-2010; Moreira, Miguel/AAN-7405-2020	Sharma, Bechan/0000-0002-7835-9406; 	Instituto Nacional de Cancer; Brazilian Research Council (CNPq) [563766/2008-5]; Rio de Janeiro State Science Foundation [E-26/102.858/2008]	Instituto Nacional de Cancer; Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation	This work was supported by intramural grants of the Instituto Nacional de Cancer, by the Brazilian Research Council (CNPq) grant # 563766/2008-5 (MAS), and by the Rio de Janeiro State Science Foundation grant # E-26/102.858/2008 (MAS). CRM was recipient of a Masters Student scholarship by CNPq while conducting this study. Use of trade names is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services, the Public Health Service, or the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUZZI A, 1993, BIOCHIM BIOPHYS ACTA, V1155, P1, DOI 10.1016/0304-419X(93)90019-9; Ayouba A, 2013, INFECT GENE IN PRESS, V18; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Betsem E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002306; Blewett EL, 2000, VIROLOGY, V278, P183, DOI 10.1006/viro.2000.0649; Boneva RS, 2007, AIDS RES HUM RETROV, V23, P1330, DOI 10.1089/aid.2007.0104; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; Casado F, 2010, J HERED, V101, P261, DOI 10.1093/jhered/esp119; Etienne L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-4; Gessain A, 2008, FUTURE VIROL, V3, P71, DOI 10.2217/17460794.3.1.71; Groves C.P., 2005, MAMMAL SPECIES WORLD, P111; Han GZ, 2012, J VIROL, V86, P7696, DOI 10.1128/JVI.00650-12; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; HERCHENRODER O, 1994, VIROLOGY, V201, P187, DOI 10.1006/viro.1994.1285; Huang F, 2012, AIDS RES HUM RETROV, V28, P591, DOI [10.1089/AID.2011.0305, 10.1089/aid.2011.0305]; Hussain AI, 2003, VIROLOGY, V309, P248, DOI 10.1016/S0042-6822(03)00070-9; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jones-Engel L, 2008, EMERG INFECT DIS, V14, P1200, DOI 10.3201/eid1408.071430; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; Khan AS, 2009, EXPERT REV ANTI-INFE, V7, P569, DOI [10.1586/eri.09.39, 10.1586/ERI.09.39]; KUPIEC JJ, 1991, GENE, V101, P185, DOI 10.1016/0378-1119(91)90410-D; Leendertz FH, 2008, J VIROL, V82, P7741, DOI 10.1128/JVI.00549-08; Leendertz SAJ, 2010, J VIROL, V84, P7427, DOI 10.1128/JVI.00697-10; Ling BH, 2004, J VIROL, V78, P8902, DOI 10.1128/JVI.78.16.8902-8908.2004; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; Menezes AN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-248; Moreira MAM, 2010, CYTOGENET GENOME RES, V128, P88, DOI 10.1159/000291485; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Mouinga-Ondeme A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-105; Murray SM, 2006, J MED PRIMATOL, V35, P225, DOI 10.1111/j.1600-0684.2006.00171.x; Nascimento FF, 2008, AM J PRIMATOL, V70, P423, DOI 10.1002/ajp.20507; Pacheco B, 2010, J VIROL, V84, P4095, DOI 10.1128/JVI.02631-09; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Sandstrom PA, 2000, LANCET, V355, P551, DOI 10.1016/S0140-6736(99)05292-7; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schweizer M, 1997, J VIROL, V71, P4821, DOI 10.1128/JVI.71.6.4821-4824.1997; Soares EA, 2010, INFECT GENET EVOL, V10, P246, DOI 10.1016/j.meegid.2009.11.012; Switzer W, 2009, 16 C RETR OPP INF MO; Switzer WM, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-100; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Switzer WM, 2004, J VIROL, V78, P2780, DOI 10.1128/JVI.78.6.2780-2789.2004; Switzer WM, 2011, MOL DETECTION VIRAL, P131; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thuemer L, 2007, VIROLOGY, V369, P191, DOI 10.1016/j.virol.2007.07.018; Wolfe ND, 2004, EMERG INFECT DIS, V10, P2094, DOI 10.3201/eid1012.040062; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	47	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67568	10.1371/journal.pone.0067568	http://dx.doi.org/10.1371/journal.pone.0067568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844033	Green Published, gold			2022-12-27	WOS:000321733000081
J	Regis, LN; Acioli, RV; Silveira, JC; Melo-Santos, MAV; Souza, WV; Ribeiro, CNMN; da Silva, JCS; Monteiro, AMV; Oliveira, CMF; Barbosa, RMR; Braga, C; Rodrigues, MAB; Silva, MGNM; Ribeiro, PJ; Bonat, WH; Medeiros, LCD; Carvalho, MS; Furtado, AF				Regis, Leda N.; Acioli, Ridelane Veiga; Silveira, Jose Constantino, Jr.; Varjal Melo-Santos, Maria Alice; Souza, Wayner Vieira; Nogueira Ribeiro, Candida M.; Serafim da Silva, Juliana C.; Vieira Monteiro, Antonio Miguel; Oliveira, Claudia M. F.; Barbosa, Rosangela M. R.; Braga, Cynthia; Benedetti Rodrigues, Marco Aurelio; Silva, Marilu Gomes N. M.; Ribeiro, Paulo Justiniano, Jr.; Bonat, Wagner Hugo; de Castro Medeiros, Liliam Cesar; Carvalho, Marilia Sa; Furtado, Andre Freire			Sustained Reduction of the Dengue Vector Population Resulting from an Integrated Control Strategy Applied in Two Brazilian Cities	PLOS ONE			English	Article							MASS TRAPPING SCHEME; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; BACILLUS-SPHAERICUS; EMILIA-ROMAGNA; URBAN AREA; ALBOPICTUS; CULICIDAE; DIPTERA; SURVEILLANCE	Aedes aegypti has developed evolution-driven adaptations for surviving in the domestic human habitat. Several trap models have been designed considering these strategies and tested for monitoring this efficient vector of Dengue. Here, we report a real-scale evaluation of a system for monitoring and controlling mosquito populations based on egg sampling coupled with geographic information systems technology. The SMCP-Aedes, a system based on open technology and open data standards, was set up from March/2008 to October/2011 as a pilot trial in two sites of Pernambuco Brazil: Ipojuca (10,000 residents) and Santa Cruz (83,000), in a joint effort of health authorities and staff, and a network of scientists providing scientific support. A widespread infestation by Aedes was found in both sites in 2008-2009, with 96.8%-100% trap positivity. Egg densities were markedly higher in SCC than in Ipojuca. A 90% decrease in egg density was recorded in SCC after two years of sustained control pressure imposed by suppression of >7,500,000 eggs and >3,200 adults, plus larval control by adding fishes to cisterns. In Ipojuca, 1.1 million mosquito eggs were suppressed and a 77% reduction in egg density was achieved. This study aimed at assessing the applicability of a system using GIS and spatial statistic analysis tools for quantitative assessment of mosquito populations. It also provided useful information on the requirements for reducing well-established mosquito populations. Results from two cities led us to conclude that the success in markedly reducing an Aedes population required the appropriate choice of control measures for sustained mass elimination guided by a user-friendly mosquito surveillance system. The system was able to support interventional decisions and to assess the program's success. Additionally, it created a stimulating environment for health staff and residents, which had a positive impact on their commitment to the dengue control program.	[Regis, Leda N.; Silveira, Jose Constantino, Jr.; Varjal Melo-Santos, Maria Alice; Oliveira, Claudia M. F.; Barbosa, Rosangela M. R.] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Entomol, Recife, PE, Brazil; [Acioli, Ridelane Veiga] Secretaria Estadual Saude, Recife, PE, Brazil; [Souza, Wayner Vieira] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Saude Colet, Recife, PE, Brazil; [Nogueira Ribeiro, Candida M.] Secretaria Municipal Saude, Santa Cruz Do Capibaribe, PE, Brazil; [Serafim da Silva, Juliana C.] Secretaria Municipal Saude, Ipojuca, PE, Brazil; [Vieira Monteiro, Antonio Miguel] INPE, Div Proc Imagens, Sao Jose Dos Campos, SP, Brazil; [Braga, Cynthia] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Parasitol, Recife, PE, Brazil; [Benedetti Rodrigues, Marco Aurelio; Silva, Marilu Gomes N. M.] Univ Fed Pernambuco, Dept Eletron & Sistemas, Recife, PE, Brazil; [Ribeiro, Paulo Justiniano, Jr.; Bonat, Wagner Hugo] Univ Fed Parana, Dept Estat, BR-80060000 Curitiba, PR, Brazil; [de Castro Medeiros, Liliam Cesar] Ctr Ciencia Sistema Terr, INPE, Sao Jose Dos Campos, SP, Brazil; [Carvalho, Marilia Sa] Fundacao Oswaldo Cruz Fiocruz, Rio De Janeiro, RJ, Brazil; [Furtado, Andre Freire] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Virol, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Instituto Nacional de Pesquisas Espaciais (INPE); Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Universidade Federal do Parana; Instituto Nacional de Pesquisas Espaciais (INPE); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Regis, LN (corresponding author), Fundacao Oswaldo Cruz Fiocruz Pe, Dept Entomol, Recife, PE, Brazil.	leda@cpqam.fiocruz.br	Medeiros, Líliam/J-8593-2014; Souza, Wayner V/H-3798-2013; Braga, Cynthia/A-8204-2013; CARVALHO, MARILIA/AAD-8283-2020; Barbosa, Rosângela/AAC-3339-2020; Ribeiro, Paulo/GYA-1014-2022; Monteiro, Antonio Miguel Vieira/C-1757-2012	Braga, Cynthia/0000-0002-7862-6455; CARVALHO, MARILIA/0000-0002-9566-0284; Barbosa, Rosângela/0000-0002-1171-598X; Monteiro, Antonio Miguel Vieira/0000-0003-1477-1749; Ribeiro Junior, Paulo Justiniano/0000-0001-5302-9446; Benedetti Rodrigues, Marco Aurelio/0000-0002-5143-3696; Souza, Wayner/0000-0002-0939-9332; Medeiros, Liliam/0000-0002-8142-6673; Silva, Juliana/0000-0002-0201-8883	CNPq [PQ-301277/2005-2, APQ-479214/2010-7]; FACEPE [APQ-0692-2.13/08]; PDTSP-FIOCRUZ [RDVE-03]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); PDTSP-FIOCRUZ	This work received financial support from grants from CNPq, http://www.cnpq.br (PQ-301277/2005-2 and APQ-479214/2010-7); FACEPE, http://www.facepe.br (APQ-0692-2.13/08); and PDTSP-FIOCRUZ, http://www.fiocruz.br (RDVE-03). The State Health Department of Pernambuco offered ground transport for people and materials related to the project from Recife to Santa Cruz do Capibaribe and Ipojuca, during 2008-2011. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albieri A, 2010, B INSECTOL, V63, P209; Bailey T, 1995, INTERACTIVE SPATIAL; Barbazan P, 1997, J AM MOSQUITO CONTR, V13, P263; Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Beech C, 2009, ASIA PAC J MOL BIOL, V17, P75; Bellini R, 1996, J AM MOSQUITO CONTR, V12, P632; Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154; Bonat WH, 2009, REV BRAS BIOM, V27, P519; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; Chansang C, 2007, AM J TROP MED HYG, V77, P897, DOI 10.4269/ajtmh.2007.77.897; De Barro P, 2011, J VERBRAUCH LEBENSM, V6, P1, DOI 10.1007/s00003-011-0692-5; Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x; Lagrotta MT, 2008, CAD SAUDE PUBLICA, V24, P70, DOI 10.1590/S0102-311X2008000100007; Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505; HOUGARD JM, 1993, B WORLD HEALTH ORGAN, V71, P367; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Kaplan L, 2010, BIOL INVASIONS, V12, P3277, DOI 10.1007/s10530-010-9721-z; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Kay BH, 2010, AM J TROP MED HYG, V82, P822, DOI 10.4269/ajtmh.2010.09-0503; Khatchikian C, 2011, MED VET ENTOMOL, V25, P268, DOI 10.1111/j.1365-2915.2010.00935.x; Kittayapong P, 2008, AM J TROP MED HYG, V78, P70, DOI 10.4269/ajtmh.2008.78.70; Kumar A, 1996, J AM MOSQUITO CONTR, V12, P409; Lenhart AE, 2005, ACTA TROP, V96, P56, DOI 10.1016/j.actatropica.2005.06.020; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; MONTGOMERY BL, 2005, ARBOVIRUS RES AUST, V9, P268; Morato VCG, 2005, REV SAUDE PUBL, V39, P553, DOI 10.1590/S0034-89102005000400006; Obenauer PJ, 2009, J MED ENTOMOL, V46, P1507, DOI 10.1603/033.046.0639; Polson K. A., 2002, Dengue Bulletin, V26, P178; Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x; Regis L, 2000, T ROY SOC TROP MED H, V94, P488, DOI 10.1016/S0035-9203(00)90061-0; Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008; Regis L, 2009, AN ACAD BRAS CIENC, V81, P655, DOI 10.1590/S0001-37652009000400004; Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076; Ritchie SA, 2009, MED VET ENTOMOL, V23, P295, DOI 10.1111/j.1365-2915.2009.00833.x; Santos S. R. A., 2003, Dengue Bulletin, V27, P156; SCHOFIELD CJ, 1991, ANN SOC BELG MED TR, V71, P201; Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001; Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77; Silva MGNM, 2011, 33 ANN INT C IEEE EN; Silva-Filha MH, 2001, J AM MOSQUITO CONTR, V17, P45; Stein M, 2005, REV SAUDE PUBL, V39, P559, DOI 10.1590/S0034-89102005000400007; Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003; WHO, 2011, TECHNICAL PUBLICATIO, V60; Williams CR, 2005, ARBOVIRUS RES AUSTR, V9, P397; Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2	53	38	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67682	10.1371/journal.pone.0067682	http://dx.doi.org/10.1371/journal.pone.0067682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844059	Green Published, gold			2022-12-27	WOS:000321733000092
J	Wang, MY; Verdier, J; Benedito, VA; Tang, YH; Murray, JD; Ge, YB; Becker, JD; Carvalho, H; Rogers, C; Udvardi, M; He, J				Wang, Mingyi; Verdier, Jerome; Benedito, Vagner A.; Tang, Yuhong; Murray, Jeremy D.; Ge, Yinbing; Becker, Joerg D.; Carvalho, Helena; Rogers, Christian; Udvardi, Michael; He, Ji			LegumeGRN: A Gene Regulatory Network Prediction Server for Functional and Comparative Studies	PLOS ONE			English	Article							EXPRESSION ATLAS; INFERENCE; DATABASE; ASSOCIATION; INFORMATION; PATHWAY; WEB	Building accurate gene regulatory networks (GRNs) from high-throughput gene expression data is a long-standing challenge. However, with the emergence of new algorithms combined with the increase of transcriptomic data availability, it is now reachable. To help biologists to investigate gene regulatory relationships, we developed a web-based computational service to build, analyze and visualize GRNs that govern various biological processes. The web server is preloaded with all available Affymetrix GeneChip-based transcriptomic and annotation data from the three model legume species, i.e., Medicago truncatula, Lotus japonicus and Glycine max. Users can also upload their own transcriptomic and transcription factor datasets from any other species/organisms to analyze their in-house experiments. Users are able to select which experiments, genes and algorithms they will consider to perform their GRN analysis. To achieve this flexibility and improve prediction performance, we have implemented multiple mainstream GRN prediction algorithms including co-expression, Graphical Gaussian Models (GGMs), Context Likelihood of Relatedness (CLR), and parallelized versions of TIGRESS and GENIE3. Besides these existing algorithms, we also proposed a parallel Bayesian network learning algorithm, which can infer causal relationships (i.e., directionality of interaction) and scale up to several thousands of genes. Moreover, this web server also provides tools to allow integrative and comparative analysis between predicted GRNs obtained from different algorithms or experiments, as well as comparisons between legume species. The web site is available at http://legumegrn.noble.org.	[Wang, Mingyi; Verdier, Jerome; Tang, Yuhong; Ge, Yinbing; Udvardi, Michael; He, Ji] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; [Benedito, Vagner A.] W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; [Murray, Jeremy D.; Rogers, Christian] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Becker, Joerg D.] Inst Gulbenkian Ciencias, Plant Genom Lab, Oeiras, Portugal; [Carvalho, Helena] Univ Porto, Inst Mol & Cell Biol, P-4100 Oporto, Portugal; [He, Ji] NCI, Canc Genom Res Lab, Div Canc Epidemiol & Genet, SAIC Frederick Inc, Bethesda, MD 20892 USA	Noble Research Institute; West Virginia University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Instituto Gulbenkian de Ciencia; Universidade do Porto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Wang, MY (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, POB 2180, Ardmore, OK 73402 USA.	mwang@noble.org	Murray, Jeremy D./F-8409-2011; Udvardi, Michael/GPX-4653-2022; Becker, Jorg/A-5930-2011; Carvalho, Helena G/E-9357-2012	Murray, Jeremy D./0000-0003-3000-9199; Udvardi, Michael/0000-0001-9850-0828; Becker, Jorg/0000-0002-6845-6122; Carvalho, Helena G/0000-0003-0651-7601; Tang, Yuhong/0000-0003-2967-778X; Verdier, Jerome/0000-0003-3039-2159	Oklahoma Center for The Advancement of Science and Technology (OCAST) [PSB11-031]; BBSRC [BB/I025441/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025441/1] Funding Source: researchfish	Oklahoma Center for The Advancement of Science and Technology (OCAST); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Oklahoma Center for The Advancement of Science and Technology (OCAST Grant No. PSB11-031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Brown G., 2005, Information Fusion, V6, P5, DOI 10.1016/j.inffus.2004.04.004; Chen T, 1999, Pac Symp Biocomput, P29; Colombo DM, 2012, MODIFICATION PC ALGO; de Borda JC, 1781, MEMOIRE ELECT SCRUTI; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Goffard N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-87; Goffard N, 2006, BIOINFORMATICS, V22, P2958, DOI 10.1093/bioinformatics/btl517; Haibe-Kains B, 2012, NUCLEIC ACIDS RES, V40, pD866, DOI 10.1093/nar/gkr1050; Haury A.-C., 2012, TIGRESS TRUSTFUL INF; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Kuffner R, 2012, BIOINFORMATICS, V28, P1376, DOI 10.1093/bioinformatics/bts143; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Monke G, 2012, NUCLEIC ACIDS RES, V40, P8240, DOI 10.1093/nar/gks594; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; OPITZ D, 1999, J ARTIFICIAL INTELLI, V11, P12; Parcy F, 1997, PLANT CELL, V9, P1265, DOI 10.1105/tpc.9.8.1265; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Shoemaker RC, 1996, GENETICS, V144, P329; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Teng S, 2008, PLANT J, V55, P372, DOI 10.1111/j.1365-313X.2008.03515.x; Verdier J, 2013, PLANT J, V74, P351, DOI 10.1111/tpj.12119; Wang MY, 2010, MOL BIOSYST, V6, P988, DOI 10.1039/b917571g; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Watanabe Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S12; Xiao YF, 2009, CURR GENOMICS, V10, P511, DOI 10.2174/138920209789208237	42	6	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67434	10.1371/journal.pone.0067434	http://dx.doi.org/10.1371/journal.pone.0067434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844010	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000072
J	Maatz, A; Strauss, B; Bar, KJ				Maatz, Anke; Strauss, Bernhard; Baer, Karl-Juergen			Development and Validation of a Set of German Stimulus-and Target Words for an Attachment Related Semantic Priming Paradigm	PLOS ONE			English	Article							ADULT ATTACHMENT; RESPONSES; CORTISOL; SELF; PSYCHOPHYSIOLOGY; REPRESENTATIONS; ACCESSIBILITY; ENVIRONMENT; ACTIVATION; STRATEGIES	Experimental research in adult attachment theory is faced with the challenge to adequately activate the adult attachment system. In view of the multitude of methods employed for this purpose so far, this paper suggests to further make use of the methodological advantages of semantic priming. In order to enable the use of such a paradigm in a German speaking context, a set of German words belonging to the semantic categories 'interpersonal closeness', 'interpersonal distance' and 'neutral' were identified and their semantics were validated combining production-and rating method. 164 university students answered corresponding online-questionnaires. Ratings were analysed using analysis of variance (ANOVA) and cluster analysis from which three clearly distinct groups emerged. Beyond providing validated stimulus-and target words which can be used to activate the adult attachment system in a semantic priming paradigm, the results of this study point at important links between attachment and stress which call for further investigation in the future.	[Maatz, Anke; Strauss, Bernhard] Univ Hosp Jena, Inst Psychosocial Med & Psychotherapy, Jena, Germany; [Baer, Karl-Juergen] Univ Hosp Jena, Dept Psychiat & Psychotherapy, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Maatz, A (corresponding author), Univ Hosp Jena, Inst Psychosocial Med & Psychotherapy, Jena, Germany.	anke.maatz@puk.zh.ch			Institute of Psychosocial Medicine and Psychotherapy, University Hospital, Jena	Institute of Psychosocial Medicine and Psychotherapy, University Hospital, Jena	All study expenses were covered by the Institute of Psychosocial Medicine and Psychotherapy, University Hospital, Jena. The funders had to role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichert I, COMPUTERBASIERTE KON; Aichert I, COMPUTERGESTUT UNPUB; Ainsworth M, 1969, DETERMINANTS INFANT, P113; Ainsworth M., 1978, PATTERNS ATTACHMENT; Atkinson L, 2009, DEV PSYCHOPATHOL, V21, P99, DOI 10.1017/S0954579409000078; Banse R, 1999, J SOC PERS RELAT, V16, P803, DOI 10.1177/0265407599166007; Besser A, 2009, J PERS, V77, P287, DOI 10.1111/j.1467-6494.2008.00546.x; Bowlby J., 1973, ATTACHMENT LOSS, P1; Bowlby J., 1969, ATTACHMENT AND LOSS; Bowlby J., 1980, ATTACHMENT AND LOSS; Brooks KP, 2011, PERS RELATIONSHIP, V18, P302, DOI 10.1111/j.1475-6811.2011.01357.x; Buchheim A, 2006, PSYCHOPATHOLOGY, V39, P144, DOI 10.1159/000091800; Buchheim A, 2006, PSYCHOPATHOLOGY, V39, P136, DOI 10.1159/000091799; Buchheim A, 2008, PSYCHIAT RES-NEUROIM, V163, P223, DOI 10.1016/j.pscychresns.2007.07.001; Buchheim A, 2007, Z PSYCHOSOM MED PSYC, V53, P339; Buchheim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033745; Cassidy J, 2009, J SOC CLIN PSYCHOL, V28, P463, DOI 10.1521/jscp.2009.28.4.463; Cofer CN, 1971, SCHLOSBERGS EXPT PSY, P847; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Crowell JA, 2002, DEV PSYCHOL, V38, P679, DOI 10.1037//0012-1649.38.5.679; Diamond LM, 2006, J SOC PERS RELAT, V23, P205, DOI 10.1177/0265407506062470; DOZIER M, 1992, CHILD DEV, V63, P1473, DOI 10.2307/1131569; Ehrenthal JC, 2011, STRESS HEALTH, V27, P251, DOI 10.1002/smi.1326; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Lahl O, 2009, BEHAV RES METHODS, V41, P13, DOI 10.3758/BRM.41.1.13; Levy K. N., 2011, PSYCHOTHERAPY RELATI, P377, DOI DOI 10.1093/ACPROF:OSO/9780199737208.003.0019; Maier MA, 2004, INT J BEHAV DEV, V28, P180, DOI 10.1080/01650250344000398; Mikulincer M, 2000, J PERS SOC PSYCHOL, V78, P509, DOI 10.1037/0022-3514.78.3.509; Mikulincer M, 2005, J PERS SOC PSYCHOL, V89, P817, DOI 10.1037/0022-3514.89.5.817; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Mikulincer M, 2002, J PERS SOC PSYCHOL, V83, P881, DOI 10.1037//0022-3514.83.4.881; Powers SI, 2006, J PERS SOC PSYCHOL, V90, P613, DOI 10.1037/0022-3514.90.4.613; Prenn N, 2011, J PSYCHOTHER INTEGR, V21, P308, DOI 10.1037/a0025491; Radcliffe N, 2001, AVOIDANT ATTACHMENT; Rifkin-Graboi A, 2008, STRESS, V11, P210, DOI 10.1080/10253890701706670; Roisman GI, 2004, DEV PSYCHOL, V40, P776, DOI 10.1037/0012-1649.40.5.776; Roisman GI, 2007, DEV PSYCHOL, V43, P39, DOI 10.1037/0012-1649.43.1.39; Vo MLH, 2006, BEHAV RES METHODS, V38, P606, DOI 10.3758/BF03193892; Waller E, 2008, PID PSYCHOTHERAPIE D, V9, P283; Zeanah CH, 2011, J CHILD PSYCHOL PSYC, V52, P819, DOI 10.1111/j.1469-7610.2011.02399.x; Zerback T., 2009, SOZIALFORSCHUNG INTE, P91, DOI DOI 10.1007/978-3-531-91791-76; Zhang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027253	42	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67684	10.1371/journal.pone.0067684	http://dx.doi.org/10.1371/journal.pone.0067684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844061	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000075
J	Bertamini, M; Makin, A; Pecchinenda, A				Bertamini, Marco; Makin, Alexis; Pecchinenda, Anna			Testing Whether and When Abstract Symmetric Patterns Produce Affective Responses	PLOS ONE			English	Article							PERCEPTUAL FLUENCY; ELECTROPHYSIOLOGICAL INDEXES; SELECTIVE ATTENTION; BEAUTY; PLEASURE; JUDGMENT; FACE	Symmetry has a central role in visual art, it is often linked to beauty, and observers can detect it efficiently in the lab. We studied what kind of fast and automatic responses are generated by visual presentation of symmetrical patterns. Specifically, we tested whether a brief presentation of novel symmetrical patterns engenders positive affect using a priming paradigm. The abstract patterns were used as primes in a pattern-word interference task. To ensure that familiarity was not a factor, no pattern and no word was ever repeated within each experiment. The task was to classify words that were selected to have either positive or negative valence. We tested irregular patterns, patterns containing vertical and horizontal reflectional symmetry, and patterns containing a 90 deg rotation. In a series of 7 experiments we found that the effect of affective congruence was present for both types of regularity but only when observers had to classify the regularity of the pattern after responding to the word. The findings show that processing abstract symmetrical shapes or random pattern can engender positive or negative affect as long as the regularity of the pattern is a feature that observers have to attend to and classify.	[Bertamini, Marco; Makin, Alexis] Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England; [Pecchinenda, Anna] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy	University of Liverpool; Sapienza University Rome	Bertamini, M (corresponding author), Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England.	m.bertamini@liv.ac.uk	Bertamini, Marco/C-2495-2011; Bertamini, Marco/H-2752-2019; Makin, Alexis/I-9828-2019	Bertamini, Marco/0000-0001-8617-6864; Bertamini, Marco/0000-0001-8617-6864; Makin, Alexis/0000-0002-4490-7400; Pecchinenda, Anna/0000-0001-9139-5295	Economic and Social Research Council; Leverhulme Trust; ESRC [ES/K000187/1] Funding Source: UKRI; Economic and Social Research Council [ES/K000187/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust(Leverhulme Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	MB was supported in part by a grant from the Economic and Social Research Council and the Leverhulme Trust. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Arnheim R., 1974, ART VISUAL PERCEPTIO; BARLOW HB, 1979, VISION RES, V19, P783, DOI 10.1016/0042-6989(79)90154-8; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Bertamini M, 1997, ACTA PSYCHOL, V95, P119, DOI 10.1016/S0001-6918(96)00038-8; Bertamini M, 2010, PERCEPTION, V39, P27, DOI 10.1068/p6393; Biederman I, 2006, AM SCI, V94, P247, DOI 10.1511/2006.3.247; BORNSTEIN RF, 1994, SOC COGNITION, V12, P103, DOI 10.1521/soco.1994.12.2.103; BRUCE VG, 1975, PERCEPTION, V4, P239, DOI 10.1068/p040239; Cavanagh P, 2005, NATURE, V434, P301, DOI 10.1038/434301a; Dittrich K, 2012, COGNITION EMOTION, V26, P193, DOI 10.1080/02699931.2011.570313; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; Fuster JM, 2009, J COGNITIVE NEUROSCI, V21, P2047, DOI 10.1162/jocn.2009.21280; Garner W. R., 1974, PROCESSING INFORM ST; GLASER WR, 1984, J EXP PSYCHOL HUMAN, V10, P640, DOI 10.1037/0096-1523.10.5.640; Hofel L, 2007, INT J PSYCHOPHYSIOL, V65, P20, DOI 10.1016/j.ijpsycho.2007.02.007; Hofel L, 2003, PERCEPT MOTOR SKILL, V96, P30, DOI 10.2466/pms.2003.96.1.30; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Jacobsen T, 2003, COGN AFFECT BEHAV NE, V3, P289, DOI 10.3758/CABN.3.4.289; KUBOVY M, 2000, ENCY PSYCHOL, P188; LATTO R, 1995, ARTFUL EYE, P66; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; MACH E, 1886, ANAL SENSATINS RELAT; Makin ADJ, 2012, NEUROPSYCHOLOGIA, V50, P3250, DOI 10.1016/j.neuropsychologia.2012.10.003; Makin ADJ, 2012, EMOTION, V12, P1021, DOI 10.1037/a0026924; McManus I.C., 1997, EMPIR STUD ARTS, V15, P209, DOI [10.2190/WWCR-VWHV-2Y2W-91EE, DOI 10.2190/WWCR-VWHV-2Y2W-91EE]; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; MOLLER AP, 1992, NATURE, V357, P238, DOI 10.1038/357238a0; Olivers CNL, 1998, PERCEPT PSYCHOPHYS, V60, P1101, DOI 10.3758/BF03206161; PALMER SE, 1978, J EXP PSYCHOL HUMAN, V4, P691, DOI 10.1037/0096-1523.4.4.691; PALMER SE, 1991, PERCEPTION OF STRUCTURE, P23, DOI 10.1037/10101-001; Pecchinenda A, 2007, EUR J COGN PSYCHOL, V19, P898, DOI 10.1080/09541440601095388; Pecchinenda A, 2006, EXP PSYCHOL, V53, P268, DOI 10.1027/1618-3169.53.4.268; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Ramachandran V.S., 1999, J CONSCIOUSNESS STUD, V6, P15, DOI [10.1179/174327908X392906, DOI 10.1179/174327908X392906]; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Reber R, 2004, CONSCIOUS COGN, V13, P47, DOI 10.1016/S1053-8100(03)00049-7; Reber R., 2006, POLISH PSYCHOL B, V37, P16; ROYER FL, 1981, J EXP PSYCHOL HUMAN, V7, P1186, DOI 10.1037/0096-1523.7.6.1186; Sasaki Y, 2005, P NATL ACAD SCI USA, V102, P3159, DOI 10.1073/pnas.0500319102; Stenberg G, 1998, COGNITION EMOTION, V12, P755, DOI 10.1080/026999398379420; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V258, P267, DOI 10.1098/rspb.1994.0172; WAGEMANS J, 1995, SPATIAL VISION, V9, P9, DOI 10.1163/156856895X00098; Washburn Dorothy, 1988, SYMMETRIES CULTURE; WEYL H, 1953, SYMMETRY; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zeki S., 1999, INNER VISION EXPLORA	52	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68403	10.1371/journal.pone.0068403	http://dx.doi.org/10.1371/journal.pone.0068403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	175ZH	23840892	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900031
J	Ebrahim, S; Guyatt, GH; Walter, SD; Heels-Ansdell, D; Bellman, M; Hanna, SE; Patelis-Siotis, I; Busse, JW				Ebrahim, Shanil; Guyatt, Gordon H.; Walter, Stephen D.; Heels-Ansdell, Diane; Bellman, Marg; Hanna, Steven E.; Patelis-Siotis, Irene; Busse, Jason W.			Association of Psychotherapy with Disability Benefit Claim Closure among Patients Disabled Due to Depression	PLOS ONE			English	Article							LONG-TERM-DISABILITY; LOW-BACK-PAIN; PROGNOSTIC-FACTORS; MENTAL-DISORDERS; SICK LEAVE; WORK; RETURN; PSYCHOPATHOLOGY; EMPLOYEES; THERAPY	Background: Depression is the most frequent reason for receiving disability benefits in North America, and treatment with psychotherapy is often funded by private insurers. No studies have explored the association between the provision of psychotherapy for depression and time to claim closure. Methods: Using administrative data from a Canadian disability insurer, we evaluated the association between the provision of psychotherapy and short-term disability (STD) and long-term disability (LTD) claim closure by performing Cox proportional hazards regression. Results: We analyzed 10,508 STD and 10,338 LTD claims for depression. In our adjusted analyses, receipt of psychotherapy was associated with longer time to STD closure (HR [99% CI] = 0.81 [0.68 to 0.97]) and faster LTD claim closure (1.42 [1.33 to 1.52]). In both STD and LTD, older age (0.90 [0.88 to 0.92] and 0.83 [0.80 to 0.85]), per decade), a primary diagnosis of recurrent depression versus non-recurrent major depression (0.78 [0.69 to 0.87] and 0.80 [0.72 to 0.89]), a psychological secondary diagnosis (0.90 [0.84 to 0.97] and 0.66 [0.61 to 0.71]), or a non-psychological secondary diagnosis (0.81 [0.73 to 0.90] and 0.77 [0.71 to 0.83]) versus no secondary diagnosis, and an administrative services only policy ([0.94 [0.88 to 1.00] and 0.87 [0.75 to 0.996]) or refund policy (0.86 [0.80 to 0.92] and 0.73 [0.68 to 0.78]) compared to non-refund policy claims were independently associated with longer time to STD claim closure. Conclusions: We found, paradoxically, that receipt of psychotherapy was independently associated with longer time to STD claim closure and faster LTD claim closure in patients with depression. We also found multiple factors that were predictive of time to both STD and LTD claim closure. Our study has limitations, and well-designed prospective studies are needed to establish the effect of psychotherapy on disabling depression.	[Ebrahim, Shanil; Guyatt, Gordon H.; Walter, Stephen D.; Heels-Ansdell, Diane; Hanna, Steven E.; Busse, Jason W.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Ebrahim, Shanil; Busse, Jason W.] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Bellman, Marg] Sun Life Financial, Policy & Procedure Dept, Natl Disabil Serv, Toronto, ON, Canada; [Patelis-Siotis, Irene] McMaster Univ, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Ebrahim, S (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	shanil.ebrahim@utoronto.ca	Walter, Stephen/AAB-5548-2022; Busse, Jason/CAH-3696-2022	Walter, Stephen/0000-0003-4157-8928; Busse, Jason/0000-0002-0178-8712; Hanna, Steven/0000-0003-3120-9600				[Anonymous], 2002, MENT HLTH NEW UND NE; Bellman M, 2010, COMMUNICATION; Blank L, 2008, J OCCUP REHABIL, V18, P27, DOI 10.1007/s10926-008-9121-8; Brown P, 2001, BRIT MED J, V323, P769, DOI 10.1136/bmj.323.7316.769; Romero CC, 2011, REV CALID ASSIST, V26, P39, DOI 10.1016/j.cali.2010.11.006; Cornelius LR, 2011, J OCCUP REHABIL, V21, P259, DOI 10.1007/s10926-010-9261-5; Dekkers-Sanchez PM, 2008, OCCUP ENVIRON MED, V65, P153, DOI 10.1136/oem.2007.034983; Detaille SI, 2009, SCAND J WORK ENV HEA, V35, P261, DOI 10.5271/sjweh.1337; Dewa CS, 2003, PSYCHIAT SERV, V54, P724, DOI 10.1176/appi.ps.54.5.724; Dobson K., 2001, HDB COGNITIVE BEHAV; Ebrahim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050202; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P268, DOI 10.4088/JCP.v61n0405; Hunter MS, 2002, J PSYCHOSOM OBST GYN, V23, P193, DOI 10.3109/01674820209074672; Kouzis AC, 2000, PSYCHIATR SERV, V51, P908, DOI 10.1176/appi.ps.51.7.908; KOUZIS AC, 1994, AM J PUBLIC HEALTH, V84, P1304, DOI 10.2105/AJPH.84.8.1304; Kouzis AC, 1997, SOC PSYCH PSYCH EPID, V32, P379; Kronstrom K, 2011, J AFFECT DISORDERS, V130, P294, DOI 10.1016/j.jad.2010.10.003; Lagerveld SE, 2012, J OCCUP HEALTH PSYCH, V17, P220, DOI 10.1037/a0027049; Leahy Robert L., 2003, ROADBLOCKS COGNITIVE; Lim KL, 2008, CHRONIC DIS CAN, V28, P92; MOORE R, 1997, EC BURDEN ILLNESS CA; Mor N, 2009, ISR J PSYCHIATR REL, V46, P269; NICE, 2009, DEPR TREATM MAN DEPR; Nielson MBD, 2010, EUR J PUBLIC HEALTH, V21, P806; Norman GR, 2008, BIOSTATISTICS BARE E, V3rd; Rose VK, 2012, OCCUP MED-OXFORD, V62, P298, DOI 10.1093/occmed/kqs038; Salkever DS, 2000, MILBANK Q, V78, P79, DOI 10.1111/1468-0009.00162; Steenstra IA, 2012, J OCCUP REHABIL, V22, P394, DOI 10.1007/s10926-011-9349-6; Steenstra IA, 2005, OCCUP ENVIRON MED, V62, P851, DOI 10.1136/oem.2004.015842; Stephens T, 2001, CHRONIC DIS CANADA, V22, P1; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Werner EL, 2009, EUR J GEN PRACT, V15, P74, DOI 10.1080/13814780903051866	33	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67162	10.1371/journal.pone.0067162	http://dx.doi.org/10.1371/journal.pone.0067162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840614	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400040
J	Jay, DC; Mitchell, DM; Williams, MA				Jay, David C.; Mitchell, Diana M.; Williams, Matthew A.			Bim Mediates the Elimination of Functionally Unfit Th1 Responders from the Memory Pool	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; APOPTOSIS REGULATORS FAS; FAMILY-MEMBER BIM; T-CELL REPERTOIRE; TRANSCRIPTION FACTOR; VIRAL-INFECTION; IMMUNE-RESPONSES; SECONDARY STIMULUS; RECALL RESPONSES; EFFECTOR	Selective clonal deletion in the CD4(+) T cell compartment during the transition from effector to memory is accompanied by enhanced expression of the pro-apoptotic Bcl-2 family member Bim. Here, we show that Bim deficiency enables the survival of poorly functional Th1 responders that are normally eliminated during contraction. However, rescued bim(-/-) CD4(+) "memory'' T cells continued to demonstrate deficient effector functions, poor sensitivity to antigen and an inability to respond to secondary challenge. Our results demonstrate that Bim activity plays a key role in shaping the CD4(+) memory T cell repertoire, ensuring the emergence of highly functional CD4(+) memory T cells and the elimination of Th1 effector cells with sub-optimal function. We propose that Bim is a key mediator of T cell death in the absence of appropriate TCR-driven activation and differentiation.	[Jay, David C.; Mitchell, Diana M.; Williams, Matthew A.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Williams, MA (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	matthew.williams@path.utah.edu		Williams, Matthew/0000-0002-4721-4482	National Institutes of Health [R01AI080830]; Department of Pathology at the University of Utah; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology at the University of Utah; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (R01AI080830) and the Department of Pathology at the University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Blattman JN, 2000, J IMMUNOL, V165, P6081, DOI 10.4049/jimmunol.165.11.6081; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bunin A, 2005, J IMMUNOL, V175, P1532, DOI 10.4049/jimmunol.175.3.1532; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Fortner KA, 2010, EUR J IMMUNOL, V40, P3043, DOI 10.1002/eji.201040577; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kim C, 2012, J IMMUNOL, V189, P2348, DOI 10.4049/jimmunol.1200244; Kim C, 2010, IMMUNOLOGY, V131, P310, DOI 10.1111/j.1365-2567.2010.03338.x; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Mendoza LM, 1997, IMMUNITY, V7, P461, DOI 10.1016/S1074-7613(00)80368-4; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; OLDSTONE MBA, 1988, J EXP MED, V168, P559, DOI 10.1084/jem.168.2.559; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Ravkov EV, 2009, J IMMUNOL, V183, P2382, DOI 10.4049/jimmunol.0900319; Reckling S, 2008, INFECT IMMUN, V76, P1179, DOI 10.1128/IAI.01093-06; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; WHITTON JL, 1988, VIROLOGY, V162, P321, DOI 10.1016/0042-6822(88)90471-0; WHITTON JL, 1988, J VIROL, V62, P687, DOI 10.1128/JVI.62.3.687-695.1988; Williams MA, 2004, J IMMUNOL, V173, P6694, DOI 10.4049/jimmunol.173.11.6694; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897	40	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67363	10.1371/journal.pone.0067363	http://dx.doi.org/10.1371/journal.pone.0067363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840678	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400069
J	Liu, B; Yang, Y; Xie, L; Zeng, G; Ma, KP				Liu, Bing; Yang, Yong; Xie, Lei; Zeng, Gang; Ma, Keping			Beilschmiedia turbinata: A Newly Recognized but Dying Species of Lauraceae from Tropical Asia Based on Morphological and Molecular Data	PLOS ONE			English	Article							SOUTHERN YUNNAN; PHYLOGENY; CHLOROPLAST; GENERA; GENUS; BIOGEOGRAPHY; EVOLUTION; LITSEA; CLASSIFICATION; PHYSIOGNOMY	China took great efforts to reforestation, even turned the long-term forest loss into a net gain, but this cannot hide the loss of species diversity due to destruction of primary forests, habitat loss, invasion of alien species, and over exploitation. Here we provide such a case by recording a dying tree species of Lauraceae from the evergreen forests of SE Yunnan of China and adjoining Vietnam. We made field collections and observations for four consecutive years from 2009 to 2012. Phylogenetic analyses were conducted based on a combined dataset from nrITS and plastid trnL-trnF region, rpl16 intron, and psbA-trnH spacer. The results indicate that the Asiatic Beilschmiedia and Syndiclis are reciprocally monophyletic with Endiandra as a sister group, and both morphology and molecular phylogeny clearly suggest that the new species belongs to Beilschmiedia. Thus Beilschmiedia turbinata Bing Liu et Y. Yang is illustrated and described as new to science, color plates, line drawings, distribution map and comparison with related species are provided. This new species is similar to B. yunnanensis in the small and ferruginous-brown tomentose terminal buds, elliptic to oblong-lanceolate and alternate or subopposite leaves bearing the fine veinlet reticulation, but differs from the latter by the smaller flowers, the eglandular stamens of the third whorl, and the large turbinate furfuraceous fruits.	[Liu, Bing; Ma, Keping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Yang, Yong; Zeng, Gang] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Xie, Lei] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Lab Systemat Evolut & Biogeog Woody Plants, Beijing, Peoples R China; [Liu, Bing; Zeng, Gang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Beijing Forestry University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, Y (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	ephedra@ibcas.ac.cn	Yang, Yong/S-1202-2019		National Natural Science Foundation of China [31970177, 31270238]; Chinese Academy of Sciences [KSCX2-YW-Z-067]; National Specimen Information Infrastructure (NSII) [2005DKA21400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Specimen Information Infrastructure (NSII)	This work was supported by the National Natural Science Foundation of China (31970177, 31270238), a project from the Chinese Academy of Sciences (KSCX2-YW-Z-067), and the National Specimen Information Infrastructure (NSII, 2005DKA21400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Chen Y, 2010, J SHANGDONG FORESTRY, V187, P101; Corlett RT., 2009, ECOLOGY TROPICAL E A; ESRI, 2008, ARCGIS DESKT REL 9 3; Fijridiyanto Izu A., 2009, Acta Phytotaxonomica et Geobotanica, V60, P1; Fijridiyanto IA, 2009, J PLANT RES, V122, P283, DOI 10.1007/s10265-009-0218-8; Hooker J.D., 1886, FLORA BRIT INDIA, VV, P116, DOI [10.5962/bhl.title.678, DOI 10.5962/BHL.TITLE.678]; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kelchner SA, 1997, MOL PHYLOGENET EVOL, V8, P385, DOI 10.1006/mpev.1997.0432; KOSTERMANS A J G H, 1973, Adansonia, V13, P333; KOSTERMANS A. J. G. H., 1956, REINWARDTIA, V4, P1; Lee SK, 1982, FLORA REIPUBLICAE PO, V31, P123; Li J, 2004, PLANT SYST EVOL, V246, P19, DOI 10.1007/s00606-003-0113-z; Li Jie, 1992, Acta Botanica Yunnanica, V14, P353; Li L, 2007, PLANT SYST EVOL, V269, P203, DOI 10.1007/s00606-007-0580-8; Li L, 2011, AM J BOT, V98, P1520, DOI 10.3732/ajb.1100006; Li X.W., 2008, FLORA CHINA, V7, P232; Li XW, 1985, ACTA BOT YUNNANICA, V7, P361; Li ZM, 2006, ACTA PHYTOTAXON SIN, V44, P272, DOI 10.1360/aps040150; Liou H., 1934, LAURACEES CHINE INDO; Meng LZ, 2012, J INSECT CONSERV, V16, P423, DOI 10.1007/s10841-011-9428-1; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nishida S, 1999, ANN MO BOT GARD, V86, P657, DOI 10.2307/2666150; Nishida S, 2008, BLUMEA, V53, P345, DOI 10.3767/000651908X608007; Nishida S, 2007, TAXON, V56, P1229, DOI 10.2307/25065914; Rambaut A, 2002, SE AL SEQUENE ALIGNM; Rohwer J. G., 1993, FAMILIES GENERA VASC, V2, P366, DOI DOI 10.1007/978-3-662-02899-5_46; Rohwer JG, 2009, TAXON, V58, P1153, DOI 10.1002/tax.584009; Rohwer JG, 2005, ANN MO BOT GARD, V92, P153; Rohwer JG, 2000, SYST BOT, V25, P60, DOI 10.2307/2666673; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Shui YM, 2010, CHECKLIST FLOWERING; Sun BL, 2009, ANN MO BOT GARD, V96, P672, DOI 10.3417/2008015; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Van der Werff H, 2001, BLUMEA, V46, P125; van der Werff Henk, 2003, Adansonia (Paris), V25, P77; van der Werff H, 2010, NOVON, V20, P493, DOI 10.3417/2010030; vanderWerff H, 1996, ANN MO BOT GARD, V83, P409, DOI 10.2307/2399870; Wang WT, 1996, B CHIN ACAD SCI, V11, P57; Wang ZH, 2010, PLANT SYST EVOL, V290, P173, DOI 10.1007/s00606-010-0359-1; Wen J, 1996, MOL PHYLOGENET EVOL, V6, P167, DOI 10.1006/mpev.1996.0069; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xu JC, 2011, NATURE, V477, P370, DOI 10.1038/477371a; Xu ZaiFu, 1996, Acta Botanica Yunnanica, V18, P433; Yang Y, 2012, SYST BOT, V37, P861, DOI 10.1600/036364412X656518; Zhu H, 2005, BIODIVERS CONSERV, V14, P2855, DOI 10.1007/s10531-004-8220-x; Zhu H, 2010, J TROP FOR SCI, V22, P49; Zhu H., 2012, NATIVE SEED PLANTS X	51	10	12	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67636	10.1371/journal.pone.0067636	http://dx.doi.org/10.1371/journal.pone.0067636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840756	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400120
J	Liu, YR; Tai, A; Joo, KI; Wang, P				Liu, Yarong; Tai, April; Joo, Kye-Il; Wang, Pin			Visualization of DC-SIGN-Mediated Entry Pathway of Engineered Lentiviral Vectors in Target Cells	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; PH-DEPENDENT FUSION; DENDRITIC CELLS; MEMBRANE-FUSION; EARLY ENDOSOMES; CANCER-IMMUNOTHERAPY; ENDOCYTIC PATHWAY; INFLUENZA-VIRUS; GENE-THERAPY; ANIMAL-CELLS	Dendritic cells (DCs) are potent antigen-presenting cells and therefore have enormous potential as vaccine targets. We have previously developed an engineered lentiviral vector (LV) that is pseudotyped with a mutated Sindbis virus glycoprotein (SVGmu), which is capable of targeting DCs through Dendritic Cell-specific ICAM3-grabbing Nonintegrin (DC-SIGN), a receptor that is predominantly expressed by DCs. In this study, we aimed to elucidate the internalization and trafficking mechanisms of this viral vector system through direct visualization of GFP-Vpr-tagged viral particles in target DCs, which was further corroborated by drug inhibition and dominant-negative mutants of cellular proteins that regulate the endocytic traffic. We demonstrated that our engineered LVs enter the cell via receptor-mediated clathrin- and dynamin-dependent endocytosis. Microtubule networks were also involved in a productive infection. Viral vector fusion was low-pH-dependent and occurred in the early endosomal stage of the intracellular transport. Autophagy was also examined for its effect on transduction efficiency, and we observed that enhanced autophage activity reduced vector infectivity, while suppressed autophagy boosted transduction efficiency. This study shed some light on the internalization and trafficking mechanisms of DC-directed LVs and offers some strategies to further improve the efficiency of LV-mediated gene therapy.	[Liu, Yarong; Tai, April; Joo, Kye-Il; Wang, Pin] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Joo, KI (corresponding author), Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.	kjoo@usc.edu; pinwang@usc.edu	Liu, Yarong/B-4952-2015	Joo, Kye Il/0000-0001-8834-5561	National Institutes of Health [R01AI68978, P01CA132681]; Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE [P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (R01AI68978 and P01CA132681) and a translational acceleration grant from the Joint Center for Translational Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2005, GENE THER, V12, P1667, DOI 10.1038/sj.gt.3302591; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brabec-Zaruba M, 2007, J VIROL, V81, P10815, DOI 10.1128/JVI.00143-07; Breckpot K, 2004, J GENE MED, V6, P1175, DOI 10.1002/jgm.615; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; Cambi A, 2009, EUR J IMMUNOL, V39, P1923, DOI 10.1002/eji.200939351; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; Espert L, 2008, AUTOPHAGY, V4, P273, DOI 10.4161/auto.5211; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gougeon ML, 2009, APOPTOSIS, V14, P501, DOI 10.1007/s10495-009-0314-1; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Joo KI, 2008, GENE THER, V15, P1384, DOI 10.1038/gt.2008.87; Joo KI, 2010, MICROSC RES TECHNIQ, V73, P886, DOI 10.1002/jemt.20841; Kirk CJ, 2000, HUM GENE THER, V11, P797, DOI 10.1089/10430340050015419; Klasse PJ, 1988, ADV DRUG DELIV REV, V34, P65; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Liu Y, 2012, GENE THER; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mountain A, 2000, TRENDS BIOTECHNOL, V18, P119, DOI 10.1016/S0167-7799(99)01416-X; Orvedahl A, 2008, CELL MICROBIOL, V10, P1747, DOI 10.1111/j.1462-5822.2008.01175.x; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shoji-Kawata S, 2009, BBA-MOL CELL RES, V1793, P1478, DOI 10.1016/j.bbamcr.2009.02.008; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; Timmerman JM, 1999, ANNU REV MED, V50, P507; Urayama A, 2004, P NATL ACAD SCI USA, V101, P12658, DOI 10.1073/pnas.0405042101; Valencia SM, 2012, J VIROL, V86, P2, DOI 10.1128/JVI.05883-11; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; WEINBERG JB, 1991, J EXP MED, V174, P1477, DOI 10.1084/jem.174.6.1477; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390	61	14	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67400	10.1371/journal.pone.0067400	http://dx.doi.org/10.1371/journal.pone.0067400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840690	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400074
J	Petko, J; Justice-Bitner, S; Jin, J; Wong, V; Kittanakom, S; Ferraro, TN; Stagljar, I; Levenson, R				Petko, Jessica; Justice-Bitner, Stephanie; Jin, Jay; Wong, Victoria; Kittanakom, Saranya; Ferraro, Thomas N.; Stagljar, Igor; Levenson, Robert			MOR Is Not Enough: Identification of Novel mu-Opioid Receptor Interacting Proteins Using Traditional and Modified Membrane Yeast Two-Hybrid Screens	PLOS ONE			English	Article							SPLIT-UBIQUITIN; MAMMALIAN HOMOLOGS; MORPHINE-TOLERANCE; BETA-CATENIN; ENDOCYTOSIS; DEGRADATION; TRAFFICKING; SYSTEM; BDNF; EXPRESSION	The mu-opioid receptor (MOR) is the G-protein coupled receptor primarily responsible for mediating the analgesic and rewarding properties of opioid agonist drugs such as morphine, fentanyl, and heroin. We have utilized a combination of traditional and modified membrane yeast two-hybrid screening methods to identify a cohort of novel MOR interacting proteins (MORIPs). The interaction between the MOR and a subset of MORIPs was validated in pulldown, co-immunoprecipitation, and co-localization studies using HEK293 cells stably expressing the MOR as well as rodent brain. Additionally, a subset of MORIPs was found capable of interaction with the delta and kappa opioid receptors, suggesting that they may represent general opioid receptor interacting proteins (ORIPS). Expression of several MORIPs was altered in specific mouse brain regions after chronic treatment with morphine, suggesting that these proteins may play a role in response to opioid agonist drugs. Based on the known function of these newly identified MORIPs, the interactions forming the MOR signalplex are hypothesized to be important for MOR signaling and intracellular trafficking. Understanding the molecular complexity of MOR/MORIP interactions provides a conceptual framework for defining the cellular mechanisms of MOR signaling in brain and may be critical for determining the physiological basis of opioid tolerance and addiction.	[Petko, Jessica; Justice-Bitner, Stephanie; Jin, Jay; Levenson, Robert] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA; [Wong, Victoria; Kittanakom, Saranya; Stagljar, Igor] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Wong, Victoria; Kittanakom, Saranya; Stagljar, Igor] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ferraro, Thomas N.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Toronto; University of Toronto; University of Pennsylvania	Levenson, R (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA USA.	rlevenson@hmc.psu.edu		Ferraro, Thomas/0000-0003-2250-8772; Levenson, Robert/0000-0002-0936-8421	NIDA [DA025995]; CURE grant from the Pennsylvania Department of Health using Tobacco Settlement Funds; Canadian Foundation for Innovation; Canadian Institute for Health Research; Canadian Cancer Society; Heart and Stroke Foundation of Canada; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA025995] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CURE grant from the Pennsylvania Department of Health using Tobacco Settlement Funds; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from NIDA (DA025995) and a CURE grant to RL (S. Grigson, PI) from the Pennsylvania Department of Health using Tobacco Settlement Funds. Support for IS was from the Canadian Foundation for Innovation, the Canadian Institute for Health Research, the Canadian Cancer Society, and the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Auerbach D, 2002, J RECEPT SIGNAL TR R, V22, P471, DOI 10.1081/RRS-120014615; Berger AC, 2011, EMBO MOL MED, V3, P385, DOI 10.1002/emmm.201100144; Blugeon C, 2011, GLIA, V59, P351, DOI 10.1002/glia.21106; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Choo YY, 2011, MOL BIOL CELL, V22, P4706, DOI 10.1091/mbc.E11-03-0251; De Codis DA, 2008, PROTEIN EXPRES PURIF, V61, P103, DOI 10.1016/j.pep.2008.06.006; Dimitrova YN, 2010, J BIOL CHEM, V285, P13507, DOI 10.1074/jbc.M109.049411; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Famulski JK, 2010, SCIENCE, V330, P1834, DOI 10.1126/science.1198480; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Georgoussi Z, 2012, CURR DRUG TARGETS, V13, P80, DOI 10.2174/138945012798868470; Ghitza UE, 2010, NEUROSCI BIOBEHAV R, V35, P157, DOI 10.1016/j.neubiorev.2009.11.009; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; He L, 2009, FASEB J, V23, P4327, DOI 10.1096/fj.09-133223; Henry AG, 2012, DEV CELL, V23, P519, DOI 10.1016/j.devcel.2012.08.003; Hislop JN, 2011, J BIOL CHEM, V286, P40193, DOI 10.1074/jbc.M111.288555; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Jin J, 2010, DEV DYNAM, V239, P2426, DOI 10.1002/dvdy.22369; Jin J, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-33; Kabbani N, 2007, EUR J PHARMACOL, V572, P83, DOI 10.1016/j.ejphar.2007.06.059; Kabbani Nadine, 2005, Current Proteomics, V2, P209, DOI 10.2174/157016405774641174; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Lentze N, 2008, CURR PROTOC PROTEIN; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Lin R, 2005, G PROTEIN COUPLED RE; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Liu YL, 2009, AM J PATHOL, V174, P1415, DOI 10.2353/ajpath.2009.080861; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Marcol W, 2007, NEUROSURG REV, V30, P235, DOI 10.1007/s10143-007-0085-5; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Maurice P, 2011, ADV PHARMACOL, V62, P349, DOI 10.1016/B978-0-12-385952-5.00001-4; Mayer Bruce J., 2006, V332, P79; Mayer Bruce J., 2009, Journal of Biology (London), V8, P81, DOI 10.1186/jbiol185; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Obata K, 2006, NEUROSCI RES, V55, P1, DOI 10.1016/j.neures.2006.01.005; Pardon MC, 2010, VITAM HORM, V82, P185, DOI 10.1016/S0083-6729(10)82010-2; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Petschnigg J, 2012, METHODS MOL BIOL, V812, P225, DOI 10.1007/978-1-61779-455-1_13; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Raehal KM, 2005, AAPS J, V7, pE587, DOI 10.1208/aapsj070360; Ren K, 2007, MOL NEUROBIOL, V35, P224, DOI 10.1007/s12035-007-0028-8; Reyes ARS, 2010, BRAIN RES, V1358, P71, DOI 10.1016/j.brainres.2010.08.080; Reyes BAS, 2012, EXP NEUROL, V233, P205, DOI 10.1016/j.expneurol.2011.09.037; Shi L, 2006, CELL SIGNAL, V18, P1995, DOI 10.1016/j.cellsig.2006.03.007; Snider J., 2010, J VIS EXP; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szargel R, 2009, J BIOL CHEM, V284, P11706, DOI 10.1074/jbc.M805990200; Talbot JN, 2009, NEUROSCI LETT, V466, P154, DOI 10.1016/j.neulet.2009.09.048; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Uchida M, 2006, J CELL SCI, V119, P3067, DOI 10.1242/jcs.03043; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yun S, 2008, J BIOL CHEM, V283, P1034, DOI 10.1074/jbc.M705874200	76	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67608	10.1371/journal.pone.0067608	http://dx.doi.org/10.1371/journal.pone.0067608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840749	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400114
J	Wu, CH; Yang, YW; Hu, YH; Tsai, YC; Kuo, KL; Lin, YH; Hung, SC; Wu, VC; Wu, KD				Wu, Che-Hsiung; Yang, Ya-Wen; Hu, Ya-Hui; Tsai, Yao-Chou; Kuo, Ko-Lin; Lin, Yen-Hung; Hung, Szu-Chun; Wu, Vin-Cent; Wu, Kwan-Dun		Taiwan Primary Aldosteronism Inves	Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism	PLOS ONE			English	Article							SALINE INFUSION TEST; HYPERTENSIVE PATIENTS; RENIN RATIO; ADENOMA; ADRENALECTOMY; CAPTOPRIL	Background: Historically, urinary aldosterone level measurement was a commonly employed confirmatory test to detect primary aldosteronism (PA). However, 24-h urine collection is inconvenient and cumbersome. We hypothesized that random urinary aldosterone measurements with correction for creatinine concentration might be comparable to 24-h urinary aldosterone levels (Uald-24 h) in the diagnosis of PA. Methods: The non-concurrent prospective study was conducted between June 2006 and March 2008 in patients admitted for confirmation of aldosteronism by salt loading test. A 24-h urine sample, which was collected during hospitalization on the day before saline infusion testing after restoration of serum hypokalemia, was collected from all subjects. Moreover, participants were asked to collect a first bladder voiding random urine sample during clinic visits. Uald-24 h and the random urinary aldosterone-to-creatinine ratio (UACR) were calculated accordingly. Results: A total of 102 PA patients (71 patients diagnosed of aldosterone-producing adenoma, 31 with idiopathic hyperaldosteronism) and 65 patients with EH were enrolled. The receiver operating characteristic curve showed comparable areas under the curves of UACR and Uald-24 h. The Bland-Altman plot showed mean bias but no obvious heteroscedasticity between the two tests. When using random UACR>3.0 ng/mg creatinine as the cutoff value, we obtained a specificity of 90.6% to confirm PA from essential hypertension. Conclusions: Our study reinforce that the diagnostic accuracy of random UACR was comparable to that of Uald-24 h in PA patients. With the quickness and simplicity of the UACR method and its equivalence to Uald-24 h, this assay could be a good alternative diagnostic tool for PA confirmation.	[Wu, Che-Hsiung; Kuo, Ko-Lin; Hung, Szu-Chun] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Div Nephrol, Taipei, Taiwan; [Yang, Ya-Wen] Natl Taiwan Univ Hosp, Dept Surg, Div Gen Surg, Taipei 100, Taiwan; [Hu, Ya-Hui] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Div Endocrine & Metab, Taipei, Taiwan; [Tsai, Yao-Chou] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Div Urol, Taipei, Taiwan; [Lin, Yen-Hung; Wu, Vin-Cent; Wu, Kwan-Dun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Yen-Hung; Wu, Vin-Cent; Wu, Kwan-Dun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	Buddhist Tzu Chi General Hospital; National Taiwan University; National Taiwan University Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Hung, SC (corresponding author), Buddhist Tzu Chi Gen Hosp, Taipei Branch, Div Nephrol, Taipei, Taiwan.	szuchun.hung@msa.hinet.ne; q91421028@ntu.edu.tw	Lin, Yen-Hung/AAQ-1242-2020; LIAO, SHIH-CHENG/C-5665-2017; Chueh, Jeff Shih-Chieh/F-5245-2011	Lin, Yen-Hung/0000-0001-8153-1441; YANG, YA-WEN/0000-0003-0412-584X; WU, VIN-CENT/0000-0001-7935-0991; LIU, KAO-LANG/0000-0003-4100-8909; LU, CHING-CHU/0000-0003-3114-582X; YEN, RUOH-FANG/0000-0003-1648-6482; LIAO, SHIH-CHENG/0000-0003-4129-0879; CHEN, YUNG-MING/0000-0002-9241-1258; Wu, Che-Hsiung/0000-0001-6164-6655; Chueh, Jeff Shih-Chieh/0000-0002-0713-4904; CHANG, CHIN-CHEN/0000-0002-0121-4866; LIN, LIAN-YU/0000-0001-7505-6429; WU, KWAN-DUN/0000-0002-3339-1509; Huang, Kuo-How/0000-0002-0989-0578; WANG, SHUO-MENG/0000-0003-2090-1757	Taiwan National Science Council [5 NSC101-2314-B-002-132-MY3, NSC100-2314-B-002-119, NSC6 101-2314-B-002-085-MY3]; National Taiwan University Hospital [100-N1776, 101-M1953, 102-S2097]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by Taiwan National Science Council (grants 5 NSC101-2314-B-002-132-MY3, NSC100-2314-B-002-119, and NSC6 101-2314-B-002-085-MY3) and National Taiwan University Hospital, 100-N1776, 101-M1953, and 102-S2097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid S, 2003, AM J HYPERTENS, V16, P522, DOI 10.1016/S0895-7061(03)00858-6; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRAVO EL, 1994, ENDOCRIN METAB CLIN, V23, P271, DOI 10.1016/S0889-8529(18)30097-5; Brown CA, 2002, AM J MED SCI, V324, P227, DOI 10.1097/00000441-200210000-00010; Chang HW, 2007, J CLIN ENDOCR METAB, V92, P1863, DOI 10.1210/jc.2006-2338; Charloux A, 1999, AM J PHYSIOL-ENDOC M, V276, pE43, DOI 10.1152/ajpendo.1999.276.1.E43; Djajadiningrat-Laanen SC, 2008, J VET INTERN MED, V22, P1283, DOI 10.1111/j.1939-1676.2008.0166.x; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; GINSBERG JM, 1983, NEW ENGL J MED, V309, P1543, DOI 10.1056/NEJM198312223092503; GOMEZSANCHEZ CE, 1981, J CLIN ENDOCR METAB, V52, P214, DOI 10.1210/jcem-52-2-214; HOLLAND OB, 1995, SEMIN NEPHROL, V15, P116; Kuo CC, 2011, J RENIN-ANGIO-ALDO S, V12, P348, DOI 10.1177/1470320310391329; Martinerie L, 2009, PEDIATR RES, V66, P323, DOI 10.1203/PDR.0b013e3181b1bbec; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Montori VM, 2001, MAYO CLIN PROC, V76, P877; Mourad JJ, 2008, AM J HYPERTENS, V21, P742, DOI 10.1038/ajh.2008.175; Mulatero P, 2005, TRENDS ENDOCRIN MET, V16, P114, DOI 10.1016/j.tem.2005.02.007; NOMURA K, 1992, J CLIN ENDOCR METAB, V75, P323, DOI 10.1210/jc.75.1.323; Novitsky YW, 2005, SURGERY, V138, P1009, DOI 10.1016/j.surg.2005.09.027; Omura M, 2002, METABOLISM, V51, P350, DOI 10.1053/meta.2002.30498; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Persson F, 2012, J RENIN-ANGIO-ALDO S, V13, P118, DOI 10.1177/1470320311417272; Rossi GP, 2007, HYPERTENSION, V50, P424, DOI 10.1161/HYPERTENSIONAHA.107.091827; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Schirpenbach C, 2006, EUR J ENDOCRINOL, V154, P865, DOI 10.1530/eje.1.02164; Steichen O, 2011, EUR J CLIN INVEST, V41, P189, DOI 10.1111/j.1365-2362.2010.02401.x; Stowasser M, 2012, HORM METAB RES, V44, P170, DOI 10.1055/s-0031-1295460; Wu KD, 2001, J FORMOS MED ASSOC, V100, P598; Wu VC, 2012, ACTA NEPHROLOGICA, V26, P111; Wu VC, 2011, CLIN CHIM ACTA, V412, P1319, DOI 10.1016/j.cca.2011.02.018; Wu VC, 2009, AM J HYPERTENS, V22, P821, DOI 10.1038/ajh.2009.89; Yen RF, 2009, J NUCL MED, V50, P1631, DOI 10.2967/jnumed.109.064873; Young WF, 2003, ENDOCRINOLOGY, V144, P2208, DOI 10.1210/en.2003-0279	33	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67417	10.1371/journal.pone.0067417	http://dx.doi.org/10.1371/journal.pone.0067417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840695	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400077
J	Zhang, JY; Middleton, KK; Fu, FH; Im, HJ; Wang, JHC				Zhang, Jianying; Middleton, Kellie K.; Fu, Freddie H.; Im, Hee-Jeong; Wang, James H-C.			HGF Mediates the Anti-inflammatory Effects of PRP on Injured Tendons	PLOS ONE			English	Article							PLATELET-RICH PLASMA; HEPATOCYTE GROWTH-FACTOR; RANDOMIZED CONTROLLED-TRIAL; INTERLEUKIN-1 RECEPTOR ANTAGONIST; STEM-CELLS; INFLAMMATORY RESPONSE; COLLAGEN-SYNTHESIS; PGE(2) INCREASES; SPORTS-MEDICINE; BASIC SCIENCE	Platelet-rich plasma (PRP) containing hepatocyte growth factor (HGF) and other growth factors are widely used in orthopaedic/sports medicine to repair injured tendons. While PRP treatment is reported to decrease pain in patients with tendon injury, the mechanism of this effect is not clear. Tendon pain is often associated with tendon inflammation, and HGF is known to protect tissues from inflammatory damages. Therefore, we hypothesized that HGF in PRP causes the anti-inflammatory effects. To test this hypothesis, we performed in vitro experiments on rabbit tendon cells and in vivo experiments on a mouse Achilles tendon injury model. We found that addition of PRP or HGF decreased gene expression of COX-1, COX-2, and mPGES-1, induced by the treatment of tendon cells in vitro with IL-1 beta. Further, the treatment of tendon cell cultures with HGF antibodies reduced the suppressive effects of PRP or HGF on IL-1 beta-induced COX-1, COX-2, and mPGES-1 gene expressions. Treatment with PRP or HGF almost completely blocked the cellular production of PGE2 and the expression of COX proteins. Finally, injection of PRP or HGF into wounded mouse Achilles tendons in vivo decreased PGE(2) production in the tendinous tissues. Injection of platelet-poor plasma (PPP) however, did not reduce PGE(2) levels in the wounded tendons, but the injection of HGF antibody inhibited the effects of PRP and HGF. Further, injection of PRP or HGF also decreased COX-1 and COX-2 proteins. These results indicate that PRP exerts anti-inflammatory effects on injured tendons through HGF. This study provides basic scientific evidence to support the use of PRP to treat injured tendons because PRP can reduce inflammation and thereby reduce the associated pain caused by high levels of PGE(2).	[Zhang, Jianying; Middleton, Kellie K.; Fu, Freddie H.; Wang, James H-C.] Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15213 USA; [Zhang, Jianying; Middleton, Kellie K.; Fu, Freddie H.; Wang, James H-C.] Univ Pittsburgh, Dept Bioengn, MechanoBiol Lab, Pittsburgh, PA USA; [Zhang, Jianying; Middleton, Kellie K.; Fu, Freddie H.; Wang, James H-C.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, MechanoBiol Lab, Pittsburgh, PA USA; [Im, Hee-Jeong] Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA; [Im, Hee-Jeong] Rush Univ, Dept Internal Med, Med Ctr, Chicago, IL 60612 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rush University; Rush University	Wang, JHC (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15213 USA.	wanghc@pitt.edu			NIH/NIAMS [AR061395, AR060920, AR049921]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061395, R01AR049921, R21AR060920, R01AR062136] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002647] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	The funding support for this study was from NIH/NIAMS (AR061395, AR060920, and AR049921). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almekinders LC, 1998, MED SCI SPORT EXER, V30, P1183, DOI 10.1097/00005768-199808000-00001; Amin Ashok R., 1999, Current Opinion in Rheumatology, V11, P202, DOI 10.1097/00002281-199905000-00009; Anitua E, 2005, J ORTHOP RES, V23, P281, DOI 10.1016/j.orthres.2004.08.015; Bendinelli P, 2010, J CELL PHYSIOL, V225, P757, DOI 10.1002/jcp.22274; Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240; Christensen B, 2011, J APPL PHYSIOL, V110, P137, DOI 10.1152/japplphysiol.00942.2010; Cilli F, 2004, CLIN J SPORT MED, V14, P232, DOI 10.1097/00042752-200407000-00006; Damm J, 2001, EXP EYE RES, V72, P611, DOI 10.1006/exer.2001.0977; de Vos RJ, 2010, JAMA-J AM MED ASSOC, V303, P144, DOI 10.1001/jama.2009.1986; El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302; Engebretsen L, 2010, BRIT J SPORT MED, V44, P1072, DOI 10.1136/bjsm.2010.079822; FERREIRA SH, 1978, PROSTAGLANDINS, V16, P31, DOI 10.1016/0090-6980(78)90199-5; Ferry Scott T, 2012, Sports Med Arthrosc Rehabil Ther Technol, V4, P2, DOI 10.1186/1758-2555-4-2; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921; GABAY C, 1994, ARTHRITIS RHEUM, V37, P1744, DOI 10.1002/art.1780371206; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Gilroy DW, 1998, EUR J PHARMACOL, V355, P211, DOI 10.1016/S0014-2999(98)00508-1; Gilroy DW, 1998, INFLAMM RES, V47, P79, DOI 10.1007/s000110050285; Gong RJ, 2008, CURR OPIN INVEST DR, V9, P1163; Homsi E, 2009, AM J NEPHROL, V29, P283, DOI 10.1159/000159275; Hsu C, 2004, J HAND SURG-AM, V29A, P551, DOI 10.1016/j.jhsa.2004.04.020; Kaido T, 1997, FEBS LETT, V411, P378, DOI 10.1016/S0014-5793(97)00744-8; Kang YH, 2011, TISSUE ENG PT A, V17, P349, DOI [10.1089/ten.tea.2010.0327, 10.1089/ten.TEA.2010.0327]; Kerr BA, 2010, NEOPLASIA, V12, P388, DOI 10.1593/neo.10166; Khan KM, 1998, BRIT J SPORT MED, V32, P346, DOI 10.1136/bjsm.32.4.346; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; Kopp UC, 1999, AM J PHYSIOL-REG I, V276, pR1241, DOI 10.1152/ajpregu.1999.276.5.R1241; Li ZZ, 2004, AM J SPORT MED, V32, P435, DOI 10.1177/0095399703258680; Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003; Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850; Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004; Molnar C, 2004, EUR CYTOKINE NETW, V15, P303; Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282; Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073; Nakamura S, 1998, J HYPERTENS, V16, P2019, DOI 10.1097/00004872-199816121-00025; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Okada M, 2004, PEDIATR RES, V56, P336, DOI 10.1203/01.PDR.0000134255.58638.59; Peerbooms JC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-69; Peerbooms JC, 2010, AM J SPORT MED, V38, P255, DOI 10.1177/0363546509355445; Renstrom P, 2006, SCAND J MED SCI SPOR, V16, P73, DOI 10.1111/j.1600-0838.2006.00540.x; Schneider A, 2004, KIDNEY INT, V65, P1205, DOI 10.1111/j.1523-1755.2004.00493.x; Sheth U, 2012, J BONE JOINT SURG AM, V94A, P298, DOI 10.2106/JBJS.K.00154; SMITH WL, 1989, BIOCHEM J, V259, P315, DOI 10.1042/bj2590315; Takai K, 1997, BLOOD, V89, P1560, DOI 10.1182/blood.V89.5.1560.1560_1560_1565; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Vavken P, 2009, TISSUE ENG A; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; WILLIAMS TJ, 1979, BRIT J PHARMACOL, V65, P517, DOI 10.1111/j.1476-5381.1979.tb07860.x; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Yang GG, 2005, GENE, V363, P166, DOI 10.1016/j.gene.2005.08.006; Zhang JY, 2011, BIOMATERIALS, V32, P6972, DOI 10.1016/j.biomaterials.2011.05.088; Zhang JY, 2010, AM J SPORT MED, V38, P2477, DOI 10.1177/0363546510376750; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962	56	87	92	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67303	10.1371/journal.pone.0067303	http://dx.doi.org/10.1371/journal.pone.0067303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840657	gold, Green Published, Green Accepted			2022-12-27	WOS:000321148400055
J	Chong, A; Child, R; Wehrly, TD; Rockx-Brouwer, D; Qin, AP; Mann, BJ; Celli, J				Chong, Audrey; Child, Robert; Wehrly, Tara D.; Rockx-Brouwer, Dedeke; Qin, Aiping; Mann, Barbara J.; Celli, Jean			Structure-Function Analysis of DipA, a Francisella tularensis Virulence Factor Required for Intracellular Replication	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; COILED-COIL DOMAINS; PATHOGENICITY ISLAND; ESCHERICHIA-COLI; MOLECULAR-MECHANISMS; PHAGOSOMAL ESCAPE; I-TASSER; SCHU S4; IDENTIFICATION; OMPA	Francisella tularensis is a highly infectious bacterium whose virulence relies on its ability to rapidly reach the macrophage cytosol and extensively replicate in this compartment. We previously identified a novel Francisella virulence factor, DipA (FTT0369c), which is required for intramacrophage proliferation and survival, and virulence in mice. DipA is a 353 amino acid protein with a Sec-dependent signal peptide, four Sel1-like repeats (SLR), and a C-terminal coiled-coil (CC) domain. Here, we determined through biochemical and localization studies that DipA is a membrane-associated protein exposed on the surface of the prototypical F. tularensis subsp. tularensis strain SchuS4 during macrophage infection. Deletion and substitution mutagenesis showed that the CC domain, but not the SLR motifs, of DipA is required for surface exposure on SchuS4. Complementation of the dipA mutant with either DipA CC or SLR domain mutants did not restore intracellular growth of Francisella, indicating that proper localization and the SLR domains are required for DipA function. Co-immunoprecipitation studies revealed interactions with the Francisella outer membrane protein FopA, suggesting that DipA is part of a membrane-associated complex. Altogether, our findings indicate that DipA is positioned at the host-pathogen interface to influence the intracellular fate of this pathogen.	[Chong, Audrey; Child, Robert; Wehrly, Tara D.; Rockx-Brouwer, Dedeke; Celli, Jean] NIAID, Intracellular Parasites Lab, Rocky Mt Labs, NIH, Hamilton, MT USA; [Qin, Aiping; Mann, Barbara J.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Mann, Barbara J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Virginia; University of Virginia	Chong, A (corresponding author), NIAID, Intracellular Parasites Lab, Rocky Mt Labs, NIH, Hamilton, MT USA.	chonga@niaid.nih.gov		Celli, Jean/0000-0002-6793-1788	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI000953-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000953] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases, project number AI000953-01. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bartra SS, 2012, MICROB PATHOGENESIS, V52, P41, DOI 10.1016/j.micpath.2011.09.009; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050473; Broms JE, 2011, INFECT IMMUN, V79, P3683, DOI 10.1128/IAI.01344-10; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Chong A, 2012, AUTOPHAGY, V8, P1342, DOI 10.4161/auto.20808; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; Clemens DL, 2009, INFECT IMMUN, V77, P1757, DOI 10.1128/IAI.01485-08; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Dabo SM, 2008, VACCINE, V26, P4345, DOI 10.1016/j.vaccine.2008.06.029; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; Delahay RM, 1999, J BIOL CHEM, V274, P35969, DOI 10.1074/jbc.274.50.35969; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Engel J, 2000, MATRIX BIOL, V19, P283, DOI 10.1016/S0945-053X(00)00075-5; Fito-Boncompte L, 2011, INFECT IMMUN, V79, P1176, DOI 10.1128/IAI.00850-10; Forestal CA, 2003, J IMMUNOL, V171, P2563, DOI 10.4049/jimmunol.171.5.2563; Fortier A H, 1994, Immunol Ser, V60, P349; Fuller JR, 2008, INFECT IMMUN, V76, P4934, DOI 10.1128/IAI.00475-08; Fulop M, 1996, FEMS IMMUNOL MED MIC, V13, P245, DOI 10.1111/j.1574-695X.1996.tb00245.x; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gazi AD, 2009, CELL MICROBIOL, V11, P719, DOI 10.1111/j.1462-5822.2009.01297.x; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; Knodler LA, 2011, CELL MICROBIOL, V13, P1497, DOI 10.1111/j.1462-5822.2011.01635.x; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lai XH, 2003, INFECT IMMUN, V71, P4642, DOI 10.1128/IAI.71.8.4642-4646.2003; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; MCCARTER LL, 1994, J BACTERIOL, V176, P5988, DOI 10.1128/jb.176.19.5988-5998.1994; Meibom KL, 2010, CURR OPIN MICROBIOL, V13, P11, DOI 10.1016/j.mib.2009.11.007; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; NANO FE, 1988, MICROB PATHOGENESIS, V5, P109, DOI 10.1016/0882-4010(88)90013-7; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nestorovich EM, 2006, J BIOL CHEM, V281, P16230, DOI 10.1074/jbc.M600650200; Newman JRS, 2000, P NATL ACAD SCI USA, V97, P13203, DOI 10.1073/pnas.97.24.13203; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Nicholson TF, 2009, INFECT IMMUN, V77, P5245, DOI 10.1128/IAI.00670-09; Okabe M, 2005, J BIOL CHEM, V280, P25659, DOI 10.1074/jbc.M500263200; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Qin AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024611; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2010, MICROBES INFECT, V12, P126, DOI 10.1016/j.micinf.2009.11.003; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1498, DOI 10.1099/mic.0.025445-0; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Serino L, 2007, MOL MICROBIOL, V64, P1391, DOI 10.1111/j.1365-2958.2007.05745.x; SONNTAG I, 1978, J BACTERIOL, V136, P280, DOI 10.1128/JB.136.1.280-285.1978; Sugawara E, 2012, J BACTERIOL, V194, P4089, DOI 10.1128/JB.00435-12; Sukumaran SK, 2003, INFECT IMMUN, V71, P5951, DOI 10.1128/IAI.71.10.5951-5961.2003; Torres AG, 2003, INFECT IMMUN, V71, P4985, DOI 10.1128/IAI.71.9.4985-4995.2003; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	87	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67965	10.1371/journal.pone.0067965	http://dx.doi.org/10.1371/journal.pone.0067965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840797	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400125
J	McDowell, AL; Filippone, AB; Balbir, A; Germain, A; O'Donnell, CP				McDowell, Angela L.; Filippone, Ashlee B.; Balbir, Alex; Germain, Anne; O'Donnell, Christopher P.			Mild Transient Hypercapnia as a Novel Fear Conditioning Stimulus Allowing Re-Exposure during Sleep	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CONTEXTUAL FEAR; REM-SLEEP; CARDIOVASCULAR-RESPONSES; RESPIRATORY DEPRESSION; CARBON-DIOXIDE; MOUSE STRAINS; MICE; BEHAVIOR; QUALITY	Introduction: Studies suggest that sleep plays a role in traumatic memories and that treatment of sleep disorders may help alleviate symptoms of posttraumatic stress disorder. Fear-conditioning paradigms in rodents are used to investigate causal mechanisms of fear acquisition and the relationship between sleep and posttraumatic behaviors. We developed a novel conditioning stimulus (CS) that evoked fear and was subsequently used to study re-exposure to the CS during sleep. Methods: Experiment 1 assessed physiological responses to a conditioned stimulus (mild transient hypercapnia, mtHC; 3.0% CO2; n = 17)+footshock for the purpose of establishing a novel CS in male FVB/J mice. Responses to the novel CS were compared to tone+footshock (n = 18) and control groups of tone alone (n = 17) and mild transient hypercapnia alone (n = 10). A second proof of principle experiment re-exposed animals during sleep to mild transient hypercapnia or air (control) to study sleep processes related to the CS. Results: Footshock elicited a response of acute tachycardia (30-40 bpm) and increased plasma epinephrine. When tone predicted footshock it elicited mild hypertension (1-2 mmHg) and a three-fold increase in plasma epinephrine. When mtHC predicted footshock it also induced mild hypertension, but additionally elicited a conditioned bradycardia and a smaller increase in plasma epinephrine. The overall mean 24 hour sleep-wake profile was unaffected immediately after fear conditioning. Discussion: Our study demonstrates the efficacy of mtHC as a conditioning stimulus that is perceptible but innocuous (relative to tone) and applicable during sleep. This novel model will allow future studies to explore sleep-dependent mechanisms underlying maladaptive fear responses, as well as elucidate the moderators of the relationship between fear responses and sleep.	[McDowell, Angela L.; Filippone, Ashlee B.; Balbir, Alex; O'Donnell, Christopher P.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA; [Germain, Anne] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	O'Donnell, CP (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA.	odonnellcp@upmc.edu		O'Donnell, Christopher/0000-0002-9120-6850	Department of Defense [DM102174]	Department of Defense(United States Department of Defense)	This work was supported by Department of Defense grant DM102174. The views expressed in this article are those of the authors, and do not represent the official policy or position of the US Department of Defense, or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; ARWAS S, 1989, BEHAV RES THER, V27, P295, DOI 10.1016/0005-7967(89)90049-1; Bao XP, 2007, CIRCULATION, V116, P1024, DOI 10.1161/CIRCULATIONAHA.107.696005; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; BENINGTON JH, 1994, SLEEP, V17, P28, DOI 10.1093/sleep/17.1.28; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Bryant RA, 1998, J CONSULT CLIN PSYCH, V66, P862, DOI 10.1037/0022-006X.66.5.862; Bryant RA, 2010, SLEEP, V33, P69, DOI 10.1093/sleep/33.1.69; Campen MJ, 2005, J APPL PHYSIOL, V99, P2028, DOI 10.1152/japplphysiol.00411.2005; Casement MD, 2012, CLIN PSYCHOL REV, V32, P566, DOI 10.1016/j.cpr.2012.06.002; Corcoran AE, 2009, RESP PHYSIOL NEUROBI, V168, P49, DOI 10.1016/j.resp.2009.04.014; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; ELLINGSEN I, 1987, ACTA PHYSIOL SCAND, V129, P157, DOI 10.1111/j.1748-1716.1987.tb08054.x; Germain A, 2004, J TRAUMA STRESS, V17, P477, DOI 10.1007/s10960-004-5796-6; Germain A, 2008, SLEEP MED REV, V12, P185, DOI 10.1016/j.smrv.2007.09.003; Germain A, 2006, ANN NY ACAD SCI, V1071, P438, DOI 10.1196/annals.1364.038; GLEESON K, 1990, AM REV RESPIR DIS, V142, P295, DOI 10.1164/ajrccm/142.2.295; GORMAN JM, 1990, BIOL PSYCHIAT, V28, P743, DOI 10.1016/0006-3223(90)90510-9; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Guyenet PG, 2010, J APPL PHYSIOL, V108, P995, DOI 10.1152/japplphysiol.00712.2009; Hagewoud R, 2010, SLEEP, V33, P1315, DOI 10.1093/sleep/33.10.1315; Hellman K, 2007, BEHAV NEUROSCI, V121, P310, DOI 10.1037/0735-7044.121.2.310; Hennevin E, 2005, BEHAV NEUROSCI, V119, P1277, DOI 10.1037/0735-7044.119.5.1277; Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006; Iiyori N, 2005, PHYSIOL GENOMICS, V24, P65, DOI 10.1152/physiolgenomics.00203.2005; Jha SK, 2005, EUR J NEUROSCI, V21, P1077, DOI 10.1111/j.1460-9568.2005.03920.x; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Krakow B, 2001, J TRAUMA STRESS, V14, P647, DOI 10.1023/A:1013029819358; Maren S, 2005, NEUROSCIENTIST, V11, P89, DOI 10.1177/1073858404269232; Mellman TA, 2006, CNS SPECTRUMS, V11, P611, DOI 10.1017/S1092852900013663; Nappi CM, 2012, NEUROPHARMACOLOGY, V62, P576, DOI 10.1016/j.neuropharm.2011.02.029; Nattie E, 2011, J APPL PHYSIOL, V110, P1, DOI 10.1152/japplphysiol.01061.2010; O'Donnell CP, 1999, AM J RESP CRIT CARE, V159, P1477, DOI 10.1164/ajrccm.159.5.9809025; Pace-Schott EF, 2009, SLEEP, V32, P19; Polotsky VY, 2004, J APPL PHYSIOL, V96, P991, DOI 10.1152/japplphysiol.00926.2003; Polotsky VY, 2001, AM J RESP CRIT CARE, V164, P1470, DOI 10.1164/ajrccm.164.8.2101100; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Rubin AE, 2003, AM J RESP CRIT CARE, V168, P1520, DOI 10.1164/rccm.200304-462OC; Sanford LD, 2010, SLEEP, V33, P621, DOI 10.1093/sleep/33.5.621; Sanford LD, 2003, J NEUROPHYSIOL, V90, P938, DOI 10.1152/jn.00993.2002; Sanford LD, 2003, SLEEP, V26, P527, DOI 10.1093/sleep/26.5.527; Sanford LD, 2003, BEHAV GENET, V33, P43, DOI 10.1023/A:1021051516829; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Spoormaker VI, 2010, J PSYCHIATR RES, V44, P1121, DOI 10.1016/j.jpsychires.2010.04.017; Tagaito Y, 2001, J APPL PHYSIOL, V91, P2758, DOI 10.1152/jappl.2001.91.6.2758; Tankersley CG, 2002, J APPL PHYSIOL, V92, P1277, DOI 10.1152/japplphysiol.00609.2001; Veasey SC, 2004, SLEEP, V27, P388, DOI 10.1093/sleep/27.3.388; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Woodward SH, 2000, PHYSIOL BEHAV, V70, P197, DOI 10.1016/S0031-9384(00)00271-7; Wu WL, 2010, GENES BRAIN BEHAV, V9, P603, DOI 10.1111/j.1601-183X.2010.00591.x; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	51	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67435	10.1371/journal.pone.0067435	http://dx.doi.org/10.1371/journal.pone.0067435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840700	gold, Green Published, Green Accepted			2022-12-27	WOS:000321424400102
J	Trudeau, MB; Catalano, PJ; Jindrich, DL; Dennerlein, JT				Trudeau, Matthieu B.; Catalano, Paul J.; Jindrich, Devin L.; Dennerlein, Jack T.			Tablet Keyboard Configuration Affects Performance, Discomfort and Task Difficulty for Thumb Typing in a Two-Handed Grip	PLOS ONE			English	Article							MOBILE PHONE USE; TRAPEZIOMETACARPAL JOINT; FEASIBILITY; MOTION; VARIES	When holding a tablet computer with two hands, the touch keyboard configuration imposes postural constraints on the user because of the need to simultaneously hold the device and type with the thumbs. Designers have provided users with several possible keyboard configurations (device orientation, keyboard layout and location). However, potential differences in performance, usability and postures among these configurations have not been explored. We hypothesize that (1) the narrower standard keyboard layout in the portrait orientation leads to lower self-reported discomfort and less reach than the landscape orientation; (2) a split keyboard layout results in better overall outcomes compared to the standard layout; and (3) the conventional bottom keyboard location leads to the best outcomes overall compared to other locations. A repeated measures laboratory experiment of 12 tablet owners measured typing speed, discomfort, task difficulty, and thumb/wrist joint postures using an active marker system during typing tasks for different combinations of device orientation (portrait and landscape), keyboard layout (standard and split), and keyboard location (bottom, middle, top). The narrower standard keyboard with the device in the portrait orientation was associated with less discomfort (least squares mean (and S.E.) 2.9 +/- 0.6) than the landscape orientation (4.5 +/- 0.7). Additionally, the split keyboard decreased the amount of reaching required by the thumb in the landscape orientation as defined by a reduced range of motion and less MCP extension, which may have led to reduced discomfort (2.7 +/- 0.6) compared to the standard layout (4.5 +/- 0.7). However, typing speed was greater for the standard layout (127 +/- 5 char./min.) compared to the split layout (113 +/- 4 char./min.) regardless of device orientation and keyboard location. Usage guidelines and designers can incorporate these findings to optimize keyboard design parameters and form factors that promote user performance and usability for thumb interaction.	[Trudeau, Matthieu B.; Catalano, Paul J.; Dennerlein, Jack T.] Harvard Sch Publ Hlth, Boston, MA USA; [Catalano, Paul J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Jindrich, Devin L.] Calif State Univ San Marcos, San Marcos, TX USA; [Dennerlein, Jack T.] Harvard Univ, Sch Med, Boston, MA USA; [Dennerlein, Jack T.] Northeastern Univ, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; California State University System; California State University San Marcos; Harvard University; Harvard Medical School; Northeastern University	Dennerlein, JT (corresponding author), Harvard Sch Publ Hlth, Boston, MA USA.	j.dennerlein@neu.edu		Dennerlein, Jack/0000-0001-7703-643X	NIOSH [R01 OH008373]; Harvard-NIOSH Education and Research Center [2 T42 OH008416-07]; National Science Foundation [0964220]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008373, T42OH008416] Funding Source: NIH RePORTER	NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Harvard-NIOSH Education and Research Center(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was funded in part by NIOSH R01 OH008373, a pilot project grant awarded by the Harvard-NIOSH Education and Research Center under Grant No. 2 T42 OH008416-07, and the National Science Foundation grant 0964220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asatryan DG., 1965, BIOPHYSICS-USSR, V10, P925; COONEY WP, 1981, J BONE JOINT SURG AM, V63, P1371, DOI 10.2106/00004623-198163090-00002; Dennerlein JT, 2006, ERGONOMICS, V49, P45, DOI 10.1080/00140130500321845; Feldman A, 1966, BIOPHYSICS-USSR, VII, P565; HEINZE HJ, 1994, PERCEPT PSYCHOPHYS, V56, P42, DOI 10.3758/BF03211689; Hogg NA, 2010, THESIS; HOLLISTER A, 1995, CLIN ORTHOP RELAT R, P188; Jobs S, 2010, IPAD LAUNCH; Kuo LC, 2003, CLIN BIOMECH, V18, P558, DOI 10.1016/S0268-0033(03)00074-3; Kuo LC, 2002, J BIOMECH, V35, P1499, DOI 10.1016/S0021-9290(02)00083-0; Li ZM, 2007, J BIOMECH, V40, P502, DOI 10.1016/j.jbiomech.2006.02.019; Muller H., 2012, P 14 C HUM COMP INT; Odell D., 1907, P HUMAN FACTORS ERGO, V56, DOI DOI 10.1177/1071181312561278; Park YS, 2010, INT J IND ERGONOM, V40, P746, DOI 10.1016/j.ergon.2010.08.001; Park YS, 2010, INT J IND ERGONOM, V40, P68, DOI 10.1016/j.ergon.2009.08.002; Trudeau MB, 2012, J BIOMECH, V45, P2349, DOI 10.1016/j.jbiomech.2012.07.012; Trudeau MB, 2012, HUM FACTORS, V54, P52, DOI 10.1177/0018720811423660; Wagner J, 2012, CHI 12 P SIGCHI C HU, P2317; Winter D, 2005, BIOMECHANICS MOTOR C; Young JG, 2012, WORK, V41, P81, DOI 10.3233/WOR-2012-1337	21	22	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67525	10.1371/journal.pone.0067525	http://dx.doi.org/10.1371/journal.pone.0067525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840730	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400109
J	Zhou, R; Yang, F; Chen, DF; Sun, YX; Yang, JS; Yang, WJ				Zhou, Rong; Yang, Fan; Chen, Dian-Fu; Sun, Yu-Xia; Yang, Jin-Shu; Yang, Wei-Jun			Acetylation of Chromatin-Associated Histone H3 Lysine 56 Inhibits the Development of Encysted Artemia Embryos	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RIBOSOMAL S6 KINASE; CHECKPOINT; DIAPAUSE; PHASE; DEACETYLATION; INVOLVEMENT; SIRTUINS; MITOSIS; ARREST	Background: As a response to harsh environments, the crustacean artemia produces diapause gastrula embryos (cysts), in which cell division and embryonic development are totally arrested. This dormant state can last for very long periods but be terminated by specific environmental stimuli. Thus, artemia is an ideal model organism in which to study cell cycle arrest and embryonic development. Principal Finding: Our study focuses on the roles of H3K56ac in the arrest of cell cycle and development during artemia diapause formation and termination. We found that the level of H3K56ac on chromatin increased during diapause formation, and decreased upon diapause termination, remaining basal level throughout subsequent embryonic development. In both HeLa cells and artemia, blocking the deacetylation with nicotinamide, a histone deacetylase inhibitor, increased the level of H3K56ac on chromatin and induced an artificial cell cycle arrest. Furthermore, we found that this arrest of the cell cycle and development was induced by H3K56ac and dephosphorylation of the checkpoint protein, retinoblastoma protein. Conclusions/Significance: These results have revealed the dynamic change in H3K56ac on chromatin during artemia diapause formation and termination. Thus, our findings provide insight into the regulation of cell division during arrest of artemia embryonic development and provide further insight into the functions of H3K56ac.	[Yang, Wei-Jun] Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, WJ (corresponding author), Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830; Yang, Jin-Shu/0000-0001-6680-7737	National Basic Research Program of China (973 Program) [2010CB833803]; 863 programs of China [2012AA10A401, 2012AA092205-2]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); 863 programs of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (973 Program, 2010CB833803), 863 programs of China (2012AA10A401 and 2012AA092205-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; Battu A, 2011, NUCLEIC ACIDS RES, V39, P7931, DOI 10.1093/nar/gkr523; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; CANO A, 1976, DEV BIOL, V54, P276, DOI 10.1016/0012-1606(76)90305-5; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Clemente-Ruiz M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002376; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; ESTEPA I, 1983, EUR J BIOCHEM, V132, P249, DOI 10.1111/j.1432-1033.1983.tb07356.x; ESTEPA I, 1981, EUR J BIOCHEM, V119, P431, DOI 10.1111/j.1432-1033.1981.tb05626.x; Franz O, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.11.e3; Frei C, 2000, GENE DEV, V14, P81; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Li R, 2012, J BIOL CHEM, V287, P15923, DOI 10.1074/jbc.M111.312413; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Miller FP, 2010, DORMANCY ORGANISM BI; Miller KM, 2006, CELL CYCLE, V5, P2561, DOI 10.4161/cc.5.22.3501; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; OLSON C, 1976, EXPERIENTIA, V32, P864, DOI 10.1007/BF02003733; OLSON CS, 1978, ROUX ARCH DEV BIOL, V184, P1, DOI 10.1007/BF00848665; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sun Y, 2004, J BIOL CHEM, V279, P39999, DOI 10.1074/jbc.M406999200; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Yang F, 2012, CELL STRESS CHAPERON, V17, P577, DOI 10.1007/s12192-012-0333-7; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032129; Zhu XJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-21	45	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e68374	10.1371/journal.pone.0068374	http://dx.doi.org/10.1371/journal.pone.0068374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840851	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200140
J	Ebrahimi, B; Eirin, A; Li, ZL; Zhu, XY; Zhang, X; Lerman, A; Textor, SC; Lerman, LO				Ebrahimi, Behzad; Eirin, Alfonso; Li, Zilun; Zhu, Xiang-Yang; Zhang, Xin; Lerman, Amir; Textor, Stephen C.; Lerman, Lilach O.			Mesenchymal Stem Cells Improve Medullary Inflammation and Fibrosis after Revascularization of Swine Atherosclerotic Renal Artery Stenosis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; EXPERIMENTAL RENOVASCULAR DISEASE; OXIDATIVE STRESS; INJURY; KIDNEY; MICROVESICLES; MECHANISMS; ISCHEMIA; PROTECT; REPAIR	Atherosclerotic renal artery stenosis (ARAS) raises blood pressure and can reduce kidney function. Revascularization of the stenotic renal artery alone does not restore renal medullary structure and function. This study tested the hypothesis that addition of mesenchymal stem cells (MSC) to percutaneous transluminal renal angioplasty (PTRA) can restore stenotic-kidney medullary tubular transport function and attenuate its remodeling. Twenty-seven swine were divided into three ARAS (high-cholesterol diet and renal artery stenosis) and a normal control group. Six weeks after ARAS induction, two groups were treated with PTRA alone or PTRA supplemented with adipose-tissue-derived MSC (10 x 10(6) cells intra-renal). Multi-detector computed tomography and blood-oxygenation-level-dependent (BOLD) MRI studies were performed 4 weeks later to assess kidney hemodynamics and function, and tissue collected a few days later for histology and micro-CT imaging. PTRA effectively decreased blood pressure, yet medullary vascular density remained low. Addition of MSC improved medullary vascularization in ARAS+PTRA+MSC and increased angiogenic signaling, including protein expression of vascular endothelial growth-factor, its receptor (FLK-1), and hypoxia-inducible factor-1 alpha. ARAS+PTRA+MSC also showed attenuated inflammation, although oxidative-stress remained elevated. BOLD-MRI indicated that MSC normalized oxygen-dependent tubular response to furosemide (-4.3 +/- 0.9, -0.1 +/- 0.4, -1.6 +/- 0.9 and -3.6 +/- 1.0 s(-1) in Normal, ARAS, ARAS+PTRA and ARAS+PTRA+MSC, respectively, p<0.05), which correlated with a decrease in medullary tubular injury score (R-2 = 0.33, p = 0.02). Therefore, adjunctive MSC delivery in addition to PTRA reduces inflammation, fibrogenesis and vascular remodeling, and restores oxygen-dependent tubular function in the stenotic-kidney medulla, although additional interventions might be required to reduce oxidative-stress. This study supports development of cell-based strategies for renal protection in ARAS.	[Ebrahimi, Behzad; Eirin, Alfonso; Li, Zilun; Zhu, Xiang-Yang; Zhang, Xin; Textor, Stephen C.; Lerman, Lilach O.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Li, Zilun] Sun Yat Sen Univ, Div Vasc Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Lerman, Amir] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Mayo Clinic; Sun Yat Sen University; Mayo Clinic	Lerman, LO (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.	lerman.lilach@mayo.edu	Lerman, Lilach/M-4962-2017; Eirin, Alfonso/N-9873-2013	Ebrahimi, Behzad/0000-0001-6907-7696; Eirin, Alfonso/0000-0002-3864-9644; Zhang, Xin/0000-0003-4128-9261	National Institutes of Health [DK73608, DK77013, HL77131, HL085307, UL1RR000135, C06-RR018898]; Mayo Clinic Center for Regenerative Medicine Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018898] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085307, R01HL077131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073608, R21DK077013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Regenerative Medicine Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly supported by National Institutes of Health Grant numbers DK73608, DK77013, HL77131, HL085307, UL1RR000135, and C06-RR018898, and in part by the Mayo Clinic Center for Regenerative Medicine Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Chade AR, 2010, STEM CELLS, V28, P1039, DOI 10.1002/stem.426; Chade AR, 2009, CIRCULATION, V119, P547, DOI 10.1161/CIRCULATIONAHA.108.788653; Cooper CJ, 2006, AM HEART J, V152, P59, DOI 10.1016/j.ahj.2005.09.011; Daghini E, 2010, J HYPERTENS, V28, pE210, DOI 10.1097/01.hjh.0000378850.53880.bd; Daghini E, 2007, RADIOLOGY, V243, P405, DOI 10.1148/radiol.2432060655; de Mast Q, 2009, J HYPERTENS, V27, P1333, DOI 10.1097/HJH.0b013e328329bbf4; Ebrahimi B, 2012, AM J PHYSIOL-RENAL, V302, pF1478, DOI 10.1152/ajprenal.00563.2011; Ebrahimi B, 2012, INVEST RADIOL, V47, P175, DOI 10.1097/RLI.0b013e318234e75b; Eirin A, 2012, HYPERTENSION, V60, P1242, DOI 10.1161/HYPERTENSIONAHA.112.199919; Eirin A, 2012, STEM CELLS, V30, P1030, DOI 10.1002/stem.1047; Eirin A, 2011, AM J PHYSIOL-RENAL, V300, pF1394, DOI 10.1152/ajprenal.00697.2010; Favreau F, 2010, KIDNEY INT, V78, P1110, DOI 10.1038/ki.2010.142; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Herrera MB, 2004, INT J MOL MED, V14, P1035; Krier JD, 2001, AM J PHYSIOL-RENAL, V281, pF630, DOI 10.1152/ajprenal.2001.281.4.F630; Lerman LO, 2009, PROG CARDIOVASC DIS, V52, P196, DOI 10.1016/j.pcad.2009.09.002; Lerman LO, 1999, J AM SOC NEPHROL, V10, P1455; Makino A, 2002, HYPERTENSION, V39, P667, DOI 10.1161/hy0202.103469; Marigo I, 2011, SEMIN IMMUNOPATHOL, V33, P593, DOI 10.1007/s00281-011-0267-7; Mori T, 2004, HYPERTENSION, V43, P341, DOI 10.1161/01.HYP.0000113295.31481.36; Mori T, 2003, HYPERTENSION, V42, P588, DOI 10.1161/01.HYP.0000091821.39824.09; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Semedo P, 2007, TRANSPL P, V39, P421, DOI 10.1016/j.transproceed.2007.01.036; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Timmers L, 2008, STEM CELL RES, V1, P129, DOI 10.1016/j.scr.2008.02.002; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Urbieta-Caceres VH, 2010, AM J PHYSIOL-RENAL, V299, pF135, DOI 10.1152/ajprenal.00159.2010; Ward WK, 2003, BIOSENS BIOELECTRON, V19, P155, DOI 10.1016/S0956-5663(03)00180-5; Warner L, 2011, INVEST RADIOL, V46, P41, DOI 10.1097/RLI.0b013e3181f0213f; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; Zhu XY, 2013, STEM CELLS, V31, P117, DOI 10.1002/stem.1263	33	79	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67474	10.1371/journal.pone.0067474	http://dx.doi.org/10.1371/journal.pone.0067474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844014	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000074
J	Majid, S; Dar, AA; Saini, S; Deng, GR; Chang, I; Greene, K; Tanaka, Y; Dahiya, R; Yamamura, S				Majid, Shahana; Dar, Altaf A.; Saini, Sharanjot; Deng, Guoren; Chang, Inik; Greene, Kirsten; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro			MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; METASTASIS; MODEL	MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression by targeted repression of transcription and translation. In this study we show that miRNA-23b (miR-23b) acts as a tumor suppressor in bladder cancer. Quantitative real-time PCR analysis showed that miR-23b is significantly down-regulated in bladder cancer cell lines and tumor tissues compared to non-malignant cells and normal tissue samples. We also demonstrate that miR-23b expression has a potential to be diagnostic and prognostic biomarker in bladder cancer. High miR-23b expression is positively correlated with higher overall survival of bladder cancer patients as revealed by Kaplan-Meier analysis. ROC analysis showed that miR-23b expression can distinguish between normal and bladder cancer tissues. Further we elucidated the biological significance of miR-23b in bladder cancer. Over-expression of miR-23b in bladder cancer cells inhibited cell proliferation and impaired colony formation. Fluorescence activated cell sorting (FACS) analysis revealed that re-expression of miR-23b in bladder cancer cells induced G0/G1 cell cycle arrest and apoptosis while inhibiting cell migration and invasion. Luciferase reporter assays demonstrated that Zeb1, a crucial regulator of epithelial-to-mesenchymal transition (EMT), is a direct target of miR-23b in bladder cancer. These results show that loss of miR-23b confers a proliferative advantage and promotes bladder cancer cell migration and invasion. Furthermore, re-expression of miR-23b may be a beneficial therapeutic strategy for the treatment of human bladder cancer.	[Majid, Shahana; Saini, Sharanjot; Deng, Guoren; Chang, Inik; Greene, Kirsten; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro] VA Med Ctr, Dept Urol, San Francisco, CA USA; [Majid, Shahana; Saini, Sharanjot; Deng, Guoren; Chang, Inik; Greene, Kirsten; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro] UCSF, San Francisco, CA USA; [Dar, Altaf A.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA	University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute	Majid, S (corresponding author), VA Med Ctr, Dept Urol, San Francisco, CA USA.	SMajid@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health [RO1CA138642, RO1CA130860, RO1CA160079, I01BX001123]; VA Merit Review; VA Program Project; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079, R01CA130860] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review(US Department of Veterans Affairs); VA Program Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Center for Research Resources of the National Institutes of Health through grant numbers RO1CA138642, RO1CA130860, RO1CA160079, I01BX001123, VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Black PC, 2007, CANCER METAST REV, V26, P623, DOI 10.1007/s10555-007-9084-9; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Majid S, 2012, CANCER RES, V72, P6435, DOI 10.1158/0008-5472.CAN-12-2181; Majid S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046743; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Metts MC, 2000, J NATL MED ASSOC, V92, P285; Saini S, 2011, CANCER PREV RES, V4, P1698, DOI 10.1158/1940-6207.CAPR-11-0267; Saunders MA, 2009, RNA BIOL, V6, P324, DOI 10.4161/rna.6.3.8871; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shen ZC, 2008, PHARM RES-DORDR, V25, P1500, DOI 10.1007/s11095-008-9566-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Uchida Y, 2011, UROL ONCOL; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050203	23	105	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67686	10.1371/journal.pone.0067686	http://dx.doi.org/10.1371/journal.pone.0067686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844063	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000077
J	Nguyen, ED; Norn, C; Frimurer, TM; Meiler, J				Nguyen, Elizabeth Dong; Norn, Christoffer; Frimurer, Thomas M.; Meiler, Jens			Assessment and Challenges of Ligand Docking into Comparative Models of G-Protein Coupled Receptors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; STRUCTURAL DIVERSITY; EXTRACELLULAR LOOPS; SEQUENCE ALIGNMENT; OPIOID RECEPTOR; SMALL-MOLECULE; GPCR; COMPLEX; BINDING	The rapidly increasing number of high-resolution X-ray structures of G-protein coupled receptors (GPCRs) creates a unique opportunity to employ comparative modeling and docking to provide valuable insight into the function and ligand binding determinants of novel receptors, to assist in virtual screening and to design and optimize drug candidates. However, low sequence identity between receptors, conformational flexibility, and chemical diversity of ligands present an enormous challenge to molecular modeling approaches. It is our hypothesis that rapid Monte-Carlo sampling of protein backbone and side-chain conformational space with Rosetta can be leveraged to meet this challenge. This study performs unbiased comparative modeling and docking methodologies using 14 distinct high-resolution GPCRs and proposes knowledge-based filtering methods for improvement of sampling performance and identification of correct ligand-receptor interactions. On average, top ranked receptor models built on template structures over 50% sequence identity are within 2.9 angstrom of the experimental structure, with an average root mean square deviation (RMSD) of 2.2 angstrom for the transmembrane region and 5 angstrom for the second extracellular loop. Furthermore, these models are consistently correlated with low Rosetta energy score. To predict their binding modes, ligand conformers of the 14 ligands co-crystalized with the GPCRs were docked against the top ranked comparative models. In contrast to the comparative models themselves, however, it remains difficult to unambiguously identify correct binding modes by score alone. On average, sampling performance was improved by 10(3) fold over random using knowledge-based and energy-based filters. In assessing the applicability of experimental constraints, we found that sampling performance is increased by one order of magnitude for every 10 residues known to contact the ligand. Additionally, in the case of DOR, knowledge of a single specific ligand-protein contact improved sampling efficiency 7 fold. These findings offer specific guidelines which may lead to increased success in determining receptor-ligand complexes.	[Nguyen, Elizabeth Dong; Meiler, Jens] Vanderbilt Univ, Med Ctr, Struct Biol Ctr, Nashville, TN 37203 USA; [Norn, Christoffer; Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Norn, Christoffer; Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Vanderbilt Program Drug Discovery, Nashville, TN 37232 USA; [Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Chem, Nashville, TN USA; [Meiler, Jens] Vanderbilt Univ, Med Ctr, Inst Chem Biol, Nashville, TN USA	Vanderbilt University; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Vanderbilt University; Vanderbilt University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Med Ctr, Struct Biol Ctr, Nashville, TN 37203 USA.	jens@meilerlab.org		Meiler, Jens/0000-0001-8945-193X; Frimruer, Thomas/0000-0002-9682-8245; Nguyen, Elizabeth/0000-0002-2798-6581; Norn, Christoffer/0000-0002-1450-4651	National Institutes of Health [R01 GM080403, R01 MH090192, R01 GM099842]; National Science Foundation [Career 0742762]; Novo Nordisk Foundation Center for Basic Metabolic Research; Novo Nordisk Foundation Center for Protein Research under Novo Nordisk Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, T32GM007347, R01GM099842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Novo Nordisk Foundation Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Foundation Center for Protein Research under Novo Nordisk Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work in the Meiler laboratory by EDN and JM is supported through National Institutes of Health (R01 GM080403, R01 MH090192, R01 GM099842) and National Science Foundation (Career 0742762). CN and TMF are supported by the Novo Nordisk Foundation Center for Basic Metabolic Research (www.metabol.ku.dk) and The Novo Nordisk Foundation Center for Protein Research (www.cpr.ku.dk) under an unconditional grant from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2011, COMPUTATIONAL ADV; Barril X, 2005, J MED CHEM, V48, P4432, DOI 10.1021/jm048972v; Beuming T, 2012, J CHEM INF MODEL, V52, P3263, DOI [10.1021/ci300411b, 10.1021/ci3004111]; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Bottegoni G, 2009, J MED CHEM, V52, P397, DOI 10.1021/jm8009958; Bowie JU, 1997, NAT STRUCT BIOL, V4, P915, DOI 10.1038/nsb1197-915; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chen KYM, 2012, P NATL ACAD SCI USA, V109, P13284, DOI 10.1073/pnas.1205512109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gelis L, 2011, ANGEW CHEM INT ED EN; Goldfeld D, 2012, PROTEINS, P1; Goldfeld DA, 2011, P NATL ACAD SCI USA, V108, P8275, DOI 10.1073/pnas.1016951108; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hoyer I, 2013, BIOCHEM SOC T, V41, P213, DOI 10.1042/BST20120319; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacobson KA, 2012, WILEY INTERDISCIP RE, V1; Katritch Vsevolod, 2012, Methods Mol Biol, V857, P189, DOI 10.1007/978-1-61779-588-6_8; Kaufmann KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050769; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Kumar A, 2012, CURR MED CHEM, V19, P5128, DOI 10.2174/092986712803530467; Kumar A, 2012, J COMPUT AID MOL DES, V26, P603, DOI 10.1007/s10822-011-9523-0; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Mobarec JC, 2009, J MED CHEM, V52, P5207, DOI 10.1021/jm9005252; Mortier J, 2012, CURR TOP MED CHEM, V12, P1935, DOI 10.2174/156802612804547371; NICKLAUS MC, 1995, BIOORGAN MED CHEM, V3, P411, DOI 10.1016/0968-0896(95)00031-B; Nikiforovich GV, 2010, PROTEINS, V78, P271, DOI 10.1002/prot.22537; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Parry JJ, 2012, ENDOCRINOLOGY, V153, P2747, DOI 10.1210/en.2011-1662; Perola E, 2004, J MED CHEM, V47, P2499, DOI 10.1021/jm030563w; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rueda M, 2010, BIOINFORMATICS, V26, P2784, DOI 10.1093/bioinformatics/btq504; Rueda M, 2010, J CHEM INF MODEL, V50, P186, DOI 10.1021/ci9003943; Schwartz TW, 1996, TRENDS PHARMACOL SCI, V17, P213, DOI 10.1016/0165-6147(96)10017-1; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WANG CD, 1991, MOL PHARMACOL, V40, P168; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Worth CL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-185; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	69	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67302	10.1371/journal.pone.0067302	http://dx.doi.org/10.1371/journal.pone.0067302			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844000	gold, Green Published			2022-12-27	WOS:000321341000038
J	Cheng, L; Ding, C; Li, Q; He, Q; Dai, LR; Zhang, H				Cheng, Lei; Ding, Chen; Li, Qiang; He, Qiao; Dai, Li-rong; Zhang, Hui			DNA-SIP Reveals That Syntrophaceae Play an Important Role in Methanogenic Hexadecane Degradation	PLOS ONE			English	Article							CRUDE-OIL BIODEGRADATION; REAL-TIME PCR; GEN. NOV.; RESIDUE DECOMPOSITION; MICROBIAL COMMUNITIES; SMITHELLA-PROPIONICA; METHANE PRODUCTION; PRODUCTION WATER; DEEP SUBSURFACE; FIELD	The methanogenic degradation of linear alkanes is a common process in oil-impacted environments. However, little is known about the key players involved in this process. Here, the hexadecane-degrading organisms in a methanogenic, hexadecane-degrading consortium designated M82 obtained from Shengli oilfield and maintained at 35 degrees C for over 4 years, were identified by DNA-stable isotope probing with UL-C-13-hexadecane, followed by density-resolved terminal restriction fragment length polymorphism (T-RFLP) analysis, cloning and phylogenetic analysis of 16S rRNA gene fragments. Compared to the fractions of the C-12 treatment, the relative abundance of two phylotypes significantly increased in the heavy fractions of the C-13-hexadecane incubated microcosm. One belongs to a uncultured member of the bacterial family Syntrophaceae, which show 95-97% rRNA sequence identity with Smithella propionica, and the other is affiliated with Methanoculleus receptaculi (>99% sequence identity). The results of the present study prove the significant role of uncultured Syntrophaceae in degradation of hexadecane, probably through syntrophic interactions with hydrogenotrophic methanogens.	[Cheng, Lei; Ding, Chen; Li, Qiang; He, Qiao; Dai, Li-rong; Zhang, Hui] Minist Agr, Biogas Inst, Key Lab Dev & Applicat Rural Renewable Energy, Chengdu, Sichuan, Peoples R China	Chinese Academy of Agricultural Sciences; Biogas Institute of Ministry of Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, H (corresponding author), Minist Agr, Biogas Inst, Key Lab Dev & Applicat Rural Renewable Energy, Chengdu, Sichuan, Peoples R China.	zhanghuits@aliyun.com			National Natural Science Foundation of China [30900049, 40973059]; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2013ZL001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China	This work is supported by the National Natural Science Foundation of China (30900049 and 40973059), and Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China (2013ZL001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CM, 2004, NATURE, V431, P291, DOI 10.1038/nature02922; Ben Hania W, 2011, SYST APPL MICROBIOL, V34, P581, DOI 10.1016/j.syapm.2011.04.001; Callaghan AV, 2012, ENVIRON MICROBIOL, V14, P101, DOI 10.1111/j.1462-2920.2011.02516.x; Callaghan AV, 2010, ENVIRON SCI TECHNOL, V44, P7287, DOI 10.1021/es1002023; Cheng L, 2008, FEMS MICROBIOL LETT, V285, P65, DOI 10.1111/j.1574-6968.2008.01212.x; Cheng L, 2013, FEMS MICROBIOL ECOL, V83, P757, DOI 10.1111/1574-6941.12031; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dahle H, 2006, INT J SYST EVOL MICR, V56, P1539, DOI 10.1099/ijs.0.63894-0; de Bok FAM, 2001, APPL ENVIRON MICROB, V67, P1800, DOI 10.1128/AEM.67.4.1800-1804.2001; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolfing J, 2008, ISME J, V2, P442, DOI 10.1038/ismej.2007.111; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fowler SJ, 2012, ENVIRON MICROBIOL, V14, P754, DOI 10.1111/j.1462-2920.2011.02631.x; Franke-Whittle IH, 2009, CAN J MICROBIOL, V55, P611, DOI [10.1139/W08-157, 10.1139/w08-157]; Gieg LM, 2008, APPL ENVIRON MICROB, V74, P3022, DOI 10.1128/AEM.00119-08; Gieg LM, 2010, ENVIRON MICROBIOL, V12, P3074, DOI 10.1111/j.1462-2920.2010.02282.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Graber JR, 2004, APPL ENVIRON MICROB, V70, P1315, DOI 10.1128/AEM.70.3.1315-1320.2004; Gray ND, 2011, ENVIRON MICROBIOL, V13, P2957, DOI 10.1111/j.1462-2920.2011.02570.x; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Herrmann S, 2010, ENVIRON MICROBIOL, V12, P401, DOI 10.1111/j.1462-2920.2009.02077.x; Jones DM, 2008, NATURE, V451, P176, DOI 10.1038/nature06484; Kuever J., 2005, BERGEYS MANUAL SYSTE, V2nd Edn, P926; Kuhner CH, 1997, INT J SYST BACTERIOL, V47, P352, DOI 10.1099/00207713-47-2-352; Kunapuli U, 2007, ISME J, V1, P643, DOI 10.1038/ismej.2007.73; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu YT, 1999, INT J SYST BACTERIOL, V49, P545, DOI 10.1099/00207713-49-2-545; Lovley DR, 2001, SCIENCE, V293, P1444, DOI 10.1126/science.1063294; Lu YH, 2005, ENVIRON MICROBIOL, V7, P326, DOI 10.1111/j.1462-2920.2005.00697.x; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; MACY JM, 1972, AM J CLIN NUTR, V25, P1318; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; Mbadinga SM, 2012, APPL MICROBIOL BIOT, V96, P531, DOI 10.1007/s00253-011-3828-8; Nesbo CL, 2012, EXTREMOPHILES, V16, P387, DOI 10.1007/s00792-012-0437-0; Nesbo CL, 2010, APPL ENVIRON MICROB, V76, P4896, DOI 10.1128/AEM.02846-09; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Peng JJ, 2008, APPL ENVIRON MICROB, V74, P2894, DOI 10.1128/AEM.00070-08; Penner TJ, 2010, CAN J MICROBIOL, V56, P459, DOI [10.1139/W10-029, 10.1139/w10-029]; Pham VD, 2009, ENVIRON MICROBIOL, V11, P176, DOI 10.1111/j.1462-2920.2008.01751.x; Pilloni G, 2011, FEMS MICROBIOL ECOL, V78, P165, DOI 10.1111/j.1574-6941.2011.01083.x; Rui JP, 2009, APPL ENVIRON MICROB, V75, P4879, DOI 10.1128/AEM.00702-09; Sakai N, 2009, J BIOSCI BIOENG, V108, P501, DOI 10.1016/j.jbiosc.2009.06.005; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Siddique T, 2012, ENVIRON SCI TECHNOL, V46, P9802, DOI 10.1021/es302202c; Siddique T, 2011, ENVIRON SCI TECHNOL, V45, P5892, DOI 10.1021/es200649t; Stevenson BS, 2011, ENVIRON MICROBIOL, V13, P1078, DOI 10.1111/j.1462-2920.2010.02413.x; Stubner S, 2002, J MICROBIOL METH, V50, P155, DOI 10.1016/S0167-7012(02)00024-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Townsend GT, 2003, ENVIRON SCI TECHNOL, V37, P5213, DOI 10.1021/es0264495; U.S. Department.of.Energy, 2006, UND DOM OIL RES PROV; van der Zaan BM, 2012, ENVIRON MICROBIOL, V14, P1171, DOI 10.1111/j.1462-2920.2012.02697.x; Wang LY, 2011, INT BIODETER BIODEGR, V65, P444, DOI 10.1016/j.ibiod.2010.12.010; [王树华 Wang Shuhua], 2012, [石油实验地质, Petroleum Geology & Experiment], V34, P490; Widdel F., 2010, HDB HYDROCARBON LIPI, P1997, DOI [10.1007/978-3-540-77587-4_146, DOI 10.1007/978-3-540-77587-4_146]; Widdel F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P1028, DOI 10.1007/0-387-30742-7_33; Winderl C, 2010, ISME J, V4, P1314, DOI 10.1038/ismej.2010.54; Yamane K, 2011, FEMS MICROBIOL ECOL, V76, P220, DOI 10.1111/j.1574-6941.2011.01044.x; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777	60	44	48	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e66784	10.1371/journal.pone.0066784	http://dx.doi.org/10.1371/journal.pone.0066784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840866	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900005
J	Bharat, S; Mahapatra, B; Roy, S; Saggurti, N				Bharat, Shalini; Mahapatra, Bidhubhusan; Roy, Suchismita; Saggurti, Niranjan			Are Female Sex Workers Able to Negotiate Condom Use with Male Clients? The Case of Mobile FSWs in Four High HIV Prevalence States of India	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CROSS-SECTIONAL SURVEYS; ANDHRA-PRADESH; COMMUNITY MOBILIZATION; PREVENTION PROGRAM; INTERVENTION; RISK; VIOLENCE; KARNATAKA; SCALE	Introduction Condom promotion among female sex workers (FSWs) is a key intervention in India's National AIDS Control Program. However, there is limited understanding of how FSWs negotiate condom use with male clients, particularly in the context of their mobility for sex work. The objective of this study is to examine the factors associated with the mobile FSWs' ability to refuse unsafe sex and successfully negotiate condom use with unwilling male clients. Methods: Data for 5498 mobile FSWs from a cross-sectional survey conducted in 22 districts of four states in southern India were analyzed. Questions assessed FSWs' ability to refuse clients unprotected sex, convince unwilling clients for condom use and negotiate condom use in a new location. Logistic regression models were constructed to examine the association between socio-demographics, economic vulnerability, sex work practice, and program exposure and condom negotiation ability. Results: A majority of FSWs (60%) reported the ability to refuse clients for unprotected sex, but less than one-fifth reported the ability to successfully convince an unwilling client to use a condom or to negotiate condom use in a new site. Younger and older mobile FSWs compared to those who were in the middle age group, those with longer sex work experience, with an income source other than sex work, with program exposure and who purchased condoms for use, reported the ability to refuse unprotected sex, to successfully negotiate condom use with unwilling clients and to do so at new sites. Conclusion: FSWs need to be empowered to not only refuse unprotected sex but also to be able to motivate and convince unwilling clients for condom use, including those in new locations. In addition to focusing on condom promotion, interventions must address the factors that impact FSWs' ability to negotiate condom use.	[Bharat, Shalini; Roy, Suchismita] Tata Inst Social Sci, Sch Hlth Syst Studies, Mumbai, Maharashtra, India; [Mahapatra, Bidhubhusan; Saggurti, Niranjan] Populat Council, HIV & AIDS Program, New Delhi, India	Tata Institute of Social Sciences	Bharat, S (corresponding author), Tata Inst Social Sci, Sch Hlth Syst Studies, Mumbai, Maharashtra, India.	sbharat@tiss.edu	Mahapatra, Bidhubhusan/M-1411-2019	Mahapatra, Bidhubhusan/0000-0003-0240-7026; Saggurti, Niranjan/0000-0002-5267-8425; Bharat, Shalini/0000-0002-2413-6987	Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative	Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative(Bill & Melinda Gates FoundationGates Foundation India)	This paper was written as part of the Knowledge Network project of the Population Council, which is a grantee of the Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation and Avahan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay N, 2006, IDS BULL-I DEV STUD, V37, P102, DOI 10.1111/j.1759-5436.2006.tb00292.x; Basuki E, 2002, AIDS EDUC PREV, V14, P102, DOI 10.1521/aeap.14.2.102.23901; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Blankenship KM, 2010, SEX TRANSM INFECT, V86, pI69, DOI 10.1136/sti.2009.038653; Busza J., 2004, ACTION RES-LONDON, P191, DOI DOI 10.1177/1476750304043730; Cheng SSY, 2010, AIDS CARE, V22, P606, DOI 10.1080/09540120903311441; Choi SYP, 2007, CULT HEALTH SEX, V9, P489, DOI 10.1080/13691050701220446; Cornish F, 2006, J COMMUNITY APPL SOC, V16, P301, DOI 10.1002/casp.866; Dandona Rakhi, 2006, BMC Int Health Hum Rights, V6, P5, DOI 10.1186/1472-698X-6-5; Dude AM, 2011, AIDS BEHAV, V15, P142, DOI 10.1007/s10461-009-9526-1; Evans C, 2010, GLOB PUBLIC HEALTH, V5, P449, DOI 10.1080/17441690902942472; Gaikwad SS, 2012, J EPIDEMIOL COMMUN H, V66, pII69, DOI 10.1136/jech-2011-200514; Ghimire L, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-42; Ghose T, 2008, SOC SCI MED, V67, P311, DOI 10.1016/j.socscimed.2008.03.045; Grayman JH, 2005, AIDS BEHAV, V9, P41, DOI 10.1007/s10461-005-1680-5; Gupta GR, 2002, BRIT MED J, V324, P183, DOI 10.1136/bmj.324.7331.183; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; Halli SS, 2010, INT J STD AIDS, V21, P746, DOI 10.1258/ijsa.2010.010192; Jain AK, 2012, J HIV-AIDS SOC SERV, V11, P169, DOI 10.1080/15381501.2012.678136; Jain AK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S5; Karnataka Health Promotion Trust Population Council, 2008, PATT MIGR MOB HIV RI; Kerrigan D, 2003, AIDS, V17, P415, DOI 10.1097/00002030-200302140-00016; McCoy SI, 2010, AIDS BEHAV, V14, P469, DOI 10.1007/s10461-009-9644-9; Morisky DE, 2006, HEALTH PSYCHOL, V25, P595, DOI 10.1037/0278-6133.25.5.595; Mumtaz Z., 2005, FOCUS GENDER COLLECT, P117; Nag M., 2006, SEX WORKERS INDIA DI; Ntumbanzondo M, 2006, AIDS CARE, V18, P777, DOI 10.1080/09540120500412824; Nyagero J, 2012, PAN AFR MED J S1, V13, P16; Oladosu M, 2005, J BIOSOC SCI, V37, P435, DOI 10.1017/S0021932004006935; Patterson TL, 2008, AM J PUBLIC HEALTH, V98, P2051, DOI 10.2105/AJPH.2007.130096; Pettifor A, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-4; Population Council, 2008, PATT MIGR MOB HIV RI; Rachakulla HK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S1; Ramakrishnan L, 2010, SEX TRANSM INFECT, V86, pI62, DOI 10.1136/sti.2009.038760; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Reed E, 2010, PUBLIC HEALTH REP, V125, P81, DOI 10.1177/00333549101250S412; Saggurti N, 2012, AIDS BEHAV, V16, P952, DOI 10.1007/s10461-011-9937-7; Saggurti N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S6; Sarkar K, 2008, J HEALTH POPUL NUTR, V26, P223; Sgaier SK, 2012, SEX TRANSM INFECT, V88, P240, DOI 10.1136/sextrans-2011-050382; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Thilakavathi S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S3; Urada LA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/812635; Urada LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033282; Wong ML, 2003, SEX TRANSM INFECT, V79, P163, DOI 10.1136/sti.79.2.163; Yang HM, 2005, SEX TRANSM DIS, V32, P572, DOI 10.1097/01.olq.0000175418.48665.95	49	32	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68043	10.1371/journal.pone.0068043	http://dx.doi.org/10.1371/journal.pone.0068043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840806	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400155
J	Mouchacca, P; Schmitt-Verhulst, AM; Boyer, C				Mouchacca, Pierre; Schmitt-Verhulst, Anne-Marie; Boyer, Claude			Visualization of Cytolytic T Cell Differentiation and Granule Exocytosis with T Cells from Mice Expressing Active Fluorescent Granzyme B	PLOS ONE			English	Article							LYMPHOCYTE DEGRANULATION; IMMUNOLOGICAL SYNAPSE; MEMBRANE-BINDING; PEPTIDASE-I; PERFORIN; ACTIVATION; POLARIZATION; RECEPTOR; REQUIRES; CONSEQUENCES	To evaluate acquisition and activation of cytolytic functions during immune responses we generated knock in (KI) mice expressing Granzyme B (GZMB) as a fusion protein with red fluorescent tdTomato (GZMB-Tom). As for GZMB in wild type (WT) lymphocytes, GZMB-Tom was absent from naive CD8 and CD4 T cells in GZMB-Tom-KI mice. It was rapidly induced in most CD8 T cells and in a subpopulation of CD4 T cells in response to stimulation with antibodies to CD3/CD28. A fraction of splenic NK cells expressed GZMB-Tom ex vivo with most becoming positive upon culture in IL-2. GZMB-Tom was present in CTL granules and active as a protease when these degranulated into cognate target cells, as shown with target cells expressing a specific FRET reporter construct. Using T cells from mice expressing GZMB-Tom but lacking perforin, we show that the transfer of fluorescent GZMB-Tom into target cells was dependent on perforin, favoring a role for perforin in delivery of GZMB at the target cells' plasma membranes. Time-lapse video microscopy showed Ca++ signaling in CTL upon interaction with cognate targets, followed by relocalization of GZMB-Tom-containing granules to the synaptic contact zone. A perforin-dependent step was next visualized by the fluorescence signal from the non-permeant dye TO-PRO-3 at the synaptic cleft, minutes before the labeling of the target cell nucleus, characterizing a previously undescribed synaptic event in CTL cytolysis. Transferred OVA-specific GZMB-Tom-expressing CD8 T cells acquired GZMB-Tom expression in Listeria monocytogenes-OVA infected mice as soon as 48h after infection. These GZMB-Tom positive CD8 T cells localized in the splenic T-zone where they interacted with CD11c positive dendritic cells (DC), as shown by GZMB-Tom granule redistribution to the T/DC contact zone. GZMB-Tom-KI mice thus also provide tools to visualize acquisition and activation of cytolytic function in vivo.	[Mouchacca, Pierre; Schmitt-Verhulst, Anne-Marie; Boyer, Claude] Aix Marseille Univ, UM2, CIML, Marseille, France; [Mouchacca, Pierre; Schmitt-Verhulst, Anne-Marie; Boyer, Claude] INSERM, U1104, F-13258 Marseille, France; [Mouchacca, Pierre; Schmitt-Verhulst, Anne-Marie; Boyer, Claude] CNRS, UMR7280, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Boyer, C (corresponding author), Aix Marseille Univ, UM2, CIML, Marseille, France.	boyer@ciml.univ-mrs.fr		Schmitt-Verhulst, Anne-Marie/0000-0002-1296-2739	INSERM; CNRS; Association pour la Recherche sur le Cancer (ARC); "Institut National du Cancer'' (INCA); INCA PROCAN program; European Communities "Cars Explorer project''	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); "Institut National du Cancer'' (INCA)(Institut National du Cancer (INCA) France); INCA PROCAN program; European Communities "Cars Explorer project''	This work was supported by institutional funding from INSERM and CNRS, and by grants from "Association pour la Recherche sur le Cancer (ARC)'', "Institut National du Cancer'' (INCA), the INCA PROCAN program and the European Communities "Cars Explorer project'' (to AMSV). PM received a doctoral fellowship from ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2003, IMMUNITY, V18, P463, DOI 10.1016/S1074-7613(03)00079-7; Bajenoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011524; Bertrand F, 2010, J IMMUNOL, V185, P2887, DOI 10.4049/jimmunol.1000739; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; BRUNET JF, 1986, NATURE, V322, P268, DOI 10.1038/322268a0; Caramalho I, 2009, J CELL MOL MED, V13, P3834, DOI 10.1111/j.1582-4934.2008.00586.x; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; D'Angelo ME, 2010, J BIOL CHEM, V285, P20514, DOI 10.1074/jbc.M109.094573; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Feldmann J, 2002, BRIT J HAEMATOL, V117, P965, DOI 10.1046/j.1365-2141.2002.03534.x; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; JENNE DE, 1988, IMMUNOL REV, V103, P53, DOI 10.1111/j.1600-065X.1988.tb00749.x; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kannan K, 1996, CELL IMMUNOL, V171, P10, DOI 10.1006/cimm.1996.0167; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kondos SC, 2010, TISSUE ANTIGENS, V76, P341, DOI 10.1111/j.1399-0039.2010.01566.x; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Lopez JA, 2013, BLOOD IN PRESS; Lovo E, 2012, J IMMUNOL, V188, P1057, DOI 10.4049/jimmunol.1102667; Ma JSY, 2007, J IMMUNOL, V178, P7814, DOI 10.4049/jimmunol.178.12.7814; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Moffat JM, 2009, EUR J IMMUNOL, V39, P1203, DOI 10.1002/eji.200839183; Mouchacca P, 2012, EUR J IMMUNOL, V42, P264, DOI 10.1002/eji.201141671; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Pardo J, 2003, INT IMMUNOL, V15, P1441, DOI 10.1093/intimm/dxg141; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; PODACK ER, 1986, J CELL BIOCHEM, V30, P133, DOI 10.1002/jcb.240300205; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stewart SE, 2012, BBA-PROTEINS PROTEOM, V1824, P59, DOI 10.1016/j.bbapap.2011.05.020; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; Tran TV, 2002, ARCH BIOCHEM BIOPHYS, V403, P160, DOI 10.1016/S0003-9861(02)00217-5; Veugelers K, 2006, MOL BIOL CELL, V17, P623, DOI 10.1091/mbc.E05-07-0631; Veugelers K, 2004, BLOOD, V103, P3845, DOI 10.1182/blood-2003-06-2156; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; WALSH CM, 1994, P NATL ACAD SCI USA, V91, P10854, DOI 10.1073/pnas.91.23.10854; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; Wiedemann A, 2005, IMMUNOL LETT, V98, P57, DOI 10.1016/j.imlet.2004.10.014; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103	61	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67239	10.1371/journal.pone.0067239	http://dx.doi.org/10.1371/journal.pone.0067239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840635	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400046
J	Sugiyama, T; Asai, T; Nedachi, YM; Katanasaka, Y; Shimizu, K; Maeda, N; Oku, N				Sugiyama, Tomoki; Asai, Tomohiro; Nedachi, Yuki Murase; Katanasaka, Yasufumi; Shimizu, Kosuke; Maeda, Noriyuki; Oku, Naoto			Enhanced Active Targeting via Cooperative Binding of Ligands on Liposomes to Target Receptors	PLOS ONE			English	Article							ANTI-NEOVASCULAR THERAPY; ANGIOGENIC VESSELS; TUMOR VASCULATURE; CANCER; DRUG; DELIVERY; IMMUNOLIPOSOMES; CHEMOTHERAPY; PEPTIDES; GROWTH	To achieve effective active targeting in a drug delivery system, we previously developed dual-targeting (DT) liposomes decorated with both vascular endothelial growth factor receptor-1 (VEGFR-1)-targeted APRPG and CD13-targeted GNGRG peptide ligands for tumor neovessels, and observed the enhanced suppression of tumor growth in Colon26 NL-17 tumor-bearing mice by the treatment with the DT liposomes encapsulating doxorubicin. In this present study, we examined the binding characteristics of DT liposomes having a different couple of ligands, namely, APRPG and integrin alpha(v)beta(3)-targeted GRGDS peptides. These DT liposomes synergistically associated to stimulated human umbilical vein endothelial cells compared with single-targeting (ST) liposomes decorated with APRPG or GRGDS. The results of a surface plasmon resonance assay showed that ST liposomes modified with APRPG or GRGDS peptide selectively bound to immobilized VEGFR-1 or integrin alpha(v)beta(3), respectively. DT liposomes showed a higher affinity for a mixture of VEGFR-1 and integrin alpha(v)beta(3) compared with ST liposomes, suggesting the cooperative binding of these 2 kinds of ligand on the liposomal surface. In a biodistribution assay, the DT liposomes accumulated to a significantly greater extent in the tumors of Colon26 NL-17 tumor-bearing mice compared with other liposomes. Moreover, the intratumoral distribution of the liposomes examined by confocal microscopy suggested that the DT liposomes targeted not only angiogenic endothelial cells but also tumor cells due to GRGDS-decoration. These findings suggest that "dual-targeting" augmented the affinity of the liposomes for the target cells and would thus be useful for active-targeting drug delivery for cancer treatment.	[Sugiyama, Tomoki; Asai, Tomohiro; Nedachi, Yuki Murase; Katanasaka, Yasufumi; Shimizu, Kosuke; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, Shizuoka 4228526, Japan; [Maeda, Noriyuki] Nippon Fine Chem Co Ltd, Takasago, Hyogo, Japan	University of Shizuoka	Oku, N (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	oku@u-shizuoka-ken.ac.jp		Shimizu, Kosuke/0000-0003-3789-2447	 [17016064]		This research was supported by Grant-in-Aid for Scientific Research on Priority Areas (17016064) http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Asai T, 2002, FEBS LETT, V520, P167, DOI 10.1016/S0014-5793(02)02821-1; Fay F, 2011, IMMUNOTHERAPY-UK, V3, P381, DOI 10.2217/IMT.11.5; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Hatakeyama H, 2011, ADV DRUG DELIVER REV, V63, P152, DOI 10.1016/j.addr.2010.09.001; Ichikawa K, 2004, BIOL PHARM BULL, V27, P443, DOI 10.1248/bpb.27.443; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Koide H, 2011, BIOL PHARM BULL, V34, P602, DOI 10.1248/bpb.34.602; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Maeda H, 2011, ADV DRUG DELIVER REV, V63, P129, DOI 10.1016/j.addr.2010.05.001; Maeda N, 2004, J CONTROL RELEASE, V100, P41, DOI 10.1016/j.jconrel.2004.07.033; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Murase Y, 2010, CANCER LETT, V287, P165, DOI 10.1016/j.canlet.2009.06.008; Nishikawa K, 2012, J CONTROL RELEASE, V160, P274, DOI 10.1016/j.jconrel.2011.10.010; Oku N, 2002, ONCOGENE, V21, P2662, DOI 10.1038/sj.onc.1205347; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Park JW, 1997, CANCER LETT, V118, P153, DOI 10.1016/S0304-3835(97)00326-1; Pasqualini R, 2000, CANCER RES, V60, P722; Pastorino F, 2003, CANCER RES, V63, P7400; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Shimizu K, 2005, INT J PHARMACEUT, V296, P133, DOI 10.1016/j.ijpharm.2005.02.030; TSURUO T, 1984, GANN, V75, P193; Xiong XB, 2005, J PHARM SCI-US, V94, P1782, DOI 10.1002/jps.20397; Yonezawa S, 2007, J CONTROL RELEASE, V118, P303, DOI 10.1016/j.jconrel.2006.12.024	24	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67550	10.1371/journal.pone.0067550	http://dx.doi.org/10.1371/journal.pone.0067550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840738	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400105
J	Weber-Kruger, M; Groschel, K; Mende, M; Seegers, J; Lahno, R; Haase, B; Niehaus, CF; Edelmann, F; Hasenfuss, G; Wachter, R; Stahrenberg, R				Weber-Krueger, Mark; Groeschel, Klaus; Mende, Meinhard; Seegers, Joachim; Lahno, Rosine; Haase, Beatrice; Niehaus, Cord-Friedrich; Edelmann, Frank; Hasenfuss, Gerd; Wachter, Rolf; Stahrenberg, Raoul			Excessive Supraventricular Ectopic Activity Is Indicative of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia	PLOS ONE			English	Article							RISK SCORE; STROKE; ARRHYTHMIAS; PREVENTION; MANAGEMENT; TRANSIENT; ONSET	Background: Detecting paroxysmal atrial fibrillation (PAF) in patients with cerebral ischemia is challenging. Frequent premature atrial complexes (PAC/h) and the longest supraventricular run on 24-h-Holter (SV-run(24 h)), summarised as excessive supraventricular ectopic activity (ESVEA), may help selecting patients for extended ECG-monitoring, especially in combination with echocardiographic marker LAVI/a' (left atrial volume index/late diastolic tissue Doppler velocity). Methods: Retrospective analysis from the prospective monocentric observational trial Find-AF (ISRCTN-46104198). Patients with acute stroke or TIA were enrolled at the University Hospital Gottingen, Germany. Those with sinus rhythm at presentation received 7-day Holter-monitoring. ESVEA was quantified in one 24-hour interval free from PAF. Echocardiographic parameters were assessed prospectively. Results: PAF was detected in 23/208 patients (11.1%). The median was 4 [IQR 1; 22] for PAC/h and 5 [IQR 0; 9] for SV-run(24 h). PAF was more prevalent in patients with ESVEA: 19.6% vs. 2.8% for PAC/h >4 vs. <= 4 (p<0.001); 17.0% vs. 4.9% for SV-run(24) (h) >5 vs. <= 5 beats (p = 0.003). Patients with PAF showed more supraventricular ectopic activity: 29 PAC/h [IQR 9; 143] vs. 4 PAC/h [1; 14] and longest SV-run(24) (h) = 10 [5; 21] vs. 0 [0; 8] beats (both p<0.001). Both markers discriminated between the PAF- and the Non-PAF-group (area under receiver-operator-characteristics-curve 0.763 [95% CI 0.667; 0.858] and 0.716 [0.600; 0.832]). In multivariate analyses log(PAC/h) and log(SV-run(24 h)) were independently indicative of PAF. In Patients with PAC/h <= 4 and normal LAVI/a' PAF was excluded, whereas those with PAC/h>4 and abnormal LAVI/a' showed high PAF-rates. Conclusions: ESVEA discriminated PAF from non-PAF beyond clinical factors including LAVI/a' in patients with cerebral ischemia. Normal LAVI/a'+PAC/h <= 4 ruled out PAF, while prevalence was high in those with abnormal LAVI/a'+PAC/h >4.	[Weber-Krueger, Mark; Seegers, Joachim; Lahno, Rosine; Haase, Beatrice; Niehaus, Cord-Friedrich; Edelmann, Frank; Hasenfuss, Gerd; Wachter, Rolf; Stahrenberg, Raoul] Univ Gottingen, Clin Cardiol & Pneumol, D-37073 Gottingen, Germany; [Groeschel, Klaus] Johannes Gutenberg Univ Mainz, Clin & Polyclin Neurol, D-55122 Mainz, Germany; [Mende, Meinhard] Univ Leipzig, Coordinat Ctr Clin Trials, D-04109 Leipzig, Germany	University of Gottingen; Johannes Gutenberg University of Mainz; Leipzig University	Stahrenberg, R (corresponding author), Univ Gottingen, Clin Cardiol & Pneumol, D-37073 Gottingen, Germany.	stahrenberg@med.uni-goettingen.de	Wachter, Rolf/AAA-4037-2020; Gröschel, Klaus/ABC-4777-2021	Gröschel, Klaus/0000-0002-0244-6116; Wachter, Rolf/0000-0003-2231-2200; Edelmann, Frank/0000-0003-4401-5936; /0000-0001-8107-4797	German Federal Ministry of Education and Research (German Heart Failure Network, TP 7) [FKZ 01GI0205]; Roche Diagnostics, Mannheim, Germany	German Federal Ministry of Education and Research (German Heart Failure Network, TP 7); Roche Diagnostics, Mannheim, Germany	This work was supported by grants from the German Federal Ministry of Education and Research (German Heart Failure Network, TP 7 (FKZ 01GI0205)). This study was supported by an unrestricted grant from Roche Diagnostics, Mannheim, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT MA, 1970, CIRCULATION, V41, P981, DOI 10.1161/01.CIR.41.6.981; Binici Z, 2010, CIRCULATION, V121, P1904, DOI 10.1161/CIRCULATIONAHA.109.874982; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Capucci A, 2005, J AM COLL CARDIOL, V46, P1913, DOI 10.1016/j.jacc.2005.07.044; CAPUCCI A, 1992, INT J CARDIOL, V36, P87, DOI 10.1016/0167-5273(92)90112-G; Crystal E, 2004, HEART, V90, P813, DOI 10.1136/hrt.2003.021642; Engstrom G, 2000, STROKE, V31, P2925, DOI 10.1161/01.STR.31.12.2925; Gaillard N, 2010, NEUROLOGY, V74, P1666, DOI 10.1212/WNL.0b013e3181e0427e; Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638; Hart RG, 2003, ANN INTERN MED, V138, P831, DOI 10.7326/0003-4819-138-10-200305200-00011; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; KILLIP T, 1965, AM HEART J, V70, P172, DOI 10.1016/0002-8703(65)90064-5; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; KOUDSTAAL PJ, 1986, STROKE, V17, P192, DOI 10.1161/01.STR.17.2.192; Liao J, 2007, STROKE, V38, P2935, DOI 10.1161/STROKEAHA.106.478685; Malik S, 2011, J NEUROL SCI, V301, P27, DOI 10.1016/j.jns.2010.11.011; Mittal S, 2011, J AM COLL CARDIOL, V58, P1741, DOI 10.1016/j.jacc.2011.07.026; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; R Development Core Team, 2011, R LANG ENV STAT COMP; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Seet RCS, 2011, CIRCULATION, V124, P477, DOI 10.1161/CIRCULATIONAHA.111.029801; Stahrenberg R, 2011, STROKE, V42, P3643, DOI 10.1161/STROKEAHA.111.632836; Stahrenberg R, 2010, STROKE, V41, P2884, DOI 10.1161/STROKEAHA.110.591958; Stahrenberg R, 2010, STROKE, V41, pE169, DOI 10.1161/STROKEAHA.109.573675; Suissa L, 2009, STROKE, V40, P2866, DOI 10.1161/STROKEAHA.109.552679; Wachter R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034351; Wallmann D, 2003, HEART, V89, P1247, DOI 10.1136/heart.89.10.1247; Wallmann D, 2007, STROKE, V38, P2292, DOI 10.1161/STROKEAHA.107.485110	29	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67602	10.1371/journal.pone.0067602	http://dx.doi.org/10.1371/journal.pone.0067602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840747	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400112
J	Zumhagen, S; Veldkamp, MW; Stallmeyer, B; Baartscheer, A; Eckardt, L; Paul, M; Remme, CA; Bhuiyan, ZA; Bezzina, CR; Schulze-Bahr, E				Zumhagen, Sven; Veldkamp, Marieke W.; Stallmeyer, Birgit; Baartscheer, Antonius; Eckardt, Lars; Paul, Matthias; Remme, Carol Ann; Bhuiyan, Zahurul A.; Bezzina, Connie R.; Schulze-Bahr, Eric			A Heterozygous Deletion Mutation in the Cardiac Sodium Channel Gene SCN5A with Loss- and Gain-of-Function Characteristics Manifests as Isolated Conduction Disease, without Signs of Brugada or Long QT Syndrome	PLOS ONE			English	Article							III-IV-LINKER; NA+-CHANNEL; ATRIAL STANDSTILL; INACTIVATION; CHANNELOPATHIES; ARRHYTHMIAS; EXPRESSION; PHENOTYPE; DEFECTS; RESIDUE	Background: The SCN5A gene encodes for the alpha-subunit of the cardiac sodium channel Na(V)1.5, which is responsible for the rapid upstroke of the cardiac action potential. Mutations in this gene may lead to multiple life-threatening disorders of cardiac rhythm or are linked to structural cardiac defects. Here, we characterized a large family with a mutation in SCN5A presenting with an atrioventricular conduction disease and absence of Brugada syndrome. Method and Results: In a large family with a high incidence of sudden cardiac deaths, a heterozygous SCN5A mutation (p. 1493delK) with an autosomal dominant inheritance has been identified. Mutation carriers were devoid of any cardiac structural changes. Typical ECG findings were an increased P-wave duration, an AV-block I degrees and a prolonged QRS duration with an intraventricular conduction delay and no signs for Brugada syndrome. HEK293 cells transfected with 1493delK showed strongly (5-fold) reduced Na+ currents with altered inactivation kinetics compared to wild-type channels. Immunocytochemical staining demonstrated strongly decreased expression of SCN5A 1493delK in the sarcolemma consistent with an intracellular trafficking defect and thereby a loss-of-function. In addition, SCN5A 1493delK channels that reached cell membrane showed gain-of-function aspects (slowing of the fast inactivation, reduction in the relative fraction of channels that fast inactivate, hastening of the recovery from inactivation). Conclusion: In a large family, congregation of a heterozygous SCN5A gene mutation (p. 1493delK) predisposes for conduction slowing without evidence for Brugada syndrome due to a predominantly trafficking defect that reduces Na+ current and depolarization force.	[Zumhagen, Sven; Stallmeyer, Birgit; Schulze-Bahr, Eric] Univ Hosp Munster, Inst Genet Heart Dis IfGH, Dept Cardiovasc Med, Munster, Germany; [Veldkamp, Marieke W.; Baartscheer, Antonius; Remme, Carol Ann; Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands; [Eckardt, Lars] Univ Hosp Munster, Div Electrophysiol, Dept Cardiovasc Med, Munster, Germany; [Paul, Matthias] Univ Hosp Munster, Div Cardiol, Dept Cardiovasc Med, Munster, Germany; [Bhuiyan, Zahurul A.] CHU Vaudois, Serv Genet Med, Lab Genet Mol, Lausanne, Switzerland; [Schulze-Bahr, Eric] Univ Hosp Munster, Interdisciplinary Ctr Clin Res IZKF, Munster, Germany	University of Munster; University of Amsterdam; Academic Medical Center Amsterdam; University of Munster; University of Munster; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Munster	Zumhagen, S (corresponding author), Univ Hosp Munster, Inst Genet Heart Dis IfGH, Dept Cardiovasc Med, Munster, Germany.	Sven.Zumhagen@ukmuenster.de	Paul, Matthias/AAI-3187-2021; Stallmeyer, Birgit/AAE-3020-2020	Bezzina, Connie/0000-0002-0633-3514	Fondation Leducq, Paris, France; German Research Foundation, Bonn, Germany (DFG) [SFB 656-C1]; Interdisciplinary Center for Clinical Research, Munster, Germany (IZKF) [Schu01-012-11]; Innovative medicine research, Munster, Germany (IMF) [ST121119]	Fondation Leducq, Paris, France(Leducq Foundation); German Research Foundation, Bonn, Germany (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research, Munster, Germany (IZKF); Innovative medicine research, Munster, Germany (IMF)	This work was supported by grants of the Fondation Leducq, Paris, France, the German Research Foundation, Bonn, Germany (DFG; SFB 656-C1) and the Interdisciplinary Center for Clinical Research, Munster, Germany (IZKF; Schu01-012-11) to ES-B as well as by grants of the Innovative medicine research, Munster, Germany (IMF; ST121119) to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Balser JR, 2001, J MOL CELL CARDIOL, V33, P599, DOI 10.1006/jmcc.2000.1346; Benitah JP, 1999, J NEUROSCI, V19, P1577; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Eckardt L, 2001, J CARDIOVASC ELECTR, V12, P680, DOI 10.1046/j.1540-8167.2001.00680.x; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; GEORGE AL, 1995, CYTOGENET CELL GENET, V68, P67; Grant AO, 2002, J CLIN INVEST, V110, P1201, DOI 10.1172/JCI200215570; HARTMANN HA, 1994, CIRC RES, V75, P114, DOI 10.1161/01.RES.75.1.114; Herfst LJ, 2003, J MOL CELL CARDIOL, V35, P549, DOI 10.1016/S0022-2828(03)00078-6; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Keller DI, 2003, J MOL CELL CARDIOL, V35, P1513, DOI 10.1016/j.yjmcc.2003.08.007; Kyndt F, 2001, CIRCULATION, V104, P3081, DOI 10.1161/hc5001.100834; Laitinen-Forsblom PJ, 2006, J CARDIOVASC ELECTR, V17, P480, DOI 10.1111/j.1540-8167.2006.00411.x; Makita N, 2005, HEART RHYTHM, V2, P1128, DOI 10.1016/j.hrthm.2005.06.032; Makita N, 2008, J CLIN INVEST, V118, P2219, DOI [10.1172/JCl34057, 10.1172/JCI34057]; Makita N, 2009, CIRC J, V73, P810, DOI 10.1253/circj.CJ-09-0014; Makiyama T, 2005, J AM COLL CARDIOL, V46, P2100, DOI 10.1016/j.jacc.2005.08.043; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; MOORMAN JR, 1990, SCIENCE, V250, P688; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Neu A, 2010, HUM MUTAT, V31, pE1609, DOI 10.1002/humu.21302; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Probst V, 2003, J AM COLL CARDIOL, V41, P643, DOI 10.1016/S0735-1097(02)02864-4; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Rook MB, 1999, CARDIOVASC RES, V44, P507, DOI 10.1016/S0008-6363(99)00350-8; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Schulze-Bahr E, 2005, HUM MUTAT, V26, P61; Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144; Smits JPP, 2002, J AM COLL CARDIOL, V40, P350, DOI 10.1016/S0735-1097(02)01962-9; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Takehara N, 2004, J INTERN MED, V255, P137, DOI 10.1046/j.0954-6820.2003.01247.x; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tester DJ, 2005, CARDIOVASC RES, V67, P388, DOI 10.1016/j.cardiores.2005.02.013; Tian Li, 2007, Zhonghua Xin Xue Guan Bing Za Zhi, V35, P1122; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Veldkamp MW, 2003, CIRC RES, V92, P976, DOI 10.1161/01.RES.0000069689.09869.A8; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Watanabe H, 2008, J CLIN INVEST, V118, P2260, DOI [10.1172/JC133891, 10.1172/JCI33891]; Wilde AAM, 2011, CIRC RES, V108, P884, DOI 10.1161/CIRCRESAHA.110.238469; World Medical Association, 2002, AM J PHYSIOL-REG I, V283, pR281, DOI DOI 10.1152/AJPREGU.00279.2002; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005; Zumhagen S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P16, DOI 10.1161/CIRCEP.107.737882	50	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67963	10.1371/journal.pone.0067963	http://dx.doi.org/10.1371/journal.pone.0067963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840796	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400148
J	Ahn, KH; Kim, SK; Choi, JM; Jung, SY; Won, JH; Back, MJ; Fu, Z; Jang, JM; Ha, HC; Kim, DK				Ahn, Kyong-Hoon; Kim, Seok-Kyun; Choi, Jong-Min; Jung, Sung-Yun; Won, Jong-Hoon; Back, Moon-Jung; Fu, Zhicheng; Jang, Ji-Min; Ha, Hae-Chan; Kim, Dae-Kyong			Identification of Heat Shock Protein 60 as a Regulator of Neutral Sphingomyelinase 2 and Its Role in Dopamine Uptake	PLOS ONE			English	Article							CELL-SURFACE LOCALIZATION; CHAPERONIN PROTEIN HSP60; RAT-BRAIN; BOVINE BRAIN; FUNCTIONAL INTERACTION; INITIATE APOPTOSIS; GENERATE CERAMIDE; EPITHELIAL-CELLS; MAMMALIAN-CELLS; PHOSPHOLIPASE-C	Activation of sphingomyelinase (SMase) by extracellular stimuli is the major pathway for cellular production of ceramide, a bioactive lipid mediator acting through sphingomyelin (SM) hydrolysis. Previously, we reported the existence of six forms of neutral pH-optimum and Mg2+-dependent SMase (N-SMase) in the membrane fractions of bovine brain. Here, we focus on N-SMase e from salt-extracted membranes. After extensive purification by 12,780-fold with a yield of 1.3%, this enzyme was eventually characterized as N-SMase2. The major single band of 60-kDa molecular mass in the active fractions of the final purification step was identified as heat shock protein 60 (Hsp60) by matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Proximity ligation assay and immunoprecipitation study showed that Hsp60 interacted with N-SMase2, prompting us to examine the effect of Hsp60 on N-SMase2 and ceramide production. Interestingly, Hsp60 siRNA treatment significantly increased the protein level of N-SMase2 in N-SMase2-overexpressed HEK293 cells. Furthermore, transfection of Hsp60 siRNA into PC12 cells effectively increased both N-SMase activity and ceramide production and increased dopamine re-uptake with paralleled increase. Taken together, these results show that Hsp60 may serve as a negative regulator in N-SMase2-induced dopamine re-uptake by decreasing the protein level of N-SMase2.	[Ahn, Kyong-Hoon; Kim, Seok-Kyun; Choi, Jong-Min; Jung, Sung-Yun; Won, Jong-Hoon; Back, Moon-Jung; Fu, Zhicheng; Jang, Ji-Min; Ha, Hae-Chan; Kim, Dae-Kyong] Chung Ang Univ, Coll Pharm, Dept Environm & Hlth Chem, Seoul 156756, South Korea	Chung Ang University	Kim, DK (corresponding author), Chung Ang Univ, Coll Pharm, Dept Environm & Hlth Chem, Seoul 156756, South Korea.	kimdk@cau.ac.kr		Jung, Sung Yun/0000-0003-1521-7977	National Research Foundation of Korea (NRF); Korea government (MEST) [20120006542]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (20120006542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beissinger M, 1998, BIOL CHEM, V379, P245; Bernardo K, 2000, J BIOL CHEM, V275, P7641, DOI 10.1074/jbc.275.11.7641; Blakely RD, 2000, CURR OPIN NEUROBIOL, V10, P328, DOI 10.1016/S0959-4388(00)00088-X; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Brenner B, 1998, CELL DEATH DIFFER, V5, P29, DOI 10.1038/sj.cdd.4400307; Chatterjee S, 1999, J BIOL CHEM, V274, P37407, DOI 10.1074/jbc.274.52.37407; Chen S, 2005, J NEUROSCI RES, V81, P522, DOI 10.1002/jnr.20575; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Garzotto M, 1998, CANCER RES, V58, P2260; Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Goldkorn T, 1998, J CELL SCI, V111, P3209; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HARTL FU, 1995, CURR OPIN STRUC BIOL, V5, P92; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; HOSTETLER KY, 1979, J LIPID RES, V20, P456; Huff RA, 1997, J NEUROCHEM, V68, P225; Hyman SE, 1996, NEURON, V16, P901, DOI 10.1016/S0896-6273(00)80111-7; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Jeon HJ, 2005, J NEUROCHEM, V95, P811, DOI 10.1111/j.1471-4159.2005.03403.x; Jiang HB, 2004, J BIOL CHEM, V279, P54380, DOI 10.1074/jbc.M409282200; Jung SY, 2000, J NEUROCHEM, V75, P1004, DOI 10.1046/j.1471-4159.2000.0751004.x; Kim SK, 2010, CELL SIGNAL, V22, P865, DOI 10.1016/j.cellsig.2010.01.012; Kim SK, 2010, J NEUROCHEM, V112, P1088, DOI 10.1111/j.1471-4159.2009.06527.x; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Liu B, 1998, J BIOL CHEM, V273, P34472, DOI 10.1074/jbc.273.51.34472; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; MARUYAMA EN, 1989, J NEUROCHEM, V52, P611, DOI 10.1111/j.1471-4159.1989.tb09163.x; Morgan JR, 2001, NEURON, V32, P289, DOI 10.1016/S0896-6273(01)00467-6; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Soltys BJ, 1996, J CELL SCI, V109, P1909; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; TAMIYAKOIZUMI K, 1989, J BIOCHEM, V106, P593, DOI 10.1093/oxfordjournals.jbchem.a122901; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; YAMAGUCHI S, 1977, J BIOL CHEM, V252, P3805; Yoo HH, 2006, J CHROMATOGR B, V843, P327, DOI 10.1016/j.jchromb.2006.06.025; Zhang L, 1996, EUR J PHARMACOL, V315, P345, DOI 10.1016/S0014-2999(96)00646-2	54	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67216	10.1371/journal.pone.0067216	http://dx.doi.org/10.1371/journal.pone.0067216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840630	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200125
J	Dalton, AM; Jones, AP; Panter, JR; Ogilvie, D				Dalton, Alice M.; Jones, Andrew P.; Panter, Jenna R.; Ogilvie, David			Neighbourhood, Route and Workplace-Related Environmental Characteristics Predict Adults' Mode of Travel to Work	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVE TRAVEL; WALKING; WALKABILITY; TRANSPORT; CAMBRIDGE; TRANSIT; PEOPLE	Objective: Commuting provides opportunities for regular physical activity which can reduce the risk of chronic disease. Commuters' mode of travel may be shaped by their environment, but understanding of which specific environmental characteristics are most important and might form targets for intervention is limited. This study investigated associations between mode choice and a range of objectively assessed environmental characteristics. Methods: Participants in the Commuting and Health in Cambridge study reported where they lived and worked, their usual mode of travel to work and a variety of socio-demographic characteristics. Using geographic information system (GIS) software, 30 exposure variables were produced capturing characteristics of areas around participants' homes and workplaces and their shortest modelled routes to work. Associations between usual mode of travel to work and personal and environmental characteristics were investigated using multinomial logistic regression. Results: Of the 1124 respondents, 50% reported cycling or walking as their usual mode of travel to work. In adjusted analyses, home-work distance was strongly associated with mode choice, particularly for walking. Lower odds of walking or cycling rather than driving were associated with a less frequent bus service (highest versus lowest tertile: walking OR 0.61 [95% CI 0.20-1.85]; cycling OR 0.43 [95% CI 0.23-0.83]), low street connectivity (OR 0.22, [0.07-0.67]; OR 0.48 [0.26-0.90]) and free car parking at work (OR 0.24 [0.10-0.59]; OR 0.55 [0.32-0.95]). Participants were less likely to cycle if they had access to fewer destinations (leisure facilities, shops and schools) close to work (OR 0.36 [0.21-0.62]) and a railway station further from home (OR 0.53 [0.30-0.93]). Covariates strongly predicted travel mode (pseudo r-squared 0.74). Conclusions: Potentially modifiable environmental characteristics, including workplace car parking, street connectivity and access to public transport, are associated with travel mode choice, and could be addressed as part of transport policy and infrastructural interventions to promote active commuting.	[Dalton, Alice M.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Jones, Andrew P.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Dalton, Alice M.; Jones, Andrew P.; Panter, Jenna R.; Ogilvie, David] Inst Publ Hlth, UKCRC Ctr Diet & Act Res CEDAR, Cambridge, England; [Panter, Jenna R.; Ogilvie, David] Inst Publ Hlth, Med Res Council Epidemiol Unit, Cambridge, England	University of East Anglia; University of East Anglia; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge	Dalton, AM (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.	a.dalton@uea.ac.uk	Jones, Andy/ABB-9742-2021	Jones, Andy/0000-0002-3130-9313; Ogilvie, David/0000-0002-0270-4672	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust; UK Clinical Research Collaboration; National Institute for Health Research Public Health Research programme [09/3001/06]; Medical Research Council (Unit Programme) [MC_U106179474]; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_U106179474, MC_UP_1001/1, G0501294, MC_UU_12015/6] Funding Source: researchfish; National Institute for Health Research [09/3001/06, PDF-2012-05-157] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UP_1001/1, MC_U106179474, G0501294, MC_UU_12015/6] Funding Source: UKRI	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; National Institute for Health Research Public Health Research programme; Medical Research Council (Unit Programme)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Commuting and Health in Cambridge study was developed by David Ogilvie, Simon Griffin, Andy Jones and Roger Mackett, and initially funded under the auspices of the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, National Institute for Health Research and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The study is now funded by the National Institute for Health Research Public Health Research programme (project number 09/3001/06: see http://www.phr.nihr.ac.uk/funded_projects). David Ogilvie is also supported by the Medical Research Council (Unit Programme number MC_U106179474). The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR PHR programme, NHS or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achuthan K, 2010, J MAPS, V6, P220, DOI 10.4113/jom.2010.1077; Badland HM, 2010, SUSTAINABILITY, V2, P576, DOI DOI 10.3390/su2020576; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Besser LM, 2005, AM J PREV MED, V29, P273, DOI 10.1016/j.amepre.2005.06.010; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Bibby P., 2004, DEV NEW CLASSIFICATI; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Carse A, 2013, J TRANSP GEOGR, V28, P67, DOI 10.1016/j.jtrangeo.2012.10.013; Cavill N, 2006, PHYS ACTIVITY HLTH E; Centre for Ecology and Hydrology (CEH), 2000, LAND COV MAP 2000 LC; Department for Transport (DfT), 2010, THAL NAT PUBL TRANSP; Department for Transport (DfT), 2009, THAL NAT PUBL TRANSP; Department of Health, 2011, START ACT STAY ACT A; DH, 2009, BE ACT BE HLTH PLAN; ESRI, 2009, ARCGIS 9 3; Evans G., 2009, BUILD ENVIRON, V35, P366, DOI DOI 10.2148/BENV.35.3.366; Forsyth A., 2010, NEAT GIS NEIGHBORHOO; Forsyth A, 2010, BUILT ENV, V36, P429, DOI DOI 10.2148/BENV.36.4.429; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; Fraser SDS, 2011, EUR J PUBLIC HEALTH, V21, P738, DOI 10.1093/eurpub/ckq145; Goodman A, 2012, SOC SCI MED, V74, P1929, DOI 10.1016/j.socscimed.2012.01.042; Grewal R, 2004, MARKET SCI, V23, P519, DOI 10.1287/mksc.1040.0070; Hendriksen IJM, 2010, PREV MED, V51, P132, DOI 10.1016/j.ypmed.2010.05.007; Hickman R, 2010, TOWN COUNTRY PLA FEB, P77; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Lachapelle U, 2009, J PUBLIC HEALTH POL, V30, pS73, DOI 10.1057/jphp.2008.52; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lovasi GS, 2008, HEALTH PLACE, V14, P453, DOI 10.1016/j.healthplace.2007.09.004; Mackett RL, 2007, WORLD C TRANSP RES B; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Natural England, 2011, GIS DIG BOUND DAT OP; Nicholls S., 2001, Managing Leisure, V6, P201, DOI 10.1080/13606710110084651; Office for National Statistics, 2001, SOC CLASS NS SEC UV; Office for National Statistics (ONS), 2001, ENGL URB AR 2001; Office for National Statistics (ONS), 2001, METH TRAV WORK DAYT; Ogilvie D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-703; Oja P, 1998, PATIENT EDUC COUNS, V33, pS87, DOI 10.1016/S0738-3991(98)00013-5; OpenStreetMap, 2010, OPENSTREETMAP FREE W; Ordnance Survey, 2022, POINTS INT; Ordnance Survey (OS), 2010, OS MASTERMAP ADDR LA; Ordnance Survey (OS), 2010, OS MASTERMAP TOP LAY; Ordnance Survey (OS), 2010, OS MASTERMAP INT TRA; Panter J, 2013, PREV MED, V56, P211, DOI 10.1016/j.ypmed.2013.01.014; Panter J, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-124; Panter JR, 2010, AM J PREV MED, V38, P268, DOI 10.1016/j.amepre.2009.10.040; Panter JR, 2010, J PHYS ACT HEALTH, V7, P551, DOI 10.1123/jpah.7.4.551; Pooley C.G., 2000, J TRANSP GEOGR, V8, P11, DOI [DOI 10.1016/S0966-6923(99)00031-9, 10.1016/S0966-6923(99)00031-9]; Predictive Analytics SoftWare (PASW), 2009, PASW STATISTICS 18, P18; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Reilly M., 2002, INFLUENCE BUILT FORM; Shill J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042831; Sustrans, 2012, AB SUSTR; UK Government, 2011, COMM BUS TRAV FACTSH; Van Dyck D, 2011, HEALTH PLACE, V17, P1011, DOI 10.1016/j.healthplace.2011.05.005; Van Dyck D, 2009, HEALTH PLACE, V15, P496, DOI 10.1016/j.healthplace.2008.08.010	56	61	61	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67575	10.1371/journal.pone.0067575	http://dx.doi.org/10.1371/journal.pone.0067575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840743	Green Published, Green Accepted, gold			2022-12-27	WOS:000322361200138
J	Halfter, W; Monnier, C; Muller, D; Oertle, P; Uechi, G; Balasubramani, M; Safi, F; Lim, R; Loparic, M; Henrich, PB				Halfter, Willi; Monnier, Christophe; Mueller, David; Oertle, Philipp; Uechi, Guy; Balasubramani, Manimalha; Safi, Farhad; Lim, Roderick; Loparic, Marko; Henrich, Paul Bernhard			The Bi-Functional Organization of Human Basement Membranes	PLOS ONE			English	Article							INNER LIMITING MEMBRANE; COLLAGEN-IV; AXONAL GROWTH; MESSENGER-RNA; 7-S COLLAGEN; BASAL LAMINA; GENE LAMC2; CHAIN GENE; EXPRESSION; LOCALIZATION	The current basement membrane (BM) model proposes a single-layered extracellular matrix (ECM) sheet that is predominantly composed of laminins, collagen IVs and proteoglycans. The present data show that BM proteins and their domains are asymmetrically organized providing human BMs with side-specific properties: A) isolated human BMs roll up in a side-specific pattern, with the epithelial side facing outward and the stromal side inward. The rolling is independent of the curvature of the tissue from which the BMs were isolated. B) The epithelial side of BMs is twice as stiff as the stromal side, and C) epithelial cells adhere to the epithelial side of BMs only. Side-selective cell adhesion was also confirmed for BMs from mice and from chick embryos. We propose that the bi-functional organization of BMs is an inherent property of BMs and helps build the basic tissue architecture of metazoans with alternating epithelial and connective tissue layers.	[Halfter, Willi] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Monnier, Christophe; Mueller, David; Oertle, Philipp; Lim, Roderick; Loparic, Marko] Univ Basel, Bioctr, CH-4056 Basel, Switzerland; [Uechi, Guy; Balasubramani, Manimalha] Univ Pittsburgh, Prote Core Facil, Pittsburgh, PA USA; [Safi, Farhad] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Henrich, Paul Bernhard] Univ Basel, Dept Ophthalmol, Basel, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Basel; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Basel	Halfter, W (corresponding author), Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA.	whalfter@pitt.edu		Muller, David/0000-0003-1914-3768; Lim, Roderick/0000-0001-5015-6087; Monnier, Christophe/0000-0002-0071-7269	University of Pittsburgh; Biocenter of the University of Basel; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	University of Pittsburgh(University of Pittsburgh); Biocenter of the University of Basel; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The publication was funded by the University of Pittsburgh and the Biocenter of the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Balasubramani M, 2010, MATRIX BIOL, V29, P471, DOI 10.1016/j.matbio.2010.04.002; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Candiello J, 2007, FEBS J, V274, P2897, DOI 10.1111/j.1742-4658.2007.05823.x; Candiello J, 2010, MATRIX BIOL, V29, P402, DOI 10.1016/j.matbio.2010.03.004; Cann GM, 1996, DEV BIOL, V180, P82, DOI 10.1006/dbio.1996.0286; Chen J, 2011, INVEST OPHTH VIS SCI, V52, P8957, DOI 10.1167/iovs.11-8078; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Danysh BP, 2009, EXP EYE RES, V88, P151, DOI 10.1016/j.exer.2008.08.002; Danysh BP, 2008, ANAT REC, V291, P1619, DOI 10.1002/ar.20753; Davis GE, 1978, SCIENCE, V236, P106; DONG LJ, 1991, DIFFERENTIATION, V48, P157, DOI 10.1111/j.1432-0436.1991.tb00254.x; Dong SC, 2002, J COMP NEUROL, V447, P261, DOI 10.1002/cne.10245; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Halfter W, 2005, INVEST OPHTH VIS SCI, V46, P2202, DOI 10.1167/iovs.04-1419; HALFTER W, 1992, EUR J NEUROSCI, V4, P840, DOI 10.1111/j.1460-9568.1992.tb00194.x; HALFTER W, 1987, J NEUROSCI, V7, P3712; HALFTER W, 1983, DEV BIOL, V95, P56, DOI 10.1016/0012-1606(83)90006-4; Hasenson S, 2005, EXP EYE RES, V81, P415, DOI 10.1016/j.exer.2005.02.015; Henrich PB, 2012, INVEST OPHTH VIS SCI, V29, P2561; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Hudson BG, 1995, EXTRACELLULAR MATRIX; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; LANGEVELD JPM, 1991, J BIOL CHEM, V266, P2622; Lee J, 2007, INVEST OPHTH VIS SCI, V48, P2483, DOI 10.1167/iovs.06-1211; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P1402; NAYAK BR, 1991, J BIOL CHEM, V266, P13978; Neumann KH, 2004, NEPHROL DIAL TRANSPL, V19, P805, DOI 10.1093/ndt/gfh067; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; SARTHY V, 1993, INVEST OPHTH VIS SCI, V34, P145; Schlie K, 2010, J VIROL, V84, P3178, DOI 10.1128/JVI.02240-09; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; SUNDARRAJ N, 1982, IMMUNOLOGY, V47, P133; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; Uechi G, 2013, PROTEOMIC ANAL UNPUB; Vazquez F, 1996, MATURITAS, V25, P209, DOI 10.1016/S0378-5122(96)01066-3; Willem M, 2002, DEVELOPMENT, V129, P2711; Yin Y, 2003, GENESIS, V36, P114, DOI 10.1002/gene.10206; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	61	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67660	10.1371/journal.pone.0067660	http://dx.doi.org/10.1371/journal.pone.0067660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844050	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000321733000089
J	Merkel, B; Lydersen, C; Yoccoz, NG; Kovacs, KM				Merkel, Benjamin; Lydersen, Christian; Yoccoz, Nigel G.; Kovacs, Kit M.			The World's Northernmost Harbour Seal Population-How Many Are There?	PLOS ONE			English	Article							PRINS KARLS FORLAND; HAUL-OUT BEHAVIOR; PHOCA-VITULINA; MAXIMUM-LIKELIHOOD; TUGIDAK ISLAND; GLACIER BAY; COMMON SEAL; ABUNDANCE; AGE; SVALBARD	This study presents the first abundance estimate for the world's northernmost harbour seal (Phoca vitulina) population, which resides in Svalbard, Norway, based on three digital stereoscopic photographic surveys conducted in 2009 and 2010. The counts from these high resolution 3D images were combined with a novel method for estimating correction factors for animals that were in the water at the time of the surveys, in which extensive behavioural data from radio-tagged harbour seals were used together with age distribution data to estimate the proportion of seals of various age and sex classes hauled out at the times of the surveys. To detect possible seasonal shifts in age distribution between surveys, lengths of hauled out seals were measured from the stereoscopic images. No body-length differences were detected between the surveys; but, this may be due to a high degree of sexual dimorphism exhibited in this population. Applying the modelled correction factors, a total of 1888 (95% CI: 1660-3023), 1742 (1381-3549) and 1812 (1656-4418) harbour seals were estimated for the surveys flown on 01 August 2009, 01 August 2010 and 19 August 2010, respectively. The similarity between the three survey estimates (despite significant differences in the number of animals actually counted on the photos from each survey effort) suggests that the variation in numbers of hauled out seals is reasonably accurately adjusted for by the haul-out probability model. The low population size, the limited spatial distribution of the population and its reduced genetic diversity make this population vulnerable to chance events, such as disease epidemics.	[Merkel, Benjamin; Lydersen, Christian; Kovacs, Kit M.] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Merkel, Benjamin; Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	Norwegian Polar Institute; UiT The Arctic University of Tromso	Kovacs, KM (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	Kit.Kovacs@npolar.no	Yoccoz, Nigel/C-8561-2014	Yoccoz, Nigel/0000-0003-2192-1039	Norwegian Research Council [184644]; Norwegian Polar Institute	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Polar Institute	This study was funded by the Norwegian Research Council (Sea and Coastal Programme, grant no 184644) and the Norwegian Polar Institute. The funding agents had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLEN SG, 1985, MAR MAMMAL SCI, V1, P84, DOI 10.1111/j.1748-7692.1985.tb00532.x; Andersen LW, 2011, BIOL J LINN SOC, V102, P420, DOI 10.1111/j.1095-8312.2010.01577.x; Andersen SM, 2004, CAN J ZOOL, V82, P1230, DOI 10.1139/Z04-093; Arndt W, 1900, FUNA ARCTICA ZUSAMME; Bigg M.A., 1981, HDB MARINE MAMMALS, V2, P1; Bigg MA, 1969, B FISH RES BD CAN, V172; Bjorge Arne, 2007, Aquatic Mammals, V33, P269, DOI 10.1578/AM.33.3.2007.269; Boulva J, 1979, B FISH RES BD CAN, V200; Boveng PL, 2003, MAR MAMMAL SCI, V19, P111, DOI 10.1111/j.1748-7692.2003.tb01096.x; Bowen WD, 1999, CAN J ZOOL, V77, P978, DOI 10.1139/cjz-77-6-978; Bowen WD, 2003, J ZOOL, V261, P155, DOI 10.1017/S0952836903004047; Burns JJ, 1984, NOAA TECHNICAL REPOR, V12, P17; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Carlens H, 2006, MAR MAMMAL SCI, V22, P379, DOI 10.1111/j.1748-7692.2006.00034.x; Cox DR, 2007, ANN APPL STAT, V1, P1, DOI 10.1214/07-AOAS113; Cronin M, 2007, J ZOOL, V273, P131, DOI 10.1111/j.1469-7998.2007.00316.x; Cunningham L, 2010, J MAR BIOL ASSOC UK, V90, P1659, DOI 10.1017/S002531540999155X; Daniel RG, 2003, MAR MAMMAL SCI, V19, P128, DOI 10.1111/j.1748-7692.2003.tb01097.x; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; Gales NJ, 2009, MAR MAMMAL SCI, V25, P725, DOI 10.1111/j.1748-7692.2008.00279.x; Gilbert JR, 2005, MAR MAMMAL SCI, V21, P519, DOI 10.1111/j.1748-7692.2005.tb01246.x; Gjertz I, 2001, POLAR BIOL, V24, P209, DOI 10.1007/s003000000197; GJERTZ I, 1992, MAR MAMMAL SCI, V8, P103, DOI 10.1111/j.1748-7692.1992.tb00369.x; Hamel S, 2012, METHODS ECOL EVOL, V3, P731, DOI 10.1111/j.2041-210X.2012.00195.x; Harkonen T, 2002, CAN J ZOOL, V80, P1498, DOI 10.1139/Z02-141; Harkonen T, 1999, J APPL ECOL, V36, P825, DOI 10.1046/j.1365-2664.1999.00434.x; HARKONEN T, 1990, OPHELIA, V32, P211; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvey JT, 2011, MAR MAMMAL SCI, V27, P719, DOI 10.1111/j.1748-7692.2010.00446.x; Hastings KK, 2012, J MAMMAL, V93, P1368, DOI 10.1644/11-MAMM-A-291.1; Hauksson Erlingur, 1992, Hafrannsoknir, V43, P23; Hoef JMV, 2010, COMPUTATION STAT, V25, P39, DOI 10.1007/s00180-009-0160-1; Hop H, 2002, POLAR RES, V21, P167, DOI 10.1111/j.1751-8369.2002.tb00073.x; Jorgensen C, 2001, J EXP BIOL, V204, P3993; King JE., 1983, SEALS WORLD BRIT MUS; Kovacs Kit M., 2008, Science Progress, V91, P117, DOI 10.3184/003685008X324010; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Labansen AL, 2007, ICES J MAR SCI, V64, P1246, DOI 10.1093/icesjms/fsm090; London JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038180; Lydersen C, 2005, POLAR BIOL, V28, P156, DOI 10.1007/s00300-004-0656-7; Lydersen Christian, 2010, NAMMCO Scientific Publications, V8, P47; Lydersen Christian, 2002, P1; MARKUSSEN NH, 1989, J ZOOL, V219, P433, DOI 10.1111/j.1469-7998.1989.tb02591.x; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; MUELBERT MMC, 1993, CAN J ZOOL, V71, P1405, DOI 10.1139/z93-194; OLESIUK PF, 1990, CAN J FISH AQUAT SCI, V47, P992, DOI 10.1139/f90-114; PITCHER KW, 1981, CAN FIELD NAT, V95, P292; PRESTRUD P, 1990, MAR MAMMAL SCI, V6, P215, DOI 10.1111/j.1748-7692.1990.tb00245.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reder S, 2003, POLAR BIOL, V27, P6, DOI 10.1007/s00300-003-0557-1; Ries EH, 1998, J APPL ECOL, V35, P332, DOI 10.1046/j.1365-2664.1998.00305.x; Roen R, 1995, DEV MAR BIO, V4, P61; Small RJ, 2003, MAR MAMMAL SCI, V19, P344, DOI 10.1111/j.1748-7692.2003.tb01113.x; Teilmann J, 2010, ICES J MAR SCI, V67, P952, DOI 10.1093/icesjms/fsq001; THOMPSON P, 1987, J ZOOL, V212, P597, DOI 10.1111/j.1469-7998.1987.tb05958.x; THOMPSON P, 1988, MAMMAL REV, V18, P105, DOI 10.1111/j.1365-2907.1988.tb00080.x; Thompson PM, 1997, J APPL ECOL, V34, P43, DOI 10.2307/2404846; VanParijs SM, 1997, ANIM BEHAV, V54, P35, DOI 10.1006/anbe.1996.0426; Venables WN., 2002, MODERN APPL STAT S 4; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	62	14	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67576	10.1371/journal.pone.0067576	http://dx.doi.org/10.1371/journal.pone.0067576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844035	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000083
J	Stenner, F; Liewen, H; Gottig, S; Henschler, R; Markuly, N; Kleber, S; Faust, M; Mischo, A; Bauer, S; Zweifel, M; Knuth, A; Renner, C; Wadle, A				Stenner, Frank; Liewen, Heike; Goettig, Stephan; Henschler, Reinhard; Markuly, Norbert; Kleber, Sascha; Faust, Michael; Mischo, Axel; Bauer, Stefan; Zweifel, Martin; Knuth, Alexander; Renner, Christoph; Wadle, Andreas			RP1 Is a Phosphorylation Target of CK2 and Is Involved in Cell Adhesion	PLOS ONE			English	Article							PROTEIN-KINASE CK2; EB1 FAMILY PROTEINS; CANCER-CELLS; GENE FAMILY; ASSOCIATION; BINDING; PROLIFERATION; EXPRESSION; ADDICTION; SURVIVAL	RP1 (synonym: MAPRE2, EB2) is a member of the microtubule binding EB1 protein family, which interacts with APC, a key regulatory molecule in the Wnt signalling pathway. While the other EB1 proteins are well characterized the cellular function and regulation of RP1 remain speculative to date. However, recently RP1 has been implicated in pancreatic cancerogenesis. CK2 is a pleiotropic kinase involved in adhesion, proliferation and anti-apoptosis. Overexpression of protein kinase CK2 is a hallmark of many cancers and supports the malignant phenotype of tumor cells. In this study we investigate the interaction of protein kinase CK2 with RP1 and demonstrate that CK2 phosphorylates RP1 at Ser(236) in vitro. Stable RP1 expression in cell lines leads to a significant cleavage and down-regulation of N-cadherin and impaired adhesion. Cells expressing a Phosphomimicking point mutant RP1-ASP(236) show a marked decrease of adhesion to endothelial cells under shear stress. Inversely, we found that the cells under shear stress downregulate endogenous RP1, most likely to improve cellular adhesion. Accordingly, when RP1 expression is suppressed by shRNA, cells lacking RP1 display significantly increased cell adherence to surfaces. In summary, RP1 phosphorylation at Ser(236) by CK2 seems to play a significant role in cell adhesion and might initiate new insights in the CK2 and EB1 family protein association.	[Stenner, Frank; Liewen, Heike; Markuly, Norbert; Kleber, Sascha; Mischo, Axel; Knuth, Alexander; Renner, Christoph; Wadle, Andreas] Univ Zurich Hosp, Div Oncol, CH-8091 Zurich, Switzerland; [Goettig, Stephan; Henschler, Reinhard] Goethe Univ Frankfurt, DRK Inst Transfus Med & Immune Hematol, D-60054 Frankfurt, Germany; [Faust, Michael] Univ Saarland, Inst Med Biochem & Mol Biol, Homburg, Germany; [Bauer, Stefan] Med Oncol Off, Lebach, Germany; [Zweifel, Martin] Univ Bern, Inselspital, Inst Med Oncol, CH-3010 Bern, Switzerland	University of Zurich; University Zurich Hospital; Goethe University Frankfurt; Saarland University; University of Bern; University Hospital of Bern	Stenner, F (corresponding author), Univ Zurich Hosp, Div Oncol, CH-8091 Zurich, Switzerland.	stennerf@uhbs.ch	knuth, alexander/H-2608-2014	knuth, alexander/0000-0002-9318-2784; Stenner, Frank/0000-0003-4541-8817; Liewen, Heike/0000-0002-6161-4749				Abiatari I, 2009, INT J ONCOL, V35, P1111, DOI 10.3892/ijo_00000426; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Bu W, 2001, ONCOGENE, V20, P3185, DOI 10.1038/sj.onc.1204429; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; Donella-Deana A, 2001, BIOCHEM J, V357, P563, DOI 10.1042/0264-6021:3570563; Duncan JS, 2010, BBA-PROTEINS PROTEOM, V1804, P505, DOI 10.1016/j.bbapap.2009.11.001; Faust M, 1999, FEBS LETT, V462, P51, DOI 10.1016/S0014-5793(99)01492-1; Grey F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000967; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; HERRMANN CPE, 1991, ONCOGENE, V6, P877; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; KNOWLES GC, 1992, J HISTOCHEM CYTOCHEM, V40, P1605, DOI 10.1177/40.10.1527379; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Renner C, 1997, J IMMUNOL, V159, P1276; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Seger D, 2001, J BIOL CHEM, V276, P16998, DOI 10.1074/jbc.M003766200; SHINOURA N, 1995, BRIT J CANCER, V72, P627, DOI 10.1038/bjc.1995.384; Su LK, 2001, GENOMICS, V71, P142, DOI 10.1006/geno.2000.6428; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67595	10.1371/journal.pone.0067595	http://dx.doi.org/10.1371/journal.pone.0067595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844040	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000085
J	Ahmad, Y; Sharma, NK; Garg, I; Ahmad, MF; Sharma, M; Bhargava, K				Ahmad, Yasmin; Sharma, Narendra K.; Garg, Iti; Ahmad, Mohammad Faiz; Sharma, Manish; Bhargava, Kalpana			An Insight into the Changes in Human Plasma Proteome on Adaptation to Hypobaric Hypoxia	PLOS ONE			English	Article							AMYLOID-P-COMPONENT; RETINOL-BINDING-PROTEIN; APOLIPOPROTEIN-A-I; INDUCIBLE FACTOR-I; PULMONARY ARTERIAL-HYPERTENSION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GC-GLOBULIN; INSULIN-RESISTANCE; ANOXIA TOLERANCE; OVARIAN-CANCER	Adaptation to hypobaric hypoxia is required by animals and human in several physiological and pathological situations. Hypobaric hypoxia is a pathophysiological condition triggering redox status disturbances of cell organization leading, via oxidative stress, to proteins, lipids, and DNA damage. Identifying the molecular variables playing key roles in this process would be of paramount importance to shed light on the mechanisms known to counteract the negative effects of oxygen lack. To obtain a molecular signature, changes in the plasma proteome were studied by using proteomic approach. To enrich the low-abundance proteins in human plasma, two highly abundant proteins, albumin and IgG, were first removed. By comparing the plasma proteins of high altitude natives with those of a normal control group, several proteins with a significant alteration were found. The up-regulated proteins were identified as vitamin D-binding protein, hemopexin, alpha-1-antitrypsin, haptoglobin beta-chain, apolipoprotein A1, transthyretin and hemoglobin beta chain. The down-regulated proteins were transferrin, complement C3, serum amyloid, complement component 4A and plasma retinol binding protein. Among these proteins, the alterations of transthyretin and transferrin were further confirmed by ELISA and Western blotting analysis. Since all the up-and down-regulated proteins identified above are well-known inflammation inhibitors and play a positive anti-inflammatory role, these results show that there is some adaptive mechanism that sustains the inflammation balance in high altitude natives exposed to hypobaric hypoxia.	[Ahmad, Yasmin; Sharma, Narendra K.; Sharma, Manish; Bhargava, Kalpana] Minist Def, Peptide & Prote Div, DIPAS, DRDO, Delhi, India; [Garg, Iti] Minist Def, Dept Genom, DIPAS, DRDO, Delhi, India; [Ahmad, Mohammad Faiz] Jamia Millia Islamia, Dept Chem, New Delhi 110025, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Jamia Millia Islamia	Ahmad, Y (corresponding author), Minist Def, Peptide & Prote Div, DIPAS, DRDO, Delhi, India.	yasminchem@gmail.com	Garg, Iti/GYU-6396-2022; Sharma, Narendra/D-2451-2017	Sharma, Narendra/0000-0002-8681-3840	Defence Research Development Organization (DRDO), Ministry of Defence, Government of India [TC/321/Task - 145 (YA)/DIPAS/2008]	Defence Research Development Organization (DRDO), Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO))	Financial support for this study is provided by a grant from TC/321/Task - 145 (YA)/DIPAS/2008, Defence Research Development Organization (DRDO), Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Salam VB, 2006, PROTEOMICS, V6, P2286, DOI 10.1002/pmic.200500510; Ahmad Y., 2009, J PROTEOM BIOINFORM, V2, P495, DOI DOI 10.4172/JPB.1000111; Ahmad Y, 2011, FUNCT INTEGR GENOMIC, V11, P407, DOI 10.1007/s10142-011-0234-3; Amador A, 2007, AM J TRANSPLANT, V7, P2180, DOI 10.1111/j.1600-6143.2007.01914.x; Anantharamaiah GM, 2007, J LIPID RES, V48, P1915, DOI 10.1194/jlr.R700010-JLR200; Anderson GJ, 2005, SEMIN LIVER DIS, V25, P420, DOI 10.1055/s-2005-923314; ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421; Bates SR, 2005, AM J PHYSIOL-LUNG C, V289, pL980, DOI 10.1152/ajplung.00234.2005; Bauer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028578; Bellovino D, 1996, EXP CELL RES, V222, P77, DOI 10.1006/excr.1996.0010; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Bradbury MWB, 1997, J NEUROCHEM, V69, P443; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cavill I, 2002, BEST PRACT RES CL HA, V15, P399, DOI 10.1053/beha.2002.0004; Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672; Chang MHY, 2004, BIOCHEM J, V382, P481, DOI 10.1042/BJ20031752; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Congote LF, 2008, PEPTIDES, V29, P39, DOI 10.1016/j.peptides.2007.10.011; Cook HT, 2006, NAT CLIN PRACT RHEUM, V2, P330, DOI 10.1038/ncprheum0191; Cowan KN, 2000, NAT MED, V6, P698, DOI 10.1038/76282; Dahl B, 2001, INTENS CARE MED, V27, P394, DOI 10.1007/s001340000837; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; FRISANCHO AR, 1975, SCIENCE, V187, P313, DOI 10.1126/science.1089311; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Han CZ, 2005, ENDOCRINE, V26, P19, DOI 10.1385/ENDO:26:1:019; Handelman GJ, 2008, HEART FAIL REV, V13, P393, DOI 10.1007/s10741-008-9086-x; HANLEY JM, 1985, ARCH BIOCHEM BIOPHYS, V239, P404, DOI 10.1016/0003-9861(85)90706-4; HAUGEN TH, 1981, J BIOL CHEM, V256, P1055; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Hulmes J.D., 2004, CLIN PROTEOM, V1, P17; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; JESSEN TH, 1991, P NATL ACAD SCI USA, V88, P6519, DOI 10.1073/pnas.88.15.6519; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lasztity N, 2002, CLIN CHEM LAB MED, V40, P1320, DOI 10.1515/CCLM.2002.227; LEDOUXCORBUSIER M, 1975, J CUTAN PATHOL, V2, P25, DOI 10.1111/j.1600-0560.1975.tb00827.x; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Lomas DA, 2002, J CLIN INVEST, V110, P1585, DOI 10.1172/JCI200216782; MAIRBAURL H, 1994, INT J SPORTS MED, V15, P51, DOI 10.1055/s-2007-1021020; Mangan MSJ, 2008, TISSUE ANTIGENS, V72, P1, DOI 10.1111/j.1399-0039.2008.01059.x; Massip-Salcedo M, 2007, LIVER INT, V27, P6, DOI 10.1111/j.1478-3231.2006.01390.x; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Napoli C, 2004, J CARDIOVASC PHARM T, V9, P1, DOI 10.1177/107424840400900i101; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; OH SK, 1987, CANCER RES, V47, P5120; Palha JA, 2002, CLIN CHEM LAB MED, V40, P1292, DOI 10.1515/CCLM.2002.223; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; PEPYS MB, 1987, BIOCHEM BIOPH RES CO, V148, P308, DOI 10.1016/0006-291X(87)91111-9; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Schellenberg D, 1998, AM J RESP CRIT CARE, V157, P957, DOI 10.1164/ajrccm.157.3.9706106; Schlossmacher P, 2002, CLIN CHEM LAB MED, V40, P1339, DOI 10.1515/CCLM.2002.231; SCHUMACKER PT, 1993, AM J PHYSIOL, V265, pL395, DOI 10.1152/ajplung.1993.265.4.L395; Schweigert FJ, 2005, CANCER RES, V65, P1114; Son WK, 2003, PROTEOMICS, V3, P2393, DOI 10.1002/pmic.200300605; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Storey KB, 1996, COMP BIOCHEM PHYS B, V113, P23, DOI 10.1016/0305-0491(95)02043-8; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Subramanian RM, 2007, HEPATOLOGY, V45, P455, DOI 10.1002/hep.21462; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673; Tseng CF, 2004, PROTEOMICS, V4, P2221, DOI 10.1002/pmic.200300787; Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X; Turko IV, 2003, J BIOL CHEM, V278, P35844, DOI 10.1074/jbc.M303139200; van Pel M, 2006, P NATL ACAD SCI USA, V103, P1469, DOI 10.1073/pnas.0510192103; Van Vlierberghe H, 2004, CLIN CHIM ACTA, V345, P35, DOI 10.1016/j.cccn.2004.03.016; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x; WOOD SP, 1988, J MOL BIOL, V202, P169, DOI 10.1016/0022-2836(88)90529-3; Xie Y, 2000, J DERMATOL SCI, V24, P25, DOI 10.1016/S0923-1811(00)00078-5; YAMAMOTO N, 1991, IMMUNOLOGY, V74, P420; Yamamoto N, 1997, CANCER RES, V57, P2187; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zhang JQ, 2009, RESP MED, V103, P1801, DOI 10.1016/j.rmed.2009.07.017; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b	96	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67548	10.1371/journal.pone.0067548	http://dx.doi.org/10.1371/journal.pone.0067548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844025	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000054
J	Beckman, NG				Beckman, Noelle G.			The Distribution of Fruit and Seed Toxicity during Development for Eleven Neotropical Trees and Vines in Central Panama	PLOS ONE			English	Article							DEFENSE TRADE-OFF; FLESHY FRUITS; SECONDARY METABOLITES; PLANT; STRATEGIES; PREDATION; ECOLOGY; SOLANUM; GROWTH; FUNGI	Secondary compounds in fruit mediate interactions with natural enemies and seed dispersers, influencing plant survival and species distributions. The functions of secondary metabolites in plant defenses have been well-studied in green tissues, but not in reproductive structures of plants. In this study, the distribution of toxicity within plants was quantified and its influence on seed survival was determined in Central Panama. To investigate patterns of allocation to chemical defenses and shifts in allocation with fruit development, I quantified variation in toxicity between immature and mature fruit and between the seed and pericarp for eleven species. Toxicity of seed and pericarp was compared to leaf toxicity for five species. Toxicity was measured as reduced hyphal growth of two fungal pathogens, Phoma sp. and Fusarium sp., and reduced survivorship of brine shrimp, Artemia franciscana, across a range of concentrations of crude extract. I used these measures of potential toxicity against generalist natural enemies to examine the effect of fruit toxicity on reductions of fruit development and seed survival by vertebrates, invertebrates, and pathogens measured for seven species in a natural enemy removal experiment. The seed or pericarp of all vertebrate-and wind-dispersed species reduced Artemia survivorship and hyphal growth of Fusarium during the immature and mature stages. Only mature fruit of two vertebrate-dispersed species reduced hyphal growth of Phoma. Predispersal seed survival increased with toxicity of immature fruit to Artemia during germination and decreased with toxicity to fungi during fruit development. This study suggests that fruit toxicity against generalist natural enemies may be common in Central Panama. These results support the hypothesis that secondary metabolites in fruit have adaptive value and are important in the evolution of fruit-frugivore interactions.	[Beckman, Noelle G.] Univ Minnesota Twin Cities, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Beckman, NG (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	beckm089@umn.edu	Beckman, Noelle G./E-5554-2011	Beckman, Noelle G./0000-0001-5822-0610	The National Science Foundation; University of Minnesota Graduate School; University of Minnesota Department of Ecology, Evolution, and Behavior; Smithsonian Tropical Research Institute; Bell Museum of Natural History;  [2 U01 TW006634-06]; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER	The National Science Foundation(National Science Foundation (NSF)); University of Minnesota Graduate School(University of Minnesota System); University of Minnesota Department of Ecology, Evolution, and Behavior(University of Minnesota System); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Bell Museum of Natural History; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Extracts from young leaves were provided by T. A. Kursar and P. D. Coley supported by 2 U01 TW006634-06. The National Science Foundation (Graduate Research Fellowship), University of Minnesota Graduate School (Doctoral Dissertation Fellowship, International Research Grant), University of Minnesota Department of Ecology, Evolution, and Behavior (Block Grant), Smithsonian Tropical Research Institute (Supplementary Award), and the Bell Museum of Natural History (Dayton Natural History Fund) funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augspurger CK, 2007, BIOTROPICA, V39, P702, DOI 10.1111/j.1744-7429.2007.00326.x; BARNEA A, 1993, BIOCHEM SYST ECOL, V21, P421, DOI 10.1016/0305-1978(93)90100-6; Bates D., 2011, PACKAGE LME4 LINEAR; Beckman NG, 2013, DATA DISTRIBUTION FR, DOI DOI 10.5061/DRYAD.B2C80; Beckman NG, 2011, ECOLOGY, V92, P2131, DOI 10.1890/10-2378.1; Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brenes-Arguedas T, 2006, OECOLOGIA, V149, P91, DOI 10.1007/s00442-006-0423-2; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Cipollini M. L., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P111, DOI 10.1079/9780851995250.0111; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; Cipollini ML, 1997, ECOLOGY, V78, P782; Cipollini ML, 2004, J CHEM ECOL, V30, P1, DOI 10.1023/B:JOEC.0000013179.45661.68; CIPOLLINI ML, 1993, ECOLOGY, V74, P751, DOI 10.2307/1940803; Cipollini ML, 1997, ECOLOGY, V78, P799, DOI 10.1890/0012-9658(1997)078[0799:AAOSFG]2.0.CO;2; CIPOLLINI ML, 1993, AM NAT, V141, P663, DOI 10.1086/285498; Coley PD, 2005, ECOLOGY, V86, P2633, DOI 10.1890/04-1283; Coley PD, 2003, FRONT ECOL ENVIRON, V1, P421, DOI 10.2307/3868139; Crawley M. J., 2000, Seeds: the ecology of regeneration in plant communities, P167, DOI 10.1079/9780851994321.0167; Dirzo R, 2007, BIOTROPICA, V39, P355, DOI 10.1111/j.1744-7429.2007.00274.x; Eriksson O, 1998, AM NAT, V152, P905, DOI 10.1086/286217; ESPIRITU EQ, 1995, ENVIRON TOXIC WATER, V10, P25, DOI 10.1002/tox.2530100105; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; Garzi Mirik, 2001, 7 DAY; Gelman A., 2007, DATA ANAL USING REGR; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Hammond D. S., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P51; Harborne JB, 2001, NAT PROD REP, V18, P361, DOI 10.1039/b005311m; HERRERA CM, 1982, AM NAT, V120, P218, DOI 10.1086/283984; Hostettmann K, 1991, ASSAYS BIOACTIVITY; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hulme Philip E., 2002, P132; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Janzen D.H., 1979, HERBIVORES THEIR INT, P331; JANZEN DH, 1969, EVOLUTION, V23, P1, DOI [10.2307/2406478, 10.1111/j.1558-5646.1969.tb03489.x]; Kursar TA, 2009, P NATL ACAD SCI USA, V106, P18073, DOI 10.1073/pnas.0904786106; Latijnhouwers M, 2003, TRENDS MICROBIOL, V11, P462, DOI 10.1016/j.tim.2003.08.002; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Lord Janice M., 2002, P55, DOI 10.1079/9780851995250.0055; Massad TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047554; McKey D., 1979, THEIR INTERACTIONS S, P56; McLaughlin J, 1990, BRENESIA, V32, P1; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; R Core Team, 2016, R FDN STAT COMP; Rhoades DF, 1979, HERBIVORES THEIR INT, P1; Ritz C, 2005, J STAT SOFTW, V12, P1; Ruebhart DR, 2008, ENVIRON TOXICOL, V23, P555, DOI 10.1002/tox.20358; Sautu A, 2006, FOREST ECOL MANAG, V234, P245, DOI 10.1016/j.foreco.2006.07.006; Schaefer HM, 2008, NAT PROD COMMUN, V3, P1267; Schaefer HM, 2003, OIKOS, V102, P318, DOI 10.1034/j.1600-0706.2003.11796.x; Sinclair J, 1997, PRINCIPLES SEED PATH; SOLIS PN, 1993, PLANTA MED, V59, P250, DOI 10.1055/s-2006-959661; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Tewksbury JJ, 2008, P NATL ACAD SCI USA, V105, P11808, DOI 10.1073/pnas.0802691105; Tewksbury JJ, 2008, ECOLOGY, V89, P107, DOI 10.1890/07-0445.1; Tsou CH, 2002, BOT BULL ACAD SINICA, V43, P37; Veldman JW, 2007, BIOTROPICA, V39, P87, DOI 10.1111/j.1744-7429.2006.00232.x; WRANGHAM RW, 1981, J ANIM ECOL, V50, P715, DOI 10.2307/4132; Wright S.J., 2003, STUDYING FOREST CANO, P196	62	15	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66764	10.1371/journal.pone.0066764	http://dx.doi.org/10.1371/journal.pone.0066764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843965	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000019
J	Chng, ZZ; Peh, GSL; Herath, WB; Cheng, TYD; Ang, HP; Toh, KP; Robson, P; Mehta, JS; Colman, A				Chng, Zhenzhi; Peh, Gary S. L.; Herath, Wishva B.; Cheng, Terence Y. D.; Ang, Heng-Pei; Toh, Kah-Peng; Robson, Paul; Mehta, Jodhbir S.; Colman, Alan			High Throughput Gene Expression Analysis Identifies Reliable Expression Markers of Human Corneal Endothelial Cells	PLOS ONE			English	Article							COL8A2 GENE; MISSENSE MUTATIONS; EYE DEVELOPMENT; VIII COLLAGEN; MESSENGER-RNA; NEURAL CREST; DYSTROPHY; SLC4A11; PITX2; PUMP	Considerable interest has been generated for the development of suitable corneal endothelial graft alternatives through cell-tissue engineering, which can potentially alleviate the shortage of corneal transplant material. The advent of less invasive suture-less key-hole surgery options such as Descemet's Stripping Endothelial Keratoplasty (DSEK) and Descemet's Membrane Endothelial Keratoplasty (DMEK), which involve transplantation of solely the endothelial layer instead of full thickness cornea, provide further impetus for the development of alternative endothelial grafts for clinical applications. A major challenge for this endeavor is the lack of specific markers for this cell type. To identify genes that reliably mark corneal endothelial cells (CECs) in vivo and in vitro, we performed RNA-sequencing on freshly isolated human CECs (from both young and old donors), CEC cultures, and corneal stroma. Gene expression of these corneal cell types was also compared to that of other human tissue types. Based on high throughput comparative gene expression analysis, we identified a panel of markers that are: i) highly expressed in CECs from both young donors and old donors; ii) expressed in CECs in vivo and in vitro; and iii) not expressed in corneal stroma keratocytes and the activated corneal stroma fibroblasts. These were SLC4A11, COL8A2 and CYYR1. The use of this panel of genes in combination reliably ascertains the identity of the CEC cell type.	[Chng, Zhenzhi; Cheng, Terence Y. D.; Colman, Alan] A STAR Inst Med Biol, Singapore, Singapore; [Peh, Gary S. L.; Ang, Heng-Pei; Toh, Kah-Peng; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Herath, Wishva B.; Robson, Paul] Genome Inst Singapore, Singapore, Singapore; [Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; Singapore National Eye Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Singapore National Eye Center; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.	jodmehta@gmail.com; alan.colman@imb.a-star.edu.sg	Peh, Gary/A-8327-2010; Robson, Paul/A-3464-2009; Mehta, Jodhbir/O-6192-2015	Peh, Gary/0000-0002-5387-4209; Robson, Paul/0000-0002-0191-3958; 	Agency for Science, Technology and Research TCRP Grant [TCR0101673]	Agency for Science, Technology and Research TCRP Grant	This study is supported by Agency for Science, Technology and Research TCRP Grant (TCR0101673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PA, 1995, INVEST OPHTH VIS SCI, V36, P1115; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Bonanno JA, 2012, EXP EYE RES, V95, P2, DOI 10.1016/j.exer.2011.06.004; BONTING SL, 1961, ARCH BIOCHEM BIOPHYS, V95, P416, DOI 10.1016/0003-9861(61)90170-9; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Corti C, 2011, SCHIZOPHR RES, V128, P7, DOI 10.1016/j.schres.2011.01.021; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Edelhauser HF, 2000, CORNEA, V19, P263, DOI 10.1097/00003226-200005000-00002; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P4504, DOI 10.1167/iovs.05-0497; Gottsch JD, 2003, ARCH OPHTHALMOL-CHIC, V121, P252; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Jiao XD, 2007, J MED GENET, V44, P64, DOI 10.1136/jmg.2006.044644; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 2002, INVEST OPHTH VIS SCI, V43, P2152; KAPOOR R, 1986, BIOCHEMISTRY-US, V25, P3930, DOI 10.1021/bi00361a029; KAUFMAN HE, 1977, INVEST OPHTH VIS SCI, V16, P265; Kobayashi A, 2004, JPN J OPHTHALMOL, V48, P195, DOI 10.1007/s10384-003-0063-6; Liskova P, 2007, BRIT J OPHTHALMOL, V91, P1717, DOI 10.1136/bjo.2007.115154; Lwigale PY, 2005, DEV BIOL, V288, P284, DOI 10.1016/j.ydbio.2005.09.046; Madan P, 2007, J BIOL CHEM, V282, P12127, DOI 10.1074/jbc.M700696200; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; Peh G. S., 2012, INT J BIOMATER, V2012; Peh Gary S L, 2013, BMC Res Notes, V6, P176, DOI 10.1186/1756-0500-6-176; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Rose L, 2009, CAN J OPHTHALMOL, V44, P401, DOI 10.3129/i09-090; Sakai R, 2002, INVEST OPHTH VIS SCI, V43, P1749; Sanchez C, 2012, AM J PHYSIOL-HEART C, V302, pH1146, DOI 10.1152/ajpheart.00668.2011; SAVION N, 1986, EXP EYE RES, V43, P355, DOI 10.1016/S0014-4835(86)80072-0; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Sugrue SP, 1997, EXP EYE RES, V64, P11, DOI 10.1006/exer.1996.0175; Sune G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013930; Tan DTH, 2009, ANN ACAD MED SINGAP, V38, P332; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Violette MI, 2006, DEV BIOL, V289, P406, DOI 10.1016/j.ydbio.2005.11.004; Vitale L, 2002, GENE, V290, P141, DOI 10.1016/S0378-1119(02)00550-4; Vitale L, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-66; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yellore VS, 2005, INVEST OPHTH VIS SCI, V46, P1599, DOI 10.1167/iovs.04-1321; Zacharias AL, 2010, DEV DYNAM, V239, P3215, DOI 10.1002/dvdy.22459	49	46	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67546	10.1371/journal.pone.0067546	http://dx.doi.org/10.1371/journal.pone.0067546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844023	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000053
J	Foster, DB; Liu, T; Rucker, J; O'Meally, RN; Devine, LR; Cole, RN; O'Rourke, B				Foster, D. Brian; Liu, Ting; Rucker, Jasma; O'Meally, Robert N.; Devine, Lauren R.; Cole, Robert N.; O'Rourke, Brian			The Cardiac Acetyl-Lysine Proteome	PLOS ONE			English	Article							REGULATORY LIGHT-CHAIN; SWISS-MODEL; MITOCHONDRIAL ENERGETICS; PEPTIDE IDENTIFICATIONS; STATISTICAL-MODEL; OXIDATIVE STRESS; PROTEINS; TANDEM; SIRT3; PHOSPHORYLATION	In the heart, lysine acetylation has been implicated in processes ranging from transcriptional control of pathological remodeling, to cardioprotection arising from caloric restriction. Given the emerging importance of this post-translational modification, we used a proteomic approach to investigate the broader role of lysine acetylation in the heart using a guinea pig model. Briefly, hearts were fractionated into myofilament-, mitochondrial- and cytosol-enriched fractions prior to proteolysis and affinity-enrichment of acetylated peptides. LC-MS/MS analysis identified 1075 acetylated peptides, harboring 994 acetylation sites that map to 240 proteins with a global protein false discovery rate <0.8%. Mitochondrial targets account for 59% of identified proteins and 64% of sites. The majority of the acetyl-proteins are enzymes involved in fatty acid metabolism, oxidative phosphorylation or the TCA cycle. Within the cytosolic fraction, the enzymes of glycolysis, fatty acid synthesis and lipid binding are prominent. Nuclear targets included histones and the transcriptional regulators E1A(p300) and CREB binding protein. Comparison of our dataset with three previous global acetylomic studies uniquely revealed 53 lysine-acetylated proteins. Specifically, newly-identified acetyl-proteins include Ca2+-handling proteins, RyR2 and SERCA2, and the myofilament proteins, myosin heavy chain, myosin light chains and subunits of the Troponin complex, among others. These observations were confirmed by anti-acetyl-lysine immunoblotting. In summary, cardiac lysine acetylation may play a role in cardiac substrate selection, bioenergetic performance, and maintenance of redox balance. New sites suggest a host of potential mechanisms by which excitation-contraction coupling may also be modulated.	[Foster, D. Brian; Liu, Ting; Rucker, Jasma; O'Rourke, Brian] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [O'Meally, Robert N.; Devine, Lauren R.; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Foster, DB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	dbrianfoster@jhmi.edu	Foster, D. Brian/C-6350-2009; Foster, D. Brian/S-9108-2019	Foster, D. Brian/0000-0002-9290-9590; Foster, D. Brian/0000-0002-9290-9590; O'Rourke, Brian/0000-0002-5548-4853; Liu, Ting/0000-0002-8304-5751	National Heart Lung and Blood Institute Proteomic Initiative [HHSN268201000032C]; NIH/NHLBI [R01HL101235, R21HL108052]; American Heart Association [12SDG12060056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101235, R01HL105216, R21HL108052] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute Proteomic Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart Lung and Blood Institute Proteomic Initiative contract HHSN268201000032C (BO, RNC) and by NIH/NHLBI grants R01HL101235 (BO) and R21HL108052 (DBF, BO). DBF is also supported by American Heart Association National Scientist Development Grant 12SDG12060056. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bers DM, 2001, EXCITATION CONTRACTI; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Diffee GM, 1996, BIOPHYS J, V71, P341, DOI 10.1016/S0006-3495(96)79231-7; Feng C, 2009, EXP CELL RES, V315, P3044, DOI 10.1016/j.yexcr.2009.05.005; Foster DB, 2008, BIOCHEM BIOPH RES CO, V366, P649, DOI 10.1016/j.bbrc.2007.11.154; Fraenkel-Conrat H, 1957, METHOD ENZYMOL, P247; Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047; Giblin FJ, 2013, MOL VIS, V19, P267; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Hanson BJ, 2001, ELECTROPHORESIS, V22, P950, DOI 10.1002/1522-2683()22:5<950::AID-ELPS950>3.0.CO;2-D; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kembro JM, 2013, BIOPHYS J, V104, P332, DOI 10.1016/j.bpj.2012.11.3808; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kou CYC, 2010, BIOCHEM BIOPH RES CO, V400, P278, DOI 10.1016/j.bbrc.2010.08.064; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Kuang SQ, 1996, J MOL CELL CARDIOL, V28, P1879, DOI 10.1006/jmcc.1996.0180; Li L, 2010, MOL CELL BIOCHEM, V345, P309, DOI 10.1007/s11010-010-0586-3; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; REINACH FC, 1986, NATURE, V322, P80, DOI 10.1038/322080a0; Riordan J F, 1972, Methods Enzymol, V25, P494, DOI 10.1016/S0076-6879(72)25045-5; Rottbauer W, 1996, CIRCULATION, V94, P943; Sack MN, 2012, J MOL CELL CARDIOL, V52, P520, DOI 10.1016/j.yjmcc.2011.11.004; Samant SA, 2011, J BIOL CHEM, V286, P5567, DOI 10.1074/jbc.M110.163865; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw PG, 2011, ANAL CHEM, V83, P3623, DOI 10.1021/ac1026176; Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Snijders APL, 2008, J PROTEOME RES, V7, P4326, DOI 10.1021/pr800260a; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Suckow MA, 2012, AM COLL LAB, P1; Tabb DL, 2006, NAT PROTOC, V1, P2213, DOI 10.1038/nprot.2006.330; Tae H, 2009, EUR BIOPHYS J BIOPHY, V39, P51, DOI 10.1007/s00249-009-0455-8; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Trivedi CM, 2008, J BIOL CHEM, V283, P26484, DOI 10.1074/jbc.M803686200; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wei AC, 2011, BIOPHYS J, V100, P2894, DOI 10.1016/j.bpj.2011.05.027; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou LF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000657	69	69	70	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67513	10.1371/journal.pone.0067513	http://dx.doi.org/10.1371/journal.pone.0067513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844019	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000049
J	Maati, HMO; Widmann, C; Gallois, DSB; Heurteaux, C; Borsotto, M; Hugues, M				Maati, Hamid Moha Ou; Widmann, Catherine; Gallois, Djamila Sedjelmaci Bernard; Heurteaux, Catherine; Borsotto, Marc; Hugues, Michel			Mapacalcine Protects Mouse Neurons against Hypoxia by Blocking Cell Calcium Overload	PLOS ONE			English	Article							CHINESE MEDICINE; SPECIFICALLY BLOCKS; GLUCOSE DEPRIVATION; CA2+ CHANNELS; NEUROPROTECTION; RECEPTORS; ISCHEMIA; GLUTAMATE; CONOTOXIN; PEPTIDE	Stroke is one of a major cause of death and adult disability. Despite intense researches, treatment for stroke remains reduced to fibrinolysis, a technique useful for less than 10% of patients. Finding molecules able to treat or at least to decrease the deleterious consequences of stroke is an urgent need. Here, we showed that mapacalcine, a homodimeric peptide purified from the marine sponge Cliona vastifica, is able to protect mouse cortical neurons against hypoxia. We have also identified a subtype of L-type calcium channel as a target for mapacalcine and we showed that the channel has to be open for mapacalcine binding. The two main L-type subunits at the brain level are CaV1.3 and CaV1.2 subunits but mapacalcine was unable to block these calcium channels. Mapacalcine did not interfere with N-, P/Q- and R-type calcium channels. The protective effect was studied by measuring internal calcium level variation triggered by Oxygen Glucose Deprivation protocol, which mimics stroke, or glutamate stimulation. We showed that NMDA/AMPA receptors are not involved in the mapacalcine protection. The protective effect was confirmed by measuring the cell survival rate after Oxygen Glucose Deprivation condition. Our data indicate that mapacalcine is a promising molecule for stroke treatment.	[Maati, Hamid Moha Ou; Widmann, Catherine; Heurteaux, Catherine; Borsotto, Marc] Univ Nice Sophia Antipolis, Ctr Natl Rech Sci UMR7275, Inst Pharmacol Mol & Cellulaire, Valbonne, France; [Hugues, Michel] Ctr Natl Rech Sci UMR5248, Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Borsotto, M (corresponding author), Univ Nice Sophia Antipolis, Ctr Natl Rech Sci UMR7275, Inst Pharmacol Mol & Cellulaire, Valbonne, France.	borsotto@ipmc.cnrs.fr; m.hugues@cbmn.u-bordeaux.fr	BORSOTTO, Marc/M-5096-2016; Maati, Hamid Moha ou/M-2240-2019; HEURTEAUX, Catherine/M-4947-2016	BORSOTTO, Marc/0000-0002-1302-7419; Maati, Hamid Moha ou/0000-0002-8711-1760; HEURTEAUX, Catherine/0000-0002-9741-9777	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche - Emergence [ANR-EMMA 2011-050]; LabEx Ionic Channels Science and Therapeutics; Fondation NRJ-Institut de France	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche - Emergence(French National Research Agency (ANR)); LabEx Ionic Channels Science and Therapeutics; Fondation NRJ-Institut de France(Fondation de France)	This work is supported by the Centre National de la Recherche Scientifique (CNRS), the Agence Nationale de la Recherche - Emergence (ANR-EMMA 2011-050), the LabEx Ionic Channels Science and Therapeutics and the "Fondation NRJ-Institut de France''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2006, NEUROSCIENCE, V141, P453, DOI 10.1016/j.neuroscience.2006.03.042; Azimi-Zonooz A, 2001, BRAIN RES, V907, P61, DOI 10.1016/S0006-8993(01)02471-4; Berthet C, 2011, STROKE, V42, P799, DOI 10.1161/STROKEAHA.110.603647; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Brenman JE, 1996, J NEUROSCI, V16, P7407; Calvert JW, 2005, NEUROL RES, V27, P246, DOI 10.1179/016164105X25216; CHARNET P, 1987, FUNDAM CLIN PHARM, V1, P413, DOI 10.1111/j.1472-8206.1987.tb00575.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clark NC, 2003, NEUROSCIENCE, V120, P435, DOI 10.1016/S0306-4522(03)00329-4; COGNARD C, 1986, P NATL ACAD SCI USA, V83, P1518, DOI 10.1073/pnas.83.5.1518; Crenesse D, 2003, EUR J BIOCHEM, V270, P1952, DOI 10.1046/j.1432-1033.2003.03558.x; de Souza AH, 2012, CELL MOL NEUROBIOL; Dingledine R, 1999, PHARMACOL REV, V51, P7; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Eckle VS, 2012, NEUROPHARMACOLOGY, V63, P266, DOI 10.1016/j.neuropharm.2012.03.018; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Ichida S, 2005, NEUROCHEM RES, V30, P457, DOI 10.1007/s11064-005-2681-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LEYBAERT L, 1993, N-S ARCH PHARMACOL, V348, P269, DOI 10.1007/BF00169155; Lukic-Panin V, 2007, BRAIN RES, V1176, P143, DOI 10.1016/j.brainres.2007.07.038; Maati HMO, 2012, NEUROPHARMACOLOGY, V63, P692, DOI 10.1016/j.neuropharm.2012.05.035; MADDEN KP, 1990, BRAIN RES, V537, P256, DOI 10.1016/0006-8993(90)90366-J; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; MCLENNAN H, 1983, PROG NEUROBIOL, V20, P251, DOI 10.1016/0301-0082(83)90004-7; MELDRUM BS, 1995, ANN NY ACAD SCI, V757, P492, DOI 10.1111/j.1749-6632.1995.tb17509.x; Montero M, 2007, EXP NEUROL, V204, P106, DOI 10.1016/j.expneurol.2006.09.026; Morel JL, 1997, MOL PHARMACOL, V51, P1042, DOI 10.1124/mol.51.6.1042; Mourre C, 2000, BRAIN RES, V858, P136, DOI 10.1016/S0006-8993(99)02449-X; Mourre C, 2003, BIOCHEM BIOPH RES CO, V308, P602, DOI 10.1016/S0006-291X(03)01432-3; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Scheibe F, 2012, CELL MOL NEUROBIOL, V32, P567, DOI 10.1007/s10571-012-9798-2; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Tauskela JS, 2005, FASEB J, V19, P1734, DOI 10.1096/fj.05-3795fje; Vidalenc P, 1998, BIOCHEM J, V331, P177, DOI 10.1042/bj3310177; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	44	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66194	10.1371/journal.pone.0066194	http://dx.doi.org/10.1371/journal.pone.0066194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843951	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000012
J	Shih, CT; Hsu, JT; Han, RP; Hsieh, BT; Chang, SJ; Wu, J				Shih, Cheng-Ting; Hsu, Jui-Ting; Han, Rou-Ping; Hsieh, Bor-Tsung; Chang, Shu-Jun; Wu, Jay			A Novel Method of Estimating Dose Responses for Polymer Gels Using Texture Analysis of Scanning Electron Microscopy Images	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; OPTICAL COMPUTED-TOMOGRAPHY; NEUTRON-CAPTURE THERAPY; X-RAY CT; 3-DIMENSIONAL DOSIMETRY; RAMAN-SPECTROSCOPY; VERIFICATION; MRI; BRACHYTHERAPY; RADIOTHERAPY	Polymer gels are regarded as a potential dosimeter for independent validation of absorbed doses in clinical radiotherapy. Several imaging modalities have been used to convert radiation-induced polymerization to absorbed doses from a macro-scale viewpoint. This study developed a novel dose conversion mechanism by texture analysis of scanning electron microscopy (SEM) images. The modified N-isopropyl-acrylamide (NIPAM) gels were prepared under normoxic conditions, and were administered radiation doses from 5 to 20 Gy. After freeze drying, the gel samples were sliced for SEM scanning with 50x, 500x, and 3500x magnifications. Four texture indices were calculated based on the gray level co-occurrence matrix (GLCM). The results showed that entropy and homogeneity were more suitable than contrast and energy as dose indices for higher linearity and sensitivity of the dose response curves. After parameter optimization, an R-2 value of 0.993 can be achieved for homogeneity using 500x magnified SEM images with 27 pixel offsets and no outlier exclusion. For dose verification, the percentage errors between the prescribed dose and the measured dose for 5, 10, 15, and 20 Gy were -7.60%, 5.80%, 2.53%, and -0.95%, respectively. We conclude that texture analysis can be applied to the SEM images of gel dosimeters to accurately convert micro-scale structural features to absorbed doses. The proposed method may extend the feasibility of applying gel dosimeters in the fields of diagnostic radiology and radiation protection.	[Shih, Cheng-Ting] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Hsu, Jui-Ting] China Med Univ, Sch Dent, Taichung, Taiwan; [Han, Rou-Ping] Cent Taiwan Univ Sci & Technol, Dept Management Informat Syst, Taichung, Taiwan; [Hsieh, Bor-Tsung] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Chang, Shu-Jun] Inst Nucl Energy Res, Div Hlth Phys, Tao Yuan, Taiwan; [Wu, Jay] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan	National Tsing Hua University; China Medical University Taiwan; Central Taiwan University Science & Technology; Central Taiwan University Science & Technology; Institute of Nuclear Energy Research - Taiwan; China Medical University Taiwan	Wu, J (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	jwu@mail.cmu.edu.tw	Hsu, Jui-Ting/I-8224-2012; Shih, Cheng-Ting/Q-2842-2019	Shih, Cheng-Ting/0000-0002-8554-9136	National Science Council of Taiwan [NSC 101-2320-B-039-003-MY3]; China Medical University, Taiwan [CMU101-S-30]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	National Science Council of Taiwan (Contract no. NSC 101-2320-B-039-003-MY3) (http://web1.nsc.gov.tw/), China Medical University, Taiwan (Contract no. CMU101-S-30) (http://www.cmu.edu.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad IAH, 2011, POLYMER, V52, P1268, DOI 10.1016/j.polymer.2011.01.032; Babic S, 2008, INT J RADIAT ONCOL, V70, P1281, DOI 10.1016/j.ijrobp.2007.11.032; BARALDI A, 1995, IEEE T GEOSCI REMOTE, V33, P293, DOI 10.1109/36.377929; Ceberg S, 2010, PHYS MED BIOL, V55, P4885, DOI 10.1088/0031-9155/55/17/001; Chang KY, 2011, NUCL INSTRUM METH A, V652, P775, DOI 10.1016/j.nima.2010.09.099; Chang YJ, 2011, NUCL INSTRUM METH A, V652, P783, DOI 10.1016/j.nima.2010.09.097; Galderisi S, 2008, SCHIZOPHRENIA BULL, V34, P393, DOI 10.1093/schbul/sbm097; Gambarini G, 2004, APPL RADIAT ISOTOPES, V61, P759, DOI 10.1016/j.apradiso.2004.05.061; Gear JI, 2006, PHYS MED BIOL, V51, P3503, DOI 10.1088/0031-9155/51/14/015; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hill B, 2005, BRIT J RADIOL, V78, P623, DOI 10.1259/bjr/46029447; Hilts M, 2000, PHYS MED BIOL, V45, P2559, DOI 10.1088/0031-9155/45/9/309; Islam KTS, 2003, MED PHYS, V30, P2159, DOI 10.1118/1.1593636; Jirasek A, 2010, PHYS MED BIOL, V55, P5269, DOI 10.1088/0031-9155/55/18/002; Jirasek AI, 2001, PHYS MED BIOL, V46, P1949, DOI 10.1088/0031-9155/46/7/315; Kairn T, 2012, PHYS MED BIOL, V57, P3359, DOI 10.1088/0031-9155/57/11/3359; Lin MH, 2009, APPL RADIAT ISOTOPES, V67, P1432, DOI 10.1016/j.apradiso.2009.02.072; Lopatiuk-Tirpak O, 2012, TECHNOL CANCER RES T, V11, P441, DOI 10.7785/tcrt.2012.500263; Mamada K, 2011, TRIBOL LETT, V42, P241, DOI 10.1007/s11249-011-9768-8; MARYANSKI MJ, 1993, MAGN RESON IMAGING, V11, P253, DOI 10.1016/0730-725X(93)90030-H; Mather ML, 2003, MED PHYS, V30, P2140, DOI 10.1118/1.1590751; Mather ML, 2002, PHYS MED BIOL, V47, P1449, DOI 10.1088/0031-9155/47/9/302; Murphy PS, 2000, PHYS MED BIOL, V45, P3213, DOI 10.1088/0031-9155/45/11/307; Murphy PS, 2000, PHYS MED BIOL, V45, P835, DOI 10.1088/0031-9155/45/4/302; Olding T, 2010, PHYS MED BIOL, V55, P2819, DOI 10.1088/0031-9155/55/10/003; Olding T, 2011, J MED PHYS, V36, P3, DOI 10.4103/0971-6203.75466; Papagiannis P, 2005, PHYS MED BIOL, V50, P1979, DOI 10.1088/0031-9155/50/9/004; Rintoul L, 2003, APPL SPECTROSC, V57, P51, DOI 10.1366/000370203321165205; Senden RJ, 2006, PHYS MED BIOL, V51, P3301, DOI 10.1088/0031-9155/51/14/001; Uusi-Simola J, 2007, J APPL CLIN MED PHYS, V8, P114, DOI 10.1120/jacmp.v8i2.2409; Venning AJ, 2005, PHYS MED BIOL, V50, P3875, DOI 10.1088/0031-9155/50/16/015; Watanabe Y, 2011, J APPL CLIN MED PHYS, V12, P14, DOI 10.1120/jacmp.v12i1.3273; Wuu CS, 2006, MED PHYS, V33, P1412, DOI 10.1118/1.2188820; Wuu CS, 2003, MED PHYS, V30, P132, DOI 10.1118/1.1533749; Xian GM, 2010, EXPERT SYST APPL, V37, P6737, DOI 10.1016/j.eswa.2010.02.067; Zeidan OA, 2010, MED PHYS, V37, P2145, DOI 10.1118/1.3388869	36	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67281	10.1371/journal.pone.0067281	http://dx.doi.org/10.1371/journal.pone.0067281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843998	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000037
J	Giudicelli, F; Brabant, AL; Grit, I; Parnet, P; Amarger, V				Giudicelli, Fanny; Brabant, Anne-Laure; Grit, Isabelle; Parnet, Patricia; Amarger, Valerie			Excess of Methyl Donor in the Perinatal Period Reduces Postnatal Leptin Secretion in Rat and Interacts with the Effect of Protein Content in Diet	PLOS ONE			English	Article							MODERATE CALORIC RESTRICTION; CATCH-UP GROWTH; GENE-EXPRESSION; METABOLIC SYNDROME; DNA METHYLATION; PREGNANT RATS; DEVELOPMENTAL ORIGINS; FEEDING-BEHAVIOR; ADIPOSE-TISSUE; LATER LIFE	Methionine, folic acid, betaine and choline interact in the one-carbon metabolism which provides methyl groups for methylation reactions. An optimal intake of these nutrients during pregnancy is required for successful completion of fetal development and evidence is growing that they could be involved in metabolic long-term programming. However, the biological pathways involved in the action of these nutrients are still poorly known. This study investigated the interaction between methyl donors and protein content in maternal diet during the preconceptual, pregnancy and lactation periods and the consequences on the rat offspring in the short and long term. Methyl donor supplementation reduced leptin secretion in offspring, whereas insulin levels were mostly affected by protein restriction. The joint effect of protein restriction and methyl donor excess strongly impaired postnatal growth in both gender and long term weight gain in male offspring only, without affecting food intake. In addition, rats born from protein restricted and methyl donor supplemented dams gained less weight when fed a hypercaloric diet. Methylation of the leptin gene promoter in adipose tissue was increased in methyl donor supplemented groups but not affected by protein restriction only. These results suggest that maternal methyl donor supplementation may influence energy homeostasis in a gender-dependent manner, without affecting food intake. Moreover, we showed that macronutrients and micronutrients in maternal diet interact to influence the programming of the offspring.	[Giudicelli, Fanny; Brabant, Anne-Laure; Grit, Isabelle; Parnet, Patricia; Amarger, Valerie] INRA, UMR1280, F-44026 Nantes, France; [Giudicelli, Fanny; Brabant, Anne-Laure; Grit, Isabelle; Parnet, Patricia; Amarger, Valerie] Univ Nantes, UMR 1280, Nantes, France	INRAE; Nantes Universite	Amarger, V (corresponding author), INRA, UMR1280, F-44026 Nantes, France.	valerie.amarger@univ-nantes.fr	Parnet, Patricia/GOH-1209-2022; Parnet, Patricia/AAW-5064-2021	Amarger, Valerie/0000-0001-9258-6675	INRA; Region Pays de la Loire	INRA; Region Pays de la Loire(Region Pays de la Loire)	FG was supported by a grant from INRA and Region Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker R, 2011, J NUTR, V141, P2172, DOI 10.3945/jn.111.142976; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Bouret SG, 2010, J NUTR, V140, P653, DOI 10.3945/jn.109.112433; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Coupe B, 2011, J NUTR BIOCHEM, V22, P956, DOI 10.1016/j.jnutbio.2010.08.007; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Furness D, 2011, MATERN CHILD NUTR; Gabory A, 2011, AM J CLIN NUTR, V94, p1943S, DOI 10.3945/ajcn.110.000927; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Greenberg James A, 2011, Rev Obstet Gynecol, V4, P52; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Helston RM, 2007, PLACENTA, V28, P437, DOI 10.1016/j.placenta.2006.07.002; Hogg K, 2013, MOL CELL ENDOCRINOL, V367, P64, DOI 10.1016/j.mce.2012.12.018; Jackson AA, 2002, CLIN SCI, V103, P633, DOI 10.1042/cs1030633; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; Jousse C, 2011, FASEB J, V25, P3271, DOI 10.1096/fj.11-181792; Langley-Evans SC, 2005, MATERN CHILD NUTR, V1, P142, DOI 10.1111/j.1740-8709.2005.00015.x; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Maloney CA, 2012, GENES NUTR; Martin-Gronert MS, 2008, AM J PHYSIOL-REG I, V294, pR494, DOI 10.1152/ajpregu.00530.2007; Mehedint MG, 2010, P NATL ACAD SCI USA, V107, P12834, DOI 10.1073/pnas.0914328107; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Orozco-Solis R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013537; Ozanne SE, 2002, TRENDS ENDOCRIN MET, V13, P368, DOI 10.1016/S1043-2760(02)00666-5; Palou M, 2011, J NUTR BIOCHEM, V22, P574, DOI 10.1016/j.jnutbio.2010.05.001; Palou M, 2010, ENDOCRINOLOGY, V151, P1030, DOI 10.1210/en.2009-0934; Qasem RJ, 2010, NUTR RES, V30, P410, DOI 10.1016/j.nutres.2010.05.008; Sanchez J, 2008, ENDOCRINOLOGY, V149, P733, DOI 10.1210/en.2007-0630; Shah PS, 2009, CAN MED ASSOC J, V180, pE99, DOI 10.1503/cmaj.081777; Stoger R, 2006, EPIGENETICS-US, V1, P155; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Teng YW, 2012, J BIOL CHEM, V287, P16187, DOI 10.1074/jbc.M111.303255; Tian X, 2013, DEV BIOL, V376, P51, DOI 10.1016/j.ydbio.2013.01.015; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Vaiman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021222; van Straten EME, 2010, AM J PHYSIOL-REG I, V298, pR275, DOI 10.1152/ajpregu.00413.2009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veenema K, 2008, AM J CLIN NUTR, V88, P685, DOI 10.1093/ajcn/88.3.685; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Zeisel SH, 2009, AM J CLIN NUTR, V89, p673S, DOI 10.3945/ajcn.2008.26811D	53	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68268	10.1371/journal.pone.0068268	http://dx.doi.org/10.1371/journal.pone.0068268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840890	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900029
J	Haffele, RD; Eichholz, MW; Dixon, CS				Haffele, Ryan D.; Eichholz, Michael W.; Dixon, Cami S.			Duck Productivity in Restored Species-Rich Native and Species-Poor Non-Native Plantings	PLOS ONE			English	Article							CONSERVATION RESERVE PROGRAM; DENSE NESTING COVER; PRAIRIE POTHOLE REGION; GRASSLAND BIRDS; WATERFOWL PRODUCTION; CANADIAN PARKLANDS; HABITAT SELECTION; TALLGRASS PRAIRIE; SMALL MAMMALS; NORTH-DAKOTA	Conservation efforts to increase duck production have led the United States Fish and Wildlife Service to restore grasslands with multi-species (3-5) mixtures of introduced cool season vegetation often termed dense nesting cover (DNC). The effectiveness of DNC to increase duck production has been variable, and maintenance of the cover type is expensive. In an effort to decrease the financial and ecological costs (increased carbon emissions from plowing and reseeding) of maintaining DNC and provide a long-term, resilient cover that will support a diversity of grassland fauna, restoration of multi-species (16-32) plantings of native plants has been explored. We investigated the vegetation characteristics, nesting density and nest survival between the 2 aforementioned cover types in the Prairie Pothole Region of North Dakota, USA from 2010-2011 to see if restored-native plantings provide similar benefits to nesting hens as DNC. We searched 14 fields (7 DNC, 271 ha; and 7 restored native, 230 ha) locating 3384 nests (1215 in restored-native vegetation and 2169 in DNC) in 2010-2011. Nest survival was similar between cover types in 2010, while DNC had greater survival than native plantings in 2011. Densities of nests adjusted for detection probability were not different between cover types in either year. We found no structural difference in vegetation between cover types in 2010; however, a difference was detected during the late sampling period in 2011 with DNC having deeper litter and taller vegetation. Our results indicate restored-native plantings are able to support similar nesting density as DNC; however, nest survival is more stable between years in DNC. It appears the annual variation in security between cover types goes undetected by hens as hens selected cover types at similar levels both years.	[Haffele, Ryan D.] So Illinois Univ, Cooperat Wildlife Res Lab, Carbondale, IL 62901 USA; [Eichholz, Michael W.] So Illinois Univ, Dept Zool, Cooperat Wildlife Res Lab, Ctr Ecol, Carbondale, IL 62901 USA; [Dixon, Cami S.] US Fish & Wildlife Serv, Chase Lake Natl Wildlife Refuge, Woodworth, ND USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; United States Department of the Interior; US Fish & Wildlife Service	Haffele, RD (corresponding author), South Dakota Game Fish & Pk, Chamberlain, SD USA.	ryan.haffele@state.sd.us			Devils Lake Wetland Management District; North Dakota State Wildlife Grant CFDA [15.634]; Delta Waterfowl Foundation; United States Fish and Wildlife Service; Cooperative Wildlife Research Laboratory, Southern Illinois University Carbondale	Devils Lake Wetland Management District; North Dakota State Wildlife Grant CFDA; Delta Waterfowl Foundation; United States Fish and Wildlife Service(US Fish & Wildlife Service); Cooperative Wildlife Research Laboratory, Southern Illinois University Carbondale	Support for this research was provided by the Devils Lake Wetland Management District, a North Dakota State Wildlife Grant CFDA#15.634, the Delta Waterfowl Foundation, United States Fish and Wildlife Service, and the Cooperative Wildlife Research Laboratory, Southern Illinois University Carbondale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Arnold TW, 2007, J WILDLIFE MANAGE, V71, P2542, DOI 10.2193/2005-568; Bakker KK, 2009, WEST N AM NATURALIST, V69, P235, DOI 10.3398/064.069.0212; Ball IJ, 1995, WILDLIFE SOC B, V23, P767; BLACK C. C., 1971, Advances in Ecological Research, V7, P87, DOI 10.1016/S0065-2504(08)60203-2; Blumenthal DM, 2005, AGR ECOSYST ENVIRON, V107, P221, DOI 10.1016/j.agee.2004.11.008; Blumenthal DM, 2003, CONSERV ECOL, V7; BOWMAN GB, 1980, J WILDLIFE MANAGE, V44, P806, DOI 10.2307/3808308; Brook RW, 2008, CAN J ZOOL, V86, P497, DOI 10.1139/Z08-019; Bue IG, 1952, T N AM WILDL C, V17, P396; CASE TJ, 1990, P NATL ACAD SCI USA, V87, P9610, DOI 10.1073/pnas.87.24.9610; Clark JP, 1977, THESIS OREGON STATE; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Delisle JM, 1997, J WILDLIFE MANAGE, V61, P318, DOI 10.2307/3802587; Devries JH, 2011, J WILDLIFE MANAGE, V75, P1340, DOI 10.1002/jwmg.164; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; DUEBBERT H F, 1986, Prairie Naturalist, V18, P99; Duebbert H. F., 1969, Transactions of the North American Wildlife Conference, V34, P218; Emery RB, 2005, J WILDLIFE MANAGE, V69, P1181, DOI 10.2193/0022-541X(2005)069[1181:SVIWNS]2.0.CO;2; Fisher RJ, 2010, J WILDLIFE MANAGE, V74, P265, DOI 10.2193/2009-020; Fletcher RJ, 2006, J WILDLIFE MANAGE, V70, P145, DOI 10.2193/0022-541X(2006)70[145:CDPFDS]2.0.CO;2; Flint PL, 1996, CONDOR, V98, P54, DOI 10.2307/1369508; Gilbert D.W., 1996, WILDLIFE MONOGR, V131, P3; GJERSING FM, 1975, J RANGE MANAGE, V28, P37, DOI 10.2307/3897576; GLOUTNEY ML, 1993, J WILDLIFE MANAGE, V57, P597, DOI 10.2307/3809288; GLOVER FRED A., 1956, JOUR WILDLIFE MANAGEMENT, V20, P28, DOI 10.2307/3797244; Guo QF, 2006, ECOL LETT, V9, P1284, DOI 10.1111/j.1461-0248.2006.00980.x; Haffele RD, 2012, THESIS SO ILLINNOIS; Hickman KR, 2006, SOUTHWEST NAT, V51, P524, DOI 10.1894/0038-4909(2006)51[524:EOOWBB]2.0.CO;2; Higgins K. F., 1982, 242 US FISH WILDL SE; HIGGINS KF, 1977, J WILDLIFE MANAGE, V41, P232, DOI 10.2307/3800600; Higgins KF, 2002, WATERBIRDS, V25, P42; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Jacobs JS, 1999, J RANGE MANAGE, V52, P626, DOI 10.2307/4003633; Jonas JL, 2002, ENVIRON ENTOMOL, V31, P1142, DOI 10.1603/0046-225X-31.6.1142; KAISER PH, 1979, J RANGE MANAGE, V32, P295, DOI 10.2307/3897835; Keith L. B., 1961, WILDLIFE MONOGR, V6, P1; KING JW, 1995, WILDLIFE SOC B, V23, P377; Klett A.T., 1986, RESOURCE PUBLICATION, V158; KLETT AT, 1988, J WILDLIFE MANAGE, V52, P431, DOI 10.2307/3801586; KLETT AT, 1984, WILDLIFE SOC B, V12, P134; Klug P, 2009, ECOGRAPHY, V32, P973, DOI 10.1111/j.1600-0587.2009.05857.x; Koper N, 2007, J WILDLIFE MANAGE, V71, P2249, DOI 10.2193/2006-354; KRAPU GL, 1983, AUK, V100, P689, DOI 10.1093/auk/100.3.689; Lariviere S, 2000, CAN J ZOOL, V78, P366, DOI 10.1139/cjz-78-3-366; McCoy TD, 2001, WILDLIFE SOC B, V29, P979; McKinnon DT, 1999, J WILDLIFE MANAGE, V63, P382, DOI 10.2307/3802523; McMaster DG, 2005, J WILDLIFE MANAGE, V69, P211, DOI 10.2193/0022-541X(2005)069&lt;0211:GBNIHO&gt;2.0.CO;2; McPherson RJ, 2003, J WILDLIFE MANAGE, V67, P843, DOI 10.2307/3802691; Menke J.W., 1992, FREMONTIA, V20, P22; Millenbah KF, 1996, WILSON BULL, V108, P760; Nocera JJ, 2008, J SUSTAIN AGR, V32, P379, DOI 10.1080/10440040802257132; Nolan V., 1978, ORNITHOL MONOGR, V26; Norrdahl K, 2000, OIKOS, V91, P528, DOI 10.1034/j.1600-0706.2000.910315.x; Packard S, 2005, TALLGRASS RESTORATIO; Pasitschniak-Arts M, 1998, CAN J ZOOL, V76, P2020, DOI 10.1139/cjz-76-11-2020; Reynolds RE, 2001, J WILDLIFE MANAGE, V65, P765, DOI 10.2307/3803027; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Rodriguez EF, 1984, THESIS COLORADO STAT; SAMPLE D, 1989, THESIS U WISCONSIN M; Schneider NA., 1998, THESIS S DAKOTA STAT; SER, 2022, US; Sheley RL, 2006, RESTOR ECOL, V14, P627, DOI 10.1111/j.1526-100X.2006.00174.x; SHERRY TW, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P431; Shirley S., 1994, RESTORING TALLGRASS; SIETMAN BE, 1994, AM MIDL NAT, V131, P1, DOI 10.2307/2426602; Smith D., 2010, TALLGRASS PRAIRIE CT, DOI [10.2307/j.ctt20mvdfs, DOI 10.2307/J.CTT20MVDFS]; SOVADA MA, 1995, J WILDLIFE MANAGE, V59, P1, DOI 10.2307/3809108; Stephens SE, 2008, CONSERV BIOL, V22, P1320, DOI 10.1111/j.1523-1739.2008.01022.x; Stephens SE, 2004, BIOL CONSERV, V115, P101, DOI 10.1016/S0006-3207(03)00098-3; Stewart R. E., 1971, RESOURCE PUBLICATION, V92; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Trowbridge WB, 2007, ECOL APPL, V17, P1312, DOI 10.1890/06-1242.1; Urbanska Krystyna M., 1997, P3; VOORHEES LD, 1980, J WILDLIFE MANAGE, V44, P155, DOI 10.2307/3808361; WELLER MILTON W., 1956, JOUR WILDLIFE MANAGEMENT, V20, P111, DOI 10.2307/3797414; West BC, 2006, RANGELAND ECOL MANAG, V59, P208, DOI 10.2111/05-118R1.1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Winter M, 2006, J WILDLIFE MANAGE, V70, P158, DOI 10.2193/0022-541X(2006)70[158:PSALEO]2.0.CO;2; Winter M, 1999, STUD AVIAN BIOL-SER, P171; With KA, 2008, BIOL CONSERV, V141, P3152, DOI 10.1016/j.biocon.2008.09.025	82	8	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68603	10.1371/journal.pone.0068603	http://dx.doi.org/10.1371/journal.pone.0068603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840898	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900037
J	Cao, YH; Liu, XY; Deng, N; Jiao, Y; Ma, YH; Hasty, KA; Stuart, JM; Gu, WK				Cao, Yanhong; Liu, Xiaoyun; Deng, Nan; Jiao, Yan; Ma, Yonghui; Hasty, Karen A.; Stuart, John M.; Gu, Weikuan			Congenic Mice Provide Evidence for a Genetic Locus That Modulates Spontaneous Arthritis Caused by Deficiency of IL-1RA	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; MOUSE STRAINS; POLYMORPHISMS; ANAKINRA	To understand the role of genetic factors involved in the development of spontaneous arthritis in mice deficient in IL-1 receptor antagonist protein (IL_1RA), we have identified a genomic region containing a major quantitative trait locus (QTL) for this disease. The QTL is on chromosome 1 and appears to be the strongest genetic region regulating arthritis. To confirm the importance of the QTL and to identify potential candidate genes within it, we conducted speed congenic breeding to transfer the QTL region from DBA/1 mice that are resistant to spontaneous arthritis into BALB/c(-/-) which are susceptible. Genetic markers along every chromosome were used to assist in the selection of progeny in each generation to backcross to BALB/c(-/-). By the 6th generation we determined that all of the chromosomes in the progeny were of BALB/c origin with the exception of portions of chromosome 1. At this stage we intercrossed selected mice to produce homozygous strains containing the genomic background of BALB/c(-/-) except for the QTL region on chromosome 1, which was from DBA/1. We were able to establish two congenic strains with overlapping DBA/1 DNA segments. These strains were observed for the development of spontaneous arthritis. Both congenic strains were relatively resistant to spontaneous arthritis and had delayed onset and reduced severity of disease. The gene/s that regulates this major QTL would appear to be located in the region of the QTL that is shared by both strains. The common transferred region is between D1Mit110 and D1Mit209 on chromosome 1. We evaluated this region for candidate genes and have identified a limited number of candidates. Confirmation of the identity and precise role of the candidates will require additional study.	[Cao, Yanhong] Harbin Med Univ, Inst Kaschin Beck Dis, Ctr Endem Dis Control, Chinese Ctr Dis Control & Prevent, Harbin, Peoples R China; [Cao, Yanhong] Educ Bur Heilongjiang Prov, Key Lab Etiol Epidemiol, Harbin, Peoples R China; [Cao, Yanhong] Minist Hlth 23618104, Harbin, Peoples R China; [Cao, Yanhong; Liu, Xiaoyun; Jiao, Yan; Ma, Yonghui; Hasty, Karen A.; Gu, Weikuan] Univ Tennessee, Ctr Hlth Sci, Dept Orthopaed Surg, Memphis, TN 38163 USA; [Cao, Yanhong; Liu, Xiaoyun; Jiao, Yan; Ma, Yonghui; Hasty, Karen A.; Gu, Weikuan] Univ Tennessee, Ctr Hlth Sci, Dept Biomed Engn, Memphis, TN 38163 USA; [Deng, Nan; Stuart, John M.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Stuart, John M.] Vet Affairs Med Ctr, Res Serv, Memphis, TN USA	Chinese Center for Disease Control & Prevention; Harbin Medical University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Stuart, JM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.	jstuart1@uthsc.edu; wgu@utusc.edu			National Institutes of Health [AR51190]; National Natural Science Foundation of China [81171679]; Department of Veterans Affairs; National Institute of Arthritis and Musculoskeletal and Skin Diseases	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (R01 AR51190 to WG), National Natural Science Foundation of China (Project 81171679 to YHC) and program directed funds from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Horai R, 2004, J CLIN INVEST, V114, P1603, DOI 10.1172/JCI200420742; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Ikonomidis I, 2011, THROMB HAEMOSTASIS, V106, P959, DOI 10.1160/TH11-02-0117; Jiao Y., 2011, GENET RES CAMB, V18, P1; Langdahl BL, 2000, J BONE MINER RES, V15, P402, DOI 10.1359/jbmr.2000.15.3.402; Lin ZW, 2011, INFLAMM BOWEL DIS, V17, pE41, DOI 10.1002/ibd.21684; Mahamid M, 2011, INT J GEN MED, V4, P657, DOI 10.2147/IJGM.S23920; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Merlin E, 2011, PEDIATR CARDIOL, V32, P862, DOI 10.1007/s00246-011-0009-6; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Rigante D, 2011, RHEUMATOL INT, V31, P1661, DOI 10.1007/s00296-010-1787-5; Xiong Q, 2008, J IMMUNOL, V181, P859, DOI 10.4049/jimmunol.181.2.859; Xiong Q, 2008, BIOINFORMATICS, V24, P1011, DOI 10.1093/bioinformatics/btn002; Zhou F, 2005, ARTHRITIS RHEUM-US, V52, P3731, DOI 10.1002/art.21481	18	5	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68158	10.1371/journal.pone.0068158	http://dx.doi.org/10.1371/journal.pone.0068158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840826	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400169
J	Chai, CY; Lin, YL; Shen, DY; Wu, YR; Li, HJ; Dou, DL				Chai, Chunyue; Lin, Yanling; Shen, Danyu; Wu, Yuren; Li, Hongjuan; Dou, Daolong			Identification and Functional Characterization of the Soybean GmaPPO12 Promoter Conferring Phytophthora sojae Induced Expression	PLOS ONE			English	Article							OXIDASE GENE FAMILY; INCREASED DISEASE RESISTANCE; DEFENSE-RELATED GENES; CIS-ACTING ELEMENTS; POLYPHENOL OXIDASE; SYNTHETIC PROMOTERS; TRANSGENIC TOBACCO; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; REGULATORY ELEMENTS	Identification of pathogen-inducible promoters largely lags behind cloning of the genes for disease resistance. Here, we cloned the soybean GmaPPO12 gene and found that it was rapidly and strongly induced by Phytophthora sojae infection. Computational analysis revealed that its promoter contained many known cis-elements, including several defense related transcriptional factor-binding boxes. We showed that the promoter could mediate induction of GUS expression upon infection in both transient expression assays in Nicotiana benthamiana and stable transgenic soybean hairy roots. Importantly, we demonstrated that pathogen-induced expression of the GmaPPO12 promoter was higher than that of the soybean GmaPR1a promoter. A progressive 5' and 3' deletion analysis revealed two fragments that were essential for promoter activity. Thus, the cloned promoter could be used in transgenic plants to enhance resistance to phytophthora pathogens, and the identified fragment could serve as a candidate to produce synthetic pathogen-induced promoters.	[Chai, Chunyue; Lin, Yanling; Shen, Danyu; Wu, Yuren; Li, Hongjuan; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Chai, Chunyue] Nanyang Normal Univ, Coll Life Sci & Technol, Nanyang, Peoples R China	Nanjing Agricultural University; Nanyang Normal College	Dou, DL (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ddou@njau.edu.cn	Shen, Danyu/AAF-1644-2019; Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642	National Natural Science Foundation of China [31171831]; National Science and Technology Major Projects [2009ZX08005-003B]; Doctoral Fund of Ministry of Education of China [20090097110032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects; Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	National Natural Science Foundation of China (No. 31171831); National Science and Technology Major Projects (No. 2009ZX08005-003B); Doctoral Fund of Ministry of Education of China (No. 20090097110032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Ainsworth C., 1996, TECHNIQUES PLANT MOL; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Belbahri L, 2001, PLANT J, V28, P419, DOI 10.1046/j.1365-313X.2001.01155.x; Biles Charles L., 1995, Proceedings of the Oklahoma Academy of Science, V75, P1; Borras-Hidalgo O, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00268; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chan CS, 2001, PLANT MOL BIOL, V46, P131, DOI 10.1023/A:1010602031070; Cho MH, 2003, P NATL ACAD SCI USA, V100, P10641, DOI 10.1073/pnas.1934562100; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; FOSTER R, 1994, FASEB J, V8, P192, DOI 10.1096/fasebj.8.2.8119490; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P275, DOI 10.1016/j.tibtech.2005.04.007; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P283, DOI 10.1016/j.tibtech.2005.04.009; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Jefferson R A, 1987, EMBO J, V6, P3901; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; Keller H, 1999, PLANT CELL, V11, P223, DOI 10.1105/tpc.11.2.223; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; Kohli A, 2003, PLANT MOL BIOL, V52, P247, DOI 10.1023/A:1023941407376; Kortekamp A, 2006, PLANT PHYSIOL BIOCH, V44, P58, DOI 10.1016/j.plaphy.2006.01.008; Koschmann J, 2012, PLANT PHYSIOL, V160, P178, DOI 10.1104/pp.112.198259; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liu WS, 2013, PLANT BIOTECHNOL J, V11, P43, DOI 10.1111/pbi.12005; Liu WS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; LOIS R, 1989, EMBO J, V8, P1641, DOI 10.1002/j.1460-2075.1989.tb03554.x; Malnoy M, 2003, PLANTA, V216, P802, DOI 10.1007/s00425-002-0932-0; Maruyama-Nakashita A, 2005, PLANT J, V42, P305, DOI 10.1111/j.1365-313X.2005.02363.x; Moschou PN, 2009, PLANT PHYSIOL, V149, P1970, DOI 10.1104/pp.108.134932; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Nakayama T, 2000, SCIENCE, V290, P1163, DOI 10.1126/science.290.5494.1163; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; PONTIER D, 1994, PLANT J, V5, P507, DOI 10.1046/j.1365-313X.1994.5040507.x; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sandhu D, 2005, J HERED, V96, P536, DOI 10.1093/jhered/esi081; SAVKA MA, 1990, PHYTOPATHOLOGY, V80, P503, DOI 10.1094/Phyto-80-503; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SHIRSAT A, 1989, MOL GEN GENET, V215, P326, DOI 10.1007/BF00339737; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thipyapong P, 1997, PLANT PHYSIOL, V113, P707, DOI 10.1104/pp.113.3.707; Thipyapong P, 2007, MOLECULES, V12, P1569, DOI 10.3390/12081569; Tran LT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-395; Tran LT, 2011, PLANTA, V234, P799, DOI 10.1007/s00425-011-1441-9; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Vega-Sanchez ME, 2005, PHYSIOL MOL PLANT P, V66, P175, DOI 10.1016/j.pmpp.2005.07.001; Venter M, 2010, PLANT DEVELOPMENTAL BIOLOGY: BIOTECHNOLOGICAL PERSPECTIVES VOL 2, P393, DOI 10.1007/978-3-642-04670-4_20; Venter M, 2007, TRENDS PLANT SCI, V12, P118, DOI 10.1016/j.tplants.2007.01.002; Wahler D, 2009, PLANT PHYSIOL, V151, P334, DOI 10.1104/pp.109.138743; Wang RC, 2010, PLANT PHYSIOL, V154, P423, DOI 10.1104/pp.110.162586; Wilkerson MD, 2009, BRIEF BIOINFORM, V10, P631, DOI 10.1093/bib/bbp051; Yamamoto S, 2004, BBA-GENE STRUCT EXPR, V1679, P279, DOI 10.1016/j.bbaexp.2004.07.005; Yang YO, 1996, P NATL ACAD SCI USA, V93, P14972, DOI 10.1073/pnas.93.25.14972; Yim HCH, 2011, P NATL ACAD SCI USA, V108, P17749, DOI 10.1073/pnas.1104892108; Zhou LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-49; Zhu SX, 2012, TRANSGENIC RES, V21, P89, DOI 10.1007/s11248-011-9510-1	72	20	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67670	10.1371/journal.pone.0067670	http://dx.doi.org/10.1371/journal.pone.0067670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840763	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400126
J	Komegae, EN; Grund, LZ; Lopes-Ferreira, M; Lima, C				Komegae, Evilin Naname; Grund, Lidiane Zito; Lopes-Ferreira, Monica; Lima, Carla			The Longevity of Th2 Humoral Response Induced by Proteases Natterins Requires the Participation of Long-Lasting Innate-Like B Cells and Plasma Cells in Spleen	PLOS ONE			English	Article							DUST-MITE ALLERGEN; ANTIBODY-SECRETING CELLS; THALASSOPHRYNE-NATTERERI; PROTEOLYTIC ACTIVITY; BONE-MARROW; FISH VENOM; KININOGENASE ACTIVITY; AIRWAY INFLAMMATION; CYSTEINE PROTEASE; EPITHELIAL-CELLS	The generation of long-lived antibody-secreting cells (ASC) and memory B cells are critical events for an effective vaccine and the choice of adjuvant can influence these processes. Various cellular and molecular mechanism involved in the protease action that determine Th2 responses have been identified. However, direct or indirect actions in the regulation of the induction, survival and longevity of ASC in differential compartments remain largely unknown. We investigated whether the proteolytic activity of proteins are determinant for the modulation of the memory immune response in mice, promoting the differentiation of memory B cells to terminally differentiated end stage cells. Here, we show that the proteolytic activity of Natterins, from the venom of Thalassophryne nattereri Brazilian fish, besides inducing a Th2 response with plasmatic titers of high-affinity antigen-specific IgE over extended periods is sufficient for the generation of signals that contribute to the formation of a survival niche in the spleen, essential for the longevity of the main subtype of ASC with B220(neg) phenotype.	[Komegae, Evilin Naname; Grund, Lidiane Zito; Lopes-Ferreira, Monica; Lima, Carla] Butantan Inst, Special Lab Appl Toxinol, Immunoregulat Unit, Sao Paulo, Brazil; [Komegae, Evilin Naname; Grund, Lidiane Zito; Lopes-Ferreira, Monica; Lima, Carla] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo	Lima, C (corresponding author), Butantan Inst, Special Lab Appl Toxinol, Immunoregulat Unit, Sao Paulo, Brazil.	carlalima@butantan.gov.br	Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; komegae, Evilin/H-4791-2015; Grund, Lidiane/AAJ-1844-2021; Lima, Carla/B-6750-2019	Grund, Lidiane/0000-0001-6587-0283; Lima, Carla/0000-0002-8161-966X; Lopes-Ferreira, Monica/0000-0003-0244-7482	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achatz-Straussberger G, 2008, EUR J IMMUNOL, V38, P3167, DOI 10.1002/eji.200838456; Arizmendi NG, 2011, J IMMUNOL, V186, P3164, DOI 10.4049/jimmunol.0903812; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bemark M, 2011, J IMMUNOL, V186, P1399, DOI 10.4049/jimmunol.1002881; Castellino F, 2009, EUR J IMMUNOL, V39, P2100, DOI 10.1002/eji.200939550; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Collins AM, 2003, PHARMACOL THERAPEUT, V100, P157, DOI 10.1016/j.pharmthera.2003.07.002; Edwards MR, 2002, J IMMUNOL, V168, P6305, DOI 10.4049/jimmunol.168.12.6305; Feichtner S, 2008, J IMMUNOL, V180, P5499, DOI 10.4049/jimmunol.180.8.5499; Foussat A, 2001, EUR J IMMUNOL, V31, P350, DOI 10.1002/1521-4141(200102)31:2<350::AID-IMMU350>3.0.CO;2-0; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Grund LZ, 2006, TOXICON, V48, P499, DOI 10.1016/j.toxicon.2006.06.014; Grund LZ, 2012, CYTOKINE, V59, P335, DOI 10.1016/j.cyto.2012.04.045; HITOSHI Y, 1990, J IMMUNOL, V144, P4218; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kerzel S, 2010, J IMMUNOL, V185, P2253, DOI 10.4049/jimmunol.0902942; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kikuchi Y, 2006, J IMMUNOL, V177, P1609, DOI 10.4049/jimmunol.177.3.1609; Kukreja N, 2008, CLIN EXP IMMUNOL, V154, P162, DOI 10.1111/j.1365-2249.2008.03762.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewkowich IP, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-122; Lopes-Ferreira M, 2004, BIOCHEM PHARMACOL, V68, P2151, DOI 10.1016/j.bcp.2004.07.037; Magalhaes GS, 2006, BIOCHIMIE, V88, P693, DOI 10.1016/j.biochi.2005.12.008; Magalhaes GS, 2005, BIOCHIMIE, V87, P687, DOI 10.1016/j.biochi.2005.03.016; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; MOTA I, 1969, LIFE SCI PT 1 PHYSI, V8, P813, DOI 10.1016/0024-3205(69)90099-X; Noh G, 2011, ALLERGY ASTHMA IMMUN, V3, P168, DOI 10.4168/aair.2011.3.3.168; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; OVARY Z, 1958, J IMMUNOL, V81, P355; Page K, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-91; Pollock KGJ, 2003, J IMMUNOL, V170, P1746, DOI 10.4049/jimmunol.170.4.1746; Roche N, 1997, EUR RESPIR J, V10, P719; Rogosch T, 2010, J IMMUNOL, V184, P4947, DOI 10.4049/jimmunol.0900859; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schwab CJ, 2004, ALLERGY, V59, P758, DOI 10.1111/j.1398-9995.2004.00481.x; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shen HD, 1998, INT ARCH ALLERGY IMM, V116, P29, DOI 10.1159/000023921; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Sudha VT, 2009, EUR J CLIN INVEST, V39, P507, DOI 10.1111/j.1365-2362.2009.02112.x; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Tripathi P, 2009, J CLIN IMMUNOL, V29, P292, DOI 10.1007/s10875-008-9261-9; Tumang JR, 2005, J IMMUNOL, V174, P3173, DOI 10.4049/jimmunol.174.6.3173; Wesemann DR, 2011, J EXP MED, V208, P2733, DOI 10.1084/jem.20111155	48	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67135	10.1371/journal.pone.0067135	http://dx.doi.org/10.1371/journal.pone.0067135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840604	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400036
J	Li, CB; Li, XX; Chen, YG; Gao, HQ; Bu, PL; Zhang, Y; Ji, XP				Li, Chuan Bao; Li, Xiao Xing; Chen, Yu Guo; Gao, Hai Qing; Bu, Pei Li; Zhang, Yun; Ji, Xiao Ping			Huang-Lian-Jie-Du-Tang Protects Rats from Cardiac Damages Induced by Metabolic Disorder by Improving Inflammation-Mediated Insulin Resistance	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TNF-ALPHA; TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; OBESITY; INHIBITION; ADIPONECTIN; SUPPRESSION; EXPRESSION; MECHANISM	Huang-lian-jie-du-tang (HLJDT), a traditional Chinese medicine, has been shown to improve insulin resistance (IR) induced by inflammation, a key event in the development of metabolic syndrome (MS). The present study aimed to investigate the protective effects of HLJDT on MS and explore the underlying mechanism. MS rats were established with obese-diets and treated with normal saline, aspirin or HLJDT. The myocardial lesions were identified by echocardiogram, transmission electron microscope, and Sirius-red staining. The inflammatory cytokines were measured by ELISA and real-time PCR. The activation of NF-kappa B, JNK, SOCS3, IRS1 and AKT in the heart was detected by immunohistochemistry and Western blot analysis. Compared with the controls, MS rats developed obvious obesity, hypertension, dyslipidemia, IR, inflammation, and cardiac damage. Moreover, phosphorylated IRS-1 at Ser307 was correlated with the activation of NF-kappa B, JNK and SOCS3 and the inhibition of AKT in the heart from MS rats. These data suggest that serine phosphorylation of IRS-1 in response to inflammation is mediated, in part, by NF-kappa B, JNK and SOCS3. Notably, HLJDT inhibited the activation of NF-kappa B and reduced serine phosphorylation of IRS-1. In summary, HLJDT protects myocardium from IR-mediated injury by inhibiting serine phosphorylation of IRS-1 in MS rats.	[Li, Chuan Bao; Li, Xiao Xing; Chen, Yu Guo; Bu, Pei Li; Zhang, Yun; Ji, Xiao Ping] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Li, Chuan Bao; Li, Xiao Xing; Chen, Yu Guo; Bu, Pei Li; Zhang, Yun; Ji, Xiao Ping] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Li, Chuan Bao; Chen, Yu Guo] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan 250100, Shandong, Peoples R China; [Li, Xiao Xing; Gao, Hai Qing] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Chen, YG (corresponding author), Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China.	yuguochen@hotmail.com; xiaopingji64@hotmail.com			National 973 Basic Research Program of China [2010CB732605]; National Natural Science Foundation of China [81170136, 81100147]; Natural Sciences Funds of Shandong Province [ZR2010HQ059, 2011GGH21834]; Independent Innovation Foundation of Shandong University, China [2012TS154]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Funds of Shandong Province; Independent Innovation Foundation of Shandong University, China	This work was supported by the National 973 Basic Research Program of China (2010CB732605), the National Natural Science Foundation of China (81170136 and 81100147), the Natural Sciences Funds of Shandong Province (ZR2010HQ059 and 2011GGH21834), and an Independent Innovation Foundation of Shandong University (2012TS154), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2007, J THROMB HAEMOST, V5, P754, DOI 10.1111/j.1538-7836.2007.02434.x; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bonora E, 2006, ANN MED, V38, P64, DOI 10.1080/07853890500401234; Breyer MD, 2005, CELL METAB, V2, P149, DOI 10.1016/j.cmet.2005.08.009; Dai Y, 1999, LIFE SCI, V66, P19, DOI 10.1016/S0024-3205(99)00557-3; Ding Lai-Biao, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P232; Fan JG, 2007, HEPATOB PANCREAT DIS, V6, P572; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Kahn R, 2005, DIABETOLOGIA, V48, P1684, DOI 10.1007/s00125-005-1876-2; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kim SG, 2006, EUR J ENDOCRINOL, V154, P433, DOI 10.1530/eje.1.02100; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Li XX, 2008, J ETHNOPHARMACOL, V119, P259, DOI 10.1016/j.jep.2008.07.019; Lu T, 2007, J ETHNOPHARMACOL, V110, P412, DOI 10.1016/j.jep.2006.09.036; Matsushita K, 2006, ARTERIOSCL THROM VAS, V26, P871, DOI 10.1161/01.ATV.0000208363.85388.8f; Muller DN, 2001, FASEB J, V15, P1822, DOI 10.1096/fj.00-0843fje; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Xiao Yan-ling, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1767; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	32	13	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67530	10.1371/journal.pone.0067530	http://dx.doi.org/10.1371/journal.pone.0067530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840732	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400100
J	Perkins, TT; Tay, CY; Thirriot, F; Marshall, B				Perkins, Timothy T.; Tay, Chin Yen; Thirriot, Fanny; Marshall, Barry			Choosing a Benchtop Sequencing Machine to Characterise Helicobacter pylori Genomes	PLOS ONE			English	Article							ERADICATION; DISEASE	The fully annotated genome sequence of the European strain, 26695 was first published in 1997 and, in 1999, it was directly compared to the USA isolate J99, promoting two standard laboratory isolates for Helicobacter pylori ( H. pylori) research. With the genomic scaffolds available from these important genomes and the advent of benchtop high-throughput sequencing technology, a bacterial genome can now be sequenced within a few days. We sequenced and analysed strains J99 and 26695 using the benchtop-sequencing machines Ion Torrent PGM and the Illumina MiSeq Nextera and Nextera XT methodologies. Using publically available algorithms, we analysed the raw data and interrogated both genomes by mapping the data and by de novo assembly. We compared the accuracy of the coding sequence assemblies to the originally published sequences. With the Ion Torrent PGM, we found an inherently high-error rate in the raw sequence data. Using the Illumina MiSeq, we found significantly more non-covered nucleotides when using the less expensive Illumina Nextera XT compared with the Illumina Nextera library creation method. We found the most accurate de novo assemblies using the Nextera technology, however, extracting an accurate multi-locus sequence type was inconsistent compared to the Ion Torrent PGM. We found the cagPAI failed to assemble onto a single contig in all technologies but was more accurate using the Nextera. Our results indicate the Illumina MiSeq Nextera method is the most accurate for de novo whole genome sequencing of H. pylori.	[Perkins, Timothy T.; Tay, Chin Yen; Thirriot, Fanny; Marshall, Barry] Univ Western Australia, Perth, WA 6009, Australia	University of Western Australia	Perkins, TT (corresponding author), Univ Western Australia, Perth, WA 6009, Australia.	tim.perkins@uwa.edu.au	Tay, Alfred Chin Yen/H-5938-2014; Tay, Chin Yen/AAZ-8785-2021	Tay, Alfred Chin Yen/0000-0001-9705-4010; Tay, Chin Yen/0000-0001-9705-4010; Marshall, Barry/0000-0003-4853-5015; Peters, Fanny/0000-0002-0920-1031	NHMRC [572723]; University of Western Australia; Western Australian Department of Commerce; ARC Linkage grant [LE110100188]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Western Australia; Western Australian Department of Commerce; ARC Linkage grant(Australian Research Council)	The NHMRC Grant 572723, Vice Chancellor of University of Western Australia, and the Western Australian Department of Commerce supported this work. The Illumina MiSeq was procured using the ARC Linkage grant LE110100188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; [Anonymous], IONT TMAP; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Buffalo V, QRQC QUICK READ QUAL; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Cover TL, 1996, ADV INTERNAL MED, V41, P85; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kim SY, 2006, CELL MICROBIOL, V8, P97, DOI 10.1111/j.1462-5822.2005.00603.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Tay CY, 2012, ALIMENT PHARM THER, V36, P1076, DOI 10.1111/apt.12089; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Walenz B, 2011, BIOINFORMATICS; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	24	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67539	10.1371/journal.pone.0067539	http://dx.doi.org/10.1371/journal.pone.0067539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840736	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400103
J	Petit, M; Lewden, A; Vezina, F				Petit, Magali; Lewden, Agnes; Vezina, Francois			Intra-Seasonal Flexibility in Avian Metabolic Performance Highlights the Uncoupling of Basal Metabolic Rate and Thermogenic Capacity	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; PHENOTYPIC FLEXIBILITY; MOUNTAIN CHICKADEES; PARUS-ATRICAPILLUS; PASSERINE BIRDS; COLD-EXPOSURE; BODY-MASS; ACCLIMATIZATION; SPARROWS; ADJUSTMENTS	Stochastic winter weather events are predicted to increase in occurrence and amplitude at northern latitudes and organisms are expected to cope through phenotypic flexibility. Small avian species wintering in these environments show acclimatization where basal metabolic rate (BMR) and maximal thermogenic capacity (M-SUM) are typically elevated. However, little is known on intra-seasonal variation in metabolic performance and on how population trends truly reflect individual flexibility. Here we report intra-seasonal variation in metabolic parameters measured at the population and individual levels in black-capped chickadees (Poecile atricapillus). Results confirmed that population patterns indeed reflect flexibility at the individual level. They showed the expected increase in BMR (6%) and M-SUM (34%) in winter relative to summer but also, and most importantly, that these parameters changed differently through time. BMR began its seasonal increase in November, while M-SUM had already achieved more than 20% of its inter-seasonal increase by October, and declined to its starting level by March, while M-SUM remained high. Although both parameters co-vary on a yearly scale, this mismatch in the timing of variation in winter BMR and M-SUM likely reflects different constraints acting on different physiological components and therefore suggests a lack of functional link between these parameters.	[Petit, Magali; Lewden, Agnes; Vezina, Francois] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Petit, Magali; Lewden, Agnes; Vezina, Francois] Grp Rech Environm Nord BOREAS, Rimouski, PQ, Canada; [Petit, Magali; Vezina, Francois] Ctr Etud Nord, Quebec City, PQ, Canada; [Petit, Magali; Vezina, Francois] Ctr Sci Biodiversite Quebec, Montreal, PQ, Canada	University of Quebec	Petit, M (corresponding author), Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	Magali.Petit@uqar.qc.ca	Petit, Magali/J-6436-2014	Petit, Magali/0000-0002-3267-5681; Lewden, Agnes/0000-0002-9303-2735	Natural Sciences and Engineering Research Council (NSERC) of Canada [9045333]; Nouveaux chercheurs grant from Fonds de Recherche du Quebec sur la nature et les technologies [132032]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nouveaux chercheurs grant from Fonds de Recherche du Quebec sur la nature et les technologies	Discovery grant (9045333) from the Natural Sciences and Engineering Research Council (NSERC) of Canada http://www.nserc-crsng.gc.ca/index_eng.asp and Nouveaux chercheurs grant (132032) from the Fonds de Recherche du Quebec sur la nature et les technologies http://www.fqrnt.gouv.qc.ca/ to FV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens JR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P579, DOI 10.1086/430235; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; BRITTINGHAM MC, 1992, J WILDLIFE MANAGE, V56, P103, DOI 10.2307/3808797; Broggi J, 2007, FUNCT ECOL, V21, P528, DOI 10.1111/j.1365-2435.2007.01255.x; Canale CI, 2010, CLIM RES, V43, P135, DOI 10.3354/cr00897; CHAPLIN SB, 1974, J COMP PHYSIOL, V89, P321, DOI 10.1007/BF00695350; Cooper SJ, 2000, CONDOR, V102, P635, DOI 10.1650/0010-5422(2000)102[0635:SEOMCA]2.0.CO;2; COOPER SJ, 1994, CONDOR, V96, P638, DOI 10.2307/1369467; Cooper SJ, 2005, CONDOR, V107, P151, DOI 10.1650/7597; Cooper SJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P386, DOI 10.1086/342256; DAWSON WR, 1983, AM J PHYSIOL, V245, pR755, DOI 10.1152/ajpregu.1983.245.6.R755; Dekinga A, 2001, J EXP BIOL, V204, P2167; DesJarlais C, 2010, SAVOIR SADAPTER CHAN; DESROCHERS A, 1990, J FIELD ORNITHOL, V61, P79; Dutenhoffer MS, 1996, PHYSIOL ZOOL, V69, P1232, DOI 10.1086/physzool.69.5.30164255; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; GESSAMAN JA, 1988, PHYSIOL ZOOL, V61, P507, DOI 10.1086/physzool.61.6.30156159; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GROSSMAN AF, 1977, ORNIS SCAND, V8, P127, DOI 10.2307/3676097; HINDS DS, 1993, J EXP BIOL, V182, P41; Laaksonen T, 2006, OIKOS, V114, P277, DOI 10.1111/j.2006.0030-1299.14652.x; LEHIKOINEN E, 1987, ORNIS SCAND, V18, P216, DOI 10.2307/3676769; Lewden A, 2012, J COMP PHYSIOL B, V182, P381, DOI 10.1007/s00360-011-0625-8; Lighton JRB, 2008, MEASURING METABOL IC; Liknes ET, 2011, J THERM BIOL, V36, P363, DOI 10.1016/j.jtherbio.2011.06.010; Liknes ET, 1996, J AVIAN BIOL, V27, P279, DOI 10.2307/3677259; Liu Jin-Song, 2006, Acta Zoologica Sinica, V52, P469; Maldonado KE, 2009, J COMP PHYSIOL B, V179, P335, DOI 10.1007/s00360-008-0317-1; Mandin C, 2012, IBIS, V154, P791, DOI 10.1111/j.1474-919X.2012.01262.x; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; Mckechnie AE, 2010, CURR ZOOL, V56, P741, DOI 10.1093/czoolo/56.6.741; MCNAB BK, 1971, ECOLOGY, V52, P845, DOI 10.2307/1936032; McNamara JM, 1990, BEHAV ECOL, V1, P12, DOI 10.1093/beheco/1.1.12; OCONNOR TP, 1995, J COMP PHYSIOL B, V165, P298, DOI 10.1007/BF00367313; Olson JR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P263, DOI 10.1086/648395; Piersma T, 2002, INTEGR COMP BIOL, V42, P51, DOI 10.1093/icb/42.1.51; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pyle P, 1997, IDENTIFICATION GUIDE; RISING JD, 1974, CONDOR, V76, P198, DOI 10.2307/1366730; Saarela S, 2003, ISR J ZOOL, V49, P185, DOI 10.1560/VAPN-M8YA-U3KU-DTK9; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; SMITH S, 1993, BIRDS N AM; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Swanson DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034271; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; SWANSON DL, 1991, CONDOR, V93, P538, DOI 10.2307/1368185; Swanson DL, 1996, J THERM BIOL, V21, P221, DOI 10.1016/0306-4565(96)00005-8; Swanson DL, 1999, PHYSIOL BIOCHEM ZOOL, V72, P566, DOI 10.1086/316696; Vaillancourt E, 2005, J EXP BIOL, V208, P317, DOI 10.1242/jeb.01397; Van Der Jeugd HP, 2009, GLOBAL CHANGE BIOL, V15, P1057, DOI 10.1111/j.1365-2486.2008.01804.x; Vezina F, 2007, AM J PHYSIOL-REG I, V292, pR1287, DOI 10.1152/ajpregu.00683.2006; Vezina F, 2006, J EXP BIOL, V209, P3141, DOI 10.1242/jeb.02338; Vezina F, 2011, INTEGR COMP BIOL, V51, P394, DOI 10.1093/icb/icr044; Vezina F, 2010, J AVIAN BIOL, V41, P88, DOI 10.1111/j.1600-048X.2009.04763.x; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P20866, DOI 10.1073/pnas.0707683104; Zheng WH, 2008, COMP BIOCHEM PHYS A, V151, P519, DOI 10.1016/j.cbpa.2008.07.009	57	47	47	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68292	10.1371/journal.pone.0068292	http://dx.doi.org/10.1371/journal.pone.0068292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840843	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400185
J	Scott, CA; Iyer, H; Bwalya, DL; McCoy, K; Meyer-Rath, G; Moyo, C; Bolton-Moore, C; Larson, B; Rosen, S				Scott, Callie A.; Iyer, Hari; Bwalya, Deophine Lembela; McCoy, Kelly; Meyer-Rath, Gesine; Moyo, Crispin; Bolton-Moore, Carolyn; Larson, Bruce; Rosen, Sydney			Retention in Care and Outpatient Costs for Children Receiving Antiretroviral Therapy in Zambia: A Retrospective Cohort Analysis	PLOS ONE			English	Article							SOUTH-AFRICA; HIV/AIDS; HEALTH; FACILITIES; DELIVERY; OUTCOMES; HIV	Background: There are few published estimates of the cost of pediatric antiretroviral therapy (ART) in Africa. Our objective was to estimate the outpatient cost of providing ART to children remaining in care at six public sector clinics in Zambia during the first three years after ART initiation, stratified by service delivery site and time on treatment. Methods: Data on resource utilization (drugs, diagnostics, outpatient visits, fixed costs) and treatment outcomes (in care, died, lost to follow up) were extracted from medical records for 1,334 children at six sites who initiated ART at <15 years of age between 2006 and 2011. Fixed and variable unit costs (reported in 2011 USD) were estimated from the provider's perspective using site level data. Results: Median age at ART initiation was 4.0 years; median CD4 percentage was 14%. One year after ART initiation, 73% of patients remained in care, ranging from 60% to 91% depending on site. The average annual outpatient cost per patient remaining in care was $209 (95% CI, $199-$219), ranging from $116 (95% CI, $107-$126) to $516 (95% CI, $499-$533) depending on site. Average annual costs decreased as time on treatment increased. Antiretroviral drugs were the largest component of all outpatient costs (>50%) at four sites. At the two remaining sites, outpatient visits and fixed costs together accounted for >50% of outpatient costs. The distribution of costs is slightly skewed, with median costs 3% to 13% lower than average costs during the first year after ART initiation depending on site. Conclusions: Outpatient costs for children initiating ART in Zambia are low and comparable to reported outpatient costs for adults. Outpatient costs and retention in care vary widely by site, suggesting opportunities for efficiency gains. Taking advantage of such opportunities will help ensure that targets for pediatric treatment coverage can be met.	[Scott, Callie A.; McCoy, Kelly; Meyer-Rath, Gesine; Larson, Bruce; Rosen, Sydney] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Scott, Callie A.; Iyer, Hari; Bwalya, Deophine Lembela] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia; [Meyer-Rath, Gesine; Rosen, Sydney] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Wits Hlth Consortium, Fac Hlth Sci, Johannesburg, South Africa; [Moyo, Crispin] Zambian Minist Hlth, Lusaka, Zambia; [Bolton-Moore, Carolyn] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Bolton-Moore, Carolyn] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Larson, Bruce] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA USA	Boston University; University of Zambia; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; Boston University	Scott, CA (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	callie@bu.edu	Iyer, Hari S./AAZ-1563-2020	Larson, Bruce/0000-0002-9322-2387; Rosen, Sydney/0000-0002-6560-2964; Meyer-Rath, Gesine/0000-0003-0439-381X; Bolton Moore, Carolyn/0000-0001-9103-7746	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [5U2GPS001418-00]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (5U2GPS001418-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Bratt JH, 2011, TROP MED INT HEALTH, V16, P110, DOI 10.1111/j.1365-3156.2010.02640.x; Ciaranello AL, 2009, CLIN INFECT DIS, V49, P1915, DOI 10.1086/648079; Marques HHD, 2007, CAD SAUDE PUBLICA, V23, pS402, DOI 10.1590/S0102-311X2007001500008; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Government of the Republic of Zambia Ministry of Health, 2007, ZAMB GUID ANT THER H; International Monetary Fund [Internet], 2012, WORLD EC OUTL DAT AP; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Marseille E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051993; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Meyer-Rath G, 2013, AIDS, V27, P243, DOI 10.1097/QAD.0b013e32835a5b92; Oanda Corporation, 2012, HIST EXCH RAT DAIL M; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Tagar E, 2012, 19 INT AIDS C 22 27; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2011, GLOB PRIC REP MECH	18	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67910	10.1371/journal.pone.0067910	http://dx.doi.org/10.1371/journal.pone.0067910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840788	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400143
J	Vendelbosch, S; de Boer, M; Gouw, RATW; Ho, CKY; Geissler, J; Swelsen, WTN; Moorhouse, MJ; Lardy, NM; Roos, D; van den Berg, TK; Kuijpers, TW				Vendelbosch, Sanne; de Boer, Martin; Gouw, Remko A. T. W.; Ho, Cynthia K. Y.; Geissler, Judy; Swelsen, Wendy T. N.; Moorhouse, Michael J.; Lardy, Neubury M.; Roos, Dirk; van den Berg, Timo K.; Kuijpers, Taco W.			Extensive Variation in Gene Copy Number at the Killer Immunoglobulin-Like Receptor Locus in Humans	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; CYTOMEGALOVIRUS-INFECTION; KIDNEY-TRANSPLANTATION; HAPLOTYPE ANALYSIS; T-CELLS; KIR; EVOLUTION; SINGLE; HLA; EXPRESSION	Killer immunoglobulin-like receptors (KIRs) are involved in the regulation of natural killer cell cytotoxicity. Within the human genome seventeen KIR genes are present, which all contain a large number of allelic variants. The high level of homology among KIR genes has hampered KIR genotyping in larger cohorts, and determination of gene copy number variation (CNV) has been difficult. We have designed a multiplex ligation-dependent probe amplification (MLPA) technique for genotyping and CNV determination in one single assay and validated the results by next-generation sequencing and with a KIR gene-specific short tandem repeat assay. In this way, we demonstrate in a cohort of 120 individuals a high level of CNV for all KIR genes except for the framework genes KIR3DL3 and KIR3DL2. Application of our MLPA assay in segregation analyses of families from the Centre d'Etude du Polymorphisme Humaine, previously KIR-genotyped by classical techniques, confirmed an earlier reported duplication and resulted in the identification of a novel duplication event in one of these families. In summary, our KIR MLPA assay allows rapid and accurate KIR genotyping and CNV detection, thus rendering improved transplantation programs and oncology treatment feasible, and enables more detailed studies on the role of KIRs in human (auto) immunity and infectious disease.	[Vendelbosch, Sanne; de Boer, Martin; Gouw, Remko A. T. W.; Ho, Cynthia K. Y.; Geissler, Judy; Moorhouse, Michael J.; Roos, Dirk; van den Berg, Timo K.; Kuijpers, Taco W.] Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands; [Swelsen, Wendy T. N.; Lardy, Neubury M.] Sanquin Blood Supply Fdn, Dept Immunogenet, Amsterdam, Netherlands; [Kuijpers, Taco W.] Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, Acad Med Ctr, Amsterdam, Netherlands	University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Vendelbosch, S (corresponding author), Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands.	s.vendelbosch@sanquin.nl	van den Berg, Timo K/AAC-2479-2022		Sanquin Blood Supply Foundation, The Netherlands [PPOC-09-018]	Sanquin Blood Supply Foundation, The Netherlands(Netherlands Government)	This research was supported by the Sanquin Blood Supply Foundation, The Netherlands, Grant number PPOC-09-018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Crum KA, 2000, TISSUE ANTIGENS, V56, P313, DOI 10.1034/j.1399-0039.2000.560403.x; Espeli M, 2010, CURR OPIN IMMUNOL, V22, P715, DOI 10.1016/j.coi.2010.10.003; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Gallez-Hawkins GM, 2011, BIOL BLOOD MARROW TR, V17, P1662, DOI 10.1016/j.bbmt.2011.04.008; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354; Kunert K, 2007, TRANSPLANTATION, V84, P1527, DOI 10.1097/01.tp.0000290681.41859.41; Leung W, 2011, BRIT J HAEMATOL, V155, P14, DOI 10.1111/j.1365-2141.2011.08823.x; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; Martin MP, 2008, IMMUNOGENETICS, V60, P767, DOI 10.1007/s00251-008-0334-y; Martin MP, 2003, J IMMUNOL, V171, P2192, DOI 10.4049/jimmunol.171.5.2192; McErlean C, 2010, IMMUNOGENETICS, V62, P431, DOI 10.1007/s00251-010-0449-9; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; Nowak I, 2011, TISSUE ANTIGENS, V78, P115, DOI 10.1111/j.1399-0039.2011.01711.x; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2010, J MED PRIMATOL, V39, P194, DOI 10.1111/j.1600-0684.2010.00432.x; Pelak K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001208; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Sambrook JG, 2005, GENOME RES, V15, P25, DOI 10.1101/gr.2381205; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Stern M, 2010, BONE MARROW TRANSPL, V45, P1607, DOI 10.1038/bmt.2010.19; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Tajik N, 2011, INT J IMMUNOGENET, V38, P403, DOI 10.1111/j.1744-313X.2011.01024.x; Traherne JA, 2010, HUM MOL GENET, V19, P737, DOI 10.1093/hmg/ddp538; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; van Bergen J, 2011, AM J TRANSPLANT, V11, P1959, DOI 10.1111/j.1600-6143.2011.03621.x; van der Slik AR, 2003, DIABETES, V52, P2639, DOI 10.2337/diabetes.52.10.2639; van Mirre E, 2006, BLOOD, V108, P584, DOI 10.1182/blood-2005-12-4997; Venstrom JM, 2010, BLOOD, V115, P3162, DOI 10.1182/blood-2009-08-236943; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wouters D, 2009, MOL IMMUNOL, V46, P592, DOI 10.1016/j.molimm.2008.07.028; Zaia JA, 2009, BIOL BLOOD MARROW TR, V15, P315, DOI 10.1016/j.bbmt.2008.11.030	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67619	10.1371/journal.pone.0067619	http://dx.doi.org/10.1371/journal.pone.0067619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840750	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400115
J	Berman, M; Andersen, AN; Hely, C; Gaucherel, C				Berman, Maia; Andersen, Alan N.; Hely, Christelle; Gaucherel, Cedric			Overview of the Distribution, Habitat Association and Impact of Exotic Ants on Native Ant Communities in New Caledonia	PLOS ONE			English	Article							WASMANNIA-AUROPUNCTATA HYMENOPTERA; ATLANTIC RAIN-FOREST; PHEIDOLE-MEGACEPHALA; FIRE ANT; FUNCTIONAL-GROUPS; SPECIES RICHNESS; INTRODUCED ANT; ARGENTINE ANT; FORMICIDAE; INVASION	Ants are among the most ubiquitous and harmful invaders worldwide, but there are few regional studies of their relationships with habitat and native ant communities. New Caledonia has a unique and diverse ant fauna that is threatened by exotic ants, but broad-scale patterns of exotic and native ant community composition in relation to habitat remain poorly documented. We conducted a systematic baiting survey of 56 sites representing the main New Caledonian habitat types: rainforest on ultramafic soils (15 sites), rainforest on volcano-sedimentary soils (13), maquis shrubland (15), Melaleuca-dominated savannas (11) and Acacia spirorbis thickets (2). We collected a total of 49 species, 13 of which were exotic. Only five sites were free of exotic species, and these were all rainforest. The five most abundant exotic species differed in their habitat association, with Pheidole megacephala associated with rainforests, Brachymyrmex cf. obscurior with savanna, and Wasmannia auropunctata and Nylanderia vaga present in most habitats. Anoplolepis gracilipes occurred primarily in maquis-shrubland, which contrasts with its rainforest affinity elsewhere. Multivariate analysis of overall ant species composition showed strong differentiation of sites according to the distribution of exotic species, and these patterns were maintained at the genus and functional group levels. Native ant composition differed at invaded versus uninvaded rainforest sites, in the absence of differences in habitat variables. Generalised Myrmicinae and Forest Opportunists were particularly affected by invasion. There was a strong negative relationship between the abundance of W. auropunctata and native ant abundance and richness. This emphasizes that, in addition to dominating many ant communities numerically, some exotic species, and in particular W. auropunctata, have a marked impact on native ant communities.	[Berman, Maia; Andersen, Alan N.] CSIRO, Ecosyst Sci, Winnellie, NT, Australia; [Berman, Maia; Andersen, Alan N.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT, Australia; [Berman, Maia] Univ Montpellier 2, Inst Natl Rech Agron, Unite Mixte Rech Bot & BioinforMat Architecture P, Montpellier, France; [Hely, Christelle] Ecole Prat Hautes Etud, Ctr Bioarcheol & Ecol, Unite Mixte Rech 5059, Montpellier, France; [Gaucherel, Cedric] Inst Francais Pondicherry, Unites Mixtes Inst Francais Rech Etranger 21, Pondicherry, India	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Darwin University; INRAE; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier	Berman, M (corresponding author), CSIRO, Ecosyst Sci, Winnellie, NT, Australia.	abeille2@gmail.com	Andersen, Alan N/F-8763-2010	Andersen, Alan N/0000-0003-1487-3323; Hely, christelle/0000-0002-7549-3239	Agence Nationale de la Recherche [BDIV-07-008]; Incendies Nouvelle Caledonie(INC); Southern Province of New Caledonia	Agence Nationale de la Recherche(French National Research Agency (ANR)); Incendies Nouvelle Caledonie(INC); Southern Province of New Caledonia	This study was funded by Agence Nationale de la Recherche BDIV-07-008, project Incendies Nouvelle Caledonie(INC). The PhD scholarship of MB was funded by the Southern Province of New Caledonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti Donat, 2000, P204; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; ANDERSEN AN, 1995, BIOL CONSERV, V73, P39, DOI 10.1016/0006-3207(95)90059-4; Bauer Aaron M., 2006, P9; Bauer Aaron M., 1993, Biodiversity Letters, V1, P107, DOI 10.2307/2999755; Berman M, BIOL INVASIONS; Bolton B., 1994, IDENTIFICATION GUIDE; BOUCHET P, 1995, BIODIVERS CONSERV, V4, P415, DOI 10.1007/BF00058425; Carvalho KS, 1999, BIOL CONSERV, V91, P151, DOI 10.1016/S0006-3207(99)00079-8; Caut S, 2009, BIOL INVASIONS, V11, P1689, DOI 10.1007/s10530-008-9397-9; Chazeau J, 2003, AIRES PROTEGEES INSU; Clarke KR, 2006, PRIMER V6 USER MANUA, V6; Clouse Ronald M., 2007, Micronesica, V39, P171; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Delsinne Thibaut, 2001, Actes des Colloques Insectes Sociaux, V14, P1; Drescher J, 2011, BIOTROPICA, V43, P93, DOI 10.1111/j.1744-7429.2010.00662.x; Emery C, 1883, B SOC ENTOMOLOGICA I, V15, P145; Espeland M, 2010, J EVOLUTION BIOL, V23, P2112, DOI 10.1111/j.1420-9101.2010.02072.x; ESRI, 2011, ARCGIS DESKT REL 10; FABRES G, 1978, J AUST ENTOMOL SOC, V17, P139; Foucaud J, 2010, HEREDITY, V105, P205, DOI 10.1038/hdy.2009.169; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Gillespie Rosemary G., 1993, Pacific Science, V47, P21; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Hely C, 2000, J VEG SCI, V11, P813, DOI 10.2307/3236551; Hill JG, 2008, ENVIRON ENTOMOL, V37, P453, DOI 10.1603/0046-225X(2008)37[453:HAOASH]2.0.CO;2; Hoffmann BD, 1999, OECOLOGIA, V120, P595, DOI 10.1007/PL00008824; Hoffmann BD, 2008, BIOL INVASIONS, V10, P1171, DOI 10.1007/s10530-007-9194-x; Holway DA, 2006, BIOL CONSERV, V127, P319, DOI 10.1016/j.biocon.2005.05.016; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Hope G, 1998, PALAEOGEOGR PALAEOCL, V142, P1, DOI 10.1016/S0031-0182(97)00140-5; Jaffre T, 1998, BIODIVERS CONSERV, V7, P109, DOI 10.1023/A:1008815930865; Jaffre T., 1997, IMPACT FEUX BROUSSE; Jaffru T., 1993, BIODIVERSITY LETT, V1, P82, DOI DOI 10.2307/2999751; Jourdan H, 2002, SOCIOBIOLOGY, V40, P483; Jourdan H., 1997, DOCUMENTS SCI TECHNI, P107; Jourdan H, 2006, INVERTEBRES INTRO AR; Jourdan H, 1999, THESIS U P SABATIER; Jourdan Herve, 1997, Pacific Conservation Biology, V3, P61; Kamura CM., 2007, Braz. J. Biol., V67, P635, DOI 10.1590/S1519-69842007000400007; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; King JR, 1998, BIODIVERS CONSERV, V7, P1627, DOI 10.1023/A:1008857214743; LaPolla JS, 2010, SYST ENTOMOL, V35, P118, DOI 10.1111/j.1365-3113.2009.00492.x; Le Breton J, 2005, J TROP ECOL, V21, P93, DOI 10.1017/S0266467404002019; Le Breton J, 2004, J INSECT BEHAV, V17, P263, DOI 10.1023/B:JOIR.0000028575.28700.71; Le Breton J, 2003, AUSTRAL ECOL, V28, P204, DOI 10.1046/j.1442-9993.2003.01266.x; Le Breton J, 2003, THESIS U TOULOUSE 3; Leal IR, 2012, BIODIVERSITY CONSERV; Legendre P, 2011, METHODS ECOL EVOL, V2, P269, DOI 10.1111/j.2041-210X.2010.00078.x; Lowe S., 2000, ENCY BIOL INVASIONS; LUBIN YD, 1984, BIOL J LINN SOC, V21, P229, DOI 10.1111/j.1095-8312.1984.tb02064.x; Lucky A, 2010, ZOOTAXA, P1; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Majer JD, 1999, INSECT SOC, V46, P281, DOI 10.1007/s000400050147; McCoy S, 1999, J BIOGEOGR, V26, P579, DOI 10.1046/j.1365-2699.1999.00309.x; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Moya-Ragoza G, 2000, ANN ENTOMOL SOC AM, V93, P929, DOI 10.1603/0013-8746(2000)093[0929:OMBDQH]2.0.CO;2; Murienne J, 2008, CLADISTICS, V24, P802, DOI 10.1111/j.1096-0031.2008.00204.x; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Orivel J, 2009, ECOL ENTOMOL, V34, P504, DOI 10.1111/j.1365-2311.2009.01096.x; Pfeiffer M, 2003, J BIOGEOGR, V30, P1921, DOI 10.1046/j.0305-0270.2003.00977.x; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; R Development Core Team, 2005, R LANG ENV STAT COMP; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; Stevenson Janelle, 1995, Archaeology in Oceania, V30, P36; Taylor RW, 1987, DIVISION ENTOMOLOGY, P1; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Vanderwoude C, 2000, AUSTRAL ECOL, V25, P253; WARD PS, 1984, AUST J ZOOL, V32, P131, DOI 10.1071/ZO9840131; WARD PS, 1987, HILGARDIA, V55, P1; WILSON EO, 1967, EVOLUTION, V21, P1, DOI 10.1111/j.1558-5646.1967.tb00125.x	73	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67245	10.1371/journal.pone.0067245	http://dx.doi.org/10.1371/journal.pone.0067245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840639	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400086
J	Ferrer-Navarro, M; Planell, R; Yero, D; Mongiardini, E; Torrent, G; Huedo, P; Martinez, P; Roher, N; Mackenzie, S; Gibert, I; Daura, X				Ferrer-Navarro, Mario; Planell, Raquel; Yero, Daniel; Mongiardini, Elias; Torrent, Gerard; Huedo, Pol; Martinez, Paula; Roher, Nerea; Mackenzie, Simon; Gibert, Isidre; Daura, Xavier			Abundance of the Quorum-Sensing Factor Ax21 in Four Strains of Stenotrophomonas maltophilia Correlates with Mortality Rate in a New Zebrafish Model of Infection	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; XANTHOMONAS-MALTOPHILIA; ANTIBIOTIC-RESISTANCE; BIOFILM FORMATION; GENOME; DIVERSITY; SEQUENCE; REVEALS; GENES	Stenotrophomonas maltophilia is a Gram-negative pathogen with emerging nosocomial incidence. Little is known about its pathogenesis and the genomic diversity exhibited by clinical isolates complicates the study of pathogenicity and virulence factors. Here, we present a strategy to identify such factors in new clinical isolates of S. maltophilia, incorporating an adult-zebrafish model of S. maltophilia infection to evaluate relative virulence coupled to 2D difference gel electrophoresis to explore underlying differences in protein expression. In this study we report upon three recent clinical isolates and use the collection strain ATCC13637 as a reference. The adult-zebrafish model shows discrimination capacity, i.e. from very low to very high mortality rates, with clinical symptoms very similar to those observed in natural S. maltophilia infections in fish. Strain virulence correlates with resistance to human serum, in agreement with previous studies in mouse and rat and therefore supporting zebrafish as a replacement model. Despite its clinical origin, the collection strain ATCC13637 showed obvious signs of attenuation in zebrafish, with null mortality. Multilocus-sequence-typing analysis revealed that the most virulent strains, UV74 and M30, exhibit the strongest genetic similitude. Differential proteomic analysis led to the identification of 38 proteins with significantly different abundance in the three clinical strains relative to the reference strain. Orthologs of several of these proteins have been already reported to have a role in pathogenesis, virulence or resistance mechanisms thus supporting our strategy. Proof of concept is further provided by protein Ax21, whose abundance is shown here to be directly proportional to mortality in the zebrafish infection model. Indeed, recent studies have demonstrated that this protein is a quorum-sensing-related virulence factor.	[Ferrer-Navarro, Mario; Planell, Raquel; Yero, Daniel; Mongiardini, Elias; Torrent, Gerard; Huedo, Pol; Martinez, Paula; Roher, Nerea; Mackenzie, Simon; Gibert, Isidre; Daura, Xavier] Univ Autonoma Barcelona, IBB, E-08193 Barcelona, Spain; [Huedo, Pol; Martinez, Paula; Gibert, Isidre] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Mackenzie, Simon] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Daura, Xavier] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Stirling; ICREA	Gibert, I (corresponding author), Univ Autonoma Barcelona, IBB, E-08193 Barcelona, Spain.	Isidre.Gibert@uab.cat; Xavier.Daura@uab.cat	Yero, Daniel/L-9366-2014; Daura, Xavier/C-9275-2009; Gibert, Isidre/L-9834-2014; Huedo, Pol/R-4029-2016; MacKenzie, Simon/Q-2362-2019; Roher, Nerea/F-3216-2016; , Gerard/L-1117-2017	Yero, Daniel/0000-0002-6234-4082; Daura, Xavier/0000-0001-9235-6730; Gibert, Isidre/0000-0003-1442-2258; Huedo, Pol/0000-0002-2933-0586; MacKenzie, Simon/0000-0003-1845-6826; Roher, Nerea/0000-0002-6659-4038; Mongiardini, Elias/0000-0002-6236-5086; Torrent, Gerard/0000-0003-4580-0063; , Gerard/0000-0003-1729-8096; Ferrer-Navarro, Mario/0000-0001-9990-914X	Seventh Research Framework Programme of the European Union [HEALTH-F3-2009-223101]; Spanish MICINN [BFU2010-17199]; Catalan AGAUR [2009SGR-00108]; Universitat Autonoma de Barcelona; ICREA Funding Source: Custom	Seventh Research Framework Programme of the European Union; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Universitat Autonoma de Barcelona; ICREA(ICREA)	This work has been supported by funding under the Seventh Research Framework Programme of the European Union (ref. HEALTH-F3-2009-223101) and the Spanish MICINN (ref. BFU2010-17199). I.G. acknowledges support from the Catalan AGAUR (ref. 2009SGR-00108). P.M. and P.H. are recipients of a fellowship from Universitat Autonoma de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Turrientes MC, 2010, APPL ENVIRON MICROB, V76, P1746, DOI 10.1128/AEM.02817-09; Cervia JS, 2008, CLIN INFECT DIS, V46, DOI 10.1086/587180; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; De Carolis E, 2011, INT J MED MICROBIOL, V301, P273, DOI 10.1016/j.ijmm.2010.10.001; de Oliveira-Garcia D, 2003, CELL MICROBIOL, V5, P625, DOI 10.1046/j.1462-5822.2003.00306.x; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Di Bonaventura G, 2010, INFECT IMMUN, V78, P2466, DOI 10.1128/IAI.01391-09; Ellis RW, 2003, MED INTELL UNIT, P80; Geng Y, 2010, AQUACULTURE, V308, P132, DOI 10.1016/j.aquaculture.2010.08.032; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Gutierrez O, 2004, ANTIMICROB AGENTS CH, V48, P3573, DOI 10.1128/AAC.48.9.3573-3575.2004; Hauben L, 1999, INT J SYST BACTERIOL, V49, P1749, DOI 10.1099/00207713-49-4-1749; Huang TP, 2006, J BACTERIOL, V188, P3116, DOI 10.1128/JB.188.8.3116-3120.2006; HUGH R, 1961, J GEN MICROBIOL, V26, P123; Jang Tsrang-Neng, 1992, Journal of the Formosan Medical Association, V91, P1170; Kaiser S, 2009, J BACTERIOL, V191, P2934, DOI 10.1128/JB.00892-08; KHARDORI N, 1990, REV INFECT DIS, V12, P997; Kinkel Mary D, 2010, J Vis Exp, DOI 10.3791/2126; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Liaw SJ, 2010, INT J ANTIMICROB AG, V35, P126, DOI 10.1016/j.ijantimicag.2009.09.015; Lira F, 2012, J BACTERIOL, V194, P3563, DOI 10.1128/JB.00602-12; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; MARSHALL WF, 1989, MAYO CLIN PROC, V64, P1097, DOI 10.1016/S0025-6196(12)64979-9; McCarthy Y, 2011, J BACTERIOL, V193, P6375, DOI 10.1128/JB.05949-11; McKay GA, 2003, INFECT IMMUN, V71, P3068, DOI 10.1128/IAI.71.6.3068-3075.2003; Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Nateche F, 2006, J MED MICROBIOL, V55, P857, DOI 10.1099/jmm.0.46513-0; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; Parraga-Nino N, 2012, J PROTEOME RES, V11, P3305, DOI 10.1021/pr300084c; Patterson H, 2012, DEV COMP IMMUNOL, V38, P447, DOI 10.1016/j.dci.2012.07.007; Pompilio A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-159; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Prunier AL, 2003, J INFECT DIS, V187, P1709, DOI 10.1086/374937; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rocco F, 2009, INT J MED MICROBIOL, V299, P535, DOI 10.1016/j.ijmm.2009.05.004; Ronald PC, 2011, DISCOV MED, V12, P461; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; Trede NS, 2001, TRENDS IMMUNOL, V22, P302, DOI 10.1016/S1471-4906(01)01939-1; Valdezate S, 2004, J CLIN MICROBIOL, V42, P693, DOI 10.1128/JCM.42.2.693-699.2003; VARTIVARIAN SE, 1994, ANN INTERN MED, V121, P969, DOI 10.7326/0003-4819-121-12-199412150-00011; Vasileuskaya-Schulz Z, 2011, SYST APPL MICROBIOL, V34, P35, DOI 10.1016/j.syapm.2010.11.011; Vojtech LN, 2009, INFECT IMMUN, V77, P914, DOI 10.1128/IAI.01201-08; Waters VJ, 2007, INFECT IMMUN, V75, P1698, DOI 10.1128/IAI.01469-06; Zhang L, 2000, ANTIMICROB AGENTS CH, V44, P287, DOI 10.1128/AAC.44.2.287-293.2000	51	27	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67207	10.1371/journal.pone.0067207	http://dx.doi.org/10.1371/journal.pone.0067207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840626	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400085
J	Gaertner, JC; Maiorano, P; Merigot, B; Colloca, F; Politou, CY; De Sola, LG; Bertrand, JA; Murenu, M; Durbec, JP; Kallianiotis, A; Mannini, A				Gaertner, Jean-Claude; Maiorano, Porza; Merigot, Bastien; Colloca, Francesco; Politou, Chrissi-Yianna; Gil De Sola, Luis; Bertrand, Jacques A.; Murenu, Matteo; Durbec, Jean-Pierre; Kallianiotis, Argyris; Mannini, Alessandro			Large-Scale Diversity of Slope Fishes: Pattern Inconsistency between Multiple Diversity Indices	PLOS ONE			English	Article							DEMERSAL FISH; SPECIES RICHNESS; MEDITERRANEAN SEA; CONTINENTAL-SHELF; GROUNDFISH ASSEMBLAGES; COMMUNITY STRUCTURE; SPATIAL-PATTERN; NEW-ZEALAND; WESTERN; BIODIVERSITY	Large-scale studies focused on the diversity of continental slope ecosystems are still rare, usually restricted to a limited number of diversity indices and mainly based on the empirical comparison of heterogeneous local data sets. In contrast, we investigate large-scale fish diversity on the basis of multiple diversity indices and using 1454 standardized trawl hauls collected throughout the upper and middle slope of the whole northern Mediterranean Sea (36 degrees 3' - 45 degrees 7' N; 5 degrees 3'W - 28 degrees E). We have analyzed (1) the empirical relationships between a set of 11 diversity indices in order to assess their degree of complementarity/redundancy and (2) the consistency of spatial patterns exhibited by each of the complementary groups of indices. Regarding species richness, our results contrasted both the traditional view based on the hump-shaped theory for bathymetric pattern and the commonly-admitted hypothesis of a large-scale decreasing trend correlated with a similar gradient of primary production in the Mediterranean Sea. More generally, we found that the components of slope fish diversity we analyzed did not always show a consistent pattern of distribution according either to depth or to spatial areas, suggesting that they are not driven by the same factors. These results, which stress the need to extend the number of indices traditionally considered in diversity monitoring networks, could provide a basis for rethinking not only the methodological approach used in monitoring systems, but also the definition of priority zones for protection. Finally, our results call into question the feasibility of properly investigating large-scale diversity patterns using a widespread approach in ecology, which is based on the compilation of pre-existing heterogeneous and disparate data sets, in particular when focusing on indices that are very sensitive to sampling design standardization, such as species richness.	[Gaertner, Jean-Claude] Univ Polynesie Francaise, UPF,IRD,Ifremer,ILM, UMR EIO 241, BP 6570, Faaa, Tahiti, France; [Gaertner, Jean-Claude] Ctr Arue, IRD, UPF,IRD,Ifremer,ILM, UMR EIO 241, Papeete, Tahiti, France; [Maiorano, Porza] Univ Bari, Dept Zool, Bari, Italy; [Merigot, Bastien] Ctr Rech Halieut Mediterrane enne & Trop, UMR Ecosyst Marins Exploites 212, Sete, France; [Colloca, Francesco] Univ Roma La Sapienza, Dept Anim & Human Biol, I-00185 Rome, Italy; [Politou, Chrissi-Yianna] Inst Marine Biol Resources, Hellen Ctr Marine Res, Ellinikon, Greece; [Gil De Sola, Luis] Ctr Oceanog Malaga IEO, Fuengirola, Malaga, Spain; [Bertrand, Jacques A.] IFREMER, Dept Ecol & Modeles Halieut, Nantes, France; [Murenu, Matteo] Univ Cagliari, Dipartimento Biol Anim & Ecol, Cagliari, Italy; [Durbec, Jean-Pierre] Univ Aix Marseille, UMR MIO, Ctr Oceanol Marseille, Marseille, France; [Kallianiotis, Argyris] Natl Agr Res Fdn, Fisheries Res Inst, Kavala, Greece; [Mannini, Alessandro] Univ Genoa, Dip Te Ris, Genoa, Italy	Ifremer; Institut de Recherche pour le Developpement (IRD); Ifremer; Institut de Recherche pour le Developpement (IRD); Universita degli Studi di Bari Aldo Moro; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Sapienza University Rome; Hellenic Centre for Marine Research; Ifremer; University of Cagliari; UDICE-French Research Universities; Aix-Marseille Universite; University of Genoa	Gaertner, JC (corresponding author), Univ Polynesie Francaise, UPF,IRD,Ifremer,ILM, UMR EIO 241, BP 6570, Faaa, Tahiti, France.	jean-claude.gaertner@ird.fr	de Sola, Luis Gil/ABE-6143-2020; Mérigot, Bastien/H-7754-2018; Mérigot, Bastien/M-7052-2019; de Sola Simarro, Luis Gil/F-6281-2019; Murenu, Matteo/M-1397-2013	de Sola, Luis Gil/0000-0003-1987-9716; Mérigot, Bastien/0000-0001-5264-4324; Mérigot, Bastien/0000-0001-5264-4324; de Sola Simarro, Luis Gil/0000-0003-1987-9716; Murenu, Matteo/0000-0003-1228-6272; Maiorano, Porzia/0000-0001-5737-3025; Mannini, Alessandro/0000-0002-5910-3413; Colloca, Francesco/0000-0002-0574-2893				BELLANSANTINI D, 1990, PROG OCEANOGR, V24, P275, DOI 10.1016/0079-6611(90)90037-3; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Colloca F, 2003, ESTUAR COAST SHELF S, V56, P469, DOI 10.1016/S0272-7714(02)00196-8; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; D'Onghia G., 2003, Journal of Northwest Atlantic Fishery Science, V31, P263; D'Onghia G, 2004, SCI MAR, V68, P87, DOI 10.3989/scimar.2004.68s387; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Dimech M, 2012, MAR ECOL PROG SER, V449, P41, DOI 10.3354/meps09475; FUJITA T, 1995, MAR ECOL PROG SER, V118, P13, DOI 10.3354/meps118013; Gaertner JC, 2008, MAR ECOL PROG SER, V366, P175, DOI 10.3354/meps07554; Gaertner JC, 2007, MAR ECOL PROG SER, V341, P191, DOI 10.3354/meps341191; Gaertner JC, 2010, ECOGRAPHY, V33, P1123, DOI 10.1111/j.1600-0587.2009.06259.x; Gage J. D., 1991, DEEP SEA BIOL NATURA; Garofalo G, 2007, HYDROBIOLOGIA, V580, P117, DOI 10.1007/s10750-006-0460-1; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Gristina M, 2006, FISH RES, V81, P60, DOI 10.1016/j.fishres.2006.05.010; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heino J, 2008, LANDSCAPE ECOL, V23, P417, DOI 10.1007/s10980-008-9199-6; Joliffe I. T., 1986, PRINCIPAL COMPONENT; Kallianiotis A, 2000, PROG OCEANOGR, V46, P429, DOI 10.1016/S0079-6611(00)00028-8; Kendall VJ, 2006, DEEP-SEA RES PT I, V53, P506, DOI 10.1016/j.dsr.2005.12.005; Labropoulou M, 2000, HYDROBIOLOGIA, V440, P281, DOI 10.1023/A:1004199917299; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Magnussen E, 2002, MAR ECOL PROG SER, V238, P211, DOI 10.3354/meps238211; Magurran A.E., 2004, MEASURING BIOL DIVER; McClatchie S, 1997, DEEP-SEA RES PT I, V44, P647, DOI 10.1016/S0967-0637(96)00096-9; Merigot B, 2007, FISH RES, V88, P120, DOI 10.1016/j.fishres.2007.08.003; Merigot B, 2007, ESTUAR COAST SHELF S, V73, P123, DOI 10.1016/j.ecss.2006.12.017; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Moranta J, 1998, MAR ECOL PROG SER, V171, P247, DOI 10.3354/meps171247; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Moutin T, 2002, J MARINE SYST, V33, P273, DOI 10.1016/S0924-7963(02)00062-3; Powell Shawna M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P19; Quignard J.P., 2000, Biologia Marina Mediterranea, V7, P1; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; SNELGROVE PVR, 1985, MAR ECOL PROG SER, V27, P99, DOI 10.3354/meps027099; Tolimieri N, 2007, ENVIRON BIOL FISH, V78, P241, DOI 10.1007/s10641-006-9093-5; Tolimieri N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010653; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; Witman JD, 2008, ECOLOGY, V89, pS66, DOI 10.1890/07-1201.1	53	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66753	10.1371/journal.pone.0066753	http://dx.doi.org/10.1371/journal.pone.0066753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843962	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000051
J	Jawahar, MS; Banurekha, VV; Paramasivan, CN; Rahman, F; Ramachandran, R; Venkatesan, P; Balasubramanian, R; Selvakumar, N; Ponnuraja, C; Iliayas, AS; Gangadevi, NP; Raman, B; Baskaran, D; Kumar, SR; Kumar, MM; Mohan, V; Ganapathy, S; Kumar, V; Shanmugam, G; Charles, N; Sakthivel, MR; Jagannath, K; Chandrasekar, C; Parthasarathy, RT; Narayanan, PR				Jawahar, Mohideen S.; Banurekha, Vaithilingam V.; Paramasivan, Chinnampedu N.; Rahman, Fathima; Ramachandran, Rajeswari; Venkatesan, Perumal; Balasubramanian, Rani; Selvakumar, Nagamiah; Ponnuraja, Chinnaiyan; Iliayas, Allaudeen S.; Gangadevi, Navaneethapandian P.; Raman, Balambal; Baskaran, Dhanaraj; Kumar, Santhanakrishnan R.; Kumar, Marimuthu M.; Mohan, Victor; Ganapathy, Sudha; Kumar, Vanaja; Shanmugam, Geetha; Charles, Niruparani; Sakthivel, Murugesan R.; Jagannath, Kannivelu; Chandrasekar, Chockalingam; Parthasarathy, Ramavaram T.; Narayanan, Paranji R.			Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients	PLOS ONE			English	Article							PHARMACOKINETICS; RIFAPENTINE; SENSITIVITY	Background: Shortening tuberculosis (TB) treatment duration is a research priority. This paper presents data from a prematurely terminated randomized clinical trial, of 4-month moxifloxacin or gatifloxacin regimens, in South India. Methods: Newly diagnosed, sputum-positive HIV-negative pulmonary TB patients were randomly allocated to receive gatifloxacin or moxifloxacin, along with isoniazid and rifampicin for 4 months with pyrazinamide for first 2 months (G or M) or isoniazid and rifampicin for 6 months with ethambutol and pyrazinamide for first 2 months (C). All regimens were administered thrice-weekly. Clinical and bacteriological assessments were done monthly during treatment and for 24 months post-treatment. The Data and Safety Monitoring Board recommended termination of the trial due to high TB recurrence rates in the G and M regimens. Results: Of 416 patients in intent-to-treat analysis, 6 (5%) of 124, 2 (2%) of 110 and 2 (2%) of 137 patients with drug-susceptible TB in the G, M and C arms respectively had unfavorable response at the end of treatment; during the next 24 months, 17 (15%) of 115, 11 (11%) of 104 and 8 (6%) of 132 patients respectively, had TB recurrence. Of 38 drug-resistant patients 1 of 8 and 3 of 26 in the G and C arms respectively had unfavourable response at the end of treatment; and TB recurrence occurred in 2 of 7 and 2 of 23 patients, respectively. The differences in TB recurrence rates between the G and C arms was statistically significant (p = 0.02). Gastro-intestinal symptoms occurred in 23%, 22% and 9% of patients in the G, M and C arms respectively, but most reactions were mild and manageable with symptomatic measures; 1% required regimen modification. Conclusions: 4-month thrice-weekly regimens of gatifloxacin or moxifloxacin with isoniazid, rifampicin and pyrazinamide, were inferior to standard 6-month treatment, in patients with newly diagnosed sputum positive pulmonary TB.	[Jawahar, Mohideen S.; Banurekha, Vaithilingam V.; Paramasivan, Chinnampedu N.; Rahman, Fathima; Ramachandran, Rajeswari; Venkatesan, Perumal; Balasubramanian, Rani; Selvakumar, Nagamiah; Ponnuraja, Chinnaiyan; Raman, Balambal; Baskaran, Dhanaraj; Ganapathy, Sudha; Kumar, Vanaja; Shanmugam, Geetha; Charles, Niruparani; Narayanan, Paranji R.] Natl Inst Res TB, TB Res Ctr, Chennai, Tamil Nadu, India; [Iliayas, Allaudeen S.; Gangadevi, Navaneethapandian P.; Kumar, Santhanakrishnan R.; Kumar, Marimuthu M.; Mohan, Victor; Sakthivel, Murugesan R.] Natl Inst Res TB, TB Res Ctr, Madurai, Tamil Nadu, India; [Jagannath, Kannivelu] Inst Thorac Med, Chennai, Tamil Nadu, India; [Chandrasekar, Chockalingam] Govt Rajaji Hosp, Madurai, Tamil Nadu, India; [Parthasarathy, Ramavaram T.] Govt Tiruvatteeswarar Hosp, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Jawahar, MS (corresponding author), Natl Inst Res TB, TB Res Ctr, Chennai, Tamil Nadu, India.	shaheedjawahar@gmail.com	Nagamiah, Selvakumar/AHB-2651-2022	Venkatesan, Perumal/0000-0002-4491-7553				ALLAN WGL, 1977, AM REV RESPIR DIS, V115, P727; Allen B, 1968, MYCOBACTERIA ISOLATI, P17; [Anonymous], 1983, TUBERCLE, V64, P73; [Anonymous], 1982, Tubercle, V63, P89; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chan CY, 2004, ANTIMICROB AGENTS CH, V48, P340, DOI 10.1128/AAC.48.1.340-343.2004; Dickinson JM, 1968, TUBERCLE, V49, P66; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Greenberg AL, 2005, CLIN INFECT DIS, V40, P1210, DOI 10.1086/428847; HOLST E, 1959, Indian J Med Res, V47, P495; India Tuberculosis Research Centre (Indian Council of Medical Research), 2002, Indian Journal of Tuberculosis, V49, P27; Kubendiran G, 2006, J CHEMOTHERAPY, V18, P617, DOI 10.1179/joc.2006.18.6.617; KUBICA GP, 1973, AM REV RESPIR DIS, V107, P9; Lober S, 1999, ANTIMICROB AGENTS CH, V43, P1067, DOI 10.1128/AAC.43.5.1067; Lounis N, 2001, ANTIMICROB AGENTS CH, V45, P3482, DOI 10.1128/AAC.45.12.3482-3486.2001; Mathew R., 1993, Indian Journal of Tuberculosis, V40, P119; Mathew R, 1997, INT J TUBERC LUNG D, V1, P509; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Sirgel FA, 2000, J ANTIMICROB CHEMOTH, V45, P859, DOI 10.1093/jac/45.6.859; Stass H, 1998, ANTIMICROB AGENTS CH, V42, P2060, DOI 10.1128/AAC.42.8.2060; SUBBAMMAL S, 1978, TUBERCLE, V59, P185, DOI 10.1016/0041-3879(78)90025-9; Sulochana S, 2005, J CHEMOTHERAPY, V17, P169, DOI 10.1179/joc.2005.17.2.169; Sulochana S, 1999, INDIAN J MED RES, V110, P186	23	75	80	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67030	10.1371/journal.pone.0067030	http://dx.doi.org/10.1371/journal.pone.0067030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843980	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321733000058
J	Esnault, S; Kelly, EA; Schwantes, EA; Liu, LY; DeLain, LP; Hauer, JA; Bochkov, YA; Denlinger, LC; Malter, JS; Mathur, SK; Jarjour, NN				Esnault, Stephane; Kelly, Elizabeth A.; Schwantes, Elizabeth A.; Liu, Lin Ying; DeLain, Larissa P.; Hauer, Jami A.; Bochkov, Yury A.; Denlinger, Loren C.; Malter, James S.; Mathur, Sameer K.; Jarjour, Nizar N.			Identification of Genes Expressed by Human Airway Eosinophils after an In Vivo Allergen Challenge	PLOS ONE			English	Article							PERIPHERAL-BLOOD EOSINOPHILS; INFLAMMATORY RESPONSES; RECEPTOR; PROTEIN; MEPOLIZUMAB; ACTIVATION; GENERATION; ASTHMA; SPUTUM; CELLS	Background: The mechanism for the contribution of eosinophils (EOS) to asthma pathophysiology is not fully understood. Genome-wide expression analysis of airway EOS by microarrays has been limited by the ability to generate high quality RNA from sufficient numbers of airway EOS. Objective: To identify, by genome-wide expression analyses, a compendium of expressed genes characteristic of airway EOS following an in vivo allergen challenge. Methods: Atopic, mild asthmatic subjects were recruited for these studies. Induced sputum was obtained before and 48h after a whole lung allergen challenge (WLAC). Individuals also received a segmental bronchoprovocation with allergen (SBP-Ag) 1 month before and after administering a single dose of mepolizumab (anti-IL-5 monoclonal antibody) to reduce airway EOS. Bronchoalveolar lavage (BAL) was performed before and 48 h after SBP-Ag. Gene expression of sputum and BAL cells was analyzed by microarrays. The results were validated by qPCR in BAL cells and purified BAL EOS. Results: A total of 299 transcripts were up-regulated by more than 2-fold in total BAL cells following SBP-Ag. Mepolizumab treatment resulted in a reduction of airway EOS by 54.5% and decreased expression of 99 of the 299 transcripts. 3 of 6 post-WLAC sputum samples showed increased expression of EOS-specific genes, along with the expression of 361 other genes. Finally, the intersection of the 3 groups of transcripts (increased in BAL post SBP-Ag (299), decreased after mepolizumab (99), and increased in sputum after WLAC (365)) was composed of 57 genes characterizing airway EOS gene expression. Conclusion: We identified 57 genes that were highly expressed by BAL EOS compared to unseparated BAL cells after in vivo allergen challenge. 41 of these genes had not been previously described in EOS and are thus potential new candidates to elucidate EOS contribution to airway biology.	[Esnault, Stephane; Kelly, Elizabeth A.; Schwantes, Elizabeth A.; Liu, Lin Ying; DeLain, Larissa P.; Hauer, Jami A.; Denlinger, Loren C.; Mathur, Sameer K.; Jarjour, Nizar N.] Univ Wisconsin, Dept Med, Allergy Pulm & Crit Care Med Div, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Bochkov, Yury A.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Malter, James S.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Southwestern Medical Center Dallas	Esnault, S (corresponding author), Univ Wisconsin, Dept Med, Allergy Pulm & Crit Care Med Div, Sch Med & Publ Hlth, Madison, WI 53706 USA.	sesnault@medicine.wisc.edu	Esnault, Stephane/AAO-4712-2020; Esnault, Stephane/AAJ-4511-2020	Esnault, Stephane/0000-0001-7238-8671; Kelly, Elizabeth/0000-0001-7335-6698; Bochkov, Yury/0000-0003-2618-4496	University of Wisconsin General Clinical Research Center [NIH M01RR03186]; University of Wisconsin Institute for Clinical and Translational Research [NCRR/NIH 1UL1RR025011];  [NIH HL088594]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011, M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER	University of Wisconsin General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Wisconsin Institute for Clinical and Translational Research; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a Program Project Grant (NIH HL088594), the University of Wisconsin General Clinical Research Center grant (NIH M01RR03186), and the University of Wisconsin Institute for Clinical and Translational Research (NCRR/NIH 1UL1RR025011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Bates ME, 2010, J IMMUNOL, V184, P7125, DOI 10.4049/jimmunol.0900634; Bates ME, 2004, AM J RESP CELL MOL, V30, P736, DOI 10.1165/rcmb.2003-0234OC; Boulay ME, 2002, CLIN EXP ALLERGY, V32, P1441, DOI 10.1046/j.1365-2745.2002.01508.x; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Broekema M, 2010, RESP MED, V104, P1254, DOI 10.1016/j.rmed.2010.03.030; Broekema M, 2010, AM J RESP CRIT CARE; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P803, DOI 10.1016/j.jaci.2009.11.048; CALHOUN WJ, 1993, AM REV RESPIR DIS, V147, P1465, DOI 10.1164/ajrccm/147.6_Pt_1.1465; Castro M, 2011, AM J RESP CRIT CARE; Chen C, 2003, BIOCHEM J, V374, P97, DOI 10.1042/BJ20030242; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; del Rio ML, 2010, J LEUKOCYTE BIOL, V87, P223, DOI 10.1189/jlb.0809590; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Esnault S, 2012, CLIN EXP ALLERGY, V42, P1756, DOI 10.1111/j.1365-2222.2012.04060.x; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Giannini L, 2008, J CELL MOL MED, V12, P2381, DOI 10.1111/j.1582-4934.2008.00258.x; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Homer RJ, 2011, ARCH PATHOL LAB MED, V135, P780, DOI 10.1043/2010-0296-RA.1; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Inoue M, 1998, BIOCHEM BIOPH RES CO, V252, P307, DOI 10.1006/bbrc.1998.9645; Jarjour NN, 1997, AM J RESP CRIT CARE, V155, P1515, DOI 10.1164/ajrccm.155.5.9154851; Johansson MW, 2013, CLIN EXP ALLERGY, V43, P292, DOI 10.1111/j.1365-2222.2012.04065.x; Johansson MW, 2008, J IMMUNOL, V180, P7622, DOI 10.4049/jimmunol.180.11.7622; Karmaus PWF, 2011, J LEUKOCYTE BIOL, V90, P983, DOI 10.1189/jlb.0511219; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kelly EAB, 2012, CYTOKINE, V58, P199, DOI 10.1016/j.cyto.2012.01.009; Kishimoto S, 2006, INT ARCH ALLERGY IMM, V140, P3, DOI 10.1159/000092704; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Lilly CM, 2005, AM J RESP CRIT CARE, V171, P579, DOI 10.1164/rccm.200404-532OC; Liu LY, 2007, J IMMUNOL, V179, P4840, DOI 10.4049/jimmunol.179.7.4840; Liu LY, 2006, ALLERGY, V61, P589, DOI 10.1111/j.1398-9995.2006.01060.x; Liu LY, 2000, J ALLERGY CLIN IMMUN, V106, P1063; Liu LY, 2002, J IMMUNOL, V169, P6452, DOI 10.4049/jimmunol.169.11.6452; Lopuhaa CE, 2002, CLIN EXP ALLERGY, V32, P1720, DOI 10.1046/j.1365-2222.2002.01542.x; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nakajima T, 2001, BLOOD, V98, P1127, DOI 10.1182/blood.V98.4.1127; Oka S, 2004, J LEUKOCYTE BIOL, V76, P1002, DOI 10.1189/jlb.0404252; Osanai A, 2011, INFECT IMMUN, V79, P858, DOI 10.1128/IAI.00466-10; Park SY, 2013, J IMMUNOL; PIN I, 1992, AM REV RESPIR DIS, V145, P1265, DOI 10.1164/ajrccm/145.6.1265; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Sashchenko LP, 2007, BLOOD, V110, P1997, DOI 10.1182/blood-2006-12-064444; Spencer LA, 2009, J LEUKOCYTE BIOL, V85, P117, DOI 10.1189/jlb.0108058; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; Temple R, 2001, AM J RESP CELL MOL, V25, P425, DOI 10.1165/ajrcmb.25.4.4456; Tydell CC, 2002, J BIOL CHEM, V277, P19658, DOI 10.1074/jbc.M200659200; Zoerner AA, 2011, CLIN PHARMACOL THER, V90, P388, DOI 10.1038/clpt.2011.94	54	44	47	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67560	10.1371/journal.pone.0067560	http://dx.doi.org/10.1371/journal.pone.0067560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844029	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000057
J	Priebe, L; Degenhardt, F; Strohmaier, J; Breuer, R; Herms, S; Witt, SH; Hoffmann, P; Kulbida, R; Mattheisen, M; Moebus, S; Meyer-Lindenberg, A; Walter, H; Mossner, R; Nenadic, I; Sauer, H; Rujescu, D; Maier, W; Rietschel, M; Nothen, MM; Cichon, S				Priebe, Lutz; Degenhardt, Franziska; Strohmaier, Jana; Breuer, Rene; Herms, Stefan; Witt, Stephanie H.; Hoffmann, Per; Kulbida, Rebecca; Mattheisen, Manuel; Moebus, Susanne; Meyer-Lindenberg, Andreas; Walter, Henrik; Moessner, Rainald; Nenadic, Igor; Sauer, Heinrich; Rujescu, Dan; Maier, Wolfgang; Rietschel, Marcella; Noethen, Markus M.; Cichon, Sven			Copy Number Variants in German Patients with Schizophrenia	PLOS ONE			English	Article							HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; HIGH-RISK; MICRODELETIONS; ASSOCIATION; DELETIONS; 16P11.2	Large rare copy number variants (CNVs) have been recognized as significant genetic risk factors for the development of schizophrenia (SCZ). However, due to their low frequency (1:150 to 1:1000) among patients, large sample sizes are needed to detect an association between specific CNVs and SCZ. So far, the majority of genome-wide CNV analyses have focused on reporting only CNVs that reached a significant P-value within the study cohort and merely confirmed the frequency of already-established risk-carrying CNVs. As a result, CNVs with a very low frequency that might be relevant for SCZ susceptibility are lost for secondary analyses. In this study, we provide a concise collection of high-quality CNVs in a large German sample consisting of 1,637 patients with SCZ or schizoaffective disorder and 1,627 controls. All individuals were genotyped on Illumina's BeadChips and putative CNVs were identified using QuantiSNP and PennCNV. Only those CNVs that were detected by both programs and spanned >= 30 consecutive SNPs were included in the data collection and downstream analyses (2,366 CNVs, 0.73 CNVs per individual). The genome-wide analysis did not reveal a specific association between a previously unknown CNV and SCZ. However, the group of CNVs previously reported to be associated with SCZ was more frequent in our patients than in the controls. The publication of our dataset will serve as a unique, easily accessible, high-quality CNV data collection for other research groups. The dataset could be useful for the identification of new disease-relevant CNVs that are currently overlooked due to their very low frequency and lack of power for their detection in individual studies.	[Priebe, Lutz; Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Kulbida, Rebecca; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, iPSYCH, Bonn, Germany; [Priebe, Lutz; Degenhardt, Franziska; Herms, Stefan; Hoffmann, Per; Kulbida, Rebecca; Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Priebe, Lutz; Strohmaier, Jana; Breuer, Rene; Witt, Stephanie H.; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Mattheisen, Manuel] Univ Bonn, Inst Genom Math, Bonn, Germany; [Mattheisen, Manuel] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Mattheisen, Manuel] Harvard Univ, Sch Med, Boston, MA USA; [Moebus, Susanne] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Meyer-Lindenberg, Andreas] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany; [Walter, Henrik] Charite Campus Mitte, Dept Psychiat & Psychotherapy, Berlin, Germany; [Moessner, Rainald; Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Nenadic, Igor; Sauer, Heinrich] Jena Univ Hosp, Dept Psychiat & Psychotherapy, Jena, Germany; [Rujescu, Dan] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, D-06108 Halle, Germany; [Maier, Wolfgang; Noethen, Markus M.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Struct & Funct Org Brain, Genom Imaging, Julich, Germany; [Herms, Stefan; Hoffmann, Per; Cichon, Sven] Univ Hosp, Div Med Genet, Basel, Switzerland; [Herms, Stefan; Hoffmann, Per; Cichon, Sven] Univ Basel, Dept Biomed, Basel, Switzerland	University of Bonn; University of Bonn; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Duisburg Essen; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; Friedrich Schiller University of Jena; University of Munich; Martin Luther University Halle Wittenberg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; Research Center Julich; University of Basel	Cichon, S (corresponding author), Univ Bonn, Inst Human Genet, iPSYCH, Bonn, Germany.	sven.cichon@uni-bonn.de	Mattheisen, Manuel/S-3725-2019; Degenhardt, Franziska/H-4169-2017; Mattheisen, Manuel/B-4949-2012; Rujescu, Dan/GRS-3875-2022; Cichon, Sven/H-8803-2013; Hoffmann, Per/A-5149-2010; Cichon, Sven/B-9618-2014; Herms, Stefan/J-1949-2014; Walter, Henrik/O-2612-2013; Meyer-Lindenberg, Andreas/H-1076-2011	Mattheisen, Manuel/0000-0002-8442-493X; Mattheisen, Manuel/0000-0002-8442-493X; Cichon, Sven/0000-0002-9475-086X; Hoffmann, Per/0000-0002-6573-983X; Cichon, Sven/0000-0002-9475-086X; Herms, Stefan/0000-0002-2786-8200; Moebus, Susanne/0000-0002-0072-5410; Walter, Henrik/0000-0002-9403-6121; Nothen, Markus/0000-0002-8770-2464; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	German Federal Ministry of Education and Research within National Genome Research Network 2; National Genome Research Network plus; Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; European Union [HEALTH-F4-2009-242257]; Alfried Krupp von Bohlen und Halbach-Stiftung; Heinz Nixdorf Foundation; Interdiziplinares Zentrum fur Klinische Forschung Jena; Lilly; Otsuka; Wyeth	German Federal Ministry of Education and Research within National Genome Research Network 2; National Genome Research Network plus; Integrated Genome Research Network (IG) MooDS; European Union(European Commission); Alfried Krupp von Bohlen und Halbach-Stiftung; Heinz Nixdorf Foundation; Interdiziplinares Zentrum fur Klinische Forschung Jena; Lilly(Eli Lilly); Otsuka(Otsuka Pharmaceutical); Wyeth(Wyeth)	This study was supported by the German Federal Ministry of Education and Research, within the context of: the National Genome Research Network 2; the National Genome Research Network plus; and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to SC and MMN, grant 01GS08147 to MR). Additionally, this work was supported by the European Union grant number HEALTH-F4-2009-242257 (Project ADAMS). MMN also received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. The HNR cohort was established with the support of the Heinz Nixdorf Foundation. IN was supported by a Junior Scientist grant of the Interdiziplinares Zentrum fur Klinische Forschung Jena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors have read the journal's policy and have the following conflicts: In 2007 and 2008, Heinrich Sauer received fees for board membership of Lilly and Otsuka, a travel grant from Lilly, and speaker's honoraria from Pfizer and Lilly. Consultancy fees were also received from Wyeth. All the other authors have no competing financial interests to declare, as defined by PLOS or any other interests that might be perceived to influence the results and discussion reported in this paper. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Degenhardt F, 2012, AM J MED GENET B, V159B, P263, DOI 10.1002/ajmg.b.32034; Grozeva D, 2012, SCHIZOPHR RES, V135, P1, DOI 10.1016/j.schres.2011.11.004; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Priebe L, 2012, MOL PSYCHIATR, V17, P421, DOI 10.1038/mp.2011.8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	24	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e64035	10.1371/journal.pone.0064035	http://dx.doi.org/10.1371/journal.pone.0064035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843933	gold, Green Published			2022-12-27	WOS:000321341000001
J	Zanacchi, FC; Lavagnino, Z; Faretta, M; Furia, L; Diaspro, A				Zanacchi, Francesca Cella; Lavagnino, Zeno; Faretta, Mario; Furia, Laura; Diaspro, Alberto			Light-Sheet Confined Super-Resolution Using Two-Photon Photoactivation	PLOS ONE			English	Article							DIFFRACTION-LIMIT; LOCALIZATION; MICROSCOPY; RECONSTRUCTION; ACTIVATION; SCATTERING; NANOSCOPY; PROTEINS; EMBRYOS; DEEP	Light-sheet microscopy is a useful tool for performing biological investigations of thick samples and it has recently been demonstrated that it can also act as a suitable architecture for super-resolution imaging of thick biological samples by means of individual molecule localization. However, imaging in depth is still limited since it suffers from a reduction in image quality caused by scattering effects. This paper sets out to investigate the advantages of non-linear photoactivation implemented in a selective plane illumination configuration when imaging scattering samples. In particular, two-photon excitation is proven to improve imaging capabilities in terms of imaging depth and is expected to reduce light-sample interactions and sample photo-damage. Here, two-photon photoactivation is coupled to individual molecule localization methods based on light-sheet illumination (IML-SPIM), allowing super-resolution imaging of nuclear pH2AX in NB4 cells.	[Zanacchi, Francesca Cella; Lavagnino, Zeno; Diaspro, Alberto] Ist Italiano Tecnol, Dept Nanophys, Genoa, Italy; [Lavagnino, Zeno; Diaspro, Alberto] Univ Genoa, Genoa, Italy; [Faretta, Mario; Furia, Laura] European Inst Oncol, Dept Expt Oncol, Milan, Italy	Istituto Italiano di Tecnologia - IIT; University of Genoa; IRCCS European Institute of Oncology (IEO)	Zanacchi, FC (corresponding author), Ist Italiano Tecnol, Dept Nanophys, Genoa, Italy.	francesca.cella@iit.it	Faretta, Mario/H-8946-2012; Diaspro, Alberto/E-7833-2010; Lavagnino, Zeno/AAB-3806-2019; Zanacchi, Francesca Cella/ABI-1651-2020; Cella Zanacchi, Francesca/H-4310-2011	Faretta, Mario/0000-0003-1678-5781; Diaspro, Alberto/0000-0002-4916-5928; Lavagnino, Zeno/0000-0002-7247-8084; Cella Zanacchi, Francesca/0000-0002-2427-3009				Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Collini M, 2006, Q REV BIOPHYS, V15, P1; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Difato F, 2011, P SPIE; Fahrbach FO, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1646; Folling J, 2007, ANGEW CHEM INT EDIT, V46, P6266, DOI 10.1002/anie.200702167; Folling J, 2008, CHEMPHYSCHEM, V9, P321, DOI 10.1002/cphc.200700655; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Gunewardene MS, 2011, BIOPHYS J, V101, P1522, DOI 10.1016/j.bpj.2011.07.049; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2011, NAT METHODS, V8, P304, DOI 10.1038/nmeth0411-304; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; LANOTTE M, 1991, BLOOD, V77, P1080; Lavagnino Z, 2013, OPT EXPRESS, V21, P5998, DOI 10.1364/OE.21.005998; Mazza D, 2007, APPL OPTICS, V46, P7401, DOI 10.1364/AO.46.007401; Mertz J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3324890; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586; Mukamel EA, 2012, BIOPHYS J, V102, P2391, DOI 10.1016/j.bpj.2012.03.070; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Palero J, 2010, OPT EXPRESS, V18, P8491, DOI 10.1364/OE.18.008491; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Post JN, 2005, FEBS LETT, V579, P325, DOI 10.1016/j.febslet.2004.11.092; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider M, 2005, BIOPHYS J, V89, P1346, DOI 10.1529/biophysj.104.054502; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; Silvestri L, 2012, OPT EXPRESS, V20, P20582, DOI 10.1364/OE.20.020582; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Starr R, 2012, OPT LETT, V37, P413, DOI 10.1364/OL.37.000413; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Vaziri A, 2008, P NATL ACAD SCI USA, V105, P20221, DOI 10.1073/pnas.0810636105; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; York AG, 2011, NAT METHODS, V8, P327, DOI 10.1038/NMETH.1571; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/NMETH.1744, 10.1038/nmeth.1744]; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	45	45	47	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67667	10.1371/journal.pone.0067667	http://dx.doi.org/10.1371/journal.pone.0067667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844052	Green Published, gold			2022-12-27	WOS:000321341000070
J	Fonseca, LM; Alvarez, AB; Rodrigues, RC; Santos, DHF; Lopes, AG; Capella, MAM				Fonseca, Leonardo M.; Alvarez, Adriana B.; Rodrigues, Rachel C.; Santos, Diego H. F.; Lopes, Anibal G.; Capella, Marcia A. M.			ABCC1 Is Related to the Protection of the Distal Nephron against Hyperosmolality and High Sodium Environment: Possible Implications for Cancer Chemotherapy	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-1; P-GLYCOPROTEIN; OXIDATIVE STRESS; MEMBRANE-TRANSPORT; ELEVATED NACL; CELL-LINE; HIGH-SALT; KIDNEY; GLUTATHIONE; EXPRESSION	Aims: Glutathione (GSH) plays an important role in protecting cells against oxidative damage. ABCC1 protein transports GSH. Although this protein is largely studied in cancer, due to multidrug resistance phenotype, its role in the tubular cells of the kidney is unknown. The goal of this study was to find out whether ABCC1 has a role in protecting cells from the distal nephron against the stress caused by high medullar osmolality. Main Methods: MA104 cells were treated with high concentrations of sodium chloride, urea, or both to raise the osmolality of the culture medium. Cell viability was accessed by MTT and trypan blue assays. ABCC1 expression and extrusion of carboxi-fluorescein (CF), a fluorescent ABCC1 substrate, were measured by flow cytometry. Key Findings: Incubation of MA104 cells in a high sodium concentration medium resulted in changes in cell granularity and altered expression and activity of ABCC1. Urea did not alter ABCC1 expression or activity, but reversed the observed NaCl effects. High sodium concentrations also had a negative effect on cell viability and urea also protected cells against this effect. Significance: Our findings demonstrate that ABCC1 plays a significant role in the protection of kidney epithelial cells against the stress caused by high sodium environment present in renal medulla.	[Fonseca, Leonardo M.; Capella, Marcia A. M.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Alvarez, Adriana B.; Rodrigues, Rachel C.; Santos, Diego H. F.; Lopes, Anibal G.; Capella, Marcia A. M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Capella, MAM (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	mcapella@biof.ufrj.br	FISIOLOGIA, PG/C-5362-2013; Capella, Marcia/F-1097-2013	Capella, Marcia/0000-0001-8407-9235; Fonseca, Leonardo/0000-0001-8239-6843	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Oncobiologia (FECD/FAF/ONCO II); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Programa de Apoio aos Nucleos de Excelencia (PRONEX)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Oncobiologia (FECD/FAF/ONCO II); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio aos Nucleos de Excelencia (PRONEX)	This work was supported by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Programa de Oncobiologia (FECD/FAF/ONCO II), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Programa de Apoio aos Nucleos de Excelencia (PRONEX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2006, AM J PHYSIOL-RENAL, V291, pF350, DOI 10.1152/ajprenal.00407.2005; Arimochi H, 2005, J MOL NEUROSCI, V27, P293, DOI 10.1385/JMN:27:3:293; Arthur JM, 2000, TISSUE CELL, V32, P446, DOI 10.1054/tice.2000.0135; Cai Q, 2004, AM J PHYSIOL-RENAL, V286, pF58, DOI 10.1152/ajprenal.00037.2003; Capella LS, 2001, BBA-GEN SUBJECTS, V1526, P293, DOI 10.1016/S0304-4165(01)00144-1; Capella MAM, 1999, Z NATURFORSCH C, V54, P119; Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; Dmitrieva N, 2000, J BIOL CHEM, V275, P18243, DOI 10.1074/jbc.M000522200; Flens MJ, 1996, AM J PATHOL, V148, P1237; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; GUILLERMINA G, 1989, TOXICOLOGY, V58, P187, DOI 10.1016/0300-483X(89)90008-5; Hadchouel J, 2011, CELL PHYSIOL BIOCHEM, V28, P505, DOI 10.1159/000335116; Hammond CL, 2001, J HEPATOL, V34, P946, DOI 10.1016/S0168-8278(01)00037-X; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Hooijberg JH, 2004, BIOCHEM PHARMACOL, V67, P1541, DOI 10.1016/j.bcp.2003.12.022; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Humanes B, 2012, KIDNEY INT, V82, P652, DOI 10.1038/ki.2012.199; Kaneko T, 1997, AM J PHYSIOL-RENAL, V272, pF610, DOI 10.1152/ajprenal.1997.272.5.F610; Kong D, 2012, J NEPHROL; Kultz D, 2001, P NATL ACAD SCI USA, V98, P1999, DOI 10.1073/pnas.98.4.1999; Kultz D, 1998, J BIOL CHEM, V273, P13645, DOI 10.1074/jbc.273.22.13645; Lahoti T, 2012, CURR NEUROVASC RES; Lalloo AK, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-16; Lameire N, 2011, ACTA CLIN BELG, V66, P337, DOI 10.2143/ACB.66.5.2062585; Lash LH, 2005, TOXICOL APPL PHARM, V204, P329, DOI 10.1016/j.taap.2004.10.004; Lash LH, 1995, TOXICOLOGY, V103, P167, DOI 10.1016/S0300-483X(95)03137-5; Laupeze B, 2001, LIFE SCI, V68, P1323, DOI 10.1016/S0024-3205(00)01026-2; Mahmoud MF, 2012, FOOD CHEM TOXICOL C, V51C, P114; Michea L, 2000, AM J PHYSIOL-RENAL, V278, pF209, DOI 10.1152/ajprenal.2000.278.2.F209; MONTROSERAFIZADEH C, 1990, ANNU REV PHYSIOL, V52, P761; Mori T, 2004, HYPERTENSION, V43, P341, DOI 10.1161/01.HYP.0000113295.31481.36; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Mueller CFH, 2008, CIRCULATION, V117, P2912, DOI 10.1161/CIRCULATIONAHA.107.747667; O'Connor R, 2007, ANTICANCER RES, V27, P1267; Peng KC, 1999, J HISTOCHEM CYTOCHEM, V47, P757, DOI 10.1177/002215549904700605; Perazella MA, 2010, SEMIN NEPHROL, V30, P570, DOI 10.1016/j.semnephrol.2010.09.005; Quezada C, 2011, BIOL CHEM, V392, P529, DOI 10.1515/BC.2011.052; ROTH MG, 1987, J CELL BIOL, V104, P769, DOI 10.1083/jcb.104.3.769; Rothnie A, 2006, J BIOL CHEM, V281, P13906, DOI 10.1074/jbc.M600869200; SAIER MH, 1981, AM J PHYSIOL, V240, pC106, DOI 10.1152/ajpcell.1981.240.3.C106; Santos BC, 2003, AM J PHYSIOL-RENAL, V284, pF564, DOI 10.1152/ajprenal.00058.2002; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Staud F, 2010, METHODS MOL BIOL, V596, P199, DOI 10.1007/978-1-60761-416-6_10; Tian W, 2001, AM J PHYSIOL-RENAL, V281, pF983, DOI 10.1152/ajprenal.0358.2000; TORRES AM, 1987, CAN J PHYSIOL PHARM, V65, P1461, DOI 10.1139/y87-229; TORRES AM, 1989, J PHARMACOL EXP THER, V250, P247; Valente RC, 2007, CELL BIOL TOXICOL, V23, P421, DOI 10.1007/s10565-007-9004-3; Valente RC, 2008, PFLUG ARCH EUR J PHY, V456, P359, DOI 10.1007/s00424-007-0397-x; Valentich J D, 1981, Ann N Y Acad Sci, V372, P384, DOI 10.1111/j.1749-6632.1981.tb15490.x; WHITAKER AM, 1985, DEV BIOL STAND, V60, P125; Widder JD, 2007, ARTERIOSCL THROM VAS, V27, P762, DOI 10.1161/01.ATV.0000259298.11129.a2; Wijnholds J, 1998, J EXP MED, V188, P797, DOI 10.1084/jem.188.5.797; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Yamane Y, 1998, J BIOL CHEM, V273, P31075, DOI 10.1074/jbc.273.47.31075; Zhang DX, 2010, FUTURE ONCOL, V6, P527, DOI [10.2217/fon.10.21, 10.2217/FON.10.21]; Zhang Z, 2000, AM J PHYSIOL-RENAL, V279, pF345, DOI 10.1152/ajprenal.2000.279.2.F345; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101; Zhou XM, 2005, AM J PHYSIOL-RENAL, V289, pF377, DOI 10.1152/ajprenal.00463.2004	62	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68049	10.1371/journal.pone.0068049	http://dx.doi.org/10.1371/journal.pone.0068049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840808	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400157
J	Zhang, Y; Liu, HY; Wang, LH; Yang, F; Hu, YF; Ren, XW; Li, GJ; Yu, Y; Sun, SX; Li, YF; Chen, XC; Li, XW; Jin, Q				Zhang, Yan; Liu, Haiying; Wang, Linghang; Yang, Fan; Hu, Yongfeng; Ren, Xianwen; Li, Guojun; Yu, Yang; Sun, Shaoxia; Li, Yufen; Chen, Xinchun; Li, Xingwang; Jin, Qi			Comparative Study of the Cytokine/Chemokine Response in Children with Differing Disease Severity in Enterovirus 71-Induced Hand, Foot, and Mouth Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN-STEM ENCEPHALITIS; PULMONARY-EDEMA; B-CELLS; IL-23; INFECTIONS; IMMUNITY; MICE; IDENTIFICATION; CYTOKINES	Background: Enterovirus 71 (EV71) infection can lead to a rapidly progressing, life-threatening, and severe neurological disease in young children, including the development of human hand, foot, and mouth disease (HFMD). This study aims to further characterize the specific immunological features in EV71-mediated HFMD patients presenting with differing degrees of disease severity. Methodology: Comprehensive cytokine and chemokine expression were broadly evaluated by cytokine antibody array in EV71-infected patients hospitalized for HFMD compared to Coxsackievirus A16-infected patients and age-matched healthy controls. More detailed analysis using Luminex-based cytokine bead array was performed in EV71-infected patients stratified into diverse clinic outcomes. Additionally, immune cell frequencies in peripheral blood and EV71-specific antibodies in plasma were also examined. Principal Findings: Expression of several cytokines and chemokines were significantly increased in plasma from EV71-infected patients compared to healthy controls, which further indicated that: (1) GM-CSF, MIP-1b, IL-2, IL-33, and IL-23 secretion was elevated in patients who rapidly developed disease and presented with uncomplicated neurological damage; (2) G-CSF and MCP-1 were distinguishably secreted in EV71 infected very severe patients presenting with acute respiratory failure; (3) IP-10, MCP-1, IL-6, IL-8, and G-CSF levels were much higher in cerebrospinal fluid than in plasma from patients with neurological damage; (4) FACS analysis revealed that the frequency of CD19+ HLADR+ mature B cells dynamically changed over time during the course of hospitalization and was accompanied by dramatically increased EV71-specific antibodies. Our data provide a panoramic view of specific immune mediator and cellular immune responses of HFMD and may provide useful immunological profiles for monitoring the progress of EV71-induced fatal neurological symptoms with acute respiratory failure.	[Zhang, Yan; Liu, Haiying; Yang, Fan; Hu, Yongfeng; Ren, Xianwen; Li, Guojun; Yu, Yang; Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Zhang, Yan; Liu, Haiying; Yang, Fan; Hu, Yongfeng; Ren, Xianwen; Li, Guojun; Yu, Yang; Jin, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Linghang; Li, Xingwang] Beijing Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Sun, Shaoxia; Li, Yufen] LinYi Peoples Hosp, Dept Paediat, Lin Yi, Shan Dong Provi, Peoples R China; [Chen, Xinchun] Shenzhen Third Peoples Hosp, Guangdong Med Coll, Shenzhen Hong Kong Inst Infect Dis, Shenzhen, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Guangdong Medical University	Li, XW (corresponding author), Beijing Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	ditanlxw@yahoo.com.cn; zdsys@vip.sina.com			National Basic Research Program from the Ministry of Science and Technology of China [2011CB504903, 2010CB534003]; Eleven-Fifth Mega-Scientific Project on infectious diseases, China [2009ZX10004-016]	National Basic Research Program from the Ministry of Science and Technology of China; Eleven-Fifth Mega-Scientific Project on infectious diseases, China	This work is supported by the National Basic Research Program from the Ministry of Science and Technology of China (Grant No. 2011CB504903,2010CB534003), and Eleven-Fifth Mega-Scientific Project on infectious diseases, China (2009ZX10004-016). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; [Anonymous], 1998, MMWR MORB MORTAL WKL, V47, P629; Belladonna ML, 2002, J IMMUNOL, V168, P5448, DOI 10.4049/jimmunol.168.11.5448; BLOMBERG J, 1974, LANCET, V2, P112; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; Fowlkes AL, 2008, J INFECT DIS, V198, P1685, DOI 10.1086/592988; Franciotta D, 2001, J NEUROIMMUNOL, V115, P192, DOI 10.1016/S0165-5728(01)00261-2; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Happel KI, 2005, INFECT IMMUN, V73, P5782, DOI 10.1128/IAI.73.9.5782-5788.2005; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; Kim B, 2008, MICROBES INFECT, V10, P302, DOI 10.1016/j.micinf.2007.12.007; LANIER LL, 1983, J IMMUNOL, V131, P1789; Liew FY, NAT REV IMMUNOL, V10, P103; Lo CH, 2003, J IMMUNOL, V171, P600, DOI 10.4049/jimmunol.171.2.600; MAMULA MJ, 1993, IMMUNOL TODAY, V14, P151, DOI 10.1016/0167-5699(93)90274-O; MELNICK JL, 1984, REV INFECT DIS, V6, pS387; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; Puneet P, 2005, AM J PHYSIOL-LUNG C, V288, pL3, DOI 10.1152/ajplung.00405.2003; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Siawaya JFD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002535; SMITH DE, 2009, CLIN EXP ALLERGY; Wang LC, 2012, CLIN DEV IMMUNOL, P1, DOI 10.1155/2012/580696; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wu TC, 2007, J VIROL, V81, P10310, DOI 10.1128/JVI.00372-07; Wu ZQ, 2009, J VIROL METHODS, V159, P233, DOI 10.1016/j.jviromet.2009.04.002; Xie J, 2010, SCAND J INFECT DIS, V42, P931, DOI 10.3109/00365548.2010.498018; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508	38	34	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67430	10.1371/journal.pone.0067430	http://dx.doi.org/10.1371/journal.pone.0067430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840697	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400079
J	Talebizadeh, Z; Arking, DE; Hu, VW				Talebizadeh, Zohreh; Arking, Dan E.; Hu, Valerie W.			A Novel Stratification Method in Linkage Studies to Address Inter- and Intra-Family Heterogeneity in Autism	PLOS ONE			English	Article							DIAGNOSTIC INTERVIEW; SPECTRUM DISORDER; LANGUAGE-SKILLS; GENOME SCAN; GENE; ASSOCIATION; LOCI; CHROMOSOME-2; IDENTIFICATION; ENGRAILED-2	Most genome linkage scans for autism spectrum disorders (ASDs) have failed to be replicated. Recently, a new ASD phenotypic sub-classification method was developed which employed cluster analyses of severity scores from the Autism Diagnostic Interview-Revised (ADI-R). Here, we performed linkage analysis for each of the four identified ADI-R stratified subgroups. Additional stratification was also applied to reduce intra-family heterogeneity and to investigate the impact of gender. For the purpose of replication, two independent sets of single nucleotide polymorphism markers for 392 families were used in our study. This deep subject stratification protocol resulted in 16 distinct group-specific datasets for linkage analysis. No locus reached significance for the combined non-stratified cohort. However, study-wide significant (P = 0.02) linkage scores were reached for chromosomes 22q11 (LOD = 4.43) and 13q21 (LOD = 4.37) for two subsets representing the most severely language impaired individuals with ASD. Notably, 13q21 has been previously linked to autism with language impairment, and 22q11 has been separately associated with either autism or language disorders. Linkage analysis on chromosome 5p15 for a combination of two stratified female-containing subgroups demonstrated suggestive linkage (LOD = 3.5), which replicates previous linkage result for female-containing pedigrees. A trend was also found for the association of previously reported 5p14-p15 SNPs in the same female-containing cohort. This study demonstrates a novel and effective method to address the heterogeneity in genetic studies of ASD. Moreover, the linkage results for the stratified subgroups provide evidence at the gene scan level for both inter- and intra-family heterogeneity as well as for gender-specific loci.	[Talebizadeh, Zohreh] Childrens Mercy Hosp & Clin, Kansas City, MO USA; [Talebizadeh, Zohreh] Univ Missouri, Kansas City, MO 64110 USA; [Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Hu, Valerie W.] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Johns Hopkins University; George Washington University	Talebizadeh, Z (corresponding author), Childrens Mercy Hosp & Clin, Kansas City, MO USA.	ztalebi@cmh.edu		Hu, Valerie/0000-0002-3357-0777	Children's Mercy Hospital; Autism Speaks [AS1991]; Simons Foundation [SFARI 221192, SFARI 137603]; LIFE Foundation; National Institutes of Health (ACE Genetics Consortium) [MH081754, MH60007]; National Institute of Mental Health [1U24MH081810]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100027, U24MH081810] Funding Source: NIH RePORTER	Children's Mercy Hospital; Autism Speaks; Simons Foundation; LIFE Foundation; National Institutes of Health (ACE Genetics Consortium); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was not directly supported by particular funds; however, the authors' efforts have been partially supported by the followings: Children's Mercy Hospital intramural fund to ZT and Autism Speaks (AS1991 to ZT), the Simons Foundation (SFARI 221192 to VWH), and a LIFE Foundation gift to VWH. DEA's contribution was supported by grants from the Simons Foundation (SFARI 137603 to DEA.) and the National Institutes of Health (ACE Genetics Consortium, MH081754 and MH60007). The authors gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium and the participating AGRE families. The Autism Genetic Resource Exchange is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). The funders had no a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2005, MOL PSYCHIATR, V10, P747, DOI 10.1038/sj.mp.4001666; Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Bartlett CW, 2004, HUM HERED, V57, P10, DOI 10.1159/000077385; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Chen YZ, 2012, AM J MED GENET B, V159B, P61, DOI 10.1002/ajmg.b.32002; Coon H, 2005, HUM HERED, V60, P220, DOI 10.1159/000090546; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Gharani N, 2004, MOL PSYCHIATR, V9, P474, DOI 10.1038/sj.mp.4001498; Glaser B, 2002, J PEDIATR-US, V140, P753, DOI 10.1067/mpd.2002.124774; Hiramoto T, 2011, HUM MOL GENET, V20, P4775, DOI 10.1093/hmg/ddr404; Hu VW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019067; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Kerin T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003479; Kilpinen H, 2009, HUM MOL GENET, V18, P2912, DOI 10.1093/hmg/ddp229; Krug A, 2009, EUR ARCH PSY CLIN N, V259, P459, DOI 10.1007/s00406-009-0010-8; Li H, 2008, AM J MED GENET B, V147B, P194, DOI 10.1002/ajmg.b.30584; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Ma DQ, 2007, MOL PSYCHIATR, V12, P376, DOI 10.1038/sj.mp.4001927; Meechan DW, 2009, P NATL ACAD SCI USA, V106, P16434, DOI 10.1073/pnas.0905696106; Monaco AP, 2001, LANCET, pS3; Palferman S, 2001, AM J HUM GENET, V69, P570; Paylor R, 2006, BIOL PSYCHIAT, V59, P1172, DOI 10.1016/j.biopsych.2006.01.018; Pebrel-Richard C, 2012, EUR J MED GENET, V55, P650, DOI 10.1016/j.ejmg.2012.06.014; Persson C, 2006, INT J LANG COMM DIS, V41, P313, DOI 10.1080/13682820500361497; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Santarelli R, 2010, GENOME MED, V2, DOI 10.1186/gm212; Schellenberg GD, 2006, MOL PSYCHIATR, V11, P1049, DOI 10.1038/sj.mp.4001874; Sen S S, 2009, GENES BRAIN BEHAV, V9, P248; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Vorstman JAS, 2011, MOL PSYCHIATR, V16, P442, DOI 10.1038/mp.2010.26; Waga C, 2011, PSYCHIAT GENET, V21, P208, DOI 10.1097/YPG.0b013e328341e069; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang LF, 2008, AM J MED GENET B, V147B, P434, DOI 10.1002/ajmg.b.30623; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490	41	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67569	10.1371/journal.pone.0067569	http://dx.doi.org/10.1371/journal.pone.0067569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840741	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400111
J	Shi, J; Wang, YL; Ceschin, R; An, X; Lao, Y; Vanderbilt, D; Nelson, MD; Thompson, PM; Panigrahy, A; Lepore, N				Shi, Jie; Wang, Yalin; Ceschin, Rafael; An, Xing; Lao, Yi; Vanderbilt, Douglas; Nelson, Marvin D.; Thompson, Paul M.; Panigrahy, Ashok; Lepore, Natasha			A Multivariate Surface-Based Analysis of the Putamen in Premature Newborns: Regional Differences within the Ventral Striatum	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; CHILDREN BORN PRETERM; HUMAN BASAL GANGLIA; PERIVENTRICULAR LEUKOMALACIA; INFANTS; BIRTH; ENCEPHALOPATHY; SEGMENTATION; HIPPOCAMPAL; MORPHOMETRY	Many children born preterm exhibit frontal executive dysfunction, behavioral problems including attentional deficit/hyperactivity disorder and attention related learning disabilities. Anomalies in regional specificity of cortico-striato-thalamocortical circuits may underlie deficits in these disorders. Nonspecific volumetric deficits of striatal structures have been documented in these subjects, but little is known about surface deformation in these structures. For the first time, here we found regional surface morphological differences in the preterm neonatal ventral striatum. We performed regional group comparisons of the surface anatomy of the striatum (putamen and globus pallidus) between 17 preterm and 19 term-born neonates at term-equivalent age. We reconstructed striatal surfaces from manually segmented brain magnetic resonance images and analyzed them using our in-house conformal mapping program. All surfaces were registered to a template with a new surface fluid registration method. Vertex-based statistical comparisons between the two groups were performed via four methods: univariate and multivariate tensor-based morphometry, the commonly used medial axis distance, and a combination of the last two statistics. We found statistically significant differences in regional morphology between the two groups that are consistent across statistics, but more extensive for multivariate measures. Differences were localized to the ventral aspect of the striatum. In particular, we found abnormalities in the preterm anterior/inferior putamen, which is interconnected with the medial orbital/prefrontal cortex and the midline thalamic nuclei including the medial dorsal nucleus and pulvinar. These findings support the hypothesis that the ventral striatum is vulnerable, within the cortico-stiato-thalamocortical neural circuitry, which may underlie the risk for long-term development of frontal executive dysfunction, attention deficit hyperactivity disorder and attention-related learning disabilities in preterm neonates.	[Shi, Jie; Wang, Yalin; An, Xing] Arizona State Univ, Sch Comp Informat Decis Syst & Engn, Tempe, AZ USA; [Ceschin, Rafael; Panigrahy, Ashok] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA USA; [Lao, Yi; Nelson, Marvin D.; Panigrahy, Ashok; Lepore, Natasha] Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA; [Lao, Yi; Lepore, Natasha] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Vanderbilt, Douglas] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Vanderbilt, Douglas] Childrens Hosp Los Angeles, Dev Behav Pediat Fellowship Program, Los Angeles, CA 90027 USA; [Nelson, Marvin D.; Lepore, Natasha] Univ So Calif, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] Univ Calif Los Angeles, Sch Med, Imaging Genet Ctr, Lab Neuro Imaging, Los Angeles, CA USA	Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Los Angeles; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lepore, N (corresponding author), Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA.	nlepore@chla.usc.edu	Gan, Zhaofeng/L-1015-2017; Shi, Jie/D-1147-2017; Thompson, Paul M/C-4194-2018	Shi, Jie/0000-0002-9095-0557; Thompson, Paul M/0000-0002-4720-8867; Ceschin, Rafael/0000-0002-3715-9627; Wang, Yalin/0000-0002-6241-735X	NIH [K23NS063371, R21EB012177]; NIH/NCRR/NCATS SC CTSI grant [UL1 RR031986]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB012177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS063371] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR/NCATS SC CTSI grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH funds K23NS063371 and NIH/NCRR/NCATS SC CTSI grant Number UL1 RR031986 to Ashok Panigrahy and NIH grant R21EB012177 awarded to NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy LJ, 2004, PEDIATR RES, V55, P884, DOI 10.1203/01.PDR.0000117843.21534.49; Aris R., 1999, VECTORS TENSORS BASI; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biederman J, 2008, J AM ACAD CHILD PSY, V47, P426, DOI 10.1097/CHI.0b013e31816429d3; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Boardman JP, 2006, NEUROIMAGE, V32, P70, DOI 10.1016/j.neuroimage.2006.03.029; Cauda F, 2011, J COGNITIVE NEUROSCI, V23, P2864, DOI 10.1162/jocn.2011.21624; Davatzikos C, 1996, J COMPUT ASSIST TOMO, V20, P656, DOI 10.1097/00004728-199607000-00031; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Lepore N, 2008, IEEE T MED IMAGING, V27, P129, DOI 10.1109/TMI.2007.906091; Ligam P, 2009, PEDIATR RES, V65, P524, DOI 10.1203/PDR.0b013e3181998baf; Lou HC, 1996, ACTA PAEDIATR, V85, P1266, DOI 10.1111/j.1651-2227.1996.tb13909.x; Mercuri E, 1997, ARCH DIS CHILD-FETAL, V77, pF111, DOI 10.1136/fn.77.2.F111; Morel A, 2002, J COMP NEUROL, V443, P86, DOI 10.1002/cne.10096; Nagasunder AC, 2011, AM J NEURORADIOL, V32, P185, DOI 10.3174/ajnr.A2243; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nosarti C, 2009, NEUROIMAGE, V47, P1904, DOI 10.1016/j.neuroimage.2009.04.041; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Pizer SM, 1999, IEEE T MED IMAGING, V18, P851, DOI 10.1109/42.811263; Powell KB, 2004, J CHILD NEUROL, V19, P785, DOI 10.1177/08830738040190100801; Presna L, 2003, J COMP NEUROL, V460, P345; Shi J, 2012, SURFACE UID REGISTRA; Shi J., 2013, NEUROIMAGE IN PRESS; Sobel LJ, 2010, AM J PSYCHIAT, V167, P977, DOI 10.1176/appi.ajp.2010.09091259; Stam J, 2003, P SIGGRAPH, P724; TE Nichols, 2009, HUM BRAIN MAPP, V25, P1; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; van de Weijer-Bergsma EV, 2008, INFANT BEHAV DEV, V31, P333, DOI 10.1016/j.infbeh.2007.12.003; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wang Y., 2011, NEUROIMAGE, V56, P1993; Wang Y., 2011, P MICCAI WORKSH IM A; Wang YL, 2007, IEEE T MED IMAGING, V26, P853, DOI 10.1109/TMI.2007.895464; Wang YL, 2010, NEUROIMAGE, V49, P2141, DOI 10.1016/j.neuroimage.2009.10.086; Y Wang, 2012, MICCAI WORKSH PER PA; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	45	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66736	10.1371/journal.pone.0066736	http://dx.doi.org/10.1371/journal.pone.0066736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843961	Green Accepted, Green Published, gold			2022-12-27	WOS:000321733000050
J	Hwang, YS; Chiang, PR; Hong, WH; Chiao, CC; Chu, IM; Hsiue, GH; Shen, CR				Hwang, Yih-Shiou; Chiang, Ping-Ray; Hong, Wei-Hsin; Chiao, Chuan-Chin; Chu, I-Ming; Hsiue, Ging-Ho; Shen, Chia-Rui			Study In Vivo Intraocular Biocompatibility of In Situ Gelation Hydrogels: Poly(2-Ethyl Oxazoline)-Block-Poly(epsilon-Caprolactone)-Block-Poly(2-Ethyl Oxazoline) Copolymer, Matrigel and Pluronic F127	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; DIBLOCK COPOLYMER; RELEASE; NEOVASCULARIZATION; VITRO; CYTOTOXICITY; RANIBIZUMAB; TRIBLOCK; BEHAVIOR	The long term in vivo biocompatibility is an essential feature for the design and development of sustained drug release carriers. In the recent intraocular drug delivery studies, hydrogels were suggested as sustained release carriers. The biocompatibility test for these hydrogels, however, was commonly performed only through in vitro cell culture examination, which is insufficient before the clinical applications. We compared three thermosensitive hydrogels that have been suggested as the carriers for drugs by their gel-solution phase-change properties. A new block terpolymer (PEOz-PCL-PEOz, ECE) and two commercial products (Matrigel (R) and Pluronic F127) were studied. The results demonstrated that the ocular media remained translucent for ECE and Pluronic F127 in the first 2 weeks, but cataract formation for Matrigel occurred in 2 weeks and for Pluronic F127 in 1 month, while turbid media was observed for both Matrigel and Pluronic F127 in 2 months. The electrophysiology examinations showed significant neuroretinal toxicity of Matrigel and Pluronic F127 but good biocompatibility of ECE. The neuroretinal toxicity of Matrigel and Pluronic F127 and superior biocompatibility of ECE hydrogel suggests ECE as more appropriate biomaterial for use in research and potentially in intraocular application.	[Hwang, Yih-Shiou] Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan; [Hwang, Yih-Shiou] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chiang, Ping-Ray; Chu, I-Ming; Hsiue, Ging-Ho] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu, Taiwan; [Hong, Wei-Hsin; Shen, Chia-Rui] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Chiao, Chuan-Chin] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Hsiue, Ging-Ho] Chung Yuan Christian Univ, Dept Chem Engn, R&D Ctr Membrane Technol, Chungli, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Tsing Hua University; Chang Gung University; National Tsing Hua University; Chung Yuan Christian University	Shen, CR (corresponding author), Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan.	crshen@mail.cgu.edu.tw	Chiao, Chuan-Chin/L-7708-2019; Chu, I-Ming/AAL-1148-2021	Shen, Chia-Rui/0000-0002-8386-3965	National Science Council of the Republic of China, Taiwan [NSC 98-2622-E-033-011-CC1, NSC 99-2622-E-033-005-CC1, 101-2320-B-182-027-MY3]; Chang Gung Memorial Hospital funds [CMRPG 390311, CMRPG 380181, CMRPD180403, BMRP440]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital funds	This work was supported by the funding from the National Science Council of the Republic of China, Taiwan (NSC 98-2622-E-033-011-CC1, NSC 99-2622-E-033-005-CC1 and 101-2320-B-182-027-MY3), and the Chang Gung Memorial Hospital funds (CMRPG 390311, CMRPG 380181, CMRPD180403 and BMRP440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s; Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019; Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033; Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067; DAVIDORF FH, 1990, RETINA-J RET VIT DIS, V10, P297, DOI 10.1097/00006982-199010000-00013; Deng JJ, 2011, SOFT MATTER, V7, P5944, DOI 10.1039/c1sm05259d; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Gong J, 2008, EXP EYE RES, V86, P957, DOI 10.1016/j.exer.2008.03.014; Gu ZY, 2004, MACROMOLECULES, V37, P912, DOI 10.1021/ma0206218; Hsiue GH, 2006, INT J PHARM, V317, P69, DOI 10.1016/j.ijpharm.2006.03.002; Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060991u; Kang Derwent J. J., 2008, T AM OPHTHAL SOC, V106, P206; Khattak SF, 2005, TISSUE ENG, V11, P974, DOI 10.1089/ten.2005.11.974; Kibbey Maura C., 1994, Journal of Tissue Culture Methods, V16, P227, DOI 10.1007/BF01540656; Kitahara S, 2010, MED MOL MORPHOL, V43, P26, DOI 10.1007/s00795-009-0481-8; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139; Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8; Kwon JW, 2005, J CATARACT REFR SURG, V31, P607, DOI 10.1016/j.jcrs.2004.05.051; Lee SC, 1999, MACROMOLECULES, V32, P1847, DOI 10.1021/ma981664k; Luxenhofer R, 2011, J CONTROL RELEASE, V153, P73, DOI 10.1016/j.jconrel.2011.04.010; Marashi SM, 2011, J ALLERGY CLIN IMMUN, V127, P1385, DOI 10.1016/j.jaci.2011.04.001; Matthew JE, 2002, BIOMATERIALS, V23, P4615, DOI 10.1016/S0142-9612(02)00208-9; Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K; Misra GP, 2009, BIOMATERIALS, V30, P6541, DOI 10.1016/j.biomaterials.2009.08.025; Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Peng K, 2010, SOFT MATTER, V6, P85, DOI 10.1039/b914166a; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Qiu G, 2006, EXP EYE RES, V83, P141, DOI 10.1016/j.exer.2005.11.014; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schlaad H, 2010, MACROMOL RAPID COMM, V31, P511, DOI 10.1002/marc.200900683; Shen DF, 2006, OPHTHALMIC RES, V38, P71, DOI 10.1159/000090266; Shen WY, 2000, GRAEF ARCH CLIN EXP, V238, P273, DOI 10.1007/s004170050353; Shishido SM, 2003, BIOMATERIALS, V24, P3543, DOI 10.1016/S0142-9612(03)00153-4; Sonoda A, 2010, CARDIOVASC INTER RAD, V33, P135, DOI 10.1007/s00270-009-9741-1; Sun L, 2010, J POLYM SCI POL CHEM, V48, P4583, DOI 10.1002/pola.24255; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058; Turturro SB, 2011, BIOMATERIALS, V32, P3620, DOI 10.1016/j.biomaterials.2011.01.058; Wang CH, 2012, BIOMACROMOLECULES, V13, P40, DOI 10.1021/bm2009558; Wolinsky JB, 2007, MACROMOLECULES, V40, P7065, DOI 10.1021/ma071276v; Zhong X, 2011, J MATER SCI-MATER M, P1	45	23	28	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67495	10.1371/journal.pone.0067495	http://dx.doi.org/10.1371/journal.pone.0067495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840873	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900012
J	Longoria, RA; Shubeita, GT				Longoria, Rafael A.; Shubeita, George T.			Cargo Transport by Cytoplasmic Dynein Can Center Embryonic Centrosomes	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS EMBRYO; TUG-OF-WAR; BIDIRECTIONAL TRANSPORT; PRONUCLEAR MIGRATION; DYNAMIC MICROTUBULES; PULLING FORCES; COPY NUMBER; CELL FIND; IN-VIVO; MECHANISM	To complete meiosis II in animal cells, the male DNA material needs to meet the female DNA material contained in the female pronucleus at the egg center, but it is not known how the male pronucleus, deposited by the sperm at the periphery of the cell, finds the cell center in large eggs. Pronucleus centering is an active process that appears to involve microtubules and molecular motors. For small and medium-sized cells, the force required to move the centrosome can arise from either microtubule pushing on the cortex, or cortically-attached dynein pulling on microtubules. However, in large cells, such as the fertilized Xenopus laevis embryo, where microtubules are too long to support pushing forces or they do not reach all boundaries before centrosome centering begins, a different force generating mechanism must exist. Here, we present a centrosome positioning model in which the cytosolic drag experienced by cargoes hauled by cytoplasmic dynein on the sperm aster microtubules can move the centrosome towards the cell's center. We find that small, fast cargoes (diameter similar to 100 nm, cargo velocity similar to 2 mu m/s) are sufficient to move the centrosome in the geometry of the Xenopus laevis embryo within the experimentally observed length and time scales.	[Longoria, Rafael A.; Shubeita, George T.] Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA; [Longoria, Rafael A.; Shubeita, George T.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Shubeita, George T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Shubeita, GT (corresponding author), Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA.	Shubeita@chaos.utexas.edu			National Science Foundation [PHY-0957811]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the National Science Foundation grant PHY-0957811 to GTS. (www.nsf.gov) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amrute-Nayak M, 2012, NAT CELL BIOL, V14, P416, DOI 10.1038/ncb2446; BATCHELOR GK, 1970, J FLUID MECH, V44, P419, DOI 10.1017/S002211207000191X; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Cox R. G., 1970, Journal of Fluid Mechanics, V44, P791, DOI 10.1017/S002211207000215X; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Feneberg W, 2001, EUR BIOPHYS J BIOPHY, V30, P284, DOI 10.1007/s002490100135; Gennerich A, 2006, PHYS BIOL, V3, P45, DOI 10.1088/1478-3975/3/1/005; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; HAMAGUCHI MS, 1986, DEV GROWTH DIFFER, V28, P143, DOI 10.1111/j.1440-169x.1986.00143.x; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; Kimura A, 2005, DEV CELL, V8, P765, DOI 10.1016/j.devcel.2005.03.007; Kimura Kenji, 2011, Bioarchitecture, V1, P74; Kimura K, 2011, P NATL ACAD SCI USA, V108, P137, DOI 10.1073/pnas.1013275108; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kunwar A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016012; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Laurent VM, 2003, BIORHEOLOGY, V40, P235; Leidel C, 2012, BIOPHYS J, V103, P492, DOI 10.1016/j.bpj.2012.06.038; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Marion S, 2005, EUR BIOPHYS J BIOPHY, V34, P262, DOI 10.1007/s00249-004-0449-5; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Reinsch S, 1998, J CELL SCI, V111, P2283; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Shinar T, 2011, P NATL ACAD SCI USA, V108, P10508, DOI 10.1073/pnas.1017369108; Shubeita GT, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P287, DOI 10.1016/B978-0-12-374920-8.00418-5; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Sims PA, 2009, CHEMPHYSCHEM, V10, P1511, DOI 10.1002/cphc.200900113; Singh MP, 2005, P NATL ACAD SCI USA, V102, P12059, DOI 10.1073/pnas.0501570102; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tolic-Norrelykke IM, 2004, CURR BIOL, V14, P1181, DOI 10.1016/j.cub.2004.06.029; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Vallee RB, 2005, TRENDS CELL BIOL, V15, P288, DOI 10.1016/j.tcb.2005.04.005; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wu J, 2011, MOL BIOL CELL, V22, P4834, DOI 10.1091/mbc.E11-07-0611; Wuhr M, 2009, CELL CYCLE, V8, P1115; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024; Zhu J, 2010, MOL BIOL CELL, V21, P4418, DOI 10.1091/mbc.E10-07-0627	45	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67710	10.1371/journal.pone.0067710	http://dx.doi.org/10.1371/journal.pone.0067710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840877	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900016
J	Braun, SR; Gregor, B; Tran, US				Braun, Sarah R.; Gregor, Bettina; Tran, Ulrich S.			Comparing Bona Fide Psychotherapies of Depression in Adults with Two Meta-Analytical Approaches	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; 2ND-GENERATION ANTIDEPRESSANTS; PSYCHOLOGICAL TREATMENTS; UNIPOLAR DEPRESSION; METAANALYSIS; EFFICACY; DISORDERS; ANXIETY; ALLEGIANCE; MEDIATORS	Objective: Despite numerous investigations, the question whether all bona fide treatments of depression are equally efficacious in adults has not been sufficiently answered. Method: We applied two different meta-analytical techniques (conventional meta-analysis and mixed treatment comparisons). Overall, 53 studies with 3,965 patients, which directly compared two or more bona fide psychotherapies in a randomized trial, were included. Meta-analyses were conducted regarding five different types of outcome measures. Additionally, the influence of possible moderators was examined. Results: Direct comparisons of cognitive behavior therapy, behavior activation therapy, psychodynamic therapy, interpersonal therapy, and supportive therapies versus all other respective treatments indicated that at the end of treatment all treatments but supportive therapies were equally efficacious whereas there was some evidence that supportive therapies were somewhat less efficacious than all other treatments according to patient self-ratings and clinical significance. At follow-up no significant differences were present. Age, gender, comorbid mental disorders, and length of therapy session were found to moderate efficacy. Cognitive behavior therapy was superior in studies where therapy sessions lasted 90 minutes or longer, behavior activation therapy was more efficacious when therapy sessions lasted less than 90 minutes. Mixed treatment comparisons indicated no statistically significant differences in treatment efficacy but some interesting trends. Conclusions: This study suggests that there might be differential effects of bona fide psychotherapies which should be examined in detail.	[Braun, Sarah R.; Gregor, Bettina; Tran, Ulrich S.] Univ Vienna, Vienna, Austria	University of Vienna	Tran, US (corresponding author), Univ Vienna, Vienna, Austria.	ulrich.tran@univie.ac.at		Tran, Ulrich/0000-0002-6589-3167				Aderka IM, 2012, J CONSULT CLIN PSYCH, V80, P93, DOI 10.1037/a0026455; Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Baardseth TP, 2013, CLIN PSYCHOL REV, V33, P395, DOI 10.1016/j.cpr.2013.01.004; Barbui C, 2004, J CLIN PSYCHOPHARM, V24, P126, DOI 10.1097/01.jcp.0000115665.45074.0d; Beck A, 1979, COGNITIVE THERAPY DE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkeljon A, 2009, PSYCHOTHER RES, V19, P511, DOI 10.1080/10503300802621172; Berman JS, 2010, EUR J PSYCHOTHER COU, V12, P11, DOI 10.1080/13642531003637775; Borenstein M, 2009, INTRO META ANAL; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cuijpers P, 2008, PSYCHOTHER RES, V18, P225, DOI 10.1080/10503300701442027; Cuijpers P, 2010, CLIN PSYCHOL REV, V30, P768, DOI 10.1016/j.cpr.2010.06.001; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; de Mello MF, 2005, EUR ARCH PSY CLIN N, V255, P75, DOI 10.1007/s00406-004-0542-x; DERUBEIS RJ, 1990, COGNITIVE THER RES, V14, P469, DOI 10.1007/BF01172968; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; DOBSON KS, 1989, J CONSULT CLIN PSYCH, V57, P414, DOI 10.1037/0022-006X.57.3.414; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Enns MW, 2000, J AFFECT DISORDERS, V60, P33, DOI 10.1016/S0165-0327(99)00156-1; Feng CY, 2012, WORLDV EVID-BASED NU, V9, P2, DOI 10.1111/j.1741-6787.2011.00229.x; Forand NR, 2011, COGNITIVE THER RES, V35, P151, DOI 10.1007/s10608-010-9348-5; GAFFAN EA, 1995, J CONSULT CLIN PSYCH, V63, P966, DOI 10.1037/0022-006X.63.6.966; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Gloaguen V, 1998, J AFFECT DISORDERS, V49, P59, DOI 10.1016/S0165-0327(97)00199-7; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hollon SD, 2010, DEPRESS ANXIETY, V27, P891, DOI 10.1002/da.20741; Imel ZE, 2008, J AFFECT DISORDERS, V110, P197, DOI 10.1016/j.jad.2008.03.018; Imel ZE, 2008, PSYCHOL ADDICT BEHAV, V22, P533, DOI 10.1037/a0013171; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; LUBORSKY L, 1975, ARCH GEN PSYCHIAT, V32, P995; Malouff JM, 2007, CLIN PSYCHOL REV, V27, P46, DOI 10.1016/j.cpr.2005.12.005; Miller S, 2008, PSYCHOTHER RES, V18, P5, DOI 10.1080/10503300701472131; Olatunji BO, 2010, CLIN PSYCHOL REV, V30, P642, DOI 10.1016/j.cpr.2010.04.008; Olatunji BO, 2010, PSYCHIAT CLIN N AM, V33, P557, DOI 10.1016/j.psc.2010.04.002; Porter JF, 2004, PROF PSYCHOL-RES PR, V35, P297, DOI 10.1037/0735-7028.35.3.297; Raffin AL, 2009, EUR PSYCHIAT, V24, P297, DOI 10.1016/j.eurpsy.2008.12.001; Riebe G, 2010, J INVEST MED, V58, P240; ROBINSON LA, 1990, PSYCHOL BULL, V108, P30, DOI 10.1037/0033-2909.108.1.30; Saito H, 2008, PSYCHOGERIATRICS, V8, P12, DOI 10.1111/j.1479-8301.2007.00216.x; Schneider D, 2008, PSYCHOTHER PSYCH MED, V58, P23, DOI 10.1055/s-2007-970946; Segrin C, 2000, CLIN PSYCHOL REV, V20, P379, DOI 10.1016/S0272-7358(98)00104-4; SHADISH WR, 1991, J CONSULT CLIN PSYCH, V59, P883, DOI 10.1037/0022-006X.59.6.883; Spielmans GI, 2011, J NERV MENT DIS, V199, P142, DOI 10.1097/NMD.0b013e31820caefb; STEINBRUECK SM, 1983, J CONSULT CLIN PSYCH, V51, P856, DOI 10.1037/0022-006X.51.6.856; Sutton AJAK, 2000, METHODS METAANALYSIS; Tolin DF, 2010, CLIN PSYCHOL REV, V30, P710, DOI 10.1016/j.cpr.2010.05.003; Trinquart L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035219; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wampold B., 2001, GREAT PSYCHOTHERAPY, P1; Wampold BE, 2002, J AFFECT DISORDERS, V68, P159, DOI 10.1016/S0165-0327(00)00287-1; Welton NJ, 2009, AM J EPIDEMIOL, V169, P1158, DOI 10.1093/aje/kwp014	55	29	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68135	10.1371/journal.pone.0068135	http://dx.doi.org/10.1371/journal.pone.0068135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840824	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400167
J	Geary, SM; Lemke, CD; Lubaroff, DM; Salem, AK				Geary, Sean M.; Lemke, Caitlin D.; Lubaroff, David M.; Salem, Aliasger K.			The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System	PLOS ONE			English	Article							T-CELL RESPONSES; SUPPRESSOR-CELLS; ANTITUMOR IMMUNITY; CANCER VACCINES; IMMUNOTHERAPY; CYCLOPHOSPHAMIDE; ANTIGEN; MICE; IMMUNIZATION; DOXORUBICIN	Standard cancer therapies, particularly those involving chemotherapy, are in need of modifications that both reduce short-term and long-term side effects as well as improve the overall survival of cancer patients. Here we show that combining low-dose chemotherapy with a therapeutic vaccination using an adenovirus encoding a model tumor-associated antigen, ovalbumin (Ad5-OVA), had a synergistic impact on survival in tumor-challenged mice. Mice that received the combinatorial treatment of Ad5-OVA plus low-dose 5-fluorouracil (5-FU) had a 95% survival rate compared to 7% and 30% survival rates for Ad5-OVA alone and 5-FU alone respectively. The presence of 5-FU enhanced the levels of OVA-specific CD8(+) T lymphocytes in the spleens and draining lymph nodes of Ad5-OVA-treated mice, a phenomenon that was dependent on the mice having been tumor-challenged. Thus 5-FU may have enhanced survival of Ad5-OVA-treated mice by enhancing the tumor-specific immune response combined with eliminating tumor bulk. We also investigated the possibility that the observed therapeutic benefit may have been derived from the capacity of 5-FU to deplete MDSC populations. The findings presented here promote the concept of combining adenoviral cancer vaccines with low-dose chemotherapy.	[Geary, Sean M.; Lemke, Caitlin D.; Salem, Aliasger K.] Univ Iowa, Coll Pharm, Div Pharmaceut, Iowa City, IA 52242 USA; [Lubaroff, David M.] Univ Iowa, Holden Comprehens Canc Ctr, Dept Urol, Iowa City, IA 52242 USA; [Lubaroff, David M.] Univ Iowa, Holden Comprehens Canc Ctr, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Salem, AK (corresponding author), Univ Iowa, Coll Pharm, Div Pharmaceut, Iowa City, IA 52242 USA.	aliasger-salem@uiowa.edu	Salem, Aliasger/J-3674-2012	Salem, Aliasger/0000-0002-1923-6633	American Cancer Society [RSG-09-015-01-CDD]; National Cancer Institute at the National Institutes of Health [1R21CA13345-01/1R21CA128414- 01A2/UI Mayo Clinic Lymphoma SPORE]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge support from the American Cancer Society (RSG-09-015-01-CDD), and the National Cancer Institute at the National Institutes of Health (1R21CA13345-01/1R21CA128414- 01A2/UI Mayo Clinic Lymphoma SPORE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato RJ, 2010, EXPERT OPIN BIOL TH, V10, P281, DOI 10.1517/14712590903586213; American Cancer Society, 2012, CANC FACTS FIG 2012; Antonia SJ, 2006, CLIN CANCER RES, V12, P878, DOI 10.1158/1078-0432.CCR-05-2013; ARDALAN B, 1992, INT J RADIAT ONCOL, V22, P511, DOI 10.1016/0360-3016(92)90864-E; Backus HHJ, 2001, ANN ONCOL, V12, P209, DOI 10.1023/A:1008331525368; Bass KK, 1998, CANCER IMMUNOL IMMUN, V47, P1, DOI 10.1007/s002620050498; Cheng C, 2007, PLOS PATHOG, V3, P239, DOI 10.1371/journal.ppat.0030025; Elzey BD, 2001, INT J CANCER, V94, P842, DOI 10.1002/ijc.1556; Emens LA, 2009, J CLIN ONCOL, V27, P5911, DOI 10.1200/JCO.2009.23.3494; Fridlender ZG, 2010, MOL THER, V18, P1947, DOI 10.1038/mt.2010.159; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Garnett CT, 2008, CLIN CANCER RES, V14, P3536, DOI 10.1158/1078-0432.CCR-07-4025; Geary SM, 2011, CANCER IMMUNOL IMMUN, V60, P1309, DOI 10.1007/s00262-011-1038-y; Hodge JW, 2012, SEMIN ONCOL, V39, P323, DOI 10.1053/j.seminoncol.2012.02.006; Karan D, 2007, INT J CANCER, V121, P1520, DOI 10.1002/ijc.22873; Kirkwood JM, 2008, J CLIN ONCOL, V26, P3445, DOI 10.1200/JCO.2007.14.6423; Ko HJ, 2007, CANCER RES, V67, P7477, DOI 10.1158/0008-5472.CAN-06-4639; Krishnamachari Y, 2011, PHARM RES-DORDR, V28, P215, DOI 10.1007/s11095-010-0241-4; Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lu P, 2005, SEMIN NUCL MED, V35, P197, DOI 10.1053/j.semnuclmed.2005.02.005; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Machiels JPH, 2001, CANCER RES, V61, P3689; MacLean GD, 1996, J IMMUNOTHER, V19, P309, DOI 10.1097/00002371-199607000-00006; Matsuzaki J, 2003, CELL IMMUNOL, V224, P98, DOI 10.1016/j.cellimm.2003.08.009; Mauti LA, 2011, J CLIN INVEST, V121, P2794, DOI 10.1172/JCI41936; Miller G, 2002, CANCER RES, V62, P5260; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Morales JK, 2009, CANCER IMMUNOL IMMUN, V58, P941, DOI 10.1007/s00262-008-0609-z; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Nowak AK, 2006, ADV DRUG DELIVER REV, V58, P975, DOI 10.1016/j.addr.2006.04.002; Ooboshi H, 1997, AM J PHYSIOL-HEART C, V273, pH265, DOI 10.1152/ajpheart.1997.273.1.H265; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Siemens DR, 2001, J IMMUNOL, V166, P731, DOI 10.4049/jimmunol.166.2.731; Sierro SR, 2011, EUR J IMMUNOL, V41, P2217, DOI 10.1002/eji.201041235; Srivastava MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040677; Tipton J. M., 2003, HDB CANC CHEMOTHERAP, P561; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	42	37	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67904	10.1371/journal.pone.0067904	http://dx.doi.org/10.1371/journal.pone.0067904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840786	gold, Green Published			2022-12-27	WOS:000321148400141
J	Hightower, GK; May, SJ; Perez-Santiago, J; Pacold, ME; Wagner, GA; Little, SJ; Richman, DD; Mehta, SR; Smith, DM; Pond, SLK				Hightower, George K.; May, Susanne J.; Perez-Santiago, Josue; Pacold, Mary E.; Wagner, Gabriel A.; Little, Susan J.; Richman, Douglas D.; Mehta, Sanjay R.; Smith, Davey M.; Pond, Sergei L. Kosakovsky			HIV-1 Clade B pol Evolution following Primary Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEOTIDE SUBSTITUTIONS; ANTIRETROVIRAL THERAPY; LIKELIHOOD APPROACH; DRUG-RESISTANCE; DUAL INFECTION; VIRAL LOAD; TRANSMISSION; GAG; SURVEILLANCE	Objective: Characterize intra-individual HIV-1 subtype B pol evolution in antiretroviral naive individuals. Design: Longitudinal cohort study of individuals enrolled during primary infection. Methods: Eligible individuals were antiretroviral naive participants enrolled in the cohort from December 1997-December 2005 and having at least two blood samples available with the first one collected within a year of their estimated date of infection. Population-based pol sequences were generated from collected blood samples and analyzed for genetic divergence over time in respect to dual infection status, HLA, CD4 count and viral load. Results: 93 participants were observed for a median of 1.8 years (Mean = 2.2 years, SD = 1.9 years). All participants classified as mono-infected had less than 0.7% divergence between any two of their pol sequences using the Tamura-Nei model (TN93), while individuals with dual infection had up to 7.0% divergence. The global substitution rates (substitutions/ nucleotide/year) for mono and dually infected individuals were significantly different (p<0.001); however, substitution rates were not associated with HLA haplotype, CD4 or viral load. Conclusions: Even after a maximum of almost 9 years of follow-up, all mono-infected participants had less than 1% divergence between baseline and longitudinal sequences, while participants with dual infection had 10 times greater divergence. These data support the use of HIV-1 pol sequence data to evaluate transmission events, networks and HIV-1 dual infection.	[Hightower, George K.; Perez-Santiago, Josue; Wagner, Gabriel A.; Little, Susan J.; Richman, Douglas D.; Mehta, Sanjay R.; Smith, Davey M.; Pond, Sergei L. Kosakovsky] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [May, Susanne J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Pacold, Mary E.] Life Technol, San Francisco, CA USA; [Richman, Douglas D.; Smith, Davey M.] Vet Adm San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Thermo Fisher Scientific	Smith, DM (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	davey@ucsd.edu	Pond, Sergei LK/G-9830-2012; Little, Susan/AAA-6116-2019	Pond, Sergei LK/0000-0003-4817-4029; Smith, Davey/0000-0003-3603-1733	Veterans Affairs; National Institutes of Health [DA034978, AI69432, AI007384, AI080193, AI096113, AI090970, AI043638, MH62512, MH083552, AI077304, AI36214, AI047745, AI74621, AI080353, AI100665, GM093939]; International AIDS Vaccine Initiative; James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069432, T32AI007384, K23AI093163, P01AI080193, R21AI077304, R01AI047745, K24AI100665, R21AI047745, U01AI069432, R21AI080353, R56AI047745, P30AI036214, U19AI096113, R24AI106039, P01AI074621, U19AI090970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093939, T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH083552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034978] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Veterans Affairs and grants from the National Institutes of Health: DA034978, AI69432, AI007384, AI080193, AI096113, AI090970, AI043638, MH62512, MH083552, AI077304, AI36214, AI047745, AI74621, AI080353, AI100665, GM093939; the International AIDS Vaccine Initiative; and the James B. Pendleton Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Aldous JL, 2012, CLIN INFECT DIS; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Buskin SE, 2008, JAIDS-J ACQ IMM DEF, V49, P205, DOI 10.1097/QAI.0b013e318185727e; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Leitner T, 1997, J VIROL, V71, P4761, DOI 10.1128/JVI.71.6.4761-4770.1997; Lemey P, 2006, AIDS REV, V8, P125; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; MCNEARNEY T, 1992, P NATL ACAD SCI USA, V89, P10247, DOI 10.1073/pnas.89.21.10247; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Pacold M, 2010, AIDS RES HUM RETROV, V26, P1291, DOI 10.1089/aid.2010.0042; Pacold ME, 2012, AIDS, V26, P157, DOI 10.1097/QAD.0b013e32834dcd26; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Smith DA, 2009, AIDS, V23, P225, DOI 10.1097/QAD.0b013e32831d2a81; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; WOLFS TFW, 1992, VIROLOGY, V189, P103, DOI 10.1016/0042-6822(92)90685-I	34	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68188	10.1371/journal.pone.0068188	http://dx.doi.org/10.1371/journal.pone.0068188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840830	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400173
J	Liu, YB; Chakroun, I; Yang, DB; Horner, E; Liang, JY; Aziz, A; Chu, A; De Repentigny, Y; Dilworth, FJ; Kothary, R; Blais, A				Liu, Yubing; Chakroun, Imane; Yang, Dabo; Horner, Ellias; Liang, Jieyi; Aziz, Arif; Chu, Alphonse; De Repentigny, Yves; Dilworth, F. Jeffrey; Kothary, Rashmi; Blais, Alexandre			Six1 Regulates MyoD Expression in Adult Muscle Progenitor Cells	PLOS ONE			English	Article							SATELLITE CELLS; CORE ENHANCER; 6 FAMILY; TRANSCRIPTION FACTORS; GENE-EXPRESSION; ACTIVATION; MYOGENIN; BINDING; LIMB; DIFFERENTIATION	Quiescent satellite cells are myogenic progenitors that enable regeneration of skeletal muscle. One of the early events of satellite cell activation following myotrauma is the induction of the myogenic regulatory factor MyoD, which eventually induces terminal differentiation and muscle function gene expression. The purpose of this study was to elucidate the mechanism by which MyoD is induced during activation of satellite cells in mouse muscle undergoing regeneration. We show that Six1, a transcription factor essential for embryonic myogenesis, also regulates MyoD expression in muscle progenitor cells. Six1 knock-down by RNA interference leads to decreased expression of MyoD in myoblasts. Chromatin immunoprecipitation assays reveal that Six1 binds the Core Enhancer Region of MyoD. Further, transcriptional reporter assays demonstrate that Core Enhancer Region reporter gene activity in myoblasts and in regenerating muscle depends on the expression of Six1 and on Six1 binding sites. Finally, we provide evidence indicating that Six1 is required for the proper chromatin structure at the Core Enhancer Region, as well as for MyoD binding at its own enhancer. Together, our results reveal that MyoD expression in satellite cells depends on Six1, supporting the idea that Six1 plays an important role in adult myogenesis, in addition to its role in embryonic muscle formation.	[Liu, Yubing; Chakroun, Imane; Yang, Dabo; Horner, Ellias; Liang, Jieyi; Chu, Alphonse; Blais, Alexandre] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Liu, Yubing; Chakroun, Imane; Yang, Dabo; Horner, Ellias; Liang, Jieyi; Chu, Alphonse; Blais, Alexandre] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Aziz, Arif; De Repentigny, Yves; Dilworth, F. Jeffrey; Kothary, Rashmi] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Dilworth, F. Jeffrey; Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Dilworth, F. Jeffrey; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Blais, A (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada.	alexandre.blais@uottawa.ca		Blais, Alexandre/0000-0003-2446-1883; Kothary, Rashmi/0000-0002-9239-7310; Chu, Alphonse/0000-0003-4091-9575; Dilworth, F. Jeffrey/0000-0002-6265-8102	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada scholarships; Fonds de la Recherche en Sante du Quebec; University Health Research Chair from the University of Ottawa	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada scholarships(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); University Health Research Chair from the University of Ottawa	This work was supported by a Canadian Institutes of Health Research operating grant to A.B., and by scholarships from Natural Sciences and Engineering Research Council of Canada scholarships (Y.L. and I.C.), and the Fonds de la Recherche en Sante du Quebec to A.C. R.K. is a recipient of a University Health Research Chair from the University of Ottawa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2012, DEVELOPMENT, V139, P1965, DOI 10.1242/dev.071670; Andreucci JJ, 2002, J BIOL CHEM, V277, P16426, DOI 10.1074/jbc.M110891200; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; ASAKURA A, 1995, DEV BIOL, V171, P386, DOI 10.1006/dbio.1995.1290; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Budry L, 2012, GENE DEV, V26, P2299, DOI 10.1101/gad.200436.112; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Chen JCJ, 2004, DEV BIOL, V265, P502, DOI 10.1016/j.ydbio.2003.09.018; Chen JCJ, 2002, DEV BIOL, V245, P213, DOI 10.1006/dbio.2002.0638; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; Chen JCJ, 1999, CELL TISSUE RES, V296, P213, DOI 10.1007/s004410051282; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Dilworth FJ, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt59; Gayraud-Morel B, 2012, J CELL SCI, V125, P1738, DOI 10.1242/jcs.097006; GOLDHAMER DJ, 1992, SCIENCE, V256, P538, DOI 10.1126/science.1315077; GOLDHAMER DJ, 1995, DEVELOPMENT, V121, P637; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; GROUNDS MD, 1992, CELL TISSUE RES, V267, P99, DOI 10.1007/BF00318695; Havis E, 2012, DEVELOPMENT, V139, P1910, DOI 10.1242/dev.072561; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Kucharczuk KL, 1999, DEVELOPMENT, V126, P1957; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; L'honore A, 2003, MOL BIOL CELL, V14, P2151, DOI 10.1091/mbc.e02-07-0451; L'honore A, 2007, MOL BIOL CELL, V18, P1992, DOI 10.1091/mbc.E06-09-0867; L'Honore A, 2010, DEVELOPMENT, V137, P3847, DOI 10.1242/dev.053421; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Grand F, 2012, J CELL BIOL, V198, P815, DOI 10.1083/jcb.201201050; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liu YB, 2012, NUCLEIC ACIDS RES, V40, P8227, DOI 10.1093/nar/gks587; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nagy A., 2003, MANIPULATING MOUSE E; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sebastian Soji, 2013, Genes Dev, V27, P1247, DOI 10.1101/gad.215400.113; SONG KN, 1992, NATURE, V360, P477, DOI 10.1038/360477a0; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; TAPSCOTT SJ, 1992, MOL CELL BIOL, V12, P4994, DOI 10.1128/MCB.12.11.4994; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; WOLOSHIN P, 1995, CELL, V82, P611, DOI 10.1016/0092-8674(95)90033-0; Yajima H, 2010, EXP CELL RES, V316, P2932, DOI 10.1016/j.yexcr.2010.08.001; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653; Zhang XP, 2012, NUCLEIC ACIDS RES, V40, P3419, DOI 10.1093/nar/gkr1297	57	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67762	10.1371/journal.pone.0067762	http://dx.doi.org/10.1371/journal.pone.0067762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840772	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400133
J	Thuma, JB; Hobbs, KH; Burstein, HJ; Seiter, NS; Hooper, SL				Thuma, Jeffrey B.; Hobbs, Kevin H.; Burstein, Helaine J.; Seiter, Natasha S.; Hooper, Scott L.			Temperature Sensitivity of the Pyloric Neuromuscular System and Its Modulation by Dopamine	PLOS ONE			English	Article							INTERRUPTUS STOMATOGASTRIC SYSTEM; CHANGING NEURONAL INPUT; CRAB CANCER-BOREALIS; ASTACUS-LEPTODACTYLUS; MUSCLE RESPONSE; NEURAL-NETWORKS; MOTOR PATTERNS; LOBSTER; CRAYFISH; TRANSMISSION	We report here the effects of temperature on the p1 neuromuscular system of the stomatogastric system of the lobster (Panulirus interruptus). Muscle force generation, in response to both the spontaneously rhythmic in vitro pyloric network neural activity and direct, controlled motor nerve stimulation, dramatically decreased as temperature increased, sufficiently that stomach movements would very unlikely be maintained at warm temperatures. However, animals fed in warm tanks showed statistically identical food digestion to those in cold tanks. Applying dopamine, a circulating hormone in crustacea, increased muscle force production at all temperatures and abolished neuromuscular system temperature dependence. Modulation may thus exist not only to increase the diversity of produced behaviors, but also to maintain individual behaviors when environmental conditions (such as temperature) vary.	[Thuma, Jeffrey B.; Hobbs, Kevin H.; Burstein, Helaine J.; Seiter, Natasha S.; Hooper, Scott L.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Thuma, JB (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	thuma@ohio.edu			NIH [5RC1DA028494-02]; NSF [IOS-0958926]; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028494] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0958926] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by NIH grant 5RC1DA028494-02 and NSF grant IOS-0958926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DIPOLO R, 1972, J PHYSIOL-LONDON, V225, P255, DOI 10.1113/jphysiol.1972.sp009939; DUDEL J, 1968, PFLUG ARCH EUR J PHY, V301, P16, DOI 10.1007/BF00412415; FISCHER L, 1981, J EXP BIOL, V94, P251; FLOREY E, 1976, J COMP PHYSIOL, V110, P51; HARRI M, 1977, J COMP PHYSIOL, V117, P47, DOI 10.1007/BF00605523; HARRI M, 1979, J EXP BIOL, V78, P281; Hoover NJ, 2002, J NEUROSCI, V22, P1895, DOI 10.1523/JNEUROSCI.22-05-01895.2002; Jorge-Rivera JC, 1998, J NEUROPHYSIOL, V80, P2559, DOI 10.1152/jn.1998.80.5.2559; Jorge-Rivera JC, 1997, J EXP BIOL, V200, P2937; JorgeRivera JC, 1996, J COMP PHYSIOL A, V179, P741; Lejeusne C, 2006, CAN J FISH AQUAT SCI, V63, P2028, DOI 10.1139/F06-102; LINGLE C, 1981, J EXP BIOL, V94, P285; MEYRAND P, 1986, J COMP PHYSIOL A, V158, P489, DOI 10.1007/BF00603795; MEYRAND P, 1991, J NEUROSCI, V11, P1150; Miyake Y, 1952, OCEANOGR MAG, V4, P95; Morris LG, 2000, NAT NEUROSCI, V3, P245, DOI 10.1038/72955; Morris LG, 1997, J NEUROSCI, V17, P5956; Morris LG, 2001, J NEUROPHYSIOL, V85, P254, DOI 10.1152/jn.2001.85.1.254; Morris LG, 1998, J NEUROSCI, V18, P3433; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; Spees JL, 2002, CELL STRESS CHAPERON, V7, P97, DOI 10.1379/1466-1268(2002)007<0097:TAASIT>2.0.CO;2; Stein W, 2009, J COMP PHYSIOL A, V195, P989, DOI 10.1007/s00359-009-0483-y; STEPHENS PJ, 1983, J COMP PHYSIOL, V153, P455, DOI 10.1007/BF00612600; Tang LS, 2012, J NEUROSCI, V32, P10075, DOI 10.1523/JNEUROSCI.1443-12.2012; Tang LS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000469; Thuma JB, 2003, J NEUROSCI, V23, P8911; Thuma JB, 2007, J COMP PHYSIOL A, V193, P1101, DOI 10.1007/s00359-007-0261-7; Thuma JB, 2010, J COMP PHYSIOL A, V196, P649, DOI 10.1007/s00359-010-0553-1; Weimann JM, 1997, J NEUROSCI, V17, P1748	29	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67930	10.1371/journal.pone.0067930	http://dx.doi.org/10.1371/journal.pone.0067930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840789	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400144
J	Umemura, Y; Yoshida, J; Wada, M; Tsuchiya, Y; Minami, Y; Watanabe, H; Kondoh, G; Takeda, J; Inokawa, H; Horie, K; Yagita, K				Umemura, Yasuhiro; Yoshida, Junko; Wada, Masashi; Tsuchiya, Yoshiki; Minami, Yoichi; Watanabe, Hitomi; Kondoh, Gen; Takeda, Junji; Inokawa, Hitoshi; Horie, Kyoji; Yagita, Kazuhiro			An In Vitro ES Cell-Based Clock Recapitulation Assay Model Identifies CK2 alpha as an Endogenous Clock Regulator	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; GENE-EXPRESSION; CKI-DELTA; RHYTHMS; TIME; TRANSCRIPTION; COORDINATION; OSCILLATORS; METABOLISM	We previously reported emergence and disappearance of circadian molecular oscillations during differentiation of mouse embryonic stem (ES) cells and reprogramming of differentiated cells, respectively. Here we present a robust and stringent in vitro circadian clock formation assay that recapitulates in vivo circadian phenotypes. This assay system first confirmed that a mutant ES cell line lacking Casein Kinase I delta (CKI delta) induced similar to 3 hours longer period-length of circadian rhythm than the wild type, which was compatible with recently reported results using CKI delta null mice. In addition, this assay system also revealed that a Casein Kinase 2 alpha subunit (CK2 alpha) homozygous mutant ES cell line developed significantly longer (about 2.5 hours) periods of circadian clock oscillations after in vitro or in vivo differentiation. Moreover, revertant ES cell lines in which mutagenic vector sequences were deleted showed nearly wild type periods after differentiation, indicating that the abnormal circadian period of the mutant ES cell line originated from the mutation in the CK2 alpha gene. Since CK2 alpha deficient mice are embryonic lethal, this in vitro assay system represents the genetic evidence showing an essential role of CK2 alpha in the mammalian circadian clock. This assay was successfully applied for the phenotype analysis of homozygous mutant ES cells, demonstrating that an ES cell-based in vitro assay is available for circadian genetic screening.	[Umemura, Yasuhiro; Wada, Masashi; Tsuchiya, Yoshiki; Minami, Yoichi; Inokawa, Hitoshi; Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Dept Physiol & Syst Biosci, Kyoto, Japan; [Yoshida, Junko; Takeda, Junji; Horie, Kyoji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan; [Watanabe, Hitomi; Kondoh, Gen] Kyoto Univ, Inst Frontier Med Sci, Lab Anim Expt Regenerat, Kyoto, Japan; [Horie, Kyoji; Yagita, Kazuhiro] Japan Sci & Technol Agcy, Saitama, Japan; [Horie, Kyoji] Nara Med Univ, Dept Physiol 2, Nara, Japan	Kyoto Prefectural University of Medicine; Osaka University; Kyoto University; Japan Science & Technology Agency (JST); Nara Medical University	Horie, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Osaka, Japan.	k-horie@naramed-u.ac.jp; kyagita@koto.kpu-m.ac.jp		Horie, Kyoji/0000-0001-9036-8180	PRESTO Program of the Japan Science and Technology Agency; JSPS KAKENHI [23390051]; Takeda Science Foundation	PRESTO Program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by PRESTO Program of the Japan Science and Technology Agency (K.Y. and K.H.), and by JSPS KAKENHI Grant Number 23390051 (K.Y.). This work was also supported by the Takeda Science Foundation (K.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Eide EJ, 2005, METHOD ENZYMOL, V393, P408, DOI 10.1016/S0076-6879(05)93019-X; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Etchegaray JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010303; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Hirota T, 2009, CHEM BIOL, V16, P921, DOI 10.1016/j.chembiol.2009.09.002; Horie K, 2011, NAT METHODS, V8, P1071, DOI [10.1038/NMETH.1739, 10.1038/nmeth.1739]; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kowalska E, 2010, J BIOL RHYTHM, V25, P442, DOI 10.1177/0748730410385281; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Masri S, 2012, ANN NY ACAD SCI, V1264, P103, DOI 10.1111/j.1749-6632.2012.06649.x; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Okamoto K, 2005, ANAL BIOCHEM, V340, P193, DOI 10.1016/j.ab.2004.11.007; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; REPPERT SM, 1983, SCIENCE, V220, P969, DOI 10.1126/science.6844923; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Smith EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040012; Sumova A, 2006, FEBS LETT, V580, P2836, DOI 10.1016/j.febslet.2006.03.023; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Yagita K, 2009, ACTA HISTOCHEM CYTOC, V42, P89, DOI 10.1267/ahc.09015	31	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67241	10.1371/journal.pone.0067241	http://dx.doi.org/10.1371/journal.pone.0067241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840637	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400048
J	Wang, HR; Liu, L; Zhao, JZ; Cui, GL; Chen, C; Ding, H; Wang, DW				Wang, Haoran; Liu, Lei; Zhao, Jinzhao; Cui, Guanglin; Chen, Chen; Ding, Hu; Wang, Dao Wen			Large Scale Meta-Analyses of Fasting Plasma Glucose Raising Variants in GCK, GCKR, MTNR1B and G6PC2 and Their Impacts on Type 2 Diabetes Mellitus Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; REGULATORY-PROTEIN GCKR; MELATONIN RECEPTOR 1B; BETA-CELL; RS780094 POLYMORPHISM; INSULIN-RESISTANCE; SUSCEPTIBILITY; POPULATION; GENE; LOCI	Background: The evidence that the variants GCK rs1799884, GCKR rs780094, MTNR1B rs10830963 and G6PC2 rs560887, which are related to fasting plasma glucose levels, increase the risk of type 2 diabetes mellitus (T2DM) is contradictory. We therefore performed a meta-analysis to derive a more precise estimation of the association between these polymorphisms and T2DM. Methods: All the publications examining the associations of these variants with risk of T2DM were retrieved from the MEDLINE and EMBASE databases. Using the data from the retrieved articles, we computed summary estimates of the associations of the four variants with T2DM risk. We also examined the studies for heterogeneity, as well as for bias of the publications. Results: A total of 113,025 T2DM patients and 199,997 controls from 38 articles were included in the meta-analysis. Overall, the pooled results indicated that GCK (rs1799884), GCKR (rs780094) and MTNR1B (rs10830963) were significantly associated with T2DM susceptibility (OR, 1.04; 95%CI, 1.01-1.08; OR, 1.08; 95%CI, 1.05-1.12 and OR, 1.05; 95%CI, 1.02-1.08, respectively). After stratification by ethnicity, significant associations for the GCK, MTNR1B and G6PC2 variants were detected only in Caucasians (OR, 1.09; 95%CI, 1.02-1.16; OR, 1.10; 95%CI, 1.08-1.13 and OR, 0.97; 95%CI, 0.95-0.99, respectively), but not in Asians (OR, 1.02, 95%CI 0.98-1.05; OR, 1.01; 95%CI, 0.98-1.04 and OR, 1.12; 95%CI, 0.91-1.32, respectively). Conclusions: Our meta-analyses demonstrated that GCKR rs780094 variant confers high cross-ethnicity risk for the development of T2DM, while significant associations between GCK, MTNR1B and G6PC2 variants and T2DM risk are limited to Caucasians.	[Wang, Haoran; Liu, Lei; Zhao, Jinzhao; Cui, Guanglin; Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China; [Chen, Chen; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Genet Diag Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Ding, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430074, Peoples R China.	dingo8369@163.com; dwwang@tjh.tjmu.edu.cn	Wang, Haoran/ABC-6993-2021; Chen, Chen/B-2080-2014	Wang, Haoran/0000-0002-5534-6610; ding, hu/0000-0002-1814-1552; Wang, Dao Wen/0000-0002-9774-3980	National "973'' project [2012CB518004]; "863'' project [2012AA02A510]; Ministry of Education of China for Outstanding Young Teachers in University [20110142120012]	National "973'' project(National Basic Research Program of China); "863'' project(National High Technology Research and Development Program of China); Ministry of Education of China for Outstanding Young Teachers in University	This work was supported by grants from National "973'' project (No. 2012CB518004), "863'' project (No. 2012AA02A510) and Ministry of Education of China for Outstanding Young Teachers in University (20110142120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Been LF, 2012, NUTR METAB CARDIOVAS, V22, P944, DOI 10.1016/j.numecd.2011.01.006; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011690; Bonetti S, 2011, DIABETES CARE, V34, P1205, DOI 10.2337/dc10-2218; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Brito EC, 2009, DIABETES, V58, P1411, DOI 10.2337/db08-1623; Cauchi S, 2012, DIABETES METAB, V38, P316, DOI 10.1016/j.diabet.2012.02.003; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Chen GJ, 2012, HUM MOL GENET, V21, P4530, DOI 10.1093/hmg/dds282; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dietrich K, 2011, DIABETIC MED, V28, P1373, DOI 10.1111/j.1464-5491.2011.03374.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ezzidi I, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-33; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Florez JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044424; Fujita H, 2012, J HUM GENET, V57, P776, DOI 10.1038/jhg.2012.110; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hishida A, 2012, ENDOCR J, V59, P589, DOI 10.1507/endocrj.EJ11-0310; Holmkvist J, 2008, DIABETES, V57, P1738, DOI 10.2337/db06-1464; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011761; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Ling Y, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-66; Ling Y, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-27; Liu C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-59; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; MATSUTANI A, 1992, GENOMICS, V12, P319, DOI 10.1016/0888-7543(92)90380-B; Mohas M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-79; Ng MCY, 2013, DIABETES, V62, P965, DOI 10.2337/db12-0266; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Olsson L, 2011, DIABETOLOGIA, V54, P1375, DOI 10.1007/s00125-011-2106-8; Onuma H, 2010, J HUM GENET, V55, P600, DOI 10.1038/jhg.2010.75; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Piche ME, 2004, DIABETES CARE, V27, P2470, DOI 10.2337/diacare.27.10.2470; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Rees SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024710; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Renstrom F, 2011, DIABETES, V60, P345, DOI 10.2337/db10-0933; Ronn T, 2009, DIABETOLOGIA, V52, P830, DOI 10.1007/s00125-009-1297-8; Rose CS, 2009, DIABETOLOGIA, V52, P2122, DOI 10.1007/s00125-009-1463-z; Rose CS, 2005, DIABETES, V54, P3026, DOI 10.2337/diabetes.54.10.3026; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Stancakova A, 2011, DIABETES, V60, P1608, DOI 10.2337/db10-1655; Tabara Y, 2011, METABOLISM, V60, P1634, DOI 10.1016/j.metabol.2011.03.014; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Tam CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011428; Teo YY, 2010, GENET EPIDEMIOL, V34, P653, DOI 10.1002/gepi.20522; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Wagner Robert, 2011, PLoS One, V6, pe23639, DOI 10.1371/journal.pone.0023639; WARNER JP, 1995, MAMM GENOME, V6, P532, DOI 10.1007/BF00356171; Weber MB, 2012, ANNU REV NUTR, V32, P417, DOI 10.1146/annurev-nutr-071811-150630; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Xia Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050107; Yang QH, 1999, EPIDEMIOLOGY, V10, P167, DOI 10.1097/00001648-199903000-00014	69	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67665	10.1371/journal.pone.0067665	http://dx.doi.org/10.1371/journal.pone.0067665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840762	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400125
J	Zhang, XM; Qu, XL; Sun, YBY; Caruana, G; Bertram, JF; Nikolic-Paterson, DJ; Li, JH				Zhang, Xueming; Qu, Xinli; Sun, Yu Bo Yang; Caruana, Georgina; Bertram, John F.; Nikolic-Paterson, David J.; Li, Jinhua			Resolvin D1 Protects Podocytes in Adriamycin-Induced Nephropathy through Modulation of 14-3-3 beta Acetylation	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; TRIGGERED 15-EPI-LIPOXIN A(4); GENE-EXPRESSION; PROMOTE RESOLUTION; NEPHROTIC SYNDROME; INFLAMMATORY PAIN; NEUROPROTECTIN D1; KIDNEY PODOCYTES; HUMAN PHAGOCYTES; CYSTIC-FIBROSIS	Resolvin D1 (RvD1) is a lipid-derived mediator generated during the resolution inflammation. While the immunoresolvent effects of Resolvins have been extensively studied in leukocytes, actions of Resolvins on intrinsic kidney cells have received little attention. The podocyte plays a central role in glomerular function, and podocyte damage can lead to proteinuria and glomerulosclerosis. This study examined whether RvD1 has renoprotective effects upon podocytes. We investigated a mouse model of adriamycin (ADR) nephropathy featuring rapid induction of podocyte damage and proteinuria followed by glomerulosclerosis. We identified a progressive loss of synaptopodin expression over a 28 day time-course of ADR nephropathy which was associated with increased acetylation of 14-3-3 beta and reduced synaptopodin phosphorylation. Groups of mice were given once daily RvD1 treatment (4 ng/g body weight/day) starting either 30 min (early treatment) or 14 days (late treatment) after ADR injection and continued until mice were killed on day 28. Early, but not late, RvD1 treatment attenuated ADR-induced proteinuria, glomerulosclerosis and tubulointerstitial fibrosis, modified macrophages from an M1 to M2 phenotype. Early RvD1 treatment prevented the down-regulation of synaptopodin expression and changes in 14-3-3 beta acetylation and synaptopodin phosphorylation. In a podocyte cell line, RvD1 was shown to prevent rapid TNF-alpha-induced down-regulation of synaptopodin expression. In transfection studies, TNF-alpha-induced a decrease in synaptopodin phosphorylation and an increase in acetylation of 14-3-3 beta, resulting in disassociation between 14-3-3 beta and synaptopodin. RvD1 prevented TNF-a induced post-translational modification of synaptopodin and 14-3-3 beta proteins, and maintained the synaptopodin/14-3-3 beta interaction. Furthermore, replacement of lysine K51, or K117+K122 in 14-3-3 beta with glutamine, to mimic lysine acetylation, significantly reduced the interaction between 14-3-3 beta and synaptopodin. In conclusion, our studies provide the first evidence that RvD1 can protect against podocyte damage by preventing down-regulation of synaptopodin through inhibition of 14-3-3 beta/synaptopodin dissociation. RvD1 treatment may have potential application in the treatment of chronic kidney disease.	[Zhang, Xueming; Qu, Xinli; Sun, Yu Bo Yang; Caruana, Georgina; Bertram, John F.; Li, Jinhua] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Zhang, Xueming] Inner Mongolia Univ Sci & Technol, Baotou Med Coll, Baotou, Peoples R China; [Nikolic-Paterson, David J.] Monash Univ, Dept Med, Clayton, Vic, Australia	Monash University; Baotou Medical College; Inner Mongolia University of Science & Technology; Monash University	Li, JH (corresponding author), Monash Univ, Dept Anat & Dev Biol, Wellington Rd, Clayton, Vic, Australia.	jinhua.li@monash.edu	Bertram, John F/I-2588-2014; Li, Jinhua/I-2741-2014	Bertram, John F/0000-0001-5863-6464; Li, Jinhua/0000-0003-4039-5759; Nikolic-Paterson, David/0000-0001-5734-2931; Sun, Yu Bo Yang/0000-0003-0863-2769	Monash University Accelerating Programme; National Health and Medical Research Council (NHMRC) of Australia; National Health and Medical Research Council (NHMRC); China Scholarship Council	Monash University Accelerating Programme; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); China Scholarship Council(China Scholarship Council)	This study was supported by the Monash University Accelerating Programme and the National Health and Medical Research Council (NHMRC) of Australia. J.L. is the recipient of a National Health and Medical Research Council (NHMRC) Career Development Award. X.Z. is the recipient of a Scholarship from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clish CB, 1999, P NATL ACAD SCI USA, V96, P8247, DOI 10.1073/pnas.96.14.8247; D'Agati VD, 2012, CURR OPIN NEPHROL HY, V21, P243, DOI 10.1097/MNH.0b013e32835200df; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Gigante M, 2011, CLIN J AM SOC NEPHRO, V6, P1626, DOI 10.2215/CJN.07830910; Gigante M, 2009, NEPHROL DIAL TRANSPL, V24, P1858, DOI 10.1093/ndt/gfn712; Ikezumi Y, 2008, BIOCHEM BIOPH RES CO, V376, P706, DOI 10.1016/j.bbrc.2008.09.049; Kajiyama H, 2009, AM J NEPHROL, V29, P153, DOI 10.1159/000151770; Karp CL, 2005, PROSTAG LEUKOTR ESS, V73, P263, DOI 10.1016/j.plefa.2005.05.015; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Li JH, 2006, AM J PATHOL, V169, P1527, DOI 10.2353/ajpath.2006.060169; Liao Z, 2012, RESP RES IN PRESS; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mahajan D, 2006, J AM SOC NEPHROL, V17, P2731, DOI 10.1681/ASN.2005080842; Marcheselli VL, 2010, PROSTAG LEUKOTR ESS, V82, P27, DOI 10.1016/j.plefa.2009.10.010; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Natarajan K, 1998, ARCH BIOCHEM BIOPHYS, V352, P59, DOI 10.1006/abbi.1998.0576; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Qu XL, 2012, J PATHOL, V228, P506, DOI 10.1002/path.4050; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sluchanko NN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1528, DOI 10.1134/S0006297910130031; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Svensson CI, 2007, J EXP MED, V204, P245, DOI 10.1084/jem.20061826; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; Takano T, 1998, J CLIN INVEST, V101, P819, DOI 10.1172/JCI1578; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Wyburn KR, 2013, AM J PHYSIOL-RENAL, V304, pF68, DOI 10.1152/ajprenal.00669.2011; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123	49	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67471	10.1371/journal.pone.0067471	http://dx.doi.org/10.1371/journal.pone.0067471			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840712	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400088
J	Zhang, YF; Hou, MM; Tan, BC				Zhang, Ya-Feng; Hou, Ming-Ming; Tan, Bao-Cai			The Requirement of WHIRLY1 for Embryogenesis Is Dependent on Genetic Background in Maize	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; DNA-BINDING PROTEIN; CHLOROPLAST GENOME; EMBRYO DEVELOPMENT; RIBOSOMAL-RNA; EXPRESSION; IDENTIFICATION; INFORMATION; MUTAGENESIS; PRECURSOR	Plastid gene expression is essential to embryogenesis in higher plants, but the underlying mechanism is obscure. Through molecular characterization of an embryo defective 16 (emb16) locus, here we report that the requirement of plastid translation for embryogenesis is dependent on the genetic background in maize (Zea mays). The emb16 mutation arrests embryogenesis at transition stage and allows the endosperm to develop largely normally. Molecular cloning reveals that Emb16 encodes WHIRLY1 (WHY1), a DNA/RNA binding protein that is required for genome stability and ribosome formation in plastids. Interestingly, the previous why1 mutant alleles (why1-1 and why1-2) do not affect embryogenesis, only conditions albino seedlings. The emb16 allele of why1 mutation is in the W22 genetic background. Crosses between emb16 and why1-1 heterozygotes resulted in both defective embryos and albino seedlings in the F1 progeny. Introgression of the emb16 allele from W22 into A188, B73, Mo17, Oh51a and the why1-1 genetic backgrounds yielded both defective embryos and albino seedlings. Similar results were obtained with two other emb mutants (emb12 and emb14) that are impaired in plastid protein translation process. These results indicate that the requirement of plastid translation for embryogenesis is dependent on genetic backgrounds, implying a mechanism of embryo lethality suppression in maize.	[Zhang, Ya-Feng; Hou, Ming-Ming; Tan, Bao-Cai] Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Inst Plant Mol Biol & Agr Biotechnol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Tan, BC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Inst Plant Mol Biol & Agr Biotechnol, Shatin, Hong Kong, Peoples R China.	bctan@cuhk.edu.hk			Hong Kong Research Grants Council [474709]; CUHK University	Hong Kong Research Grants Council(Hong Kong Research Grants Council); CUHK University	This work was supported by a grant from the Hong Kong Research Grants Council (Project no. 474709 to BCT; www.ugc.edu.hk) and CUHK University direct grants (to BCT; www.cuhk.edu.hk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBE EC, 1954, AM J BOT, V41, P285, DOI 10.2307/2438600; Asakura Y, 2006, PLANT PHYSIOL, V142, P1656, DOI 10.1104/pp.106.088096; Babiychuk E, 2011, P NATL ACAD SCI USA, V108, P6674, DOI 10.1073/pnas.1103442108; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bellaoui M, 2003, PLANT MOL BIOL, V53, P531, DOI 10.1023/B:PLAN.0000019061.79773.06; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; Cappadocia L, 2010, PLANT CELL, V22, P1849, DOI 10.1105/tpc.109.071399; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chen J., 1994, MAIZE HDB, P526, DOI [10.1007/978-1-4612-2694-9_85, DOI 10.1007/978-1-4612-2694-9_85]; [丁承强 Chengqiang Ding], 2011, [植物学报, Chinese Bulletin of Botany], V46, P67; CLARK JK, 1991, PLANT CELL, V3, P935, DOI 10.1105/tpc.3.9.935; CLINE K, 1986, J BIOL CHEM, V261, P4804; COE EH, 1988, AM J BOT, V75, P634, DOI 10.2307/2444197; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; Desveaux D, 2004, DEV CELL, V6, P229, DOI 10.1016/S1534-5807(04)00028-0; Desveaux D, 2000, PLANT CELL, V12, P1477, DOI 10.1105/tpc.12.8.1477; Dominguez F, 2001, PLANTA, V213, P352, DOI 10.1007/s004250000517; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Grabowski E, 2008, PLANT PHYSIOL, V147, P1800, DOI 10.1104/pp.108.122796; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; JOHANSEN DA, 1940, PLANT MICROTECHNIQUE, P80; Kesari R, 2012, P NATL ACAD SCI USA, V109, P9197, DOI 10.1073/pnas.1203433109; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Krause K, 2005, FEBS LETT, V579, P3707, DOI 10.1016/j.febslet.2005.05.059; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Li X, 2011, PLANT PHYSIOL, V155, P293, DOI 10.1104/pp.110.165910; Liu HJ, 2010, NEW PHYTOL, V187, P83, DOI 10.1111/j.1469-8137.2010.03264.x; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Lu YQ, 2011, PLANT J, V67, P13, DOI 10.1111/j.1365-313X.2011.04569.x; Ma ZR, 2004, PLANT J, V37, P92, DOI 10.1046/j.1365-313X.2003.01942.x; Magnard JL, 2004, PLANT PHYSIOL, V134, P649, DOI 10.1104/pp.103.030767; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Marechal A, 2009, P NATL ACAD SCI USA, V106, P14693, DOI 10.1073/pnas.0901710106; McCarty DR, 2005, PLANT J, V44, P52, DOI 10.1111/j.1365-313X.2005.02509.x; McElver J, 2001, GENETICS, V159, P1751; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Myers AM, 2011, PLANT CELL, V23, P2331, DOI 10.1105/tpc.111.087205; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ostheimer GJ, 2003, EMBO J, V22, P3919, DOI 10.1093/emboj/cdg372; Prikryl J, 2008, NUCLEIC ACIDS RES, V36, P5152, DOI 10.1093/nar/gkn492; Romani I, 2012, PLANT J, V72, P922, DOI 10.1111/tpj.12000; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Settles AM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh052; Shen Y, 2013, PLANT J IN PRESS; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Sosso D, 2012, J EXP BOT, V63, P5843, DOI 10.1093/jxb/ers232; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Sylvester Anne W., 1994, P83; Tan BC, 2011, G3-GENES GENOM GENET, V1, P293, DOI 10.1534/g3.111.000398; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Wakasugi T, 2001, PHOTOSYNTH RES, V70, P107, DOI 10.1023/A:1013892009589; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004; Xiong JY, 2009, PLANT MOL BIOL, V71, P437, DOI 10.1007/s11103-009-9533-7; Yoo HH, 2007, PLANT J, V49, P442, DOI 10.1111/j.1365-313X.2006.02974.x; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x	61	23	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67369	10.1371/journal.pone.0067369	http://dx.doi.org/10.1371/journal.pone.0067369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840682	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400071
J	Bontjer, I; Melchers, M; Tong, T; van Montfort, T; Eggink, D; Montefiori, D; Olson, WC; Moore, JP; Binley, JM; Berkhout, B; Sanders, RW				Bontjer, Ilja; Melchers, Mark; Tong, Tommy; van Montfort, Thijs; Eggink, Dirk; Montefiori, David; Olson, William C.; Moore, John P.; Binley, James M.; Berkhout, Ben; Sanders, Rogier W.			Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein Trimers	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INTERMOLECULAR DISULFIDE BOND; PLASMACYTOID DENDRITIC CELLS; NEUTRALIZING ANTIBODY PG9; VACCINE DESIGN; MONOCLONAL-ANTIBODIES; HYPERVARIABLE REGION; PARTIAL DELETION; EFFICACY TRIAL; GP41 SUBUNITS	Despite almost 30 years of research, no effective vaccine has yet been developed against HIV-1. Probably such a vaccine would need to induce both an effective T cell and antibody response. Any vaccine component focused on inducing humoral immunity requires the HIV-1 envelope (Env) glycoprotein complex as it is the only viral protein exposed on the virion surface. HIV-1 has evolved several mechanisms to evade broadly reactive neutralizing antibodies. One such a mechanism involves variable loop domains, which are highly flexible structures that shield the underlying conserved epitopes. We hypothesized that removal of such loops would increase the exposure and immunogenicity of these conserved regions. Env variable loop deletion however often leads to protein misfolding and aggregation because hydrophobic patches becoming solvent accessible. We have therefore previously used virus evolution to acquire functional Env proteins lacking the V1V2 loop. We then expressed them in soluble (uncleaved) gp140 forms. Three mutants were found to perform optimally in terms of protein expression, stability, trimerization and folding. In this study, we characterized the immune responses to these antigens in rabbits. The V1V2 deletion mutant Delta V1V2.9.VK induced a prominent response directed to epitopes that are not fully available on the other Env proteins tested but that effectively bound and neutralized the Delta V1V2 Env virus. This Env variant also induced more efficient neutralization of the tier 1 virus SF162. The immune refocusing effect was lost after booster immunization with a full-length gp140 protein with intact V1V2 loops. Collectively, this result suggests that deletion of variable domains could alter the specificity of the humoral immune response, but did not result in broad neutralization of neutralization-resistant virus isolates.	[Bontjer, Ilja; Melchers, Mark; van Montfort, Thijs; Eggink, Dirk; Berkhout, Ben; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol,Lab Expt Virol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Tong, Tommy; Binley, James M.] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Montefiori, David] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Olson, William C.] Progen Pharmaceut, Tarrytown, NY USA; [Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Amsterdam; Academic Medical Center Amsterdam; Torrey Pines Institute for Molecular Studies, California; Duke University; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol,Lab Expt Virol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl		Eggink, Dirk/0000-0002-4248-6008	AIDS fund (Amsterdam) [2005021, 2008013]; NIH [P01 AI82362, R01 AI45463, R01 AI58763, R01 AI84714]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC) [38619]; Torrey Pines Institute's AIDS and Infectious Disease Science Center; Netherlands Organization for Scientific Research (NWO); European Research Council [ERC-StG-2011-280829- SHEV]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093278, R01AI100790, R33AI084714, R37AI036082] Funding Source: NIH RePORTER	AIDS fund (Amsterdam); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC); Torrey Pines Institute's AIDS and Infectious Disease Science Center; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by AIDS fund (Amsterdam) grants #2005021 to BB and #2008013 to RWS, by NIH grants P01 AI82362 and R01 AI45463 to JPM, by NIH grants R01 AI58763 and R01 AI84714 to JMB, the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (J.M.B.; CAVD-VIMC grant 38619), and the Torrey Pines Institute's AIDS and Infectious Disease Science Center. R. W. S. is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829- SHEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee K, 2009, VIROLOGY, V389, P108, DOI 10.1016/j.virol.2009.04.001; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Beddows S, 2005, J VIROL, V79, P8812, DOI 10.1128/JVI.79.14.8812-8827.2005; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blower SM, 2001, P NATL ACAD SCI USA, V98, P3618, DOI 10.1073/pnas.061029998; Bonsignori M, 2011, J VIROL; Bontjer I, 2010, J BIOL CHEM, V285, P36456, DOI 10.1074/jbc.M110.156588; Bontjer I, 2009, J VIROL, V83, P368, DOI 10.1128/JVI.01404-08; Broomall EM, 2010, POSTGRAD MED, V122, P121, DOI 10.3810/pgm.2010.03.2129; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Center RJ, 2001, P NATL ACAD SCI USA, V98, P14877, DOI 10.1073/pnas.261573898; CHOU SH, 1992, AIDS RES HUM RETROV, V8, P1611, DOI 10.1089/aid.1992.8.1611; Chung NPY, 2012, J IMMUNOL, V189, P5257, DOI 10.4049/jimmunol.1201905; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Crooks ET, 2008, VIROLOGY, V377, P364, DOI 10.1016/j.virol.2008.04.045; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Dolin R, 2009, NEW ENGL J MED, V361, P2279, DOI 10.1056/NEJMe0909972; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Flynn NM, 2005, J INFECT DIS, V191, P645; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gzy J, 2004, VIROLOGY, V318, P493, DOI 10.1016/j.virol.2003.10.009; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Jeffs SA, 2002, J GEN VIROL, V83, P2723, DOI 10.1099/0022-1317-83-11-2723; Jeffs SA, 1996, J GEN VIROL, V77, P1403, DOI 10.1099/0022-1317-77-7-1403; Johnson RP, 1998, CURR OPIN IMMUNOL, V10, P436, DOI 10.1016/S0952-7915(98)80118-0; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Letvin NL, 2002, ANNU REV IMMUNOL, V20, P73, DOI 10.1146/annurev.immunol.20.081501.094854; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lu S, 1998, AIDS RES HUM RETROV, V14, P151, DOI 10.1089/aid.1998.14.151; LU YC, 1990, J VIROL, V64, P5226, DOI 10.1128/JVI.64.10.5226-5229.1990; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Melchers M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-48; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Parren PWHI, 1997, IMMUNOL LETT, V57, P105, DOI 10.1016/S0165-2478(97)00043-6; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; POLLARD SR, 1992, EMBO J, V11, P585, DOI 10.1002/j.1460-2075.1992.tb05090.x; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Sanders RW, 2000, J VIROL, V74, P5091, DOI 10.1128/JVI.74.11.5091-5100.2000; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; TRAVIS BM, 1992, VIROLOGY, V186, P313, DOI 10.1016/0042-6822(92)90088-7; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward AB, 2013, HIV VACC KEYSTONE S; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993	67	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67484	10.1371/journal.pone.0067484	http://dx.doi.org/10.1371/journal.pone.0067484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840716	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400105
J	Duncan, JE; Lytle, NK; Zuniga, A; Goldstein, LSB				Duncan, Jason E.; Lytle, Nikki K.; Zuniga, Alfredo; Goldstein, Lawrence S. B.			The Microtubule Regulatory Protein Stathmin Is Required to Maintain the Integrity of Axonal Microtubules in Drosophila	PLOS ONE			English	Article							PROGRESSIVE-MOTOR-NEURONOPATHY; ONCOPROTEIN 18; TRANSPOSABLE ELEMENT; MISSENSE MUTATION; WHITE LOCUS; TUBULIN; KINESIN; EXPRESSION; FAMILY; GENE	Axonal transport, a form of long-distance, bi-directional intracellular transport that occurs between the cell body and synaptic terminal, is critical in maintaining the function and viability of neurons. We have identified a requirement for the stathmin (stai) gene in the maintenance of axonal microtubules and regulation of axonal transport in Drosophila. The stai gene encodes a cytosolic phosphoprotein that regulates microtubule dynamics by partitioning tubulin dimers between pools of soluble tubulin and polymerized microtubules, and by directly binding to microtubules and promoting depolymerization. Analysis of stai function in Drosophila, which has a single stai gene, circumvents potential complications with studies performed in vertebrate systems in which mutant phenotypes may be compensated by genetic redundancy of other members of the stai gene family. This has allowed us to identify an essential function for stai in the maintenance of the integrity of axonal microtubules. In addition to the severe disruption in the abundance and architecture of microtubules in the axons of stai mutant Drosophila, we also observe additional neurological phenotypes associated with loss of stai function including a posterior paralysis and tail-flip phenotype in third instar larvae, aberrant accumulation of transported membranous organelles in stai deficient axons, a progressive bang-sensitive response to mechanical stimulation reminiscent of the class of Drosophila mutants used to model human epileptic seizures, and a reduced adult lifespan. Reductions in the levels of Kinesin-1, the primary anterograde motor in axonal transport, enhance these phenotypes. Collectively, our results indicate that stai has an important role in neuronal function, likely through the maintenance of microtubule integrity in the axons of nerves of the peripheral nervous system necessary to support and sustain long-distance axonal transport.	[Duncan, Jason E.; Lytle, Nikki K.; Zuniga, Alfredo] Willamette Univ, Dept Biol, Salem, OR 97301 USA; [Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Willamette University; Howard Hughes Medical Institute; University of California System; University of California San Diego	Duncan, JE (corresponding author), Willamette Univ, Dept Biol, Salem, OR 97301 USA.	jduncan@willamette.edu			M. J. Murdock Charitable Trust [2007160]; National Science Foundation [MRI DBI-112673]; Willamette University; Research Corporation for Science Advancement; Mary Stuart Rogers Foundation; Div Of Biological Infrastructure [1126273] Funding Source: National Science Foundation	M. J. Murdock Charitable Trust; National Science Foundation(National Science Foundation (NSF)); Willamette University; Research Corporation for Science Advancement(Research Corporation for Science Advancement); Mary Stuart Rogers Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the M. J. Murdock Charitable Trust (Grant No. 2007160 to JED) (http://www.murdock-trust.org) and the National Science Foundation (MRI DBI-112673 to CoPI JED). NKL and AZ were recipients of undergraduate Science Collaborative Research Program summer fellowships from Willamette University, supported with funding from Research Corporation for Science Advancement, the Mary Stuart Rogers Foundation and the M. J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BINGHAM PM, 1981, CELL, V25, P705, DOI 10.1016/0092-8674(81)90177-X; Bommel H, 2002, J CELL BIOL, V159, P563, DOI 10.1083/jcb.200208001; Borghese L, 2006, DEV CELL, V10, P497, DOI 10.1016/j.devcel.2006.02.004; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Bowman AB, 1999, J CELL BIOL, V146, P165; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; COTE B, 1986, GENETICS, V112, P769; Duncan JE, 2006, PLOS GENET, V2, P1275, DOI 10.1371/journal.pgen.0020124; Falzone TL, 2010, HUM MOL GENET, V19, P4399, DOI 10.1093/hmg/ddq363; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Fergestad T, 2008, GENETICS, V178, P947, DOI 10.1534/genetics.107.082115; Fergestad Tim, 2006, Genetics, V173, P1357, DOI 10.1534/genetics.106.057463; GANETZKY B, 1982, GENETICS, V100, P597; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Graf ER, 2011, J NEUROSCI, V31, P15026, DOI 10.1523/JNEUROSCI.2024-11.2011; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; HAMILTON BA, 1994, METHOD CELL BIOL, V44, P81, DOI 10.1016/S0091-679X(08)60907-3; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Holmfeldt P, 2007, MOL BIOL CELL, V18, P1909, DOI 10.1091/mbc.E07-01-0019; Howell B, 1999, J CELL SCI, V112, P3713; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Hurd DD, 1996, GENETICS, V142, P195; Hurd DD, 1996, GENETICS, V144, P1075; JACK JW, 1985, CELL, V42, P869, DOI 10.1016/0092-8674(85)90283-1; Jin S, 2009, DEVELOPMENT, V136, P1571, DOI 10.1242/dev.029983; Kanaan NM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.006; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kasher PR, 2009, J NEUROCHEM, V110, P34, DOI 10.1111/j.1471-4159.2009.06104.x; Lachkar S, 2010, J BIOL CHEM, V285, P11667, DOI 10.1074/jbc.M109.096727; Larsson N, 1999, J CELL BIOL, V146, P1289, DOI 10.1083/jcb.146.6.1289; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Liedtke W, 2002, AM J PATHOL, V160, P469, DOI 10.1016/S0002-9440(10)64866-3; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Martin N, 2002, NAT GENET, V32, P443, DOI 10.1038/ng1016; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Ozon S, 1999, J NEUROSCI RES, V56, P553, DOI 10.1002/(SICI)1097-4547(19990601)56:5<553::AID-JNR11>3.0.CO;2-J; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Parfitt K, 1995, COLD SPRING HARB SYM, V60, P371, DOI 10.1101/SQB.1995.060.01.041; Parker L, 2011, INT REV NEUROBIOL, V99, P1, DOI 10.1016/B978-0-12-387003-2.00001-X; PARKHURST SM, 1986, MOL CELL BIOL, V6, P47, DOI 10.1128/MCB.6.1.47; PARKHURST SM, 1986, BIOESSAYS, V5, P52, DOI 10.1002/bies.950050203; PIRROTTA V, 1984, EMBO J, V3, P563, DOI 10.1002/j.1460-2075.1984.tb01847.x; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; RING BC, 2001, FUNCTIONAL ANAL DROS; Ringhoff DN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-343; Ringhoff DN, 2009, MOL BIOL CELL, V20, P3451, DOI 10.1091/mbc.E09-02-0140; RUBIN GM, 1983, JA SHAPIRO MOBILE GE, P329; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Schubart UK, 1996, J BIOL CHEM, V271, P14062, DOI 10.1074/jbc.271.24.14062; SCHUBIGER M, 1994, NEURON, V12, P373, DOI 10.1016/0896-6273(94)90278-X; Schulte J, 2010, J NEUROSCI, V30, P5189, DOI 10.1523/JNEUROSCI.5823-09.2010; Sellin ME, 2008, MOL BIOL CELL, V19, P2897, DOI 10.1091/mbc.E08-01-0058; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STRAND DJ, 1989, GENETICS, V121, P787; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tarrade A, 2006, HUM MOL GENET, V15, P3544, DOI 10.1093/hmg/ddl431; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; Yang NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040632; Yoshie M, 2006, MOL REPROD DEV, V73, P164, DOI 10.1002/mrd.20408; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zhao FH, 2012, SYNAPSE, V66, P781, DOI 10.1002/syn.21567; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	83	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e68324	10.1371/journal.pone.0068324	http://dx.doi.org/10.1371/journal.pone.0068324			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840848	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400134
J	Kadariya, Y; Tang, BQ; Wang, LQ; Al-Saleem, T; Hayakawa, K; Slifker, MJ; Kruger, WD				Kadariya, Yuwaraj; Tang, Baiqing; Wang, Liqun; Al-Saleem, Tahseen; Hayakawa, Kyoko; Slifker, Michael J.; Kruger, Warren D.			Germline Mutations in Mtap Cooperate with Myc to Accelerate Tumorigenesis in Mice	PLOS ONE			English	Article							METHYLTHIOADENOSINE PHOSPHORYLASE GENE; ORNITHINE-DECARBOXYLASE OVEREXPRESSION; HOMOZYGOUS DELETIONS; BONE-MARROW; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; CELL LYMPHOMA; CANCER; CDKN2; LINE	Objective: The gene encoding the methionine salvage pathway methylthioadenosine phosphorylase (MTAP) is a tumor suppressor gene that is frequently inactivated in a wide variety of human cancers. In this study, we have examined if heterozygosity for a null mutation in Mtap (Mtap(lacZ)) could accelerate tumorigenesis development in two different mouse cancer models, E mu-myc transgenic and Pten(+/-). Methods: Mtap Em-myc and Mtap Pten mice were generated and tumor-free survival was monitored over time. Tumors were also examined for a variety of histological and protein markers. In addition, microarray analysis was performed on the livers of Mtap(lacZ/+) and Mtap(+/+) mice. Results: Survival in both models was significantly decreased in Mtap(lacZ/+) compared to Mtap(+/+) mice. In E mu-myc mice, Mtap mutations accelerated the formation of lymphomas from cells in the early pre-B stage, and these tumors tended to be of higher grade and have higher expression levels of ornithine decarboxylase compared to those observed in control Em-myc Mtap(+/+) mice. Surprisingly, examination of Mtap status in lymphomas in E mu-myc Mtap(lacZ/+) and E mu-myc Mtap(+/+) animals did not reveal significant differences in the frequency of loss of Mtap protein expression, despite having shorter latency times, suggesting that haploinsufficiency of Mtap may be playing a direct role in accelerating tumorigenesis. Consistent with this idea, microarray analysis on liver tissue from age and sex matched Mtap(+/+) and Mtap(lacZ/+) animals found 363 transcripts whose expression changed at least 1.5-fold (P<0.01). Functional categorization of these genes reveals enrichments in several pathways involved in growth control and cancer. Conclusion: Our findings show that germline inactivation of a single Mtap allele alters gene expression and enhances lymphomagenesis in E mu-myc mice.	[Kadariya, Yuwaraj; Tang, Baiqing; Wang, Liqun; Slifker, Michael J.; Kruger, Warren D.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Al-Saleem, Tahseen; Hayakawa, Kyoko] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Kruger, WD (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	Kruger, Warren/Y-2541-2018; kruger, warren/A-6407-2008	kruger, warren/0000-0002-4990-3695	NIH [CA06927]; NCI [HL057299, CA131024, CA129330, CA145445]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH core grant CA06927, NCI grants HL057299, CA131024 (WK), CA129330 (KH), CA145445 (KJ) and an appropriation from the Commonwealth of Pennsylvania. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; Behrmann I, 2003, AM J PATHOL, V163, P683, DOI 10.1016/S0002-9440(10)63695-4; Brat DJ, 1999, AM J PATHOL, V154, P1431, DOI 10.1016/S0002-9440(10)65397-7; Camacho-Vanegas O, 2012, AM J HUM GENET, V90, P614, DOI 10.1016/j.ajhg.2012.02.024; Chen YJ, 2004, J PATHOL, V204, P326, DOI 10.1002/path.1640; Christopher SA, 2002, CANCER RES, V62, P6639; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dreyling MH, 1998, GENE CHROMOSOME CANC, V22, P72, DOI 10.1002/(SICI)1098-2264(199805)22:1<72::AID-GCC10>3.3.CO;2-G; Garcia-Castellano JM, 2002, CLIN CANCER RES, V8, P782; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hardy Richard R, 2004, Methods Mol Biol, V271, P1; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Hori Y, 1998, INT J CANCER, V75, P51, DOI 10.1002/(SICI)1097-0215(19980105)75:1<51::AID-IJC9>3.0.CO;2-0; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Hustinx SR, 2005, CANCER BIOL THER, V4, P83, DOI 10.4161/cbt.4.1.1380; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Kadariya Y, 2003, CANCER SCI, V94, P519, DOI 10.1111/j.1349-7006.2003.tb01476.x; Kadariya Y, 2009, CANCER RES, V69, P5961, DOI 10.1158/0008-5472.CAN-09-0145; KAMATANI N, 1981, BIOCHIM BIOPHYS ACTA, V675, P344, DOI 10.1016/0304-4165(81)90024-6; Karikari CA, 2005, MOL CANCER THER, V4, P1860, DOI 10.1158/1535-7163.MCT-05-0103; Kim J, 2011, GENE CHROMOSOME CANC, V50, P421, DOI 10.1002/gcc.20867; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; M'soka TJ, 2000, LEUKEMIA, V14, P935, DOI 10.1038/sj.leu.2401771; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; MOSHIER JA, 1993, CANCER RES, V53, P2618; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Nobori T, 1996, P NATL ACAD SCI USA, V93, P6203, DOI 10.1073/pnas.93.12.6203; OBrien TG, 1997, CANCER RES, V57, P2630; OLOPADE OI, 1995, P NATL ACAD SCI USA, V92, P6489, DOI 10.1073/pnas.92.14.6489; Orloff MS, 2008, ONCOGENE, V27, P5387, DOI 10.1038/onc.2008.237; OSMOND DG, 1984, EUR J IMMUNOL, V14, P495, DOI 10.1002/eji.1830140604; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Roes EM, 2002, CLIN CHEM LAB MED, V40, P496, DOI 10.1515/CCLM.2002.086; Schmid M, 1998, ONCOGENE, V17, P2669, DOI 10.1038/sj.onc.1202205; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Stadler WM, 1996, UROL RES, V24, P239, DOI 10.1007/BF00295899; Stambolic V, 2000, CANCER RES, V60, P3605; Subhi AL, 2004, CLIN CANCER RES, V10, P7290, DOI 10.1158/1078-0432.CCR-04-0972; Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200; Wen LJ, 2005, IMMUNITY, V23, P297, DOI 10.1016/j.immuni.2005.08.007; Wong YF, 1998, GYNECOL OBSTET INVES, V45, P272, DOI 10.1159/000009983; Wu CL, 2011, J BIOCHEM MOL TOXIC, V25, P312, DOI 10.1002/jbt.20391; Wu YF, 2002, ONCOGENE, V21, P1518, DOI 10.1038/sj.onc.1205208; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67635	10.1371/journal.pone.0067635	http://dx.doi.org/10.1371/journal.pone.0067635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840755	gold, Green Submitted, Green Published			2022-12-27	WOS:000321424400112
J	Kaiser, BLD; Li, J; Sanford, JA; Kim, YM; Kronewitter, SR; Jones, MB; Peterson, CT; Peterson, SN; Frank, BC; Purvine, SO; Brown, JN; Metz, TO; Smith, RD; Heffron, F; Adkins, JN				Kaiser, Brooke L. Deatherage; Li, Jie; Sanford, James A.; Kim, Young-Mo; Kronewitter, Scott R.; Jones, Marcus B.; Peterson, Christine T.; Peterson, Scott N.; Frank, Bryan C.; Purvine, Samuel O.; Brown, Joseph N.; Metz, Thomas O.; Smith, Richard D.; Heffron, Fred; Adkins, Joshua N.			A Multi-Omic View of Host-Pathogen-Commensal Interplay in Salmonella-Mediated Intestinal Infection	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MASS-SPECTROMETRY; MICROBIAL ECOLOGY; VIRULENCE FACTORS; MUCIN DYNAMICS; IMMUNE-SYSTEM; SP NOV.; RESISTANCE; PROTEIN; CELLS	The potential for commensal microorganisms indigenous to a host (the 'microbiome' or 'microbiota') to alter infection outcome by influencing host-pathogen interplay is largely unknown. We used a multi-omics "systems'' approach, incorporating proteomics, metabolomics, glycomics, and metagenomics, to explore the molecular interplay between the murine host, the pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium), and commensal gut microorganisms during intestinal infection with S. Typhimurium. We find proteomic evidence that S. Typhimurium thrives within the infected 129/SvJ mouse gut without antibiotic pre-treatment, inducing inflammation and disrupting the intestinal microbiome (e. g., suppressing Bacteroidetes and Firmicutes while promoting growth of Salmonella and Enterococcus). Alteration of the host microbiome population structure was highly correlated with gut environmental changes, including the accumulation of metabolites normally consumed by commensal microbiota. Finally, the less characterized phase of S. Typhimurium's lifecycle was investigated, and both proteomic and glycomic evidence suggests S. Typhimurium may take advantage of increased fucose moieties to metabolize fucose while growing in the gut. The application of multiple omics measurements to Salmonella-induced intestinal inflammation provides insights into complex molecular strategies employed during pathogenesis between host, pathogen, and the microbiome.	[Kaiser, Brooke L. Deatherage; Sanford, James A.; Kim, Young-Mo; Kronewitter, Scott R.; Brown, Joseph N.; Metz, Thomas O.; Smith, Richard D.; Adkins, Joshua N.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Li, Jie; Heffron, Fred] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Jones, Marcus B.; Peterson, Christine T.; Peterson, Scott N.; Frank, Bryan C.] J Craig Venter Inst, Dept Infect Dis, Rockville, MD USA; [Purvine, Samuel O.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Oregon Health & Science University; J. Craig Venter Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Adkins, JN (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	Joshua.Adkins@pnnl.gov	Kim, Young-Mo/AAG-2866-2019; Smith, Richard D/J-3664-2012; Kim, Young-Mo/D-3282-2009; Purvine, Samuel O/O-3358-2017	Kim, Young-Mo/0000-0002-8972-7593; Smith, Richard D/0000-0002-2381-2349; Kim, Young-Mo/0000-0002-8972-7593; Purvine, Samuel O/0000-0002-2257-2400; Adkins, Joshua/0000-0003-0399-0700; Sanford, James/0000-0001-7901-5579; Metz, Tom/0000-0001-6049-3968	National Institute of Allergy and Infectious Diseases NIH/DHHS [Y1-AI-8401, R01AI022933-022A1]; U.S. Department of Energy Office of Biological and Environmental Research (DOE/BER) [8 P41 GM103493-10]; Pacific Northwest National Laboratory [DE-AC05-76RLO1830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022933, R01AI008401, R22AI008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Energy Office of Biological and Environmental Research (DOE/BER)(United States Department of Energy (DOE)); Pacific Northwest National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	(This work was supported in part by the National Institute of Allergy and Infectious Diseases NIH/DHHS through interagency agreement Y1-AI-8401 (project websitewww.SysBEP.org with links to raw data) and Grant R01AI022933-022A1. This work used instrumentation and capabilities developed under support from the National Institute of General Medical Sciences grant 8 P41 GM103493-10 and the U.S. Department of Energy Office of Biological and Environmental Research (DOE/BER). Significant portions of this work were performed in the Environmental Molecular Sciences Laboratory, a DOE/BER national scientific user facility located at Pacific Northwest National Laboratory. The Pacific Northwest National Laboratory is operated for the DOE by Battelle under Contract DE-AC05-76RLO1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JN, 2006, MOL CELL PROTEOMICS, V5, P1450, DOI 10.1074/mcp.M600139-MCP200; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; Bolam DN, 2011, GUT MICROBES, V2, P86, DOI 10.4161/gmic.2.2.15232; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chow WL, 2008, BRIT J NUTR, V99, P449, DOI 10.1017/S0007114507812062; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Cummings LA, 2009, ECOSAL ESCHERICHIA C; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Horn DM, 2000, J AM SOC MASS SPECTR, V11, P320, DOI 10.1016/S1044-0305(99)00157-9; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Joosten CE, 2004, BIOTECHNOL PROGR, V20, P1273, DOI 10.1021/bp034378n; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kim YM, 2011, RAPID COMMUN MASS SP, V25, P2561, DOI 10.1002/rcm.5134; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kronewitter SR, 2010, J PROTEOME RES, V9, P4952, DOI 10.1021/pr100202a; Kronewitter SR, 2009, PROTEOMICS, V9, P2986, DOI 10.1002/pmic.200800760; Kulagina EV, 2012, BIOSCI BIOTECHNOL BI; KURODA M, 1992, CHEM PHARM BULL, V40, P1637, DOI 10.1248/cpb.40.1637; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li M, 2010, J PROTEOME RES, V9, P4295, DOI 10.1021/pr100527g; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Morotomi M, 2008, INT J SYST EVOL MICR, V58, P2716, DOI 10.1099/ijs.0.2008/000810-0; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Sakamoto M, 2007, INT J SYST EVOL MICR, V57, P342, DOI 10.1099/ijs.0.64709-0; Sanchez-Vargas FM, 2011, TRAVEL MED INFECT DI, V9, P263, DOI 10.1016/j.tmaid.2011.11.001; Santos RL, 2003, BRAZ J MED BIOL RES, V36, P3, DOI 10.1590/S0100-879X2003000100002; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Shen YF, 2001, ANAL CHEM, V73, P3011, DOI 10.1021/ac001393n; Slysz G. W., 2010, DECONTOOLS FRAMEWORK; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Tam MA, 2008, IMMUNOL REV, V225, P140, DOI 10.1111/j.1600-065X.2008.00679.x; Team RDC, 2019, R LANG ENV STAT COMP; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Yoon H, 2011, INFECT IMMUN, V79, P360, DOI 10.1128/IAI.00873-10	59	65	65	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67155	10.1371/journal.pone.0067155	http://dx.doi.org/10.1371/journal.pone.0067155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840608	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400076
J	Tondeleir, D; Drogat, B; Slowicka, K; Bakkali, K; Bartunkova, S; Goossens, S; Haigh, JJ; Ampe, C				Tondeleir, Davina; Drogat, Benjamin; Slowicka, Karolina; Bakkali, Karima; Bartunkova, Sonia; Goossens, Steven; Haigh, Jody J.; Ampe, Christophe			Beta-Actin Is Involved in Modulating Erythropoiesis during Development by Fine-Tuning Gata2 Expression Levels	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-2; ZINC-FINGER GENE; ERYTHROID DEVELOPMENT; MESSENGER-RNA; MICE LACKING; GAMMA-ACTIN; CELL-GROWTH; IN-VITRO; DIFFERENTIATION; SKELETAL	The functions of actin family members during development are poorly understood. To investigate the role of beta-actin in mammalian development, a beta-actin knockout mouse model was used. Homozygous beta-actin knockout mice are lethal at embryonic day (E) 10.5. At E10.25 beta-actin knockout embryos are growth retarded and display a pale yolk sac and embryo proper that is suggestive of altered erythropoiesis. Here we report that lack of beta-actin resulted in a block of primitive and definitive hematopoietic development. Reduced levels of Gata2, were associated to this phenotype. Consistently, ChIP analysis revealed multiple binding sites for beta-actin in the Gata2 promoter. Gata2 mRNA levels were almost completely rescued by expression of an erythroid lineage restricted ROSA26-promotor based GATA2 transgene. As a result, erythroid differentiation was restored and the knockout embryos showed significant improvement in yolk sac and embryo vascularization. These results provide new molecular insights for a novel function of beta-actin in erythropoiesis by modulating the expression levels of Gata2 in vivo.	[Tondeleir, Davina; Bakkali, Karima; Ampe, Christophe] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Drogat, Benjamin; Slowicka, Karolina; Bartunkova, Sonia; Goossens, Steven; Haigh, Jody J.] VIB, Vasc Cell Biol Unit, Dept Mol Biomed Res, Ghent, Belgium; [Drogat, Benjamin; Slowicka, Karolina; Bartunkova, Sonia; Goossens, Steven; Haigh, Jody J.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Haigh, JJ (corresponding author), VIB, Vasc Cell Biol Unit, Dept Mol Biomed Res, Ghent, Belgium.	Jody.Haigh@dmbr.UGent.be; christophe.ampe@ugent.be		Goossens, Steven/0000-0002-5693-8570; benjamin, Drogat/0000-0002-0020-4826; haigh, jody/0000-0002-7319-8922	Fund for Scientific Research - Flanders (Belgium);  [G.0441.10N]	Fund for Scientific Research - Flanders (Belgium)(FWO); 	This work was supported by Fund for Scientific Research - Flanders (Belgium). Davina Tondeleir is a pre doctoral fellow of this Fund and Christophe Ampe received a research grant G.0441.10N (http://www.fwo.be/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose F, 2006, MOL CELL BIOL, V26, P3942, DOI 10.1128/MCB.26.10.3942-3954.2006; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Bunnell TM, 2010, CYTOSKELETON, V67, P564, DOI 10.1002/cm.20467; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Drogat B, 2010, BLOOD, V116, P2141, DOI 10.1182/blood-2010-01-264143; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; HILL MA, 1993, J CELL BIOL, V122, P825, DOI 10.1083/jcb.122.4.825; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; Huang Z, 2009, MOL CELL BIOL, V29, P5168, DOI 10.1128/MCB.00482-09; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Kaplan J, 1997, NUCLEIC ACIDS RES, V25, P1108, DOI 10.1093/nar/25.6.1108; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Lee BK, 2012, J BIOL CHEM, V287, P30906, DOI 10.1074/jbc.R111.324962; Liao W, 2000, DEVELOPMENT, V127, P4303; Lim KC, 2012, J CLIN INVEST, V122, P3705, DOI 10.1172/JCI61619; Liu C, 1999, EXP HEMATOL, V27, P313, DOI 10.1016/S0301-472X(98)00035-6; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; MOOS M, 1983, EMBO J, V2, P757, DOI 10.1002/j.1460-2075.1983.tb01496.x; MORRIS JF, 1995, BLOOD, V86, P3640; Nagy A, 2003, MANIPULATING MOUSE E, VIX, P764; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Orford RL, 1998, MOL CELL BIOL, V18, P5557, DOI 10.1128/MCB.18.9.5557; Peckham M, 2001, J CELL SCI, V114, P1367; PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shmerling D, 2005, GENESIS, V42, P229, DOI 10.1002/gene.20135; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; Tondeleir D, 2012, MOL CELL PROTEOMICS; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Watanabe H, 1998, J CELL SCI, V111, P1287; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	45	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67855	10.1371/journal.pone.0067855	http://dx.doi.org/10.1371/journal.pone.0067855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840778	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400118
J	de Araujo, RF; Souza, TO; de Medeiros, CAX; de Souza, LB; Freitas, MD; de Lucena, HF; Alves, MDCF; de Araujo, AA				de Araujo Junior, Raimundo Fernandes; Souza, Tatiana Oliveira; Xavier de Medeiros, Caroline Addison; de Souza, Lelia Batista; Freitas, Maria de Lourdes; de Lucena, Hevio Freitas; Costa Feitosa Alves, Maria do Socorro; de Araujo, Aurigena Antunes			Carvedilol Decrease IL-1 beta and TNF-alpha, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of Periodontitis	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; MATRIX METALLOPROTEINASE-2 AND-9; DISEASE; ANTIOXIDANT; ATHEROSCLEROSIS; DOXORUBICIN; DAMAGE; CELLS	Periodontal diseases are initiated primarily by Gram-negative, tooth-associated microbial biofilms that elicit a host response that causes osseous and soft tissue destruction. Carvedilol is a beta-blocker used as a multifunctional neurohormonal antagonist that has been shown to act not only as an anti-oxidant but also as an anti-inflammatory drug. This study evaluated whether Carvedilol exerted a protective role against ligature-induced periodontitis in a rat model and defined how Carvedilol affected metalloproteinases and RANKL/RANK/OPG expression in the context of bone remodeling. Rats were randomly divided into 5 groups (n = 10/group): (1) non-ligated (NL), (2) ligature-only (LO), and (3) ligature plus Carvedilol (1, 5 or 10 mg/kg daily for 10 days). Periodontal tissue was analyzed for histopathlogy and using immunohistochemical analysis characterized the expression profiles of MMP-2, MMP-9, COX-2, and RANKL/RANK/OPG and determined the presence of IL-1 beta, IL-10 and TNF-alpha, myeloperoxidase (MPO), malonaldehyde (MDA) and, glutathione (GSH). MPO activity in the group with periodontal disease was significantly increased compared to the control group (p<0.05). Rats treated with 10 mg/kg Carvedilol presented with significantly reduced MPO and MDA concentrations (p<0.05) in addition to presenting with reduced levels of the pro-inflammatory cytokines IL-1 beta and TNF-alpha (p<0.05). IL-10 levels in Carvedilol-treated rats remained unaltered. Immunohistochemical analysis demonstrated reduced expression of MMP-2, MMP-9, RANK, RANKL, COX-2, and OPG in rats treated with 10 mg/kg Carvedilol. This study demonstrated that Carvedilol affected bone formation/destruction and anti-inflammatory activity in a rat model of periodontitis.	[de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Post Grad Program Hlth Sci, Post Grad Program Funct & Struct Biol, Natal, RN, Brazil; [Souza, Tatiana Oliveira] UFRN, Post Grad Program Hlth Sci, Mossoro, RN, Brazil; [Souza, Tatiana Oliveira] FACENE, Mossoro, RN, Brazil; [Xavier de Medeiros, Caroline Addison] UERN, Post Grad Program Hlth & Soc, Mossoro, RN, Brazil; [de Souza, Lelia Batista] Univ Fed Rio Grande do Norte, Postgrad Program Oral Pathol, Natal, RN, Brazil; [Freitas, Maria de Lourdes] Univ Fed Rio Grande do Norte, Dept Morphol, Natal, RN, Brazil; [de Lucena, Hevio Freitas] Univ Fed Rio Grande do Norte, Dept Dent, Natal, RN, Brazil; [Costa Feitosa Alves, Maria do Socorro] Univ Fed Rio Grande do Norte, Postgrad Program Publ Hlth, Postgrad Program Hlth Sci, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Postgrad Program Pharmaceut Sci, Postgrad Program Publ Hlth, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade do Estado do Rio Grande do Norte (UERN); Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Araujo, AA (corresponding author), Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Postgrad Program Pharmaceut Sci, Postgrad Program Publ Hlth, Natal, RN, Brazil.	aurigena@ufrnet.br	de Araujo, Aurigena/ABI-8455-2020					Akbas H, 2005, J INT MED RES, V33, P528, DOI 10.1177/147323000503300508; Batista RD, 2012, CAD SAUDE PUBLICA, V28, P965, DOI 10.1590/S0102-311X2012000500015; Chen-Scarabelli C, 2012, AM J CARDIOVASC DRUG, V12, P391, DOI 10.2165/11636090-000000000-00000; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Goto S, 2011, AM J NEPHROL, V34, P281, DOI 10.1159/000330853; Kaner D, 2006, J PERIODONTAL RES, V41, P132, DOI 10.1111/j.1600-0765.2005.00849.x; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Kim YH, 2012, TOXICOL MECH METHOD, V22, P488, DOI 10.3109/15376516.2012.678406; Kowalski J, 2008, CELL MOL BIOL LETT, V13, P230, DOI 10.2478/s11658-007-0049-3; Kowalski Jan, 2005, Pol Merkur Lekarski, V18, P156; Kumar A, 2009, PHARMACOL BIOCHEM BE, V92, P25, DOI 10.1016/j.pbb.2008.10.005; Leitao RFC, 2005, J PERIODONTOL, V76, P956, DOI 10.1902/jop.2005.76.6.956; Li B, 2006, INT J CARDIOL, V111, P247, DOI 10.1016/j.ijcard.2005.08.065; Li YC, 2008, J CARDIOVASC PHARM, V51, P92, DOI 10.1097/FJC.0b013e31815c6624; Lorencini M, 2009, HISTOL HISTOPATHOL, V24, P157, DOI 10.14670/HH-24.157; Maeso G, 2007, QUINTESSENCE INT, V38, P247; Marazzi G, 2011, J CARD FAIL, V17, P703, DOI 10.1016/j.cardfail.2011.05.001; Miyaki K, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-131; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Smith PC, 2004, J PERIODONTAL RES, V39, P87, DOI 10.1111/j.1600-0765.2004.00705.x; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Wu TC, 2007, FREE RADICAL BIO MED, V43, P1508, DOI 10.1016/j.freeradbiomed.2007.08.010; Xu L, 2008, ACTA ODONTOL SCAND, V66, P219, DOI 10.1080/00016350802183393; Yuan ZY, 2004, AM J PHYSIOL-HEART C, V286, pH83, DOI 10.1152/ajpheart.00536.2003	26	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66391	10.1371/journal.pone.0066391	http://dx.doi.org/10.1371/journal.pone.0066391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843954	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000047
J	Fernandes, AD; Macklaim, JM; Linn, TG; Reid, G; Gloor, GB				Fernandes, Andrew D.; Macklaim, Jean M.; Linn, Thomas G.; Reid, Gregor; Gloor, Gregory B.			ANOVA-Like Differential Expression (ALDEx) Analysis for Mixed Population RNA-Seq	PLOS ONE			English	Article							COMPOSITIONAL DATA; GENE-EXPRESSION; STATISTICAL-METHODS; R-PACKAGE; METATRANSCRIPTOMES; READS; TOOLS	Experimental variance is a major challenge when dealing with high-throughput sequencing data. This variance has several sources: sampling replication, technical replication, variability within biological conditions, and variability between biological conditions. The high per-sample cost of RNA-Seq often precludes the large number of experiments needed to partition observed variance into these categories as per standard ANOVA models. We show that the partitioning of within-condition to between-condition variation cannot reasonably be ignored, whether in single-organism RNA-Seq or in Meta-RNA-Seq experiments, and further find that commonly-used RNA-Seq analysis tools, as described in the literature, do not enforce the constraint that the sum of relative expression levels must be one, and thus report expression levels that are systematically distorted. These two factors lead to misleading inferences if not properly accommodated. As it is usually only the biological between-condition and within-condition differences that are of interest, we developed ALDEx, an ANOVA-like differential expression procedure, to identify genes with greater between- to within-condition differences. We show that the presence of differential expression and the magnitude of these comparative differences can be reasonably estimated with even very small sample sizes.	[Fernandes, Andrew D.] YouKaryote Genom, London, ON, Canada; [Macklaim, Jean M.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Linn, Thomas G.; Reid, Gregor] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Reid, Gregor] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Macklaim, Jean M.; Reid, Gregor; Gloor, Gregory B.] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Gloor, GB (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	ggloor@uwo.ca	Gloor, Greg B/D-1671-2013; Reid, Gregor/ABE-8327-2020	Reid, Gregor/0000-0001-9658-5696; Gloor, Gregory/0000-0001-5803-3380	NSERC; CIHR; NSERC PDF; Ontario Graduate Scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); NSERC PDF(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	Funding for this work was under TL by NSERC, GR by NSERC and CIHR, GG by NSERC, AF by NSERC PDF and JM by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 2005, MATH GEOL, V37, P829, DOI 10.1007/s11004-005-7383-7; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bela A, 2010, UWEETR20100006; Berger JO, 2009, ANN STAT, V37, P905, DOI 10.1214/07-AOS587; BERGER JO, 1992, BIOMETRIKA, V79, P25, DOI 10.2307/2337144; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Efron B., 1993, INTRO BOOTSTRAP, V57; Egozcue JJ, 2005, MATH GEOL, V37, P795, DOI 10.1007/s11004-005-7381-9; Egozcue JJ, 2003, MATH GEOL, V35, P279, DOI 10.1023/A:1023818214614; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P183, DOI 10.4056/sigs.1202536; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Jaynes E.T., 2003, PROBABILITY THEORY L; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Macklaim JM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-12; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Mols M, 2010, INT J FOOD MICROBIOL, V137, P13, DOI 10.1016/j.ijfoodmicro.2009.09.027; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Newey W. K., 1994, HDB ECONOMETRICS, V4, P2111; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Pachter L, 2011, ARXIV11043889; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pawlowsky-Glahn V, 2006, GEOL SOC SPEC PUBL, V264, P1, DOI 10.1144/GSL.SP.2006.264.01.01; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Polymenakou PN, 2009, SYST APPL MICROBIOL, V32, P17, DOI 10.1016/j.syapm.2008.09.006; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rosenthal AZ, 2011, ISME J, V5, P1133, DOI 10.1038/ISMEJ.2011.3; Roy NC, 2011, BRIEF FUNCT GENOMICS, V10, P135, DOI 10.1093/bfgp/elr005; Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu ZJ, 2009, STAT METHODS MED RES, V18, P533, DOI 10.1177/0962280209351924	56	299	302	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67019	10.1371/journal.pone.0067019	http://dx.doi.org/10.1371/journal.pone.0067019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843979	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000028
J	Gushchin, I; Gordeliy, V; Grudinin, S				Gushchin, Ivan; Gordeliy, Valentin; Grudinin, Sergei			Two Distinct States of the HAMP Domain from Sensory Rhodopsin Transducer Observed in Unbiased Molecular Dynamics Simulations	PLOS ONE			English	Article							PROTEIN FORCE-FIELDS; HISTIDINE KINASE; LINKER REGION; STRUCTURAL-ANALYSIS; MUTATIONAL ANALYSIS; RECEPTOR; MECHANISM; COMPLEX; HELICES; CONFORMATIONS	HAMP domain is a ubiquitous module of bacterial and archaeal two-component signaling systems. Considerable progress has been made recently in studies of its structure and conformational changes. However, the mechanism of signal transduction through the HAMP domain is not clear. It remains a question whether all the HAMPs have the same mechanism of action and what are the differences between the domains from different protein families. Here, we present the results of unbiased molecular dynamics simulations of the HAMP domain from the archaeal phototaxis signal transducer NpHtrII. Two distinct conformational states of the HAMP domain are observed, that differ in relative position of the helices AS1 and AS2. The longitudinal shift is roughly equal to a half of an alpha-helix turn, although sometimes it reaches one full turn. The states are closely related to the position of bulky hydrophobic aminoacids at the HAMP domain core. The observed features are in good agreement with recent experimental results and allow us to propose that the states detected in the simulations are the resting state and the signaling state of the NpHtrII HAMP domain. To the best of our knowledge, this is the first observation of the same HAMP domain in different conformations. The simulations also underline the difference between AMBER ff99-SB- ILDN and CHARMM22-CMAP forcefields, as the former favors the resting state and the latter favors the signaling state.	[Gushchin, Ivan; Gordeliy, Valentin] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Gushchin, Ivan; Gordeliy, Valentin] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Gushchin, Ivan; Gordeliy, Valentin] CNRS, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Gushchin, Ivan; Gordeliy, Valentin] Moscow Inst Phys & Technol, Res Educ Ctr Bionanophys, Dolgoprudnyi, Russia; [Gordeliy, Valentin] Res Ctr Julich, Inst Complex Syst, ICS Struct Biochem 6, Julich, Germany; [Grudinin, Sergei] Inria Grenoble Rhone Alpes Res Ctr, NANO D, Montbonnot St Martin, France; [Grudinin, Sergei] CNRS, Lab Jean Kuntzmann, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Moscow Institute of Physics & Technology; Helmholtz Association; Research Center Julich; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Inria	Grudinin, S (corresponding author), Inria Grenoble Rhone Alpes Res Ctr, NANO D, Montbonnot St Martin, France.	sergei.grudinin@inria.fr	Gordeliy, Valentin I/J-3636-2013; Gushchin, Ivan/AAO-8829-2020; Gushchin, Ivan/K-9197-2015; Grudinin, Sergei/S-6555-2019	Gordeliy, Valentin I/0000-0001-5782-5896; Gushchin, Ivan/0000-0002-5348-6070; Gushchin, Ivan/0000-0002-5348-6070; Grudinin, Sergei/0000-0002-1903-7220	ANR France; CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement; MC grant (Marie Curie, project SBMPs) [FP7-PEOPLE-2007-1-1-ITN]; EC FP7 grant for the EDICT consortium [HEALTH-201924]; BMBF (PhoNa - Photonic Nanomaterials); Federal Target Program "Scientific and academic research cadres of innovative Russia"; Russian Academy of Sciences; ONEXIM, Russia	ANR France(French National Research Agency (ANR)); CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement(French Atomic Energy Commission); MC grant (Marie Curie, project SBMPs); EC FP7 grant for the EDICT consortium; BMBF (PhoNa - Photonic Nanomaterials); Federal Target Program "Scientific and academic research cadres of innovative Russia"; Russian Academy of Sciences(Russian Academy of Sciences); ONEXIM, Russia	The simulations were performed with a grant for computing time at the Juelich Supercomputing Center. The work was supported by the program "Chaires d'excellence'' edition 2008 of ANR France, CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement, the MC grant (Marie Curie, FP7-PEOPLE-2007-1-1-ITN, project SBMPs) and an EC FP7 grant for the EDICT consortium (HEALTH-201924). Part of this work was supported by BMBF (PhoNa - Photonic Nanomaterials). The work was partially supported by the Federal Target Program "Scientific and academic research cadres of innovative Russia for 2009-2013 years and by the "Molecular and Cellular Biology'' program of the Russian Academy of Sciences. The authors greatly acknowledge support of this work by ONEXIM, Russia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airola MV, 2010, STRUCTURE, V18, P436, DOI 10.1016/j.str.2010.01.013; Ames P, 2008, J BACTERIOL, V190, P6676, DOI 10.1128/JB.00750-08; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Bordignon E, 2005, J BIOL CHEM, V280, P38767, DOI 10.1074/jbc.M509391200; Butler SL, 1998, BIOCHEMISTRY-US, V37, P10746, DOI 10.1021/bi980607g; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Cheung J, 2009, STRUCTURE, V17, P190, DOI 10.1016/j.str.2008.12.013; Doebber M, 2008, J BIOL CHEM, V283, P28691, DOI 10.1074/jbc.M801931200; Etzkorn M, 2010, STRUCTURE, V18, P293, DOI 10.1016/j.str.2010.01.011; Falke JJ, 2009, STRUCTURE, V17, P1149, DOI 10.1016/j.str.2009.08.005; Ferris HU, 2012, STRUCTURE, V20, P56, DOI 10.1016/j.str.2011.11.014; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Gushchin IY, 2011, BIOCHEMISTRY-US, V50, P574, DOI 10.1021/bi101032a; Hall BA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002685; Hall BA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002204; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Lemmin T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002878; Lindorff-Larsen K., 2012, PLOS ONE, V7, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0032131, 10.1371/journal.pone.0032131]; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Nishikata K, 2012, BIOCHEMISTRY-US, V51, P5958, DOI 10.1021/bi300696b; Nishikata Koro, 2010, Biophysics (Nagoya-shi), V6, P27, DOI 10.2142/biophysics.6.27; Park H, 2011, BIOPHYS J, V100, P2955, DOI 10.1016/j.bpj.2011.05.030; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; Wang JH, 2012, J BIOL CHEM, V287, P21316, DOI 10.1074/jbc.M112.344622; Watts KJ, 2008, J BACTERIOL, V190, P2118, DOI 10.1128/JB.01858-07; Williams SB, 1999, MOL MICROBIOL, V33, P1093, DOI 10.1046/j.1365-2958.1999.01562.x; Zhou Q, 2011, MOL MICROBIOL, V80, P596, DOI 10.1111/j.1365-2958.2011.07577.x; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x	42	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66917	10.1371/journal.pone.0066917	http://dx.doi.org/10.1371/journal.pone.0066917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843970	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000022
J	Lohse, B; Helgstrand, C; Kristensen, JBL; Leurs, U; Cloos, PAC; Kristensen, JL; Clausen, RP				Lohse, Brian; Helgstrand, Charlotte; Kristensen, Jan B. L.; Leurs, Ulrike; Cloos, Paul A. C.; Kristensen, Jesper L.; Clausen, Rasmus P.			Posttranslational Modifications of the Histone 3 Tail and Their Impact on the Activity of Histone Lysine Demethylases In Vitro	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; CHROMATIN; H3; GENOME; GENES; CODE; PHOSPHORYLATION; HETEROCHROMATIN; SENESCENCE; DYNAMICS	Posttranslational modifications (PTMs) of the histone H3 tail such as methylation, acetylation and phosphorylation play important roles in epigenetic signaling. Here we study the effect of some of these PTMs on the demethylation rates of methylated lysine 9 in vitro using peptide substrates mimicking histone H3. Various combinations with other PTMs were employed to study possible cross-talk effects by comparing enzyme kinetic characteristics. We compared the kinetics of histone tail substrates for truncated histone lysine demethylases KDM4A and KDM4C containing only the catalytic core (cc) and some combinations were characterized on full length (FL) KDM4A and KDM4C. We found that the substrates combining trimethylated K4 and K9 resulted in a significant increase in the catalytic activity for FL-KDM4A. For the truncated versions of KDM4A and KDM4C a two-fold increase in the catalytic activity toward bis-trimethylated substrates could be observed. Furthermore, a significant difference in the catalytic activity between dimethylated and trimethylated substrates was found for full length demethylases in line with what has been reported previously for truncated demethylases. Histone peptide substrates phosphorylated at T11 could not be demethylated by neither truncated nor full length KDM4A and KDM4C, suggesting that phosphorylation of threonine 11 prevents demethylation of the H3K9me3 mark on the same peptide. Acetylation of K14 was also found to influence demethylation rates significantly. Thus, for truncated KDM4A, acetylation on K14 of the substrate leads to an increase in enzymatic catalytic efficiency (k(cat)/K-m), while for truncated KDM4C it induces a decrease, primarily caused by changes in K-m. This study demonstrates that demethylation activities towards trimethylated H3K9 are significantly influenced by other PTMs on the same peptide, and emphasizes the importance of studying these interactions at the peptide level to get a more detailed understanding of the dynamics of epigenetic marks.	[Lohse, Brian; Helgstrand, Charlotte; Kristensen, Jan B. L.; Leurs, Ulrike; Kristensen, Jesper L.; Clausen, Rasmus P.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Cloos, Paul A. C.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Lohse, B (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark.	bril@sund.ku.dk; rac@sund.ku.dk	Kristensen, Jesper/AAP-4439-2021; Clausen, Rasmus P/A-6812-2008; Kristensen, Jesper/E-3581-2010	Kristensen, Jesper/0000-0002-5613-1267; Clausen, Rasmus P/0000-0001-9466-9431; Kristensen, Jesper/0000-0002-5613-1267; Leurs, Ulrike/0000-0002-8828-3505; Cloos, Paul/0000-0001-5863-0054; Lohse, Brian/0000-0003-0479-8980	University of Copenhagen Program of Excellence; Danish National Research Foundation; Danish Medical Research Council; Danish Cancer Society; Lundbeckfonden	University of Copenhagen Program of Excellence; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Lundbeckfonden(Lundbeckfonden)	The University of Copenhagen Program of Excellence, the Danish National Research Foundation, the Danish Medical Research Council, and the Danish Cancer Society are gratefully acknowledged for supporting the research. Lundbeckfonden is acknowledged for support to J.B.L. Kristensen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Govin J, 2010, GENE DEV, V24, P1772, DOI 10.1101/gad.1954910; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krishnan S, 2013, STRUCTURE, V21, P98, DOI 10.1016/j.str.2012.10.018; Krishnan S, 2012, ANAL BIOCHEM, V420, P48, DOI 10.1016/j.ab.2011.08.034; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lohse B, 2011, ANGEW CHEM INT EDIT, V50, P9100, DOI 10.1002/anie.201101849; Lohse B, 2011, BIOORGAN MED CHEM, V19, P3625, DOI 10.1016/j.bmc.2011.01.046; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Wang Y, 2012, J BIOL CHEM, V287, P4386, DOI 10.1074/jbc.M111.329417; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yang YW, 2003, ENDOCRINOLOGY, V144, P5658, DOI 10.1210/en.2003-0798	31	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67653	10.1371/journal.pone.0067653	http://dx.doi.org/10.1371/journal.pone.0067653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844048	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000068
J	Ohba, S; Ohashi, K; Pujiyati, E; Higa, Y; Kawada, H; Mito, N; Takagi, M				Ohba, Shin-ya; Ohashi, Kazunori; Pujiyati, Endang; Higa, Yukiko; Kawada, Hitoshi; Mito, Nobuaki; Takagi, Masahiro			The Effect of Pyriproxyfen as a "Population Growth Regulator" against Aedes albopictus under Semi-Field Conditions	PLOS ONE			English	Article							INSECT DEVELOPMENTAL INHIBITORS; JUVENILE-HORMONE; MOSQUITO LARVAE; AEGYPTI DIPTERA; PYRETHROID SUSCEPTIBILITY; STEGOMYIA AEGYPTI; DENGUE VECTORS; CULICIDAE; TIRES; CHIKUNGUNYA	An insect growth regulator, pyriproxyfen, has been used for the control of a range of pest insects, including mosquitoes. Pyriproxyfen is effective in inhibiting adult emergence and sterilizing adult females. The Asian tiger mosquito, Aedes albopictus (Skuse), is an important vector of dengue and chikungunya, and is expanding its distribution throughout Europe and the Americas. In the present study, we evaluated the impact of pyriproxyfen-treated bed nets on population growth of Ae. albopictus under semi-field conditions, using 6 small microcosms. We created microcosms containing breeding sites to simulate the natural ecosystem of vector mosquito and installing miniature bed net treated with 350 mg/m(2) pyriproxyfen in Experiment I and 35 mg/m(2) in Experiment II. For each experiment, we also established microcosms installing untreated polyethylene net (untreated control). The installing nets were provided with artificially torn holes, to simulate damage and allow mosquitoes to penetrate. We released 100 pairs of Ae. albopictus into each microcosm, and allowed them to feed on a mouse under the bed nets at approximately 1-week intervals. In comparison with the untreated control microcosms, the number of eggs laid by the released adults in the pyriproxyfen-treated microcosms was significantly lower in both Experiment I and II. Moreover, egg hatchability was significantly suppressed and pupal mortality was increased. Our results indicate that tarsal contact with pyriproxyfen has been shown to suppress egg production and hatchability in adult females and the auto-dissemination of pyriproxyfen into larval breeding sites by adult mosquitoes, through contact with pyriproxyfen-treated polyethylene bed nets, may suppress the mosquito population density.	[Ohba, Shin-ya] Nagasaki Univ, Fac Educ, Biol Lab, Nagasaki 852, Japan; [Pujiyati, Endang; Higa, Yukiko; Kawada, Hitoshi; Takagi, Masahiro] Nagasaki Univ, Inst Trop Med, Dept Vector Ecol & Environm, Nagasaki 852, Japan	Nagasaki University; Nagasaki University	Ohba, S (corresponding author), Nagasaki Univ, Fac Educ, Biol Lab, Nagasaki 852, Japan.	ooba@nagasaki-u.ac.jp	Ohba, Shin-ya/M-5406-2019	Ohba, Shin-ya/0000-0003-3854-0902	Innovative Vector Control Consortium (IVCC); Bill & Melinda Gates Foundation; Nagasaki University; Sumitomo Chemical Co. Ltd.	Innovative Vector Control Consortium (IVCC); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Nagasaki University; Sumitomo Chemical Co. Ltd.(Sumitomo Chem Co Ltd)	The study was funded by the Innovative Vector Control Consortium (IVCC), a Product Development Partnership established as a not-for-profit company and registered charity, with funding from the Bill & Melinda Gates Foundation and the joint research fund between Nagasaki University and Sumitomo Chemical Co. Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXTELL RC, 1980, MOSQ NEWS, V40, P36; BONNET DD, 1946, AM J TROP MED, V26, P465, DOI 10.4269/ajtmh.1946.s1-26.465; Cancrini G, 2003, VET PARASITOL, V118, P195, DOI 10.1016/j.vetpar.2003.10.011; Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793; Chism BD, 2003, MED VET ENTOMOL, V17, P211, DOI 10.1046/j.1365-2915.2003.00433.x; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; ESTRADA JG, 1986, J AM MOSQUITO CONTR, V2, P57; Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI [10.1111/j.1365-3156.2007.01838, 10.1111/j.1365-3156.2007.01838.x]; Gaugler R, 2012, MED VET ENTOMOL, V26, P37, DOI 10.1111/j.1365-2915.2011.00970.x; Hatakoshi M., 1987, Japanese Journal of Sanitary Zoology, V38, P271; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Hirano M., 1998, REV TOXICOL, V2, P357; Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495; Igarashi A, 1997, FEMS IMMUNOL MED MIC, V18, P291, DOI 10.1111/j.1574-695X.1997.tb01058.x; Iseki R., 2013, ANOVA KUN; ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344; Itoh T, 1994, TROP MED, V35, P259; Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2; JUDSON CL, 1976, J MED ENTOMOL, V13, P197, DOI 10.1093/jmedent/13.2.197; KARCH S, 1995, J AM MOSQUITO CONTR, V11, P191; Kawada H., 1988, Japanese Journal of Sanitary Zoology, V39, P339; Kawada H, 2010, JPN J INFECT DIS, V63, P19; Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000391; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; KIRITANI K, 1967, Researches on Population Ecology (Tokyo), V9, P143, DOI 10.1007/BF02514921; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Lounibos LP, 2007, J AM MOSQUITO CONTR, V23, P276, DOI 10.2987/8756-971X(2007)23[276:CDAR]2.0.CO;2; MANLY B F J, 1976, Researches on Population Ecology (Tokyo), V17, P191, DOI 10.1007/BF02530770; Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x; MIURA T, 1974, ENVIRON ENTOMOL, V3, P631, DOI 10.1093/ee/3.4.631; MIURA T, 1973, J ECON ENTOMOL, V66, P917, DOI 10.1093/jee/66.4.917; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; MULLA MS, 1986, J AM MOSQUITO CONTR, V2, P314; Ng LFP, 2009, MICROBES INFECT, V11, P1163, DOI 10.1016/j.micinf.2009.09.001; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006; PATTERSON JW, 1974, J INSECT PHYSIOL, V20, P2095, DOI 10.1016/0022-1910(74)90036-5; Pethuan S, 2007, TROP BIOMED, V24, P7; Ping LT, 2001, J AM MOSQUITO CONTR, V17, P144; Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Satho Tomomitsu, 2003, Medical Entomology and Zoology, V54, P155; SHAPIRO AB, 1986, J INSECT PHYSIOL, V32, P867, DOI 10.1016/0022-1910(86)90102-2; Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2; Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2; Sunahara T, 2002, J VECTOR ECOL, V27, P8; Sunahara T, 1997, RES POPUL ECOL, V39, P173, DOI 10.1007/BF02765263; Takagi Masahiro, 1995, Japanese Journal of Sanitary Zoology, V46, P131; Takagi Masahiro, 1995, Tropical Medicine, V37, P87; Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2; Zaim M., 2007, GLOBAL INSECTICIDE U	56	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67045	10.1371/journal.pone.0067045	http://dx.doi.org/10.1371/journal.pone.0067045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843982	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000029
J	Li, T; Wu, KL; You, L; Xing, XY; Wang, P; Cui, LL; Liu, HB; Cui, YQ; Bian, YH; Ning, YN; Zhao, H; Tang, R; Chen, ZJ				Li, Tao; Wu, Keliang; You, Li; Xing, Xiuye; Wang, Peng; Cui, Linlin; Liu, Hongbin; Cui, Yuqian; Bian, Yuehong; Ning, Yunna; Zhao, Han; Tang, Rong; Chen, Zi-Jiang			Common Variant rs9939609 in Gene FTO Confers Risk to Polycystic Ovary Syndrome	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; FAT MASS; OBESITY; WOMEN; METAANALYSIS; PREVALENCE; CHILDHOOD; LOCI	Background: Fat mass and obesity-associated gene (FTO) has been associated with obesity, especially the common variant rs9939609. Polycystic ovary syndrome (PCOS) is a complex endocrine-metabolic disorder and over 50% of patients are overweight/obese. Thus FTO is a potential candidate gene for PCOS but their relationship is confusing and remains to be clarified in different population with a large sample size. Method: This study was performed adopting a two-stage design by genotyping SNP rs9939609. The first set comprise of 741 PCOS and 704 control subjects, with data from our previous GWAS. The second phase of replication study was performed among another independent group of 2858 PCOS and 2358 control subjects using TaqMan-MGB probe assay. All subjects are from Han Chinese. Results: The less meaningful association of FTO rs9939609 and PCOS discovered in GWAS (P = 2.47E-03), was further confirmed in the replication study (P = 1.86E-09). Using meta-analysis, the P-meta value has reached 6.89E-12, over-exceeding the genome-wide association level of 5.00E-8. By combination, the P value was 1.26E-11 and after BMI adjustment it remained significant(P = 1.82E-06). To further elucidate whether this association is resulted from obesity or PCOS per se, the samples were divided into two groups-obese and non-obese PCOS, and the results were still positive in obese group (P obese = 5.81E-05, OR = 1.55), as well as in non-obese PCOS group (P non-obese = 7.06E-04, OR = 1.28). Conclusion: Variant rs9939609 in FTO is associated with PCOS in Chinese women, not only in obese PCOS subjects, but also in non-obese cases.	[Li, Tao; Wu, Keliang; You, Li; Xing, Xiuye; Wang, Peng; Cui, Linlin; Liu, Hongbin; Bian, Yuehong; Ning, Yunna; Zhao, Han; Tang, Rong; Chen, Zi-Jiang] Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China; [Li, Tao; Wu, Keliang; You, Li; Xing, Xiuye; Wang, Peng; Cui, Linlin; Liu, Hongbin; Bian, Yuehong; Ning, Yunna; Zhao, Han; Tang, Rong; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Wu, Keliang; You, Li; Liu, Hongbin; Bian, Yuehong; Ning, Yunna; Zhao, Han; Chen, Zi-Jiang] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Wu, Keliang; You, Li; Liu, Hongbin; Bian, Yuehong; Ning, Yunna; Zhao, Han; Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China; [Cui, Yuqian; Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University	Tang, R (corresponding author), Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China.	tangrong2293@yahoo.com.cn; chenzijiang@hotmail.com	Chen, Zi-Jiang/GOE-6119-2022; WANG, Peng/GSN-5263-2022; Li, Yuan/GXV-1310-2022; Wu, Ke/HCQ-3503-2022; Yan, Junhao/AAH-8310-2019	Chen, Zi-Jiang/0000-0001-6637-6631	National Basic Research Program of China (973 program) [2012CB944700, 2011CB944502]; National Natural Science Foundation of China [81000238, 81200409]; Scientific Research Foundation of Shandong Province of Outstanding Young Scientist [2012BSE27089]; Clinical Postdoctoral Science Foundation [2011M500745]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Shandong Province of Outstanding Young Scientist; Clinical Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Basic Research Program of China (973 program) (2012CB944700, 2011CB944502), the National Natural Science Foundation of China (81000238, 81200409) and the Scientific Research Foundation of Shandong Province of Outstanding Young Scientist (2012BSE27089). Clinical Postdoctoral Science Foundation funded project (2011M500745). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato P, 2004, BEST PRACT RES CL OB, V18, P707, DOI 10.1016/j.bpobgyn.2004.05.002; Attaoua R, 2008, BIOCHEM BIOPH RES CO, V373, P230, DOI 10.1016/j.bbrc.2008.06.039; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P453, DOI 10.1210/jc.2003-031122; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; BALEN AH, 1995, HUM REPROD, V10, P2107, DOI 10.1093/oxfordjournals.humrep.a136243; Barber TM, 2008, DIABETOLOGIA, V51, P1153, DOI 10.1007/s00125-008-1028-6; Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Carmina E, 2006, FERTIL STERIL, V86, pS7, DOI 10.1016/j.fertnstert.2006.03.012; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Ewens KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016390; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Hatziagelaki E, 2012, HORM METAB RES; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Kim JI, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-482; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Lim SS, 2013, OBES REV, V14, P95, DOI 10.1111/j.1467-789X.2012.01053.x; Lim SS, 2012, HUM REPROD UPDATE, V18, P618, DOI 10.1093/humupd/dms030; Olszewski PK, 2011, PHYSIOL BEHAV, V103, P248, DOI 10.1016/j.physbeh.2011.01.022; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Qu F, 2012, J MOL MED, V90, P911, DOI 10.1007/s00109-012-0881-4; Saxena R, 2012, ACTA DIABETOL; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Shi YH, 2007, NEUROENDOCRINOL LETT, V28, P807; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tan S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-12; Velders FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049131; Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Walley AJ, 2006, HUM MOL GENET, V15, pR124, DOI 10.1093/hmg/ddl215; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wehr E, 2010, METABOLISM, V59, P575, DOI 10.1016/j.metabol.2009.08.023; Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wojciechowski P, 2012, DIABETOLOGIA; Wu Q, 2010, BIOCHEM BIOPH RES CO, V401, P390, DOI 10.1016/j.bbrc.2010.09.064; Yan Q, 2009, ENDOCRINE, V36, P377, DOI 10.1007/s12020-009-9257-0	45	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e66250	10.1371/journal.pone.0066250	http://dx.doi.org/10.1371/journal.pone.0066250			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840863	gold, Green Published, Green Submitted			2022-12-27	WOS:000321271900002
J	Chen, G; Zhao, L; Feng, JT; You, GX; Sun, QM; Li, PL; Han, D; Zhou, H				Chen, Gan; Zhao, Lian; Feng, Jiantao; You, Guoxing; Sun, Quanmei; Li, Penglong; Han, Dong; Zhou, Hong			Validation of Reliable Reference Genes for Real-Time PCR in Human Umbilical Vein Endothelial Cells on Substrates with Different Stiffness	PLOS ONE			English	Article							NEUTROPHIL TRANSMIGRATION; ARTERIAL STIFFNESS; MATRIX STIFFNESS; EXPRESSION; ACTIVATION; PROTEIN; SOFT	Background: The mechanical properties of cellular microenvironments play important roles in regulating cellular functions. Studies of the molecular response of endothelial cells to alterations in substrate stiffness could shed new light on the development of cardiovascular disease. Quantitative real-time PCR is a current technique that is widely used in gene expression assessment, and its accuracy is highly dependent upon the selection of appropriate reference genes for gene expression normalization. This study aimed to evaluate and identify optimal reference genes for use in studies of the response of endothelial cells to alterations in substrate stiffness. Methodology/Principal Findings: Four algorithms, GeNorm(PLUS), NormFinder, BestKeeper, and the Comparative Delta Ct method, were employed to evaluate the expression of nine candidate genes. We observed that the stability of potential reference genes varied significantly in human umbilical vein endothelial cells on substrates with different stiffness. B2M, HPRT-1, and YWHAZ are suitable for normalization in this experimental setting. Meanwhile, we normalized the expression of YAP and CTGF using various reference genes and demonstrated that the relative quantification varied according to the reference genes. Conclusion/Significance:: Consequently, our data show for the first time that B2M, HPRT-1, and YWHAZ are a set of stably expressed reference genes for accurate gene expression normalization in studies exploring the effect of subendothelial matrix stiffening on endothelial cell function. We furthermore caution against the use of GAPDH and ACTB for gene expression normalization in this experimental setting because of the low expression stability in this study.	[Chen, Gan; Zhao, Lian; You, Guoxing; Li, Penglong; Zhou, Hong] Acad Mil Med Sci, Inst Transfus Med, Beijing, Peoples R China; [Feng, Jiantao; Sun, Quanmei; Han, Dong] Natl Ctr Nanosci & Technol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Han, D (corresponding author), Natl Ctr Nanosci & Technol, Beijing, Peoples R China.	dhan@nanoctr.cn; zhouhtt1966@163.com	Chen, Gan/O-8508-2019	Chen, Gan/0000-0003-4586-4526	National Natural Science Foundation of China [31271001]; National High Technology Research and Development Program of China [2012AA021902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 31271001) and the National High Technology Research and Development Program of China (No. 2012AA021902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104; Bouvier M, 2003, MOL IMMUNOL, V39, P697, DOI 10.1016/S0161-5890(02)00261-4; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Byfield FJ, 2009, J BIOMECH, V42, P1114, DOI 10.1016/j.jbiomech.2009.02.012; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Cohn JN, 2006, CIRCULATION, V113, P601, DOI 10.1161/CIRCULATIONAHA.105.600866; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Duprez DA, 2010, HYPERTENSION, V55, P612, DOI 10.1161/HYPERTENSIONAHA.109.144725; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Johnson LA, 2012, EXP MOL PATHOL, V93, P91, DOI 10.1016/j.yexmp.2012.04.014; Kolahi KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041717; Liao FL, 2006, TRENDS PHARMACOL SCI, V27, P287, DOI 10.1016/j.tips.2006.04.001; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; O'Connor RS, 2012, J IMMUNOL, V189, P1330, DOI 10.4049/jimmunol.1102757; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peloquin J, 2011, J BIOMECH, V44, P815, DOI 10.1016/j.jbiomech.2010.12.018; Peng XQ, 2003, HYPERTENSION, V41, P378, DOI 10.1161/01.HYP.0000049624.99844.3D; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6; Raghunathan VK, 2013, INVEST OPHTH VIS SCI, V54, P378, DOI 10.1167/iovs.12-11007; Rao SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035852; Saunders RL, 2010, CELL MOL BIOENG, V3, P60, DOI 10.1007/s12195-010-0112-4; Schlunck G, 2008, INVEST OPHTH VIS SCI, V49, P262, DOI 10.1167/iovs.07-0956; Schram MT, 2004, HYPERTENSION, V43, P176, DOI 10.1161/01.HYP.0000111829.46090.92; Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; STOUT JT, 1985, ANNU REV GENET, V19, P127, DOI 10.1146/annurev.genet.19.1.127; Stroka KM, 2012, J BIOMECH, V45, P1828, DOI 10.1016/j.jbiomech.2012.04.011; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Tilghman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037231; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Wood JA, 2010, MATERIALS, V3, P1620, DOI 10.3390/ma3031620; Wood JA, 2011, BIOMATERIALS, V32, P5056, DOI 10.1016/j.biomaterials.2011.03.054; Yeh YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046889	43	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67360	10.1371/journal.pone.0067360	http://dx.doi.org/10.1371/journal.pone.0067360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840676	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400067
J	Hosseini, SMH; Kesler, SR				Hosseini, S. M. Hadi; Kesler, Shelli R.			Influence of Choice of Null Network on Small-World Parameters of Structural Correlation Networks	PLOS ONE			English	Article							CORTICAL THICKNESS; BRAIN NETWORKS; MODULAR ORGANIZATION; ANATOMICAL NETWORKS; CONNECTIVITY; EFFICIENCY	In recent years, coordinated variations in brain morphology (e.g., volume, thickness) have been employed as a measure of structural association between brain regions to infer large-scale structural correlation networks. Recent evidence suggests that brain networks constructed in this manner are inherently more clustered than random networks of the same size and degree. Thus, null networks constructed by randomizing topology are not a good choice for benchmarking small-world parameters of these networks. In the present report, we investigated the influence of choice of null networks on small-world parameters of gray matter correlation networks in healthy individuals and survivors of acute lymphoblastic leukemia. Three types of null networks were studied: 1) networks constructed by topology randomization (TOP), 2) networks matched to the distributional properties of the observed covariance matrix (HQS), and 3) networks generated from correlation of randomized input data (COR). The results revealed that the choice of null network not only influences the estimated small-world parameters, it also influences the results of between-group differences in small-world parameters. In addition, at higher network densities, the choice of null network influences the direction of group differences in network measures. Our data suggest that the choice of null network is quite crucial for interpretation of group differences in small-world parameters of structural correlation networks. We argue that none of the available null models is perfect for estimation of small-world parameters for correlation networks and the relative strengths and weaknesses of the selected model should be carefully considered with respect to obtained network measures.	[Hosseini, S. M. Hadi; Kesler, Shelli R.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Kesler, Shelli R.] Stanford Canc Inst, Palo Alto, CA USA	Stanford University; Stanford Cancer Institute	Hosseini, SMH (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	hosseiny@stanford.edu	Hosseini, Hadi/AAF-7095-2020	Hosseini, Hadi/0000-0001-5186-7008	National Institutes of Health [1 DP2 OD004445-01]; National Cancer Institute [K07 CA134639]; NATIONAL CANCER INSTITUTE [R01CA172145, K07CA134639] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (1 DP2 OD004445-01 to SK) and the National Cancer Institute (K07 CA134639 to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Del Genio CI, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010012, 10.1371/journal.pone.0015369]; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Friston KJ, 2007, STAT PARAMETRIC MAPP, Vvii, P647; Gillis J, 2011, BIOINFORMATICS, V27, P1860, DOI 10.1093/bioinformatics/btr288; Gkantsidis C., 2003, P 5 WORKSH ALG ENG E; Gong GL, 2012, NEUROIMAGE, V59, P1239, DOI 10.1016/j.neuroimage.2011.08.017; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hirschberger M, 2007, EUR J OPER RES, V177, P1610, DOI 10.1016/j.ejor.2005.10.014; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Hosseini SMH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-28; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kesler SR, 2010, BRAIN IMAGING BEHAV, V4, P256, DOI 10.1007/s11682-010-9104-1; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lv B, 2010, NEUROIMAGE, V53, P373, DOI 10.1016/j.neuroimage.2010.05.020; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Raj A, 2010, NEUROIMAGE, V52, P1302, DOI 10.1016/j.neuroimage.2010.05.045; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schaeffer SE, 2007, COMPUT SCI REV, V1, P27, DOI 10.1016/j.cosrev.2007.05.001; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O., 2011, NETWORKS BRAIN; Sun JF, 2012, AGING DIS, V3, P181; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Viger F, 2005, LECT NOTES COMPUT SC, V3595, P440, DOI 10.1007/11533719_45; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhou LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021935; Zlatic V, 2009, EUR PHYS J B, V67, P271, DOI 10.1140/epjb/e2009-00007-9	60	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67354	10.1371/journal.pone.0067354	http://dx.doi.org/10.1371/journal.pone.0067354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840672	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400063
J	Jiang, HN; Zeng, B; Zhang, Y; Daskoulidou, N; Fan, H; Qu, JM; Xu, SZ				Jiang, Hong-Ni; Zeng, Bo; Zhang, Yi; Daskoulidou, Nikoleta; Fan, Hong; Qu, Jie-Ming; Xu, Shang-Zhong			Involvement of TRPC Channels in Lung Cancer Cell Differentiation and the Correlation Analysis in Human Non-Small Cell Lung Cancer	PLOS ONE			English	Article							TRANS-RETINOIC ACID; RECEPTOR POTENTIAL CHANNELS; CA2+ ENTRY; EPITHELIAL-CELLS; EXPRESSION; GROWTH; ARREST; PROLIFERATION; ACTIVATION; INDUCTION	The canonical transient receptor potential (TRPC) channels are Ca2+-permeable cationic channels controlling the Ca2+ influx evoked by G protein-coupled receptor activation and/or by Ca2+ store depletion. Here we investigate the involvement of TRPCs in the cell differentiation of lung cancer. The expression of TRPCs and the correlation to cancer differentiation grade in non-small cell lung cancer (NSCLC) were analyzed by real-time PCR and immunostaining using tissue microarrays from 28 patient lung cancer samples. The association of TRPCs with cell differentiation was also investigated in the lung cancer cell line A549 by PCR and Western blotting. The channel activity was monitored by Ca2+ imaging and patch recording after treatment with all-trans-retinoic acid (ATRA). The expression of TRPC1, 3, 4 and 6 was correlated to the differentiation grade of NSCLC in patients, but there was no correlation to age, sex, smoking history and lung cancer cell type. ATRA upregulated TRPC3, TRPC4 and TRPC6 expression and enhanced Ca2+ influx in A549 cells, however, ATRA showed no direct effect on TRPC channels. Inhibition of TRPC channels by pore-blocking antibodies decreased the cell mitosis, which was counteracted by chronic treatment with ATRA. Blockade of TRPC channels inhibited A549 cell proliferation, while overexpression of TRPCs increased the proliferation. We conclude that TRPC expression correlates to lung cancer differentiation. TRPCs mediate the pharmacological effect of ATRA and play important roles in regulating lung cancer cell differentiation and proliferation, which gives a new understanding of lung cancer biology and potential anti-cancer therapy.	[Jiang, Hong-Ni] Fudan Univ, Sch Med, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Jiang, Hong-Ni; Zeng, Bo; Daskoulidou, Nikoleta; Xu, Shang-Zhong] Univ Hull, Hull York Med Sch, Ctr Cardiovasc & Metab Res, Kingston Upon Hull HU6 7RX, N Humberside, England; [Zhang, Yi; Fan, Hong] Fudan Univ, Dept Thorac Surg, Zhongshan Hosp, Sch Med, Shanghai 200433, Peoples R China; [Qu, Jie-Ming] Fudan Univ, Dept Pulm Med, Huadong Hosp, Sch Med, Shanghai 200433, Peoples R China	Fudan University; University of Hull; University of York - UK; Fudan University; Fudan University	Qu, JM (corresponding author), Fudan Univ, Dept Pulm Med, Huadong Hosp, Sch Med, Shanghai 200433, Peoples R China.	jmqu0906@163.com; sam.xu@hyms.ac.uk	Xu, Shang-Zhong/P-2807-2015	Xu, Shang-Zhong/0000-0002-7295-9347; Daskoulidou, Nikoleta/0000-0002-7782-1232	Shanghai Leading Talent Projects [036, 2010]; Shuguang Tracking Project of Shanghai Education Committee [01SG06]; Leverhulme Trust Fellowship Award; Natural Science Foundation of Shanghai [09ZR1406100]; Shanghai Leading Academic Discipline Project [B115]; China Scholarship Council; University of Hull	Shanghai Leading Talent Projects; Shuguang Tracking Project of Shanghai Education Committee; Leverhulme Trust Fellowship Award(Leverhulme Trust); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); China Scholarship Council(China Scholarship Council); University of Hull	This work was supported by the grants from Shanghai Leading Talent Projects (No. 036, 2010) and Shuguang Tracking Project of Shanghai Education Committee (01SG06) (to J.M.Q.); Leverhulme Trust Fellowship Award (to S.Z.X.); Natural Science Foundation of Shanghai (No. 09ZR1406100) and Shanghai Leading Academic Discipline Project (No. B115) (to H.N.J.). B.Z. was supported by China Scholarship Council and the university studentship. N.D. received 80th anniversary PhD studentship from the University of Hull. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta O, 2010, J CLIN ONCOL, V28, P3463, DOI 10.1200/JCO.2009.26.6452; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Beck B, 2008, CELL CALCIUM, V43, P492, DOI 10.1016/j.ceca.2007.08.005; Bhandari S, 2008, J HISTOCHEM CYTOCHEM, V56, P733, DOI 10.1369/jhc.2008.950998; Bomben VC, 2008, CELL PROLIFERAT, V41, P98, DOI 10.1111/j.1365-2184.2007.00504.x; Cai R, 2009, INT J CANCER, V125, P2281, DOI 10.1002/ijc.24551; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Chigurupati S, 2010, CANCER RES, V70, P418, DOI 10.1158/0008-5472.CAN-09-2654; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; den Dekker E, 2001, BBA-MOL CELL RES, V1539, P243, DOI 10.1016/S0167-4889(01)00112-4; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Flemming R, 2003, BRIT J PHARMACOL, V139, P955, DOI 10.1038/sj.bjp.0705327; Gilligan D, 2007, LANCET, V369, P1929, DOI 10.1016/S0140-6736(07)60714-4; Giltnane JM, 2004, NAT CLIN PRACT ONCOL, V1, P104, DOI 10.1038/ncponc0046; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Guilbert A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-125; Hanano T, 2004, J PHARMACOL SCI, V95, P403, DOI 10.1254/jphs.FP0040273; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jiang HN, 2012, BIOCHEM PHARMACOL, V83, P923, DOI 10.1016/j.bcp.2012.01.014; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Kawakami S, 2006, J CONTROL RELEASE, V110, P514, DOI 10.1016/j.jconrel.2005.10.030; Kawarabayashi Y, 2012, MOL ENDOCRINOL, V26, P846, DOI 10.1210/me.2011-1259; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Mangiarotti R, 1998, BRIT J CANCER, V77, P186, DOI 10.1038/bjc.1998.32; Nakao K, 2008, J NEUROSCI RES, V86, P2722, DOI 10.1002/jnr.21711; Nasman J, 2006, J NEUROSCI, V26, P10658, DOI 10.1523/JNEUROSCI.2609-06.2006; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Saito H, 2011, ANN SURG ONCOL, V18, P3377, DOI 10.1245/s10434-011-1798-9; Shapovalov G, 2011, CELL CALCIUM, V50, P295, DOI 10.1016/j.ceca.2011.05.006; Tajeddine N, 2012, J BIOL CHEM, V287, P16146, DOI 10.1074/jbc.M112.340034; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Travis WD., 2004, TRAVIS WB WHO CLASSI; Vanden Abeele F, 2003, J BIOL CHEM, V278, P15381, DOI 10.1074/jbc.M212106200; Veliceasa D, 2007, FEBS J, V274, P6365, DOI 10.1111/j.1742-4658.2007.06159.x; Xu HT, 2006, PATHOL INT, V56, P375, DOI 10.1111/j.1440-1827.2006.01974.x; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Xu SZ, 2011, TRP CHANNELS, P149; Xu SZ, 2012, TOXICOL SCI, V125, P56, DOI 10.1093/toxsci/kfr268; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yu ZL, 2005, TOXICOL SCI, V83, P349, DOI 10.1093/toxsci/kfi030; Zeng B, 2013, CURR CANCER DRUG TAR, V13, P103, DOI 10.2174/156800913804486629; Zhang Qi, 2010, Zhongguo Fei Ai Za Zhi, V13, P612, DOI 10.3779/j.issn.1009-3419.2010.06.009; Zhou RJ, 2012, CELL BIOCHEM BIOPHYS, V62, P177, DOI 10.1007/s12013-011-9279-0	50	62	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67637	10.1371/journal.pone.0067637	http://dx.doi.org/10.1371/journal.pone.0067637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840757	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400121
J	Paschalis, EI; Chodosh, J; Sperling, RA; Salvador-Culla, B; Dohlman, C				Paschalis, Eleftherios I.; Chodosh, James; Sperling, Ralph A.; Salvador-Culla, Borja; Dohlman, Claes			A Novel Implantable Glaucoma Valve Using Ferrofluid	PLOS ONE			English	Article							AQUEOUS-HUMOR; SURGERY; SHUNTS	Purpose: To present a novel design of an implantable glaucoma valve based on ferrofluidic nanoparticles and to compare it with a well-established FDA approved valve. Setting: Massachusetts Eye & Ear Infirmary, Boston, USA. Methods: A glaucoma valve was designed using soft lithography techniques utilizing a water-immiscible magnetic fluid (ferrofluid) as a pressure-sensitive barrier to aqueous flow. Two rare earth micro magnets were used to calibrate the opening and closing pressure. In-vitro flow measurements were performed to characterize the valve and to compare it to Ahmed (TM) glaucoma valve. The reliability and predictability of the new valve was verified by pressure/flow measurements over a period of three months and X-ray diffraction (XRD) analysis over a period of eight weeks. In vivo assessment was performed in three rabbits. Results: In the in vitro experiments, the opening and closing pressures of the valve were 10 and 7 mmHg, respectively. The measured flow/pressure response was linearly proportional and reproducible over a period of three months (1.8 mu l/min at 12 mmHg; 4.3 mu l/min at 16 mmHg; 7.6 mu l/min at 21 mmHg). X-ray diffraction analysis did not show oxidization of the ferrofluid when exposed to water or air. Preliminary in vivo results suggest that the valve is biocompatible and can control the intraocular pressure in rabbits. Conclusions: The proposed valve utilizes ferrofluid as passive, tunable constriction element to provide highly predictable opening and closing pressures while maintaining ocular tone. The ferrofluid maintained its magnetic properties in the aqueous environment and provided linear flow to pressure response. Our in-vitro tests showed reliable and reproducible results over a study period of three months. Preliminary in-vivo results were very promising and currently more thorough investigation of this device is underway.	[Paschalis, Eleftherios I.; Chodosh, James; Salvador-Culla, Borja; Dohlman, Claes] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA; [Sperling, Ralph A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University	Paschalis, EI (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA.	Eleftherios_paschalis@meei.harvard.edu	Sperling, Ralph A/I-7050-2013; Salvador-Culla, Borja/AAX-4966-2020; Paschalis, Eleftherios/AAO-4613-2020	Sperling, Ralph A/0000-0002-8027-0697; Salvador-Culla, Borja/0000-0001-7244-7301; Paschalis, Eleftherios/0000-0002-4544-4452	Boston Keratoprosthesis Fund; Massachusetts Eye and Ear Infirmary, Boston, USA	Boston Keratoprosthesis Fund; Massachusetts Eye and Ear Infirmary, Boston, USA	This work was funded by the Boston Keratoprosthesis Fund, Massachusetts Eye and Ear Infirmary, Boston, USA. The authors would like to acknowledge the contribution of Dr. Kuldip Raj and Ms. Vanessa Rene from Ferrotec (USA) Corporation for providing the custom fluorophilic ferrofluid material.	Barton K, 2011, OPHTHALMOLOGY, V118, P435, DOI 10.1016/j.ophtha.2010.07.015; Barton K, 2008, PROG BRAIN RES, V173, P263, DOI 10.1016/S0079-6123(08)01119-9; BRUBAKER RF, 1991, INVEST OPHTH VIS SCI, V32, P3145; Diekmann H, 2013, CELL TISSUE RES, V353, P327, DOI 10.1007/s00441-013-1596-8; Dohlman CH, 2010, J GLAUCOMA, V19, P111, DOI 10.1097/IJG.0b013e3181a2fbeb; Freidl KB, 2012, SURV OPHTHALMOL, V57, P372, DOI 10.1016/j.survophthal.2012.02.008; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Gedde SJ, 2011, EXP EYE RES, V93, P284, DOI 10.1016/j.exer.2011.03.013; Gilstrap K, 2011, AM J CANCER RES, V1, P508; Helm E, 2007, NANOTECHNOLOGY MAY R; Holtze C, 2008, LAB CHIP, V8, P1632, DOI 10.1039/b806706f; Kapoian T, 2012, ANN PHARMACOTHER, V46, P1308, DOI 10.1345/aph.1Q614; Le A, 2003, INVEST OPHTH VIS SCI, V44, P3783, DOI 10.1167/iovs.03-0077; Lee N, 2012, J AM CHEM SOC, V134, P10309, DOI 10.1021/ja3016582; Liu Y, 2013, CELL TISSUE RES, V353, P253, DOI 10.1007/s00441-013-1584-z; Malchiodi-Albedi F, 2002, J BIOMED MATER RES, V60, P548, DOI 10.1002/jbm.10079; Pajic B, 2011, CURR EYE RES, V36, P1129, DOI 10.3109/02713683.2011.608240; Rosensweig R, 1987, ANN REV FLUID MECH; Russo P, 2012, J NANOTECHNOL, V2012, DOI 10.1155/2012/728326; Schubert HD, 1996, SURV OPHTHALMOL, V41, P97, DOI 10.1016/S0039-6257(96)80001-4; Schwartz KS, 2006, CURR OPIN OPHTHALMOL, V17, P181, DOI 10.1097/01.icu.0000193080.55240.7e	21	19	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67404	10.1371/journal.pone.0067404	http://dx.doi.org/10.1371/journal.pone.0067404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840691	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400075
J	Rothe, C; Sloan, DJ; Goodson, P; Chikafa, J; Mukaka, M; Denis, B; Harrison, T; van Oosterhout, JJ; Heyderman, RS; Lalloo, DG; Allain, T; Feasey, NA				Rothe, Camilla; Sloan, Derek J.; Goodson, Patrick; Chikafa, Jean; Mukaka, Mavuto; Denis, Brigitte; Harrison, Tom; van Oosterhout, Joep J.; Heyderman, Robert S.; Lalloo, David G.; Allain, Theresa; Feasey, Nicholas A.			A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis following Treatment Induction with 800 mg Oral Fluconazole in Blantyre, Malawi	PLOS ONE			English	Article							HIGH-DOSE FLUCONAZOLE; EARLY FUNGICIDAL ACTIVITY; AMPHOTERICIN-B; INFECTED PATIENTS; RANDOMIZED-TRIAL; HIV; FLUCYTOSINE; COMBINATION; ADULTS; AIDS	Introduction: Cryptococcal meningitis is the most common neurological infection in HIV infected patients in Sub Saharan Africa, where gold standard treatment with intravenous amphotericin B and 5 flucytosine is often unavailable or difficult to administer. Fluconazole monotherapy is frequently recommended in national guidelines but is a fungistatic drug compromised by uncertainty over optimal dosing and a paucity of clinical end-point outcome data. Methods: From July 2010 until March 2011, HIV infected adults with a first episode of cryptococcal meningitis were recruited at Queen Elizabeth Central Hospital, Blantyre, Malawi. Patients were treated with oral fluconazole monotherapy 800 mg daily, as per national guidelines. ART was started at 4 weeks. Outcomes and factors associated with treatment failure were assessed 4, 10 and 52 weeks after fluconazole initiation. Results: Sixty patients were recruited. 26/60 (43%) died by 4 weeks. 35/60 (58.0%) and 43/56 (77%) died or failed treatment by 10 or 52 weeks respectively. Reduced consciousness (Glasgow Coma Score <14 of 15), moderate/severe neurological disability (modified Rankin Score >3 of 5) and confusion (Abbreviated Mental Test Score <8 of 10) were all common at baseline and associated with death or treatment failure. ART prior to recruitment was not associated with better outcomes. Conclusions: Mortality and treatment failure from cryptococcal meningitis following initiation of treatment with 800 mg oral fluconazole is unacceptably high. To improve outcomes, there is an urgent need for better therapeutic strategies and point-of-care diagnostics, allowing earlier diagnosis before development of neurological deficit.	[Rothe, Camilla; Sloan, Derek J.; Mukaka, Mavuto; van Oosterhout, Joep J.; Allain, Theresa; Feasey, Nicholas A.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Sloan, Derek J.] Univ Liverpool, Inst Global Hlth, Liverpool L69 3BX, Merseyside, England; [Mukaka, Mavuto; Heyderman, Robert S.; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Sloan, Derek J.; Goodson, Patrick] Queen Elizabeth Cent Hosp, Minist Hlth, Blantyre, Malawi; [Chikafa, Jean; Mukaka, Mavuto; Denis, Brigitte; Heyderman, Robert S.; Feasey, Nicholas A.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Harrison, Tom] Univ London, St Georges Med Sch, Infect & Immun Res Ctr, London, England; [Feasey, Nicholas A.] Univ Liverpool, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England	University of Malawi; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Malawi; St Georges University London; University of London; University of Liverpool	Feasey, NA (corresponding author), Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi.	nfeasey@liverpool.ac.uk		Lalloo, David/0000-0001-7680-2200; Harrison, Thomas/0000-0003-3619-4348; Heyderman, Robert/0000-0003-4573-449X; Feasey, Nicholas/0000-0003-4041-1405; Sloan, Derek James/0000-0002-7888-5449	Wellcome Research Training Fellowship; Wellcome Trust Major Overseas Project Grant [084679/Z/08/Z]; MRC [G1100814] Funding Source: UKRI; Medical Research Council [G1100814] Funding Source: researchfish	Wellcome Research Training Fellowship; Wellcome Trust Major Overseas Project Grant(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Feasey was supported by a Wellcome Research Training Fellowship and MLW is funded by a Wellcome Trust Major Overseas Project Grant (award number 084679/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain T. J., 1996, Central African Journal of Medicine, V42, P98; Bekondi C, 2006, INT J INFECT DIS, V10, P387, DOI 10.1016/j.ijid.2005.07.004; Bicanic T, 2011, 18 C RETR OPP INF BO; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; Evaluation and Standards Laboratory Centre for Infections, 2012, BACTERIOLOGY B, V27, P1; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Hakim JG, 2000, AIDS, V14, P1401, DOI 10.1097/00002030-200007070-00013; Heikinheimo T, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0033765; Heyderman RS, 1998, CLIN INFECT DIS, V26, P284, DOI 10.1086/516298; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Johansson KA, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-3; Kisenge PR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-39; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Mayanja-Kizza H, 1998, CLIN INFECT DIS, V26, P1362, DOI 10.1086/516372; McCarthy K, 2007, S AFR J HIV MED, V8, P25; Milefchik E, 2008, MED MYCOL, V46, P393, DOI 10.1080/13693780701851695; Ministry of Health, 2008, MAN HIV REL DIS; Muzoora CK, 2012, J INFECTION, V64, P76, DOI 10.1016/j.jinf.2011.10.014; Mwaba P, 2001, POSTGRAD MED J, V77, P769, DOI 10.1136/pmj.77.914.769; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Pappas PG, 2009, CLIN INFECT DIS, V48, P1775, DOI 10.1086/599112; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Schaars CF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-118; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	32	47	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67311	10.1371/journal.pone.0067311	http://dx.doi.org/10.1371/journal.pone.0067311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840659	Green Published, Green Accepted, gold			2022-12-27	WOS:000321148400056
J	Yu, W; Ying, HH; Tong, FD; Zhang, C; Quan, YP; Zhang, YZ				Yu, Wei; Ying, Huihui; Tong, Fudan; Zhang, Chen; Quan, Yanping; Zhang, Yaozhou			Protective Effect of the Silkworm Protein 30Kc6 on Human Vascular Endothelial Cells Damaged by Oxidized Low Density Lipoprotein (Ox-LDL)	PLOS ONE			English	Article							RHGM-CSF; APOPTOSIS; INHIBITION	Although the 30K family proteins are important anti-apoptotic molecules in silkworm hemolymph, the underlying mechanism remains to be investigated. This is especially the case in human vascular endothelial cells (HUVECs). In this study, a 30K protein, 30Kc6, was successfully expressed and purified using the Bac-to-Bac baculovirus expression system in silkworm cells. Furthermore, the 30Kc6 expressed in Escherichia coli was used to generate a polyclonal antibody. Western blot analysis revealed that the antibody could react specifically with the purified 30Kc6 expressed in silkworm cells. The In vitro cell apoptosis model of HUVEC that was induced by oxidized low density lipoprotein (Ox-LDL) and in vivo atherosclerosis rabbit model were constructed and were employed to analyze the protective effects of the silkworm protein 30Kc6 on these models. The results demonstrated that the silkworm protein 30Kc6 significantly enhanced the cell viability in HUVEC cells treated with Ox-LDL, decreased the degree of DNA fragmentation and markedly reduced the level of 8-isoprostane. This could be indicative of the silkworm protein 30Kc6 antagonizing the Ox-LDL-induced cell apoptosis by inhibiting the intracellular reactive oxygen species (ROS) generation. Furthermore, Ox-LDL activated the cell mitogen activated protein kinases (MAPK), especially JNK and p38. As demonstrated with Western analysis, 30Kc6 inhibited Ox-LDL-induced cell apoptosis in HUVEC cells by preventing the MAPK signaling pathways. In vivo data have demonstrated that oral feeding of the silkworm protein 30Kc6 dramatically improved the conditions of the atherosclerotic rabbits by decreasing serum levels of total triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDLC) and total cholesterol (TC). Furthermore, 30Kc6 alleviated the extent of lesions in aorta and liver in the atherosclerotic rabbits. These data are not only helpful in understanding the anti-apoptotic mechanism of the 30K family proteins, but also provide important information on prevention and treatment of human cardiovascular diseases.	[Yu, Wei; Ying, Huihui; Tong, Fudan; Zhang, Chen; Quan, Yanping; Zhang, Yaozhou] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Zhejiang, Peoples R China; [Yu, Wei; Ying, Huihui; Tong, Fudan; Zhang, Chen; Quan, Yanping; Zhang, Yaozhou] Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Yu, W (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Zhejiang, Peoples R China.	mikkyu@163.com			National High-tech R&D program (863 Program) [2011AA100603]; Natural Science Foundation of Zhejiang Province [Y3090339, Y3110187]; Major National Science and Technology project [2012ZX09102301-009]	National High-tech R&D program (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Major National Science and Technology project	This work was supported by the National High-tech R&D program (863 Program) (No. 2011AA100603) and Natural Science Foundation of Zhejiang Province (No. Y3090339, No. Y3110187). In addition, this work was also supported by the Major National Science and Technology project (No. 2012ZX09102301-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang HC, 2011, J CEREBR BLOOD F MET, V31, P842, DOI 10.1038/jcbfm.2010.180; CHEN YL, 1994, CARDIOVASC RES, V28, P1679, DOI 10.1093/cvr/28.11.1679; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gao JH, 2011, CIRCULATION, V124, P830, DOI 10.1161/CIRCULATIONAHA.110.014050; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; Jin RZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003933; Kim EJ, 2003, BIOCHEM BIOPH RES CO, V308, P523, DOI 10.1016/S0006-291X(03)01425-6; Kim EJ, 2001, BIOCHEM BIOPH RES CO, V285, P224, DOI 10.1006/bbrc.2001.5148; Koo TY, 2009, PROCESS BIOCHEM, V44, P146, DOI 10.1016/j.procbio.2008.09.018; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Li JM, 2008, J VASC SURG, V47, P1048, DOI 10.1016/j.jvs.2007.12.005; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Park HJ, 2003, ENZYME MICROB TECH, V33, P466, DOI 10.1016/S0141-0229(03)00149-2; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Sudoh N, 2001, CIRCULATION, V103, P724; Tian XY, 2012, J MOL CELL CARDIOL, V52, P237, DOI 10.1016/j.yjmcc.2011.10.013; Wang N, 2011, ATHEROSCLEROSIS, V218, P543, DOI 10.1016/j.atherosclerosis.2011.08.002; Wang ZS, 2010, PROCESS BIOCHEM, V45, P1852, DOI 10.1016/j.procbio.2010.03.029; Zhang WP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005353; Zhang YZ, 2006, EUR J PHARM SCI, V28, P212, DOI 10.1016/j.ejps.2006.02.014	20	14	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68746	10.1371/journal.pone.0068746	http://dx.doi.org/10.1371/journal.pone.0068746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840859	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400198
J	Keil, FC; Kominsky, JF				Keil, Frank C.; Kominsky, Jonathan F.			Missing Links in Middle School: Developing Use of Disciplinary Relatedness in Evaluating Internet Search Results	PLOS ONE			English	Article							DIVISION	In the "digital native'' generation, internet search engines are a commonly used source of information. However, adolescents may fail to recognize relevant search results when they are related in discipline to the search topic but lack other cues. Middle school students, high school students, and adults rated simulated search results for relevance to the search topic. The search results were designed to contrast deep discipline-based relationships with lexical similarity to the search topic. Results suggest that the ability to recognize disciplinary relatedness without supporting cues may continue to develop into high school. Despite frequent search engine usage, younger adolescents may require additional support to make the most of the information available to them.	[Keil, Frank C.; Kominsky, Jonathan F.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Keil, FC (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	frank.keil@yale.edu	Kominsky, Jonathan/AAK-4654-2020; Kominsky, Jonathan/AFR-1734-2022	Kominsky, Jonathan/0000-0002-3236-4787; Kominsky, Jonathan/0000-0002-3236-4787	National Institutes of Health [R-37-HD023922]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD023922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by National Institutes of Health Grant R-37-HD023922 to Frank C. Keil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilal D, 2002, INFORM PROCESS MANAG, V38, P649, DOI 10.1016/S0306-4573(01)00057-7; Borzekowski DLG, 2006, DEV PSYCHOL, V42, P450, DOI 10.1037/0012-1649.42.3.450; Danovitch JH, 2004, CHILD DEV, V75, P918, DOI 10.1111/j.1467-8624.2004.00714.x; Iwata M, 2011, 14 INT C NETW BAS IN, DOI [10.1109/NBiS.2011.6, DOI 10.1109/NBIS.2011.6]; Keil FC, 2008, COGNITIVE SCI, V32, P259, DOI 10.1080/03640210701863339; Livingstone S, 2010, NEW MEDIA SOC, V12, P309, DOI 10.1177/1461444809342697; Lutz DJ, 2002, CHILD DEV, V73, P1073, DOI 10.1111/1467-8624.00458; Pan B, 2007, J COMPUT-MEDIAT COMM, V12, P801, DOI 10.1111/j.1083-6101.2007.00351.x; Pew Internet & American Life Project, 2000, UPD CHANG INT ACC AG; Prensky M., 2001, HORIZON, V9, P1, DOI [10.1108/10748120110424843, DOI 10.1108/10748120110424816, 10.1108/10748120110424816]; Rouet JF, 2011, LEARN INSTR, V21, P205, DOI 10.1016/j.learninstruc.2010.02.007; Tu YW, 2008, COMPUT EDUC, V51, P1142, DOI 10.1016/j.compedu.2007.11.003; Walraven A, 2008, COMPUT HUM BEHAV, V24, P623, DOI 10.1016/j.chb.2007.01.030; Zhang H, 2005, INFORM PROCESS MANAG, V41, P691, DOI 10.1016/j.ipm.2003.12.002	14	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67777	10.1371/journal.pone.0067777	http://dx.doi.org/10.1371/journal.pone.0067777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840774	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400116
J	Ng, KT; Ong, LY; Lim, SH; Takebe, Y; Kamarulzaman, A; Tee, KK				Ng, Kim Tien; Ong, Lai Yee; Lim, Sin How; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng			Evolutionary History of HIV-1 Subtype B and CRF01_AE Transmission Clusters among Men Who Have Sex with Men (MSM) in Kuala Lumpur, Malaysia	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; RISK; INFECTION; EPIDEMIC; PREVALENCE; TYPE-1; IDENTIFICATION; SURVEILLANCE; NETWORKS; REVEALS	HIV-1 epidemics among men who have sex with men (MSM) continue to expand in developed and developing countries. Although HIV infection in MSM is amongst the highest of the key affected populations in many countries in Southeast Asia, comprehensive molecular epidemiological study of HIV-1 among MSM remains inadequate in the region including in Malaysia. Here, we reported the phylodynamic profiles of HIV-1 genotypes circulating among MSM population in Kuala Lumpur, Malaysia. A total of n = 459 newly-diagnosed treatment-naive consenting subjects were recruited between March 2006 and August 2012, of whom 87 (18.9%) were self-reported MSM. Transmitted drug resistance mutations were absent in these isolates. Cumulatively, phylogenetic reconstructions of the pro-rt gene (HXB2: 2253-3275) showed that HIV-1 subtype B and CRF01_AE were predominant and contributed to approximately 80% of the total HIV-1 infection among MSM. In addition to numerous unique transmission lineages within these genotypes, twelve monophyletic transmission clusters of different sizes (2-7 MSM sequences, supported by posterior probability value of 1) were identified in Malaysia. Bayesian coalescent analysis estimated that the divergence times for these clusters were mainly dated between 1995 and 2005 with four major transmission clusters radiating at least 12 years ago suggesting that active spread of multiple sub-epidemic clusters occurred during this period. The changes in effective population size of subtype B showed an exponential growth within 5 years between 1988 and 1993, while CRF01_AE lineage exhibited similar expansion between 1993 and 2003. Our study provides the first insight of the phylodynamic profile of HIV-1 subtype B and CRF01_AE circulating among MSM population in Kuala Lumpur, Malaysia, unravelling the importance of understanding transmission behaviours as well as evolutionary history of HIV-1 in assessing the risk of outbreak or epidemic expansion.	[Ng, Kim Tien; Ong, Lai Yee; Lim, Sin How; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Toyama, Tokyo, Japan	Universiti Malaya; National Institute of Infectious Diseases (NIID)	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Lim, Sin How/L-7168-2017; Ng, Kim Tien/K-7667-2013; KAMARULZAMAN, ADEEBA/B-5216-2010; Tee, Kok Keng/A-8148-2008; Lim, Sin How/AAC-8004-2020	Lim, Sin How/0000-0002-8727-4826; Ng, Kim Tien/0000-0002-4097-9984; Tee, Kok Keng/0000-0002-7923-5448; 	Ministry of Higher Education, Malaysia [E-000001-20001, H-500001-00-A000011-000001, H-500001-00-A000012-000001, J-50001-73596]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This work was supported by grants from the Ministry of Higher Education, Malaysia: High Impact Research E-000001-20001 to AK, and High Impact Research H-500001-00-A000011-000001, H-500001-00-A000012-000001 and J-50001-73596 to KKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Ananworanich J, 2008, JAIDS-J ACQ IMM DEF, V49, P151, DOI 10.1097/QAI.0b013e318183a96d; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deng XT, 2008, ALGORITHMICA, V52, P1, DOI 10.1007/s00453-007-9001-1; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Giuliani M, 2005, AIDS, V19, P1429, DOI 10.1097/01.aids.0000180808.27298.af; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Kanter J, 2011, INT J STD AIDS, V22, P30, DOI 10.1258/ijsa.2010.010277; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Li J, 2006, CHINESE MED J-PEKING, V119, P1972, DOI 10.1097/00029330-200612010-00006; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Malim MH, 2001, CELL, V104, P469, DOI 10.1016/S0092-8674(01)00234-3; Nguyen TA, 2008, AIDS BEHAV, V12, P476, DOI 10.1007/s10461-007-9267-y; Ng OT, 2011, AIDS RES HUM RETROV, V27, P1135, DOI [10.1089/aid.2010.0364, 10.1089/AID.2010.0364]; Poteat T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028760; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith DA, 2009, AIDS, V23, P225, DOI 10.1097/QAD.0b013e32831d2a81; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2006, AIDS RES HUM RETROV, V22, P121, DOI 10.1089/aid.2006.22.121; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Wang YM, 2000, AIDS, V14, P2265, DOI 10.1097/00002030-200010200-00007; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67286	10.1371/journal.pone.0067286	http://dx.doi.org/10.1371/journal.pone.0067286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840653	Green Published, gold			2022-12-27	WOS:000322342800127
J	Puglisi, F; Vanni, V; Ponterio, G; Tassone, A; Sciamanna, G; Bonsi, P; Pisani, A; Mandolesi, G				Puglisi, Francesca; Vanni, Valentina; Ponterio, Giulia; Tassone, Annalisa; Sciamanna, Giuseppe; Bonsi, Paola; Pisani, Antonio; Mandolesi, Georgia			Torsin A Localization in the Mouse Cerebellar Synaptic Circuitry	PLOS ONE			English	Article							MUTANT TORSINA; DYT1 DYSTONIA; NUCLEAR-ENVELOPE; CLIMBING FIBERS; BASAL GANGLIA; PROTEIN; EXPRESSION; CELLS; RAT; MEMBRANE	Torsin A (TA) is a ubiquitous protein belonging to the superfamily of proteins called "ATPases associated with a variety of cellular activities" (AAA(+) ATPase). To date, a great deal of attention has been focused on neuronal TA since its mutant form causes early-onset (DYT1) torsion dystonia, an inherited movement disorder characterized by sustained muscle contractions and abnormal postures. Interestingly, it has been proposed that TA, by interacting with the cytoskeletal network, may contribute to the control of neurite outgrowth and/or by acting as a chaperone at synapses could affect synaptic vesicle turnover and neurotransmitter release. Accordingly, both its peculiar developmental expression in striatum and cerebellum and evidence from DYT1 knock-in mice suggest that TA may influence dendritic arborization and synaptogenesis in the brain. Therefore, to better understand TA function a detailed description of its localization at synaptic level is required. Here, we characterized by means of rigorous quantitative confocal analysis TA distribution in the mouse cerebellum at postnatal day 14 (P14), when both cerebellar synaptogenesis and TA expression peak. We observed that the protein is broadly distributed both in cerebellar cortex and in the deep cerebellar nuclei (DCN). Of note, Purkinje cells (PC) express high levels of TA also in the spines and axonal terminals. In addition, abundant expression of the protein was found in the main GABA-ergic and glutamatergic inputs of the cerebellar cortex. Finally, TA was observed also in glial cells, a cellular population little explored so far. These results extend our knowledge on TA synaptic localization providing a clue to its potential role in synaptic development.	[Puglisi, Francesca; Vanni, Valentina; Ponterio, Giulia; Tassone, Annalisa; Sciamanna, Giuseppe; Bonsi, Paola; Pisani, Antonio; Mandolesi, Georgia] Univ Roma Tor Vergata, Dept Syst Med, Lab Neurophysiol & Synapt Plast, Fdn Santa Lucia, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata	Pisani, A (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Lab Neurophysiol & Synapt Plast, Fdn Santa Lucia, Rome, Italy.	pisani@uniroma2.it	Mandolesi, Georgia/G-6595-2011; Sciamanna, Giuseppe/B-6553-2013; vanni, valentina/K-1978-2016; tassone, annalisa/J-9950-2016; Pisani, Antonio/G-2492-2012; Bonsi, Paola/K-4688-2012; Ponterio, Giulia/K-2114-2016	Sciamanna, Giuseppe/0000-0002-0070-1638; vanni, valentina/0000-0003-1762-6563; tassone, annalisa/0000-0001-9643-2446; Pisani, Antonio/0000-0002-8432-594X; Bonsi, Paola/0000-0001-5940-9028; Ponterio, Giulia/0000-0001-5886-3368; Mandolesi, Georgia/0000-0003-3612-6820	Dystonia Medical Research Foundation; Ministero della salute, Ricerca Finalizzata [18/RF2010-2311657]	Dystonia Medical Research Foundation; Ministero della salute, Ricerca Finalizzata(Ministry of Health, Italy)	Dystonia Medical Research Foundation (www.dystonia-foundation.org/); Ministero della salute, Ricerca Finalizzata 2010 18/RF2010-2311657 (http://www.salute.gov.it/). The authors have declared that no competing interests exist.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.3.CO;2-Q; Augood SJ, 2003, BRAIN RES, V986, P12, DOI 10.1016/S0006-8993(03)03164-0; Bell JJL, 2010, NEURON GLIA BIOL, V6, P193, DOI 10.1017/S1740925X10000165; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bostan AC, 2010, NEUROPSYCHOL REV, V20, P261, DOI 10.1007/s11065-010-9143-9; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Buchwalow IB, 2010, IMMUNOHISTOCHEMISTRY: BASICS AND METHODS, P1, DOI 10.1007/978-3-642-04609-4; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Craig AM, 2001, NAT NEUROSCI, V4, P219; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; DEBLAS AL, 1984, J NEUROSCI, V4, P265; DEZEEUW CI, 1995, EUR J NEUROSCI, V7, P2322; Dino MR, 1999, J NEUROCYTOL, V28, P99, DOI 10.1023/A:1007072105919; ECCLES JC, 1967, EXP BRAIN RES, V3, P81; Esapa CT, 2007, HUM MOL GENET, V16, P327, DOI 10.1093/hmg/ddl472; FERRARITONINELL.G, 2004, B RES; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Garin N, 2001, NEUROSCIENCE, V105, P431, DOI 10.1016/S0306-4522(01)00127-0; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Granata A, 2011, EMBO J, V30, P181, DOI 10.1038/emboj.2010.285; Granata A, 2009, J NEUROCHEM, V109, P1596, DOI 10.1111/j.1471-4159.2009.06095.x; Grosche J, 2002, J NEUROSCI RES, V68, P138, DOI 10.1002/jnr.10197; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett JW, 2008, HUM MOL GENET, V17, P1436, DOI 10.1093/hmg/ddn032; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; ITO M, 1984, JPN J PHYSIOL, V34, P781, DOI 10.2170/jjphysiol.34.781; Kakazu Y, 2012, SYNAPSE, V66, P807, DOI 10.1002/syn.21571; Kakazu Y, 2012, SYNAPSE, V66, P453, DOI 10.1002/syn.21534; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Konakova M, 2001, ARCH NEUROL-CHICAGO, V58, P921, DOI 10.1001/archneur.58.6.921; Konakova M, 2001, BRAIN RES, V922, P1, DOI 10.1016/S0006-8993(01)03014-1; LARRAMENDI LM, 1969, ELECT MICROSCOPIC ST; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; Mandolesi G, 2009, NEUROSCIENCE, V164, P1084, DOI 10.1016/j.neuroscience.2009.08.067; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Misbahuddin A, 2005, MOVEMENT DISORD, V20, P432, DOI 10.1002/mds.20351; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Nery FC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1383; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; Neychev VK, 2011, NEUROBIOL DIS, V42, P185, DOI 10.1016/j.nbd.2011.01.026; Ozelius L J, 1998, Adv Neurol, V78, P93; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Palay S. L., 1974, CEREBELLAR CORTEX CY; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; SASSOEPOGNETTO M, 2013, HDB CEREBELLUM CEREB; Sciamanna G, 2012, J NEUROSCI, V32, P11991, DOI 10.1523/JNEUROSCI.0041-12.2012; Shashidharan P, 2000, BRAIN RES, V853, P197, DOI 10.1016/S0006-8993(99)02232-5; Sotelo C, 2008, J COMP NEUROL, V506, P240, DOI 10.1002/cne.21501; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Ulug AM, 2011, P NATL ACAD SCI USA, V108, P6638, DOI 10.1073/pnas.1016445108; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vasudevan A, 2006, BRAIN RES, V1073, P139, DOI 10.1016/j.brainres.2005.12.087; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Walker RH, 2001, BRAIN RES, V900, P348, DOI 10.1016/S0006-8993(01)02302-2; Warner TT, 2010, BIOCHEM SOC T, V38, P452, DOI 10.1042/BST0380452; Watanabe M, 2013, HDB CEREBELLUM CEREB; Xiao HF, 2004, DEV BRAIN RES, V152, P47, DOI 10.1016/j.devbrainres.2004.05.012; Yuzaki M, 2010, EUR J NEUROSCI, V32, P191, DOI 10.1111/j.1460-9568.2010.07346.x; Zhang L, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0URNAL.P0NE.0018357.PUBMED:21479250; Zhao Y, 2008, NEUROSCIENCE, V155, P439, DOI 10.1016/j.neuroscience.2008.04.053; Ziefer P, 2002, MOL BRAIN RES, V101, P132, DOI 10.1016/S0169-328X(02)00176-6	71	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e68063	10.1371/journal.pone.0068063	http://dx.doi.org/10.1371/journal.pone.0068063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840813	gold, Green Submitted, Green Published			2022-12-27	WOS:000322361200139
J	Kaushik, S; Singh, N; Yamini, S; Singh, A; Sinha, M; Arora, A; Kaur, P; Sharma, S; Singh, TP				Kaushik, Sanket; Singh, Nagendra; Yamini, Shavait; Singh, Avinash; Sinha, Mau; Arora, Ashish; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			The Mode of Inhibitor Binding to Peptidyl-tRNA Hydrolase: Binding Studies and Structure Determination of Unbound and Bound Peptidyl- tRNA Hydrolase from Acinetobacter baumannii	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PHOSPHOLIPASE A(2); RESISTANT; PROTEIN; COMPLEX; INFECTIONS; REFINEMENT; RESOLUTION; PNEUMONIA; ACID	The incidences of infections caused by an aerobic Gram-negative bacterium, Acinetobacter baumannii are very common in hospital environments. It usually causes soft tissue infections including urinary tract infections and pneumonia. It is difficult to treat due to acquired resistance to available antibiotics is well known. In order to design specific inhibitors against one of the important enzymes, peptidyl-tRNA hydrolase from Acinetobacter baumannii, we have determined its three-dimensional structure. Peptidyl-tRNA hydrolase (AbPth) is involved in recycling of peptidyl-tRNAs which are produced in the cell as a result of premature termination of translation process. We have also determined the structures of two complexes of AbPth with cytidine and uridine. AbPth was cloned, expressed and crystallized in unbound and in two bound states with cytidine and uridine. The binding studies carried out using fluorescence spectroscopic and surface plasmon resonance techniques revealed that both cytidine and uridine bound to AbPth at nanomolar concentrations. The structure determinations of the complexes revealed that both ligands were located in the active site cleft of AbPth. The introduction of ligands to AbPth caused a significant widening of the entrance gate to the active site region and in the process of binding, it expelled several water molecules from the active site. As a result of interactions with protein atoms, the ligands caused conformational changes in several residues to attain the induced tight fittings. Such a binding capability of this protein makes it a versatile molecule for hydrolysis of peptidyl-tRNAs having variable peptide sequences. These are the first studies that revealed the mode of inhibitor binding in Peptidyl-tRNA hydrolases which will facilitate the structure based ligand design.	[Kaushik, Sanket; Singh, Nagendra; Yamini, Shavait; Singh, Avinash; Sinha, Mau; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Arora, Ashish] Cent Drug Res Inst, Lucknow 226001, Uttar Pradesh, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com		Singh, Nagendra/0000-0003-0419-0684; SINHA, MAU/0000-0003-3011-9160	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi; Indian Council of Medical Research, New Delhi	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	TPS thanks the Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi for the award of Distinguished Biotechnology Research Professorship. The financial assistance from the Indian Council of Medical Research, New Delhi is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; Brisse S, 2000, J CLIN MICROBIOL, V38, P3636, DOI 10.1128/JCM.38.10.3636-3645.2000; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; Charland M. B., 1995, SIGMAPLOT SCI VERSIO; Chen MZ, 2001, CHEST, V120, P1072, DOI 10.1378/chest.120.4.1072; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endimiani A, 2011, CLIN INFECT DIS, V52, pS373, DOI 10.1093/cid/cir054; Fan Ji-cai, 2006, J Zhejiang Univ Sci B, V7, P452, DOI 10.1631/jzus.2006.B0452; GOODHART GL, 1977, JAMA-J AM MED ASSOC, V238, P1516, DOI 10.1001/jama.238.14.1516; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Hsueh PR, 2002, EMERG INFECT DIS, V8, P827; Hughes RC, 2012, ACTA CRYSTALLOGR F, V68, P1472, DOI 10.1107/S1744309112045770; Ito K, 2012, NUCLEIC ACIDS RES, V40, P10521, DOI 10.1093/nar/gks790; Jabeen T, 2005, ACTA CRYSTALLOGR D, V61, P1579, DOI 10.1107/S0907444905029604; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar Ashok, 2012, Int J Biochem Mol Biol, V3, P58; Kushwaha GS, 2013, PROTEINS, V81, P896, DOI 10.1002/prot.24248; Kushwaha GS, 2012, BBA-PROTEINS PROTEOM, V1824, P679, DOI 10.1016/j.bbapap.2012.02.005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee K, 2011, YONSEI MED J, V52, P879, DOI 10.3349/ymj.2011.52.6.879; Lim TP, 2011, PLOS ONE, V6, P184; Ling J, 2007, P NATL ACAD SCI USA, V104, P72, DOI 10.1073/pnas.0606272104; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MENNINGER JR, 1979, J BACTERIOL, V137, P694, DOI 10.1128/JB.137.1.694-696.1979; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oncul O, 2002, J HOSP INFECT, V51, P47, DOI 10.1053/jhin.2002.1205; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pachon J, 2009, CURR OPIN INVEST DR, V10, P150; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Schmitt E, 1997, EMBO J, V16, P4760, DOI 10.1093/emboj/16.15.4760; SEIFERT H, 1993, ANTIMICROB AGENTS CH, V37, P750, DOI 10.1128/AAC.37.4.750; Selvaraj M, 2007, J MOL BIOL, V372, P186, DOI 10.1016/j.jmb.2007.06.053; Singh G, 2005, PROTEIN SCI, V14, P395, DOI 10.1110/ps.041115505; Singh N, 2008, PROTEINS, V64, P80; Singh N, 2009, J MOL RECOGNIT, V22, P437, DOI 10.1002/jmr.960; Singh NS, 2004, NUCLEIC ACIDS RES, V32, P6028, DOI 10.1093/nar/gkh924; Singh RK, 2005, J DRUG TARGET, V13, P113, DOI 10.1080/10611860400024078; Tickle IJ, 2012, ACTA CRYSTALLOGR D, V68, P454, DOI 10.1107/S0907444911035918; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Zeana C, 2003, INFECT CONT HOSP EP, V24, P275, DOI 10.1086/502209; Zhou H, 2011, ANTIMICROB AGENTS CH, V55, P4506, DOI 10.1128/AAC.01134-10	45	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67547	10.1371/journal.pone.0067547	http://dx.doi.org/10.1371/journal.pone.0067547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844024	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000078
J	Yanovich, P; Isenhower, RW; Sage, J; Torres, EB				Yanovich, Polina; Isenhower, Robert W.; Sage, Jacob; Torres, Elizabeth B.			Spatial-Orientation Priming Impedes Rather than Facilitates the Spontaneous Control of Hand-Retraction Speeds in Patients with Parkinson's Disease	PLOS ONE			English	Article							BASAL GANGLIA; LEWY BODIES; AUTONOMIC DYSFUNCTION; DORSOMEDIAL STRIATUM; REMEMBERED TARGETS; MOTOR CONTROL; 3D SPACE; DEMENTIA; MOVEMENTS; EXPRESSION	Background: Often in Parkinson's disease (PD) motor-related problems overshadow latent non-motor deficits as it is difficult to dissociate one from the other with commonly used observational inventories. Here we ask if the variability patterns of hand speed and acceleration would be revealing of deficits in spatial-orientation related decisions as patients performed a familiar reach-to-grasp task. To this end we use spatial-orientation priming which normally facilitates motor-program selection and asked whether in PD spatial-orientation priming helps or hinders performance. Methods: To dissociate spatial-orientation- and motor-related deficits participants performed two versions of the task. The biomechanical version (DEFAULT) required the same postural- and hand-paths as the orientation-priming version (primed-UP). Any differences in the patients here could not be due to motor issues as the tasks were biomechanically identical. The other priming version (primed-DOWN) however required additional spatial and postural processing. We assessed in all three cases both the forward segment deliberately aimed towards the spatial-target and the retracting segment, spontaneously bringing the hand to rest without an instructed goal. Results and Conclusions: We found that forward and retracting segments belonged in two different statistical classes according to the fluctuations of speed and acceleration maxima. Further inspection revealed conservation of the forward (voluntary) control of speed but in PD a discontinuity of this control emerged during the uninstructed retractions which was absent in NC. Two PD groups self-emerged: one group in which priming always affected the retractions and the other in which only the more challenging primed-DOWN condition was affected. These PD-groups self-formed according to the speed variability patterns, which systematically changed along a gradient that depended on the priming, thus dissociating motor from spatial-orientation issues. Priming did not facilitate the motor task in PD but it did reveal a breakdown in the spatial-orientation decision that was independent of the motor-postural path.	[Yanovich, Polina; Torres, Elizabeth B.] Rutgers State Univ, Dept Comp Sci, Piscataway, NJ USA; [Isenhower, Robert W.; Torres, Elizabeth B.] Rutgers State Univ, Dept Psychol, Piscataway, NJ USA; [Sage, Jacob] Robert Wood Johnson Med Sch, Piscataway, NJ USA; [Torres, Elizabeth B.] Indiana Univ, Med Sch Indianapolis, Indianapolis, IN 46204 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Torres, EB (corresponding author), Rutgers State Univ, Dept Comp Sci, Piscataway, NJ USA.	ebtorres@rci.rutgers.edu	Torres, Elizabeth Barbara/AAM-1783-2020; Torres, Elizabeth/ABB-9873-2021	Torres, Elizabeth Barbara/0000-0002-4011-3611; 	Rutgers University VPR office (Academic Excellence Award); NSF CDI Type I [0941587]	Rutgers University VPR office (Academic Excellence Award); NSF CDI Type I	This project was funded by Rutgers University VPR office (Academic Excellence Award to EBT), NSF CDI Type I 0941587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; Adamovich SV, 1999, EXP BRAIN RES, V125, P200, DOI 10.1007/s002210050674; Adler CH, 2010, MOVEMENT DISORD, V25, P642, DOI 10.1002/mds.22971; Albin Roger L., 1995, Trends in Neurosciences, V18, P63, DOI 10.1016/0166-2236(95)93872-U; Avez A., 1968, ERGODIC PROBLEMS CLA, V9; Ballard C, 2011, DRUG AGING, V28, P769, DOI 10.2165/11594110-000000000-00000; Bernstein N, 1967, COORDINATION REGULAT; Beyer K, 2011, J NEUROL SCI, V310, P112, DOI 10.1016/j.jns.2011.05.049; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; Cummings JL, 2004, J GERIATR PSYCH NEUR, V17, P112, DOI 10.1177/0891988704267473; de Wit S, 2011, J COGNITIVE NEUROSCI, V23, P1218, DOI 10.1162/jocn.2010.21514; DeLong M, 2009, PARKINSONISM RELAT D, V15, pS237, DOI 10.1016/S1353-8020(09)70822-3; Desmurget M, 2004, BRAIN, V127, P1755, DOI 10.1093/brain/awh206; Desmurget M, 1998, EXP BRAIN RES, V119, P511, DOI 10.1007/s002210050367; Elmer L, 2004, NEUROL CLIN, V22, pS91, DOI 10.1016/j.ncl.2004.06.009; Galpin A, 2011, CORTEX, V47, P332, DOI 10.1016/j.cortex.2010.01.011; Goldstein DS, 2011, J NEUROL SCI, V310, P118, DOI 10.1016/j.jns.2011.04.011; Gross RG, 2008, NEUROSIGNALS, V16, P24, DOI 10.1159/000109756; Henchcliffe C, 2011, PROG NEUROBIOL, V95, P601, DOI 10.1016/j.pneurobio.2011.09.002; Idiaquez J, 2011, J NEUROL SCI, V305, P22, DOI 10.1016/j.jns.2011.02.033; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; IZENMAN AJ, 1991, J AM STAT ASSOC, V86, P205, DOI 10.2307/2289732; Jellinger KA, 2004, J NEURAL TRANSM, V111, P1219, DOI 10.1007/s00702-004-0138-7; Kotzbauer P.T., 2012, ARCH NEUROL-CHICAGO, P1; Lee JM, 2012, CAN J NEUROL SCI, V39, P473, DOI 10.1017/S0317167100013986; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Masson MEJ, 2011, J EXP PSYCHOL HUMAN, V37, P1470, DOI 10.1037/a0023509; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Morales-Briceno H, 2011, GAC MED MEX, V147, P22; Nishikawa KC, 1999, J NEUROPHYSIOL, V81, P2582, DOI 10.1152/jn.1999.81.5.2582; O'Rahilly R., 1983, BASIC HUMAN ANATOMY; Paul SS, 2012, NEUROREHABIL NEURAL; Poliakoff E, 2007, NEUROREPORT, V18, P483, DOI 10.1097/WNR.0b013e32805867a1; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; ROSENBAUM DA, 1993, J MOTOR BEHAV, V25, P217, DOI 10.1080/00222895.1993.9942051; ROSENBAUM DA, 1982, ACTA PSYCHOL, V51, P223, DOI 10.1016/0001-6918(82)90036-1; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; Schettino LF, 2003, EXP BRAIN RES, V151, P158, DOI 10.1007/s00221-003-1435-3; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Soechting J F, 1991, Exerc Sport Sci Rev, V19, P389; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; Tanaka J, 1997, Nihon Rinsho, V55, P32; Torres EB, 2004, J APPL PHYSIOL, V96, P1978, DOI 10.1152/japplphysiol.00872.2003; Torres EB, 2002, J NEUROPHYSIOL, V88, P2355, DOI 10.1152/jn.00030.2002; Torres EB, 2013, FRONTIERS I IN PRESS; Torres EB, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-10; Torres EB, 2011, J NEUROSCI, V31, P17848, DOI 10.1523/JNEUROSCI.1150-11.2011; Torres EB, 2011, EXP BRAIN RES, V215, P269, DOI 10.1007/s00221-011-2892-8; Torres EB, 2013, NEUROCASE, V19, P150, DOI 10.1080/13554794.2011.654224; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Tunik E, 2004, EXP BRAIN RES, V159, P23, DOI 10.1007/s00221-004-1929-7; Tunik E, 2004, MOVEMENT DISORD, V19, P897, DOI 10.1002/mds.20138; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Warr L, 2012, Q J NUCL MED MOL IM, V56, P39; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	60	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66757	10.1371/journal.pone.0066757	http://dx.doi.org/10.1371/journal.pone.0066757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23843963	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000052
J	Gour, DS; Bhagavatula, J; Bhavanishankar, M; Reddy, PA; Gupta, JA; Sarkar, MS; Hussain, SM; Harika, S; Gulia, R; Shivaji, S				Gour, Digpal Singh; Bhagavatula, Jyotsna; Bhavanishankar, Maradani; Reddy, Patlolla Anuradha; Gupta, Jaya A.; Sarkar, Mriganka Shekhar; Hussain, Shaik Mohammed; Harika, Segu; Gulia, Ravinder; Shivaji, Sisinthy			Philopatry and Dispersal Patterns in Tiger (Panthera tigris)	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; BOBCATS LYNX-RUFUS; MAXIMUM-LIKELIHOOD-ESTIMATION; MOLECULAR-GENETIC-ANALYSIS; INBREEDING AVOIDANCE; POPULATION-STRUCTURE; SOLITARY CARNIVORE; MADHYA-PRADESH; RELATEDNESS; MICROSATELLITE	Background: Tiger populations are dwindling rapidly making it increasingly difficult to study their dispersal and mating behaviour in the wild, more so tiger being a secretive and solitary carnivore. Methods: We used non-invasively obtained genetic data to establish the presence of 28 tigers, 22 females and 6 males, within the core area of Pench tiger reserve, Madhya Pradesh. This data was evaluated along with spatial autocorrelation and relatedness analyses to understand patterns of dispersal and philopatry in tigers within this well-managed and healthy tiger habitat in India. Results: We established male-biased dispersal and female philopatry in tigers and reiterated this finding with multiple analyses. Females show positive correlation up to 7 kms (which corresponds to an area of approximately 160 km(2)) however this correlation is significantly positive only upto 4 kms, or 50 km(2) (r = 0.129, p<0.0125). Males do not exhibit any significant correlation in any of the distance classes within the forest (upto 300 km(2)). We also show evidence of female dispersal upto 26 kms in this landscape. Conclusions: Animal movements are important for fitness, reproductive success, genetic diversity and gene exchange among populations. In light of the current endangered status of tigers in the world, this study will help us understand tiger behavior and movement. Our findings also have important implications for better management of habitats and interconnecting corridors to save this charismatic species.	[Gour, Digpal Singh; Bhagavatula, Jyotsna; Bhavanishankar, Maradani; Reddy, Patlolla Anuradha; Gupta, Jaya A.; Sarkar, Mriganka Shekhar; Hussain, Shaik Mohammed; Harika, Segu; Gulia, Ravinder; Shivaji, Sisinthy] Ctr Cellular & Mol Biol, CSIR, Lab Conservat Endangered Species, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Reddy, PA (corresponding author), Ctr Cellular & Mol Biol, CSIR, Lab Conservat Endangered Species, Hyderabad 500007, Andhra Pradesh, India.	anuradha@ccmb.res.in; shivas@ccmb.res.in	Gulia, Ravinder/AAD-3983-2021; Reddy, Anuradha/U-5864-2019; Sarkar, Mriganka Shekhar/AAB-9892-2019	Sarkar, Mriganka Shekhar/0000-0001-8367-2774; shivaji, sisinthy/0000-0003-0376-4658	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was funded by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, POPGENE VERSION 1 3; [Anonymous], 2010, STRIPES, V1, P10; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Bhagavatula J, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-48; Biek R, 2006, BIOL LETT-UK, V2, P312, DOI 10.1098/rsbl.2005.0437; Biswas S, 2002, J ZOOL, V256, P411, DOI 10.1017/S0952836902000456; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Campbell V, 2006, CAN J ZOOL, V84, P1112, DOI 10.1139/Z06-099; Croteau EK, 2010, CAN J ZOOL, V88, P536, DOI 10.1139/Z10-024; Dalerum F, 2007, J MAMMAL, V88, P793, DOI 10.1644/05-MAMM-A-427R1.1; Devillard S, 2003, J ANIM ECOL, V72, P203, DOI 10.1046/j.1365-2656.2003.00692.x; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferreras P, 2004, BEHAV ECOL, V15, P31, DOI 10.1093/beheco/arg097; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Janecka JE, 2006, J ZOOL, V269, P494, DOI 10.1111/j.1469-7998.2006.00099.x; Janecka JE, 2007, WILDLIFE BIOL, V13, P38, DOI 10.2981/0909-6396(2007)13[38:EFMDIB]2.0.CO;2; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kamler JF, 2000, CAN FIELD NAT, V114, P388; Karanth K. Ullas, 2003, Journal of the Bombay Natural History Society, V100, P169; KIMURA M, 1964, GENETICS, V49, P725; KITCHINGS JT, 1984, J WILDLIFE MANAGE, V48, P957, DOI 10.2307/3801447; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Lariviere Serge, 1997, Mammalian Species, V563, P1, DOI 10.2307/3504533; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Lode T, 2001, GENES GENET SYST, V76, P221, DOI 10.1266/ggs.76.221; Macdonald David W., 2001, P358; Majumder A., 2012, Wildlife Biology in Practice, V8, P36; McCord C.M., 1982, P728; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Milligan BG, 2003, GENETICS, V163, P1153; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Mossman CA, 1999, MOL ECOL, V8, P1063, DOI 10.1046/j.1365-294x.1999.00652.x; MOTRO U, 1991, AM NAT, V137, P108, DOI 10.1086/285148; Moyer MA, 2006, J MAMMAL, V87, P255, DOI 10.1644/05-MAMM-A-192R1.1; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nielsen CLR, 2007, J MAMMAL, V88, P441, DOI 10.1644/06-MAMM-A-126R2.1; Nielsen Clayton K., 2003, Transactions of the Illinois State Academy of Science, V96, P313; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Ranganathan J, 2008, BIOL CONSERV, V141, P67, DOI 10.1016/j.biocon.2007.09.003; Ratnayeke S, 2002, MOL ECOL, V11, P1115, DOI 10.1046/j.1365-294X.2002.01505.x; Ravan S, 2005, CURR SCI INDIA, V88, P1441; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046732; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; Reed JZ, 1997, MOL ECOL, V6, P225, DOI 10.1046/j.1365-294X.1997.00175.x; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Sandell M., 1989, P164; Sankar K, 2001, MAPPING PROTECTED AR, P130; Schaller GB, 1998, DEER TIGER STUDY WIL; Shields W.M., 1987, P3; Sinha PR, 2011, 2011003 TR NAT TIG C, P302; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Spong G, 2000, MOL ECOL, V9, P1773, DOI 10.1046/j.1365-294x.2000.01067.x; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; WOLFF JO, 1994, OIKOS, V71, P349, DOI 10.2307/3546284; Zimmermann F, 2005, J ZOOL, V267, P381, DOI 10.1017/S0952836905007545	74	34	37	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66956	10.1371/journal.pone.0066956	http://dx.doi.org/10.1371/journal.pone.0066956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843973	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000023
J	Pylro, VS; de Freitas, ALM; Otoni, WC; da Silva, IR; Borges, AC; Costa, MD				Pylro, Victor Satler; Moreira de Freitas, Andre Luiz; Otoni, Wagner Campos; da Silva, Ivo Ribeiro; Borges, Arnaldo Chaer; Costa, Mauricio Dutra			Calcium Oxalate Crystals in Eucalypt Ectomycorrhizae: Morphochemical Characterization	PLOS ONE			English	Article							CYTOSOLIC CALCIUM; ACCUMULATION; HYPAPHORINE; MORPHOLOGY; CRYSTALLIZATION; LEGUMINOSAE; RAPHIDES; LEAVES	Ectomycorrhizal fungi are ubiquitous in forest ecosystems, benefitting plants principally by increasing the uptake of water and nutrients such as calcium from the soil. Previous work has demonstrated accumulation of crystallites in eucalypt ectomycorrhizas, but detailed morphological and chemical characterization of these crystals has not been performed. In this work, cross sections of acetic acid-treated and cleared ectomycorrhizal fragments were visualized by polarized light microscopy to evaluate the location of crystals within cortical root cells. Ectomycorrhizal sections were also observed by scanning electron microscopy (SEM) coupled with energy dispersive x-ray (EDS) microprobe analysis. The predominant forms of crystals were crystal sand (granules) and concretions. Calcium, carbon and oxygen were detected by EDS as constituent elements and similar elemental profiles were observed between both crystal morphologies. All analyzed crystalline structures were characterized as calcium oxalate crystals. This is the first report of the stoichiometry and morphology of crystals occurring in eucalypt ectomycorrhizas in tropical soils. The data corroborates the role of ectomycorrhizae in the uptake and accumulation of calcium in the form of calcium oxalate crystals in hybrid eucalypt plants.	[Pylro, Victor Satler; Moreira de Freitas, Andre Luiz; Borges, Arnaldo Chaer; Costa, Mauricio Dutra] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil; [Otoni, Wagner Campos] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil; [da Silva, Ivo Ribeiro] Univ Fed Vicosa, Dept Solos, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Costa, MD (corresponding author), Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil.	mdcosta@ufv.br	Otoni, Wagner C/D-6439-2013; Pylro, Victor Satler/G-6045-2010; Costa, Maurício/AAV-1267-2020	Otoni, Wagner C/0000-0002-9614-9373; Pylro, Victor Satler/0000-0003-2154-9150; Costa, Mauricio/0000-0002-0828-4437	FAPEMIG [APQ-00403-09]; CNPq; CAPES	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by FAPEMIG (www.fapemig.br) grant APQ-00403-09, CNPq (www.cnpq.br), and CAPES (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez V. V. H., 2000, Boletim Informativo da Sociedade Brasileira de Cie~ncia do Solo, V25, P27; Arnott HJ, 2000, INT J PLANT SCI, V161, P133, DOI 10.1086/314230; Arocena JM, 2001, MYCORRHIZA, V10, P209, DOI 10.1007/s005720000082; ASSAILLY A, 1954, CR HEBD ACAD SCI, V238, P1902; Bradbury JH, 1998, J SCI FOOD AGR, V76, P608, DOI [10.1002/(SICI)1097-0010(199804)76:4&lt;608::AID-JSFA996&gt;3.0.CO;2-2, 10.1002/(SICI)1097-0010(199804)76:4<608::AID-JSFA996>3.3.CO;2-U]; BRUBAKER CL, 1989, CAN J BOT, V67, P1664, DOI 10.1139/b89-210; BUSH DS, 1993, PLANT PHYSIOL, V103, P7, DOI 10.1104/pp.103.1.7; CALMES J, 1970, B SOC BOT FR, V117, P189, DOI 10.1080/00378941.1970.10838762; CONNOLLY JH, 1995, CAN J BOT, V73, P927, DOI 10.1139/b95-101; Copley J, 2000, NATURE, V406, P452, DOI 10.1038/35020131; Dauphin A, 2007, PROTOPLASMA, V231, P83, DOI 10.1007/s00709-006-0240-9; Ditengou FA, 2000, PLANTA, V211, P722, DOI 10.1007/s004250000342; ENTRY JA, 1992, SOIL BIOL BIOCHEM, V24, P447, DOI 10.1016/0038-0717(92)90207-E; Faheed F, 2013, TURK J BOT, V37, P139, DOI 10.3906/bot-1112-19; Franceschi V, 2001, TRENDS PLANT SCI, V6, P331, DOI 10.1016/S1360-1385(01)02014-3; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; GOEDERT WJ, 1983, J SOIL SCI, V34, P405, DOI 10.1111/j.1365-2389.1983.tb01045.x; Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+; Harper JF, 2001, TRENDS PLANT SCI, V6, P395, DOI 10.1016/S1360-1385(01)02023-4; He HH, 2012, ANN BOT-LONDON, V109, P887, DOI 10.1093/aob/mcs004; Horner H.T., 1995, CALCIUM OXALATE BIOL, P53; Horner HT, 2009, INT J PLANT SCI, V170, P343, DOI 10.1086/596338; Jauregui-Zuniga D, 2005, PLANT SCI, V168, P1163, DOI 10.1016/j.plantsci.2004.12.013; KAUSCH AP, 1981, SCAN ELECTRON MICROS, P263; Lersten NR, 2011, AM J BOT, V98, P1, DOI 10.3732/ajb.1000247; Macnish AJ, 2003, AUST J BOT, V51, P565, DOI 10.1071/BT03035; MALAJCZUK N, 1982, NEW PHYTOL, V92, P527, DOI 10.1111/j.1469-8137.1982.tb03411.x; Mazen AMA, 2004, NEW PHYTOL, V161, P435, DOI 10.1111/j.1469-8137.2004.00923.x; Meric C, 2009, ACTA BIOL CRACOV BOT, V51, P105; Modenesi P, 2000, LICHENOLOGIST, V32, P505, DOI 10.1006/lich.2000.0276; Monje PV, 2002, PLANT PHYSIOL, V128, P707, DOI 10.1104/pp.010630; Nakata PA, 2003, PLANT SCI, V164, P901, DOI 10.1016/S0168-9452(03)00120-1; Panheleux M, 1999, BRIT POULTRY SCI, V40, P240, DOI 10.1080/00071669987665; Pereira J.C.D., 2000, CARACTERISTICAS MADE; Pittman JK, 2003, CURR OPIN PLANT BIOL, V6, P257, DOI 10.1016/S1369-5266(03)00036-0; Reboutier D, 2002, MOL PLANT MICROBE IN, V15, P932, DOI 10.1094/MPMI.2002.15.9.932; RITCHEY KD, 1982, SOIL SCI, V133, P378, DOI 10.1097/00010694-198206000-00007; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Saltz D, 2000, PLANT ECOL, V148, P127, DOI 10.1023/A:1009895512145; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; SPITZER E, 1982, CAN J BOT, V60, P1381, DOI 10.1139/b82-175; SWANSON FJ, 1988, BIOSCIENCE, V38, P92, DOI 10.2307/1310614; Touryan LA, 2004, NAT MATER, V3, P239, DOI 10.1038/nmat1096; Vale F.R, 1996, PESQ AGROPEC BRAS BE, V31, P609; Volk GM, 2004, ANN BOT-LONDON, V93, P741, DOI 10.1093/aob/mch092; Volk GM, 2002, PLANT BIOLOGY, V4, P34, DOI 10.1055/s-2002-20434; Webb MA, 1999, PLANT CELL, V11, P751, DOI 10.1105/tpc.11.4.751; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Gonzalez JAZ, 2009, REV BRAS CIENC SOLO, V33, P555, DOI 10.1590/S0100-06832009000300007	51	5	5	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67685	10.1371/journal.pone.0067685	http://dx.doi.org/10.1371/journal.pone.0067685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844062	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000076
J	Thibault, D; Loustalot, F; Fortin, GM; Bourque, MJ; Trudeau, LE				Thibault, Dominic; Loustalot, Fabien; Fortin, Guillaume M.; Bourque, Marie-Josee; Trudeau, Louis-Eric			Evaluation of D1 and D2 Dopamine Receptor Segregation in the Developing Striatum Using BAC Transgenic Mice	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS NEURONS; GENE-EXPRESSION; MESSENGER-RNAS; INDIRECT PATHWAYS; BASAL GANGLIA; COLOCALIZATION; MODULATION; VISUALIZATION; ORGANIZATION; HETEROMER	The striatum is predominantly composed of medium spiny neurons (MSNs) that send their axons along two parallel pathways known as the direct and indirect pathways. MSNs from the direct pathway express high levels of D1 dopamine receptors, while MSNs from the indirect pathway express high levels of D2 dopamine receptors. There has been much debate over the extent of colocalization of these two major dopamine receptors in MSNs of adult animals. In addition, the ontogeny of the segregation process has never been investigated. In this paper, we crossed bacterial artificial chromosome drd1a-tdTomato and drd2-GFP reporter transgenic mice to characterize these models and estimate D1-D2 co-expression in the developing striatum as well as in striatal primary cultures. We show that segregation is already extensive at E18 and that the degree of co-expression further decreases at P0 and P14. Finally, we also demonstrate that cultured MSNs maintain their very high degree of D1-D2 reporter protein segregation, thus validating them as a relevant in vitro model.	[Thibault, Dominic; Loustalot, Fabien; Fortin, Guillaume M.; Bourque, Marie-Josee; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol & Neurosci, Neurosci Res Grp, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol & Neurosci, Neurosci Res Grp, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Trudeau, Louis-Eric/AAE-4782-2020	Trudeau, Louis-Eric/0000-0003-4684-1377	Canadian Institutes of Health Research [MOP-106556]; Brain Canada Foundation; Krembil Foundation; Fonds de la recherche en sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada Foundation; Krembil Foundation; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research (MOP-106556) and from the Brain Canada and Krembil Foundations to L.-E. Trudeau, as well as from an infrastructure grant from the Fonds de la recherche en sante du Quebec to the Groupe de Recherche sur le Systeme Nerveux Central (GRSNC). D. Thibault was supported by a Canadian Institutes of Health Research graduate studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade KK, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00032; Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; Bertran-Gonzalez J, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00136; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Chan CS, 2012, J NEUROSCI, V32, P9124, DOI 10.1523/JNEUROSCI.0229-12.2012; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; Ferrari DC, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00007; Fortin GM, 2012, J NEUROSCI, V32, P17477, DOI 10.1523/JNEUROSCI.1939-12.2012; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hasbi A, 2010, CURR OPIN PHARMACOL, V10, P93, DOI 10.1016/j.coph.2009.09.011; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Kawaguchi Y, 1997, NEUROSCI RES, V27, P1, DOI 10.1016/S0168-0102(96)01134-0; LARSON ER, 1994, NEUROSCI LETT, V172, P101, DOI 10.1016/0304-3940(94)90672-6; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; LEMOINE C, 1991, P NATL ACAD SCI USA, V88, P4205, DOI 10.1073/pnas.88.10.4205; LESTER J, 1993, BRAIN RES, V621, P106, DOI 10.1016/0006-8993(93)90303-5; MEADORWOODRUFF JH, 1991, NEUROPSYCHOPHARMACOL, V5, P231; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Nelson AB, 2012, J NEUROSCI, V32, P9119, DOI 10.1523/JNEUROSCI.0224-12.2012; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; Perreault ML, 2012, NEUROSCIENCE, V225, P130, DOI 10.1016/j.neuroscience.2012.08.042; Perrone-Capano C, 2000, INT J DEV BIOL, V44, P679; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Shetreat ME, 1996, J NEUROCHEM, V66, P1475; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Smith Y, 1998, NEUROSCIENCE, V86, P353; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; Surmeier DJ, 2011, NEUROSCIENCE, V198, P3, DOI 10.1016/j.neuroscience.2011.08.051; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Swift JL, 2011, P NATL ACAD SCI USA, V108, P7016, DOI 10.1073/pnas.1018280108; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; Wong AC, 1999, NEUROSCIENCE, V89, P221, DOI 10.1016/S0306-4522(98)00284-X; Wu Y, 2000, NEUROSCI RES, V38, P49, DOI 10.1016/S0168-0102(00)00140-1	45	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67219	10.1371/journal.pone.0067219	http://dx.doi.org/10.1371/journal.pone.0067219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843993	Green Published, Green Submitted			2022-12-27	WOS:000321341000036
J	Yoshihara, M; Akasaka, H; Ohnishi, H; Miki, T; Furukawa, T; Yuda, S; Saitoh, S; Miura, T				Yoshihara, Mayumi; Akasaka, Hiroshi; Ohnishi, Hirofumi; Miki, Takayuki; Furukawa, Tetsuaki; Yuda, Satoshi; Saitoh, Shigeyuki; Miura, Tetsuji			Glucagon-Like Peptide-1 Secretory Function as an Independent Determinant of Blood Pressure: Analysis in the Tanno-Sobetsu Study	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; NITRIC-OXIDE PRODUCTION; GLP-1 RECEPTOR; ANALOG LIRAGLUTIDE; ENDOTHELIAL-CELLS; HEALTHY-SUBJECTS; HUMANS; EXENDIN-4; GLUCOSE; HYPERTENSION	Aims: Roles of glucagon-like peptide-1 (GLP-1) in extra-pancreatic tissues remain unclear. The aim of this study was to examine determinants of GLP-1 secretory function and possible contribution of GLP-1 to blood pressure (BP) regulation. Methods and Results: We recruited 128 subjects who received annual examinations and 75g-oral glucose tolerance tests (OGTT) in the Tanno-Sobetsu cohort. Subjects on regular medications for cardiovascular and/or metabolic diseases were excluded, and data for the remaining 103 subjects were used for the univariate and multivariate analyses. Age, plasma glucose (PG), hemoglobin A1c (HbA1c), plasma insulin, and serum lipids were not selected as independent determinants of fasting GLP-1 level by multiple linear regression analysis. However, age and female sex were selected as independent positive determinants of the area under the curve of GLP-1 level during OGTT (AUC(GLP-1)), an index of GLP-1 secretory function. Multiple linear regression analysis indicated that AUC(GLP-1) was an independent negative predictor of systolic BP (SBP), while AUC(GLP-1) was not correlated with fasting PG or HbA1c level. In subgroup analyses using the median of AUC(GLP-1) to divide the study subjects into high and low GLP-1 response groups, AUC(GLP-1) was significantly correlated with both SBP and diastolic BP (r = 0.40 and 0.28, respectively) in the low GLP-1 response group but not in the high GLP-1 response group. Conclusions: The results of the present study suggest that GLP-1 secretory function is involved in prevention of BP elevation and that the GLP-1 response to oral glucose rather increases with aging perhaps as an adaptive phenomenon.	[Yoshihara, Mayumi; Akasaka, Hiroshi; Ohnishi, Hirofumi; Miki, Takayuki; Furukawa, Tetsuaki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Ohnishi, Hirofumi] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Yuda, Satoshi] Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Sapporo, Hokkaido, Japan; [Saitoh, Shigeyuki] Sapporo Med Univ, Dept Nursing, Sch Hlth Sci, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Miura, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan.	miura@sapmed.ac.jp		Ohnishi, Hirofumi/0000-0002-5873-6438	Japanese Ministry of Health, Labor, and Welfare [H19-cardiovascular-common-021, H20-cardiovascular-common-013]	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by research grants from Scientific Research (H19-cardiovascular-common-021 and H20-cardiovascular-common-013) from the Japanese Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TCM, 2005, OBES RES, V13, P710, DOI 10.1038/oby.2005.80; Akasaka H, 2012, J HYPERTENS, V30, pe303; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bharucha AE, 2008, AM J PHYSIOL-REG I, V295, pR874, DOI 10.1152/ajpregu.00153.2008; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Carroll JF, 2007, OBESITY, V15, P2974, DOI 10.1038/oby.2007.355; Damholt B, 2006, J CLIN PHARMACOL, V46, P635, DOI 10.1177/0091270006288215; de Luis D, 2012, ANN NUTR METAB, V61, P70, DOI 10.1159/000339378; Dong ZH, 2013, AM J PHYSIOL-ENDOC M, V304, pE222, DOI 10.1152/ajpendo.00473.2012; Edwards CMB, 1998, CLIN SCI, V95, P719, DOI 10.1042/cs0950719; Erdogdu O, 2010, MOL CELL ENDOCRINOL, V325, P26, DOI 10.1016/j.mce.2010.04.022; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Goto H, 2011, BIOCHEM BIOPH RES CO, V405, P79, DOI 10.1016/j.bbrc.2010.12.131; Gutzwiller JP, 2006, DIGESTION, V73, P142, DOI 10.1159/000094334; Gutzwiller JP, 2004, J CLIN ENDOCR METAB, V89, P3055, DOI 10.1210/jc.2003-031403; Hattori Y, 2010, DIABETOLOGIA, V53, P2256, DOI 10.1007/s00125-010-1831-8; Hirata Y, 2013, EUR J PHARMACOL, V699, P106, DOI 10.1016/j.ejphar.2012.11.057; Jorgensen TOL, 2000, EUR J ENDOCRINOL, V143, P593, DOI 10.1530/eje.0.1430593; Kawano Y, 2007, HYPERTENS RES, V30, P887, DOI 10.1291/hypres.30.887; Kim M, 2013, NAT MED, V19, P567, DOI 10.1038/nm.3128; Korosi J, 2001, J GERONTOL A-BIOL, V56, pM575, DOI 10.1093/gerona/56.9.M575; Li W, 2010, PEPTIDES, V31, P625, DOI 10.1016/j.peptides.2009.11.008; Lim GE, 2009, ENDOCRINOLOGY, V150, P580, DOI 10.1210/en.2008-0726; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendis B, 2012, BRIT J CLIN PHARMACO, V74, P437, DOI 10.1111/j.1365-2125.2012.04214.x; Mitsumata K, 2012, HYPERTENSION, V60, P1124, DOI 10.1161/HYPERTENSIONAHA.112.201129; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Ohnishi H, 2006, DIABETES CARE, V29, P1128, DOI 10.2337/dc06-0222; Okerson T, 2010, AM J HYPERTENS, V23, P334, DOI 10.1038/ajh.2009.245; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Ravassa S, 2012, CARDIOVASC RES, V94, P316, DOI 10.1093/cvr/cvs123; Rieg T, 2012, AM J PHYSIOL-RENAL, V303, pF963, DOI 10.1152/ajprenal.00259.2012; SCHUSDZIARRA V, 1988, HORM RES, V29, P75, DOI 10.1159/000180972; Tahara N, 2013, CLIN BIOCHEM, V46, P300, DOI 10.1016/j.clinbiochem.2012.11.023; Tesauro M, 2013, DIABETES CARE, V36, P683, DOI 10.2337/dc12-0763; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Yerram P, 2012, CURR OPIN NEPHROL HY, V21, P463, DOI 10.1097/MNH.0b013e328356bccd; Yu M, 2003, J HYPERTENS, V21, P1125, DOI 10.1097/00004872-200306000-00012; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	43	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67578	10.1371/journal.pone.0067578	http://dx.doi.org/10.1371/journal.pone.0067578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844037	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000061
J	Zhou, Y; Kou, G; Ergu, D; Peng, Y				Zhou, Yu; Kou, Gang; Ergu, Daji; Peng, Yi			Mission Availability for Bounded-Cumulative-Downtime System	PLOS ONE			English	Article							RELIABILITY; FIELD; MODEL	In this research, a mathematics model is proposed to describe the mission availability for bounded-cumulative-downtime system. In the proposed model, the cumulative downtime and cumulative uptime are considered as constraints simultaneously. The mission availability can be defined as the probability that all repairs do not exceed the bounded cumulative downtime constraint of such system before the cumulative uptime has accrued. There are two mutually exclusive cases associated with the probability. One case is the system has not failed, where the probability can be described by system reliability. The other case is the system has failed and the cumulative downtime does not exceed the constraint before the cumulative uptime has accrued. The mathematic description of the probability under the second case is very complex. And the cumulative downtime in a mission can be set as a random variable, whose cumulative distribution means the probability that the failure system can be restored to the operating state. Giving the dependence in the scheduled mission, a mission availability model with closed form expression under this assumption is proposed. Numerical simulations are presented to illustrate the effectiveness of the proposed model. The results indicate that the relative errors are acceptable and the proposed model is effective. Furthermore, three important applications of the proposed mission availability model are discussed.	[Zhou, Yu; Ergu, Daji; Peng, Yi] Univ Elect Sci & Technol China, Sch Management & Econ, Chengdu 610054, Peoples R China; [Kou, Gang] Southwestern Univ Finance & Econ, Sch Business Adm, Chengdu, Peoples R China; [Ergu, Daji] Southwest Univ Nationalities, Chengdu, Peoples R China	University of Electronic Science & Technology of China; Southwestern University of Finance & Economics - China; Southwest Minzu University	Peng, Y (corresponding author), Univ Elect Sci & Technol China, Sch Management & Econ, Chengdu 610054, Peoples R China.	pengyicd@gmail.com	Kou, Gang/G-3869-2010	Kou, Gang/0000-0002-9220-8647; Zhou, Yu/0000-0002-6196-5012	National Natural Science Foundation of China [70901015, 71222108]; Fundamental Research Funds for the Central Universities [ZYGX2012YB035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research has been partially supported by grants from the National Natural Science Foundation of China (#70901015 and #71222108) and the Fundamental Research Funds for the Central Universities (#ZYGX2012YB035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono H, 2005, MICROELECTRON RELIAB, V45, P1109, DOI 10.1016/j.microrel.2004.12.015; Birolini A., 2007, RELIABILITY ENG THEO, V5th; Blischke W.R., 2000, RELIABILITY MODELING, V1st ed.; BLOCK HW, 1985, J APPL PROBAB, V22, P370, DOI 10.2307/3213780; BRYANT JL, 1981, AIIE T, V13, P249, DOI 10.1080/05695558108974558; Cassady CR, 2005, IEEE T RELIAB, V54, P564, DOI 10.1109/TR.2005.857633; Clarotti C, 2004, RELIAB ENG SYST SAFE, V84, P57, DOI 10.1016/j.ress.2004.01.005; CSENKI A, 1995, STATISTICS, V26, P75, DOI 10.1080/02331889508802468; DAVIES A, 1994, INT J PROD ECON, V37, P259, DOI 10.1016/0925-5273(94)90177-5; de Smidt-Destombes KS, 2007, INT J PROD ECON, V107, P404, DOI 10.1016/j.ijpe.2006.08.013; DUNBAR LC, 1984, RELIAB ENG SYST SAFE, V7, P169, DOI 10.1016/0143-8174(84)90015-5; Fan HD, 2011, IEEE T RELIAB, V60, P144, DOI 10.1109/TR.2011.2104432; Fitouhi MC, 2012, INT J PROD ECON, V136, P344, DOI 10.1016/j.ijpe.2011.12.021; Gao Wen, 2001, Chinese Journal of Computers, V24, P876; GOYAL A, 1988, IEEE T COMPUT, V37, P25, DOI 10.1109/12.75148; GOYAL A, 1987, IEEE T RELIAB, V36, P202, DOI 10.1109/TR.1987.5222341; Goyal A., 1987, Annals of Operations Research, V8, P285, DOI 10.1007/BF02187098; GUPTA SM, 1982, INT J SYST SCI, V13, P1385, DOI 10.1080/00207728208926438; GUPTA SM, 1983, MICROELECTRON RELIAB, V23, P333, DOI 10.1016/0026-2714(83)90341-4; Hwang HS, 2005, INT J PROD ECON, V98, P143, DOI 10.1016/j.ijpe.2004.05.022; Jia JS, 2009, APPL MATH COMPUT, V214, P133, DOI 10.1016/j.amc.2009.03.064; KODAMA M, 1973, IEEE T RELIAB, VR 22, P268, DOI 10.1109/TR.1973.5215676; Liao GL, 2011, INT J PROD ECON, V130, P118, DOI 10.1016/j.ijpe.2010.12.004; Martorell S, 2005, RELIAB ENG SYST SAFE, V87, P65, DOI 10.1016/j.ress.2004.04.009; Peng Y, 2008, INT J INF TECH DECIS, V7, P639, DOI 10.1142/S0219622008003204; Rehmert IJ, 2009, IEEE T SYST MAN CY A, V39, P272, DOI [10.1109/TSMCA.2009.2007945, 10.1109/TSMCA.2008.2007945]; Sun KBA, 2010, INT J PROD ECON, V124, P151, DOI 10.1016/j.ijpe.2009.10.018; Tillman FA, 2007, AIIE T, V9, P247; Trivedi D, 1989, MICROELECTRON RELIAB, V32, P49; van Dijkhuizen G, 1999, RELIAB ENG SYST SAFE, V66, P13, DOI 10.1016/S0951-8320(99)00013-7; Yang K, 2005, RELIAB ENG SYST SAFE, V87, P191, DOI 10.1016/j.ress.2004.04.016; Zhou Y, 2012, P ROMANIAN ACAD A, V13, P133; Zhu Y, 2010, EUR J OPER RES, V202, P781, DOI 10.1016/j.ejor.2009.06.008	33	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e65375	10.1371/journal.pone.0065375	http://dx.doi.org/10.1371/journal.pone.0065375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843940	gold, Green Published, Green Submitted			2022-12-27	WOS:000321341000005
J	Bartomeus, I				Bartomeus, Ignasi			Understanding Linkage Rules in Plant-Pollinator Networks by Using Hierarchical Models That Incorporate Pollinator Detectability and Plant Traits	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; FLORAL TRAITS; COEVOLUTIONARY NETWORKS; SAMPLING COMPLETENESS; ECOLOGICAL NETWORKS; INVASIVE PLANTS; PATTERNS; SPECIALIZATION; COMMUNITIES; VISITATION	The analysis of mutualistic networks has become a central tool in answering theoretical and applied questions regarding our understanding of ecological processes. Significant gaps in knowledge do however need to be bridged in order to effectively and accurately be able to describe networks. Main concern are the incorporation of species level information, accounting for sampling limitations and understanding linkage rules. Here I propose a simple method to combine plant pollinator effort-limited sampling with information about plant community to gain understanding of what drives linkage rules, while accounting for possible undetected linkages. I use hierarchical models to estimate the probability of detection of each plant-pollinator interaction in 12 Mediterranean plant-pollinator networks. As it is possible to incorporate plant traits as co-variables in the models, this method has the potential to be used for predictive purposes, such as identifying undetected links among existing species, as well as potential interactions with new plant species. Results show that pollinator detectability is very skewed and usually low. Nevertheless, 84% of the models are enhanced by the inclusion of co-variables, with flower abundance and inflorescence type being the most commonly retained co-variables. The predicted networks increase network Connectance by 13%, but not Nestedness, which is known to be robust to sampling effects. However, 46% of the pollinator interactions in the studied networks comprised a single observation and hence could not be modeled. The hierarchical modeling approach suggested here is highly flexible and can be used on binary or frequency networks, accommodate different observers or include collection day weather variables as confounding factors. An R script is provided for a rapid adoption of this method.	Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Bartomeus, I (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	nacho.bartomeus@gmail.com		Bartomeus, Ignasi/0000-0001-7893-4389				Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bascompte J, 2007, BASIC APPL ECOL, V8, P485, DOI 10.1016/j.baae.2007.06.003; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bosch J, 1997, OECOLOGIA, V109, P583, DOI 10.1007/s004420050120; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; Chittka L, 2005, COGNITIVE ECOLOGY PO; Colwell RK, 2012, ANNU REV ECOL EVOL S, V43, P183, DOI 10.1146/annurev-ecolsys-110411-160304; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Devoto M, 2005, OIKOS, V109, P461, DOI 10.1111/j.0030-1299.2005.13712.x; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Dorado J, 2011, ECOLOGY, V92, P19, DOI 10.1890/10-0794.1; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Encinas-Viso F, 2012, ECOL LETT, V15, P198, DOI 10.1111/j.1461-0248.2011.01726.x; Endress PK, 2001, J EXP ZOOL, V291, P105, DOI 10.1002/jez.1063; Essenberg CJ, 2012, AM NAT, V180, P153, DOI 10.1086/666610; Fiske I, 2011, J STAT SOFT, V43; Frund J, 2010, OIKOS, V119, P1581, DOI 10.1111/j.1600-0706.2010.18450.x; Gibson MR, 2012, J ECOL, V100, P1216, DOI 10.1111/j.1365-2745.2012.02004.x; Gibson RH, 2011, OIKOS, V120, P822, DOI 10.1111/j.1600-0706.2010.18927.x; Goldwasser L, 1997, ECOLOGY, V78, P41; Gumbert A, 1999, P ROY SOC B-BIOL SCI, V266, P1711, DOI 10.1098/rspb.1999.0836; Hegland SJ, 2005, OECOLOGIA, V145, P586, DOI 10.1007/s00442-005-0165-6; Hegland SJ, 2010, BIOL CONSERV, V143, P2092, DOI 10.1016/j.biocon.2010.05.018; HEINRICH B, 1975, ANNU REV ECOL SYST, V6, P139, DOI 10.1146/annurev.es.06.110175.001035; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Junker RR, 2013, FUNCT ECOL, V27, P329, DOI 10.1111/1365-2435.12005; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Ollerton J, 2002, OIKOS, V98, P340, DOI 10.1034/j.1600-0706.2002.980215.x; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Rivera-Hutinel A, 2012, ECOLOGY, V93, P1593, DOI 10.1890/11-1803.1; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Sorensen PB, 2012, J POLLINATION ECOL, V6, P129; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Trojelsgaard K, 2013, GLOBAL ECOL BIOGEOGR, V22, P149, DOI 10.1111/j.1466-8238.2012.00777.x; Vila M, 2009, P ROY SOC LOND B BIO, V276, P2887, DOI [10.1098/rspb.2009.0551, DOI 10.1098/RSPB.2009.0551]; Wells K, 2013, METHODS ECOL EVOL, V4, P1, DOI 10.1111/j.2041-210x.2012.00249.x	53	40	40	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e69200	10.1371/journal.pone.0069200	http://dx.doi.org/10.1371/journal.pone.0069200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840909	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900048
J	Sanna, D; Cossu, P; Dedola, GL; Scarpa, F; Maltagliati, F; Castelli, A; Franzoi, P; Lai, T; Cristo, B; Curini-Galletti, M; Francalacci, P; Casu, M				Sanna, Daria; Cossu, Piero; Dedola, Gian Luca; Scarpa, Fabio; Maltagliati, Ferruccio; Castelli, Alberto; Franzoi, Piero; Lai, Tiziana; Cristo, Benedetto; Curini-Galletti, Marco; Francalacci, Paolo; Casu, Marco			Mitochondrial DNA Reveals Genetic Structuring of Pinna nobilis across the Mediterranean Sea	PLOS ONE			English	Article							CERASTODERMA-GLAUCUM; POPULATION-STRUCTURE; MARINE; DISPERSAL; PHYLOGEOGRAPHY; MOLLUSCA; BIVALVIA; EASTERN; RECRUITMENT; FISH	Pinna nobilis is the largest endemic Mediterranean marine bivalve. During past centuries, various human activities have promoted the regression of its populations. As a consequence of stringent standards of protection, demographic expansions are currently reported in many sites. The aim of this study was to provide the first large broad-scale insight into the genetic variability of P. nobilis in the area that encompasses the western Mediterranean, Ionian Sea, and Adriatic Sea marine ecoregions. To accomplish this objective twenty-five populations from this area were surveyed using two mitochondrial DNA markers (COI and 16S). Our dataset was then merged with those obtained in other studies for the Aegean and Tunisian populations (eastern Mediterranean), and statistical analyses (Bayesian model-based clustering, median-joining network, AMOVA, mismatch distribution, Tajima's and Fu's neutrality tests and Bayesian skyline plots) were performed. The results revealed genetic divergence among three distinguishable areas: (1) western Mediterranean and Ionian Sea; (2) Adriatic Sea; and (3) Aegean Sea and Tunisian coastal areas. From a conservational point of view, populations from the three genetically divergent groups found may be considered as different management units.	[Sanna, Daria; Cossu, Piero; Scarpa, Fabio; Lai, Tiziana; Cristo, Benedetto; Curini-Galletti, Marco; Francalacci, Paolo; Casu, Marco] Univ Sassari, Sez Zool Archeozool & Genet, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy; [Dedola, Gian Luca] Univ Sassari, Sez Anat, Dipartimento Med Vet, I-07100 Sassari, Italy; [Maltagliati, Ferruccio; Castelli, Alberto] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Franzoi, Piero] Univ Ca Foscari, Dipartimento Sci Ambientali Informat & Stat, Venice, Italy	University of Sassari; University of Sassari; University of Pisa; Universita Ca Foscari Venezia	Casu, M (corresponding author), Univ Sassari, Sez Zool Archeozool & Genet, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy.	marcasu@uniss.it	Cossu, Piero/B-8528-2019; Franzoi, Piero/F-6217-2014	Cossu, Piero/0000-0002-8946-8261; CASTELLI, ALBERTO/0000-0002-0762-1403; Franzoi, Piero/0000-0003-3686-8525; LAI, Tiziana/0000-0003-0731-1656; FRANCALACCI, Paolo/0000-0001-7912-162X; CASU, Marco/0000-0002-5042-4851	RAS (PO Sardegna)	RAS (PO Sardegna)	The research benefited from a grant by RAS (PO Sardegna FSE 2007-2013) L.R. 7/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, GLOBAL BIODIVERSITY; Apte Smita, 2000, Biological Invasions, V2, P75, DOI 10.1023/A:1010024818644; Arnaud-Haond S, 2007, J BIOGEOGR, V34, P963, DOI 10.1111/j.1365-2699.2006.01671.x; Astraldi M, 1999, PROG OCEANOGR, V44, P65, DOI 10.1016/S0079-6611(99)00021-X; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beranger K, 2004, DEEP-SEA RES PT II, V51, P411, DOI 10.1016/j.dsr2.2003.08.004; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Biktashev VN, 2004, B MATH BIOL, V66, P233, DOI 10.1016/j.bulm.2003.08.008; Borrero-Perez GH, 2011, MOL ECOL, V20, P1964, DOI 10.1111/j.1365-294X.2011.05068.x; Butler Alan, 1994, Marine Life, V3, P37; Calvo M, 2009, BIOL J LINN SOC, V96, P898, DOI 10.1111/j.1095-8312.2008.01167.x; CARLTON JT, 1995, MAR BIOL, V121, P721, DOI 10.1007/BF00349308; Casu M, 2011, BIOL J LINN SOC, V103, P117, DOI 10.1111/j.1095-8312.2011.01630.x; Chen G, 2008, MOL ECOL, V17, P1451, DOI 10.1111/j.1365-294X.2007.03657.x; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; Dailianis T, 2011, MOL ECOL, V20, P3757, DOI 10.1111/j.1365-294X.2011.05222.x; DEGAULEJAC B, 1990, HALIOTIS, V10, P83; Depaulis F, 2003, J MOL EVOL, V57, pS190, DOI 10.1007/s00239-003-0027-y; Domingues VS, 2005, MOL ECOL, V14, P4051, DOI 10.1111/j.1365-294X.2005.02723.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Emerson BC, 2007, SYST BIOL, V56, P337, DOI 10.1080/10635150701258795; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez MV, 2013, J SEA RES IN PRESS; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; FREY JK, 1993, SYST BIOL, V42, P373, DOI 10.2307/2992471; Fu YX, 1997, GENETICS, V147, P915; Galinou-Mitsoudi Sofia, 2006, Journal of Biological Research (Thessaloniki), V5, P47; Gollasch Stephan, 2007, V193, P49; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Greenwald M, 1996, CRUISING CHEF COOKBO; Hein J., 2005, GENE GENEALOGIES VAR; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Horne JB, 2011, MOL ECOL, V20, P2291, DOI 10.1111/j.1365-294X.2011.05097.x; Johnson LE, 1996, ECOLOGY, V77, P1686, DOI 10.2307/2265774; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; KATSANEVAKIS S, 2006, ENDANGER SPECIES RES, V1, P51, DOI DOI 10.3354/ESR001051; Katsares V, 2008, BIOLOGIA, V63, P412, DOI 10.2478/s11756-008-0061-8; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Kunz GF, 1993, BOOK PEARL HIST ART; Larmuseau MHD, 2009, J BIOGEOGR, V36, P1138, DOI 10.1111/j.1365-2699.2008.02072.x; Lazoski C, 2011, MAR ECOL PROG SER, V426, P197, DOI 10.3354/meps09035; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luttikhuizen PC, 2003, MOL ECOL, V12, P2215, DOI 10.1046/j.1365-294X.2003.01872.x; Magoulas A, 1996, MOL BIOL EVOL, V13, P178, DOI 10.1093/oxfordjournals.molbev.a025554; Maltagliati F, 2010, BIOL J LINN SOC, V100, P910, DOI 10.1111/j.1095-8312.2010.01482.x; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; Nikula R, 2003, MAR BIOL, V143, P339, DOI 10.1007/s00227-003-1088-6; OSPAR, 2006, OSPAR BIOD SER; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Peharda M, 2008, ACTA ADRIAT, V49, P25; Peijnenburg KTCA, 2006, MOL ECOL, V15, P3319, DOI 10.1111/j.1365-294X.2006.03002.x; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Petersen CH, 2007, MAR BIOL, V150, P1289, DOI 10.1007/s00227-006-0442-x; Pitchford JW, 2001, B MATH BIOL, V63, P527; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rabaou L, 2008, CAH BIOL MAR, V49, P67; Rabaoui L, 2011, HYDROBIOLOGIA, V678, P99, DOI 10.1007/s10750-011-0827-9; Rabaoui L, 2010, J MOLLUS STUD, V76, P340, DOI 10.1093/mollus/eyq023; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Richardson CA, 2004, J EXP MAR BIOL ECOL, V299, P1, DOI 10.1016/j.jembe.2003.08.012; Rio MH, 2007, J MARINE SYST, V65, P484, DOI 10.1016/j.jmarsys.2005.02.006; Robinson A.R., 2001, OCEAN CURRENTS MEDIT, DOI [10.1006/rwos.2001.0376, DOI 10.1006/RWOS.2001.0376]; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sa-Pinto A, 2010, BIOL J LINN SOC, V100, P154, DOI 10.1111/j.1095-8312.2010.01405.x; Schneider S, 1999, GENETICS, V152, P1079; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Svitoch AA, 2000, OCEANOLOGY+, V40, P868; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tarnowska K, 2010, MAR ECOL PROG SER, V406, P173, DOI 10.3354/meps08549; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varney RL, 2009, J SHELLFISH RES, V28, P855, DOI 10.2983/035.028.0415; Vinas J, 2004, MOL PHYLOGENET EVOL, V33, P32, DOI 10.1016/j.ympev.2004.04.009; Walpole MJ, 2002, BIODIVERS CONSERV, V11, P543, DOI 10.1023/A:1014864708777; Wing SR, 1998, LIMNOL OCEANOGR, V43, P1710, DOI 10.4319/lo.1998.43.7.1710; Xiao J, 2010, MAR BIOL, V157, P1767, DOI 10.1007/s00227-010-1449-x; Zavodnik Dusan, 1991, P169; Zulliger DE, 2009, MAR BIOL, V156, P597, DOI 10.1007/s00227-008-1111-z	93	35	35	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67372	10.1371/journal.pone.0067372	http://dx.doi.org/10.1371/journal.pone.0067372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840684	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400073
J	Zhao, Y; Kong, CC; Cui, XL; Cui, HY; Shi, XM; Zhang, XM; Hu, SL; Hao, LW; Wang, YF				Zhao, Yan; Kong, Congcong; Cui, Xianlan; Cui, Hongyu; Shi, Xingming; Zhang, Xiaomin; Hu, Shunlei; Hao, Lianwei; Wang, Yunfeng			Detection of Infectious Laryngotracheitis Virus by Real-Time PCR in Naturally and Experimentally Infected Chickens	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RESTRICTION-ENDONUCLEASE ANALYSIS; FRAGMENT-LENGTH-POLYMORPHISM; VACCINE STRAINS; RAPID DETECTION; DIFFERENTIATION; PRODUCTS; ANTIBODY; ASSAY; DNA	Infectious laryngotracheitis (ILT) is an acute, highly contagious upper-respiratory infectious disease of chickens. In this study, a real-time PCR method was developed for fast and accurate detection and quantitation of ILTV DNA of chickens experimentally infected with ILTV strain LJS09 and naturally infected chickens. The detection lower limit of the assay was 10 copies of DNA. There were no cross reactions with the DNA and RNA of infectious bursal disease virus, chicken anemia virus, reticuloendotheliosis virus, avian reovirus, Newcastle disease virus, and Marek's disease virus. The real-time PCR was reproducible as the coefficients of variation of reproducibility of the intra-assay and the inter-assay were less than 2%. The real-time PCR was used to detect the levels of the ILTV DNA in the tissues of specific pathogen free (SPF) chickens infected with ILTV at different times post infection. ILTV DNA was detected by real-time PCR in the heart, liver, spleen, lung, kidney, larynx, tongue, thymus, glandular stomach, duodenum, pancreatic gland, small intestine, large intestine, cecum, cecal tonsil, bursa of Fabricius, and brain of chickens in the infection group and the contact-exposure group. The sensitivity, specificity, and reproducibility of the ILTV real-time PCR assay revealed its suitability for detection and quantitation of ILTV in the samples from clinically and experimentally ILTV infected chickens.	[Zhao, Yan; Kong, Congcong; Cui, Hongyu; Shi, Xingming; Hu, Shunlei; Hao, Lianwei; Wang, Yunfeng] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China; [Zhao, Yan; Kong, Congcong; Cui, Hongyu; Shi, Xingming; Hu, Shunlei; Hao, Lianwei; Wang, Yunfeng] Natl Engn Res Ctr Vet Biol, Harbin, Peoples R China; [Zhang, Xiaomin] Yunnan Agr Univ, Inst Anim Sci & Technol, Kunming, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Yunnan Agricultural University	Wang, YF (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China.	yfwang@hvri.ac.cn	Cui, Xianlan/N-1734-2017	Cui, Xianlan/0000-0002-5029-1286	Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard [0302012009]	Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard	This research was supported by the Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard (0302012009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas F, 1996, AVIAN DIS, V40, P56, DOI 10.2307/1592371; Alexander HS, 1997, AVIAN DIS, V41, P646, DOI 10.2307/1592156; ANDREASEN JR, 1990, AVIAN DIS, V34, P646, DOI 10.2307/1591259; BAGUST TJ, 1986, AVIAN DIS, V30, P179, DOI 10.2307/1590631; Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; BAINES JD, 1992, J VIROL, V66, P5621, DOI 10.1128/JVI.66.9.5621-5626.1992; Callison SA, 2007, J VIROL METHODS, V139, P31, DOI 10.1016/j.jviromet.2006.09.001; Chang PC, 1997, J VIROL METHODS, V66, P179, DOI 10.1016/S0166-0934(97)00050-5; Creelan JL, 2006, AVIAN PATHOL, V35, P173, DOI 10.1080/03079450600598244; Fuchs W, 2007, VET RES, V38, P261, DOI 10.1051/vetres:200657; GUY JS, 1989, AVIAN DIS, V33, P316, DOI 10.2307/1590850; Humberd J, 2002, AVIAN DIS, V46, P64, DOI 10.1637/0005-2086(2002)046[0064:DOILVI]2.0.CO;2; IDE PR, 1978, CAN J COMP MED, V42, P54; JOHNSON MA, 1991, ARCH VIROL, V119, P181, DOI 10.1007/BF01310669; KEELER CL, 1993, AVIAN DIS, V37, P418, DOI 10.2307/1591668; King A.M.Q., 2012, 9 INT COMM TAX VIR, P1344; Kirkpatrick NC, 2006, AVIAN PATHOL, V35, P449, DOI 10.1080/03079450601028803; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; KOTIW M, 1982, AVIAN DIS, V26, P718, DOI 10.2307/1589858; LEIB DA, 1987, ARCH VIROL, V93, P287, DOI 10.1007/BF01310982; LONGENECKER BM, 1977, J NATL CANCER I, V58, P853, DOI 10.1093/jnci/58.4.853; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; Ojkic D, 2006, AVIAN PATHOL, V35, P286, DOI 10.1080/03079450600815481; Przech AJ, 2003, J VIROL, V77, P9613, DOI 10.1128/JVI.77.17.9613-9621.2003; REED L. J., 1938, AMER JOUR HYG, V27, P493; RUSSELL RG, 1983, CAN J COMP MED, V47, P163; SHIRLEY MW, 1990, J VIROL METHODS, V30, P251, DOI 10.1016/0166-0934(90)90067-P; Tittsler RP, 1925, J AM VET MED ASS, V67, P229; Vogtlin A, 1999, VACCINE, V17, P2501, DOI 10.1016/S0264-410X(99)00068-7; YORK JJ, 1983, AVIAN DIS, V27, P409, DOI 10.2307/1590167	31	34	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67598	10.1371/journal.pone.0067598	http://dx.doi.org/10.1371/journal.pone.0067598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840745	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400110
J	Busquets, A; Marina, M; Irurtia, A; Angulo-Barroso, RM				Busquets, Albert; Marina, Michel; Irurtia, Alfredo; Angulo-Barroso, Rosa M.			Coordination Analysis Reveals Differences in Motor Strategies for the High Bar Longswing among Novice Adults	PLOS ONE			English	Article							EXPERT PERFORMANCE; SKILL ACQUISITION; INERTIA; TALENT; TASK	Coordination between arm-trunk and trunk-leg is important for effective longswing performance. This research describes inter-segmental coordination changes after a practice period of longswing on high bar in a novice cohort. Novices were divided by initial skill level (talent) into two groups: spontaneously-talented, (ST, n = 10, closer to expert performance) and non-spontaneously-talented (NST, n = 15). Additionally, post-practice longswing coordination was compared to expert gymnasts (n = 9). Longswing amplitude and coordination (inter-joint reversal points and continuous relative phase, CRP) were assessed for pre- and post-practice sessions. ANOVAs showed similar practice effects in swing enlargements for the ST (11%) and NST (18%), but inter-joint reversal points and positive area in CRP during the downswing were different. Due to practice, the ST group paired shoulder and hip reversal points (events) during the downswing closer and with larger velocity of the arm in relation to the trunk than the NST group. The NST failed to modify coordination probably due to a large variability at the beginning of the downswing. Given a similar amount of practice, talent could help to achieve the right temporal events' sequence during downswing, which would allow the exploration of different segmental coordination. However, upswing coordination of the novice groups (ST and NST) requires more focused practice to achieve expert levels than downswing, especially the arm-trunk coordination.	[Busquets, Albert; Marina, Michel; Irurtia, Alfredo; Angulo-Barroso, Rosa M.] Univ Barcelona, Inst Nacl Educ Fis Catalunya, Barcelona, Spain; [Angulo-Barroso, Rosa M.] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Angulo-Barroso, Rosa M.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	University of Barcelona; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Angulo-Barroso, RM (corresponding author), Univ Barcelona, Inst Nacl Educ Fis Catalunya, Barcelona, Spain.	rangulo@umich.edu	Marina, Michel/I-4551-2015; IRURTIA, ALFREDO/R-3360-2019; Angulo-Barroso, Rosa M/I-3562-2017; Busquets, Albert/I-5544-2015	Marina, Michel/0000-0001-7783-5178; Angulo-Barroso, Rosa M/0000-0001-7757-6399; Busquets, Albert/0000-0002-8879-1577; Irurtia, Alfredo/0000-0002-3463-6643				Arampatzis A, 1999, J BIOMECH, V32, P811, DOI 10.1016/S0021-9290(99)00065-2; Bernstein N, 1967, COORDINATION REGULAT; Busquets A, 2011, RES Q EXERCISE SPORT, V82, P9, DOI 10.1080/02701367.2011.10599717; CLARK JE, 1995, RES Q EXERCISE SPORT, V66, P173, DOI 10.1080/02701367.1995.10608831; CLARK JE, 1993, CHILD DEV, V64, P1143, DOI 10.1111/j.1467-8624.1993.tb04192.x; Davids K, 2000, J SPORT SCI, V18, P703, DOI 10.1080/02640410050120087; Delignieres D, 1998, HUM MOVEMENT SCI, V17, P221, DOI 10.1016/S0167-9457(97)00031-6; Dempster W.T, 1955, SPACE REQUIREMENTS S, P55; Elferink-Gemser MT, 2007, J SPORT SCI, V25, P481, DOI 10.1080/02640410600719945; ERICSSON KA, 1994, AM PSYCHOL, V49, P725, DOI 10.1037/0003-066X.49.8.725; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Federation International Gymnastics, 2009, COD POINTS; Frederiksen C, 2011, LEARN INSTR, V21, P601, DOI 10.1016/j.learninstruc.2011.01.002; Gentile AM., 1998, SCANDIA, V5, P7, DOI DOI 10.3109/11038129809035723; Giakas G, 1998, J BIOMECH, V31, P87, DOI 10.1016/S0021-9290(97)98097-0; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Hiley MJ, 2003, J APPL BIOMECH, V19, P119, DOI 10.1123/jab.19.2.119; Hung YC, 2008, EXP BRAIN RES, V191, P197, DOI 10.1007/s00221-008-1511-9; Irwin G, 2007, SPORT BIOMECH, V6, P361, DOI 10.1080/14763140701491336; Irwin Gareth, 2005, Sports Biomech, V4, P163, DOI 10.1080/14763140508522861; JENSEN RK, 1989, J BIOMECH, V22, P529, DOI 10.1016/0021-9290(89)90004-3; JENSEN RK, 1988, MED SCI SPORT EXER, V20, P594; Kopp P M, 1980, Can J Appl Sport Sci, V5, P98; Kugler PT, 1980, TUTORIAL MOTOR BEHAV; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Nourrit D, 2000, J SPORT SCI, V18, P201, DOI 10.1080/026404100365108; Peccolo HP, 1997, GYM TECHNIC, V18, P7; Stergiou N, 2001, CLIN BIOMECH, V16, P213, DOI 10.1016/S0268-0033(00)00090-5; Temprado J, 1997, HUM MOVEMENT SCI, V16, P653, DOI 10.1016/S0167-9457(97)00014-6; Teulier C, 2007, HUM MOVEMENT SCI, V26, P376, DOI 10.1016/j.humov.2007.01.013; Teulier C, 2006, RES Q EXERCISE SPORT, V77, P464; Vereijken B, 1997, HUM MOVEMENT SCI, V16, P823, DOI 10.1016/S0167-9457(97)00021-3; Williams G, 2012, SPORT BIOMECH, V11, P20, DOI 10.1080/14763141.2011.637120; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Yeadon MR, 2000, HUM MOVEMENT SCI, V19, P153, DOI 10.1016/S0167-9457(00)00008-7; Young J. W, 1969, AMRLTR6970AD710622 N	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67491	10.1371/journal.pone.0067491	http://dx.doi.org/10.1371/journal.pone.0067491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840720	gold, Green Submitted, Green Published			2022-12-27	WOS:000321424400106
J	Nieto-Gonzalez, JL; Jensen, K				Nieto-Gonzalez, Jose Luis; Jensen, Kimmo			BDNF Depresses Excitability of Parvalbumin-Positive Interneurons through an M-Like Current in Rat Dentate Gyrus	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MODULATION; CHANNELS; NEURONS; TRANSMISSION; RECEPTORS; SEIZURES; ROLES	In addition to their classical roles in neuronal growth, survival and differentiation, neurotrophins are also rapid regulators of excitability, synaptic transmission and activity-dependent synaptic plasticity. We have recently shown that mature BDNF (Brain Derived Neurotrophic Factor), but not proBDNF, modulates the excitability of interneurons in dentate gyrus within minutes. Here, we used brain slice patch-clamp recordings to study the mechanisms through which BDNF modulates the firing of interneurons in rat dentate gyrus by binding to TrkB receptors. Bath application of BDNF (15 ng/ml) under current-clamp decreased the firing frequency (by 80%) and input resistance, blocking the delayed firing observed at near-threshold voltage ranges, with no changes in resting membrane potential or action potential waveform. Using TEA (tetraethylammonium), or XE991(a Kv7/KCNQ channel antagonist), the effect of BDNF was abolished, whereas application of retigabine (a Kv7/KCNQ channel opener) mimicked the effect of BDNF, suggesting that the M-current could be implicated in the modulation of the firing. In voltage-clamp experiments, BDNF increased the M-like current amplitude with no change in holding current. This effect was again blocked by XE991 and mimicked by retigabine, the latter accompanied with a change in holding current. In agreement with the electrophysiology, parvalbumin-positive interneurons co-expressed TrkB receptors and Kv7.2/KCNQ2 channels. In conclusion, BDNF depresses the excitability of interneurons by activating an M-like current and possibly blocking Kv1 channels, thereby controlling interneuron resting membrane potential and excitability.	[Nieto-Gonzalez, Jose Luis; Jensen, Kimmo] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Jensen, Kimmo] Aarhus Univ, Lundbeck Fdn Res Ctr MIND, Aarhus C, Denmark	Aarhus University; Aarhus University; Lundbeckfonden	Nieto-Gonzalez, JL (corresponding author), Aarhus Univ, Dept Biomed, Aarhus C, Denmark.	jlnieto@us.es	Nieto-Gonzalez, Jose L/B-7165-2013	Nieto-Gonzalez, Jose L/0000-0003-1757-4951; Jensen, Kimmo/0000-0001-8895-6194	Lundbeck Foundation, Denmark; Danish Medical Research Council	Lundbeck Foundation, Denmark(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Lundbeck Foundation, Denmark (JLNG and KJ) and the Danish Medical Research Council (KJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzori M, 2000, NAT NEUROSCI, V3, P791, DOI 10.1038/77693; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Blasco-Ibanez JM, 2000, NEUROREPORT, V11, P3219, DOI 10.1097/00001756-200009280-00034; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Carrascal L, 2006, NEUROSCIENCE, V140, P1223, DOI 10.1016/j.neuroscience.2006.03.006; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Drasbek KR, 2006, CEREB CORTEX, V16, P1134, DOI 10.1093/cercor/bhj055; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; Dugladze T, 2007, P NATL ACAD SCI USA, V104, P17530, DOI 10.1073/pnas.0708301104; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gorter JA, 2001, EUR J NEUROSCI, V13, P657, DOI 10.1046/j.1460-9568.2001.01428.x; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Henneberger C, 2002, J NEUROPHYSIOL, V88, P595, DOI 10.1152/jn.2002.88.2.595; Holm MM, 2009, J NEUROSCI, V29, P12412, DOI 10.1523/JNEUROSCI.2978-09.2009; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Lawrence JJ, 2006, J NEUROSCI, V26, P12325, DOI 10.1523/JNEUROSCI.3521-06.2006; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Rose CR, 2004, BIOESSAYS, V26, P1185, DOI 10.1002/bies.20118; Scharfman HE, 2002, EXP NEUROL, V174, P201, DOI 10.1006/exnr.2002.7869; Scharfman Helen E, 2005, Epilepsy Curr, V5, P83, DOI 10.1111/j.1535-7511.2005.05312.x; Tucker K, 2002, J PHYSIOL-LONDON, V542, P413, DOI 10.1113/jphysiol.2002.017376; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Zheng K, 2011, P NATL ACAD SCI USA, V108, P17201, DOI 10.1073/pnas.1114241108; ZIPP F, 1989, BRAIN RES, V495, P161, DOI 10.1016/0006-8993(89)91231-6; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	38	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67318	10.1371/journal.pone.0067318	http://dx.doi.org/10.1371/journal.pone.0067318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840662	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200130
J	Bartz, D; Hatrick, K; Hesse, CW; Muller, KR; Lemm, S				Bartz, Daniel; Hatrick, Kerr; Hesse, Christian W.; Mueller, Klaus-Robert; Lemm, Steven			Directional Variance Adjustment: Bias Reduction in Covariance Matrices Based on Factor Analysis with an Application to Portfolio Optimization	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; MAXIMUM-LIKELIHOOD; EM; ALGORITHMS	Robust and reliable covariance estimates play a decisive role in financial and many other applications. An important class of estimators is based on factor models. Here, we show by extensive Monte Carlo simulations that covariance matrices derived from the statistical Factor Analysis model exhibit a systematic error, which is similar to the well-known systematic error of the spectrum of the sample covariance matrix. Moreover, we introduce the Directional Variance Adjustment (DVA) algorithm, which diminishes the systematic error. In a thorough empirical study for the US, European, and Hong Kong stock market we show that our proposed method leads to improved portfolio allocation.	[Bartz, Daniel; Mueller, Klaus-Robert] Tech Univ Berlin, Dept Comp Sci, Machine Learning Grp, Berlin, Germany; [Hatrick, Kerr] Barclays Capital, London, England; [Hesse, Christian W.] Deutsch Bank AG, Global Markets Equ, London, England; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Lemm, Steven] Zalando GmbH, Data Intelligence Team, Berlin, Germany	Technical University of Berlin; Barclays; Deutsche Bank; Korea University	Bartz, D (corresponding author), Tech Univ Berlin, Dept Comp Sci, Machine Learning Grp, Berlin, Germany.	daniel.bartz@tu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685	Deutsche Bank AG via the Quantitative Products laboratory; World Class University Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [R31-10008]; Deutsche Bank AG	Deutsche Bank AG via the Quantitative Products laboratory; World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Deutsche Bank AG	This work was supported in part by Deutsche Bank AG via the Quantitative Products laboratory and by the World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology, under Grant R31-10008. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KH is an employee of Barclays Capital and SL is an employee of Zalando GmbH. CWH is an employee of Deutsche Bank AG, whose company partly funded this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The opinions and ideas expressed in this article are those of the authors alone, and do not necessarily reflect the views of Deutsche Bank AG, Barclays Capital or Zalando GmbH, its subsidiaries or affiliates.	Abrahamsen TJ, 2011, J MACH LEARN RES, V12, P2027; Basilevsky A.T., 1994, STAT FACTOR ANAL REL; Bouchaud JP, 2011, OXFORD HDB RANDOM MA; Campbell RAJ, 2008, J EMPIR FINANC, V15, P287, DOI 10.1016/j.jempfin.2007.01.001; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Connor G, 2010, PORTFOLIO RISK ANALYSIS, P1; Connor G., 1995, FINANC ANAL J, V51, P42, DOI DOI 10.2469/FAJ.V51.N3.1904; DeMiguel V, 2009, REV FINANC STUD, V22, P1915, DOI 10.1093/rfs/hhm075; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Edelman A, 2005, ACT NUMERIC, V14, P233, DOI 10.1017/S0962492904000236; El Karoui N, 2008, ANN STAT, V36, P2757, DOI 10.1214/07-AOS581; FAMA EF, 1992, J FINANC, V47, P427, DOI 10.2307/2329112; Fan JQ, 2008, J ECONOMETRICS, V147, P186, DOI 10.1016/j.jeconom.2008.09.017; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Goldfarb D, 2003, MATH OPER RES, V28, P1, DOI 10.1287/moor.28.1.1.14260; Huber P. J, 1981, ROBUST STAT; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jagannathan R, 2003, J FINANC, V58, P1651, DOI 10.1111/1540-6261.00580; Jolliffe I., 1986, SPRINGER SERIES STAT; Kjems U, 2001, ADV NEUR IN, V13, P549; Kourtis A, 2012, J BANK FINANC, V36, P2522, DOI 10.1016/j.jbankfin.2012.05.005; Laloux L., 2000, INT J THEOR APPL FIN, V3, P391, DOI DOI 10.1142/S0219024900000255; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Ledoit O., 2003, J EMPIR FINANCE, V10, P603, DOI [10.1016/S0927-5398(03)00007-0, DOI 10.1016/S0927-5398(03)00007-0]; Longin F, 2005, J BANK FINANC, V29, P1017, DOI 10.1016/j.jbankfin.2004.08.011; Loretan M., 1994, J EMPIR FINANC, V1, P211, DOI DOI 10.1016/0927-5398(94)90004-3; Marcenko V. A., 1967, MATH USSR SB, V1, P457, DOI [10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; McLachlan GJ, 2007, COMPUT STAT DATA AN, V51, P5327, DOI 10.1016/j.csda.2006.09.015; Michaud R.O., 1998, EFFICIENT ASSET MANA; Miller G, 2006, J PORTFOLIO MANAGE, V32, P25, DOI 10.3905/jpm.2006.611800; PAGAN AR, 1990, ECON LETT, V33, P165, DOI 10.1016/0165-1765(90)90163-U; ROLL R, 1980, J FINANC, V35, P1073, DOI 10.2307/2327087; Rosenow B, 2002, EUROPHYS LETT, V59, P500, DOI 10.1209/epl/i2002-00135-4; Roweis S., 1999, NEURAL COMPUTATION; RUBIN DB, 1982, PSYCHOMETRIKA, V47, P69, DOI 10.1007/BF02293851; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Scherer B, 2004, FINANCIAL MARKETS PO, V18, P382, DOI DOI 10.1007/s11408-004-0403-7; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; SHANKEN J, 1992, REV FINANC STUD, V5, P1, DOI 10.1093/rfs/5.1.1; Stein C., 1956, INADMISSIBILITY USUA, DOI DOI 10.1525/9780520313880-018; Tulino A. M., 2004, Foundations and Trends in Communications and Information Theory, V1, P1, DOI 10.1561/0100000001; Zhao JH, 2008, STAT COMPUT, V18, P109, DOI 10.1007/s11222-007-9042-y	45	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67503	10.1371/journal.pone.0067503	http://dx.doi.org/10.1371/journal.pone.0067503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844016	Green Published, gold			2022-12-27	WOS:000321733000075
J	Castillo-Trivino, T; Braithwaite, D; Bacchetti, P; Waubant, E				Castillo-Trivino, Tamara; Braithwaite, Dejana; Bacchetti, Peter; Waubant, Emmanuelle			Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review	PLOS ONE			English	Review							PLACEBO-CONTROLLED TRIAL; MULTIFOCAL LEUKOENCEPHALOPATHY; DOUBLE-BLIND; DIAGNOSTIC-CRITERIA; B-CELLS; INTERFERON BETA-1A; CLONAL EXPANSION; NATALIZUMAB; MULTICENTER; DISABILITY	Background: Rituximab is an anti-CD20 monoclonal antibody approved for non Hodgkin lymphoma and rheumatoid arthritis. It is being considered for the treatment of MS. Objectives: To evaluate the efficacy and safety of rituximab for MS treatment. Data collection: Studies were selected if they were clinical trials, irrespective of the dosage or combination therapies. Main results: Four studies with a total of 599 patients were included. One assessed the efficacy of rituximab for primary progressive (PP) MS while the other three focused on relapsing-remitting (RR) MS. In the PPMS study, rituximab delayed time to confirmed disease progression (CDP) in pre-planned sub-group analyses. The increase in T2 lesion volume was lower in the rituximab group at week 96 compared with placebo. For the RRMS studies, an open-label phase I study found that rituximab reduced the annualized relapse rate to 0.25 from pre-therapy baseline to week 24, while in the randomized placebo-controlled phase II trial, annualized relapse rates were 0.37 in the rituximab group and 0.84 in the placebo group (p = 0.04) at week 24. Rituximab dramatically reduced the number of gadolinium-enhancing lesions on brain MRI scans for both RRMS studies. Off-label rituximab as an add-on therapy in patients with breakthrough disease on first-line agents was associated with an 88% reduction when comparing the mean number of gadolinium-enhancing lesions prior to and after the treatment. Although frequent adverse events classified as mild or moderate occurred in up to 77% of the patients, there were no grade 4 infusion-related adverse events. Author's conclusion: Despite the frequent mild/moderate adverse events related to the drug, rituximab appears overall safe for up to 2 years of therapy and has a substantial impact on the inflammatory disease activity (clinical and/or radiological) of RRMS. The effect of rituximab on disease progression in PPMS appears to be marginal.	[Castillo-Trivino, Tamara; Waubant, Emmanuelle] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA 94143 USA; [Castillo-Trivino, Tamara] Hosp Univ Donostia, Dept Neurol, Multiple Sclerosis Unit, San Sebastian, Guipuzcoa, Spain; [Castillo-Trivino, Tamara] Biodonostia Inst, Neurosci Area, San Sebastian, Guipuzcoa, Spain; [Braithwaite, Dejana; Bacchetti, Peter] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Instituto de Investigacion Sanitaria Biodonostia; University of California System; University of California San Francisco	Castillo-Trivino, T (corresponding author), Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA 94143 USA.	tamara.castillo@biodonostia.org	Braithwaite, Dejana/L-9000-2019; Castillo, Tamara/GYQ-5428-2022; Castillo, Tamara/ABH-4121-2020	Castillo-Trivino, Tamara/0000-0002-9249-3185	Spanish Society of Neurology; Carlos III Institute of Health; Multiple Sclerosis International Federation	Spanish Society of Neurology; Carlos III Institute of Health(Instituto de Salud Carlos III); Multiple Sclerosis International Federation	Dr. Castillo-Trivino received a Rio Hortega grant from the Spanish Society of Neurology and the Carlos III Institute of Health and a Du Pre grant from the Multiple Sclerosis International Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antel J, 2006, J NEUROIMMUNOL, V180, P3, DOI 10.1016/j.jneuroim.2006.06.032; Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Baranzini SE, 1999, J IMMUNOL, V163, P5133; Clifford DB, 2011, ARCH NEUROL-CHICAGO, V68, P1156, DOI 10.1001/archneurol.2011.103; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Colombo M, 2000, J IMMUNOL, V164, P2782, DOI 10.4049/jimmunol.164.5.2782; Cross AH, 2001, J NEUROIMMUNOL, V112, P1, DOI 10.1016/S0165-5728(00)00409-4; Duddy M, 2006, Int MS J, V13, P84; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Jacobs LD, 1996, ANN NEUROL, V40, P480; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Naismith RT, 2010, NEUROLOGY, V74, P1860, DOI 10.1212/WNL.0b013e3181e24373; Plosker GL, 2003, DRUGS, V63, P803, DOI 10.2165/00003495-200363080-00005; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; REFF ME, 1994, BLOOD, V83, P435; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Tuccori M, 2010, ONCOLOGIST, V15, P1214, DOI 10.1634/theoncologist.2010-0098; Vermersch P, 2011, NEUROLOGY, V76, P1697, DOI 10.1212/WNL.0b013e31821a446b; Zhang YP, 2005, J NEUROIMMUNOL, V167, P120, DOI 10.1016/j.jneuroim.2005.05.006	28	76	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66308	10.1371/journal.pone.0066308	http://dx.doi.org/10.1371/journal.pone.0066308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843952	gold, Green Published			2022-12-27	WOS:000321341000013
J	Cheng, M; Guan, XM; Li, H; Cui, XD; Zhang, XY; Li, X; Jing, X; Wu, HY; Avsar, E				Cheng, Min; Guan, Xiumei; Li, Hong; Cui, Xiaodong; Zhang, Xiaoyun; Li, Xin; Jing, Xu; Wu, Haiyan; Avsar, Emil			Shear Stress Regulates Late EPC Differentiation via Mechanosensitive Molecule-Mediated Cytoskeletal Rearrangement	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; FOCAL ADHESIONS; NEOINTIMAL FORMATION; ACTIVATION; INTEGRINS; REENDOTHELIALIZATION; MECHANOTRANSDUCTION; ATHEROSCLEROSIS; RECRUITMENT; DYNAMICS	Background: Previous studies have demonstrated that endothelial progenitor cells (EPCs), in particular late EPCs, play important roles in endothelial maintenance and repair. Recent evidence has revealed shear stress as a key regulator for EPC differentiation. However, the underlying mechanisms regulating the shear stress-induced EPC differentiation have not been understood completely. The present study was undertaken to further investigate the effects of shear stress on the late EPC differentiation, and to elucidate the signal mechanism involved. Methodology/Principal Finding: In vitro and in vivo assays revealed that cytoskeletal remodeling was involved in the shear stress-upregulated expression of endothelial markers vWF and CD31 in late EPCs, with subsequently increased in vivo reendothelialization after arterial injury. Moreover, shear stress activated several mechanosensitive molecules including integrin beta(1), Ras, ERK1/2, paxillin and FAK, which were all involved in both cytoskeletal rearrangement and cell differentiation in response to shear stress in late EPCs. Conclusions/Significance: Shear stress is a key regulator for late EPC differentiation into endothelial cells, which is important for vascular repair, and the cytoskeletal rearrangement mediated by the activation of the cascade of integrin beta(1), Ras, ERK1/2, paxillin and FAK is crucial in this process.	[Cheng, Min; Guan, Xiumei; Li, Hong; Cui, Xiaodong; Zhang, Xiaoyun; Li, Xin; Jing, Xu; Wu, Haiyan] Weifang Med Univ, Med Res Ctr, Weifang, Shandong, Peoples R China; [Avsar, Emil] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Weifang Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cheng, M (corresponding author), Weifang Med Univ, Med Res Ctr, Weifang, Shandong, Peoples R China.	chengmin1976@wfmc.edu.cn			National Natural Science Foundation of China [30900290, 31270993]; Shandong Provincial Natural Science Foundation [ZR2009CQ027]; Program for New Century Excellent Talents in University [NCET-10-0922]; Shandong Province Higher Educational Science and Technology Program [J09LF06]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shandong Province Higher Educational Science and Technology Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by the National Natural Science Foundation of China [grant numbers 30900290, 31270993], the Shandong Provincial Natural Science Foundation [grant number ZR2009CQ027], the Program for New Century Excellent Talents in University [grant number NCET-10-0922], the Shandong Province Higher Educational Science and Technology Program [grant number J09LF06], and the Project-sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan T, 2010, TISSUE ENG PT A, V16, P3547, DOI [10.1089/ten.tea.2010.0014, 10.1089/ten.TEA.2010.0014]; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Brown MA, 2009, TISSUE ENG PT A, V15, P3575, DOI 10.1089/ten.TEA.2008.0444; Campioni D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056377; Cecchi E, 2011, ATHEROSCLEROSIS, V214, P249, DOI 10.1016/j.atherosclerosis.2010.09.008; Cohen D. M., 2008, MECH CONTROL STEM CE; Cui XD, 2012, BIOCHEM BIOPH RES CO, V425, P419, DOI 10.1016/j.bbrc.2012.07.115; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Koskinas KC, 2012, J AM COLL CARDIOL, V59, P1337, DOI 10.1016/j.jacc.2011.10.903; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Obi S, 2012, AM J PHYSIOL-CELL PH, V303, pC595, DOI 10.1152/ajpcell.00133.2012; Osborn EA, 2006, AM J PHYSIOL-CELL PH, V290, pC444, DOI 10.1152/ajpcell.00218.2005; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Shepherd BR, 2006, FASEB J, V20, P1739, DOI 10.1096/fj.05-5682fje; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Tanaka K, 2008, FASEB J, V22, P428, DOI 10.1096/fj.06-6884com; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; van Zyp JV, 2006, CANCER BIOL THER, V5, P1169; Vittorio O, 2013, INTEGR BIOL-UK, V5, P291, DOI 10.1039/c2ib20152f; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Xia WH, 2012, HYPERTENSION, V59, P1225, DOI 10.1161/HYPERTENSIONAHA.111.179820; Xiaodong C, 2012, J MED BIOMECHANICS, V27, P548; Xu QB, 2006, NAT CLIN PRACT CARD, V3, P94, DOI 10.1038/ncpcardio0396; Ye C, 2008, CLIN BIOMECH, V23, pS118, DOI 10.1016/j.clinbiomech.2007.08.018; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050899; Ziegler ME, 2012, AM J PHYSIOL-CELL PH, V303, pC872, DOI 10.1152/ajpcell.00199.2012	37	34	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67675	10.1371/journal.pone.0067675	http://dx.doi.org/10.1371/journal.pone.0067675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844056	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000072
J	Wang, L; Shi, F; Li, G; Shen, DG				Wang, Li; Shi, Feng; Li, Gang; Shen, Dinggang			4D Segmentation of Brain MR Images with Constrained Cortical Thickness Variation	PLOS ONE			English	Article							CEREBRAL-CORTEX; LEVEL SETS; RECONSTRUCTION; EXTRACTION; TEMPLATE; SURFACES; VOLUMES; TISSUE	Segmentation of brain MR images plays an important role in longitudinal investigation of developmental, aging, disease progression changes in the cerebral cortex. However, most existing brain segmentation methods consider multiple time-point images individually and thus cannot achieve longitudinal consistency. For example, cortical thickness measured from the segmented image will contain unnecessary temporal variations, which will affect the time related change pattern and eventually reduce the statistical power of analysis. In this paper, we propose a 4D segmentation framework for the adult brain MR images with the constraint of cortical thickness variations. Specifically, we utilize local intensity information to address the intensity inhomogeneity, spatial cortical thickness constraint to maintain the cortical thickness being within a reasonable range, and temporal cortical thickness variation constraint in neighboring time-points to suppress the artificial variations. The proposed method has been tested on BLSA dataset and ADNI dataset with promising results. Both qualitative and quantitative experimental results demonstrate the advantage of the proposed method, in comparison to other state-of-the-art 4D segmentation methods.	[Wang, Li; Shi, Feng; Li, Gang; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA; [Wang, Li; Shi, Feng; Li, Gang; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Shen, Dinggang] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Korea University	Shen, DG (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Li, Gang/D-3324-2013; Shen, Dinggang/ABF-6812-2020; wang, li/O-1425-2015	Shen, Dinggang/0000-0002-7934-5698; wang, li/0000-0001-8927-6772; Li, Gang/0000-0001-9585-1382	National Institutes of Health (NIH) [EB006733, EB008374, EB009634, AG041721]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009634, R01EB006733, R01EB008374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041721, P30AG010129, U01AG024904, R01AG042599, K01AG030514] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health (NIH) grants EB006733, EB008374, EB009634, and AG041721. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The Baltimore Longitudinal Study of Aging (BLSA) dataset used in this paper was provided by Dr. Susan Resnick. The University of North Carolina at Chapel Hill's Libraries provided support for open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta O, 2009, MED IMAGE ANAL, V13, P730, DOI 10.1016/j.media.2009.07.003; Aganj I, 2009, HUM BRAIN MAPP, V30, P3188, DOI 10.1002/hbm.20740; CARDOSO MJ, 2011, MICCAI, V6892, P467; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Goldenberg R, 2002, IEEE T MED IMAGING, V21, P1544, DOI 10.1109/TMI.2002.806594; Haidar H, 2006, J NEUROIMAGING, V16, P146, DOI 10.1111/j.1552-6569.2006.00036.x; Han X, 2004, NEUROIMAGE, V23, P997, DOI 10.1016/j.neuroimage.2004.06.043; Han X., 2001, MATH METH BIOM IM AN, P213; HENERY CC, 1989, J ANAT, V167, P167; Holland D, 2009, P NATL ACAD SCI; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Karacali B, 2004, IEEE T MED IMAGING, V23, P868, DOI 10.1109/TMI.2004.827963; Li C.-J., 2007, CVPR, P1; Li G, 2012, NEUROIMAGE, V59, P3805, DOI 10.1016/j.neuroimage.2011.11.012; Li Y, 2010, LECT NOTES COMPUT SC, V6362, P133; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; Shen DG, 2004, NEUROIMAGE, V21, P1508, DOI 10.1016/j.neuroimage.2003.12.015; Shi F, 2011, LECT NOTES COMPUT SC, V6893, P313, DOI 10.1007/978-3-642-23626-6_39; Sisodiya S, 1996, J ANAT, V188, P425; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Thompson PM, 2005, J NEUROSCI, V25, P4146, DOI 10.1523/JNEUROSCI.0165-05.2005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; von Economo CF, 1929, CYTOARCHITECTONICS H; Wang L, 2013, HUM BRAIN MAPP, V34, P956, DOI 10.1002/hbm.21486; Wang L, 2011, NEUROIMAGE, V58, P805, DOI 10.1016/j.neuroimage.2011.06.064; Wolz R, 2010, NEUROIMAGE, V52, P109, DOI 10.1016/j.neuroimage.2010.04.006; Wu GR, 2010, LECT NOTES COMPUT SC, V6362, P618; Xue Z, 2006, NEUROIMAGE, V30, P388, DOI 10.1016/j.neuroimage.2005.09.054; ZENG X, 1999, IEEE T MED IMAGING, V18, P100	36	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e64207	10.1371/journal.pone.0064207	http://dx.doi.org/10.1371/journal.pone.0064207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843934	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000002
J	Davidson, B; Murray, AA; Elfick, A; Spears, N				Davidson, Bryony; Murray, Alison A.; Elfick, Alistair; Spears, Norah			Raman Micro-Spectroscopy Can Be Used to Investigate the Developmental Stage of the Mouse Oocyte	PLOS ONE			English	Article							IN-VITRO; MATURATION; EMBRYO; FERTILIZATION; COMPETENCE; FOLLICLE; SPINDLE; GROWTH; LIGHT	In recent years, the uptake of assisted reproductive techniques such as in vitro fertilisation has risen exponentially. However, there is much that is still not fully understood about the biochemical modifications that take place during the development and maturation of the oocyte. As such, it is essential to further the understanding of how oocyte manipulation during these procedures ultimately affects its developmental potential; yet, there are few methods currently available which are capable of providing a quantitative measure of oocyte quality. Raman spectroscopy enables investigation of the global biochemical profile of intact cells without the need for labelling. Here, Raman spectra were acquired from the ooplasm of mouse oocytes at various stages of development, from late pre-antral follicles, collected after in vitro maturation within their ovarian follicles and from unstimulated and stimulated ovulatory cycles. Using a combination of univariate and multivariate statistical methods, it was found that ooplasm lipid content could be used to discriminate between different stages of oocyte development. Furthermore, the spectral profiles of mature oocytes revealed that oocytes which have developed in vitro are protein-deficient when compared to in vivo grown oocytes. Finally, the ratio of two Raman peak intensities, namely 1605: 1447 cm(-1), used as a proxy for the protein-to-lipid ratio of the ooplasm, was shown to be indicative of the oocyte's quality. Together, results indicate that Raman spectroscopy may present an alternative analytical tool for investigating the biochemistry of oocyte developmental stage and quality.	[Davidson, Bryony; Elfick, Alistair] Univ Edinburgh, Sch Engn, Edinburgh, Midlothian, Scotland; [Murray, Alison A.; Spears, Norah] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Spears, N (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	norah.spears@ed.ac.uk		ELFICK, ALISTAIR/0000-0002-4429-6232	Engineering and Physical Sciences Research Council (EPSRC) [EP/C54711X]; Carnegie Trust; Royal Academy of Engineering; EPSRC [GR/S52148]; Engineering and Physical Sciences Research Council [EP/C54711X/1] Funding Source: researchfish; Medical Research Council [G1002033] Funding Source: researchfish; EPSRC [EP/C54711X/1] Funding Source: UKRI; MRC [G1002033] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Carnegie Trust(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Royal Academy of Engineering(Royal Academy of Engineering - UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grant EP/C54711X from the Engineering and Physical Sciences Research Council (EPSRC). BD was supported by a scholarship from The Carnegie Trust for the Universities of Scotland and a Research Student Development Fellowship from The Royal Academy of Engineering. AE was supported by an EPSRC Advanced Research Fellowship (GR/S52148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amharref N, 2007, BBA-BIOMEMBRANES, V1768, P2605, DOI 10.1016/j.bbamem.2007.06.032; Ami D, 2011, BBA-MOL CELL RES, V1813, P1220, DOI 10.1016/j.bbamcr.2011.03.009; Baker SJ, 1999, HUM REPROD UPDATE, V5, P153, DOI 10.1093/humupd/5.2.153; Borini A, 2009, TXB ASSISTED REPROD, P255; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Combelles CMH, 2002, HUM REPROD, V17, P1006, DOI 10.1093/humrep/17.4.1006; Davidson B, 2012, J RAMAN SPECTROSC, V43, P24, DOI 10.1002/jrs.2964; Braga DPDF, 2008, FERTIL STERIL, V90, P429, DOI 10.1016/j.fertnstert.2007.06.088; Downes A, 2011, J RAMAN SPECTROSC, V42, P1864, DOI 10.1002/jrs.2975; GOSDEN RG, 1995, GAMETES OOCYTE, P23; GOSDEN RG, 1995, GAMETES OOCYTE, P119; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; Jess PRT, 2007, INT J CANCER, V121, P2723, DOI 10.1002/ijc.23046; KASTROP PMM, 1991, MOL REPROD DEV, V29, P271, DOI 10.1002/mrd.1080290309; Kim DH, 2004, J ASSIST REPROD GEN, V21, P233, DOI 10.1023/B:JARG.0000042008.83699.cc; Madaschi C, 2008, FERTIL STERIL, V90, P194, DOI 10.1016/j.fertnstert.2007.05.071; Maquelin K, 2000, ANAL CHEM, V72, P12, DOI 10.1021/ac991011h; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Moon JH, 2003, HUM REPROD, V18, P817, DOI 10.1093/humrep/deg165; Murray AA, 2008, MOL HUM REPROD, V14, P75, DOI 10.1093/molehr/gam092; Nagy A., 2003, MANIPULATING MOUSE E; Niimura Sueo, 2004, Reprod Med Biol, V3, P231, DOI 10.1111/j.1447-0578.2004.00075.x; Picton H, 1998, MOL CELL ENDOCRINOL, V145, P27, DOI 10.1016/S0303-7207(98)00166-X; SATHANATHAN AH, 1994, MICROSC RES TECHNIQ, V27, P145, DOI 10.1002/jemt.1070270208; Schultz RM, 2007, P NATL ACAD SCI USA, V104, P14547, DOI 10.1073/pnas.0707142104; Scott R, 2008, FERTIL STERIL, V90, P77, DOI 10.1016/j.fertnstert.2007.11.058; Seli E, 2007, FERTIL STERIL, V88, P1350, DOI 10.1016/j.fertnstert.2007.07.1390; SPEARS N, 1994, HUM REPROD, V9, P527, DOI 10.1093/oxfordjournals.humrep.a138539; Telfer EE, 2007, REPROD BIOMED ONLINE, V15, P288, DOI 10.1016/S1472-6483(10)60341-0; Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051; Vergara GJ, 1997, THERIOGENOLOGY, V47, P1245, DOI 10.1016/S0093-691X(97)00104-0; Wang WH, 2001, HUM REPROD, V16, P1464, DOI 10.1093/humrep/16.7.1464; Wood BR, 2008, ANAL CHEM, V80, P9065, DOI 10.1021/ac8015483	34	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67972	10.1371/journal.pone.0067972	http://dx.doi.org/10.1371/journal.pone.0067972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840882	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900021
J	Hafko, R; Villapol, S; Nostramo, R; Symes, A; Sabban, EL; Inagami, T; Saavedra, JM				Hafko, Roman; Villapol, Sonia; Nostramo, Regina; Symes, Aviva; Sabban, Esther L.; Inagami, Tadashi; Saavedra, Juan M.			Commercially Available Angiotensin II At-2 Receptor Antibodies Are Nonspecific	PLOS ONE			English	Article							TYPE-2 AT(2) RECEPTOR; MESSENGER-RNA; CONVERTING-ENZYME; BIOCHEMICAL-PROPERTIES; AT(1) RECEPTORS; ADRENAL-GLAND; RAT-BRAIN; EXPRESSION; SUBTYPES; SPECIFICITY	Commercially available angiotensin II AT(2) receptor antibodies are widely employed for receptor localization and quantification, but they have not been adequately validated. In this study, we characterized three commercially available AT(2) receptor antibodies: 2818-1 from Epitomics, sc-9040 from Santa Cruz Biotechnology, Inc., and AAR-012 from Alomone Labs. Using western blot analysis the immunostaining patterns observed were different for every antibody tested, and in most cases consisted of multiple immunoreactive bands. Identical immunoreactive patterns were present in wild-type and AT(2) receptor knockout mice not expressing the target protein. In the mouse brain, immunocytochemical studies revealed very different cellular immunoreactivity for each antibody tested. While the 2818-1 antibody reacted only with endothelial cells in small parenchymal arteries, the sc-9040 antibody reacted only with ependymal cells lining the cerebral ventricles, and the AAR-012 antibody reacted only with multiple neuronal cell bodies in the cerebral cortex. Moreover, the immunoreactivities were identical in brain tissue from wildtype or AT(2) receptor knockout mice. Furthermore, in both mice and rat tissue extracts, there was no correlation between the observed immunoreactivity and the presence or absence of AT(2) receptor binding or gene expression. We conclude that none of these commercially available AT(2) receptor antibodies tested met the criteria for specificity. In the absence of full antibody characterization, competitive radioligand binding and determination of mRNA expression remain the only reliable approaches to study AT(2) receptor expression.	[Hafko, Roman; Saavedra, Juan M.] NIMH, Pharmacol Sect, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA; [Villapol, Sonia; Symes, Aviva] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Villapol, Sonia; Symes, Aviva] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Nostramo, Regina; Sabban, Esther L.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Inagami, Tadashi] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Uniformed Services University of the Health Sciences - USA; New York Medical College; Vanderbilt University	Saavedra, JM (corresponding author), NIMH, Pharmacol Sect, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA.	Saavedrj@mail.nih.gov	Symes, Aviva J/S-7471-2016; Saavedra, Juan/AAO-7149-2020; Saavedra, Juan/ABB-8516-2020; Villapol, Sonia/D-1949-2014	Symes, Aviva J/0000-0003-2557-9939; Saavedra, Juan/0000-0002-7238-9647; Saavedra, Juan/0000-0002-7238-9647; Villapol, Sonia/0000-0002-6174-4113	Intramural Research Program of the National Institute of Mental Health [MH002762-16]; Center for Neuroscience and Regenerative Medicine [300604 11.060855]; American Heart Association [10GRNT442001]; NIH [HL58205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058205, R01HL058205] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center for Neuroscience and Regenerative Medicine(United States Department of Defense); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Juan M. Saavedra was funded by the Intramural Research Program of the National Institute of Mental Health: MH002762-16 (2012). Sonia Villapol and Aviva Symes were funded by: Center for Neuroscience and Regenerative Medicine (grant no: 300604 11.060855), http://www.usuhs.mil/cnrm/. Drs. Esther Sabban and Regina Nostramu were funded by the American Heart Association, Grant # 10GRNT442001 to Esther L. Sabban. Tadashi Inagami was funded by grant HL58205 from NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1994, KIDNEY INT, V46, P973, DOI 10.1038/ki.1994.356; Allen AM, 1999, J AM SOC NEPHROL, V10, pS23; Armando I, 2002, AM J PHYSIOL-RENAL, V283, pF934, DOI 10.1152/ajprenal.00145.2002; Armando I, 2002, NEUROENDOCRINOLOGY, V76, P137, DOI 10.1159/000064525; Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Baiardi G, 2005, REGUL PEPTIDES, V124, P7, DOI 10.1016/j.regpep.2004.06.021; Benicky J, 2012, CELL MOL NEUROBIOL, V32, P1353, DOI 10.1007/s10571-012-9862-y; Bodei S, 2009, N-S ARCH PHARMACOL, V379, P413, DOI 10.1007/s00210-008-0384-6; CIUFFO GM, 1993, AM J PHYSIOL, V265, pF264, DOI 10.1152/ajprenal.1993.265.2.F264; CORREA FMA, 1995, PEPTIDES, V16, P19, DOI 10.1016/0196-9781(94)00150-5; de Gasparo M, 1999, REGUL PEPTIDES, V81, P11, DOI 10.1016/S0167-0115(99)00023-3; Elliott KJ, 2013, HYPERTENSION, V61, pE31, DOI 10.1161/HYPERTENSIONAHA.111.00943; GIBSON RE, 1991, AM J PHYSIOL, V261, pF512, DOI 10.1152/ajprenal.1991.261.3.F512; Griffin CA, 1997, NEPHRON, V76, P103, DOI 10.1159/000190148; Hamdani N, 2009, N-S ARCH PHARMACOL, V379, P403, DOI 10.1007/s00210-009-0392-1; Hauser W, 1998, EUR J PHARMACOL, V348, P101, DOI 10.1016/S0014-2999(98)00134-4; HEEMSKERK FMJ, 1995, BRAIN RES, V677, P29, DOI 10.1016/0006-8993(95)00092-5; Herrera M, 2013, HYPERTENSION, V61, P253, DOI 10.1161/HYPERTENSIONAHA.112.203679; Hunley TE, 2000, KIDNEY INT, V57, P570, DOI 10.1046/j.1523-1755.2000.t01-1-00877.x; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; ICHIKI T, 1995, CIRC RES, V76, P693, DOI 10.1161/01.RES.76.5.693; INAGAMI T, 1994, EUR HEART J, V15, P104, DOI 10.1093/eurheartj/15.suppl_D.104; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Johren O, 1996, MOL BRAIN RES, V37, P192, DOI 10.1016/0169-328X(95)00309-G; Johren O, 2003, HYPERTENSION, V41, P984, DOI 10.1161/01.HYP.0000062466.38314.B7; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; KAKUCHI J, 1995, KIDNEY INT, V47, P140, DOI 10.1038/ki.1995.16; LAZARD D, 1994, EUR J BIOCHEM, V220, P919, DOI 10.1111/j.1432-1033.1994.tb18695.x; Lenkei Z, 1997, FRONT NEUROENDOCRIN, V18, P383, DOI 10.1006/frne.1997.0155; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Lu XY, 2009, N-S ARCH PHARMACOL, V379, P417, DOI 10.1007/s00210-009-0394-z; McCarthy CA, 2009, STROKE, V40, P1482, DOI 10.1161/STROKEAHA.108.531509; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Padia SH, 2013, PFLUG ARCH EUR J PHY, V465, P99, DOI 10.1007/s00424-012-1146-3; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pavel J, 2009, REGUL PEPTIDES, V158, P156, DOI 10.1016/j.regpep.2009.09.004; Porrello ER, 2009, FRONT BIOSCI-LANDMRK, V14, P958, DOI 10.2741/3289; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; PUCELL AG, 1991, ENDOCRINOLOGY, V128, P1947, DOI 10.1210/endo-128-4-1947; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Rompe F, 2010, DRUG NEWS PERSPECT, V23, P104, DOI 10.1358/dnp.2010.23.2.1475901; Saavedra JM, 2001, AM J PHYSIOL-RENAL, V280, pF71, DOI 10.1152/ajprenal.2001.280.1.F71; Saavedra JM, 2001, REGUL PEPTIDES, V102, P41, DOI 10.1016/S0167-0115(01)00303-2; Saavedra JM, 2005, CELL MOL NEUROBIOL, V25, P485, DOI 10.1007/s10571-005-4011-5; Saavedra JM, 2012, CLIN SCI, V123, P567, DOI 10.1042/CS20120078; Saavedra JM, 2011, PSYCHONEUROENDOCRINO, V36, P1, DOI 10.1016/j.psyneuen.2010.10.001; Sanvitto GL, 1997, AM J PHYSIOL-ENDOC M, V273, pE156, DOI 10.1152/ajpendo.1997.273.1.E156; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; SELTZER A, 1992, NEUROENDOCRINOLOGY, V55, P460, DOI 10.1159/000126157; SERVANT G, 1994, MOL PHARMACOL, V45, P1112; SHANMUGAM S, 1995, AM J PHYSIOL-RENAL, V268, pF922, DOI 10.1152/ajprenal.1995.268.5.F922; Shanmugam S, 1996, HYPERTENSION, V28, P91, DOI 10.1161/01.HYP.28.1.91; Siragy HM, 2009, CURR HYPERTENS REP, V11, P260, DOI 10.1007/s11906-009-0044-3; Skrbic R, 2009, PEPTIDES, V30, P1945, DOI 10.1016/j.peptides.2009.07.003; Steckelings UM, 2012, EXPERT OPIN INV DRUG, V21, P763, DOI 10.1517/13543784.2012.681046; TSUTSUMI K, 1992, PEPTIDES, V13, P291, DOI 10.1016/0196-9781(92)90111-F; TSUTSUMI K, 1991, AM J PHYSIOL, V261, pR209, DOI 10.1152/ajpregu.1991.261.1.R209; TSUTSUMI K, 1991, ENDOCRINOLOGY, V129, P1075, DOI 10.1210/endo-129-2-1075; TSUTSUMI K, 1991, ENDOCRINOLOGY, V129, P3001, DOI 10.1210/endo-129-6-3001; YEE DK, 1994, REGUL PEPTIDES, V54, P355, DOI 10.1016/0167-0115(94)90533-9; ZHUO JL, 1992, RENAL PHYSIOL BIOCH, V15, P231	66	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e69234	10.1371/journal.pone.0069234	http://dx.doi.org/10.1371/journal.pone.0069234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840911	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900050
J	Kumar, P; Sharoyko, VV; Spegel, P; Gullberg, U; Mulder, H; Olsson, I; Ajore, R				Kumar, Parveen; Sharoyko, Vladimir V.; Spegel, Peter; Gullberg, Urban; Mulder, Hindrik; Olsson, Inge; Ajore, Ram			The Transcriptional Co-Repressor Myeloid Translocation Gene 16 Inhibits Glycolysis and Stimulates Mitochondrial Respiration	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; LEUKEMIA-CELL-LINE; ETO HOMOLOGS; PROTEIN; COREPRESSOR; METABOLISM; EXPRESSION; COMPLEX; ESTABLISHMENT; TARGET	The myeloid translocation gene 16 product MTG16 is found in multiple transcription factor-containing complexes as a regulator of gene expression implicated in development and tumorigenesis. A stable Tet-On system for doxycycline-dependent expression of MTG16 was established in B-lymphoblastoid Raji cells to unravel its molecular functions in transformed cells. A noticeable finding was that expression of certain genes involved in tumor cell metabolism including 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4 (PFKFB3 and PFKFB4), and pyruvate dehydrogenase kinase isoenzyme 1 (PDK1) was rapidly diminished when MTG16 was expressed. Furthermore, hypoxia-stimulated production of PFKFB3, PFKFB4 and PDK1 was inhibited by MTG16 expression. The genes in question encode key regulators of glycolysis and its coupling to mitochondrial metabolism and are commonly found to be overexpressed in transformed cells. The MTG16 Nervy Homology Region 2 (NHR2) oligomerization domain and the NHR3 protein-protein interaction domain were required intact for inhibition of PFKFB3, PFKFB4 and PDK1 expression to occur. Expression of MTG16 reduced glycolytic metabolism while mitochondrial respiration and formation of reactive oxygen species increased. The metabolic changes were paralleled by increased phosphorylation of mitogen-activated protein kinases, reduced levels of amino acids and inhibition of proliferation with a decreased fraction of cells in S-phase. Overall, our findings show that MTG16 can serve as a brake on glycolysis, a stimulator of mitochondrial respiration and an inhibitor of cell proliferation. Hence, elevation of MTG16 might have anti-tumor effect.	[Kumar, Parveen; Gullberg, Urban; Olsson, Inge; Ajore, Ram] Lund Univ, Dept Hematol, Lund, Sweden; [Sharoyko, Vladimir V.; Spegel, Peter; Mulder, Hindrik] Lund Univ, Ctr Diabet, Malmo Univ Hosp, Dept Clin Sci,Unit Mol Metab, Malmo, Sweden	Lund University; Lund University; Skane University Hospital	Ajore, R (corresponding author), Lund Univ, Dept Hematol, Lund, Sweden.	Ram.Ajore@med.lu.se	Sharoyko, Vladimir/J-3625-2014; Spégel, Peter/G-9947-2018; Mulder, Hindrik/E-1045-2012	Sharoyko, Vladimir/0000-0002-3717-0471; Spégel, Peter/0000-0002-6092-2387; Mulder, Hindrik/0000-0002-6593-8417	Swedish Research Council [K2011-11546, K2013-14196]; Swedish Cancer Foundation [CAN 2010/434, 11 0450]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This work was supported by grants to UG from the Swedish Research Council (#K2011-11546) (www.vr.se/) and the Swedish Cancer Foundation (#CAN 2010/434) (www.cancerfonden.se/), by grants to HM from the Swedish Research Council (#K2013-14196) (www.vr.se/) and by a grant to IO from the Swedish Cancer Foundation (#11 0450) (www.cancerfonden.se/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASOU H, 1991, BLOOD, V77, P2031; Atsumi T, 2002, CANCER RES, V62, P5881; Bais AJ, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-22; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Chevallier N, 2004, BLOOD, V103, P1454, DOI 10.1182/blood-2003-06-2081; Chorell E, 2009, J PROTEOME RES, V8, P2966, DOI 10.1021/pr900081q; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chyla BJ, 2008, MOL CELL BIOL, V28, P6234, DOI 10.1128/MCB.00404-08; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; DUNAWAY GA, 1988, BIOCHEM J, V251, P677, DOI 10.1042/bj2510677; Engel ME, 2010, MOL CELL BIOL, V30, P1852, DOI 10.1128/MCB.01342-09; ERICKSON P, 1992, BLOOD, V80, P1825; FEINSTEIN PG, 1995, GENETICS, V140, P573; Fischer MA, 2012, EMBO J, V31, P1494, DOI 10.1038/emboj.2011.500; GALLAGHER R, 1979, BLOOD, V54, P713; Gamou T, 1998, BLOOD, V91, P4028, DOI 10.1182/blood.V91.11.4028.411a45_4028_4037; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; Guastadisegni MC, 2010, LEUKEMIA, V24, P1516, DOI 10.1038/leu.2010.106; Hamlett I, 2008, BLOOD, V112, P2738, DOI 10.1182/blood-2008-03-146605; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hildebrand D, 2001, J BIOL CHEM, V276, P9889, DOI 10.1074/jbc.M010582200; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hunt A, 2011, MOL CELL BIOL, V31, P2544, DOI 10.1128/MCB.01458-10; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Jonsson P, 2006, J PROTEOME RES, V5, P1407, DOI 10.1021/pr0600071; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kitabayashi I, 1998, MOL CELL BIOL, V18, P846, DOI 10.1128/MCB.18.2.846; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kochetkova M, 2002, CANCER RES, V62, P4599; Krus U, 2010, BIOCHEM J, V429, P205, DOI 10.1042/BJ20100142; Lindberg SR, 2003, EUR J HAEMATOL, V71, P439, DOI 10.1046/j.0902-4441.2003.00166.x; Lindberg SR, 2005, EXP HEMATOL, V33, P189, DOI 10.1016/j.exphem.2004.10.011; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; Melnick AM, 2000, MOL CELL BIOL, V20, P2075, DOI 10.1128/MCB.20.6.2075-2086.2000; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Minchenko O, 2004, FEBS LETT, V576, P14, DOI 10.1016/j.febslet.2004.08.053; Minchenko O, 2003, FEBS LETT, V554, P264, DOI 10.1016/S0014-5793(03)01179-7; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; NISSON PE, 1993, CANCER GENET CYTOGEN, V66, P81; OGURA M, 1985, BLOOD, V66, P1384; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Olsson A, 2008, BBA-GENE REGUL MECH, V1779, P590, DOI 10.1016/j.bbagrm.2008.06.001; PULVERTAFT RJV, 1964, LANCET, V1, P238; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; Rossetti S, 2004, GENOMICS, V84, P1, DOI 10.1016/j.ygeno.2004.02.011; Rossetti S, 2010, J CELL MOL MED, V14, P1358, DOI 10.1111/j.1582-4934.2009.00982.x; Salat D, 2008, MOL CELL BIOL, V28, P3502, DOI 10.1128/MCB.01966-07; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Spegel P, 2010, METABOLOMICS, V6, P56, DOI 10.1007/s11306-009-0177-z; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei YF, 2007, NAT STRUCT MOL BIOL, V14, P653, DOI 10.1038/nsmb1258; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu M, 2006, AM J PHYSIOL-CELL PH, V292, pC125, DOI DOI 10.1152/AJPCELL.00247.2006; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937	71	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68502	10.1371/journal.pone.0068502	http://dx.doi.org/10.1371/journal.pone.0068502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840896	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900035
J	Skelly, DT; Hennessy, E; Dansereau, MA; Cunningham, C				Skelly, Donal T.; Hennessy, Edel; Dansereau, Marc-Andre; Cunningham, Colm			A Systematic Analysis of the Peripheral and CNS Effects of Systemic LPS, IL-1B, TNF-alpha and IL-6 Challenges in C57BL/6 Mice	PLOS ONE			English	Article							INDUCED SICKNESS BEHAVIOR; LIPOPOLYSACCHARIDE-INDUCED FEVER; ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; NECROSIS-FACTOR-ALPHA; ACUTE-PHASE RESPONSE; INFLAMMATORY RESPONSE; PROINFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; WORKING-MEMORY	`It is increasingly clear that systemic inflammation has both adaptive and deleterious effects on the brain. However, detailed comparisons of brain effects of systemic challenges with different pro-inflammatory cytokines are lacking. In the present study, we challenged female C57BL/6 mice intraperitoneally with LPS (100 mu g/kg), IL-1 beta (15 or 50 mu g/kg), TNF-alpha (50 or 250 mu g/kg) or IL-6 (50 or 125 mu g/kg). We investigated effects on core body temperature, open field activity and plasma levels of inflammatory markers at 2 hours post injection. We also examined levels of hepatic, hypothalamic and hippocampal inflammatory cytokine transcripts. Hypothermia and locomotor hypoactivity were induced by LPS> IL-1 beta>TNF-alpha>>IL-6. Systemic LPS, IL-1 beta and TNF-alpha challenges induced robust and broadly similar systemic and central inflammation compared to IL-6, which showed limited effects, but did induce a hepatic acute phase response. Important exceptions included IFN beta, which could only be induced by LPS. Systemic IL-1 beta could not induce significant blood TNF-alpha, but induced CNS TNF-alpha mRNA, while systemic TNF-alpha could induce IL-1 beta in blood and brain. Differences between IL-1 beta and TNF-alpha-induced hippocampal profiles, specifically for IL-6 and CXCL1 prompted a temporal analysis of systemic and central responses at 1, 2, 4, 8 and 24 hours, which revealed that IL-1 beta and TNF-alpha both induced the chemokines CXCL1 and CCL2 but only IL-1 beta induced the pentraxin PTX3. Expression of COX-2, CXCL1 and CCL2, with nuclear localisation of the p65 subunit of NF kappa B, in the cerebrovasculature was demonstrated by immunohistochemistry. Furthermore, we used cFOS immunohistochemistry to show that LPS, IL-1 beta and to a lesser degree, TNF-alpha activated the central nucleus of the amygdala. Given the increasing attention in the clinical literautre on correlating specific systemic inflammatory mediators with neurological or neuropsychiatric conditions and complications, these data will provide a useful resource on the likely CNS inflammatory profiles resulting from systemic elevation of particular cytokines.	[Cunningham, Colm] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Cunningham, C (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	colm.cunningham@tcd.ie	Hennessy, Edel/H-4438-2019; Cunningham, Colm/A-1743-2010	Hennessy, Edel/0000-0003-4024-0802; Cunningham, Colm/0000-0003-1423-5209; Skelly, Donal/0000-0002-2426-3097	Wellcome Trust Senior Research Fellowship; Health Research Board PhD studentship	Wellcome Trust Senior Research Fellowship(Wellcome Trust); Health Research Board PhD studentship	This work was supported by a Wellcome Trust Senior Research Fellowship to Dr Colm Cunningham and Dr Donal Skelly was supported by a Health Research Board PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222; Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9; Balsara RD, 2011, VASC CELL, V10, P3; Banisadr G, 2005, J COMP NEUROL, V489, P275, DOI 10.1002/cne.20598; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; Beloosesky Y, 2007, J GERONTOL A-BIOL, V62, P420, DOI 10.1093/gerona/62.4.420; BLUTHE RM, 1994, PSYCHONEUROENDOCRINO, V19, P197, DOI 10.1016/0306-4530(94)90009-4; Campbell SJ, 2010, BRAIN BEHAV IMMUN, V24, P738, DOI 10.1016/j.bbi.2010.01.011; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chapman TR, 2010, J NEUROSCI, V30, P7598, DOI 10.1523/JNEUROSCI.5172-09.2010; Chen H, 2008, AM J EPIDEMIOL, V167, P90, DOI 10.1093/aje/kwm260; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; Cho J, 2008, J NEUROIMMUNOL, V199, P94, DOI 10.1016/j.jneuroim.2008.05.011; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2008, BRAIN BEHAV IMMUN, V22, P1117, DOI 10.1016/j.bbi.2008.05.007; Cunningham C, 2013, BRAIN BEHAV IMMUN, V28, P1, DOI 10.1016/j.bbi.2012.07.012; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Cunningham O, 2009, GLIA, V57, P1802, DOI 10.1002/glia.20892; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Dantzer R, 2001, BRAIN BEHAV IMMUN, V15, P7, DOI 10.1006/brbi.2000.0613; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; De Paola M, 2008, NEUROIMMUNOMODULAT, V14, P310, DOI 10.1159/000123834; de Rooij SE, 2007, J PSYCHOSOM RES, V62, P521, DOI 10.1016/j.jpsychores.2006.11.013; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Dzenko KA, 2005, MICROVASC RES, V70, P53, DOI 10.1016/j.mvr.2005.04.005; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Elander L, 2007, AM J PHYSIOL-REG I, V292, pR258, DOI 10.1152/ajpregu.00511.2006; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Fantuzzi G, 1996, J LEUKOCYTE BIOL, V59, P489, DOI 10.1002/jlb.59.4.489; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Field RH, 2012, J NEUROSCI, V32, P6288, DOI 10.1523/JNEUROSCI.4673-11.2012; Fiore M, 1996, BRAIN BEHAV IMMUN, V10, P126, DOI 10.1006/brbi.1996.0013; FONG YM, 1989, J EXP MED, V170, P1627, DOI 10.1084/jem.170.5.1627; George J, 1997, AGE AGEING, V26, P423, DOI 10.1093/ageing/26.6.423; Giovannelli A, 1998, J NEUROIMMUNOL, V92, P122, DOI 10.1016/S0165-5728(98)00192-1; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Goehler LE, 1998, BRAIN RES, V804, P306, DOI 10.1016/S0006-8993(98)00685-4; Gosselin D, 2008, MOL PSYCHIATR, V13, P480, DOI 10.1038/sj.mp.4002122; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; GRANOWITZ EV, 1993, BLOOD, V82, P2985; Harden LM, 2006, PHYSIOL BEHAV, V89, P146, DOI 10.1016/j.physbeh.2006.05.016; Harden LM, 2011, PSYCHONEUROENDOCRINO, V36, P608, DOI 10.1016/j.psyneuen.2010.09.003; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Inui A, 2001, TRENDS IMMUNOL, V22, P469, DOI 10.1016/S1471-4906(01)01981-0; Kahlke V, 2000, CYTOKINE, V12, P69, DOI 10.1006/cyto.1999.0511; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Ko CY, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.017; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Konsman JP, 2000, EUR J NEUROSCI, V12, P4434, DOI 10.1046/j.0953-816X.2000.01319.x; Lacroix S, 1998, J NEUROCHEM, V70, P452, DOI 10.1046/j.1471-4159.1998.70020452.x; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Luterman JD, 2000, ARCH NEUROL-CHICAGO, V57, P1153, DOI 10.1001/archneur.57.8.1153; MacLullich AMJ, 2011, J AM GERIATR SOC, V59, P1151, DOI 10.1111/j.1532-5415.2011.03428.x; Margheri F, 2011, BLOOD, V118, P3743, DOI 10.1182/blood-2011-02-338681; MARINKOVIC S, 1989, J IMMUNOL, V142, P808; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Merkel SM, 2001, INFECT IMMUN, V69, P6119, DOI 10.1128/IAI.69.10.6119-6122.2001; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Mormede C, 2003, BRAIN BEHAV IMMUN, V17, P110, DOI 10.1016/S0889-1591(02)00054-5; Moxley G, 2002, ARTHRITIS RHEUM, V46, P250, DOI 10.1002/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T; Murray C, 2012, NEUROBIOL AGING, V33, P603, DOI 10.1016/j.neurobiolaging.2010.04.002; Murray CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-50; Nadjar A, 2005, NEUROPSYCHOPHARMACOL, V30, P1492, DOI 10.1038/sj.npp.1300755; Nadjar A, 2003, J NEUROCHEM, V87, P1024, DOI 10.1046/j.1471-4159.2003.02097.x; NELSON T, 2011, BRAIN BEHAV IMMUN S1, V25, P19; Nilsberth C, 2009, ENDOCRINOLOGY, V150, P1850, DOI 10.1210/en.2008-0806; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; OSERA C, 2011, AGEING RES REV; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Puma C, 2001, J NEUROCHEM, V78, P960, DOI 10.1046/j.1471-4159.2001.00469.x; Rivest S, 2001, PSYCHONEUROENDOCRINO, V26, P761, DOI 10.1016/S0306-4530(01)00064-6; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Saia RS, 2008, SHOCK, V29, P119; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Stach K, 2012, CARDIOL J, V19, P20, DOI 10.5603/CJ.2012.0005; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Swiergiel AH, 1999, BRAIN BEHAV IMMUN, V13, P252, DOI 10.1006/brbi.1999.0565; Swiergiel AH, 2007, PHARMACOL BIOCHEM BE, V86, P651, DOI 10.1016/j.pbb.2007.02.010; Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da; Teeling JL, 2010, BRAIN BEHAV IMMUN, V24, P409, DOI 10.1016/j.bbi.2009.11.006; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Turrin NP, 2004, EXP BIOL MED, V229, P996, DOI 10.1177/153537020422901003; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; van Munster BC, 2008, J AM GERIATR SOC, V56, P1704, DOI 10.1111/j.1532-5415.2008.01851.x; Walker QD, 2001, NEUROPSYCHOPHARMACOL, V25, P118, DOI 10.1016/S0893-133X(00)00248-7; Walker QD, 2001, J PHARMACOL EXP THER, V297, P291; Wang JP, 1997, NEUROIMMUNOMODULAT, V4, P230, DOI 10.1159/000097341; Wang JP, 1998, NEUROCHEM INT, V33, P143, DOI 10.1016/S0197-0186(98)00016-3; Watson K, 2005, MOL PHARMACOL, V67, P757, DOI 10.1124/mol.104.004812; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Wright Clinton B, 2006, J Stroke Cerebrovasc Dis, V15, P34, DOI 10.1016/j.jstrokecerebrovasdis.2005.08.009; Xia MQ, 2002, J NEUROIMMUNOL, V122, P55, DOI 10.1016/S0165-5728(01)00463-5; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhang J, 2003, NEWS PHYSIOL SCI, V18, P137, DOI 10.1152/nips.01415.2002; Zhou Y, 2011, J NEUROCHEM, V116, P406, DOI 10.1111/j.1471-4159.2010.07121.x	124	183	192	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e69123	10.1371/journal.pone.0069123	http://dx.doi.org/10.1371/journal.pone.0069123			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840908	gold, Green Submitted, Green Published			2022-12-27	WOS:000321271900047
J	Smith, IC; Bombardier, E; Vigna, C; Tupling, AR				Smith, Ian Curtis; Bombardier, Eric; Vigna, Chris; Tupling, A. Russell			ATP Consumption by Sarcoplasmic Reticulum Ca2+ Pumps Accounts for 40-50% of Resting Metabolic Rate in Mouse Fast and Slow Twitch Skeletal Muscle	PLOS ONE			English	Article							CA2+-DEPENDENT HEAT-PRODUCTION; CYCLOPIAZONIC ACID; CA2+-ATPASE ACTIVITY; SR CA2+-ATPASE; FIBERS; THERMOGENESIS; PHOSPHOLAMBAN; SARCOLIPIN; TRANSPORT; PHOSPHORYLATION	The main purpose of this study was to directly quantify the relative contribution of Ca2+ cycling to resting metabolic rate in mouse fast (extensor digitorum longus, EDL) and slow (soleus) twitch skeletal muscle. Resting oxygen consumption of isolated muscles (VO2, mu L/g wet weight/s) measured polarographically at 30 degrees C was similar to 20% higher (P<0.05) in soleus (0.326 +/- 0.022) than in EDL (0.261 +/- 0.020). In order to quantify the specific contribution of Ca2+ cycling to resting metabolic rate, the concentration of MgCl2 in the bath was increased to 10 mM to block Ca2+ release through the ryanodine receptor, thus eliminating a major source of Ca2+ leak from the sarcoplasmic reticulum (SR), and thereby indirectly inhibiting the activity of the sarco(endo) plasmic reticulum Ca2+-ATPases (SERCAs). The relative (%) reduction in muscle VO2 in response to 10 mM MgCl2 was similar between soleus (48.0 +/- 3.7) and EDL (42.4 +/- 3.2). Using a different approach, we attempted to directly inhibit SERCA ATPase activity in stretched EDL and soleus muscles (1.42x optimum length) using the specific SERCA inhibitor cyclopiazonic acid (CPA, up to 160 mu M), but were unsuccessful in removing the energetic cost of Ca2+ cycling in resting isolated muscles. The results of the MgCl2 experiments indicate that ATP consumption by SERCAs is responsible for 40-50% of resting metabolic rate in both mouse fast-and slow-twitch muscles at 30 degrees C, or 12-15% of whole body resting VO2. Thus, SERCA pumps in skeletal muscle could represent an important control point for energy balance regulation and a potential target for metabolic alterations to oppose obesity.	[Smith, Ian Curtis; Bombardier, Eric; Vigna, Chris; Tupling, A. Russell] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Tupling, AR (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	rtupling@uwaterloo.ca	Smith, Ian/HHD-2243-2022	Tupling, A. Russell/0000-0002-3895-6767; Smith, Ian/0000-0001-5269-1710	Canadian Institutes of Health Research [MOP-86618]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-86618 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (to ART).	Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Allen DL, 2001, AM J PHYSIOL-CELL PH, V280, pC637, DOI 10.1152/ajpcell.2001.280.3.C637; APELT D, 1989, TISSUE CELL, V21, P783, DOI 10.1016/0040-8166(89)90087-6; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Barclay CJ, 2008, ACTA PHYSIOL, V193, P381, DOI 10.1111/j.1748-1716.2008.01855.x; Barclay CJ, 2007, J MUSCLE RES CELL M, V28, P259, DOI 10.1007/s10974-007-9116-7; Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809; BAUDET S, 1993, CIRC RES, V73, P813, DOI 10.1161/01.RES.73.5.813; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; BRIGGS FN, 1992, J BIOL CHEM, V267, P26056; CHINET A, 1992, J PHYSIOL-LONDON, V455, P663, DOI 10.1113/jphysiol.1992.sp019321; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; CROW MT, 1982, J GEN PHYSIOL, V79, P147, DOI 10.1085/jgp.79.1.147; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; de Meis L, 2001, BIOSCIENCE REP, V21, P113, DOI 10.1023/A:1013640006611; DECROUY A, 1993, EXPERIENTIA, V49, P843, DOI 10.1007/BF01952595; Delbono O, 1996, J MEMBRANE BIOL, V151, P123, DOI 10.1007/s002329900063; DORRSCHEIDTKAFER M, 1976, PFLUG ARCH EUR J PHY, V362, P33, DOI 10.1007/BF00588678; DULLOO AG, 1994, METABOLISM, V43, P931, DOI 10.1016/0026-0495(94)90169-4; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Frank K, 2000, BIOCHEMISTRY-US, V39, P14176, DOI 10.1021/bi001049k; Fu MH, 2009, AM J PHYSIOL-HEART C, V296, pH1175, DOI 10.1152/ajpheart.01276.2008; GOEGER DE, 1988, BIOCHEM PHARMACOL, V37, P978, DOI 10.1016/0006-2952(88)90195-5; HASSELBACH W, 1983, ANN REV PHYSL, V45; Holloway GP, 2006, AM J PHYSIOL-REG I, V290, pR393, DOI 10.1152/ajpregu.00006.2005; INESI G, 1994, J MEMBRANE BIOL, V141, P1; Inesi G, 1978, Ann N Y Acad Sci, V307, P224, DOI 10.1111/j.1749-6632.1978.tb41947.x; KUREBAYASHI N, 1991, J MUSCLE RES CELL M, V12, P355, DOI 10.1007/BF01738590; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb GD, 1999, J PHYSIOL-LONDON, V519, P815, DOI 10.1111/j.1469-7793.1999.0815n.x; Levine JA, 2004, NUTR REV, V62, pS82, DOI 10.1111/j.1753-4887.2004.tb00094.x; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Macdonald WA, 2006, J PHYSIOL-LONDON, V573, P187, DOI 10.1113/jphysiol.2006.105775; Macdonald WA, 2001, J PHYSIOL-LONDON, V532, P499, DOI 10.1111/j.1469-7793.2001.0499f.x; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; RALL JA, 1979, J PHYSIOL-LONDON, V291, P265, DOI 10.1113/jphysiol.1979.sp012811; Reis M, 2002, MOL MEMBR BIOL, V19, P301, DOI 10.1080/09687680210166217; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X; Schertzer JD, 2003, AM J PHYSIOL-ENDOC M, V284, pE597, DOI 10.1152/ajpendo.00190.2002; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Smith IC, 2013, J GEN PHYSIOL, V141, P297, DOI 10.1085/jgp.201210918; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Tupling R, 2001, AM J PHYSIOL-REG I, V281, pR1681, DOI 10.1152/ajpregu.2001.281.5.R1681; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; WENDT IR, 1980, AM J PHYSIOL, V238, pC56, DOI 10.1152/ajpcell.1980.238.1.C56; WU KD, 1993, AM J PHYSIOL, V264, pC333, DOI 10.1152/ajpcell.1993.264.2.C333; ZOT AS, 1987, J BIOL CHEM, V262, P1966; Zubrzycka-Gaarn E, 1984, Prog Clin Biol Res, V168, P19; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	53	73	74	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68924	10.1371/journal.pone.0068924	http://dx.doi.org/10.1371/journal.pone.0068924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840903	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900042
J	Coolon, JD; Jones, KL; Todd, TC; Blair, JM; Herman, MA				Coolon, Joseph D.; Jones, Kenneth L.; Todd, Timothy C.; Blair, John M.; Herman, Michael A.			Long-Term Nitrogen Amendment Alters the Diversity and Assemblage of Soil Bacterial Communities in Tallgrass Prairie	PLOS ONE			English	Article							MICROBIAL COMMUNITY; FUNGAL COMMUNITIES; CONIFEROUS FOREST; HIGH-THROUGHPUT; LAND-USE; FERTILIZATION; BIOMASS; FIRE; QUALITY; DENITRIFICATION	Anthropogenic changes are altering the environmental conditions and the biota of ecosystems worldwide. In many temperate grasslands, such as North American tallgrass prairie, these changes include alteration in historically important disturbance regimes (e.g., frequency of fires) and enhanced availability of potentially limiting nutrients, particularly nitrogen. Such anthropogenically-driven changes in the environment are known to elicit substantial changes in plant and consumer communities aboveground, but much less is known about their effects on soil microbial communities. Due to the high diversity of soil microbes and methodological challenges associated with assessing microbial community composition, relatively few studies have addressed specific taxonomic changes underlying microbial community-level responses to different fire regimes or nutrient amendments in tallgrass prairie. We used deep sequencing of the V3 region of the 16S rRNA gene to explore the effects of contrasting fire regimes and nutrient enrichment on soil bacterial communities in a long-term (20 yrs) experiment in native tallgrass prairie in the eastern Central Plains. We focused on responses to nutrient amendments coupled with two extreme fire regimes (annual prescribed spring burning and complete fire exclusion). The dominant bacterial phyla identified were Proteobacteria, Verrucomicrobia, Bacteriodetes, Acidobacteria, Firmicutes, and Actinobacteria and made up 80% of all taxa quantified. Chronic nitrogen enrichment significantly impacted bacterial community diversity and community structure varied according to nitrogen treatment, but not phosphorus enrichment or fire regime. We also found significant responses of individual bacterial groups including Nitrospira and Gammaproteobacteria to long-term nitrogen enrichment. Our results show that soil nitrogen enrichment can significantly alter bacterial community diversity, structure, and individual taxa abundance, which have important implications for both managed and natural grassland ecosystems.	[Coolon, Joseph D.; Jones, Kenneth L.; Todd, Timothy C.; Blair, John M.; Herman, Michael A.] Kansas State Univ, Div Biol, Ecol Genom Inst, Manhattan, KS 66506 USA; [Coolon, Joseph D.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Jones, Kenneth L.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Todd, Timothy C.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	Kansas State University; University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Anschutz Medical Campus; Kansas State University	Coolon, JD (corresponding author), Kansas State Univ, Div Biol, Ecol Genom Inst, Ackert Hall, Manhattan, KS 66506 USA.	jcoolon@umich.edu	Blair, John M/I-4082-2014; Jones, Kenneth/GXF-4945-2022	Blair, John M/0000-0003-0072-0721; Herman, Michael/0000-0001-6796-1568	Kansas State University Open Access Publishing Fund; National Institutes of Health (NIH) National Research Service Award (NRSA) fellowship [1F32GM089009-02]; National Science Foundation (NSF) EPSCoR grant [EPS-0236913]; NSF [EF-0723862, DEB-0823341]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089009] Funding Source: NIH RePORTER	Kansas State University Open Access Publishing Fund; National Institutes of Health (NIH) National Research Service Award (NRSA) fellowship; National Science Foundation (NSF) EPSCoR grant; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. Joseph Coolon was supported by National Institutes of Health (NIH) National Research Service Award (NRSA) fellowship 1F32GM089009-02. This research was supported by National Science Foundation (NSF) EPSCoR grant EPS-0236913 to Michael Herman and Loretta Johnson, by NSF grant EF-0723862 to Michael Herman, and by NSF grant DEB-0823341 to the Konza Prairie LTER program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Allison VJ, 2005, SOIL SCI SOC AM J, V69, P1412, DOI 10.2136/sssaj2004.0252; BAATH E, 1995, SOIL BIOL BIOCHEM, V27, P229, DOI 10.1016/0038-0717(94)00140-V; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bittman S, 2005, SOIL BIOL BIOCHEM, V37, P613, DOI 10.1016/j.soilbio.2004.07.038; Blair JM, 1997, ECOLOGY, V78, P2359, DOI 10.1890/0012-9658(1997)078[2359:FNAAPR]2.0.CO;2; Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1872; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins SL, 2012, J VEG SCI, V23, P563, DOI 10.1111/j.1654-1103.2011.01369.x; Coolon JD, 2010, MOL ECOL, V19, P67, DOI 10.1111/j.1365-294X.2009.04485.x; Dell CJ, 2005, ECOLOGY, V86, P1280, DOI 10.1890/03-0790; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans SE, 2012, BIOGEOCHEMISTRY, V109, P101, DOI 10.1007/s10533-011-9638-3; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; GARCIA FO, 1994, SOIL SCI SOC AM J, V58, P816, DOI 10.2136/sssaj1994.03615995005800030026x; GROFFMAN PM, 1993, ECOLOGY, V74, P855, DOI 10.2307/1940811; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jangid K, 2010, SOIL BIOL BIOCHEM, V42, P302, DOI 10.1016/j.soilbio.2009.11.008; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Jumpponen A, 2009, NEW PHYTOL, V184, P279; Jumpponen A, 2010, MYCOLOGIA, V102, P1027, DOI 10.3852/09-316; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kitchen DJ, 2009, PLANT SOIL, V323, P235, DOI 10.1007/s11104-009-9931-2; KNAPP AK, 1986, BIOSCIENCE, V36, P662, DOI 10.2307/1310387; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Miller SR, 2009, APPL ENVIRON MICROB, V75, P4565, DOI 10.1128/AEM.02792-08; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; PIETIKAINEN J, 1995, SOIL BIOL BIOCHEM, V27, P101, DOI 10.1016/0038-0717(94)00125-K; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sotomayor D, 1996, SOIL SCI SOC AM J, V60, P1822, DOI 10.2136/sssaj1996.03615995006000060030x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Trosvik P, 2007, APPL ENVIRON MICROB, V73, P4975, DOI 10.1128/AEM.00128-07; Turner CL, 1997, ECOLOGY, V78, P1832, DOI 10.1890/0012-9658(1997)078[1832:SNAPRT]2.0.CO;2; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; VAZQUEZ FJ, 1993, FEMS MICROBIOL ECOL, V13, P93, DOI 10.1016/0168-6496(93)90027-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Williams MA, 2007, APPL SOIL ECOL, V35, P535, DOI 10.1016/j.apsoil.2006.09.014; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	62	67	72	4	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67884	10.1371/journal.pone.0067884	http://dx.doi.org/10.1371/journal.pone.0067884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840782	gold, Green Published			2022-12-27	WOS:000321148400138
J	Lacombe, A; Li, RW; Klimis-Zacas, D; Kristo, AS; Tadepalli, S; Krauss, E; Young, R; Wu, VCH				Lacombe, Alison; Li, Robert W.; Klimis-Zacas, Dorothy; Kristo, Aleksandra S.; Tadepalli, Shravani; Krauss, Emily; Young, Ryan; Wu, Vivian C. H.			Lowbush Wild Blueberries Have the Potential to Modify Gut Microbiota and Xenobiotic Metabolism in the Rat Colon	PLOS ONE			English	Article							DIET VACCINIUM-ANGUSTIFOLIUM; POLYPHENOLS; ANTHOCYANINS; IMPROVEMENTS; COMPONENTS; PROBIOTICS; SEVERITY; BACTERIA; MODEL; FATE	The gastrointestinal tract is populated by an array of microbial species that play an important role in metabolic and immune functions. The composition of microorganisms is influenced by the components of the host's diet and can impact health. In the present study, dietary enrichment of lowbush wild blueberries (LWB) was examined to determine their effect on colon microbial composition and their potential in promoting gut health. The microbial composition and functional potential of the colon microbiota from Sprague Dawley rats fed control diets (AIN93) and LWB-enriched diets (AIN93+8% LWB powder substituting for dextrose) for 6 weeks were assessed using Illumina shotgun sequencing and bioinformatics tools. Our analysis revealed an alteration in the relative abundance of 3 phyla and 22 genera as representing approximately 14 and 8% of all phyla and genera identified, respectively. The LWB-enriched diet resulted in a significant reduction in the relative abundance of the genera Lactobacillus and Enterococcus. In addition, hierarchal analysis revealed a significant increase in the relative abundance of the phylum Actinobacteria, the order Actinomycetales, and several novel genera under the family Bifidobacteriaceae and Coriobacteriaceae, in the LWB group. Functional annotation of the shotgun sequences suggested that approximately 9% of the 4709 Kyoto Encyclopaedia of Gene and Genome (KEGG) hits identified were impacted by the LWB-diet. Open Reading Frames (ORFs) assigned to KEGG category xenobiotics biodegradation and metabolism were significantly greater in the LWB-enriched diet compared to the control and included the pathway for benzoate degradation [PATH:ko00362] and glycosaminoglycan degradation [PATH:ko00531]. Moreover, the number of ORFs assigned to the bacterial invasion of epithelial cells [PATH:ko05100] pathway was approximately 8 fold lower in the LWB group compared to controls. This study demonstrated that LWBs have the potential to promote gut health and can aid in the development of optimal diets.	[Lacombe, Alison; Klimis-Zacas, Dorothy; Kristo, Aleksandra S.; Tadepalli, Shravani; Krauss, Emily; Wu, Vivian C. H.] Univ Maine, Dept Food Sci & Human Nutr, Orono, ME USA; [Li, Robert W.] ARS, USDA, BARC, Bovine Funct Genom Lab, Beltsville, MD USA; [Young, Ryan] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA	University of Maine System; University of Maine Orono; United States Department of Agriculture (USDA); University of Maine System; University of Maine Orono	Wu, VCH (corresponding author), Univ Maine, Dept Food Sci & Human Nutr, Orono, ME USA.	vivian.wu@umit.maine.edu	Kristo, Aleksandra/AHC-3770-2022	Wu, Vivian C.H./0000-0002-1525-1078; Kristo, Aleksandra S./0000-0002-0733-4041	USDA ARS, and USDA National Needs Graduate Fellowship [2007-38420-17764]; UMaine Center for Excellence in Teaching and Assessment Active Student Learning Micro-Grants; Maine Agricultural and Forest Experiment Station at the University of Maine; Hatch from the USDA National Institute of Food and Agriculture [ME08562-10]	USDA ARS, and USDA National Needs Graduate Fellowship; UMaine Center for Excellence in Teaching and Assessment Active Student Learning Micro-Grants; Maine Agricultural and Forest Experiment Station at the University of Maine; Hatch from the USDA National Institute of Food and Agriculture	This research was supported by USDA ARS, and USDA National Needs Graduate Fellowship Competitive (award #:2007-38420-17764), UMaine Center for Excellence in Teaching and Assessment Active Student Learning Micro-Grants, and the Maine Agricultural and Forest Experiment Station at the University of Maine. This work is based upon research supported in part by Hatch (Grant number ME08562-10) from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; [Anonymous], J ANTIBIOT, V49, P560; Barnett AM, 2012, FOOD FUNCT, V3, P690, DOI 10.1039/c2fo30017f; Bo Liu TG, 2010, METAPHYLER TAXONOMIC; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Conterno L, 2011, GENES NUTR, V6, P241, DOI 10.1007/s12263-011-0230-1; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Del Bo' C, 2012, NUTR METAB CARDIOVAS, V22, P127, DOI 10.1016/j.numecd.2010.05.004; Del Bo C, 2010, MUTAT RES-GEN TOX EN, V703, P158, DOI 10.1016/j.mrgentox.2010.08.013; Del Bo C, 2010, J AGR FOOD CHEM, V58, P2491, DOI 10.1021/jf903472x; Gerth K, 1996, J ANTIBIOT, V49, P560, DOI 10.7164/antibiotics.49.560; Gonzalez-Barrio R, 2011, DRUG METAB DISPOS, V39, P1680, DOI 10.1124/dmd.111.039651; Haiser HJT, 2012, PHARM RES, V11; Hakansson AB, 2012, PLOS ONE, V7, P14; Hakansson A, 2009, SCAND J GASTROENTERO, V44, P1213, DOI 10.1080/00365520903171268; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Harmsen HJM, 2000, APPL ENVIRON MICROB, V66, P4523, DOI 10.1128/AEM.66.10.4523-4527.2000; Hidalgo M, 2012, J AGR FOOD CHEM, V60, P3882, DOI 10.1021/jf3002153; Huang LP, 2011, J CHEM TECHNOL BIOT, V86, P481, DOI 10.1002/jctb.2551; Imhoff JF, 2010, PHOTOSYNTH RES, V104, P123, DOI 10.1007/s11120-009-9510-7; Jin JS, 2010, INT J SYST EVOL MICR, V60, P1721, DOI 10.1099/ijs.0.016774-0; Juskiewicz J, 2011, NUTRITION, V27, P351, DOI 10.1016/j.nut.2010.02.002; Kahle K, 2006, MOL NUTR FOOD RES, V50, P418, DOI 10.1002/mnfr.200500211; Kemperman RA, 2010, MICROBIOL-SGM, V156, P3224, DOI 10.1099/mic.0.042127-0; Keppler K, 2005, BIOORGAN MED CHEM, V13, P5195, DOI 10.1016/j.bmc.2005.05.003; Kiely PD, 2011, BIORESOURCE TECHNOL, V102, P361, DOI 10.1016/j.biortech.2010.05.017; Kristo AS, 2010, J AGR FOOD CHEM, V58, P11600, DOI 10.1021/jf101839u; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Laparra JM, 2010, PHARMACOL RES, V61, P219, DOI 10.1016/j.phrs.2009.11.001; Le Roes-Hill M, 2011, ANTON LEEUW INT J G, V100, P589, DOI 10.1007/s10482-011-9614-x; le Roes-Hill M, 2011, APPL BIOCHEM BIOTECH, V164, P681, DOI 10.1007/s12010-011-9167-5; Leon-Tejera H, 2011, FOTTEA, V11, P235, DOI 10.5507/fot.2011.022; Li RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024417; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Milbury PEK, 2010, J AGR FOOD CHEM, V58, P6; Molan AL, 2009, WORLD J MICROB BIOT, V25, P1243, DOI 10.1007/s11274-009-0011-9; Molan AL, 2010, WORLD J MICROB BIOT, V26, P1735, DOI 10.1007/s11274-010-0352-4; Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e; Osman N, 2008, DIGEST DIS SCI, V53, P2464, DOI 10.1007/s10620-007-0174-x; Paturi G, 2012, NUTRITION, V28, P324, DOI 10.1016/j.nut.2011.07.018; Pezzoni M, 2011, J BASIC MICROB, V51, P325, DOI 10.1002/jobm.201000223; Poetsch A, 2011, PROTEOMICS, V11, P3244, DOI 10.1002/pmic.201000786; Possemiers S, 2011, FITOTERAPIA, V82, P53, DOI 10.1016/j.fitote.2010.07.012; Rastmanesh R, 2011, CHEM-BIOL INTERACT, V189, P1, DOI 10.1016/j.cbi.2010.10.002; Reeves PG, 1997, J NUTR, V127, pS838; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Saad R, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-16; Sarethy IP, 2011, J IND MICROBIOL BIOT, V38, P769, DOI 10.1007/s10295-011-0968-x; Scott KP, 2011, P NATL ACAD SCI USA, V108, P4672, DOI 10.1073/pnas.1000091107; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Serafini M, 2010, P NUTR SOC, V69, P273, DOI 10.1017/S002966511000162X; Silbaq FS, 2009, J APPL MICROBIOL, V106, P106, DOI 10.1111/j.1365-2672.2008.03981.x; Tokiwa Y, 2006, APPL MICROBIOL BIOT, V72, P244, DOI 10.1007/s00253-006-0488-1; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Dorsten FA, 2010, MOL NUTR FOOD RES, V54, P897, DOI 10.1002/mnfr.200900212; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; van Duynhoven J, 2009, MAGNETIC RESONANCE IN FOOD SCIENCE: CHALLENGES IN A CHANGING WORLD, P20; Vendrame S, 2013, J NUTR BIOC IN PRESS; Vendrame S, 2011, J AGR FOOD CHEM, V59, P12815, DOI 10.1021/jf2028686; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; White MA, 2009, PLOS GENET, V5, P12; Wishon LM, 2010, MILCHWISSENSCHAFT, V65, P369	64	55	58	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67497	10.1371/journal.pone.0067497	http://dx.doi.org/10.1371/journal.pone.0067497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840722	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400092
J	Rossi, S; Studer, V; Moscatelli, A; Motta, C; Coghe, G; Fenu, G; Caillier, S; Buttari, F; Mori, F; Barbieri, F; Castelli, M; De Chiara, V; Monteleone, F; Mancino, R; Bernardi, G; Baranzini, SE; Marrosu, MG; Oksenberg, JR; Centonze, D				Rossi, Silvia; Studer, Valeria; Moscatelli, Alessandro; Motta, Caterina; Coghe, Giancarlo; Fenu, Giuseppe; Caillier, Stacy; Buttari, Fabio; Mori, Francesco; Barbieri, Francesca; Castelli, Maura; De Chiara, Valentina; Monteleone, Fabrizia; Mancino, Raffaele; Bernardi, Giorgio; Baranzini, Sergio E.; Marrosu, Maria G.; Oksenberg, Jorge R.; Centonze, Diego			Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; OPTICAL COHERENCE TOMOGRAPHY; LONG-TERM POTENTIATION; HUMAN MOTOR CORTEX; NERVE-FIBER LAYER; TRANSCRANIAL MAGNETIC STIMULATION; SUBUNIT GENE GRIN2B; SYNAPTIC PLASTICITY; COGNITIVE IMPAIRMENT; NR1 SUBUNIT	Synaptic transmission and plasticity mediated by NMDA receptors (NMDARs) could modulate the severity of multiple sclerosis (MS). Here the role of NMDARs in MS was first explored in 691 subjects carrying specific allelic variants of the NR1 subunit gene or of the NR2B subunit gene of this glutamate receptor. The analysis was replicated for significant SNPs in an independent sample of 1548 MS subjects. The C allele of rs4880213 was found to be associated with reduced NMDAR-mediated cortical excitability, and with increased probability of having more disability than the CT/TT MS subjects. MS severity was higher in the CC group among relapsing-remitting MS (RR-MS) patients, while primary progressive MS (PP-MS) subjects homozygous for the T allele had more pronounced clinical worsening. Mean time to first relapse, but not to an active MRI scan, was lower in the CC group of RR-MS patients, and the number of subjects with two or more clinical relapses in the first two years of the disease was higher in CC compared to CT/TT group. Furthermore, the percentage of relapses associated with residual disability was lower in subjects carrying the T allele. Lesion load at the MRI was conversely unaffected by the C or T allele of this SNP in RR-MS patients. Axonal and neuronal degeneration at the optical coherence tomography was more severe in the TT group of PP-MS patients, while reduced retinal nerve fiber thickness had less consequences on visual acuity in RR-MS patients bearing the T allele. Finally, the T allele was associated with preserved cognitive abilities at the Rao's brief repeatable neuropsychological battery in RR-MS. Signaling through glutamate NMDARs enhances both compensatory synaptic plasticity and excitotoxic neurodegeneration, impacting in opposite ways on RR-MS and PP-MS pathophysiological mechanisms.	[Rossi, Silvia; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Mori, Francesco; Barbieri, Francesca; Castelli, Maura; De Chiara, Valentina; Monteleone, Fabrizia; Bernardi, Giorgio; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy; [Rossi, Silvia; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Mori, Francesco; Barbieri, Francesca; Castelli, Maura; De Chiara, Valentina; Monteleone, Fabrizia; Bernardi, Giorgio; Centonze, Diego] Fdn Santa Lucia, Ctr Europeo Ric Cervello, Rome, Italy; [Coghe, Giancarlo; Fenu, Giuseppe; Marrosu, Maria G.] Univ Cagliari, Dipartimento Sanita Pubbl Med Clin & Mol, Ctr Sclerosi Multipla, Cagliari, Italy; [Caillier, Stacy; Baranzini, Sergio E.; Oksenberg, Jorge R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Mancino, Raffaele] Univ Roma Tor Vergata, Dipartimento Biopatol, Clin Oculist, Rome, Italy; [Moscatelli, Alessandro] Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany; [Moscatelli, Alessandro] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Cagliari; University of California System; University of California San Francisco; University of Rome Tor Vergata; University of Bielefeld; University of Bielefeld	Centonze, D (corresponding author), Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy.	centonze@uniroma2.it	Centonze, Diego/J-7767-2016; Motta, Caterina/L-1513-2018; Mori, Francesco/AGX-1659-2022; Moscatelli, Alessandro/L-1391-2018	Centonze, Diego/0000-0002-8390-8545; Mori, Francesco/0000-0002-4761-6174; Rossi, Silvia/0000-0003-3257-8248; MANCINO, Raffaele/0000-0001-9968-9714; Moscatelli, Alessandro/0000-0001-6269-4536; Baranzini, Sergio/0000-0003-0067-194X; Fenu, Giuseppe/0000-0003-0198-0488; Marrosu, Maria Giovanna/0000-0003-2334-2081; studer, valeria/0000-0003-2529-7640	Fondazione Italiana Sclerosi Multipla (Progetto Speciale FISM); Italian National Ministero della Salute; Italian National Ministero dell'Universita; National Institute of Health [R01NS 026799]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799] Funding Source: NIH RePORTER	Fondazione Italiana Sclerosi Multipla (Progetto Speciale FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Italian National Ministero della Salute(Ministry of Health, Italy); Italian National Ministero dell'Universita; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was supported by Fondazione Italiana Sclerosi Multipla (Progetto Speciale FISM), by the Italian National Ministero della Salute, and by the Italian National Ministero dell'Universita to DC, and by National Institute of Health (R01NS 026799) to JO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Arnold PD, 1995, GLUTAMATE RECEPTOR G; BAI G, 1995, J BIOL CHEM, V270, P7737, DOI 10.1074/jbc.270.13.7737; Baier ML, 2005, NEUROLOGY, V64, P992, DOI 10.1212/01.WNL.0000154521.40686.63; Baranzini SE, 2010, BRAIN, V133, P2603, DOI 10.1093/brain/awq192; Barbarotto R, 1998, ITAL J NEUROL SCI, V19, P161, DOI 10.1007/BF00831566; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Bennett MR, 2000, PROG NEUROBIOL, V60, P109, DOI 10.1016/S0301-0082(99)00006-4; Bergamaschi R, 2007, J NEUROL NEUROSUR PS, V78, P757, DOI 10.1136/jnnp.2006.107052; Bolton C, 1997, J PHARMACOL EXP THER, V282, P397; Bosma LVAE, 2012, MULT SCLER J, V18, P345, DOI 10.1177/1352458511419880; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Calabresi P, 1998, ANN NEUROL, V43, P586, DOI 10.1002/ana.410430506; Calabresi P, 2003, LANCET NEUROL, V2, P622, DOI 10.1016/S1474-4422(03)00532-5; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109; Centonze D, 2007, NEUROBIOL DIS, V27, P44, DOI 10.1016/j.nbd.2007.03.012; Chen C, 2010, NEUROSCI BULL, V26, P395, DOI 10.1007/s12264-010-0729-2; Cianfoni A, 2007, AM J NEURORADIOL, V28, P272; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Cooke Sam F, 2005, Curr Opin Investig Drugs, V6, P25; Costello F, 2009, J NEUROL SCI, V281, P74, DOI 10.1016/j.jns.2009.02.354; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Di Filippo M, 2008, NEUROPHARMACOLOGY, V55, P353, DOI 10.1016/j.neuropharm.2008.01.012; Di Lazzaro V, 2010, CEREB CORTEX, V20, P1523, DOI 10.1093/cercor/bhp216; Ding YX, 2010, DEV MED CHILD NEUROL, V52, P1028, DOI 10.1111/j.1469-8749.2010.03746.x; Dorval KM, 2007, GENES BRAIN BEHAV, V6, P444, DOI 10.1111/j.1601-183X.2006.00273.x; Ellis NA, 2008, BLOOD, V112, P741, DOI 10.1182/blood-2007-11-126508; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Errico F, 2008, MOL CELL NEUROSCI, V37, P236, DOI 10.1016/j.mcn.2007.09.012; Errico F, 2011, NEUROBIOL AGING, V32, P2229, DOI 10.1016/j.neurobiolaging.2010.01.002; Errico F, 2011, NEUROBIOL AGING, V32, P2061, DOI 10.1016/j.neurobiolaging.2009.12.007; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Frohman E, 2006, LANCET NEUROL, V5, P853, DOI 10.1016/S1474-4422(06)70573-7; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Galehdari H, 2009, J MOL NEUROSCI, V38, P178, DOI 10.1007/s12031-008-9148-5; Georgi A, 2007, PSYCHIAT GENET, V17, P308, DOI 10.1097/YPG.0b013e3280c1e5fb; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Grasselli G, 2013, BRIT J PHARMACOL, V168, P502, DOI 10.1111/j.1476-5381.2012.02178.x; Grazioli E, 2008, J NEUROL SCI, V268, P12, DOI 10.1016/j.jns.2007.10.020; Greenamyre JT, 2001, CLIN NEUROPHARMACOL, V24, P65, DOI 10.1097/00002826-200103000-00001; Halene TB, 2009, GENES BRAIN BEHAV, V8, P661, DOI 10.1111/j.1601-183X.2009.00504.x; HOLM S, 1979, SCAND J STAT, V6, P65; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kalman B, 2007, J NEUROIMMUNOL, V188, P1, DOI 10.1016/j.jneuroim.2007.03.020; Kambe Y, 2011, NEUROCHEM INT, V59, P10, DOI 10.1016/j.neuint.2011.03.018; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Killestein J, 2005, J NEUROL SCI, V233, P113, DOI 10.1016/j.jns.2005.03.011; Kiy G, 2011, MULT SCLER J, V17, P1088, DOI 10.1177/1352458511403530; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-55; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; Matute C, 2011, J ANAT, V219, P53, DOI 10.1111/j.1469-7580.2010.01339.x; McEachern JC, 1999, J NEUROSCI RES, V58, P42, DOI 10.1002/(SICI)1097-4547(19991001)58:1<42::AID-JNR6>3.3.CO;2-C; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Miglio G, 2005, BIOCHEM BIOPH RES CO, V338, P1875, DOI 10.1016/j.bbrc.2005.10.164; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Mori F, 2011, J NEUROPHYSIOL, V106, P1637, DOI 10.1152/jn.00318.2011; Mori F, 2011, NEUROPSYCHOPHARMACOL, V36, P559, DOI 10.1038/npp.2010.187; Mundo E, 2003, MOL PSYCHIATR, V8, P241, DOI 10.1038/sj.mp.4001218; Neuhaus W, 2011, BRAIN RES, V1394, P49, DOI 10.1016/j.brainres.2011.04.003; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Pampliega O, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-63; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Patti F, 2009, MULT SCLER J, V15, P2, DOI 10.1177/1352458508096684; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Picconi B, 2006, STROKE, V37, P1895, DOI 10.1161/01.STR.0000226981.57777.b0; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PORTER RHP, 1994, J NEUROSCI, V14, P7192; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Que M, 1999, NEUROSCI LETT, V273, P77, DOI 10.1016/S0304-3940(99)00598-4; Rao S, 1990, MANUAL BRIEF REPEATA; Reijerkerk A, 2010, J NEUROCHEM, V113, P447, DOI 10.1111/j.1471-4159.2010.06598.x; REVESZ T, 1994, BRAIN, V117, P759, DOI 10.1093/brain/117.4.759; Rodriguez MC, 1998, ANN NEUROL, V44, pS175, DOI 10.1002/ana.410440726; Rosenstock TR, 2010, EUR J NEUROSCI, V32, P60, DOI 10.1111/j.1460-9568.2010.07268.x; Rossi S, 2011, MULT SCLER J, V17, P1301, DOI 10.1177/1352458511410342; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schipke CG, 2001, FASEB J, V15, P1270, DOI 10.1096/fj.00-0439fje; Schwenkreis P, 1999, NEUROSCI LETT, V270, P137, DOI 10.1016/S0304-3940(99)00492-9; Schwenkreis P, 2000, EXP BRAIN RES, V135, P293, DOI 10.1007/s002210000532; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sombekke MH, 2010, MULT SCLER J, V16, P652, DOI 10.1177/1352458510364633; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Stanika RI, 2010, NEUROBIOL DIS, V37, P403, DOI 10.1016/j.nbd.2009.10.020; Stover JF, 1997, NEUROSCI LETT, V238, P25, DOI 10.1016/S0304-3940(97)00840-9; Sucher NJ, 1997, VISION RES, V37, P3483, DOI 10.1016/S0042-6989(97)00047-3; Villoslada P, 2009, NEUROLOGY, V72, P1630, DOI 10.1212/01.wnl.0000342388.73185.80; Witte ME, 2010, MITOCHONDRION, V10, P411, DOI 10.1016/j.mito.2010.05.014; Wu SL, 2010, NEUROSCI LETT, V478, P61, DOI 10.1016/j.neulet.2010.04.063; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Ziemann U, 1998, NEUROLOGY, V51, P1320, DOI 10.1212/WNL.51.5.1320; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	111	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67357	10.1371/journal.pone.0067357	http://dx.doi.org/10.1371/journal.pone.0067357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840674	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400065
J	Bonaccorso, E; Guayasamin, JM				Bonaccorso, Elisa; Guayasamin, Juan M.			On the Origin of Pantepui montane biotas: A Perspective Based on the Phylogeny of Aulacorhynchus toucanets	PLOS ONE			English	Article							ADAPTIVE RADIATION; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENETICS; NORTHERN ANDES; EVOLUTION; INTERCHANGE; SPECIATION; INSIGHTS; AVES; DIVERSIFICATION	To understand the origin of Pantepui montane biotas, we studied the biogeography of toucanets in the genus Aulacorhynchus. These birds are ideal for analyzing historical relationships among Neotropical montane regions, given their geographic distribution from Mexico south to Bolivia, including northern Venezuela (Cordillera de la Costa), and the Pantepui. Analyses were based on molecular phylogenies using mitochondrial and nuclear DNA sequences. Topology tests were applied to compare alternative hypotheses that may explain the current distribution of Aulacorhynchus toucanets, in the context of previous hypotheses of the origin of Pantepui montane biotas. Biogeographic reconstructions in RASP and Lagrange were used to estimate the ancestral area of the genus, and an analysis in BEAST was used to estimate a time framework for its diversification. A sister relationship between the Pantepui and Andes+Cordillera de la Costa was significantly more likely than topologies indicating other hypothesis for the origin of Pantepui populations. The Andes was inferred as the ancestral area for Aulacorhynchus, and the group has diversified since the late Miocene. The biogeographic patterns found herein, in which the Andes are the source for biotas of other regions, are consistent with those found for flowerpiercers and tanagers, and do not support the hypothesis of the geologically old Pantepui as a source of Neotropical montain diversity. Based on the high potential for cryptic speciation and isolation of Pantepui populations, we consider that phylogenetic studies of additional taxa are important from a conservation perspective.	[Bonaccorso, Elisa; Guayasamin, Juan M.] Univ Tecnol Indoame, Ctr Invest Biodiversidad & Cambio Climat, Quito, Pichincha, Ecuador; [Bonaccorso, Elisa] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	University of Kansas	Bonaccorso, E (corresponding author), Univ Tecnol Indoame, Ctr Invest Biodiversidad & Cambio Climat, Quito, Pichincha, Ecuador.	elisabonaccorso@gmail.com		Guayasamin, Juan/0000-0003-0098-978X; Bonaccorso, Elisa/0000-0002-7262-9356	NSF [DEB-0508910]; Universidad Tecnologica Indoamerica	NSF(National Science Foundation (NSF)); Universidad Tecnologica Indoamerica	This work was supported by NSF (Dissertation Improvement Grant DEB-0508910) and Universidad Tecnologica Indoamerica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, THESIS U TEXAS AUSTI; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Barker FK, 2007, BIOL J LINN SOC, V90, P687, DOI 10.1111/j.1095-8312.2007.00758.x; Berry P. E., 1995, FLORA VENEZUELAN GUA, V1, P161; Bonaccorso E, 2011, ZOOL SCR, V40, P336, DOI 10.1111/j.1463-6409.2011.00475.x; BRICENO H, 1990, J S AM EARTH SCI, V3, P179, DOI 10.1016/0895-9811(90)90002-I; BRICENO H.O., 1990, GEOMORPHOLOGY, V3, P125, DOI DOI 10.1016/0169-555X(90)90041-N; Cadena CD, 2011, J EVOLUTION BIOL, V24, P402, DOI 10.1111/j.1420-9101.2010.02175.x; Chapman FM, 1931, B AM MUS NAT HIST, V63, P1; Chaves JA, 2011, MOL ECOL, V20, P4564, DOI 10.1111/j.1365-294X.2011.05304.x; COATES AG, 1992, GEOL SOC AM BULL, V104, P814, DOI 10.1130/0016-7606(1992)104<0814:COTIOP>2.3.CO;2; Coates Anthony G., 1996, P21; CROIZAT L, 1974, SYST ZOOL, V23, P265, DOI 10.2307/2412139; Croizat L, 1976, BIBLIOTECA ACAD CIEN, V15, P1; Doan TM, 2003, J BIOGEOGR, V30, P361, DOI 10.1046/j.1365-2699.2003.00833.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farris DW, 2006, GEOLOGY, P1007; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Givnish TJ, 2011, AM J BOT, V98, P872, DOI 10.3732/ajb.1000059; Givnish Thomas J., 2007, Aliso, V23, P3; Givnish TJ, 2000, EVOLUTION, V54, P1915; GRAVES GR, 1982, CONDOR, V84, P1, DOI 10.2307/1367812; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Haffer J., 1974, AVIAN SPECIATION TRO; Hoogmoed M.S., 1979, University of Kansas Museum of Natural History Monograph, P241; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; HUBER O, 1988, TAXON, V37, P595, DOI 10.2307/1221102; Huber O., 1987, PANTEPUI, V2, P2; Huber O., 1995, FLORA VENEZUELAN GUA, V1, P1, DOI DOI 10.2307/2399074; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; Leal Cesar A., 2011, Ornitologia Colombiana, V11, P91; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; MAGUIRE B, 1970, Biotropica, V2, P85, DOI 10.2307/2989766; MARSHALL LG, 1979, SCIENCE, V204, P272, DOI 10.1126/science.204.4390.272; Mauck WM, 2009, BIOL J LINN SOC, V98, P14, DOI 10.1111/j.1095-8312.2009.01278.x; Mayr E., 1967, Bulletin of the American Museum of Natural History, V136, P269; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Navarro AG, 2001, WILSON BULL, V113, P363, DOI 10.1676/0043-5643(2001)113[0363:SLIMAT]2.0.CO;2; Omland KE, 2000, EVOLUTION, V54, P2119; ORiain MJ, 1996, NATURE, V380, P619, DOI 10.1038/380619a0; Perez-Eman JL, 2005, MOL PHYLOGENET EVOL, V37, P511, DOI 10.1016/j.ympev.2005.04.013; Peterson AT, 2006, J AVIAN BIOL, V37, P541, DOI 10.1111/j.0908-8857.2006.04029.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puebla-Olivares F, 2008, AUK, V125, P39, DOI 10.1525/auk.2008.125.1.39; Rambaut A., 2004, TRACER; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Remsen JVJ, 2012, CLASSIFICATION BIRD; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rull V, 2004, NATURWISSENSCHAFTEN, V91, P139, DOI 10.1007/s00114-004-0504-1; Salerno PE, 2012, EVOLUTION, V66, P3000, DOI 10.1111/j.1558-5646.2012.01666.x; Sanchez-Gonzalez LA, 2008, BIOL J LINN SOC, V94, P175, DOI 10.1111/j.1095-8312.2008.00979.x; Sedano RE, 2010, J BIOGEOGR, V37, P325, DOI 10.1111/j.1365-2699.2009.02200.x; Steyermark J. A., 1979, TROPICAL BOT; STEYERMARK JA, 1979, TAXON, V28, P45, DOI 10.2307/1219557; Tate GHH, 1938, GEOGR REV, V28, P452, DOI 10.2307/209741; Weckstein JD, 2005, AUK, V122, P1191, DOI 10.1642/0004-8038(2005)122[1191:MPOTRT]2.0.CO;2; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weir JT, 2009, P NATL ACAD SCI USA, V106, P21737, DOI 10.1073/pnas.0903811106; Weir JT, 2009, ANN MO BOT GARD, V96, P410, DOI 10.3417/2008011; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zamudio KR, 1997, BIOL J LINN SOC, V62, P421, DOI 10.1111/j.1095-8312.1997.tb01634.x	66	18	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67321	10.1371/journal.pone.0067321	http://dx.doi.org/10.1371/journal.pone.0067321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840663	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400095
J	Helsen, K; Jacquemyn, H; Hermy, M; Vandepitte, K; Honnay, O				Helsen, Kenny; Jacquemyn, Hans; Hermy, Martin; Vandepitte, Katrien; Honnay, Olivier			Rapid Buildup of Genetic Diversity in Founder Populations of the Gynodioecious Plant Species Origanum vulgare after Semi-Natural Grassland Restoration	PLOS ONE			English	Article							PRIMARY SUCCESSION; VOLCAN LONQUIMAY; SEX-RATIO; ASTERACEAE MUTISIEAE; LANDSCAPE GENETICS; PRIMULA-ELATIOR; MALE-STERILITY; METAPOPULATION; EXTINCTION; DIFFERENTIATION	In most landscapes the success of habitat restoration is largely dependent on spontaneous colonization of plant species. This colonization process, and the outcome of restoration practices, can only be considered successful if the genetic makeup of founding populations is not eroded through founder effects and subsequent genetic drift. Here we used 10 microsatellite markers to investigate the genetic effects of recent colonization of the long-lived gynodioecious species Origanum vulgare in restored semi-natural grassland patches. We compared the genetic diversity and differentiation of fourteen recent populations with that of thirteen old, putative source populations, and we evaluated the effects of spatial configuration of the populations on colonization patterns. We did not observe decreased genetic diversity in recent populations, or inflated genetic differentiation among them. Nevertheless, a significantly higher inbreeding coefficient was observed in recent populations, although this was not associated with negative fitness effects. Overall population genetic differentiation was low (F-ST = 0.040). Individuals of restored populations were assigned to on average 6.1 different source populations (likely following the 'migrant pool' model). Gene flow was, however, affected by the spatial configuration of the grasslands, with gene flow into the recent populations mainly originating from nearby source populations. This study demonstrates how spontaneous colonization after habitat restoration can lead to viable populations in a relatively short time, overcoming pronounced founder effects, when several source populations are nearby. Restored populations can therefore rapidly act as stepping stones and sources of genetic diversity, likely increasing overall metapopulation viability of the study species.	[Helsen, Kenny; Jacquemyn, Hans; Vandepitte, Katrien; Honnay, Olivier] Katholieke Univ Leuven, Dept Biol, Louvain, Belgium; [Hermy, Martin] Katholieke Univ Leuven, Div Forest Nat & Landscape Res, Dept Earth & Environm Sci, Louvain, Belgium	KU Leuven; KU Leuven	Helsen, K (corresponding author), Katholieke Univ Leuven, Dept Biol, Louvain, Belgium.	kenny.helsen@bio.kuleuven.be	Helsen, Kenny/D-7759-2015; Jacquemyn, Hans/AAC-4875-2019; Honnay, Olivier/AAH-8625-2019; Helsen, Kenny/AAE-7555-2020	Helsen, Kenny/0000-0001-6856-7095; Jacquemyn, Hans/0000-0001-9600-5794; Honnay, Olivier/0000-0002-4287-8511; Helsen, Kenny/0000-0001-6856-7095	Flemish fund for scientific research (FWO)	Flemish fund for scientific research (FWO)(FWO)	This work was funded by the Flemish fund for scientific research (FWO) through a predoctoral fellowship of Kenny Helsen; Website FWO: http://www.fwo.be/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens D, 2006, BIOL CONSERV, V133, P212, DOI 10.1016/j.biocon.2006.06.006; ANTROBUS S, 1993, HEREDITY, V71, P252, DOI 10.1038/hdy.1993.133; Austerlitz F, 2000, GENETICS, V154, P1309; Bailey MF, 2007, OIKOS, V116, P1609, DOI 10.1111/j.0030-1299.2007.15315.x; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Bossuyt B, 2008, PLANT ECOL, V199, P1, DOI 10.1007/s11258-008-9416-z; Cornuet JM, 1996, GENETICS, V144, P2001; Cauwer I, 2012, MOL ECOL, V21, P834, DOI 10.1111/j.1365-294X.2011.05414.x; Dufay M, 2012, ANN BOT-LONDON, V109, P505, DOI 10.1093/aob/mcr062; Erickson DL, 2004, MOL ECOL, V13, P1655, DOI 10.1111/j.1365-294X.2004.02139.x; Esfeld K, 2008, BIODIVERS CONSERV, V17, P2441, DOI 10.1007/s10531-008-9391-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Giles BE, 1997, AM NAT, V149, P507, DOI 10.1086/286002; Green EC, 2012, PLANT SYST EVOL, V298, P109, DOI 10.1007/s00606-011-0527-y; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Helsen K, 2012, OIKOS, V121, P2121, DOI 10.1111/j.1600-0706.2012.20499.x; Holderegger R, 2010, TRENDS PLANT SCI, V15, P675, DOI 10.1016/j.tplants.2010.09.002; Honnay O, 2013, BRENNERS ENCY GENETI; Honnay O, 2009, J ECOL, V97, P131, DOI 10.1111/j.1365-2745.2008.01452.x; Huxel GR, 1999, RESTOR ECOL, V7, P309, DOI 10.1046/j.1526-100X.1999.72024.x; IETSWAART JH, 1984, ACTA BOT NEERL, V33, P335, DOI 10.1111/j.1438-8677.1984.tb01824.x; Ingvarsson PK, 1997, EVOLUTION, V51, P29, DOI 10.1111/j.1558-5646.1997.tb02385.x; Jacquemyn H, 2006, HEREDITY, V96, P471, DOI 10.1038/sj.hdy.6800825; Jacquemyn H, 2004, MOL ECOL, V13, P211, DOI 10.1046/j.1365-294X.2003.02033.x; Jacquemyn H, 2009, ANN BOT-LONDON, V103, P777, DOI 10.1093/aob/mcn253; Jamieson IG, 2012, TRENDS ECOL EVOL, V27, P578, DOI 10.1016/j.tree.2012.07.001; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KHEYRPOUR A, 1980, J HERED, V71, P253, DOI 10.1093/oxfordjournals.jhered.a109359; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S, 2002, SCHRIFTENREIHE VEGET, V38; Lambinon J., 1998, FLORA BELGIE GROOTHE; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LEWIS D, 1956, EVOLUTION, V10, P115, DOI 10.2307/2405887; Lian CL, 2003, MOL ECOL, V12, P609, DOI 10.1046/j.1365-294X.2003.01756.x; Litrico I, 2005, MOL ECOL, V14, P1575, DOI 10.1111/j.1365-294X.2005.02502.x; Lopez PG, 2010, AM J BOT, V97, P423, DOI 10.3732/ajb.0900208; Manicacci D, 1996, MOL ECOL, V5, P63, DOI 10.1111/j.1365-294X.1996.tb00291.x; MCCAULEY DE, 1991, TRENDS ECOL EVOL, V6, P5, DOI 10.1016/0169-5347(91)90139-O; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Montalvo AM, 1997, RESTOR ECOL, V5, P277, DOI 10.1046/j.1526-100X.1997.00542.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nilsson E, 2006, J EVOLUTION BIOL, V19, P825, DOI 10.1111/j.1420-9101.2005.01045.x; Novak J, 2008, MOL ECOL RESOUR, V8, P599, DOI 10.1111/j.1471-8286.2007.02059.x; Pannell JR, 1999, EVOLUTION, V53, P664, DOI 10.1111/j.1558-5646.1999.tb05362.x; Pannell JR, 2000, PHILOS T R SOC B, V355, P1851, DOI 10.1098/rstb.2000.0740; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pluess AR, 2004, AM J BOT, V91, P2013, DOI 10.3732/ajb.91.12.2013; Pritchard JK, 2000, GENETICS, V155, P945; Raffl C, 2008, HEREDITY, V100, P526, DOI 10.1038/hdy.2008.8; Raffl C, 2006, MOL ECOL, V15, P2433, DOI 10.1111/j.1365-294X.2006.02964.x; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; Sork VL, 2006, LANDSCAPE ECOL, V21, P821, DOI 10.1007/s10980-005-5415-9; StatSoft, 2000, STATISTICA WIND COMP; Tero N, 2003, MOL ECOL, V12, P2073, DOI 10.1046/j.1365-294X.2003.01898.x; Thompson K, 1998, J ECOL, V86, P163, DOI 10.1046/j.1365-2745.1998.00240.x; Travis SE, 2002, RESTOR ECOL, V10, P37, DOI 10.1046/j.1526-100X.2002.10104.x; Tremetsberger K, 2003, MOL ECOL, V12, P2649, DOI 10.1046/j.1365-294X.2003.01956.x; Van Looy K, 2009, BIOL CONSERV, V142, P870, DOI 10.1016/j.biocon.2008.12.006; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandepitte K, 2007, MOL ECOL, V16, P4171, DOI 10.1111/j.1365-294X.2007.03473.x; Vandepitte K, 2012, MOL ECOL, V21, P4206, DOI 10.1111/j.1365-294X.2012.05698.x; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Yang S, 2008, MOL ECOL, V17, P731, DOI [10.1111/j.1365-294X.2007.03625.x, 10.1111/j.1365-294X.2008.03976.x]; Zartman CE, 2006, MOL ECOL, V15, P2305, DOI 10.1111/j.1365-294X.2006.02929.x	74	22	22	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67255	10.1371/journal.pone.0067255	http://dx.doi.org/10.1371/journal.pone.0067255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840642	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200127
J	Zhang, T; Du, J; Xue, Y; Su, HX; Yang, F; Jin, Q				Zhang, Ting; Du, Jiang; Xue, Ying; Su, Haoxiang; Yang, Fan; Jin, Qi			Epidemics and Frequent Recombination within Species in Outbreaks of Human Enterovirus B-Associated Hand, Foot and Mouth Disease in Shandong China in 2010 and 2011	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; ASEPTIC-MENINGITIS; ENVIRONMENTAL SURVEILLANCE; CIRCULATING ENTEROVIRUSES; SEQUENCE-ANALYSIS; ECHOVIRUS 6; GENOME; IDENTIFICATION; PROVINCE; SEROTYPES	The epidemiology and molecular characteristics of human enterovirus B (HEV-B) associated with hand, foot and mouth disease (HFMD) outbreaks in China are not well known. In the present study, we tested 201 HEV isolates from 233 clinical specimens from patients with severe HFMD during 2010-2011 in Linyi, Shandong, China. Of the 201 isolates, 189 were fully typed and 18 corresponded to HEV-B species (six serotypes CVA9, CVB1, CVB4, Echo 6, Echo 25 and Echo 30) using sensitive semi-nested polymerase chain reaction analysis of VP1 gene sequences. Phylogenetic analysis based on the VP1 region showed that eight E30SD belonged to a novel sub-genogroup D2; E25SD belonged to a novel sub-genogroup D6; E6SD belonged to sub-lineage C6 and five CVB1SD belonged to subgroup 4C; and B4SD belonged sub-lineage D2. The full viral genomes of the CVB1SD, E6SD, E25SD and E30SD isolates were sequenced. Analysis of phylogenetic and similarity plots indicated that E25SD recombined with E25-HN-2, E30FDJS03 and E4AUS250 at noncontiguous P2A-P3D regions, while E30SD, E30FDJ03, E25-HN-2 and E9 DM had shared sequences in discrete regions of P2 and P3. Both E6SD and B1SD shared sequences with E1-HN, B4/GX/10, B5-HN, and A9-Alberta in contiguous regions of most of P2 and P3. Genetic algorithm recombination detection analysis further confirmed the existence of multiple potential recombination points. In conclusion, analysis of the complete genomes of E25SD, E30SD, CVB1SD and E6SD isolated from HFMD patients revealed that they formed novel subgenogroup. Given the prevalence and recombination of these viruses in outbreaks of HFMD, persistent surveillance of HFMD-associated HEV-B pathogens is required to predict potential emerging viruses and related disease outbreaks.	[Yang, Fan] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, F (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	ymf129@163.com; jinqi36@yahoo.com.cn	Zhang, Ting/S-8215-2019		National S&T Major Project, "China Mega-Project for Infectious Disease" from PR China [2011ZX10004-001]	National S&T Major Project, "China Mega-Project for Infectious Disease" from PR China	This work was supported by the National S&T Major Project, "China Mega-Project for Infectious Disease" (Grant No. 2011ZX10004-001) from PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Baek K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-297; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P761; Chao Ling, 2010, Chinese Journal of Virology, V26, P443; Choi YJ, 2010, J MICROBIOL BIOTECHN, V20, P643, DOI 10.4014/jmb.0909.09002; Han JF, 2011, J CLIN VIROL, V50, P348, DOI 10.1016/j.jcv.2011.01.005; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Hu YF, 2012, J INFECTION, V65, P189, DOI 10.1016/j.jinf.2012.03.021; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; KELEN AE, 1964, CAN MED ASSOC J, V90, P1349; Kim H, 2012, SPACE, P38; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kyriakopoulou Z, J CLIN MICROBIOLOGY, V48, P1513; Kyriakopoulou Z, 2010, J CLIN MICROBIOL, V48, P1513, DOI 10.1128/JCM.00475-09; LEDINKO N, 1963, VIROLOGY, V20, P107, DOI 10.1016/0042-6822(63)90145-4; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 2001, J GEN VIROL, V82, P409, DOI 10.1099/0022-1317-82-2-409; Oprisan G, 2002, J GEN VIROL, V83, P2193, DOI 10.1099/0022-1317-83-9-2193; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Tao ZX, 2012, APPL ENVIRON MICROB, V78, P6946, DOI 10.1128/AEM.01861-12; Tao ZX, 2011, APPL ENVIRON MICROB, V77, P3786, DOI 10.1128/AEM.03044-10; Tebruegge M, 2009, SEMIN FETAL NEONAT M, V14, P222, DOI 10.1016/j.siny.2009.02.002; Wang HaiYan, 2005, Chinese Journal of Virology, V21, P106; Wei Hai-Yan, 2012, Chinese Journal of Virology, V28, P114; Wikswo ME, 2009, CLIN INFECT DIS, V49, pE44, DOI 10.1086/605090; Yang F, 2011, CLIN INFECT DIS, V53, P400, DOI 10.1093/cid/cir346; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao YN, 2006, J CLIN MICROBIOL, V44, P4142, DOI 10.1128/JCM.01049-06; Zhao Ya-nan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P282; Zhao YN, 2005, EMERG INFECT DIS, V11, P562, DOI 10.3201/eid1104.040995	38	35	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67157	10.1371/journal.pone.0067157	http://dx.doi.org/10.1371/journal.pone.0067157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840610	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200123
J	Griffiths, HJ; Whittle, RJ; Roberts, SJ; Belchier, M; Linse, K				Griffiths, Huw J.; Whittle, Rowan J.; Roberts, Stephen J.; Belchier, Mark; Linse, Katrin			Antarctic Crabs: Invasion or Endurance?	PLOS ONE			English	Article							LITHODIDAE CRUSTACEA DECAPODA; SOUTH SHETLAND ISLANDS; VI ICE SHELF; CLIMATE-CHANGE; MARGUERITE BAY; GLACIER FLUCTUATIONS; ENVIRONMENTAL-CHANGE; BENTHIC COMMUNITIES; TEMPERATURE LIMITS; PALMER-DEEP	Recent scientific interest following the "discovery'' of lithodid crabs around Antarctica has centred on a hypothesis that these crabs might be poised to invade the Antarctic shelf if the recent warming trend continues, potentially decimating its native fauna. This "invasion hypothesis'' suggests that decapod crabs were driven out of Antarctica 40-15 million years ago and are only now returning as "warm'' enough habitats become available. The hypothesis is based on a geographically and spatially poor fossil record of a different group of crabs (Brachyura), and examination of relatively few Recent lithodid samples from the Antarctic slope. In this paper, we examine the existing lithodid fossil record and present the distribution and biogeographic patterns derived from over 16,000 records of Recent Southern Hemisphere crabs and lobsters. Globally, the lithodid fossil record consists of only two known specimens, neither of which comes from the Antarctic. Recent records show that 22 species of crabs and lobsters have been reported from the Southern Ocean, with 12 species found south of 60 degrees S. All are restricted to waters warmer than 0 degrees C, with their Antarctic distribution limited to the areas of seafloor dominated by Circumpolar Deep Water (CDW). Currently, CDW extends further and shallower onto the West Antarctic shelf than the known distribution ranges of most lithodid species examined. Geological evidence suggests that West Antarctic shelf could have been available for colonisation during the last 9,000 years. Distribution patterns, species richness, and levels of endemism all suggest that, rather than becoming extinct and recently re-invading from outside Antarctica, the lithodid crabs have likely persisted, and even radiated, on or near to Antarctic slope. We conclude there is no evidence for a modern-day "crab invasion''. We recommend a repeated targeted lithodid sampling program along the West Antarctic shelf to fully test the validity of the "invasion hypothesis''.	[Griffiths, Huw J.; Whittle, Rowan J.; Roberts, Stephen J.; Belchier, Mark; Linse, Katrin] British Antarctic Survey, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Griffiths, HJ (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	hjg@bas.ac.uk	Griffiths, Huw J/D-4234-2009	Griffiths, Huw J/0000-0003-1764-223X; Roberts, Stephen/0000-0003-3407-9127; Linse, Katrin/0000-0003-3477-3047	Natural Environment Research Council (UK); Government of South Georgia; South Sandwich Islands; NERC [bas0100024, bas0100026] Funding Source: UKRI; Natural Environment Research Council [bas0100024, bas0100026] Funding Source: researchfish	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Government of South Georgia; South Sandwich Islands; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (UK) as a contribution to the British Antarctic Survey core project, Environmental Change and Evolution. Funding for MB was provided by the Government of South Georgia and the South Sandwich Islands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELLAN LJL, 1993, CCAMLR SCI, V1, P165; Ahyong Shane T., 2010, NIWA Biodiversity Memoir, V123, P3; Gonzalez-Wevar CA, 2012, REV CHIL HIST NAT, V85, P445, DOI 10.4067/S0716-078X2012000400007; Allen CS, 2010, HOLOCENE, V20, P551, DOI 10.1177/0959683609356581; Anderson RF, 2002, DEEP-SEA RES PT II, V49, P1909, DOI 10.1016/S0967-0645(02)00018-8; Arana E. Patricio M., 1999, Investigaciones Marinas Universidad Catolica de Valparaiso, V27, P101; Arnaud P.M., 1985, P381; Aronson RB, 2001, AM ZOOL, V41, P27, DOI 10.1668/0003-1569(2001)041[0027:GCCATO]2.0.CO;2; Aronson RB, 1997, GEOLOGY, V25, P903, DOI 10.1130/0091-7613(1997)025<0903:RCSITL>2.3.CO;2; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Aronson RB, 2011, ANN NY ACAD SCI, V1223, P82, DOI 10.1111/j.1749-6632.2010.05926.x; Aronson RB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004385; Ashworth AC, 2004, PALAEOGEOGR PALAEOCL, V213, P65, DOI 10.1016/j.palaeo.2004.07.002; Barnes DKA, 2009, MAR ECOL PROG SER, V393, P13, DOI 10.3354/meps08246; Belchier M, 2012, CCAMLR SCI, V19, P1; Bentley MJ, 2007, QUATERNARY SCI REV, V26, P2690, DOI 10.1016/j.quascirev.2007.07.005; Bentley MJ, 2007, QUATERNARY SCI REV, V26, P644, DOI 10.1016/j.quascirev.2006.11.019; Bentley MJ, 2011, QUATERNARY SCI REV, V30, P3338, DOI 10.1016/j.quascirev.2011.09.002; Bentley MJ, 2009, HOLOCENE, V19, P51, DOI 10.1177/0959683608096603; Bentley MJ, 2005, QUATERNARY SCI REV, V24, P1203, DOI 10.1016/j.quascirev.2004.10.004; BIRNIE J, 1990, J QUATERNARY SCI, V5, P171, DOI 10.1002/jqs.3390050302; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Britayev TA, 2010, J APPL ICHTHYOL, V26, P66, DOI 10.1111/j.1439-0426.2010.01494.x; CLAPPERTON CM, 1989, QUATERNARY RES, V31, P210, DOI 10.1016/0033-5894(89)90006-9; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Clarke A, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000886; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Cofaigh CO, 2005, QUATERNARY SCI REV, V24, P709, DOI 10.1016/j.quascirev.2004.10.006; Collins MA, 2002, ICES J MAR SCI, V59, P370, DOI 10.1006/jmsc.2001.1167; Convey P, 2008, BIOL REV, V83, P103, DOI 10.1111/j.1469-185X.2008.00034.x; Cook AJ, 2010, CRYOSPHERE, V4, P77, DOI 10.5194/tc-4-77-2010; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; De Grave S, 2009, RAFFLES B ZOOL, P1; De Melo GAS, 1995, MANUAL IDENTIFICACAO; Domack E, 2001, HOLOCENE, V11, P1, DOI 10.1191/095968301673881493; Downey RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041672; ESCOBARBRIONES E, 2002, CONTRIBUTIONS STUDY, V1, P37; Feldmann R.M., 1988, Geological Society of America Memoir, V169, P465; Feldmann RM, 2006, J PALEONTOL, V80, P83, DOI 10.1666/0022-3360(2006)080[0083:POSHDC]2.0.CO;2; Feldmann RM, 2003, J GEOL SOC LONDON, V160, P151, DOI 10.1144/0016-764901-136; Feldmann RM, 1998, NEW ZEAL J GEOL GEOP, V41, P35, DOI 10.1080/00288306.1998.9514788; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; Fretwell PT, 2010, QUATERNARY SCI REV, V29, P1880, DOI 10.1016/j.quascirev.2010.04.006; Gorny M, 1999, SCI MAR, V63, P367, DOI 10.3989/scimar.1999.63s1367; Graham AGC, 2012, QUATERNARY SCI REV, V35, P63, DOI 10.1016/j.quascirev.2012.01.008; Graham AGC, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001993; Griffiths HJ, 2011, DEEP-SEA RES PT II, V58, P18, DOI 10.1016/j.dsr2.2010.10.008; Griffiths HJ, 2011, ECOGRAPHY, V34, P616, DOI 10.1111/j.1600-0587.2010.06612.x; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; Hall S, 2011, POLAR BIOL, V34, P363, DOI 10.1007/s00300-010-0890-0; Hall S, 2009, J BIOGEOGR, V36, P2125, DOI 10.1111/j.1365-2699.2009.02153.x; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Henderson JR, 1888, REPORT ANOMURA COLLE; Heroy DC, 2007, QUATERNARY SCI REV, V26, P3286, DOI 10.1016/j.quascirev.2007.07.012; Heroy DC, 2005, GEOL SOC AM BULL, V117, P1497, DOI 10.1130/B25694.1; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hillenbrand CD, 2010, QUATERNARY SCI REV, V29, P2741, DOI 10.1016/j.quascirev.2010.06.028; Hodgson DA, 2013, QUATERNARY SCI REV, V68, P216, DOI 10.1016/j.quascirev.2013.02.002; Hogg OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019795; JEWETT SC, 1982, MAR BIOL, V66, P243, DOI 10.1007/BF00397029; Johnson GC, 2008, J CLIMATE, V21, P5351, DOI 10.1175/2008JCLI2384.1; Karasawa Hiiroaki, 2012, Bulletin of the Mizunami Fossil Museum, V38, P53; Kilfeather AA, 2011, GEOL SOC AM BULL, V123, P997, DOI 10.1130/B30282.1; Kirshner AE, 2012, QUATERNARY SCI REV, V38, P11, DOI 10.1016/j.quascirev.2012.01.017; KLAGES M, 1995, POLAR BIOL, V15, P73; Krause RA, 2011, PALAEOGEOGR PALAEOCL, V312, P350, DOI 10.1016/j.palaeo.2011.03.020; LAWRENCE DR, 1968, GEOL SOC AM BULL, V79, P1315, DOI 10.1130/0016-7606(1968)79[1315:TAILIF]2.0.CO;2; Macpherson E, 2004, POLAR BIOL, V27, P418, DOI 10.1007/s00300-004-0609-1; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Marsh L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048348; Martin R.E., 1999, TAPHONOMY PROCESS AP; Masson-Delmotte V, 2011, CLIM PAST, V7, P397, DOI 10.5194/cp-7-397-2011; Meredith MP, 2008, J CLIMATE, V21, P3327, DOI 10.1175/2007JCLI2238.1; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; MIQUEL JC, 1985, MAR BIOL, V89, P263, DOI 10.1007/BF00393660; Morley SA, 2009, COMP BIOCHEM PHYS A, V153, P154, DOI 10.1016/j.cbpa.2009.02.001; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Peck Lloyd S, 2005, Front Zool, V2, P9, DOI 10.1186/1742-9994-2-9; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Purkey SG, 2012, J CLIMATE, V25, P5830, DOI 10.1175/JCLI-D-11-00612.1; Purves MG, 2003, FISH B-NOAA, V101, P874; Raso JEG, 2008, POLAR BIOL, V31, P1281, DOI 10.1007/s00300-008-0476-2; Raso JG, 2005, POLAR BIOL, V28, P642, DOI 10.1007/s00300-005-0722-9; Roberts SJ, 2008, PALAEOGEOGR PALAEOCL, V259, P258, DOI 10.1016/j.palaeo.2007.10.010; Roberts SJ, 2010, GEOGR ANN A, V92A, P125, DOI 10.1111/j.1468-0459.2010.00382.x; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Rosqvist GC, 2003, QUATERNARY RES, V59, P470, DOI 10.1016/S0033-5894(03)00036-X; Rosqvist GC, 1999, GEOLOGY, V27, P967, DOI 10.1130/0091-7613(1999)027<0967:LGTMHC>2.3.CO;2; ROWE GT, 1974, DEEP-SEA RES, V21, P641, DOI 10.1016/0011-7471(74)90048-5; Shimada K, 2012, OCEAN SCI, V8, P419, DOI 10.5194/os-8-419-2012; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Smith CR, 2012, P ROY SOC B-BIOL SCI, V279, P1017, DOI 10.1098/rspb.2011.1496; Smith JA, 2007, QUATERNARY SCI REV, V26, P500, DOI 10.1016/j.quascirev.2006.05.006; Smith JA, 2011, QUATERNARY SCI REV, V30, P488, DOI 10.1016/j.quascirev.2010.11.020; Spiridonov V, 2006, POLAR BIOL, V29, P137, DOI 10.1007/s00300-005-0087-0; STAFF GM, 1986, GEOL SOC AM BULL, V97, P428, DOI 10.1130/0016-7606(1986)97<428:TTATIO>2.0.CO;2; Stebbing TRR, 1914, T ROY SOC EDINBURGH, V50, P253, DOI DOI 10.1017/S008045680003595X; Strugnell JM, 2012, MOL ECOL, V21, P2775, DOI 10.1111/j.1365-294X.2012.05572.x; Strugnell JM, 2008, CLADISTICS, V24, P853, DOI 10.1111/j.1096-0031.2008.00234.x; SUGDEN DE, 1977, QUATERNARY RES, V7, P268, DOI 10.1016/0033-5894(77)90041-2; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Tavares M, 2004, ANTARCT SCI, V16, P129, DOI 10.1017/S0954102004001877; Thatje S, 2005, ECOLOGY, V86, P619, DOI 10.1890/04-0620; Thatje S, 2004, POLAR BIOL, V27, P195, DOI 10.1007/s00300-003-0583-z; Thatje S, 2003, POLAR BIOL, V26, P279, DOI 10.1007/s00300-002-0476-6; Thatje S, 2008, POLAR BIOL, V31, P1143, DOI 10.1007/s00300-008-0457-5; Tiefenbacher Ludwig, 1994, Spixiana, V17, P13; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; Van der Putten N, 2009, QUATERNARY SCI REV, V28, P65, DOI 10.1016/j.quascirev.2008.09.023; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Watters G., 1997, CCAMLR Science, V4, P141; Watters G, 1995, AMLR 1994 95 FIELD S, P113; Zarenkov N.A., 1968, BIOL REP SOV ANTARCT, V4, P153	115	45	48	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66981	10.1371/journal.pone.0066981	http://dx.doi.org/10.1371/journal.pone.0066981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843974	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000321733000057
J	Ladwig, KH; Brockhaus, AC; Baumert, J; Lukaschek, K; Emeny, RT; Kruse, J; Codd, V; Hafner, S; Albrecht, E; Illig, T; Samani, NJ; Wichmann, HE; Gieger, C; Peters, A				Ladwig, Karl-Heinz; Brockhaus, Anne Catharina; Baumert, Jens; Lukaschek, Karoline; Emeny, Rebecca T.; Kruse, Johannes; Codd, Veryan; Haefner, Sibylle; Albrecht, Eva; Illig, Thomas; Samani, Nilesh J.; Wichmann, H. Erich; Gieger, Christian; Peters, Annette			Posttraumatic Stress Disorder and Not Depression Is Associated with Shorter Leukocyte Telomere Length: Findings from 3,000 Participants in the Population-Based KORA F4 Study	PLOS ONE			English	Article							GENERAL-POPULATION; MAJOR DEPRESSION; DIAGNOSTIC SCALE; LIFE STRESS; DISEASE; HEALTH; SEVERITY; VALIDITY; EROSION; OBESITY	Background: A link between severe mental stress and shorter telomere length (TL) has been suggested. We analysed the impact of Posttraumatic Stress Disorder (PTSD) on TL in the general population and postulated a dose-dependent TL association in subjects suffering from partial PTSD compared to full PTSD. Methods: Data are derived from the population-based KORA F4 study (2006-2008), located in southern Germany including 3,000 individuals (1,449 men and 1,551 women) with valid and complete TL data. Leukocyte TL was measured using a quantitative PCR-based technique. PTSD was assessed in a structured interview and by applying the Posttraumatic Diagnostic Scale (PDS) and the Impact of Event Scale (IES). A total of 262 (8.7%) subjects qualified for having partial PTSD and 51 (1.7%) for full PTSD. To assess the association of PTSD with the average TL, linear regression analyses with adjustments for potential confounding factors were performed. Results: The multiple model revealed a significant association between partial PTSD and TL (beta = -0.051, p = 0.009) as well as between full PTSD and shorter TL (beta = -0.103, p = 0.014) indicating shorter TL on average for partial and full PTSD. An additional adjustment for depression and depressed mood/exhaustion gave comparable beta estimations. Conclusions: Participants with partial and full PTSD had significantly shorter leukocyte TL than participants without PTSD. The dose-dependent variation in TL of subjects with partial and full PTSD exceeded the chronological age effect, and was equivalent to an estimated 5 years in partial and 10 years in full PTSD of premature aging.	[Ladwig, Karl-Heinz; Baumert, Jens; Lukaschek, Karoline; Emeny, Rebecca T.; Haefner, Sibylle; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Ladwig, Karl-Heinz] Univ Munich, Klinikum Rechts Isar, Dept Psychosomat Med & Psychotherapy, Munich, Germany; [Brockhaus, Anne Catharina; Albrecht, Eva; Gieger, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Brockhaus, Anne Catharina] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [Kruse, Johannes] Univ Giessen, Univ Hosp, Dept Psychosomat Med & Psychotherapy, D-35390 Giessen, Germany; [Haefner, Sibylle] Univ Gottingen, Univ Med Ctr, Dept Psychiat, D-37073 Gottingen, Germany; [Illig, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Codd, Veryan; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Codd, Veryan; Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England; [Wichmann, H. Erich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Justus Liebig University Giessen; University of Gottingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ladwig, KH (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany.	ladwig@helmholtz-muenchen.de	Peters, Annette/A-6117-2011; Ladwig, Karl-Heinz/B-5351-2014; Emeny, Rebecca/I-1100-2014; Wichmann, Heinz Erich/AAA-5695-2022; Lukaschek, Karoline/N-6224-2014	Peters, Annette/0000-0001-6645-0985; Ladwig, Karl-Heinz/0000-0003-0710-1720; Emeny, Rebecca/0000-0002-8780-5439; Lukaschek, Karoline/0000-0002-7966-2001; Codd, Veryan/0000-0002-9430-8254; Gieger, Christian/0000-0001-6986-9554	Helmholtz Zentrum Munchen; German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF), Berlin, Germany; British Heart Foundation; ENGAGE consortium	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF), Berlin, Germany(Federal Ministry of Education & Research (BMBF)); British Heart Foundation(British Heart Foundation); ENGAGE consortium	The MONICA/KORA Augsburg studies were financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany (formerly GSF - National Research Center for Environment and Health) and the German Federal Ministry of Education and Research (BMBF), Berlin, Germany. VC and NJS are funded by the British Heart Foundation and this work falls under the research portfolio of the Leicester NIHR Cardiovascular Biomedical Research Unit. Telomere assays were funded by the ENGAGE consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040186; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Breslau N, 2004, PSYCHOL MED, V34, P1205, DOI 10.1017/S0033291704002594; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Elvsashagen T, 2011, J AFFECT DISORDERS, V135, P43, DOI 10.1016/j.jad.2011.08.006; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Glass Daniel, 2010, Biol Psychiatry, V68, pe21, DOI 10.1016/j.biopsych.2010.02.026; Hartmann N, 2010, DEPRESS ANXIETY, V27, P1111, DOI 10.1002/da.20749; Heppner PS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-1; Hoen P.W., 2012, PSYCHOL MED, P1; Hoen PW, 2011, PSYCHOSOM MED, V73, P541, DOI 10.1097/PSY.0b013e31821b1f6e; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Hornsby PJ, 2006, AGING CELL, V5, P577, DOI 10.1111/j.1474-9726.2006.00249.x; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Huzen J, 2010, AGE AGEING, V39, P223, DOI 10.1093/ageing/afp256; International Classification of Diseases, 1992, INT CLASS DIS 10 REV; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kiecolt-Glaser JK, 2011, PSYCHOSOM MED, V73, P16, DOI 10.1097/PSY.0b013e31820573b6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Ladwig KH, 2004, ANN EPIDEMIOL, V14, P332, DOI 10.1016/j.annepidem.2003.09.003; Lansdorp PM, 2006, AGING CELL, V5, P583, DOI 10.1111/j.1474-9726.2006.00247.x; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Lukaschek K, 2012, SOCPSYCHPSYCHEPI; Lukaschek K, 2013, J PSYCHOSOM RES, V74, P340, DOI 10.1016/j.jpsychores.2012.12.011; Lung FW, 2008, J HUM HYPERTENS, V22, P230, DOI 10.1038/sj.jhh.1002314; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Moller P, 2009, AGING-US, V1, P733; Morris MC, 2012, CLIN PSYCHOL REV, V32, P301, DOI 10.1016/j.cpr.2012.02.002; Moverare-Skrtic S, 2009, J CLIN ENDOCR METAB, V94, P5078, DOI 10.1210/jc.2009-1450; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donovan A, 2011, BIOL PSYCHIAT, V70, P465, DOI 10.1016/j.biopsych.2011.01.035; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Pavanello S, 2011, INT J CANCER, V129, P983, DOI 10.1002/ijc.25999; Pietrzak RH, 2012, J AM GERIATR SOC, V60, P296, DOI 10.1111/j.1532-5415.2011.03788.x; Riegert-Johnson DL, 2012, INT J BIOL MARKER, V27, pE375, DOI 10.5301/JBM.2012.9347; Savela S, 2012, EXP GERONTOL; Shalev I, 2012, MOL PSYCHIAT; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Strandberg TE, 2011, J AM GERIATR SOC, V59, P1979, DOI 10.1111/j.1532-5415.2011.03610_13.x; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Von Zerssen D., 1976, BESCHWERDENLISTE MAN; Wikgren M, 2012, BIOL PSYCHIAT, V71, P294, DOI 10.1016/j.biopsych.2011.09.015; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Xie H, 2013, CANCER; Yehuda R, 2010, PSYCHOPHARMACOLOGY, V212, P405, DOI 10.1007/s00213-010-1969-6	60	53	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e64762	10.1371/journal.pone.0064762	http://dx.doi.org/10.1371/journal.pone.0064762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843935	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000039
J	Petrov, Y; Sridhar, S				Petrov, Yury; Sridhar, Srinivas			Electric Field Encephalography as a Tool for Functional Brain Research: A Modeling Study	PLOS ONE			English	Article							EEG; CONDUCTIVITY; MEG; TISSUE; HEAD; LOCALIZATION; LAPLACIANS; SIMULATION; ANISOTROPY; EEG/MEG	We introduce the notion of Electric Field Encephalography (EFEG) based on measuring electric fields of the brain and demonstrate, using computer modeling, that given the appropriate electric field sensors this technique may have significant advantages over the current EEG technique. Unlike EEG, EFEG can be used to measure brain activity in a contactless and reference-free manner at significant distances from the head surface. Principal component analysis using simulated cortical sources demonstrated that electric field sensors positioned 3 cm away from the scalp and characterized by the same signal-to-noise ratio as EEG sensors provided the same number of uncorrelated signals as scalp EEG. When positioned on the scalp, EFEG sensors provided 2-3 times more uncorrelated signals. This significant increase in the number of uncorrelated signals can be used for more accurate assessment of brain states for non-invasive brain-computer interfaces and neurofeedback applications. It also may lead to major improvements in source localization precision. Source localization simulations for the spherical and Boundary Element Method (BEM) head models demonstrated that the localization errors are reduced two-fold when using electric fields instead of electric potentials. We have identified several techniques that could be adapted for the measurement of the electric field vector required for EFEG and anticipate that this study will stimulate new experimental approaches to utilize this new tool for functional brain research.	[Petrov, Yury; Sridhar, Srinivas] Northeastern Univ, Boston, MA 02115 USA	Northeastern University	Petrov, Y (corresponding author), Northeastern Univ, Boston, MA 02115 USA.	y.petrov@neu.edu			National Science Foundation (NSF) [NSF-IIP-1264216, NSF-DGE-0965843]; Northeastern University; Div Of Industrial Innovation & Partnersh [1264216] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Northeastern University; Div Of Industrial Innovation & Partnersh(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation (NSF) grants NSF-IIP-1264216 and NSF-DGE-0965843. Internal funding by the Northeastern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 2010, BRAIN TOPOGR, V23, P227, DOI 10.1007/s10548-010-0154-x; Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dannhauer M, 2011, HUM BRAIN MAPP, V32, P1383, DOI 10.1002/hbm.21114; Gibson R. S., 2009, THESIS B YOUNG U; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Gutierrez-Martinez C, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/3/035207; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Haueisen J, 2002, NEUROIMAGE, V15, P159, DOI 10.1006/nimg.2001.0962; Hoekema R, 2003, BRAIN TOPOGR, V16, P29, DOI 10.1023/A:1025606415858; Komssi S, 2004, CLIN NEUROPHYSIOL, V115, P534, DOI 10.1016/j.clinph.2003.10.034; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Malmivuo J, 2012, BRAIN TOPOGR, V25, P1, DOI 10.1007/s10548-011-0202-1; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Petrov Y, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOUR-NAL.PONE.0044439; Petrov Y, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011917; Ramon Ceon, 2006, Biomed Eng Online, V5, P55, DOI 10.1186/1475-925X-5-55; Runde D, 2007, APPL PHYS B-LASERS O, V86, P91, DOI 10.1007/s00340-006-2423-7; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; YAMASHITA Y, 1982, IEEE T BIO-MED ENG, V29, P719, DOI 10.1109/TBME.1982.325002	25	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67692	10.1371/journal.pone.0067692	http://dx.doi.org/10.1371/journal.pone.0067692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844066	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000093
J	Woolfall, K; Shilling, V; Hickey, H; Smyth, RL; Sowden, E; Williamson, PR; Young, B				Woolfall, Kerry; Shilling, Valerie; Hickey, Helen; Smyth, Rosalind L.; Sowden, Emma; Williamson, Paula R.; Young, Bridget			Parents' Agendas in Paediatric Clinical Trial Recruitment Are Different from Researchers' and Often Remain Unvoiced: A Qualitative Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; INFORMED-CONSENT; HEALTH LITERACY; PHYSICIAN GENDER; CANCER; PATIENT; PARTICIPATION; INFORMATION; CARE; COMMUNICATION	Ensuring parents make an informed decision about their child's participation in a clinical trial is a challenge for practitioners as a parent's comprehension of a trial may differ from that intended by the practitioners responsible for recruitment. We explored what issues parents consider important when making a decision about participation in a paediatric clinical trial and their comprehension of these issues to inform future recruitment practice. This qualitative interview and observational study examined recruitment in four placebo-controlled, double-blind randomised clinical trials of medicines for children. Audio-recorded trial recruitment discussions between practitioners and parents (N = 41) were matched with semi-structured interviews with parents (N = 41). When making a decision about trial entry parents considered clinical benefit, child safety, practicalities of participation, research for the common good, access to medication and randomisation. Within these prioritised issues parents had specific misunderstandings, which had the potential to influence their decisions. While parents had many questions and concerns about trial participation which influenced their decision-making, they rarely voiced these during discussions about the trials with practitioners. Those involved in the recruitment of children to clinical trials need to be aware of parents' priorities and the sorts of misunderstandings that can arise with parents. Providing trial information that is tailored to what parents consider important in making a decision about a clinical trial may improve recruitment practice and ultimately benefit evidence-based paediatric medicine.	[Woolfall, Kerry; Sowden, Emma; Young, Bridget] Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England; [Shilling, Valerie] Exeter Med Sch, Child Hlth Grp, Exeter, Devon, England; [Hickey, Helen] Alder Hey Childrens Natl Hlth Serv NHS Fdn Trust, Med Children Res Network Clin Trials Unit, Liverpool, Merseyside, England; [Smyth, Rosalind L.] UCL, Inst Child Hlth, London, England; [Williamson, Paula R.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of London; University College London; University of Liverpool	Woolfall, K (corresponding author), Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England.	K.Woolfall@liverpool.ac.uk	Williamson, Paula R/B-6425-2016; Young, Bridget/A-2184-2014	Williamson, Paula R/0000-0001-9802-6636; Sowden, Emma/0000-0002-3538-8725; Young, Bridget/0000-0001-6041-9901; Woolfall, Kerry/0000-0002-5726-5304	Health Technology Agency; Wellcome Trust; MRC [G0800792] Funding Source: UKRI; Medical Research Council [G0800792] Funding Source: researchfish; National Institute for Health Research [05/516/08] Funding Source: researchfish	Health Technology Agency; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	RECRUIT was funded by the Health Technology Agency. Wellcome Trust supported this paper, as the lead author (KW) is a Wellcome Trust grantee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmark P, 2006, J MED ETHICS, V32, P439, DOI 10.1136/jme.2005.013722; [Anonymous], 1999, EVID-BASED MENT HEAL, DOI DOI 10.1136/EBMH.2.4.99; Austin J, 2006, CHRONIC ILLNESS, V2; Baker S.E., 2012, NATL CTR RES METHODS; Bergenmar M, 2008, EUR J CANCER, V44, P2627, DOI 10.1016/j.ejca.2008.08.013; Bertakis KD, 2012, J WOMENS HEALTH, V21, P326, DOI 10.1089/jwh.2011.2903; Brody JL, 2012, J HEALTH PSYCHOL, V17, P724, DOI 10.1177/1359105311425273; Brown RF, 2004, SOC SCI MED, V58, P2445, DOI 10.1016/j.socscimed.2003.09.007; Brown RF, 2011, SUPPORT CARE CANCER, V19, P1227, DOI 10.1007/s00520-010-0942-6; Caldwell PHY, 2012, PEDIATRICS, V129, pS118, DOI 10.1542/peds.2012-0055D; Caldwell PH, 2010, 4 STAR CHILD HLTH, V4; Caldwell PHY, 2002, J PEDIATR-US, V141, P798, DOI 10.1067/mpd.2002.129173; Campbell M K, 2007, Health Technol Assess, V11, pix; Chapple A, 1998, FAM PRACT, V15, P556, DOI 10.1093/fampra/15.6.556; Chappuy H, 2006, ARCH DIS CHILD, V91, P112, DOI 10.1136/adc.2005.076141; Chappuy H, 2010, ARCH DIS CHILD, V95, P800, DOI 10.1136/adc.2009.180695; Chinn D, 2011, SOC SCI MED, V73, P60, DOI 10.1016/j.socscimed.2011.04.004; Davis TC, 2002, CA-CANCER J CLIN, V52, P134, DOI 10.3322/canjclin.52.3.134; Denzen EM, 2012, BIOL BLOOD MARROW TR, V18, P183, DOI 10.1016/j.bbmt.2011.07.022; Dixon-Woods M, 2007, SOC SCI MED, V65, P2212, DOI 10.1016/j.socscimed.2007.08.010; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Entwistle VA, 2010, J GEN INTERN MED, V25, P741, DOI 10.1007/s11606-010-1292-2; Fisher HR, 2011, J MED ETHICS, V37, P544, DOI 10.1136/jme.2010.040220; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Gillies K, 2012, J MED ETHICS, V38, P751, DOI 10.1136/medethics-2011-100059; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Groger L, 1999, QUAL HEALTH RES, V9, P829, DOI 10.1177/104973299129122180; Heritage J, 2007, J GEN INTERN MED, V22, P1429, DOI 10.1007/s11606-007-0279-0; Hietanen P, 2000, EUR J CANCER, V36, P2096, DOI 10.1016/S0959-8049(00)00191-X; Howard L, 2009, CONTEMP CLIN TRIALS, V30, P40, DOI 10.1016/j.cct.2008.07.007; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Klassen TP, 2009, LANCET, V374, P1310, DOI 10.1016/S0140-6736(09)61803-1; Masty J, 2008, ETHICS BEHAV, V18, P139, DOI 10.1080/10508420802063897; Matsui D, 2003, CAN MED ASSOC J, V169, P1033; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McCully S, 2011, GCP CONSIDERATIONS I; Meropol NJ, 2003, J CLIN ONCOL, V21, P2589, DOI 10.1200/JCO.2003.10.072; Miller CK, 1996, PHARMACOTHERAPY, V16, P872; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; Nelson RM, 2011, AM J BIOETHICS, V11, P6, DOI 10.1080/15265161.2011.583318; ONS, 2001, OFF NAT STAT 2001 CE; Onwuegbuzie A. J., 2003, HDB MIXED METHODS SO, P351, DOI DOI 10.1080/13645570305055; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; Sandelowski M, 2001, RES NURS HEALTH, V24, P230, DOI 10.1002/nur.1025; Shilling V, 2011, PROCESSES RECRUITMEN, P15; Shilling V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021604; Smyth RL, 2007, ARCH DIS CHILD, V92, P835, DOI 10.1136/adc.2006.113357; Soto C, 2012, ARCH DIS CHILD, V97, P632, DOI 10.1136/archdischild-2011-301165; Strauss A., 1998, BASICS QUALITATIVE R; Street RL, 2005, MED CARE, V43, P960, DOI 10.1097/01.mlr.0000178172.40344.70; Taylor B, 1999, J ADV NURS, V29, P570, DOI 10.1046/j.1365-2648.1999.00924.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Stuijvenberg M, 1998, ARCH DIS CHILD, V79, P120, DOI 10.1136/adc.79.2.120; Wade J, 2009, SOC SCI MED, V68, P2018, DOI 10.1016/j.socscimed.2009.02.023; Williams MV, 2002, FAM MED, V34, P383; Ziebland S, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-4	56	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67352	10.1371/journal.pone.0067352	http://dx.doi.org/10.1371/journal.pone.0067352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23844006	Green Accepted, Green Published, gold			2022-12-27	WOS:000321733000070
J	Yamane, K; Kimura, F; Unoda, K; Hosokawa, T; Hirose, T; Tani, H; Doi, Y; Ishida, S; Nakajima, H; Hanafusa, T				Yamane, Kazushi; Kimura, Fumiharu; Unoda, Kiichi; Hosokawa, Takafumi; Hirose, Takahiko; Tani, Hiroki; Doi, Yoshimitsu; Ishida, Simon; Nakajima, Hideto; Hanafusa, Toshiaki			Postural Abnormality as a Risk Marker for Leg Deep Venous Thrombosis in Parkinson's Disease	PLOS ONE			English	Article							ECONOMY CLASS SYNDROME; PULMONARY-EMBOLISM; THROMBOEMBOLISM; DIAGNOSIS; EPIDEMIOLOGY; STROKE	Background: Pulmonary thromboembolism is a common cause of death in patients with autopsy-confirmed Parkinsonism. This study investigated the incidence of leg deep vein thrombosis in Parkinson's disease and relationships between deep vein thrombosis and clinical/laboratory findings, including postural abnormalities as assessed by photographic measurements. Methods: This cross-sectional study assessed the presence of deep vein thrombosis using bilateral leg Doppler ultrasonography in 114 asymptomatic outpatients with Parkinson's disease. Results: Deep vein thrombosis was detected in 23 patients (20%) with Parkinson's disease. Deep vein thrombosis was located in the distal portion in 18 patients and in the proximal portion in 5 patients. No significant differences in age, sex, body mass index, disease duration, Hoehn-Yahr stage, anti-Parkinson's drugs, or daily levodopa-equivalent dose were seen between deep vein thrombosis-positive and -negative groups. Univariate analysis for developing deep vein thrombosis in patients with Parkinson's disease identified the following markers: long-term wheelchair use, bent knee, bent spine, and D-dimer elevation. Bending angles were significantly greater in the deep vein thrombosis-positive group at the knee and spine than in the deep vein thrombosis-negative group. Half of Parkinson's disease patients with camptocormia had deep vein thrombosis. Among diabetes mellitus cases, long-term wheelchair use, bent knee over 15 degrees, camptocormia, D-dimer elevation, the more risk markers were associated with a higher incidence of DVT. The presence of risk markers contributed to the development of deep vein thrombosis. On multivariate logistic regression analysis, a bent knee posture was strongly associated with an increased risk of deep vein thrombosis. Conclusion: Presence of leg deep vein thrombosis correlated with postural abnormalities in Parkinson's disease. We recommend non-invasive ultrasonographic screening for leg deep vein thrombosis in these high-risk patients with Parkinson's disease.	[Yamane, Kazushi; Kimura, Fumiharu; Unoda, Kiichi; Hosokawa, Takafumi; Hirose, Takahiko; Tani, Hiroki; Doi, Yoshimitsu; Ishida, Simon; Nakajima, Hideto; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Div Neurol, Takatsuki, Osaka 569, Japan	Osaka Medical College	Kimura, F (corresponding author), Osaka Med Coll, Dept Internal Med 1, Div Neurol, Takatsuki, Osaka 569, Japan.	in1110@poh.osaka-med.ac.jp		Nakajima, Hideto/0000-0002-2154-9196	Japanese Ministry of Education, Science and Culture [19590705]	Japanese Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research (C) (19590705) from the Japanese Ministry of Education, Science and Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini A, 2009, LANCET NEUROL, V8, P929, DOI 10.1016/S1474-4422(09)70225-X; Biglan KM, 2007, NEUROLOGY, V69, P187, DOI 10.1212/01.wnl.0000265593.34438.00; Bounameaux H, 2010, VASC MED, V15, P399, DOI 10.1177/1358863X10378788; Burbridge BE, 1999, J PSYCHIATR NEUROSCI, V24, P338; CRUICKSHANK JM, 1988, LANCET, V2, P497, DOI 10.1016/S0140-6736(88)90134-1; Djaldetti R, 2004, MOVEMENT DISORD, V19, P1325, DOI 10.1002/mds.20187; Doherty KM, 2011, LANCET NEUROL, V10, P538, DOI 10.1016/S1474-4422(11)70067-9; Gaber TAZK, 2007, DISABIL REHABIL, V29, P1544, DOI 10.1080/09638280601055618; Gaber TAZK, 2002, CLIN REHABIL, V16, P190, DOI 10.1191/0269215502cr475oa; GERKIN TM, 1993, J VASC SURG, V18, P760, DOI 10.1016/0741-5214(93)90329-K; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; Kelly J, 2001, STROKE, V32, P262, DOI 10.1161/01.STR.32.1.262; Kelly J, 2010, THROMB RES, V125, P315, DOI [10.1016/j.thromres.2009.06.023, DOI 10.1016/J.THR0MRES.2009.06.023.PUBMED:19640570]; Kesieme E, 2011, J BLOOD MED, V2, P59, DOI 10.2147/JBM.S19009; Kimura F, 2006, NEUROMUSCULAR DISORD, V16, P204, DOI 10.1016/j.nmd.2005.12.006; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MOSEWICH RK, 1994, MOVEMENT DISORD, V9, P350, DOI 10.1002/mds.870090316; Newman EJ, 2009, NEUROCRIT CARE, V10, P136, DOI 10.1007/s12028-008-9125-4; OCZKOWSKI WJ, 1992, ARCH PHYS MED REHAB, V73, P712; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Petrauskiene V, 2005, DIABETOLOGIA, V48, P1017, DOI 10.1007/s00125-005-1715-5; Pforte A, 2004, EUR J MED RES, V9, P171; Righini M, 2006, THROMB HAEMOSTASIS, V95, P56, DOI 10.1160/TH05-08-0588; Samama M M, 2005, Semin Vasc Med, V5, P371, DOI 10.1055/s-2005-922482; Samuel ZG, 1999, LANCET, V353, P1375, DOI [10.1016/S0140-6736(99)90053-3, DOI 10.1016/S0140-6736(99)90053-3.PUBMED:10227212]; Schellong SM, 2007, J THROMB HAEMOST, V5, P51, DOI 10.1111/j.1538-7836.2007.02490.x; Stein PD, 2010, AM J MED, V123, P426, DOI 10.1016/j.amjmed.2009.09.037; Subramaniam RM, 2006, AM J ROENTGENOL, V186, P206, DOI 10.2214/AJR.04.1398; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429	30	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66984	10.1371/journal.pone.0066984	http://dx.doi.org/10.1371/journal.pone.0066984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843975	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000024
J	Arico, M; Boggio, E; Cetica, V; Melensi, M; Orilieri, E; Clemente, N; Cappellano, G; Buttini, S; Soluri, MF; Comi, C; Dufour, C; Pende, D; Dianzani, I; Ellis, SR; Pagliano, S; Marcenaro, S; Ramenghi, U; Chiocchetti, A; Dianzani, U				Arico, Maurizio; Boggio, Elena; Cetica, Valentina; Melensi, Matteo; Orilieri, Elisabetta; Clemente, Nausicaa; Cappellano, Giuseppe; Buttini, Sara; Soluri, Maria Felicia; Comi, Cristoforo; Dufour, Carlo; Pende, Daniela; Dianzani, Irma; Ellis, Steven R.; Pagliano, Sara; Marcenaro, Stefania; Ramenghi, Ugo; Chiocchetti, Annalisa; Dianzani, Umberto			Variations of the UNC13D Gene in Patients with Autoimmune Lymphoproliferative Syndrome	PLOS ONE			English	Article							MACROPHAGE ACTIVATION SYNDROME; TYPE-1 DIABETES-MELLITUS; FAS APOPTOSIS PATHWAY; PERFORIN GENE; DEFECTIVE FAS; CELL APOPTOSIS; RISK-FACTOR; MUTATIONS; MUNC13-4; AUTOIMMUNITY/LYMPHOPROLIFERATION	Autoimmune lymphoproliferative syndrome (ALPS) is caused by genetic defects decreasing Fas function and is characterized by lymphadenopathy/splenomegaly and expansion of CD4/CD8 double-negative T cells. This latter expansion is absent in the ALPS variant named Dianzani Autoimmune/lymphoproliferative Disease (DALD). In addition to the causative mutations, the genetic background influences ALPS and DALD development. We previously suggested a disease-modifying role for the perforin gene involved in familial hemophagocytic lymphohistiocytosis (FHL). The UNC13D gene codes for Munc13-4, which is involved in perforin secretion and FHL development, and thus, another candidate for a disease-modifying role in ALPS and DALD. In this work, we sequenced UNC13D in 21 ALPS and 20 DALD patients and compared these results with sequences obtained from 61 healthy subjects and 38 multiple sclerosis (MS) patients. We detected four rare missense variations in three heterozygous ALPS patients carrying p.Cys112Ser, p.Val781Ile, and a haplotype comprising both p.Ile848Leu and p.Ala995Pro. Transfection of the mutant cDNAs into HMC-1 cells showed that they decreased granule exocytosis, compared to the wild-type construct. An additional rare missense variation, p.Pro271Ser, was detected in a healthy subject, but this variation did not decrease Munc13-4 function. These data suggest that rare loss-of-function variations of UND13D are risk factors for ALPS development.	[Arico, Maurizio; Cetica, Valentina] Meyer Children Hosp, Dept Pediat Hematol, Florence, Italy; [Boggio, Elena; Melensi, Matteo; Orilieri, Elisabetta; Clemente, Nausicaa; Cappellano, Giuseppe; Buttini, Sara; Soluri, Maria Felicia; Comi, Cristoforo; Dianzani, Irma; Chiocchetti, Annalisa; Dianzani, Umberto] A Avogadro Univ Eastern Piedmont, IRCAD, Novara, Italy; [Boggio, Elena; Melensi, Matteo; Orilieri, Elisabetta; Clemente, Nausicaa; Cappellano, Giuseppe; Soluri, Maria Felicia; Dianzani, Irma; Chiocchetti, Annalisa; Dianzani, Umberto] A Avogadro Univ Eastern Piedmont, Dept Hlth Sci, Novara, Italy; [Buttini, Sara; Comi, Cristoforo] A Avogadro Univ Eastern Piedmont, Dept Translat Med, Novara, Italy; [Dufour, Carlo; Marcenaro, Stefania] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Pende, Daniela] IRCCS AOU San Martino IST, Genoa, Italy; [Ellis, Steven R.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Pagliano, Sara; Ramenghi, Ugo] Univ Turin, Dept Pediat, I-10124 Turin, Italy	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS AOU San Martino IST; University of Louisville; University of Turin	Chiocchetti, A (corresponding author), A Avogadro Univ Eastern Piedmont, IRCAD, Novara, Italy.	annalisa.chiocchetti@med.unipmn.it	Comi, Cristoforo/A-7495-2014; Boggio, Elena/T-2649-2017; Dianzani, Umberto/K-1952-2016; Dufour, Carlo/AAB-1000-2021; Cetica, Valentina/J-2885-2018; Cappellano, Giuseppe/ABE-4980-2020; Pende, Daniela/J-7429-2016; Comi, Cristoforo/I-2117-2019; Arico, Maurizio/S-3039-2019	Comi, Cristoforo/0000-0002-6862-9468; Boggio, Elena/0000-0003-2700-3597; Cetica, Valentina/0000-0001-8549-4158; Pende, Daniela/0000-0003-1565-451X; Comi, Cristoforo/0000-0002-6862-9468; Arico, Maurizio/0000-0002-1908-6671; Chiocchetti, Annalisa/0000-0002-4349-1087; clemente, nausicaa/0000-0002-9860-0148; DIANZANI, Umberto/0000-0001-6723-3931; Marcenaro, Stefania/0000-0002-5232-0220; Cappellano, Giuseppe/0000-0001-5193-4688	Antonio Pinzino - Associazione per la Ricerca sulle Sindromi Emofagocitiche - ARSE (Palermo); Italian Ministry of Health Progetti di ricerca finalizzata; Bando "Malattie Rare" (Rome) [RF-TOS-2008-1219488]; Fondazione Cariplo Ricerca (Milan); Fondazione Amici di Jean (Turin); FISM (Genoa) [2011-R]; Fondazione Cassa di Risparmio di Cuneo (Cuneo); AIRC (Milan); Regione Piemonte (Piattaforme Innovative Project) (Turin); PRIN-MIUR project (Rome)	Antonio Pinzino - Associazione per la Ricerca sulle Sindromi Emofagocitiche - ARSE (Palermo); Italian Ministry of Health Progetti di ricerca finalizzata; Bando "Malattie Rare" (Rome); Fondazione Cariplo Ricerca (Milan); Fondazione Amici di Jean (Turin); FISM (Genoa); Fondazione Cassa di Risparmio di Cuneo (Cuneo); AIRC (Milan); Regione Piemonte (Piattaforme Innovative Project) (Turin); PRIN-MIUR project (Rome)(Ministry of Education, Universities and Research (MIUR))	This work was partly supported by Antonio Pinzino - Associazione per la Ricerca sulle Sindromi Emofagocitiche - ARSE (Palermo), Italian Ministry of Health Progetti di ricerca finalizzata 2008, Bando "Malattie Rare 2008" RF-TOS-2008-1219488 (Rome), Fondazione Cariplo Ricerca (Milan), Fondazione Amici di Jean (Turin), FISM 2011-R (Genoa), Fondazione Cassa di Risparmio di Cuneo (Cuneo), AIRC (Milan), Regione Piemonte (Piattaforme Innovative Project) (Turin), and PRIN-MIUR project (Rome). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico M, 2001, BRIT J HAEMATOL, V114, P761, DOI 10.1046/j.1365-2141.2001.02936.x; Barizzone N, 2011, HUM IMMUNOL, V72, P930, DOI 10.1016/j.humimm.2011.06.009; Boggio E, 2012, HUM IMMUNOL, V73, P585, DOI 10.1016/j.humimm.2012.02.025; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Campagnoli MF, 2006, HAEMATOLOGICA, V91, P538; Cappellano G, 2008, GENES IMMUN, V9, P438, DOI 10.1038/gene.2008.35; Carroll HP, 2001, CLIN EXP IMMUNOL, V126, P589, DOI 10.1046/j.1365-2249.2001.01706.x; Cetica V, 2010, HAEMATOL-HEMATOL J, V95, P538, DOI 10.3324/haematol.2009.019562; Chiocchetti A, 2005, J NEUROIMMUNOL, V163, P172, DOI 10.1016/j.jneuroim.2005.02.020; Chiocchetti A, 2004, BLOOD, V103, P1376, DOI 10.1182/blood-2003-05-1748; Chiocchetti A, 2010, INT J IMMUNOPATH PH, V23, P263, DOI 10.1177/039463201002300124; Clementi R, 2004, NEW ENGL J MED, V351, P1419, DOI 10.1056/NEJMoa041432; Clementi R, 2006, BLOOD, V108, P3079, DOI 10.1182/blood-2006-02-001412; Comi C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/212893; De Franco S, 2007, INT J IMMUNOPATH PH, V20, P567, DOI 10.1177/039463200702000314; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Dianzani U, 2003, LIFE SCI, V72, P2803, DOI 10.1016/S0024-3205(03)00196-6; Dianzani U, 1997, BLOOD, V89, P2871, DOI 10.1182/blood.V89.8.2871; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Hazen MM, 2008, ARTHRITIS RHEUM, V58, P567, DOI 10.1002/art.23199; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lenardo Michael J, 2010, Immunity, V32, P291, DOI 10.1016/j.immuni.2010.03.013; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Lunemann A, 2009, MOL MED, V15, P352, DOI 10.2119/molmed.2009.00035; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Oliveira JB, 2010, BLOOD, V116, pE35, DOI 10.1182/blood-2010-04-280347; Orilieri E, 2008, DIABETES, V57, P1078, DOI 10.2337/db07-0947; Pivot-Pajot C, 2008, J IMMUNOL, V180, P6786, DOI 10.4049/jimmunol.180.10.6786; Ramenghi U, 2000, BLOOD, V95, P3176; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Rudd E, 2008, J MED GENET, V45, P134, DOI 10.1136/jmg.2007.054288; Santoro A, 2006, J MED GENET, V43, P953, DOI 10.1136/jmg.2006.041863; Sieni E, 2011, J MED GENET, V48, P343, DOI 10.1136/jmg.2010.085456; Solomou EE, 2007, BLOOD, V109, P5234, DOI 10.1182/blood-2006-12-063495; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Vastert SJ, 2010, RHEUMATOLOGY, V49, P441, DOI 10.1093/rheumatology/kep418; Villanueva J, 2005, ARTHRITIS RES THER, V7, pR30, DOI 10.1186/ar1453; Voskoboinik I, 2010, IMMUNOL REV, V235, P35, DOI 10.1111/j.0105-2896.2010.00896.x; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; Zhang K, 2008, ARTHRITIS RHEUM, V58, P2892, DOI 10.1002/art.23734	47	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68045	10.1371/journal.pone.0068045	http://dx.doi.org/10.1371/journal.pone.0068045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840885	Green Submitted, Green Published, gold			2022-12-27	WOS:000321271900024
J	Anderson, OA; Finkelstein, A; Shima, DT				Anderson, Owen A.; Finkelstein, Arthur; Shima, David T.			A2E Induces IL-1 beta Production in Retinal Pigment Epithelial Cells via the NLRP3 Inflammasome	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; LIPOFUSCIN FLUOROPHORE; NALP3 INFLAMMASOME; BRUCHS MEMBRANE; HUMAN RPE; CHOROIDAL NEOVASCULARIZATION; PHOTOOXIDATION PRODUCTS; COMPLEMENT ACTIVATION; ALZHEIMERS-DISEASE	Aims: With ageing extracellular material is deposited in Bruch's membrane, as drusen. Lipofuscin is deposited in retinal pigment epithelial cells. Both of these changes are associated with age related macular degeneration, a disease now believed to involve chronic inflammation at the retinal-choroidal interface. We hypothesise that these molecules may act as danger signals, causing the production of inflammatory chemokines and cytokines by the retinal pigment epithelium, via activation of pattern recognition receptors. Methods: ARPE-19 cells were stimulated in vitro with the following reported components of drusen: amyloid-beta (1-42), Carboxyethylpyrrole (CEP) modified proteins (CEP-HSA), N epsilon-(Carboxymethyl)lysine (CML) modified proteins and aggregated vitronectin. The cells were also stimulated with the major fluorophore of lipofuscin: N-retinylidene-N-retinylethanolamine (A2E). Inflammatory chemokine and cytokine production was assessed using Multiplex assays and ELISA. The mechanistic evaluation of the NLRP3 inflammasome pathway was assessed in a stepwise fashion. Results: Of all the molecules tested only A2E induced inflammatory chemokine and cytokine production. 25 mu M A2E induced the production of significantly increased levels of the chemokines IL-8, MCP-1, MCG and MIP-1 alpha, the cytokines IL-1 beta, IL-2, IL-6, and TNF-alpha, and the protein VEGF-A. The release of IL-1 beta was studied further, and was determined to be due to NLRP3 inflammasome activation. The pathway of activation involved endocytosis of A2E, and the three inflammasome components NLRP3, ASC and activated caspase-1. Immunohistochemical staining of ABCA4 knockout mice, which show progressive accumulation of A2E levels with age, showed increased amounts of IL-1 beta proximal to the retinal pigment epithelium. Conclusions: A2E has the ability to stimulate inflammatory chemokine and cytokine production by RPE cells. The pattern recognition receptor NLRP3 is involved in this process. This provides further evidence for the link between A2E, inflammation, and the pathogenesis of AMD. It also supports the recent discovery of NLRP3 inflammasome activation in AMD.	[Anderson, Owen A.; Finkelstein, Arthur; Shima, David T.] UCL Inst Ophthalmol Ocular Biol & Therapeut, London, England	University of London; University College London	Shima, DT (corresponding author), UCL Inst Ophthalmol Ocular Biol & Therapeut, London, England.	d.shima@ucl.ac.uk			Department of Health; UCL Institute of Ophthalmology for a Biomedical Research Centre for Ophthalmology; MRC [G0800946] Funding Source: UKRI; Medical Research Council [G0800946] Funding Source: researchfish	Department of Health; UCL Institute of Ophthalmology for a Biomedical Research Centre for Ophthalmology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge (a proportion of their) financial support from the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health (http://www.nihr.ac.uk/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Bian ZM, 2004, INVEST OPHTH VIS SCI, V45, P1887, DOI 10.1167/iovs.03-0608; Bruban J, 2009, AGING CELL, V8, P162, DOI 10.1111/j.1474-9726.2009.00456.x; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; DASTGHEIB K, 1994, ARCH OPHTHALMOL-CHIC, V112, P813, DOI 10.1001/archopht.1994.01090180111045; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Eldred GE, 1995, GERONTOLOGY, V41, P15; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Green W R, 1999, Mol Vis, V5, P27; Grossniklaus HE, 2002, MOL VIS, V8, P119; Gutierrez DB, 2010, PHOTOCH PHOTOBIO SCI, V9, P1513, DOI 10.1039/c0pp00230e; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hollyfield JG, 2010, MOL NEUROBIOL, V41, P290, DOI 10.1007/s12035-010-8110-z; Holtkamp GM, 1998, CLIN EXP IMMUNOL, V112, P34; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Iriyama A, 2008, J BIOL CHEM, V283, P11947, DOI 10.1074/jbc.M708989200; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; Kaarniranta K, 2009, J MOL MED, V87, P117, DOI 10.1007/s00109-008-0418-z; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Klein ML, 2008, OPHTHALMOLOGY, V115, P1019, DOI 10.1016/j.ophtha.2008.01.036; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kobayashi S, 2007, BIOL PHARM BULL, V30, P133, DOI 10.1248/bpb.30.133; Kramer M, 2012, CLIN EXP OPHTHALMOL, V40, P617, DOI 10.1111/j.1442-9071.2011.02747.x; LOPEZ PF, 1993, OPHTHALMOLOGY, V100, P415; Lu L, 2009, BIOORGAN MED CHEM, V17, P7548, DOI 10.1016/j.bmc.2009.09.009; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao H, 2012, MOL VIS, V18, P574; Ni JQ, 2009, MOL CELL PROTEOMICS, V8, P1921, DOI 10.1074/mcp.M900127-MCP200; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Okubo A, 1999, INVEST OPHTH VIS SCI, V40, P443; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Penfold PL, 2001, CLIN EXP OPHTHALMOL, V29, P188, DOI 10.1046/j.1442-9071.2001.00407.x; PLANCK SR, 1992, INVEST OPHTH VIS SCI, V33, P78; PLANCK SR, 1993, CURR EYE RES, V12, P205, DOI 10.3109/02713689308999465; Ragauskaite L, 2001, PHOTOCHEM PHOTOBIOL, V74, P483, DOI 10.1562/0031-8655(2001)074<0483:EEOTPO>2.0.CO;2; Rahmani B, 1996, OPHTHALMOLOGY, V103, P1721, DOI 10.1016/S0161-6420(96)30435-1; Reszka K, 1995, PHOTOCHEM PHOTOBIOL, V62, P1005; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; SWANSON J, 1989, METHOD CELL BIOL, V29, P137; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Wasmuth S, 2009, INVEST OPHTH VIS SCI, V50, P5304, DOI 10.1167/iovs.08-3326; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou J, 2009, INVEST OPHTH VIS SCI, V50, P1392, DOI 10.1167/iovs.08-2868	68	110	111	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67263	10.1371/journal.pone.0067263	http://dx.doi.org/10.1371/journal.pone.0067263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840644	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400050
J	Cederberg, H; Gylling, H; Miettinen, TA; Paananen, J; Vangipurapu, J; Pihlajamaki, J; Kuulasmaa, T; Stancakova, A; Smith, U; Kuusisto, J; Laakso, M				Cederberg, Henna; Gylling, Helena; Miettinen, Tatu A.; Paananen, Jussi; Vangipurapu, Jagadish; Pihlajamaki, Jussi; Kuulasmaa, Teemu; Stancakova, Alena; Smith, Ulf; Kuusisto, Johanna; Laakso, Markku			Non-Cholesterol Sterol Levels Predict Hyperglycemia and Conversion to Type 2 Diabetes in Finnish Men	PLOS ONE			English	Article							INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; ABSORPTION; METABOLISM; ASSOCIATION; ABCG5; SECRETION; RELEASE	We investigated the levels of non-cholesterol sterols as predictors for the development of hyperglycemia (an increase in the glucose area under the curve in an oral glucose tolerance test) and incident type 2 diabetes in a 5-year follow-up study of a population-based cohort of Finnish men (METSIM Study, N = 1,050) having non-cholesterol sterols measured at baseline. Additionally we determined the association of 538,265 single nucleotide polymorphisms (SNP) with non-cholesterol sterol levels in a cross-sectional cohort of non-diabetic offspring of type 2 diabetes (the Kuopio cohort of the EUGENE2 Study, N = 273). We found that in a cross-sectional METSIM Study the levels of sterols indicating cholesterol absorption were reduced as a function of increasing fasting glucose levels, whereas the levels of sterols indicating cholesterol synthesis were increased as a function of increasing 2-hour glucose levels. A cholesterol synthesis marker desmosterol significantly predicted an increase, and two absorption markers (campesterol and avenasterol) a decrease in the risk of hyperglycemia and incident type 2 diabetes in a 5-year follow-up of the METSIM cohort, mainly attributable to insulin sensitivity. A SNP of ABCG8 was associated with fasting plasma glucose levels in a cross-sectional study but did not predict hyperglycemia or incident type 2 diabetes. In conclusion, the levels of some, but not all non-cholesterol sterols are markers of the worsening of hyperglycemia and type 2 diabetes.	[Cederberg, Henna; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Cederberg, Henna; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Gylling, Helena; Pihlajamaki, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Gylling, Helena; Miettinen, Tatu A.] Univ Helsinki, Dept Med, Div Internal Med, Helsinki, Finland; [Paananen, Jussi; Vangipurapu, Jagadish; Kuulasmaa, Teemu; Stancakova, Alena] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Helsinki; University of Eastern Finland; University of Gothenburg	Laakso, M (corresponding author), Univ Eastern Finland, Dept Med, Kuopio, Finland.	markku.laakso@kuh.fi	Stancakova, Alena/AAN-6723-2020	Stancakova, Alena/0000-0002-1375-0252; Cederberg, Henna/0000-0003-2901-9373; Pihlajamaki, Jussi/0000-0002-6241-6859; Paananen, Jussi/0000-0001-5100-4907	Academy of Finland; Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; University of Eastern Finland, Kuopio, Finland; EVO grant from the Kuopio University Hospital [5263]	Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; University of Eastern Finland, Kuopio, Finland; EVO grant from the Kuopio University Hospital	This work has been supported by the Academy of Finland (M.L.), the Finnish Diabetes Research Foundation (M.L.), the Finnish Cardiovascular Research Foundation (M.L.), the Strategic Research Funding from the University of Eastern Finland, Kuopio, Finland (M.L.), and EVO grant 5263 from the Kuopio University Hospital (M.L.). The funding bodies named above had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE401, DOI 10.1152/ajpendo.00674.2007; Adiels M, 2006, CURR OPIN LIPIDOL, V17, P238, DOI 10.1097/01.mol.0000226115.97436.c0; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Berge KE, 2002, J LIPID RES, V43, P486; BRIONES ER, 1986, AM J CLIN NUTR, V44, P353, DOI 10.1093/ajcn/44.3.353; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Genuth S, 2003, DIABETES CARE, V26, P3160; Gylling H, 2004, J LIPID RES, V45, P1660, DOI 10.1194/jlr.M300522-JLR200; Gylling H, 2010, J LIPID RES, V51, P2422, DOI 10.1194/jlr.P006619; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Laakso M, 2012, J INTERN MED, V272, P1, DOI 10.1111/j.1365-2796.2012.02528.x; Lu YC, 2010, ATHEROSCLEROSIS, V213, P200, DOI 10.1016/j.atherosclerosis.2010.08.053; Matthan NR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005066; MIETTINEN TA, 1988, J LIPID RES, V29, P43; Miettinen TA, 2000, ATHEROSCLEROSIS, V153, P241, DOI 10.1016/S0021-9150(00)00404-4; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pihlajamaki J, 2004, J LIPID RES, V45, P507, DOI 10.1194/jlr.M300368-JLR200; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Simonen P, 2008, ATHEROSCLEROSIS, V197, P883, DOI 10.1016/j.atherosclerosis.2007.08.003; Simonen PP, 2002, DIABETES CARE, V25, P1511, DOI 10.2337/diacare.25.9.1511; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Strandberg TE, 1996, DIABETES, V45, P755, DOI 10.2337/diabetes.45.6.755; SUTHERLAND WH, 1992, HORM METAB RES, V24, P172, DOI 10.1055/s-2007-1003287; Teupser D, 2010, CIRC-CARDIOVASC GENE, V3, P331, DOI 10.1161/CIRCGENETICS.109.907873; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	26	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67406	10.1371/journal.pone.0067406	http://dx.doi.org/10.1371/journal.pone.0067406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840693	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400076
J	Kaur, J; Sawhney, M; DattaGupta, S; Shukla, NK; Srivastava, A; Walfish, PG; Ralhan, R				Kaur, Jatinder; Sawhney, Meenakshi; DattaGupta, Siddhartha; Shukla, Nootan Kumar; Srivastava, Anurag; Walfish, Paul G.; Ralhan, Ranju			Clinical Significance of Altered Expression of beta-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; ADHESION MOLECULE; ABERRANT EXPRESSION; ADHERENS JUNCTIONS; SMOKELESS TOBACCO; CLINICOPATHOLOGICAL FEATURES; TUMOR PROGRESSION; NECK-CANCER	Background: Perturbations in cell adhesion molecules are linked to alterations in cadherin-catenin complexes and likely play major roles in invasion and metastasis; their impact on early precancerous stages remains yet unknown. We showed ALCAM overexpression in early oral lesions and its cytoplasmic accumulation in oral squamous cell carcinoma (OSCC) to be a predictor of disease progression and poor prognosis. This study tested the hypothesis that alterations in E-cadherin and b -catenin expressions are early events in oral tumorigenesis, associated with disease prognosis, and correlate with perturbations in ALCAM expression. Methods: Expressions of E-cadherin and beta-catenin were analyzed in the same cohort of 105 OSCCs, 76 oral lesions and 30 normal oral tissues by immunohistochemistry and correlated with clinicopathological parameters and prognosis. The effect of siRNA mediated ALCAM knockdown on E-cadherin and beta-catenin was determined using western blot, confocal microscopy and RT-PCR analysis in oral cancer cells. Results: Significant loss of membranous E-cadherin and beta-catenin expression was observed from normal, hyperplasia, dysplasia to OSCCs (p(trend) < 0.001); and correlated with cytoplasmic ALCAM accumulation in OSCCs (p = 0.006). Multivariate analysis revealed beta-catenin membrane loss and ALCAM/beta-catenin(nuclear/cytoplasmic) accumulation to be significant predictors for late clinical stage (p, 0.001, OR = 8.7; p = 0.006, OR = 9.9, respectively) and nodal metastasis (p = 0.003, OR = 3.8; p = 0.025, OR = 3.4 respectively). Cox's regression showed E-cadherin membrane loss/ALCAM cytoplasmic expression [p < 0.001; HR = 4.8] to be independent adverse prognosticators in OSCCs. siRNA mediated silencing of ALCAM resulted in concurrent increase in E-cadherin and beta-catenin both at the transcript and protein levels. Conclusions: Losses of E-cadherin and beta-catenin expressions are early events in oral tumorigenesis; their associations with aggressive tumor behavior and disease recurrence underscore their potential as prognostic markers. Correlation of loss of E-cadherin and beta-catenin with cytoplasmic ALCAM accumulation both in vitro and in in vivo suggests that these dynamic changes in cell adhesion system may play pivotal role in oral cancer.	[Kaur, Jatinder; Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Sawhney, Meenakshi] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [DattaGupta, Siddhartha] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Shukla, Nootan Kumar] All India Inst Med Sci, Inst Rotary Canc Hosp, Dept Surg Oncol, New Delhi, India; [Srivastava, Anurag] All India Inst Med Sci, Dept Surg Disciplines, New Delhi, India; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; DR. B.R.A. Institute Rotary Cancer Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Ralhan, R (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	rralhan@mtsinai.on.ca		Kaur, Jatinder/0000-0003-1650-0707; Vachher, Meenakshi/0000-0003-4039-1985	Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics; George Knudson Oakdale Golf Tournament Fund Raiser; Mount Sinai Hospital Department of Medicine Research Fund	Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics(Canadian Institutes of Health Research (CIHR)); George Knudson Oakdale Golf Tournament Fund Raiser; Mount Sinai Hospital Department of Medicine Research Fund	The financial support of this work from Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Cancer, Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics, George Knudson Oakdale Golf Tournament Fund Raiser, and the Mount Sinai Hospital Department of Medicine Research Fund is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt-Holland A, 2005, SEMIN CANCER BIOL, V15, P84, DOI 10.1016/j.semcancer.2004.08.007; de Aguiar FCA, 2007, ORAL ONCOL, V43, P593, DOI 10.1016/j.oraloncology.2006.07.003; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Bankfalvi A, 2002, J ORAL PATHOL MED, V31, P450, DOI 10.1034/j.1600-0714.2002.00147.x; Bankfalvi A, 2000, J ORAL PATHOL MED, V29, P291, DOI 10.1034/j.1600-0714.2000.290701.x; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Campo-Trapero J, 2008, ANTICANCER RES, V28, P1197; Chien MH, 2012, HEAD NECK-J SCI SPEC, V34, P405, DOI 10.1002/hed.21746; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Franceschi S, 2000, ORAL ONCOL, V36, P106, DOI 10.1016/S1368-8375(99)00070-6; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; GUPTA PC, 1980, COMMUNITY DENT ORAL, V8, P287, DOI 10.1111/j.1600-0528.1980.tb01302.x; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Ihnen M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-140; Ishida K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-62; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaur J, 2003, ORAL ONCOL, V39, P806, DOI 10.1016/S1368-8375(03)00084-8; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Lim SC, 2004, CLIN CANCER RES, V10, P166, DOI 10.1158/1078-0432.CCR-0533-3; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Lo Muzio L, 2001, CRIT REV ORAL BIOL M, V12, P152, DOI 10.1177/10454411010120020501; Lunter PC, 2005, CANCER RES, V65, P8801, DOI 10.1158/0008-5472.CAN-05-0378; Lyons AJ, 2007, INT J ORAL MAX SURG, V36, P671, DOI 10.1016/j.ijom.2007.04.002; Maeda G, 2007, ODONTOLOGY, V95, P24, DOI 10.1007/s10266-007-0068-6; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Matta A, 2008, J PROTEOME RES, V7, P2078, DOI 10.1021/pr7007797; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Nijkamp MM, 2011, RADIOTHER ONCOL, V99, P344, DOI 10.1016/j.radonc.2011.05.066; Odajima T, 2005, HUM PATHOL, V36, P234, DOI 10.1016/j.humpath.2004.12.009; Ofori-Acquah SF, 2008, TRANSL RES, V151, P122, DOI 10.1016/j.trsl.2007.09.006; Piao DX, 2012, MOL BIOL REP, V39, P661, DOI 10.1007/s11033-011-0783-5; Priyadarsini RV, 2012, ORAL ONCOL, V48, P33, DOI 10.1016/j.oraloncology.2011.08.008; Rohatgi N, 2006, TOXICOLOGY, V224, P1, DOI 10.1016/j.tox.2006.03.014; Sawhney M, 2007, INT J CANCER, V120, P2545, DOI 10.1002/ijc.22657; Sawhney M, 2009, INT J CANCER, V124, P2098, DOI 10.1002/ijc.24192; Scanlon CS, 2013, J DENT RES, V92, P114, DOI 10.1177/0022034512467352; Shieh YS, 2003, J ORAL PATHOL MED, V32, P297, DOI 10.1034/j.1600-0714.2003.00144.x; Stenner M, 2011, HISTOPATHOLOGY, V58, P1117, DOI 10.1111/j.1365-2559.2011.03805.x; Tachezy M, 2012, J SURG RES, V177, pE15, DOI 10.1016/j.jss.2012.02.013; Tanaka Y, 2003, MOL BIOL CELL, V14, P1597, DOI 10.1091/mbc.E02-10-0632; Ueda G, 2006, INT J ORAL MAX SURG, V35, P356, DOI 10.1016/j.ijom.2005.07.023; Uraguchi M, 2004, J DENT RES, V83, P327, DOI 10.1177/154405910408300411; van Kilsdonk JWJ, 2012, J INVEST DERMATOL, V132, P1462, DOI 10.1038/jid.2011.487; Wai Wong C, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/340296; Wang LH, 2007, VIRCHOWS ARCH, V451, P959, DOI 10.1007/s00428-007-0485-5; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang WT, 2006, J CELL SCI, V119, P283, DOI 10.1242/jcs.02738; Zhao D, 2012, CLIN EXP METASTAS, V29, P957, DOI 10.1007/s10585-012-9485-1	54	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67361	10.1371/journal.pone.0067361	http://dx.doi.org/10.1371/journal.pone.0067361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840677	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400068
J	Roettger, Y; Zerr, I; Dodel, R; Bach, JP				Roettger, Yvonne; Zerr, Inga; Dodel, Richard; Bach, Jan-Philipp			Prion Peptide Uptake in Microglial Cells - The Effect of Naturally Occurring Autoantibodies against Prion Protein	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; MOUSE MODEL; FIBRIL FORMATION; AMYLOID-BETA; IN-VITRO; MACROPHAGE; ANTIBODIES; BRAIN; NEUROTOXICITY; PRP106-126	In prion disease, a profound microglial activation that precedes neurodegeneration has been observed in the CNS. It is still not fully elucidated whether microglial activation has beneficial effects in terms of prion clearance or whether microglial cells have a mainly detrimental function through the release of pro-inflammatory cytokines. To date, no disease-modifying therapy exists. Several immunization attempts have been performed as one therapeutic approach. Recently, naturally occurring autoantibodies against the prion protein (nAbs-PrP) have been detected. These autoantibodies are able to break down fibrils of the most commonly used mutant prion variant PrP106-126 A117V and prevent PrP106-126 A117V-induced toxicity in primary neurons. In this study, we examined the phagocytosis of the prion peptide PrP106-126 A117V by primary microglial cells and the effect of nAbs-PrP on microglia. nAbs-PrP considerably enhanced the uptake of PrP106-126 A117V without inducing an inflammatory response in microglial cells. PrP106-126 A117V uptake was at least partially mediated through scavenger receptors. Phagocytosis of PrP106-126 A117V with nAbs-PrP was inhibited by wortmannin, a potent phosphatidylinositol 3-kinase inhibitor, indicating a separate uptake mechanism for nAbs-PrP mediated phagocytosis. These data suggest the possible mechanisms of action of nAbs-PrP in prion disease.	[Roettger, Yvonne; Dodel, Richard; Bach, Jan-Philipp] Univ Marburg, Dept Neurol, Marburg, Germany; [Zerr, Inga] Univ Gottingen, Dept Neurol, Gottingen, Germany; [Zerr, Inga] Univ Gottingen, Natl Reference Ctr Surveillance Transmissible Spo, D-37073 Gottingen, Germany	Philipps University Marburg; University of Gottingen; University of Gottingen	Dodel, R (corresponding author), Univ Marburg, Dept Neurol, Marburg, Germany.	dodel@med.uni-marburg.de			Alzheimer Forschungsinitiative (AFI); University Medical Center Giessen and Marburg (UKGM); Competence Network Degenerative Dementias (German Ministery of Education and Research) [BMBF 01GI1008C]; Grifols; Baxter; Teva pharmaceuticals; University of Marburg	Alzheimer Forschungsinitiative (AFI); University Medical Center Giessen and Marburg (UKGM); Competence Network Degenerative Dementias (German Ministery of Education and Research); Grifols; Baxter; Teva pharmaceuticals(Teva Pharmaceutical Industries); University of Marburg	Dr. J.-P. Bach received research grants by the Alzheimer Forschungsinitiative (AFI), Grifols and Baxter as well as the University of Marburg. This work was supported by a research grant of the University Medical Center Giessen and Marburg (UKGM). Yvonne Rottger was in part supported by a grant of the Competence Network Degenerative Dementias (German Ministery of Education and Research, BMBF 01GI1008C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interests. Dr. J.-P. Bach received research grants from Grifols and Baxter and lecturing fees from Teva pharmaceuticals. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aguzzi A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002651; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; AXLINE SG, 1974, J CELL BIOL, V62, P647, DOI 10.1083/jcb.62.3.647; Bacher M, 2009, NEUROSCI LETT, V449, P240, DOI 10.1016/j.neulet.2008.08.083; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bate C, 2005, J NEUROIMMUNOL, V170, P62, DOI 10.1016/j.jneuroim.2005.08.021; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown DR, 1996, GLIA, V18, P59, DOI 10.1002/(SICI)1098-1136(199609)18:1<59::AID-GLIA6>3.0.CO;2-Z; Brown DR, 2000, BIOCHEM J, V346, P785, DOI 10.1042/0264-6021:3460785; Ciesielski-Treska J, 2004, GLIA, V46, P101, DOI 10.1002/glia.10363; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DREVETS DA, 1991, J IMMUNOL METHODS, V142, P31, DOI 10.1016/0022-1759(91)90289-R; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Esen N, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-10; Fabrizi C, 2001, J BIOL CHEM, V276, P25692, DOI 10.1074/jbc.M100133200; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Garcao P, 2006, J NEUROSCI RES, V84, P182, DOI 10.1002/jnr.20870; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Giese A, 1998, BRAIN PATHOL, V8, P449; Gold M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-5; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Kellner A, 2009, ANN NEUROL, V65, P24, DOI 10.1002/ana.21475; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Levy Y, 2001, PROTEINS, V45, P382, DOI 10.1002/prot.1157; Liu YB, 1997, J NEUROCHEM, V69, P2285; McHattie SJ, 1999, J NEUROCYTOL, V28, P149, DOI 10.1023/A:1007028323666; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Neff F, 2008, AUTOIMMUN REV, V7, P501, DOI 10.1016/j.autrev.2008.04.010; NEWMAN SL, 1991, J IMMUNOL, V146, P967; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Pastore A, 2007, PRION, V1, P185, DOI 10.4161/pri.1.3.5281; Peyrin JM, 1999, NEUROREPORT, V10, P723, DOI 10.1097/00001756-199903170-00012; POWIS G, 1994, CANCER RES, V54, P2419; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Pul R, 2002, CLIN NEUROPHARMACOL, V25, P254, DOI 10.1097/00002826-200209000-00005; Re FB, 2002, J IMMUNOL, V169, P2264, DOI 10.4049/jimmunol.169.5.2264; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Rezaie P, 2001, BRAIN RES REV, V35, P55, DOI 10.1016/S0165-0173(01)00042-X; Roettger Y, 2012, NAT REV NEUROL; Salmona M, 1999, BIOCHEM J, V342, P207, DOI 10.1042/0264-6021:3420207; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Shoenfeld Y, 2006, AUTOANTIBODIES; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Sulahian TH, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-59; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Wei X, 2012, J BIOL CHEM, V287, P12858, DOI 10.1074/jbc.M111.255836	52	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67743	10.1371/journal.pone.0067743	http://dx.doi.org/10.1371/journal.pone.0067743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840767	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400129
J	Ruiz, S; Ferreiro, MJ; Menhert, KI; Casanova, G; Olivera, A; Cantera, R				Ruiz, Santiago; Jose Ferreiro, Maria; Menhert, Kerstin I.; Casanova, Gabriela; Olivera, Alvaro; Cantera, Rafael			Rhythmic Changes in Synapse Numbers in Drosophila melanogaster Motor Terminals	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; LONGITUDINAL FLIGHT-MUSCLE; NEUROMUSCULAR-JUNCTION; CIRCADIAN-RHYTHMS; HORSERADISH-PEROXIDASE; GLUTAMATE RECEPTORS; ABDOMINAL-MUSCLES; PLASTICITY; NEURONS; GROWTH	Previous studies have shown that the morphology of the neuromuscular junction of the flight motor neuron MN5 in Drosophila melanogaster undergoes daily rhythmical changes, with smaller synaptic boutons during the night, when the fly is resting, than during the day, when the fly is active. With electron microscopy and laser confocal microscopy, we searched for a rhythmic change in synapse numbers in this neuron, both under light: darkness (LD) cycles and constant darkness (DD). We expected the number of synapses to increase during the morning, when the fly has an intense phase of locomotion activity under LD and DD. Surprisingly, only our DD data were consistent with this hypothesis. In LD, we found more synapses at midnight than at midday. We propose that under LD conditions, there is a daily rhythm of formation of new synapses in the dark phase, when the fly is resting, and disassembly over the light phase, when the fly is active. Several parameters appeared to be light dependent, since they were affected differently under LD or DD. The great majority of boutons containing synapses had only one and very few had either two or more, with a 70:25:5 ratio (one, two and three or more synapses) in LD and 75:20:5 in DD. Given the maintenance of this proportion even when both bouton and synapse numbers changed with time, we suggest that there is a homeostatic mechanism regulating synapse distribution among MN5 boutons.	[Ruiz, Santiago; Jose Ferreiro, Maria; Cantera, Rafael] Estable, Montevideo, Uruguay; [Casanova, Gabriela; Olivera, Alvaro] UdelaR, Fac Ciencias, Unidad Microscopia Elect Transmis, Montevideo, Uruguay; [Menhert, Kerstin I.; Cantera, Rafael] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay; Stockholm University		rcantera@zoologi.su.se	Ruíz, Santiago/HGU-6016-2022	Ruiz, Santiago/0000-0002-2626-6160	Programa de Desarrollo Tecnologico [058-54]; Swedish Research Council; Programa de Deserrollo de las Ciencias Basicas (PEDECIBA); Tullberg Foundation (Uppsala University); Silen Foundation (Stockholm University); Boehringer Ingelheim Fonds; NICHD	Programa de Desarrollo Tecnologico; Swedish Research Council(Swedish Research CouncilEuropean Commission); Programa de Deserrollo de las Ciencias Basicas (PEDECIBA); Tullberg Foundation (Uppsala University); Silen Foundation (Stockholm University); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Programa de Desarrollo Tecnologico (058-54) and the Swedish Research Council. S.R. has a PhD Fellowship from Programa de Deserrollo de las Ciencias Basicas (PEDECIBA). K.I.M received travel grants from the Tullberg Foundation (Uppsala University), the Silen Foundation (Stockholm University) and Boehringer Ingelheim Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The nc82 antibody, developed by Dr. Buchner, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. We thank Dr. W. Norbis for advice with statistics and Dr. Olivier Bosler for constructive comments. S.R. thanks Magdalena Cardenas and the Molecular Human Genetics Laboratory of the Institute Pasteur Montevideo for supplying the isotype-specific secondary antibodies. S.R. thanks Dr. Omar Trujillo-Cenoz for helpful advice in the preparation of TEM serial section images.	Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Barth M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009217; Becquet D, 2008, GLIA, V56, P294, DOI 10.1002/glia.20613; Beramendi A, 2007, J COMP NEUROL, V501, P498, DOI 10.1002/cne.21253; Besse F, 2007, J CELL BIOL, V177, P843, DOI 10.1083/jcb.200701111; Budnik V, 2006, FLY NEUROMUSCULAR JU; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Chen KY, 2011, MOL CELL NEUROSCI, V48, P171, DOI 10.1016/j.mcn.2011.07.009; COGGSHALL JC, 1978, J COMP NEUROL, V177, P707, DOI 10.1002/cne.901770410; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Consoulas C, 2002, J NEUROSCI, V22, P4906, DOI 10.1523/JNEUROSCI.22-12-04906.2002; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Dajno R, 2011, PLOS ONE, V6; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Girardet C, 2010, EUR J NEUROSCI, V32, P2133, DOI 10.1111/j.1460-9568.2010.07520.x; Girardet C, 2010, EUR J NEUROSCI, V31, P359, DOI 10.1111/j.1460-9568.2009.07071.x; Godenschwege TA, 2004, EUR J NEUROSCI, V20, P611, DOI 10.1111/j.1460-9568.2004.03527.x; Guldner FH, 1997, CELL TISSUE RES, V287, P43; Hamanaka Y, 2010, J COMP NEUROL, V518, P1133, DOI 10.1002/cne.22268; Hebbar S, 2004, J NEUROBIOL, V60, P499, DOI 10.1002/neu.20031; Hebbar S, 2006, J NEUROBIOL, V66, P1140, DOI 10.1002/neu.20279; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hofbauer A, 1991, THESIS U WURZBURG GE; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; IKEDA K, 1980, J NEUROCYTOL, V9, P799, DOI 10.1007/BF01205020; IKEDA K, 1988, J COMP NEUROL, V273, P436, DOI 10.1002/cne.902730312; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Jordan-Alvarez S, 2012, J CELL SCI, V125, P3621, DOI 10.1242/jcs.102806; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Klarsfeld A, 2003, BEHAV PROCESS, V64, P161, DOI 10.1016/S0376-6357(03)00133-5; KOENIG JH, 1989, J NEUROSCI, V9, P1937; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Liebl FLW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012778; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; Mehnert KI, 2008, CELL TISSUE RES, V334, P103, DOI 10.1007/s00441-008-0670-0; Mehnert KI, 2007, DEV NEUROBIOL, V67, P415, DOI 10.1002/dneu.20332; Mehnert KI, 2011, CELL TISSUE RES, V344, P381, DOI 10.1007/s00441-011-1174-x; Meinertzhagen IA, 1996, TRENDS NEUROSCI, V19, P285, DOI 10.1016/S0166-2236(96)10033-3; Owald D, 2012, NAT NEUROSCI, V15, P1219, DOI 10.1038/nn.3183; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Prokop A, 1999, CELL TISSUE RES, V297, P169, DOI 10.1007/s004410051345; Pyza E, 2003, NEUROPEPTIDES, V37, P277, DOI 10.1016/j.npep.2003.06.001; PYZA E, 1993, P ROY SOC B-BIOL SCI, V254, P97, DOI 10.1098/rspb.1993.0133; Pyza E, 2008, ACTA NEUROBIOL EXP, V68, P322; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Renger JJ, 2000, J NEUROSCI, V20, P3980; Rivlin PK, 2004, J COMP NEUROL, V468, P596, DOI 10.1002/cne.10977; Ruiz S, 2010, SYNAPSE, V64, P14, DOI 10.1002/syn.20699; Rybak J, 1997, EUR J NEUROSCI, V9, P319, DOI 10.1111/j.1460-9568.1997.tb01402.x; Saunders DS, 2002, INSECT CLOCKS; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Stewart BA, 2005, J COMP NEUROL, V488, P101, DOI 10.1002/cne.20603; SUN BH, 1995, J NEUROCHEM, V65, P434, DOI 10.1046/j.1471-4159.1995.65010434.x; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; Sun YA, 1997, J COMP NEUROL, V387, P157; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; TRUJILLO-CENOZ O, 1969, Journal of Ultrastructure Research, V27, P533, DOI 10.1016/S0022-5320(69)80048-1; Viquez NM, 2009, J NEUROSCI, V29, P11484, DOI 10.1523/JNEUROSCI.5584-08.2009; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	71	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67161	10.1371/journal.pone.0067161	http://dx.doi.org/10.1371/journal.pone.0067161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840613	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400039
J	Vindeirinho, J; Costa, GN; Correia, MB; Cavadas, C; Santos, PF				Vindeirinho, Joana; Costa, Gabriel N.; Correia, Mariana B.; Cavadas, Claudia; Santos, Paulo F.			Effect of Diabetes/Hyperglycemia on the Rat Retinal Adenosinergic System	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INDUCED DIABETIC-RATS; NECROSIS-FACTOR-ALPHA; LONG-TERM ACTIVATION; FACTOR-KAPPA-B; HIGH GLUCOSE; RECEPTOR EXPRESSION; A(1) RECEPTORS; CELL-DEATH; TNF-ALPHA	The early stages of diabetic retinopathy (DR) are characterized by alterations similar to neurodegenerative and inflammatory conditions such as increased neural apoptosis, microglial cell activation and amplified production of pro-inflammatory cytokines. Adenosine regulates several physiological functions by stimulating four subtypes of receptors, A(1)AR, A(2A)AR, A(2B)AR, and A(3)AR. Although the adenosinergic signaling system is affected by diabetes in several tissues, it is unknown whether diabetic conditions in the retina can also affect it. Adenosine delivers potent suppressive effects on virtually all cells of the immune system, but its potential role in the context of DR has yet to be studied in full. In this study, we used primary mixed cultures of rat retinal cells exposed to high glucose conditions, to mimic hyperglycemia, and a streptozotocin rat model of type 1 diabetes to determine the effect diabetes/hyperglycemia have on the expression and protein levels of adenosine receptors and of the enzymes adenosine deaminase and adenosine kinase. We found elevated mRNA and protein levels of A(1)AR and A(2A)AR, in retinal cell cultures under high glucose conditions and a transient increase in the levels of the same receptors in diabetic retinas. Adenosine deaminase and adenosine kinase expression and protein levels showed a significant decrease in diabetic retinas 30 days after diabetes induction. An enzymatic assay performed in retinal cell cultures revealed a marked decrease in the activity of adenosine deaminase under high glucose conditions. We also found an increase in extracellular adenosine levels accompanied by a decrease in intracellular levels when retinal cells were subjected to high glucose conditions. In conclusion, this study shows that several components of the retinal adenosinergic system are affected by diabetes and high glucose conditions, and the modulation observed may uncover a possible mechanism for the alleviation of the inflammatory and excitotoxic conditions observed in diabetic retinas.	[Vindeirinho, Joana; Costa, Gabriel N.; Correia, Mariana B.; Cavadas, Claudia; Santos, Paulo F.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Vindeirinho, Joana] Univ Coimbra, Inst Interdisciplinary Res, Coimbra, Portugal; [Cavadas, Claudia] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Santos, Paulo F.] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Santos, PF (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	pfsantos@ci.uc.pt	dos Santos, Paulo Fernando Martins/AAC-6818-2020; Cavadas, Claudia/K-8271-2014; Cavadas, Claudia/AAB-6904-2021	dos Santos, Paulo Fernando Martins/0000-0002-2225-455X; Cavadas, Claudia/0000-0001-8020-9266; Cavadas, Claudia/0000-0001-8020-9266; Costa, Gabriel/0000-0001-9630-1155	European Regional Development Fund (ERDF) through COMPETE (Programa Operacional Factores de Competitividade); FCT (Fundacao para a Ciencia e a Tecnologia) [SFRH/BD/43968/2008, PEst-C/SAU/LA0001/2013-201]	European Regional Development Fund (ERDF) through COMPETE (Programa Operacional Factores de Competitividade); FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology)	This work was co-financed by European Regional Development Fund (ERDF) through COMPETE (Programa Operacional Factores de Competitividade) and by national funds through the FCT (Fundacao para a Ciencia e a Tecnologia) grants SFRH/BD/43968/2008 and PEst-C/SAU/LA0001/2013-201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; Costa G, 2009, J NEUROSCI RES, V87, P1375, DOI 10.1002/jnr.21956; Costa GN, 2012, MOL CELL NEUROSCI, V50, P113, DOI 10.1016/j.mcn.2012.04.003; Cunha-Vaz Jose, 2007, Dev Ophthalmol, V39, P13, DOI 10.1159/000098497; Dong RP, 1996, J IMMUNOL, V156, P1349; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Duarte JMN, 2006, NEUROCHEM INT, V48, P144, DOI 10.1016/j.neuint.2005.08.008; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; ELY SW, 1992, J MOL CELL CARDIOL, V24, P1321, DOI 10.1016/0022-2828(92)93097-4; Ferreira JM, 2001, BRAIN RES, V900, P169, DOI 10.1016/S0006-8993(01)02279-X; Franco R, 1997, PROG NEUROBIOL, V52, P283, DOI 10.1016/S0301-0082(97)00013-0; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Green Brian D, 2006, Diab Vasc Dis Res, V3, P159, DOI 10.3132/dvdr.2006.024; Guisti G., 1984, METHODS ENZYMATIC AN, P315; Hamano R, 2008, SHOCK, V29, P154, DOI 10.1097/shk.0b013e31812385da; Hammond LC, 2004, BIOCHEM PHARMACOL, V67, P421, DOI 10.1016/j.bcp.2003.09.003; Hasko G, 2005, TRENDS PHARMACOL SCI, V26, P511, DOI 10.1016/j.tips.2005.08.004; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hilaire CS, 2009, J CELL PHYSIOL, V218, P35, DOI 10.1002/jcp.21579; Ibrahim AS, 2011, AM J PATHOL, V178, P2136, DOI 10.1016/j.ajpath.2011.01.018; Jhaveri KA, 2007, NEUROSCIENCE, V146, P415, DOI 10.1016/j.neuroscience.2006.12.035; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kowluru RA, 2001, NEUROCHEM INT, V38, P385, DOI 10.1016/S0197-0186(00)00112-1; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Kreckler LM, 2006, J PHARMACOL EXP THER, V317, P172, DOI 10.1124/jpet.105.096016; KROLL K, 1993, CIRC RES, V73, P846, DOI 10.1161/01.RES.73.5.846; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Li Q, 2002, INVEST OPHTH VIS SCI, V43, P3109; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Liou GI, 2008, INVEST OPHTH VIS SCI, V49, P5526, DOI 10.1167/iovs.08-2196; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Nie ZZ, 1998, MOL PHARMACOL, V53, P663, DOI 10.1124/mol.53.4.663; PAK MA, 1994, NEUROPHARMACOLOGY, V33, P1049, DOI 10.1016/0028-3908(94)90142-2; Pawelczyk T, 2003, EXP CELL RES, V286, P152, DOI 10.1016/S0014-4827(03)00090-9; Pawelczyk T, 2000, ARCH BIOCHEM BIOPHYS, V375, P1, DOI 10.1006/abbi.1999.1548; Pereira MR, 2010, J NEUROCHEM, V113, P661, DOI 10.1111/j.1471-4159.2010.06641.x; Rego AC, 2000, EXP EYE RES, V70, P577, DOI 10.1006/exer.1999.0815; Santiago AR, 2007, NEUROBIOL DIS, V25, P464, DOI 10.1016/j.nbd.2006.10.023; Santiago AR, 2009, MOL VIS, V15, P1620; Santiago AR, 2006, NEUROCHEM INT, V48, P453, DOI 10.1016/j.neuint.2005.10.013; Santos PF, 2000, BRAIN RES, V852, P10, DOI 10.1016/S0006-8993(99)02155-1; Schmatz R, 2009, LIFE SCI, V84, P345, DOI 10.1016/j.lfs.2008.12.019; Pereira TDS, 2010, BRAIN RES, V1316, P129, DOI 10.1016/j.brainres.2009.12.034; Varani K, 2009, ARTHRITIS RHEUM-US, V60, P2880, DOI 10.1002/art.24794; Wurm A, 2008, EXP EYE RES, V87, P385, DOI 10.1016/j.exer.2008.07.004; Xin H, 2007, J NEUROSCI METH, V159, P35, DOI 10.1016/j.jneumeth.2006.06.013	51	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67499	10.1371/journal.pone.0067499	http://dx.doi.org/10.1371/journal.pone.0067499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840723	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400093
J	Handke, B; Poernbacher, I; Goetze, S; Ahrens, CH; Omasits, U; Marty, F; Simigdala, N; Meyer, I; Wollscheid, B; Brunner, E; Hafen, E; Lehner, CF				Handke, Bjoern; Poernbacher, Ingrid; Goetze, Sandra; Ahrens, Christian H.; Omasits, Ulrich; Marty, Florian; Simigdala, Nikiana; Meyer, Imke; Wollscheid, Bernd; Brunner, Erich; Hafen, Ernst; Lehner, Christian F.			The Hemolymph Proteome of Fed and Starved Drosophila Larvae	PLOS ONE			English	Article							IMMUNE-RESPONSE; SERUM-PROTEIN; HUMAN PLASMA; FAT-BODY; MELANOGASTER; GROWTH; CELLS; EXPRESSION; PEPTIDES; HOMEOSTASIS	The co-operation of specialized organ systems in complex multicellular organisms depends on effective chemical communication. Thus, body fluids (like blood, lymph or intraspinal fluid) contain myriads of signaling mediators apart from metabolites. Moreover, these fluids are also of crucial importance for immune and wound responses. Compositional analyses of human body fluids are therefore of paramount diagnostic importance. Further improving their comprehensiveness should increase our understanding of inter-organ communication. In arthropods, which have trachea for gas exchange and an open circulatory system, the single dominating interstitial fluid is the hemolymph. Accordingly, a detailed analysis of hemolymph composition should provide an especially comprehensive picture of chemical communication and defense in animals. Therefore we used an extensive protein fractionation workflow in combination with a discovery-driven proteomic approach to map out the detectable protein composition of hemolymph isolated from Drosophila larvae. Combined mass spectrometric analysis revealed more than 700 proteins extending far beyond the previously known Drosophila hemolymph proteome. Moreover, by comparing hemolymph isolated from either fed or starved larvae, we provide initial provisional insights concerning compositional changes in response to nutritional state. Storage proteins in particular were observed to be strongly reduced by starvation. Our hemolymph proteome catalog provides a rich basis for data mining, as exemplified by our identification of potential novel cytokines, as well as for future quantitative analyses by targeted proteomics.	[Handke, Bjoern; Goetze, Sandra; Ahrens, Christian H.; Marty, Florian; Simigdala, Nikiana; Meyer, Imke; Brunner, Erich; Lehner, Christian F.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Poernbacher, Ingrid; Omasits, Ulrich; Wollscheid, Bernd; Hafen, Ernst] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lehner, CF (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	christian.lehner@imls.uzh.ch	Wollscheid, Bernd/E-8909-2010; Ahrens, Christian H./F-4656-2011; Goetze, Sandra/K-4337-2012	Wollscheid, Bernd/0000-0002-3923-1610; Ahrens, Christian H./0000-0002-8148-7257; Goetze, Sandra/0000-0001-6880-8020; Poernbacher, Ingrid/0000-0003-2766-9700; Marty, Florian/0000-0002-6801-6549; Goldmann, Ulrich/0000-0003-1120-6912	SystemsX.ch WingX; University Research Priority Program Systems Biology/Functional Genomics of the University of Zurich; Swiss National Science Foundation	SystemsX.ch WingX; University Research Priority Program Systems Biology/Functional Genomics of the University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from SystemsX.ch WingX), the University Research Priority Program Systems Biology/Functional Genomics of the University of Zurich, and the Swiss National Science Foundation. CHA and EB are members of the Quantitative Model Organism Proteomics Initiative, which is funded in part by the University Research Priority Program Systems Biology/Functional Genomics of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ashburner M., 1989, DROSOPHILA LAB HDB; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Bogaerts A, 2009, PROTEOMICS, V9, P3201, DOI 10.1002/pmic.200800604; BOWNES M, 1992, J LIPID RES, V33, P777; Britton JS, 1998, DEVELOPMENT, V125, P2149; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Bryant PJ, 2001, NOVART FDN SYMP, V237, P182, DOI 10.1002/0470846666.ch14; Burmester T, 2002, J COMP PHYSIOL B, V172, P95, DOI 10.1007/s00360-001-0247-7; Burmester T, 1999, NATURWISSENSCHAFTEN, V86, P468, DOI 10.1007/s001140050656; Burmester T, 1999, EUR J BIOCHEM, V262, P49, DOI 10.1046/j.1432-1327.1999.00315.x; Cardoen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020043; Carvalho PC, 2008, GENET MOL RES, V7, P342, DOI 10.4238/vol7-2gmr426; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen J, 2012, DEVELOPMENT, V139, P2170, DOI 10.1242/dev.073817; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Dushay MS, 2009, CELL MOL LIFE SCI, V66, P2643, DOI 10.1007/s00018-009-0036-0; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Farhadian SF, 2012, PHYSIOL BEHAV, V105, P544, DOI 10.1016/j.physbeh.2011.09.007; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Fujikawa K, 2009, GENE, V446, P11, DOI 10.1016/j.gene.2009.06.017; Furusawa T, 2008, J PROTEOME RES, V7, P938, DOI 10.1021/pr070405j; Gade G, 2004, ANNU REV ENTOMOL, V49, P93, DOI 10.1146/annurev.ento.49.061802.123354; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Guedes SD, 2005, BIOCHEM BIOPH RES CO, V328, P106, DOI 10.1016/j.bbrc.2004.12.135; Guedes SD, 2003, BIOCHEM BIOPH RES CO, V312, P545, DOI 10.1016/j.bbrc.2003.10.156; Han YS, 1999, DEV COMP IMMUNOL, V23, P553, DOI 10.1016/S0145-305X(99)00047-6; Heller M, 2005, ELECTROPHORESIS, V26, P1174, DOI 10.1002/elps.200410106; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hou Y, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-45; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kaeslin M, 2005, J INSECT PHYSIOL, V51, P975, DOI 10.1016/j.jinsphys.2005.04.012; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kawamura K, 1999, DEVELOPMENT, V126, P211; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Krzemien J, 2010, INT J DEV BIOL, V54, P1117, DOI 10.1387/ijdb.093053jk; Kutty RK, 1996, J BIOL CHEM, V271, P20641, DOI 10.1074/jbc.271.34.20641; Lai R, 2004, BIOCHEM J, V379, P681, DOI 10.1042/BJ20031429; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Levy F, 2004, BIOCHIMIE, V86, P607, DOI 10.1016/j.biochi.2004.07.007; Li XH, 2006, J PROTEOME RES, V5, P2809, DOI 10.1021/pr0603093; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liu YS, 2013, PROTEOMICS, V13, P1247, DOI 10.1002/pmic.201200417; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Mirth Christen Kerry, 2012, Front Endocrinol (Lausanne), V3, P49, DOI 10.3389/fendo.2012.00049; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Novakova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017741; Palm W, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002828; Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002; Perez-Hedo M, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-58; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POWELL D, 1984, DEV BIOL, V102, P206, DOI 10.1016/0012-1606(84)90185-4; Qeli E, 2010, NAT BIOTECHNOL, V28, P647, DOI 10.1038/nbt0710-647; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Razavi M, 2012, J PROTEOME RES, V11, P5642, DOI 10.1021/pr300652v; Reichhart JM, 2011, METHOD ENZYMOL, V499, P205, DOI 10.1016/B978-0-12-386471-0.00011-0; ROBERTS DB, 1977, J INSECT PHYSIOL, V23, P871, DOI 10.1016/0022-1910(77)90013-0; ROBERTS DB, 1991, EUR J BIOCHEM, V195, P195, DOI 10.1111/j.1432-1033.1991.tb15695.x; Ruegg KM, 1968, Z VERGL PHYSIOL, V60, P275; Sheldon TJ, 2007, FEBS LETT, V581, P5268, DOI 10.1016/j.febslet.2007.10.016; Stahl-Zeng J, 2007, MOL CELL PROTEOMICS, V6, P1809, DOI 10.1074/mcp.M700132-MCP200; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; Verleyen P, 2006, J INSECT PHYSIOL, V52, P379, DOI 10.1016/j.jinsphys.2005.12.007; Vierstraete E, 2005, ANN NY ACAD SCI, V1040, P504, DOI 10.1196/annals.1327.104; Vierstraete E, 2004, BIOCHEM BIOPH RES CO, V317, P1052, DOI 10.1016/j.bbrc.2004.03.150; Vierstraete E, 2004, P NATL ACAD SCI USA, V101, P470, DOI 10.1073/pnas.0304567101; Vierstraete E, 2003, BIOCHEM BIOPH RES CO, V304, P831, DOI 10.1016/S0006-291X(03)00683-1; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; WYATT GR, 1961, ANNU REV ENTOMOL, V6, P75, DOI 10.1146/annurev.en.06.010161.000451; WYATT GR, 1978, ANNU REV BIOCHEM, V47, P779, DOI 10.1146/annurev.bi.47.070178.004023; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhao XF, 2006, J PROTEOME RES, V5, P164, DOI 10.1021/pr0502424; Zhou ZH, 2008, J PROTEOME RES, V7, P5103, DOI 10.1021/pr800383r	83	46	46	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67208	10.1371/journal.pone.0067208	http://dx.doi.org/10.1371/journal.pone.0067208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840627	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000322342800124
J	Gall, AJ; Smale, L; Yan, L; Nunez, AA				Gall, Andrew J.; Smale, Laura; Yan, Lily; Nunez, Antonio A.			Lesions of the Intergeniculate Leaflet Lead to a Reorganization in Circadian Regulation and a Reversal in Masking Responses to Photic Stimuli in the Nile Grass Rat	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; SUPRACHIASMATIC NUCLEUS; ACTIVITY RHYTHMS; ARVICANTHIS-NILOTICUS; BEHAVIORAL-RESPONSES; BODY-TEMPERATURE; GENERAL ACTIVITY; FOS EXPRESSION; MURID RODENT; LIGHT	Light influences the daily patterning of behavior by entraining circadian rhythms and through its acute effects on activity levels (masking). Mechanisms of entrainment are quite similar across species, but masking can be very different. Specifically, in diurnal species, light generally increases locomotor activity (positive masking), and in nocturnal ones, it generally suppresses it (negative masking). The intergeniculate leaflet (IGL), a subdivision of the lateral geniculate complex, receives direct retinal input and is reciprocally connected with the primary circadian clock, the suprachiasmatic nucleus (SCN). Here, we evaluated the influence of the IGL on masking and the circadian system in a diurnal rodent, the Nile grass rat (Arvicanthis niloticus), by determining the effects of bilateral IGL lesions on general activity under different lighting conditions. To examine masking responses, light or dark pulses were delivered in the dark or light phase, respectively. Light pulses at Zeitgeber time (ZT) 14 increased activity in control animals but decreased it in animals with IGL lesions. Dark pulses had no effect on controls, but significantly increased activity in lesioned animals at ZT0. Lesions also significantly increased activity, primarily during the dark phase of a 12:12 light/dark cycle, and during the subjective night when animals were kept in constant conditions. Taken together, our results suggest that the IGL plays a vital role in the maintenance of both the species-typical masking responses to light, and the circadian contribution to diurnality in grass rats.	[Gall, Andrew J.] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Gall, AJ (corresponding author), Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA.	gall@msu.edu	Nunez, Antonio/AAG-1818-2021; Yan, Lily/AAU-2005-2021; Gall, Andrew/A-2443-2016	Yan, Lily/0000-0002-6261-2542; Gall, Andrew/0000-0003-1258-0658	National Science Foundation (NSF) [IOS-1051919]; National Institutes of Health (NIH) [T32 MH070343B]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH070343] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by a National Science Foundation (NSF) grant (IOS-1051919, to LS, AAN, and LY) and AJG was supported by a National Institutes of Health (NIH) Training Grant (T32 MH070343B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchong JA, 1999, J BIOL RHYTHM, V14, P364, DOI 10.1177/074873099129000777; Blanchong JA, 2000, J MAMMAL, V81, P595, DOI 10.1644/1545-1542(2000)081<0595:TPOAOT>2.0.CO;2; Castillo-Ruiz A, 2011, PHYSIOL BEHAV, V103, P384, DOI 10.1016/j.physbeh.2011.03.011; Edelstein K, 1999, J NEUROSCI, V19, P372, DOI 10.1523/JNEUROSCI.19-01-00372.1999; Edelstein K, 2001, BRAIN RES, V918, P107, DOI 10.1016/S0006-8993(01)02966-3; Freeman DA, 2004, BRAIN RES, V1028, P31, DOI 10.1016/j.brainres.2004.08.049; Gaillard F, 2013, J COMP NEUROL, V521, P1699, DOI 10.1002/cne.23303; Goel N, 1999, NEUROSCIENCE, V92, P1491, DOI 10.1016/S0306-4522(99)00056-1; Goel N, 2000, BRAIN RES, V877, P306, DOI 10.1016/S0006-8993(00)02696-2; Harrington M E, 1986, J Biol Rhythms, V1, P309, DOI 10.1177/074873048600100405; HARRINGTON ME, 1988, PHYSIOL BEHAV, V42, P183, DOI 10.1016/0031-9384(88)90296-X; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; HICKEY TL, 1976, EXP BRAIN RES, V24, P523; HOBBS SH, 1972, PHYSIOL BEHAV, V9, P349, DOI 10.1016/0031-9384(72)90157-6; JOHNSON RF, 1989, BRAIN RES BULL, V22, P411, DOI 10.1016/0361-9230(89)90068-3; JOHNSON RF, 1988, P NATL ACAD SCI USA, V85, P5301, DOI 10.1073/pnas.85.14.5301; Katona C, 1997, PHYSIOL BEHAV, V61, P365, DOI 10.1016/S0031-9384(96)00407-6; Lewandowski MH, 2002, BEHAV BRAIN RES, V128, P13, DOI 10.1016/S0166-4328(01)00264-9; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Li XD, 2005, J COMP PHYSIOL A, V191, P23, DOI 10.1007/s00359-004-0569-5; Mahoney M, 2001, J BIOL RHYTHM, V16, P149, DOI 10.1177/074873001129001854; Maywood ES, 2011, EXP NEUROL; McElhinny TL, 1997, PHYSIOL BEHAV, V62, P91, DOI 10.1016/S0031-9384(97)00146-7; MOORE RY, 1994, J COMP NEUROL, V344, P403, DOI 10.1002/cne.903440306; MORIN LP, 1994, BRAIN RES REV, V19, P102, DOI 10.1016/0165-0173(94)90005-1; Morin LP, 2001, J COMP NEUROL, V437, P79, DOI 10.1002/cne.1271; Morin LP, 1998, J COMP NEUROL, V396, P288; Morin LP, 1999, VISUAL NEUROSCI, V16, P1037, DOI 10.1017/S0952523899166069; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pickard G E, 1987, J Biol Rhythms, V2, P35, DOI 10.1177/074873048700200104; PICKARD GE, 1989, BRAIN RES, V494, P151, DOI 10.1016/0006-8993(89)90154-6; PICKARD GE, 1994, NEUROREPORT, V5, P2186, DOI 10.1097/00001756-199410270-00049; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Ramanathan C, 2008, NEUROSCIENCE, V156, P48, DOI 10.1016/j.neuroscience.2008.07.020; Redlin U, 1999, J COMP PHYSIOL A, V184, P449, DOI 10.1007/s003590050344; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; Schrader JA, 2009, PHYSIOL BEHAV, V98, P547, DOI 10.1016/j.physbeh.2009.08.012; Schwartz MD, 2009, CHRONOBIOL INT, V26, P1290, DOI 10.3109/07420520903415742; Shuboni DD, 2012, J BIOL RHYTHM, V27, P299, DOI 10.1177/0748730412449723; SMALE L, 1990, BRAIN RES BULL, V24, P185, DOI 10.1016/0361-9230(90)90204-D; Smale L, 1999, J COMP NEUROL, V403, P190, DOI 10.1002/(SICI)1096-9861(19990111)403:2<190::AID-CNE4>3.0.CO;2-K; Smale L, 2008, BIOL RHYTHM RES, V39, P305, DOI 10.1080/09291010701682666; Weinert D, 1999, PHYSIOL BEHAV, V66, P605, DOI 10.1016/S0031-9384(98)00342-4; WICKLAND C, 1994, BRAIN RES, V660, P293, DOI 10.1016/0006-8993(94)91302-1	45	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67387	10.1371/journal.pone.0067387	http://dx.doi.org/10.1371/journal.pone.0067387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840688	Green Published, gold			2022-12-27	WOS:000322361200132
J	Stoler, J; Weeks, JR; Otoo, RA				Stoler, Justin; Weeks, John R.; Otoo, Richard Appiah			Drinking Water in Transition: A Multilevel Cross-sectional Analysis of Sachet Water Consumption in Accra	PLOS ONE			English	Article							HEALTH; GHANA; NEIGHBORHOODS; POVERTY	Rapid population growth in developing cities often outpaces improvements to drinking water supplies, and sub-Saharan Africa as a region has the highest percentage of urban population without piped water access, a figure that continues to grow. Accra, Ghana, implements a rationing system to distribute limited piped water resources within the city, and privately-vended sachet water-sealed single-use plastic sleeves-has filled an important gap in urban drinking water security. This study utilizes household survey data from 2,814 Ghanaian women to analyze the sociodemographic characteristics of those who resort to sachet water as their primary drinking water source. In multilevel analysis, sachet use is statistically significantly associated with lower overall self-reported health, younger age, and living in a lower-class enumeration area. Sachet use is marginally associated with more days of neighborhood water rationing, and significantly associated with the proportion of vegetated land cover. Cross-level interactions between rationing and proxies for poverty are not associated with sachet consumption after adjusting for individual-level sociodemographic, socioeconomic, health, and environmental factors. These findings are generally consistent with two other recent analyses of sachet water in Accra and may indicate a recent transition of sachet consumption from higher to lower socioeconomic classes. Overall, the allure of sachet water displays substantial heterogeneity in Accra and will be an important consideration in planning for future drinking water demand throughout West Africa.	[Stoler, Justin] Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33124 USA; [Stoler, Justin] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Weeks, John R.] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Otoo, Richard Appiah] Ghana Urban Water Ltd, Head Off Operat, Accra, Ghana	University of Miami; University of Miami; California State University System; San Diego State University	Stoler, J (corresponding author), Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33124 USA.	stoler@miami.edu	Stoler, Justin/AAY-8224-2021; Sharifzadeh, Aghil/Q-9405-2016	Stoler, Justin/0000-0001-8435-7012; Sharifzadeh, Aghil/0000-0001-6442-0053	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD054906]; Hewlett/PRB; World Health Organization; United States Agency for International Development; Fulbright New Century Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054906] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hewlett/PRB; World Health Organization(World Health Organization); United States Agency for International Development(United States Agency for International Development (USAID)); Fulbright New Century Scholars Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded in part by grant number R01 HD054906 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development ("Health, Poverty and Place in Accra, Ghana," John R. Weeks, Project Director/Principal Investigator). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Child Health and Human Development or the National Institutes of Health. Additional funding was provided by Hewlett/PRB ("Reproductive and Overall Health Outcomes and Their Economic Consequences for Households in Accra, Ghana," Allan G. Hill, Project Director/Principal Investigator). The 2003 Women's Health Study of Accra was funded by the World Health Organization, the United States Agency for International Development, and the Fulbright New Century Scholars Award (Allan G. Hill, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AfDB, 2017, AFR EC OUTL 2017; [Anonymous], MILL DEV GOALS REP 2; [Anonymous], 2010, WORLD URB PROSP 2009; Arku G, 2011, SOC SCI MED, V72, P1864, DOI 10.1016/j.socscimed.2011.03.023; Clasen T, 2009, SCALING HOUSEHOLD WA; Collignon B., 2000, INDEPENDENT WATER SA; Dominguez Torres C., 2012, FUTURE WATER AFRICAN; Fink G, 2011, INT J EPIDEMIOL, P1; Hill AG, 2007, INT J GYNECOL OBSTET, V99, P150, DOI 10.1016/j.ijgo.2007.05.024; International Development Committee, 2007, SAN WAT 6 REP SESS 2; Kessides Christine, 2005, AFRICA REGION WORKIN, V97; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Macro International Inc, 2011, MEASURE DHS STATCOMP; Moe Christine L., 2006, Journal of Water and Health, V4, P41; Nsiah-Gyabaah K, 2001, 2 WORKSH PER NAT RES; Stoler J, 2012, J WATER SANIT HYG DE, V2, P223, DOI 10.2166/washdev.2012.104; Stoler J, 2012, TROP MED INT HEALTH, V17, P1506, DOI 10.1111/j.1365-3156.2012.03099.x; Stoler J, 2012, HEALTH PLACE, V18, P250, DOI 10.1016/j.healthplace.2011.09.020; Stoler J, 2009, AM J TROP MED HYG, V80, P547, DOI 10.4269/ajtmh.2009.80.547; Sverdlik A, 2011, ENVIRON URBAN, V23, P123, DOI 10.1177/0956247811398604; The WHSA-II Writing Team, 2011, FIN REP WOM HLTH STU; Thompson J, 2000, ENVIRON URBAN, V12, P37, DOI 10.1177/095624780001200204; *UN DEV PROGR, 2006, HUM DEV REP 2006 SCA; UNDP-UNEP Poverty and Environment Initiative, 2008, POV ENV IND; Van-Rooijen DJ, 2008, DOMESTIC WATER SUPPL; Weeks JR, 2007, GEOJOURNAL, V69, P9, DOI 10.1007/s10708-007-9098-4; Weeks JR, 2012, ANN ASSOC AM GEOGR, V102, P932, DOI 10.1080/00045608.2012.671132; Weeks JR, 2010, ANN ASSOC AM GEOGR, V100, P558, DOI 10.1080/00045601003791391; WHO/UNICEF, 2011, DRINK WAT EQ SAF SUS; WHO UNICEF, 2010, PROGR SAN DRINK WAT	32	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67257	10.1371/journal.pone.0067257	http://dx.doi.org/10.1371/journal.pone.0067257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840643	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200128
J	Webster, J; Kayentao, K; Diarra, S; Diawara, SI; Haiballa, AA; Doumbo, OK; Hill, J				Webster, Jayne; Kayentao, Kassoum; Diarra, Samba; Diawara, Sory I.; Haiballa, Alhassane Ag; Doumbo, Ogobara K.; Hill, Jenny			A Qualitative Health Systems Effectiveness Analysis of the Prevention of Malaria in Pregnancy with Intermittent Preventive Treatment and Insecticide Treated Nets in Mali	PLOS ONE			English	Article							GUIDELINE IMPLEMENTABILITY; SULFADOXINE-PYRIMETHAMINE; COMBINATION; AMODIAQUINE; COVERAGE; SAFETY; TRIAL; WOMEN	Introduction: Delivery of intermittent preventive treatment with sulphadoxine-pyrimethamine to pregnant women (IPTp-SP) through antenatal clinic (ANC) in Mali is low, and whilst ANC delivery of insecticide treated nets (ITNs) is higher, coverage is still below national and international targets. The aim of this study was to explain quantitative data from a related study which identified ineffective processes in the delivery of these interventions in one district in Mali. Methods: In-depth interviews were conducted with health workers at the national, regional, district and health facility levels on their perceptions of reasons for the ineffective processes identified in the quantitative study, and their reported practices. Themes were coded for each ineffective process, and within these a health systems lens was used. Content analysis was used for emergent themes within this framework. MindMaps were used to display the findings. Results: Intervention specific factors for the ineffective delivery of IPTp-SP included misunderstanding of the upper limit of the gestational age at which SP could be given and side effects of SP. Incorrect practices had been recommended in training and supervision of health workers. Pregnant women who were ill on attendance at ANC were not consistently managed across health facilities. The most common reason for not offering women an ITN on their first ANC visit was if they were from outside the health facility catchment area. Broader health systems issues influencing the effectiveness of delivery of each of these interventions were also identified. Conclusion: In this setting, intervention-specific factors resulted in the ineffective delivery of IPTp-SP. These relate to complex policy guidelines, lack of guidance on how to implement the guidelines, and the institutionalising of practices that undermine the national guidelines. Interventions may be implemented and show real gains in the shorter-term whilst waiting for broader health systems issues to be addressed.	[Webster, Jayne] London Sch Hyg & Trop Med, Dis Control Dept, London WC1, England; [Kayentao, Kassoum; Diarra, Samba; Diawara, Sory I.; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Haiballa, Alhassane Ag] Programme Natl Lutte Paludisme, Bamako, Mali; [Hill, Jenny] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; University of Bamako; Liverpool School of Tropical Medicine; University of Liverpool	Webster, J (corresponding author), London Sch Hyg & Trop Med, Dis Control Dept, London WC1, England.	Jayne.webster@lshtm.ac.uk	Hill, Jenny/C-3839-2017	Hill, Jenny/0000-0003-1588-485X; Webster, Jayne/0000-0002-0498-8883	Malaria in Pregnancy Consortium; Bill & Melinda Gates Foundation	Malaria in Pregnancy Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by the Malaria in Pregnancy Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MAL PREGN GUID MEAS; [Anonymous], REF UPD GMAP OBJ TAR; [Anonymous], 2004, STRATEGIC FRAMEWORK; Bardaji A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-27; Cellule de Planification et de Statistique du Ministere de la Sante (CPS/MS) Direction Nationale de la Statistique et de l'Informatique de l'Industrie et du Commerce (DNSI/MEIC) et Macro International Inc., 2007, ENQ DEM SANT MAL 200; Clerk CA, 2008, J INFECT DIS, V198, P1202, DOI 10.1086/591944; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Gagliardi AR, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-26; Gross K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-140; Killian A, 2009, REV ELIVERY STRATEGI; Maiga OM, 2011, CLIN INFECT DIS, V53, P215, DOI 10.1093/cid/cir374; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Programme National de Lutte Contre le Paludisme, 2011, POL NAT LUTT PAL MAL; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Shekelle P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-62; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Tagbor H, 2006, LANCET, V368, P1349, DOI 10.1016/S0140-6736(06)69559-7; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021; WHO, 2007, EV BUS STRENGTH HLTH	23	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e65437	10.1371/journal.pone.0065437	http://dx.doi.org/10.1371/journal.pone.0065437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843941	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000042
J	Skogberg, G; Gudmundsdottir, J; van der Post, S; Sandstrom, K; Bruhn, S; Benson, M; Mincheva-Nilsson, L; Baranov, V; Telemo, E; Ekwall, O				Skogberg, Gabriel; Gudmundsdottir, Judith; van der Post, Sjoerd; Sandstrom, Kerstin; Bruhn, Soren; Benson, Mikael; Mincheva-Nilsson, Lucia; Baranov, Vladimir; Telemo, Esbjorn; Ekwall, Olov			Characterization of Human Thymic Exosomes	PLOS ONE			English	Article							PROMISCUOUS GENE-EXPRESSION; MHC CLASS-II; DENDRITIC CELLS; EPITHELIAL-CELLS; ANTIGEN PRESENTATION; T-CELLS; SELF-ANTIGEN; TOLERANCE; PROTEINS; VESICLES	Exosomes are nanosized membrane-bound vesicles that are released by various cell types and are capable of carrying proteins, lipids and RNAs which can be delivered to recipient cells. Exosomes play a role in intercellular communication and have been described to mediate immunologic information. In this article we report the first isolation and characterization of exosomes from human thymic tissue. Using electron microscopy, particle size determination, density gradient measurement, flow cytometry, proteomic analysis and microRNA profiling we describe the morphology, size, density, protein composition and microRNA content of human thymic exosomes. The thymic exosomes share characteristics with previously described exosomes such as antigen presentation molecules, but they also exhibit thymus specific features regarding surface markers, protein content and microRNA profile. Interestingly, thymic exosomes carry proteins that have a tissue restricted expression in the periphery which may suggest a role in T cell selection and the induction of central tolerance. We speculate that thymic exosomes may provide the means for intercellular information exchange necessary for negative selection and regulatory T cell formation of the developing thymocytes within the human thymic medulla.	[Skogberg, Gabriel; Gudmundsdottir, Judith; Telemo, Esbjorn; Ekwall, Olov] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Inst Med, Gothenburg, Sweden; [Gudmundsdottir, Judith; Ekwall, Olov] Univ Gothenburg, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden; [van der Post, Sjoerd] Univ Gothenburg, Prote Core Facil, Gothenburg, Sweden; [Sandstrom, Kerstin] Univ Gothenburg, Dept Pediat Anesthesia & Intens Care, Sahlgrenska Acad, Gothenburg, Sweden; [Bruhn, Soren; Benson, Mikael] Linkoping Univ, Ctr Invidualized Medicat, Linkoping, Sweden; [Benson, Mikael] Linkoping Univ, Dept Pediat, Linkoping, Sweden; [Mincheva-Nilsson, Lucia; Baranov, Vladimir] Umea Univ, Dept Clin Microbiol, Div Clin Immunol, Umea, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Linkoping University; Linkoping University; Umea University	Skogberg, G (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Inst Med, Gothenburg, Sweden.	xskoga@gu.se		Ekwall, Olov/0000-0002-4506-9955; van der Post, Sjoerd/0000-0002-7965-5311	Swedish Research Council [80409601]; Region Vastra Gotaland [ALFGBG-771712]; AFA Forsakring [100258]; IngaBritt and Arne Lundbergs Research Foundation; Gothenburg Medical Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Vastra Gotaland; AFA Forsakring; IngaBritt and Arne Lundbergs Research Foundation; Gothenburg Medical Society	This project was supported by the Swedish Research Council (contract 80409601), Region Vastra Gotaland (ALFGBG-771712), AFA Forsakring (contract 100258), IngaBritt and Arne Lundbergs Research Foundation and The Gothenburg Medical Society (all grants received by OE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393; HUMBLET C, 1994, INT IMMUNOL, V6, P1949, DOI 10.1093/intimm/6.12.1949; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Kasai M, 2009, J IMMUNOL, V183, P7278, DOI 10.4049/jimmunol.0804087; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Milicevic Z, 2010, IMMUNOL CELL BIOL, V88, P50, DOI 10.1038/icb.2009.55; Millet V, 2008, EUR J IMMUNOL, V38, P1257, DOI 10.1002/eji.200737982; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Peche H, 2006, AM J TRANSPLANT, V6, P1541, DOI 10.1111/j.1600-6143.2006.01344.x; Petersen SH, 2011, EUR J IMMUNOL, V41, P2556, DOI 10.1002/eji.201141438; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Segura E, 2007, J IMMUNOL, V179, P1489, DOI 10.4049/jimmunol.179.3.1489; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Yang CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022517	50	53	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67554	10.1371/journal.pone.0067554	http://dx.doi.org/10.1371/journal.pone.0067554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844026	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000055
J	Xiao, MS; Chang, L; Li, WL; Du, YS; Pan, Y; Zhang, DF; Wen, Y; Luo, J; Li, XY; Yao, YG				Xiao, Mei-Sheng; Chang, Le; Li, Wen-Liang; Du, Yong-Sheng; Pan, Yue; Zhang, Deng-Feng; Wen, Yu; Luo, Juan; Li, Xiao-Yan; Yao, Yong-Gang			Genetic Polymorphisms of the CASP8 Gene Promoter May Not Be Associated with Colorectal Cancer in Han Chinese from Southwest China	PLOS ONE			English	Article							INSERTION-DELETION POLYMORPHISM; NON-HODGKIN-LYMPHOMA; SIGNALING PATHWAYS; RISK; APOPTOSIS; SUSCEPTIBILITY; POPULATION; CASPASE-8; CIGARETTES; CARCINOMAS	Purpose: Caspase 8 (CASP8) plays a critical role in the apoptotic pathway and aberrant regulation of this pathway causes many diseases including cancers. Genetic variants rs3834129 (CTTACT/-) and rs3769821 (T/C) in the promoter region of the CASP8 gene were documented to be associated with multiple solid cancers and non-Hodgkin's lymphoma (NHL), respectively, despite of some controversies. We aimed to discern potential association of these two variants and rs113686495 (CTGTCATT/2), as well as CASP8 mRNA and protein expression levels with colorectal cancer (CRC) in Han Chinese. Methods: We genotyped CASP8 genetic variants in 305 CRC patients and 342 healthy individuals from Kunming, Southwest China. Expression levels of CASP8 mRNA and protein were quantified in paired cancerous and paracancerous normal tissues by using real-time quantitative PCR and western blot, respectively. We compared the frequencies of alleles, genotypes, and haplotypes between the cases and controls. Correlation of CASP8 mRNA and protein expression levels in paired cancerous and paracancerous normal tissues from patients with different genotypes and clinical expression were also evaluated. Results: There was no association of the CASP8 genetic variants with CRC in our case-control study. The CASP8 gene mRNA expression levels in cancerous and paracancerous normal tissues were similar and there was no significant difference between subjects with different genotypes and clinical features. However, we found that CASP8 protein level was significantly lower in cancerous tissues than in paired paracancerous normal tissues. Conclusions: Our results suggest that the three CASP8 genetic variants may not be associated with CRC risk in Han Chinese from southwest China. Aberrant CASP8 protein expression may play a role in the pathogenesis of CRC.	[Xiao, Mei-Sheng; Zhang, Deng-Feng; Yao, Yong-Gang] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China; [Chang, Le; Du, Yong-Sheng; Pan, Yue; Wen, Yu; Luo, Juan; Li, Xiao-Yan] Kunming Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Kunming, Peoples R China; [Li, Wen-Liang] Kunming Med Univ, Dept Oncol, Affiliated Hosp 1, Kunming, Peoples R China; [Zhang, Deng-Feng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; Kunming Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XY (corresponding author), Kunming Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Kunming, Peoples R China.	lixiaoyan-0808@163.com; ygyaozh@gmail.com	Zhang, Deng-Feng/K-1125-2015; Xiao, Meisheng/AAE-9432-2020; Yao, Yong-Gang/AAH-2303-2021	Xiao, Meisheng/0000-0001-9601-9598; Yao, Yong-Gang/0000-0002-2955-0693; Zhang, Deng-Feng/0000-0002-0777-5859	Top Talents Program of Yunnan Province [2009CI119]; National Natural Science Foundation of China [30925021]; Chinese Academy of Sciences	Top Talents Program of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Top Talents Program of Yunnan Province (2009CI119), National Natural Science Foundation of China (30925021) and Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CHEAH PY, 1990, NUTR CANCER, V14, P5, DOI 10.1080/01635589009514073; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; De Vecchi G, 2009, BREAST CANCER RES TR, V113, P607, DOI 10.1007/s10549-008-9963-y; Edge S, 2010, AJCC CANC STAGING HD; Frank B, 2008, BREAST CANCER RES TR, V111, P139, DOI 10.1007/s10549-007-9752-z; Gangwar R, 2009, ANN SURG ONCOL, V16, P2028, DOI 10.1245/s10434-009-0488-3; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Haiman CA, 2008, NAT GENET, V40, P259, DOI 10.1038/ng0308-259; Heijink DM, 2007, CELL ONCOL, V29, P409; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HOSHIYAMA Y, 1993, TOHOKU J EXP MED, V171, P153, DOI 10.1620/tjem.171.153; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Lan Q, 2007, CARCINOGENESIS, V28, P823, DOI 10.1093/carcin/bgl196; Lan Q, 2009, BLOOD, V114, P264, DOI 10.1182/blood-2009-01-198697; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ni CH, 2009, J TOXICOL ENV HEAL A, V72, P712, DOI 10.1080/15287390902841102; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Pan Yi-feng, 2011, Zhejiang Da Xue Xue Bao Yi Xue Ban, V40, P245; Pittman AM, 2008, BRIT J CANCER, V98, P1434, DOI 10.1038/sj.bjc.6604314; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Savas S, 2010, HUM MUTAT, V31, P901, DOI 10.1002/humu.21285; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Sun T, 2008, NAT GENET, V40, P260, DOI 10.1038/ng0308-260; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; Umar M, 2011, J SURG ONCOL, V103, P716, DOI 10.1002/jso.21881; Wang ML, 2009, CLIN CANCER RES, V15, P2567, DOI 10.1158/1078-0432.CCR-08-2829; Xiao MS, 2011, ANN HEMATOL, V90, P1137, DOI 10.1007/s00277-011-1265-5; Xu B, 2008, ONCOLOGY-BASEL, V74, P229, DOI 10.1159/000151392; Yao YG, 2005, FEBS LETT, V579, P1227, DOI 10.1016/j.febslet.2005.01.017; Yin M, 2010, CARCINOGENESIS, V31, P850, DOI 10.1093/carcin/bgq047	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67577	10.1371/journal.pone.0067577	http://dx.doi.org/10.1371/journal.pone.0067577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844036	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000060
J	Yu, Y; Li, CF; Kita, A; Katayama, Y; Kubouchi, K; Udo, M; Imanaka, Y; Ueda, S; Masuko, T; Sugiura, R				Yu, Yang; Li, Cuifang; Kita, Ayako; Katayama, Yuta; Kubouchi, Koji; Udo, Masako; Imanaka, Yukako; Ueda, Shiho; Masuko, Takashi; Sugiura, Reiko			Sip1, an AP-1 Accessory Protein in Fission Yeast, Is Required for Localization of Rho3 GTPase	PLOS ONE			English	Article							DISTINCT PHENOTYPES; CYTOKINESIS; INTERACTS; DELETION; COMPLEX; GROWTH	Rho family GTPases act as molecular switches to regulate a range of physiological functions, including the regulation of the actin-based cytoskeleton, membrane trafficking, cell morphology, nuclear gene expression, and cell growth. Rho function is regulated by its ability to bind GTP and by its localization. We previously demonstrated functional and physical interactions between Rho3 and the clathrin-associated adaptor protein-1 (AP-1) complex, which revealed a role of Rho3 in regulating Golgi/endosomal trafficking in fission yeast. Sip1, a conserved AP-1 accessory protein, recruits the AP-1 complex to the Golgi/endosomes through physical interaction. In this study, we showed that Sip1 is required for Rho3 localization. First, overexpression of rho3(+) suppressed defective membrane trafficking associated with sip1-i4 mutant cells, including defects in vacuolar fusion, Golgi/endosomal trafficking and secretion. Notably, Sip1 interacted with Rho3, and GFP-Rho3, similar to Apm1-GFP, did not properly localize to the Golgi/endosomes in sip1-i4 mutant cells at 27 degrees C. Interestingly, the C-terminal region of Sip1 is required for its localization to the Golgi/endosomes, because Sip1-i4-GFP protein failed to properly localize to Golgi/endosomes, whereas the fluorescence of Sip1 Delta N mutant protein co-localized with that of FM4-64. Consistently, in the sip1-i4 mutant cells, which lack the C-terminal region of Sip1, binding between Apm1 and Rho3 was greatly impaired, presumably due to mislocalization of these proteins in the sip1-i4 mutant cells. Furthermore, the interaction between Apm1 and Rho3 as well as Rho3 localization to the Golgi/endosomes were significantly rescued in sip1-i4 mutant cells by the expression of Sip1 Delta N. Taken together, these results suggest that Sip1 recruits Rho3 to the Golgi/endosomes through physical interaction and enhances the formation of the Golgi/endosome AP-1/Rho3 complex, thereby promoting crosstalk between AP-1 and Rho3 in the regulation of Golgi/endosomal trafficking in fission yeast.	[Yu, Yang; Li, Cuifang; Kita, Ayako; Katayama, Yuta; Kubouchi, Koji; Udo, Masako; Imanaka, Yukako; Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 577, Japan; [Li, Cuifang] Japan Soc Promot Sci, Tokyo, Japan; [Ueda, Shiho; Masuko, Takashi] Kinki Univ, Sch Pharmaceut Sci, Mol Cell Biol Lab, Higashiosaka, Osaka 577, Japan	Kindai University (Kinki University); Japan Society for the Promotion of Science; Kindai University (Kinki University)	Sugiura, R (corresponding author), Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 577, Japan.	sugiurar@phar.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [11J10625] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Edamatsu M, 2003, BIOCHEM BIOPH RES CO, V301, P641, DOI 10.1016/S0006-291X(03)00017-2; Estravis M, 2011, TRAFFIC, V12, P1744, DOI 10.1111/j.1600-0854.2011.01275.x; Fernandez GE, 2006, MOL BIOL CELL, V17, P3304, DOI 10.1091/mbc.E06-02-0096; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hirst J, 2005, MOL BIOL CELL, V16, P2554, DOI 10.1091/mbc.E04-12-1077; Jourdain I, 2009, BIOCHEM J, V420, P169, DOI 10.1042/BJ20081659; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016842; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045324	24	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68488	10.1371/journal.pone.0068488	http://dx.doi.org/10.1371/journal.pone.0068488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840894	gold, Green Published, Green Submitted			2022-12-27	WOS:000321271900033
J	Brock, PM; Hall, AJ; Goodman, SJ; Cruz, M; Acevedo-Whitehouse, K				Brock, Patrick M.; Hall, Ailsa J.; Goodman, Simon J.; Cruz, Marilyn; Acevedo-Whitehouse, Karina			Immune Activity, Body Condition and Human-Associated Environmental Impacts in a Wild Marine Mammal	PLOS ONE			English	Article							INFECTIOUS-DISEASES; COST; SIZE; MASS; SURVIVAL; DEFENSE; VARIABILITY; ALLOCATION; EVOLUTION; SYSTEM	Within individuals, immunity may compete with other life history traits for resources, such as energy and protein, and the damage caused by immunopathology can sometimes outweigh the protective benefits that immune responses confer. However, our understanding of the costs of immunity in the wild and how they relate to the myriad energetic demands on free-ranging organisms is limited. The endangered Galapagos sea lion (Zalophus wollebaeki) is threatened simultaneously by disease from domestic animals and rapid changes in food availability driven by unpredictable environmental variation. We made use of this unique ecology to investigate the relationship between changes in immune activity and changes in body condition. We found that during the first three months of life, changes in antibody concentration were negatively correlated with changes in mass per unit length, skinfold thickness and serum albumin concentration, but only in a sea lion colony exposed to anthropogenic environmental impacts. It has previously been shown that changes in antibody concentration during early Galapagos sea lion development were higher in a colony exposed to anthropogenic environmental impacts than in a control colony. This study allows for the possibility that these relatively large changes in antibody concentration are associated with negative impacts on fitness through an effect on body condition. Our findings suggest that energy availability and the degree of plasticity in immune investment may influence disease risk in natural populations synergistically, through a trade-off between investment in immunity and resistance to starvation. The relative benefits of such investments may change quickly and unpredictably, which allows for the possibility that individuals fine-tune their investment strategies in response to changes in environmental conditions. In addition, our results suggest that anthropogenic environmental impacts may impose subtle energetic costs on individuals, which could contribute to population declines, especially in times of energy shortage.	[Brock, Patrick M.; Acevedo-Whitehouse, Karina] Zool Soc London, Inst Zool, London NW1 4RY, England; [Brock, Patrick M.; Goodman, Simon J.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Hall, Ailsa J.] Univ St Andrews, Sea Mammal Res Unit, St Andrews KY16 9AJ, Fife, Scotland; [Cruz, Marilyn] Galapagos Natl Pk, Galapagos Genet, Epidemiol & Pathol Lab, Puerto Ayora, Ecuador; [Acevedo-Whitehouse, Karina] Autonomous Univ Queretaro, Unit Basic & Appl Microbiol, Queretaro, Mexico	Zoological Society of London; University of Leeds; University of St Andrews; Universidad Autonoma de Queretaro	Brock, PM (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	p.brock@imperial.ac.uk; karina.acevedo.whitehouse@uaq.mx	Hall, Ailsa/E-1596-2011	Brock, Paddy/0000-0002-1035-1619; Hall, Ailsa/0000-0002-7562-1771; Goodman, Simon/0000-0003-4118-8575	Natural Environment Research Council; Universities Federation for Animal Welfare; Sea Mammal Research Unit; Natural Environment Research Council [smru10001] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Universities Federation for Animal Welfare; Sea Mammal Research Unit; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PMB was funded by the Natural Environment Research Council (www.nerc.ac.uk), the Universities Federation for Animal Welfare (www.ufaw.org.uk) and the Sea Mammal Research Unit (www.smru.st-and.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiainen JJ, 2005, J EVOLUTION BIOL, V18, P985, DOI 10.1111/j.1420-9101.2005.00907.x; Alava JJ, 2011, THESIS S FRASER U CA; Alava JJ, 2009, ENVIRON TOXICOL CHEM, V28, P2271, DOI 10.1897/08-331.1; Alava JJ, 2006, LOW WAKE FI, P495; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Aurioles D., 2008, ZALOPHUS WOLLEBAEKI; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bossart GD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P383, DOI 10.1201/9781420041637.sec4; Brock PM, 2013, ANIM CONSERV, V16, P19, DOI 10.1111/j.1469-1795.2012.00567.x; Cordoba DR, 2008, WATER QUALITY MONITO, P1; Cunningham AA, 2003, J PARASITOL, V89, P78; Day MJ, 2007, J COMP PATHOL, V137, pS10, DOI 10.1016/j.jcpa.2007.04.005; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Dubiec A, 2006, P R SOC B, V273, P1759, DOI 10.1098/rspb.2006.3510; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Eraud C, 2009, EVOLUTION, V63, P1036, DOI 10.1111/j.1558-5646.2008.00540.x; Field IC, 2007, MAR ECOL PROG SER, V331, P281, DOI 10.3354/meps331281; FREITAS AA, 1991, P NATL ACAD SCI USA, V88, P5640, DOI 10.1073/pnas.88.13.5640; Graham AL, 2011, FUNCT ECOL, V25, P5, DOI 10.1111/j.1365-2435.2010.01777.x; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Hall AJ, 2007, MAR MAMMAL SCI, V23, P650, DOI 10.1111/j.1748-7692.2007.00132.x; Hall AJ, 2002, FUNCT ECOL, V16, P462, DOI 10.1046/j.1365-2435.2002.00649.x; Hall AJ, 2001, J ANIM ECOL, V70, P138; Hewison AJM, 2011, OIKOS, V120, P1217, DOI 10.1111/j.1600-0706.2011.19316.x; Iverson S., 2002, ENCY MARINE MAMMALS, P107; Levy JK, 2008, J VET INTERN MED, V22, P60, DOI 10.1111/j.1939-1676.2007.0034.x; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Luque SP, 2001, MAR MAMMAL SCI, V17, P147, DOI 10.1111/j.1748-7692.2001.tb00985.x; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin LB, 2011, FUNCT ECOL, V25, P1, DOI 10.1111/j.1365-2435.2010.01820.x; Martin LB, 2007, AM J PHYSIOL-REG I, V292, pR316, DOI 10.1152/ajpregu.00386.2006; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; McDade TW, 2003, YEARB PHYS ANTHROPOL, V46, P100, DOI 10.1002/ajpa.10398; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; McKean KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-76; Moreno-Rueda G, 2010, P ROY SOC B-BIOL SCI, V277, P2083, DOI 10.1098/rspb.2010.0109; Mueller B, 2011, MAR MAMMAL SCI, V27, P350, DOI 10.1111/j.1748-7692.2010.00404.x; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Pond C.M., 1998, FATS LIFE; R Development Core Team, 2011, R LANG ENV STAT COMP; Rodriguez A, 2000, ACTA OCEANOGRAFICA P, V10, P79; Romano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022805; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Schmid-Hempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P98; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Tizard I. R., 2009, VET IMMUNOLOGY; Townsend AK, 2010, P ROY SOC B-BIOL SCI, V277, P2875, DOI 10.1098/rspb.2010.0480; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Ujvari B, 2006, BEHAV ECOL, V17, P20, DOI 10.1093/beheco/ari091; Uller T, 2006, FUNCT ECOL, V20, P873, DOI 10.1111/j.1365-2435.2006.01163.x; Valtonen TM, 2010, EVOL BIOL, V37, P49, DOI 10.1007/s11692-009-9078-3; van Boven M, 2004, AM NAT, V163, P277, DOI 10.1086/381407; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Verhulst S, 2005, J AVIAN BIOL, V36, P22, DOI 10.1111/j.0908-8857.2005.03342.x; Williams TM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P433, DOI 10.1086/518346; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002; Wolf JBW, 2007, OECOLOGIA, V152, P553, DOI 10.1007/s00442-007-0665-7; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; Zuur Alain F., 2009, P1	65	34	34	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67132	10.1371/journal.pone.0067132	http://dx.doi.org/10.1371/journal.pone.0067132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840603	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000321148400035
J	Dezecache, G; Conty, L; Chadwick, M; Philip, L; Soussignan, R; Sperber, D; Grezes, J				Dezecache, Guillaume; Conty, Laurence; Chadwick, Michele; Philip, Leonor; Soussignan, Robert; Sperber, Dan; Grezes, Julie			Evidence for Unintentional Emotional Contagion Beyond Dyads	PLOS ONE			English	Article							FACIAL ELECTROMYOGRAPHIC RESPONSES; EXPRESSIONS; MIMICRY; BEHAVIOR; FACES; FEAR	Little is known about the spread of emotions beyond dyads. Yet, it is of importance for explaining the emergence of crowd behaviors. Here, we experimentally addressed whether emotional homogeneity within a crowd might result from a cascade of local emotional transmissions where the perception of another's emotional expression produces, in the observer's face and body, sufficient information to allow for the transmission of the emotion to a third party. We reproduced a minimal element of a crowd situation and recorded the facial electromyographic activity and the skin conductance response of an individual C observing the face of an individual B watching an individual A displaying either joy or fear full body expressions. Critically, individual B did not know that she was being watched. We show that emotions of joy and fear displayed by A were spontaneously transmitted to C through B, even when the emotional information available in B's faces could not be explicitly recognized. These findings demonstrate that one is tuned to react to others' emotional signals and to unintentionally produce subtle but sufficient emotional cues to induce emotional states in others. This phenomenon could be the mark of a spontaneous cooperative behavior whose function is to communicate survival-value information to conspecifics.	[Dezecache, Guillaume; Chadwick, Michele; Philip, Leonor; Grezes, Julie] Ecole Normale Super, INSERM, U960, LNC, F-75231 Paris, France; [Dezecache, Guillaume; Chadwick, Michele; Philip, Leonor; Sperber, Dan; Grezes, Julie] Ecole Normale Super, IEC, F-75231 Paris, France; [Dezecache, Guillaume; Sperber, Dan] Ecole Normale Super, CNRS, UMR 8129, IJN, Paris, France; [Dezecache, Guillaume; Sperber, Dan] Ecole Hautes Etud Sci Sociales ENS EHESS, Paris, France; [Conty, Laurence] Univ Paris 08, EA2027, LPN, St Denis, France; [Soussignan, Robert] Univ Bourgogne, CNRS, UMR 6265, CSGA,INRA 1324, Dijon, France; [Sperber, Dan] CEU, Dept Cognit Sci, Budapest, Hungary	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Ecole des Hautes Etudes en Sciences Sociales (EHESS); Universite Paris-VIII; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Central European University	Dezecache, G (corresponding author), Ecole Normale Super, INSERM, U960, LNC, 24 Rue Lhomond, F-75231 Paris, France.	guillaume.dezecache@ens.fr; julie.grezes@ens.fr	Grèzes, Julie/E-5060-2016; Grezes, julie/I-3012-2019	Grèzes, Julie/0000-0002-5066-9154; Grezes, julie/0000-0002-5066-9154; Dezecache, Guillaume/0000-0002-9366-6287	DGA-MRIS scholarship; Agence National of Research (ANR) [ANR 11 EMCO 00902, ANR-11-0001-02 PSL, ANR-10-LABX-0087]	DGA-MRIS scholarship; Agence National of Research (ANR)(French National Research Agency (ANR))	The research was supported by a DGA-MRIS scholarship and the Agence National of Research (ANR) "Emotion(s), Cognition, Comportement" 2011 program (ANR 11 EMCO 00902), as well as an ANR-11-0001-02 PSL*, and an ANR-10-LABX-0087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; BAVELAS JB, 1986, J PERS SOC PSYCHOL, V50, P322, DOI 10.1037/0022-3514.50.2.322; Buss DM, 2000, AM PSYCHOL, V55, P15, DOI 10.1037/0003-066X.55.1.15; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; CHOVIL N, 1991, J NONVERBAL BEHAV, V15, P141, DOI 10.1007/BF01672216; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Dimberg U, 1998, SCAND J PSYCHOL, V39, P75, DOI 10.1111/1467-9450.00059; Ekman P., 2002, FACIAL ACTION CODING; FRIDLUND AJ, 1991, J PERS SOC PSYCHOL, V60, P229, DOI 10.1037/0022-3514.60.2.229; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; FRITH CD, 1983, BIOL PSYCHOL, V17, P27, DOI 10.1016/0301-0511(83)90064-9; Grezes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055885; Hall Judith A., 1990, NONVERBAL SEX DIFFER; Hatfield E., 1994, REV PERSONALITY SOCI; Hess U, 1998, COGNITION EMOTION, V12, P509, DOI 10.1080/026999398379547; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hietanen JK, 1998, PSYCHOPHYSIOLOGY, V35, P530, DOI 10.1017/S0048577298970445; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Le Bon G, 1896, PSYCHOL FOULES; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; Magnee MJCM, 2007, NEUROREPORT, V18, P369, DOI 10.1097/WNR.0b013e32801776e6; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Moody E. J., 2006, IMITATION SOCIAL MIN, V71; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Niedenthal PM, 2012, ANNU REV PSYCHOL, V63, P259, DOI 10.1146/annurev.psych.121208.131605; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Raafat RM, 2009, TRENDS COGN SCI, V13, P420, DOI 10.1016/j.tics.2009.08.002; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Sequeira H, 2009, INT J PSYCHOPHYSIOL, V71, P50, DOI 10.1016/j.ijpsycho.2008.07.009; Sighele S., 1901, FOULE CRIMINELLE ESS; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Soussignan R, 2013, EMOTION, V13, P330, DOI 10.1037/a0029892; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Tarde, 1890, LOIS LIMITATION TUDE	37	32	34	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67371	10.1371/journal.pone.0067371	http://dx.doi.org/10.1371/journal.pone.0067371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840683	Green Published, gold			2022-12-27	WOS:000321148400072
J	Fuchino, Y; Naoi, N; Shibata, M; Niwa, F; Kawai, M; Konishi, Y; Okanoya, K; Myowa-Yamakoshi, M				Fuchino, Yutaka; Naoi, Nozomi; Shibata, Minoru; Niwa, Fusako; Kawai, Masahiko; Konishi, Yukuo; Okanoya, Kazuo; Myowa-Yamakoshi, Masako			Effects of Preterm Birth on Intrinsic Fluctuations in Neonatal Cerebral Activity Examined Using Optical Imaging	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; ANTERIOR CINGULATE; DEFAULT NETWORK; WEIGHT INFANTS; CHILDREN BORN; RISK-FACTORS; BRAIN; CORTEX	Medical advancements in neonatology have significantly increased the number of high-risk preterm survivors. However, recent long-term follow-up studies have suggested that preterm infants are at risk for behavioral, educational, and emotional problems. Although clear relationships have been demonstrated between preterm infants and developmental problems during childhood and adolescence, less is known about the early indications of these problems. Recently, numerous studies on resting-state functional connectivity (RSFC) have demonstrated temporal correlations of activity between spatially remote cortical regions not only in healthy adults but also in neuropathological disorders and early childhood development. In order to compare RSFC of the cerebral cortex between preterm infants at term-equivalent ages and full-term neonates without any anatomical abnormality risk during natural sleep, we used an optical topography system, which is a recently developed extension of near-infrared spectroscopy. We clarified the presence of RSFC in both preterm infants and full-term neonates and showed differences between these groups. The principal differences were that on comparison of RSFC between the bilateral temporal regions, and bilateral parietal regions, RSFC was enhanced in preterm infants compared with full-term neonates; whereas on comparison of RSFC between the left temporal and left parietal regions, RSFC was enhanced in full-term neonates compared with preterm infants. We also demonstrated a difference between the groups in developmental changes of RSFC related to postmenstrual age. Most importantly, these findings suggested that preterm infants and full-term neonates follow different developmental trajectories during the perinatal period because of differences in perinatal experiences and physiological and structural development.	[Fuchino, Yutaka; Naoi, Nozomi; Shibata, Minoru; Niwa, Fusako; Okanoya, Kazuo; Myowa-Yamakoshi, Masako] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Okanoya Emot Informat Project, Kawaguchi, Saitama, Japan; [Fuchino, Yutaka; Naoi, Nozomi; Myowa-Yamakoshi, Masako] Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto, Japan; [Shibata, Minoru; Niwa, Fusako; Kawai, Masahiko] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Konishi, Yukuo] Doshisha Univ, Ctr Baby Sci, Kyoto 602, Japan; [Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Okanoya, Kazuo] RIKEN Brain Sci Inst, Wako, Saitama, Japan	Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; Doshisha University; University of Tokyo; RIKEN	Fuchino, Y (corresponding author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Okanoya Emot Informat Project, Kawaguchi, Saitama, Japan.	yfuchino@tmu.ac.jp	Myowa, Masako/E-8965-2010	Kawai, Masahiko/0000-0002-3347-5155	Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project	Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project	This work is supported by funding from the Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Burns A., 2011, P 2011 IEEE 32 REAL, P1; Clark CAC, 2008, CHILD DEV, V79, P1444, DOI 10.1111/j.1467-8624.2008.01198.x; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Ebisch SJH, 2011, HUM BRAIN MAPP, V32, P1013, DOI 10.1002/hbm.21085; Eswaran H, 2004, EXP NEUROL, V190, pS52, DOI 10.1016/j.expneurol.:2004.04.007; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Gaddlin PO, 2011, ACTA PAEDIATR, V100, P940, DOI 10.1111/j.1651-2227.2011.02288.x; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Geng XJ, 2012, NEUROIMAGE, V61, P542, DOI 10.1016/j.neuroimage.2012.03.057; Gerhardt K J, 2000, J Perinatol, V20, pS21; Hayes B, 2009, J MATERN-FETAL NEO M, V22, P849, DOI 10.1080/14767050902994507; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Itabashi K, 2009, PEDIATRICS, V123, P445, DOI 10.1542/peds.2008-0763; JACQUES SL, 1987, PHOTOCHEM PHOTOBIOL, V45, P637, DOI 10.1111/j.1751-1097.1987.tb07391.x; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kusuda S, 2006, PEDIATRICS, V118, pE1130, DOI 10.1542/peds.2005-2724; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Lax ID, 2012, BRAIN STRUCT FUNCT; Limperopoulos C, 2005, PEDIATRICS, V116, P844, DOI 10.1542/peds.2004-2282; Lin W, 2008, AM J NEURORADIOL, V29, P1883, DOI 10.3174/ajnr.A1256; Liu WC, 2008, BRAIN RES, V1223, P42, DOI 10.1016/j.brainres.2008.05.054; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Matsuishi T, 1999, J AUTISM DEV DISORD, V29, P161, DOI 10.1023/A:1023048812202; Naoi N, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00094; Parraguez VH, 1998, ANIM REPROD SCI, V52, P123, DOI 10.1016/S0378-4320(98)00094-3; Pritchard VE, 2009, EARLY HUM DEV, V85, P215, DOI 10.1016/j.earlhumdev.2008.10.004; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sasai S, 2011, NEUROIMAGE, V56, P252, DOI 10.1016/j.neuroimage.2010.12.075; Schleussner E, 2004, EXP NEUROL, V190, pS59, DOI 10.1016/j.expneurol.2004.04.008; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Srinivasan L, 2007, PEDIATRICS, V119, P759, DOI 10.1542/peds.2006-2508; Sun L, 2012, PSYCHIAT RES-NEUROIM, V201, P120, DOI 10.1016/j.pscychresns.2011.07.001; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Taga G, 2007, NEUROIMAGE, V38, P452, DOI 10.1016/j.neuroimage.2007.07.050; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; White BR, 2012, NEUROIMAGE, V59, P2529, DOI 10.1016/j.neuroimage.2011.08.094; Zhang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051584; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	58	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67432	10.1371/journal.pone.0067432	http://dx.doi.org/10.1371/journal.pone.0067432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840698	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400080
J	Kim, HJ; Pourmand, N				Kim, Hyunsung John; Pourmand, Nader			HLA Haplotyping from RNA-seq Data Using Hierarchical Read Weighting	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; HIGH-RESOLUTION HLA; HIGH-THROUGHPUT; GENE FUSIONS; GENERATION; CANCER; MHC; NOMENCLATURE; POPULATION; ALLELES	Correctly matching the HLA haplotypes of donor and recipient is essential to the success of allogenic hematopoietic stem cell transplantation. Current HLA typing methods rely on targeted testing of recognized antigens or sequences. Despite advances in Next Generation Sequencing, general high throughput transcriptome sequencing is currently underutilized for HLA haplotyping due to the central difficulty in aligning sequences within this highly variable region. Here we present the method, HLAforest, that can accurately predict HLA haplotype by hierarchically weighting reads and using an iterative, greedy, top down pruning technique. HLAforest correctly predicts >99% of allele group level (2 digit) haplotypes and 93% of peptide-level (4 digit) haplotypes of the most diverse HLA genes in simulations with read lengths and error rates modeling currently available sequencing technology. The method is very robust to sequencing error and can predict 99% of allele-group level haplotypes with substitution rates as high as 8.8%. When applied to data generated from a trio of cell lines, HLAforest corroborated PCR-based HLA haplotyping methods and accurately predicted 16/18 (89%) major class I genes for a daughter-father-mother trio at the peptide level. Major class II genes were predicted with 100% concordance between the daughter-father-mother trio. In fifty HapMap samples with paired end reads just 37 nucleotides long, HLAforest predicted 96.5% of allele group level HLA haplotypes correctly and 83% of peptide level haplotypes correctly. In sixteen RNAseq samples with limited coverage across HLA genes, HLAforest predicted 97.7% of allele group level haplotypes and 85% of peptide level haplotypes correctly.	[Kim, Hyunsung John; Pourmand, Nader] Univ Calif Santa Cruz, Dept Biomol Engn, Baskin Sch Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Kim, HJ (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Baskin Sch Engn, Santa Cruz, CA 95064 USA.	hyjkim@soe.ucsc.edu; pourmand@soe.ucsc.edu		Pourmand, Nader/0000-0003-0251-9060	NIH [U19 AI089987]; NCI [U54CA143803]; NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089987] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported in part by NIH (nih.gov) grant U19 AI089987 and NCI (cancer.gov) grant U54CA143803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; Boegel S, 2012, GENOME MED, V4, DOI 10.1186/gm403; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel C, 2009, HUM IMMUNOL, V70, P960, DOI 10.1016/j.humimm.2009.08.009; Holcomb CL, 2011, TISSUE ANTIGENS, V77, P206, DOI 10.1111/j.1399-0039.2010.01606.x; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Krishnakumar S, 2012, TISSUE ANTIGENS, V79, P426; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lank SM, 2010, HUM IMMUNOL, V71, P1011, DOI 10.1016/j.humimm.2010.07.012; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lind C, 2010, HUM IMMUNOL, V71, P1033, DOI 10.1016/j.humimm.2010.06.016; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; PARHAM P, 1989, J IMMUNOL, V142, P3937; Park I, 2000, HUM IMMUNOL, V61, P185, DOI 10.1016/S0198-8859(99)00154-8; Paunic V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043585; Proll J, 2011, DNA RES, V18, P201, DOI 10.1093/dnares/dsr008; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Tait BD, 2011, TRANSPLANT REV-ORLAN, V25, P1, DOI 10.1016/j.trre.2010.08.001; Warren RL, 2012, GENOME MED, V4, DOI 10.1186/gm396; Warren RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019816; Williams A, 2002, TISSUE ANTIGENS, V59, P3, DOI 10.1034/j.1399-0039.2002.590103.x	34	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67885	10.1371/journal.pone.0067885	http://dx.doi.org/10.1371/journal.pone.0067885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840783	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400139
J	Lai, YC; Chen, YF; Chiang, YW				Lai, Yei-Chen; Chen, Yi-Fan; Chiang, Yun-Wei			ESR Study of Interfacial Hydration Layers of Polypeptides in Water-Filled Nanochannels and in Vitrified Bulk Solvents	PLOS ONE			English	Article							PAIR DISTANCE DISTRIBUTIONS; PROTEIN HYDRATION; ESEEM SPECTROSCOPY; DYNAMIC CROSSOVER; X-RAY; SPIN; MESOPORES; MECHANISM; RESIDUES; PROBES	There is considerable evidence for the essential role of surface water in protein function and structure. However, it is unclear to what extent the hydration water and protein are coupled and interact with each other. Here, we show by ESR experiments (cw, DEER, ESEEM, and ESE techniques) with spin-labeling and nanoconfinement techniques that the vitrified hydration layers can be evidently recognized in the ESR spectra, providing nanoscale understanding for the biological interfacial water. Two peptides of different secondary structures and lengths are studied in vitrified bulk solvents and in water-filled nanochannels of different pore diameter (6.1 similar to 7.6 nm). The existence of surface hydration and bulk shells are demonstrated. Water in the immediate vicinity of the nitroxide label (within the van der Waals contacts, similar to 0.35 nm) at the water-peptide interface is verified to be non-crystalline at 50 K, and the water accessibility changes little with the nanochannel dimension. Nevertheless, this water accessibility for the nanochannel cases is only half the value for the bulk solvent, even though the peptide structures remain largely the same as those immersed in the bulk solvents. On the other hand, the hydration density in the range of similar to 2 nm from the nitroxide spin increases substantially with decreasing pore size, as the density for the largest pore size (7.6 nm) is comparable to that for the bulk solvent. The results demonstrate that while the peptides are confined but structurally unaltered in the nanochannels, their surrounding water exhibits density heterogeneity along the peptide surface normal. The causes and implications, especially those involving the interactions between the first hydration water and peptides, of these observations are discussed. Spin-label ESR techniques are proven useful for studying the structure and influences of interfacial hydration.	[Lai, Yei-Chen; Chiang, Yun-Wei] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Lai, Yei-Chen; Chiang, Yun-Wei] Natl Tsing Hua Univ, Frontier Res Ctr Fundamental & Appl Sci Matters, Hsinchu, Taiwan; [Chen, Yi-Fan] Natl Cent Univ, Dept Chem & Mat Engn, Jhongli, Taiwan	National Tsing Hua University; National Tsing Hua University; National Central University	Chiang, YW (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan.	ywchiang@mx.nthu.edu.tw	Lai, Yei-Chen/AAT-5314-2021; Chiang, Yun-Wei/AAK-4285-2020; Chen, Yi-Fan/HII-7531-2022	Lai, Yei-Chen/0000-0002-5723-5412; Chiang, Yun-Wei/0000-0002-2101-8918; Chen, Yi-Fan/0000-0001-5421-9233	Taiwan NSC [NSC100-2113-M-007-013-MY2]	Taiwan NSC(Ministry of Science and Technology, Taiwan)	This work was supported by Taiwan NSC grants, NSC100-2113-M-007-013-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Banerjee D, 2009, P NATL ACAD SCI USA, V106, P11448, DOI 10.1073/pnas.0900734106; Banerjee D, 2012, PLOS ONE, V7; Borbat PP, 2007, METHOD ENZYMOL, V423, P52, DOI 10.1016/S0076-6879(07)23003-4; Bourgeois D, 2005, CURR OPIN STRUC BIOL, V15, P538, DOI 10.1016/j.sbi.2005.08.002; Carmieli R, 2006, BIOPHYS J, V90, P492, DOI 10.1529/biophysj.105.062992; Chen SH, 2006, P NATL ACAD SCI USA, V103, P9012, DOI 10.1073/pnas.0602474103; Chiang YW, 2005, J MAGN RESON, V177, P184, DOI 10.1016/j.jmr.2005.07.021; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Deligiannakis Y, 2000, COORDIN CHEM REV, V204, P1, DOI 10.1016/S0010-8545(99)00218-0; Engemann S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.205701; Erilov DA, 2005, J PHYS CHEM B, V109, P12003, DOI 10.1021/jp050886z; Fleissner MR, 2011, P NATL ACAD SCI USA, V108, P16241, DOI 10.1073/pnas.1111420108; Gallat FX, 2012, J AM CHEM SOC, V134, P13168, DOI 10.1021/ja303894g; Gallo P, 2010, J PHYS CHEM LETT, V1, P729, DOI 10.1021/jz9003125; Georgieva ER, 2012, J MAGN RESON, V216, P69, DOI 10.1016/j.jmr.2012.01.004; Halle B, 2004, P NATL ACAD SCI USA, V101, P4793, DOI 10.1073/pnas.0308315101; Halle B, 2004, PHILOS T R SOC B, V359, P1207, DOI 10.1098/rstb.2004.1499; Huang YW, 2011, PHYS CHEM CHEM PHYS, V13, P17521, DOI 10.1039/c1cp20986h; Huang YW, 2011, P NATL ACAD SCI USA, V108, P14145, DOI 10.1073/pnas.1102395108; ICHIKAWA T, 1979, J CHEM PHYS, V71, P1167, DOI 10.1063/1.438462; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Juers DH, 2001, J MOL BIOL, V311, P851, DOI 10.1006/jmbi.2001.4891; Kim J, 2006, J PHYS CHEM B, V110, P21994, DOI 10.1021/jp062806c; Kohtani M, 2004, J AM CHEM SOC, V126, P7420, DOI 10.1021/ja048766c; Kozin SA, 2001, J BIOL CHEM, V276, P46364, DOI 10.1074/jbc.M108014200; Kriminski S, 2003, ACTA CRYSTALLOGR D, V59, P697, DOI 10.1107/S0907444903002713; KUNTZ ID, 1969, SCIENCE, V163, P1329, DOI 10.1126/science.163.3873.1329; Megy S, 2004, PROTEIN SCI, V13, P3151, DOI 10.1110/ps.04745004; Merzel F, 2002, P NATL ACAD SCI USA, V99, P5378, DOI 10.1073/pnas.082335099; Milischuk AA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3657408; Milov AD, 1999, CHEM PHYS LETT, V303, P135, DOI 10.1016/S0009-2614(99)00220-1; MORROW BA, 1994, ADV CHEM SER, V234, P183; Nucci NV, 2011, J AM CHEM SOC, V133, P12326, DOI 10.1021/ja202033k; Ortony JH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/015006; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; Parkin S, 1996, ACTA CRYSTALLOGR D, V52, P18, DOI 10.1107/S0907444995008675; Pinnick ER, 2010, MOL PHYS, V108, P2027, DOI 10.1080/00268976.2010.503199; Qiu WH, 2006, P NATL ACAD SCI USA, V103, P13979, DOI 10.1073/pnas.0606235103; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Sandalova T, 1999, ACTA CRYSTALLOGR D, V55, P610, DOI 10.1107/S090744499801381X; Schiro G, 2011, J PHYS CHEM LETT, V2, P2275, DOI 10.1021/jz200797g; Smirnova TI, 2007, J AM CHEM SOC, V129, P3476, DOI 10.1021/ja068395v; Smith JV, 1999, P NATL ACAD SCI USA, V96, P3479, DOI 10.1073/pnas.96.7.3479; Stoll S, 2009, PHYS CHEM CHEM PHYS, V11, P6614, DOI 10.1039/b907277b; Sung TC, 2010, PHYS CHEM CHEM PHYS, V12, P13117, DOI 10.1039/c0cp00685h; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Swenson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.247802; Theisen MJ, 2004, P NATL ACAD SCI USA, V101, P16442, DOI 10.1073/pnas.0405809101; Tong JS, 2009, P NATL ACAD SCI USA, V106, P5141, DOI 10.1073/pnas.0813138106; Tsai CJ, 2012, J PHYS CHEM C, V116, P19798, DOI 10.1021/jp306478c; Volkov A, 2009, BIOPHYS J, V96, P1124, DOI 10.1016/j.bpj.2008.09.047; von Hagens T, 2013, PHYS CHEM CHEM PHYS, V15, P5854, DOI 10.1039/c3cp44462g; Yang CM, 2004, CHEM MATER, V16, P2918, DOI 10.1021/cm049526z; Zecevic A, 1998, MOL PHYS, V95, P1255, DOI 10.1080/00268979809483256	58	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68264	10.1371/journal.pone.0068264	http://dx.doi.org/10.1371/journal.pone.0068264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840841	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400183
J	Lin, B; Peng, EB				Lin, Bin; Peng, Edward Bo			Retinal Ganglion Cells are Resistant to Photoreceptor Loss in Retinal Degeneration	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; MOUSE RETINA; VISUAL FUNCTION; MORPHOLOGICAL CLASSIFICATION; MORPHOMETRIC-ANALYSIS; CONE PHOTORECEPTORS; NEUROTROPHIC FACTOR; ECTOPIC EXPRESSION; ENHANCED SURVIVAL; SYNAPTIC INPUT	The rapid and massive degeneration of photoreceptors in retinal degeneration might have a dramatic negative effect on retinal circuits downstream of photoreceptors. However, the impact of photoreceptor loss on the morphology and function of retinal ganglion cells (RGCs) is not fully understood, precluding the rational design of therapeutic interventions that can reverse the progressive loss of retinal function. The present study investigated the morphological changes in several identified RGCs in the retinal degeneration rd1 mouse model of retinitis pigmentosa (RP), using a combination of viral transfection, microinjection of neurobiotin and confocal microscopy. Individual RGCs were visualized with a high degree of detail using an adeno-associated virus (AAV) vector carrying the gene for enhanced green fluorescent protein (EGFP), allowed for large-scale surveys of the morphology of RGCs over a wide age range. Interestingly, we found that the RGCs of nine different types we encountered were especially resistant to photoreceptor degeneration, and retained their fine dendritic geometry well beyond the complete death of photoreceptors. In addition, the RGC-specific markers revealed a remarkable degree of stability in both morphology and numbers of two identified types of RGCs for up to 18 months of age. Collectively, our data suggest that ganglion cells, the only output cells of the retina, are well preserved morphologically, indicating the ganglion cell population might be an attractive target for treating vision loss.	[Lin, Bin; Peng, Edward Bo] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Lin, Bin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Pokfulam, Hong Kong, Peoples R China; [Lin, Bin; Peng, Edward Bo] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Lin, B (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	blin@hku.hk	Peng, Bo/AAU-3941-2021; Peng, Bo/W-5129-2019; Peng, Bo/A-7125-2017; Lin, Bin/E-9871-2010	Peng, Bo/0000-0003-4183-5939; Peng, Bo/0000-0003-4183-5939; Peng, Bo/0000-0003-4183-5939; Lin, Bin/0000-0003-1309-3480	University of Hong Kong Seed Funding Program for Basic Research and General Research Fund from the Hong Kong Research Grants Council [772810]	University of Hong Kong Seed Funding Program for Basic Research and General Research Fund from the Hong Kong Research Grants Council	This work was supported by The University of Hong Kong Seed Funding Program for Basic Research and General Research Fund from the Hong Kong Research Grants Council (772810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; BAYES M, 1995, HUM MUTAT, V5, P228, DOI 10.1002/humu.1380050307; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; BLANKS JC, 1974, J COMP NEUROL, V156, P81, DOI 10.1002/cne.901560107; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Chen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044036; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; Contini M, 2010, J COMP NEUROL, V518, P2035, DOI 10.1002/cne.22320; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Damiani D, 2012, J COMP NEUROL, V520, P1406, DOI 10.1002/cne.22802; de Zavalia N, 2011, J NEUROCHEM, V117, P904, DOI 10.1111/j.1471-4159.2011.07260.x; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; DOI M, 1995, J COMP NEUROL, V356, P368, DOI 10.1002/cne.903560305; DRAGER UC, 1978, J COMP NEUROL, V180, P85, DOI 10.1002/cne.901800107; DRAGER UC, 1984, J NEUROSCI, V4, P2025; EISENFELD AJ, 1984, J COMP NEUROL, V223, P22, DOI 10.1002/cne.902230103; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Garcia-Ayuso D, 2010, EXP EYE RES, V91, P800, DOI 10.1016/j.exer.2010.10.003; GARCIAFERNANDEZ JM, 1995, NEUROSCI LETT, V187, P33; GRAFSTEI.B, 1972, BRAIN RES, V44, P37, DOI 10.1016/0006-8993(72)90364-2; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HAYDEN SA, 1980, SCIENCE, V210, P435, DOI 10.1126/science.7433984; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; KOLB H, 1974, INVEST OPHTH VISUAL, V13, P487; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LaVail MM, 1997, EXP EYE RES, V65, P45, DOI 10.1006/exer.1997.0308; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Li SY, 2008, CELL MOL NEUROBIOL, V28, P1095, DOI 10.1007/s10571-008-9286-x; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Martin KR, 2002, INVEST OPHTH VIS SCI, V44, P4357; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Schmidt TM, 2011, J COMP NEUROL, V519, P1492, DOI 10.1002/cne.22579; Sekirnjak C, 2009, J NEUROPHYSIOL, V102, P3260, DOI 10.1152/jn.00663.2009; Spalding KL, 2004, J NEUROBIOL, V60, P319, DOI 10.1002/neu.20028; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; STONE JL, 1992, ARCH OPHTHALMOL-CHIC, V110, P1634, DOI 10.1001/archopht.1992.01080230134038; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Villegas-Perez MP, 1998, J COMP NEUROL, V392, P58, DOI 10.1002/(SICI)1096-9861(19980302)392:1<58::AID-CNE5>3.0.CO;2-O; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang SM, 2000, INVEST OPHTH VIS SCI, V41, P537; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Wyatt TJ, 2010, EXPERT OPIN BIOL TH, V10, P1587, DOI 10.1517/14712598.2010.529895; Zhang J, 2003, BRAIN RES, V959, P111, DOI 10.1016/S0006-8993(02)03735-6; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	69	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68084	10.1371/journal.pone.0068084	http://dx.doi.org/10.1371/journal.pone.0068084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840814	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400161
J	Owens, P; Polikowsky, H; Pickup, MW; Gorska, AE; Jovanovic, B; Shaw, AK; Novitskiy, SV; Hong, CC; Moses, HL				Owens, Philip; Polikowsky, Hannah; Pickup, Michael W.; Gorska, Agnieszka E.; Jovanovic, Bojana; Shaw, Aubie K.; Novitskiy, Sergey V.; Hong, Charles C.; Moses, Harold L.			Bone Morphogenetic Proteins Stimulate Mammary Fibroblasts to Promote Mammary Carcinoma Cell Invasion	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; STROMAL FIBROBLASTS; BREAST-CARCINOMA; TUMOR STROMA; GROWTH; METASTASIS; EXPRESSION; PROGRESSION; RECEPTOR; MUTATIONS	Bone Morphogenetic Proteins (BMPs) are secreted cytokines that are part of the Transforming Growth Factor beta (TGF beta) superfamily. BMPs have been shown to be highly expressed in human breast cancers, and loss of BMP signaling in mammary carcinomas has been shown to accelerate metastases. Interestingly, other work has indicated that stimulation of dermal fibroblasts with BMP can enhance secretion of pro-tumorigenic factors. Furthermore, treatment of carcinoma-associated fibroblasts (CAFs) derived from a mouse prostate carcinoma with BMP4 was shown to stimulate angiogenesis. We sought to determine the effect of BMP treatment on mammary fibroblasts. A large number of secreted pro-inflammatory cytokines and matrix-metallo proteases (MMPs) were found to be upregulated in response to BMP4 treatment. Fibroblasts that were stimulated with BMP4 were found to enhance mammary carcinoma cell invasion, and these effects were inhibited by a BMP receptor kinase antagonist. Treatment with BMP in turn elevated pro-tumorigenic secreted factors such as IL-6 and MMP-3. These experiments demonstrate that BMP may stimulate tumor progression within the tumor microenvironment.	[Owens, Philip; Polikowsky, Hannah; Pickup, Michael W.; Gorska, Agnieszka E.; Jovanovic, Bojana; Shaw, Aubie K.; Novitskiy, Sergey V.; Moses, Harold L.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA; [Owens, Philip; Polikowsky, Hannah; Pickup, Michael W.; Gorska, Agnieszka E.; Jovanovic, Bojana; Shaw, Aubie K.; Novitskiy, Sergey V.; Moses, Harold L.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Hong, Charles C.] Vet Affairs Tennessee Valley Helathcare Syst, Nashville, TN USA; [Hong, Charles C.] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA; [Moses, Harold L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Hong, Charles C.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Moses, HL (corresponding author), Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	hal.moses@vanderbilt.edu	Polikowsky, Hannah/G-5257-2015	Polikowsky, Hannah/0000-0001-7226-9752; Shaw, Aubie/0000-0002-5298-801X; Owens, Philip/0000-0002-1452-9285	Vanderbilt-Ingram Cancer Center Core Facilities Grant [CA068485]; TJ Martell Foundation/Frances Preston Williams Laboratory; Department of Defense-Breast Cancer Research Program postdoctoral fellowship awards [W81XWH-09-1-0421, W81XWH-09-4-0468]; National Institutes of Health [R01 CA085492, R01 CA102162]; NATIONAL CANCER INSTITUTE [R01CA085492, T32CA009582, P30CA068485, R01CA102162] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040] Funding Source: NIH RePORTER	Vanderbilt-Ingram Cancer Center Core Facilities Grant; TJ Martell Foundation/Frances Preston Williams Laboratory; Department of Defense-Breast Cancer Research Program postdoctoral fellowship awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Vanderbilt-Ingram Cancer Center Core Facilities Grant CA068485; the TJ Martell Foundation/Frances Preston Williams Laboratory; Department of Defense-Breast Cancer Research Program postdoctoral fellowship awards W81XWH-09-1-0421 (to P.O.) W81XWH-09-4-0468 (to A.K.S.); and National Institutes of Health Grants R01 CA085492 and R01 CA102162 (to H.L.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarmo EL, 2007, BREAST CANCER RES TR, V103, P239, DOI 10.1007/s10549-006-9362-1; Anderberg C, 2009, CELL CYCLE, V8, P1461, DOI 10.4161/cc.8.10.8557; Balboni AL, 2012, CANC RES; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Calvo MB, 2009, CLIN TRANSL ONCOL, V11, P126, DOI 10.1007/S12094-009-0328-8; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Buijs JT, 2010, CURR PHARM DESIGN, V16, P1291; Campbell I, 2009, CANCER RES, V69, P6765, DOI 10.1158/0008-5472.CAN-08-4253; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Cheng N, 2008, MOL CANCER RES, V6, P1521, DOI 10.1158/1541-7786.MCR-07-2203; Cheng N, 2007, CANCER RES, V67, P4869, DOI 10.1158/0008-5472.CAN-06-3381; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Farnsworth RH, 2011, CANCER RES, V71, P6547, DOI 10.1158/0008-5472.CAN-11-0200; Fessing MY, 2010, J INVEST DERMATOL, V130, P398, DOI 10.1038/jid.2009.259; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hong CC, 2009, CYTOKINE GROWTH F R, V20, P409, DOI 10.1016/j.cytogfr.2009.10.021; Hong Charles C., 2009, V486, P43, DOI 10.1007/978-1-60327-545-3_4; Hosein AN, 2010, CANCER RES, V70, P5770, DOI 10.1158/0008-5472.CAN-10-0673; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Ketolainen JM, 2010, BREAST CANCER RES TR, V124, P377, DOI 10.1007/s10549-010-0808-0; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Kurebayashi J, 2000, Breast Cancer, V7, P124, DOI 10.1007/BF02967443; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lee GT, 2011, MOL IMMUNOL, V48, P1540, DOI 10.1016/j.molimm.2011.04.019; Lee YC, 2011, CANCER RES, V71, P5194, DOI 10.1158/0008-5472.CAN-10-4374; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Matsumura Y, 2012, ADV DRUG DELIVER REV, V64, P710, DOI 10.1016/j.addr.2011.12.010; Mendes O, 2005, CLIN EXP METASTAS, V22, P237, DOI 10.1007/s10585-005-8115-6; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Owens P, 2012, P NATL ACAD SCI USA, V109, P2814, DOI 10.1073/pnas.1101139108; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Yang S, 2008, CANCER RES, V68, P198, DOI 10.1158/0008-5472.CAN-07-5074; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Ye L, 2011, FRONT BIOSCI-LANDMRK, V16, P865, DOI 10.2741/3725; Zhang GJ, 1999, ANTICANCER RES, V19, P1427	45	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67533	10.1371/journal.pone.0067533	http://dx.doi.org/10.1371/journal.pone.0067533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840733	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400101
J	Weinstein, JA; Zeng, X; Chien, YH; Quake, SR				Weinstein, Joshua A.; Zeng, Xun; Chien, Yueh-Hsiu; Quake, Stephen R.			Correlation of Gene Expression and Genome Mutation in Single B-Cells	PLOS ONE			English	Article							DELTA T-CELLS; ACTIVATION; RECEPTOR; ANTIGEN; AUTOIMMUNITY; DIFFERENTIATION; LYMPHOCYTES; CLONING; IG	High-throughput measurement of gene-expression and immune receptor repertoires have recently become powerful tools in the study of adaptive immune response. However, despite their now-widespread use, both tend to discard cell identity by treating cell populations in bulk, and therefore lose the correlation between genetic variability and gene-expression at the single cell level. In order to recover this information, we developed a method to simultaneously measure gene expression profiles and genome mutations in single cells. We applied this method by quantifying the relationships between gene expression and antibody mutation in ensembles of individual B-cells from immunized mice. The results reveal correlations reflecting the manner in which information propagates between a B-cell's antigen receptors, its gene expression, and its mutagenic machinery, and demonstrate the power of this approach to illuminate both heterogeneity and physiology in cell populations.	[Weinstein, Joshua A.; Quake, Stephen R.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Zeng, Xun; Chien, Yueh-Hsiu] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Quake, SR (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	quake@stanford.edu	Zeng, Xun/HHM-7791-2022		National Institutes of Health; National Science Foundation Graduate Student Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Student Fellowship(National Science Foundation (NSF))	The work was supported by grant support from the National Institutes of Health (to Y.C. and S.R.Q.) and a National Science Foundation Graduate Student Fellowship (to J.A.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS TA, 1995, J IMMUNOL, V155, P1685; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; CONG YZ, 1991, INT IMMUNOL, V3, P467; Deng J, 2002, INT IMMUNOL, V14, P513, DOI 10.1093/intimm/14.5.513; Durali D, 2003, BLOOD, V102, P4084, DOI 10.1182/blood-2003-02-0518; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Guo BC, 2004, CURR OPIN IMMUNOL, V16, P367, DOI 10.1016/j.coi.2004.03.012; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Holland SJ, 2001, J EXP MED, V194, P1263, DOI 10.1084/jem.194.9.1263; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jiang N, 2011, P NATL ACAD SCI USA, V108, P5348, DOI 10.1073/pnas.1014277108; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Santos L, 2008, J IMMUNOL, V180, P4561, DOI 10.4049/jimmunol.180.7.4561; Senaldi G, 2002, J IMMUNOL, V168, P5690, DOI 10.4049/jimmunol.168.11.5690; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; SHANEBECK KD, 1995, EUR J IMMUNOL, V25, P2147, DOI 10.1002/eji.1830250805; TEDDER TF, 1988, J IMMUNOL, V141, P4388; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; WANG F, 1987, P NATL ACAD SCI USA, V84, P3452, DOI 10.1073/pnas.84.10.3452; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zeng X, 2012, IMMUNITY, V37, P524, DOI 10.1016/j.immuni.2012.06.011; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265	29	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67624	10.1371/journal.pone.0067624	http://dx.doi.org/10.1371/journal.pone.0067624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840752	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400117
J	Knutsen, H; Jorde, PE; Gonzalez, EB; Robalo, J; Albretsen, J; Almada, V				Knutsen, Halvor; Jorde, Per Erik; Gonzalez, Enrique Blanco; Robalo, Joana; Albretsen, Jon; Almada, Vitor			Climate Change and Genetic Structure of Leading Edge and Rear End Populations in a Northwards Shifting Marine Fish Species, the Corkwing Wrasse (Symphodus melops)	PLOS ONE			English	Article							COD GADUS-MORHUA; FRESH-WATER; ANADROMOUS FISHES; EASTERN ATLANTIC; ICE AGES; SEA; MICROSATELLITES; PHYLOGEOGRAPHY; CONSEQUENCES; DIVERGENCE	One mechanism by which marine organisms may respond to climate shifts is range shifts. The corkwing wrasse (Symphodus melops) is a temperate fish species, inhabiting the coasts of Europe, that show strong indications of current as well as historical (ice-age) range shifts towards the north. Nine neutral microsatellite DNA markers were screened to study genetic signatures and spatial population structure over the entire geographic and thermal gradient of the species from Portugal to Norway. A major genetic break (F-ST = 0.159 average among pairs) was identified between Scandinavian and more southern populations, with a marked reduction (30% or more) in levels of genetic variability in Scandinavia. The break is probably related to bottleneck(s) associated with post-glacial colonization of the Scandinavian coasts, and indicates a lack of present gene flow across the North Sea. The lack of gene flow can most likely be attributed to the species' need for rocky substrate for nesting and a relatively short pelagic larval phase, limiting dispersal by ocean currents. These findings demonstrate that long-distance dispersal may be severely limited in the corkwing wrasse, and that successful range-shifts following present climate change may be problematic for this and other species with limited dispersal abilities, even in the seemingly continuous marine environment.	[Knutsen, Halvor; Gonzalez, Enrique Blanco; Albretsen, Jon] Inst Marine Res, Flodevigen Marine Res Stn, His, Norway; [Knutsen, Halvor; Jorde, Per Erik] Univ Oslo, CEES, Dept Biol, Oslo, Norway; [Knutsen, Halvor; Gonzalez, Enrique Blanco] Univ Agder, Kristiansand, Norway; [Robalo, Joana; Almada, Vitor] ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal	Institute of Marine Research - Norway; University of Oslo; University of Agder; Instituto Superior Psicologia Aplicada (ISPA)	Knutsen, H (corresponding author), Inst Marine Res, Flodevigen Marine Res Stn, His, Norway.	halvor.knutsen@imr.no	Albretsen, Jon/AAM-9001-2020; Robalo, Joana Isabel/N-9960-2014; Knutsen, Halvor/A-4261-2009; Gonzalez, Enrique Blanco/O-7721-2019; Robalo, Joana I./HIK-2365-2022	Robalo, Joana Isabel/0000-0002-7470-0574; Knutsen, Halvor/0000-0002-7627-7634; Gonzalez, Enrique Blanco/0000-0002-2631-2331; Robalo, Joana I./0000-0002-7470-0574; Jorde, Per Erik/0000-0001-5515-7257; Albretsen, Jon/0000-0001-5863-2439	Norwegian Research Council (NFR) [189570/S40]; Department of Fishery and Coastal Affairs; FCT: Fundacao para a Ciencia e Tecnologia [PEst-OE/MAR/UI0331/2011]	Norwegian Research Council (NFR)(Research Council of Norway); Department of Fishery and Coastal Affairs; FCT: Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	The Norwegian participants were funded by the Norwegian Research Council (NFR, 189570/S40) and Department of Fishery and Coastal Affairs, while the Eco-Ethology Research Unit of ISPA-IU: Instituto Universitario was also funded by FCT: Fundacao para a Ciencia e Tecnologia through the project PEst-OE/MAR/UI0331/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almada VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044404; Angers B, 1998, MOL BIOL EVOL, V15, P143, DOI 10.1093/oxfordjournals.molbev.a025911; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; BELL LJ, 1982, MAR BIOL, V72, P99, DOI 10.1007/BF00396909; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chenoweth SF, 1998, P ROY SOC B-BIOL SCI, V265, P415, DOI 10.1098/rspb.1998.0310; Chevolot M, 2006, J SEA RES, V56, P305, DOI 10.1016/j.seares.2006.05.005; Coles B.J., 1998, P PREHIST SOC, V64, P45, DOI [10.1017/S0079497X00002176, DOI 10.1017/S0079497X00002176]; DARWALL WRT, 1992, J FISH BIOL, V41, P111, DOI 10.1111/j.1095-8649.1992.tb03873.x; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; DOHERTY PJ, 1995, ECOLOGY, V76, P2373, DOI 10.2307/2265814; Domingues VS, 2007, MOL ECOL, V16, P3592, DOI 10.1111/j.1365-294X.2007.03405.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Francisco SM, 2009, MAR BIOL, V156, P1421, DOI 10.1007/s00227-009-1182-5; Gaffney V., 2009, EUROPES LOST WORLD R; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1999, PCAGEN VERS 1 2 1; Gyory Joanna, OCEAN SURFACE CURREN; Gysels ES, 2004, MOL ECOL, V13, P403, DOI 10.1046/j.1365-294X.2003.02087.x; Hanel R, 2002, J MOL EVOL, V55, P776, DOI 10.1007/s00239-002-2373-6; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hutchinson WF, 2001, MAR ECOL PROG SER, V223, P251, DOI 10.3354/meps223251; Jolly MT, 2012, MAR BIOL, V159, P675, DOI 10.1007/s00227-011-1845-x; Jorde PE, 2007, MAR ECOL PROG SER, V343, P229, DOI 10.3354/meps06922; Kettle AJ, 2011, CLIM PAST, V7, P181, DOI 10.5194/cp-7-181-2011; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; Knutsen H, 2009, CONSERV GENET RESOUR, V1, P433, DOI 10.1007/s12686-009-9100-1; Langella O., 1999, POPULATIONS 1 2 32; Larmuseau MHD, 2009, J BIOGEOGR, V36, P1138, DOI 10.1111/j.1365-2699.2008.02072.x; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Makinen HS, 2006, MOL ECOL, V15, P1519, DOI 10.1111/j.1365-294X.2006.02871.x; McCusker MR, 2010, MOL ECOL, V19, P4228, DOI 10.1111/j.1365-294X.2010.04806.x; McKinney Michael L., 1998, Diversity and Distributions, V4, P3; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Nei M., 1987, MOL EVOLUTIONARY GEN; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Quignard J.-P., 1986, P919; R Core Team, 2012, R LANG ENV STAT COMP; Raventos N, 2001, MAR BIOL, V138, P1115; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Robalo JI, 2012, ECOL EVOL, V2, P153, DOI 10.1002/ece3.77; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sayer MDJ, 1996, WRASSE: BIOLOGY AND USE IN AQUACULTURE, P119; Sherman K, 2009, AMBIO, V38, P215, DOI 10.1579/0044-7447-38.4.215; Smith T. D., 2002, ICES MAR SCI S, V215, P402; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; STEPIEN CA, 1991, COPEIA, P873; Takezaki N, 1996, GENETICS, V144, P389; Van der Molen J, 2003, J GEOPHYS RES, V106, P9339; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vikebo FB, 2010, ICES J MAR SCI, V67, P1948, DOI 10.1093/icesjms/fsq084; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	63	30	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67492	10.1371/journal.pone.0067492	http://dx.doi.org/10.1371/journal.pone.0067492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840721	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400107
J	Pottier, G; Viau, M; Ricoul, M; Shim, G; Bellamy, M; Cuceu, C; Hempei, WM; Sabatier, L				Pottier, Geraldine; Viau, Muriel; Ricoul, Michelle; Shim, Grace; Bellamy, Marion; Cuceu, Corina; Hempei, William M.; Sabatier, Laure			Lead Exposure Induces Telomere Instability in Human Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; G-QUADRUPLEX; DNA-DAMAGE; CHROMOSOME INSTABILITY; CANCER-CELLS; LINE; LENGTH; MECHANISMS; CYCLES; SITES	Lead (Pb) is an important environmental contaminant due to its widespread use over many centuries. While it affects primarily every organ system of the body, the most pernicious effects of Pb are on the central nervous system leading to cognitive and behavioral modification. Despite decades of research, the mechanisms responsible for Pb toxicity remain poorly understood. Recent work has suggested that Pb exposure may have consequences on chromosomal integrity as it was shown that Pb exposure leads to the generation of gamma H2Ax foci, a well-established biomarker for DNA double stranded break (DSB formation). As the chromosomal localization of gamma H2Ax foci plays an important role in determining the molecular mechanism responsible for their formation, we examined the localization of Pb-induced foci with respect to telomeres. Indeed, short or dysfunctional telomeres (uncapped or damaged telomeres) may be recognized as DSB by the DNA repair machinery, leading to "telomere-Induced Foci'' (TIFs). In the current study, we show that while Pb exposure did not increase intra-chromosomal foci, it significantly induced TIFs, leading in some cases, to chromosomal abnormalities including telomere loss. The evidence suggests that these chromosomal abnormalities are likely due to perturbation of telomere replication, in particular on the lagging DNA strand. We propose a mechanism by which Pb exposure leads to the loss of telomere maintenance. As numerous studies have demonstrated a role for telomere maintenance in brain development and tissue homeostasis, our results suggest a possible mechanism for lead-induced neurotoxicity.	[Pottier, Geraldine; Viau, Muriel; Ricoul, Michelle; Shim, Grace; Bellamy, Marion; Cuceu, Corina; Hempei, William M.; Sabatier, Laure] CEA, LRO, Fontenay Aux Roses, France	CEA	Sabatier, L (corresponding author), CEA, LRO, Fontenay Aux Roses, France.	laure.sabatier@cea.fr		Sabatier, Laure/0000-0003-0552-6549	European 7th framework grant BOOSTER [242361]; European 7th framework grant DoReMi [249689]; Agence Nationale de la Recherche (ANR); Institute National Du Cancer (INCa), Hemi-BREAKS; Institute National Du Cancer (INCa), HEMIBREAKS-T	European 7th framework grant BOOSTER; European 7th framework grant DoReMi; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Institute National Du Cancer (INCa), Hemi-BREAKS; Institute National Du Cancer (INCa), HEMIBREAKS-T	M.V. is supported by the European 7th framework grant BOOSTER: grant agreement no. 242361 (http://ec.europa.eu/research/fp7/index_en.cfm). W.H. is supported by the European 7th framework grant DoReMi: grant agreement no. 249689 (http://ec.europa.eu/research/fp7/index_en.cfm). This work was supported by the grants from the Agence Nationale de la Recherche (ANR) (http://www.agence-nationale-recherche.fr/) and the Institute National Du Cancer (INCa) (http://www.e-cancer.fr/recherche), Hemi-BREAKS and HEMIBREAKS-T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayouaz A, 2008, BIOCHIMIE, V90, P60, DOI 10.1016/j.biochi.2007.09.011; Bai YL, 2003, MOL CANCER RES, V1, P1058; Bellinger DC, 2006, J CLIN INVEST, V116, P853, DOI 10.1172/JCI28232; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brown M, 2012, P I CIVIL ENG-GEOTEC, V165, P1, DOI 10.1680/geng.2012.165.1.1; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DUTRILLAUX B, 1981, MUTAT RES, V82, P191, DOI 10.1016/0027-5107(81)90149-4; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Ferron SR, 2009, J NEUROSCI, V29, P14394, DOI 10.1523/JNEUROSCI.3836-09.2009; Fouladi B, 2000, NEOPLASIA, V2, P540, DOI 10.1038/sj.neo.7900107; Garcia-Leston J, 2010, ENVIRON INT, V36, P623, DOI 10.1016/j.envint.2010.04.011; Gastaldo J, 2007, TOXICOL LETT, V173, P201, DOI 10.1016/j.toxlet.2007.08.003; Gilbert SG, 2006, NEUROTOXICOLOGY, V27, P693, DOI 10.1016/j.neuro.2006.06.008; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; KATO T, 1977, TOHOKU J EXP MED, V121, P157, DOI 10.1620/tjem.121.157; Kotch FW, 2000, ORG LETT, V2, P3277, DOI 10.1021/ol0065120; Kulkarni A, 2010, MOL CELL BIOL, V30, P578, DOI 10.1128/MCB.01137-09; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Leonhardt EA, 1997, RADIAT RES, V148, P548, DOI 10.2307/3579730; Li T, 2009, J AM CHEM SOC, V131, P15082, DOI 10.1021/ja9051075; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Lo AWI, 2002, NEOPLASIA, V4, P531, DOI 10.1038/sj.neo.7900267; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Magyar JS, 2005, J AM CHEM SOC, V127, P9495, DOI 10.1021/ja0424530; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Nakamura AJ, 2009, AGING-US, V1, P212, DOI 10.18632/aging.100019; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; OTOOLE CM, 1983, NATURE, V301, P429, DOI 10.1038/301429a0; Pennarun G, 2005, ONCOGENE, V24, P2917, DOI 10.1038/sj.onc.1208468; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sabatier L, 2005, MOL CANCER RES, V3, P139, DOI 10.1158/1541-7786.MCR-04-0194; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; Sanders Talia, 2009, Reviews on Environmental Health, V24, P15; Silbergeld EK, 2003, MUTAT RES-FUND MOL M, V533, P121, DOI 10.1016/j.mrfmmm.2003.07.010; Tahara H, 2006, ONCOGENE, V25, P1955, DOI 10.1038/sj.onc.1209217; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verstraeten S, 2008, ARCH TOXICOL, V82, P789, DOI 10.1007/s00204-008-0345-3; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Williams ES, 2011, METHODS MOL BIOL, V735, P113, DOI 10.1007/978-1-61779-092-8_11; Wu YX, 2012, OCCUP ENVIRON MED, V69, P557, DOI 10.1136/oemed-2011-100478; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032; Zhou QG, 2011, J NEUROSCI, V31, P12258, DOI 10.1523/JNEUROSCI.0805-11.2011	51	34	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67501	10.1371/journal.pone.0067501	http://dx.doi.org/10.1371/journal.pone.0067501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840724	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400108
J	Yang, JL; Kanazawa, S; Yamaguchi, MK				Yang, Jiale; Kanazawa, So; Yamaguchi, Masami K.			Can Infants Tell the Difference between Gold and Yellow?	PLOS ONE			English	Article							SPONTANEOUS COLOR PREFERENCES; PERCEPTION; SENSITIVITY; VISION; CONSTANCY; LUMINANCE; DEPTH; CATEGORIZATION; TRANSPARENCY; CONTRAST	There is a large literature focused on the color perception of matte surface. However, recent research showed that the component of surface specular reflection, such as glossiness, also affects categorical color perception. For instance, the color term "gold'' was used to name high specular stimuli within a specific range of chromaticity, which overlaps with those of yellow and orange for low specular stimuli. In the present study, we investigated whether the component of surface specular reflectance affects the color perception of 5- to 8-month-old infants by using the preferential looking technique. In the first experiment, we conducted a simple test to determine whether infants perceive yellow and gold as the same color by comparing their preference for these colors over green. If the infants perceive yellow and gold as the same color, they would show similar preference scores over green. On the other hand, if infants show different preference scores over green, it indicates that infants do not perceive yellow and gold as the same color. Only the 7-8 month-old infants showed different preference scores for gold and yellow over green. This result indicates that the 7-8 month-old infants perceive gold and yellow as different colors. In Experiment 2, we eliminated the component of specular reflectance on the gold surface and presented it against green to infants. A similar preference score of yellow over green was obtained. This result suggests that the difference between the preference scores for gold and yellow over green in Experiment 1 was based on representations of glossiness.	[Yang, Jiale; Kanazawa, So; Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Hachioji, Tokyo, Japan	Chuo University	Yang, JL (corresponding author), Chuo Univ, Dept Psychol, Hachioji, Tokyo, Japan.	ning.k2@gmail.com			JSPS [23 2049]; MEXT, Japan [25135729]; Japan Society for the Promotion of Science [21243041]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grant-in-Aid for Scientific Research by JSPS Research Fellowships for Young Scientists (23 2049) to JY, Grant-in-Aid for Scientific Research on Innovative Areas "Shitsukan'' (No. 25135729) from MEXT, Japan to MKY, and Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 21243041) to MKY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RJ, 1987, INFANT BEHAV DEV, V10, P143, DOI 10.1016/0163-6383(87)90029-4; Adelson EH, 2001, PROC SPIE, V4299, P1, DOI 10.1117/12.429489; ALLEN D, 1993, VISION RES, V33, P2553, DOI 10.1016/0042-6989(93)90134-I; Berlin B., 1969, BASIC COLOR TERMS TH; BORNSTEIN MH, 1976, J EXP PSYCHOL HUMAN, V2, P115, DOI 10.1037/0096-1523.2.1.115; BORNSTEIN MH, 1975, J EXP CHILD PSYCHOL, V19, P401, DOI 10.1016/0022-0965(75)90070-3; Chien SHL, 2006, VISION RES, V46, P2139, DOI 10.1016/j.visres.2005.11.027; DANNEMILLER JL, 1989, DEV PSYCHOL, V25, P171, DOI 10.1037/0012-1649.25.2.171; DANNEMILLER JL, 1987, J EXP CHILD PSYCHOL, V44, P255, DOI 10.1016/0022-0965(87)90033-6; Fleming RW., 2005, ACM T APPL PERCEPT, V2, P346, DOI [10.1145/1077399.1077409, DOI 10.1145/1077399.1077409]; Franklin A, 2008, P NATL ACAD SCI USA, V105, P3221, DOI 10.1073/pnas.0712286105; Franklin A, 2005, J EXP CHILD PSYCHOL, V91, P227, DOI 10.1016/j.jecp.2005.03.003; Franklin A, 2004, BRIT J DEV PSYCHOL, V22, P349, DOI 10.1348/0261510041552738; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; GRANRUD CE, 1985, PERCEPT PSYCHOPHYS, V37, P415, DOI 10.3758/BF03202872; HAMER RD, 1982, VISION RES, V22, P575, DOI 10.1016/0042-6989(82)90116-X; Ho YX, 2008, PSYCHOL SCI, V19, P196, DOI 10.1111/j.1467-9280.2008.02067.x; Imura T, 2006, VISION RES, V46, P652, DOI 10.1016/j.visres.2005.07.028; Imura T, 2008, VISION RES, V48, P1420, DOI 10.1016/j.visres.2008.03.011; Johnson SP, 2000, DEV PSYCHOL, V36, P808, DOI 10.1037//0012-1649.36.6.808; Kersten D, 1996, NATURE, V379, P31, DOI 10.1038/379031a0; KNILL DC, 1991, NATURE, V351, P228, DOI 10.1038/351228a0; MATSUZAWA T, 1985, J HUM EVOL, V14, P283, DOI 10.1016/S0047-2484(85)80069-5; MORRONE MC, 1993, VISION RES, V33, P2535, DOI 10.1016/0042-6989(93)90133-H; Motoyoshi I, 2010, J VISION, V10, DOI 10.1167/10.9.6; NAKAYAMA K, 1990, PERCEPTION, V19, P497, DOI 10.1068/p190497; Okazawa G, 2011, J VISION, V11, DOI 10.1167/11.8.4; Otsuka Y, 2006, PERCEPTION, V35, P1625, DOI 10.1068/p5386; Otsuka Y, 2008, J VISION, V8, DOI 10.1167/8.16.6; PEEPLES DR, 1978, VISION RES, V18, P49, DOI 10.1016/0042-6989(78)90076-7; RUDDUCK GA, 1994, INT J PSYCHOPHYSIOL, V16, P209, DOI 10.1016/0167-8760(89)90048-2; Suttle CM, 2002, VISION RES, V42, P2879, DOI 10.1016/S0042-6989(02)00333-4; Teller DY, 2004, VISUAL NEUROSCI, V21, P397, DOI 10.1017/S0952523804213360; TELLER DY, 1978, VISION RES, V18, P41, DOI 10.1016/0042-6989(78)90075-5; Tsuruhara A, 2009, INFANT BEHAV DEV, V32, P468, DOI 10.1016/j.infbeh.2009.09.002; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551; Wilcox T, 2008, DEVELOPMENTAL SCI, V11, P361, DOI 10.1111/j.1467-7687.2008.00681.x; Yang JL, 2013, J EXP CHILD PSYCHOL, V115, P126, DOI 10.1016/j.jecp.2012.11.013; Yang JL, 2011, PERCEPTION, V40, P1491, DOI 10.1068/p6893; Yonas A, 2006, PERCEPT PSYCHOPHYS, V68, P154, DOI 10.3758/BF03193665; Zemach I, 2007, VISION RES, V47, P1368, DOI 10.1016/j.visres.2006.09.024; Zemach IK, 2007, VISION RES, V47, P1362, DOI 10.1016/j.visres.2007.02.002	42	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67535	10.1371/journal.pone.0067535	http://dx.doi.org/10.1371/journal.pone.0067535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840734	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400110
J	Zulfiqar, F; Hozo, I; Rangarajan, S; Mariuzza, RA; Dziarski, R; Gupta, D				Zulfiqar, Fareeha; Hozo, Iztok; Rangarajan, Sneha; Mariuzza, Roy A.; Dziarski, Roman; Gupta, Dipika			Genetic Association of Peptidoglycan Recognition Protein Variants with Inflammatory Bowel Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; HOST RECOGNITION; STRUCTURAL BASIS; IMMUNE-SYSTEM; PSORS4 LOCUS; RISK LOCI; SUSCEPTIBILITY; NOD2; COLITIS	Inflammatory bowel disease (IBD) is a common disease, includes Crohn's disease (CD) and ulcerative colitis (UC), and is determined by altered gut bacterial populations and aberrant host immune response. Peptidoglycan recognition proteins (PGLYRP) are innate immunity bactericidal proteins expressed in the intestine. In mice, PGLYRPs modulate bacterial populations in the gut and sensitivity to experimentally induced UC. The role of PGLYRPs in humans with CD and/or UC has not been previously investigated. Here we tested the hypothesis that genetic variants in PGLYRP1, PGLYRP2, PGLYRP3 and PGLYRP4 genes associate with CD and/or UC and with gender and/or age of onset of disease in the patient population. We sequenced all PGLYRP exons in 372 CD patients, 77 UC patients, 265 population controls, 210 familial CD controls, and 24 familial UC controls, identified all polymorphisms in these populations, and analyzed the variants for significant association with CD and UC. We identified 16 polymorphisms in the four PGLYRP genes that significantly associated with CD, UC, and/or subgroups of patient populations. Of the 16, 5 significantly associated with both CD and UC, 6 with CD, and 5 with UC. 12 significant variants result in amino acid substitutions and based on structural modeling several of these missense variants may have structural and/or functional consequences for PGLYRP proteins. Our data demonstrate that genetic variants in PGLYRP genes associate with CD and UC and may provide a novel insight into the mechanism of pathogenesis of IBD.	[Zulfiqar, Fareeha; Dziarski, Roman; Gupta, Dipika] Indiana Univ Sch Med Northwest, Gary, IN USA; [Hozo, Iztok] Indiana Univ Northwest, Dept Math, Gary, IN USA; [Rangarajan, Sneha; Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA	Indiana University System; Indiana University Northwest	Gupta, D (corresponding author), Indiana Univ Sch Med Northwest, Gary, IN USA.	dgupta@iun.edu	Hozo, ihozo@iun.edu/R-3498-2016	Hozo, ihozo@iun.edu/0000-0003-2349-5707	USPHS Grants from National Institutes of Health (NIH) [AI028797, AI073290]; IUCR Grant from Indiana University	USPHS Grants from National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IUCR Grant from Indiana University	This work was supported by USPHS Grants AI028797, AI073290 from National Institutes of Health (NIH), and the IUCR Grant from Indiana University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Budarf ML, 2009, TRENDS GENET, V25, P137, DOI 10.1016/j.tig.2009.01.001; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Cho S, 2007, P NATL ACAD SCI USA, V104, P8761, DOI 10.1073/pnas.0701453104; De Leeneer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025531; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kainu K, 2009, EXP DERMATOL, V18, P109, DOI 10.1111/j.1600-0625.2008.00769.x; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kumar S, 2005, J BIOL CHEM, V280, P37005, DOI 10.1074/jbc.M506385200; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P1829, DOI 10.3748/wjg.v12.i12.1829; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Park SY, 2011, J IMMUNOL, V187, P5813, DOI 10.4049/jimmunol.1101068; Park SY, 2013, J IMMUNOL, V190, P3480, DOI 10.4049/jimmunol.1202675; Park SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024961; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Sharma P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228163; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Strober W, 2011, MUCOSAL IMMUNOL, V4, P484, DOI 10.1038/mi.2011.29; Sun C, 2006, HUM GENET, V119, P113, DOI 10.1007/s00439-005-0115-8; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Tydell CC, 2006, J IMMUNOL, V176, P1154, DOI 10.4049/jimmunol.176.2.1154; van Gunsteren W.F., 1996, BIOMOLECULAR SIMULAT, P1; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	60	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67393	10.1371/journal.pone.0067393	http://dx.doi.org/10.1371/journal.pone.0067393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840689	Green Submitted, gold, Green Published			2022-12-27	WOS:000322361200133
J	Voss, GJ; Kump, DK; Walker, JA; Voss, SR				Voss, Gareth J.; Kump, D. Kevin; Walker, John A.; Voss, S. Randal			Variation in Salamander Tail Regeneration Is Associated with Genetic Factors That Determine Tail Morphology	PLOS ONE			English	Article							AMBYSTOMA-MEXICANUM; NOTOPHTHALMUS-VIRIDESCENS; TISSUE REGENERATION; LIMB REGENERATION; QTL; TRAIT; NEWT; EVOLUTION	Very little is known about the factors that cause variation in regenerative potential within and between species. Here, we used a genetic approach to identify heritable genetic factors that explain variation in tail regenerative outgrowth. A hybrid ambystomatid salamander (Ambystoma mexicanum x A. andersoni) was crossed to an A. mexicanum and 217 offspring were induced to undergo metamorphosis and attain terrestrial adult morphology using thyroid hormone. Following metamorphosis, each salamander's tail tip was amputated and allowed to regenerate, and then amputated a second time and allowed to regenerate. Also, DNA was isolated from all individuals and genotypes were determined for 187 molecular markers distributed throughout the genome. The area of tissue that regenerated after the first and second amputations was highly positively correlated across males and females. Males presented wider tails and regenerated more tail tissue during both episodes of regeneration. Approximately 66-68% of the variation in regenerative outgrowth was explained by tail width, while tail length and genetic sex did not explain a significant amount of variation. A small effect QTL was identified as having a sex-independent effect on tail regeneration, but this QTL was only identified for the first episode of regeneration. Several molecular markers significantly affected regenerative outgrowth during both episodes of regeneration, but the effect sizes were small (<4%) and correlated with tail width. The results show that ambysex and minor effect QTL explain variation in adult tail morphology and importantly, tail width. In turn, tail width at the amputation plane largely determines the rate of regenerative outgrowth. Because amputations in this study were made at approximately the same position of the tail, our results resolve an outstanding question in regenerative biology: regenerative outgrowth positively co-varies as a function of tail width at the amputation site.	[Voss, Gareth J.; Kump, D. Kevin; Walker, John A.; Voss, S. Randal] Univ Kentucky, Dept Biol, Lexington, KY USA; [Voss, Gareth J.; Kump, D. Kevin; Walker, John A.; Voss, S. Randal] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Voss, Gareth J.] Paul Laurence Dunbar High Sch, Math Sci & Technol Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky	Voss, SR (corresponding author), Univ Kentucky, Dept Biol, Lexington, KY USA.	srvoss@uky.edu			National Institutes of Health (NIH) [R24-RR016344, R24-OD010435, RC2-NS069480]; Army Research Office [W911NF-09-1-0305]; National Science Foundation [DBI-0951484]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069480] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010435] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants R24-RR016344, R24-OD010435, and RC2-NS069480 from the National Institutes of Health (NIH). The project also used resources developed under Multidisciplinary University Research Initiative grant W911NF-09-1-0305 from the Army Research Office, and resources from the Ambystoma Genetic Stock Center, which is funded by grant DBI-0951484 from the National Science Foundation. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of NCRR, NIH, ARO, or NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARANOWITZ SA, 1979, J EXP ZOOL, V210, P17, DOI 10.1002/jez.1402100104; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V88, P35; Blankenhorn EP, 2009, MAMM GENOME, V20, P720, DOI 10.1007/s00335-009-9216-3; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHURCHILL GA, 1994, GENETICS, V138, P963; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; ITEN LE, 1976, J EXP ZOOL, V196, P283, DOI 10.1002/jez.1401960303; ITEN LE, 1976, J EXP ZOOL, V196, P293, DOI 10.1002/jez.1401960304; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Masinde GL, 2001, GENOME RES, V11, P2027, DOI 10.1101/gr.203701; McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792; Monaghan JR, 2007, J NEUROCHEM, V101, P27, DOI 10.1111/j.1471-4159.2006.04344.x; SCADDING SR, 1977, J EXP ZOOL, V202, P57, DOI 10.1002/jez.1402020108; Seifert AW, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-2; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Smith JJ, 2009, HEREDITY, V102, P542, DOI 10.1038/hdy.2009.15; Tsonis TA, 1996, LIMB REGENERATION; Voss SR, 2012, HEREDITY, V109, P293, DOI 10.1038/hdy.2012.41; Voss SR, 2000, MOL ECOL, V9, P1401, DOI 10.1046/j.1365-294x.2000.01025.x; Voss SR, 1997, P NATL ACAD SCI USA, V94, P14185, DOI 10.1073/pnas.94.25.14185; Voss SR, 2011, GENOME RES, V21, P1306, DOI 10.1101/gr.116491.110; YOUNG HE, 1983, ANAT RECORD, V206, P289, DOI 10.1002/ar.1092060307; Young HE, 1983, ANAT REC, V212, P183; Yu HR, 2005, MAMM GENOME, V16, P918, DOI 10.1007/s00335-005-0077-0	24	20	20	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67274	10.1371/journal.pone.0067274	http://dx.doi.org/10.1371/journal.pone.0067274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843997	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000067
J	Feess, D; Krell, MM; Metzen, JH				Feess, David; Krell, Mario M.; Metzen, Jan H.			Comparison of Sensor Selection Mechanisms for an ERP-Based Brain-Computer Interface	PLOS ONE			English	Article							CHANNEL SELECTION; BCI	A major barrier for a broad applicability of brain-computer interfaces (BCIs) based on electroencephalography (EEG) is the large number of EEG sensor electrodes typically used. The necessity for this results from the fact that the relevant information for the BCI is often spread over the scalp in complex patterns that differ depending on subjects and application scenarios. Recently, a number of methods have been proposed to determine an individual optimal sensor selection. These methods have, however, rarely been compared against each other or against any type of baseline. In this paper, we review several selection approaches and propose one additional selection criterion based on the evaluation of the performance of a BCI system using a reduced set of sensors. We evaluate the methods in the context of a passive BCI system that is designed to detect a P300 event-related potential and compare the performance of the methods against randomly generated sensor constellations. For a realistic estimation of the reduced system's performance we transfer sensor constellations found on one experimental session to a different session for evaluation. We identified notable (and unanticipated) differences among the methods and could demonstrate that the best method in our setup is able to reduce the required number of sensors considerably. Though our application focuses on EEG data, all presented algorithms and evaluation schemes can be transferred to any binary classification task on sensor arrays.	[Feess, David] German Res Ctr Artificial Intelligence, Robot Innovat Ctr, Bremen, Germany; [Krell, Mario M.; Metzen, Jan H.] Univ Bremen, Robot Res Grp, D-28359 Bremen, Germany	University of Bremen	Krell, MM (corresponding author), Univ Bremen, Robot Res Grp, D-28359 Bremen, Germany.	krell@uni-bremen.de		Krell, Mario Michael/0000-0002-7823-3336	German Bundesministerium f\"ur Wirtschaft und Technologie (BMWi) [FKZ 50 RA 1012, FKZ 50 RA 1011]	German Bundesministerium f\"ur Wirtschaft und Technologie (BMWi)(Federal Ministry for Economic Affairs and Energy (BMWi))	This work was supported by the German Bundesministerium f\"ur Wirtschaft und Technologie (BMWi, grant FKZ 50 RA 1012 and grant FKZ 50 RA 1011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Arvaneh M, 2011, IEEE T BIO-MED ENG, V58, P1865, DOI 10.1109/TBME.2011.2131142; Atyabi A., 2012, IEEE C EV COMP, P1, DOI DOI 10.1109/CEC.2012.6256130; Barachant A, 2011, I IEEE EMBS C NEUR E, P348, DOI 10.1109/NER.2011.5910558; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P82; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; COURCHESNE E, 1977, PSYCHOPHYSIOLOGY, V14, P590, DOI 10.1111/j.1469-8986.1977.tb01206.x; Farquhar J., 2006, P 3 INT BCI WORKSH T; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Folgheraiter M, 2012, INT J SOC ROBOT, V4, P285, DOI 10.1007/s12369-012-0147-x; Ghaderi F, 2013, P INT WORKSH BIOM AS; Ghaderi F, 2013, P IASTED INT C BIOM; Guger C., 2012, FRONT NEUROSCI, V6; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Kirchner E. A., 2010, P 10 INT S ART INT R, P448; Lal TN, 2004, IEEE T BIO-MED ENG, V51, P1003, DOI 10.1109/TBME.2004.827827; Lan T, 2005, P ANN INT IEEE EMBS, P7064; Metzen Jan Hendrik, 2011, Pattern Recognition. Proceedings 33rd DAGM Symposium, P366, DOI 10.1007/978-3-642-23123-0_37; Metzen J. H., 2011, P 2011 C GERM CLASS, P138; Metzen JH, 2011, 2011 IEEE STATISTICAL SIGNAL PROCESSING WORKSHOP (SSP), P797, DOI 10.1109/SSP.2011.5967825; Millan JD, 2009, IEEE ENG MED BIO, P3361, DOI 10.1109/IEMBS.2009.5332828; Rivet B, 2012, BRAIN TOPOGR, V25, P55, DOI 10.1007/s10548-011-0193-y; Rivet B, 2010, IEEE ENG MED BIO, P5379, DOI 10.1109/IEMBS.2010.5626485; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Sannelli C, 2010, BRAIN TOPOGR, V23, P186, DOI 10.1007/s10548-010-0135-0; Slater JD, 2012, J NEUROSCI METH, V208, P134, DOI 10.1016/j.jneumeth.2012.05.011; Tam WK, 2011, IEEE T NEUR SYS REH, V19, P617, DOI 10.1109/TNSRE.2011.2168542; Wang YJ, 2005, P ANN INT IEEE EMBS, P5392; Wohrle H, 2013, P INT C BIOM ENG TEC; Zander T. O., 2011, J NEURAL ENG, V8	31	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67543	10.1371/journal.pone.0067543	http://dx.doi.org/10.1371/journal.pone.0067543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844021	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000051
J	Lei, DX; Li, FQ; Su, HB; Liu, JB; Wei, N; Wang, XJ				Lei, Daoxiong; Li, Faqian; Su, Huabo; Liu, Jinbao; Wei, Ning; Wang, Xuejun			Hepatic Deficiency of COP9 Signalosome Subunit 8 Induces Ubiquitin-Proteasome System Impairment and Bim-Mediated Apoptosis in Murine Livers	PLOS ONE			English	Article							26S PROTEASOME; NEDD8-ACTIVATING ENZYME; BCL-2 FAMILY; INHIBITOR; SCF; SUBSTRATE; BAX; DEGRADATION; ACTIVATION; MLN4924	The COP9 signalosome (CSN), an evolutionally highly conserved protein complex composed of 8 unique subunits (CSN1 through CSN8) in higher eukaryotes, is purported to modulate protein degradation mediated by the ubiquitin-proteasome system (UPS) but this has not been demonstrated in a critical mitotic parenchymal organ of vertebrates. Hepatocyte-specific knockout of the Cops8 gene (HS-Csn8KO) was shown to cause massive hepatocyte apoptosis and liver malfunction but the underlying mechanism remains unclear. Here, we report that Csn8/CSN exerts profound impacts on hepatic UPS function and is critical to the stability of the pro-apoptotic protein Bim. Significant decreases in CIS (cytokine-inducible Src homology 2 domain-containing protein), a Bim receptor of a cullin2-based ubiquitin ligase, were found to co-exist with a marked increase of Bim proteins. Csn8 deficiency also significantly decreased 19S proteasome subunit Rpt5 and markedly increased high molecular weight neddylated and ubiquitinated proteins. The use of a surrogate UPS substrate further reveals severe impairment of UPS-mediated proteolysis in HS-Csn8KO livers. Inclusion body-like materials were accumulated in Csn8 deficient hepatocytes. In addition to Bim, massive hepatocyte apoptosis in HS-Csn8KO livers is also associated with elevated expression of other members of the Bcl2 family, including pro-apoptotic Bax as well as anti-apoptotic Bcl2 and Bcl-XL. Increased interaction between Bcl2 and Bim, but not between Bcl2 and Bax, was detected. Hence, it is concluded that hepatic CSN8 deficiency impairs the UPS in the liver and the resultant Bim upregulation likely plays an important role in triggering hepatocyte apoptosis via sequestering Bcl2 away from Bax.	[Lei, Daoxiong; Su, Huabo; Liu, Jinbao; Wang, Xuejun] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Lei, Daoxiong] Tianjin Med Univ, Dept Hepatobiliary Surg, Tianjin Cent Hosp 4, Tianjin, Peoples R China; [Lei, Daoxiong] Tianjin Med Univ, Cent Clin Coll 4, Tianjin, Peoples R China; [Li, Faqian] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Su, Huabo] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA; [Su, Huabo] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA USA; [Liu, Jinbao] Guangzhou Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Wei, Ning] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	University of South Dakota; Tianjin Medical University; Tianjin Medical University; University of Rochester; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Guangzhou Medical University; Yale University	Wang, XJ (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA.	xuejun.wang@usd.edu	Wang, Xuejun/AAT-9490-2021; Wang, Xuejun/K-8874-2013	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343; Su, Huabo/0000-0002-8475-2685; Wei, Ning/0000-0001-8827-1320	United States National Institutes of Health [R01HL072166, R01HL085629, R01HL068936, R01HL111480]; American Heart Association (AHA) [0740025N]; AHA postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068936, R01HL072166, R01HL085629, R01HL111480] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA postdoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by United States National Institutes of Health grants R01HL072166, R01HL085629, and R01HL068936 (to XW); R01HL111480 (to FL), American Heart Association (AHA) grant 0740025N (to XW), and an AHA postdoctoral fellowship (to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardag-Gorce F, 2011, WORLD J GASTROENTERO, V17, P2558, DOI 10.3748/wjg.v17.i20.2558; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Choo YY, 2011, MOL BIOL CELL, V22, P4706, DOI 10.1091/mbc.E11-03-0251; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dawson SP, 2008, BBA-MOL BASIS DIS, V1782, P775, DOI 10.1016/j.bbadis.2008.08.003; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Harari-Steinberg O, 2007, GENES CELLS, V12, P183, DOI 10.1111/j.1365-2443.2007.01049.x; Huang XH, 2005, FEBS J, V272, P3909, DOI 10.1111/j.1742-4658.2005.04807.x; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Lei D, 2011, CELL DEATH DIFFER, V18, P259, DOI 10.1038/cdd.2010.98; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Li J, 2011, FASEB J, V25, P883, DOI 10.1096/fj.10-160895; Li L, 2003, TRENDS CELL BIOL, V13, P507, DOI 10.1016/j.tcb.2003.08.002; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Liu JB, 2006, FASEB J, V20, P362, DOI 10.1096/fj.05-4869fje; Liu Y, 2002, PLANT CELL, V14, P1483, DOI 10.1105/tpc.002493; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oren-Giladi P, 2008, GENES CELLS, V13, P221, DOI 10.1111/j.1365-2443.2008.01164.x; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Raaben M, 2010, J VIROL, V84, P7880, DOI 10.1128/JVI.00486-10; Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Soriano ME, 2011, CELL, V145, P15, DOI 10.1016/j.cell.2011.03.025; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Su HB, 2011, CIRCULATION, V124, P2117, DOI 10.1161/CIRCULATIONAHA.111.048934; Su HB, 2011, CIRC RES, V108, P40, DOI 10.1161/CIRCRESAHA.110.230607; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; Wang XJ, 2013, CIRC RES, V112, P367, DOI 10.1161/CIRCRESAHA.112.268706; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang WZ, 2008, J BIOL CHEM, V283, P16416, DOI 10.1074/jbc.M802360200	59	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67793	10.1371/journal.pone.0067793	http://dx.doi.org/10.1371/journal.pone.0067793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840878	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900017
J	Ojo, OO; Bhadauria, S; Rath, SK				Ojo, Olajumoke Omolara; Bhadauria, Smrati; Rath, Srikanta Kumar			Dose-Dependent Adverse Effects of Salinomycin on Male Reproductive Organs and Fertility in Mice	PLOS ONE			English	Article							BROILER-CHICKENS; LIPID-PEROXIDATION; DNA-DAMAGE; CELLS; RAT; PROTEIN; CANCER; TESTIS; SPERM; ACID	Salinomycin is used as an antibiotic in animal husbandry. Its implication in cancer therapy has recently been proposed. Present study evaluated the toxic effects of Salinomycin on male reproductive system of mice. Doses of 1, 3 or 5 mg/kg of Salinomycin were administered daily for 28 days. Half of the mice were sacrificed after 24 h of the last treatment and other half were sacrificed 28 days after withdrawal of treatment. Effects of SAL on body and reproductive organ weights were studied. Histoarchitecture of testis and epididymis was evaluated along with ultrastructural changes in Leydig cells. Serum and testicular testosterone and luteinizing hormones were estimated. Superoxide dismutase, reduced glutathione, lipid peroxidation, catalase and lactate dehydrogenase activities were measured. Spermatozoa count, morphology, motility and fertility were evaluated. Expression patterns of steroidogenic acute regulatory protein (StAR) and cytochrome P450 side chain cleavage proteins (CYP11A1) were assessed by Western blotting. Salinomycin treatment was lethal to few mice and retarded body growth in others with decreased weight of testes and seminal vesicles in a dose dependent manner. Seminiferous tubules in testes were disrupted and the epithelium of epididymis showed frequent occurrence of vacuolization and necrosis. Leydig cells showed hypertrophied cytoplasm with shrunken nuclei, condensed mitochondria, proliferated endoplasmic reticulum and increased number of lipid droplets. Salinomycin decreased motility and spermatozoa count with increased number of abnormal spermatozoa leading to infertility. The testosterone and luteinizing hormone levels were decreased in testis but increased in serum at higher doses. Depletion of superoxide dismutase and reduced glutathione with increased lipid peroxidation in both testis and epididymis indicated generation of oxidative stress. Suppressed expression of StAR and CYP11A1 proteins indicates inhibition of steroidogenesis. Spermatogenesis was however observed in testis 28 days after Salinomycin withdrawal. The results indicate reversible dose-dependent adverse effects of Salinomycin on male reproductive system of mice.	[Ojo, Olajumoke Omolara; Bhadauria, Smrati; Rath, Srikanta Kumar] Cent Drug Res Inst, Div Toxicol, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Rath, SK (corresponding author), Cent Drug Res Inst, Div Toxicol, CSIR, Lucknow 226001, Uttar Pradesh, India.	skrath@cdri.res.in	郑, 丽丽/HGE-2239-2022; Ojo, Olajumoke/AAV-7616-2020		CSIR [BSC0103]	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR Network Project BSC0103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H.U., 1983, CATALASE BERGMEYER H, VIII, P276; Agrawal RC, 1997, FOOD CHEM TOXICOL, V35, P523, DOI 10.1016/S0278-6915(97)00017-3; Al-Shabanah OA, 1997, RES COMMUNICATIONS P, V2, P69; Saraiva KLA, 2006, REPROD TOXICOL, V22, P754, DOI 10.1016/j.reprotox.2006.07.008; Aleman M, 2007, JAVMA-J AM VET MED A, V230, P1822, DOI 10.2460/javma.230.12.1822; ANDERSON RA, 1983, J PHARMACOL EXP THER, V225, P479; Anita H, 2007, STRUCTURAL HISTOLOGI, P33; Arash O, 2010, CAN VET J, V51, P1143; Bagchi D, 1996, BIOL TRACE ELEM RES, V52, P143, DOI 10.1007/BF02789456; Bezerra PS, 1999, VET HUM TOXICOL, V41, P383; Boehmerle W, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.46; Brake J, 2001, POULTRY SCI, V80, P260, DOI 10.1093/ps/80.3.260; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Butenandt A, 1931, ANGEW CHEM, V44, P905, DOI 10.1002/ange.19310444602; CHALMERS GA, 1981, CAN VET J, V22, P21; Chard T, 1978, INTRO RADIOIMMUNOASS, V534; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; COOKE BA, 1975, BIOCHEM J, V150, P413, DOI 10.1042/bj1500413; COPPOLA JA, 1969, LIFE SCI PT 1 PHYSI, V8, P43, DOI 10.1016/0024-3205(69)90291-4; Czerwinski J, 2012, ARCH ANIM NUTR, V66, P102, DOI 10.1080/1745039X.2012.663668; Dorne JL, 2011, TOXICOL APPL PHARM; El-Maraghy SA, 2001, J BIOCHEM MOL TOXIC, V15, P207, DOI 10.1002/jbt.18.abs; Ewing L., 1977, The testis. Volume IV. Advances in physiology, biochemistry, and function., P239; Gava A, 1997, PESQUISA VET BRASIL, V17, P127, DOI 10.1590/S0100-736X1997000300007; Gill B. S., 1991, Journal of Research Punjab Agricultural University, V28, P401; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hess RA, 2000, HISTOL HISTOPATHOL, V15, P207, DOI 10.14670/HH-15.207; Huczynski A, 2012, BIOORGAN MED CHEM; Huczynski A, 2012, BIOORG MED CHEM LETT, V22, P7002, DOI 10.1016/j.bmcl.2012.09.046; Huczynski A, 2012, CHEM BIOL DRUG DES, V79, P235, DOI 10.1111/j.1747-0285.2011.01287.x; JONES JE, 1990, POULTRY SCI, V69, P27, DOI 10.3382/ps.0690027; Kamashi K., 2004, Indian Journal of Physiology and Pharmacology, V48, P89; KESHAVARZ K, 1981, POULTRY SCI, V60, P2423, DOI 10.3382/ps.0602423; Kilarkaje N, 2008, J TOXICOL SCI, V33, P85, DOI [10.2131/jts.33.85, DOI 10.2131/JTS.33.85.PUBMED:18303187]; Kim JH, 2011, BRIT J PHARMACOL, V162, P773, DOI 10.1111/j.1476-5381.2010.01089.x; KINASHI H, 1973, TETRAHEDRON LETT, P4955; Lee KW, 2012, RES VET SCI, V93, P721, DOI 10.1016/j.rvsc.2012.01.001; Li LH, 1997, TOXICOL APPL PHARM, V144, P105, DOI 10.1006/taap.1997.8129; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; Mauldin J. M., 1987, Poultry Science, V66, P27; MITANI M, 1976, ANTIMICROB AGENTS CH, V9, P655, DOI 10.1128/AAC.9.4.655; MITANI M, 1975, BIOCHEM BIOPH RES CO, V66, P1231, DOI 10.1016/0006-291X(75)90490-8; Narayana K, 2005, MUTAT RES-GEN TOX EN, V588, P28, DOI 10.1016/j.mrgentox.2005.08.012; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Naujokat C, 2010, MOL MED REP, V3, P555, DOI 10.3892/mmr_00000296; Neuschl J, 2001, B VET I PULAWY, V45, P315; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pakozdy A., 2010, VET MED INT, V2010, P147142, DOI [10.4061/2010/147142, DOI 10.4061/2010/147142]; PORAT O, 1990, MOL REPROD DEV, V25, P400, DOI 10.1002/mrd.1080250414; POTTER LM, 1986, POULTRY SCI, V65, P1955, DOI 10.3382/ps.0651955; QURESHI S, 1988, DRUG CHEM TOXICOL, V11, P151, DOI 10.3109/01480548808998219; Qureshi S, 1979, INDAIN J HEREDITY, V2, P372; REDINS C. A., 2002, Braz. J. Biol., V62, P517, DOI 10.1590/S1519-69842002000300017; Rizvi F, 1999, VET ARHIV, V69, P39; Rocha JS, 2007, EXP BIOL MED, V232, P1050, DOI 10.3181/0703-RM-52; RUSSELL LD, 1996, LEYDIG CELL, P00043; SALLES MS, 1994, VET HUM TOXICOL, V36, P437; Sambeth W, 1985, ZOOTECH INT, V18, P50; SANGUINETTI RE, 1995, EXP ANIM TOKYO, V44, P71, DOI 10.1538/expanim.44.71; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shane SM, 1992, ZOOTECNICA INT, V12, P24; Sharma S, 1999, ADV CONTRACEPT, V15, P15, DOI 10.1023/A:1006627410734; SINGH SK, 1990, ARCH HISTOL CYTOL, V53, P393, DOI 10.1679/aohc.53.393; SPRINKER L H, 1971, Nutrition Reports International, V4, P335; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Story Phillipa, 2004, N Z Med J, V117, pU799; Timmermans L M, 1989, Acta Urol Belg, V57, P35; Tramer F, 1998, BIOL REPROD, V59, P753, DOI 10.1095/biolreprod59.4.753; Van Assen EJ, 2006, CAN VET J, V47, P256; van der Linde-Sipman JS, 1999, VET PATHOL, V36, P152, DOI 10.1354/vp.36-2-152; Verma RJ, 2003, TOXICOL INT, V10, P76; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050638; WILSON JS, 1980, CAN VET J, V21, P30; WYROBEK AJ, 1983, MUTAT RES, V115, P73, DOI 10.1016/0165-1110(83)90015-5; WYROBEK AJ, 1975, P NATL ACAD SCI USA, V72, P4425, DOI 10.1073/pnas.72.11.4425; Yamaguchi M, 2005, INT J MOL MED, V15, P371; ZIRKIN BR, 1980, ENDOCRINOLOGY, V107, P1867, DOI 10.1210/endo-107-6-1867	78	32	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e69086	10.1371/journal.pone.0069086	http://dx.doi.org/10.1371/journal.pone.0069086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840907	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900046
J	Stephan-Blanchard, E; Chardon, K; Leke, A; Delanaud, S; Bach, V; Telliez, F				Stephan-Blanchard, Erwan; Chardon, Karen; Leke, Andre; Delanaud, Stephane; Bach, Veronique; Telliez, Frederic			Heart Rate Variability in Sleeping Preterm Neonates Exposed to Cool and Warm Thermal Conditions	PLOS ONE			English	Article							SUDDEN-INFANT-DEATH; SPECTRAL-ANALYSIS; AMBIENT-TEMPERATURE; BLOOD-PRESSURE; QT INTERVAL; ENVIRONMENT; VICTIMS; RESPONSES; HEALTHY; DYSFUNCTION	Sudden infant death syndrome (SIDS) remains the main cause of postneonatal infant death. Thermal stress is a major risk factor and makes infants more vulnerable to SIDS. Although it has been suggested that thermal stress could lead to SIDS by disrupting autonomic functions, clinical and physiopathological data on this hypothesis are scarce. We evaluated the influence of ambient temperature on autonomic nervous activity during sleep in thirty-four preterm neonates (mean +/- SD gestational age: 31.4 +/- 1.5 weeks, postmenstrual age: 36.2 +/- 0.9 weeks). Heart rate variability was assessed as a function of the sleep stage at three different ambient temperatures (thermoneutrality and warm and cool thermal conditions). An elevated ambient temperature was associated with a higher basal heart rate and lower short-and long-term variability in all sleep stages, together with higher sympathetic activity and lower parasympathetic activity. Our study results showed that modification of the ambient temperature led to significant changes in autonomic nervous system control in sleeping preterm neonates. The latter changes are very similar to those observed in infants at risk of SIDS. Our findings may provide greater insight into the thermally-induced disease mechanisms related to SIDS and may help improve prevention strategies.	[Stephan-Blanchard, Erwan; Chardon, Karen; Leke, Andre; Delanaud, Stephane; Bach, Veronique; Telliez, Frederic] Jules Verne Univ Picardy, PeriTox INERIS Lab, Amiens, France; [Leke, Andre] Amiens Univ, Med Ctr, Neonatal & Pediat Intens Care Unit, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Stephan-Blanchard, E (corresponding author), Jules Verne Univ Picardy, PeriTox INERIS Lab, Amiens, France.	erwan.stephan@u-picardie.fr	chardon, Karen/AAD-5837-2022; Bach, Veronique/AAD-5958-2022; stepahne, delanaud/AAD-2762-2022; Telliez, Frédéric/AFP-2594-2022	Stephan-Blanchard, Erwan/0000-0002-9427-4699	French Ministry of Health	French Ministry of Health	This work was funded by grants from the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariagno RL, 2003, PEDIATRICS, V111, P622, DOI 10.1542/peds.111.3.622; Aronson D, 2001, INT J CARDIOL, V79, P31, DOI 10.1016/S0167-5273(01)00401-6; Bach Veronique, 2011, Handb Clin Neurol, V98, P215, DOI 10.1016/B978-0-444-52006-7.00014-9; Bader D, 1998, J Perinatol, V18, P5; BERGER RD, 1986, IEEE T BIO-MED ENG, V33, P900, DOI 10.1109/TBME.1986.325789; BERTEROTTIERE D, 1990, J DEV PHYSIOL, V13, P303; Blair PS, 2008, ARCH DIS CHILD, V93, P778, DOI 10.1136/adc.2007.136366; CAMPBELL MJ, 1989, MED J AUSTRALIA, V151, P365, DOI 10.5694/j.1326-5377.1989.tb101216.x; Carpenter RG, 2004, LANCET, V363, P185, DOI 10.1016/S0140-6736(03)15323-8; Chardon K, 2003, NEUROPHYSIOL CLIN, V33, P196, DOI 10.1016/S0987-7053(03)00052-2; Fortrat JO, 2002, AM J CARDIOL, V90, P346, DOI 10.1016/S0002-9149(02)02399-8; FOX GPP, 1989, LANCET, V2, P1065; FOX GPP, 1991, IRISH J MED SCI, V160, P249, DOI 10.1007/BF02973398; Franco P, 2003, SLEEP MED, V4, P569, DOI 10.1016/S1389-9457(03)00107-2; Franco P, 1996, PEDIATRICS, V97, P174; Franco P, 2003, J SLEEP RES, V12, P125, DOI 10.1046/j.1365-2869.2003.00340.x; Franco P, 2000, SLEEP, V23, P401; Galland BC, 2006, J APPL PHYSIOL, V100, P933, DOI 10.1152/japplphysiol.01275.2005; Galland BC, 2000, PEDIATR RES, V48, P360, DOI 10.1203/00006450-200009000-00017; GIDDENS DP, 1985, J THEOR BIOL, V113, P759, DOI 10.1016/S0022-5193(85)80192-2; GLASS L, 1968, PEDIATRICS, V41, P1033; GORDON D, 1984, PEDIATR RES, V18, P921, DOI 10.1203/00006450-198418100-00001; GORDON D, 1986, PEDIATR RES, V20, P680, DOI 10.1203/00006450-198607000-00021; GOZAL D, 1988, PEDIATRICS, V82, P738; Grigg-Damberger M, 2007, J CLIN SLEEP MED, V3, P201; Guntheroth WG, 2001, PEDIATRICS, V107, P693, DOI 10.1542/peds.107.4.693; Harper RM, 2000, PEDIATR RES, V48, P140, DOI 10.1203/00006450-200008000-00004; HEY EN, 1970, ARCH DIS CHILD, V45, P328, DOI 10.1136/adc.45.241.328; Hunt CE, 2006, CAN MED ASSOC J, V174, P1861, DOI 10.1503/cmaj.051671; KELLY DH, 1986, J PEDIATR-US, V109, P249, DOI 10.1016/S0022-3476(86)80380-8; Kinugasa H, 1999, EXP PHYSIOL, V84, P369, DOI 10.1017/S0958067099018394; KITNEY RI, 1980, STUDY HEART RATE VAR; KLUGE KA, 1988, PEDIATR RES, V24, P667, DOI 10.1203/00006450-198812000-00005; Laude D, 2008, CLIN EXP PHARMACOL P, V35, P454, DOI 10.1111/j.1440-1681.2008.04895.x; Ledwidge M, 1998, ARCH DIS CHILD, V78, P481, DOI 10.1136/adc.78.5.481; LEISTNER HL, 1980, J PEDIATR-US, V97, P51, DOI 10.1016/S0022-3476(80)80129-6; LOSSIUS K, 1994, J AUTONOM NERV SYST, V47, P245, DOI 10.1016/0165-1838(94)90185-6; PONSONBY AL, 1992, BRIT MED J, V304, P277, DOI 10.1136/bmj.304.6822.277; SAUER PJJ, 1984, ARCH DIS CHILD, V59, P18, DOI 10.1136/adc.59.1.18; SCHECHTMAN VL, 1992, PEDIATR RES, V31, P606, DOI 10.1203/00006450-199206000-00014; SCHECHTMAN VL, 1989, EARLY HUM DEV, V19, P167, DOI 10.1016/0378-3782(89)90077-7; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; STANTON AN, 1980, LANCET, V1, P1054; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Telliez F, 2004, J SLEEP RES, V13, P337, DOI 10.1111/j.1365-2869.2004.00416.x; Telliez F, 1997, MED BIOL ENG COMPUT, V35, P521, DOI 10.1007/BF02525534; Thayer J F, 1997, Biomed Sci Instrum, V34, P252; Toichi M, 1997, J AUTONOM NERV SYST, V62, P79, DOI 10.1016/S0165-1838(96)00112-9; WILSON AJ, 1985, BRIT MED J, V290, P497, DOI 10.1136/bmj.290.6467.497	49	18	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68211	10.1371/journal.pone.0068211	http://dx.doi.org/10.1371/journal.pone.0068211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840888	gold, Green Published, Green Submitted			2022-12-27	WOS:000321271900027
J	Chapman, AL; Bennett, EJ; Ramesh, TM; De Vos, KJ; Grierson, AJ				Chapman, Anna L.; Bennett, Ellen J.; Ramesh, Tennore M.; De Vos, Kurt J.; Grierson, Andrew J.			Axonal Transport Defects in a Mitofusin 2 Loss of Function Model of Charcot-Marie-Tooth Disease in Zebrafish	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MITOCHONDRIAL MORPHOLOGY; SWIMMING PERFORMANCE; MOUSE MODEL; MUTATIONS; NEUROPATHY; PATHWAY; COMPLEX; PROTEIN; FUSION	Charcot-Marie-Tooth disease (CMT) represents a group of neurodegenerative disorders typically characterised by demyelination (CMT1) or distal axon degeneration (CMT2) of motor and sensory neurons. The majority of CMT2 cases are caused by mutations in mitofusin 2 (MFN2); an essential gene encoding a protein responsible for fusion of the mitochondrial outer membrane. The mechanism of action of MFN2 mutations is still not fully resolved. To investigate a role for loss of Mfn2 function in disease we investigated an ENU-induced nonsense mutation in zebrafish MFN2 and characterised the phenotype of these fish at the whole organism, pathological, and subcellular level. We show that unlike mice, loss of MFN2 function in zebrafish leads to an adult onset, progressive phenotype with predominant symptoms of motor dysfunction similar to CMT2. Mutant zebrafish show progressive loss of swimming associated with alterations at the neuro-muscular junction. At the cellular level, we provide direct evidence that mitochondrial transport along axons is perturbed in Mfn2 mutant zebrafish, suggesting that this is a key mechanism of disease in CMT. The progressive phenotype and pathology suggest that zebrafish will be useful for further investigating the disease mechanism and potential treatment of axonal forms of CMT. Our findings support the idea that MFN2 mutation status should be investigated in patients presenting with early-onset recessively inherited axonal CMT.	[Chapman, Anna L.; Bennett, Ellen J.; Ramesh, Tennore M.; De Vos, Kurt J.; Grierson, Andrew J.] Univ Sheffield, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Chapman, Anna L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Grierson, Andrew J.] Univ Sheffield, Med Res Council Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England	University of Sheffield; University of Manchester; University of Sheffield	Grierson, AJ (corresponding author), Univ Sheffield, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.	a.j.grierson@shef.ac.uk	Grierson, Andy/A-5067-2009; De Vos, Kurt/D-8380-2011; Ramesh, Tennore M/A-5049-2009	Grierson, Andy/0000-0001-7039-6731; De Vos, Kurt/0000-0003-2161-6309; Ramesh, Tennore M/0000-0001-8398-5367; Bennett, Ellen/0000-0002-9818-827X	Wolfson Foundation; United Kingdom Motor Neurone Disease Association (AJG); National Centre for the Replacement, Refinement and Reduction of Animals in Research (AJG); University of Sheffield Prize Studentship; MRC [MR/K005146/1] Funding Source: UKRI; Medical Research Council [MR/K005146/1] Funding Source: researchfish	Wolfson Foundation; United Kingdom Motor Neurone Disease Association (AJG); National Centre for the Replacement, Refinement and Reduction of Animals in Research (AJG); University of Sheffield Prize Studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Confocal imaging was enabled by an equipment grant from the Wolfson Foundation. (http://www.wolfson.org.uk/). The United Kingdom Motor Neurone Disease Association (AJG) and the National Centre for the Replacement, Refinement and Reduction of Animals in Research (AJG) supported this work. ALC was supported by a University of Sheffield Prize Studentship. (http://www.mndassociation.org/, http://www.nc3rs.org.uk/, http://www.sheffield.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Boon KL, 2009, HUM MOL GENET, V18, P3615, DOI 10.1093/hmg/ddp310; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Davison W, 1997, COMP BIOCHEM PHYS A, V117, P67, DOI 10.1016/S0300-9629(96)00284-8; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Detmer SA, 2007, HUM MOL GENET; Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314; Drogemuller C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018931; Fassier C, 2010, NAT NEUROSCI, V13, P1380, DOI 10.1038/nn.2662; Fyfe JC, 2011, NEUROGENETICS, V12, P223, DOI 10.1007/s10048-011-0285-6; Hewamadduma CA, 2013, HUMAN MOL GENETICS; Kasher PR, 2009, J NEUROCHEM, V110, P34, DOI 10.1111/j.1471-4159.2009.06104.x; Lange M, 2012, MOL PSYCHIATR, V17, P946, DOI 10.1038/mp.2012.29; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Plaut I, 2000, J EXP BIOL, V203, P813; Polke JM, 2011, NEUROLOGY, V77, P168, DOI 10.1212/WNL.0b013e3182242d4d; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Ramesh T, 2010, DIS MODEL MECH, V3, P652, DOI 10.1242/dmm.005538; Rasband W., 2006, IMAGEJ; Sakowski SA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-44; Santel A, 2001, J CELL SCI, V114, P867; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Vettori A, 2011, NEUROMUSCULAR DISORD, V21, P58, DOI 10.1016/j.nmd.2010.09.002; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797	34	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67276	10.1371/journal.pone.0067276	http://dx.doi.org/10.1371/journal.pone.0067276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840650	Green Published, gold			2022-12-27	WOS:000321424400090
J	Garnica, DP; Upadhyaya, NM; Dodds, PN; Rathjen, JP				Garnica, Diana P.; Upadhyaya, Narayana M.; Dodds, Peter N.; Rathjen, John P.			Strategies for Wheat Stripe Rust Pathogenicity Identified by Transcriptome Sequencing	PLOS ONE			English	Article							RICE BLAST FUNGUS; AMINO-ACID TRANSPORTER; MEMBRANE H+-ATPASE; F-SP TRITICI; PUCCINIA-STRIIFORMIS; HISTIDINE KINASE; NEUROSPORA-CRASSA; USTILAGO-MAYDIS; OBLIGATE BIOTROPHY; HOST PENETRATION	Stripe rust caused by the fungus Puccinia striiformis f.sp. tritici (Pst) is a major constraint to wheat production worldwide. The molecular events that underlie Pst pathogenicity are largely unknown. Like all rusts, Pst creates a specialized cellular structure within host cells called the haustorium to obtain nutrients from wheat, and to secrete pathogenicity factors called effector proteins. We purified Pst haustoria and used next-generation sequencing platforms to assemble the haustorial transcriptome as well as the transcriptome of germinated spores. 12,282 transcripts were assembled from 454-pyrosequencing data and used as reference for digital gene expression analysis to compare the germinated uredinospores and haustoria transcriptomes based on Illumina RNAseq data. More than 400 genes encoding secreted proteins which constitute candidate effectors were identified from the haustorial transcriptome, with two thirds of these up-regulated in this tissue compared to germinated spores. RT-PCR analysis confirmed the expression patterns of 94 effector candidates. The analysis also revealed that spores rely mainly on stored energy reserves for growth and development, while haustoria take up host nutrients for massive energy production for biosynthetic pathways and the ultimate production of spores. Together, these studies substantially increase our knowledge of potential Pst effectors and provide new insights into the pathogenic strategies of this important organism.	[Garnica, Diana P.; Rathjen, John P.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Upadhyaya, Narayana M.; Dodds, Peter N.] CSIRO, Div Plant Ind, Canberra, ACT 2601, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rathjen, JP (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	john.rathjen@anu.edu.au	rathjen, john p/C-9327-2009; Upadhyaya, Narayana M/A-1480-2008; Dodds, Peter/D-1181-2009	rathjen, john p/0000-0003-4073-8088; Upadhyaya, Narayana M/0000-0002-3052-0416; Dodds, Peter/0000-0003-0620-5923	ARC Future Fellow [FT0992129]; Bioplatforms Australia; Commonwealth Government NCRIS; Education Investment Fund Super Science programs	ARC Future Fellow(Australian Research Council); Bioplatforms Australia; Commonwealth Government NCRIS; Education Investment Fund Super Science programs	J.P.R. is an ARC Future Fellow (FT0992129). This project has been supported by Bioplatforms Australia through funding from the Commonwealth Government NCRIS and Education Investment Fund Super Science programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex LA, 1996, P NATL ACAD SCI USA, V93, P3416, DOI 10.1073/pnas.93.8.3416; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bhadauria V, 2013, EUKARYOT CELL, V12, P2, DOI 10.1128/EC.00192-12; Both M, 2005, PLANT CELL, V17, P2107, DOI 10.1105/tpc.105.032631; Bourgis F, 1999, PLANT CELL, V11, P1485, DOI 10.1105/tpc.11.8.1485; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Broeker K, 2006, FEMS MICROBIOL LETT, V256, P273, DOI 10.1111/j.1574-6968.2006.00127.x; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Calcagno AM, 2003, MOL MICROBIOL, V50, P1309, DOI 10.1046/j.1365-2958.2003.03755.x; Cantu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024230; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; CASTRO IM, 1991, J GEN MICROBIOL, V137, P1497, DOI 10.1099/00221287-137-7-1497; Catanzariti AM, 2011, METHODS MOL BIOL, V712, P79, DOI 10.1007/978-1-61737-998-7_8; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chang YC, 2001, P NATL ACAD SCI USA, V98, P3258, DOI 10.1073/pnas.061031998; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Chrost B, 2007, PLANTA, V225, P311, DOI 10.1007/s00425-006-0350-9; Cid VJ, 2001, MICROBIOL-SGM, V147, P1437, DOI 10.1099/00221287-147-6-1437; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui W, 2002, FUNGAL GENET BIOL, V36, P187, DOI 10.1016/S1087-1845(02)00009-9; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DEISING H, 1995, FEMS MICROBIOL LETT, V127, P207; Deng JX, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-30; Dong YL, 2011, WORLD J MICROB BIOT, V27, P1261, DOI 10.1007/s11274-010-0565-6; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; EHRLICH MA, 1969, CAN J BOTANY, V47, P2061, DOI 10.1139/b69-297; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; Elias-Villalobos A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002235; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fabro G, 2008, PLANT PHYSIOL, V146, P1421, DOI 10.1104/pp.107.111286; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.E04-10-0884; Flor-Parra I, 2007, PLANT CELL, V19, P3280, DOI 10.1105/tpc.107.052738; Garcia-Muse T, 2004, J CELL SCI, V117, P487, DOI 10.1242/jcs.00877; Grbavec D, 1999, BIOCHEM J, V337, P13, DOI 10.1042/0264-6021:3370013; Gupta A, 2008, FEMS MICROBIOL LETT, V278, P22, DOI 10.1111/j.1574-6968.2007.00937.x; Hacquard S, 2012, MOL PLANT MICROBE IN, V25, P279, DOI 10.1094/MPMI-09-11-0238; HAHN M, 1992, PROTOPLASMA, V170, P95, DOI 10.1007/BF01378785; Hahn M, 1997, MOL PLANT MICROBE IN, V10, P438, DOI 10.1094/MPMI.1997.10.4.438; Hahn M, 1997, MOL PLANT MICROBE IN, V10, P427, DOI 10.1094/MPMI.1997.10.4.427; Hahn M., 1997, P33; Harder D, 1984, CEREAL RUST, VI; Heath MC, 1997, ANN BOT-LONDON, V80, P713, DOI 10.1006/anbo.1997.0507; Hoi JWS, 2007, MOL MICROBIOL, V64, P68, DOI 10.1111/j.1365-2958.2007.05639.x; Hoi JWS, 2010, EUKARYOT CELL, V9, P480, DOI 10.1128/EC.00333-09; Horst RJ, 2010, PLANT PHYSIOL, V152, P293, DOI 10.1104/pp.109.147702; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Hu GG, 2007, MOL PLANT PATHOL, V8, P451, DOI [10.1111/j.1364-3703.2007.00406.x, 10.1111/J.1364-3703.2007.00406.X]; Ipcho SVS, 2012, MOL PLANT PATHOL, V13, P531, DOI 10.1111/j.1364-3703.2011.00770.x; Jakupovic M, 2006, FUNGAL GENET BIOL, V43, P8, DOI 10.1016/j.fgb.2005.09.001; Jin Y, 2010, PHYTOPATHOLOGY, V100, P432, DOI 10.1094/PHYTO-100-5-0432; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Kolmer JA., 2009, RUST FUNGI ENCY LIFE; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Ling P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-145; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Ma JB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-586; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Marasas C., 2003, EC PROGRAM PAPERS 48, DOI [10.22004/ag.econ.48768, DOI 10.22004/AG.ECON.48768]; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; Meti R.S., 2011, RECENT RES SCI TECHN, V2, P28; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; Murray GM, 2009, CURRENT POTENTIAL CO; Nadal M, 2008, FEMS MICROBIOL LETT, V284, P127, DOI 10.1111/j.1574-6968.2008.01173.x; NIEUWENHUIS BJWM, 1984, BIOCHIM BIOPHYS ACTA, V770, P40, DOI 10.1016/0005-2736(84)90071-3; Oide S, 2010, EUKARYOT CELL, V9, P1867, DOI 10.1128/EC.00150-10; PAIETTA JV, 1987, MOL CELL BIOL, V7, P2506, DOI 10.1128/MCB.7.7.2506; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Pillonel C, 1997, PESTIC SCI, V49, P229, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;229::AID-PS525&gt;3.0.CO;2-T; Pocsi I, 2004, ADV MICROB PHYSIOL, V49, P1, DOI 10.1016/S0065-2911(04)49001-8; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rispail N, 2009, MOL PLANT MICROBE IN, V22, P830, DOI 10.1094/MPMI-22-7-0830; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Saunders DGO, 2010, PLANT CELL, V22, P497, DOI 10.1105/tpc.109.072447; Scarpari LM, 2005, J EXP BOT, V56, P865, DOI 10.1093/jxb/eri079; Schumacher MM, 1997, CURR MICROBIOL, V34, P340, DOI 10.1007/s002849900193; Secco D, 2012, NEW PHYTOL, V193, P842, DOI 10.1111/j.1469-8137.2011.04002.x; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Spanu P, 2010, CURR OPIN PLANT BIOL, V13, P409, DOI 10.1016/j.pbi.2010.03.004; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; STAPLES RICHARD C., 1965, BOT REV, V31, P537, DOI 10.1007/BF02858608; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Struck C, 2004, MOL PLANT PATHOL, V5, P183, DOI [10.1111/j.1364-3703.2004.00222.x, 10.1111/J.1364-3703.2004.00222.X]; Struck C, 1996, FUNGAL GENET BIOL, V20, P30, DOI 10.1006/fgbi.1996.0006; Struck C, 1998, MOL PLANT MICROBE IN, V11, P458, DOI 10.1094/MPMI.1998.11.6.458; Struck C, 2002, MOL PLANT PATHOL, V3, P23, DOI 10.1046/j.1464-6722.2001.00091.x; Sun CB, 2006, PLANT CELL, V18, P3686, DOI 10.1105/tpc.105.037861; Szabo LJ, 2001, P NATL ACAD SCI USA, V98, P7654, DOI 10.1073/pnas.151262398; Tao Y, 1998, J BACTERIOL, V180, P478, DOI 10.1128/JB.180.3.478-482.1998; Thara VK, 2003, MOL PLANT PATHOL, V4, P51, DOI 10.1046/j.1364-3703.2003.00142.x; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Tollot M, 2009, NEW PHYTOL, V181, P693, DOI 10.1111/j.1469-8137.2008.02696.x; Tsuji G, 2003, MYCOL RES, V107, P854, DOI 10.1017/S0953756203008001; VANDENBOSSCHE H, 1990, BRIT J CLIN PRACT, V44, P41; VANETTEN HD, 1995, CAN J BOT, V73, pS518, DOI 10.1139/b95-291; Vieira A, 2012, EUR J PLANT PATHOL, V133, P261, DOI 10.1007/s10658-011-9864-5; Vincent D, 2012, J PROTEOME RES, V11, P157, DOI 10.1021/pr200895f; Voegele RT, 2011, EUPHYTICA, V179, P41, DOI 10.1007/s10681-011-0358-5; Voegele RT, 2003, NEW PHYTOL, V159, P93, DOI 10.1046/j.1469-8137.2003.00761.x; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Wan AM, 2004, PLANT DIS, V88, P896, DOI 10.1094/PDIS.2004.88.8.896; Wei YD, 2004, J BIOL CHEM, V279, P429, DOI 10.1074/jbc.M308363200; Wellings CR, 2007, AUST J AGR RES, V58, P567, DOI 10.1071/AR07130; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; Wykoff DD, 2001, GENETICS, V159, P1491; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-203	123	76	83	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67150	10.1371/journal.pone.0067150	http://dx.doi.org/10.1371/journal.pone.0067150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840606	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400075
J	Morales, JA; Cardoso, DG; Della Lucia, TMC; Guedes, RNC				Morales, Juliana A.; Cardoso, Danubia G.; Della Lucia, Terezinha Maria C.; Guedes, Raul Narciso C.			Weevil x Insecticide: Does 'Personality' Matter?	PLOS ONE			English	Article							SITOPHILUS-ZEAMAIS; MAIZE WEEVIL; BEHAVIORAL SYNDROMES; PHYSIOLOGICAL RESISTANCE; PYRETHROID RESISTANCE; ANIMAL TEMPERAMENT; WALKING RESPONSE; POPULATIONS; CONSEQUENCES; ECOLOGY	An insect's behavior is the expression of its integrated physiology in response to external and internal stimuli, turning insect behavior into a potential determinant of insecticide exposure. Behavioral traits may therefore influence insecticide efficacy against insects, compromising the validity of standard bioassays of insecticide activity, which are fundamentally based on lethality alone. By extension, insect 'personality' (i.e., an individual's integrated set of behavioral tendencies that is inferred from multiple empirical measures) may also be an important determinant of insecticide exposure and activity. This has yet to be considered because the behavioral studies involving insects and insecticides focus on populations rather than on individuals. Even among studies of animal 'personality', the relative contributions of individual and population variation are usually neglected. Here, we assessed behavioral traits (within the categories: activity, boldness/shyness, and exploration/avoidance) of individuals from 15 populations of the maize weevil (Sitophilus zeamais), an important stored-grain pest with serious problems of insecticide resistance, and correlated the behavioral responses with the activity of the insecticide deltamethrin. This analysis was performed at both the population and individual levels. There was significant variation in weevil 'personality' among individuals and populations, but variation among individuals within populations accounted for most of the observed variation (92.57%). This result emphasizes the importance of individual variation in behavioral and 'personality' studies. When the behavioral traits assessed were correlated with median lethal time (LT50) at the population level and with the survival time under insecticide exposure, activity traits, particularly the distance walked, significantly increased survival time. Therefore, behavioral traits are important components of insecticide efficacy, and individual variation should be considered in such studies. This is so because population differences provided only crude approximation of the individual personality in a restrained experimental setting likely to restrict individual behavior favoring the transposition of the individual variation to the population.	[Morales, Juliana A.; Cardoso, Danubia G.; Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Della Lucia, Terezinha Maria C.] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Guedes, RNC (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	guedes@ufv.br	Guedes, Raul Narciso Carvalho/L-3924-2013	Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Morales Monje, Juliana Andrea/0000-0002-9613-4083	Brazilian agencies: Minas Gerais State Foundation of Research Aid (FAPEMIG); CAPES Foundation (Brazilian Ministry of Education; National Council for Scientific and Technological Development (CNPq; Brazilian Ministry of Science and Technology)	Brazilian agencies: Minas Gerais State Foundation of Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES Foundation (Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq; Brazilian Ministry of Science and Technology)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the following Brazilian agencies: Minas Gerais State Foundation of Research Aid (FAPEMIG; www.fapemig.br), the CAPES Foundation (Brazilian Ministry of Education; www.capes.gov.br), and the National Council for Scientific and Technological Development (CNPq; Brazilian Ministry of Science and Technology; www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA J, 1973, T ROY SOC TROP MED H, V67, P440; [Anonymous], 2008, SAS US GUID STAT; Araujo RA, 2011, INSECT MOL BIOL, V20, P437, DOI 10.1111/j.1365-2583.2011.01079.x; Barth MB, 2010, BIOL LETTERS, V6, P329, DOI 10.1098/rsbl.2009.0849; Bijttebier P, 2003, PSYCHOL HEALTH, V18, P645, DOI 10.1080/0887044031000094831; Boissy A, 2005, LIVEST PROD SCI, V93, P23, DOI 10.1016/j.livprodsci.2004.11.003; Boissy A, 1995, APPL ANIM BEHAV SCI, V46, P17, DOI 10.1016/0168-1591(95)00633-8; Braga LS, 2011, J STORED PROD RES, V47, P161, DOI 10.1016/j.jspr.2010.11.001; Capitanio JP, 1999, AM J PRIMATOL, V47, P299, DOI 10.1002/(SICI)1098-2345(1999)47:4<299::AID-AJP3>3.0.CO;2-P; Carlstead K, 1999, ZOO BIOL, V18, P17, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;17::AID-ZOO4&gt;3.0.CO;2-K; Caspi A, 1997, J PERS SOC PSYCHOL, V73, P1052, DOI 10.1037/0022-3514.73.5.1052; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Cordeiro EMG, 2010, CHEMOSPHERE, V81, P1352, DOI 10.1016/j.chemosphere.2010.08.021; Correa AS, 2011, CROP PROT, V30, P1655, DOI 10.1016/j.cropro.2011.08.022; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Ellis BJ, 2006, DEV REV, V26, P175, DOI 10.1016/j.dr.2006.02.004; EXCOFFIER L, 1992, GENETICS, V131, P479; Fragoso DB, 2007, J STORED PROD RES, V43, P167, DOI 10.1016/j.jspr.2006.04.002; Fragoso DB, 2003, ENTOMOL EXP APPL, V109, P21, DOI 10.1046/j.1570-7458.2003.00085.x; Garzon DL, 2008, ARCH PSYCHIAT NURS, V22, P288, DOI 10.1016/j.apnu.2007.12.006; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Guedes NMP, 2009, B ENTOMOL RES, V99, P393, DOI 10.1017/S0007485309006610; Guedes NMP, 2009, J APPL ENTOMOL, V133, P524, DOI 10.1111/j.1439-0418.2009.01391.x; GUEDES RNC, 1995, J STORED PROD RES, V31, P145, DOI 10.1016/0022-474X(94)00043-S; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Jallow MFA, 2005, J ECON ENTOMOL, V98, P2195, DOI 10.1603/0022-0493-98.6.2195; Johnson JC, 2007, ANIM BEHAV, V74, P1131, DOI 10.1016/j.anbehav.2007.02.006; Katrivanou A, 2004, J PSYCHOSOM RES, V57, P95, DOI 10.1016/S0022-3999(03)00544-0; LeNeindre P, 1996, APPL ANIM BEHAV SCI, V49, P73, DOI 10.1016/0168-1591(95)00669-9; Lockwood J.A., 1984, Bulletin of the Entomological Society of America, V30, P41; LOCKWOOD JA, 1985, ENVIRON ENTOMOL, V14, P873, DOI 10.1093/ee/14.6.873; Malmkvist J, 2001, ANIM WELFARE, V10, P41; MARGOLIS JA, 1971, PEDIATRICS, V47, P439; Martini X, 2012, PEST MANAG SCI, V68, P1471, DOI 10.1002/ps.3330; MATHER JA, 1993, J COMP PSYCHOL, V107, P336, DOI 10.1037/0735-7036.107.3.336; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; Ministerio da Agricultura Pecuaria e Abastecimento, 2012, AGROFIT SIST AGR FIT; Miyatake T, 2008, ANIM BEHAV, V75, P113, DOI 10.1016/j.anbehav.2007.04.019; Muenworn V, 2006, J AM MOSQUITO CONTR, V22, P689, DOI 10.2987/8756-971X(2006)22[689:IBRITP]2.0.CO;2; Nakayama S, 2012, J INSECT PHYSIOL, V58, P750, DOI 10.1016/j.jinsphys.2012.02.011; Ogden LE, 2012, BIOSCIENCE, V62, P533, DOI 10.1525/bio.2012.62.6.4; Ohno T, 2007, P R SOC B, V274, P555, DOI 10.1098/rspb.2006.3750; Pereira CJ, 2009, CROP PROT, V28, P168, DOI 10.1016/j.cropro.2008.10.001; Pimentel MAG, 2012, PEST MANAG SCI, V68, P1368, DOI 10.1002/ps.3314; Pinter-Wollman N, 2012, CURR ZOOL, V58, P580, DOI 10.1093/czoolo/58.4.580; Pruitt JN, 2008, ANIM BEHAV, V76, P871, DOI 10.1016/j.anbehav.2008.05.009; Pruitt JN, 2012, CURR ZOOL, V58, P589; Pruitt JN, 2010, J EVOLUTION BIOL, V23, P748, DOI 10.1111/j.1420-9101.2010.01940.x; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Riley JR, 1997, ENTOMOL EXP APPL, V83, P317, DOI 10.1023/A:1003034517752; Schuett W, 2011, DEV PSYCHOBIOL, V53, P631, DOI 10.1002/dev.20538; SIBERT JR, 1977, POSTGRAD MED J, V53, P254, DOI 10.1136/pgmj.53.619.254; Siebert C, 2006, NY TIMES, V1, P7; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Sousa AH, 2012, J ECON ENTOMOL, V105, P2187, DOI 10.1603/EC12218; SUITER KA, 1994, ENTOMOL EXP APPL, V71, P1, DOI 10.1007/BF02380564; TOLPO NC, 1965, TEX J SCI, V17, P122; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; Uher J, 2011, DEV PSYCHOBIOL, V53, P521, DOI 10.1002/dev.20544; Wang CL, 2004, J ECON ENTOMOL, V97, P2067, DOI 10.1603/0022-0493-97.6.2067; Wazana A, 1997, CAN J PSYCHIAT, V42, P602, DOI 10.1177/070674379704200606; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Wray MK, 2011, BEHAV ECOL SOCIOBIOL, V65, P2061, DOI 10.1007/s00265-011-1215-1	68	39	39	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67283	10.1371/journal.pone.0067283	http://dx.doi.org/10.1371/journal.pone.0067283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840652	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400092
J	Pot, I; Patel, S; Deng, LL; Chandhoke, AS; Zhang, C; Bonni, A; Bonni, S				Pot, Isabelle; Patel, Shachi; Deng, Lili; Chandhoke, Amrita Singh; Zhang, Chi; Bonni, Azad; Bonni, Shirin			Identification of a Novel Link between the Protein Kinase NDR1 and TGF beta Signaling in Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ANAPHASE-PROMOTING COMPLEX; NEGATIVE REGULATORS; SNON; RECEPTOR; CANCER; SKI; ROLES; PHOSPHORYLATION; TRANSCRIPTION	Transforming growth factor-beta (TGF beta) is a secreted polypeptide that plays essential roles in cellular development and homeostasis. Although mechanisms of TGF beta-induced responses have been characterized, our understanding of TGFb signaling remains incomplete. Here, we uncover a novel function for the protein kinase NDR1 (nuclear Dbf2-related 1) in TGF beta responses. Using an immunopurification approach, we find that NDR1 associates with SnoN, a key component of TGF beta signaling. Knockdown of NDR1 by RNA interference promotes the ability of TGF beta to induce transcription and cell cycle arrest in NMuMG mammary epithelial cells. Conversely, expression of NDR1 represses TGFb-induced transcription and inhibits the ability of TGF beta to induce cell cycle arrest in NMuMG cells. Mechanistically, we find that NDR1 acts in a kinase-dependent manner to suppress the ability of TGF beta to induce the phosphorylation and consequent nuclear accumulation of Smad2, which is critical for TGF beta-induced transcription and responses. Strikingly, we also find that TGF beta reciprocally regulates NDR1, whereby TGF beta triggers the degradation of NDR1 protein. Collectively, our findings define a novel and intimate link between the protein kinase NDR1 and TGF beta signaling. NDR1 suppresses TGFb-induced transcription and cell cycle arrest, and counteracting NDR1' s negative regulation, TGF beta signaling induces the downregulation of NDR1 protein. These findings advance our understanding of TGF beta signaling, with important implications in development and tumorigenesis.	[Pot, Isabelle; Patel, Shachi; Deng, Lili; Chandhoke, Amrita Singh; Bonni, Shirin] Univ Calgary, Southern Alberta Canc Res Inst, Calgary, AB, Canada; [Pot, Isabelle; Patel, Shachi; Deng, Lili; Chandhoke, Amrita Singh; Bonni, Shirin] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Zhang, Chi; Bonni, Azad] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bonni, Azad] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Calgary; University of Calgary; Harvard University; Harvard Medical School; Washington University (WUSTL)	Bonni, S (corresponding author), Univ Calgary, Southern Alberta Canc Res Inst, Calgary, AB, Canada.	sbonni@ucalgary.ca			Alberta Cancer Foundation (ACF); Canadian Institutes of Health Research; National Institutes of Health [NS041021]; Alberta Heritage Medical Foundation for Research (AHFMR); ACF postdoctoral fellowships; ACF graduate studentship award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER	Alberta Cancer Foundation (ACF); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Medical Foundation for Research (AHFMR); ACF postdoctoral fellowships; ACF graduate studentship award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from the Alberta Cancer Foundation (ACF) and the Canadian Institutes of Health Research to S.B., a National Institutes of Health grant to A.B. (NS041021), Alberta Heritage Medical Foundation for Research (AHFMR) and ACF postdoctoral fellowships to I.P., and an ACF graduate studentship award to A.S.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Adeyinka A, 2002, CLIN CANCER RES, V8, P3788; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bonni S, 2012, FEBS LETT, V586, P1977, DOI 10.1016/j.febslet.2012.02.048; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cornils H, 2011, CELL CYCLE, V10, P1897, DOI 10.4161/cc.10.12.15826; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cornils H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000681; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eapen SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040684; FENG XH, 2005, ANN REV CELL DEV BIO; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Heiz M, 2004, J BIOL CHEM, V279, P31149, DOI 10.1074/jbc.M403587200; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2008, BBA-PROTEINS PROTEOM, V1784, P3, DOI 10.1016/j.bbapap.2007.07.017; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Huang T, 2011, EMBO J, V30, P1263, DOI 10.1038/emboj.2011.54; Huynh MA, 2011, NEURON, V69, P930, DOI 10.1016/j.neuron.2011.02.008; Iwano Masayuki, 2010, Front Biosci (Schol Ed), V2, P229; Kim SJ, 2003, LEUKEMIA, V17, P1731, DOI 10.1038/sj.leu.2403069; Kortlever RM, 2008, J BIOL CHEM, V283, P24308, DOI 10.1074/jbc.M803341200; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Netherton SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013971; OWENS RB, 1974, J NATL CANCER I, V53, P261, DOI 10.1093/jnci/53.1.261; OWENS RB, 1974, J NATL CANCER I, V52, P1375, DOI 10.1093/jnci/52.4.1375; Pot I, 2010, CURR MOL MED, V10, P667, DOI 10.2174/156652410792630616; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Sarker KP, 2008, J BIOL CHEM, V283, P13269, DOI 10.1074/jbc.M708834200; Scherr M, 2003, CURR MED CHEM, V10, P245, DOI 10.2174/0929867033368493; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; SPORN MB, 1990, CELL REGUL, V1, P875, DOI 10.1091/mbc.1.12.875; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilkins-Port CE, 2009, CANCER RES, V69, P4081, DOI 10.1158/0008-5472.CAN-09-0043; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; WRANA JL, 1992, COLD SPRING HARB SYM, V57, P81, DOI 10.1101/SQB.1992.057.01.011; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; WRANA JL, 1994, MOL CELL BIOL, V14, P944, DOI 10.1128/MCB.14.2.944; Wrana JL, 2000, CYTO GROWTH IN PRESS; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yingling JM, 1996, P NATL ACAD SCI USA, V93, P8940, DOI 10.1073/pnas.93.17.8940	76	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67178	10.1371/journal.pone.0067178	http://dx.doi.org/10.1371/journal.pone.0067178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840619	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400080
J	Kessler, RL; Gradia, DF; Rampazzo, RDP; Lourenco, EE; Fidencio, NJ; Manhaes, L; Probst, CM; Avila, AR; Fragoso, SP				Kessler, Rafael Luis; Gradia, Daniela Fiori; Pontello Rampazzo, Rita de Cassia; Lourenco, Edio Eligio; Fidencio, Nilson Jose; Manhaes, Lauro; Probst, Christian Macagnan; Avila, Andrea Rodrigues; Fragoso, Stenio Perdigao			Stage-Regulated GFP Expression in Trypanosoma cruzi: Applications from Host-Parasite Interactions to Drug Screening	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VITRO; GENE-EXPRESSION; LIFE-CYCLE; LEISHMANIA; TRANSCRIPTION; RNA; DIFFERENTIATION; AMASTIGOTES; DISCOVERY	Trypanosoma cruzi is the etiological agent of Chagas disease, an illness that affects about 10 million people, mostly in South America, for which there is no effective treatment or vaccine. In this context, transgenic parasites expressing reporter genes are interesting tools for investigating parasite biology and host-parasite interactions, with a view to developing new strategies for disease prevention and treatment. We describe here the construction of a stably transfected fluorescent T. cruzi clone in which the GFP gene is integrated into the chromosome carrying the ribosomal cistron in T. cruzi Dm28c. This fluorescent T. cruzi produces detectable amounts of GFP only at replicative stages (epimastigote and amastigote), consistent with the larger amounts of GFP mRNA detected in these forms than in the non replicative trypomastigote stages. The fluorescence signal was also strongly correlated with the total number of parasites in T. cruzi cultures, providing a simple and rapid means of determining the growth inhibitory dose of anti-T. cruzi drugs in epimastigotes, by fluorometric microplate screening, and in amastigotes, by the flow cytometric quantification of T. cruzi-infected Vero cells. This fluorescent T. cruzi clone is, thus, an interesting tool for unbiased detection of the proliferating stages of the parasite, with multiple applications in the genetic analysis of T. cruzi, including analyses of host-parasite interactions, gene expression regulation and drug development.	[Kessler, Rafael Luis; Gradia, Daniela Fiori; Pontello Rampazzo, Rita de Cassia; Lourenco, Edio Eligio; Fidencio, Nilson Jose; Manhaes, Lauro; Probst, Christian Macagnan; Avila, Andrea Rodrigues; Fragoso, Stenio Perdigao] Fiocruz MS, Inst Carlos Chagas, Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz	Fragoso, SP (corresponding author), Fiocruz MS, Inst Carlos Chagas, Curitiba, Parana, Brazil.	sfragoso@fiocruz.br	Probst, Christian/B-8678-2009; Gradia, Daniela Fiori/I-8068-2012; Rampazzo, Rita/AAA-4590-2020; Kessler, Rafael/E-9291-2018; Fragoso, Stenio/AAB-4703-2019	Probst, Christian/0000-0001-9993-6375; Gradia, Daniela Fiori/0000-0002-1452-5807; Rampazzo, Rita/0000-0002-8367-999X; Kessler, Rafael/0000-0002-6365-8251; Fragoso, Stenio/0000-0002-0909-7940	CNPq; Fundacao Araucaria; FIOCRUZ; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); FIOCRUZ; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by CNPq, Fundacao Araucaria, FIOCRUZ, CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P334; Batista M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-259; Bolhassani A, 2011, EXP PARASITOL, V127, P637, DOI 10.1016/j.exppara.2010.12.006; BONALDO MC, 1988, J CELL BIOL, V106, P1349, DOI 10.1083/jcb.106.4.1349; Boucher N, 2002, MOL BIOCHEM PARASIT, V119, P153, DOI 10.1016/S0166-6851(01)00410-8; Campos MCO, 2010, PARASITOL RES, V107, P1193, DOI 10.1007/s00436-010-1988-6; Canavaci AMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000740; Chan MMY, 2003, PARASITOL RES, V89, P266, DOI 10.1007/s00436-002-0706-4; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; da Silva C, 2011, PARASITOLOGY, P1; DaRocha WD, 2004, PARASITOL RES, V92, P113, DOI 10.1007/s00436-003-1004-5; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; DECARVALHO TU, 1983, Z PARASITENKD, V69, P571; dos Santos WG, 2000, J PARASITOL, V86, P1281, DOI 10.1645/0022-3395(2000)086[1281:SSEONP]2.0.CO;2; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; Dube A, 2009, TRENDS PARASITOL, V25, P432, DOI 10.1016/j.pt.2009.06.006; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Ferreira LRP, 2008, AN ACAD BRAS CIENC, V80, P157, DOI 10.1590/S0001-37652008000100011; Fumarola L, 2004, RES MICROBIOL, V155, P224, DOI 10.1016/j.resmic.2004.01.001; GAMARRO F, 1985, Z PARASITENKD, V71, P15, DOI 10.1007/BF00932914; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Guevara P, 2005, J MED ENTOMOL, V42, P48, DOI 10.1603/0022-2585(2005)042[0048:EOFGIT]2.0.CO;2; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Heussler V, 2006, TRENDS PARASITOL, V22, P192, DOI 10.1016/j.pt.2006.03.001; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Lorenzi HA, 2003, GENE, V310, P91, DOI 10.1016/S0378-1119(03)00502-X; MartinezCalvillo S, 1997, GENE, V199, P71, DOI 10.1016/S0378-1119(97)00348-X; Mehta SR, 2008, CLIN VACCINE IMMUNOL, V15, P1764, DOI 10.1128/CVI.00270-08; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Moreno M, 2010, MEM I OSWALDO CRUZ, V105, P918, DOI 10.1590/S0074-02762010000700014; Nunes LR, 1997, MOL BIOCHEM PARASIT, V86, P211, DOI 10.1016/S0166-6851(97)02857-0; Okuno T, 2003, EXP ANIM TOKYO, V52, P109, DOI 10.1538/expanim.52.109; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; de Souza FSP, 2010, MOL BIOCHEM PARASIT, V172, P90, DOI 10.1016/j.molbiopara.2010.03.014; Pires SF, 2008, INT J PARASITOL, V38, P289, DOI 10.1016/j.ijpara.2007.08.013; Plock A, 2001, EXP PARASITOL, V97, P141, DOI 10.1006/expr.2001.4598; Sambrook, 2006, CONDENSED PROTOCOLS, pV; SCHMATZ DM, 1981, J PARASITOL, V67, P517, DOI 10.2307/3280483; Striepen B, 1998, MOL BIOCHEM PARASIT, V92, P325, DOI 10.1016/S0166-6851(98)00011-5; Sultan AA, 1999, INFECT IMMUN, V67, P2602, DOI 10.1128/IAI.67.5.2602-2606.1999; Taylor MC, 2011, ADV PARASIT, V75, P231, DOI 10.1016/B978-0-12-385863-4.00011-3; Teixeira MMG, 2011, PROTIST, V162, P503, DOI 10.1016/j.protis.2011.01.001; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; TYLERCROSS RE, 1995, MOL BIOCHEM PARASIT, V72, P23, DOI 10.1016/0166-6851(95)00061-5; VanWye JD, 1997, MOL BIOCHEM PARASIT, V87, P225, DOI 10.1016/S0166-6851(97)00059-5; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8	50	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67441	10.1371/journal.pone.0067441	http://dx.doi.org/10.1371/journal.pone.0067441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840703	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800134
J	Aizenberg-Gershtein, Y; Izhaki, I; Halpern, M				Aizenberg-Gershtein, Yana; Izhaki, Ido; Halpern, Malka			Do Honeybees Shape the Bacterial Community Composition in Floral Nectar?	PLOS ONE			English	Article							FLOWER CONSTANCY; GUT BACTERIA; YEASTS; DIVERSITY; IDENTIFICATION; VARIABILITY; POPULATIONS; PROKARYOTES; ECOLOGY; PLANTS	Floral nectar is considered the most important reward animal-pollinated plants offer to attract pollinators. Here we explore whether honeybees, which act as pollinators, affect the composition of bacterial communities in the nectar. Nectar and honeybees were sampled from two plant species: Amygdalus communis and Citrus paradisi. To prevent the contact of nectar with pollinators, C. paradisi flowers were covered with net bags before blooming (covered flowers). Comparative analysis of bacterial communities in the nectar and on the honeybees was performed by the 454-pyrosequencing technique. No significant differences were found among bacterial communities in honeybees captured on the two different plant species. This resemblance may be due to the presence of dominant bacterial OTUs, closely related to the Arsenophonus genus. The bacterial communities of the nectar from the covered and uncovered C. paradisi flowers differed significantly; the bacterial communities on the honeybees differed significantly from those in the covered flowers' nectar, but not from those in the uncovered flowers' nectar. We conclude that the honeybees may introduce bacteria into the nectar and/or may be contaminated by bacteria introduced into the nectar by other sources such as other pollinators and nectar thieves.	[Aizenberg-Gershtein, Yana; Izhaki, Ido; Halpern, Malka] Univ Haifa, Dept Evolutionary & Environm Biol, Fac Nat Sci, IL-31999 Haifa, Israel; [Halpern, Malka] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Oranim, Tivon, Israel	University of Haifa; University of Haifa	Halpern, M (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, Fac Nat Sci, IL-31999 Haifa, Israel.	mhalpern@research.haifa.ac.il	Izhaki, Ido/I-9712-2019; Halpern, Malka/AAH-1498-2019	Izhaki, Ido/0000-0002-4525-4683; Halpern, Malka/0000-0002-3407-2198	Israel Science Foundation (ISF) [189/08, 1094/12]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by grants from the Israel Science Foundation (ISF, grants 189/08 and 1094/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Perez S, 2013, INT J SYST EVOL MICR, V63, P1532, DOI 10.1099/ijs.0.043489-0; Alvarez-Perez S, 2013, FEMS MICROBIOL ECOL, V83, P685, DOI 10.1111/1574-6941.12027; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Bailey MT, 2010, BRAIN BEHAV IMMUN, V24, P577, DOI 10.1016/j.bbi.2009.12.010; Baker H.G., 1983, P126; Brysch-Herzberg M, 2004, FEMS MICROBIOL ECOL, V50, P87, DOI 10.1016/j.femsec.2004.06.003; Canto A, 2011, FLORA, V206, P668, DOI 10.1016/j.flora.2011.02.003; Carter C, 2006, NATURWISSENSCHAFTEN, V93, P72, DOI 10.1007/s00114-005-0062-1; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Endo A, 2012, INT J SYST EVOL MICR, V62, P500, DOI 10.1099/ijs.0.031054-0; Felske A, 1997, MICROBIOL-UK, V143, P2983, DOI 10.1099/00221287-143-9-2983; FREE JB, 1963, J ANIM ECOL, V32, P119, DOI 10.2307/2521; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; GILLIAM M, 1983, APIDOLOGIE, V14, P299, DOI 10.1051/apido:19830403; GILLIAM M, 1990, APIDOLOGIE, V21, P99, DOI 10.1051/apido:19900202; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Gruter C, 2011, J EXP BIOL, V214, P1397, DOI 10.1242/jeb.050583; Halpern M, 2013, INT J SYST EVOL MICR, V63, P268, DOI 10.1099/ijs.0.033654-0; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P1827, DOI 10.1098/rspb.2009.2252; Herrera CM, 2009, ANN BOT-LONDON, V103, P1415, DOI 10.1093/aob/mcp026; Izhaki I, 2013, CURR MICROBIOL, V66, P227, DOI 10.1007/s00284-012-0261-x; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kim M, 2012, MICROB ECOL, V63, P674, DOI 10.1007/s00248-011-9953-1; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Lachance MA, 2001, FEMS YEAST RES, V1, P1; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Maurizio A, 1969, TRACHT PFLANZENBUCH; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; PHAFF HJ, 1978, INT J SYST BACTERIOL, V28, P326, DOI 10.1099/00207713-28-2-326; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Ruppel S, 2008, MICROB ECOL, V56, P364, DOI 10.1007/s00248-007-9354-7; SANDHU DK, 1985, MICROB ECOL, V11, P51, DOI 10.1007/BF02015108; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tadmor-Melamed H, 2004, FUNCT ECOL, V18, P844, DOI 10.1111/j.0269-8463.2004.00929.x; Vannette RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2601; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilkes TE, 2012, FRONT MICROBIOL SER, P225; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898	51	74	76	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67556	10.1371/journal.pone.0067556	http://dx.doi.org/10.1371/journal.pone.0067556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844027	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000079
J	Acosta, CD; Knight, M; Lee, HC; Kurinczuk, JJ; Gould, JB; Lyndon, A				Acosta, Colleen D.; Knight, Marian; Lee, Henry C.; Kurinczuk, Jennifer J.; Gould, Jeffrey B.; Lyndon, Audrey			The Continuum of Maternal Sepsis Severity: Incidence and Risk Factors in a Population-Based Cohort Study	PLOS ONE			English	Article							SEVERE OBSTETRIC MORBIDITY; PREGNANCY-RELATED MORTALITY; INTENSIVE-CARE UNITS; HOSPITAL VOLUME; PRENATAL-CARE; STATES; EPIDEMIOLOGY; INFECTION; LINKAGE	Objective: To investigate the incidence and risk factors associated with uncomplicated maternal sepsis and progression to severe sepsis in a large population-based birth cohort. Methods: This retrospective cohort study used linked hospital discharge and vital statistics records data for 1,622,474 live births in California during 2005-2007. Demographic and clinical factors were adjusted using multivariable logistic regression with robust standard errors. Results: 1598 mothers developed sepsis; incidence of all sepsis was 10 per 10,000 live births (95% CI = 9.4-10.3). Women had significantly increased adjusted odds (aOR) of developing sepsis if they were older (25-34 years: aOR = 1.29; >= 35 years: aOR = 1.41), had <= high-school education (aOR = 1.63), public/no-insurance (aOR = 1.22) or a cesarean section (primary: aOR = 1.99; repeat: aOR = 1.25). 791 women progressed to severe sepsis; incidence of severe sepsis was 4.9 per 10,000 live births (95% CI = 4.5-5.2). Women had significantly increased adjusted odds of progressing to severe sepsis if they were Black (aOR = 2.09), Asian (aOR = 1.59), Hispanic (aOR = 1.42), had public/no-insurance (aOR = 1.52), delivered in hospitals with <1,000 births/year (aOR = 1.93), were primiparous (aOR = 2.03), had a multiple birth (aOR = 3.5), diabetes (aOR = 1.47), or chronic hypertension (aOR = 8.51). Preeclampsia and postpartum hemorrhage were also significantly associated with progression to severe sepsis (aOR = 3.72; aOR = 4.18). For every cumulative factor, risk of uncomplicated sepsis increased by 25% (95% CI = 17.4-32.3) and risk of progression to severe sepsis/septic shock increased by 57% (95% CI = 40.8-74.4). Conclusions: The rate of severe sepsis was approximately twice the 1991-2003 national estimate. Risk factors identified are relevant to obstetric practice given their cumulative risk effect and the apparent increase in severe sepsis incidence.	[Acosta, Colleen D.; Knight, Marian; Kurinczuk, Jennifer J.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Lee, Henry C.; Gould, Jeffrey B.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Lee, Henry C.; Gould, Jeffrey B.] Calif Perinatal Qual Care Collaborat, Stanford, CA USA; [Lyndon, Audrey] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA; [Gould, Jeffrey B.; Lyndon, Audrey] Calif Maternal Qual Care Collaborat, Stanford, CA USA	University of Oxford; Stanford University; University of California System; University of California San Francisco	Acosta, CD (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England.	colleen.acosta@npeu.ox.ac.uk	Lee, Henry/GVS-2114-2022; Knight, Marian/B-6225-2009; Lyndon, Audrey/ABD-7493-2021; Lyndon, Audrey/GLS-0866-2022	Knight, Marian/0000-0002-1984-4575; Lyndon, Audrey/0000-0003-2215-4273	National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI [KL2TR000143]; National Institute for Health Research (NIHR) [RP-PG-0608-10038]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; National Institute for Health Research [RP-PG-0608-10038] Funding Source: researchfish	National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI grant number KL2TR000143, and by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (award reference RP-PG-0608-10038). The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of the NIH, the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CD, 2012, BJOG-INT J OBSTET GY, V119, P474, DOI 10.1111/j.1471-0528.2011.03239.x; [Anonymous], 2010, Obstet Gynecol, V116, P791, DOI 10.1097/AOG.0b013e3181f68086; [Anonymous], 2009, Obstet Gynecol, V113, P748, DOI 10.1097/AOG.0b013e31819e9ee2; [Anonymous], 2012, BACT SEPS FOLL PREGN; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bryant AS, 2010, AM J OBSTET GYNECOL, V202, P335, DOI 10.1016/j.ajog.2009.10.864; Chu SY, 2008, AM J OBSTET GYNECOL, V199, pE18, DOI [10.1016/j.ajog.2008.02.038, 10.1016/j.ajog.2007.12.020]; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Egerter S, 2002, AM J PUBLIC HEALTH, V92, P423, DOI 10.2105/AJPH.92.3.423; Esper A, 2007, CRIT CARE MED, V35, P1414, DOI 10.1097/01.CCM.0000262946.68003.21; Geller SE, 2004, AM J OBSTET GYNECOL, V191, P939, DOI 10.1016/j.ajog.2004.05.099; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Herrchen B, 1997, COMPUT BIOMED RES, V30, P290, DOI 10.1006/cbmr.1997.1448; Herrera JA, 2001, MED HYPOTHESES, V57, P393, DOI 10.1054/mehy.2001.1378; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Kramer HMC, 2009, ACTA OBSTET GYN SCAN, V88, P647, DOI 10.1080/00016340902926734; Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25; Kuklina EV, 2009, OBSTET GYNECOL, V113, P293, DOI 10.1097/AOG.0b013e3181954e5b; Lucas DN, 2012, INT J OBSTET ANESTH, V21, P56, DOI 10.1016/j.ijoa.2011.11.001; Lyndon A, 2012, J MATERN-FETAL NEO M, V25, P2529, DOI 10.3109/14767058.2012.710280; Maharaj D, 2007, OBSTET GYNECOL SURV, V62, P393, DOI 10.1097/01.ogx.0000265998.40912.5e; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Minino AM, 2011, DEATHS FINAL DATA 20; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Paruk F, 2008, BEST PRACT RES CL OB, V22, P865, DOI 10.1016/j.bpobgyn.2008.06.011; Royal College of Obstetricians and Gynaecologists (RCOG), 2012, BACT SEPS PREGN GREE; Schmidt GA, 2012, UPTODATE; STAMLER EF, 1990, AM J OBSTET GYNECOL, V163, P1217, DOI 10.1016/0002-9378(90)90694-3; Takoudes TC, 2004, AM J OBSTET GYNECOL, V191, P958, DOI 10.1016/j.ajog.2004.05.063; The California Pregnancy-Associated Mortality Review, 2011, CAL PREGN ASS MORT R; Tucker MJ, 2007, AM J PUBLIC HEALTH, V97, P247, DOI 10.2105/AJPH.2005.072975; van Dillen J, 2010, CURR OPIN INFECT DIS, V23, P249, DOI 10.1097/QCO.0b013e328339257c; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vitale MA, 2005, J PEDIATR ORTHOPED, V25, P393, DOI 10.1097/01.bpo.0000153880.05314.be; von Dadelszen P, 2002, ACTA OBSTET GYN SCAN, V81, P642, DOI 10.1034/j.1600-0412.2002.810710.x; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089	40	67	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67175	10.1371/journal.pone.0067175	http://dx.doi.org/10.1371/journal.pone.0067175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23843991	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000034
J	Choi, HJ; Ki, KH; Yang, JY; Jang, BY; Song, JA; Baek, WY; Kim, JH; An, JH; Kim, SW; Kim, SY; Kim, JE; Shin, CS				Choi, Hyung Jin; Ki, Kyoung Ho; Yang, Jae-Yeon; Jang, Bo Young; Song, Jung Ah; Baek, Wook-Young; Kim, Jung Hee; An, Jee Hyun; Kim, Sang Wan; Kim, Seong Yeon; Kim, Jung-Eun; Shin, Chan Soo			Chronic Central Administration of Ghrelin Increases Bone Mass through a Mechanism Independent of Appetite Regulation	PLOS ONE			English	Article							ACYLATED PEPTIDE; BODY-COMPOSITION; MINERAL DENSITY; LEPTIN; FAT; DIFFERENTIATION; OSTEOBLASTS; ADIPOSITY; APOPTOSIS; OBESITY	Leptin plays a critical role in the central regulation of bone mass. Ghrelin counteracts leptin. In this study, we investigated the effect of chronic intracerebroventricular administration of ghrelin on bone mass in Sprague-Dawley rats (1.5 mg/day for 21 days). Rats were divided into control, ghrelin ad libitum-fed (ghrelin ad lib-fed), and ghrelin pair-fed groups. Ghrelin intracerebroventricular infusion significantly increased body weight in ghrelin ad lib-fed rats but not in ghrelin pair-fed rats, as compared with control rats. Chronic intracerebroventricular ghrelin infusion significantly increased bone mass in the ghrelin pair-fed group compared with control as indicated by increased bone volume percentage, trabecular thickness, trabecular number and volumetric bone mineral density in tibia trabecular bone. There was no significant difference in trabecular bone mass between the control group and the ghrelin ad-lib fed group. Chronic intracerebroventricular ghrelin infusion significantly increased the mineral apposition rate in the ghrelin pair-fed group as compared with control. In conclusion, chronic central administration of ghrelin increases bone mass through a mechanism that is independent of body weight, suggesting that ghrelin may have a bone anabolic effect through the central nervous system.	[Choi, Hyung Jin; Ki, Kyoung Ho; Yang, Jae-Yeon; Jang, Bo Young; Song, Jung Ah; Kim, Jung Hee; An, Jee Hyun; Kim, Sang Wan; Kim, Seong Yeon; Shin, Chan Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Baek, Wook-Young; Kim, Jung-Eun] Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Dept Mol Med, Taegu 702701, South Korea	Seoul National University (SNU); Kyungpook National University	Shin, CS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	csshin@snu.ac.kr	Choi, Hyung Jin/AAU-9629-2020; Kim, Sang Wan/J-5399-2012	Kim, Sang Wan/0000-0001-9561-9110; Baek, Wook-Young/0000-0002-2501-4439; Choi, Hyung Jin/0000-0003-0593-6978	Ministry of Health & Welfare, Republic of Korea [A110566]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Health technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea (A110566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamizu T, 2011, PEPTIDES, V32, P2295, DOI 10.1016/j.peptides.2011.05.018; Ambati S, 2010, ENDOCRINE, V37, P115, DOI 10.1007/s12020-009-9274-z; Ashitani J, 2009, PEPTIDES, V30, P1951, DOI 10.1016/j.peptides.2009.07.002; Baek K, 2009, J BONE MINER RES, V24, P792, DOI [10.1359/JBMR.081241, 10.1359/jbmr.081241]; Belloni AS, 2004, INT J MOL MED, V14, P165; Cho NH, 2011, OSTEOPOROS INT; Costa Jessica L, 2011, Int J Pept, V2011, P605193, DOI 10.1155/2011/605193; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Dunbar JC, 1999, BRAIN RES BULL, V50, P215, DOI 10.1016/S0361-9230(99)00197-5; Dunbar JC, 1997, DIABETES, V46, P2040, DOI 10.2337/diabetes.46.12.2040; Elbaz A, 2010, J CELL MOL MED, V14, P982, DOI 10.1111/j.1582-4934.2009.00751.x; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; Fukushima N, 2005, J BONE MINER RES, V20, P790, DOI 10.1359/JBMR.041237; Gaddam DR, 2011, J BONE MINERAL RES O; Gilsanz V, 2009, J CLIN ENDOCR METAB, V94, P3387, DOI 10.1210/jc.2008-2422; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; Holloway WR, 2002, J BONE MINER RES, V17, P200, DOI 10.1359/jbmr.2002.17.2.200; Hotta M, 2009, ENDOCR J, V56, P1119, DOI 10.1507/endocrj.K09E-168; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Iwaniec UT, 2011, J BONE MINER RES, V26, P1506, DOI 10.1002/jbmr.365; Karsenty G, 2010, J CLIN ENDOCR METAB, V95, P4795, DOI 10.1210/jc.2010-1030; Katzmarzyk PT, 2012, BONE, V50, P576, DOI 10.1016/j.bone.2011.04.012; Kim GS, 2003, J BIOL CHEM, V278, P21920, DOI 10.1074/jbc.M204598200; Kim MS, 2004, INT J OBESITY, V28, P1264, DOI 10.1038/sj.ijo.0802647; Kim SW, 2005, BONE, V37, P359, DOI 10.1016/j.bone.2005.04.020; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Matsumura K, 2002, HYPERTENSION, V40, P694, DOI 10.1161/01.HYP.0000035395.51441.10; Migliaccio S, 2011, DIABETES METAB SYNDR, V4, P273, DOI 10.2147/DMSO.S11920; Nagy TR, 2001, J BONE MINER RES, V16, P1682, DOI 10.1359/jbmr.2001.16.9.1682; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Napoli N, 2011, BONE, V49, P257, DOI 10.1016/j.bone.2011.03.772; Nass R, 2008, ANN INTERN MED, V149, P601, DOI 10.7326/0003-4819-149-9-200811040-00003; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perez-Tilve D, 2011, FASEB J, V25, P2814, DOI 10.1096/fj.11-183632; Sangiao-Alvarellos S, 2009, ENDOCRINOLOGY, V150, P4562, DOI 10.1210/en.2009-0482; Schlienger RG, 2004, JAMA-J AM MED ASSOC, V292, P1326, DOI 10.1001/jama.292.11.1326; Shan XY, 2011, REV ENDOCR METAB DIS, V12, P197, DOI 10.1007/s11154-011-9171-7; Stengel A, 2011, CURR PHARM DESIGN, V17, P1587, DOI 10.2174/138161211796196990; Stevanovic D, 2012, NEUROENDOCRINOLOGY, V96, P24, DOI 10.1159/000333963; Stevanovic D, 2012, BRAIN BEHAV IMMUN, V26, P150, DOI 10.1016/j.bbi.2011.08.009; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Williams GA, 2011, J BONE MINER RES, V26, P1698, DOI 10.1002/jbmr.367; Yang SM, 2011, BONE, V48, P451, DOI 10.1016/j.bone.2010.10.170; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572	48	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e65505	10.1371/journal.pone.0065505	http://dx.doi.org/10.1371/journal.pone.0065505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843943	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000006
J	Roszell, BR; Tao, JQ; Yu, KJ; Gao, L; Huang, SH; Ning, Y; Feinstein, SI; Vite, CH; Bates, SR				Roszell, Blair R.; Tao, Jian-Qin; Yu, Kevin J.; Gao, Ling; Huang, Shaohui; Ning, Yue; Feinstein, Sheldon I.; Vite, Charles H.; Bates, Sandra R.			Pulmonary Abnormalities in Animal Models Due to Niemann-Pick Type C1 (NPC1) or C2 (NPC2) Disease	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; LAMELLAR BODIES; CHOLESTEROL HOMEOSTASIS; EVERY ORGAN; MOUSE MODEL; II CELLS; SP-A; SURFACTANT; LUNG; MICE	Niemann-Pick C (NPC) disease is due to loss of NPC1 or NPC2 protein function that is required for unesterified cholesterol transport from the endosomal/lysosomal compartment. Though lung involvement is a recognized characteristic of Niemann-Pick type C disease, the pathological features are not well understood. We investigated components of the surfactant system in both NPC1 mutant mice and felines and in NPC2 mutant mice near the end of their expected life span. Histological analysis of the NPC mutant mice demonstrated thickened septae and foamy macrophages/leukocytes. At the level of electron microscopy, NPC1-mutant type II cells had uncharacteristically larger lamellar bodies (LB, mean area 2-fold larger), while NPC2-mutant cells had predominantly smaller lamellar bodies (mean area 50% of normal) than wild type. Bronchoalveolar lavage from NPC1 and NPC2 mutant mice had an approx. 4-fold and 2.5-fold enrichment in phospholipid, respectively, and an approx. 9-fold and 35-fold enrichment in cholesterol, consistent with alveolar lipidosis. Phospholipid and cholesterol also were elevated in type II cell LBs and lung tissue while phospholipid degradation was reduced. Enrichment of surfactant protein-A in the lung and surfactant of the mutant mice was found. Immunocytochemical results showed that cholesterol accumulated in the LBs of the type II cells isolated from the affected mice. Alveolar macrophages from the NPC1 and NPC2 mutant mice were enlarged compared to those from wild type mice and were enriched in phospholipid and cholesterol. Pulmonary features of NPC1 mutant felines reflected the disease described in NPC1 mutant mice. Thus, with the exception of lamellar body size, the lung phenotype seen in the NPC1 and NPC2 mutant mice were similar. The lack of NPC1 and NPC2 proteins resulted in a disruption of the type II cell surfactant system contributing to pulmonary abnormalities.	[Roszell, Blair R.; Tao, Jian-Qin; Yu, Kevin J.; Gao, Ling; Huang, Shaohui; Ning, Yue; Feinstein, Sheldon I.; Bates, Sandra R.] Univ Penn, Perelman Sch Med, Inst Environm Med, Philadelphia, PA 19104 USA; [Huang, Shaohui; Bates, Sandra R.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vite, Charles H.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bates, SR (corresponding author), Univ Penn, Perelman Sch Med, Inst Environm Med, Philadelphia, PA 19104 USA.	batekenn@mail.med.upenn.edu	Shaohui Huang, Shaohui Huang Huang Shaohui/AAW-4531-2021		National Heart, Lung and Blood Institute [HL-19737]; National Research Service Award [T32-HL-07748]; NIH [R01-NS073661-01];  [NCRR02512]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007748, P01HL019737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073661] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by National Heart, Lung and Blood Institute Grant HL-19737, National Research Service Award T32-HL-07748, NIH R01-NS073661-01 and NCRR02512. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hammed M, 2010, J LIPID RES, V51, P1747, DOI 10.1194/jlr.M003822; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Besnard V, 2010, AM J PHYSIOL-LUNG C, V298, pL646, DOI 10.1152/ajplung.00409.2009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bortnick AE, 2003, AM J PHYSIOL-LUNG C, V285, pL869, DOI 10.1152/ajplung.00077.2003; BROWN DE, 1994, AM J PATHOL, V144, P1412; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHANDER A, 1986, J BIOL CHEM, V261, P6126; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; FISHER AB, 1998, MED INTELL UNIT, V5, P165; Griese M, 2010, CLIN GENET, V77, P119, DOI 10.1111/j.1399-0004.2009.01325.x; Gunasekara L, 2005, BBA-MOL CELL BIOL L, V1737, P27, DOI 10.1016/j.bbalip.2005.09.002; Gurel O, 2001, AM J PHYSIOL-LUNG C, V280, pL1266, DOI 10.1152/ajplung.2001.280.6.L1266; Guttentag SH, 2005, AM J RESP CELL MOL, V33, P14, DOI 10.1165/rcmb.2004-0293OC; HASS MA, 1979, BIOCHIM BIOPHYS ACTA, V573, P166, DOI 10.1016/0005-2760(79)90183-8; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Jain D, 2003, AM J PHYSIOL-LUNG C, V284, pL759, DOI 10.1152/ajplung.00200.2002; KING RJ, 1972, AM J PHYSIOL, V223, P715, DOI 10.1152/ajplegacy.1972.223.3.715; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lee WS, 2011, ARCH BIOCHEM BIOPHYS, V514, P57, DOI 10.1016/j.abb.2011.07.014; Leonenko Z, 2007, BIOPHYS J, V93, P674, DOI 10.1529/biophysj.107.106310; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANABE T, 1995, VIRCHOWS ARCH, V427, P77; MASON RJ, 1976, J LIPID RES, V17, P281; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Meiner V, 2001, GENET MED, V3, P343, DOI 10.1097/00125817-200109000-00003; Millat G, 2001, AM J HUM GENET, V69, P1013, DOI 10.1086/324068; MORRIS MD, 1982, AM J PATHOL, V108, P140; Muralidhar A, 2011, MOL GENET METAB, V103, P142, DOI 10.1016/j.ymgme.2011.03.001; Nakatani Y, 2000, VIRCHOWS ARCH, V437, P304, DOI 10.1007/s004280000241; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Orgeig S, 2001, COMP BIOCHEM PHYS A, V129, P75, DOI 10.1016/S1095-6433(01)00307-5; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Roszell BR, 2012, AM J PHYSIOL-LUNG C, V302, pL919, DOI 10.1152/ajplung.00383.2011; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Somers KL, 2003, MOL GENET METAB, V79, P99, DOI 10.1016/S1096-7192(03)00074-X; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Vockeroth D, 2010, AM J PHYSIOL-LUNG C, V298, pL117, DOI 10.1152/ajplung.00218.2009; Ward S, 2010, PEDIATR RES, V68, P52, DOI [10.1203/PDR.0b013e3181df4623, 10.1203/00006450-201011001-00099]; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730	46	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67084	10.1371/journal.pone.0067084	http://dx.doi.org/10.1371/journal.pone.0067084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843985	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000031
J	Tang, HYLL; Goh, J; Peto, T; Ling, BWK; Al Turk, LI; Hu, Y; Wang, S; Saleh, GM				Tang, Hongying Lilian; Goh, Jonathan; Peto, Tunde; Ling, Bingo Wing-Kuen; Al Turk, Lutfiah Ismail; Hu, Yin; Wang, Su; Saleh, George Michael			The Reading of Components of Diabetic Retinopathy: An Evolutionary Approach for Filtering Normal Digital Fundus Imaging in Screening and Population Based Studies	PLOS ONE			English	Article							AUTOMATIC DETECTION; CLASSIFICATION	In any diabetic retinopathy screening program, about two-thirds of patients have no retinopathy. However, on average, it takes a human expert about one and a half times longer to decide an image is normal than to recognize an abnormal case with obvious features. In this work, we present an automated system for filtering out normal cases to facilitate a more effective use of grading time. The key aim with any such tool is to achieve high sensitivity and specificity to ensure patients' safety and service efficiency. There are many challenges to overcome, given the variation of images and characteristics to identify. The system combines computed evidence obtained from various processing stages, including segmentation of candidate regions, classification and contextual analysis through Hidden Markov Models. Furthermore, evolutionary algorithms are employed to optimize the Hidden Markov Models, feature selection and heterogeneous ensemble classifiers. In order to evaluate its capability of identifying normal images across diverse populations, a population-oriented study was undertaken comparing the software's output to grading by humans. In addition, population based studies collect large numbers of images on subjects expected to have no abnormality. These studies expect timely and cost-effective grading. Altogether 9954 previously unseen images taken from various populations were tested. All test images were masked so the automated system had not been exposed to them before. This system was trained using image subregions taken from about 400 sample images. Sensitivities of 92.2% and specificities of 90.4% were achieved varying between populations and population clusters. Of all images the automated system decided to be normal, 98.2% were true normal when compared to the manual grading results. These results demonstrate scalability and strong potential of such an integrated computational intelligence system as an effective tool to assist a grading service.	[Tang, Hongying Lilian; Goh, Jonathan; Hu, Yin; Wang, Su] Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England; [Peto, Tunde; Saleh, George Michael] Moorfields Eye Hosp NHS Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Peto, Tunde; Saleh, George Michael] UCL Inst Ophthalmol, London, England; [Ling, Bingo Wing-Kuen] Guangdong Univ Technol, Fac Informat Engn, Guangzhou, Guangdong, Peoples R China; [Al Turk, Lutfiah Ismail] King Abdulaziz Univ, Dept Stat, Jeddah 21413, Saudi Arabia	University of Surrey; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Guangdong University of Technology; King Abdulaziz University	Tang, HYLL (corresponding author), Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England.	h.tang@surrey.ac.uk	turk, Lutfiah Ismail Al/L-3227-2016; Peto, Tunde/G-8812-2018	turk, Lutfiah Ismail Al/0000-0002-0333-6584; Peto, Tunde/0000-0001-6265-0381	Engineering and Physical Sciences Research Council (EPSRC), UK [EP/H500189/1]; Department of Health through National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust; Department of Health through UCL Institute of Ophthalmology for a Biomedical Research Centre; Hundred People Plan from the Guangdong University of Technology; Young Thousand People Plan from the Ministry of Education of China	Engineering and Physical Sciences Research Council (EPSRC), UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Health through National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust; Department of Health through UCL Institute of Ophthalmology for a Biomedical Research Centre; Hundred People Plan from the Guangdong University of Technology; Young Thousand People Plan from the Ministry of Education of China	HLT and JG's work are supported by Engineering and Physical Sciences Research Council (EPSRC), UK. Ref: EP/H500189/1. The authors [TP and GMS] acknowledge (a proportion of their) financial support from the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Biomedical Research Centre. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. BWKL was supported partly by the Hundred People Plan from the Guangdong University of Technology and the Young Thousand People Plan from the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2010, OPHTHALMOLOGY, V117, P1147, DOI 10.1016/j.ophtha.2010.03.046; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Castellano M, 2008, INT CONF SYST SIGNAL, P335, DOI 10.1109/IWSSIP.2008.4604435; CHAUDHURI S, 1989, IEEE T MED IMAGING, V8, P263, DOI 10.1109/42.34715; Cheung N, 2008, CONTEMP DIABETES, P465, DOI 10.1007/978-1-59745-563-3_21; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chutatape O, 1998, P ANN INT IEEE EMBS, V20, P3144, DOI 10.1109/IEMBS.1998.746160; Cornforth DJ, 2004, P 8 AS PAC S INT EV; Cree MJ, 2005, P IM VIS COMP C; Dua S, 2005, ITCC 2005: International Conference on Information Technology: Coding and Computing, Vol 1, P26, DOI 10.1109/ITCC.2005.120; Estrabridia K, 2006, 19 IEEE S COMP BAS M; Fleming AD, 2007, PHYS MED BIOL, V52, P331, DOI 10.1088/0031-9155/52/2/002; Fleming AD, 2006, IEEE T MED IMAGING, V25, P1223, DOI 10.1109/TMI.2006.879953; Fu Y, 2007, IEEE IJCNN, P1590, DOI 10.1109/IJCNN.2007.4371195; Gang L, 2002, IEEE T BIO-MED ENG, V49, P168, DOI 10.1109/10.979356; Gao XH, 2001, C P MED IM UND AN U; Gardner GG, 1996, BRIT J OPHTHALMOL, V80, P940, DOI 10.1136/bjo.80.11.940; Goatman K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027524; Goh J, 2012, IEEE C EVOL COMPUTAT; Goh J, 2011, HEALTHINF 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P235; Hsu W, 2001, PROC CVPR IEEE, P246; Igel C., 2005, TRENDS APPL CONSTRUC, P103; IMAGERET, 2005, OPT DET DEC SUPP DIA; Jang PB, 2010, J DIGIT IMAGING; Kass M., 1987, Proceedings of the First International Conference on Computer Vision (Cat. No.87CH2465-3), P259, DOI 10.1007/BF00133570; Kyoung KW, 2006, IEEE T EVOLUTIONARY, V10; Lam HK, 2003, 4 IEEE INT C INF COM, V3, P1437; Leandro JJG, 2001, XIV BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P84, DOI 10.1109/SIBGRAPI.2001.963041; Lee S, 2003, P IM VIS COMP NZ, P280; Li HQ, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P394; Li HQ, 2000, P ANN INT IEEE EMBS, V22, P3071, DOI 10.1109/IEMBS.2000.901530; Li J, 2000, IEEE T SIGNAL PROCES, V48, P517, DOI 10.1109/78.823977; Lowell J, 2004, IEEE T MED IMAGING, V23; NHS Center for Reviews Dissemination, 1999, EFF HLTH CARE, V5, P1; Niemeijer M, 2005, IEEE T MED IMAGING, V25; Osareh A, 2003, BRIT J OPHTHALMOL, V87, P1220, DOI 10.1136/bjo.87.10.1220; Osareh A, 2002, INT C PATT RECOG, P743, DOI 10.1109/ICPR.2002.1044865; Park M., 2006, INT C COMP GRAPH IM, P141; Parui SK, 2008, INT C PATT RECOG, P2731; Philip S, 2007, BR J OPHTHALMOLOGY; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Reynolds RG, 2008, IEEE COMPUT INTELL M, V3, P31, DOI 10.1109/MCI.2007.913386; Sagar AV, 2007, P INT C COMP THEOR A; Sanchez CI, 2004, P ANN INT IEEE EMBS, V26, P1624; Sinthanayothin C, 2003, ISPA 2003: PROCEEDINGS OF THE 3RD INTERNATIONAL SYMPOSIUM ON IMAGE AND SIGNAL PROCESSING AND ANALYSIS, PTS 1 AND 2, P915; Sinthanayothin C, 2002, DIABETIC MED, V19, P105, DOI 10.1046/j.1464-5491.2002.00613.x; Sinthanayothin C, 1999, THESIS KINGS COLL LO; Siu M, 2006, IEEE T AUDIO SPEECH, V14, P2122, DOI 10.1109/TASL.2006.872592; UK National screening committee, 2012, UK SCREEN PORT; Walter T, 2002, IEEE T MED IMAGING, V21, P1236, DOI 10.1109/TMI.2002.806290; Walter T, 2000, P 3 INT S MED DAT AN; Wang JJ, 2006, INT C PATT RECOG, P778; World Health Organization, 2020, DIABETES; Zhang XH, 2004, IEEE IMAGE PROC, P139; Zhu XL, 2010, J DIGIT IMAGING, V23, P332, DOI 10.1007/s10278-009-9189-5	55	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e66730	10.1371/journal.pone.0066730	http://dx.doi.org/10.1371/journal.pone.0066730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840865	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900004
J	Cabezas-Clavijo, A; Robinson-Garcia, N; Escabias, M; Jimenez-Contreras, E				Cabezas-Clavijo, Alvaro; Robinson-Garcia, Nicolas; Escabias, Manuel; Jimenez-Contreras, Evaristo			Reviewers' Ratings and Bibliometric Indicators: Hand in Hand When Assessing Over Research Proposals?	PLOS ONE			English	Review							PREDICTIVE-VALIDITY; EXCELLENCE; IMPACT; AREA	Background: The peer review system has been traditionally challenged due to its many limitations especially for allocating funding. Bibliometric indicators may well present themselves as a complement. Objective: We analyze the relationship between peers' ratings and bibliometric indicators for Spanish researchers in the 2007 National R&D Plan for 23 research fields. Methods and Materials: We analyze peers' ratings for 2333 applications. We also gathered principal investigators' research output and impact and studied the differences between accepted and rejected applications. We used the Web of Science database and focused on the 2002-2006 period. First, we analyzed the distribution of granted and rejected proposals considering a given set of bibliometric indicators to test if there are significant differences. Then, we applied a multiple logistic regression analysis to determine if bibliometric indicators can explain by themselves the concession of grant proposals. Results: 63.4% of the applications were funded. Bibliometric indicators for accepted proposals showed a better previous performance than for those rejected; however the correlation between peer review and bibliometric indicators is very heterogeneous among most areas. The logistic regression analysis showed that the main bibliometric indicators that explain the granting of research proposals in most cases are the output (number of published articles) and the number of papers published in journals that belong to the first quartile ranking of the Journal Citations Report. Discussion: Bibliometric indicators predict the concession of grant proposals at least as well as peer ratings. Social Sciences and Education are the only areas where no relation was found, although this may be due to the limitations of the Web of Science's coverage. These findings encourage the use of bibliometric indicators as a complement to peer review in most of the analyzed areas.	[Cabezas-Clavijo, Alvaro; Robinson-Garcia, Nicolas; Jimenez-Contreras, Evaristo] Univ Granada, Fac Comunicac & Documentac, Granada, Spain; [Escabias, Manuel] Univ Granada, Fac Comunicac & Documentac, Dept Estadist & Invest Operat, Granada, Spain	University of Granada; University of Granada	Robinson-Garcia, N (corresponding author), Univ Granada, Fac Comunicac & Documentac, Granada, Spain.	elrobin@ugr.es	Cabezas-Clavijo, Alvaro/ABE-1654-2020; Robinson-Garcia, Nicolas/B-3590-2012; Escabias, Manuel/L-2510-2017; Cabezas-Clavijo, Alvaro/C-8670-2009	Cabezas-Clavijo, Alvaro/0000-0001-9641-8855; Robinson-Garcia, Nicolas/0000-0002-0585-7359; Escabias, Manuel/0000-0002-1653-9022; Cabezas-Clavijo, Alvaro/0000-0001-9641-8855	National RD Plan [TIN2008-03180-E]; FPU Grant of the Ministerio de Economia y Competitividad of the Spanish Government	National RD Plan; FPU Grant of the Ministerio de Economia y Competitividad of the Spanish Government	This work was supported by the National R&D Plan 2008 (research project Parameterization of citation indicators at a national level according with the ANEP categories [TIN2008-03180-E]. Nicolas Robinson-Garcia is currently supported by a FPU Grant of the Ministerio de Economia y Competitividad of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoul H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046054; Abramo G, 2011, SCIENTOMETRICS, V89, P929, DOI 10.1007/s11192-011-0459-x; Abramo G, 2009, RES POLICY, V38, P206, DOI 10.1016/j.respol.2008.11.001; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Aksnes DW, 2004, RES EVALUAT, V13, P33, DOI 10.3152/147154404781776563; Allen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005910; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; [Anonymous], 2010, NATURE, V465, P845, DOI 10.1038/465845a; Benda WGG, 2011, INT J FORECASTING, V27, P166, DOI 10.1016/j.ijforecast.2010.03.003; Bornmann L, 2005, SCIENTOMETRICS, V63, P297, DOI 10.1007/s11192-005-0214-2; Bornmann L, 2011, ANNU REV INFORM SCI, V45, P199, DOI 10.1002/aris.2011.1440450112; Campanario JM, 1996, J AM SOC INFORM SCI, V47, P302, DOI 10.1002/(SICI)1097-4571(199604)47:4<302::AID-ASI6>3.0.CO;2-0; Costas R, 2005, RES EVALUAT, V14, P110, DOI 10.3152/147154405781776238; Delgado-Lopez-Cozar E, 2009, PROF INFORM, V18, P81, DOI 10.3145/epi.2009.ene.11; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Fernando MGNAS, 2011, ICSIT 2011: THE 2ND INTERNATIONAL CONFERENCE ON SOCIETY AND INFORMATION TECHNOLOGIES, P93; FernuYndez Esquinas M., 2006, RADIOGRAFIA INVESTIG, P148; GIBBONS JD, 1985, NONPARAMETRIC STAT I; Gordillo V, 2004, PSICOTHEMA, V16, P343; Haslam N, 2010, AUST J PSYCHOL, V62, P112, DOI 10.1080/00049530903334489; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jimenez-Contreras E, 2003, RES POLICY, V32, P123, DOI 10.1016/S0048-7333(02)00008-2; Jimenez-Contreras E, 2011, REV ESP DOC CIENT, V34, P505, DOI 10.3989/redc.2011.4.828; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; Lariviere V, 2010, RES EVALUAT, V19, P45, DOI 10.3152/095820210X492495; Moed H.F., 2005, CITATION ANAL RES EV, V9; Moed HF, 2008, SCIENTOMETRICS, V74, P153, DOI 10.1007/s11192-008-0108-1; Norris M, 2003, J DOC, V59, P709, DOI 10.1108/00220410310698734; Randles R, 1979, INTRO THEORY NONPARA; Reale E, 2007, RES EVALUAT, V16, P216, DOI 10.3152/095820207X227501; Rossner M, 2007, J CELL BIOL, V179, P1091, DOI 10.1083/jcb.200711140; Sanz-Menendez Luis., 1995, RES EVALUAT, V5, P79, DOI [DOI 10.1093/REV/5.1.79.SELWYN, 10.1093/rev/5.1.79]; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Smith R, 2006, J ROY SOC MED, V99, P178, DOI 10.1258/jrsm.99.4.178; Torres-Salinas D, 2012, REV ESP DOC CIENT, V35, P615, DOI 10.3989/redc.2012.4.1010; Van Diest PJ, 2001, J CLIN PATHOL, V54, P817, DOI 10.1136/jcp.54.11.817; van Leeuwen TN, 2012, RES EVALUAT, V21, P189, DOI 10.1093/reseval/rvs009; vanRaan AFJ, 1996, SCIENTOMETRICS, V36, P397, DOI 10.1007/BF02129602; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1	41	29	29	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68258	10.1371/journal.pone.0068258	http://dx.doi.org/10.1371/journal.pone.0068258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840840	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400182
J	Coffield, DJ; Spagnuolo, AM; Shillor, M; Mema, E; Pell, B; Pruzinsky, A; Zetye, A				Coffield, Daniel J., Jr.; Spagnuolo, Anna Maria; Shillor, Meir; Mema, Ensela; Pell, Bruce; Pruzinsky, Amanda; Zetye, Alexandra			A Model for Chagas Disease with Oral and Congenital Transmission	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; TRIATOMA-INFESTANS HEMIPTERA; CONTACT PROCESS SATURATION; SYLVATIC TRANSMISSION; POPULATION-DYNAMICS; YUCATAN PENINSULA; VECTOR; ELIMINATION; INTERRUPTION; PROBABILITY	This work presents a new mathematical model for the domestic transmission of Chagas disease, a parasitic disease affecting humans and other mammals throughout Central and South America. The model takes into account congenital transmission in both humans and domestic mammals as well as oral transmission in domestic mammals. The model has time-dependent coefficients to account for seasonality and consists of four nonlinear differential equations, one of which has a delay, for the populations of vectors, infected vectors, infected humans, and infected mammals in the domestic setting. Computer simulations show that congenital transmission has a modest effect on infection while oral transmission in domestic mammals substantially contributes to the spread of the disease. In particular, oral transmission provides an alternative to vector biting as an infection route for the domestic mammals, who are key to the infection cycle. This may lead to high infection rates in domestic mammals even when the vectors have a low preference for biting them, and ultimately results in high infection levels in humans.	[Coffield, Daniel J., Jr.] Univ Michigan, Dept Math, Flint, MI 48503 USA; [Spagnuolo, Anna Maria; Shillor, Meir; Zetye, Alexandra] Oakland Univ, Dept Math & Stat, Rochester, MI 48063 USA; [Mema, Ensela] New Jerseys Sci & Technol Univ, Dept Math Sci, Newark, NJ USA; [Pell, Bruce] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ USA; [Pruzinsky, Amanda] US EPA, Chesapeake Res Consortium, Chesapeake Bay Program Off, Annapolis, MD USA	University of Michigan System; University of Michigan; University of Michigan Flint; Oakland University; Arizona State University; Arizona State University-Tempe; United States Environmental Protection Agency	Spagnuolo, AM (corresponding author), Oakland Univ, Dept Math & Stat, Rochester, MI 48063 USA.	spagnuol@oakland.edu		Spagnuolo, Anna/0000-0003-3039-0970; Pell, Bruce/0000-0003-1358-8061	National Science Foundation REU Grant [DMS 0649099]	National Science Foundation REU Grant(National Science Foundation (NSF))	National Science Foundation REU Grant DMS 0649099 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbu C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000416; Bhatia V, 2005, EXPERT REV VACCINES, V4, P867, DOI 10.1586/14760584.4.6.867; Buckner FS, 1998, ANTIMICROB AGENTS CH, V42, P3245, DOI 10.1128/AAC.42.12.3245; CAMANDAROBA Edson Luiz P., 2002, Rev. Inst. Med. trop. S. Paulo, V44, P97, DOI 10.1590/S0036-46652002000200008; Cardinal MV, 2007, ACTA TROP, V103, P201, DOI 10.1016/j.actatropica.2007.06.007; Castanera MB, 2003, ECOL MODEL, V162, P33, DOI 10.1016/S0304-3800(02)00388-5; CATALA S, 1991, MED VET ENTOMOL, V5, P325, DOI 10.1111/j.1365-2915.1991.tb00558.x; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; Cruz-Pacheco G, 2012, MATH BIOSCI, V237, P49, DOI 10.1016/j.mbs.2012.03.005; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; DIOTAIUTI L, 1995, MEM I OSWALDO CRUZ, V90, P443, DOI 10.1590/S0074-02761995000400002; GORLA D E, 1985, Bulletin of the Society of Vector Ecologists, V10, P107; Gourbiere S, 2008, AM J TROP MED HYG, V78, P133, DOI 10.4269/ajtmh.2008.78.133; Gurtler RE, 2007, PARASITOLOGY, V134, P69, DOI 10.1017/S0031182006001259; Gurtler RE, 2003, EMERG INFECT DIS, V9, P29; Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000447; Hall CA, 2010, J PARASITOL, V96, P371, DOI 10.1645/GE-2296.1; Kribs-Zaleta C, 2006, MATH POPUL STUD, V13, P135, DOI 10.1080/08898480600788576; Kribs-Zaleta C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000656; Kribs-Zaleta CM, 2010, MATH BIOSCI ENG, V7, P657, DOI 10.3934/mbe.2010.7.657; Massad E, 2008, EPIDEMIOL INFECT, V136, P1153, DOI 10.1017/S0950268807009879; Moncayo A, 2003, MEM I OSWALDO CRUZ, V98, P577, DOI 10.1590/S0074-02762003000500001; Murta SMF, 1998, PARASITOLOGY, V116, P165, DOI 10.1017/S0031182097002084; *ORG PAN SAL, 2006, OPSHDMCD42506; Rabinovich J, 2001, AM J TROP MED HYG, V65, P125, DOI 10.4269/ajtmh.2001.65.125; RABINOVICH JE, 1990, B WORLD HEALTH ORGAN, V68, P737; RABINOVICH JE, 1990, ECOL MODEL, V52, P249, DOI 10.1016/0304-3800(90)90019-D; Rassi A, 2009, MEM I OSWALDO CRUZ, V104, P152, DOI 10.1590/S0074-02762009000900021; Reithinger R, 2005, T ROY SOC TROP MED H, V99, P502, DOI 10.1016/j.trstmh.2004.11.013; Rodriques CJ, 2002, MEM I O CRUZ, V97, P3; Roellig DM, 2009, J PARASITOL, V95, P360, DOI 10.1645/GE-1740.1; Schmunis GA, 2005, CLIN MICROBIOL REV, V18, P12, DOI 10.1128/CMR.18.1.12-29.2005; Schmunis GA, 1999, MEM I OSWALDO CRUZ, V94, P93, DOI 10.1590/S0074-02761999000700010; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; Silveira AC, 1999, MEM I OSWALDO CRUZ, V94, P405, DOI 10.1590/S0074-02761999000700080; Spagnuolo AM, 2012, J BIOL DYNAM, V6, P377, DOI 10.1080/17513758.2011.587896; Spagnuolo Anna Maria, 2011, Journal of Biological Dynamics, V5, P299, DOI 10.1080/17513758.2010.505985; Vassena CV, 2000, MED VET ENTOMOL, V14, P51, DOI 10.1046/j.1365-2915.2000.00203.x	38	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67267	10.1371/journal.pone.0067267	http://dx.doi.org/10.1371/journal.pone.0067267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840647	Green Published, gold			2022-12-27	WOS:000321148400052
J	Gao, Y; Su, PZ; Wang, CQ; Zhu, KQ; Chen, XL; Liu, SD; He, JM				Gao, Yuan; Su, Peizhu; Wang, Chuqiong; Zhu, Kongqin; Chen, Xiaolan; Liu, Side; He, Jiman			The Role of PTEN in Chronic Growth Hormone-Induced Hepatic Insulin Resistance	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; GLUCOSE-HOMEOSTASIS; TRANSGENIC MICE; FATTY LIVER; HYPERSENSITIVITY; DELETION; PROTEIN; GENE; SENSITIVITY	Chronic growth hormone (GH) therapy has been shown to cause insulin resistance, but the mechanism remains unknown. PTEN, a tumor suppressor gene, is a major negative regulator of insulin signaling. In this study, we explored the effect of chronic GH on insulin signaling in the context of PTEN function. Balb/c healthy mice were given recombinant human or bovine GH intraperitoneally for 3 weeks. We found that phosphorylation of Akt was significantly decreased in chronic GH group and the expression of PTEN was significantly increased. We further examined this effect in the streptozotocin-induced Type I diabetic mouse model, in which endogenous insulin secretion was disrupted. Insulin/PI3K/Akt signaling was impaired. However, different from the observation in healthy mice, the expression of PTEN did not increase. Similarly, PTEN expression did not significantly increase in chronic GH-treated mice with hypoinsulinemia induced by prolonged fasting. We conducted in-vitro experiments in HepG2 cells to validate our in-vivo findings. Long-term exposure to GH caused similar resistance of insulin/PI3K/Akt signaling in HepG2 cells; and over-expression of PTEN enhanced the impairment of insulin signaling. On the other hand, disabling the PTEN gene by transfecting the mutant PTEN construct C124S or siPTEN, disrupted the chronic GH induced insulin resistance. Our data demonstrate that PTEN plays an important role in chronic-GHinduced insulin resistance. These findings may have implication in other pathological insulin resistance.	[Gao, Yuan; Su, Peizhu; Wang, Chuqiong; Zhu, Kongqin; Chen, Xiaolan; Liu, Side; He, Jiman] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [He, Jiman] Brown Univ, Liver Res Ctr, Providence, RI 02912 USA	Southern Medical University - China; Brown University	Liu, SD (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China.	sideliucn@163.com; jiman_he@brown.edu			Natural Science Foundation of China [81170743]; Experts Foundation of Nanfang Hospital [2010111501]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Experts Foundation of Nanfang Hospital	This work was supported by Natural Science Foundation of China (81170743), and Experts Foundation of Nanfang Hospital (2010111501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADER M, 1987, ENDOCRINOLOGY, V120, P725, DOI 10.1210/endo-120-2-725; BOUGNERES PF, 1985, J CLIN ENDOCR METAB, V61, P1152, DOI 10.1210/jcem-61-6-1152; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Cutfield WS, 2000, LANCET, V355, P610, DOI 10.1016/S0140-6736(99)04055-6; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001; Dominici FP, 1999, J ENDOCRINOL, V161, P383, DOI 10.1677/joe.0.1610383; Dominici FP, 1999, AM J PHYSIOL-ENDOC M, V277, pE447, DOI 10.1152/ajpendo.1999.277.3.E447; He JM, 2007, HEPATOLOGY, V46, P1791, DOI 10.1002/hep.21904; He JM, 2010, BIOCHEM BIOPH RES CO, V397, P513, DOI 10.1016/j.bbrc.2010.05.146; Ishihara H, 2003, FEBS LETT, V554, P450, DOI 10.1016/S0014-5793(03)01225-0; Johansen T, 2005, GROWTH HORM IGF RES, V15, P55, DOI 10.1016/j.ghir.2004.11.006; Jorgensen JOL, 2004, HORM RES, V62, P51, DOI 10.1159/000080499; Kong M, 2000, J BIOL CHEM, V275, P36035, DOI 10.1074/jbc.M005621200; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Lee JS, 2007, DIABETES RES CLIN PR, V77, pS49, DOI 10.1016/j.diabres.2007.01.033; NG SF, 1990, METABOLISM, V39, P264, DOI 10.1016/0026-0495(90)90045-E; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ridderstrale Martin, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P79, DOI 10.2174/1568008053174787; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sakharova AA, 2008, J CLIN ENDOCR METAB, V93, P2755, DOI 10.1210/jc.2008-0079; Savastano S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-136; Smith TR, 1997, AM J PHYSIOL-ENDOC M, V272, pE1071, DOI 10.1152/ajpendo.1997.272.6.E1071; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tarantino G, 2007, J GASTROEN HEPATOL, V22, P293, DOI 10.1111/j.1440-1746.2007.04824.x; Thirone ACP, 1997, MOL CELL ENDOCRINOL, V130, P33, DOI 10.1016/S0303-7207(97)00071-3; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wong JT, 2007, DIABETOLOGIA, V50, P395, DOI 10.1007/s00125-006-0531-x; Xu J, 2009, VITAM HORM, V80, P125, DOI 10.1016/S0083-6729(08)00606-7	34	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68105	10.1371/journal.pone.0068105	http://dx.doi.org/10.1371/journal.pone.0068105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840818	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400164
J	He, Q; Wang, M; Xu, JX; Zhang, CH; Wang, H; Zhu, W; Fu, CX				He, Qing; Wang, Ming; Xu, Jianxiong; Zhang, Chunhuan; Wang, Hui; Zhu, Wei; Fu, Chuanxi			Rotavirus Vaccination Coverage among Children Aged 2-59 Months: A Report from Guangzhou, China	PLOS ONE			English	Article							ROUTINE INFANT VACCINES; UNITED-STATES; GASTROENTERITIS; IMMUNOGENICITY; SAFETY; IMPACT	Objective: We aimed to estimate the Lanzhou lamb rotavirus (LLR) vaccination coverage (VC) and timeliness among children aged 2 to 59 months in Guangzhou, China. Methods: An electronic system-based VC survey was conducted using stratified cluster random sampling. Results: We reported an overall Lanzhou lamb rotavirus vaccine coverage of 25.3% among children aged 2-59 months (2-8 months, 2.6%) in Guangzhou, China. Conclusion: Great efforts should be taken to increase LLR VC in eligible children in Guangzhou, China.	[He, Qing; Wang, Ming; Xu, Jianxiong; Zhang, Chunhuan; Wang, Hui; Zhu, Wei; Fu, Chuanxi] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [He, Qing] Southern Med Univ, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Fu, CX (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	fuchuanxi@gmail.com	Fu, Chuanxi/K-5462-2016; xu, jianxiong/H-1786-2013		Guangdong Provincial Department of Science and Technology [2011B050300001, 2012B091100045]; department of Science and Information Technology of Guangzhou [2012J5100005]	Guangdong Provincial Department of Science and Technology; department of Science and Information Technology of Guangzhou	This work was supported by grants from the Guangdong Provincial Department of Science and Technology (2011B050300001 and 2012B091100045), The department of Science and Information Technology of Guangzhou (2012J5100005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black Carla L., 2012, Morbidity and Mortality Weekly Report, V61, P689; Centers for Disease Control and Prevention, 2010, ROT; Dennehy PH, 2008, PEDIATRICS, V122, pE1062, DOI 10.1542/peds.2008-1059; Duan ZJ, 2009, J INFECT DIS, V200, pS167, DOI 10.1086/605039; Fu CX, 2007, VACCINE, V25, P8756, DOI 10.1016/j.vaccine.2007.10.036; Fu CX, 2012, VACCINE, V31, P154, DOI 10.1016/j.vaccine.2012.10.078; Fu CX, 2010, HUM VACCINES, V6, P953, DOI 10.4161/hv.6.11.12847; Fu CX, 2010, PEDIATR INFECT DIS J, V29, P690, DOI 10.1097/INF.0b013e3181d7380e; Glass RI, 2012, AM CLIN CLIMATOL ASS, V123, P36; Li YH, 2010, CHIN PRIM HLTH CARE, V24, P24, DOI DOI 10.1096/FJ.09-149328; [刘娜 Liu Na], 2012, [中华实验和临床病毒学杂志, Chinese Journal of Experimental and Clinical Virology], V26, P199; Liu N, 2012, VACCINE, V30, P6940, DOI 10.1016/j.vaccine.2012.05.084; Rodriguez ZM, 2007, PEDIATR INFECT DIS J, V26, P221, DOI 10.1097/01.inf.0000254391.71103.e8; Steele AD, 2010, J INFECT DIS, V202, pS93, DOI 10.1086/653550; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tregnaghi MW, 2011, PEDIATR INFECT DIS J, V30, pE103, DOI 10.1097/INF.0b013e3182138278; Vesikari T, 2010, VACCINE, V28, P5272, DOI 10.1016/j.vaccine.2010.05.057; Yee EL, 2009, VACCINE, V27, pF46, DOI 10.1016/j.vaccine.2009.08.065	18	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68169	10.1371/journal.pone.0068169	http://dx.doi.org/10.1371/journal.pone.0068169			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840828	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400171
J	Kageyama, A; Matsui, H; Ohta, M; Sambuichi, K; Kawano, H; Notsu, T; Imada, K; Yokoyama, T; Kurabayashi, M				Kageyama, Aiko; Matsui, Hiroki; Ohta, Masahiko; Sambuichi, Keisuke; Kawano, Hiroyuki; Notsu, Tatsuto; Imada, Kazunori; Yokoyama, Tomoyuki; Kurabayashi, Masahiko			Palmitic Acid Induces Osteoblastic Differentiation in Vascular Smooth Muscle Cells through ACSL3 and NF-kappa B, Novel Targets of Eicosapentaenoic Acid	PLOS ONE			English	Article							FREE FATTY-ACID; ARTERY ENDOTHELIAL-CELLS; DEPENDENT ACTIVATION; PROTEIN-KINASE; CALCIFICATION; DISEASE; EXPRESSION; CALCIUM; RISK; SUPPLEMENTATION	Free fatty acids (FFAs), elevated in metabolic syndrome and diabetes, play a crucial role in the development of atherosclerotic cardiovascular disease, and eicosapentaenoic acid (EPA) counteracts many aspects of FFA-induced vascular pathology. Although vascular calcification is invariably associated with atherosclerosis, the mechanisms involved are not completely elucidated. In this study, we tested the hypothesis that EPA prevents the osteoblastic differentiation and mineralization of vascular smooth muscle cells (VSMC) induced by palmitic acid (PA), the most abundant long-chain saturated fatty acid in plasma. PA increased and EPA abolished the expression of the genes for bone-related proteins, including bone morphogenetic protein (BMP)-2, Msx2 and osteopontin in human aortic smooth muscle cells (HASMC). Among the long-chain acyl-CoA synthetase (ACSL) subfamily, ACSL3 expression was predominant in HASMC, and PA robustly increased and EPA efficiently inhibited ACSL3 expression. Importantly, PA-induced osteoblastic differentiation was mediated, at least in part, by ACSL3 activation because acyl-CoA synthetase (ACS) inhibitor or siRNA targeted to ACSL3 completely prevented the PA induction of both BMP-2 and Msx2. Conversely, adenovirus-mediated ACSL3 overexpression enhanced PA-induced BMP-2 and Msx2 expression. In addition, EPA, ACSL3 siRNA and ACS inhibitor attenuated calcium deposition and caspase activation induced by PA. Notably, PA induced activation of NF-kappa B, and NF-kappa B inhibitor prevented PA-induction of osteoblastic gene expression and calcium deposition. Immunohistochemistry revealed the prominent expression of ACSL3 in VSMC and macrophages in human non-calcifying and calcifying atherosclerotic plaques from the carotid arteries. These results identify ACSL3 and NF-kB as mediators of PA-induced osteoblastic differentiation and calcium deposition in VSMC and suggest that EPA prevents vascular calcification by inhibiting such a new molecular pathway elicited by PA.	[Kageyama, Aiko; Ohta, Masahiko; Sambuichi, Keisuke; Kawano, Hiroyuki; Notsu, Tatsuto; Imada, Kazunori] Mochida Pharmaceut Co Ltd, Dev Res, Gotemba, Shizuoka, Japan; [Matsui, Hiroki; Kurabayashi, Masahiko] Gunma Univ, Dept Med & Biol Sci, Grad Sch Med, Maebashi, Gunma, Japan; [Matsui, Hiroki; Yokoyama, Tomoyuki] Gunma Univ, Dept Lab Sci, Grad Sch Hlth Sci, Maebashi, Gunma, Japan	Mochida Pharmaceutical Co Ltd; Gunma University; Gunma University	Kawano, H (corresponding author), Mochida Pharmaceut Co Ltd, Dev Res, Gotemba, Shizuoka, Japan.	h-kawano@mochida.co.jp	Matsui, Hiroki/P-4033-2019	Matsui, Hiroki/0000-0003-3243-333X	Japan Society for the Promotion of Science; Japan Cardiovascular Foundation; Grants-in-Aid for Scientific Research [25504002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to MK), and a grant from the Japan Cardiovascular Foundation (to MK). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2006, CIRC RES, V98, P727, DOI 10.1161/01.RES.0000216009.68958.e6; Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Askari B, 2007, DIABETES, V56, P1143, DOI 10.2337/db06-0267; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; BURGESS NA, 1995, UROL RES, V23, P239, DOI 10.1007/BF00393305; Carlsson M, 2000, ARTERIOSCL THROM VAS, V20, P1588, DOI 10.1161/01.ATV.20.6.1588; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; Fagot-Campagna A, 1998, INT J EPIDEMIOL, V27, P808, DOI 10.1093/ije/27.5.808; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Heine-Broring RC, 2010, AM J CLIN NUTR, V91, P1317, DOI 10.3945/ajcn.2009.28416; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Kanai S, 2011, ATHEROSCLEROSIS, V215, P43, DOI 10.1016/j.atherosclerosis.2010.12.001; Kato T, 2008, DIABETES, V57, P2382, DOI 10.2337/db06-1806; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lockridge JB, 2008, J LIPID RES, V49, P1395, DOI 10.1194/jlr.M700517-JLR200; Mashek DG, 2004, J LIPID RES, V45, P1958, DOI 10.1194/jlr.E400002-JLR200; Masuda M, 2012, J LIPID RES, V53, P1543, DOI 10.1194/jlr.M025981; Matsui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033283; Mazzini MJ, 2006, EUR J RADIOL, V57, P384, DOI 10.1016/j.ejrad.2005.12.025; Mugabo Y, 2011, METABOLISM, V60, P640, DOI 10.1016/j.metabol.2010.06.014; Pirro M, 2002, ATHEROSCLEROSIS, V160, P377, DOI 10.1016/S0021-9150(01)00588-3; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Schlemmer CK, 1998, PROSTAG LEUKOTR ESS, V59, P221, DOI 10.1016/S0952-3278(98)90066-7; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shioi A, 2009, J RENAL NUTR, V19, P78, DOI 10.1053/j.jrn.2008.10.015; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Staiger H, 2004, DIABETES, V53, P3209, DOI 10.2337/diabetes.53.12.3209; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Ting TC, 2011, J BIOL CHEM, V286, P23938, DOI 10.1074/jbc.M111.237065; Vattikuti R, 2004, AM J PHYSIOL-ENDOC M, V286, pE686, DOI 10.1152/ajpendo.00552.2003; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	39	46	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68197	10.1371/journal.pone.0068197	http://dx.doi.org/10.1371/journal.pone.0068197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840832	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400175
J	Kim, SY; Lee, JY; Park, YD; Kang, KL; Lee, JC; Heo, JS				Kim, So Yeon; Lee, Jin-Yong; Park, Yong-Duk; Kang, Kyung Lhi; Lee, Jeong-Chae; Heo, Jung Sun			Hesperetin Alleviates the Inhibitory Effects of High Glucose on the Osteoblastic Differentiation of Periodontal Ligament Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; OXIDATIVE STRESS; IN-VITRO; BONE; ADIPOGENESIS; HESPERIDIN; AKT2	Hesperetin (3', 5,7-trihydroxy-4-methoxyflavanone) is a metabolite of hesperidin (hesperetin-7-O-rutinoside), which belongs to the flavanone subgroup and is found mainly in citrus fruits. Hesperetin has been reported to be an effective osteoinductive compound in various in vivo and in vitro models. However, how hesperetin effects osteogenic differentiation is not fully understood. In this study, we investigated the capacity of hesperetin to stimulate the osteogenic differentiation of periodontal ligament stem cells (PDLSCs) and to relieve the anti-osteogenic effect of high glucose. Osteogenesis of PDLSCs was assessed by measurement of alkaline phosphatase (ALP) activity, and evaluation of the mRNA expression of ALP, runt-related gene 2 (Runx2), osterix (OSX), and FRA1 as osteogenic transcription factors, as well as assessment of protein expression of osteopontin (OPN) and collagen type IA (COLIA). When PDLSCs were exposed to a high concentration (30 mM) of glucose, osteogenic activity decreased compared to control cells. Hesperetin significantly increased ALP activity at doses of 1, 10, and 100 mu M. Pretreatment of cells with hesperetin alleviated the high-glucose-induced suppression of the osteogenic activity of PDLSCs. Hesperetin scavenged intracellular reactive oxygen species (ROS) produced under high glucose condition. Furthermore, hesperetin increased the activity of the PI3K/Akt and beta-catenin pathways. Consistent with this, blockage of Akt or beta-catenin diminished the protective effect of hesperetin against high glucose-inhibited osteogenic differentiation. Collectively, our results suggest that hesperetin alleviates the high glucose-mediated suppression of osteogenic differentiation in PDLSCs by regulating ROS levels and the PI3K/Akt and beta-catenin signaling pathways.	[Kim, So Yeon; Lee, Jin-Yong; Heo, Jung Sun] Kyung Hee Univ, Sch Dent, Dept Maxillofacial Biomed Engn, Seoul, South Korea; [Kim, So Yeon; Lee, Jin-Yong; Heo, Jung Sun] Kyung Hee Univ, Sch Dent, Inst Oral Biol, Seoul, South Korea; [Park, Yong-Duk] Kyung Hee Univ, Sch Dent, Dept Prevent & Social Dent, Seoul, South Korea; [Kang, Kyung Lhi] Kyung Hee Univ, Sch Dent, Dept Periodontol, Seoul, South Korea; [Lee, Jeong-Chae] Chonbuk Natl Univ, Res Ctr Bioact Mat, Inst Oral Biosci, Jeonju, South Korea; [Lee, Jeong-Chae] Chonbuk Natl Univ, Res Ctr Bioact Mat, Sch Dent, Jeonju, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Jeonbuk National University; Jeonbuk National University	Heo, JS (corresponding author), Kyung Hee Univ, Sch Dent, Dept Maxillofacial Biomed Engn, Seoul, South Korea.	heojs@khu.ac.kr			Kyung Hee University [KHU-20120799]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0013595]	Kyung Hee University; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Kyung Hee University in 2012 (KHU-20120799) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0013595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2006, AM J PHYSIOL-LUNG C, V291, pL38, DOI 10.1152/ajplung.00287.2004; Amado NG, 2012, CURR TOP MED CHEM, V12, P2103; Ariffin SHZ, 2012, SCI WORLD J, DOI 10.1100/2012/827149; Balint E, 2001, BONE, V28, P21, DOI 10.1016/S8756-3282(00)00426-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chadipiralla K, 2010, CELL TISSUE RES, V340, P323, DOI 10.1007/s00441-010-0953-0; Choi EJ, 2006, NUTRITION, V22, P947, DOI 10.1016/j.nut.2006.05.004; Choi EM, 2008, CELL BIOL TOXICOL, V24, P225, DOI 10.1007/s10565-007-9031-0; Clarkson MR, 2002, J BIOL CHEM, V277, P9707, DOI 10.1074/jbc.M109172200; GALATI EM, 1994, FARMACO, V49, P709; Garg A, 2001, PHYTOTHER RES, V15, P655, DOI 10.1002/ptr.1074; Ge SH, 2012, INT J NANOMED, V7, P5405, DOI 10.2147/IJN.S36714; Govindasamy V, 2011, J DENT RES, V90, P646, DOI 10.1177/0022034510396879; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hobbs HC, 1999, J PERIODONTOL, V70, P736, DOI 10.1902/jop.1999.70.7.736; Hsieh HL, 2006, J CELL PHYSIOL, V206, P246, DOI 10.1002/jcp.20457; Hwang SL, 2012, FOOD FUNCT, V3, P1082, DOI 10.1039/c2fo30100h; Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161; Kao CL, 2010, STEM CELLS DEV, V19, P247, DOI 10.1089/scd.2009.0186; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kim HS, 2006, DIABETES RES CLIN PR, V74, P41, DOI 10.1016/j.diabres.2006.03.034; Kim JY, 2004, FREE RADICAL RES, V38, P761, DOI 10.1080/10715760410001713844; Kim NR, 2011, J BIOMED MATER RES B, V98B, P300, DOI 10.1002/jbm.b.31852; Kim WK, 2010, J CELL BIOCHEM, V111, P1199, DOI 10.1002/jcb.22846; Ko CH, 2011, J AGR FOOD CHEM, V59, P9870, DOI 10.1021/jf202015t; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Miyake Y, 1998, LIPIDS, V33, P689, DOI 10.1007/s11745-998-0258-y; Mukherjee A, 2010, MOL CELL BIOL, V30, P1018, DOI 10.1128/MCB.01401-09; Nakashima M, 2009, CYTOKINE GROWTH F R, V20, P435, DOI 10.1016/j.cytogfr.2009.10.012; Nones J, 2012, CELL TISSUE RES, V350, P305, DOI 10.1007/s00441-012-1472-y; Pari L, 2012, EXP TOXICOL PATHOL, V64, P513, DOI 10.1016/j.etp.2010.11.007; Partridge CR, 2008, MATRIX BIOL, V27, P462, DOI 10.1016/j.matbio.2008.01.009; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Salvi GE, 2008, J CLIN PERIODONTOL, V35, P398, DOI 10.1111/j.1600-051X.2008.01282.x; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shouhed D, 2005, J CELL BIOCHEM, V95, P1276, DOI 10.1002/jcb.20497; Singhatanadgit W, 2009, TISSUE ENG PT A, V15, P2625, DOI [10.1089/ten.tea.2008.0442, 10.1089/ten.TEA.2008.0442]; Terada M, 1998, BONE, V22, P17, DOI 10.1016/S8756-3282(97)00220-2; Trzeciakiewicz A, 2010, J NUTR BIOCHEM, V21, P424, DOI 10.1016/j.jnutbio.2009.01.017; Trzeciakiewicz A, 2010, J AGR FOOD CHEM, V58, P668, DOI 10.1021/jf902680n; Weaver Connie M., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P239, DOI 10.1080/21551197.2012.698220; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]	43	50	51	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67504	10.1371/journal.pone.0067504	http://dx.doi.org/10.1371/journal.pone.0067504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840726	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400095
J	Li, GY; Zhou, L				Li, Guangyao; Zhou, Lei			Genome-Wide Identification of Chromatin Transitional Regions Reveals Diverse Mechanisms Defining the Boundary of Facultative Heterochromatin	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; CHIP-SEQ DATA; DROSOPHILA-MELANOGASTER; ENHANCER-BLOCKING; GENE-EXPRESSION; COMPLEXES; INSULATOR; NUCLEOSOMES; PROTEINS; BARRIER	Due to the self-propagating nature of the heterochromatic modification H3K27me3, chromatin barrier activities are required to demarcate the boundary and prevent it from encroaching into euchromatic regions. Studies in Drosophila and vertebrate systems have revealed several important chromatin barrier elements and their respective binding factors. However, epigenomic data indicate that the binding of these factors are not exclusive to chromatin boundaries. To gain a comprehensive understanding of facultative heterochromatin boundaries, we developed a two-tiered method to identify the Chromatin Transitional Region (CTR), i.e. the nucleosomal region that shows the greatest transition rate of the H3K27me3 modification as revealed by ChIP-Seq. This approach was applied to identify CTRs in Drosophila S2 cells and human HeLa cells. Although many insulator proteins have been characterized in Drosophila, less than half of the CTRs in S2 cells are associated with known insulator proteins, indicating unknown mechanisms remain to be characterized. Our analysis also revealed that the peak binding of insulator proteins are usually 1-2 nucleosomes away from the CTR. Comparison of CTR-associated insulator protein binding sites vs. those in heterochromatic region revealed that boundaryassociated binding sites are distinctively flanked by nucleosome destabilizing sequences, which correlates with significant decreased nucleosome density and increased binding intensities of co-factors. Interestingly, several subgroups of boundaries have enhanced H3.3 incorporation but reduced nucleosome turnover rate. Our genome-wide study reveals that diverse mechanisms are employed to define the boundaries of facultative heterochromatin. In both Drosophila and mammalian systems, only a small fraction of insulator protein binding sites co-localize with H3K27me3 boundaries. However, boundary-associated insulator binding sites are distinctively flanked by nucleosome destabilizing sequences, which correlates with significantly decreased nucleosome density and increased binding of co-factors.	[Zhou, Lei] Univ Florida, Grad Program Genet & Genom, Genet Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhou, L (corresponding author), Univ Florida, Grad Program Genet & Genom, Genet Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	leizhou@ufl.edu	Li, Guangyao/I-8241-2015	Li, Guangyao/0000-0003-0029-3854	National Institutes of Health [R56 AI095960]; Florida Department of Health [2BF01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health	Supported in part by National Institutes of Health R56 AI095960, Florida Department of Health 2BF01 (LZ). GL is a University of Florida Alumni fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; Bao XM, 2007, GENETICS, V176, P1355, DOI 10.1534/genetics.107.073676; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; GEYER PK, 1986, EMBO J, V5, P2657, DOI 10.1002/j.1460-2075.1986.tb04548.x; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Gilbert MK, 2006, GENETICS, V173, P1365, DOI 10.1534/genetics.106.056002; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; Gurudatta B. V., 2009, Briefings in Functional Genomics & Proteomics, V8, P276, DOI 10.1093/bfgp/elp032; HARRISON DA, 1993, GENE DEV, V7, P1966, DOI 10.1101/gad.7.10.1966; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Li M, 2010, MOL CELL BIOL, V30, P1067, DOI 10.1128/MCB.00183-09; Li XG, 2011, BLOOD, V118, P1386, DOI 10.1182/blood-2010-11-319111; Lin N, 2011, MOL CELL BIOL; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meyer CA, 2011, BIOINFORMATICS, V27, P1867, DOI 10.1093/bioinformatics/btr279; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Raab JR, 2012, EMBO J, V31, P330, DOI 10.1038/emboj.2011.406; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; SCHWARTZ YB, 2012, GENOME RES; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schweinsberg S, 2004, GENETICS, V168, P1371, DOI 10.1534/genetics.104.029561; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tolstorukov MY, 2012, MOL CELL, V47, P596, DOI 10.1016/j.molcel.2012.06.011; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhang YP, 2008, DEV CELL, V14, P481, DOI 10.1016/j.devcel.2008.01.018	58	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67156	10.1371/journal.pone.0067156	http://dx.doi.org/10.1371/journal.pone.0067156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840609	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400037
J	Schellekens, W; Van Wezel, RJA; Petridou, N; Ramsey, NF; Raemaekers, M				Schellekens, Wouter; Van Wezel, Richard J. A.; Petridou, Natalia; Ramsey, Nick F.; Raemaekers, Mathijs			Integration of Motion Responses Underlying Directional Motion Anisotropy in Human Early Visual Cortical Areas	PLOS ONE			English	Article							RECEPTIVE-FIELD SIZE; SPATIOTEMPORAL INTEGRATION; INTRINSIC CONNECTIONS; FUNCTIONAL-PROPERTIES; TEMPORAL INTEGRATION; OPTIC FLOW; FMRI DATA; SENSITIVITY; MECHANISMS; CONTRAST	Recent imaging studies have reported directional motion biases in human visual cortex when perceiving moving random dot patterns. It has been hypothesized that these biases occur as a result of the integration of motion detector activation along the path of motion in visual cortex. In this study we investigate the nature of such motion integration with functional MRI (fMRI) using different motion stimuli. Three types of moving random dot stimuli were presented, showing either coherent motion, motion with spatial decorrelations or motion with temporal decorrelations. The results from the coherent motion stimulus reproduced the centripetal and centrifugal directional motion biases in V1, V2 and V3 as previously reported. The temporally decorrelated motion stimulus resulted in both centripetal and centrifugal biases similar to coherent motion. In contrast, the spatially decorrelated motion stimulus resulted in small directional motion biases that were only present in parts of visual cortex coding for higher eccentricities of the visual field. In combination with previous results, these findings indicate that biased motion responses in early visual cortical areas most likely depend on the spatial integration of a simultaneously activated motion detector chain.	[Schellekens, Wouter; Ramsey, Nick F.; Raemaekers, Mathijs] UMC Utrecht, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Schellekens, Wouter; Petridou, Natalia; Ramsey, Nick F.; Raemaekers, Mathijs] Univ Utrecht, Rudolf Magnus Inst, UMC Utrecht, Utrecht, Netherlands; [Van Wezel, Richard J. A.] Radboud Univ Nijmegen, Dept Biophys, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Van Wezel, Richard J. A.] Univ Twente, MIRA, NL-7500 AE Enschede, Netherlands; [Petridou, Natalia] UMC Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Radboud University Nijmegen; University of Twente	Schellekens, W (corresponding author), UMC Utrecht, Dept Neurol & Neurosurg, Utrecht, Netherlands.	w.schellekens@umcutrecht.nl	Schellekens, Wouter/AAK-4990-2021; van Wezel, Richard R J/G-4455-2011	Schellekens, Wouter/0000-0001-5409-9665; van Wezel, Richard R J/0000-0001-5753-7069; , Natalia/0000-0002-0783-0387; ramsey, nick/0000-0002-7136-259X	Dutch Organization for Scientific Research [NWO VENI 863.09.008]	Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Dutch Organization for Scientific Research (NWO VENI 863.09.008). http://www.nwo.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Amano K, 2009, J VISION, V9, DOI 10.1167/9.3.4; ANSTIS SM, 1975, VISION RES, V15, P957, DOI 10.1016/0042-6989(75)90236-9; Apthorp D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2339; Baker CL, 1999, CURR OPIN NEUROBIOL, V9, P461, DOI 10.1016/S0959-4388(99)80069-5; Baker DH, 2011, J VISION, V11, DOI 10.1167/11.14.14; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Beckett A, 2012, NEUROIMAGE, V63, P1623, DOI 10.1016/j.neuroimage.2012.07.066; Berzhanskaya J, 2007, SPATIAL VISION, V20, P337, DOI 10.1163/156856807780919000; BLASDEL GG, 1985, J NEUROSCI, V5, P3350; Borghuis BG, 2008, J NEUROSCI, V28, P3178, DOI 10.1523/JNEUROSCI.5259-07.2008; Bours RJE, 2009, VISION RES, V49, P1, DOI 10.1016/j.visres.2008.09.014; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; Cavanagh P, 2008, J VISION, V8, DOI 10.1167/8.12.1; Clifford CWG, 2009, J NEUROPHYSIOL, V102, P2974, DOI 10.1152/jn.00411.2009; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Festa EK, 1997, VISION RES, V37, P3129, DOI 10.1016/S0042-6989(97)00118-1; FREDERICKSEN RE, 1994, VISION RES, V34, P3171, DOI 10.1016/0042-6989(94)90082-5; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Giaschi D, 2007, VISION RES, V47, P887, DOI 10.1016/j.visres.2006.12.017; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; Harvey BM, 2011, J NEUROSCI, V31, P13604, DOI 10.1523/JNEUROSCI.2572-11.2011; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Kastner S, 1997, VISION RES, V37, P371, DOI 10.1016/S0042-6989(96)00184-8; KOENDERINK JJ, 1985, J OPT SOC AM A, V2, P252, DOI 10.1364/JOSAA.2.000252; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Mauchly JW, 1940, ANN MATH STAT, V11, P204, DOI 10.1214/aoms/1177731915; MOTTER BC, 1987, J NEUROSCI, V7, P154; NOTHDURFT HC, 1992, PERCEPT PSYCHOPHYS, V52, P355, DOI 10.3758/BF03206697; Raemaekers M, 2009, HUM BRAIN MAPP, V30, P3970, DOI 10.1002/hbm.20822; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ringbauer S, 2011, LECT NOTES COMPUT SC, V6593, P110, DOI 10.1007/978-3-642-20282-7_12; Schluppeck D., 2010, J VISUAL-JAPAN, V3, P282, DOI [DOI 10.1167/3.9.282, 10.1167/3.9.282]; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; SNOWDEN RJ, 1989, VISION RES, V29, P1621, DOI 10.1016/0042-6989(89)90143-0; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Spratling MW, 2010, J NEUROSCI, V30, P3531, DOI 10.1523/JNEUROSCI.4911-09.2010; STEINMETZ MA, 1987, J NEUROSCI, V7, P177; Sun P, 2012, CEREBRAL CORTEX; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; VANDOORN AJ, 1984, VISION RES, V24, P47, DOI 10.1016/0042-6989(84)90143-3; WATAMANIUK SNJ, 1992, VISION RES, V32, P2341, DOI 10.1016/0042-6989(92)90097-3; Webb BS, 2007, P NATL ACAD SCI USA, V104, P3532, DOI 10.1073/pnas.0611288104; Webb BS, 2011, J NEUROSCI, V31, P4917, DOI 10.1523/JNEUROSCI.6185-10.2011	53	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67468	10.1371/journal.pone.0067468	http://dx.doi.org/10.1371/journal.pone.0067468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840711	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400087
J	Yamauchi, T; Tabuchi, H; Takase, K; Ohsugi, H; Ohara, Z; Kiuchi, Y				Yamauchi, Tomofusa; Tabuchi, Hitoshi; Takase, Kosuke; Ohsugi, Hideharu; Ohara, Zaigen; Kiuchi, Yoshiaki			Comparison of Visual Performance of Multifocal Intraocular Lenses with Same Material Monofocal Intraocular Lenses	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONTRAST SENSITIVITY; FUNCTION QUESTIONNAIRE; IMPLANTATION; VISION; EYE; OUTCOMES; IMPROVEMENTS; CRYSTALENS; DISTANCE	Purpose: To compare the visual performance of multifocal intraocular lenses (IOLs) and monofocal IOLs made of the same material. Methods: The subjects included patients implanted with either Tecnis (R) monofocal IOLs (ZA9003 or ZCB00) or Tecnis (R) multifocal IOLs (ZMA00 or ZMB00) bilaterally. We conducted a retrospective study comparing the two types of IOLs. The multifocal group included 46 patients who were implanted with Tecnis (R) multifocal IOLs bilaterally. The monofocal group was an age-and sex-matched control group, and included 85 patients who were implanted with Tecnis (R) monofocal IOLs bilaterally. Lens opacity grading, the radius of corneal curvature, corneal astigmatism, axial length and the refractive status were measured preoperatively. Pupil size, ocular aberrometry, distance, intermediate and near visual acuity, contrast sensitivity with and without glare and the responses to a quality-of-vision questionnaire were evaluated pre-and postoperatively. Results: The uncorrected near visual acuity was significantly better in the multifocal group, whereas both the corrected intermediate and near visual acuity were better in the monofocal group. Contrast sensitivity (with and without glare) was significantly better in the monofocal group. The rate of spectacle dependency was significantly lower in the multifocal group. There were no significant differences between the two groups regarding most items of the postoperative quality-ofvision questionnaire (VFQ-25), with the exception that the patients in the monofocal group reported fewer problems with nighttime driving. Conclusions: The multifocal IOLs used in this study reduced spectacle dependency more so than monofocal IOLs and did not compromise the subjective visual function, with the exception of nighttime driving.	[Yamauchi, Tomofusa; Tabuchi, Hitoshi; Takase, Kosuke; Ohsugi, Hideharu; Ohara, Zaigen] Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol, Hiroshima, Japan	Hiroshima University	Yamauchi, T (corresponding author), Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	t.yamauchi@tsukazaki-eye.net						Alfonso JF, 2007, J CATARACT REFR SURG, V33, P1235, DOI 10.1016/j.jcrs.2007.03.034; Alio JL, 2004, J CATARACT REFR SURG, V30, P2494, DOI 10.1016/j.jcrs.2004.04.052; Alio JL, 2008, J CATARACT REFR SURG, V34, P942, DOI 10.1016/j.jcrs.2007.11.057; Alio JL, 2011, J CATARACT REFR SURG, V37, P638, DOI 10.1016/j.jcrs.2010.10.056; Bradley EA, 2006, OPHTHALMOLOGY, V113, P1450, DOI 10.1016/j.ophtha.2006.02.060; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Cillino S, 2008, OPHTHALMOLOGY, V115, P1508, DOI 10.1016/j.ophtha.2008.04.017; Cumming JS, 2006, J CATARACT REFR SURG, V32, P812, DOI 10.1016/j.jcrs.2006.02.007; Denoyer A, 2007, J CATARACT REFR SURG, V33, P210, DOI 10.1016/j.jcrs.2006.10.035; Finkelman YM, 2009, J CATARACT REFR SURG, V35, P998, DOI 10.1016/j.jcrs.2009.01.035; Goes FJ, 2008, J REFRACT SURG, V24, P300, DOI 10.3928/1081597X-20080301-13; Hirneiss C, 2007, BRIT J OPHTHALMOL, V91, P481, DOI 10.1136/bjo.2006.102376; Hyman LG, 2005, OPHTHALMOLOGY, V112, P1505, DOI 10.1016/j.ophtha.2005.03.028; Ito M, 2009, J CATARACT REFR SURG, V35, P710, DOI 10.1016/j.jcrs.2008.12.019; Kohnen T, 2006, OPHTHALMOLOGY, V113, P578, DOI 10.1016/j.ophtha.2005.11.020; Leyland M, 2003, OPHTHALMOLOGY, V110, P1789, DOI 10.1016/S0161-6420(03)00722-X; Lin IC, 2008, J CATARACT REFR SURG, V34, P1312, DOI 10.1016/j.jcrs.2008.04.028; LINDSTROM RL, 1993, OPHTHALMOLOGY, V100, P91; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mester U, 2007, J CATARACT REFR SURG, V33, P1033, DOI 10.1016/j.jcrs.2007.02.037; Montes-Mico R, 2003, J CATARACT REFR SURG, V29, P703, DOI 10.1016/S0886-3350(02)01648-6; Munoz G, 2007, J CATARACT REFR SURG, V33, P1573, DOI 10.1016/j.jcrs.2007.05.024; OLSEN T, 1990, J CATARACT REFR SURG, V16, P42, DOI 10.1016/S0886-3350(13)80872-3; Packer M, 2010, AM J OPHTHALMOL, V149, P577, DOI 10.1016/j.ajo.2009.10.022; Palmer AM, 2008, J REFRACT SURG, V24, P257, DOI 10.3928/1081597X-20080301-07; Pepose JS, 2007, AM J OPHTHALMOL, V144, P347, DOI 10.1016/j.ajo.2007.05.036; Pesudovs K, 2007, J REFRACT SURG, V23, P492, DOI 10.3928/1081-597X-20070501-13; Pieh S, 2001, BRIT J OPHTHALMOL, V85, P816, DOI 10.1136/bjo.85.7.816; Steinert RF, 1999, OPHTHALMOLOGY, V106, P1243, DOI 10.1016/S0161-6420(99)00704-6; Suzukamo Yoshimi, 2005, Health Qual Life Outcomes, V3, P65, DOI 10.1186/1477-7525-3-65; Takahashi Y., 2001, IOL RS, V15, P192; Vaquero-Ruano M, 1998, J CATARACT REFR SURG, V24, P118, DOI 10.1016/S0886-3350(98)80084-9; Weghaupt H, 1996, J CATARACT REFR SURG, V22, P1313, DOI 10.1016/S0886-3350(96)80091-5; Woodward MA, 2009, J CATARACT REFR SURG, V35, P992, DOI 10.1016/j.jcrs.2009.01.031; Zelichowska B, 2008, J CATARACT REFR SURG, V34, P2036, DOI 10.1016/j.jcrs.2008.06.045	36	40	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68236	10.1371/journal.pone.0068236	http://dx.doi.org/10.1371/journal.pone.0068236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840836	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400178
J	Inoue, Y; Nakajima, A; Mizukami, S; Hata, H				Inoue, Yusuke; Nakajima, Ai; Mizukami, Shinya; Hata, Hirofumi			Effect of Breath Holding on Spleen Volume Measured by Magnetic Resonance Imaging	PLOS ONE			English	Article							NORMAL SPLENIC VOLUME; COMPUTED-TOMOGRAPHY; GAUCHER-DISEASE; LIVER; APNEAS; CONTRACTION; DIVERS; SIZE; MASS	Objective: Ultrasonographic studies have demonstrated transient reduction in spleen volume in relation to apnea diving. We measured spleen volume under various respiratory conditions by MR imaging to accurately determine the influence of ordinary breath holding on spleen volumetry. Materials and Methods: Twelve healthy adult volunteers were examined. Contiguous MR images of the spleen were acquired during free breathing and during respiratory manipulations, including breath holding at the end of normal expiration, breath holding at deep inspiration, and the valsalva maneuver, and spleen volume was measured from each image set based on the sum-of-areas method. Acquisition during free breathing was performed with respiratory triggering. The duration of each respiratory manipulation was 30 s, and five sets of MR images were acquired serially during each manipulation. Results: Baseline spleen volume before respiratory manipulation was 173.0 +/- 79.7 mL, and the coefficient of variance for two baseline measures was 1.4% +/- 1.6%, suggesting excellent repeatability. Spleen volume decreased significantly just after the commencement of respiratory manipulation, remained constant during the manipulation, and returned to the control value 2 min after the cessation of the manipulation, irrespective of manipulation type. The percentages of volume reduction were 10.2% +/- 2.9%, 10.2% +/- 3.5%, and 13.3% +/- 5.7% during expiration breath holding, deep-inspiration breath holding, and the valsalva maneuver, respectively, and these values did not differ significantly. Conclusions: Spleen volume is reduced during short breath-hold apnea in healthy adults. Physiological responses of the spleen to respiratory manipulations should be considered in the measurement and interpretation of spleen volume.	[Inoue, Yusuke] Kitasato Univ, Sch Med, Dept Diagnost Radiol, Sagamihara, Kanagawa 228, Japan; [Nakajima, Ai; Mizukami, Shinya; Hata, Hirofumi] Kitasato Univ Hosp, Dept Radiol, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University	Inoue, Y (corresponding author), Kitasato Univ, Sch Med, Dept Diagnost Radiol, Sagamihara, Kanagawa 228, Japan.	inoueys34@gmail.com						Bakovic D, 2003, J APPL PHYSIOL, V95, P1460, DOI 10.1152/japplphysiol.00221.2003; Betal D, 2000, CLIN ANAT, V13, P404, DOI 10.1002/1098-2353(2000)13:6<404::AID-CA2>3.3.CO;2-J; BREIMAN RS, 1982, AM J ROENTGENOL, V138, P329, DOI 10.2214/ajr.138.2.329; Espersen K, 2002, J APPL PHYSIOL, V92, P2071, DOI 10.1152/japplphysiol.00055.2001; Farraher SW, 2005, RADIOLOGY, V237, P322, DOI 10.1148/radiol.2371041416; Frances MF, 2008, APPL PHYSIOL NUTR ME, V33, P990, DOI 10.1139/H08-087; HEYMSFIELD SB, 1979, ANN INTERN MED, V90, P185, DOI 10.7326/0003-4819-90-2-185; Hoofs JC, 1999, J NUCL MED, V40, P1745; HURFORD WE, 1990, J APPL PHYSIOL, V69, P932, DOI 10.1152/jappl.1990.69.3.932; ISHIBASHI H, 1991, J CLIN ULTRASOUND, V19, P21, DOI 10.1002/jcu.1870190106; Kaneko J, 2002, HEPATO-GASTROENTEROL, V49, P1726; Lamb PM, 2002, BRIT J RADIOL, V75, P573, DOI 10.1259/bjr.75.895.750573; Loftus WK, 1999, J CLIN ULTRASOUND, V27, P71, DOI 10.1002/(SICI)1097-0096(199902)27:2<71::AID-JCU4>3.3.CO;2-L; Mazonakis M, 2000, EUR RADIOL, V10, P1899, DOI 10.1007/s003300000551; Palada I, 2007, J APPL PHYSIOL, V103, P1958, DOI 10.1152/japplphysiol.00182.2007; Prassopoulos P, 1997, EUR RADIOL, V7, P246, DOI 10.1007/s003300050145; Prommer N, 2007, EUR J APPL PHYSIOL, V101, P753, DOI 10.1007/s00421-007-0556-y; ROSENTHAL DI, 1992, RADIOLOGY, V185, P841, DOI 10.1148/radiology.185.3.1438773; Roshdy MSE, 1997, ACAD RADIOL, V4, P193, DOI 10.1016/S1076-6332(05)80290-9; Schagatay E, 2005, EUR J APPL PHYSIOL, V93, P447, DOI 10.1007/s00421-004-1224-0; SCHLESINGER AE, 1993, AM J ROENTGENOL, V160, P1107, DOI 10.2214/ajr.160.5.8470587; Stefanescu H, 2011, J GASTROEN HEPATOL, V26, P164, DOI 10.1111/j.1440-1746.2010.06325.x; Stewart IB, 2002, SPORTS MED, V32, P361, DOI 10.2165/00007256-200232060-00002; Terk MR, 2000, SKELETAL RADIOL, V29, P563, DOI 10.1007/s002560000276; Vogel ER, 2008, J CLIN NEUROPHYSIOL, V25, P313, DOI 10.1097/WNP.0b013e318182d319; Yetter EM, 2003, AM J ROENTGENOL, V181, P1615, DOI 10.2214/ajr.181.6.1811615	26	11	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e68670	10.1371/journal.pone.0068670	http://dx.doi.org/10.1371/journal.pone.0068670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840858	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400135
J	Palmsten, K; Huybrechts, KF; Mogun, H; Kowal, MK; Williams, PL; Michels, KB; Setoguchi, S; Hernandez-Diaz, S				Palmsten, Kristin; Huybrechts, Krista F.; Mogun, Helen; Kowal, Mary K.; Williams, Paige L.; Michels, Karin B.; Setoguchi, Soko; Hernandez-Diaz, Sonia			Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations	PLOS ONE			English	Article							ISSUES; PREECLAMPSIA; DEPRESSION; OUTCOMES; INFANTS; RECORDS	Background: In the absence of clinical trial data, large post-marketing observational studies are essential to evaluate the safety and effectiveness of medications during pregnancy. We identified a cohort of pregnancies ending in live birth within the 2000-2007 Medicaid Analytic eXtract (MAX). Herein, we provide a blueprint to guide investigators who wish to create similar cohorts from healthcare utilization data and we describe the limitations in detail. Methods: Among females ages 12-55, we identified pregnancies using delivery-related codes from healthcare utilization claims. We linked women with pregnancies to their offspring by state, Medicaid Case Number (family identifier) and delivery/birth dates. Then we removed inaccurate linkages and duplicate records and implemented cohort eligibility criteria (i.e., continuous and appropriate enrollment type, no private insurance, no restricted benefits) for claim information completeness. Results: From 13,460,273 deliveries and 22,408,810 child observations, 6,107,572 pregnancies ending in live birth were available after linkage, cleaning, and removal of duplicate records. The percentage of linked deliveries varied greatly by state, from 0 to 96%. The cohort size was reduced to 1,248,875 pregnancies after requiring maternal eligibility criteria throughout pregnancy and to 1,173,280 pregnancies after further applying infant eligibility criteria. Ninety-one percent of women were dispensed at least one medication during pregnancy. Conclusions: Mother-infant linkage is feasible and yields a large pregnancy cohort, although the size decreases with increasing eligibility requirements. MAX is a useful resource for studying medications in pregnancy and a spectrum of maternal and infant outcomes within the indigent population of women and their infants enrolled in Medicaid. It may also be used to study maternal characteristics, the impact of Medicaid policy, and healthcare utilization during pregnancy. However, careful attention to the limitations of these data is necessary to reduce biases.	[Palmsten, Kristin; Michels, Karin B.; Setoguchi, Soko; Hernandez-Diaz, Sonia] Harvard Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA 02114 USA; [Huybrechts, Krista F.; Mogun, Helen; Kowal, Mary K.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Huybrechts, Krista F.; Mogun, Helen; Kowal, Mary K.] Harvard Univ, Sch Med, Boston, MA USA; [Williams, Paige L.] Harvard Univ, Dept Biostat, Sch Publ Hlth, Boston, MA USA; [Michels, Karin B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr,Dept Obstet Gyneco, Boston, MA USA; [Michels, Karin B.] Univ Freiburg, Med Ctr, Inst Prevent & Canc Epidemiol, Freiburg, Germany; [Setoguchi, Soko] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Freiburg; Duke University	Palmsten, K (corresponding author), Harvard Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA 02114 USA.	kkp762@mail.harvard.edu			Agency for Healthcare Research and Quality (AHRQ) [R01HS018533]; National Institute of Child Health and Human Development (NICHD), National Institutes of Health [T32HD060454]; Pfizer; Asisa; AHRQ [K02-HS017731]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018533, K02HS017731] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060454] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Child Health and Human Development (NICHD), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Pfizer(Pfizer); Asisa; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Agency for Healthcare Research and Quality (AHRQ) (Grant R01HS018533 to SHD). KP is supported by Training Grant T32HD060454 in Reproductive, Perinatal and Pediatric Epidemiology from the National Institute of Child Health and Human Development (NICHD), National Institutes of Health. The Pharmacoepidemiology Program at the Harvard School of Public Health receives funding from Pfizer and Asisa. SHD has consulted for GSK and Novartis. SS was supported by a mid-career development award from the AHRQ (grant K02-HS017731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Andrade SE, 2012, MATERN CHILD HLTH J, V16, P1349, DOI 10.1007/s10995-011-0902-x; Bennett IM, 2010, PSYCHIAT SERV, V61, P386, DOI 10.1176/ps.2010.61.4.386; Brandon AR, 2009, CURR OPIN PSYCHIATR, V22, P601, DOI 10.1097/YCO.0b013e3283318e6f; Bronstein JM, 2009, MATERN CHILD HLTH J, V13, P250, DOI 10.1007/s10995-008-0347-z; BUESCHER PA, 1991, AM J PUBLIC HEALTH, V81, P1625, DOI 10.2105/AJPH.81.12.1625; Centers for Medicare and Medicaid Services, MED AN EXTRACT MAX G; Centers for Medicare & Medicaid Services, MAX DOD DAT DEATH AU; Centers for Medicare & Medicaid Services, IMP IP REC LAYOUT DA; Centers for Medicare & Medicaid Services. Medicaid Analytic eXtract (MAX) General Information, PERS SUMM PS REC LAY; Cole JA, 2007, PHARMACOEPIDEM DR S, V16, P474, DOI 10.1002/pds.1296; Correa A, 2007, CLIN MOL TERATOLOGY, V79, P65; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; Department of Health and Human Services Office of Inspector General, 2009, MED MAN CAR ENC DAT; DeVoe JE, 2011, ANN FAM MED, V9, P351, DOI 10.1370/afm.1279; Eworuke E, 2012, PHARMACOEPIDEM DR S, V21, P640, DOI 10.1002/pds.3264; Garcia G, 2008, MATERN CHILD HLTH J; Gavin NI, 2006, WOMEN HEALTH ISS, V16, P313, DOI 10.1016/j.whi.2006.10.003; Grisso J A, 1997, J Matern Fetal Med, V6, P230; Hennessy S, 2012, PHARMACOEPIDEM DR S, P209, DOI DOI 10.1002/9781119959946.CH14; Hennessy S, 2007, EPIDEMIOLOGY, V18, P518, DOI 10.1097/EDE.0b013e31806466bb; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hoyert Donna L, 2007, Vital Health Stat 3, P1; Huybrechts KF, 2011, ANN FAMILY MED; Macdorman Marian F, 2008, NCHS Data Brief, P1; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P16, DOI 10.1002/pds.3284; Martin JA., 2009, NATL VITAL STAT REP, V57, P1; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Martin Joyce A, 2003, Natl Vital Stat Rep, V52, P1; Martin Joyce A, 2007, Natl Vital Stat Rep, V56, P1; Martin Joyce A, 2006, Natl Vital Stat Rep, V55, P1; Martin Joyce A, 2002, Natl Vital Stat Rep, V51, P1; Martin Joyce A, 2005, Natl Vital Stat Rep, V54, P1; Martin Joyce A, 2002, Natl Vital Stat Rep, V50, P1; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Palmsten K, 2012, AM J EPIDEMIOL, V175, P988, DOI 10.1093/aje/kwr394; PIPER JM, 1990, AM J EPIDEMIOL, V132, P561, DOI 10.1093/oxfordjournals.aje.a115692; Research Data Assistance Center, CMS DAT REQ CTR; Research Data Assistance Center, FIND CMS DAT FIL; Research Data Assistance Center, 2011, CMS 102 COND RES MED; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; The Kaiser Family Foundation, 2010, MED PROGR GLANC; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Weinberg C.R., 2008, MODERN EPIDEMIOLOGY, P620	44	101	102	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67405	10.1371/journal.pone.0067405	http://dx.doi.org/10.1371/journal.pone.0067405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840692	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400099
J	Vuong, L; Brobst, DE; Ivanovic, I; Sherry, DM; Al-Ubaidi, MR				Vuong, Linda; Brobst, Daniel E.; Ivanovic, Ivana; Sherry, David M.; Al-Ubaidi, Muayyad R.			p53 Selectively Regulates Developmental Apoptosis of Rod Photoreceptors	PLOS ONE			English	Article							TRANSGENIC MICE; COLORECTAL ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE; CELL-DIFFERENTIATION; RETINAL DEGENERATION; P53-DEFICIENT MICE; SPONTANEOUS TUMORS; RODLESS RETINA; EXPRESSION; PROTEIN	Retinal cells become post-mitotic early during post-natal development. It is likely that p53, a well-known cell cycle regulator, is involved in regulating the genesis, differentiation and death of retinal cells. Furthermore, retinal cells are under constant oxidative stress that can result in DNA damage, due to the extremely high level of metabolic activity associated with phototransduction. If not repaired, this damage may result in p53-dependent cell death and ensuing vision loss. In this study, the role of p53 during retinal development and in the post-mitotic retina is investigated. A previously described super p53 transgenic mouse that expresses an extra copy of the mouse p53 gene driven by its endogenous promoter is utilized. Another transgenic mouse (HIP) that expresses the p53 gene in rod and cone photoreceptors driven by the human interphotoreceptor retinoid binding protein promoter was generated. The electroretinogram (ERG) of the super p53 mouse exhibited reduced rod-driven scotopic a and b wave and cone-driven photopic b wave responses. This deficit resulted from a reduced number of rod photoreceptors and inner nuclear layer cells. However, the reduced photopic signal arose only from lost inner retinal neurons, as cone numbers did not change. Furthermore, cell loss was non-progressive and resulted from increased apoptosis during retinal developmental as determined by TUNEL staining. In contrast, the continuous and specific expression of p53 in rod and cone photoreceptors in the mature retinas of HIP mice led to the selective loss of both rods and cones. These findings strongly support a role for p53 in regulating developmental apoptosis in the retina and suggest a potential role, either direct or indirect, for p53 in the degenerative photoreceptor loss associated with human blinding disorders.	[Vuong, Linda; Brobst, Daniel E.; Ivanovic, Ivana; Sherry, David M.; Al-Ubaidi, Muayyad R.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Sherry, David M.; Al-Ubaidi, Muayyad R.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Sherry, David M.] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Al-Ubaidi, MR (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.	muayyad-al-ubaidi@ouhsc.edu		Vuong, Linda/0000-0001-5253-3712	Foundation Fighting Blindness; National Center For Research Resources [P20RR017703]; National Eye Institute [P30EY12190, R01EY018137]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018137, P30EY012190] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was partially supported by the Foundation Fighting Blindness (MRA), the National Center For Research Resources P20RR017703, and the National Eye Institute P30EY12190 and R01EY018137 (MRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of National Institutes of Health or any of its institutes.	ALI IU, 1994, CANCER RES, V54, P1; Allocati N, 2012, EXP CELL RES, V318, P1285, DOI 10.1016/j.yexcr.2012.01.023; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Berberich T, 1997, MOL GEN GENET, V254, P275, DOI 10.1007/s004380050416; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DRAGER UC, 1978, J COMP NEUROL, V180, P85, DOI 10.1002/cne.901800107; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Ikeda S, 1999, INVEST OPHTH VIS SCI, V40, P1874; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; KEELER C, 1966, J HERED, V57, P47, DOI 10.1093/oxfordjournals.jhered.a107462; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Linden R, 1999, PROG RETIN EYE RES, V18, P133, DOI 10.1016/S1350-9462(98)00020-2; LIOU GI, 1990, J BIOL CHEM, V265, P8373; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Montes de Oca LR, 1995, NATURE, V378, P203; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; PEZZELLA F, 1993, HISTOPATHOLOGY, V22, P39, DOI 10.1111/j.1365-2559.1993.tb00067.x; PITTLER SJ, 1993, P NATL ACAD SCI USA, V90, P9616, DOI 10.1073/pnas.90.20.9616; Rentzsch F, 2003, GENE, V323, P19, DOI 10.1016/j.gene.2003.10.002; SCHMID P, 1991, DEVELOPMENT, V113, P857; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Sherry DM, 2010, EUR J NEUROSCI, V32, P1461, DOI 10.1111/j.1460-9568.2010.07431.x; Shin DH, 1999, NEUROREPORT, V10, P2165, DOI 10.1097/00001756-199907130-00030; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; SUN XF, 1992, LANCET, V340, P1369, DOI 10.1016/0140-6736(92)92558-W; SUN XF, 1993, VIRCHOWS ARCH A, V423, P443, DOI 10.1007/BF01606533; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Tendler Y, 1999, MOL BRAIN RES, V72, P40, DOI 10.1016/S0169-328X(99)00202-8; VANVELDHUIZEN PJ, 1993, AM J MED SCI, V305, P275, DOI 10.1097/00000441-199305000-00001; Vuong L, 2012, INVEST OPHTH VIS SCI, V53, P4821, DOI 10.1167/iovs.11-8681; Vuong L, 2012, INVEST OPHTH VIS SCI, V53, P1362, DOI 10.1167/iovs.11-8909; WEISS J, 1993, INT J CANCER, V54, P693, DOI 10.1002/ijc.2910540427; Xu XP, 2000, EXP NEUROL, V163, P207, DOI 10.1006/exnr.2000.7370; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	47	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67381	10.1371/journal.pone.0067381	http://dx.doi.org/10.1371/journal.pone.0067381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840687	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800132
J	Hyde, SJ; Rao, BS; Eckenroth, BE; Jackman, JE; Doublie, S				Hyde, Samantha J.; Rao, Bhalchandra S.; Eckenroth, Brian E.; Jackman, Jane E.; Doublie, Sylvie			Structural Studies of a Bacterial tRNA(HIS) Guanylyltransferase (Thg1)-Like Protein, with Nucleotide in the Activation and Nucleotidyl Transfer Sites	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE TRNA(HIS); TRANSFER-RNAS; CATALYZES; TERMINUS; THG1	All nucleotide polymerases and transferases catalyze nucleotide addition in a 5' to 3' direction. In contrast, tRNA(His) guanylyltransferase (Thg1) enzymes catalyze the unusual reverse addition (3' to 5') of nucleotides to polynucleotide substrates. In eukaryotes, Thg1 enzymes use the 3'-5' addition activity to add G(-1) to the 5'-end of tRNA(His), a modification required for efficient aminoacylation of the tRNA by the histidyl-tRNA synthetase. Thg1-like proteins (TLPs) are found in Archaea, Bacteria, and mitochondria and are biochemically distinct from their eukaryotic Thg1 counterparts TLPs catalyze 5'-end repair of truncated tRNAs and act on a broad range of tRNA substrates instead of exhibiting strict specificity for tRNA(His). Taken together, these data suggest that TLPs function in distinct biological pathways from the tRNA(His) maturation pathway, perhaps in tRNA quality control. Here we present the first crystal structure of a TLP, from the gram-positive soil bacterium Bacillus thuringiensis (BtTLP). The enzyme is a tetramer like human THG1, with which it shares substantial structural similarity. Catalysis of the 3'-5' reaction with 5'-monophosphorylated tRNA necessitates first an activation step, generating a 5'-adenylylated intermediate prior to a second nucleotidyl transfer step, in which a nucleotide is transferred to the tRNA 5'-end. Consistent with earlier characterization of human THG1, we observed distinct binding sites for the nucleotides involved in these two steps of activation and nucleotidyl transfer. A BtTLP complex with GTP reveals new interactions with the GTP nucleotide in the activation site that were not evident from the previously solved structure. Moreover, the BtTLP-ATP structure allows direct observation of ATP in the activation site for the first time. The BtTLP structural data, combined with kinetic analysis of selected variants, provide new insight into the role of key residues in the activation step.	[Hyde, Samantha J.; Eckenroth, Brian E.; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Rao, Bhalchandra S.; Jackman, Jane E.] Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol & Mol, Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA	University of Vermont; University System of Ohio; Ohio State University	Jackman, JE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol & Mol, Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA.	jackman.14@osu.edu; sdoublie@uvm.edu	jackman, jane/AAE-1854-2022	jackman, jane/0000-0001-9291-8852; Eckenroth, Brian/0000-0003-4818-311X; Doublie, Sylvie/0000-0002-6294-5304; , Samantha/0000-0002-0235-2654	National Institutes of Health [GM087543]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health Grant GM087543 (to J.E.J.). The beamline GM/CA CAT has been funded, in whole or in part, with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad MG, 2011, RNA, V17, P613, DOI 10.1261/rna.2517111; Abad MG, 2010, P NATL ACAD SCI USA, V107, P674, DOI 10.1073/pnas.0910961107; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOLEY L, 1982, P NATL ACAD SCI-BIOL, V79, P6475, DOI 10.1073/pnas.79.21.6475; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gu WF, 2005, MOL CELL BIOL, V25, P8191, DOI 10.1128/MCB.25.18.8191-8201.2005; Gu WF, 2003, GENE DEV, V17, P2889, DOI 10.1101/gad.1148603; Heinemann IU, 2010, FEBS LETT, V584, P3567, DOI 10.1016/j.febslet.2010.07.023; Hyde SJ, 2010, P NATL ACAD SCI USA, V107, P20305, DOI 10.1073/pnas.1010436107; Jackman JE, 2008, BIOCHEMISTRY-US, V47, P4817, DOI 10.1021/bi702517q; Jackman JE, 2006, P NATL ACAD SCI USA, V103, P8640, DOI 10.1073/pnas.0603068103; Jackman JE, 2012, RNA, V18, P886, DOI 10.1261/rna.032300.112; JAHN D, 1991, J BIOL CHEM, V266, P22832; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LONERGAN KM, 1993, SCIENCE, V259, P812, DOI 10.1126/science.8430334; LONERGAN KM, 1993, NUCLEIC ACIDS RES, V21, P4402, DOI 10.1093/nar/21.18.4402; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; ORELLANA O, 1986, MOL CELL BIOL, V6, P525, DOI 10.1128/MCB.6.2.525; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Preston MA, 2010, RNA, V16, P1068, DOI 10.1261/rna.2087510; Rao BS, 2011, NUCLEIC ACIDS RES, V39, P1833, DOI 10.1093/nar/gkq976; Sawaya Michael R, 2007, Methods Mol Biol, V364, P95; Smith BA, 2012, BIOCHEMISTRY-US, V51, P453, DOI 10.1021/bi201397f; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	32	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67465	10.1371/journal.pone.0067465	http://dx.doi.org/10.1371/journal.pone.0067465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844012	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000073
J	Taillade, M; Sauzeon, H; Pala, PA; Dejos, M; Larrue, F; Gross, C; N'Kaoua, B				Taillade, Mathieu; Sauzeon, Helene; Pala, Prashant Arvind; Dejos, Marie; Larrue, Florian; Gross, Christian; N'Kaoua, Bernard			Age-Related Wayfinding Differences in Real Large-Scale Environments: Detrimental Motor Control Effects during Spatial Learning Are Mediated by Executive Decline?	PLOS ONE			English	Article							VIRTUAL ENVIRONMENT; INDIVIDUAL-DIFFERENCES; PATH-INTEGRATION; MEMORY; KNOWLEDGE; ROUTE; INFORMATION; EXPLORATION; GENDER; NAVIGATION	The aim of this study was to evaluate motor control activity (active vs. passive condition) with regards to wayfinding and spatial learning difficulties in large-scale spaces for older adults. We compared virtual reality (VR)-based wayfinding and spatial memory (survey and route knowledge) performances between 30 younger and 30 older adults. A significant effect of age was obtained on the wayfinding performances but not on the spatial memory performances. Specifically, the active condition deteriorated the survey measure in all of the participants and increased the age-related differences in the wayfinding performances. Importantly, the age-related differences in the wayfinding performances, after an active condition, were further mediated by the executive measures. All of the results relative to a detrimental effect of motor activity are discussed in terms of a dual task effect as well as executive decline associated with aging.	[Taillade, Mathieu; Sauzeon, Helene; Pala, Prashant Arvind; Dejos, Marie; N'Kaoua, Bernard] Univ Bordeaux, EA 4136, Bordeaux, France; [Taillade, Mathieu; Sauzeon, Helene; Pala, Prashant Arvind; Dejos, Marie; N'Kaoua, Bernard] INSERM, IFR Handicap, EA 4136, Bordeaux, France; [Sauzeon, Helene; N'Kaoua, Bernard] Inria, Equipe Phoenix, Talence, France; [Larrue, Florian] Inria, Equipe Potioc LaBri, Talence, France; [Gross, Christian] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Inria; Centre National de la Recherche Scientifique (CNRS); Inria; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Sauzeon, H (corresponding author), Univ Bordeaux, EA 4136, Bordeaux, France.	helene.sauzeon@u-bordeaux2.fr	N'Kaoua, Bernard/T-3577-2019; Sauzéon, Hélène/T-1178-2019	Sauzéon, Hélène/0000-0001-5781-9891; Pala, Prashant/0000-0002-3335-7044				Allen GL, 1999, WAYFINDING BEHAVIOR, P46; Allen GL, 2004, PERCEPT PSYCHOPHYS, V66, P170, DOI 10.3758/BF03194870; [Anonymous], 2002, COGNIT PROCESS, DOI DOI 10.1155/2008/953640; Attree E. A., 1996, P 1 EUR C DIS VIRT R, P117; Brooks BM, 1999, MEMORY, V7, P65, DOI 10.1080/741943713; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Chrastil ER, 2012, PSYCHON B REV, V19, P1, DOI 10.3758/s13423-011-0182-x; CRAIK FIM, 1983, PHILOS T ROY SOC B, V302, P341, DOI 10.1098/rstb.1983.0059; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Cutmore TRH, 2000, INT J HUM-COMPUT ST, V53, P223, DOI 10.1006/ijhc.2000.0389; De Beni R, 2006, APPL COGNITIVE PSYCH, V20, P807, DOI 10.1002/acp.1229; Deltour J.J, 1993, MILL HILL VOCABULARY; Dennis NA, 2008, HDB AGING COGNITION, P311; Dijkstra K, 2012, ACTA PSYCHOL, V140, P58, DOI 10.1016/j.actpsy.2012.02.003; Doumas M, 2008, EXP BRAIN RES, V187, P275, DOI 10.1007/s00221-008-1302-3; Etchamendy N, 2012, HIPPOCAMPUS, V22, P869, DOI 10.1002/hipo.20948; Farrell MJ, 2003, J EXP PSYCHOL-APPL, V9, P219, DOI 10.1037/1076-898X.9.4.219; Foreman, 2003, J HLTH SOCIAL ENV IS, V4, P15; Foreman N, 2005, ENVIRON BEHAV, V37, P275, DOI 10.1177/0013916504269649; Foreman N, 2004, CYBERPSYCHOL BEHAV, V7, P451, DOI 10.1089/cpb.2004.7.451; Gaunet F, 2001, COGNITIVE BRAIN RES, V11, P409, DOI 10.1016/S0926-6410(01)00013-1; Golledge RG, 1999, WAYFINDING BEHAVIOR, P5; Harris MA, 2012, HIPPOCAMPUS, V22, P1770, DOI 10.1002/hipo.22011; Head D, 2010, BEHAV BRAIN RES, V209, P49, DOI 10.1016/j.bbr.2010.01.012; Hegarty M, 2006, INTELLIGENCE, V34, P151, DOI 10.1016/j.intell.2005.09.005; Hegarty M., 2005, CAM BRIDGE HDB VISUO, P121, DOI DOI 10.1017/CBO9780511610448.005; Iaria G, 2009, BEHAV BRAIN RES, V196, P187, DOI 10.1016/j.bbr.2008.08.040; Ishikawa T, 2006, COGNITIVE PSYCHOL, V52, P93, DOI 10.1016/j.cogpsych.2005.08.003; Kalia AA, 2008, PERCEPTION, V37, P1677, DOI 10.1068/p5915; Kavcic V, 2006, BRAIN, V129, P736, DOI 10.1093/brain/awh727; Kennedy R. S., 1994, IM 7 C TUCS AZ; Ketcham CJ, 2001, HDB PSYCHOL AGING, P349; Klencklen G, 2012, AGEING RES REV, V11, P123, DOI 10.1016/j.arr.2011.10.001; KormiNouri R, 1995, EUR J COGN PSYCHOL, V7, P337, DOI 10.1080/09541449508403103; Lapeyre B, 2011, HUM FACTORS, V53, P647, DOI 10.1177/0018720811421171; Li K., 2005, COGNITIVE LIMITATION, V49, P190, DOI [https://doi.org/10.1017/CBO9780511720413.009, DOI 10.1017/CBO9780511720413.009]; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Liu I, 2011, BRAIN RES, V1410, P112, DOI 10.1016/j.brainres.2011.07.005; Loomis JM, 1999, BEHAV RES METH INS C, V31, P557, DOI 10.3758/BF03200735; Lorenz CA, 1986, 10 GA7 EM U EM COGN; Lovden M, 2005, PSYCHOL AGING, V20, P683, DOI 10.1037/0882-7974.20.4.683; Meulenbroek O, 2004, NEUROIMAGE, V22, P1503, DOI 10.1016/j.neuroimage.2004.04.007; Moffat SD, 2009, NEUROPSYCHOL REV, V19, P478, DOI 10.1007/s11065-009-9120-3; Moffat SD, 2001, NEUROBIOL AGING, V22, P787, DOI 10.1016/S0197-4580(01)00251-2; Montello DR., 1998, SPATIAL TEMPORAL REA, P143; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; PERUCH P, 1995, ECOL PSYCHOL, V7, P1, DOI 10.1207/s15326969eco0701_1; Plancher G, 2008, PSYCHOL NEUROPSYCHIA, V6, P7, DOI 10.1684/pnv.2008.0119; Pugnetti L, 1998, ITAL J NEUROL SCI, V19, pS424, DOI 10.1007/BF00539600; Raven J., 2004, MANUAL RAVENS PROGR; Reitan RM, 1992, TRAIL MAKING TEST MA; RIEDIGER M, 2006, HDB PSYCHOL AGING, P289; Sandamas G, 2007, J ENVIRON PSYCHOL, V27, P126, DOI 10.1016/j.jenvp.2007.03.001; Shelton AL, 2004, J EXP PSYCHOL LEARN, V30, P158, DOI 10.1037/0278-7393.30.1.158; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Sorita E, 2012, DISABIL REHABIL, V00, P1; Spiers HJ, 2008, NEUROPSYCHOLOGIA, V46, P2106, DOI 10.1016/j.neuropsychologia.2008.01.028; Spiers HJ, 2007, HIPPOCAMPUS, V17, P618, DOI 10.1002/hipo.20298; Taillade M, 2013, AGING NEUROPSYCHOL C, V20, P298, DOI 10.1080/13825585.2012.706247; Trewartha KM, 2009, PSYCHOL AGING, V24, P450, DOI 10.1037/a0015498; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; van Asselen M, 2006, PSYCHOL RES-PSYCH FO, V70, P151, DOI 10.1007/s00426-004-0199-0; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Waller D, 2004, PSYCHON B REV, V11, P157, DOI 10.3758/BF03206476; Wallet G., 2009, J VIRTUAL REALITY BR, V6, P572; Wallet G., 2008, VIRTUAL REAL SOFTW T, P175, DOI [10.1145/1450579.1450616, DOI 10.1145/1450579.1450616]; Wallet G, 2011, CYBERPSYCH BEH SOC N, V14, P417, DOI 10.1089/cyber.2009.0187; Wallet G, 2010, STUD HEALTH TECHNOL, V154, P145, DOI 10.3233/978-1-60750-561-7-145; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wiener J., 2009, SPAT COGN COMPUT, V9, P1; Wilson PN, 1997, ECOL PSYCHOL, V9, P207, DOI 10.1207/s15326969eco0903_3; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001	75	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67193	10.1371/journal.pone.0067193	http://dx.doi.org/10.1371/journal.pone.0067193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23843992	Green Published, gold			2022-12-27	WOS:000321341000035
J	Amitay, S; Guiraud, J; Sohoglu, E; Zobay, O; Edmonds, BA; Zhang, YX; Moore, DR				Amitay, Sygal; Guiraud, Jeanne; Sohoglu, Ediz; Zobay, Oliver; Edmonds, Barrie A.; Zhang, Yu-Xuan; Moore, David R.			Human Decision Making Based on Variations in Internal Noise: An EEG Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HUMAN AUDITORY-CORTEX; VISUAL-CORTEX; SENSORY DISCRIMINATION; RESPONSE VARIABILITY; PERCEPTUAL DECISION; IDENTICAL STIMULI; BINOCULAR-RIVALRY; BRAIN ACTIVITY; TASK	Perceptual decision making is prone to errors, especially near threshold. Physiological, behavioural and modeling studies suggest this is due to the intrinsic or 'internal' noise in neural systems, which derives from a mixture of bottom-up and top-down sources. We show here that internal noise can form the basis of perceptual decision making when the external signal lacks the required information for the decision. We recorded electroencephalographic (EEG) activity in listeners attempting to discriminate between identical tones. Since the acoustic signal was constant, bottom-up and top-down influences were under experimental control. We found that early cortical responses to the identical stimuli varied in global field power and topography according to the perceptual decision made, and activity preceding stimulus presentation could predict both later activity and behavioural decision. Our results suggest that activity variations induced by internal noise of both sensory and cognitive origin are sufficient to drive discrimination judgments.	[Amitay, Sygal; Guiraud, Jeanne; Sohoglu, Ediz; Zobay, Oliver; Edmonds, Barrie A.; Zhang, Yu-Xuan; Moore, David R.] MRC, Inst Hearing Res, Nottingham, England		Amitay, S (corresponding author), MRC, Inst Hearing Res, Nottingham, England.	Sygal@ihr.mrc.ac.uk	Amitay, Sygal/D-7323-2012	Zobay, Oliver/0000-0002-0229-0668; Sohoglu, Ediz/0000-0002-0755-6445; Amitay, Sygal/0000-0001-9482-3435	Medical Research Council United Kingdom [U135097130]; Medical Research Council [MC_U135097130] Funding Source: researchfish; MRC [MC_U135097130] Funding Source: UKRI	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded by the Medical Research Council United Kingdom, Grant #U135097130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; Barry J. G., 2010, JOVE-J VIS EXP, V44, P2139, DOI [10.3791/2139, DOI 10.3791/2139]; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Ben-David BM, 2011, PSYCHOPHYSIOLOGY, V48, P797, DOI 10.1111/j.1469-8986.2010.01139.x; Bernasconi F, 2011, J NEUROSCI, V31, P17971, DOI 10.1523/JNEUROSCI.3715-11.2011; Biermann S, 2000, J NEUROPHYSIOL, V84, P2426, DOI 10.1152/jn.2000.84.5.2426; Bode S, 2012, J NEUROSCI, V32, P12488, DOI 10.1523/JNEUROSCI.1708-12.2012; BRAIDA LD, 1984, J ACOUST SOC AM, V76, P722, DOI 10.1121/1.391258; Briley PM, 2012, CEREB CORTEX, DOI [10.1093/cercor/bhs242, DOI 10.1093/CERC0R/BHS242.PUBMED:22918980]; British Society of Audiology, 2004, PUR TON AIR BON COND; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BUTLER RA, 1968, J ACOUST SOC AM, V44, P945, DOI 10.1121/1.1911233; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; CRONER LJ, 1993, P NATL ACAD SCI USA, V90, P8128, DOI 10.1073/pnas.90.17.8128; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Garrido MI, 2007, P NATL ACAD SCI USA, V104, P20961, DOI 10.1073/pnas.0706274105; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Green DM, 1966, SIGNAL DETECTION THE; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Haig AR, 1998, PSYCHOPHYSIOLOGY, V35, P591, DOI 10.1017/S0048577298970512; Halliday LF, 2011, ATTEN PERCEPT PSYCHO, V73, P1329, DOI 10.3758/s13414-011-0148-0; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Jaaskelainen IP, 2007, TRENDS NEUROSCI, V30, P653, DOI 10.1016/j.tins.2007.09.003; Kim YJ, 2006, VISION RES, V46, P392, DOI 10.1016/j.visres.2005.08.009; Krug K, 2004, PHILOS T R SOC B, V359, P929, DOI 10.1098/rstb.2003.1415; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Luck S, 2005, EVENTRELATED POTENTI, P17; Micheyl C, 2009, ATTEN PERCEPT PSYCHO, V71, P5, DOI 10.3758/APP.71.1.5; MICHIE PT, 1993, PSYCHOPHYSIOLOGY, V30, P205, DOI 10.1111/j.1469-8986.1993.tb01733.x; MICHIE PT, 1990, BIOL PSYCHOL, V30, P219, DOI 10.1016/0301-0511(90)90141-I; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Neri P, 2010, PSYCHON B REV, V17, P802, DOI 10.3758/PBR.17.6.802; Patel Salil H, 2005, Int J Med Sci, V2, P147; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; RITTER W, 1984, ANN NY ACAD SCI, V425, P24, DOI 10.1111/j.1749-6632.1984.tb23521.x; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; RITTER W, 1979, SCIENCE, V203, P1358, DOI 10.1126/science.424760; ROHRBAUGH JW, 1978, ELECTROEN CLIN NEURO, V45, P551, DOI 10.1016/0013-4694(78)90156-6; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Sweeny TD, 2011, J NEUROPHYSIOL, V105, P1236, DOI 10.1152/jn.00061.2010; Thielscher A, 2007, J NEUROSCI, V27, P2908, DOI 10.1523/JNEUROSCI.3024-06.2007; Wyart V, 2009, J NEUROSCI, V29, P8715, DOI 10.1523/JNEUROSCI.0962-09.2009; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; Zouridakis G, 1998, BRAIN TOPOGR, V10, P183, DOI 10.1023/A:1022246825461	58	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68928	10.1371/journal.pone.0068928	http://dx.doi.org/10.1371/journal.pone.0068928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840904	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000321271900043
J	Han, CH; Zhao, R; Kroger, J; Qu, MH; Wani, AA; Wang, QE				Han, Chunhua; Zhao, Ran; Kroger, John; Qu, Meihua; Wani, Altaf A.; Wang, Qi-En			Caspase-2 Short Isoform Interacts with Membrane-Associated Cytoskeleton Proteins to Inhibit Apoptosis	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; DAMAGE-INDUCED APOPTOSIS; ALPHA-II-SPECTRIN; DEATH GENE CED-3; CELL-DEATH; DNA-DAMAGE; NEURONAL APOPTOSIS; FAMILY PROTEINS; BODY FORMATION; MESSENGER-RNA	Caspase-2 (casp-2) is the most conserved caspase across species, and is one of the initiator caspases activated by various stimuli. The casp-2 gene produces several alternative splicing isoforms. It is believed that the long isoform, casp-2L, promotes apoptosis, whereas the short isoform, casp-2S, inhibits apoptosis. The actual effect of casp-2S on apoptosis is still controversial, however, and the underlying mechanism for casp-2S-mediated apoptosis inhibition is unclear. Here, we analyzed the effects of casp-2S on DNA damage induced apoptosis through "gain-of-function" and "loss-of-function" strategies in ovarian cancer cell lines. We clearly demonstrated that the over-expression of casp-2S inhibited, and the knockdown of casp-2S promoted, the cisplatin-induced apoptosis of ovarian cancer cells. To explore the mechanism by which casp-2S mediates apoptosis inhibition, we analyzed the proteins which interact with casp-2S in cells by using immunoprecipitation (IP) and mass spectrometry. We have identified two cytoskeleton proteins, Fodrin and alpha-Actinin 4, which interact with FLAG-tagged casp-2S in HeLa cells and confirmed this interaction through reciprocal IP. We further demonstrated that casp-2S (i) is responsible for inhibiting DNA damage-induced cytoplasmic Fodrin cleavage independent of cellular p53 status, and (ii) prevents cisplatin-induced membrane blebbing. Taken together, our data suggests that casp-2S affects cellular apoptosis through its interaction with membrane-associated cytoskeletal Fodrin protein.	[Han, Chunhua; Zhao, Ran; Kroger, John; Wani, Altaf A.; Wang, Qi-En] Ohio State Univ, Dept Radiol, Wexner Med Ctr, Columbus, OH 43210 USA; [Qu, Meihua] Weifang Med Univ, Dept Pharmacol, Weifang, Peoples R China; [Wani, Altaf A.; Wang, Qi-En] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Weifang Medical University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Wang, QE (corresponding author), Ohio State Univ, Dept Radiol, Wexner Med Ctr, Columbus, OH 43210 USA.	qi-en.wang@osumc.edu	Qu, Mei-Hua/ABE-5521-2020	Qu, Mei-Hua/0000-0003-2464-6773	National Institute of Health [CA151248, CA093413]; NATIONAL CANCER INSTITUTE [R01CA151248, R01CA093413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002388, R01ES012991] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding came from a National Institute of Health grant CA151248 (QEW), and CA093413 (AAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; ANDREWS PA, 1988, CANCER RES, V48, P68; Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; BEHRENS BC, 1987, CANCER RES, V47, P414; Brown TL, 1999, J BIOL CHEM, V274, P23256, DOI 10.1074/jbc.274.33.23256; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; COTTER TG, 1992, CANCER RES, V52, P997; Cryns VL, 1996, J BIOL CHEM, V271, P31277, DOI 10.1074/jbc.271.49.31277; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; Delmastro DA, 1997, CANCER CHEMOTH PHARM, V39, P245; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Droin N, 2001, ONCOGENE, V20, P260, DOI 10.1038/sj.onc.1204066; Fulda S, 2004, CURR CANCER DRUG TAR, V4, P569, DOI 10.2174/1568009043332763; HU RJ, 1991, J BIOL CHEM, V266, P18200; Ito A, 2000, FEBS LETT, V470, P360, DOI 10.1016/S0014-5793(00)01351-X; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; KASHIMA T, 1995, J NEUROPATH EXP NEUR, V54, P23, DOI 10.1097/00005072-199501000-00003; KAUFMANN SH, 1989, CANCER RES, V49, P5870; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Kumar S, 1997, CELL DEATH DIFFER, V4, P2, DOI 10.1038/sj.cdd.4400208; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lassus P, 2004, SCIENCE, V306, P1683; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Logette E, 2003, ONCOGENE, V22, P935, DOI 10.1038/sj.onc.1206172; Makin G, 2001, TRENDS CELL BIOL, V11, pS22, DOI 10.1016/S0962-8924(01)82111-5; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Marsden VS, 2004, J CELL BIOL, V165, P775, DOI 10.1083/jcb.200312030; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Martinet W, 2003, AM J PATHOL, V162, P731, DOI 10.1016/S0002-9440(10)63869-2; McMahon LW, 1999, J BIOL CHEM, V274, P32904, DOI 10.1074/jbc.274.46.32904; Narine KAD, 2010, DNA REPAIR, V9, P161, DOI 10.1016/j.dnarep.2009.11.010; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; Parent N, 2005, APOPTOSIS, V10, P313, DOI 10.1007/s10495-005-0805-7; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Paroni G, 2001, J BIOL CHEM, V276, P21907, DOI 10.1074/jbc.M011565200; PRINDULL G, 1995, EUR J CANCER, V31A, P116, DOI 10.1016/0959-8049(94)00502-V; Rao JY, 1999, J CELL BIOCHEM, V75, P686, DOI 10.1002/(SICI)1097-4644(19991215)75:4<686::AID-JCB14>3.0.CO;2-F; Reed JC, 1997, SEMIN HEMATOL, V34, P9; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Rotter B, 2004, BIOCHEM J, V378, P161, DOI 10.1042/BJ20030955; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shikama Y, 2001, EXP CELL RES, V264, P315, DOI 10.1006/excr.2000.5153; Shimohama S, 2001, NEUROSCI LETT, V315, P125, DOI 10.1016/S0304-3940(01)02336-9; Shirakura H, 2005, BIOCHEM BIOPH RES CO, V331, P1007, DOI 10.1016/j.bbrc.2005.04.019; Solier S, 2005, CELL DEATH DIFFER, V12, P687, DOI 10.1038/sj.cdd.4401594; Suarez-Huerta N, 2000, J CELL PHYSIOL, V184, P239, DOI 10.1002/1097-4652(200008)184:2<239::AID-JCP12>3.0.CO;2-R; Suria H, 1999, LIFE SCI, V65, P2697, DOI 10.1016/S0024-3205(99)00538-X; Tinnikov AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061085; Troy CM, 1997, J NEUROSCI, V17, P1911; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang QE, 2012, CANCER RES, V72, P666, DOI 10.1158/0008-5472.CAN-11-2774; Yamazaki Y, 2000, EXP CELL RES, V259, P64, DOI 10.1006/excr.2000.4970; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536	64	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67033	10.1371/journal.pone.0067033	http://dx.doi.org/10.1371/journal.pone.0067033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840868	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900007
J	Nett, JH; Cook, WJ; Chen, MT; Davidson, RC; Bobrowicz, P; Kett, W; Brevnova, E; Potgieter, TI; Mellon, MT; Prinz, B; Choi, BK; Zha, DX; Burnina, I; Bukowski, JT; Du, M; Wildt, S; Hamilton, SR				Nett, Juergen H.; Cook, W. James; Chen, Ming-Tang; Davidson, Robert C.; Bobrowicz, Piotr; Kett, Warren; Brevnova, Elena; Potgieter, Thomas I.; Mellon, Mark T.; Prinz, Bianka; Choi, Byung-Kwon; Zha, Dongxing; Burnina, Irina; Bukowski, John T.; Du, Min; Wildt, Stefan; Hamilton, Stephen R.			Characterization of the Pichia pastoris Protein-O-mannosyltransferase Gene Family	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; LINKED GLYCOSYLATION; AFFECT GROWTH; PMT FAMILY; MANNOSYLATION; YEAST; GLYCOPROTEINS; DISRUPTION; MORPHOGENESIS; EXPRESSION	The methylotrophic yeast, Pichia pastoris, is an important organism used for the production of therapeutic proteins. However, the presence of fungal-like glycans, either N-linked or O-linked, can elicit an immune response or enable the expressed protein to bind to mannose receptors, thus reducing their efficacy. Previously we have reported the elimination of beta-linked glycans in this organism. In the current report we have focused on reducing the O-linked mannose content of proteins produced in P. pastoris, thereby reducing the potential to bind to mannose receptors. The initial step in the synthesis of O-linked glycans in P. pastoris is the transfer of mannose from dolicholphosphomannose to a target protein in the yeast secretory pathway by members of the protein-O-mannosyltransferase (PMT) family. In this report we identify and characterize the members of the P. pastoris PMT family. Like Candida albicans, P. pastoris has five PMT genes. Based on sequence homology, these PMTs can be grouped into three sub-families, with both PMT1 and PMT2 sub-families possessing two members each (PMT1 and PMT5, and PMT2 and PMT6, respectively). The remaining sub-family, PMT4, has only one member (PMT4). Through gene knockouts we show that PMT1 and PMT2 each play a significant role in O-glycosylation. Both, by gene knockouts and the use of Pmt inhibitors we were able to significantly reduce not only the degree of O-mannosylation, but also the chain-length of these glycans. Taken together, this reduction of O-glycosylation represents an important step forward in developing the P. pastoris platform as a suitable system for the production of therapeutic glycoproteins.	[Nett, Juergen H.; Cook, W. James; Chen, Ming-Tang; Davidson, Robert C.; Bobrowicz, Piotr; Kett, Warren; Brevnova, Elena; Potgieter, Thomas I.; Mellon, Mark T.; Prinz, Bianka; Choi, Byung-Kwon; Zha, Dongxing; Burnina, Irina; Bukowski, John T.; Du, Min; Wildt, Stefan; Hamilton, Stephen R.] Merck Res Labs, Biol Discovery GlycoFi Inc, Lebanon, NH USA	Merck & Company	Nett, JH (corresponding author), Merck Res Labs, Biol Discovery GlycoFi Inc, Lebanon, NH USA.	juergen_nett@merck.com			Merck and Co, Inc.	Merck and Co, Inc.(Merck & Company)	The sole funding source for the described work was Merck and Co, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Argyros R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062229; Arroyo J, 2011, MOL MICROBIOL, V79, P1529, DOI 10.1111/j.1365-2958.2011.07537.x; BALLOU CE, 1990, METHOD ENZYMOL, V185, P440; Barnard GC, 2010, J IND MICROBIOL BIOT, V37, P961, DOI 10.1007/s10295-010-0746-1; Bobrowicz P, 2004, GLYCOBIOLOGY, V14, P757, DOI 10.1093/glycob/cwh104; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; Cantero PD, 2011, MOL MICROBIOL, V80, P715, DOI 10.1111/j.1365-2958.2011.07604.x; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Cukan MC, 2012, J IMMUNOL METHODS, V386, P34, DOI 10.1016/j.jim.2012.08.015; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Duman JG, 1998, BIOTECHNOL APPL BIOC, V28, P39; DURAND H, 1988, ENZYME MICROB TECH, V10, P341, DOI 10.1016/0141-0229(88)90012-9; Finck M, 1996, GLYCOBIOLOGY, V6, P313, DOI 10.1093/glycob/6.3.313; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Govindappa N, 2013, PROTEIN EXPRES PURIF, V88, P164, DOI 10.1016/j.pep.2012.12.009; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hopkins D, 2011, GLYCOBIOLOGY, V21, P1616, DOI 10.1093/glycob/cwr108; Jahic M, 2006, BIOTECHNOL PROGR, V22, P1465, DOI 10.1021/bp060171t; Kriangkripipat T, 2009, EUKARYOT CELL, V8, P1475, DOI 10.1128/EC.00040-09; Kuroda K, 2008, APPL ENVIRON MICROB, V74, P446, DOI 10.1128/AEM.02106-07; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu LM, 2013, PHARM RES-DORDR, V30, P803, DOI 10.1007/s11095-012-0921-3; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Nett JH, 2005, YEAST, V22, P295, DOI 10.1002/yea.1202; Nett JH, 2003, YEAST, V20, P1279, DOI 10.1002/yea.1049; Orchard MG, 2004, BIOORG MED CHEM LETT, V14, P3975, DOI 10.1016/j.bmcl.2004.05.050; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Sauer M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-17; Stadheim TA, 2008, NAT PROTOC, V3, P1026, DOI 10.1038/nprot.2008.76; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Werten MWT, 1999, YEAST, V15, P1087, DOI 10.1002/(SICI)1097-0061(199908)15:11<1087::AID-YEA436>3.0.CO;2-F; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321	42	30	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68325	10.1371/journal.pone.0068325	http://dx.doi.org/10.1371/journal.pone.0068325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840891	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900030
J	Vuckovic, A; Herber-Jonat, S; Flemmer, AW; Roubliova, XI; Jani, JC				Vuckovic, Aline; Herber-Jonat, Susanne; Flemmer, Andreas W.; Roubliova, Xenia I.; Jani, Jacques C.			Alveolarization Genes Modulated by Fetal Tracheal Occlusion in the Rabbit Model for Congenital Diaphragmatic Hernia: A Randomized Study	PLOS ONE			English	Article							LUNG-TISSUE MECHANICS; MATRIX METALLOPROTEINASES; GROWTH-FACTOR; TENASCIN-C; RAT LUNG; DIFFERENTIAL EXPRESSION; RELATIVE QUANTIFICATION; INTEGRIN RECEPTORS; UP-REGULATION; MOUSE LUNG	The mechanisms by which tracheal occlusion (TO) improves alveolarization in congenital diaphragmatic hernia (CDH) are incompletely understood. Therefore transcriptional and histological effects of TO on alveolarization were studied in the rabbit model for CDH. The question of the best normalization strategy for gene expression analysis was also addressed. Methods: Fetal rabbits were randomized for CDH or sham operation on gestational day 23/31 and for TO or sham operation on day 28/31 resulting in four study groups. Untouched littermates were added. At term and before lung harvest, fetuses were subjected to mechanical ventilation or not. Quantitative real-time PCR was performed on lungs from 4-5 fetuses of each group with and without previous ventilation. Stability of ten housekeeping genes (HKGs) and optimal number of HKGs for normalization were determined, followed by assessment of HKG expression levels. Expression levels of eleven target genes were studied in ventilated lungs, including genes regulating elastogenesis, cell-environment interactions, and thinning of alveolar walls. Elastic staining, immunohistochemistry and Western blotting completed gene analysis. Results: Regarding HKG expression, TO increased beta-actin and beta-subunit of ATP synthase. Mechanical ventilation increased beta-actin and beta 2- microglobulin. Flavoprotein subunit of succinate dehydrogenase and DNA topoisomerase were the most stable HKGs. CDH lungs showed disorganized elastin deposition with lower levels for tropoelastin, fibulin-5, tenascin-C, and alpha 6-integrin. After TO, CDH lungs displayed a normal pattern of elastin distribution with increased levels for tropoelastin, fibulin-5, tenascin-C, alpha 6-integrin, beta 1-integrin, lysyl oxidase, and drebrin. TO increased transcription and immunoreactivity of tissue inhibitor of metalloproteinase-1. Conclusions: Experimental TO might improve alveolarization through the mechanoregulation of crucial genes for late lung development. However part of the transcriptional changes involved genes that were not affected in CDH, raising the question of TO-induced disturbances of alveolar remodeling. Attention should also be paid to selection of HKGs for studies on mechanotransduction-mediated gene expressions.	[Vuckovic, Aline] Univ Libre Bruxelles, Fac Med, Lab Physiol & Physiopathol, Brussels, Belgium; [Herber-Jonat, Susanne; Flemmer, Andreas W.] Univ Munich, Univ Childrens Hosp, Div Neonatol, Perinatal Ctr, Munich, Germany; [Roubliova, Xenia I.] AZ Middelheim, HistoGeneX, Antwerp, Belgium; [Jani, Jacques C.] Univ Hosp Brugmann, Dept Obstet & Gynecol, Brussels, Belgium	Universite Libre de Bruxelles; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Vuckovic, A (corresponding author), Univ Libre Bruxelles, Fac Med, Lab Physiol & Physiopathol, Brussels, Belgium.	avuckovi@ulb.ac.be	Vuckovic, Aline/I-1639-2019; W., Andreas Flemmer/AAQ-5654-2021	VUCKOVIC, ALINE/0000-0001-7412-8259	Belgian Kids' Fund (BKF); Belgian "Fonds de la Recherche Scientifique" (FNRS); FNRS [1.5129.11]	Belgian Kids' Fund (BKF); Belgian "Fonds de la Recherche Scientifique" (FNRS)(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS)	A. Vuckovic is a recipient of the Belgian Kids' Fund (BKF; http://www.belgiankidsfund.be/) and the Belgian "Fonds de la Recherche Scientifique" (FNRS; http://www2.frs-fnrs.be/). This study was supported by FNRS grant "Credit aux Chercheurs" (1.5129.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORN DG, 1981, ANAT REC, V201, P655, DOI 10.1002/ar.1092010410; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; Benachi A, 1999, AM J RESP CELL MOL, V20, P805, DOI 10.1165/ajrcmb.20.4.3359; Benachi A, 1998, AM J RESP CRIT CARE, V157, P921, DOI 10.1164/ajrccm.157.3.9611023; Bland RD, 2007, AM J PHYSIOL-LUNG C, V293, pL1099, DOI 10.1152/ajplung.00217.2007; Boucherat O, 2007, PEDIATR RES, V62, P20, DOI 10.1203/PDR.0b013e3180686cc5; Boucherat O, 2007, AM J RESP CRIT CARE, V175, P1066, DOI 10.1164/rccm.200601-050OC; Boucherat O, 2010, AM J PHYSIOL-LUNG C, V298, pL849, DOI 10.1152/ajplung.00333.2009; BURRI PH, 1974, ANAT REC, V178, P711, DOI 10.1002/ar.1091780405; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chailley-Heu B, 2005, AM J PHYSIOL-LUNG C, V288, pL43, DOI 10.1152/ajplung.00096.2004; Chinoy MR, 2006, BIOL NEONATE, V90, P185, DOI 10.1159/000093308; Cloutier M, 2005, EXP LUNG RES, V31, P391, DOI 10.1080/019021490927079; Cloutier M, 2008, EXP LUNG RES, V34, P101, DOI 10.1080/01902140701884331; Coraux C, 2002, DEV DYNAM, V225, P176, DOI 10.1002/dvdy.10147; Davey MG, 2003, J APPL PHYSIOL, V94, P1054, DOI 10.1152/japplphysiol.00733.2002; DeRuisseau KC, 2005, AM J RESP CRIT CARE, V172, P1267, DOI 10.1164/rccm.200503-403OC; FLAKE AW, 1987, J PEDIATR SURG, V22, P816, DOI 10.1016/S0022-3468(87)80643-7; Flemmer AW, 2007, PEDIATR PULM, V42, P505, DOI 10.1002/ppul.20618; Frenckner B, 2005, J PEDIATR SURG, V40, P457, DOI 10.1016/j.jpedsurg.2004.11.038; Friedmacher F, 2012, PEDIATR SURG INT, V28, P195, DOI 10.1007/s00383-011-2985-2; FUKUDA Y, 2002, AM J PHYSIOL-LUNG C, V279, pL555; Grzenda A, 2013, DIS MODEL MECH, V6, P106, DOI 10.1242/dmm.008821; Hardie WD, 2007, AM J RESP CELL MOL, V37, P309, DOI 10.1165/rcmb.2006-0455OC; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V301, pL712, DOI 10.1152/ajplung.00157.2011; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; James MF, 1998, DEV DYNAM, V213, P170, DOI 10.1002/(SICI)1097-0177(199810)213:2<170::AID-AJA2>3.0.CO;2-D; Jani JC, 2009, ULTRASOUND OBST GYN, V34, P304, DOI 10.1002/uog.6450; Jani JC, 2009, PEDIATR PULM, V44, P112, DOI 10.1002/ppul.20915; Joyce BJ, 2003, AM J PHYSIOL-LUNG C, V284, pL643, DOI 10.1152/ajplung.00090.2002; Kaarteenaho-Wiik R, 2001, AM J RESP CELL MOL, V25, P341, DOI 10.1165/ajrcmb.25.3.4460; Kheradmand F, 2002, J CELL SCI, V115, P839; KIKKAWA Y, 1968, AM J PATHOL, V52, P177; Kim DS, 2008, BIOCHEM BIOPH RES CO, V377, P479, DOI 10.1016/j.bbrc.2008.10.010; Kitano Y, 2001, J APPL PHYSIOL, V90, P493, DOI 10.1152/jappl.2001.90.2.493; Klaritsch P, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.877; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; McCabe AJ, 2001, J PEDIATR SURG, V36, P128, DOI 10.1053/jpsu.2001.20029; Mesas-Burgos C, 2009, J PEDIATR SURG, V44, P720, DOI 10.1016/j.jpedsurg.2008.06.020; MOESSINGER AC, 1990, J CLIN INVEST, V86, P1270, DOI 10.1172/JCI114834; Mychaliska GB, 2004, J PEDIATR SURG, V39, P666, DOI 10.1016/j.jpedsurg.2004.01.028; Nishimaki S, 2003, J PEDIATR-US, V143, P120, DOI 10.1016/S0022-3476(03)00249-X; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinhu L, 2008, RESPIROLOGY, V13, P990, DOI 10.1111/j.1440-1843.2008.01396.x; Quinn TM, 1999, J PEDIATR SURG, V34, P701, DOI 10.1016/S0022-3468(99)90359-7; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Roth-Kleiner M, 2005, PEDIATR PULM, V40, P113, DOI 10.1002/ppul.20252; Roth-Kleiner M, 2004, AM J RESP CELL MOL, V30, P360, DOI 10.1165/rcmb.2002-0266OC; Roubliova XI, 2004, AM J OBSTET GYNECOL, V191, P830, DOI 10.1016/j.ajog.2004.01.006; Ryu J, 2005, THROMB HAEMOSTASIS, V94, P175, DOI 10.1160/TH04-10-0656; Sanchez-Esteban J, 2001, J APPL PHYSIOL, V91, P589, DOI 10.1152/jappl.2001.91.2.589; Sato T, 1997, J CELL SCI, V110, P589; Schunemann HJ, 1998, DIFFERENTIATION, V63, P181, DOI 10.1111/j.1432-0436.1998.00181.x; Seaborn T, 2008, PEDIATR RES, V63, P124, DOI 10.1203/PDR.0b013e31815eba47; Sozo F, 2006, PHYSIOL GENOMICS, V24, P105, DOI 10.1152/physiolgenomics.00148.2005; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Tatekawa Y, 2003, PEDIATR SURG INT, V19, P25, DOI 10.1007/s00383-002-0890-4; Unbekandt M, 2008, MECH DEVELOP, V125, P314, DOI 10.1016/j.mod.2007.10.013; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vuckovic A, 2012, PEDIATR PULM, V47, P1088, DOI 10.1002/ppul.22512; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Wu J, 2002, J PEDIATR SURG, V37, P11, DOI 10.1053/jpsu.2002.29418; Wu J, 2000, HUM REPROD, V15, P2483, DOI 10.1093/humrep/15.12.2483; Xu J, 1999, AM J PHYSIOL-LUNG C, V276, pL728, DOI 10.1152/ajplung.1999.276.5.L728; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; YANG L, 2013, BJU INT, P5285; Yoshizawa J, 2003, AM J PHYSIOL-LUNG C, V285, pL344, DOI 10.1152/ajplung.00281.2002; Zucker S, 2009, CONNECT TISSUE RES, V50, P223, DOI 10.1080/03008200802626970	73	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e69210	10.1371/journal.pone.0069210	http://dx.doi.org/10.1371/journal.pone.0069210			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840910	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900049
J	Liu, X; Shi, ZH; Ma, YN; Qin, JG; Han, SH				Liu, Xi; Shi, Zhenhao; Ma, Yina; Qin, Jungang; Han, Shihui			Dynamic Neural Processing of Linguistic Cues Related to Death	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; SELF-ESTEEM; TIME-COURSE; ANXIETY; WORDS; ERP; THOUGHT; THREAT; OPTIMISM; LATENCY	Behavioral studies suggest that humans evolve the capacity to cope with anxiety induced by the awareness of deaths inevitability. However, the neurocognitive processes that underlie online death-related thoughts remain unclear. Our recent functional MRI study found that the processing of linguistic cues related to death was characterized by decreased neural activity in human insular cortex. The current study further investigated the time course of neural processing of death-related linguistic cues. We recorded event-related potentials (ERP) to death-related, life-related, negative-valence, and neutral-valence words in a modified Stroop task that required color naming of words. We found that the amplitude of an early frontal/central negativity at 84120 ms (N1) decreased to death-related words but increased to life-related words relative to neutral-valence words. The N1 effect associated with death-related and life-related words was correlated respectively with individuals pessimistic and optimistic attitudes toward life. Death-related words also increased the amplitude of a frontal/central positivity at 124300 ms (P2) and of a frontal/central positivity at 300500 ms (P3). However, the P2 and P3 modulations were observed for both death-related and negative-valence words but not for life-related words. The ERP results suggest an early inverse coding of linguistic cues related to life and death, which is followed by negative emotional responses to death-related information.	[Liu, Xi; Shi, Zhenhao; Ma, Yina; Qin, Jungang; Han, Shihui] Peking Univ, Dept Psychol, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University	Han, SH (corresponding author), Peking Univ, Dept Psychol, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China.	shan@pku.edu.cn	Ma, Yina/AAI-4307-2020; Ma, Yina/H-6203-2017	Ma, Yina/0000-0002-5457-0354; Shi, Zhenhao/0000-0001-5697-2034	National Natural Science Foundation of China [91024032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 91024032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt J, 2001, MOTIV EMOTION, V25, P253, DOI 10.1023/A:1012276524327; Balconi M, 2003, INT J PSYCHOPHYSIOL, V49, P67, DOI 10.1016/S0167-8760(03)00081-3; Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Berman SL, 2006, J YOUTH ADOLESCENCE, V35, P303, DOI 10.1007/s10964-006-9032-y; Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321; Carretie L, 2001, J COGNITIVE NEUROSCI, V13, P1109, DOI 10.1162/089892901753294400; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; DeWall CN, 2007, PSYCHOL SCI, V18, P984, DOI 10.1111/j.1467-9280.2007.02013.x; Dien J, 2009, BIOL PSYCHOL, V80, P10, DOI 10.1016/j.biopsycho.2008.04.013; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Franken IHA, 2009, NEUROREPORT, V20, P776, DOI 10.1097/WNR.0b013e32832b02fe; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Gootjes L, 2011, INT J PSYCHOPHYSIOL, V79, P356, DOI 10.1016/j.ijpsycho.2010.12.003; Greenberg J., 1986, PUBLIC SELF PRIVATE, P189, DOI [10.1007/978-1-4613-9564-5_10, DOI 10.1007/978-1-4613-9564-5_10]; Gur RC, 2002, CEREB CORTEX, V12, P998, DOI 10.1093/cercor/12.9.998; Han SH, 2010, NEUROPSYCHOLOGIA, V48, P3436, DOI 10.1016/j.neuropsychologia.2010.07.026; Hayes J, 2010, PSYCHOL BULL, V136, P699, DOI 10.1037/a0020524; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; King LA, 2009, PSYCHOL SCI, V20, P1459, DOI 10.1111/j.1467-9280.2009.02466.x; Klackl J, 2013, SOC COGN AFFECT NEUR, V8, P333, DOI 10.1093/scan/nss003; Koole SL, 2006, CURR DIR PSYCHOL SCI, V15, P212, DOI 10.1111/j.1467-8721.2006.00438.x; Kubota JT, 2007, J EXP SOC PSYCHOL, V43, P738, DOI 10.1016/j.jesp.2006.10.023; Li W, 2007, COGN AFFECT BEHAV NE, V7, P25, DOI 10.3758/CABN.7.1.25; Luo S, SOC COGN AF IN PRESS; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paz-Caballero D, 2006, BRAIN RES, V1067, P189, DOI 10.1016/j.brainres.2005.10.046; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Proverbio Alice M, 2007, BMC Neurosci, V8, P24, DOI 10.1186/1471-2202-8-24; Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037/0033-295X.106.4.835; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Quirin M, 2012, SOC COGN AFFECT NEUR, V7, P193, DOI 10.1093/scan/nsq106; Russac RJ, 2007, DEATH STUD, V31, P549, DOI 10.1080/07481180701356936; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; Schimel J, 2007, J PERS SOC PSYCHOL, V92, P789, DOI 10.1037/0022-3514.92.5.789; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P1077, DOI 10.1037/a0015091; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Seligman MEP, 1995, OPT6IMISTIC CHILD; Shi Z, SOC COGN AF IN PRESS; SHOWERS C, 1992, J PERS SOC PSYCHOL, V63, P474, DOI 10.1037/0022-3514.63.3.474; Sun H, 1997, AN 5 INT S TEACH CHI, P459; Szalma JL, 2009, PERS INDIV DIFFER, V47, P444, DOI 10.1016/j.paid.2009.04.019; Taake I, 2009, BIOL PSYCHOL, V81, P48, DOI 10.1016/j.biopsycho.2009.01.006; TEMPLER DI, 1970, J GEN PSYCHOL, V82, P165, DOI 10.1080/00221309.1970.9920634; Thomas SJ, 2007, INT J PSYCHOPHYSIOL, V63, P221, DOI 10.1016/j.ijpsycho.2006.10.002; van Hooff JC, 2008, INT J PSYCHOPHYSIOL, V67, P23, DOI 10.1016/j.ijpsycho.2007.09.002; Woldorff MG, 2002, COGNITIVE BRAIN RES, V15, P1, DOI 10.1016/S0926-6410(02)00212-4; Yuan L., 2007, J GUANGDONG ED I, V27, P55	52	8	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67905	10.1371/journal.pone.0067905	http://dx.doi.org/10.1371/journal.pone.0067905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840787	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400142
J	Muller, HP; Kassubek, J; Vernikouskaya, I; Ludolph, AC; Stiller, D; Rasche, V				Mueller, Hans-Peter; Kassubek, Jan; Vernikouskaya, Ina; Ludolph, Albert C.; Stiller, Detlef; Rasche, Volker			Diffusion Tensor Magnetic Resonance Imaging of the Brain in APP Transgenic Mice: A Cohort Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; AMYLOID PLAQUES; FIBER TRACKING; MRI; DETECTS; ATROPHY; INJURY	Introduction: Fast in-vivo high resolution diffusion tensor imaging (DTI) of the mouse brain has recently been shown to enable cohort studies by the combination of appropriate pulse sequences and cryogenically cooled resonators (CCR). The objective of this study was to apply this DTI approach at the group level to beta-amyloid precursor protein (APP) transgenic mice. Methods: Twelve mice (5 wild type, 7 APP transgenic tg2576) underwent DTI examination at 156(2) x 250 mu m(3) spatial resolution with a CCR at ultrahigh field (11.7 T). Diffusion images were acquired along 30 gradient directions plus 5 references without diffusion encoding with a total acquisition time of 35 minutes. Fractional anisotropy (FA) maps were statistically compared by whole brain-based spatial statistics (WBSS) at the group level vs. wild type controls. Results: FA-map comparison showed characteristic regional patterns of differences between the groups with localizations associated with Alzheimer's disease in humans, such as the hippocampus, the entorhinal cortex, and the caudoputamen. Conclusion: In this proof-of-principle study, regions associated with amyloid-beta deposition could be identified by WBSS of FA maps in APP transgenic mice vs. wild type mice. Thus, DTI in the mouse brain acquired at 11.7 T by use of a CCR was demonstrated to be feasible for cohort studies.	[Mueller, Hans-Peter; Kassubek, Jan; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Vernikouskaya, Ina; Rasche, Volker] Univ Ulm, Core Facil Small Anim MRI, D-89069 Ulm, Germany; [Stiller, Detlef] Boehringer Ingelheim Pharma GmbH & Co KG, Target Discovery Res Germany, Biberach, Germany	Ulm University; Ulm University; Boehringer Ingelheim	Muller, HP (corresponding author), Univ Ulm, Dept Neurol, D-89069 Ulm, Germany.	hans-peter.mueller@uni-ulm.de	Kassubek, Jan/GPX-0910-2022; Rasche, Volker/P-6523-2016; Vernikouskaya, Ina/AAU-5675-2021; Kassubek, Jan/O-1740-2019; Kassubek, Jan/F-2774-2015	Kassubek, Jan/0000-0002-7106-9270; Rasche, Volker/0000-0001-8844-3583; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270				Aggarwal M, 2010, MAGN RESON MED, V64, P249, DOI 10.1002/mrm.22426; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braunstein KE, 2010, HUM MOL GENET, V19, P4385, DOI 10.1093/hmg/ddq361; Delatour B, 2006, NEUROBIOL AGING, V27, P835, DOI 10.1016/j.neurobiolaging.2005.04.011; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grinberg LT, 2009, NEUROPATH APPL NEURO, V35, P406, DOI [10.1111/j.1365-2990.2009.00997.x, 10.1111/j.1365-2990.2008.00997.x]; Gutman DA, 2012, NEUROIMAGE, V63, P800, DOI 10.1016/j.neuroimage.2012.07.014; Harms MP, 2006, EXP NEUROL, V199, P408, DOI 10.1016/j.expneurol.2006.01.002; Harsan LA, 2010, NMR BIOMED, V23, P884, DOI 10.1002/nbm.1496; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jack CR, 2004, MAGN RESON MED, V52, P1263, DOI 10.1002/mrm.20266; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Mohammadi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036851; Muller HP, 2007, PHYS MED BIOL, V52, pN99, DOI 10.1088/0031-9155/52/6/N01; Muller HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053389; Muller H.P., 2011, PLOS CURR, V3; MULLER HP, 2013, JOVE IN PRESS; Ota M, 2012, INT J GERIATR PSYCH, V27, P722, DOI 10.1002/gps.2779; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stebbins GT, 2009, BEHAV NEUROL, V21, P39, DOI [10.3233/BEN-2009-0234, 10.1155/2009/915041]; Sun SW, 2005, EXP NEUROL, V191, P77, DOI 10.1016/j.expneurol.2004.09.006; Unrath A, 2010, HUM BRAIN MAPP, V31, P1727, DOI 10.1002/hbm.20971; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Zerbi V, 2012, NEUROBIOL AGING	34	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67630	10.1371/journal.pone.0067630	http://dx.doi.org/10.1371/journal.pone.0067630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840754	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400119
J	Palermo, R; O'Connor, KB; Davis, JM; Irons, J; McKone, E				Palermo, Romina; O'Connor, Kirsty B.; Davis, Joshua M.; Irons, Jessica; McKone, Elinor			New Tests to Measure Individual Differences in Matching and Labelling Facial Expressions of Emotion, and Their Association with Ability to Recognise Vocal Emotions and Facial Identity	PLOS ONE			English	Article							FACE MEMORY TEST; PERCEPTION; IDENTIFICATION; INFORMATION; FEAR; REPRESENTATIONS; DEFICITS; VOICE; BODY	Although good tests are available for diagnosing clinical impairments in face expression processing, there is a lack of strong tests for assessing "individual differences'' - that is, differences in ability between individuals within the typical, nonclinical, range. Here, we develop two new tests, one for expression perception (an odd-man-out matching task in which participants select which one of three faces displays a different expression) and one additionally requiring explicit identification of the emotion (a labelling task in which participants select one of six verbal labels). We demonstrate validity (careful check of individual items, large inversion effects, independence from nonverbal IQ, convergent validity with a previous labelling task), reliability (Cronbach's alphas of. 77 and. 76 respectively), and wide individual differences across the typical population. We then demonstrate the usefulness of the tests by addressing theoretical questions regarding the structure of face processing, specifically the extent to which the following processes are common or distinct: (a) perceptual matching and explicit labelling of expression (modest correlation between matching and labelling supported partial independence); (b) judgement of expressions from faces and voices (results argued labelling tasks tap into a multi-modal system, while matching tasks tap distinct perceptual processes); and (c) expression and identity processing (results argued for a common first step of perceptual processing for expression and identity).	[Palermo, Romina] Univ Western Australia, Sch Psychol, Crawley, Australia; [Palermo, Romina] Univ Western Australia, ARC Ctr Excellence Cognit & Its Disorders, Crawley, Australia; [Palermo, Romina; O'Connor, Kirsty B.; Davis, Joshua M.; Irons, Jessica; McKone, Elinor] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [McKone, Elinor] Australian Natl Univ, ARC Ctr Excellence Cognit & Its Disorders, Canberra, ACT, Australia	University of Western Australia; University of Western Australia; Australian National University; Australian National University	Palermo, R (corresponding author), Univ Western Australia, Sch Psychol, Crawley, Australia.	Romina.Palermo@uwa.edu.au	Palermo, Romina/G-2533-2014	Palermo, Romina/0000-0002-8678-4592; Irons, Jessica/0000-0002-0671-5168; McKone, Elinor/0000-0003-1655-4297	Australian Research Council [DP110100850]; Australian Research Council Centre of Excellence for Cognition and its Disorders [CE110001021]	Australian Research Council(Australian Research Council); Australian Research Council Centre of Excellence for Cognition and its Disorders(Australian Research Council)	This research was supported by the Australian Research Council (http://www.arc.gov.au/) grant DP110100850 to RP and EM and the Australian Research Council Centre of Excellence for Cognition and its Disorders (CE110001021) http://www.ccd.edu.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 1998, SCHIZOPHR RES, V32, P171, DOI 10.1016/S0920-9964(98)00042-5; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1285, DOI 10.1016/S0028-3932(99)00023-8; Adolphs R, 2013, CURR BIOL, V23, pR79, DOI 10.1016/j.cub.2012.11.055; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Anastasi A., 1988, PSYCHOL TESTING; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Avidan G, 2011, NEUROPSYCHOLOGIA, V49, P2541, DOI 10.1016/j.neuropsychologia.2011.05.002; Banziger T, 2009, EMOTION, V9, P691, DOI 10.1037/a0017088; Banissy MJ, 2010, J NEUROSCI, V30, P13552, DOI 10.1523/JNEUROSCI.0786-10.2010; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; Benton A., 1983, CONTRIBUTION NEUROPS; Bewick V, 2003, CRIT CARE, V7, P451, DOI 10.1186/cc2401; Borod JC, 2000, COGNITION EMOTION, V14, P193, DOI 10.1080/026999300378932; Bowles DC, 2009, COGN NEUROPSYCHOL, V26, P423, DOI 10.1080/02643290903343149; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Calder A.J., 2011, OXFORD HDB FACE PERC, P427; Calder AJ, 2004, BRAIN, V127, P1958, DOI 10.1093/brain/awh214; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Cattell R. B., 1961, MEASURING INTELLIGEN; Chen YH, 2010, EUR J NEUROSCI, V31, P1818, DOI 10.1111/j.1460-9568.2010.07203.x; Colom R, 2002, PERS INDIV DIFFER, V32, P903, DOI 10.1016/S0191-8869(01)00095-2; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Davis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028800; Dawel A, 2012, NEUROSCI BIOBEHAV R, V36, P2288, DOI 10.1016/j.neubiorev.2012.08.006; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; Dennett HW, 2012, PSYCHOL SCI, V23, P1279, DOI 10.1177/0956797612446350; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine BC, 2003, NEUROPSYCHOLOGIA, V41, P713, DOI 10.1016/S0028-3932(02)00222-1; EKMAN P, 1969, PSYCHIATR, V32, P88, DOI 10.1080/00332747.1969.11023575; Ekman P., 1976, PICTURES FACIAL AFFE; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Fitousi D, 2013, J EXP PSYCHOL HUMAN, V39, P133, DOI 10.1037/a0028001; Fox E., 2012, OXFORD HDB FACE PERC, P515, DOI [10.1093/oxfordhb/9780199559053.013.0026., DOI 10.1093/OXFORDHB/9780199559053.013.0026]; George D, 2003, SPSS WINDOWS STEP ST; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Gray HA, 2010, NEUROPSYCHOLOGY, V24, P176, DOI 10.1037/a0018104; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Herzmann G, 2008, BEHAV RES METHODS, V40, P840, DOI 10.3758/BRM.40.3.840; Hsu SM, 2012, SEQUENTIAL EFFECTS F, DOI [10.1037/a0027285, DOI 10.1037/A0027285]; Kanske P, 2010, J NEUROSCI, V30, P16417, DOI 10.1523/JNEUROSCI.5078-10.2010; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kaplan R.M., 2001, PSYCHOL TESTING PRIN, V5th; Kawasaki H, 2012, J COGNITIVE NEUROSCI, V24, P1358, DOI 10.1162/jocn_a_00175; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Klasen M, 2011, J NEUROSCI, V31, P13635, DOI 10.1523/JNEUROSCI.2833-11.2011; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Lau JYF, 2009, DEV NEUROPSYCHOL, V34, P37, DOI 10.1080/87565640802564424; Li YH, 2013, EMOTION, V13, P196, DOI 10.1037/a0030755; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Lundqvist D., 1998, KAROLINSKA DIRECTED; Marsh AA, 2007, EMOTION, V7, P239, DOI 10.1037/1528-3542.7.2.239; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; McKone E, 2010, P NATL ACAD SCI USA, V107, P4795, DOI 10.1073/pnas.1000567107; McKone E, 2009, PSYCHON B REV, V16, P778, DOI 10.3758/PBR.16.5.778; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Misyak JB, 2012, LANG LEARN, V62, P302, DOI 10.1111/j.1467-9922.2010.00626.x; Nowicki Jr S, 1989, S AM PSYCH SOC AL VA; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Palermo R, 2011, NEUROPSYCHOLOGIA, V49, P1226, DOI 10.1016/j.neuropsychologia.2011.02.021; Philip RCM, 2010, PSYCHOL MED, V40, P1919, DOI 10.1017/S0033291709992364; Phillips LH, 2008, EMOTION, V8, P184, DOI 10.1037/1528-3542.8.2.184; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Ruiz PE, 2009, BEHAV RES METHODS, V41, P439, DOI 10.3758/BRM.41.2.439; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Sauter DA, 2011, EMOTION, V11, P1479, DOI 10.1037/a0025336; Scherer K.R., 2007, SCI EMOTIONAL INTELL, P101; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Wang RS, 2012, PSYCHOL SCI, V23, P169, DOI 10.1177/0956797611420575; Weisbuch M., 2011, OXFORD HDB FACE PERC, P479; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; Young AW, 2002, FACIAL EXPRESSIONS E; Yovel G, 2008, PSYCHON B REV, V15, P933, DOI 10.3758/PBR.15.5.933; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V9, P159, DOI [10.1207/S15324826AN0903_4, DOI 10.1207/S15324826AN0903_]; Zhu Q, 2010, CURR BIOL, V20, P137, DOI 10.1016/j.cub.2009.11.067	81	52	52	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68126	10.1371/journal.pone.0068126	http://dx.doi.org/10.1371/journal.pone.0068126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840821	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400165
J	Park, B; Choi, KS; Suh, M; Shin, JY; Jun, JK				Park, Boyoung; Choi, Kui Son; Suh, Mina; Shin, Ji-Yeon; Jun, Jae Kwan			Factors Associated with Compliance with Recommendations for Liver Cancer Screening in Korea: A Nationwide Survey in Korea	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; SURVEY KNCSS; BREAST; SURVEILLANCE; INEQUALITIES; DISPARITIES; TRENDS	To investigate the factors associated with compliance with recommendations regarding liver cancer screening intervals and methods among individuals at high-risk for liver cancer in the Republic of Korea. We used data from the fourth Korean National Health and Nutrition Examination Survey (KNHANES IV), a representative cross-sectional nationwide survey conducted between 2007 and 2009. The liver cancer screening rate and factors associated with compliance with recommended screening intervals (6 months) and methods (both abdominal ultrasonography and serum alpha-fetoprotein testing) among individuals at high risk for liver cancer such as hepatitis B virus (HBV) carriers were investigated. Out of 24,871 KNHANES IV participants, 604 HBV carriers aged >= 20 years were included in our analysis. 39.6% of our study sample reported attending liver cancer screening at least once in their lifetime, 12.3% had attended within the previous 6 months, and 14.6% were screened using both recommended methods. Older age was associated with increased compliance with screening intervals (P-trend 0.011) and methods (40-49 year: OR = 3.25, 95% CI: 1.62-6.51; 50-59 years: OR = 3.09, 95% CI: 1.44-6.66; 60-69 years: OR = 3.17, 95% CI: 1.28-7.82). Unawareness of HBV infection status was negatively related to compliance with screening intervals and methods (OR = 0.30, 95% CI: 0.17-0.53; OR = 0.45, 95% CI: 0.26-0.79). Female sex (OR = 0.45, 95% CI: 0.25-0.78), lower household income (P-trend 0.011), and routine and manual occupations (OR = 0.46, 95% CI: 0.22-0.97) were associated with decreased compliance with screening methods. The liver cancer screening rate among high-risk individuals is much less suboptimal. Considering that those unaware of their HBV infection status got regular and complete liver cancer screening much less often, efforts should be made not only to decrease sociodemographic disparities, but also to better identify the high-risk population.	[Park, Boyoung; Choi, Kui Son; Suh, Mina; Shin, Ji-Yeon; Jun, Jae Kwan] Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, South Korea	National Cancer Center - Korea (NCC)	Jun, JK (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, South Korea.	jkjun@ncc.re.kr			National Cancer Center of Korea [1310230]	National Cancer Center of Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (#1310230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRESLOW N, 1982, ANNU REV PUBL HEALTH, V3, P29, DOI 10.1146/annurev.pu.03.050182.000333; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Burack RC, 1998, J GEN INTERN MED, V13, P366, DOI 10.1046/j.1525-1497.1998.00116.x; Caplan LS, 2003, CANCER EPIDEM BIOMAR, V12, P1182; Carlos RC, 2005, ACAD RADIOL, V12, P451, DOI 10.1016/j.acra.2004.12.024; Chen JG, 2003, J MED SCREEN, V10, P204, DOI 10.1258/096914103771773320; Cho ER, 2010, CANCER EPIDEMIOL, V34, P713, DOI 10.1016/j.canep.2010.09.003; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jerant AF, 2004, ANN FAM MED, V2, P481, DOI 10.1370/afm.118; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Khang YH, 2004, INT J EPIDEMIOL, V33, P299, DOI 10.1093/ije/dyg244; Khoja S, 2007, CAN FAM PHYSICIAN, V53, P1192; Kim DY, 2011, ONCOLOGY-BASEL, V81, P56, DOI 10.1159/000333261; Kim YS, 2003, J KOREAN MED SCI, V18, P833, DOI 10.3346/jkms.2003.18.6.833; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Kwon YM, 2009, WORLD J GASTROENTERO, V15, P3653, DOI 10.3748/wjg.15.3653; Lee EH, 2010, ASIAN PAC J CANCER P, V11, P1305; Lee HY, 2010, CANCER EPIDEM BIOMAR, V19, P1919, DOI 10.1158/1055-9965.EPI-09-1308; McMahon BJ, 2000, HEPATOLOGY, V32, P842, DOI 10.1053/jhep.2000.17914; Miles A, 2011, CANCER EPIDEM BIOMAR, V20, P2132, DOI 10.1158/1055-9965.EPI-11-0453; Myong JP, 2012, INT J COLORECTAL DIS, V27, P1061, DOI 10.1007/s00384-012-1428-4; Noh DK, 2012, ASIAN PAC J CANCER P, V13, P731, DOI 10.7314/APJCP.2012.13.2.731; Park B, 2012, VACCINE, V30, P5844, DOI 10.1016/j.vaccine.2012.07.022; Park B, 2012, CANCER RES TREAT, V44, P113, DOI 10.4143/crt.2012.44.2.113; Park B, 2012, ASIAN PAC J CANCER P, V13, P1187, DOI 10.7314/APJCP.2012.13.4.1187; Park MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-257; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Shin A, 2009, CANCER EPIDEM BIOMAR, V18, P1894, DOI 10.1158/1055-9965.EPI-08-1228; Vernon Sally W., 1999, Journal of the National Cancer Institute Monographs, P101; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	32	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68315	10.1371/journal.pone.0068315	http://dx.doi.org/10.1371/journal.pone.0068315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840846	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400188
J	Paynter, S; Ware, RS; Lucero, MG; Tallo, V; Nohynek, H; Simoes, EAF; Weinstein, P; Sly, PD; Williams, G				Paynter, Stuart; Ware, Robert S.; Lucero, Marilla G.; Tallo, Veronica; Nohynek, Hanna; Simoes, Eric A. F.; Weinstein, Philip; Sly, Peter D.; Williams, Gail		ARIVAC Consortium	Poor Growth and Pneumonia Seasonality in Infants in the Philippines: Cohort and Time Series Studies	PLOS ONE			English	Article							BIRTH-WEIGHT; CHILDREN; INFECTIONS; DISEASE; AGE; UNDERNUTRITION; MALNUTRITION; MORTALITY; INFLUENZA; PATTERNS	Children with poor nutrition are at increased risk of pneumonia. In many tropical settings seasonal pneumonia epidemics occur during the rainy season, which is often a period of poor nutrition. We have investigated whether seasonal hunger may be a driver of seasonal pneumonia epidemics in children in the tropical setting of the Philippines. In individual level cohort analysis, infant size and growth were both associated with increased pneumonia admissions, consistent with findings from previous studies. A low weight for age z-score in early infancy was associated with an increased risk of pneumonia admission over the following 12 months (RR for infants in the lowest quartile of weight for age z-scores 1.28 [95% CI 1.08 to 1.51]). Poor growth in smaller than average infants was also associated with an increased risk of pneumonia (RR for those in the lowest quartile of growth in early infancy 1.31 [95% CI 1.02 to 1.68]). At a population level, we found that seasonal undernutrition preceded the seasonal increase in pneumonia and respiratory syncytial virus admissions by approximately 10 weeks (pairwise correlation at this lag was -0.41 [95% CI -0.53 to -0.27] for pneumonia admissions, and -0.63 [95% CI -0.72 to -0.51] for respiratory syncytial virus admissions). This lag appears biologically plausible. These results suggest that in addition to being an individual level risk factor for pneumonia, poor nutrition may act as a population level driver of seasonal pneumonia epidemics in the tropics. Further investigation of the seasonal level association, in particular	[Paynter, Stuart; Ware, Robert S.; Williams, Gail] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Lucero, Marilla G.; Tallo, Veronica] Res Inst Trop Med, Dept Hlth, Muntinlupa, Metro Manila, Philippines; [Nohynek, Hanna] Natl Inst Hlth & Welf, Dept Vaccines & Immune Protect, Helsinki, Finland; [Simoes, Eric A. F.] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Simoes, Eric A. F.] Colorado Sch Publ Hlth, Aurora, CO USA; [Weinstein, Philip] Univ S Australia, Barbara Hardy Inst, Adelaide, SA 5001, Australia; [Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Childrens Hlth & Environm Program, Brisbane, Qld, Australia	University of Queensland; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Finland National Institute for Health & Welfare; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of South Australia; University of Queensland	Paynter, S (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	s.paynter@uq.edu.au	Sly, Peter D/F-1486-2010; Ware, Robert S./B-2024-2014; Williams, Gail/S-8833-2019; Weinstein, Phil/C-9805-2011	Sly, Peter D/0000-0001-6305-2201; Ware, Robert S./0000-0002-6129-6736; Williams, Gail/0000-0002-4822-5263; Weinstein, Philip/0000-0001-9860-7166	European Commission [IC18-CY97-2019, ICA4-CT-1999-10008, ICA4-CT-2002-10062]; Academy of Finland [206283, 106974, 108873, 108878]; Finnish Ministry of Foreign Affairs [75502901, 327/412/2000]; Finnish Physicians for Social Responsibility; GAVI ADIP Pneumo; Sanofi Pasteur; Research Institute for Tropical Medicine of the Philippines; National Public Health Institute Finland; University of Queensland; University of Colorado; National Health and Medical Research Council of Australia; Programme for appropriate Technology in Health (PATH)	European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland(Academy of Finland); Finnish Ministry of Foreign Affairs; Finnish Physicians for Social Responsibility; GAVI ADIP Pneumo; Sanofi Pasteur; Research Institute for Tropical Medicine of the Philippines; National Public Health Institute Finland; University of Queensland(University of Queensland); University of Colorado; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Programme for appropriate Technology in Health (PATH)	This study is part of the research of the ARIVAC Consortium. The ARIVAC project was supported by the European Commission DG Research INCO program (contracts IC18-CY97-2019, ICA4-CT-1999-10008, ICA4-CT-2002-10062); Academy of Finland (contracts: 206283, 106974, 108873, and 108878); Finnish Ministry of Foreign Affairs (bilateral contracts 75502901 and 327/412/2000); Finnish Physicians for Social Responsibility; GAVI ADIP Pneumo; Sanofi Pasteur; Research Institute for Tropical Medicine of the Philippines; National Public Health Institute Finland; University of Queensland; University of Colorado; National Health and Medical Research Council of Australia; and Programme for appropriate Technology in Health (PATH). The views expressed by the authors do not necessarily reflect the views of PATH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifeen SE, 2000, AM J CLIN NUTR, V72, P1010; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Carlos CC, 2009, J INFECT DIS, V200, pS174, DOI 10.1086/605044; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Colosia AD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-95; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Food and Nutrition Research Institute, 2003, PHILL FACTS FIG 20 1; Goldmann DA, 2000, PEDIATR INFECT DIS J, V19, pS97, DOI 10.1097/00006454-200010001-00002; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; HART N, 1993, POP STUD-J DEMOG, V47, P27, DOI 10.1080/0032472031000146716; HORT KP, 1987, ANN TROP PAEDIATR, V7, P66, DOI 10.1080/02724936.1987.11748476; Hui LL, 2010, EPIDEMIOLOGY, V21, P332, DOI 10.1097/EDE.0b013e3181cd709e; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; Lucero MG, 1996, IMPACT CASE MANAGEME; Okiro EA, 2008, TROP MED INT HEALTH, V13, P914, DOI 10.1111/j.1365-3156.2008.02092.x; Paynter S, 2012, EPIDEMIOLOGY INFECT, V1, P1; Peng RD, 2008, USE R, P1; Philippines Bureau of Agricultural Statistics, 2012, VOL CER PROD 1994 20; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Simoes EAF, 2013, J CLIN MICROBIOL, V51, P945, DOI 10.1128/JCM.02317-12; Stein AD, 2004, INT J EPIDEMIOL, V33, P831, DOI 10.1093/ije/dyh083; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; TUPASI TE, 1990, REV INFECT DIS, V12, pS1047; Vaitla B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000101; Vasickova P, 2010, FOOD ENVIRON VIROL, V2, P24, DOI 10.1007/s12560-010-9025-6; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; Walker VP, 2009, PEDIATR RES, V65, p106R, DOI 10.1203/PDR.0b013e31819dba91; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; World Health Organization, 2012, CHILD GROWTH STAND W; Yoon PW, 1997, AM J CLIN NUTR, V65, P1070, DOI 10.1093/ajcn/65.4.1070; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	34	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67528	10.1371/journal.pone.0067528	http://dx.doi.org/10.1371/journal.pone.0067528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840731	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000321148400099
J	Santer, DM; Ma, MM; Hockman, D; Landi, A; Tyrrell, DLJ; Houghton, M				Santer, Deanna M.; Ma, Mang M.; Hockman, Darren; Landi, Abdolamir; Tyrrell, D. Lorne J.; Houghton, Michael			Enhanced Activation of Memory, but Not Naive, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis	PLOS ONE			English	Article							MARGINAL ZONE-LIKE; MIXED CRYOGLOBULINEMIA; BLOOD; EXPANSION; LYMPHOCYTES; CIRRHOSIS; CONTAIN; ANTIGEN	Mixed cryoglobulinemia is the most common extrahepatic disease manifestation of chronic hepatitis C virus (HCV) infection, where immunoglobulins precipitate at low temperatures and cause symptoms such as vasculitis, glomerulonephritis and arthralgia. HCV-associated cryoglobulinemia is also strongly linked with the development of B cell non-Hodgkin lymphoma. Abnormal B cell function in HCV infections can lead to the formation of HCV cryoglobulin complexes that usually comprise monoclonal rheumatoid factor and HCV-specific immune complexes. The aim of this study was to characterize the activation phenotype of B cells from patients with chronic HCV infection in comparison to healthy controls using flow cytometry. In addition, we determined how the activation status varies depending on the presence of cryoglobulinemia and advanced liver fibrosis. We found that only memory B cells, not naive cells, were significantly activated in chronic HCV infection when compared with healthy controls. We also identified markers of memory B cell activation that were specific for HCV patients with cryoglobulinemia (CD86, CD71, HLA-DR) and advanced liver disease (CD86). Our results demonstrate that HCV infection has differential effects on B cells depending on the severity of hepatic and extrahepatic disease.	[Santer, Deanna M.; Hockman, Darren; Landi, Abdolamir; Tyrrell, D. Lorne J.; Houghton, Michael] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada; [Santer, Deanna M.; Hockman, Darren; Landi, Abdolamir; Tyrrell, D. Lorne J.; Houghton, Michael] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Ma, Mang M.] Univ Alberta, Dept Gastroenterol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Santer, DM (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.	deanna.santer@ualberta.ca; michael.houghton@ualberta.ca		Houghton, Michael/0000-0003-3762-6771; Santer, Deanna/0000-0001-6169-7735	Canada Excellence Research Chair Program; Canadian Institutes for Health Research (CIHR); Alberta Innovates Health Solutions postdoctoral fellowships	Canada Excellence Research Chair Program; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions postdoctoral fellowships	This research was supported by funding from the Canada Excellence Research Chair Program (MH holds the Canada Excellence Research Chair in Virology) (http://www.cerc.gc.ca/hp-pa-eng.shtml). DMS is supported by Canadian Institutes for Health Research (CIHR) and Alberta Innovates Health Solutions postdoctoral fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Charles ED, 2009, KIDNEY INT, V76, P818, DOI 10.1038/ki.2009.247; Chen Stephen L, 2006, Int J Med Sci, V3, P47; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Curry MP, 2000, J HEPATOL, V32, P121, DOI 10.1016/S0168-8278(00)80198-1; DAMMACCO F, 1993, INT J CLIN LAB RES, V23, P45, DOI 10.1007/BF02592281; Doi H, 2012, HEPATOLOGY, V55, P709, DOI 10.1002/hep.24689; FERRI C, 1991, ARTHRITIS RHEUM, V34, P1606; Geri G, 2010, ANN RHEUM DIS, V69, P2177, DOI 10.1136/ard.2010.132001; Hardy RR, 2006, CURR OPIN IMMUNOL, V18, P547, DOI 10.1016/j.coi.2006.07.010; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; Horcajada JP, 1999, ANN MED, V31, P352, DOI 10.3109/07853899908995902; Jiang W, 2007, EUR J IMMUNOL, V37, P2205, DOI 10.1002/eji.200636984; Kayali Z, 2002, HEPATOLOGY, V36, P978, DOI 10.1053/jhep.2002.35620; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; LUNEL F, 1994, GASTROENTEROLOGY, V106, P1291, DOI 10.1016/0016-5085(94)90022-1; Mizuochi T, 2010, J INTERF CYTOK RES, V30, P243, DOI 10.1089/jir.2009.0047; Ni JH, 2003, J IMMUNOL, V170, P3429, DOI 10.4049/jimmunol.170.6.3429; Oliviero B, 2011, J HEPATOL, V55, P53, DOI 10.1016/j.jhep.2010.10.016; Ramos-Casals M, 2012, LANCET, V379, P348, DOI 10.1016/S0140-6736(11)60242-0; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Sansonno D, 2003, CLIN EXP IMMUNOL, V133, P275, DOI 10.1046/j.1365-2249.2003.02204.x; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; Schmidt WN, 2000, HEPATOLOGY, V31, P737, DOI 10.1002/hep.510310326; Seo S, 2008, DIAGNOSTIC CRITERIA IN AUTOIMMUNE DISEASES, P137, DOI 10.1007/978-1-60327-285-8_27; Tai WC, 2009, J FORMOS MED ASSOC, V108, P210, DOI 10.1016/S0929-6646(09)60054-1; Terrier B, 2011, J IMMUNOL, V187, P6550, DOI 10.4049/jimmunol.1102022; Visentini M, 2012, EUR J IMMUNOL, V42, P1468, DOI 10.1002/eji.201142313	30	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68308	10.1371/journal.pone.0068308	http://dx.doi.org/10.1371/journal.pone.0068308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840845	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400187
J	Yang, LY; Xu, MB; Jin, XL; Xu, JJ; Lu, JJ; Zhang, C; Tian, T; Teng, L				Yang, Liya; Xu, Meibang; Jin, Xiaolei; Xu, Jiajie; Lu, Jianjian; Zhang, Chao; Tian, Tian; Teng, Li			Complications of Absorbable Fixation in Maxillofacial Surgery: A Meta-Analysis	PLOS ONE			English	Article							SPLIT RAMUS OSTEOTOMY; BIMAXILLARY ORTHOGNATHIC SURGERY; TITANIUM SCREW FIXATION; SKELETAL STABILITY; MINIPLATE OSTEOSYNTHESIS; MANDIBULAR ADVANCEMENT; PLATE FIXATION; FRACTURES; MAXILLARY; SYSTEMS	Background: The use of titanium during maxillofacial fixation is limited due to its palpability, mutagenic effects and interference with imaging, which lead to the requirement for subsequent removal. The use of a biologically absorbable fixation material will potentially eliminate these limitations. In this meta-analysis, we analyzed the complications of absorbable fixation in maxillofacial surgery. Methods: We performed a systematic search of PubMed, Embase, Cochrane Central Register of Systematic Reviews and Cochrane Central Register of Controlled Trials for trials published through December 2012. Data extracted from literature were analyzed with Review manager 5.0.24. Results: Relevant data was extracted from 20 studies (1673 participants) and revealed that patients in the absorbable group had significantly more complications than those in the titanium group (RR = 1.20; 95% CI: 1.02-1.42; P = 0.03) in all enrolled maxillofacial surgeries. For bimaxillary operation subgroup, the absorbable fixation group did not have a significant increase in complications when compared with the titanium group (RR = 1.89; 95% CI: 0.85-4.22; P = 0.12). There was no significant difference observed between the absorbable and titanium groups receiving a bilateral sagittal split ramus osteotomy (BSSRO) (RR = 1.45; 95% CI: 0.84-2.48; P = 0.18) and Le Fort I osteotomy (RR = 0.65; 95% CI: 0.34-1.23; P = 0.18). The combined results of the five trials revealed that the absorbable group had a significantly lower rate of complications compared to the titanium group (RR = 0.71; 95% CI: 0.52-0.97; P = 0.03) in fracture fixation. Conclusion: This meta-analysis shows that absorbable fixation systems used for fixation in maxillofacial surgery do not have adequate safety profiles. Subgroup indicated the safety of absorbable fixation systems was superior during fracture fixation. The absorbable fixation systems tend to have a similar favorable safety profile as titanium fixation during Le Fort I, bimaxillary operation and BSSRO.	[Teng, Li] Chinese Acad Med Sci, Plast Surg Hosp, Dept Craniomaxillofacial Surg 2, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Teng, L (corresponding author), Chinese Acad Med Sci, Plast Surg Hosp, Dept Craniomaxillofacial Surg 2, Beijing 100730, Peoples R China.	zhengxingwuke@163.com	xu, jiajie/AFO-0140-2022					Ahn YS, 2010, J ORAL MAXIL SURG, V68, P287, DOI 10.1016/j.joms.2009.07.020; Bhatt K, 2010, J ORAL MAXIL SURG, V68, P1842, DOI 10.1016/j.joms.2009.09.005; BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7; BOSTMAN OM, 1992, CLIN ORTHOP RELAT R, P193, DOI 10.1097/00003086-199205000-00031; Buijs GJ, 2012, J DENT RES, V91, P299, DOI 10.1177/0022034511434353; Buijs GJ, 2011, RANDOMIZED CLIN TRIA, P91; Cheung LK, 2004, ORAL SURG ORAL MED O, V98, P386, DOI 10.1016/j.tripleo.2004.02.069; Costa F, 2006, J ORAL MAXIL SURG, V64, P642, DOI 10.1016/j.joms.2005.11.043; Dhol WS, 2008, AM J ORTHOD DENTOFAC, V134, P67, DOI 10.1016/j.ajodo.2006.04.049; Dorri M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007158.pub2; Haers PE, 1998, J CRANIO MAXILL SURG, V26, P87, DOI 10.1016/S1010-5182(98)80045-0; Kim SG, 2007, J ORAL MAXIL SURG, V65, P2438, DOI 10.1016/j.joms.2007.05.030; Landes CA, 2006, CLEFT PALATE-CRAN J, V43, P67, DOI 10.1597/04-167R1.1; Landes CA, 2007, J CRANIOFAC SURG, V18, P1216, DOI 10.1097/scs.0b013e31814b29df; Landes CA, 2006, PLAST RECONSTR SURG, V118, P703, DOI 10.1097/01.prs.0000232985.05153.bf; Lee HB, 2010, J ORAL MAXIL SURG, V68, P2065, DOI 10.1016/j.joms.2009.08.004; Lee JG, 2007, J ORAL MAXIL SURG, V65, P74, DOI 10.1016/j.joms.2005.11.098; Leonhardt H, 2008, BRIT J ORAL MAX SURG, V46, P631, DOI 10.1016/j.bjoms.2008.04.021; Matthews NS, 2003, BRIT J ORAL MAX SURG, V41, P179, DOI 10.1016/S0266-4356(03)00048-2; Meningaud JP, 2001, INT J ORAL MAX SURG, V30, P185, DOI 10.1054/ijom.2000.0039; Menon S, 2007, Med J Armed Forces India, V63, P331, DOI 10.1016/S0377-1237(07)80008-6; Moher D, 1996, INT J TECHNOL ASSESS, V12, P195, DOI 10.1017/S0266462300009570; Norholt SE, 2004, INT J ORAL MAX SURG, V33, P245, DOI 10.1006/ijom.2003.0505; Paeng JY, 2012, J CRANIO MAXILL SURG, V40, P660, DOI 10.1016/j.jcms.2011.11.001; Park CH, 2011, ARCH OTOLARYNGOL, V137, P125, DOI 10.1001/archoto.2010.241; Ray MS, 1999, BRIT J ORAL MAX SURG, V37, P14, DOI 10.1054/bjom.1998.0264; Shah NM, 2007, EUR J CONTRACEP REPR, V12, P260, DOI 10.1080/13625180701440560; Siniscalchi EN, 2013, J CRANIOFAC SURG, V24, pE1, DOI 10.1097/SCS.0b013e31826d07b9; Stockmann P, 2010, J CRANIO MAXILL SURG, V38, P522, DOI 10.1016/j.jcms.2010.01.002; Tuovinen V, 2010, INT J ORAL MAX SURG, V39, P1059, DOI 10.1016/j.ijom.2010.07.012; Turvey TA, 2006, J ORAL MAXIL SURG, V64, P40, DOI 10.1016/j.joms.2005.09.011; Ueki K, 2005, INT J ORAL MAX SURG, V34, P627, DOI 10.1016/j.ijom.2005.02.013; Ueki K, 2012, INT J ORAL MAX SURG, V41, P942, DOI 10.1016/j.ijom.2012.02.023; Ueki K, 2009, J ORAL MAXIL SURG, V67, P1062, DOI 10.1016/j.joms.2008.11.016; Wittwer G, 2006, ORAL SURG ORAL MED O, V101, P419, DOI 10.1016/j.tripleo.2005.07.026; Yoshioka I, 2012, J ORAL MAXIL SURG, V70, P919, DOI 10.1016/j.joms.2011.02.136	36	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67449	10.1371/journal.pone.0067449	http://dx.doi.org/10.1371/journal.pone.0067449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840705	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400082
J	Park, MJ; Moon, SJ; Lee, SH; Yang, EJ; Min, JK; Cho, SG; Yang, CW; Park, SH; Kim, HY; Cho, ML				Park, Min-Jung; Moon, Su-Jin; Lee, Sung-Hee; Yang, Eun-Ji; Min, Jun-Ki; Cho, Seok-Goo; Yang, Chul-Woo; Park, Sung-Hwan; Kim, Ho-Youn; Cho, Mi-La			Curcumin Attenuates Acute Graft-versus-Host Disease Severity via In Vivo Regulations on Th1, Th17 and Regulatory T Cells	PLOS ONE			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIUM; DOWN-REGULATION; TURMERIC OIL; TRANSPLANTATION; AUTOIMMUNE; EXPRESSION; EXPANSION; APOPTOSIS; LYMPHOMA	Background: In this study we examined the in vivo and in vitro effects and mechanisms of action of curcumin on the development of acute graft-versus-host disease (GVHD) using a murine model. Methodology/Principal Findings: Mixed lymphocyte reactions were used to determine the in vitro effects of curcumin. Treatment with curcumin attenuated alloreactive T cell proliferation and inhibited the production of interferon (IFN)-gamma and interleukin (IL)-17. In a murine acute GVHD model, transplantation of curcumin-treated allogeneic splenocytes into irradiated recipient mice significantly reduced the clinical severity scores of acute GVHD manifested in the liver, skin, colon and lung as compared with animals receiving vehicle-treated splenocytes. c-Fos and c-Jun expression levels in the skin and intestine, which are major target organs, were analyzed using immunohistochemical staining. Expression of both proteins was reduced in epithelial tissues of skin and intestine from curcumin-treated GVHD animals. The IFN-gamma-expressing CD4(+) splenocytes and IFN-gamma-expressing lymph node cells were dramatically decreased in curcumin-treated mice. In contrast, CD4(+)Foxp3(+) splenocytes were increased in the curcumin-treated acute GVHD animals. Flow cytometric analysis revealed that animals transplanted with curcumin-treated allogeneic splenocytes showed increased populations of CD4(+) regulatory T cells (Tregs) as well as CD8(+) Treg cells, compared to animals administered vehicle-treated splenocytes. Curcumin-treated acute GVHD animals could have a change in B cell subpopulations. Conclusion/Significance: In the present study, we investigated the efficacy and mechanism of action of curcumin treatment against acute GVHD. The acute GVHD mice administered with curcumin-treated splenocytes showed significantly reduced severity of acute GVHD. Curcumin exerted in vivo preventive effects on acute GVHD by reciprocal regulation of T helper 1 (Th1) and Treg (both CD4(+) and CD8(+) Treg) cell lineages as well as B cell homeostasis.	[Park, Min-Jung; Lee, Sung-Hee; Yang, Eun-Ji; Park, Sung-Hwan; Kim, Ho-Youn; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Moon, Su-Jin; Min, Jun-Ki] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Cho, Seok-Goo] Catholic Univ Korea, Coll Med, Catholic Blood & Marrow Transplantat Ctr, Seoul, South Korea; [Yang, Chul-Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Cho, ML (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.	iammila@catholic.ac.kr	LEE, Sunghee/HCH-4510-2022	Cho, Seok-Goo/0000-0002-5429-4839	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A092258]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea	This work was supported by a grant (A092258) from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Ali T, 2012, DIGESTION, V85, P249, DOI 10.1159/000336720; Alizadeh AM, 2012, EUR J PHARMACOL, V689, P226, DOI 10.1016/j.ejphar.2012.06.016; Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Apisariyakul A, 1995, J ETHNOPHARMACOL, V49, P163, DOI 10.1016/0378-8741(95)01320-2; Baumeister P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/902716; BLAND PW, 1992, IMMUNOLOGY, V75, P366; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Bolanos-Meade J, 2006, CURR OPIN ONCOL, V18, P120, DOI 10.1097/01.cco.0000208783.69076.7e; Carlson MJ, 2009, BLOOD, V113, P1365, DOI 10.1182/blood-2008-06-162420; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Cong YZ, 2009, EUR J IMMUNOL, V39, P3134, DOI 10.1002/eji.200939052; Cooke KR, 1998, J CLIN INVEST, V102, P1882, DOI 10.1172/JCI4285; Dhandapani KM, 2007, J NEUROCHEM, V102, P522, DOI 10.1111/j.1471-4159.2007.04633.x; Duramad O, 2011, BIOL BLOOD MARROW TR, V17, P1154, DOI 10.1016/j.bbmt.2010.11.022; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fukui J, 2007, STEM CELLS, V25, P1595, DOI 10.1634/stemcells.2006-0234; Han SS, 1999, CLIN IMMUNOL, V93, P152, DOI 10.1006/clim.1999.4769; Hayun R, 2009, LEUKEMIA LYMPHOMA, V50, P625, DOI 10.1080/10428190902789181; Huang G, 2011, EUR J PHARMACOL, V650, P451, DOI 10.1016/j.ejphar.2010.09.065; Janssens W, 2003, J IMMUNOL, V171, P4604, DOI 10.4049/jimmunol.171.9.4604; Kang BY, 1999, BRIT J PHARMACOL, V128, P380, DOI 10.1038/sj.bjp.0702803; Khouri IF, 2008, BLOOD, V111, P5530, DOI 10.1182/blood-2008-01-136242; Kim BS, 2009, J INVEST DERMATOL, V129, P2805, DOI 10.1038/jid.2009.176; Korwek Z, 2013, MUTAGENESIS, V28, P411, DOI 10.1093/mutage/get017; Krenger W, 1996, IMMUNOL RES, V15, P50, DOI 10.1007/BF02918284; Kroger N, 2002, BONE MARROW TRANSPL, V29, P683, DOI 10.1038/sj.bmt.1703530; Lu Y, 2009, BIOL BLOOD MARROW TR, V15, P1347, DOI 10.1016/j.bbmt.2009.07.015; MacMillan ML, 2002, BIOL BLOOD MARROW TR, V8, P387, DOI 10.1053/bbmt.2002.v8.pm12171485; Magenau JM, 2010, BIOL BLOOD MARROW TR, V16, P907, DOI 10.1016/j.bbmt.2010.02.026; MARTIN PJ, 1990, BLOOD, V76, P1464, DOI 10.1182/blood.V76.8.1464.1464; Mielcarek M, 2003, BLOOD, V102, P756, DOI 10.1182/blood-2002-08-2628; Miura Y, 2004, BLOOD, V104, P2187, DOI 10.1182/blood-2004-03-1040; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Pasquini Marcelo C, 2010, Clin Transpl, P87; Ramsewak RS, 2000, PHYTOMEDICINE, V7, P303, DOI 10.1016/S0944-7113(00)80048-3; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; SCHATTENFROH NC, 1995, TRANSPLANTATION, V59, P268, DOI 10.1097/00007890-199501270-00020; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; SVILAND L, 1988, TRANSPLANTATION, V46, P402, DOI 10.1097/00007890-198809000-00013; Teshima T, 2011, IMMUNOTHERAPY-UK, V3, P833, DOI [10.2217/imt.11.51, 10.2217/IMT.11.51]; Ukena SN, 2011, ANN HEMATOL, V90, P213, DOI 10.1007/s00277-010-1068-0; Vishvakarma NK, 2011, TOXICOL APPL PHARM, V252, P298, DOI 10.1016/j.taap.2011.03.002; Xiao XF, 2012, J SURG RES, V176, pE31, DOI 10.1016/j.jss.2011.11.1032; Xie L, 2009, INT IMMUNOPHARMACOL, V9, P575, DOI 10.1016/j.intimp.2009.01.025; Young JS, 2012, J IMMUNOL, V189, P222, DOI 10.4049/jimmunol.1200677; Zandi K, 2010, NAT PROD COMMUN, V5, P1935; Zhang M, 2006, ACTA PHARMACOL SIN, V27, P1071, DOI 10.1111/j.1745-7254.2006.00322.x; Zhao DC, 2008, BLOOD, V112, P2129, DOI 10.1182/blood-2008-02-140277; Zhao GJ, 2012, INT IMMUNOPHARMACOL, V14, P99, DOI 10.1016/j.intimp.2012.06.016; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zorn E, 2005, BLOOD, V106, P2903, DOI 10.1182/blood-2005-03-1257	53	30	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67171	10.1371/journal.pone.0067171	http://dx.doi.org/10.1371/journal.pone.0067171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840617	Green Submitted, gold, Green Published			2022-12-27	WOS:000322342800122
J	Vadivel, A; Alphonse, RS; Collins, JJP; van Haaften, T; O'Reilly, M; Eaton, F; Thebaud, B				Vadivel, Arul; Alphonse, Rajesh S.; Collins, Jennifer J. P.; van Haaften, Tim; O'Reilly, Megan; Eaton, Farah; Thebaud, Bernard			The Axonal Guidance Cue Semaphorin 3C Contributes to Alveolar Growth and Repair	PLOS ONE			English	Article							PROMOTES LUNG ANGIOGENESIS; BRANCHING MORPHOGENESIS; MOUSE LUNG; REGENERATION; NEUROPILIN-1; NEUTROPHIL; EXPRESSION; DISEASE; BURDEN; INJURY	Lung diseases characterized by alveolar damage such as bronchopulmonary dysplasia (BPD) in premature infants and emphysema lack efficient treatments. Understanding the mechanisms contributing to normal and impaired alveolar growth and repair may identify new therapeutic targets for these lung diseases. Axonal guidance cues are molecules that guide the outgrowth of axons. Amongst these axonal guidance cues, members of the Semaphorin family, in particular Semaphorin 3C (Sema3C), contribute to early lung branching morphogenesis. The role of Sema3C during alveolar growth and repair is unknown. We hypothesized that Sema3C promotes alveolar development and repair. In vivo Sema3C knock down using intranasal siRNA during the postnatal stage of alveolar development in rats caused significant air space enlargement reminiscent of BPD. Sema3C knock down was associated with increased TLR3 expression and lung inflammatory cells influx. In a model of O-2-induced arrested alveolar growth in newborn rats mimicking BPD, air space enlargement was associated with decreased lung Sema3C mRNA expression. In vitro, Sema3C treatment preserved alveolar epithelial cell viability in hyperoxia and accelerated alveolar epithelial cell wound healing. Sema3C preserved lung microvascular endothelial cell vascular network formation in vitro under hyperoxic conditions. In vivo, Sema3C treatment of hyperoxic rats decreased lung neutrophil influx and preserved alveolar and lung vascular growth. Sema3C also preserved lung plexinA2 and Sema3C expression, alveolar epithelial cell proliferation and decreased lung apoptosis. In conclusion, the axonal guidance cue Sema3C promotes normal alveolar growth and may be worthwhile further investigating as a potential therapeutic target for lung repair.	[Vadivel, Arul; Collins, Jennifer J. P.; Thebaud, Bernard] Univ Ottawa, Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON, Canada; [Vadivel, Arul; Collins, Jennifer J. P.; Thebaud, Bernard] Univ Ottawa, Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Alphonse, Rajesh S.; van Haaften, Tim; O'Reilly, Megan; Eaton, Farah] Univ Alberta, Dept Pediat, Sch Human Dev, Women & Childrens Hlth Res Inst,Cardiovasc Res Ct, Edmonton, AB, Canada; [Alphonse, Rajesh S.; van Haaften, Tim; O'Reilly, Megan; Eaton, Farah] Univ Alberta, Pulm Res Grp, Edmonton, AB, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Alberta; University of Alberta	Thebaud, B (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON, Canada.	bthebaud@ohri.ca		Collins, Jennifer/0000-0002-7556-0526	Canadian Institutes of Health Research (CIHR); Mazankowski Heart Institute; Maternal Fetal Neonatal Health Training Program (MFN); CIHR-IHDCYH; Alberta Heritage Foundation for Medical Research (AHFMR)/Alberta Innovates Health Solutions (AIHS); Canada Research Chairs Program, Canada Foundation for Innovation (CFI); Stollery Children's Hospital Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Mazankowski Heart Institute; Maternal Fetal Neonatal Health Training Program (MFN); CIHR-IHDCYH(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research (AHFMR)/Alberta Innovates Health Solutions (AIHS); Canada Research Chairs Program, Canada Foundation for Innovation (CFI); Stollery Children's Hospital Foundation	This work was supported by the Canadian Institutes of Health Research (CIHR). AV was supported by a studentship from the Mazankowski Heart Institute. TvH was supported by a stipend from the Maternal Fetal Neonatal Health Training Program (MFN) sponsored by CIHR-IHDCYH. RSA was supported by the Alberta Heritage Foundation for Medical Research (AHFMR)/Alberta Innovates Health Solutions (AIHS). BT is a Clinical Scholar of AHFMR/AIHS, and supported by the Canada Research Chairs Program, Canada Foundation for Innovation (CFI) and by the Stollery Children's Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario B, 2012, PEDIATR RES, V71, P583, DOI 10.1038/pr.2012.14; Alphonse RS, 2011, AM J RESP CELL MOL, V44, P146, DOI 10.1165/rcmb.2009-0182OC; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Becker PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027449; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bourbon JR, 2009, TRENDS MOL MED, V15, P169, DOI 10.1016/j.molmed.2009.02.003; Brown CB, 2001, DEVELOPMENT, V128, P3071; Feiner L, 2001, DEVELOPMENT, V128, P3061; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Ito T, 2000, MECH DEVELOP, V97, P35, DOI 10.1016/S0925-4773(00)00401-9; Joza S, 2012, AM J PATHOL; Kagoshima M, 2001, GENES CELLS, V6, P559, DOI 10.1046/j.1365-2443.2001.00441.x; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Le A, 2009, AM J RESP CRIT CARE, V180, P396, DOI 10.1164/rccm.200809-1483OC; Massaro D, 2004, AM J PHYSIOL-LUNG C, V287, pL1066, DOI 10.1152/ajplung.00067.2004; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morishige N, 2010, BIOCHEM BIOPH RES CO, V395, P451, DOI 10.1016/j.bbrc.2010.03.124; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Piaton G, 2011, BRAIN, V134, P1156, DOI 10.1093/brain/awr022; Prodhan P, 2002, BIOESSAYS, V24, P1052, DOI 10.1002/bies.10177; Roth-Kleiner M, 2005, PEDIATR PULM, V40, P113, DOI 10.1002/ppul.20252; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Stockley Robert A, 2009, Proc Am Thorac Soc, V6, P524, DOI 10.1513/pats.200904-016DS; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Vadivel A, 2012, AM J RESP CRIT CARE, V185, P564, DOI 10.1164/rccm.201103-0545OC; Vadivel A, 2010, AM J RESP CELL MOL, V43, P152, DOI 10.1165/rcmb.2009-0004OC; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Vozzelli MA, 2004, AM J PHYSIOL-LUNG C, V286, pL488, DOI 10.1152/ajplung.00414.2002; Yi M, 2004, AM J RESP CRIT CARE, V170, P1188, DOI 10.1164/rccm.200402-215OC	34	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67225	10.1371/journal.pone.0067225	http://dx.doi.org/10.1371/journal.pone.0067225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840631	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800125
J	Shtarkman, YM; Kocer, ZA; Edgar, R; Veerapaneni, RS; D'Elia, T; Morris, PF; Rogers, SO				Shtarkman, Yury M.; Kocer, Zeynep A.; Edgar, Robyn; Veerapaneni, Ram S.; D'Elia, Tom; Morris, Paul F.; Rogers, Scott O.			Subglacial Lake Vostok (Antarctica) Accretion Ice Contains a Diverse Set of Sequences from Aquatic, Marine and Sediment-Inhabiting Bacteria and Eukarya	PLOS ONE			English	Article							DEEP-SEA; WATER; MICROORGANISMS; MICROBES; ECOLOGY; FUNGI; CORE	Lake Vostok, the 7th largest (by volume) and 4th deepest lake on Earth, is covered by more than 3,700 m of ice, making it the largest subglacial lake known. The combination of cold, heat (from possible hydrothermal activity), pressure (from the overriding glacier), limited nutrients and complete darkness presents extreme challenges to life. Here, we report metagenomic/metatranscriptomic sequence analyses from four accretion ice sections from the Vostok 5G ice core. Two sections accreted in the vicinity of an embayment on the southwestern end of the lake, and the other two represented part of the southern main basin. We obtained 3,507 unique gene sequences from concentrates of 500 ml of 0.22 mu m-filtered accretion ice meltwater. Taxonomic classifications (to genus and/or species) were possible for 1,623 of the sequences. Species determinations in combination with mRNA gene sequence results allowed deduction of the metabolic pathways represented in the accretion ice and, by extension, in the lake. Approximately 94% of the sequences were from Bacteria and 6% were from Eukarya. Only two sequences were from Archaea. In general, the taxa were similar to organisms previously described from lakes, brackish water, marine environments, soil, glaciers, ice, lake sediments, deep-sea sediments, deep-sea thermal vents, animals and plants. Sequences from aerobic, anaerobic, psychrophilic, thermophilic, halophilic, alkaliphilic, acidophilic, desiccation-resistant, autotrophic and heterotrophic organisms were present, including a number from multicellular eukaryotes.	[Shtarkman, Yury M.; Kocer, Zeynep A.; Edgar, Robyn; Veerapaneni, Ram S.; D'Elia, Tom; Morris, Paul F.; Rogers, Scott O.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA	University System of Ohio; Bowling Green State University	Rogers, SO (corresponding author), Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA.	srogers@bgsu.edu	Kocer, Zeynep A./P-8983-2019	Kocer, Zeynep A./0000-0001-9178-0142; Morris, Paul/0000-0002-2989-041X	National Science Foundation [ANT 0536870, 0131969]; Bowling Green State University; United States Department of Agriculture [NIFA_2011-68004-30104]	National Science Foundation(National Science Foundation (NSF)); Bowling Green State University; United States Department of Agriculture(United States Department of Agriculture (USDA))	The project was partially funded by the National Science Foundation (ANT 0536870) and Bowling Green State University. RE was supported in part by National Science Foundation 0131969 and United States Department of Agriculture NIFA_2011-68004-30104. The 454 sequencing services were supplied by 454 Life Sciences as part of a test for their 454 GS junior pyrosequencing system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov SS., 2005, LIFE IN ANCIENT ICE, P240; Bar-Even A, 2012, J EXP BOT, V63, P2325, DOI 10.1093/jxb/err417; Beatty JT, 2005, P NATL ACAD SCI USA, V102, P9306, DOI 10.1073/pnas.0503674102; Bell EM, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P1, DOI 10.1079/9781845938147.0000; Bell R., 2005, LIFE ANCIENT ICE, P251; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P13455, DOI 10.1073/pnas.0702196104; Bulat SA, 2009, MICROBIOLOGY+, V78, P808, DOI 10.1134/S0026261709060216; Bulat S.A., 2004, INT J ASTROBIOL, V3, P1, DOI DOI 10.1017/S1473550404001879; Burgaud G, 2009, ENVIRON MICROBIOL, V11, P1588, DOI 10.1111/j.1462-2920.2009.01886.x; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Christner BC, 2001, ENVIRON MICROBIOL, V3, P570, DOI 10.1046/j.1462-2920.2001.00226.x; Christner BC, 2006, LIMNOL OCEANOGR, V51, P2485, DOI 10.4319/lo.2006.51.6.2485; COHEN DM, 1990, DEEP-SEA RES, V37, P267, DOI 10.1016/0198-0149(90)90127-H; D'Elia T, 2008, APPL ENVIRON MICROB, V74, P4962, DOI 10.1128/AEM.02501-07; D'Elia T, 2009, MYCOLOGIA, V101, P751, DOI 10.3852/08-184; Ferraccioli F, 2011, NATURE, V479, P388, DOI 10.1038/nature10566; Ferrer M, 2012, ENVIRON MICROBIOL, V14, P268, DOI 10.1111/j.1462-2920.2011.02634.x; GAILL F, 1995, J MOL BIOL, V246, P284, DOI 10.1006/jmbi.1994.0084; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gramling C, 2012, SCIENCE, V335, P788, DOI 10.1126/science.335.6070.788; Jouzel J, 1999, SCIENCE, V286, P2138, DOI 10.1126/science.286.5447.2138; Kapitsa AP, 1996, NATURE, V381, P684, DOI 10.1038/381684a0; Karl DM, 1999, SCIENCE, V286, P2144, DOI 10.1126/science.286.5447.2144; Klok CJ, 2010, J EXP BIOL, V213, piv; Lavire C, 2006, ENVIRON MICROBIOL, V8, P2106, DOI 10.1111/j.1462-2920.2006.01087.x; MacGregor JA, 2009, EARTH PLANET SC LETT, V282, P222, DOI 10.1016/j.epsl.2009.03.018; Masolov VN, 2001, DOKL EARTH SCI, V379, P734; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nagahama T, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P241, DOI 10.1007/3-540-30985-3_12; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; Rogers, 2005, LIFE ANCIENT ICE, P127; Rogers S.O., 2005, LIFE IN ANCIENT ICE, P5; Rogers Scott O, 2013, Biology (Basel), V2, P629, DOI 10.3390/biology2020629; Rogers SO, 2004, APPL ENVIRON MICROB, V70, P2540, DOI 10.1128/AEM.70.4.2540-2544.2004; Salamatin AN, 2004, ANN GLACIOL-SER, V39, P283, DOI 10.3189/172756404781814023; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Siegert MJ, 2003, HYDROL PROCESS, V17, P795, DOI 10.1002/hyp.1166; Siegert MJ, 2001, NATURE, V414, P603, DOI 10.1038/414603a; SOMME L, 1995, POLAR BIOL, V15, P221; Studinger M, 2003, EARTH PLANET SC LETT, V216, P663, DOI 10.1016/S0012-821X(03)00548-X; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; TOTH DJ, 1975, LIMNOL OCEANOGR, V20, P715, DOI 10.4319/lo.1975.20.5.0715; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Vishnivetskaya T.A., 2005, VIABLE PHOTOTROPHS C; Vrijenhoek RC, 1997, J HERED, V88, P285, DOI 10.1093/oxfordjournals.jhered.a023106; Wingham DJ, 2006, NATURE, V440, P1033, DOI 10.1038/nature04660; Wright A, 2011, GEOPHYS MONOGR SER, V192, P9, DOI 10.1029/2010GM000933; Yashina S, 2012, P NATL ACAD SCI USA, V109, P4008, DOI 10.1073/pnas.1118386109; Young DA, 2011, NATURE, V474, P72, DOI 10.1038/nature10114; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	53	63	68	5	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67221	10.1371/journal.pone.0067221	http://dx.doi.org/10.1371/journal.pone.0067221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843994	Green Published, gold			2022-12-27	WOS:000321733000064
J	Ma, FY; Li, M; Li, TT; Liu, W; Liu, YY; Li, Y; Hu, W; Zheng, Q; Wang, YQ; Li, KX; Chang, JL; Chen, MJ; Yang, GX; Wang, YS; He, GY				Ma, Fengyun; Li, Miao; Li, Tingting; Liu, Wei; Liu, Yunyi; Li, Yin; Hu, Wei; Zheng, Qian; Wang, Yaqiong; Li, Kexiu; Chang, Junli; Chen, Mingjie; Yang, Guangxiao; Wang, Yuesheng; He, Guangyuan			Overexpression of Avenin-Like b Proteins in Bread Wheat (Triticum aestivum L.) Improves Dough Mixing Properties by Their Incorporation into Glutenin Polymers	PLOS ONE			English	Article							SDS-SEDIMENTATION TEST; NEAR-ISOGENIC LINES; STARCHY ENDOSPERM; TRANSGENIC WHEAT; DISULFIDE BONDS; SUBUNIT GENES; DURUM-WHEAT; STORAGE PROTEINS; MAKING QUALITY; HMW SUBUNIT	Avenin-like b proteins are a small family of wheat storage proteins, each containing 18 or 19 cysteine residues. The role of these proteins, with high numbers of cysteine residues, in determining the functional properties of wheat flour is unclear. In the present study, two transgenic lines of the bread wheat overexpressing avenin-like b gene were generated to investigate the effects of Avenin-like b proteins on dough mixing properties. Sodium dodecyl sulfate sedimentation (SDSS) test and Mixograph analysis of these lines demonstrated that overexpression of Avenin-like b proteins in both transgenic wheat lines significantly increased SDSS volume and improved dough elasticity, mixing tolerance and resistance to extension. These changes were associated with the increased proportion of polymeric proteins due to the incorporation of overexpressed Avenin-like b proteins into the glutenin polymers. The results of this study were critical to confirm the hypothesis that Avenin-like b proteins could be integrated into glutenin polymers by inter-chain disulphide bonds, which could help understand the mechanism behind strengthening wheat dough strength.	[Ma, Fengyun; Li, Miao; Li, Tingting; Liu, Wei; Liu, Yunyi; Li, Yin; Hu, Wei; Zheng, Qian; Wang, Yaqiong; Li, Kexiu; Chang, Junli; Chen, Mingjie; Yang, Guangxiao; Wang, Yuesheng; He, Guangyuan] Huazhong Univ Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base,Minist Sci & Technol, Coll Life Sci & Technol,Key Lab Mol Biophys,Chine, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Wang, YS (corresponding author), Huazhong Univ Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base,Minist Sci & Technol, Coll Life Sci & Technol,Key Lab Mol Biophys,Chine, Wuhan 430074, Peoples R China.	wysh@hust.edu.cn; hegy@hust.edu.cn	Ma, Fengyun/I-8408-2019		National Natural Science Foundation of China [30871524, 31071403]; National Natural Science Foundation of Hubei, China [2010CBD02403]; Wuhan Municipal S & T research project [201120922286]; International S & T Cooperation Key Projects of MoST [2009DFB30340]; National Genetically Modified New Varieties of Major Projects of China [2011ZX08002-004, 2011ZX08010-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei, China; Wuhan Municipal S & T research project; International S & T Cooperation Key Projects of MoST; National Genetically Modified New Varieties of Major Projects of China	This work was supported by the National Natural Science Foundation of China (30871524,31071403), the National Natural Science Foundation of Hubei, China (2010CBD02403), Wuhan Municipal S & T research project (201120922286), International S & T Cooperation Key Projects of MoST (Grant No. 2009DFB30340), and National Genetically Modified New Varieties of Major Projects of China (2011ZX08002-004, 2011ZX08010-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altpeter F, 1996, NAT BIOTECHNOL, V14, P1155, DOI 10.1038/nbt0996-1155; Anderson OD, 2001, THEOR APPL GENET, V103, P307, DOI 10.1007/s001220100576; AYOUB M, 1993, CAN J PLANT SCI, V73, P995, DOI 10.4141/cjps93-130; Barro F, 2003, J CEREAL SCI, V37, P65, DOI 10.1006/jcrs.2002.0479; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Blechl A, 2007, J CEREAL SCI, V45, P172, DOI 10.1016/j.jcs.2006.07.009; Bordes J, 2008, J CEREAL SCI, V48, P569, DOI 10.1016/j.jcs.2008.05.005; Bushuk W, 1998, EUPHYTICA, V100, P137, DOI 10.1023/A:1018368316547; Carter BP, 1999, CEREAL CHEM, V76, P907, DOI 10.1094/CCHEM.1999.76.6.907; Chen P, 2010, CEREAL RES COMMUN, V38, P406, DOI 10.1556/CRC.38.2010.3.11; Chen P, 2008, J CEREAL SCI, V48, P734, DOI 10.1016/j.jcs.2008.04.002; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Clarke BC, 2003, THEOR APPL GENET, V106, P629, DOI 10.1007/s00122-002-1091-1; De Caro S, 2010, J CEREAL SCI, V52, P426, DOI 10.1016/j.jcs.2010.07.005; Deng ZY, 2005, PLANT BREEDING, V124, P428, DOI 10.1111/j.1439-0523.2005.01158.x; DuPont FM, 2005, J AGR FOOD CHEM, V53, P1575, DOI 10.1021/jf048697l; GUPTA RB, 1993, J CEREAL SCI, V18, P23, DOI 10.1006/jcrs.1993.1031; He GY, 2005, J CEREAL SCI, V42, P225, DOI 10.1016/j.jcs.2005.04.004; He GY, 1999, MOL BREEDING, V5, P377, DOI 10.1023/A:1009681321708; Joudrier P, 2005, BIOTECHNOL ADV, V23, P81, DOI 10.1016/j.biotechadv.2004.09.003; Kan YC, 2006, J CEREAL SCI, V44, P75, DOI 10.1016/j.jcs.2006.04.004; Lafiandra D, 2001, ADV FOOD NUTR RES, V45, P220; Leon E, 2009, J CEREAL SCI, V49, P148, DOI 10.1016/j.jcs.2008.08.002; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Li YC, 2009, MOL PLANT, V2, P430, DOI 10.1093/mp/ssp025; LORENZO A, 1987, CROP SCI, V27, P247, DOI 10.2135/cropsci1987.0011183X002700020025x; Mamone G, 2009, J MASS SPECTROM, V44, P1709, DOI 10.1002/jms.1680; Martinant JP, 1998, J CEREAL SCI, V27, P179, DOI 10.1006/jcrs.1997.0156; Marx C, 2003, PLANTA, V216, P454, DOI 10.1007/s00425-002-0857-7; Montrichard F, 2003, PLANT PHYSIOL, V132, P1707, DOI 10.1104/pp.102.019562; MULLER S, 1995, J CEREAL SCI, V22, P21, DOI 10.1016/S0733-5210(05)80004-9; Muller S, 1997, J CEREAL SCI, V26, P169, DOI 10.1006/S0733-5210(97)90100-4; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1984, J CEREAL SCI, V2, P73, DOI 10.1016/S0733-5210(84)80020-X; Pirozi MR, 2008, J CEREAL SCI, V48, P117, DOI 10.1016/j.jcs.2007.08.011; Piston F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024754; POGNA NE, 1990, J CEREAL SCI, V11, P15, DOI 10.1016/S0733-5210(09)80178-1; POPINEAU Y, 1994, J CEREAL SCI, V19, P231, DOI 10.1006/jcrs.1994.1030; RUITZ M, 1995, J CEREAL SCI, V21, P137; SALCEDO G, 1979, PHYTOCHEMISTRY, V18, P725, DOI 10.1016/0031-9422(79)80003-5; Shen G, 2005, PLANT PHYSIOL BIOCH, V43, P836, DOI 10.1016/j.plaphy.2005.06.010; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry PR, 2006, THEOR APPL GENET, V113, P128, DOI 10.1007/s00122-006-0279-1; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shewry PR, 1997, J CEREAL SCI, V25, P207, DOI 10.1006/jcrs.1996.0100; Sparks CA, 2004, TRANSGENIC CROPS OF THE WORLD: ESSENTIAL PROTOCOLS, P19; Stacey J, 1994, Methods Mol Biol, V28, P9; Takata K, 2000, BREEDING SCI, V50, P303, DOI 10.1270/jsbbs.50.303; Tosi P, 2005, MOL BREEDING, V16, P113, DOI 10.1007/s11032-005-5912-1; Tosi P, 2004, THEOR APPL GENET, V108, P468, DOI 10.1007/s00122-003-1459-x; Wang YS, 2010, J SCI FOOD AGR, V90, P106, DOI 10.1002/jsfa.3790; Wong JH, 2004, PLANT CELL PHYSIOL, V45, P407, DOI 10.1093/pcp/pch044; Wong JH, 2003, FEBS LETT, V547, P151, DOI 10.1016/S0014-5793(03)00696-3	53	29	32	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66758	10.1371/journal.pone.0066758	http://dx.doi.org/10.1371/journal.pone.0066758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843964	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000018
J	Alsharifi, M; Koskinen, A; Wijesundara, DK; Bettadapura, J; Mullbacher, A				Alsharifi, Mohammed; Koskinen, Aulikki; Wijesundara, Danushka K.; Bettadapura, Jayaram; Muellbacher, Arno			MHC Class II-Alpha Chain Knockout Mice Support Increased Viral Replication That Is Independent of Their Lack of MHC Class II Cell Surface Expression and Associated Immune Function Deficiencies	PLOS ONE			English	Article							T-CELLS; TARGETED DISRUPTION; FOREST-VIRUS; INFECTION; GENES; DIFFERENTIATION; ENCEPHALITIS; INTERFERONS; PROTECTS; STRAIN	MHCII molecules are heterodimeric cell surface proteins composed of an alpha and beta chain. These molecules are almost exclusively expressed on thymic epithelium and antigen presenting cells (APCs) and play a central role in the development and function of CD4 T cells. Various MHC-II knockout mice have been generated including MHC-IIA alpha(-/-)(I-A alpha(-/-)), MHC-IIA beta(-/-)(I-beta(-/-)) and the double knockout (I-A alpha x beta(-/-)). Here we report a very striking observation, namely that alphaviruses including the avirulent strain of Semliki Forest virus (aSFV), which causes asymptomatic infection in wild-type C57BL6/J (B6) mice, causes a very acute and lethal infection in I-A alpha(-/-), but not in I-beta(-/-) or I-A alpha x beta(-/-), mice. This susceptibility to aSFV is associated with high virus titres in muscle, spleen, liver, and brain compared to B6 mice. In addition, I-Aa -/-mice show intact IFN-I responses in terms of IFN-I serum levels and IFN-I receptor expression and function. Radiation bone marrow chimeras of B6 mice reconstituted with I-A alpha(-/-) bone marrow expressed B6 phenotype, whereas radiation chimeras of I-A alpha(-/-) mice reconstituted with B6 bone marrow expressed the phenotype of high viral susceptibility. Virus replication experiments both in vivo and in vitro showed enhanced virus growth in tissues and cell cultures derived form I-A alpha(-/-) compared to B6 mice. This enhanced virus replication is evident for other alpha-, flavi-and poxviruses and may be of great benefit to producers of viral vaccines. In conclusion, I-A alpha(-/-) mice exhibit a striking susceptibility to virus infections independent of their defective MHC-II expression. Detailed genetic analysis will be carried out to characterise the underlining genetic defects responsible for the observed phenomenon.	[Alsharifi, Mohammed; Koskinen, Aulikki; Wijesundara, Danushka K.; Bettadapura, Jayaram; Muellbacher, Arno] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Alsharifi, M (corresponding author), Univ Adelaide, Dept Microbiol & Immunol, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	mohammed.alsharifi@adelaide.edu.au; arno.mullbacher@anu.edu.au		Wijesundara, Danushka/0000-0002-0740-8362				Alsharifi M, 2005, J IMMUNOL, V175, P4635, DOI 10.4049/jimmunol.175.7.4635; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; BODMER H, 1993, EUR J IMMUNOL, V23, P1649, DOI 10.1002/eji.1830230738; BROWN MA, 1990, MOL IMMUNOL, V27, P645, DOI 10.1016/0161-5890(90)90007-M; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Fazakerley JK, 2002, J NEUROVIROL, V8, P66, DOI 10.1080/135502802901068000; Fiette L, 1996, J VIROL, V70, P4811, DOI 10.1128/JVI.70.7.4811-4815.1996; Flatz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000836; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HOU S, 1995, J VIROL, V69, P1429, DOI 10.1128/JVI.69.3.1429-1434.1995; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; LAUFER TM, 1993, J EXP MED, V178, P589, DOI 10.1084/jem.178.2.589; Luna RML, 2002, J VIROL, V76, P3202, DOI 10.1128/JVI.76.7.3202-3211.2002; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; MATHIS DJ, 1983, P NATL ACAD SCI-BIOL, V80, P273, DOI 10.1073/pnas.80.1.273; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLBACHER A, 1979, J EXP MED, V149, P786, DOI 10.1084/jem.149.3.786; MULLBACHER A, 1986, J GEN VIROL, V67, P295, DOI 10.1099/0022-1317-67-2-295; Mullbacher A, 1999, J IMMUNOL, V162, P7315; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Njenga MK, 1996, J VIROL, V70, P1729, DOI 10.1128/JVI.70.3.1729-1737.1996; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Serreze DV, 1998, J IMMUNOL, V160, P1472; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Vanhecke D, 1997, J IMMUNOL, V158, P3730; Wang Y, 2006, J GEN VIROL, V87, P3599, DOI 10.1099/vir.0.81306-0; WU LX, 1988, CELL IMMUNOL, V116, P112, DOI 10.1016/0008-8749(88)90214-6; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Zinkernagel MS, 2009, J VIROL, V83, P159, DOI 10.1128/JVI.01211-08; ZINKERNAGEL RM, 1978, J EXP MED, V148, P592, DOI 10.1084/jem.148.2.592	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68458	10.1371/journal.pone.0068458	http://dx.doi.org/10.1371/journal.pone.0068458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840854	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400195
J	Glen, AS; Cockburn, S; Nichols, M; Ekanayake, J; Warburton, B				Glen, Alistair S.; Cockburn, Stuart; Nichols, Margaret; Ekanayake, Jagath; Warburton, Bruce			Optimising Camera Traps for Monitoring Small Mammals	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; NEW-ZEALAND; POPULATIONS; TIGER; LANDSCAPE; INDEXES; FOREST; NESTS; BIRDS	Practical techniques are required to monitor invasive animals, which are often cryptic and occur at low density. Camera traps have potential for this purpose, but may have problems detecting and identifying small species. A further challenge is how to standardise the size of each camera's field of view so capture rates are comparable between different places and times. We investigated the optimal specifications for a low-cost camera trap for small mammals. The factors tested were 1) trigger speed, 2) passive infrared vs. microwave sensor, 3) white vs. infrared flash, and 4) still photographs vs. video. We also tested a new approach to standardise each camera's field of view. We compared the success rates of four camera trap designs in detecting and taking recognisable photographs of captive stoats (Mustela erminea), feral cats (Felis catus) and hedgehogs (Erinaceus europaeus). Trigger speeds of 0.2-2.1 s captured photographs of all three target species unless the animal was running at high speed. The camera with a microwave sensor was prone to false triggers, and often failed to trigger when an animal moved in front of it. A white flash produced photographs that were more readily identified to species than those obtained under infrared light. However, a white flash may be more likely to frighten target animals, potentially affecting detection probabilities. Video footage achieved similar success rates to still cameras but required more processing time and computer memory. Placing two camera traps side by side achieved a higher success rate than using a single camera. Camera traps show considerable promise for monitoring invasive mammal control operations. Further research should address how best to standardise the size of each camera's field of view, maximise the probability that an animal encountering a camera trap will be detected, and eliminate visible or audible cues emitted by camera traps.	[Glen, Alistair S.; Ekanayake, Jagath; Warburton, Bruce] Landcare Res, Lincoln, New Zealand; [Cockburn, Stuart] Dept Conservat, Wellington, New Zealand; [Nichols, Margaret] Univ Canterbury, Christchurch 1, New Zealand	Landcare Research - New Zealand; University of Canterbury	Glen, AS (corresponding author), Landcare Res, Lincoln, New Zealand.	glena@landcareresearch.co.nz	Leimgruber, Peter/O-1304-2015; Glen, Alistair Stuart/AGH-1175-2022	Leimgruber, Peter/0000-0002-3682-0153; Glen, Alistair Stuart/0000-0002-7777-7630	New Zealand Department of Conservation	New Zealand Department of Conservation	Funding was provided by the New Zealand Department of Conservation, who also contributed to the study design and preparation of the manuscript.	Bengsen AJ, 2011, J WILDLIFE MANAGE, V75, P1222, DOI 10.1002/jwmg.132; Blackwell GL, 2002, NEW ZEAL J ECOL, V26, P43; Brown KP, 1998, IBIS, V140, P274, DOI 10.1111/j.1474-919X.1998.tb04389.x; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Glen AS, 2003, WILDLIFE RES, V30, P29, DOI 10.1071/WR01059; Innes J., 1994, P RESOURCE TECHNOLOG, P439; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Latham ADM, 2012, WILDLIFE RES, V39, P621, DOI 10.1071/WR12050; Lyra-Jorge MC, 2008, EUR J WILDLIFE RES, V54, P739, DOI 10.1007/s10344-008-0205-8; Meek P, 2012, INTRO CAMERA TRAPPIN; Nelson JL, 2009, 200936 A RYL I ENV R; Newbold HG, 2009, WILDLIFE RES, V36, P309, DOI 10.1071/WR08083; Noss AJ, 2012, ANIM CONSERV, V15, P527, DOI 10.1111/j.1469-1795.2012.00545.x; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Reconyx, 2011, HYP HIGH PERF CAM IN; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Sanders MD, 2002, BIOL CONSERV, V106, P225, DOI 10.1016/S0006-3207(01)00248-8; Smith JK, 2012, AUST MAMMAL, V34, P196, DOI 10.1071/AM11034	20	104	113	5	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67940	10.1371/journal.pone.0067940	http://dx.doi.org/10.1371/journal.pone.0067940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840790	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400145
J	Karimian, E; Tamm, C; Chagin, AS; Samuelsson, K; Kjartansdottir, KR; Ohlsson, C; Savendahl, L				Karimian, Elham; Tamm, Chen; Chagin, Andrei S.; Samuelsson, Karin; Kjartansdottir, Kristin Ros; Ohlsson, Claes; Savendahl, Lars			Resveratrol Treatment Delays Growth Plate Fusion and Improves Bone Growth in Female Rabbits	PLOS ONE			English	Article							IDIOPATHIC SHORT STATURE; TUMOR-GROWTH; RED WINE; CONSTITUTIONAL DELAY; VERTEBRAL MORPHOLOGY; HEALTHY-VOLUNTEERS; ESTROGEN AGONIST; IN-VIVO; AROMATASE; ANGIOGENESIS	Trans-resveratrol (RES), naturally produced by many plants, has a structure similar to synthetic estrogen diethylstilbestrol, but any effect on bone growth has not yet been clarified. Pre-pubertal ovary-intact New Zealand white rabbits received daily oral administration of either vehicle (control) or RES (200 mg/kg) until growth plate fusion occurred. Bone growth and growth plate size were longitudinally monitored by X-ray imaging, while at the endpoint, bone length was assessed by a digital caliper. In addition, pubertal ovariectomized (OVX) rabbits were treated with vehicle, RES or estradiol cypionate (positive control) for 7 or 10 weeks and fetal rat metatarsal bones were cultured in vitro with RES (0.03 mu M-50 mu M) and followed for up to 19 days. In ovary-intact rabbits, sixteen-week treatment with RES increased tibiae and vertebrae bone growth and subsequently improved final length. In OVX rabbits, RES delayed fusion of the distal tibia, distal femur and proximal tibia epiphyses and femur length and vertebral bone growth increased when compared with controls. Histomorphometrical analysis showed that RES-treated OVX rabbits had a wider distal femur growth plate, enlarged resting zone, increased number/size of hypertrophic chondrocytes, increased height of the hypertrophic zone, and suppressed chondrocyte expression of VEGF and laminin. In cultured fetal rat metatarsal bones, RES stimulated growth at 0.3 mM while at higher concentrations (10 mu M and 50 mu M) growth was inhibited. We conclude that RES has the potential to improve longitudinal bone growth. The effect was associated with a delay of growth plate fusion resulting in increased final length. These effects were accompanied by a profound suppression of VEGF and laminin expression suggesting that impairment of growth plate vascularization might be an underlying mechanism.	[Karimian, Elham; Tamm, Chen; Chagin, Andrei S.; Samuelsson, Karin; Kjartansdottir, Kristin Ros; Savendahl, Lars] Karolinska Inst, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Ohlsson, Claes] Sahlgrens Univ Hosp, Div Endocrinol, Dept Internal Med, Gothenburg, Sweden; [Chagin, Andrei S.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Sahlgrenska University Hospital; Karolinska Institutet	Karimian, E (corresponding author), Karolinska Inst, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Elham.Karimian@ki.se	Ohlsson, Claes/AGP-3544-2022; Chagin, Andrei S/F-4080-2014	Ohlsson, Claes/0000-0002-9633-2805; Chagin, Andrei S/0000-0002-2696-5850; Savendahl, Lars/0000-0003-1067-4976	Swedish Research Council [K2007-54X-15073-04-3]; Novo Nordisk Fonden [NNF13OC0005785] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Research Council (K2007-54X- 15073-04-3), Sallskapet Barnavard, Stiftelsen Frimurare Barnhuset i Stockholm, Stiftelsen Samariten and HKH Kronprinsessan Lovisas forening for Barnasjukvard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bhat KPL, 2001, CANCER RES, V61, P7456; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Brakenhielm E, 2001, FASEB J, V15, P1798, DOI 10.1096/fj.01-0028fje; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Chagin AS, 2007, BONE, V40, P1415, DOI 10.1016/j.bone.2006.12.066; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Das S, 2005, VASC PHARMACOL, V42, P281, DOI 10.1016/j.vph.2005.02.013; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Genazzani AR, 2001, MATURITAS, V40, P117, DOI 10.1016/S0378-5122(01)00282-1; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; GOLDZIEHER MA, 1956, J CLIN ENDOCR METAB, V16, P249, DOI 10.1210/jcem-16-2-249; Hero M, 2006, CLIN ENDOCRINOL, V64, P510, DOI 10.1111/j.1365-2265.2006.02499.x; Hero M, 2005, J CLIN ENDOCR METAB, V90, P6396, DOI 10.1210/jc.2005-1392; Hero M, 2010, J BONE MINER RES, V25, P1536, DOI 10.1002/jbmr.56; Hero M, 2009, HORM RES, V71, P290, DOI 10.1159/000208803; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Karimian E, 2008, J BONE MINER RES, V23, P1267, DOI 10.1359/JBMR.080319; Kimura Y, 2001, J NUTR, V131, P1844, DOI 10.1093/jn/131.6.1844; Lee SK, 1997, EXP CELL RES, V236, P212, DOI 10.1006/excr.1997.3710; Liu FC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3127; Martensson K, 2004, J BONE MINER RES, V19, P1805, DOI 10.1359/JBMR.040805; Nilsson O, 2003, ENDOCRINOLOGY, V144, P1481, DOI 10.1210/en.2002-221108; NONOMURA S, 1963, Yakugaku Zasshi, V83, P988; SIEMANN EH, 1992, AM J ENOL VITICULT, V43, P49; Tivesten A, 2004, J BONE MINER RES, V19, P1833, DOI 10.1359/JBMR.040819; Tseng SH, 2004, CLIN CANCER RES, V10, P2190, DOI 10.1158/1078-0432.CCR-03-0105; Turner RT, 1999, ENDOCRINOLOGY, V140, P50, DOI 10.1210/en.140.1.50; Venn A BF, 2005, OBSTET GYNECOLOGY SU, P306; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Vitaglione P, 2005, MOL NUTR FOOD RES, V49, P495, DOI 10.1002/mnfr.200500002; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang J, 2011, RHEUMATOL INT, V201; Wang Y, 2006, TOXICOL SCI, V92, P71, DOI 10.1093/toxsci/kfj190; Weimann E, 1996, HORM RES, V45, P261, DOI 10.1159/000184801; Weise M, 2001, P NATL ACAD SCI USA, V98, P6871, DOI 10.1073/pnas.121180498; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613	39	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67859	10.1371/journal.pone.0067859	http://dx.doi.org/10.1371/journal.pone.0067859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840780	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400137
J	Lowe, AJ; Ekeus, C; Braback, L; Rajaleid, K; Forsberg, B; Hjern, A				Lowe, Adrian J.; Ekeus, Cecilia; Braback, Lennart; Rajaleid, Kristiina; Forsberg, Bertil; Hjern, Anders			Impact of Maternal Obesity on Inhaled Corticosteroid Use in Childhood: A Registry Based Analysis of First Born Children and a Sibling Pair Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; PREPREGNANCY OBESITY; ASTHMA; PREGNANCY; METAANALYSIS; DELIVERY; COHORT; ADOLESCENTS; MICROBIOTA; OVERWEIGHT	Background: It has been proposed that maternal obesity during pregnancy may increase the risk that the child develops allergic disease and asthma, although the mechanisms underpinning this relationship are currently unclear. We sought to assess if this association may be due to confounding by genetic or environmental risk factors that are common to maternal obesity and childhood asthma, using a sibling pair analysis. Methods: The study population comprised a Swedish national cohort of term children born between 1992 and 2008 to native Swedish parents. Maternal body mass index (BMI) was measured at 8-10 weeks gestation. Unconditional logistic regression models were used to determine if maternal obesity was associated with increased risk of inhaled corticosteroid (ICS) in 431,718 first-born children, while adjusting for potential confounders. An age-matched discordant sib-pair analysis was performed, taking into account shared genetic and environmental risk factors. Results: Maternal over-weight and obesity were associated with increased risk that the child would require ICS (for BMI >= 35 kg/m(2), aOR = 1.30, 95% CI = 1.10-1.52 compared with normal weight mothers) in children aged 6-12 years. Similar effects were seen in younger children, but in children aged 13-16 years, maternal obesity (BMI >= 30) was related to increased risk of ICS use in girls (aOR = 1.28, 95% CI = 1.07-1.53) but not boys (OR = 1.05, 95% CI = 0.87-1.26). The sib-pair analysis, which included 2,034 sib-pairs older than six years who were discordant for both ICS use and maternal BMI category, failed to find any evidence that increasing maternal weight was related to increased risk of ICS use. Conclusion: Maternal obesity is associated with increased risk of childhood ICS use up to approximately 12 years of age, but only in girls after this age. These effects could not be confirmed in a sib pair analysis, suggesting either limited statistical power, or the effects of maternal BMI may be due to shared genetic or environmental risk factors.	[Lowe, Adrian J.; Braback, Lennart; Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Lowe, Adrian J.] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden; [Lowe, Adrian J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Lowe, Adrian J.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Ekeus, Cecilia] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Ekeus, Cecilia; Rajaleid, Kristiina; Hjern, Anders] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, S-10691 Stockholm, Sweden; [Braback, Lennart] Vasternorrland Cty Council, Dept Res & Dev, Sundsvall, Sweden; [Hjern, Anders] Natl Board Hlth & Welf, Ctr Epidemiol, Stockholm, Sweden; [Hjern, Anders] Karolinska Inst, Dept Med, Stockholm, Sweden	Umea University; Umea University; Murdoch Children's Research Institute; University of Melbourne; Karolinska Institutet; Karolinska Institutet; Stockholm University; National Board of Health & Welfare; Karolinska Institutet	Lowe, AJ (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	lowea@unimelb.edu.au	Rajaleid, Kristiina/AAI-3452-2020; Braback, Lennart/A-3793-2015	Hjern, Anders/0000-0002-1645-2058; Lowe, Adrian/0000-0002-4691-8162; Ekeus, Cecilia/0000-0002-5861-4692; Braback, Lennart/0000-0001-9930-7755	Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) network [2008-7491]; Australian National Health and Medical Research Council; Swedish Research Council	Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) network; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project was supported by Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) network, grant no. 2008-7491, who provided financial support to A.L. and L.B. to undertake this project. Also, A.L. was supported by the Australian National Health and Medical Research Council, C.E. was supported with grants from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Beuther DA, 2010, CURR OPIN PULM MED, V16, P64, DOI 10.1097/MCP.0b013e3283338fa7; Biro FM, 2006, INT J ANDROL, V29, P272, DOI 10.1111/j.1365-2605.2005.00602.x; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Chinn S, 2002, THORAX, V57, P1028, DOI 10.1136/thorax.57.12.1028; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Furu K, 2011, J CLIN EPIDEMIOL, V64, P878, DOI 10.1016/j.jclinepi.2010.10.014; Haberg SE, 2009, PAEDIATR PERINAT EP, V23, P352, DOI 10.1111/j.1365-3016.2009.01034.x; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P1235, DOI 10.1016/j.jaci.2005.09.016; Hjern A, 2000, CLIN EXP ALLERGY, V30, P521; Ho WC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-542; Jaakkola JJK, 2006, J ALLERGY CLIN IMMUN, V118, P823, DOI 10.1016/j.jaci.2006.06.043; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Loomba-Albrecht LA, 2009, CURR OPIN ENDOCRINOL, V16, P10, DOI 10.1097/MED.0b013e328320d54c; Lowe A, 2011, J ALLERGY CLIN IMMUN, V128, P1107, DOI 10.1016/j.jaci.2011.08.025; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Macsali F, 2011, AM J RESP CRIT CARE, V183, P8, DOI 10.1164/rccm.200912-1886OC; Mandhane PJ, 2005, AM J RESP CRIT CARE, V172, P45, DOI 10.1164/rccm.200412-1738OC; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Murray CS, 2011, CLIN EXP ALLERGY, V41, P78, DOI 10.1111/j.1365-2222.2010.03598.x; Nwaru BI, 2011, CLIN RESPIR J, V5, P211, DOI 10.1111/j.1752-699X.2010.00222.x; ono t, 2005, WHO GLOBAL COMPARABL; Patel SP, 2012, J EPIDEMIOL COMMUN H, V66, P809, DOI 10.1136/jech.2011.133777; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Reichman NE, 2008, MATERN CHILD HLTH J, V12, P725, DOI 10.1007/s10995-007-0292-2; Scholtens S, 2010, INT J OBESITY, V34, P606, DOI 10.1038/ijo.2009.194; Thomsen SF, 2007, ALLERGY, V62, P1199, DOI 10.1111/j.1398-9995.2007.01480.x; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Vogt H, 2011, PEDIATRICS, V127, P1052, DOI 10.1542/peds.2010-3083; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537; Wood LG, 2011, J ALLERGY CLIN IMMUN, V127, P1133, DOI 10.1016/j.jaci.2011.01.036	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67368	10.1371/journal.pone.0067368	http://dx.doi.org/10.1371/journal.pone.0067368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840681	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400070
J	Mao, H; Kano, G; Hudson, SA; Brummet, M; Zimmermann, N; Zhu, Z; Bochner, BS				Mao, Hui; Kano, Gen; Hudson, Sherry A.; Brummet, Mary; Zimmermann, Nives; Zhu, Zhou; Bochner, Bruce S.			Mechanisms of Siglec-F-Induced Eosinophil Apoptosis: A Role for Caspases but Not for SHP-1, Src Kinases, NADPH Oxidase or Reactive Oxygen	PLOS ONE			English	Article							MSIGLEC-F; CD33-RELATED SIGLECS; NEGATIVE REGULATION; MOUSE EOSINOPHILS; IMMUNE-SYSTEM; MAST-CELLS; T-CELLS; LEWIS-X; ASTHMA; MEPOLIZUMAB	Background: Siglec-F and Siglec-8 are functional paralog proapoptotic cell surface receptors expressed on mouse and human eosinophils, respectively. Whereas Siglec-8 mediated death involves caspases and/or reactive oxygen species (ROS) generation and mitochondrial injury, very little is known about Siglec-F-mediated signaling and apoptosis. Therefore the objective of the current experiments was to better define apoptosis pathways mediated by Siglec-F and Siglec-8. Given that Siglec-F-induced apoptosis is much less robust than Siglec-8-induced apoptosis, we hypothesized that mechanisms involved in cell death via these receptors would differ. Methods: Consequences of engagement of Siglec-F on mouse eosinophils were studied by measuring ROS production, and by performing apoptosis assays using eosinophils from normal, hypereosinophilic, NADPH oxidase-deficient, src homology domain-containing protein tyrosine phosphatase (SHP)-1-deficient, and Lyn kinase-deficient mice. Inhibitors of caspase and Src family kinase activity were also used. Results: Engagement of Siglec-F induced mouse eosinophil apoptosis that was modest in magnitude and dependent on caspase activity. There was no detectable ROS generation, or any role for ROS, NADPH oxidase, SHP-1, or Src family kinases in this apoptotic process. Conclusions: These data suggest that Siglec-F-mediated apoptosis is different in both magnitude and mechanisms when compared to published data on Siglec-8-mediated human eosinophil apoptosis. One likely implication of this work is that models targeting Siglec-F in vivo in mice may not provide identical mechanistic predictions for consequences of Siglec-8 targeting in vivo in humans.	[Mao, Hui; Hudson, Sherry A.; Brummet, Mary; Zhu, Zhou; Bochner, Bruce S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Kano, Gen; Zimmermann, Nives] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Kano, Gen; Zimmermann, Nives] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Johns Hopkins University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Bochner, BS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA.	bbochner@jhmi.edu			NIH [AI72265, HL107151, P30 DK078392]; Cosner Scholar in Translational Research from Johns Hopkins University; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072265, R01AI072265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cosner Scholar in Translational Research from Johns Hopkins University; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI72265, HL107151 (to BSB) and P30 DK078392 (pilot grant to NZ). Dr. Bochner also received support as a Cosner Scholar in Translational Research from Johns Hopkins University. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2003, GENOMICS, V82, P521, DOI 10.1016/S0888-7543(03)00171-X; Angata T, 2001, J BIOL CHEM, V276, P45128, DOI 10.1074/jbc.M108573200; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Bochner BS, 2010, J ALLERGY CLIN IMMUN, V126, P16, DOI 10.1016/j.jaci.2010.02.026; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P1237, DOI 10.1016/j.jaci.2010.04.005; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Cho JY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-154; Conus S, 2010, J ALLERGY CLIN IMMUN, V126, P175, DOI 10.1016/j.jaci.2010.04.029; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Elsner J, 2000, METH MOL B, V138, P153; Floyd H, 2000, J BIOL CHEM, V275, P861, DOI 10.1074/jbc.275.2.861; Guo JP, 2011, AM J RESP CELL MOL, V44, P238, DOI 10.1165/rcmb.2010-0007OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hudson SA, 2011, J CLIN IMMUNOL, V31, P1045, DOI 10.1007/s10875-011-9589-4; Hudson SA, 2009, J PHARMACOL EXP THER, V330, P608, DOI 10.1124/jpet.109.152439; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Kikly KK, 2000, J ALLERGY CLIN IMMUN, V105, P1093, DOI 10.1067/mai.2000.107127; Lee NA, 1997, J IMMUNOL, V158, P1332; Malbec O, 1998, J IMMUNOL, V160, P1647; Munitz A, 2008, BLOOD, V111, P5694, DOI 10.1182/blood-2007-12-126748; Munitz A, 2007, J ALLERGY CLIN IMMUN, V119, P1382, DOI 10.1016/j.jaci.2007.01.031; Na HJ, 2012, CYTOKINE, V57, P169, DOI 10.1016/j.cyto.2011.10.007; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nutku E, 2005, BIOCHEM BIOPH RES CO, V336, P918, DOI 10.1016/j.bbrc.2005.08.202; Nutku E, 2003, BLOOD, V101, P5014, DOI 10.1182/blood-2002-10-3058; Nutku-Bilir E, 2008, AM J RESP CELL MOL, V38, P121, DOI 10.1165/rcmb.2007-0154OC; Otipoby KL, 2001, J BIOL CHEM, V276, P44315, DOI 10.1074/jbc.M105446200; Rothenberg ME, 2008, NEW ENGL J MED, V358, P1215, DOI 10.1056/NEJMoa070812; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rubinstein E, 2011, J PEDIATR GASTR NUTR, V53, P409, DOI 10.1097/MPG.0b013e3182182ff8; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; Song DJ, 2009, J IMMUNOL, V183, P5333, DOI 10.4049/jimmunol.0801421; Song DJ, 2009, CLIN IMMUNOL, V131, P157, DOI 10.1016/j.clim.2008.11.009; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vely F, 1997, J IMMUNOL, V159, P2075; von Gunten S, 2007, J ALLERGY CLIN IMMUN, V119, P1005, DOI 10.1016/j.jaci.2007.01.023; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Walter RB, 2008, J LEUKOCYTE BIOL, V83, P200, DOI 10.1189/jlb.0607388; Yokoi H, 2008, J ALLERGY CLIN IMMUN, V121, P499, DOI 10.1016/j.jaci.2007.10.004; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x	48	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68143	10.1371/journal.pone.0068143	http://dx.doi.org/10.1371/journal.pone.0068143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840825	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400168
J	Meyer, GF; Shao, F; White, MD; Hopkins, C; Robotham, AJ				Meyer, Georg F.; Shao, Fei; White, Mark D.; Hopkins, Carl; Robotham, Antony J.			Modulation of Visually Evoked Postural Responses by Contextual Visual, Haptic and Auditory Information: A 'Virtual Reality Check'	PLOS ONE			English	Article							MOTION SICKNESS; SOMATOSENSORY CONTRIBUTIONS; MULTISENSORY INTEGRATION; AUDIO-BIOFEEDBACK; SWAY; ENVIRONMENTS; CUES; DETERMINANTS; IMMERSION; IMPROVE	Externally generated visual motion signals can cause the illusion of self-motion in space (vection) and corresponding visually evoked postural responses (VEPR). These VEPRs are not simple responses to optokinetic stimulation, but are modulated by the configuration of the environment. The aim of this paper is to explore what factors modulate VEPRs in a high quality virtual reality (VR) environment where real and virtual foreground objects served as static visual, auditory and haptic reference points. Data from four experiments on visually evoked postural responses show that: 1) visually evoked postural sway in the lateral direction is modulated by the presence of static anchor points that can be haptic, visual and auditory reference signals; 2) real objects and their matching virtual reality representations as visual anchors have different effects on postural sway; 3) visual motion in the anterior-posterior plane induces robust postural responses that are not modulated by the presence of reference signals or the reality of objects that can serve as visual anchors in the scene. We conclude that automatic postural responses for laterally moving visual stimuli are strongly influenced by the configuration and interpretation of the environment and draw on multisensory representations. Different postural responses were observed for real and virtual visual reference objects. On the basis that automatic visually evoked postural responses in high fidelity virtual environments should mimic those seen in real situations we propose to use the observed effect as a robust objective test for presence and fidelity in VR.	[Meyer, Georg F.] Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England; [Shao, Fei] STFC Daresbury Lab, Virtual Engn Ctr, Warrington, Cheshire, England; [White, Mark D.] Univ Liverpool, Dept Engn, Liverpool L69 3BX, Merseyside, England; [Hopkins, Carl] Univ Liverpool, Sch Architecture, Acoust Res Unit, Liverpool L69 3BX, Merseyside, England; [Robotham, Antony J.] Auckland Univ Technol, Sch Engn, Auckland, New Zealand	University of Liverpool; STFC Daresbury Laboratory; University of Liverpool; University of Liverpool; Auckland University of Technology	Meyer, GF (corresponding author), Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England.	georg@liv.ac.uk	Hopkins, Carl/C-6317-2008; White, Mark/AAG-8761-2020	White, Mark/0000-0002-8611-9525; Robotham, Antony/0000-0002-0470-1539; Hopkins, Carl/0000-0002-9716-0793; Meyer, Georg/0000-0002-3739-1653	ESRC Case award [North West DTC ES/J500094/1]; EPSRC Institutional Sponsorship [EP/K503538/1]; Engineering and Physical Sciences Research Council [EP/K503538/1] Funding Source: researchfish	ESRC Case award(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); EPSRC Institutional Sponsorship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an ESRC Case award (North West DTC ES/J500094/1) and by EPSRC Institutional Sponsorship (EP/K503538/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLARD B, 1980, PERCEPT MOTOR SKILL, V51, P903, DOI 10.2466/pms.1980.51.3.903; Berthoz A, 1979, Prog Brain Res, V50, P197; BLES W, 1980, ACTA OTO-LARYNGOL, V89, P534, DOI 10.3109/00016488009127171; Bonnet CT, 2012, J MOTOR BEHAV, V44, P125, DOI 10.1080/00222895.2012.654526; Bowman DA, 2007, COMPUTER, V40, P36, DOI 10.1109/MC.2007.257; BRONSTEIN AM, 1986, EXP BRAIN RES, V63, P655, DOI 10.1007/BF00237488; Bronstein AM, 1997, EXP BRAIN RES, V113, P243, DOI 10.1007/BF02450322; Chiari L, 2005, IEEE T BIO-MED ENG, V52, P2108, DOI 10.1109/TBME.2005.857673; Dakin CJ, 2010, J NEUROPHYSIOL, V103, P1048, DOI 10.1152/jn.00881.2009; Deviterne D, 2005, BRAIN RES BULL, V64, P487, DOI 10.1016/j.brainresbull.2004.10.007; DICHGANS J, 1976, AGRESSOLOGIE, V17, P15; Dichgans J, 1978, HDB SENSORY PHYSL; DIJKSTRA TMH, 1994, BIOL CYBERN, V71, P489, DOI 10.1007/BF00198467; Dozza M, 2004, P ANN INT IEEE EMBS, V26, P4799; Easton RD, 1998, EXP BRAIN RES, V118, P541, DOI 10.1007/s002210050310; Freeman J, 2000, PRESENCE-TELEOP VIRT, V9, P149, DOI 10.1162/105474600566691; Guerraz M, 2001, PERCEPT PSYCHOPHYS, V63, P47, DOI 10.3758/BF03200502; Guerraz M, 2008, NEUROSCI LETT, V443, P12, DOI 10.1016/j.neulet.2008.07.053; Hale KS, 2009, ERGONOMICS, V52, P187, DOI 10.1080/00140130802376000; Harrison NR, 2010, J VISION, V10, DOI 10.1167/10.14.16; HEBRANK J, 1974, J ACOUST SOC AM, V56, P1829, DOI 10.1121/1.1903520; HORAK FB, 1994, EXP BRAIN RES, V100, P93; Kolasinski EM.., 1995, SIMULATOR SICKNESS V, DOI 10.1121/1.404501; Krishnamoorthy V, 2002, EXP BRAIN RES, V147, P71, DOI 10.1007/s00221-002-1206-6; Laha B, 2012, IEEE T VIS COMPUT GR, V18, P597, DOI 10.1109/TVCG.2012.42; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; Maurer C, 2000, NEUROSCI LETT, V281, P99, DOI 10.1016/S0304-3940(00)00814-4; MCCLENAGHAN BA, 1994, CLIN BIOMECH, V9, P21, DOI 10.1016/0268-0033(94)90054-X; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Mergner T, 2005, EXP BRAIN RES, V167, P535, DOI 10.1007/s00221-005-0065-3; Meyer G., 2012, SEEING PERCEIVING, V25, P77, DOI [10.1163/187847612x646983, DOI 10.1163/187847612X646983]; Meyer GF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044381; Meyer GF, 2011, J COGNITIVE NEUROSCI, V23, P2291, DOI 10.1162/jocn.2010.21593; Meyer GF, 2005, EXP BRAIN RES, V166, P538, DOI 10.1007/s00221-005-2394-7; Meyer GF, 2001, NEUROREPORT, V12, P2557, DOI 10.1097/00001756-200108080-00053; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; Riecke BE, 2006, ACM T APPL PERCEPT, V3, P194, DOI [10.1145/1166087.1166091., DOI 10.1145/1166087.1166091, 10.1145/1166087.1166091]; Riecke BE, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P2799; Riecke BE, 2011, VIRTUAL REALITY, P149; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Shao F, 2012, ADV MANUFACTURING TE, V2, P468; Simoneau G., 1995, GAIT POSTURE, V3, P115, DOI [DOI 10.1016/0966-6362(95)99061-O, 10.1016/0966-6362(95)99061-O]; Slater Mel, 2003, NOTE PRESENCE TERMIN, V3; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Streepey JW, 2007, GAIT POSTURE, V25, P49, DOI 10.1016/j.gaitpost.2005.12.013; Thurrell AEI, 2002, EXP BRAIN RES, V147, P558, DOI 10.1007/s00221-002-1296-1; Valjamae A, 2008, PRESENCE-TELEOP VIRT, V17, P43, DOI 10.1162/pres.17.1.43; Vuillerme N, 2003, ARCH PHYS MED REHAB, V84, P1560, DOI 10.1016/S0003-9993(03)00235-1; Webb NA, 2003, AVIAT SPACE ENVIR MD, V74, P622; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Yokota Y, 2005, ACTA OTO-LARYNGOL, V125, P280, DOI 10.1080/00016480510003192	57	19	19	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67651	10.1371/journal.pone.0067651	http://dx.doi.org/10.1371/journal.pone.0067651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840760	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400123
J	Pascoal, S; de Lima, JE; Leslie, JD; Hughes, SM; Saude, L				Pascoal, Susana; de Lima, Joana Esteves; Leslie, Jonathan D.; Hughes, Simon M.; Saude, Leonor			Notch Signalling Is Required for the Formation of Structurally Stable Muscle Fibres in Zebrafish	PLOS ONE			English	Article							PROGENITOR CELLS; MIND BOMB-2; LIMB; EXPRESSION; DIFFERENTIATION; SPECIFICATION; GENE; INTEGRITY; DEFECTS; PATTERN	Background: Accurate regulation of Notch signalling is central for developmental processes in a variety of tissues, but its function in pectoral fin development in zebrafish is still unknown. Methodology/Principal Findings: Here we show that core elements necessary for a functional Notch pathway are expressed in developing pectoral fins in or near prospective muscle territories. Blocking Notch signalling at different levels of the pathway consistently leads to the formation of thin, wavy, fragmented and mechanically weak muscles fibres and loss of stress fibres in endoskeletal disc cells in pectoral fins. Although the structural muscle genes encoding Desmin and Vinculin are normally transcribed in Notch-disrupted pectoral fins, their proteins levels are severely reduced, suggesting that weak mechanical forces produced by the muscle fibres are unable to stabilize/localize these proteins. Moreover, in Notch signalling disrupted pectoral fins there is a decrease in the number of Pax7-positive cells indicative of a defect in myogenesis. Conclusions/Significance: We propose that by controlling the differentiation of myogenic progenitor cells, Notch signalling might secure the formation of structurally stable muscle fibres in the zebrafish pectoral fin.	[Pascoal, Susana; de Lima, Joana Esteves; Saude, Leonor] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Pascoal, Susana; de Lima, Joana Esteves; Saude, Leonor] Univ Lisbon, Fac Med, Inst Histol & Biol Desenvolvimento, P-1699 Lisbon, Portugal; [Pascoal, Susana; de Lima, Joana Esteves; Saude, Leonor] Gulbenkian Inst Sci, Oeiras, Portugal; [Leslie, Jonathan D.; Hughes, Simon M.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Universidade de Lisboa; Universidade de Lisboa; University of London; King's College London	Saude, L (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal.	msaude@fm.ul.pt	Hughes, Simon M/S-1073-2016; Saúde, Leonor/D-2720-2012	Hughes, Simon M/0000-0001-8227-9225; Saúde, Leonor/0000-0001-5933-8872; Esteves de Lima, Joana/0000-0002-5497-5669; Pascoal, Susana/0000-0002-2294-8084	Fundacao para a Ciencia e Tecnologia fellowship [SFRH/BPD/26638/2006]; Fundacao para a Ciencia e Tecnologia [PTDC/SAUOBD/64628/2006, PTDC/SAU-OBD/100202/2008]; Wellcome Trust [085057/Z/08]; MRC (Medical Research Council); MRC [G1001029] Funding Source: UKRI; Medical Research Council [G1001029] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia fellowship; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S.P. was supported by a Fundacao para a Ciencia e Tecnologia fellowship (SFRH/BPD/26638/2006). L.S. was supported by Fundacao para a Ciencia e Tecnologia grants (PTDC/SAUOBD/64628/2006 and PTDC/SAU-OBD/100202/2008). J.L. was supported by Wellcome Trust project grant 085057/Z/08 to S.M.H., who is an MRC (Medical Research Council) Scientist with Programme Grant support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; AKIMENKO MA, 1995, DEV BIOL, V170, P243, DOI 10.1006/dbio.1995.1211; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Carrasco-Rando M, 2008, DEVELOPMENT, V135, P849, DOI 10.1242/dev.015529; Charvet B, 2011, CELL TISSUE RES, V346, P439, DOI 10.1007/s00441-011-1266-7; Crowe R, 1999, DEVELOPMENT, V126, P987; Delfini MC, 2000, DEVELOPMENT, V127, P5213; Echeverri K, 2007, DEV BIOL, V301, P388, DOI 10.1016/j.ydbio.2006.10.003; Francis JC, 2005, DEV DYNAM, V234, P1006, DOI 10.1002/dvdy.20590; Frost HM, 2001, ANN REV MATH SCI, V28, P271; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; HATTA K, 1991, DEVELOPMENT, V112, P821; Hinits Y, 2011, DEV BIOL, V358, P102, DOI 10.1016/j.ydbio.2011.07.015; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lewis Julian, 2009, Journal of Biology (London), V8, P44, DOI 10.1186/jbiol145; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Mercader N, 2007, DEV GROWTH DIFFER, V49, P421, DOI 10.1111/j.1440-169x.2007.00942.x; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Mourikis P, 2012, DEVELOPMENT, V139, P4536, DOI 10.1242/dev.084756; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Nguyen HT, 2007, J CELL BIOL, V179, P219, DOI 10.1083/jcb.200708135; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pascoal S, 2007, J MOL BIOL, V368, P303, DOI 10.1016/j.jmb.2007.01.089; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Robert B, 2006, DEV DYNAM, V235, P2337, DOI 10.1002/dvdy.20890; Robling AG, 2009, MED SCI SPORT EXER, V41, P2044, DOI 10.1249/MSS.0b013e3181a8c702; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Sharir A, 2011, DEVELOPMENT, V138, P3247, DOI 10.1242/dev.063768; Shwartz Y, 2012, DEV BIOL, V370, P154, DOI 10.1016/j.ydbio.2012.07.026; Sidow A, 1997, NATURE, V389, P722, DOI 10.1038/39587; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thorsen DH, 2005, J MORPHOL, V266, P241, DOI 10.1002/jmor.10374; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Vinagre T, 2010, DEV CELL, V18, P655, DOI 10.1016/j.devcel.2010.02.011; Vivian JL, 2000, DEV BIOL, V224, P29, DOI 10.1006/dbio.2000.9788; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Watanabe N, 2003, J BONE MINER METAB, V21, P344, DOI 10.1007/s00774-003-0428-4; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034	57	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68021	10.1371/journal.pone.0068021	http://dx.doi.org/10.1371/journal.pone.0068021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840804	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400153
J	Wang, KL; Hsia, SM; Yeh, JY; Cheng, SC; Wang, PS; Wang, SW				Wang, Kai-Lee; Hsia, Shih-Min; Yeh, Jiun-Yih; Cheng, Shao-Chi; Wang, Paulus S.; Wang, Shyi-Wu			Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells	PLOS ONE			English	Article							IN-VITRO; PURE ANTIESTROGEN; ER-ALPHA; APOPTOSIS; GROWTH; BAX; PROLIFERATION; INHIBITION; ACTIVATION; MECHANISMS	Endocrine sensitivity, assessed by the expression of estrogen receptor (ER), has long been the predict factor to guide therapeutic decisions. Tamoxifen has been the most successful hormonal treatment in endocrine-sensitive breast cancer. However, in estrogen-insensitive cancer tamoxifen showed less effectiveness than in estrogen-sensitive cancer. It is interesting to develop new drugs against both hormone-sensitive and insensitive tumor. In this present study we examined anticancer effects of evodiamine extracted from the Chinese herb, Evodiae fructus, in estrogen-dependent and - independent human breast cancer cells, MCF-7 and MDA-MB-231 cells, respectively. Evodiamine inhibited the proliferation of MCF-7 and MDA-MB-231 cells in a concentration-dependent manner with concentration of 1x10(-6) and 1x10(-5) M. Evodiamine also induced apoptosis via up-regulation of caspase 7 activation, PARP cleavage (Bik and Bax expression). The expression of ER alpha and beta in protein and mRNA levels was down-regulated by evodiamine according to data from immunoblotting and RT-PCR analysis. Overall, our results indicate that evodiamine mediates degradation of ER and induces caspase-dependent pathway leading to inhibit proliferation of breast cancer cell lines. It suggests that evodiamine may in part mediate through ER-inhibitory pathway to inhibit breast cancer cell proliferation.	[Wang, Kai-Lee; Cheng, Shao-Chi; Wang, Paulus S.] Natl Yang Ming Univ, Dept Physiol, Sch Med, Taipei 112, Taiwan; [Hsia, Shih-Min] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Wang, Paulus S.] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Yeh, Jiun-Yih] Mithra Biotechnol Inc, Div Qual Assurance, Taipei, Taiwan; [Wang, Shyi-Wu] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Wang, Paulus S.] China Med Univ, Coll Med, Ph D Program Aging, Taichung, Taiwan; [Wang, Paulus S.] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Wang, Kai-Lee] Natl Taipei Univ Nursing & Hlth Sci, Ctr Gen Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Veterans General Hospital; Chang Gung University; China Medical University Taiwan; Asia University Taiwan; National Taipei University of Nursing & Health Science (NTUNHS)	Wang, PS (corresponding author), Natl Yang Ming Univ, Dept Physiol, Sch Med, Taipei 112, Taiwan.	pswang3879@gmail.com; swwang@mail.cgu.edu.tw	Hsia, Shih-Min/AAL-2026-2020	Wang, Kai-Lee/0000-0002-3058-3804	National Science Council, Taiwan, R. O. C. [NSC97-2320-B-010-017-MY3]	National Science Council, Taiwan, R. O. C.(Ministry of Science and Technology, Taiwan)	This study was supported by the grant NSC97-2320-B-010-017-MY3 from the National Science Council, Taiwan, R. O. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanc C, 2000, CANCER RES, V60, P4386; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; Essmann F, 2004, CANCER RES, V64, P7065, DOI 10.1158/0008-5472.CAN-04-1082; FAWELL SE, 1990, P NATL ACAD SCI USA, V87, P6883, DOI 10.1073/pnas.87.17.6883; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Kan SF, 2004, INT J CANCER, V110, P641, DOI 10.1002/ijc.20138; Ko HC, 2007, EUR J PHARMACOL, V555, P211, DOI 10.1016/j.ejphar.2006.10.002; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li YW, 2011, J CELL BIOCHEM, V112, P217, DOI 10.1002/jcb.22922; Liao CH, 2005, CARCINOGENESIS, V26, P968, DOI 10.1093/carcin/bgi041; Nolan E, 1998, MOL CELL BIOCHEM, V188, P13, DOI 10.1023/A:1006879213501; Ogasawara M, 2002, BIOL PHARM BULL, V25, P1491, DOI 10.1248/bpb.25.1491; Ogasawara M, 2001, BIOL PHARM BULL, V24, P917, DOI 10.1248/bpb.24.917; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Ponzone R, 2006, ANN NY ACAD SCI, V1089, P143, DOI 10.1196/annals.1386.037; Radetzki S, 2002, ONCOGENE, V21, P227, DOI 10.1038/sj/onc/1205010; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shin YW, 2007, BIOL PHARM BULL, V30, P197, DOI 10.1248/bpb.30.197; Shyu KG, 2006, LIFE SCI, V78, P2234, DOI 10.1016/j.lfs.2005.09.027; Steel RGD, 1980, PRINCIPLES PROCEDURE; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; WAKELING AE, 1991, CANCER RES, V51, P3867; WAKELING AE, 1995, BIOCHEM PHARMACOL, V49, P1545, DOI 10.1016/0006-2952(94)00528-T; Wang KL, 2013, EXPERT OPIN THER TAR, V17, P337, DOI 10.1517/14728222.2013.756869; Wang KL, 2011, HUM REPROD, V26, P2209, DOI 10.1093/humrep/der165; Wang LM, 2012, ASIAN PAC J CANCER P, V13, P1431, DOI 10.7314/APJCP.2012.13.4.1431; WARD HWC, 1973, BMJ-BRIT MED J, V1, P13, DOI 10.1136/bmj.1.5844.13; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu JJ, 2010, TOXICOLOGY, V268, P1, DOI 10.1016/j.tox.2009.10.030; Zhan YZ, 2012, CANCER PREV RES, V5, P864, DOI 10.1158/1940-6207.CAPR-11-0575	33	35	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67297	10.1371/journal.pone.0067297	http://dx.doi.org/10.1371/journal.pone.0067297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840656	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400093
J	Falagas, ME; Korbila, IP; Kapaskelis, A; Manousou, K; Leontiou, L; Tansarli, GS				Falagas, Matthew E.; Korbila, Ioanna P.; Kapaskelis, Anastasios; Manousou, Kyriaki; Leontiou, Lili; Tansarli, Giannoula S.			Trends of Mortality due to Septicemia in Greece: An 8-Year Analysis	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; METALLO-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RISK-FACTORS; RESISTANCE; IMPACT; OUTBREAK; SEPSIS; CLONES	Background: Infectious diseases are among the major causes of death worldwide. We evaluated the trends of mortality due to septicemia in Greece and compared it with mortality due to other infections. Methods: Data on mortality stratified by cause of death during 2003-2010 was obtained from the Hellenic Statistical Authority. Deaths caused by infectious diseases were grouped by site of infection and analyzed using SPSS 17.0 software. Results: 45,451 deaths due to infections were recorded in Greece during the 8-year period of time, among which 12.2% were due to septicemia, 69.7% pneumonia, 1.5% pulmonary tuberculosis, 0.2% influenza, 0.5% other infections of the respiratory tract, 7.9% intra-abdominal infections (IAIs), 2.5% urinary tract infections (UTIs), 2.2% endocarditis or pericarditis or myocarditis, 1.6% hepatitis, 1% infections of the central nervous system, and 0.7% other infections. A percentage of 99.4% of deaths due to septicemia were caused by bacteria that were not reported on the death certificate (noted as indeterminate septicemia). More deaths due to indeterminate septicemia were observed during 2007-2010 compared to 2003-2006 (3,558 versus 1,966; p<0.05). Conclusion: Despite the limitations related to the quality of death certificates, this study shows that the mortality rate due to septicemia has almost doubled after 2007 in Greece. Proportionally, septicemia accounted for a greater increase in the mortality rate within the infectious causes of death for the same period of time. The emergence of resistance could partially explain this alarming phenomenon. Therefore, stricter infection control measures should be urgently applied in all Greek healthcare facilities.	[Falagas, Matthew E.; Korbila, Ioanna P.; Kapaskelis, Anastasios; Tansarli, Giannoula S.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.; Korbila, Ioanna P.; Kapaskelis, Anastasios] Mitera Hosp, Dept Internal Med Infect Dis, Hygeia Grp, Athens, Greece; [Manousou, Kyriaki; Leontiou, Lili] Natl Tech Univ Athens, Dept Appl Math & Phys, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; National Technical University of Athens; Tufts University	Falagas, ME (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr						[Anonymous], 2011, DEATHS PREL DAT 2011; Chaniotaki S, 2004, CLIN MICROBIOL INFEC, V10, P75, DOI 10.1111/j.1469-0691.2004.00807.x; Daikos GL, 2007, INT J ANTIMICROB AG, V29, P471, DOI 10.1016/j.ijantimicag.2006.11.006; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Daniels R, 2011, J ANTIMICROB CHEMOTH, V66, pII11, DOI 10.1093/jac/dkq515; Dremsizov T, 2006, CHEST, V129, P968, DOI 10.1378/chest.129.4.968; Falagas ME, 2007, J ANTIMICROB CHEMOTH, V60, P1124, DOI 10.1093/jac/dkm356; Fridkin SK, 2001, CRIT CARE MED, V29, pN64, DOI 10.1097/00003246-200104001-00002; Friedman B, 2011, SEPT US HOSP 2009; HCDCP, 2012, BACT MEAN EP DAT GRE; HCDCP, 2012, ED; HCDCP, 2011, 1 HCDCP; HCDCP, 2011, 10 HCDCP; Karapavlidou P, 2005, MICROB DRUG RESIST, V11, P351, DOI 10.1089/mdr.2005.11.351; Kopterides P, 2007, INT J ANTIMICROB AG, V30, P409, DOI 10.1016/j.ijantimicag.2007.06.026; Labelle A, 2012, CRIT CARE MED, V40, P2016, DOI 10.1097/CCM.0b013e318250aa72; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Maltezou HC, 2009, J INFECTION, V58, P213, DOI 10.1016/j.jinf.2009.01.010; Maraki S, 2012, ANTIMICROB AGENTS CH, V56, P3067, DOI 10.1128/AAC.06358-11; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Miyakis S, 2011, CLIN INFECT DIS, V53, P177, DOI 10.1093/cid/cir323; Mouloudi E, 2010, INFECT CONT HOSP EP, V31, P1250, DOI 10.1086/657135; Park SH, 2012, ANN HEMATOL; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pournaras S, 2003, J ANTIMICROB CHEMOTH, V51, P1409, DOI 10.1093/jac/dkg239; Routsi C, 2010, INFECTION, V38, P173, DOI 10.1007/s15010-010-0008-1; Tsakris A, 2003, J ANTIMICROB CHEMOTH, V52, P1046, DOI 10.1093/jac/dkg470; Tsakris A, 2011, ANTIMICROB AGENTS CH, V55, P3164, DOI 10.1128/AAC.00102-11; Tzelepi E, 2003, INT J ANTIMICROB AG, V21, P285, DOI 10.1016/S0924-8579(02)00361-8	29	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67621	10.1371/journal.pone.0067621	http://dx.doi.org/10.1371/journal.pone.0067621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844042	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000063
J	Leaper, D; Munter, C; Meaume, S; Scalise, A; Mompo, NB; Jakobsen, BP; Gottrup, F				Leaper, David; Muenter, Christian; Meaume, Sylvie; Scalise, Alessandro; Blanes Mompo, Nacho; Jakobsen, Birte Petersen; Gottrup, Finn			The Use of Biatain Ag in Hard-to-Heal Venous Leg Ulcers: Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Article							SILVER-RELEASING DRESSINGS; WOUND CARE; MANAGEMENT; PREVALENCE; ETIOLOGY; VULCAN	Background: Venous leg ulcers are common, troublesome, and their failure to heal is often related to a heavy bio-burden. Ionized silver has both anti-inflammatory and antimicrobial properties. The ulcer healing properties of the silver releasing foam dressing Biatain Ag has been examined in 4 randomized controlled trials (RCTs). Aim: To evaluate ulcer healing through a meta-analytic approach after treatment with either Biatain Ag or a non-active dressing. Patients and Methods: 685 subjects with pure or mixed hard-to-heal venous leg ulcers were included in the meta-analysis. Results: Biatain Ag showed a significant treatment effect (p < 0.0001), responder rate (p < 0.001), and healing rate (p = 0.002). Conclusion: The meta-analysis of the 4 RCTs provided statistical significant evidence to support the use of Biatain Ag dressing in treatment of hard-to-heal venous leg ulcers.	[Leaper, David] Cardiff Univ, Wound Healing Res Unit, Cardiff CF10 3AX, S Glam, Wales; [Meaume, Sylvie] Hop Rothschild, F-75571 Paris, France; [Scalise, Alessandro] Ancona Politech Univ, Fac Med, Ancona, Italy; [Blanes Mompo, Nacho] Hosp Manises, Valencia, Spain; [Jakobsen, Birte Petersen] Coloplast AS, Humlebaek, Denmark; [Gottrup, Finn] Bispebjerg Hosp, Copenhagen Wound Healing Ctr, Copenhagen, Denmark	Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen; Bispebjerg Hospital	Jakobsen, BP (corresponding author), Coloplast AS, Humlebaek, Denmark.	dkbir@coloplast.com		Scalise, Alessandro/0000-0002-9198-4943	Coloplast A/S	Coloplast A/S	Coloplast A/S funded the study and provided full access to individual data sets. BPJ, employed by Coloplast A/S, participated as a author in the preparation of the manuscript. The funders had no role in study design, data collection, data analysis and decision to publish.	[Anonymous], 2007, TACKL ANT RES EUR; Ayello Elizabeth A, 2004, Nurse Pract, V29, P8, DOI 10.1097/00006205-200403000-00002; BAKER SR, 1992, EUR J VASCULAR SURG, V6, P245, DOI 10.1016/S0950-821X(05)80313-5; Carter MJ, 2010, J AM ACAD DERMATOL, V63, P668, DOI 10.1016/j.jaad.2009.09.007; Chambers H, 2007, WOUND REPAIR REGEN, V15, P165, DOI 10.1111/j.1524-475X.2007.00201.x; CORNWALL JV, 1986, BRIT J SURG, V73, P693, DOI 10.1002/bjs.1800730905; Cutting Keith, 2007, Int Wound J, V4, P177, DOI 10.1111/j.1742-481X.2007.00338.x; Davies CE, 2007, WOUND REPAIR REGEN, V15, P17, DOI 10.1111/j.1524-475X.2006.00180.x; Dissemond J, 2011, SKIN PHARMACOL PHYS, V24, P245, DOI 10.1159/000327210; Flanagan M, 2003, J Wound Care, V12, P189; Gottrup F, 2010, BRIT J SURG, V97, P303, DOI 10.1002/bjs.7030; Gottrup F, 2012, DIABETES-METAB RES, V28, P64, DOI 10.1002/dmrr.2242; Gray D, 2010, WOUNDS UK, V6, P40; Harding K, 2012, INT WOUND J, V9, P285, DOI 10.1111/j.1742-481X.2011.00881.x; Hermans Michel H, 2007, Adv Skin Wound Care, V20, P166, DOI 10.1097/01.ASW.0000262712.05035.61; Humbert P, 2006, J PLAIES CICATRISATI, V52, P41; International consensus, 2012, APPR US SILV DRESS W; Ip M, 2006, J HOSP INFECT, V63, P342, DOI 10.1016/j.jhin.2006.02.005; Jorgensen Bo, 2005, Int Wound J, V2, P64, DOI 10.1111/j.1742-4801.2005.00084.x; Karlsmark T, 2003, J Wound Care, V12, P351; Landsdown A B G, 2007, J Wound Care, V16, P15; Lansdown A B G, 2002, J Wound Care, V11, P125; Lazareth I, 2007, J Wound Care, V16, P129; Leaper D, 2010, J WOUND TECHNOL, V7, P34; Leaper D, 2011, INT WOUND J, V8, P547, DOI 10.1111/j.1742-481X.2011.00872.x; Leaper D, 2011, INT WOUND J, V8, P1, DOI 10.1111/j.1742-481X.2010.00766.x; Leaper D, 2009, INT WOUND J, V6, P309, DOI 10.1111/j.1742-481X.2009.00620_2.x; Leaper D, 2009, INT WOUND J, V6, P89, DOI 10.1111/j.1742-481X.2009.00581.x; Leaper David J, 2006, Int Wound J, V3, P282, DOI 10.1111/j.1742-481X.2006.00265.x; Leaper DJ, 2012, INT WOUND J, V9, P1, DOI 10.1111/j.1742-481X.2012.01097.x; Lo SF, 2008, J CLIN NURS, V17, P1973, DOI 10.1111/j.1365-2702.2007.02264.x; Lo SF, 2009, J CLIN NURS, V18, P716, DOI 10.1111/j.1365-2702.2008.02534.x; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Mekkes JR, 2003, BRIT J DERMATOL, V148, P388, DOI 10.1046/j.1365-2133.2003.05222.x; Michaels JA, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13560; Moher D, 2011, EPIDEMIOLOGY, V22, P128, DOI 10.1097/EDE.0b013e3181fe7825; Munter K C, 2006, J Wound Care, V15, P199; Percival SL, 2008, WOUND REPAIR REGEN, V16, P52, DOI 10.1111/j.1524-475X.2007.00350.x; Robson MC, 1997, SURG CLIN N AM, V77, P637, DOI 10.1016/S0039-6109(05)70572-7; Senet P, 2013, INT WOUND J; Storm-Versloot MN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006478.pub2; Vanscheidt W, 2003, WOUNDS, V15, P371; Vermeulen H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005486.pub2; White R, 2006, WOUNDS, V18, P307; WUNDERLICH U, 1991, HAUTARZT, V42, P446	45	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67083	10.1371/journal.pone.0067083	http://dx.doi.org/10.1371/journal.pone.0067083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843984	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000030
J	Li, PX; Yuan, SL; Galipeau, J				Li, Pingxin; Yuan, Shala; Galipeau, Jacques			A Fusion Cytokine Coupling GMCSF to IL9 Induces Heterologous Receptor Clustering and STAT1 Hyperactivation through JAK2 Promiscuity	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SIGNALING PATHWAY; JAK/STAT PATHWAY; ACTIVATION; GROWTH; IL-9; INTERLEUKIN-9; INFLAMMATION; LIGANDS; CELLS	Cytokine receptors are randomly distributed on the cell surface membrane and are activated upon binding of their extracellular ligands to mediate downstream cellular activities. We hypothesized that pharmaceutical clustering of ligand-bound, activated receptors may lead to heretofore unrealized gain-of-function with therapeutically desirable properties. We here describe an engineered bifunctional cytokine borne of the fusion of Granulocyte Macrophage Colony Stimulating Factor (GMCSF) and Interleukin-9 (IL9) (hereafter GIFT9 fusokine) and demonstrate that it chaperones co-clustering of the functionally unrelated GMCSF receptor (GMCSFR) and IL9 receptor (IL9R) on cell surface of target cells. We demonstrate that GIFT9 treatment of MC/9 cells leads to transhyperphosphorylation of IL9R-associated STAT1 by GMCSFR-associated JAK2. We also show that IL9R-associated JAK1 and JAK3 augment phosphorylation of GMCSFR-linked STAT5. The functional relevance of these synergistic JAK/STAT transphosphorylation events translates to an increased mitogenic response by GMCSFR/IL9R-expressing primary marrow mast cells. The notion of inducing heterologous receptor clustering by engineered fusokines such as GIFT9 opens the door to a novel type of biopharmaceutical platform where designer fusokines modulate cell physiology through clustering of targeted receptor complexes.	[Li, Pingxin; Yuan, Shala; Galipeau, Jacques] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Galipeau, Jacques] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	Emory University; Emory University	Galipeau, J (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	jgalipe@emory.edu	Galipeau, Jacques/R-9909-2019	Galipeau, Jacques/0000-0002-9374-1996	National Institutes of Health [R01AI093881]; Emory University Integrated Cellular Imaging Microscopy Core of the Winship Cancer Institute comprehensive cancer center grant [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Integrated Cellular Imaging Microscopy Core of the Winship Cancer Institute comprehensive cancer center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health R01AI093881 and was supported in part by the Emory University Integrated Cellular Imaging Microscopy Core of the Winship Cancer Institute comprehensive cancer center grant P30CA138292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN SW, 1992, ARCH BIOCHEM BIOPHYS, V293, P349, DOI 10.1016/0003-9861(92)90405-L; Chames P, 2009, IDRUGS, V12, P276; Chang YP, 2010, J BIOL CHEM, V285, P28715, DOI 10.1074/jbc.M110.133355; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Giron-Michel J, 2003, J EXP MED, V197, P763, DOI 10.1084/jem.20020150; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; Rafei M, 2009, NAT MED, V15, P1038, DOI 10.1038/nm.2003; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rojas M, 2002, CELL IMMUNOL, V217, P58, DOI 10.1016/S0008-8749(02)00515-4; Saulle E, 2009, BRIT J HAEMATOL, V145, P399, DOI 10.1111/j.1365-2141.2009.07627.x; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shelburne CP, 2003, BLOOD, V102, P1290, DOI 10.1182/blood-2002-11-3490; Stagg J, 2004, CANCER RES, V64, P8795, DOI 10.1158/0008-5472.CAN-04-1776; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Wang YJ, 2012, J BIOL CHEM, V287, P25941, DOI 10.1074/jbc.M112.375725; Williams P, 2011, J IMMUNOL, V186, P5527, DOI 10.4049/jimmunol.1003699; Williams P, 2010, MOL THER, V18, P1293, DOI 10.1038/mt.2010.49; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103	31	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e69405	10.1371/journal.pone.0069405	http://dx.doi.org/10.1371/journal.pone.0069405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840913	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900052
J	Anayama, T; Nakajima, T; Dunne, M; Zheng, JZ; Allen, C; Driscoll, B; Vines, D; Keshavjee, S; Jaffray, D; Yasufuku, K				Anayama, Takashi; Nakajima, Takahiro; Dunne, Michael; Zheng, Jinzi; Allen, Christine; Driscoll, Brandon; Vines, Douglass; Keshavjee, Shaf; Jaffray, David; Yasufuku, Kazuhiro			A Novel Minimally Invasive Technique to Create a Rabbit VX2 Lung Tumor Model for Nano-Sized Image Contrast and Interventional Studies	PLOS ONE			English	Article							COOLED-TIP-ELECTRODE; RADIOFREQUENCY ABLATION; COMPUTED-TOMOGRAPHY; AGENT; CT; ERADICATION; NODULES	Background: The rabbit VX2 lung cancer model is a large animal model useful for preclinical lung cancer imaging and interventional studies. However, previously reported models had issues in terms of invasiveness of tumor inoculation, control of tumor aggressiveness and incidence of complications. Purpose: We aimed to develop a minimally invasive rabbit VX2 lung cancer model suitable for imaging and transbronchial interventional studies. Methods: New Zealand white rabbits and VX2 tumors were used in the study. An ultra-thin bronchoscope was inserted through a miniature laryngeal mask airway into the bronchus. Different numbers of VX2 tumor cells were selectively inoculated into the lung parenchyma or subcarinal mediastinum to create a uniform tumor with low incidence of complications. The model was characterized by CT, FDG-PET, and endobronchial ultrasound (EBUS). Liposomal dual-modality contrast agent was used to evaluate liposome drug delivery system in this model. Results: Both peripheral and mediastinal lung tumor models were created. The tumor making success rate was 75.8% (25/33) in the peripheral lung tumor model and 60% (3/5) in the mediastinal tumor model. The group of 1.0 x 10(6) of VX2 tumor cells inoculation showed a linear growth curve with less incidence of complications. Radial probe EBUS visualized the internal structure of the tumor and the size measurement correlated well with CT measurements (r(2) = 0.98). Over 7 days of continuous enhancement of the lung tumor by liposomal contrast in the lung tumor was confirmed both CT and fluorescence imaging. Conclusion: Our minimally invasive bronchoscopic rabbit VX2 lung cancer model is an ideal platform for lung cancer imaging and preclinical bronchoscopic interventional studies.	[Anayama, Takashi; Nakajima, Takahiro; Keshavjee, Shaf; Yasufuku, Kazuhiro] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Div Thorac Surg,Dept Surg, Toronto, ON M5G 1L7, Canada; [Dunne, Michael; Zheng, Jinzi; Driscoll, Brandon; Vines, Douglass; Jaffray, David] Princess Margaret Hosp, Univ Hlth Network, Dept Radiat Phys, Radiat Med Program, Toronto, ON M4X 1K9, Canada; [Dunne, Michael; Allen, Christine] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Yasufuku, K (corresponding author), Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Div Thorac Surg,Dept Surg, Toronto, ON M5G 1L7, Canada.	kazuhiro.yasufuku@uhn.ca	Dunne, Michael/AAB-6107-2019; Nakajima, Takahiro/GRX-7909-2022	Dunne, Michael/0000-0001-6646-1051; Nakajima, Takahiro/0000-0002-4937-5378; Zheng, Jinzi/0000-0002-7650-3910; Allen, Christine/0000-0002-4916-3965; Jaffray, David/0000-0001-7378-7543; Keshavjee, Shaf/0000-0003-4547-8094	Ontario Institute of Cancer Research (OICR)	Ontario Institute of Cancer Research (OICR)	The work was supported by Ontario Institute of Cancer Research (OICR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Badea CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034496; Bae KT, 2005, RADIOLOGY, V236, P677, DOI 10.1148/radiol.2362041558; Cavanaugh Dawn, 2004, Mol Imaging, V3, P55, DOI 10.1162/153535004773861723; Cohen J.E., 1988, STAT POWER ANAL BEHA; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Goldberg SN, 1996, ACAD RADIOL, V3, P929; Ho YJ, 2009, J ENDOUROL, V23, P677, DOI 10.1089/end.2008.0293; Kirsch DG, 2010, INT J RADIAT ONCOL, V76, P973, DOI 10.1016/j.ijrobp.2009.11.038; Lee JM, 2003, INVEST RADIOL, V38, P129; Liang XM, 2009, WORLD J GASTROENTERO, V15, P2139, DOI 10.3748/wjg.15.2139; Ma Lianjun, 2002, Zhongguo Fei Ai Za Zhi, V5, P115, DOI 10.3779/j.issn.1009-3419.2002.02.11; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Miao Y, 2000, EUR RADIOL, V10, P188, DOI 10.1007/s003300050031; Miao Y, 2001, J SURG RES, V99, P265, DOI 10.1006/jsre.2001.6208; Miao Y, 2001, ANN SURG ONCOL, V8, P651, DOI 10.1245/aso.2001.8.8.651; Schwartz LH, 2000, J CLIN ONCOL, V18, P2179, DOI 10.1200/JCO.2000.18.10.2179; Shomura Yuzo, 2003, Jpn J Thorac Cardiovasc Surg, V51, P337, DOI 10.1007/BF02719464; Vasey PA, 1999, CLIN CANCER RES, V5, P83; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Zheng JZ, 2007, PHARM RES-DORDR, V24, P1193, DOI 10.1007/s11095-006-9220-1; Zheng JZ, 2010, CONTRAST MEDIA MOL I, V5, P147, DOI 10.1002/cmmi.378; Zheng J, 2009, MOL PHARMACEUT, V6, P571, DOI 10.1021/mp800234r; Zheng JZ, 2006, INVEST RADIOL, V41, P339, DOI 10.1097/01.rli.0000186568.50265.64; Zhou CW, 2008, WORLD J GASTROENTERO, V14, P6743, DOI 10.3748/wjg.14.6743	26	33	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67355	10.1371/journal.pone.0067355	http://dx.doi.org/10.1371/journal.pone.0067355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840673	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400064
J	Geng, LY; Gao, Y; Chen, XB; Hou, SR; Zhan, CG; Radic, Z; Parks, RJ; Russell, SJ; Pham, L; Brimijoin, S				Geng, Liyi; Gao, Yang; Chen, Xiabin; Hou, Shurong; Zhan, Chang-Guo; Radic, Zoran; Parks, Robin J.; Russell, Stephen J.; Linh Pham; Brimijoin, Stephen			Gene Transfer of Mutant Mouse Cholinesterase Provides High Lifetime Expression and Reduced Cocaine Responses with No Evident Toxicity	PLOS ONE			English	Article							HUMAN SERUM BUTYRYLCHOLINESTERASE; IN-VIVO STABILITY; MONOCLONAL-ANTIBODIES; RATS; VECTOR; HYDROLASE; VIRUS; ACETYLCHOLINESTERASE; IMMUNIZATION; VACCINE	Gene transfer of a human cocaine hydrolase (hCocH) derived from butyrylcholinesterase (BChE) by 5 mutations (A199S/F227A/S287G/A328W/Y332G) has shown promise in animal studies for treatment of cocaine addiction. To predict the physiological fate and immunogenicity of this enzyme in humans, a comparable enzyme was created and tested in a conspecific host. Thus, similar mutations (A199S/S227A/S287G/A328W/Y332G) were introduced into mouse BChE to obtain a mouse CocH (mCocH). The cDNA was incorporated into viral vectors based on: a) serotype-5 helper-dependent adenovirus (hdAD) with ApoE promoter, and b) serotype-8 adeno-associated virus with CMV promoter (AAV-CMV) or multiple promoter and enhancer elements (AAV-VIP). Experiments on substrate kinetics of purified mCocH expressed in HEK293T cells showed 30-fold higher activity (U/mg) with H-3-cocaine and 25% lower activity with butyrylthiocholine, compared with wild type BChE. In mice given modest doses of AAV-CMV-mCocH vector (0.7 or 3610(11) particles) plasma hydrolase activity rose 10-fold above control for over one year with no observed immune response. Under the same conditions, transduction of the human counterpart continued less than 2 months and antibodies to hCocH were readily detected. The advanced AAV-VIP-mCocH vector generated a dose-dependent rise in plasma cocaine hydrolase activity from 20-fold (10(10) particles) to 20,000 fold (10(13) particles), while the hdAD vector (1.7610(12) particles) yielded a 300,000-fold increase. Neither vector caused adverse reactions such as motor weakness, elevated liver enzymes, or disturbance in spontaneous activity. Furthermore, treatment with high dose hdAD-ApoE-mCocH vector (1.7610(12) particles) prevented locomotor abnormalities, other behavioral signs, and release of hepatic alanine amino transferase after a cocaine dose fatal to most control mice (120 mg/kg). This outcome suggests that viral gene transfer can yield clinically effective cocaine hydrolase expression for lengthy periods without immune reactions or cholinergic dysfunction, while blocking toxicity from drug overdose.	[Geng, Liyi; Gao, Yang; Brimijoin, Stephen] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Chen, Xiabin; Hou, Shurong; Zhan, Chang-Guo] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA; [Radic, Zoran] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA; [Parks, Robin J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Russell, Stephen J.; Linh Pham] Mayo Clin, Dept Mol Med, Rochester, MN USA	Mayo Clinic; University of Kentucky; University of California System; University of California San Diego; University of Ottawa; Ottawa Hospital Research Institute; Mayo Clinic	Brimijoin, S (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.	brimijoin@mayo.edu	RADIC, ZORAN/P-7924-2017	Russell, Stephen/0000-0002-0799-6432	National Institutes of Health (NIDA) [DP1 DA031340, R01 DA023979, R01 DA023979 S1, R01 DA032910, and R01 DA13930]; National Institutes of Health (NIGMS) [NIGMS RO1-GM18360]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032910, R01DA013930, R01DA023979, DP1DA031340] Funding Source: NIH RePORTER	National Institutes of Health (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All extramural funding came from the National Institutes of Health (NIDA and NIGMS) through the following research grants: NIDA grants DP1 DA031340, R01 DA023979, R01 DA023979 S1, R01 DA032910, and R01 DA13930; NIGMS RO1-GM18360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano CV, 1999, BIOCHEMISTRY-US, V38, P13414, DOI 10.1021/bi991475+; Anglister L, 1998, J NEUROSCI METH, V81, P63, DOI 10.1016/S0165-0270(98)00015-6; Anker JJ, 2012, BIOL PSYCHIAT, V71, P700, DOI 10.1016/j.biopsych.2011.11.014; [Anonymous], 2011, GUIDE CARE USE LAB A; ARPAGAUS M, 1991, J BIOL CHEM, V266, P6966; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; BERGMEYER HU, 1978, CLIN CHEM, V24, P58; BONESE KF, 1974, NATURE, V252, P708, DOI 10.1038/252708a0; Brimijoin S, 2002, ANAL BIOCHEM, V309, P200, DOI 10.1016/S0003-2697(02)00238-5; Brimijoin S, 2008, NEUROPSYCHOPHARMACOL, V33, P2715, DOI 10.1038/sj.npp.1301666; Brimijoin S, 2011, CNS NEUROL DISORD-DR, V10, P880, DOI 10.2174/187152711799219398; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Carroll ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043536; Carroll ME, 2011, PSYCHOPHARMACOLOGY B; Carroll ME, 2012, PLOS ONE IN PRESS; Elman I, 2001, AM J DRUG ALCOHOL AB, V27, P193, DOI 10.1081/ADA-100103705; Fox BS, 1996, NAT MED, V2, P1129, DOI 10.1038/nm1096-1129; Gao Y, 2005, MOL PHARMACOL, V67, P204, DOI 10.1124/mol.104.006924; Gao Y, 2012, CHEM BIOL INTERACT; Genovese RF, 2010, BASIC CLIN PHARMACOL, V106, P428, DOI 10.1111/j.1742-7843.2009.00508.x; Hieda Y, 1997, J PHARMACOL EXP THER, V283, P1076; HOSEA NA, 1995, BIOCHEMISTRY-US, V34, P11528, DOI 10.1021/bi00036a028; Keyler D, 2003, CANCER LETT, V202, P1, DOI 10.1016/j.canlet.2003.07.004; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Kosten TR, 2002, VACCINE, V20, P1196, DOI 10.1016/S0264-410X(01)00425-X; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; Li H, 2008, BIOCHEM J, V411, P425, DOI 10.1042/BJ20071551; Logan GJ, 2012, CURR GENE THER, V12, P333, DOI 10.2174/156652312802083639; Martell BA, 2005, BIOL PSYCHIAT, V58, P158, DOI 10.1016/j.biopsych.2005.04.032; McMillan DE, 2004, J PHARMACOL EXP THER, V309, P1248, DOI 10.1124/jpet.103.061762; Miyagi N, 2008, J HEART LUNG TRANSPL, V27, P554, DOI 10.1016/j.healun.2008.01.025; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Myers TM, 2012, NEUROTOXICOL TERATOL, V34, P323, DOI 10.1016/j.ntt.2012.02.002; Norman AB, 2007, J PHARMACOL EXP THER, V320, P145, DOI 10.1124/jpet.106.111781; Orson FM, 2009, HUM VACCIN, V5; Orson FM, 2008, ANN NY ACAD SCI, V1141, P257, DOI 10.1196/annals.1441.027; Parikh K, 2011, J PHARMACOL EXP THER, V337, P92, DOI 10.1124/jpet.110.175646; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Peterson EC, 2007, J PHARMACOL EXP THER, V322, P30, DOI 10.1124/jpet.106.117150; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Roiko SA, 2009, PHARMACOL BIOCHEM BE, V93, P105, DOI 10.1016/j.pbb.2009.04.011; Rosenberg YJ, 2010, CHEM-BIOL INTERACT, V187, P279, DOI 10.1016/j.cbi.2010.02.042; Saxena A, 2005, CHEM-BIOL INTERACT, V157, P199, DOI 10.1016/j.cbi.2005.10.028; Saxena A, 2011, BIOCHEM PHARMACOL, V81, P164, DOI 10.1016/j.bcp.2010.09.007; Schirmer JM, 2007, TRANSPL INT, V20, P550, DOI 10.1111/j.1432-2277.2007.00479.x; Silver A., 1974, BIOL CHOLINESTERASES; Sun H, 2002, MOL PHARMACOL, V62, P220, DOI 10.1124/mol.62.2.220; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Weber A, 2011, VOX SANG, V100, P285, DOI 10.1111/j.1423-0410.2010.01415.x; Xue L, 2011, MOL PHARMACOL, V79, P290, DOI 10.1124/mol.110.068494; Yang WC, 2010, CHEM-BIOL INTERACT, V187, P148, DOI 10.1016/j.cbi.2010.01.004; Zheng F, 2008, J AM CHEM SOC, V130, P12148, DOI 10.1021/ja803646t	53	33	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67446	10.1371/journal.pone.0067446	http://dx.doi.org/10.1371/journal.pone.0067446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840704	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400081
J	Simko, GI; Csermely, P				Simko, Gabor I.; Csermely, Peter			Nodes Having a Major Influence to Break Cooperation Define a Novel Centrality Measure: Game Centrality	PLOS ONE			English	Article							EVOLUTIONARY GAMES; SOCIAL DILEMMAS; NETWORK; DYNAMICS; ELEMENTS; PROTEINS; RULES	Cooperation played a significant role in the self-organization and evolution of living organisms. Both network topology and the initial position of cooperators heavily affect the cooperation of social dilemma games. We developed a novel simulation program package, called 'NetworGame', which is able to simulate any type of social dilemma games on any model, or real world networks with any assignment of initial cooperation or defection strategies to network nodes. The ability of initially defecting single nodes to break overall cooperation was called as 'game centrality'. The efficiency of this measure was verified on well-known social networks, and was extended to 'protein games', i.e. the simulation of cooperation between proteins, or their amino acids. Hubs and in particular, party hubs of yeast protein-protein interaction networks had a large influence to convert the cooperation of other nodes to defection. Simulations on methionyl-tRNA synthetase protein structure network indicated an increased influence of nodes belonging to intra-protein signaling pathways on breaking cooperation. The efficiency of single, initially defecting nodes to convert the cooperation of other nodes to defection in social dilemma games may be an important measure to predict the importance of nodes in the integration and regulation of complex systems. Game centrality may help to design more efficient interventions to cellular networks (in forms of drugs), to ecosystems and social networks.	[Simko, Gabor I.; Csermely, Peter] Semmelweis Univ, Dept Med Chem, H-1085 Budapest, Hungary; [Simko, Gabor I.] Vanderbilt Univ, Nashville, TN 37235 USA	Semmelweis University; Vanderbilt University	Csermely, P (corresponding author), Semmelweis Univ, Dept Med Chem, H-1085 Budapest, Hungary.	csermely.peter@med.semmelweis-univ.hu	Csermely, Peter/J-2067-2017	Csermely, Peter/0000-0001-9234-0659	Hungarian National Science Foundation [OTKA-K83314]; European Union [TAMOP-4.2.2/B-10/1-2010-0013]	Hungarian National Science Foundation; European Union(European Commission)	Funding has been provided by research grants from the Hungarian National Science Foundation (OTKA-K83314) and from the European Union (TAMOP-4.2.2/B-10/1-2010-0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom CT, 2002, PHILOS T R SOC B, V357, P1595, DOI 10.1098/rstb.2002.1068; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Braha D, 2006, COMPLEXITY, V12, P59, DOI 10.1002/cplx.20156; Chen X, 2008, PHYS LETT A, V372, P1161, DOI 10.1016/j.physleta.2007.09.044; Chettaoui C, 2007, BIOSYSTEMS, V87, P136, DOI 10.1016/j.biosystems.2006.09.006; Csermely P, 2006, WEAK LINKS STABILIZE; Csermely P, 2012, CURR PROTEIN PEPT SC, V13, P19, DOI 10.2174/138920312799277992; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Csermely P, 2008, TRENDS BIOCHEM SCI, V33, P569, DOI 10.1016/j.tibs.2008.09.006; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Donaldson MC, 2007, J THEOR BIOL, V246, P225, DOI 10.1016/j.jtbi.2006.12.031; DWH Sandholm, 2012, DYNAMO DIAGRAMS EVOL; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Fu F, 2007, PHYS LETT A, V371, P58, DOI 10.1016/j.physleta.2007.05.116; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; GHOSH R, 2012, RETHINKING CENTRALIT; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Holme P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.030901; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Klemm K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00292; Komurov K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100149; Kotter Rolf, 2007, Front Neuroinform, V1, P2, DOI 10.3389/neuro.11.002.2007; Kovacs IA, 2005, FEBS LETT, V579, P2254, DOI 10.1016/j.febslet.2005.03.056; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Langlois JP, 1996, GAMEPLAN; Lerman K., 2010, P 8 WORKSH MIN LEARN, P70, DOI DOI 10.1145/1830252.1830262; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Liu T, 2007, P NATL ACAD SCI USA, V104, P4347, DOI 10.1073/pnas.0607132104; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Masuda N, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056107; McKelvey Richard D., 2021, GAMBIT SOFTWARE TOOL; Michael JH, 1997, FOREST PROD J, V47, P41; Mihalik A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002187; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; Rader AJ, 2011, MOL BIOSYST, V7, P464, DOI 10.1039/c0mb00054j; Saif MA, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07023; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Schuster S, 2008, J BIOL PHYS, V34, P1, DOI 10.1007/s10867-008-9101-4; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.037102; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Traulsen A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041901; Wang SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001917; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Yang HX, 2008, CHINESE PHYS B, V17, P2759, DOI 10.1088/1674-1056/17/8/002; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhuravlev PI, 2010, Q REV BIOPHYS, V43, P295, DOI 10.1017/S0033583510000119; Zollman KJS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1878	64	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67159	10.1371/journal.pone.0067159	http://dx.doi.org/10.1371/journal.pone.0067159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840611	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400038
J	Tanaka, A; Ide, T; Fujino, T; Onitsuka, K; Ikeda, M; Takehara, T; Hata, Y; Ylikallio, E; Tyynismaa, H; Suomalainen, A; Sunagawa, K				Tanaka, Atsushi; Ide, Tomomi; Fujino, Takeo; Onitsuka, Ken; Ikeda, Masataka; Takehara, Takako; Hata, Yuko; Ylikallio, Emil; Tyynismaa, Henna; Suomalainen, Anu; Sunagawa, Kenji			The Overexpression of Twinkle Helicase Ameliorates the Progression of Cardiac Fibrosis and Heart Failure in Pressure Overload Model in Mice	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; MITOCHONDRIAL-FUNCTION; OXIDATIVE STRESS; COPY NUMBER; DISEASE; PROTEIN; DEFICIENCIES; MUTATIONS; DELETIONS; PREVENTS	Myocardial mitochondrial DNA (mtDNA) copy number decreases in heart failure. In post-myocardial infarction mice, increasing mtDNA copy number by overexpressing mitochondrial transcription factor attenuates mtDNA deficiency and ameliorates pathological remodeling thereby markedly improving survival. However, the functional significance of increased mtDNA copy number in hypertensive heart disease remains unknown. We addressed this question using transgenic mice that overexpress Twinkle helicase (Twinkle; Tg), the mtDNA helicase, and examined whether Twinkle overexpression protects the heart from left ventricular (LV) remodeling and failure after pressure overload created by transverse aortic constriction (TAC). Twinkle overexpression increased mtDNA copy number by 2.2 +/- 0.1-fold. Heart weight, LV diastolic volume and wall thickness were comparable between Tg and wild type littermates (WT) at 28 days after TAC operation. LV end-diastolic pressure increased in WT after TAC (8.6 +/- 2.8 mmHg), and this increase was attenuated in Tg (4.6 +/- 2.6 mmHg). Impaired LV fractional shortening after TAC operation was also suppressed in Tg, as measured by echocardiography (WT: 16.2 +/- 7.2% vs Tg: 20.7 +/- 6.2%). These LV functional improvements were accompanied by a decrease in interstitial fibrosis (WT: 10.6 +/- 1.1% vs Tg: 3.0 +/- 0.6%). In in vitro studies, overexpressing Twinkle using an adenovirus vector in cultured cardiac fibroblasts significantly suppressed mRNA of collagen 1a, collagen 3a and connective tissue growth factor, and angiotensin II-induced transforming growth factor beta 1 expression. The findings suggest that Twinkle overexpression prevents LV function deterioration. In conclusion, Twinkle overexpression increases mtDNA copy number and ameliorates the progression of LV fibrosis and heart failure in a mouse pressure overload model. Increasing mtDNA copy number by Twinkle overexpression could be a novel therapeutic strategy for hypertensive heart disease.	[Tanaka, Atsushi; Ide, Tomomi; Fujino, Takeo; Onitsuka, Ken; Ikeda, Masataka; Takehara, Takako; Hata, Yuko; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Ylikallio, Emil; Tyynismaa, Henna; Suomalainen, Anu] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland	Kyushu University; University of Helsinki	Ide, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan.	tomomi_i@cardiol.med.kyushu-u.ac.jp	Ylikallio, Emil/S-9434-2019	Ylikallio, Emil/0000-0001-5178-0703; Tyynismaa, Henna/0000-0002-2493-2422; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195	Japan Society for the Promotion of Science [23220013, 23591084]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (S) (23220013) and for Scientific Research(C) (23591084) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.0000017264.66561.3D; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Fujii T, 2005, J BIOL CHEM, V280, P23041, DOI 10.1074/jbc.M409397200; Fujino T, 2012, MITOCHONDRION; Gonzalez A, 2011, J AM COLL CARDIOL, V58, P1833, DOI 10.1016/j.jacc.2011.06.058; Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051180; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lyly A, 2008, HUM MOL GENET, V17, P1406, DOI 10.1093/hmg/ddn028; Matsusaka H, 2006, HYPERTENSION, V47, P711, DOI 10.1161/01.HYP.0000208840.30778.00; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Moncrieff J, 2004, CURR OPIN CARDIOL, V19, P326, DOI 10.1097/01.hco.0000127134.66225.97; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163	28	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67642	10.1371/journal.pone.0067642	http://dx.doi.org/10.1371/journal.pone.0067642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840758	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400122
J	Vezzulli, L; Pezzati, E; Huete-Stauffer, C; Pruzzo, C; Cerrano, C				Vezzulli, Luigi; Pezzati, Elisabetta; Huete-Stauffer, Caria; Pruzzo, Caria; Cerrano, Cario			16SrDNA Pyrosequencing of the Mediterranean Gorgonian Paramuricea clavata Reveals a Link among Alterations in Bacterial Holobiont Members, Anthropogenic Influence and Disease Outbreaks	PLOS ONE			English	Article							MASS MORTALITY EVENTS; BENTHIC COMMUNITIES; LIGURIAN SEA; SP NOV.; CORAL; MUCUS; DMSP; DIVERSITY; DYNAMICS; SUMMER	Mass mortality events of benthic invertebrates in the Mediterranean Sea are becoming an increasing concern with catastrophic effects on the coastal marine environment. Sea surface temperature anomalies leading to physiological stress, starvation and microbial infections were identified as major factors triggering animal mortality. However the highest occurrence of mortality episodes in particular geographic areas and occasionally in low temperature deep environments suggest that other factors play a role as well. We conducted a comparative analysis of bacterial communities associated with the purple gorgonian Paramuricea clavata, one of the most affected species, collected at different geographic locations and depth, showing contrasting levels of anthropogenic disturbance and health status. Using massive parallel 16SrDNA gene pyrosequencing we showed that the bacterial community associated with healthy P. clavata in pristine locations was dominated by a single genus Endozoicomonas within the order Oceanospirillales which represented similar to 90% of the overall bacterial community. P. clavata samples collected in human impacted areas and during disease events had higher bacterial diversity and abundance of disease-related bacteria, such as vibrios, than samples collected in pristine locations whilst showed a reduced dominance of Endozoicomonas spp. In contrast, bacterial symbionts exhibited remarkable stability in P. clavata collected both at euphotic and mesophotic depths in pristine locations suggesting that fluctuations in environmental parameters such as temperature have limited effect in structuring the bacterial holobiont. Interestingly the coral pathogen Vibrio coralliilyticus was not found on diseased corals collected during a deep mortality episode suggesting that neither temperature anomalies nor recognized microbial pathogens are solely sufficient to explain for the events. Overall our data suggest that anthropogenic influence may play a significant role in determining the coral health status by affecting the composition of the associated microbial community. Environmental stressful events and microbial infections may thus be superimposed to compromise immunity and trigger mortality outbreaks.	[Vezzulli, Luigi; Pezzati, Elisabetta; Pruzzo, Caria] Univ Genoa, Dept Life Earth & Environm Sci DISTAV, Genoa, Italy; [Huete-Stauffer, Caria; Cerrano, Cario] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy	University of Genoa; Marche Polytechnic University	Vezzulli, L (corresponding author), Univ Genoa, Dept Life Earth & Environm Sci DISTAV, Genoa, Italy.	luigi.vezzulli@unige.it	Cerrano, Carlo/AAF-3557-2019; Vezzulli, Luigi/J-2312-2015	Cerrano, Carlo/0000-0001-9580-5546; Vezzulli, Luigi/0000-0002-4368-1454	Committee for Research and Exploration of the National Geographic Society [887611]; Italy-Israel joint research Programme, Directorate General Political and Affairs of the Foreign Affairs, Italy [3697760016]; PRIN Italian funds [2008YBE-321 ANX_002]	Committee for Research and Exploration of the National Geographic Society(National Geographic Society); Italy-Israel joint research Programme, Directorate General Political and Affairs of the Foreign Affairs, Italy; PRIN Italian funds	This work was promoted and funded by the Committee for Research and Exploration of the National Geographic Society (grant Grant Agreement 887611), by the Italy-Israel joint research Programme, Directorate General Political and Affairs of the Foreign Affairs, Italy (contract number 3697760016) and by PRIN 2008 Italian funds (2008YBE-321 ANX_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Bayer T, 2013, MAR ECOL PROG SER, V479, P75, DOI 10.3354/meps10197; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Broadbent AD, 2004, MAR FRESHWATER RES, V55, P849, DOI 10.1071/MF04114; Broadbent AD, 2002, ESTUAR COAST SHELF S, V55, P547, DOI 10.1006/ecss.2002.1021; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Cerrano C, 2008, CHEM ECOL, V24, P73, DOI 10.1080/02757540801979648; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coma R, 2004, ECOL APPL, V14, P1466, DOI 10.1890/03-5176; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Di Camillo CG, 2012, MAR BIOL, V159, P1593, DOI 10.1007/s00227-012-1948-z; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kelman D, 2006, MAR BIOL, V149, P357, DOI 10.1007/s00227-005-0218-8; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Kormas K. A., 2011, PROTEOBACTERIA PHYLO, P73; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Linares C, 2010, MAR ECOL PROG SER, V402, P59, DOI 10.3354/meps08437; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; Mitra S, 2009, BIOINFORMATICS, V25, P1849, DOI 10.1093/bioinformatics/btp341; Oliver J. D., 2013, Food microbiology: fundamentals and frontiers, P401; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rivoire G, 1991, ESPECES MARINES PROT, P53; Rosenberg E, 2009, ISME J, V3, P139, DOI 10.1038/ismej.2008.104; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Speck Mark D., 2012, Journal of Marine Biology, P1; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Vezzulli L, 2012, ISME J, V6, P21, DOI 10.1038/ismej.2011.89; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Vezzulli L, 2009, MICROB ECOL, V58, P808, DOI 10.1007/s00248-009-9542-8; Wilson B, PLOS ONE IN PRESS; Yang CS, 2010, INT J SYST EVOL MICR, V60, P1158, DOI 10.1099/ijs.0.014357-0	41	84	86	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67745	10.1371/journal.pone.0067745	http://dx.doi.org/10.1371/journal.pone.0067745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840768	Green Submitted, gold, Green Published			2022-12-27	WOS:000321424400115
J	Holden, AR; Harris, JM; Timm, RM				Holden, Anna R.; Harris, John M.; Timm, Robert M.			Paleoecological and Taphonomic Implications of Insect-Damaged Pleistocene Vertebrate Remains from Rancho La Brea, Southern California	PLOS ONE			English	Article							JURASSIC MORRISON FORMATION; DINOSAUR BONE; PIOPHILIDAE; COLEOPTERA; DIPTERA; CLIMATE	The La Brea Tar Pits, the world's richest and most important Late Pleistocene fossil locality, offers unsurpassed insights into southern California's past environments. Recent studies at Rancho La Brea document that insects serve as sensitive and valuable paleoecological and taphonomic indicators. Of the thousands of fossil bird and mammal bones recovered from the Tar Pits, insect trace damage is thus far almost exclusively confined to the foot bones of large herbivores, especially bison, camel, and horse species. Our laboratory experiments with dermestid and tenebrionid beetles establish that the larvae of both consume bone, producing different characteristic feeding traces and providing the first documentation that tenebrionids consume bone. The presence of carcass-exploiting insects in the Rancho La Brea biota provides insight into the taphonomy of the asphaltic bone masses and the environmental conditions under which they accumulated. The succession of dermestids, tenebrionids, and indeterminate traces on many of the foot elements, combined with the climate restrictions and life cycles of these insects, indicate that carcasses could remain unsubmerged for at least 17-20 weeks, thus providing the most reliable estimate to date. Attribution of these traces also suggests that the asphaltic fossils only accumulated during warmer intervals of the Late Pleistocene. Forensic studies need to reevaluate the role of tenebrionids in carcass decomposition and other additional insects that modify bone.	[Holden, Anna R.] Nat Hist Museum Los Angeles Cty, Dept Entomol, Los Angeles, CA USA; [Harris, John M.] George C Page Museum, Los Angeles, CA USA; [Timm, Robert M.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Timm, Robert M.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Holden, AR (corresponding author), Nat Hist Museum Los Angeles Cty, Dept Entomol, Los Angeles, CA USA.	aholden@nhm.org		Timm, Robert/0000-0001-6203-3316				[Anonymous], 1968, BEETLES US MANUAL ID; Ashworth AC, 1996, ANN ZOOL FENN, V33, P125; Backwell LR, 2012, PALAEOGEOGR PALAEOCL, V337, P72, DOI 10.1016/j.palaeo.2012.03.032; Bader KS, 2009, PALAIOS, V24, P140, DOI 10.2110/palo.2008.p08-058r; Baker CW, 1968, BUL UNITED STATES NA, V279, P1; Bonduriansky R, 1998, CAN J ZOOL, V76, P1277, DOI 10.1139/cjz-76-7-1277; Bonduriansky R, 1995, CAN ENTOMOL, V127, P859, DOI 10.4039/Ent127859-6; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; Byrd J. H., 2010, FORENSIC ENTOMOLOGY; Caterino M., 2009, CALIFORNIA BEETLE PR; Coope G. R., 1961, Proceedings of the Linnean Society of London, V172, P62; COOPE GR, 1977, PHILOS T ROY SOC B, V280, P313, DOI 10.1098/rstb.1977.0112; De Geer C, 1774, MEMOIRES SERVIR HIST; Deyrup M., 2005, American Entomologist, V51, P245; ELIAS S.A., 1994, QUATERNARY INSECTS T; Fabricius, 1775, SYSTEMA ENTOMOLOGIAE; Fabricius JC, 1794, ENTOMOLOGIA SYSTEMAT; Fejfar O, 2005, PALAEONTOL ELECTRON, V8; Heusser L, 1998, PALEOCEANOGRAPHY, V13, P252, DOI 10.1029/98PA00670; Hill A., 1987, P543; Larew H.G., 1986, Proceedings of the Entomological Society of Washington, V88, P385; Linnaeus C., 1758, TOMUS I SYSTEMA NATU; MacFarlane JA, 1971, STUD SPELEOL, V2, P149; MARTIN LD, 1995, PALAEOGEOGR PALAEOCL, V113, P303, DOI 10.1016/0031-0182(95)00058-T; Martin-Vega D, 2011, FORENSIC SCI INT, V212, P1, DOI 10.1016/j.forsciint.2011.06.016; McCullough JW, 1918, J ECON ENTOMOL, V11, P212; McPeak Ron H., 2008, Proceedings of the San Diego Society of Natural History, P1; Megnin P, 1894, ENCY SCI; Miller S.E., 1982, P377; MILLER SE, 1983, QUATERNARY RES, V20, P90, DOI 10.1016/0033-5894(83)90067-4; O'Keefe F. Robin, 2009, Contributions in Science (Los Angeles), P1; Payne J. A, 1970, Entomologist's mon. Mag., V105, P224; Pierce W, 1947, B SOUTHERN CALIF ACA, V46, P136; Pierce W. Dwight, 1946, BULL SO CALIFORNIA ACAD SCI, V45, P113; Richardson MS, 2001, J MED ENTOMOL, V38, P347, DOI 10.1603/0022-2585-38.3.347; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; RUSSELL WC, 1947, J MAMMAL, V28, P284, DOI 10.2307/1375178; Smith KGV, 1986, MANUAL FORENSIC ENTO; Spencer LM, 2003, PALEOBIOLOGY, V29, P561, DOI 10.1666/0094-8373(2003)029<0561:TAOLMR>2.0.CO;2; Stock C., 1992, RANCHO BREA RECORD P; Stock CS, 1949, RANCHO BREA RECORD P; Timm R.M., 1982, Field Museum of Natural History Bulletin, V53, P14; TODD LC, 1990, AM ANTIQUITY, V55, P813, DOI 10.2307/281252; West DL, 2002, I TERTIARY QUATERNAY, V3, P163; WHITE R. E., 1983, FIELD GUIDE BEETLES; Zacher F, 1884, VORRATS SPEICHER MAT	46	47	49	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67119	10.1371/journal.pone.0067119	http://dx.doi.org/10.1371/journal.pone.0067119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843988	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000062
J	Ianez, E; Azorin, JM; Perez-Vidal, C				Ianez, Eduardo; Azorin, Jose M.; Perez-Vidal, Carlos			Using Eye Movement to Control a Computer: A Design for a Lightweight Electro-Oculogram Electrode Array and Computer Interface	PLOS ONE			English	Article							ROBOT INTERFACE; EOG	This paper describes a human-computer interface based on electro-oculography (EOG) that allows interaction with a computer using eye movement. The EOG registers the movement of the eye by measuring, through electrodes, the difference of potential between the cornea and the retina. A new pair of EOG glasses have been designed to improve the user's comfort and to remove the manual procedure of placing the EOG electrodes around the user's eye. The interface, which includes the EOG electrodes, uses a new processing algorithm that is able to detect the gaze direction and the blink of the eyes from the EOG signals. The system reliably enabled subjects to control the movement of a dot on a video screen.	[Ianez, Eduardo; Azorin, Jose M.; Perez-Vidal, Carlos] Miguel Hernandez Elche Univ, Biomed Neuroengn Grp, Elche, Spain		Ianez, E (corresponding author), Miguel Hernandez Elche Univ, Biomed Neuroengn Grp, Elche, Spain.	eianez@umh.es	Azorin, Jose M./M-8956-2019; Azorin, Jose M/G-2157-2011; Iáñez, Eduardo/J-9765-2014	Azorin, Jose M./0000-0001-5548-9657; Azorin, Jose M/0000-0001-5548-9657; Iáñez, Eduardo/0000-0001-8057-5952	Ministerio de Economia y Competitividad of Spain [DPI2011-27022-C02-01]; Conselleria d'Educacio, Cultura i Esport of Generalitat Valenciana of Spain [VALi+d ACIF/2012/135, ACOMP/2013/018]	Ministerio de Economia y Competitividad of Spain(Spanish Government); Conselleria d'Educacio, Cultura i Esport of Generalitat Valenciana of Spain	This research has been supported by grant DPI2011-27022-C02-01 from Ministerio de Economia y Competitividad of Spain and by Conselleria d'Educacio, Cultura i Esport of Generalitat Valenciana of Spain through grants VALi+d ACIF/2012/135 and ACOMP/2013/018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas Bulling GT, 2009, J AMBIENT INTELLIGEN, P1; Barea R, 2002, J INTELL ROBOT SYST, V34, P279, DOI 10.1023/A:1016359503796; Chen YX, 2004, IEEE INT CONF ROBOT, P243; Huang P, 2000, P INT C INF SOC 21 C, P1; Ianez E, 2012, ROBOT AUTON SYST, V60, P1069, DOI 10.1016/j.robot.2012.05.006; Ianez E, 2010, APPL BIONICS BIOMECH, V7, P199, DOI 10.1080/11762322.2010.503107; Ianez E, 2010, ROBOT AUTON SYST, V58, P1238, DOI 10.1016/j.robot.2010.08.007; Jong IC, 2009, AM SOC ENG ED, V1, P157; Massaro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037285; Perez-Vidal C, 2012, ROBOT AUTON SYST, V60, P901, DOI 10.1016/j.robot.2012.01.005; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Postelnicu CC, 2012, EXPERT SYST APPL, V39, P10857, DOI 10.1016/j.eswa.2012.03.007; Ramos-Murguialday A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047048; Sibert L.E., 2000, P SIGCHI C HUM FACT, P281, DOI DOI 10.1145/332040.332445; Blasco JLS, 2012, EXPERT SYST APPL, V39, P7908, DOI 10.1016/j.eswa.2012.01.110; Society AE, 1991, J CLIN NEUROPHYSIOL, V200-202; Su MC, 2001, COMPUT CONTROL ENG J, V12, P225, DOI 10.1049/cce:20010504; Team OUSR, 2010, AUTODESK TUTORIAL EX, P1; Ubeda A, 2011, IEEE-ASME T MECH, V16, P870, DOI 10.1109/TMECH.2011.2160354; Zhang XA, 2007, LECT NOTES COMPUT SC, V4552, P779; Zhu-ping W, 2012, INFORM AN INT INTERD, V15, P4329	21	17	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67099	10.1371/journal.pone.0067099	http://dx.doi.org/10.1371/journal.pone.0067099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843986	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000061
J	Kugler, JM; Chen, YW; Weng, RF; Cohen, SM				Kugler, Jan-Michael; Chen, Ya-Wen; Weng, Ruifen; Cohen, Stephen M.			miR-989 Is Required for Border Cell Migration in the Drosophila Ovary	PLOS ONE			English	Article							JAK/STAT PATHWAY; MICRORNA; GUIDANCE; PROTEIN; BEHAVIOR	microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by destabilizing target transcripts and/or inhibiting their translation. miRNAs are thought to have roles in buffering gene expression to confer robustness. miRNAs have been shown to play important roles during tissue development to control cell proliferation, differentiation and morphogenesis. Many miRNAs are expressed in the germ line of Drosophila, and functions have been reported for a few miRNAs in maintenance of stem cell proliferation during oogenesis. Here, we analyse the function of Drosophila miR-989 in oogenesis. miR-989 is abundant in ovaries. Mutants lacking miR-989 did not display gross abnormalities affecting egg chamber formation or maturation. However, the migration of the border cell cluster was severely delayed in miR-989 mutant egg chambers. We demonstrate that miR-989 function is required in the somatic cells in the egg chamber, not in germ line cells for border cell migration. Loss of miR-989 from a fraction of the border cell cluster was sufficient to impair cluster migration as a whole, suggesting a role in border cells. Gene ontology analysis reveals that many predicted miR-989 target mRNAs are implicated in regulating cell migration, cell projection morphogenesis, cell adhesion as well as receptor tyrosine kinase and ecdysone signalling, consistent with an important regulatory role for miR-989 in border cell migration.	[Kugler, Jan-Michael; Chen, Ya-Wen; Weng, Ruifen; Cohen, Stephen M.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Weng, Ruifen; Cohen, Stephen M.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Cohen, SM (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	scohen@imcb.a-star.edu.sg	Verma (Sharma), Pushpa/AAZ-9768-2021; Cohen, Stephen M/G-9930-2011	Verma (Sharma), Pushpa/0000-0002-9481-6304; Cohen, Stephen M/0000-0003-2858-9163	IMCB-Institute of Molecular and Cell Biology; Singapore National Research Foundation	IMCB-Institute of Molecular and Cell Biology; Singapore National Research Foundation(National Research Foundation, Singapore)	Work in the SMC lab was supported by core funding from IMCB-Institute of Molecular and Cell Biology. Work in the JYY lab was supported by the Singapore National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Beccari S, 2002, MECH DEVELOP, V111, P115, DOI 10.1016/S0925-4773(01)00615-3; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen YW, 2011, METHODS MOL BIOL, V732, P99, DOI 10.1007/978-1-61779-083-6_8; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Godt D, 2009, NAT CELL BIOL, V11, P536, DOI 10.1038/ncb0509-536; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Poukkula M, 2011, J CELL BIOL, V192, P513, DOI 10.1083/jcb.201010003; Rorth P, 2000, MOL CELL, V6, P23; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Szuplewski S, 2012, GENETICS, V190, P617, DOI 10.1534/genetics.111.136689; Weng RF, 2009, GENETICS, V183, P399, DOI 10.1534/genetics.109.105213; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004	28	21	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67075	10.1371/journal.pone.0067075	http://dx.doi.org/10.1371/journal.pone.0067075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843983	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000060
J	Wu, XL; Huang, RZ; Liu, ZH; Zhang, GP				Wu, Xuelong; Huang, Ruizhi; Liu, Zhihong; Zhang, Guoping			Functional Characterization of cis-Elements Conferring Vascular Vein Expression of At4g34880 Amidase Family Protein Gene in Arabidopsis	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; CELL-SPECIFIC EXPRESSION; BETA-GLUCURONIDASE; PHLOEM; PROMOTER; TRANSFORMATION; TRANSPORTER; SYMPORTER; NITROGEN; CARBON	The expression of At4g34880 gene encoding amidase in Arabidopsis was characterized in this study. A promoter region of 1.5 kb on the upstream of the start codon of the gene (referred as AmidP) was fused with uidA (GUS) reporter gene, and transformed into Arabidopsis plant for determining its spatial expression. The results indicated that AmidP drived GUS expression in vascular system, predominately in leaves. Truncation analysis of AmidP demonstrated that VASCULAR VEIN ELEMENT (VVE) motif with a region of 176 bp sequence (-1500 to -1324) was necessary and sufficient to direct the vascular vein specific GUS expression in the transgenic plant. Tandem copy of VVE increased vascular system expression, and 5'- and 3'-deletions of VVE motif in combination with a truncated -65 CaMV 35S minimal promoter showed that 11bp cis-acting element, naming DOF2 domain, played an essential role for the vascular vein specific expression. Meanwhile, it was also observed that the other cis-acting elements among the VVE region are also associated with specificity or strength of GUS activities in vascular system.	[Wu, Xuelong; Zhang, Guoping] Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xuelong; Huang, Ruizhi; Liu, Zhihong] Zhejiang Acad Agr Sci, Inst Virol & Biotechnol, Key Lab Plant Metab Engn Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences	Zhang, GP (corresponding author), Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	zhanggp@zju.edu.cn						ARNAUD A, 1976, FOLIA MICROBIOL, V21, P178, DOI 10.1007/BF02883153; Ayre BG, 2003, PLANT PHYSIOL, V133, P1229, DOI 10.1104/pp.103.027714; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BORK P, 1994, PROTEIN SCI, V3, P1344, DOI 10.1002/pro.5560030821; Buelow Lorenz, 2006, In Silico Biology, V6, P243; Casson S, 2005, PLANT J, V42, P111, DOI 10.1111/j.1365-313X.2005.02355.x; Ckurshumova W, 2011, PLANT SCI, V181, P96, DOI 10.1016/j.plantsci.2011.04.008; Clay NK, 2005, PLANT PHYSIOL, V138, P767, DOI 10.1104/pp.104.055756; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Donner TJ, 2010, PLANT SIGNAL BEHAV, V5, P70, DOI 10.4161/psb.5.1.10233; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; FRANKENBERGER WT, 1982, PLANT SOIL, V64, P153, DOI 10.1007/BF02184247; Freitas RL, 2007, PLANT MOL BIOL, V65, P603, DOI 10.1007/s11103-007-9225-0; Frommer WB, 1995, P NATL ACAD SCI USA, V92, P12036, DOI 10.1073/pnas.92.26.12036; Gardiner J, 2010, INT J DEV BIOL, V54, P1389, DOI 10.1387/ijdb.093006jg; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Hoffmann M, 2010, PLANT SIGNAL BEHAV, V5, P1642, DOI 10.4161/psb.5.12.13810; Ivashikina N, 2003, PLANT J, V36, P931, DOI 10.1046/j.1365-313X.2003.01931.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Lacombe E, 2000, PLANT J, V23, P663, DOI 10.1046/j.1365-313x.2000.00838.x; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; McGarry RC, 2008, PLANTA, V228, P839, DOI 10.1007/s00425-008-0786-1; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Patricelli MP, 2000, J BIOL CHEM, V275, P19177, DOI 10.1074/jbc.M001607200; Pollmann S, 2006, PLANTA, V224, P1241, DOI 10.1007/s00425-006-0304-2; Pommerrenig B, 2006, PLANT PHYSIOL, V142, P1427, DOI 10.1104/pp.106.089169; Sawa S, 2005, PLANT PHYSIOL, V138, P819, DOI 10.1104/pp.105.061689; Schneidereit A, 2008, PLANTA, V228, P651, DOI 10.1007/s00425-008-0767-4; Sharma Monica, 2009, Reviews in Environmental Science and Bio/Technology, V8, P343, DOI 10.1007/s11157-009-9175-x; Skirycz A, 2006, PLANT J, V47, P10, DOI 10.1111/j.1365-313X.2006.02767.x; Srivastava AC, 2008, PLANT PHYSIOL, V148, P200, DOI 10.1104/pp.108.124776; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Wright KM, 2003, PLANT PHYSIOL, V131, P1555, DOI 10.1104/pp.102.016022; Wu XueLong, 2011, Acta Agriculturae Zhejiangensis, V23, P645	35	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67562	10.1371/journal.pone.0067562	http://dx.doi.org/10.1371/journal.pone.0067562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844031	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000059
J	Liu, Z; Wang, SH; Zhang, QC; Tian, MJ; Hou, J; Wang, RM; Liu, C; Ji, X; Liu, Y; Shao, YM				Liu, Zheng; Wang, Shuhui; Zhang, Qicheng; Tian, Meijuan; Hou, Jue; Wang, Rongmin; Liu, Chang; Ji, Xu; Liu, Ying; Shao, Yiming			Deletion of C7L and K1L Genes Leads to Significantly Decreased Virulence of Recombinant Vaccinia Virus TianTan	PLOS ONE			English	Article							T-CELL RESPONSES; HOST-RANGE GENES; TAN STRAIN; VACCINATION; TRIAL; MULTIPLICATION; IMMUNOGENICITY; EXPRESSION; POXVIRUSES; DELIVERY	The vaccinia virus TianTan (VTT) has been modified as an HIV vaccine vector in China and has shown excellent performance in immunogenicity and safety. However, its adverse effects in immunosuppressed individuals warrant the search for a safer vector in the following clinic trails. In this study, we deleted the C7L and K1L genes of VTT and constructed six recombinant vaccinia strains VTT Delta C7L, VTT Delta K1L, VTT Delta C7LK1L, VTKgpe Delta C7L, VTKgpe Delta K1L and VTT Delta C7LK1L-gag. The pathogenicity and immunogenicity of these recombinants were evaluated in mouse and rabbit models. Comparing to parental VTT, VTT Delta C7L and VTT Delta K1L showed significantly decreased replication capability in CEF, Vero, BHK-21 and HeLa cell lines. In particular, replication of VTT Delta C7LK1L decreased more than 10-fold in all four cell lines. The virulence of all these mutants were decreased in BALB/c mouse and rabbit models; VTT Delta C7LK1L once again showed the greatest attenuation, having resulted in no evident damage in mice and erythema of only 0.4 cm diameter in rabbits, compared to 1.48 cm for VTT. VTKgpe Delta C7L, VTKgpe Delta K1L and VTT Delta C7LK1L-gag elicited as strong cellular and humoral responses against HIV genes as did VTKgpe, while humoral immune response against the vaccinia itself was reduced by 4-8-fold. These data show that deletion of C7L and K1L genes leads to significantly decreased virulence without compromising animal host immunogenicity, and may thus be key to creating a more safe and effective HIV vaccine vector.	[Liu, Zheng; Wang, Shuhui; Zhang, Qicheng; Hou, Jue; Liu, Chang; Ji, Xu; Liu, Ying; Shao, Yiming] China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, Div Res Virol & Immunol, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Qicheng] Nankai Univ, Minist Educ, Key Lab Mol Microbiol & Biotechnol, Tianjin 300071, Peoples R China; [Zhang, Qicheng] Nankai Univ, Coll Life Sci, Key Lab Microbial Funct Genom Tianjin, Tianjin 300071, Peoples R China; [Tian, Meijuan] Case Western Reserve Univ, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Wang, Rongmin] Zhaoyuan CDC, Clin Lab, Zhaoyuan, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Nankai University; Nankai University; Case Western Reserve University	Liu, Y (corresponding author), China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, Div Res Virol & Immunol, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yingliu@chinaaids.cn; yshao08@gmail.com	Hou, Jue/S-8184-2017	Hou, Jue/0000-0001-9913-8365; Liu, Zheng/0000-0002-7260-209X; zhang, qicheng/0000-0001-7277-0280	National Major projects for Infectious Diseases Control and Prevention [2012ZX10001008]; National Natural Science Foundation of China [81020108030]; SKLID [2011SKLID303]; Young Scholar Scientific Research Foundation of China CDC [2012A105]	National Major projects for Infectious Diseases Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SKLID; Young Scholar Scientific Research Foundation of China CDC	This work was funded through four grants: National Major projects for Infectious Diseases Control and Prevention 2012ZX10001008, National Natural Science Foundation of China (81020108030), SKLID Development grant (2011SKLID303), and Young Scholar Scientific Research Foundation of China CDC (2012A105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Chung CS, 1997, VIRUS RES, V52, P121, DOI 10.1016/S0168-1702(97)00111-1; *COMM BIOL PROD ST, 1979, REQ MAN BIOL PROD CH; Dai KF, 2008, VACCINE, V26, P5062, DOI 10.1016/j.vaccine.2008.06.011; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; DRILLIEN R, 1981, VIROLOGY, V111, P488, DOI 10.1016/0042-6822(81)90351-2; Earl PL, 2007, VIROLOGY, V366, P84, DOI 10.1016/j.virol.2007.02.041; Gomez CE, 2012, HUM VACC IMMUNOTHER, V8, P1192, DOI 10.4161/hv.20778; Fang Q, 2005, VIROLOGY, V335, P242, DOI 10.1016/j.virol.2005.02.014; Gherardi MM, 2004, J IMMUNOL, V172, P6209, DOI 10.4049/jimmunol.172.10.6209; Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152; GILLARD S, 1986, P NATL ACAD SCI USA, V83, P5573, DOI 10.1073/pnas.83.15.5573; Harari A, 2012, EUR J IMMUNOL, V42, P3038, DOI 10.1002/eji.201242696; Huang XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004180; Kan SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031979; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Kristen LW, 2009, VIROLOGY, V394, P73, DOI [10.1016/j.virol.2009.08.020, DOI 10.1016/J.VIR0L.2009.08.020.PUBMED:19744687]; Li P, 2000, CHIN J MICROBIOL IMM, V20, P481; Li YC, 2010, J VIROL, V84, P3331, DOI 10.1128/JVI.02332-09; Liu Ying, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P281; Meng XZ, 2008, VIROLOGY, V372, P372, DOI 10.1016/j.virol.2007.10.023; Moss B, 1996, P NATL ACAD SCI USA, V93, P11341, DOI 10.1073/pnas.93.21.11341; Moss B, 2007, FIELDS VIROLOGY; OGUIURA N, 1993, J GEN VIROL, V74, P1409, DOI 10.1099/0022-1317-74-7-1409; PAOLETTI E, 1994, DEV BIOL STAND, V82, P65; Paoletti E, 1996, P NATL ACAD SCI USA, V93, P11349, DOI 10.1073/pnas.93.21.11349; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; RamseyEwing AL, 1996, VIROLOGY, V222, P75, DOI 10.1006/viro.1996.0399; Ranasinghe C, 2011, VACCINE, V29, P3008, DOI 10.1016/j.vaccine.2011.01.106; Rerks-Ngarm S, 2012, J INFECT DIS, P478; Rodriguez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034445; Simone B, 2010, J GEN VIROL, V91, P470, DOI [10.1099/vir.0.015347-0, DOI 10.1099/VIR.0.015347-0.PUBMED:19846675]; SUTTER G, 1994, J VIROL, V68, P4109, DOI 10.1128/JVI.68.7.4109-4116.1994; Tang XA, 2010, VIRUSES-BASEL, V2, P283, DOI 10.3390/v2010283; Tian MeiJuan, 2010, China Tropical Medicine, V10, P653; Wang Wen-ling, 2007, Chinese Journal of Virology, V23, P377; Werden SJ, 2008, ADV VIRUS RES, V71, P135, DOI 10.1016/S0065-3527(08)00003-1; Weyer J, 2008, EPIDEMIOL INFECT, V136, P670, DOI 10.1017/S0950268807008965; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024296; Zhu WJ, 2007, J VIROL METHODS, V144, P17, DOI 10.1016/j.jviromet.2007.03.012	42	13	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68115	10.1371/journal.pone.0068115	http://dx.doi.org/10.1371/journal.pone.0068115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840887	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900026
J	Field, AC; Vink, C; Gabriel, R; Al-Subki, R; Schmidt, M; Goulden, N; Stauss, H; Thrasher, A; Morris, E; Qasim, W				Field, Anne-Christine; Vink, Conrad; Gabriel, Richard; Al-Subki, Roua; Schmidt, Manfred; Goulden, Nicholas; Stauss, Hans; Thrasher, Adrian; Morris, Emma; Qasim, Waseem			Comparison of Lentiviral and Sleeping Beauty Mediated alpha beta T Cell Receptor Gene Transfer	PLOS ONE			English	Article							SPECIFICITY; EXPRESSION; THERAPY; VECTOR; TRANSPOSITION; TRANSDUCTION; ACTIVATION; GENERATION; ABSENCE	Transfer of tumour antigen-specific receptors to T cells requires efficient delivery and integration of transgenes, and currently most clinical studies are using gamma retroviral or lentiviral systems. Whilst important proof-of-principle data has been generated for both chimeric antigen receptors and ab T cell receptors, the current platforms are costly, time-consuming and relatively inflexible. Alternative, more cost-effective, Sleeping Beauty transposon-based plasmid systems could offer a pathway to accelerated clinical testing of a more diverse repertoire of recombinant high affinity T cell receptors. Nucleofection of hyperactive SB100X transposase-mediated stable transposition of an optimised murine-human chimeric T cell receptor specific for Wilm's tumour antigen from a Sleeping Beauty transposon plasmid. Whilst transfer efficiency was lower than that mediated by lentiviral transduction, cells could be readily enriched and expanded, and mediated effective target cells lysis in vitro and in vivo. Integration sites of transposed TCR genes in primary T cells were almost randomly distributed, contrasting the predilection of lentiviral vectors for transcriptionally active sites. The results support exploitation of the Sleeping Beauty plasmid based system as a flexible and adaptable platform for accelerated, early-phase assessment of T cell receptor gene therapies.	[Field, Anne-Christine; Vink, Conrad; Al-Subki, Roua; Goulden, Nicholas; Thrasher, Adrian; Qasim, Waseem] UCL, Mol Immunol Unit, Inst Child Hlth, London, England; [Gabriel, Richard; Schmidt, Manfred] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Gabriel, Richard; Schmidt, Manfred] German Canc Res Ctr, Heidelberg, Germany; [Stauss, Hans; Morris, Emma] UCL, Inst Immun & Transplantat, London, England	University of London; University College London; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of London; University College London	Qasim, W (corresponding author), UCL, Mol Immunol Unit, Inst Child Hlth, London, England.	W.Qasim@ucl.ac.uk		QASIM, WASEEM/0000-0001-8353-4494; Morris, Emma/0000-0003-4834-1130; Field, Anne-Christine/0000-0002-4894-1964	Children with Cancer, Leukaemia and Lymphoma Research Fund; GOSHCC; Department of Health's NIHR Biomedical Research Centre's funding scheme; MRC [G0501446, G9721629, G0900950] Funding Source: UKRI; Medical Research Council [G0900950, G9721629B, G9721629, G0501446, G0900950B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10001] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1223, V1259] Funding Source: researchfish	Children with Cancer, Leukaemia and Lymphoma Research Fund; GOSHCC; Department of Health's NIHR Biomedical Research Centre's funding scheme(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity	This work was supported by the Children with Cancer, Leukaemia and Lymphoma Research Fund. WQ receives funding support from GOSHCC. AT is a Wellcome Trust Senior Fellow. GOSH/UCL Institute of Child Health receives funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens A, 2012, HUM GENE THER METHOD, V23, P111, DOI 10.1089/hgtb.2011.219; Cavalieri S, 2003, BLOOD, V102, P497, DOI 10.1182/blood-2003-01-0297; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Huang X, 2006, BLOOD, V107, P483, DOI 10.1182/blood-2005-05-2133; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Huang X, 2010, HUM GENE THER, V21, P1577, DOI 10.1089/hum.2009.138; Huls MH, 2013, JOVE-J VIS EXP, DOI 10.3791/50070; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; Jin Z, 2011, GENE THER, V18, P849, DOI 10.1038/gt.2011.40; Maiti SN, 2013, J IMMUNOTHER, V36, P112, DOI 10.1097/CJI.0b013e3182811ce9; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mommaas B, 2005, HAEMATOLOGICA, V90, P1415; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Noser JA, 2006, J VIROL, V80, P7769, DOI 10.1128/JVI.02427-05; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Perro M, 2010, GENE THER, V17, P721, DOI 10.1038/gt.2010.4; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pospori C, 2011, BLOOD, V117, P6813, DOI 10.1182/blood-2010-08-304568; Qasim W, 2007, MOL THER, V15, P355, DOI 10.1038/sj.mt.6300042; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; VandenDriessche T, 2009, HUM GENE THER, V20, P1559, DOI 10.1089/hum.2009.1109; Vink CA, 2009, MOL THER, V17, P1197, DOI 10.1038/mt.2009.94; Xue SA, 2005, BLOOD, V106, P3062, DOI 10.1182/blood-2005-01-0146; Xue SA, 2010, HAEMATOL-HEMATOL J, V95, P126, DOI 10.3324/haematol.2009.006486	29	62	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68201	10.1371/journal.pone.0068201	http://dx.doi.org/10.1371/journal.pone.0068201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840834	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400176
J	Gao, WD; Bai, S; Li, QM; Gao, CQ; Liu, GF; Li, GD; Tan, FL				Gao, Weidong; Bai, Shuang; Li, Qingmei; Gao, Caiqiu; Liu, Guifeng; Li, Guangde; Tan, Feili			Overexpression of TaLEA Gene from Tamarix androssowii Improves Salt and Drought Tolerance in Transgenic Poplar (Populus simonii x P. nigra)	PLOS ONE			English	Article							WATER-USE EFFICIENCY; LEA GENE; ARABIDOPSIS-THALIANA; OSMOTIC-STRESS; EXPRESSION; PROTEIN; PLANTS	Late embryogenesis abundant (LEA) genes were confirmed to confer resistance to drought and water deficiency. An LEA gene from Tamarix androssowii (named TaLEA) was transformed into Xiaohei poplar (Populus simonii x P. nigra) via Agrobacterium. Twenty-five independent transgenic lines were obtained that were resistant to kanamycin, and 11 transgenic lines were randomly selected for further analysis. The polymerase chain reaction (PCR) and ribonucleic acid (RNA) gel blot indicated that the TaLEA gene had been integrated into the poplar genome. The height growth rate, malondialdehyde (MDA) content, relative electrolyte leakage and damages due to salt or drought to transgenic and non-transgenic plants were compared under salt and drought stress conditions. The results showed that the constitutive expression of the TaLEA gene in transgenic poplars could induce an increase in height growth rate and a decrease in number and severity of wilted leaves under the salt and drought stresses. The MDA content and relative electrolyte leakage in transgenic lines under salt and drought stresses were significantly lower compared to those in non-transgenic plants, indicating that the TaLEA gene may enhance salt and drought tolerance by protecting cell membranes from damage. Moreover, amongst the lines analyzed for stress tolerance, the transgenic line 11 (T11) showed the highest tolerance levels under both salinity and drought stress conditions. These results indicated that the TaLEA gene could be a salt and drought tolerance candidate gene and could confer a broad spectrum of tolerance under abiotic stresses in poplars.	[Gao, Weidong; Li, Qingmei] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Bai, Shuang; Gao, Caiqiu; Liu, Guifeng] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China; [Li, Guangde] Open Univ China, Sch Agroforestry & Med, Beijing, Peoples R China; [Tan, Feili] Zhanjiang Normal Univ, Sch Life Sci & Technol, Zhanjiang, Peoples R China; [Bai, Shuang] Beijing Ba Da Chu Pk, Engn & Garden Dept, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Northeast Forestry University - China; LingNan Normal University	Li, QM (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	qingmeili202@163.com	Gao, Wei/GXH-0380-2022		National High-Tech Research and Development Program of China, 863 Program (Molecular Breeding and New Species Creating of Poplar) [2011AA100201]; National Natural Science Foundation of China [31000312]; Fundamental Research Funds for the Central Universities [DL12CA03]; Central Public-interest Scientific Institution Basal Research Fund [RIF2012-09]	National High-Tech Research and Development Program of China, 863 Program (Molecular Breeding and New Species Creating of Poplar); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Central Public-interest Scientific Institution Basal Research Fund	This work was supported by the National High-Tech Research and Development Program of China, 863 Program (Molecular Breeding and New Species Creating of Poplar) (Grant No. 2011AA100201), the National Natural Science Foundation of China (No. 31000312), the Fundamental Research Funds for the Central Universities (No. DL12CA03) and the Central Public-interest Scientific Institution Basal Research Fund (No. RIF2012-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Benali MA, 2005, BBA-GENE STRUCT EXPR, V1730, P56, DOI 10.1016/j.bbaexp.2005.05.011; An Y, 2011, J PLANT RES, V124, P689, DOI 10.1007/s10265-011-0403-4; Babu RC, 2004, PLANT SCI, V166, P855, DOI 10.1016/j.plantsci.2003.11.023; Bai YQ, 2012, MOL BIOL REP, V39, P2883, DOI 10.1007/s11033-011-1048-z; Brini F, 2007, PLANT CELL REP, V26, P2017, DOI 10.1007/s00299-007-0412-x; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327; Ganguly M, 2012, PLANT SIGNAL BEHAV, V7, P502, DOI 10.4161/psb.19646; Gao CQ, 2012, MOL BIOL REP, V39, P4889, DOI 10.1007/s11033-011-1284-2; Hu L, 2005, TREE PHYSIOL, V25, P1273, DOI 10.1093/treephys/25.10.1273; Kim EY, 2010, PLANTA, V232, P71, DOI 10.1007/s00425-010-1149-2; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Liang CY, 2004, PLANT SCI, V167, P491, DOI 10.1016/j.plantsci.2004.04.015; Lim GH, 2010, NEW PHYTOL, V185, P103, DOI 10.1111/j.1469-8137.2009.03032.x; [刘桂丰 Liu Guifeng], 2002, [植物生理学通讯, Plant Physiology Communications], V38, P591; Munoz-Mayor A, 2012, J PLANT PHYSIOL, V169, P459, DOI 10.1016/j.jplph.2011.11.018; Park BJ, 2005, PLANT SCI, V169, P553, DOI 10.1016/j.plantsci.2005.05.008; Park SC, 2011, PLANTA, V233, P621, DOI 10.1007/s00425-010-1326-3; Porcel R, 2005, J EXP BOT, V56, P1933, DOI 10.1093/jxb/eri188; Singh S, 2005, PROTEIN SCI, V14, P2601, DOI 10.1110/ps.051579205; Tsuchihira A, 2010, TREE PHYSIOL, V30, P417, DOI 10.1093/treephys/tpp127; Wang C, 2012, MOL BIOL REP, V39, P1047, DOI 10.1007/s11033-011-0830-2; Wang X, 2011, MOL BIOL REP, V38, P4813, DOI 10.1007/s11033-010-0624-y; Wang YC, 2010, MOL BIOL REP, V37, P1119, DOI 10.1007/s11033-009-9884-9; Wang YC, 2006, PLANT SCI, V171, P655, DOI 10.1016/j.plantsci.2006.06.011; Wang YC, 2010, J PLANT PHYSIOL, V167, P222, DOI 10.1016/j.jplph.2009.09.008; Xing HT, 2011, PLANTA, V234, P229, DOI 10.1007/s00425-011-1389-9; Zhao PS, 2011, MOL BIOL+, V45, P785, DOI 10.1134/S0026893311050165	28	32	36	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67462	10.1371/journal.pone.0067462	http://dx.doi.org/10.1371/journal.pone.0067462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840708	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400084
J	Mowls, DS; Cheruvu, VK; Zullo, MD				Mowls, Dana S.; Cheruvu, Vinay K.; Zullo, Melissa D.			Influenza Vaccination in Adults with Chronic Obstructive Pulmonary Disease: The Impact of a Diagnostic Breathing Test on Vaccination Rates	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; HIGH-RISK ADULTS; UNITED-STATES; ACUTE EXACERBATIONS; ELDERLY PERSONS; GLOBAL BURDEN; LUNG-DISEASE; COPD; MORTALITY; SPIROMETRY	Introduction: Influenza vaccination rates are low in adults with chronic obstructive pulmonary disease (COPD). A diagnostic breathing test in adults with COPD may increase vaccination rates; however, research has not demonstrated this relationship. The purpose of this research was to determine if adults with COPD diagnosed by a breathing test were more likely to have had an influenza vaccination during the past 12 months when compared to those with COPD diagnosed without a breathing test. Methods: This was a cross-sectional study using data from the 2011 Behavioral Risk Factor Surveillance System. Logistic regression examined the relationship between influenza vaccination among adults with COPD diagnosed with a breathing test (n = 13,201) compared to those diagnosed without a breathing test (n = 3,108), after controlling for all potential confounders. Results: Overall, 49% of respondents with COPD received an influenza vaccination within the past 12 months and 78% reported their COPD was diagnosed by a breathing test. The prevalence of influenza vaccination in the past 12 months was greater in those with COPD diagnosed by a breathing test (53%) compared to those diagnosed without a breathing test (36%). In adjusted analysis, adults with COPD who had a breathing test were 31% (confidence interval 1.1, 1.6) more likely to have received an influenza vaccination in the past 12 months compared to those without a breathing test. Discussion: A diagnostic breathing test for COPD was associated with increased likelihood of having had an influenza vaccination in the past 12 months. This may be an indicator of the relationship between knowledge of lung function and the need for preventative care, a sign of quality healthcare, or good health-seeking behaviors in patients with COPD. This research is the first to use a nationally representative sample to suggest that spirometry diagnosis of COPD may increase rates of influenza vaccination.				mellenbu@kent.edu						[Anonymous], 2009, MORB MORT 2009 CHART; Beckham JD, 2005, J INFECTION, V50, P322, DOI 10.1016/j.jinf.2004.07.011; Centers for Disease Control and Prevention, 2012, BEH RISK FACT SURV S; Centers for Disease Control and Prevention, 2011, SEAS INFL FLU WHO SH; Egede LE, 2003, AM J PUBLIC HEALTH, V93, P2074, DOI 10.2105/AJPH.93.12.2074; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Grasso ME, 1998, AM J RESP CRIT CARE, V158, P133, DOI 10.1164/ajrccm.158.1.9710041; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Han MK, 2007, CHEST, V132, P403, DOI 10.1378/chest.06-2846; HOWELLS CH, 1961, LANCET, V2, P1428; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; Lee TA, 2006, CHEST, V129, P1509, DOI 10.1378/chest.129.6.1509; Lin K, 2008, ANN INTERN MED, V148, P535, DOI 10.7326/0003-4819-148-7-200804010-00213; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Mannino David M, 2002, Respir Care, V47, P1184; Methvin JN, 2009, CHEST, V135, P102, DOI 10.1378/chest.08-1315; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Poole PJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002733.pub2; Poole PJ, 1997, NEW ZEAL MED J, V110, P272; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Setse Rosanna W., 2011, Morbidity and Mortality Weekly Report, V60, P38; Singleton J A, 2000, MMWR CDC Surveill Summ, V49, P39; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Sullivan SD, 2000, CHEST, V117, P5; Tan WC, 2003, AM J MED, V115, P272, DOI 10.1016/S0002-9343(03)00353-X; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Treanor JD, 2007, NEW ENGL J MED, V357, P1439, DOI 10.1056/NEJMe078140; U.S. Department of Health and Human Services, 2012, HLTH PEOPL 2020; WILT TJ, 2005, EVID REP TECHNOL ASS, V121, P1; Wongsurakiat P, 2004, CHEST, V125, P2011, DOI 10.1378/chest.125.6.2011; Zimmerman RK, 2003, AM J MED, V114, P31, DOI 10.1016/S0002-9343(02)01421-3	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67600	10.1371/journal.pone.0067600	http://dx.doi.org/10.1371/journal.pone.0067600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840746	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400111
J	Visvanathan, A; Ahmed, K; Even-Faitelson, L; Lleres, D; Bazett-Jones, DP; Lamond, AI				Visvanathan, Ashwat; Ahmed, Kashif; Even-Faitelson, Liron; Lleres, David; Bazett-Jones, David P.; Lamond, Angus I.			Modulation of Higher Order Chromatin Conformation in Mammalian Cell Nuclei Can Be Mediated by Polyamines and Divalent Cations	PLOS ONE			English	Article							H3 TAIL DOMAIN; NUCLEOSOME ARRAYS; SELF-ASSOCIATION; LIVING CELLS; HELA-CELLS; IN-SITU; DYNAMICS; PROTEIN; ARCHITECTURE; FIBERS	The organisation of the large volume of mammalian genomic DNA within cell nuclei requires mechanisms to regulate chromatin compaction involving the reversible formation of higher order structures. The compaction state of chromatin varies between interphase and mitosis and is also subject to rapid and reversible change upon ATP depletion/repletion. In this study we have investigated mechanisms that may be involved in promoting the hyper-condensation of chromatin when ATP levels are depleted by treating cells with sodium azide and 2-deoxyglucose. Chromatin conformation was analysed in both live and permeabilised HeLa cells using FLIM-FRET, high resolution fluorescence microscopy and by electron spectroscopic imaging microscopy. We show that chromatin compaction following ATP depletion is not caused by loss of transcription activity and that it can occur at a similar level in both interphase and mitotic cells. Analysis of both live and permeabilised HeLa cells shows that chromatin conformation within nuclei is strongly influenced by the levels of divalent cations, including calcium and magnesium. While ATP depletion results in an increase in the level of unbound calcium, chromatin condensation still occurs even in the presence of a calcium chelator. Chromatin compaction is shown to be strongly affected by small changes in the levels of polyamines, including spermine and spermidine. The data are consistent with a model in which the increased intracellular pool of polyamines and divalent cations, resulting from depletion of ATP, bind to DNA and contribute to the large scale hyper-compaction of chromatin by a charge neutralisation mechanism.	[Visvanathan, Ashwat; Lleres, David; Lamond, Angus I.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland; [Ahmed, Kashif; Even-Faitelson, Liron; Bazett-Jones, David P.] Hosp Sick Children, Genet & Genome Biol Program, Toronto, ON M5G 1X8, Canada	University of Dundee; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Lamond, AI (corresponding author), Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland.	a.i.lamond@dundee.ac.uk	Llères, David/G-9157-2018	Llères, David/0000-0003-1630-8758; Lamond, Angus/0000-0001-6204-6045	Wellcome Trust [083524/Z/07/Z, 073980/Z/03/Z, 08136/Z/03/Z, 0909444/Z/09/Z]; EU FP7 EpiGeneSys network [HEALTH-F4-2010-257082]; Natural Sciences and Engineering Research Council (Canada)	Wellcome Trust(Wellcome TrustEuropean Commission); EU FP7 EpiGeneSys network; Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Wellcome Trust (Grant#: 083524/Z/07/Z, 073980/Z/03/Z, 08136/Z/03/Z, and 0909444/Z/09/Z) www.wellcome.ac.uk/. EU FP7 EpiGeneSys network (Grant#: HEALTH-F4-2010-257082) www.epigenesys.eu/. Natural Sciences and Engineering Research Council (Canada) www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Alm K, 2009, ESSAYS BIOCHEM, V46, P63, DOI [10.1042/BSE0460005, 10.1042/bse0460005]; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bazett-Jones DP, 2008, CHROMOSOME RES, V16, P397, DOI 10.1007/s10577-008-1237-3; Caudron-Herger M, 2011, NUCLEUS-PHILA, V2, P410, DOI 10.4161/nucl.2.5.17736; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Dikovskaya D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038102; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Endale M, 2010, AM J PHYSIOL-CELL PH, V298, pC611, DOI 10.1152/ajpcell.00517.2008; FORSTER T, 1949, Z NATURFORSCH A, V4, P321; Fussner E, 2012, EMBO REPORTS; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; JOHNSON TC, 1965, J CELL BIOL, V27, P565, DOI 10.1083/jcb.27.3.565; Joti Y, 2012, NUCLEUS, V3, P0; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Korolev N, 2010, BIOPHYS J, V99, P1896, DOI 10.1016/j.bpj.2010.07.017; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lleres D, 2007, DETECTING PROTEIN PR; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Martin RM, 2007, CELL CYCLE, V6, P2422, DOI 10.4161/cc.6.19.4738; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Persson L, 2009, ESSAYS BIOCHEM, V46, P11, DOI [10.1042/BSE0460002, 10.1042/bse0460002]; Rial NS, 2009, ESSAYS BIOCHEM, V46, P111, DOI [10.1042/BSE0460008, 10.1042/bse0460008]; Scheffer MP, 2011, P NATL ACAD SCI USA, V108, P16992, DOI 10.1073/pnas.1108268108; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; SEHGAL PB, 1976, CELL, V9, P473, DOI 10.1016/0092-8674(76)90092-1; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Strayer DS, 1999, BIOCHEM J, V344, P39, DOI 10.1042/0264-6021:3440039; Strick R, 2001, J CELL BIOL, V155, P899, DOI 10.1083/jcb.200105026; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Vishwanath K, 2006, OPT EXPRESS, V14, P7776, DOI 10.1364/OE.14.007776; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922; Zampese E, 2012, CELL MOL LIFE SCI, V69, P1077, DOI 10.1007/s00018-011-0845-9; Zheng CY, 2005, J BIOL CHEM, V280, P33552, DOI 10.1074/jbc.M507241200	50	53	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67689	10.1371/journal.pone.0067689	http://dx.doi.org/10.1371/journal.pone.0067689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840764	gold, Green Published			2022-12-27	WOS:000321424400114
J	Coppola, N; Potenza, N; Pisaturo, M; Mosca, N; Tonziello, G; Signoriello, G; Messina, V; Sagnelli, C; Russo, A; Sagnelli, E				Coppola, Nicola; Potenza, Nicoletta; Pisaturo, Mariantonietta; Mosca, Nicola; Tonziello, Gilda; Signoriello, Giuseppe; Messina, Vincenzo; Sagnelli, Caterina; Russo, Aniello; Sagnelli, Evangelista			Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA; EPIDEMIOLOGY; RISK; CIRRHOSIS	To study in HBsAg chronic carriers the expression of liver hsa-miR-125a-5p and its correlation with liver HBV-DNA values and clinical presentation, 27 consecutive Caucasian, HBsAg/anti-HBe/HBV-DNA-positive patients who were naive to nucleos(t)ide analogues and interferon therapy and had no marker of HCV, HDV or HIV infection and no history of alcohol intake were enrolled. For each patient, liver HBV DNA and liver hsa-miR-125a-5p were quantified by real-time PCR in relation to beta-globin DNA or RNU6B, respectively. Liver fibrosis and necroinflammation were graded by applying Ishak's scoring system. Liver hsa-miR-125a-5p was detected in all patients enrolled and a correlation between its concentration and liver HBV DNA was demonstrated (p<0.0001). Higher liver hsa-miR-125a-5p concentrations were observed in patients with HBV-DNA plasma level >10(3) IU/ml (p<0.02), in those with HAI >6 (p = 0.02) and those with fibrosis score >2 (p<0.02) than in patients with lower scores. Higher HBV-DNA liver concentrations were found in patients with abnormal AST (p = 0.005) and ALT serum levels (p = 0.05), in those with serum HBV DNA higher than 10E3 IU/mL (p = 0.001) and those with fibrosis score >2 (p = 0.02) than in patients with a lower load. By multivariate logistic regression analysis, liver hsa-miR-125a-5p was identified as an independent predictor of disease progression: O.R. = 4.21, C.I. 95% = 1.08-16.43, p<0.05, for HAI >6; O.R. = 3.12, C.I. 95% = 1.17-8.27, p<0.05, for fibrosis score >2. In conclusion, in HBsAg/anti-HBe-positive patients, the liver hsa-miR-125a-5p level correlated with liver and plasma HBV-DNA values and was associated to a more severe disease progression.	[Coppola, Nicola; Pisaturo, Mariantonietta; Tonziello, Gilda; Sagnelli, Evangelista] Univ Naples 2, Infect Dis Sect, Dept Mental Hlth & Publ Med, Naples, Italy; [Potenza, Nicoletta; Mosca, Nicola; Russo, Aniello] Univ Naples 2, Dept Life Sci, Caserta, Italy; [Signoriello, Giuseppe] Univ Naples 2, Sect Stat, Dept Mental Hlth & Publ Med, Naples, Italy; [Messina, Vincenzo; Sagnelli, Evangelista] AORN St Anna & San Sebastiano Caserta, Div Infect & Trop Dis, Caserta, Italy; [Sagnelli, Caterina] Univ Naples 2, Dept Clin & Expt Med & Surg F Magrassi & A Lanzar, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Sagnelli, E (corresponding author), Univ Naples 2, Infect Dis Sect, Dept Mental Hlth & Publ Med, Naples, Italy.	evangelista.sagnelli@unina2.it	Sagnelli, Caterina/AAD-4950-2022; messina, vincenzo/AAC-2685-2022; Mosca, Nicola/AAU-7621-2021; Tonziello, Gilda/GYU-0906-2022; Sagnelli, caterina/K-9338-2016; MOSCA, Nicola/ABI-2453-2020	Sagnelli, Caterina/0000-0002-6413-7810; messina, vincenzo/0000-0003-1323-5127; Sagnelli, caterina/0000-0002-6413-7810; MOSCA, Nicola/0000-0003-0405-3807; Tonziello, Gilda/0000-0001-6506-9322; Signoriello, Giuseppe/0000-0002-6609-2708; Russo, Aniello/0000-0001-5421-3552; Potenza, Nicoletta/0000-0002-9736-792X; Coppola, Nicola/0000-0001-5897-4949; Sagnelli, Evangelista/0000-0003-2817-8436; Pisaturo, mariantonietta/0000-0001-5870-0956				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CM, 2006, SEMIN LIVER DIS, V26, P142, DOI 10.1055/s-2006-939752; Coppola N, 2010, J VIRAL HEPATITIS, V17, P493, DOI 10.1111/j.1365-2893.2009.01201.x; Coppola N, 2008, ANTIVIR THER, V13, P307; Coppola N, 2011, J MED VIROL, V83, P1909, DOI 10.1002/jmv.22199; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Fattovich G, 2008, GUT, V57, P84, DOI 10.1136/gut.2007.128496; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liu Y, 2009, CHINESE MED J-PEKING, V122, P10, DOI 10.3760/cma.j.issn.0366-6999.2009.01.003; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Park SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039276; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; Sagnelli E, 2008, J MED VIROL, V80, P1547, DOI 10.1002/jmv.21239; Sagnelli E, 2008, CLIN INFECT DIS, V46, P110, DOI 10.1086/524074; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Thursz M, 2011, SEMIN LIVER DIS, V31, P115, DOI 10.1055/s-0031-1276642; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008	38	62	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e65336	10.1371/journal.pone.0065336	http://dx.doi.org/10.1371/journal.pone.0065336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843939	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000041
J	King, AJ; Arnone, MR; Bleam, MR; Moss, KG; Yang, JS; Fedorowicz, KE; Smitheman, KN; Erhardt, JA; Hughes-Earle, A; Kane-Carson, LS; Sinnamon, RH; Qi, HW; Rheault, TR; Uehling, DE; Laquerre, SG				King, Alastair J.; Arnone, Marc R.; Bleam, Maureen R.; Moss, Katherine G.; Yang, Jingsong; Fedorowicz, Kelly E.; Smitheman, Kimberly N.; Erhardt, Joseph A.; Hughes-Earle, Angela; Kane-Carson, Laurie S.; Sinnamon, Robert H.; Qi, Hongwei; Rheault, Tara R.; Uehling, David E.; Laquerre, Sylvie G.			Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; B-RAF; SELECTIVE INHIBITOR; KINASE; MELANOMA; RESISTANCE; MUTATIONS; PATHWAY; SORAFENIB; DISCOVERY	Mitogen-Activated Protein Kinase (MAPK) pathway activation has been implicated in many types of human cancer. BRAF mutations that constitutively activate MAPK signalling and bypass the need for upstream stimuli occur with high prevalence in melanoma, colorectal carcinoma, ovarian cancer, papillary thyroid carcinoma, and cholangiocarcinoma. In this report we characterize the novel, potent, and selective BRAF inhibitor, dabrafenib (GSK2118436). Cellular inhibition of BRAF(V600E) kinase activity by dabrafenib resulted in decreased MEK and ERK phosphorylation and inhibition of cell proliferation through an initial G(1) cell cycle arrest, followed by cell death. In a BRAF(V600E)-containing xenograft model of human melanoma, orally administered dabrafenib inhibited ERK activation, downregulated Ki67, and upregulated p27, leading to tumor growth inhibition. However, as reported for other BRAF inhibitors, dabrafenib also induced MAPK pathway activation in wild-type BRAF cells through CRAF (RAF1) signalling, potentially explaining the squamous cell carcinomas and keratoacanthomas arising in patients treated with BRAF inhibitors. In addressing this issue, we showed that concomitant administration of BRAF and MEK inhibitors abrogated paradoxical BRAF inhibitor-induced MAPK signalling in cells, reduced the occurrence of skin lesions in rats, and enhanced the inhibition of human tumor xenograft growth in mouse models. Taken together, our findings offer preclinical proof of concept for dabrafenib as a specific and highly efficacious BRAF inhibitor and provide evidence for its potential clinical benefits when used in combination with a MEK inhibitor.	[King, Alastair J.; Arnone, Marc R.; Bleam, Maureen R.; Moss, Katherine G.; Smitheman, Kimberly N.; Laquerre, Sylvie G.] GlaxoSmithKline Dept Oncol Biol, Collegeville, PA USA; [Yang, Jingsong; Fedorowicz, Kelly E.] GlaxoSmithKline Dept Enzymol & Mechanist Pharmaco, Collegeville, PA USA; [Erhardt, Joseph A.] GlaxoSmithKline Portfolio Management, Collegeville, PA USA; [Hughes-Earle, Angela] GlaxoSmithKline Dept Safety Assessment, King Of Prussia, PA USA; [Kane-Carson, Laurie S.] GlaxoSmithKline, GlaxoSmithKline Dept Screening & Compound Profili, Durham, NC USA; [Sinnamon, Robert H.; Qi, Hongwei] GlaxoSmithKline Dept Biol Reagents & Assay Dev, King Of Prussia, PA USA; [Rheault, Tara R.; Uehling, David E.] GlaxoSmithKline, GlaxoSmithKline Dept Med Chem, Durham, NC USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Laquerre, SG (corresponding author), GlaxoSmithKline Dept Oncol Biol, Collegeville, PA USA.	sylvie.g.laquerre@gsk.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnault JP, 2009, J CLIN ONCOL, V27, pE59, DOI 10.1200/JCO.2009.23.4823; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Carnahan J, 2010, MOL CANCER THER, V9, P2399, DOI 10.1158/1535-7163.MCT-10-0181; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cichowski K, 2010, NATURE, V464, P358, DOI 10.1038/464358a; Corcoran RB, 2011, ONCOTARGET, V2, P336; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dubauskas Z, 2009, CLIN GENITOURIN CANC, V7, P20, DOI 10.3816/CGC.2009.n.003; Eggermont AMM, 2011, EUR J CANCER, V47, P2150, DOI 10.1016/j.ejca.2011.06.052; FLAHERTY K, 2009, J CLIN ONCOL S, V27, pNIL18; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Hong DS, 2008, ARCH DERMATOL, V144, P779, DOI 10.1001/archderm.144.6.779; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kefford R., 2010, J CLIN ONCOL S, V28; Kefford R, 2010, PIGM CELL MELANOMA R, V23, P874; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kong HH, 2008, ARCH DERMATOL, V144, P820, DOI 10.1001/archderm.144.6.820; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ralph JM, 2011, 242 ACS NAT M; Rheault TR, 2013, ACS MED CHEM LETT, V4, P358, DOI 10.1021/ml4000063; Rominger CM, 2007, ARCH BIOCHEM BIOPHYS, V464, P130, DOI 10.1016/j.abb.2007.04.004; Sharfman WH, 2011, J CLIN ONCOL S, V29; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	46	116	129	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67583	10.1371/journal.pone.0067583	http://dx.doi.org/10.1371/journal.pone.0067583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844038	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000084
J	Villanova, F; Di Meglio, P; Inokuma, M; Aghaeepour, N; Perucha, E; Mollon, J; Nomura, L; Hernandez-Fuentes, M; Cope, A; Prevost, AT; Heck, S; Maino, V; GrahamLord; Brinkman, RR; Nestle, FO				Villanova, Federica; Di Meglio, Paola; Inokuma, Margaret; Aghaeepour, Nima; Perucha, Esperanza; Mollon, Jennifer; Nomura, Laurel; Hernandez-Fuentes, Maria; Cope, Andrew; Prevost, A. Toby; Heck, Susanne; Maino, Vernon; GrahamLord; Brinkman, Ryan R.; Nestle, Frank O.			Integration of Lyoplate Based Flow Cytometry and Computational Analysis for Standardized Immunological Biomarker Discovery	PLOS ONE			English	Article							CELL; IDENTIFICATION	Discovery of novel immune biomarkers for monitoring of disease prognosis and response to therapy in immune-mediated inflammatory diseases is an important unmet clinical need. Here, we establish a novel framework for immunological biomarker discovery, comparing a conventional (liquid) flow cytometry platform (CFP) and a unique lyoplate-based flow cytometry platform (LFP) in combination with advanced computational data analysis. We demonstrate that LFP had higher sensitivity compared to CFP, with increased detection of cytokines (IFN-gamma and IL-10) and activation markers (Foxp3 and CD25). Fluorescent intensity of cells stained with lyophilized antibodies was increased compared to cells stained with liquid antibodies. LFP, using a plate loader, allowed medium-throughput processing of samples with comparable intra- and inter-assay variability between platforms. Automated computational analysis identified novel immunophenotypes that were not detected with manual analysis. Our results establish a new flow cytometry platform for standardized and rapid immunological biomarker discovery with wide application to immune-mediated diseases.	[Villanova, Federica; Di Meglio, Paola; Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Villanova, Federica; Di Meglio, Paola; Hernandez-Fuentes, Maria; Heck, Susanne; GrahamLord; Nestle, Frank O.] NIHR GSTT KCL London, Guys & St Thomas NHS Fdn Trust, Comprehens Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Di Meglio, Paola] Natl Inst Med Res, London NW7 1AA, England; [Inokuma, Margaret; Nomura, Laurel; Maino, Vernon] BD Biosci, Biol Res & Dev, San Jose, CA USA; [Aghaeepour, Nima; Brinkman, Ryan R.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Perucha, Esperanza; Hernandez-Fuentes, Maria; GrahamLord] Kings Coll London, Med Res Council MRC Ctr Transplantat, London WC2R 2LS, England; [Mollon, Jennifer] Kings Coll London, Div Genet & Mol Med, Stat Genet Unit, London WC2R 2LS, England; [Cope, Andrew] Kings Coll London, Acad Dept Rheumatol, London WC2R 2LS, England; [Prevost, A. Toby] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Brinkman, Ryan R.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; MRC National Institute for Medical Research; British Columbia Cancer Agency; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of British Columbia	Nestle, FO (corresponding author), Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England.	frank.nestle@kcl.ac.uk	Perucha, Esperanza/S-7380-2019; Brinkman, Ryan/B-1108-2008; Fuentes, Maria/HGA-8617-2022; Maria, Hernandez-Fuentes/B-5011-2010	Perucha, Esperanza/0000-0002-7802-0875; Brinkman, Ryan/0000-0002-9765-2990; Maria, Hernandez-Fuentes/0000-0002-7558-9441; Prevost, A. Toby/0000-0003-1723-0796; Di Meglio, Paola/0000-0002-2066-7780; Lord, Graham/0000-0003-2069-4743; Cope, Andrew/0000-0001-6735-5496	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Medical Research Council [MR/J006742/1, G0802068] Funding Source: researchfish; MRC [G0802068] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2012, CYTOMETRY A; Aghaeepour N, FLOWTYPE PACKAGE BIO; Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Aghaeepour N, 2012, BIOINFORMATICS, V28, P1009, DOI 10.1093/bioinformatics/bts082; Aghaeepour N, 2011, CYTOM PART A, V79A, P6, DOI 10.1002/cyto.a.21007; Aronson JK, 2012, BRIT J CLIN PHARMACO, V73, P900, DOI 10.1111/j.1365-2125.2012.04234.x; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Chattopadhyay PK, 2010, CYTOM PART A, V77A, P614, DOI 10.1002/cyto.a.20905; Costa ES, 2010, LEUKEMIA, V24, P1927, DOI 10.1038/leu.2010.160; Disis ML, 2011, CANCER IMMUNOL IMMUN, V60, P433, DOI 10.1007/s00262-010-0960-8; Dunne JF, 2004, AUTOMATION CYTOKINE; Ge Y, 2012, BIOINFORMATICS, V28, P2052, DOI 10.1093/bioinformatics/bts300; Halim SA, 2012, CLIN CHEM, V58, P45, DOI 10.1373/clinchem.2011.165787; Heidt S, 2011, TRANSPLANTATION, V92, P1, DOI 10.1097/TP.0b013e318218e978; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Inokuma M, 2007, J IMMUNOL, V179, P2627, DOI 10.4049/jimmunol.179.4.2627; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nomura L, 2008, CYTOM PART A, V73A, P984, DOI 10.1002/cyto.a.20602; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Robinson JP, 2012, EXPERT OPIN DRUG DIS, V7, P679, DOI 10.1517/17460441.2012.693475; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Suni Maria A, 2003, BMC Immunol, V4, P9, DOI 10.1186/1471-2172-4-9; Villanova F, 2013, ANN RHEUM DIS, V72, P104, DOI 10.1136/annrheumdis-2012-203037; Zare H, 2012, AM J CLIN PATHOL, V137, P75, DOI 10.1309/AJCPMMLQ67YOMGEW	30	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e65485	10.1371/journal.pone.0065485	http://dx.doi.org/10.1371/journal.pone.0065485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843942	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000043
J	Lee, WC; Micchelli, CA				Lee, Wen-Chih; Micchelli, Craig A.			Development and Characterization of a Chemically Defined Food for Drosophila	PLOS ONE			English	Article							LIFE-SPAN; NUTRITIONAL-REQUIREMENTS; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; STEM-CELLS; GROWTH; REPRODUCTION; INSIGHTS	Diet can affect a spectrum of biological processes ranging from behavior to cellular metabolism. Yet, the precise role of an individual dietary constituent can be a difficult variable to isolate experimentally. A chemically defined food (CDF) permits the systematic evaluation of individual macro- and micronutrients. In addition, CDF facilitates the direct comparison of data obtained independently from different laboratories. Here, we report the development and characterization of a CDF for Drosophila. We show that CDF can support the long-term culture of laboratory strains and demonstrate that this formulation has utility in isolating macronutrient from caloric density requirements in studies of development, longevity and reproduction.	[Lee, Wen-Chih; Micchelli, Craig A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Micchelli, CA (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA.	micchelli@wustl.edu			NIH [R01 DK095871]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH R01 DK095871; http://www2.niddk.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIERI JG, 1977, J NUTR, V107, P1394; Britton JS, 1998, DEVELOPMENT, V125, P2149; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Good TP, 2001, J INSECT PHYSIOL, V47, P1467, DOI 10.1016/S0022-1910(01)00138-X; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; HINTON T, 1951, PHYSIOL ZOOL, V24, P335, DOI 10.1086/physzool.24.4.30152141; HOUSE HL, 1966, J INSECT PHYSIOL, V12, P299, DOI 10.1016/0022-1910(66)90145-4; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; King RC, 1970, OVARIAN DEV DROSOPHI, P149; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Li L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-7; LU NC, 1993, NEMATOLOGICA, V39, P303, DOI 10.1163/187529293X00259; Mair W, 2010, AGING CELL, V9, P916, DOI 10.1111/j.1474-9726.2010.00602.x; Marshall L, 2012, EMBO J, V31, P1916, DOI 10.1038/emboj.2012.33; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; RUDKIN GT, 1947, ANAT REC, V99, P613; Sang J.H., 1978, P159; SANG JH, 1956, J EXP BIOL, V33, P45; SANG JH, 1961, J EXP BIOL, V38, P793; SCHULTZ J, 1946, ANAT REC, V96, P540; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Stafford N, 2010, NATURE, V468, pS16, DOI 10.1038/468S16a; Szewczyk NJ, 2006, J EXP BIOL, V209, P4129, DOI 10.1242/jeb.02492; Szewczyk NJ, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-19; Tatar M, 2011, EXP GERONTOL, V46, P363, DOI 10.1016/j.exger.2010.12.002; Tennessen JM, 2011, CURR BIOL, V21, pR750, DOI 10.1016/j.cub.2011.06.033; Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4; Troen AM, 2010, AGE, V32, P123, DOI 10.1007/s11357-010-9133-0; Warden CH, 2008, CELL METAB, V7, P277, DOI 10.1016/j.cmet.2008.03.014; Willett W C, 2000, Oncologist, V5, P393, DOI 10.1634/theoncologist.5-5-393; WINITZ M, 1970, AM J CLIN NUTR, V23, P546; WINITZ M, 1970, AM J CLIN NUTR, V23, P525; Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z	38	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67308	10.1371/journal.pone.0067308	http://dx.doi.org/10.1371/journal.pone.0067308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844001	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000039
J	Sali, A; Many, GM; Gordish-Dressman, H; van der Meulen, JH; Phadke, A; Spurney, CF; Cnaan, A; Hoffman, EP; Nagaraju, K				Sali, Arpana; Many, Gina M.; Gordish-Dressman, Heather; van der Meulen, Jack H.; Phadke, Aditi; Spurney, Christopher F.; Cnaan, Avital; Hoffman, Eric P.; Nagaraju, Kanneboyina			The Proton Pump Inhibitor Lansoprazole Improves the Skeletal Phenotype in Dystrophin Deficient mdx Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; INTRACELLULAR CA2+; NITRIC-OXIDE; MUSCLE; MOUSE; NECROSIS; ATPASE; PERMEABILITY; EXPRESSION; OMEPRAZOLE	Background: In Duchenne muscular dystrophy (DMD), loss of the membrane stabilizing protein dystrophin results in myofiber damage. Microinjury to dystrophic myofibers also causes secondary imbalances in sarcolemmic ion permeability and resting membrane potential, which modifies excitation-contraction coupling and increases proinflammatory/apoptotic signaling cascades. Although glucocorticoids remain the standard of care for the treatment of DMD, there is a need to investigate the efficacy of other pharmacological agents targeting the involvement of imbalances in ion flux on dystrophic pathology. Methodology/Principal Findings: We designed a preclinical trial to investigate the effects of lansoprazole (LANZO) administration, a proton pump inhibitor, on the dystrophic muscle phenotype in dystrophin deficient (mdx) mice. Eight to ten week-old female mice were assigned to one of four treatment groups (n = 12 per group): (1) vehicle control; (2) 5 mg/kg/day LANZO; (3) 5 mg/kg/day prednisolone; and (4) combined treatment of 5 mg/kg/day prednisolone (PRED) and 5 mg/kg/day LANZO. Treatment was administered orally 5 d/wk for 3 months. At the end of the study, behavioral (Digiscan) and functional outcomes (grip strength and Rotarod) were assessed prior to sacrifice. After sacrifice, body, tissue and organ masses, muscle histology, in vitro muscle force, and creatine kinase levels were measured. Mice in the combined treatment groups displayed significant reductions in the number of degenerating muscle fibers and number of inflammatory foci per muscle field relative to vehicle control. Additionally, mice in the combined treatment group displayed less of a decline in normalized forelimb and hindlimb grip strength and declines in in vitro EDL force after repeated eccentric contractions. Conclusions/Significance: Together our findings suggest that combined treatment of LANZO and prednisolone attenuates some components of dystrophic pathology in mdx mice. Our findings warrant future investigation of the clinical efficacy of LANZO and prednisolone combined treatment regimens in dystrophic pathology.	[Sali, Arpana; Many, Gina M.; Gordish-Dressman, Heather; van der Meulen, Jack H.; Phadke, Aditi; Spurney, Christopher F.; Cnaan, Avital; Hoffman, Eric P.; Nagaraju, Kanneboyina] George Washington Univ, Sch Med & Hlth Sci, Childrens Natl Med Ctr, Ctr Genet Med Res,Dept Integrat Syst Biol, Washington, DC 20052 USA; [Spurney, Christopher F.] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA	Children's National Health System; George Washington University; Children's National Health System	Nagaraju, K (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Childrens Natl Med Ctr, Ctr Genet Med Res,Dept Integrat Syst Biol, Washington, DC 20052 USA.	knagaraju@cnmcresearch.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021	Hoffman, Eric/0000-0001-6470-5139; Many, Gina/0000-0003-4779-1690	Charley's Fund; Department of Defense USAMRAA [W81XWH-05-1-0616]; Foundation to Eradicate Duchenne, Inc.; Muscular Dystrophy Association; National Institutes of Health [R01-AR050478, K26OD011171, 1U54HD053177]; National Center for Medical Rehabilitation Research/National Institute for Neurological Disorders and Stroke [2R24HD050846-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	Charley's Fund; Department of Defense USAMRAA(United States Department of Defense); Foundation to Eradicate Duchenne, Inc.; Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Medical Rehabilitation Research/National Institute for Neurological Disorders and Stroke; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided by Charley's Fund (http://www.charleysfund.com), the Department of Defense USAMRAA (W81XWH-05-1-0616), the Foundation to Eradicate Duchenne, Inc. (http://www.duchennemd.org), the Muscular Dystrophy Association, and the National Institutes of Health (R01-AR050478, K26OD011171, and 1U54HD053177). This work was also partially supported by the National Center for Medical Rehabilitation Research/National Institute for Neurological Disorders and Stroke (2R24HD050846-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard B, 2006, J MUSCLE RES CELL M, V27, P367, DOI 10.1007/s10974-006-9083-4; ALLEN DG, 1983, J PHYSIOL-LONDON, V345, P391, DOI 10.1113/jphysiol.1983.sp014984; Bensen ES, 1996, ARCH PHYS MED REHAB, V77, P512, DOI 10.1016/S0003-9993(96)90043-X; BERTORINI TE, 1982, NEUROLOGY, V32, P1088, DOI 10.1212/WNL.32.10.1088; Carlson CG, 1998, NEUROBIOL DIS, V5, P3, DOI 10.1006/nbdi.1998.0188; Chin ER, 1996, J PHYSIOL-LONDON, V491, P813, DOI 10.1113/jphysiol.1996.sp021259; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Consolino CM, 2004, J APPL PHYSIOL, V96, P633, DOI 10.1152/japplphysiol.00587.2003; De Luca A., 2008, USE TREADMILL WHEEL; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; DeLuca A, 1997, AM J PHYSIOL-CELL PH, V272, pC333, DOI 10.1152/ajpcell.1997.272.1.C333; Denlinger LC, 1996, J BIOL CHEM, V271, P337, DOI 10.1074/jbc.271.1.337; Devarajan P, 2000, AM J PHYSIOL-RENAL, V279, pF1132, DOI 10.1152/ajprenal.2000.279.6.F1132; DUNN JF, 1993, J NEUROL SCI, V114, P76, DOI 10.1016/0022-510X(93)90052-Z; FENG Y, 1994, J BIOL CHEM, V269, P13224; Gehrig SM, 2008, EXP PHYSIOL, V93, P1190, DOI 10.1113/expphysiol.2008.042838; Guerron AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011220; Hinoki A, 2006, PEDIATR SURG INT, V22, P915, DOI 10.1007/s00383-006-1767-8; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Ingalls CP, 1998, J APPL PHYSIOL, V85, P58, DOI 10.1152/jappl.1998.85.1.58; Isomoto H, 2007, J CLIN BIOCHEM NUTR, V41, P84, DOI 10.3164/jcbn.2007012; Ito K, 2007, J PHARMACOL EXP THER, V323, P308, DOI 10.1124/jpet.107.121350; KERR LM, 1983, EXP NEUROL, V82, P203, DOI 10.1016/0014-4886(83)90255-8; Lamb GD, 1995, J PHYSIOL-LONDON, V489, P349, DOI 10.1113/jphysiol.1995.sp021056; LEON SH, 1986, GASTROENTEROLOGY, V90, P455, DOI 10.1016/0016-5085(86)90948-0; MAEDA M, 1994, J BIOCHEM-TOKYO, V115, P6, DOI 10.1093/oxfordjournals.jbchem.a124306; Nakagawa S, 2012, INFLAMMATION, V35, P1062, DOI 10.1007/s10753-011-9412-7; PATO CN, 1983, P NATL ACAD SCI-BIOL, V80, P4732, DOI 10.1073/pnas.80.15.4732; Rayavarapu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012981; Schmarda A, 2000, BRIT J PHARMACOL, V129, P598, DOI 10.1038/sj.bjp.0703070; SELLIN LC, 1978, EXP NEUROL, V62, P605, DOI 10.1016/0014-4886(78)90272-8; Spugnini EP, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-221; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Tanigawa T, 2009, J CLIN BIOCHEM NUTR, V45, P86, DOI 10.3164/jcbn.08-267; Tidball JG, 2000, INT J BIOCHEM CELL B, V32, P1, DOI 10.1016/S1357-2725(99)00095-3; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; WANDALL JH, 1992, GUT, V33, P617, DOI 10.1136/gut.33.5.617; Yoshida M, 2006, AM J PHYSIOL-REG I, V290, pR449, DOI 10.1152/ajpregu.00684.2004; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	40	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66617	10.1371/journal.pone.0066617	http://dx.doi.org/10.1371/journal.pone.0066617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843959	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000016
J	Franke, R; Hoerstgen-Schwark, G				Franke, Robert; Hoerstgen-Schwark, Gabriele			Lunar-Rhythmic Molting in Laboratory Populations of the Noble Crayfish Astacus astacus (Crustacea, Astacidea): An Experimental Analysis	PLOS ONE			English	Article							CRAB CARCINUS-MAENAS; SANDHOPPERS AMPHIPODA; CIRCADIAN RHYTHMS; SELFISH HERD; ORIENTATION; PERIODICITY; MOONLIGHT; TALITRIDAE; SYSTEMS; MOON	Juvenile noble crayfish, Astacus astacus (Crustacea, Astacidea) in the second year of age were kept in the laboratory for a twelve-month period under continuing "summer conditions" (LD 16: 8, 19 degrees C). Molting processes in this population could be synchronized by artificial moonlight cycles. Peaks of exuviations occurred at "new moons". Males showed a slightly higher degree of synchronization than females. A phase-shift of the artificial lunar cycle in relation to the natural cycle resulted in a corresponding shift of the molting cycle. This clearly demonstrates that changes in the nocturnal light regime provide the primary external information for the lunar-monthly molting rhythm. There is a first indication that lunar photic stimuli do not act directly but as a zeitgeber which entrains an endogenous molting rhythm to the lunar cycle. Moreover, the results of the long-term experiments suggest that the hibernal resting period of A. astacus in the field (no molts between October and April) may also involve some endogenous programming. Continuing artificial summer conditions can delay but not completely suppress this resting period. The adaptive significance of the phenomena and how the findings may be applied to improve the management of crowded crayfish stocks are discussed.	[Franke, Robert; Hoerstgen-Schwark, Gabriele] Univ Gottingen, Dept Anim Sci, Div Aquaculture & Freshwater Ecol, D-37073 Gottingen, Germany	University of Gottingen	Franke, R (corresponding author), Univ Gottingen, Dept Anim Sci, Div Aquaculture & Freshwater Ecol, D-37073 Gottingen, Germany.	robert.franke@gmx.de						Abello P, 1997, J MAR BIOL ASSOC UK, V77, P277, DOI 10.1017/S0025315400033981; Ackefors H, 1989, AQUACULTURE BIOTECHN, P356; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; ASCHOFF J, 1969, OECOLOGIA, V3, P125, DOI 10.1007/BF00416979; Batschelet E, 1981, CIRCULAR STAT BIOL; BROWN FA, 1976, BIOSYSTEMS, V8, P67, DOI 10.1016/0303-2647(76)90010-1; Charmantier-Daures M, 2004, CRUSTACEA, P161; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Conan G.Y., 1985, Crustacean Issues, V3, P73; CORBET PS, 1964, CAN ENTOMOL, V96, P264, DOI 10.4039/Ent96264-1; CULLEY DD, 1987, AQUACULTURE, V64, P343, DOI 10.1016/0044-8486(87)90197-9; Dacke M, 2004, P ROY SOC B-BIOL SCI, V271, P361, DOI 10.1098/rspb.2003.2594; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; ERKERT HG, 1974, OECOLOGIA, V14, P269, DOI 10.1007/BF01039797; Franke R, 2013, AQUAC RES, V44, P451, DOI 10.1111/j.1365-2109.2011.03052.x; Gwinner Eberhard, 1992, Verhandlungen der Deutschen Zoologischen Gesellschaft, V85, P201; Gydemo R., 1989, P383; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HAUENSCHILD C, 1960, COLD SPRING HARB SYM, V25, P491, DOI 10.1101/SQB.1960.025.01.051; HOFMANN J, 1971, FLUSSKREBSE; KLAPOW LA, 1972, BIOL BULL-US, V143, P568, DOI 10.2307/1540184; LANG HJ, 1977, J INTERDISCIPL CYCLE, V8, P317, DOI 10.1080/09291017709359593; LOHMANN KJ, 1987, SCIENCE, V235, P331, DOI 10.1126/science.3798115; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; Mercier A, 2007, MAR ECOL PROG SER, V329, P179, DOI 10.3354/meps329179; Morgan E, 2001, EARTH MOON PLANETS, V85-6, P279; Naylor E., 1985, Symposia of the Society for Experimental Biology, P63; Naylor E, 2001, EARTH MOON PLANETS, V85-6, P291, DOI 10.1023/A:1017088504226; Neumann D, 1985, Int J Biometeorol, V29 Suppl 2, P165; Neumann D, 1981, BIOL RHYTHMS, P351; Neumann D., 1987, COMP PHYSL ENV ADAPT, VIII, P152; Palmer JD, 1995, BIOL RHYTHMS CLOCKS; PAPI F, 1963, BIOL BULL, V124, P97, DOI 10.2307/1539571; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Pursiainen M., 1983, Freshwater Crayfish, V5, P392; REAKA ML, 1976, BIOL BULL, V150, P468, DOI 10.2307/1540686; SAIGUSA M, 1980, OECOLOGIA, V46, P38, DOI 10.1007/BF00346963; Smolian K, 1926, HDB BINNENFISCHERE A, V5A, P421; Sokol A., 1988, P401; Takemura A, 2010, J FISH BIOL, V76, P7, DOI 10.1111/j.1095-8649.2009.02481.x; TAUGBOL T, 1992, Aquaculture and Fisheries Management, V23, P411, DOI 10.1111/j.1365-2109.1992.tb00785.x; Ugolini A, 2003, P ROY SOC B-BIOL SCI, V270, P279, DOI 10.1098/rspb.2002.2221; Williams J.A., 1979, European Marine Biology Symposium, P407; WOLFE JL, 1989, ANIM BEHAV, V37, P410, DOI 10.1016/0003-3472(89)90088-2; YOUTHED GJ, 1969, J INSECT PHYSIOL, V15, P1259, DOI 10.1016/0022-1910(69)90235-2; Zeng C, 1997, MAR BIOL, V128, P299, DOI 10.1007/s002270050095; Zeng CS, 1999, MAR ECOL PROG SER, V191, P257, DOI 10.3354/meps191257	47	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68653	10.1371/journal.pone.0068653	http://dx.doi.org/10.1371/journal.pone.0068653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840899	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900038
J	Curra, C; Di Luca, M; Picci, L; dos Santos, CDSG; Siden-Kiamos, I; Pace, T; Ponzi, M				Curra, Chiara; Di Luca, Marco; Picci, Leonardo; Silva Gomes dos Santos, Carina de Sousa; Siden-Kiamos, Inga; Pace, Tomasino; Ponzi, Marta			The ETRAMP Family Member SEP2 Is Expressed throughout Plasmodium berghei Life Cycle and Is Released during Sporozoite Gliding Motility	PLOS ONE			English	Article							MALARIA CIRCUMSPOROZOITE PROTEIN; HOST CELL INTERFACE; PROTECTIVE ANTIGEN; STAGE; PARASITE; INVASION; INFECTION; DEPLETION; OOCYST; FALCIPARUM	The early transcribed membrane proteins ETRAMPs belong to a family of small, transmembrane molecules unique to Plasmodium parasite, which share a signal peptide followed by a short lysine-rich stretch, a transmembrane domain and a variable, highly charged C-terminal region. ETRAMPs are usually expressed in a stage-specific manner. In the blood stages they localize to the parasitophorous vacuole membrane and, in described cases, to vesicle-like structures exported to the host erythrocyte cytosol. Two family members of the rodent parasite Plasmodium berghei, uis3 and uis4, localize to secretory organelles of sporozoites and to the parasitophorous membrane vacuole of the liver stages. By the use of specific antibodies and the generation of transgenic lines, we showed that the P. berghei ETRAMP family member SEP2 is abundantly expressed in gametocytes as well as in mosquito and liver stages. In intracellular parasite stages, SEP2 is routed to the parasitophorous vacuole membrane while, in invasive ookinete and sporozoite stages, it localizes to the parasite surface. To date SEP2 is the only ETRAMP protein detected throughout the parasite life cycle. Furthermore, SEP2 is also released during gliding motility of salivary gland sporozoites. A limited number of proteins are known to be involved in this key function and the best characterized, the CSP and TRAP, are both promising transmission-blocking candidates. Our results suggest that ETRAMP members may be viewed as new potential candidates for malaria control.	[Curra, Chiara; Di Luca, Marco; Picci, Leonardo; Pace, Tomasino; Ponzi, Marta] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Silva Gomes dos Santos, Carina de Sousa] Inst Mol Med, Lisbon, Portugal; [Siden-Kiamos, Inga] FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece	Istituto Superiore di Sanita (ISS); Universidade de Lisboa; Foundation for Research & Technology - Hellas (FORTH)	Ponzi, M (corresponding author), Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.	marta.ponzi@iss.it	Di Luca, Marco/C-4966-2016	Di Luca, Marco/0000-0003-1442-3672; Ponzi, Marta/0000-0003-0936-3548; Picci, Leonardo/0000-0002-1263-1307; Curra, Chiara/0000-0001-7851-1087	OzMalNet fund of the EVIMalaR Network of Excellence enabled ISK to carry out the deconvolution microscopy experiments at the Bio21 Institute, University of Melbourne; European Community [242095]; Italian FLAGSHIP "InterOmics'' project [PB.P05]; MIUR	OzMalNet fund of the EVIMalaR Network of Excellence enabled ISK to carry out the deconvolution microscopy experiments at the Bio21 Institute, University of Melbourne; European Community(European Commission); Italian FLAGSHIP "InterOmics'' project; MIUR(Ministry of Education, Universities and Research (MIUR))	A travel grant from the OzMalNet fund of the EVIMalaR Network of Excellence enabled ISK to carry out the deconvolution microscopy experiments at the Bio21 Institute, University of Melbourne. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 242095 and from The Italian FLAGSHIP "InterOmics'' project (PB.P05) funded by MIUR and coordinated by the CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1981, J IMMUNOL, V126, P2494; Birago C, 2003, MOL BIOCHEM PARASIT, V126, P209, DOI 10.1016/S0166-6851(02)00275-X; Curra C, 2012, TRAFFIC, V13, P388, DOI 10.1111/j.1600-0854.2011.01313.x; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Duffy PE, 2012, EXPERT REV VACCINES, V11, P1261, DOI [10.1586/ERV.12.92, 10.1586/erv.12.92]; Engelmann S, 2009, EUKARYOT CELL, V8, P640, DOI 10.1128/EC.00347-08; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hugel FU, 1996, MOL BIOCHEM PARASIT, V81, P151, DOI 10.1016/0166-6851(96)02701-6; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; JANSE CJ, 1992, EXP PARASITOL, V74, P1, DOI 10.1016/0014-4894(92)90133-U; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kappe SHI, 2004, ANNU REV CELL DEV BI, V20, P29, DOI 10.1146/annurev.cellbio.20.011603.150935; Kappe SHI, 2003, TRENDS PARASITOL, V19, P135, DOI 10.1016/S1471-4922(03)00007-2; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Labaied M, 2007, MOL BIOCHEM PARASIT, V153, P158, DOI 10.1016/j.molbiopara.2007.03.001; Lal K, 2009, PROTEOMICS, V9, P1142, DOI 10.1002/pmic.200800404; Laurentino EC, 2011, CELL MICROBIOL, V13, P1956, DOI 10.1111/j.1462-5822.2011.01683.x; Liehl P, 2010, CELL MICROBIOL, V12, P506, DOI 10.1111/j.1462-5822.2009.01411.x; MacKellar DC, 2011, CELL MICROBIOL, V13, P1755, DOI 10.1111/j.1462-5822.2011.01656.x; MacKellar DC, 2010, EUKARYOT CELL, V9, P784, DOI 10.1128/EC.00336-09; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Menard R, 2001, CELL MICROBIOL, V3, P63, DOI 10.1046/j.1462-5822.2001.00097.x; MESZOELY CAM, 1989, AM J TROP MED HYG, V41, P499, DOI 10.4269/ajtmh.1989.41.499; Mikolajczak SA, 2007, INT J PARASITOL, V37, P483, DOI 10.1016/j.ijpara.2007.01.002; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Myung JM, 2004, MOL BIOCHEM PARASIT, V133, P53, DOI 10.1016/j.molbiopara.2003.09.002; Pace T, 2006, MOL MICROBIOL, V60, P870, DOI 10.1111/j.1365-2958.2006.05141.x; Pace T, 2000, GENOME RES, V10, P1414, DOI 10.1101/gr.140000; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Sharma A, 2008, J BIOL CHEM, V283, P24077, DOI 10.1074/jbc.M801946200; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; Sinden Robert E, 2002, Methods Mol Med, V72, P25, DOI 10.1385/1-59259-271-6:25; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; Thathy V, 2002, EMBO J, V21, P1586, DOI 10.1093/emboj/21.7.1586; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Van Lin LH, 1997, MOL BIOCHEM PARASIT, V85, P111; Vaughan AM, 2008, CELL HOST MICROBE, V4, P209, DOI 10.1016/j.chom.2008.08.010; Wang Q, 2005, CELL MICROBIOL, V7, P1616, DOI 10.1111/j.1462-5822.2005.00579.x; YOSHIDA N, 1981, J EXP MED, V154, P1225, DOI 10.1084/jem.154.4.1225; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745	44	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67238	10.1371/journal.pone.0067238	http://dx.doi.org/10.1371/journal.pone.0067238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840634	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400045
J	Herr, MJ; Kotha, J; Hagedorn, N; Smith, B; Jennings, LK				Herr, Michael J.; Kotha, Jayaprakash; Hagedorn, Nikolaus; Smith, Blake; Jennings, Lisa K.			Tetraspanin CD9 Promotes the Invasive Phenotype of Human Fibrosarcoma Cells via Upregulation of Matrix Metalloproteinase-9	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; COLON-CARCINOMA CELLS; BREAST-CANCER CELLS; TISSUE INHIBITOR; DOWN-REGULATION; EXTRACELLULAR LOOP; GENE-EXPRESSION; LUNG-CANCER; METASTASIS; ACTIVATION	Tumor cell metastasis, a process which increases the morbidity and mortality of cancer patients, is highly dependent upon matrix metalloproteinase (MMP) production. Small molecule inhibitors of MMPs have proven unsuccessful at reducing tumor cell invasion in vivo. Therefore, finding an alternative approach to regulate MMP is an important endeavor. Tetraspanins, a family of cell surface organizers, play a major role in cell signaling events and have been implicated in regulating metastasis in numerous cancer cell lines. We stably expressed tetraspanin CD9 in an invasive and metastatic human fibrosarcoma cell line (CD9-HT1080) to investigate its role in regulating tumor cell invasiveness. CD9-HT1080 cells displayed a highly invasive phenotype as demonstrated by matrigel invasion assays. Statistically significant increases in MMP-9 production and activity were attributed to CD9 expression and were not due to any changes in other key tetraspanin complex members or MMP regulators. Increased invasion of CD9-HT1080 cells was reversed upon silencing of MMP-9 using a MMP-9 specific siRNA. Furthermore, we determined that the second extracellular loop of CD9 was responsible for the upregulation of MMP-9 production and subsequent cell invasion. We demonstrated for the first time that tetraspanin CD9 controls HT1080 cell invasion via upregulation of an integral member of the MMP family, MMP-9. Collectively, our studies provide mounting evidence that altered expression of CD9 may be a novel approach to regulate tumor cell progression.	[Herr, Michael J.; Hagedorn, Nikolaus; Smith, Blake; Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr Excellence, Memphis, TN 38163 USA; [Herr, Michael J.; Hagedorn, Nikolaus; Smith, Blake; Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Dept Internal Med, Memphis, TN 38163 USA; [Herr, Michael J.; Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Dept Biochem Microbiol & Immunol, Memphis, TN 38163 USA; [Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Joint Program Biomed Engn, Memphis, TN 38163 USA; [Jennings, Lisa K.] Univ Memphis, Memphis, TN 38152 USA; [Kotha, Jayaprakash; Jennings, Lisa K.] CirQuest Labs LLC, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis	Jennings, LK (corresponding author), Univ Tennessee, Ctr Hlth Sci, Vasc Biol Ctr Excellence, Memphis, TN 38163 USA.	ljennings@uthsc.edu		, Michael/0000-0002-8895-7733	American Heart Association Grant [11GRNT7590037]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007405] Funding Source: NIH RePORTER	American Heart Association Grant(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an American Heart Association Grant #11GRNT7590037 awarded to Dr. Lisa K. Jennings. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarre M, 2012, J CELL SCI, V125, P3858, DOI 10.1242/jcs.104018; Berditchevski F, 2001, J CELL SCI, V114, P4143; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Chen SL, 2011, MOL CELL BIOCHEM, V350, P89, DOI 10.1007/s11010-010-0685-1; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Cho SJ, 2008, MOL MED REP, V1, P83; Close DR, 2001, ANN RHEUM DIS, V60, pIII62; Cook GA, 2002, BLOOD, V100, P4502, DOI 10.1182/blood.V100.13.4502; Fujita Y, 2006, ARTHRITIS RHEUM-US, V54, P3233, DOI 10.1002/art.22140; Funakoshi T, 2003, ONCOGENE, V22, P674, DOI 10.1038/sj.onc.1206106; Furuya M, 2005, CANCER RES, V65, P2617, DOI 10.1158/0008-5472.CAN-04-3123; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; Hanyu A, 2009, CANCER SCI, V100, P2085, DOI 10.1111/j.1349-7006.2009.01305.x; Hasuwa H, 2001, BIOCHEM BIOPH RES CO, V289, P782, DOI 10.1006/bbrc.2001.6053; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Hori H, 2004, J SURG RES, V117, P208, DOI 10.1016/j.jss.2004.01.014; Hwang JR, 2012, CARCINOGENESIS, V33, P77, DOI 10.1093/carcin/bgr257; Iwasaki T, 2012, J BIOL CHEM; Jee BK, 2006, BIOCHEM BIOPH RES CO, V342, P655, DOI 10.1016/j.bbrc.2006.01.153; JENNINGS LK, 1990, J BIOL CHEM, V265, P3815; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kanetaka K, 2003, J GASTROEN HEPATOL, V18, P1309, DOI 10.1046/j.1440-1746.2003.03182.x; Kischel P, 2012, ANTICANCER RES, V32, P5211; Kohno M, 2002, INT J CANCER, V97, P336, DOI 10.1002/ijc.1605; Kotha J, 2008, EXP CELL RES, V314, P1811, DOI 10.1016/j.yexcr.2008.01.024; Kotha J, 2009, ATHEROSCLEROSIS, V203, P377, DOI 10.1016/j.atherosclerosis.2008.07.036; Lafleur MA, 2009, MOL BIOL CELL, V20, P2030, DOI 10.1091/mbc.E08-11-1149; Leco KJ, 1997, FEBS LETT, V401, P213, DOI 10.1016/S0014-5793(96)01474-3; Longhurst CM, 2002, J BIOL CHEM, V277, P32445, DOI 10.1074/jbc.M204420200; Murayama Y, 2008, J CELL PHYSIOL, V216, P135, DOI 10.1002/jcp.21384; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamoto T, 2009, J GASTROENTEROL, V44, P889, DOI 10.1007/s00535-009-0081-3; Nakazawa Y, 2008, BLOOD, V112, P1730, DOI 10.1182/blood-2007-11-124693; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Ovalle S, 2007, INT J CANCER, V121, P2140, DOI 10.1002/ijc.22902; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Peterfia B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039474; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548; Saito Y, 2006, CANCER RES, V66, P9557, DOI 10.1158/0008-5472.CAN-06-1131; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; Sordat I, 2002, LAB INVEST, V82, P1715, DOI 10.1097/01.LAB.0000044350.18215.0D; Soyuer S, 2010, PATHOL RES PRACT, V206, P607, DOI 10.1016/j.prp.2010.04.004; Takeda Y, 2008, J BIOL CHEM, V283, P26089, DOI 10.1074/jbc.M801902200; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Testa JE, 1999, CANCER RES, V59, P3812; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Tohami T, 2007, FASEB J, V21, P691, DOI 10.1096/fj.06-6610com; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang HX, 2011, BIOCHEM SOC T, V39, P547, DOI 10.1042/BST0390547; Wang JC, 2007, CLIN CANCER RES, V13, P2354, DOI 10.1158/1078-0432.CCR-06-1692; Yanez-Mo M, 2008, BLOOD, V112, P3217, DOI 10.1182/blood-2008-02-139394; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zhang C, 2010, BMB REP, V43, P62, DOI 10.5483/BMBRep.2010.43.1.062; Zhu GZ, 2002, DEVELOPMENT, V129, P1995; Zhu XS, 2012, CLIN LAB, V58, P313; Zhu XS, 2011, J BIOCHEM, V149, P405, DOI 10.1093/jb/mvr016; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Zoller M, 2006, Z GASTROENTEROL, V44, P573, DOI 10.1055/s-2006-926795; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097; Zvierev V, 2005, BIOCHEM BIOPH RES CO, V337, P498, DOI 10.1016/j.bbrc.2005.09.073	62	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67766	10.1371/journal.pone.0067766	http://dx.doi.org/10.1371/journal.pone.0067766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840773	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400134
J	Moser, LA; Pollard, AM; Knoll, LJ				Moser, Lindsey A.; Pollard, Angela M.; Knoll, Laura J.			A Genome-Wide siRNA Screen to Identify Host Factors Necessary for Growth of the Parasite Toxoplasma gondii	PLOS ONE			English	Article							EXON JUNCTION COMPLEX; MESSENGER-RNA; HUMAN FIBROBLASTS; GENE-EXPRESSION; KINASES; EXPORT	Toxoplasma gondii is an obligate intracellular parasite that is able to infect virtually any nucleated cell of all warm-blooded animals. The host cell factors important for parasite attachment, invasion, and replication are poorly understood. We screened a siRNA library targeting 18,200 individual human genes in order to identify host proteins with a role in T. gondii growth. Our screen identified 19 genes whose inhibition by siRNA consistently and significantly lowered parasite replication. The gene ontology categories for those 19 genes represented a wide variety of functions with several genes implicated in regulation of the cell cycle, ion channels and receptors, G-protein coupled receptors, and cytoskeletal structure as well as genes involved in transcription, translation and protein degradation. Further investigation of 5 of the 19 genes demonstrated that the primary reason for the reduction in parasite growth was death of the host cell. Our results suggest that once T. gondii has invaded and established an infection, global changes in the host cell may be necessary to reduce parasite replication. While siRNA screens have been used, albeit rarely, in other parasite systems, this is the first report to describe a high-throughput siRNA screen for host proteins that affect T. gondii replication.	[Moser, Lindsey A.; Knoll, Laura J.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Pollard, Angela M.] Agile Sci Inc, Raleigh, NC USA	University of Wisconsin System; University of Wisconsin Madison	Knoll, LJ (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	ljknoll@wisc.edu			Lead Development Initiative of the Wisconsin Alumni Research Foundation; University of Wisconsin-Madison Small Molecule Screening and Synthesis Facility; American Heart Association [0840059N]; National Institutes of Health (NIH) [NSRA AI072817]; Hartwell Foundation postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI072817] Funding Source: NIH RePORTER	Lead Development Initiative of the Wisconsin Alumni Research Foundation; University of Wisconsin-Madison Small Molecule Screening and Synthesis Facility; American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Lead Development Initiative of the Wisconsin Alumni Research Foundation and the University of Wisconsin-Madison Small Molecule Screening and Synthesis Facility, the American Heart Association 0840059N (Laura J. Knoll), a National Institutes of Health (NIH) NSRA AI072817 (Angela M. Pollard) and The Hartwell Foundation postdoctoral fellowship (Lindsey A. Moser) (http://www.thehartwellfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Hye-Jin, 2007, Korean Journal of Parasitology, V45, P165, DOI 10.3347/kjp.2007.45.3.165; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Custodio N, 2004, RNA, V10, P622, DOI 10.1261/rna.5258504; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dubey JP, 2009, INT J PARASITOL, V39, P877, DOI 10.1016/j.ijpara.2009.01.005; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; Genovesio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019733; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Hautbergue GM, 2008, P NATL ACAD SCI USA, V105, P5154, DOI 10.1073/pnas.0709167105; Hill RD, 2012, INFECT IMMUN, V80, P968, DOI 10.1128/IAI.05421-11; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Kumar M, 2011, MICROB PATHOGENESIS, V50, P31, DOI 10.1016/j.micpath.2010.10.003; Lavine MD, 2009, MOL BIOCHEM PARASIT, V164, P95, DOI 10.1016/j.molbiopara.2008.11.014; Molestina RE, 2008, CELL MICROBIOL, V10, P1153, DOI 10.1111/j.1462-5822.2008.01117.x; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Nash PB, 1998, J IMMUNOL, V160, P1824; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Pendergast AM, 1996, CURR OPIN CELL BIOL, V8, P174, DOI 10.1016/S0955-0674(96)80063-9; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Sato M, 2010, NUCLEUS-PHILA, V1, P231, DOI 10.1038/embor.2009.158; Shapira S, 2005, J CELL SCI, V118, P3501, DOI 10.1242/jcs.02428; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Sibley LD, 2000, TRAFFIC, V1, P100, DOI 10.1034/j.1600-0854.2000.010202.x; Sorensen CS, 2012, NUCLEIC ACIDS RES, V40, P477, DOI 10.1093/nar/gkr697; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Walker' ME, 2008, MICROBES INFECT, V10, P1440, DOI 10.1016/j.micinf.2008.08.014; Xiao JC, 2011, INFECT IMMUN, V79, P1363, DOI 10.1128/IAI.00947-10; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782	35	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68129	10.1371/journal.pone.0068129	http://dx.doi.org/10.1371/journal.pone.0068129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840822	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400166
J	Muili, KA; Gopalakrishnan, S; Eells, JT; Lyons, JA				Muili, Kamaldeen A.; Gopalakrishnan, Sandeep; Eells, Janis T.; Lyons, Jeri-Anne			Photobiomodulation Induced by 670 nm Light Ameliorates MOG35-55 Induced EAE in Female C57BL/6 Mice: A Role for Remediation of Nitrosative Stress	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NITRIC-OXIDE SYNTHASE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NEAR-INFRARED LIGHT; LEVEL LASER THERAPY; EMITTING DIODE IRRADIATION; MULTIPLE-SCLEROSIS; OXIDATIVE STRESS; INDUCED NEUROTOXICITY; DOSE-RESPONSE	Background: Experimental autoimmune encephalomyelitis (EAE) is the most commonly studied animal model of multiple sclerosis (MS), a chronic autoimmune demyelinating disorder of the central nervous system. Immunomodulatory and immunosuppressive therapies currently approved for the treatment of MS slow disease progression, but do not prevent it. A growing body of evidence suggests additional mechanisms contribute to disease progression. We previously demonstrated the amelioration of myelin oligodendrocyte glycoprotein (MOG)-induced EAE in C57BL/6 mice by 670 nm light-induced photobiomodulation, mediated in part by immune modulation. Numerous other studies demonstrate that near-infrared/far red light is therapeutically active through modulation of nitrosoxidative stress. As nitric oxide has been reported to play diverse roles in EAE/MS, and recent studies suggest that axonal loss and progression of disability in MS is mediated by nitrosoxidative stress, we investigated the effect of 670 nm light treatment on nitrosative stress in MOG-induced EAE. Methodology: Cell culture experiments demonstrated that 670 nm light-mediated photobiomodulation attenuated antigen-specific nitric oxide production by heterogenous lymphocyte populations isolated from MOG immunized mice. Experiments in the EAE model demonstrated down-regulation of inducible nitric oxide synthase (iNOS) gene expression in the spinal cords of mice with EAE over the course of disease, compared to sham treated animals. Animals receiving 670 nm light treatment also exhibited up-regulation of the Bcl-2 anti-apoptosis gene, an increased Bcl-2: Bax ratio, and reduced apoptosis within the spinal cord of animals over the course of disease. 670 nm light therapy failed to ameliorate MOG-induced EAE in mice deficient in iNOS, confirming a role for remediation of nitrosative stress in the amelioration of MOG-induced EAE by 670 nm mediated photobiomodulation. Conclusions: These data indicate that 670 nm light therapy protects against nitrosative stress and apoptosis within the central nervous system, contributing to the clinical effect of 670 nm light therapy previously noted in the EAE model.	[Muili, Kamaldeen A.; Gopalakrishnan, Sandeep; Eells, Janis T.; Lyons, Jeri-Anne] Univ Wisconsin, Dept Biomed Sci, Coll Hlth Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Lyons, JA (corresponding author), Univ Wisconsin, Dept Biomed Sci, Coll Hlth Sci, Milwaukee, WI 53201 USA.	jlyons@uwm.edu			Quantum Biomedical; Graduate School, UW-Milwaukee; College of Health Sciences, UW-Milwaukee	Quantum Biomedical; Graduate School, UW-Milwaukee; College of Health Sciences, UW-Milwaukee	Funding was provided by Quantum Biomedical; Graduate School, UW-Milwaukee; and the College of Health Sciences, UW-Milwaukee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankri R, 2010, LASER SURG MED, V42, P348, DOI 10.1002/lsm.20849; Arany PR, 2007, WOUND REPAIR REGEN, V15, P866, DOI 10.1111/j.1524-475X.2007.00306.x; Brenner T, 1997, J IMMUNOL, V158, P2940; Calabrese V, 2002, J NEUROSCI RES, V70, P580, DOI 10.1002/jnr.10408; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chung H, 2011, ANN BIOMEDICAL ENG; Cross AH, 2006, J NEUROIMMUNOL, V173, P79, DOI 10.1016/j.jneuroim.2005.11.022; Cross AH, 1996, J NEUROIMMUNOL, V71, P145, DOI 10.1016/S0165-5728(96)00147-6; CROSS AH, 1994, J CLIN INVEST, V93, P2684, DOI 10.1172/JCI117282; Croxford AL, 2011, BBA-MOL BASIS DIS, V1812, P177, DOI 10.1016/j.bbadis.2010.06.010; Das A, 2008, J NEUROSCI RES, V86, P2992, DOI 10.1002/jnr.21737; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Eells JT, 2004, INVEST OPHTH VIS SCI, V45, P828; Eells JT, 2008, LIGHT ACTIVATED TISS, P39; Espejo C, 2002, EXP NEUROL, V177, P21, DOI 10.1006/exnr.2002.7982; Fenyk-Melody JE, 1998, J IMMUNOL, V160, P2940; Gavish L, 2008, LASER SURG MED, V40, P371, DOI 10.1002/lsm.20635; Hamblin MR, 2006, PROC SPIE, V6140, DOI 10.1117/12.646294; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hooper DC, 1997, P NATL ACAD SCI USA, V94, P2528, DOI 10.1073/pnas.94.6.2528; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Jendrysik MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028198; Jolivalt CG, 2003, J NEUROIMMUNOL, V138, P56, DOI 10.1016/S0165-5728(03)00097-3; Li S, 2011, NEUROSCIENCE, V184, P107, DOI 10.1016/j.neuroscience.2011.04.007; Li XH, 2010, J NEUROSCI RES, V88, P1858, DOI 10.1002/jnr.22355; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Lim J, 2008, J BIOCHEM MOL TOXIC, V22, P230, DOI 10.1002/jbt.20233; Lim J, 2009, J BIOCHEM MOL TOXIC, V23, P1, DOI 10.1002/jbt.20257; LYONS RF, 1987, ANN PLAS SURG, V18, P47, DOI 10.1097/00000637-198701000-00011; Muili KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030655; O'Brien NC, 1999, J IMMUNOL, V163, P6841; O'Brien NC, 2001, J IMMUNOL, V167, P5904, DOI 10.4049/jimmunol.167.10.5904; Offen D, 2000, J MOL NEUROSCI, V15, P167, DOI 10.1385/JMN:15:3:167; Okuda Y, 1998, J NEUROIMMUNOL, V81, P201, DOI 10.1016/S0165-5728(97)00180-X; Okuda Y, 1997, J NEUROIMMUNOL, V73, P107, DOI 10.1016/S0165-5728(96)00194-4; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027739; Poyton RO, 2011, DISCOV MED, V11, P154; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P681, DOI 10.1167/iovs.06-0553; Qi XP, 2006, J BIOL CHEM, V281, P31950, DOI 10.1074/jbc.M603717200; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Sharma SK, 2011, LASER SURG MED, V43, P851, DOI 10.1002/lsm.21100; Song S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-219; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Whelan HT, 2003, J CLIN LASER MED SUR, V21, P67, DOI 10.1089/104454703765035484; Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758; Xiao BG, 2008, MOL IMMUNOL, V45, P1191, DOI 10.1016/j.molimm.2007.07.003; Ying R, 2008, BRAIN RES, V1243, P167, DOI 10.1016/j.brainres.2008.09.057; Yoo BK, 2008, NEUROCHEM INT, V52, P1188, DOI 10.1016/j.neuint.2007.12.009; Zhao WG, 1996, J NEUROIMMUNOL, V64, P123, DOI 10.1016/0165-5728(95)00158-1; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200	53	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67358	10.1371/journal.pone.0067358	http://dx.doi.org/10.1371/journal.pone.0067358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840675	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400066
J	Prass, M; Grimsen, C; Konig, M; Fahle, M				Prass, Maren; Grimsen, Cathleen; Koenig, Martina; Fahle, Manfred			Ultra Rapid Object Categorization: Effects of Level, Animacy and Context	PLOS ONE			English	Article							NATURAL SCENE CATEGORIZATION; BASIC-LEVEL; TIME-COURSE; TOP-DOWN; SPATIAL-FREQUENCIES; VISUAL FEATURES; PERCEPTION; RECOGNITION; SPEED; REPRESENTATIONS	It is widely agreed that in object categorization bottom-up and top-down influences interact. How top-down processes affect categorization has been primarily investigated in isolation, with only one higher level process at a time being manipulated. Here, we investigate the combination of different top-down influences (by varying the level of category, the animacy and the background of the object) and their effect on rapid object categorization. Subjects participated in a two-alternative forced choice rapid categorization task, while we measured accuracy and reaction times. Subjects had to categorize objects on the superordinate, basic or subordinate level. Objects belonged to the category animal or vehicle and each object was presented on a gray, congruent (upright) or incongruent (inverted) background. The results show that each top-down manipulation impacts object categorization and that they interact strongly. The best categorization was achieved on the superordinate level, providing no advantage for basic level in rapid categorization. Categorization between vehicles was faster than between animals on the basic level and vice versa on the subordinate level. Objects in homogenous gray background (context) yielded better overall performance than objects embedded in complex scenes, an effect most prominent on the subordinate level. An inverted background had no negative effect on object categorization compared to upright scenes. These results show how different top-down manipulations, such as category level, category type and background information, are related. We discuss the implications of top-down interactions on the interpretation of categorization results.	[Prass, Maren; Grimsen, Cathleen; Koenig, Martina; Fahle, Manfred] Univ Bremen, Ctr Cognit Sci, D-28359 Bremen, Germany; [Fahle, Manfred] City Univ London, Henry Wellcome Labs Vis Sci, London EC1V 0HB, England	University of Bremen; City University London	Prass, M (corresponding author), Univ Bremen, Ctr Cognit Sci, D-28359 Bremen, Germany.	mprass@uni-bremen.de		Grimsen, Cathleen/0000-0003-3985-3695; Prass, Maren/0000-0003-1236-658X				Bar M, 1996, PERCEPTION, V25, P343, DOI 10.1068/p250343; Bell AH, 2009, J NEUROPHYSIOL, V101, P688, DOI 10.1152/jn.90657.2008; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; BROWN R, 1958, PSYCHOL REV, V65, P14, DOI 10.1037/h0041727; Bussey TJ, 2002, EUR J NEUROSCI, V15, P355, DOI 10.1046/j.0953-816x.2001.01850.x; Chao LL, 2002, CEREB CORTEX, V12, P545, DOI 10.1093/cercor/12.5.545; Cohen MA, 2011, PSYCHOL SCI, V22, P1165, DOI 10.1177/0956797611419168; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P1, DOI 10.20982/tqmp.011.p001; Crouzet SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051471; Crouzet SM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00326; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Delorme A, 2004, COGNITIVE BRAIN RES, V19, P103, DOI 10.1016/j.cogbrainres.2003.11.010; Delorme A, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00021; Evans KK, 2005, J EXP PSYCHOL HUMAN, V31, P1476, DOI 10.1037/0096-1523.31.6.1476; Fabre-Thorpe M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00243; Fenske MJ, 2006, PROG BRAIN RES, V155, P3, DOI 10.1016/S0079-6123(06)55001-0; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gerlach C, 2007, J COGNITIVE NEUROSCI, V19, P296, DOI 10.1162/jocn.2007.19.2.296; Goffaux V, 2011, CEREB CORTEX, V21, P467, DOI 10.1093/cercor/bhq112; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Harel A, 2011, J VISION, V11, DOI 10.1167/11.8.18; Harel A, 2009, J EXP PSYCHOL HUMAN, V35, P1264, DOI 10.1037/a0013621; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hollingworth A, 1998, J EXP PSYCHOL GEN, V127, P398, DOI 10.1037/0096-3445.127.4.398; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; Johnson KE, 1997, J EXP PSYCHOL GEN, V126, P248, DOI 10.1037/0096-3445.126.3.248; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Joubert OR, 2008, J VISION, V8, DOI 10.1167/8.13.11; Kiefer M, 2001, MEM COGNITION, V29, P100, DOI 10.3758/BF03195745; Kveraga K, 2011, P NATL ACAD SCI USA, V108, P3389, DOI 10.1073/pnas.1013760108; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Loschky LC, 2010, VIS COGN, V18, P513, DOI 10.1080/13506280902937606; Mace MJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005927; Mack ML, 2010, J VISION, V10, DOI 10.1167/10.3.11; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; McMullen PA, 2006, BRAIN COGNITION, V62, P228, DOI 10.1016/j.bandc.2006.06.002; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Moss HE, 2000, NEUROPSYCHOLOGIA, V38, P60, DOI 10.1016/S0028-3932(99)00044-5; Naber M, 2012, J VISION, V12, DOI 10.1167/12.1.25; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Proverbio Alice M, 2007, BMC Neurosci, V8, P24, DOI 10.1186/1471-2202-8-24; Riddoch MJ, 2008, COGN NEUROPSYCHOL, V25, P56, DOI 10.1080/02643290701848901; Rieger JW, 2008, J EXP PSYCHOL HUMAN, V34, P56, DOI 10.1037/0096-1523.34.1.56; Rogers TT, 2007, J EXP PSYCHOL GEN, V136, P451, DOI 10.1037/0096-3445.136.3.451; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rousselet GA, 2005, VIS COGN, V12, P852, DOI 10.1080/13506280444000553; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Sun HM, 2011, BRAIN RES, V1398, P40, DOI 10.1016/j.brainres.2011.04.029; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029; Viggiano MP, 2006, ARCH GERONTOL GERIAT, V42, P329, DOI 10.1016/j.archger.2005.08.003; Viggiano MP, 2004, COGNITIVE BRAIN RES, V20, P519, DOI 10.1016/j.cogbrainres.2004.03.010; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829	65	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68051	10.1371/journal.pone.0068051	http://dx.doi.org/10.1371/journal.pone.0068051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840810	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400159
J	Riegel, JB; Bernhardt, E; Swenson, J				Riegel, Joseph B.; Bernhardt, Emily; Swenson, Jennifer			Estimating Above-Ground Carbon Biomass in a Newly Restored Coastal Plain Wetland Using Remote Sensing	PLOS ONE			English	Article							DISCRETE-RETURN LIDAR; STAND STRUCTURE; FOREST STANDS; FOOTPRINT	Developing accurate but inexpensive methods for estimating above-ground carbon biomass is an important technical challenge that must be overcome before a carbon offset market can be successfully implemented in the United States. Previous studies have shown that LiDAR (light detection and ranging) is well-suited for modeling above-ground biomass in mature forests; however, there has been little previous research on the ability of LiDAR to model above-ground biomass in areas with young, aggrading vegetation. This study compared the abilities of discrete-return LiDAR and high resolution optical imagery to model above-ground carbon biomass at a young restored forested wetland site in eastern North Carolina. We found that the optical imagery model explained more of the observed variation in carbon biomass than the LiDAR model (adj-R-2 values of 0.34 and 0.18 respectively; root mean squared errors of 0.14 Mg C/ha and 0.17 Mg C/ha respectively). Optical imagery was also better able to predict high and low biomass extremes than the LiDAR model. Combining both the optical and LiDAR improved upon the optical model but only marginally (adj-R-2 of 0.37). These results suggest that the ability of discrete-return LiDAR to model above-ground biomass may be rather limited in areas with young, small trees and that high spatial resolution optical imagery may be the better tool in such areas.	[Riegel, Joseph B.; Swenson, Jennifer] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Bernhardt, Emily] Duke Univ, Dept Biol, Durham, NC USA	Duke University; Duke University	Riegel, JB (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	ben.riegel@gmail.com	Bernhardt, Emily S/D-9940-2011; Bernhardt, Emily/B-4541-2010	Bernhardt, Emily S/0000-0003-3031-621X; Swenson, Jennifer J./0000-0002-2069-667X	Edna Bailey Sussman Fund; Great Dismal Mitigation Bank, Limited Liability Company; Department of Energy's National Institute of Climate Change Research; National Science Foundation Ecosystems Program [1021149]	Edna Bailey Sussman Fund; Great Dismal Mitigation Bank, Limited Liability Company; Department of Energy's National Institute of Climate Change Research(United States Department of Energy (DOE)); National Science Foundation Ecosystems Program	JBR received support for this study from the Edna Bailey Sussman Fund. Support and site access provided by the Great Dismal Mitigation Bank, Limited Liability Company and by grants from the Department of Energy's National Institute of Climate Change Research and from the National Science Foundation Ecosystems Program (DEB # 1021149) to ESB. LiDAR data provided by a grant from the National Center for Airborne Laser Mapping (NCALM) to Jennifer L. Morse. Funding agencies and property owners played no role in study design, data analysis, or preparation of the manuscript.	Ardon M, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001169; Asner GP, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034009; Baltsavias EP, 1999, ISPRS J PHOTOGRAMM, V54, P199, DOI 10.1016/S0924-2716(99)00015-5; CARTER LJ, 1975, SCIENCE, V189, P271, DOI 10.1126/science.189.4199.271; Chatterjee R, 2009, ENVIRON SCI TECHNOL, V43, P557, DOI 10.1021/es803353g; Clark AI, 1985, SE250 USDA FOR SERV, V250; COHEN WB, 1992, REMOTE SENS ENVIRON, V41, P1, DOI 10.1016/0034-4257(92)90056-P; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Evans JS, 2007, IEEE T GEOSCI REMOTE, V45, P1029, DOI 10.1109/TGRS.2006.890412; Evans J, 2009, PARLIAMENT AFF, V62, P1, DOI 10.1093/pa/gsn045; Fletcher LS, 2009, NORTH J APPL FOR, V26, P35, DOI 10.1093/njaf/26.1.35; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Gleason CJ, 2011, GISCI REMOTE SENS, V48, P141, DOI 10.2747/1548-1603.48.2.141; Gonzalez P, 2010, REMOTE SENS ENVIRON, V114, P1561, DOI 10.1016/j.rse.2010.02.011; Hall SA, 2005, FOREST ECOL MANAG, V208, P189, DOI 10.1016/j.foreco.2004.12.001; Hansen LT, 2009, J AGR RESOUR ECON, V34, P350; Jenkins JC, 2003, FOREST SCI, V49, P12; Lefsky MA, 2005, REMOTE SENS ENVIRON, V95, P532, DOI 10.1016/j.rse.2005.01.010; Lefsky MA, 2002, GLOBAL ECOL BIOGEOGR, V11, P393, DOI 10.1046/j.1466-822x.2002.00303.x; Lim K, 2003, PROG PHYS GEOG, V27, P88, DOI 10.1191/0309133303pp360ra; Means JE, 1999, REMOTE SENS ENVIRON, V67, P298, DOI 10.1016/S0034-4257(98)00091-1; Morse JL, 2012, ECOL APPL, V22, P264, DOI 10.1890/11-0527.1; Naesset E, 2001, REMOTE SENS ENVIRON, V78, P328, DOI 10.1016/S0034-4257(01)00228-0; Nelson L, 1975, MISS AGR FOR EXP STA, V73; Olander LP, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/025011; Phillips D, 1981, SE223 USDA FOR SERV, V223; Popescu SC, 2007, BIOMASS BIOENERG, V31, P646, DOI 10.1016/j.biombioe.2007.06.022; RICHARDSON CJ, 1983, BIOSCIENCE, V33, P626, DOI 10.2307/1309491; RITCHIE JC, 1995, J SOIL WATER CONSERV, V50, P440; Schlesinger WH., 1998, BIOGEOCHEMISTRY ANAL, V73, P353, DOI 10.1016/0016-7037(92)90106-s; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; Sexton JO, 2009, FOREST ECOL MANAG, V257, P1136, DOI 10.1016/j.foreco.2008.11.022; Smart LS, 2012, FOREST ECOL MANAG, V281, P100, DOI 10.1016/j.foreco.2012.06.020; Solomon S., 2007, PHYS SCI BASIS WORKI; Streutker DR, 2006, REMOTE SENS ENVIRON, V102, P135, DOI 10.1016/j.rse.2006.02.011; van Leeuwen M, 2010, EUR J FOREST RES, V129, P749, DOI 10.1007/s10342-010-0381-4; Wessels KJ, 2011, FOREST ECOL MANAG, V261, P19, DOI 10.1016/j.foreco.2010.09.012; Young HE, 1980, 230 U MAIN LIF SCI A, V230; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	40	19	19	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68251	10.1371/journal.pone.0068251	http://dx.doi.org/10.1371/journal.pone.0068251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840837	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400179
J	Webster, J; Kayentao, K; Bruce, J; Diawara, SI; Abathina, A; Haiballa, AA; Doumbo, OK; Hill, J				Webster, Jayne; Kayentao, Kassoum; Bruce, Jane; Diawara, Sory I.; Abathina, Amadou; Haiballa, Alhassane Ag; Doumbo, Ogobara K.; Hill, Jenny			Prevention of Malaria in Pregnancy with Intermittent Preventive Treatment and Insecticide Treated Nets in Mali: A Quantitative Health Systems Effectiveness Analysis	PLOS ONE			English	Article							ANTENATAL CARE; RURAL TANZANIA; COVERAGE; DELIVERY; SERVICES; FACILITY; QUALITY; AREA	Introduction: The objectives of the study were to evaluate the health system effectiveness of ANC for the delivery of a dose of IPTp and an ITN to women attending ANC during eligible gestation, and to identify the predictors of systems effectiveness. Methods: A cross sectional study was undertaken in 10 health facilities including structured non-participant observations of the ANC process for 780 pregnant women followed by exit interviews. The proportion of pregnant women receiving a dose of IPTp-SP and an ITN was assessed. Predictors of each ineffective intermediate process were identified using multivariable logistic regression. Results: Overall, 0% and 24.5% of pregnant women of eligible gestation on the first visit to ANC received a dose of IPTp-SP by DOT at the district and community levels respectively. Ineffective intermediate processes were 'given IPTp-SP at the ANC' 63.9% and 74.0% (95% CI 62.0, 83.3), and 'given IPTp-SP by DOT' 0% and 34.3% (95% CI 10.5, 69.8), at district and community levels, respectively. Delivery of ITNs was effective where they were in stock; however stock-outs were a problem. Predictors of receiving IPTp-SP at the district level were 4 to 6 months gestation, not reporting symptoms of malaria at ANC visit and the amount of money spent during the visit. At the community level, the predictors were 4 to 6 months gestation, maternal education below primary level, routine ANC visit (not for an illness), palpation of the abdomen, and expenditure of money in ANC. Conclusion: In Segou District, the delivery of IPTp-SP was ineffective; whilst ITN delivery was effective if ITNs were in stock. Predictors of receiving IPTp-SP at the district and community levels included gestational age, the amount of expenditure during the ANC visit and no illness.	[Webster, Jayne; Bruce, Jane] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Kayentao, Kassoum; Diawara, Sory I.; Abathina, Amadou; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Kayentao, Kassoum; Hill, Jenny] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Haiballa, Alhassane Ag] Programme Natl Lutte Paludisme, Bamako, Mali	University of London; London School of Hygiene & Tropical Medicine; University of Bamako; Liverpool School of Tropical Medicine; University of Liverpool	Webster, J (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	Jayne.webster@lshtm.ac.uk	Hill, Jenny/C-3839-2017	Hill, Jenny/0000-0003-1588-485X; Webster, Jayne/0000-0002-0498-8883	Malaria in Pregnancy Consortium through Bill & Melinda Gates Foundation	Malaria in Pregnancy Consortium through Bill & Melinda Gates Foundation	The study was funded by the Malaria in Pregnancy Consortium which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2007, ENQ DEM SANT MAL 200; [Anonymous], 2001, SAMPL MAN FAC SURV P; [Anonymous], 2007, MAL PREGN GUID MEAS; [Anonymous], 2012, INT PREV TREATM MAL; [Anonymous], 2000, GLOB PARTN ROLL BACK; [Anonymous], GLOB MAL ACT PLAN MA; [Anonymous], 2008, ANAL HLTH EQUITY USI; [Anonymous], 2004, STRATEGIC FRAMEWORK; Baiden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028944; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Brabin BJ, 1991, RISKS SEVERITY MALAR; Carlson M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-341; Faye A, 2011, B SOC PATHOL EXOT; FENASCOM, 2010, PLAN STRAT FENASCOM; Filmer D., 1998, ESTIMATING WEALTH EF; Lauritsen JM, 2000, EPIDATA DATA ENTRY D; Leonard K, 2006, SOC SCI MED, V63, P2330, DOI 10.1016/j.socscimed.2006.06.003; Marchant T, 2010, CAN MED ASSOC J, V182, P152, DOI 10.1503/cmaj.090268; Marchant T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-260; McKenzie DJ, 2005, J POPULATION EC, V18; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Mubyazi GM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-54; Namusoke F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-310; Ndyomugyenyi R, 2010, T ROY SOC TROP MED H, V104, P536, DOI 10.1016/j.trstmh.2010.02.003; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Pembe AB, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-35; Programme National de Lutte Contre le Paludisme, 2003, POL NAT LUTT PAL; RBM Vector Control Working Group: Continuous Distribution Work Stream, 2011, CONS STAT CONT DISTR; Rowe AK, 2002, INT J QUAL HEALTH C, V14, P521, DOI 10.1093/intqhc/14.6.521; Rowe SY, 2006, INT J QUAL HEALTH C, V18, P299, DOI 10.1093/intqhc/mzl009; Sogoba N, 2007, ACTA TROP, V101, P232, DOI 10.1016/j.actatropica.2007.02.005; Stata Corp LP, 2007, STAT DAT AN STAT SOR; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; van Eijk AM, 2005, TROP MED INT HEALTH, V10, P1134, DOI 10.1111/j.1365-3156.2005.01497.x; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webster J, 2010, AM J TROP MED HYG, V82, P672, DOI 10.4269/ajtmh.2010.09-0473; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization UNICEF, 2003, ANT CAR DEV COUNTR P	43	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67520	10.1371/journal.pone.0067520	http://dx.doi.org/10.1371/journal.pone.0067520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840729	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000321148400098
J	Woodland, RJ; Holland, DP; Beardall, J; Smith, J; Scicluna, T; Cook, PLM				Woodland, Ryan J.; Holland, Daryl P.; Beardall, John; Smith, Jonathan; Scicluna, Todd; Cook, Perran L. M.			Assimilation of Diazotrophic Nitrogen into Pelagic Food Webs	PLOS ONE			English	Article							BALTIC SEA; TOXIC CYANOBACTERIA; NODULARIA-SPUMIGENA; INORGANIC NITROGEN; TROPHIC POSITION; STABLE-ISOTOPES; CARBON; PLANKTON; SUMMER; EUTROPHICATION	The fate of diazotrophic nitrogen (N-D) fixed by planktonic cyanobacteria in pelagic food webs remains unresolved, particularly for toxic cyanophytes that are selectively avoided by most herbivorous zooplankton. Current theory suggests that N-D fixed during cyanobacterial blooms can enter planktonic food webs contemporaneously with peak bloom biomass via direct grazing of zooplankton on cyanobacteria or via the uptake of bioavailable N-D (exuded from viable cyanobacterial cells) by palatable phytoplankton or microbial consortia. Alternatively, N-D can enter planktonic food webs post-bloom following the remineralization of bloom detritus. Although the relative contribution of these processes to planktonic nutrient cycles is unknown, we hypothesized that assimilation of bioavailable N-D (e.g., nitrate, ammonium) by palatable phytoplankton and subsequent grazing by zooplankton (either during or after the cyanobacterial bloom) would be the primary pathway by which N-D was incorporated into the planktonic food web. Instead, in situ stable isotope measurements and grazing experiments clearly documented that the assimilation of N-D by zooplankton outpaced assimilation by palatable phytoplankton during a bloom of toxic Nodularia spumigena Mertens. We identified two distinct temporal phases in the trophic transfer of N-D from N. spumigena to the plankton community. The first phase was a highly dynamic transfer of N-D to zooplankton with rates that covaried with bloom biomass while bypassing other phytoplankton taxa; a trophic transfer that we infer was routed through bloom-associated bacteria. The second phase was a slowly accelerating assimilation of the dissolved-N-D pool by phytoplankton that was decoupled from contemporaneous variability in N. spumigena concentrations. These findings provide empirical evidence that N-D can be assimilated and transferred rapidly throughout natural plankton communities and yield insights into the specific processes underlying the propagation of N-D through pelagic food webs.	[Woodland, Ryan J.; Scicluna, Todd; Cook, Perran L. M.] Monash Univ, Water Studies Ctr, Sch Chem, Clayton, Vic, Australia; [Holland, Daryl P.; Beardall, John] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Smith, Jonathan] South East Algae Project SEAPRO, Metung, Vic, Australia	Monash University; Monash University	Woodland, RJ (corresponding author), Monash Univ, Water Studies Ctr, Sch Chem, Clayton, Vic, Australia.	ryan.woodland@monash.edu	Beardall, John/L-5262-2019; Woodland, Ryan J/D-5344-2017	Beardall, John/0000-0001-7684-446X; Woodland, Ryan J/0000-0002-3309-3413; Cook, Perran/0000-0002-0444-3488	Australian Research Council Linkage [LP110100040]; Melbourne Water; Australian Research Council Discovery Project Grant [DP1095693]; DSE (Victoria) Blue Green Algae Monitoring Program; EPA Victoria Marine Monitoring Program; Monash University Faculty of Science Deans Scholarship	Australian Research Council Linkage(Australian Research Council); Melbourne Water; Australian Research Council Discovery Project Grant(Australian Research Council); DSE (Victoria) Blue Green Algae Monitoring Program; EPA Victoria Marine Monitoring Program; Monash University Faculty of Science Deans Scholarship	RJW was funded by an Australian Research Council Linkage Grant (LP110100040; http://www.arc.gov.au/ncgp/lp/lp_default.htm) with industry support from Melbourne Water, The Gippsland Lakes Ministerial Advisory Council, The Department of Sustainability and Environment (Victoria), Parks Victoria, and The Environmental Protection Authority (Victoria) awarded to PC and JB. DPH was funded by the Australian Research Council Discovery Project Grant (DP1095693) awarded to JB. JS was funded by the DSE (Victoria) Blue Green Algae Monitoring Program and EPA Victoria Marine Monitoring Program (http://www.epa.vic.gov.au/). TS was funded by a Monash University Faculty of Science Deans Scholarship (http://monash.edu/science/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1972, SCIENCE, V177, P885, DOI 10.1126/science.177.4052.885; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Bauersachs T, 2009, LIMNOL OCEANOGR, V54, P1403, DOI 10.4319/lo.2009.54.4.1403; BRONK DA, 1993, MAR BIOL, V115, P501, DOI 10.1007/BF00349849; BRONK DA, 1993, MAR ECOL PROG SER, V96, P291, DOI 10.3354/meps096291; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Cook PLM, 2010, LIMNOL OCEANOGR, V55, P1123, DOI 10.4319/lo.2010.55.3.1123; Engstrom-Ost J, 2002, MAR ECOL PROG SER, V232, P1, DOI 10.3354/meps232001; ESTEP MLF, 1985, CAN J FISH AQUAT SCI, V42, P1712, DOI 10.1139/f85-215; GAST V, 1985, MAR ECOL PROG SER, V22, P107, DOI 10.3354/meps022107; Gorokhova E, 2009, HARMFUL ALGAE, V8, P264, DOI 10.1016/j.hal.2008.06.006; Green EP, 1997, J PLANKTON RES, V19, P435, DOI 10.1093/plankt/19.4.435; Gu BH, 1996, CAN J FISH AQUAT SCI, V53, P875, DOI 10.1139/cjfas-53-4-875; Hambright KD, 2007, LIMNOL OCEANOGR, V52, P1018, DOI 10.4319/lo.2007.52.3.1018; HEISKANEN AS, 1994, ARCH HYDROBIOL, V131, P175; Holland DP, 2012, MAR ECOL PROG SER, V461, P47, DOI 10.3354/meps09843; HORRIGAN SG, 1990, ESTUAR COAST SHELF S, V30, P393, DOI 10.1016/0272-7714(90)90005-C; HORRIGAN SG, 1990, ESTUAR COAST SHELF S, V30, P369, DOI 10.1016/0272-7714(90)90004-B; KLEPPEL GS, 1993, MAR ECOL PROG SER, V99, P183, DOI 10.3354/meps099183; Landrum JP, 2011, DEEP-SEA RES PT I, V58, P615, DOI 10.1016/j.dsr.2011.01.012; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; Loick-Wilde N, 2012, LIMNOL OCEANOGR, V57, P199, DOI 10.4319/lo.2012.57.1.0199; MONTOYA JP, 1990, MAR ECOL PROG SER, V65, P35, DOI 10.3354/meps065035; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Ohlendieck U, 2000, J MARINE SYST, V25, P213, DOI 10.1016/S0924-7963(00)00016-6; Ohtsuka Susumu, 1996, Bulletin of Plankton Society of Japan, V43, P89; Paerl HW, 2006, ECOL STU AN, V189, P95, DOI 10.1007/978-3-540-32210-8_8; PAERL HW, 1984, J PHYCOL, V20, P600, DOI 10.1111/j.0022-3646.1984.00600.x; PAERL HW, 1989, J PHYCOL, V25, P773, DOI 10.1111/j.0022-3646.1989.00773.x; Peters J, 2006, MAR BIOL, V149, P1417, DOI 10.1007/s00227-006-0290-8; Ploug H, 2011, ISME J, V5, P1549, DOI 10.1038/ismej.2011.20; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rolff C, 2000, MAR ECOL PROG SER, V203, P47, DOI 10.3354/meps203047; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Sellner KG, 1997, LIMNOL OCEANOGR, V42, P1089, DOI 10.4319/lo.1997.42.5_part_2.1089; SELLNER KG, 1994, HYDROBIOLOGIA, V293, P249, DOI 10.1007/BF00229948; Sharp JH, 2009, ESTUAR COAST, V32, P1023, DOI 10.1007/s12237-009-9210-8; Sopanen S, 2009, AQUAT MICROB ECOL, V55, P115, DOI 10.3354/ame01289; Toupoint N, 2012, ECOLOGY, V93, P1922, DOI 10.1890/11-1292.1; Townsend D.W., 1988, BIOL OCEANOGR, V5, P215, DOI DOI 10.1080/01965581.1987.10749514; Tuomainen J, 2006, MICROB ECOL, V52, P513, DOI 10.1007/s00248-006-9130-0; Turner JT, 2004, ZOOL STUD, V43, P255; TURNER JT, 1986, PSZNI MAR ECOL, V7, P289; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Veuger B, 2004, ESTUAR COAST SHELF S, V61, P507, DOI 10.1016/j.ecss.2004.06.014; Wawrik B, 2009, APPL ENVIRON MICROB, V75, P6662, DOI 10.1128/AEM.01002-09	52	18	18	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67588	10.1371/journal.pone.0067588	http://dx.doi.org/10.1371/journal.pone.0067588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840744	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400109
J	Greene, SK; Rett, MD; Vellozzi, C; Li, LL; Kulldorff, M; Marcy, SM; Daley, MF; Belongia, EA; Baxter, R; Fireman, BH; Jackson, ML; Omer, SB; Nordin, JD; Jin, R; Weintraub, ES; Vijayadeva, V; Lee, GM				Greene, Sharon K.; Rett, Melisa D.; Vellozzi, Claudia; Li, Lingling; Kulldorff, Martin; Marcy, S. Michael; Daley, Matthew F.; Belongia, Edward A.; Baxter, Roger; Fireman, Bruce H.; Jackson, Michael L.; Omer, Saad B.; Nordin, James D.; Jin, Robert; Weintraub, Eric S.; Vijayadeva, Vinutha; Lee, Grace M.			Guillain-Barre Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011	PLOS ONE			English	Article							UNITED-STATES; FISHER-SYNDROME; A H1N1; IMMUNIZATION; RISK; ASSOCIATION; KINGDOM; SURVEILLANCE; ACCURACY; RECEIPT	Background: Guillain-Barre Syndrome (GBS) can be triggered by gastrointestinal or respiratory infections, including influenza. During the 2009 influenza A (H1N1) pandemic in the United States, monovalent inactivated influenza vaccine (MIV) availability coincided with high rates of wildtype influenza infections. Several prior studies suggested an elevated GBS risk following MIV, but adjustment for antecedent infection was limited. Methods: We identified patients enrolled in health plans participating in the Vaccine Safety Datalink and diagnosed with GBS from July 2009 through June 2011. Medical records of GBS cases with 2009-10 MIV, 2010-11 trivalent inactivated influenza vaccine (TIV), and/or a medically-attended respiratory or gastrointestinal infection in the 1 through 141 days prior to GBS diagnosis were reviewed and classified according to Brighton Collaboration criteria for diagnostic certainty. Using a case-centered design, logistic regression models adjusted for patient-level time-varying sources of confounding, including seasonal vaccinations and infections in GBS cases and population-level controls. Results: Eighteen confirmed GBS cases received vaccination in the 6 weeks preceding onset, among 1.27 million 2009-10 MIV recipients and 2.80 million 2010-11 TIV recipients. Forty-four confirmed GBS cases had infection in the 6 weeks preceding onset, among 3.77 million patients diagnosed with medically-attended infection. The observed-versus-expected odds that 2009-10MIV/2010-11 TIV was received in the 6 weeks preceding GBS onset was odds ratio = 1.54, 95% confidence interval (CI), 0.59-3.99; risk difference= 0.93 per million doses, 95% CI, 20.71-5.16. The association between GBS and medically-attended infection was: odds ratio = 7.73, 95% CI, 3.60-16.61; risk difference = 11.62 per million infected patients, 95% CI, 4.49-26.94. These findings were consistent in sensitivity analyses using alternative infection definitions and risk intervals for prior vaccination shorter than 6 weeks. Conclusions: After adjusting for antecedent infections, we found no evidence for an elevated GBS risk following 2009-10 MIV/2010-11 TIV influenza vaccines. However, the association between GBS and antecedent infection was strongly elevated.	[Greene, Sharon K.; Rett, Melisa D.; Li, Lingling; Kulldorff, Martin; Jin, Robert; Lee, Grace M.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Greene, Sharon K.; Rett, Melisa D.; Li, Lingling; Kulldorff, Martin; Jin, Robert; Lee, Grace M.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Vellozzi, Claudia; Weintraub, Eric S.] Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, Atlanta, GA USA; [Marcy, S. Michael] Kaiser Permanente So Calif, Pasadena, CA 91101 USA; [Daley, Matthew F.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Daley, Matthew F.] Univ Colorado, Dept Pediat, Aurora, CO USA; [Belongia, Edward A.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Baxter, Roger; Fireman, Bruce H.] Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA; [Jackson, Michael L.] Grp Hlth Res Inst, Seattle, WA USA; [Omer, Saad B.] Kaiser Permanente Georgia, Ctr Hlth Res Southeast, Atlanta, GA USA; [Nordin, James D.] HealthPartners Res Fdn, Minneapolis, MN USA; [Vijayadeva, Vinutha] Kaiser Permanente Hawaii, Ctr Hlth Res Hawaii, Honolulu, HI USA; [Lee, Grace M.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Lee, Grace M.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Centers for Disease Control & Prevention - USA; Kaiser Permanente; Kaiser Permanente; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Kaiser Permanente; HealthPartners Institute for Education & Research; Kaiser Permanente; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Greene, SK (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, Queens, NY USA.	sgreene4@health.nyc.gov		Belongia, Edward/0000-0001-7478-0415; Nordin, James/0000-0002-3359-5843; Kulldorff, Martin/0000-0002-5284-2993; Greene, Sharon K./0000-0002-3509-2377	Centers for Disease Control and Prevention (CDC) [200-2002-00732]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by a subcontract with America's Health Insurance Plans (AHIP) under contract 200-2002-00732 from the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, although the CDC reviewed and approved this report before submission.	Andrews N, 2011, VACCINE, V29, P7878, DOI 10.1016/j.vaccine.2011.08.069; Baggs J, 2011, PEDIATRICS, V127, pS45, DOI 10.1542/peds.2010-1722H; De Wals P, 2012, JAMA-J AM MED ASSOC, V308, P175, DOI 10.1001/jama.2012.7342; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Greene SK, 2012, AM J EPIDEMIOL, V175, P1100, DOI 10.1093/aje/kws195; Greene SK, 2009, AM J PREV MED, V37, P552, DOI 10.1016/j.amepre.2009.08.022; Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072; Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RA, 2006, ARCH INTERN MED, V166, P1301, DOI 10.1001/archinte.166.12.1301; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Jhung M., 2010, Morbidity and Mortality Weekly Report, V59, P423; KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698; Klein NP, 2010, PEDIATRICS, V126, pE1, DOI 10.1542/peds.2010-0665; Klein NP, 2010, PEDIATR INFECT DIS J, V29, P613, DOI 10.1097/INF.0b013e3181d581f9; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Kramarz P, 2001, J PEDIATR-US, V138, P306, DOI 10.1067/mpd.2001.112168; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Liang XF, 2011, NEW ENGL J MED, V364, P638, DOI 10.1056/NEJMoa1008553; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Mullooly J, 1999, AM J EPIDEMIOL, V149, P186; Pahud BA, 2012, VACCINE, V30, P247, DOI 10.1016/j.vaccine.2011.10.104; Pattie David C, 2009, Qual Manag Health Care, V18, P91, DOI 10.1097/QMH.0b013e3181a0274d; Poland GA, 2012, VACCINE, V30, P5801, DOI 10.1016/j.vaccine.2012.06.093; Prothro C., 2010, Morbidity and Mortality Weekly Report, V59, P657; ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974; Rowhani-Rahbar A, 2012, VACCINE, V31, P271, DOI 10.1016/j.vaccine.2012.07.024; Rowhani-Rahbar A, 2012, AM J EPIDEMIOL, V175, P878, DOI 10.1093/aje/kws011; Ruts L, 2005, NEUROLOGY, V65, P138, DOI 10.1212/01.wnl.0000167549.09664.b8; Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sejvar James J, 2011, Curr Infect Dis Rep, V13, P387, DOI 10.1007/s11908-011-0194-8; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Shaikh AG, 2012, VACCINE, V30, P3251, DOI 10.1016/j.vaccine.2012.03.013; Shui IM, 2012, NEUROEPIDEMIOLOGY, V39, P109, DOI 10.1159/000339248; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Stratton KR, 1994, ADVERSE EVENTS ASS C, P45; Sy LS, 2010, VACCINE, V28, P5254, DOI 10.1016/j.vaccine.2010.05.061; Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344; Tokars JI, 2012, PHARMACOEPIDEM DR S, V21, P546, DOI 10.1002/pds.3220; Verity C, 2011, LANCET, V378, P1545, DOI 10.1016/S0140-6736(11)61665-6; Wise ME, 2012, AM J EPIDEMIOL, V175, P1110, DOI 10.1093/aje/kws196; Yih W Katherine, 2004, MMWR Suppl, V53, P43; Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525	48	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67185	10.1371/journal.pone.0067185	http://dx.doi.org/10.1371/journal.pone.0067185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840621	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400082
J	Iwasaki, Y; Shimomura, K; Kohno, D; Dezaki, K; Ayush, EA; Nakabayashi, H; Kubota, N; Kadowaki, T; Kakei, M; Nakata, M; Yada, T				Iwasaki, Yusaku; Shimomura, Kenju; Kohno, Daisuke; Dezaki, Katsuya; Ayush, Enkh-Amar; Nakabayashi, Hajime; Kubota, Naoto; Kadowaki, Takashi; Kakei, Masafumi; Nakata, Masanori; Yada, Toshihiko			Insulin Activates Vagal Afferent Neurons Including those Innervating Pancreas via Insulin Cascade and Ca2+ Influx: Its Dysfunction in IRS2-KO Mice with Hyperphagic Obesity	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; CENTRAL-NERVOUS-SYSTEM; REDUCE FOOD-INTAKE; BODY-WEIGHT; VAGUS NERVE; ARCUATE NUCLEUS; GHRELIN; BRAIN; RAT; CHOLECYSTOKININ	Some of insulin's functions, including glucose/lipid metabolism, satiety and neuroprotection, involve the alteration of brain activities. Insulin could signal to the brain via penetrating through the blood-brain barrier and acting on the vagal afferents, while the latter remains unproved. This study aimed to clarify whether insulin directly regulates the nodose ganglion neurons (NGNs) of vagal afferents in mice. NGs expressed insulin receptor (IR) and insulin receptor substrate-2 (IRS2) mRNA, and some of NGNs were immunoreactive to IR. In patch-clamp and fura-2 microfluorometric studies, insulin (10(-12)similar to 10(-6) M) depolarized and increased cytosolic Ca2+ concentration ([Ca2+](i)) in single NGNs. The insulin-induced [Ca2+](i) increases were attenuated by L-and N-type Ca2+ channel blockers, by phosphatidylinositol 3 kinase (PI3K) inhibitor, and in NGNs from IRS2 knockout mice. Half of the insulin-responsive NGNs contained cocaine-and amphetamine-regulated transcript. Neuronal fibers expressing IRs were distributed in/around pancreatic islets. The NGNs innervating the pancreas, identified by injecting retrograde tracer into the pancreas, responded to insulin with much greater incidence than unlabeled NGNs. Insulin concentrations measured in pancreatic vein was 64-fold higher than that in circulation. Elevation of insulin to 10(-7) M recruited a remarkably greater population of NGNs to [Ca2+](i) increases. Systemic injection of glibenclamide rapidly released insulin and phosphorylated AKT in NGs. Furthermore, in IRS2 knockout mice, insulin action to suppress [Ca2+](i) in orexigenic ghrelin-responsive neurons in hypothalamic arcuate nucleus was intact while insulin action on NGN was markedly attenuated, suggesting a possible link between impaired insulin sensing by NGNs and hyperphagic obese phenotype in IRS2 knockout mice These data demonstrate that insulin directly activates NGNs via IR-IRS2-PI3K-AKT-cascade and depolarization-gated Ca2+ influx. Pancreas-innervating NGNs may effectively sense dynamic changes of insulin released in response to nutritional states. These interactions could serve to convey the changes in pancreatic and systemic insulin to the brain.	[Iwasaki, Yusaku; Shimomura, Kenju; Kohno, Daisuke; Dezaki, Katsuya; Ayush, Enkh-Amar; Nakata, Masanori; Yada, Toshihiko] Jichi Med Univ, Sch Med, Dept Physiol, Div Integrat Physiol, Shimotsuke, Tochigi, Japan; [Nakabayashi, Hajime] Kanazawa Univ, Hlth Sci Serv Ctr, Kanazawa, Ishikawa, Japan; [Kubota, Naoto; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Kakei, Masafumi] Jichi Med Univ, Sch Med, Saitama Med Ctr, Dept Med 1, Saitama, Japan; [Yada, Toshihiko] Natl Inst Physiol Sci, Div Adaptat Dev, Dept Dev Physiol, Okazaki, Aichi 444, Japan	Jichi Medical University; Kanazawa University; University of Tokyo; Jichi Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Yada, T (corresponding author), Jichi Med Univ, Sch Med, Dept Physiol, Div Integrat Physiol, Shimotsuke, Tochigi, Japan.	tyada@jichi.ac.jp	Dezaki, Katsuya/AAE-1048-2021; Kubota, Naoto/N-7892-2015		Japan Society for the Promotion of Science (JSPS) [22790218, 24790221]; Jichi medical university young investigator award; JSPS [20390061, 23390044, 23115715]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [10036069]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Japan Diabetes Foundation, Takeda Science Foundation; Uehara Memorial Foundation; Sumitomo Foundation; KEIRIN RACE; Grants-in-Aid for Scientific Research [24790221] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Jichi medical university young investigator award; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Diabetes Foundation, Takeda Science Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Sumitomo Foundation; KEIRIN RACE(Keirin Race); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Young Scientist (B) (22790218, 24790221) from Japan Society for the Promotion of Science (JSPS) and Jichi medical university young investigator award to YI. A part of this study was supported by Grant-in-Aid for Scientific Research (B) (20390061, 23390044), for Challenging Exploratory Research (22659044, 24659101) and for Scientific Research on Innovative Areas (23115715) from JSPS, Strategic Research Program for Brain Sciences (10036069) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2008-2012, 2011-2015), Grants from Japan Diabetes Foundation, Takeda Science Foundation and Uehara Memorial Foundation, and Insulin Research Award from Novo Nordisk and Basic Science Research Award from Sumitomo Foundation to TY. This study was subsidized by JKA through its promotion funds from KEIRIN RACE to TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony K, 2006, DIABETES, V55, P2986, DOI 10.2337/db06-0376; Ao Y, 2005, PANCREAS, V31, P142, DOI 10.1097/01.mpa.0000172562.96168.59; Banks WA, 1998, PEPTIDES, V19, P883, DOI 10.1016/S0196-9781(98)00018-7; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; BENDAYAN M, 1993, AM J PHYSIOL, V264, pG187, DOI 10.1152/ajpgi.1993.264.2.G187; Berthoud HR, 2008, REGUL PEPTIDES, V149, P15, DOI 10.1016/j.regpep.2007.08.024; Broberger C, 1999, P NATL ACAD SCI USA, V96, P13506, DOI 10.1073/pnas.96.23.13506; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; de Lartigue G, 2007, J NEUROSCI, V27, P2876, DOI 10.1523/JNEUROSCI.5508-06.2007; De Lartigue G, 2010, GASTROENTEROLOGY, V138, P1479, DOI 10.1053/j.gastro.2009.10.034; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Dezaki K, 2006, DIABETES, V55, P3486, DOI 10.2337/db06-0878; Fasanella KE, 2008, J COMP NEUROL, V509, P42, DOI 10.1002/cne.21736; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Heidenreich KA, 1993, ANN N Y ACAD SCI, V692, P72; Iwasaki Y, 2013, NEUROPEPTIDES, V47, P19, DOI 10.1016/j.npep.2012.07.006; Iwasaki Y, 2012, NEUROPEPTIDES, V46, P291, DOI 10.1016/j.npep.2012.08.009; Iwasaki Y, 2009, BIOCHEM BIOPH RES CO, V390, P958, DOI 10.1016/j.bbrc.2009.10.085; Jimenez-Feltstrom J, 2004, REGUL PEPTIDES, V122, P109, DOI 10.1016/j.regpep.2004.06.004; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kroner Z, 2009, ALTERN MED REV, V14, P373; Li Y, 1996, J PHYSIOL-LONDON, V494, P773, DOI 10.1113/jphysiol.1996.sp021531; Li Y, 1997, AM J PHYSIOL-GASTR L, V273, pG679, DOI 10.1152/ajpgi.1997.273.3.G679; Maejima Y, 2011, AGING-US, V3, P1092, DOI 10.18632/aging.100400; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NEUHUBER WL, 1989, J AUTONOM NERV SYST, V29, P13, DOI 10.1016/0165-1838(89)90015-5; Noetzel S, 2009, REGUL PEPTIDES, V157, P84, DOI 10.1016/j.regpep.2009.06.009; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Patel JD, 2008, EUR J PHARMACOL, V580, P143, DOI 10.1016/j.ejphar.2007.10.046; Peter L, PEPTIDES, V31, P1118; Peters JH, 2006, AM J PHYSIOL-REG I, V290, pR1544, DOI 10.1152/ajpregu.00811.2005; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; RAYBOULD HE, 1988, AM J PHYSIOL, V255, pG242, DOI 10.1152/ajpgi.1988.255.2.G242; RITTER RC, 1985, AM J PHYSIOL, V248, pR501, DOI 10.1152/ajpregu.1985.248.4.R501; ROBINSON LJ, 1994, ENDOCRINOLOGY, V135, P2568, DOI 10.1210/en.135.6.2568; Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008; SOUTH EH, 1988, PEPTIDES, V9, P601, DOI 10.1016/0196-9781(88)90171-4; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Withers DJ, 2001, BIOCHEM SOC T, V29, P525, DOI 10.1042/BST0290525; Zawalich WS, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740247	45	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67198	10.1371/journal.pone.0067198	http://dx.doi.org/10.1371/journal.pone.0067198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840624	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400084
J	Mracek, P; Pagano, C; Frohlich, N; Idda, ML; Cuesta, IH; Lopez-Olmeda, JF; Sanchez-Vazquez, FJ; Vallone, D; Foulkes, NS				Mracek, Philipp; Pagano, Cristina; Froehlich, Nadine; Idda, M. Laura; Cuesta, Ines H.; Lopez-Olmeda, Jose Fernando; Javier Sanchez-Vazquez, F.; Vallone, Daniela; Foulkes, Nicholas S.			ERK Signaling Regulates Light-Induced Gene Expression via D-Box Enhancers in a Differential, Wavelength-Dependent Manner	PLOS ONE			English	Article							CIRCADIAN CLOCK; MAP KINASES; ZEBRAFISH; TRANSCRIPTION; ENTRAINMENT; PATHWAY; SYSTEM	The day-night and seasonal cycles are dominated by regular changes in the intensity as well as spectral composition of sunlight. In aquatic environments the spectrum of sunlight is also strongly affected by the depth and quality of water. During evolution, organisms have adopted various key strategies in order to adapt to these changes, including the development of clocks and photoreceptor mechanisms. These mechanisms enable the detection and anticipation of regular changes in lighting conditions and thereby direct an appropriate physiological response. In teleosts, a growing body of evidence points to most cell types possessing complex photoreceptive systems. However, our understanding of precisely how these systems are regulated and in turn dictate changes in gene expression remains incomplete. In this manuscript we attempt to unravel this complexity by comparing the effects of two specific wavelengths of light upon signal transduction and gene expression regulatory mechanisms in zebrafish cells. We reveal a significant difference in the kinetics of light-induced gene expression upon blue and red light exposure. Importantly, both red and blue light-induced gene expression relies upon D-box enhancer promoter elements. Using pharmacological and genetic approaches we demonstrate that the ERK/MAPK pathway acts as a negative regulator of blue but not red light activated transcription. Thus, we reveal that D-box-driven gene expression is regulated via ERK/MAPK signaling in a strongly wavelength-dependent manner.	[Mracek, Philipp; Pagano, Cristina; Froehlich, Nadine; Idda, M. Laura; Cuesta, Ines H.; Lopez-Olmeda, Jose Fernando; Vallone, Daniela; Foulkes, Nicholas S.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein, Germany; [Javier Sanchez-Vazquez, F.] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain	Helmholtz Association; Karlsruhe Institute of Technology; University of Murcia	Vallone, D (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein, Germany.	Daniela.Vallone@kit.edu; nicholas.foulkes@kit.edu	Lopez-Olmeda, Jose Fernando/K-3848-2014; Vallone, Daniela/S-2244-2019; Foulkes, Nicholas S/K-7003-2013; Sanchez Vazquez, Francisco Javier/J-7712-2016	Lopez-Olmeda, Jose Fernando/0000-0003-4920-5704; Foulkes, Nicholas S/0000-0002-1794-9891; Pagano, Cristina/0000-0002-9181-6595; Sanchez Vazquez, Francisco Javier/0000-0002-2366-9714	Karlsruhe Institute of Technology (KIT, Germany) through the Helmholtz funding programme: BioInterfaces; SENECA [08743/PI/08]; MINECO [CSD2007-0002, AGL2010-22139-c03-01]; FEDER; BioInterfaces programme; Fundacion Seneca (Murcia Spain); Italian percorso ad alta formazione Master and Back for the Sardinian region; FP7 EU integrated project, ZFHEALTH [HEALTH-F4-2010-242048]	Karlsruhe Institute of Technology (KIT, Germany) through the Helmholtz funding programme: BioInterfaces; SENECA(Fundacion Seneca); MINECO(Spanish Government); FEDER(European Commission); BioInterfaces programme; Fundacion Seneca (Murcia Spain)(Fundacion Seneca); Italian percorso ad alta formazione Master and Back for the Sardinian region; FP7 EU integrated project, ZFHEALTH	This work was supported by the Karlsruhe Institute of Technology (KIT, Germany) through the Helmholtz funding programme: BioInterfaces (to NSF, DV). FJS-V received financial support from SENECA (08743/PI/08) and MINECO (CSD2007-0002 and AGL2010-22139-c03-01) co-funded by FEDER. PM, CP and IHC were supported by funding by the BioInterfaces programme. JFL-O was supported by a postdoctoral fellowship from Fundacion Seneca (Murcia Spain). MLI was supported by the Italian percorso ad alta formazione Master and Back for the Sardinian region as well as the BioInterfaces programme. NF was supported by a PhD fellowship from the FP7 EU integrated project, ZFHEALTH (HEALTH-F4-2010-242048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini A, 1996, J BIOL CHEM, V271, P31612, DOI 10.1074/jbc.271.49.31612; Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Ben-Moshe Z, 2010, CHRONOBIOL INT, V27, P1509, DOI 10.3109/07420528.2010.510229; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Cohen JH, 2002, BIOL BULL-US, V203, P307, DOI 10.2307/1543573; Cohen P, 2003, CELL TRANS, V19, P11; Coogan AN, 2004, J NEUROCHEM, V90, P769, DOI 10.1111/j.1471-4159.2004.02554.x; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Fukushima N, 2009, BIOCHEM BIOPH RES CO, V383, P231, DOI 10.1016/j.bbrc.2009.03.158; Gavriouchkina D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012542; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; Hirayama J, 2009, CELL CYCLE, V8, P2794, DOI 10.4161/cc.8.17.9447; Karin M, 1996, PHILOS T ROY SOC B, V351, P127, DOI 10.1098/rstb.1996.0008; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Mracek P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051278; Munz FW, 1977, HDB SENSORY PHYSL, P193; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Pierce LX, 2008, BRAIN RES, V1223, P11, DOI 10.1016/j.brainres.2008.05.020; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Uchida Y, 2010, BIOL PHARM BULL, V33, P535, DOI 10.1248/bpb.33.535; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Vallone Daniela, 2007, Methods Mol Biol, V362, P429; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; YASUHIRA S, 1992, J BIOL CHEM, V267, P25644; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	41	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67858	10.1371/journal.pone.0067858	http://dx.doi.org/10.1371/journal.pone.0067858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840779	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400119
J	Paton, D; Underhill, A; Meredith, J; Eggleston, P; Tripet, F				Paton, Doug; Underhill, Anne; Meredith, Janet; Eggleston, Paul; Tripet, Frederic			Contrasted Fitness Costs of Docking and Antibacterial Constructs in the EE and EVida3 Strains Validates Two-Phase Anopheles gambiae Genetic Transformation System	PLOS ONE			English	Article							INCIPIENT SPECIATION; MOSQUITOS	The deployment of transgenic mosquitoes carrying genes for refractoriness to malaria has long been seen as a futuristic scenario riddled with technical difficulties. The integration of anti-malarial effector genes and a gene-drive system into the mosquito genome without affecting mosquito fitness is recognized as critical to the success of this malaria control strategy. Here we conducted detailed fitness studies of two Anopheles gambiae s.s. transgenic lines recently developed using a two-phase targeted genetic transformation system. In replicated cage-invasion experiments, males and females of the EE Phase-1 docking strain and EVida3 Phase-2 strain loaded with an antimicrobial peptide (AMP) expressed upon blood-feeding, were mixed with individuals of a recently-colonized strain of the Mopti chromosomal form. The experimental design enabled us to detect initial strain reproductive success differences, assortative mating and hybrid vigor that may characterize mosquito release situations. In addition, the potential fitness costs of the unloaded Phase-1 and loaded Phase-2 genetic constructs, independent of the strains' original genetic backgrounds, were estimated between the 1st instar larvae, pupae and adult stages over 10 generations. The Phase-1 unloaded docking cassette was found to have significantly lower allelic fitness relative to the wild type allele during larval development. However, overall genotypic fitness was comparable to the wild type allele across all stages leading to stable equilibrium in all replicates. In contrast, the Phase-2 construct expressing EVida3 disappeared from all replicates within 10 generations due to lower fitness of hemi-and homozygous larvae, suggesting costly background AMP expression and/or of the DsRed2 marker. This is the first study to effectively partition independent fitness stage-specific determinants in unloaded and loaded transgenic strains of a Phase-1-2 transformation system. Critically, the high fitness of the Phase-1 docking strain makes it the ideal model system for measuring the genetic load of novel candidate anti-malarial molecules in vivo.	[Paton, Doug; Underhill, Anne; Meredith, Janet; Eggleston, Paul; Tripet, Frederic] Keele Univ, Ctr Appl Entomol & Parasitol, Sch Life Sci, Keele ST5 5BG, Staffs, England	Keele University	Tripet, F (corresponding author), Keele Univ, Ctr Appl Entomol & Parasitol, Sch Life Sci, Keele ST5 5BG, Staffs, England.	f.tripet@keele.ac.uk	Tripet, Frederic/M-6693-2015; Paton, Douglas/ABB-4877-2020	Tripet, Frederic/0000-0002-7939-0712; Paton, Douglas/0000-0001-5755-2410	 [041085]		This work was supported by a Program Grant (#041085) to FT (co-PI) and PE (PI) (www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2010, INSECT MOL BIOL, V19, P263, DOI 10.1111/j.1365-2583.2009.00986.x; Arrighi RBG, 2002, ANTIMICROB AGENTS CH, V46, P2104, DOI 10.1128/AAC.46.7.2104-2110.2002; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; Kaiser M, 1997, HEREDITY, V78, P1, DOI 10.1038/hdy.1997.1; Lee HL, 2013, TRANSGENIC RES, V22, P47, DOI 10.1007/s11248-012-9625-z; Li CY, 2008, J HERED, V99, P275, DOI 10.1093/jhered/esn004; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Maynard Smith J, 1989, EVOL GENET, P319; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Nolan T, 2011, GENETICA, V139, P33, DOI 10.1007/s10709-010-9482-8; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; Rodrigues FG, 2008, INSECT MOL BIOL, V17, P175, DOI 10.1111/j.1365-2583.2008.00791.x; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	29	70	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67364	10.1371/journal.pone.0067364	http://dx.doi.org/10.1371/journal.pone.0067364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840679	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000321424400098
J	Wang, BS; Mao, JF; Zhao, W; Wang, XR				Wang, Baosheng; Mao, Jian-Feng; Zhao, Wei; Wang, Xiao-Ru			Impact of Geography and Climate on the Genetic Differentiation of the Subtropical Pine Pinus yunnanensis	PLOS ONE			English	Article							CHLOROPLAST DNA VARIATION; EUROPEAN WHITE OAKS; HYBRID SPECIATION; MITOCHONDRIAL-DNA; LANDSCAPE GENETICS; SOUTHWEST CHINA; TIBETAN PLATEAU; CYTOCHROME-B; SCOTS PINE; PHYLOGEOGRAPHY	Southwest China is a biodiversity hotspot characterized by complex topography, heterogeneous regional climates and rich flora. The processes and driving factors underlying this hotspot remain to be explicitly tested across taxa to gain a general understanding of the evolution of biodiversity and speciation in the region. In this study, we examined the role played by historically neutral processes, geography and environment in producing the current genetic diversity of the subtropical pine Pinus yunnanensis. We used genetic and ecological methods to investigate the patterns of genetic differentiation and ecological niche divergence across the distribution range of this species. We found both continuous genetic differentiation over the majority of its range, and discrete isolated local clusters. The discrete differentiation between two genetic groups in the west and east peripheries is consistent with niche divergence and geographical isolation of these groups. In the central area of the species' range, population structure was shaped mainly by neutral processes and geography rather than by ecological selection. These results show that geographical and environmental factors together created stronger and more discrete genetic differentiation than isolation by distance alone, and illustrate the importance of ecological factors in forming or maintaining genetic divergence across a complex landscape. Our findings differ from other phylogenetic studies that identified the historical drainage system in the region as the primary factor shaping population structure, and highlight the heterogeneous contributions that geography and environment have made to genetic diversity among taxa in southwest China.	[Wang, Baosheng; Wang, Xiao-Ru] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Mao, Jian-Feng] Beijing Forestry Univ, Natl Engn Lab Forest Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ, Beijing, Peoples R China; [Zhao, Wei] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing, Peoples R China	Umea University; Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Wang, XR (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	xiao-ru.wang@emg.umu.se	Wang, Xiao-Ru/AAC-4444-2020; Wang, Xiao-Ru/H-6811-2012; Mao, Jian-Feng/V-9251-2019	Wang, Xiao-Ru/0000-0002-6150-7046; Wang, Xiao-Ru/0000-0002-6150-7046; Mao, Jian-Feng/0000-0001-9735-8516	Natural Science Foundation of China [NSFC 30830010, 31100158]; National Basic Research Program of China [2009CB119104]; Vetenskapsradet, Sweden	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Vetenskapsradet, Sweden(Swedish Research Council)	This study was supported by grants from the Natural Science Foundation of China (NSFC 30830010 and 31100158; http://www.nsfc.gov.cn), the National Basic Research Program of China (2009CB119104; http://www.973.gov.cn), and Vetenskapsradet, Sweden (http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ERDKUNDE; ARNOLD ML, 1991, P NATL ACAD SCI USA, V88, P1398, DOI 10.1073/pnas.88.4.1398; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Cheng WC, 1975, ACTA PHYTOTAXON SIN, V13, P85; Clark MK, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000294; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Cook CG, 2011, QUATERNARY SCI REV, V30, P808, DOI 10.1016/j.quascirev.2011.01.003; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fay MP, 2010, J STAT SOFTW, V36, P1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fu L., 1999, PINACEAE, V4, P11; Gao J, 2012, MOL ECOL, V21, P4811, DOI 10.1111/j.1365-294X.2012.05712.x; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gugerli F, 2001, MOL ECOL, V10, P1255, DOI 10.1046/j.1365-294X.2001.01279.x; Guo XG, 2005, MOL PHYLOGENET EVOL, V35, P344, DOI 10.1016/j.ympev.2004.12.015; Hall D, 2007, EVOLUTION, V61, P2849, DOI 10.1111/j.1558-5646.2007.00230.x; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Huang JH, 2012, DIVERS DISTRIB, V18, P673, DOI 10.1111/j.1472-4642.2011.00845.x; Jacques FMB, 2011, PALAEOGEOGR PALAEOCL, V304, P318, DOI 10.1016/j.palaeo.2010.04.014; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; Lee CR, 2011, MOL ECOL, V20, P4631, DOI 10.1111/j.1365-294X.2011.05310.x; Lehmkuhl F, 1998, QUATERN INT, V45-6, P123, DOI 10.1016/S1040-6182(97)00010-4; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Li ZJ, 1981, J PLANT ECOL, V5, P28; Lozier JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005901; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2010, MOL ECOL, V19, P3760, DOI 10.1111/j.1365-294X.2010.04717.x; Mao JF, 2011, AM NAT, V177, P424, DOI 10.1086/658905; Mao JF, 2009, EVOL ECOL, V23, P447, DOI 10.1007/s10682-008-9244-6; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Navascues M, 2006, MOL ECOL, V15, P2691, DOI 10.1111/j.1365-294X.2006.02960.x; Naydenov K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-233; NEALE DB, 1989, THEOR APPL GENET, V77, P212, DOI 10.1007/BF00266189; Nosil P, 2005, EVOLUTION, V59, P705; Ouimet W, 2010, LITHOSPHERE-US, V2, P50, DOI 10.1130/L57.1; Peng ZG, 2006, MOL PHYLOGENET EVOL, V39, P568, DOI 10.1016/j.ympev.2005.10.016; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Petit RJ, 2002, FOREST ECOL MANAG, V156, P5, DOI 10.1016/S0378-1127(01)00645-4; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pons O, 1996, GENETICS, V144, P1237; Provan J, 1998, P ROY SOC B-BIOL SCI, V265, P1697, DOI 10.1098/rspb.1998.0491; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROMESBURG HC, 1985, COMPUT GEOSCI, V11, P19, DOI 10.1016/0098-3004(85)90036-6; Rundel Philip W., 1998, P296; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Song BH, 2003, MOL ECOL, V12, P2995, DOI 10.1046/j.1365-294X.2003.01962.x; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; Thibert-Plante X, 2010, MOL ECOL, V19, P2301, DOI 10.1111/j.1365-294X.2010.04641.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vendramin GG, 1996, MOL ECOL, V5, P595, DOI 10.1111/j.1365-294X.1996.tb00353.x; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang FY, 2008, J SYST EVOL, V46, P13, DOI 10.3724/SP.J.1002.2008.07049; Wang XiaoRu, 1996, Forest Genetics, V3, P37; Wang XR, 2001, GENETICS, V159, P337; WANG XR, 1994, EVOLUTION, V48, P1020, DOI 10.1111/j.1558-5646.1994.tb05290.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wu C. L., 1956, Acta Phytotaxonomica Sinica, Peking, V5, P131; Xing YW, 2010, REV PALAEOBOT PALYNO, V160, P1, DOI 10.1016/j.revpalbo.2009.12.008; Xu JX, 2008, REV PALAEOBOT PALYNO, V148, P36, DOI 10.1016/j.revpalbo.2007.08.004; Yao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037760; Yu H, 2000, ACTA BOT SIN, V42, P107; Yu H, 1998, BIODIVERSITY, V6, P267; Yuan QJ, 2008, MOL ECOL, V17, P1054, DOI 10.1111/j.1365-294X.2007.03628.x; Yue LL, 2012, AM J BOT, V99, P1726, DOI 10.3732/ajb.1100506; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009	84	32	36	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67345	10.1371/journal.pone.0067345	http://dx.doi.org/10.1371/journal.pone.0067345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840668	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400097
J	Jia, Y; Li, S; Yang, R; Zhou, H; Xiang, QY; Hu, T; Zhang, QH; Chen, ZL; Ma, D; Feng, L				Jia, Yao; Li, Shuang; Yang, Ru; Zhou, Hang; Xiang, Qunying; Hu, Ting; Zhang, Qinghua; Chen, Zhilan; Ma, Ding; Feng, Ling			Knowledge about Cervical Cancer and Barriers of Screening Program among Women in Wufeng County, a High-Incidence Region of Cervical Cancer in China	PLOS ONE			English	Article							MAINLAND CHINA; PAP-SMEAR; BEHAVIOR; BREAST; DETERMINANTS; ATTITUDES; TRIAL; INDIA	Purpose: Cervical cancer screening is an effective method for reducing the incidence and mortality of cervical cancer, but the screening attendance rate in developing countries is far from satisfactory, especially in rural areas. Wufeng is a region of high cervical cancer incidence in China. This study aimed to investigate the issues that concern cervical cancer and screening and the factors that affect women's willingness to undergo cervical cancer screening in the Wufeng area. Participants and Methods: A cross-sectional survey of women was conducted to determine their knowledge about cervical cancer and screening, demographic characteristics and the barriers to screening. Results: Women who were willing to undergo screenings had higher knowledge levels. "Anxious feeling once the disease was diagnosed'' (47.6%), "No symptoms/discomfort'' (34.1%) and "Do not know the benefits of cervical cancer screening'' (13.4%) were the top three reasons for refusing cervical cancer screening. Women who were younger than 45 years old or who had lower incomes, positive family histories of cancer, secondary or higher levels of education, higher levels of knowledge and fewer barriers to screening were more willing to participate in cervical cancer screenings than women without these characteristics. Conclusion: Efforts are needed to increase women's knowledge about cervical cancer, especially the screening methods, and to improve their perceptions of the screening process for early detection to reduce cervical cancer incidence and mortality rates.	[Jia, Yao; Li, Shuang; Yang, Ru; Zhou, Hang; Hu, Ting; Zhang, Qinghua; Chen, Zhilan; Ma, Ding; Feng, Ling] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gynecol & Obstet, Wuhan 430074, Peoples R China; [Xiang, Qunying] Tujia Nationality Autonomous Cty, Matern & Child Hlth Care Hosp, Wufeng, Peoples R China	Huazhong University of Science & Technology	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gynecol & Obstet, Wuhan 430074, Peoples R China.	dma@tjh.tjmu.edu.cn; fltj007@163.com		Zhou, Hang/0000-0003-2719-790X	Key Basic Research and Development Program Foundation of China (973 Program) [2009CB521808]; National Natural Science Foundation of China [30973472, 81001151, 81071663, 30973205, 30973184, 81172464, 81101964]; National Major Science and Technology Project (Key New Drug Creation and Development Program) [2009ZX09103-739]	Key Basic Research and Development Program Foundation of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Science and Technology Project (Key New Drug Creation and Development Program)	This study was endorsed by the Key Basic Research and Development Program Foundation of China (973 Program; No. 2009CB521808) and was supported by grants from the National Natural Science Foundation of China (NO. 30973472; 81001151; 81071663; 30973205; 30973184; 81172464; 81101964) and National Major Science and Technology Project (Key New Drug Creation and Development Program) (No. 2009ZX09103-739). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah ASM, 2001, PUBLIC HEALTH, V115, P212, DOI 10.1016/S0033-3506(01)00446-2; Access to Sanitation in Developing Countries (ASDC, 2002, 190 ASDC; Ackerson K, 2007, J AM ACAD NURSE PRAC, V19, P591, DOI 10.1111/j.1745-7599.2007.00268.x; Ackerson K, 2009, J ADV NURS, V65, P1130, DOI 10.1111/j.1365-2648.2009.04981.x; Adab P, 2006, HONG KONG MED J S2, V12, P19; [Anonymous], 2009, LANCET, V374, P358; Ansink AC, 2008, T ROY SOC TROP MED H, V102, P499, DOI 10.1016/j.trstmh.2008.01.022; Boonpongmanee C, 2007, CANCER NURS, V30, P384, DOI 10.1097/01.NCC.0000290804.38335.32; Cao SP, 2009, J PUBLIC HLTH PREVEN, V20, P39; Cao ZY, 2004, CHINESE OBSTET GYNEC; Cronje HS, 2005, BEST PRACT RES CL OB, V19, P517, DOI 10.1016/j.bpobgyn.2005.02.005; Dinshaw K, 2007, ONCOLOGY-BASEL, V73, P154, DOI 10.1159/000126498; Elovainio L, 1997, INT J GYNECOL OBSTET, V58, P137, DOI 10.1016/S0020-7292(97)02859-2; Friedman AL, 2007, HEALTH EDUC BEHAV, V34, P471, DOI 10.1177/1090198106292022; Fylan F, 1998, BRIT J GEN PRACT, V48, P1509; Gu C, 2010, CANCER NURS, V33, P445, DOI 10.1097/NCC.0b013e3181e456dc; Holroyd E, 2004, J ADV NURS, V46, P42, DOI 10.1111/j.1365-2648.2003.02964.x; Kim K, 2009, J GYNECOL ONCOL, V20, P72, DOI 10.3802/jgo.2009.20.2.72; Lee J, 2002, HEALTH EDUC BEHAV, V29, P207, DOI 10.1177/1090198102029002006; Li J, 2011, ASIAN PAC J CANCER P, V12, P1149; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; Nene B, 2007, B WORLD HEALTH ORGAN, V85, P264, DOI 10.2471/BLT.06.031195; POLIT DF, 1999, NURSING RES PRINCIPL; Pomery EA, 2009, PERS SOC PSYCHOL B, V35, P894, DOI 10.1177/0146167209335166; SIRKEN MG, 1970, J AM STAT ASSOC, V65, P257, DOI 10.2307/2283590; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; WHO, 2006, COMPR CERV CANC CONT; Wong LP, 2009, SINGAP MED J, V50, P49; World Health Organization, 2009, IN VACC RES TEAM DEP; Zhang QH, 2012, J HUAZHONG U SCI-MED, V32, P252, DOI 10.1007/s11596-012-0045-3	30	52	59	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67005	10.1371/journal.pone.0067005	http://dx.doi.org/10.1371/journal.pone.0067005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23843976	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000025
J	Li, XM; Xia, MF; Ma, H; Hu, Y; Yan, HM; He, WY; Lin, HD; Zhao, NQ; Gao, J; Gao, X				Li, Xiaoming; Xia, Mingfeng; Ma, Hui; Hu, Yu; Yan, Hongmei; He, Wanyuan; Lin, Huandong; Zhao, Naiqing; Gao, Jian; Gao, Xin			Liver Fat Content, Evaluated through Semi-Quantitative Ultrasound Measurement, Is Associated with Impaired Glucose Profiles: A Community-Based Study in Chinese	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; HEPATIC STEATOSIS; SEVERITY; INDICATOR; DISEASE; NAFLD; RISK	Nonalcoholic fatty liver disease (NAFLD) is closely associated with type 2 diabetes mellitus. We investigated whether the deposition of fat in the liver is associated with glycemic abnormalities and evaluated the contribution of the liver fat content (LFC) to the impaired glucose regulation. We conducted a community-based study among 2836 residents (1018 males and 1818 females) without prior known diabetes mellitus from the Changfeng Study who were at least 45 years old. A standard interview, anthropometrics and laboratory parameters were performed for each participant. The standardised ultrasound hepatic-renal echo-intensity and hepatic echo-intensity attenuation rate were used to assess the LFC. The cohort was stratified according to the quintiles for LFC. Two-hour glucose and fasting blood glucose increased across the LFC quintiles after adjustment for age and gender. LFC increased continuously among glucose categories after adjustment for age and gender (NGT: 7.7 +/- 0.3%, IFG: 10.0 +/- 0.8%, IGT: 11.8 +/- 0.5%, IFG+IGT: 11.7 +/- 0.9%, new-DM: 12.4 +/- 0.6%, P<0.001). By logistic regression analysis, 1% LFC increment independently predicted prediabetes and diabetes (OR 1.032, 1.019-1.045, P<0.001; 1.021, 1.005-1.037, P=0.012, respectively) after adjustment for all potential confounders. Furthermore, participants with LFC higher than 10% had higher odds ratios of impaired glucose regulation as compared with those with LFC below 10% in fully adjusted logistic models. These results suggest that the LFC is strongly associated with impaired glucose regulation in the Chinese population, and that an even slightly elevated LFC is associated with increased glucose dysregulation.	[Li, Xiaoming; Xia, Mingfeng; Ma, Hui; Hu, Yu; Yan, Hongmei; Lin, Huandong; Gao, Xin] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [He, Wanyuan] Fudan Univ, Zhongshan Hosp, Dept Ultrasonog, Shanghai 200433, Peoples R China; [Zhao, Naiqing] Fudan Univ, Coll Publ Hlth, Dept Stat, Shanghai 200433, Peoples R China; [Gao, Jian] Fudan Univ, Zhongshan Hosp, Dept Evidence Base Med Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Gao, X (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China.	gao.xin@zs-hospital.sh.cn	Xia, Ming-Feng/AAL-1403-2020	Xia, Ming-Feng/0000-0002-5650-0165; Gao, Xin/0000-0003-1864-7796	National Basic Research Program of China [2012CB524906, 2011CB504004]; Science and Technology Commission of Shanghai Municipality [10411956400, 10411962600]; National Ministry of Education Program [985 III-YFX0302]; Shanghai Municipal Health Bureau Foundation [12GWZX0103]	National Basic Research Program of China(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Ministry of Education Program; Shanghai Municipal Health Bureau Foundation	This work was supported by grants from the National Basic Research Program of China (2012CB524906 and 2011CB504004 to XG; http://www.973.gov.cn/Default_3.aspx), the Science and Technology Commission of Shanghai Municipality (10411956400 to XG and 10411962600 to HMY), the National Ministry of Education Program (985 III-YFX0302 to XG) and Shanghai Municipal Health Bureau Foundation (12GWZX0103 to XG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Ballestri S, 2012, LIVER INT, V32, P1242, DOI 10.1111/j.1478-3231.2012.02804.x; Burgert TS, 2006, J CLIN ENDOCR METAB, V91, P4287, DOI 10.1210/jc.2006-1010; Cali AMG, 2009, HEPATOLOGY, V49, P1896, DOI 10.1002/hep.22858; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Forouhi NG, 2006, DIABETOLOGIA, V49, P822, DOI 10.1007/s00125-006-0189-4; Gao X, 2010, EUR J EPIDEMIOL, V25, P885, DOI 10.1007/s10654-010-9525-6; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Jung CH, 2013, DIABETIC MED, V30, P428, DOI 10.1111/dme.12104; Kang HL, 2006, AM J GASTROENTEROL, V101, P2247, DOI 10.1111/j.1572-0241.2006.00719.x; Kantartzis K, 2010, DIABETOLOGIA, V53, P882, DOI 10.1007/s00125-010-1663-6; Kasturiratne A, 2013, J GASTROEN HEPATOL, V28, P142, DOI 10.1111/j.1440-1746.2012.07264.x; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Meng-su Z, 2010, CHIN J ENDOCRINOL ME, V26; Moon SY, 2013, ATHEROSCLEROSIS; Nakanishi N, 2004, DIABETES CARE, V27, P1427, DOI 10.2337/diacare.27.6.1427; Park SK, 2012, HEPATOLOGY; Ryan MC, 2005, DIABETES CARE, V28, P1222, DOI 10.2337/diacare.28.5.1222; Shaw JE, 1999, DIABETES CARE, V22, P762, DOI 10.2337/diacare.22.5.762; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Xia MF, 2012, OBESITY, V20, P444, DOI 10.1038/oby.2011.302	29	14	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e65210	10.1371/journal.pone.0065210	http://dx.doi.org/10.1371/journal.pone.0065210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843938	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000004
J	Tan, ZJ; Liang, Y; Liu, SM; Cao, WJ; Tu, HB; Guo, LX; Xu, YY				Tan, Zhijun; Liang, Ying; Liu, Siming; Cao, Wenjun; Tu, Haibo; Guo, Lingxia; Xu, Yongyong			Health-Related Quality of Life as Measured with EQ-5D among Populations with and without Specific Chronic Conditions: A Population-Based Survey in Shaanxi Province, China	PLOS ONE			English	Article							CHRONIC DISEASES; CARE; EUROQOL; IMPACT; SF-36	Introduction: The aim of this study was to examine health-related quality of life (HRQoL) as measured by EQ-5D and to investigate the influence of chronic conditions and other risk factors on HRQoL based on a distributed sample located in Shaanxi Province, China. Methods: A multi-stage stratified cluster sampling method was performed to select subjects. EQ-5D was employed to measure the HRQoL. The likelihood that individuals with selected chronic diseases would report any problem in the EQ-5D dimensions was calculated and tested relative to that of each of the two reference groups. Multivariable linear regression models were used to investigate factors associated with EQ VAS. Results: The most frequently reported problems involved pain/discomfort (8.8%) and anxiety/depression (7.6%). Nearly half of the respondents who reported problems in any of the five dimensions were chronic patients. Higher EQ VAS scores were associated with the male gender, higher level of education, employment, younger age, an urban area of residence, access to free medical service and higher levels of physical activity. Except for anemia, all the selected chronic diseases were indicative of a negative EQ VAS score. The three leading risk factors were cerebrovascular disease, cancer and mental disease. Increases in age, number of chronic conditions and frequency of physical activity were found to have a gradient effect. Conclusion: The results of the present work add to the volume of knowledge regarding population health status in this area, apart from the known health status using mortality and morbidity data. Medical, policy, social and individual attention should be given to the management of chronic diseases and improvement of HRQoL. Longitudinal studies must be performed to monitor changes in HRQoL and to permit evaluation of the outcomes of chronic disease intervention programs.	[Tan, Zhijun; Liang, Ying; Xu, Yongyong] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Shaanxi, Peoples R China; [Tan, Zhijun; Liang, Ying; Xu, Yongyong] Fourth Mil Med Univ, Key Lab Hazard Assessment & Control Special Opera, Minist Educ, Xian 710032, Shaanxi, Peoples R China; [Liu, Siming] Brunel Univ, Sch Social Sci, Dept Econ & Finance, London, England; [Tu, Haibo] Fourth Mil Med Univ, Xijing Hosp, Div Med Serv, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Brunel University; University of Greenwich; Air Force Military Medical University	Xu, YY (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Shaanxi, Peoples R China.	xuyongy@fmmu.edu.cn		Liu, Siming/0000-0001-6855-8391	National Nature Science Foundation [81072393]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	Financial support of this study was provided by the National Nature Science Foundation (No. 81072393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Bharmal M, 2006, VALUE HEALTH, V9, P262, DOI 10.1111/j.1524-4733.2006.00108.x; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Calvert MJ, 2005, EUR J HEART FAIL, V7, P243, DOI 10.1016/j.ejheart.2005.01.012; Center for Health Statistics and Information National Health and Family Planning Commission, 2009, AN REP NAT HLTH SERV; Centre for Health Statistics and Information, 2004, RES NAT HLTH SERV AN; Centre for Health Statistics and Information of Ministry of Health of People's Republic of China, 2008, PROT GUID 4 NAT HLTH; Centre of Health Statistics Health General Office of Shaanxi Province, 2009, REP 4 NAT HLTH SERV; Chinese center for disease control and prevention, 2006, REP CHRON CHIN 2006; Department of Health and Human Services (US), 1992, HLTH PEOPL 2000; Department of Health and Human Services (US), 2000, HLTH PEOPL 2010; Dyer MTD, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-13; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Gao F, 2009, J CLIN EPIDEMIOL, V62, P206, DOI 10.1016/j.jclinepi.2008.03.007; Hou JW, 2011, SOC SCI J, V48, P514, DOI 10.1016/j.soscij.2011.06.002; Hsu G. K., 2005, HONG KONG J PSYCHIAT, V15, P71; Javanbakht M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044526; Lam CLK, 2000, FAM PRACT, V17, P159, DOI 10.1093/fampra/17.2.159; Lubetkin EI, 2004, QUAL LIFE RES, V13, P1459, DOI 10.1023/B:QURE.0000040793.40831.72; Ministry of Health of Republic of China, 2011, CHIN CHRON DIS PREV; Ministry of Health of the People's Republic of China, 2010, GUID SCHEM COMPR PRE; Ministry of Health of the People's Republic of China, 2011, NAT BAS PUBL SERV SP; Oppe M, 2008, EUROQOL GROUP EQ 5D; Pappa E, 2009, INT J PUBLIC HEALTH, V54, P241, DOI 10.1007/s00038-009-8057-x; Patrick DL, 1993, HLTH STAT HLTH POL Q, p200P; Picavet HSJ, 2004, ANN RHEUM DIS, V63, P723, DOI 10.1136/ard.2003.010769; Pickard AS, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-26; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Shi SS, 2012, CHINESE SECURITY SYS, V3, P57; Sun S, 2011, HEALTH PLACE, V17, P671, DOI 10.1016/j.healthplace.2011.01.007; Supina AL, 2007, QUAL LIFE RES, V16, P749, DOI 10.1007/s11136-006-9159-z; Tajima R, 2010, CLIN EXP NEPHROL, V14, P340, DOI 10.1007/s10157-010-0304-1; Tian F, 2007, HLTH EC RES, V9, P42; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2010, GLOB STAT REP NONC D; Williams JG, 2005, J ADHES SCI TECHNOL, V19, P257, DOI [10.1163/1568561054352586, 10.1016/j.jaging.2004.06.009]; World Health Organization, 2008, 2008 2013 ACT PLAN G; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yeung A, 2010, AM J PUBLIC HEALTH, V100, P2397, DOI 10.2105/AJPH.2009.184911; Yu YF, 1992, CHINESE RURAL HLTH S, V5, P56; Zhang YT, 2006, J AGING STUD, V20, P151, DOI 10.1016/j.jaging.2005.07.002	44	49	60	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e65958	10.1371/journal.pone.0065958	http://dx.doi.org/10.1371/journal.pone.0065958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23843948	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000009
J	Tellez-Sosa, J; Rodriguez, MH; Gomez-Barreto, RE; Valdovinos-Torres, H; Hidalgo, AC; Cruz-Hervert, P; Luna, RS; Carrillo-Valenzo, E; Ramos, C; Garcia-Garcia, L; Martinez-Barnetche, J				Tellez-Sosa, Juan; Henry Rodriguez, Mario; Gomez-Barreto, Rosa E.; Valdovinos-Torres, Humberto; Cecilia Hidalgo, Ana; Cruz-Hervert, Pablo; Santos Luna, Rene; Carrillo-Valenzo, Erik; Ramos, Celso; Garcia-Garcia, Lourdes; Martinez-Barnetche, Jesus			Using High-Throughput Sequencing to Leverage Surveillance of Genetic Diversity and Oseltamivir Resistance: A Pilot Study during the 2009 Influenza A(H1N1) Pandemic	PLOS ONE			English	Article							VIRUS; MUTATIONS; TRANSMISSION; INFECTIONS; VARIANTS; TOOL	Background: Influenza viruses display a high mutation rate and complex evolutionary patterns. Next-generation sequencing (NGS) has been widely used for qualitative and semi-quantitative assessment of genetic diversity in complex biological samples. The "deep sequencing" approach, enabled by the enormous throughput of current NGS platforms, allows the identification of rare genetic viral variants in targeted genetic regions, but is usually limited to a small number of samples. Methodology and Principal Findings: We designed a proof-of-principle study to test whether redistributing sequencing throughput from a high depth-small sample number towards a low depth-large sample number approach is feasible and contributes to influenza epidemiological surveillance. Using 454-Roche sequencing, we sequenced at a rather low depth, a 307 bp amplicon of the neuraminidase gene of the Influenza A(H1N1) pandemic (A(H1N1)pdm) virus from cDNA amplicons pooled in 48 barcoded libraries obtained from nasal swab samples of infected patients (n = 299) taken from May to November, 2009 pandemic period in Mexico. This approach revealed that during the transition from the first (May-July) to second wave (September-November) of the pandemic, the initial genetic variants were replaced by the N248D mutation in the NA gene, and enabled the establishment of temporal and geographic associations with genetic diversity and the identification of mutations associated with oseltamivir resistance. Conclusions: NGS sequencing of a short amplicon from the NA gene at low sequencing depth allowed genetic screening of a large number of samples, providing insights to viral genetic diversity dynamics and the identification of genetic variants associated with oseltamivir resistance. Further research is needed to explain the observed replacement of the genetic variants seen during the second wave. As sequencing throughput rises and library multiplexing and automation improves, we foresee that the approach presented here can be scaled up for global genetic surveillance of influenza and other infectious diseases.	[Tellez-Sosa, Juan; Henry Rodriguez, Mario; Gomez-Barreto, Rosa E.; Valdovinos-Torres, Humberto; Cecilia Hidalgo, Ana; Cruz-Hervert, Pablo; Ramos, Celso; Garcia-Garcia, Lourdes; Martinez-Barnetche, Jesus] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Santos Luna, Rene] Inst Nacl Salud Publ, Ctr Informac Decisiones Salud Publ, Cuernavaca, Morelos, Mexico; [Carrillo-Valenzo, Erik] Serv Salud Morelos, Dept Epidemiol, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Universidad Autonoma del Estado de Morelos	Martinez-Barnetche, J (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	jmbarnet@insp.mx	Ramos, Celso Dario/A-1485-2013; Santos Luna, Rene/C-8724-2014; Cruz-Hervert, Luis Pablo/AEI-4595-2022; García, Maria de Lourdes/I-2724-2019	Ramos, Celso Dario/0000-0002-1312-1026; Santos Luna, Rene/0000-0002-4730-5317; Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; García, Maria de Lourdes/0000-0001-5262-1157; Martinez-Barnetche, Jesus/0000-0002-5228-3554				ALI SA, 1995, BIOTECHNIQUES, V18, P746; Alteri C, 2011, J ANTIMICROB CHEMOTH, V66, P2615, DOI 10.1093/jac/dkr354; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Brockhurst MA, 2011, MOL ECOL, V20, P972, DOI 10.1111/j.1365-294X.2010.04835.x; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Ramirez-Gonzalez JE, 2011, EMERG INFECT DIS, V17, P283, DOI 10.3201/eid1702.100897; Fereidouni SR, 2009, EUROSURVEILLANCE, V14, P2; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2012, J INFECT DIS, V206, P1504, DOI 10.1093/infdis/jis571; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Gubareva LV, 2010, ANTIVIR THER, V15, P1151, DOI 10.3851/IMP1678; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019075; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Hollants S, 2012, CLIN CHEM, V58, P717, DOI 10.1373/clinchem.2011.173963; Holmes EC, 2011, J VIROL, V85, P6923, DOI 10.1128/JVI.00438-11; Holmes EC, 2009, J CLIN INVEST, V119, P2488, DOI 10.1172/JCI38050; Hurt AC, 2011, EUROSURVEILLANCE, V16, P2; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kozarewa I, 2011, METHODS MOL BIOL, V733, P279, DOI 10.1007/978-1-61779-089-8_20; Kryazhimskiy S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001301; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nelson M, 2009, PLOS CURRENTS, V1; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; Ramakrishnan MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007105; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Renaud C, 2011, J CLIN VIROL, V52, P70, DOI 10.1016/j.jcv.2011.05.019; Selleri M., 2012, CLIN MICROBIOL INFEC; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Suenaga H, 2012, ENVIRON MICROBIOL, V14, P13, DOI 10.1111/j.1462-2920.2011.02438.x; Tu J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-43; van der Vries E, 2011, CURR OPIN INFECT DIS, V24, P599, DOI 10.1097/QCO.0b013e32834cfb43; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046	50	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67010	10.1371/journal.pone.0067010	http://dx.doi.org/10.1371/journal.pone.0067010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843978	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000027
J	van de Ven, G; Draskovic, I; Adang, EMM; Donders, R; Zuidema, SU; Koopmans, RTCM; Vernooij-Dassen, MJFJ				van de Ven, Geertje; Draskovic, Irena; Adang, Eddy M. M.; Donders, Rogier; Zuidema, Sytse U.; Koopmans, Raymond T. C. M.; Vernooij-Dassen, Myrra J. F. J.			Effects of Dementia-Care Mapping on Residents and Staff of Care Homes: A Pragmatic Cluster-Randomised Controlled Trial	PLOS ONE			English	Article							PERSON-CENTERED CARE; NURSING-HOMES; EFFICACY; INTERVENTIONS; AGITATION; DESIGN; CADRES	Background: The effectiveness of dementia-care mapping (DCM) for institutionalised people with dementia has been demonstrated in an explanatory cluster-randomised controlled trial (cRCT) with two DCM researchers carrying out the DCM intervention. In order to be able to inform daily practice, we studied DCM effectiveness in a pragmatic cRCT involving a wide range of care homes with trained nursing staff carrying out the intervention. Methods: Dementia special care units were randomly assigned to DCM or usual care. Nurses from the intervention care homes received DCM training and conducted the 4-months DCM-intervention twice during the study. The primary outcome was agitation, measured with the Cohen-Mansfield agitation inventory (CMAI). The secondary outcomes included residents' neuropsychiatric symptoms (NPSs) and quality of life, and staff stress and job satisfaction. The nursing staff made all measurements at baseline and two follow-ups at 4-month intervals. We used linear mixed-effect models to test treatment and time effects. Results: 34 units from 11 care homes, including 434 residents and 382 nursing staff members, were randomly assigned. Ten nurses from the intervention units completed the basic and advanced DCM training. Intention-to-treat analysis showed no statistically significant effect on the CMAI (mean difference between groups 2.4, 95% CI -2.7 to 7.6; p = 0.34). More NPSs were reported in the intervention group than in usual care (p = 0.02). Intervention staff reported fewer negative and more positive emotional reactions during work (p = 0.02). There were no other significant effects. Conclusions: Our pragmatic findings did not confirm the effect on the primary outcome of agitation in the explanatory study. Perhaps the variability of the extent of implementation of DCM may explain the lack of effect.	[van de Ven, Geertje; Draskovic, Irena; Koopmans, Raymond T. C. M.; Vernooij-Dassen, Myrra J. F. J.] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Adang, Eddy M. M.; Donders, Rogier] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Zuidema, Sytse U.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Vernooij-Dassen, Myrra J. F. J.] Radboud Univ Nijmegen, Sci Inst Qual Healthcare, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Vernooij-Dassen, Myrra J. F. J.] Kalorama Fdn, Beek Ubbergen, Netherlands; [van de Ven, Geertje; Draskovic, Irena; Koopmans, Raymond T. C. M.; Vernooij-Dassen, Myrra J. F. J.] Radboud Univ Nijmegen, Radboud Alzheimer Ctr, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen	van de Ven, G (corresponding author), Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	G.vandeVen@elg.umcn.nl	Vernooij-Dassen, M.J.F.J./H-8107-2014; Koopmans, R.T.C.M./H-8062-2014; Adang, E.M.M./L-4169-2015; Draskovic, Irena/GZG-9712-2022; Donders, A.R.T./L-4277-2015	Donders, A.R.T./0000-0002-0484-1419; Draskovic, Irena/0000-0002-1677-5543	Netherlands Organisation for Health Research and Development (ZonMw) [171002502]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The Netherlands Organisation for Health Research and Development (ZonMw) funded this study (Dossier number: 171002502; website: www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2001, DIAGN STAT MAN MENT; Bouman AIE, 2011, INT J GERIATR PSYCH, V26, P711, DOI 10.1002/gps.2585; Brodaty H, 2003, J ADV NURS, V44, P583, DOI 10.1046/j.0309-2402.2003.02848.x; Brooker D, 1998, AGING MENT HEALTH, V2, P60, DOI 10.1080/13607869856957; Brooker D., 2004, WHAT IS PERSONCENTRE, V13, P215, DOI [DOI 10.1017/S095925980400108X, 10.1017/S095925980400108X]; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chalkidou K, 2012, CLIN TRIALS, V9, P436, DOI 10.1177/1740774512450097; Chenoweth L, 2007, AGING MENT HEALTH, V11, P237, DOI 10.1080/13607860600844226; Chenoweth L, 2009, LANCET NEUROL, V8, P317, DOI 10.1016/S1474-4422(09)70045-6; Cohen-Mansfield J, 2012, J CLIN PSYCHIAT, V73, P1255, DOI 10.4088/JCP.12m07918; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Edvardsson D, 2008, LANCET NEUROL, V7, P362, DOI 10.1016/S1474-4422(08)70063-2; Ettema TP, 2007, THESIS FREE U AMSTER; Goldberg DP, 1982, DETECTION PSYCHIAT I; Jeon YH, 2012, INT J NURS STUD, V49, P508, DOI 10.1016/j.ijnurstu.2011.10.020; Kitwood Tom, 1992, Ageing Soc, V12, P269, DOI 10.1017/S0144686X0000502X; KOETER MWJ, 1992, J AFFECT DISORDERS, V24, P271, DOI 10.1016/0165-0327(92)90112-J; Koopmans RTCM, 2010, J AM GERIATR SOC, V58, P1807, DOI 10.1111/j.1532-5415.2010.03043.x; Kuiper D, 2009, Tijdschr Gerontol Geriatr, V40, P102; Landeweerd J. A, 1996, BEDRIJFSGEZONDHEIDSZ, V11; Leontjevas R, 2012, J AM MED DIR ASS, V13; Perry M, 2010, J CLIN EPIDEMIOL, V63, P1118, DOI 10.1016/j.jclinepi.2009.11.014; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Ribbe MW, 1997, AGE AGEING, V26, P3, DOI 10.1093/ageing/26.suppl_2.3; van de Ven G, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-1; van Veldhoven M, 2002, SERVICES SKBV; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zuidema SU, 2007, INT J GERIATR PSYCH, V22, P632, DOI 10.1002/gps.1722; Zuidema SU, 2007, DEMENT GERIATR COGN, V23, P35, DOI 10.1159/000096681; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	30	55	55	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67325	10.1371/journal.pone.0067325	http://dx.doi.org/10.1371/journal.pone.0067325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	176XV	23844003	gold, Green Published			2022-12-27	WOS:000321341000041
J	Zhang, XL; Jiang, L; Wang, GQ; Yu, L; Zhang, Q; Xin, Q; Wu, W; Gong, ZZ; Chen, ZZ				Zhang, Xingliang; Jiang, Lun; Wang, Guoqiang; Yu, Lin; Zhang, Qi; Xin, Qi; Wu, Wei; Gong, Zhizhong; Chen, Zhongzhou			Structural Insights into the Abscisic Acid Stereospecificity by the ABA Receptors PYR/PYL/RCAR	PLOS ONE			English	Article							MOLECULAR-BASIS; INHIBITION; MECHANISM; ANALOGS; COMPLEX; REVEAL	The phytohormone abscisic acid ((+)-ABA) plays a key role in many processes. The biological and biochemical activities of unnatural (-)-ABA have been extensively investigated since 1960s. However, the recognition mechanism by which only a few members among PYR/PYL/RCAR (PYLs) family can bind (-)-ABA remains largely unknown. Here we systematically characterized the affinity of PYLs binding to the (-)-ABA and reported the crystal structures of apo-PYL5, PYL3-(-)-ABA and PYL9-(+)-ABA. PYL5 showed the strongest binding affinity with (-)-ABA among all the PYLs. PYL9 is a stringently exclusive (+)-ABA receptor with interchangeable disulfide bonds shared by a subclass of PYLs. PYL3 is a dual receptor to both ABA enantiomers. The binding orientation and pocket of (-)-ABA in PYLs are obviously different from those of (+)-ABA. Steric hindrance and hydrophobic interaction are the two key factors in determining the stereospecificity of PYLs binding to (-)-ABA, which is further confirmed by gain-of-function and loss-of-function mutagenesis. Our results provide novel insights of the bioactivity of ABA enantiomers onto PYLs, and shed light on designing the selective ABA receptors agonists.	[Zhang, Xingliang; Jiang, Lun; Wang, Guoqiang; Yu, Lin; Zhang, Qi; Wu, Wei; Chen, Zhongzhou] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhang, Xingliang] Guangdong Med Coll, Clin Med Res Ctr, Affiliated Hosp, Guangzhou, Guangdong, Peoples R China; [Xin, Qi; Gong, Zhizhong] China Agr Univ, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University; Guangdong Medical University; China Agricultural University	Chen, ZZ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	chenzhongzhou@cau.edu.cn	Gong, Zhizhong/AAS-4796-2021; chen, zhong/E-3900-2015	chen, zhong/0000-0003-1319-9664; Zhang, Qi/0000-0003-1121-8817	Chinese Universities Scientific Fund [2013QJ027]; National Basic Research Program of China (973 Program) [2011CB965304, 2009CB825501]; National Natural Science Foundation of China [31222032, 90919043, 31070664, J1103520]; Fok Ying Tung Education Foundation [121025]	Chinese Universities Scientific Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by Chinese Universities Scientific Fund (2013QJ027), National Basic Research Program of China (973 Program, 2011CB965304 and 2009CB825501), National Natural Science Foundation of China (31222032, 90919043 and 31070664), Chinese Universities Scientific Fund and Fok Ying Tung Education Foundation (121025). YL was supported by National Natural Science Foundation of China (J1103520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BALSEVICH JJ, 1994, PLANT PHYSIOL, V106, P135, DOI 10.1104/pp.106.1.135; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dupeux F, 2011, EMBO J, V30, P4171, DOI 10.1038/emboj.2011.294; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Hao Q, 2011, MOL CELL, V42, P662, DOI 10.1016/j.molcel.2011.05.011; Huang DQ, 2007, PLANT J, V50, P414, DOI 10.1111/j.1365-313X.2007.03056.x; Lin BL, 2005, J EXP BOT, V56, P2935, DOI 10.1093/jxb/eri290; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; MILBORROW BV, 1974, ANNU REV PLANT PHYS, V25, P259, DOI 10.1146/annurev.pp.25.060174.001355; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nambara E, 2002, GENETICS, V161, P1247; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Sun DM, 2012, BIOCHEM BIOPH RES CO, V418, P122, DOI 10.1016/j.bbrc.2011.12.145; Szostkiewicz I, 2010, PLANT J, V61, P25, DOI 10.1111/j.1365-313X.2009.04025.x; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALKERSIMMONS MK, 1992, PLANT PHYSIOL, V99, P501, DOI 10.1104/pp.99.2.501; WALKERSIMMONS MK, 1994, PLANT PHYSIOL, V106, P1279, DOI 10.1104/pp.106.4.1279; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhang XL, 2012, STRUCTURE, V20, P780, DOI 10.1016/j.str.2012.02.019	31	33	44	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67477	10.1371/journal.pone.0067477	http://dx.doi.org/10.1371/journal.pone.0067477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844015	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000048
J	Gu, JB; Hu, WQ; Wu, JY; Zheng, PM; Chen, MS; James, AA; Chen, XG; Tu, ZJ				Gu, Jinbao; Hu, Wanqi; Wu, Jinya; Zheng, Peiming; Chen, Maoshan; James, Anthony A.; Chen, Xiaoguang; Tu, Zhijian			miRNA Genes of an Invasive Vector Mosquito, Aedes albopictus	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; DISCOVERY	Aedes albopictus, a vector of Dengue and Chikungunya viruses, is a robust invasive species in both tropical and temperate environments. MicroRNAs (miRNAs) regulate gene expression and biological processes including embryonic development, innate immunity and infection. While a number of miRNAs have been discovered in some mosquitoes, no comprehensive effort has been made to characterize them from different developmental stages from a single species. Systematic analysis of miRNAs in Ae. albopictus will improve our understanding of its basic biology and inform novel strategies to prevent virus transmission. Between 10-14 million Illumina sequencing reads per sample were obtained from embryos, larvae, pupae, adult males, sugar-fed and blood-fed adult females. A total of 119 miRNA genes represented by 215 miRNA or miRNA star (miRNA*) sequences were identified, 15 of which are novel. Eleven, two, and two of the newly-discovered miRNA genes appear specific to Aedes, Culicinae, and Culicidae, respectively. A number of miRNAs accumulate predominantly in one or two developmental stages and the large number that showed differences in abundance following a blood meal likely are important in blood-induced mosquito biology. Gene Ontology (GO) analysis of the targets of all Ae. albopictus miRNAs provides a useful starting point for the study of their functions in mosquitoes. This study is the first systematic analysis of miRNAs based on deep-sequencing of small RNA samples of all developmental stages of a mosquito species. A number of miRNAs are related to specific physiological states, most notably, pre- and post-blood feeding. The distribution of lineage-specific miRNAs is consistent with mosquito phylogeny and the presence of a number of Aedes-specific miRNAs likely reflects the divergence between the Aedes and Culex genera.	[Gu, Jinbao; Wu, Jinya; Zheng, Peiming; Chen, Xiaoguang] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Pathogen Biol,Guangdong Higher Educ Inst, Key Lab Prevent & Control Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China; [Hu, Wanqi; Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Chen, Maoshan] Beijing Genom Inst, Shenzhen, Guangdong, Peoples R China; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	Southern Medical University - China; Virginia Polytechnic Institute & State University; Beijing Genomics Institute (BGI); University of California System; University of California Irvine; University of California System; University of California Irvine	Chen, XG (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Pathogen Biol,Guangdong Higher Educ Inst, Key Lab Prevent & Control Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China.	xgchen2001@hotmail.com	Gu, Jinbao/AAE-6764-2021	CHEN, MAOSHAN/0000-0002-3827-4969; James, Anthony/0000-0001-5577-3308	National Natural Science Foundation of China [U0832004]; GDUPS; National Institute of Allergy and Infectious Diseases [AI070854, U54AI065359]; NSFC [30828027]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, R21AI070854] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); GDUPS; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported in part by grants from the National Natural Science Foundation of China (U0832004) and GDUPS (2009) to Xiaoguang Chen, the National Institute of Allergy and Infectious Diseases (AI070854) and NSFC (30828027) to Zhijian Tu and the National Institute of Allergy and Infectious Diseases (U54AI065359) to Anthony A. James. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; de Wit E, 2009, GENOME RES, V19, P2064, DOI 10.1101/gr.093781.109; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; Guerra-Assuncao JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-133; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-581; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lyson TR, 2012, BIOL LETTERS, V8, P104, DOI 10.1098/rsbl.2011.0477; MARCHI A, 1986, CAN J GENET CYTOL, V28, P198, DOI 10.1139/g86-027; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Nelder M, 2010, AM J TROP MED HYG, V82, P831, DOI 10.4269/ajtmh.2010.09-0546; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Zheng Pei-ming, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P677	35	23	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67638	10.1371/journal.pone.0067638	http://dx.doi.org/10.1371/journal.pone.0067638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840875	Green Submitted, Green Published, gold			2022-12-27	WOS:000321271900014
J	Liao, GN; Liu, G				Liao, Guoning; Liu, Gang			Immediate Translation of Formin DIAPH1 mRNA after Its Exiting the Nucleus Is Required for Its Perinuclear Localization in Fibroblasts	PLOS ONE			English	Article							INTRACELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; PROTEIN-SYNTHESIS; MAMMALIAN-CELLS; MDIA1; MEMBRANE; MECHANISMS; NUCLEATION; INITIATION; MIGRATION	DIAPH1 is a formin protein which promotes actin polymerization, stabilizes microtubules and consequently is involved in cytoskeleton dynamics, cell migration and differentiation. In contrast to the relatively well-understood signaling cascades that regulate DIAPH1 activity, its spatial regulation of biogenesis is not understood. A recent report showed that synthesis of DIAPH1 is confined in the perinuclear ER compartment through translation-dependent mRNA targeting. However, the underlying mechanism of DIAPH1 local synthesis is yet to be elucidated. Here, we provide evidence to demonstrate that the 5'-cap-mediated immediate translation of DIAPH1 mRNA upon exiting nucleus is required for localizing the mRNA in the perinuclear ER compartment. This is supported by data: 1) Delayed translation of DIAPH1 mRNA resulted in loss of perinuclear localization of the mRNA; 2) Once delocalized, DIAPH1 mRNA could not be retargeted to the perinuclear region; and 3) The translation of DIAPH1 mRNA is 5'-cap dependent. These results provide new insights into the novel mechanism of DIAPH1 local synthesis. In addition, these findings have led to the development of new approaches for manipulating DIAPH1 mRNA localization and local protein synthesis in cells for functional studies. Furthermore, a correlation of DIAPH1 mRNA and DIAPH1 protein localization has been demonstrated using a new method to quantify the intracellular distribution of protein.	[Liao, Guoning; Liu, Gang] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	Liu, G (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	liug@mail.amc.edu			NIH [R01GM70560]; Albany Medical College Brige fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070560] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albany Medical College Brige fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01GM70560 and Albany Medical College Brige fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Benham AM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012872; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cencic R, 2011, P NATL ACAD SCI USA, V108, P1046, DOI 10.1073/pnas.1011477108; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chubb JR, 2010, CURR OPIN GENET DEV, V20, P478, DOI 10.1016/j.gde.2010.06.009; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; JOKLIK W. K., 1965, J MOL BIOL, V13, P496; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Liao Guoning, 2011, Commun Integr Biol, V4, P560, DOI 10.4161/cib.4.5.15794; Liao GN, 2011, EXP CELL RES, V317, P812, DOI 10.1016/j.yexcr.2010.12.002; Liao GN, 2011, J CELL SCI, V124, P589, DOI 10.1242/jcs.072421; Lionnet T, 2012, EMBO REP, V13, P313, DOI 10.1038/embor.2012.31; Macchi P, 2003, MOL BIOL CELL, V14, P1570, DOI 10.1091/mbc.E02-08-0505; Meignin C, 2010, CURR OPIN CELL BIOL, V22, P112, DOI 10.1016/j.ceb.2009.11.011; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Oleynikov Y, 1998, TRENDS CELL BIOL, V8, P381, DOI 10.1016/S0962-8924(98)01348-8; Paknikar KM, 2007, J CELL MOL MED, V11, P393, DOI 10.1111/j.1582-4934.2007.00051.x; Paraskeva E, 1999, MOL CELL BIOL, V19, P807; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; SUNDELL CL, 1990, J CELL BIOL, V111, P2397, DOI 10.1083/jcb.111.6.2397; Tanizaki H, 2010, BLOOD, V116, P5875, DOI 10.1182/blood-2010-01-264150; Toure F, 2012, CIRC RES, V110, P1279, DOI 10.1161/CIRCRESAHA.111.262519; WALTER P, 1981, J CELL BIOL, V91, P551, DOI 10.1083/jcb.91.2.551; Wen YD, 2004, KENYON REV, V26, P1; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; YARMOLINSKY MB, 1959, P NATL ACAD SCI USA, V45, P1721, DOI 10.1073/pnas.45.12.1721; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	61	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68190	10.1371/journal.pone.0068190	http://dx.doi.org/10.1371/journal.pone.0068190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840831	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400174
J	Mauri, V; Lotfi, P; Segatori, L; Sardiello, M				Mauri, Victor; Lotfi, Parisa; Segatori, Laura; Sardiello, Marco			A Rapid and Sensitive Method for Measuring N-Acetylglucosaminidase Activity in Cultured Cells	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISEASES; ENZYME-REPLACEMENT THERAPY; SYNDROME TYPE-B; MUCOPOLYSACCHARIDOSIS TYPE-III; IONIZATION MASS-SPECTROMETRY; CODON READ-THROUGH; SANFILIPPO-SYNDROME; GAUCHER-DISEASE; PHARMACOLOGICAL CHAPERONES; MOLECULAR DEFECTS	A rapid and sensitive method to quantitatively assess N-acetylglucosaminidase (NAG) activity in cultured cells is highly desirable for both basic research and clinical studies. NAG activity is deficient in cells from patients with Mucopolysaccharidosis type IIIB (MPS IIIB) due to mutations in NAGLU, the gene that encodes NAG. Currently available techniques for measuring NAG activity in patient-derived cell lines include chromogenic and fluorogenic assays and provide a biochemical method for the diagnosis of MPS IIIB. However, standard protocols require large amounts of cells, cell disruption by sonication or freeze-thawing, and normalization to the cellular protein content, resulting in an error-prone procedure that is material-and time-consuming and that produces highly variable results. Here we report a new procedure for measuring NAG activity in cultured cells. This procedure is based on the use of the fluorogenic NAG substrate, 4-Methylumbelliferyl-2-acetamido-2-deoxy-alpha-D-glucopyranoside (MUG), in a one-step cell assay that does not require cell disruption or post-assay normalization and that employs a low number of cells in 96-well plate format. We show that the NAG one-step cell assay greatly discriminates between wild-type and MPS IIIB patient-derived fibroblasts, thus providing a rapid method for the detection of deficiencies in NAG activity. We also show that the assay is sensitive to changes in NAG activity due to increases in NAGLU expression achieved by either overexpressing the transcription factor EB (TFEB), a master regulator of lysosomal function, or by inducing TFEB activation chemically. Because of its small format, rapidity, sensitivity and reproducibility, the NAG one-step cell assay is suitable for multiple procedures, including the high-throughput screening of chemical libraries to identify modulators of NAG expression, folding and activity, and the investigation of candidate molecules and constructs for applications in enzyme replacement therapy, gene therapy, and combination therapies.	[Mauri, Victor; Lotfi, Parisa; Sardiello, Marco] Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Dept Mol & Human Genet, Houston, TX 77030 USA; [Segatori, Laura] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA; [Segatori, Laura] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Segatori, Laura] Rice Univ, Dept Bioengn, Houston, TX USA	Baylor College of Medicine; Rice University; Rice University; Rice University	Sardiello, M (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Dept Mol & Human Genet, Houston, TX 77030 USA.	sardiell@bcm.edu			Team Sanfilippo Foundation; Virginia and LS. Simmons Family Foundation Collaborative Research Fund; Welch foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079618] Funding Source: NIH RePORTER	Team Sanfilippo Foundation; Virginia and LS. Simmons Family Foundation Collaborative Research Fund; Welch foundation(The Welch Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Team Sanfilippo Foundation to MS, the Virginia and LS. Simmons Family Foundation Collaborative Research Fund to MS and LS, and the Welch foundation to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair D, 2010, MOL GENET METAB, V99, P132, DOI 10.1016/j.ymgme.2009.10.002; Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; Beesley C, 2004, CLIN GENET, V65, P143, DOI 10.1111/j.0009-9163.2004.00210.x; Beesley CE, 2005, J INHERIT METAB DIS, V28, P759, DOI 10.1007/s10545-005-0093-y; Beesley GE, 1998, J MED GENET, V35, P910, DOI 10.1136/jmg.35.11.910; Brooks DA, 2006, TRENDS MOL MED, V12, P367, DOI 10.1016/j.molmed.2006.06.001; Butterworth J, 1978, J Inherit Metab Dis, V1, P25, DOI 10.1007/BF01805711; CHOW P, 1981, CARBOHYD RES, V96, P87, DOI 10.1016/S0008-6215(00)84698-4; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; de Ruijter J, 2011, CURR PHARM BIOTECHNO, V12, P923, DOI 1389-2010/11 $58.00+.00; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Durand P, 2000, HUM MOL GENET, V9, P967, DOI 10.1093/hmg/9.6.967; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellinwood NM, 2011, MOL THER, V19, P251, DOI 10.1038/mt.2010.265; Fan JQ, 2007, FEBS J, V274, P4962, DOI 10.1111/j.1742-4658.2007.06041.x; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Fu H, 2002, MOL THER, V5, P42, DOI 10.1006/mthe.2001.0514; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gerber SA, 2001, BIOCONJUGATE CHEM, V12, P603, DOI 10.1021/bc010007l; Gerber SA, 2001, ANAL CHEM, V73, P1651, DOI 10.1021/ac0100650; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Hein LK, 2004, J MOL BIOL, V338, P453, DOI 10.1016/j.jmb.2004.03.012; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Heron B, 2011, AM J MED GENET A, V155A, P58, DOI 10.1002/ajmg.a.33779; HOPWOOD JJ, 1982, CLIN CHIM ACTA, V120, P77, DOI 10.1016/0009-8981(82)90079-1; Huynh HT, 2012, P NATL ACAD SCI USA, V109, P17022, DOI 10.1073/pnas.1214779109; Jakobkiewicz-Banecka J, 2007, J APPL GENET, V48, P383, DOI 10.1007/BF03195237; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Lachmann R, 2010, BIOCHEM SOC T, V38, P1465, DOI 10.1042/BST0381465; Lee-Chen G J, 2002, J Med Genet, V39, pE3, DOI 10.1136/jmg.39.2.e3; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Linde L, 2008, TRENDS GENET, V24, P552, DOI 10.1016/j.tig.2008.08.010; Lu J, 2011, P NATL ACAD SCI USA, V108, P21200, DOI 10.1073/pnas.1119181109; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; Maegawa GHB, 2009, J BIOL CHEM, V284, P23502, DOI 10.1074/jbc.M109.012393; MARSH J, 1985, CLIN GENET, V27, P258; Matsuda J, 2003, P NATL ACAD SCI USA, V100, P15912, DOI 10.1073/pnas.2536657100; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Munoz-Rojas MV, 2008, AM J MED GENET A, V146A, P2538, DOI 10.1002/ajmg.a.32294; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; OBRIEN JS, 1972, P NATL ACAD SCI USA, V69, P1720, DOI 10.1073/pnas.69.7.1720; OKADA S, 1971, AM J HUM GENET, V23, P55; Okumiya T, 2007, MOL GENET METAB, V90, P49, DOI 10.1016/j.ymgme.2006.09.010; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Parenti G, 2007, MOL THER, V15, P508, DOI 10.1038/sj.mt.6300074; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Porto C, 2012, J INHERIT METAB DIS, V35, P513, DOI 10.1007/s10545-011-9424-3; Porto C, 2009, MOL THER, V17, P964, DOI 10.1038/mt.2009.53; Sands MS, 2006, MOL THER, V13, P839, DOI 10.1016/j.ymthe.2006.01.006; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkar C, 2011, MOL GENET METAB, V104, P338, DOI 10.1016/j.ymgme.2011.05.021; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmidtchen A, 1998, AM J HUM GENET, V62, P64, DOI 10.1086/301685; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Song W, 2013, HUMAN MOL GENETICS; Tessitore A, 2000, HUM GENET, V107, P568, DOI 10.1007/s004390000429; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Tropak MB, 2007, CHEM BIOL, V14, P153, DOI 10.1016/j.chembiol.2006.12.006; Tsunemi T, 2012, SCI TRANSLATIONAL ME, V4; Urban DJ, 2008, COMB CHEM HIGH T SCR, V11, P817, DOI 10.2174/138620708786734244; Valayannopoulos V, 2011, RHEUMATOLOGY, V50, pV49, DOI 10.1093/rheumatology/ker396; Valenzano KJ, 2011, ASSAY DRUG DEV TECHN, V9, P213, DOI 10.1089/adt.2011.0370; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5; Walkley SU, 2009, J INHERIT METAB DIS, V32, P181, DOI 10.1007/s10545-008-1040-5; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang F, 2011, CHEM BIOL, V18, P766, DOI 10.1016/j.chembiol.2011.04.008; Wang F, 2011, ACS CHEM BIOL, V6, P158, DOI 10.1021/cb100321m; Wolfe BJ, 2012, BIOCONJUGATE CHEM, V23, P557, DOI 10.1021/bc200609x; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Yu T, 2012, HUM MOL GENET, V21, P3205, DOI 10.1093/hmg/dds145; Yu ZQ, 2007, FEBS J, V274, P4944, DOI 10.1111/j.1742-4658.2007.06042.x; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104	80	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68060	10.1371/journal.pone.0068060	http://dx.doi.org/10.1371/journal.pone.0068060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840811	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400160
J	Yang, WW; Tang, HZ; Ni, J; Wu, QL; Hua, DL; Tao, F; Xu, P				Yang, Wenwen; Tang, Hongzhi; Ni, Jun; Wu, Qiulin; Hua, Dongliang; Tao, Fei; Xu, Ping			Characterization of Two Streptomyces Enzymes That Convert Ferulic Acid to Vanillin	PLOS ONE			English	Article							BIOTECHNOLOGICAL PRODUCTION; BAKERS-YEAST; BIOCONVERSION; IDENTIFICATION; BIOSYNTHESIS; CLEAVAGE; CLONING; LIGASE; GENES	Production of flavors from natural substrates by microbial transformation has become a growing and expanding field of study over the past decades. Vanillin, a major component of vanilla flavor, is a principal flavoring compound used worldwide. Streptomyces sp. strain V-1 is known to be one of the most promising microbial producers of natural vanillin from ferulic acid. Although identification of the microbial genes involved in the biotransformation of ferulic acid to vanillin has been previously reported, purification and detailed characterization of the corresponding enzymes with important functions have rarely been studied. In this study, we isolated and identified 2 critical genes, fcs and ech, encoding feruloyl-CoA synthetase and enoyl-CoA hydratase/aldolase, respectively, which are involved in the vanillin production from ferulic acid. Both genes were heterologously expressed in Escherichia coli, and the resting cell reactions for converting ferulic acid to vanillin were performed. The corresponding crucial enzymes, Fcs and Ech, were purified for the first time and the enzymatic activity of each purified protein was studied. Furthermore, Fcs was comprehensively characterized, at an optimal pH of 7.0 and temperature of 30 degrees C. Kinetic constants for Fcs revealed the apparent K-m, k(cat), and V-max values to be 0.35 mM, 67.7 s(-1), and 78.2 U mg(-1), respectively. The catalytic efficiency (k(cat)/K-m) value of Fcs was 193.4 mM(-1) s(-1) for ferulic acid. The characterization of Fcs and Ech may be helpful for further research in the field of enzymatic engineering and metabolic regulation.	[Yang, Wenwen; Tang, Hongzhi; Ni, Jun; Wu, Qiulin; Tao, Fei; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Hua, Dongliang] Shandong Acad Sci, Energy Res Inst, Key Lab Biomass Gasificat Technol Shandong Prov, Jinan, Peoples R China	Shanghai Jiao Tong University; Qilu University of Technology	Tang, HZ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	tanghongzhi@sjtu.edu.cn; pingxu@sjtu.edu.cn		Xu, Ping/0000-0002-4418-9680	National Basic Research Program of China [2011CBA00800]; National Natural Science Foundation of China [31100034, 31100030, 31121064]; Shanghai Rising-Star Program [13QA1401700]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported in part by the National Basic Research Program of China (2011CBA00800), the National Natural Science Foundation of China (31100034, 31100030, and 31121064), and sponsored by "Shanghai Rising-Star Program" (13QA1401700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterholt S, 2000, APPL MICROBIOL BIOT, V54, P799, DOI 10.1007/s002530000431; Basnet DB, 2006, MOL CELLS, V22, P154; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brochado AR, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-84; Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI [10.1002/(SICI)1097-0010(19990301)79:3&lt;362::AID-JSFA256&gt;3.0.CO;2-D, 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D]; Davis JR, 2012, J BACTERIOL, V194, P2396, DOI 10.1128/JB.00186-12; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Ehlting J, 2001, PLANT J, V27, P455, DOI 10.1046/j.1365-313X.2001.01122.x; Gasson MJ, 1998, J BIOL CHEM, V273, P4163, DOI 10.1074/jbc.273.7.4163; Hansen EH, 2009, APPL ENVIRON MICROB, V75, P2765, DOI 10.1128/AEM.02681-08; Holder JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002219; Hua D, 2001, APPL MICROBIOL BIOT, V74, P783; Kaneko M, 2003, J BACTERIOL, V185, P20, DOI 10.1128/JB.185.1.20-27.2003; Krings U, 1998, APPL MICROBIOL BIOT, V49, P1, DOI 10.1007/s002530051129; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EG, 2009, BIOTECHNOL BIOENG, V102, P200, DOI 10.1002/bit.22040; Masai E, 2002, APPL ENVIRON MICROB, V68, P4416, DOI 10.1128/AEM.68.9.4416-4424.2002; Muheim A, 1999, APPL MICROBIOL BIOT, V51, P456, DOI 10.1007/s002530051416; Muheim A., 2001, [No title captured], Patent No. [6235507, US6235507 (B1)]; Overhage J, 1999, APPL ENVIRON MICROB, V65, P4837; Plaggenborg R, 2006, APPL MICROBIOL BIOT, V72, P745, DOI 10.1007/s00253-005-0302-5; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Priefert H, 2001, APPL MICROBIOL BIOT, V56, P296, DOI 10.1007/s002530100687; RABENHORST J, 2000, Patent No. 6133003; Sambrook J., 2001, MOL CLONING LAB MANU; Venturi V, 1998, MICROBIOL-SGM, V144, P965, DOI 10.1099/00221287-144-4-965; Wang SM, 2007, APPL ENVIRON MICROB, V73, P5048, DOI 10.1128/AEM.02973-06; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; Wu H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-337	29	70	75	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67339	10.1371/journal.pone.0067339	http://dx.doi.org/10.1371/journal.pone.0067339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840666	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400059
J	Moujalled, D; James, JL; Parker, SJ; Lidgerwood, GE; Duncan, C; Meyerowitz, J; Nonaka, T; Hasegawa, M; Kanninen, KM; Grubman, A; Liddell, JR; Crouch, PJ; White, AR				Moujalled, Diane; James, Janine L.; Parker, Sarah J.; Lidgerwood, Grace E.; Duncan, Clare; Meyerowitz, Jodi; Nonaka, Takashi; Hasegawa, Masato; Kanninen, Katja M.; Grubman, Alexandra; Liddell, Jeffrey R.; Crouch, Peter J.; White, Anthony R.			Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen Synthase Kinase 3 as Potential Modulators of TDP-43 Cytosolic Accumulation during Cell Stress	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR RIBONUCLEOPROTEIN A1; MESSENGER-RNA STABILITY; BINDING PROTEIN 43; ALZHEIMERS-DISEASE; HNRNP-K; NEURODEGENERATIVE DISEASES; CYTOPLASMIC ACCUMULATION; MOUSE MODELS	Abnormal processing of TAR DNA binding protein 43 (TDP-43) has been identified as a major factor in neuronal degeneration during amyotrophic lateral sclerosis (ALS) or frontotemporal lobar degeneration (FTLD). It is unclear how changes to TDP-43, including nuclear to cytosolic translocation and subsequent accumulation, are controlled in these diseases. TDP-43 is a member of the heterogeneous ribonucleoprotein (hnRNP) RNA binding protein family and is known to associate with cytosolic RNA stress granule proteins in ALS and FTLD. hnRNP trafficking and accumulation is controlled by the action of specific kinases including members of the mitogen-activated protein kinase (MAPK) pathway. However, little is known about how kinase pathways control TDP-43 movement and accumulation. In this study, we used an in vitro model of TDP-43-positve stress granule formation to screen for the effect of kinase inhibitors on TDP-43 accumulation. We found that while a number of kinase inhibitors, particularly of the MAPK pathways modulated both TDP-43 and the global stress granule marker, human antigen R (HuR), multiple inhibitors were more specific to TDP-43 accumulation, including inhibitors of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3 (GSK3). Close correlation was observed between effects of these inhibitors on TDP-43, hnRNP K and TIAR, but often with different effects on HuR accumulation. This may indicate a potential interaction between TDP-43, hnRNP K and TIAR. CDK inhibitors were also found to reverse pre-formed TDP-43-positive stress granules and both CDK and GSK3 inhibitors abrogated the accumulation of C-terminal TDP-43 (219-414) in transfected cells. Further studies are required to confirm the specific kinases involved and whether their action is through phosphorylation of the TDP-43 binding partner hnRNP K. This knowledge provides a valuable insight into the mechanisms controlling abnormal cytoplasmic TDP-43 accumulation and may herald new opportunities for kinase modulation-based therapeutic intervention in ALS and FTLD.	[Moujalled, Diane; James, Janine L.; Parker, Sarah J.; Lidgerwood, Grace E.; Duncan, Clare; Meyerowitz, Jodi; Grubman, Alexandra; Liddell, Jeffrey R.; Crouch, Peter J.; White, Anthony R.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Moujalled, Diane; James, Janine L.; Parker, Sarah J.; Lidgerwood, Grace E.; Duncan, Clare; Meyerowitz, Jodi; Grubman, Alexandra; Liddell, Jeffrey R.; Crouch, Peter J.; White, Anthony R.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Nonaka, Takashi; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Neuropathol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Kanninen, Katja M.] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Lab Mol Brain Res, Kuopio, Finland	University of Melbourne; Florey Institute of Neuroscience & Mental Health; Tokyo Metropolitan Institute of Medical Science; University of Eastern Finland	White, AR (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.	arwhite@unimelb.edu.au	Grubman, Alexandra/AAD-3109-2019; Lidgerwood, Grace/AAS-7439-2020; Liddell, Jeffrey/AAH-3685-2021; Nonaka, Takashi/L-8572-2017; White, Anthony/P-5596-2016	Grubman, Alexandra/0000-0003-4408-4499; Lidgerwood, Grace/0000-0002-1774-5944; Liddell, Jeffrey/0000-0002-0798-5338; Nonaka, Takashi/0000-0002-0830-9403; Crouch, Peter/0000-0002-7777-4747; Moujalled, Diane/0000-0002-6405-2788; White, Anthony/0000-0003-1802-9891	Motor Neuron Disease Research Institute of Australia (Terry Quinn MND Research Grant); Australian Rotary Health; Bethlehem Griffiths Research Foundation; CASS Foundation; Australian Research Council	Motor Neuron Disease Research Institute of Australia (Terry Quinn MND Research Grant); Australian Rotary Health; Bethlehem Griffiths Research Foundation; CASS Foundation; Australian Research Council(Australian Research Council)	This research was funded by the Motor Neuron Disease Research Institute of Australia (Terry Quinn MND Research Grant), Australian Rotary Health, the Bethlehem Griffiths Research Foundation and CASS Foundation. ARW is a recipient of an Australian Research Council Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Atzori C, 2001, J NEUROPATH EXP NEUR, V60, P1190, DOI 10.1093/jnen/60.12.1190; Ayala V, 2011, ACTA NEUROPATHOL, V122, P259, DOI 10.1007/s00401-011-0850-y; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251; Bartoli K. M., 2011, INT J CELL BIOL, V2011, DOI DOI 10.1155/2011/939848; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Chang JW, 2009, INT IMMUNOL, V21, P1351, DOI 10.1093/intimm/dxp106; Chen LC, 2009, ONCOGENE, V28, P1904, DOI 10.1038/onc.2009.55; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Ferrari R, 2011, CURR ALZHEIMER RES, V8, P273, DOI 10.2174/156720511795563700; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Higashi S, 2013, J NEUROCHEM, V126, P288, DOI 10.1111/jnc.12194; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hostetter C, 2008, CANCER BIOL THER, V7, P1498, DOI 10.4161/cbt.7.9.6490; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Liachko NF, 2013, ANN NEUROL, V74, P39, DOI 10.1002/ana.23870; Lian XJ, 2009, J BIOL CHEM, V284, P8868, DOI 10.1074/jbc.M806372200; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Nagao M, 2011, AMYOTROPHIC LATERAL, V12, P141; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Palomo V, 2011, CURR MED CHEM, V18, P3028, DOI 10.2174/092986711796391697; Parker SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042277; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Petit-Paitel A, 2010, M S-MED SCI, V26, P516, DOI 10.1051/medsci/2010265516; Rosania GR, 1999, P NATL ACAD SCI USA, V96, P4797, DOI 10.1073/pnas.96.9.4797; Sanchez-Martinez C, 2003, BIOORG MED CHEM LETT, V13, P3835, DOI 10.1016/S0960-894X(03)00791-1; Schmetsdorf S, 2009, EUR J NEUROSCI, V29, P1096, DOI 10.1111/j.1460-9568.2009.06661.x; Shimada N, 2009, RNA BIOL, V6, P293, DOI 10.4161/rna.6.3.8497; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Veglianese P, 2006, MOL CELL NEUROSCI, V31, P218, DOI 10.1016/j.mcn.2005.09.009; Wiedau-Pazos M, 2009, NEUROBIOL AGING, V30, P14, DOI 10.1016/j.neurobiolaging.2007.05.015; Yang RQ, 2010, J BIOL CHEM, V285, P8887, DOI 10.1074/jbc.M109.013128; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744; Zhu XW, 2003, REDOX REP, V8, P129, DOI 10.1179/135100003225001494	62	42	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67433	10.1371/journal.pone.0067433	http://dx.doi.org/10.1371/journal.pone.0067433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840699	Green Published, gold			2022-12-27	WOS:000321424400101
J	Schraml, F; Chen, KW; Ayutyanont, N; Auttawut, R; Langbaum, JBS; Lee, W; Liu, XF; Bandy, D; Reeder, SQ; Alexander, GE; Caselli, RJ; Fleisher, AS; Reiman, EM				Schraml, Frank; Chen, Kewei; Ayutyanont, Napatkamon; Auttawut, Roontiva; Langbaum, Jessica B. S.; Lee, Wendy; Liu, Xiaofen; Bandy, Dan; Reeder, Stephanie Q.; Alexander, Gene E.; Caselli, Richard J.; Fleisher, Adam S.; Reiman, Eric M.		Alzheimer's Dis Neuroimaging	Association between an Alzheimer's Disease-Related Index and APOE epsilon 4 Gene Dose	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E; FDG-PET; DEMENTIA; ALLELE; RISK	Background: We introduced a hypometabolic convergence index (HCI) to characterize in a single measurement the extent to which a person's fluorodeoxyglucose positron emission tomogram (FDG PET) corresponds to that in Alzheimer's disease (AD). Apolipoprotein E epsilon 4 (APOE epsilon 4) gene dose is associated with three levels of risk for late-onset AD. We explored the association between gene dose and HCI in cognitively normal epsilon 4 homozygotes, heterozygotes, and non-carriers. Methods: An algorithm was used to characterize and compare AD-related HCIs in cognitively normal individuals, including 36 epsilon 4 homozygotes, 46 heterozygotes, and 78 non-carriers. Results: These three groups differed significantly in their HCIs (ANOVA, p = 0.004), and there was a significant association between HCIs and gene dose (linear trend, p = 0.001). Conclusions: The HCI is associated with three levels of genetic risk for late-onset AD. This supports the possibility of using a single FDG PET measurement to help in the preclinical detection and tracking of AD.	[Chen, Kewei; Ayutyanont, Napatkamon; Auttawut, Roontiva; Langbaum, Jessica B. S.; Lee, Wendy; Liu, Xiaofen; Bandy, Dan; Reeder, Stephanie Q.; Fleisher, Adam S.; Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ 85006 USA; [Chen, Kewei; Ayutyanont, Napatkamon; Auttawut, Roontiva; Langbaum, Jessica B. S.; Lee, Wendy; Liu, Xiaofen; Bandy, Dan; Reeder, Stephanie Q.; Fleisher, Adam S.; Reiman, Eric M.] Banner Good Samaritan PET Ctr, Phoenix, AZ USA; [Chen, Kewei] Arizona State Univ, Dept Math & Stat, Tempe, AZ USA; [Alexander, Gene E.] Univ Arizona, Dept Psychol, Tucson, AZ USA; [Alexander, Gene E.] Evelyn F McKnight Brain Inst, Tucson, AZ USA; [Alexander, Gene E.; Reiman, Eric M.] Univ Arizona, Dept Psychiat, Tucson, AZ USA; [Fleisher, Adam S.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Caselli, Richard J.] Mayo Clin Arizona, Dept Neurol, Scottsdale, AZ USA; [Bandy, Dan; Reiman, Eric M.] Translat Genom Res Inst, Div Neurogen, Phoenix, AZ USA; [Chen, Kewei; Ayutyanont, Napatkamon; Auttawut, Roontiva; Langbaum, Jessica B. S.; Lee, Wendy; Liu, Xiaofen; Reeder, Stephanie Q.; Alexander, Gene E.; Caselli, Richard J.; Fleisher, Adam S.; Reiman, Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ USA; [Schraml, Frank] St Josephs Hosp, Barrow Neurol Inst, Dept Radiol, Phoenix, AZ USA; [Schraml, Frank] St Josephs Hosp, Barrow Neurol Inst, Dept Psychiat, Phoenix, AZ USA; [Schraml, Frank] Creighton Univ, Sch Med, Dept Radiol, Omaha, NE USA	Banner Research; Banner Health; Banner Alzheimer's Institute; Banner Research; Banner Health; Arizona State University; Arizona State University-Tempe; University of Arizona; University of Arizona; University of California System; University of California San Diego; Mayo Clinic; Mayo Clinic Phoenix; Translational Genomics Research Institute; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Creighton University	Chen, KW (corresponding author), Banner Alzheimers Inst, Phoenix, AZ 85006 USA.	Kewei.Chen@bannerhealth.com	Chen, kewei/P-6304-2015	Chen, kewei/0000-0001-8497-3069	National Institute on Aging [R01AG031581, P30AG19610, R01AG025526]; National Institute of Mental Health [R01MH057899]; Evelyn G. McKnight Brain Institute; State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610, R01AG025526, R01AG031581] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Evelyn G. McKnight Brain Institute; State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partly supported by grants from the National Institute on Aging (R01AG031581 to EMR), (P30AG19610 to EMR), (R01AG025526 to GEA), the National Institute of Mental Health (R01MH057899 to EMR), the Evelyn G. McKnight Brain Institute (to GEA), the State of Arizona (to EMR, RJC, GEA, KC), and contributions from the Banner Alzheimer's Foundation and Mayo Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caroli A, 2012, J NUCL MED, V53, P592, DOI 10.2967/jnumed.111.094946; Caselli RJ, 2012, J ALZHEIMER IN PRESS; Chen KW, 2011, NEUROIMAGE, V56, P52, DOI 10.1016/j.neuroimage.2011.01.049; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; First M.B., 1990, USERS GUIDE STRUCTUR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Herholz K, 2011, J NUCL MED, V52, P1218, DOI 10.2967/jnumed.111.090902; HIXSON JE, 1990, J LIPID RES, V31, P545; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Linden DEJ, 2012, NEURON, V73, P8, DOI 10.1016/j.neuron.2011.12.014; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi L, 2010, J ALZHEIMERS DIS, V20, P843, DOI 10.3233/JAD-2010-091504; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2004, RES PER ALZ, P151; Rey A., 1941, ARCH PSYCHOL, V28, P215; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467	22	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67163	10.1371/journal.pone.0067163	http://dx.doi.org/10.1371/journal.pone.0067163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840615	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400078
J	Lazarevic, V; Gaia, N; Girard, M; Francois, P; Schrenzel, J				Lazarevic, Vladimir; Gaia, Nadia; Girard, Myriam; Francois, Patrice; Schrenzel, Jacques			Comparison of DNA Extraction Methods in Analysis of Salivary Bacterial Communities	PLOS ONE			English	Article							MICROBIOME; PERIODONTITIS; ALIGNMENTS; SEQUENCES; TAXONOMY; HEALTH; FLORA	Culture-independent high-throughput sequencing-based methods are widely used to study bacterial communities. Although these approaches are superior to traditional culture-based methods, they introduce bias at the experimental and bioinformatics levels. We assessed the diversity of the human salivary microbiome by pyrosequencing of the 16S rDNA V1-3 amplicons using metagenomic DNA extracted by two different protocols: a simple proteinase K digestion without a subsequent DNA clean-up step, and a bead-beating mechanical lysis protocol followed by column DNA purification. A high degree of congruence was found between the two extraction methods, most notably in regard to the microbial community composition. The results showed that for a given bioinformatics pipeline, all the taxa with an average proportion >0.12% in samples processed using one extraction method were also detected in samples extracted using the other method. The same taxa tended to be abundant and frequent for both extraction methods. The relative abundance of sequence reads assigned to the phyla Actinobacteria, Spirochaetes, TM7, Synergistetes, and Tenericutes was significantly higher in the mechanically-treated samples than in the enzymatically-treated samples, whereas the phylum Firmicutes showed the opposite pattern. No significant differences in diversity indices were found between the extraction methods, although the mechanical lysis method revealed higher operational taxonomic unit richness. Differences between the extraction procedures outweighed the variations due to the bioinformatics analysis pipelines used.	[Lazarevic, Vladimir; Gaia, Nadia; Girard, Myriam; Francois, Patrice; Schrenzel, Jacques] Univ Hosp Geneva, Div Infect Dis, Genom Res Lab, Geneva, Switzerland	University of Geneva	Lazarevic, V (corresponding author), Univ Hosp Geneva, Div Infect Dis, Genom Res Lab, Geneva, Switzerland.	vladimir.lazarevic@genomic.ch	Schrenzel, Jacques/AAC-5685-2021; francois, patrice/AAL-5583-2020; Schrenzel, Jacques/P-8525-2017	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X; Lazarevic, Vladimir/0000-0002-6839-2536	HUG institutional funds	HUG institutional funds	This work was supported by HUG institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lazarevic V, 2011, J INTEGR OMICS, V1, P25, DOI DOI 10.5584/JI0MICS.V1I1.43; Lazarevic Vladimir, 2012, J Clin Bioinforma, V2, P4, DOI 10.1186/2043-9113-2-4; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moore E, 2004, MOL MICROBIAL ECOLOG, V2nd, P3; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RICHARDSON ROBERT L., 1958, JOUR DENTAL RES, V37, P697, DOI 10.1177/00220345580370041701; ROSS PW, 1971, J CLIN PATHOL, V24, P717, DOI 10.1136/jcp.24.8.717; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sergeant MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038094; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang L, 2009, MOL DIAGN THER, V13, P245, DOI 10.2165/11317160-000000000-00000	39	60	61	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67699	10.1371/journal.pone.0067699	http://dx.doi.org/10.1371/journal.pone.0067699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844068	Green Submitted, gold, Green Published			2022-12-27	WOS:000321733000095
J	Aizawa, S; Sakata, I; Nagasaka, M; Higaki, Y; Sakai, T				Aizawa, Sayaka; Sakata, Ichiro; Nagasaka, Mai; Higaki, Yuriko; Sakai, Takafumi			Negative Regulation of Neuromedin U mRNA Expression in the Rat Pars Tuberalis by Melatonin	PLOS ONE			English	Article							PORCINE SPINAL-CORD; THYROTROPIN-RELEASING-HORMONE; PHOTOPERIODIC RESPONSE; SIGNAL-TRANSDUCTION; ENERGY HOMEOSTASIS; G-PROTEIN; PITUITARY; CELLS; BETA; RECEPTOR	The pars tuberalis (PT) is part of the anterior pituitary gland surrounding the median eminence as a thin cell layer. The characteristics of PT differ from those of the pars distalis (PD), such as cell composition and gene expression, suggesting that the PT has a unique physiological function compared to the PD. Because the PT highly expresses melatonin receptor type 1, it is considered a mediator of seasonal and/or circadian signals of melatonin. Expression of neuromedin U (NMU) that is known to regulate energy balance has been previously reported in the rat PT; however, the regulatory mechanism of NMU mRNA expression and secretion in the PT are still obscure. In this study, we examined both the diurnal change of NMU mRNA expression in the rat PT and the effects of melatonin on NMU in vivo. In situ hybridization and quantitative PCR analysis of laser microdissected PT samples revealed that NMU mRNA expression in the PT has diurnal variation that is high during the light phase and low during the dark phase. Furthermore, melatonin administration significantly suppressed NMU mRNA expression in the PT in vivo. On the other hand, 48 h fasting did not have an effect on PT-NMU mRNA expression, and the diurnal change of NMU mRNA expression was maintained. We also found the highest expression of neuromedin U receptor type 2 (NMUR2) mRNA in the third ventricle ependymal cell layer, followed by the arcuate nucleus and the spinal cord. These results suggest that NMU mRNA expression in the PT is downregulated by melatonin during the dark phase and shows diurnal change. Considering that NMU mRNA in the PT showed the highest expression level in the brain, PT-NMU may act on NMUR2 in the brain, especially in the third ventricle ependymal cell layer, with a circadian rhythm.	[Aizawa, Sayaka; Sakata, Ichiro; Nagasaka, Mai; Higaki, Yuriko; Sakai, Takafumi] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Area Regulatory Biol,Sakura Ku, Saitama 3388570, Japan	Saitama University	Sakai, T (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Area Regulatory Biol,Sakura Ku, Saitama 3388570, Japan.	tsakai@mail.saitama-u.ac.jp	AIZAWA, SAYAKA/AAF-3284-2019; Sakata, Ichiro/F-9194-2012	Sakata, Ichiro/0000-0002-6067-0407				AGUADO LI, 1981, CELL TISSUE RES, V218, P345; Aizawa S, 2007, J NEUROENDOCRINOL, V19, P839, DOI 10.1111/j.1365-2826.2007.01603.x; Aizawa S, 2012, J ENDOCRINOL, V212, P383, DOI 10.1530/JOE-11-0388; Arai Y, 2004, CELL TISSUE RES, V317, P279, DOI 10.1007/s00441-004-0912-8; AUSTIN C, 1994, J MOL ENDOCRINOL, V12, P257, DOI 10.1677/jme.0.0120257; BARTNESS TJ, 1993, J PINEAL RES, V15, P161; BENITOORFILA MA, 1991, EUR J PHARMACOL, V193, P329, DOI 10.1016/0014-2999(91)90147-I; BERGMANN M, 1989, CELL TISSUE RES, V256, P649; Bockmann J, 1996, ENDOCRINOLOGY, V137, P1804, DOI 10.1210/en.137.5.1804; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; BROWN DR, 1988, EUR J PHARMACOL, V155, P159, DOI 10.1016/0014-2999(88)90415-3; CARLSON LL, 1989, ENDOCRINOLOGY, V125, P2670, DOI 10.1210/endo-125-5-2670; CONLON JM, 1988, J NEUROCHEM, V51, P988, DOI 10.1111/j.1471-4159.1988.tb01837.x; DOMIN J, 1987, PEPTIDES, V8, P779, DOI 10.1016/0196-9781(87)90058-1; Graham ES, 2003, J NEUROCHEM, V87, P1165, DOI 10.1046/j.1471-4159.2003.02079.x; Graham ES, 2002, J NEUROENDOCRINOL, V14, P945, DOI 10.1046/j.1365-2826.2002.00848.x; Guerra M, 2010, CELL TISSUE RES, V339, P359, DOI 10.1007/s00441-009-0885-8; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Hanada T, 2003, BIOCHEM BIOPH RES CO, V311, P954, DOI 10.1016/j.bbrc.2003.10.098; Hashimoto K, 2000, J BIOL CHEM, V275, P33365, DOI 10.1074/jbc.M006819200; HASHIMOTO T, 1995, CHEM PHARM BULL, V43, P1154; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Ivanov TR, 2002, ENDOCRINOLOGY, V143, P3813, DOI 10.1210/en.2002-220121; KIM MK, 1993, J BIOL CHEM, V268, P23366; Klosen P, 2002, J HISTOCHEM CYTOCHEM, V50, P1647, DOI 10.1177/002215540205001209; Kojima M, 2000, BIOCHEM BIOPH RES CO, V276, P435, DOI 10.1006/bbrc.2000.3502; Kowalski TJ, 2005, J ENDOCRINOL, V185, P151, DOI 10.1677/joe.1.05948; LINCOLN GA, 1994, J NEUROENDOCRINOL, V6, P251, DOI 10.1111/j.1365-2826.1994.tb00580.x; MAGGI CA, 1990, BRIT J PHARMACOL, V99, P186, DOI 10.1111/j.1476-5381.1990.tb14675.x; McNulty S, 1996, J NEUROENDOCRINOL, V8, P635; MCNULTY S, 1994, J NEUROENDOCRINOL, V6, P523, DOI 10.1111/j.1365-2826.1994.tb00615.x; MINAMINO N, 1988, BIOCHEM BIOPH RES CO, V156, P355, DOI 10.1016/S0006-291X(88)80848-9; MINAMINO N, 1985, PEPTIDES, V6, P245, DOI 10.1016/0196-9781(85)90381-X; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Nakahara K, 2004, BIOCHEM BIOPH RES CO, V318, P156, DOI 10.1016/j.bbrc.2004.04.014; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nakazato M, 2000, BIOCHEM BIOPH RES CO, V277, P191, DOI 10.1006/bbrc.2000.3669; Niimi M, 2001, ENDOCRINE, V16, P201, DOI 10.1385/ENDO:16:3:201; Nogueiras R, 2006, J ENDOCRINOL, V190, P545, DOI 10.1677/joe.1.06577; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Ozaki Y, 2002, ENDOCRINOLOGY, V143, P4320, DOI 10.1210/en.2002-220201; RUDOLF T, 1993, ANN ANAT, V175, P171, DOI 10.1016/S0940-9602(11)80177-9; SAKAI T, 1992, ARCH HISTOL CYTOL, V55, P151, DOI 10.1679/aohc.55.151; Sakamoto S, 2000, HISTOCHEM CELL BIOL, V114, P213; SUMI S, 1987, LIFE SCI, V41, P1585, DOI 10.1016/0024-3205(87)90725-9; Szekeres PG, 2000, J BIOL CHEM, V275, P20247, DOI 10.1074/jbc.C000244200; WILLIAMS LM, 1988, J ENDOCRINOL, V119, pR1, DOI 10.1677/joe.0.119R001; Wren AM, 2002, ENDOCRINOLOGY, V143, P4227, DOI 10.1210/en.2002-220308; Yasuo S, 2010, J NEUROENDOCRINOL, V22, P43, DOI 10.1111/j.1365-2826.2009.01936.x; Yasuo S, 2011, GEN COMP ENDOCR, V172, P15, DOI 10.1016/j.ygcen.2010.11.006; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	51	17	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67118	10.1371/journal.pone.0067118	http://dx.doi.org/10.1371/journal.pone.0067118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843987	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000032
J	Wang, Y; Wu, HJ; Liu, QJ; Wang, CH; Fu, L; Wang, H; Zhu, WJ; Fu, WJ; Lv, YJ; Wang, SK; Hu, LK				Wang, Yang; Wu, Haijian; Liu, Qiji; Wang, Cuihong; Fu, Lei; Wang, Han; Zhu, Wenjie; Fu, Weijiang; Lv, Yajuan; Wang, Shikun; Hu, Likuan			Association of CHRNA5-A3-B4 Variation with Esophageal Squamous Cell Carcinoma Risk and Smoking Behaviors in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER RISK; SUSCEPTIBILITY LOCUS; NICOTINIC RECEPTOR; TOBACCO; ACETYLCHOLINE; NITROSAMINES; POLYMORPHISM; VARIANTS; AREAS	Background: CHRNA5-A3-B4, the gene cluster encoding nicotinic acetylcholine receptor subunits, is associated with lung cancer risk and smoking behaviors in people of European descent. Because cigarette smoking is also a major risk factor for esophageal squamous cell carcinoma (ESCC), we investigated the associations between variants in CHRNA5-A3-B4 and ESCC risk, as well as smoking behaviors, in a Chinese population. Methods: A case-control study of 866 ESCC patients and 952 healthy controls was performed to study the association of polymorphisms (rs667282 and rs3743073) in CHRNA5-A3-B4 with cancer risk using logistic regression models. The relationships between CHRNA5-A3-B4 polymorphisms and smoking behaviors that can be quantified by cigarettes smoked per day (CPD) and pack-years of smoking were separately estimated with Kruskal-Wallis tests among all 840 smokers. Results: CHRNA5-A3-B4 rs667282 TT/TG genotypes were associated with significantly increased risk of ESCC [ adjusted odds ratio (OR) = 1.32, 95% confidence interval (CI) = 1.03 - 1.69, P = 0.029]. The increased ESCC risk was even higher among younger subjects (<= 60 years) (OR = 1.44, 95% CI = 1.04 - 1.98, P = 0.024). These effects were not found in another polymorphism rs3743073. No evident association between the two polymorphisms and smoking behaviors was observed. Conclusions: These results support the hypothesis that CHRNA5-A3-B4 is a susceptibility gene cluster for ESCC. The relationship between CHRNA5-A3-B4 and smoking behaviors in a Chinese population needs further investigation.	[Wang, Yang; Wu, Haijian; Wang, Cuihong; Zhu, Wenjie; Fu, Weijiang; Wang, Shikun; Hu, Likuan] Shandong Univ, Qilu Hosp, Radiat Dept, Ctr Oncol, Jinan, Shandong, Peoples R China; [Wu, Haijian; Wang, Shikun] Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Wu, Haijian; Wang, Shikun] Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China; [Liu, Qiji] Shandong Univ, Dept Med Genet, Sch Med, Jinan, Shandong, Peoples R China; [Fu, Lei] Shandong Tumor Hosp & Inst, Radiat Dept, Jinan, Shandong, Peoples R China; [Wang, Han] Shandong Univ, Hosp 2, Ctr Oncol, Jinan, Shandong, Peoples R China; [Lv, Yajuan] Shandong Univ, Jinan Cent Hosp, Dept Oncol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Hu, LK (corresponding author), Shandong Univ, Qilu Hosp, Radiat Dept, Ctr Oncol, Jinan, Shandong, Peoples R China.	hulikuan.sdu@hotmail.com			National Natural Science Foundation of China [30300310, 30671956]; Natural Science Foundation of Shandong Province [ZR2012HM083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work is supported by grants from National Natural Science Foundation of China (No. 30300310 and No. 30671956) and Natural Science Foundation of Shandong Province (No. ZR2012HM083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Arredondo J, 2006, CANCER BIOL THER, V5, P511, DOI 10.4161/cbt.5.5.2601; Benowitz NL, 2008, AM J MED, V121, pS3, DOI 10.1016/j.amjmed.2008.01.015; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Darazy M, 2011, GENET TEST MOL BIOMA, V15, P423, DOI 10.1089/gtmb.2010.0206; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Demeester Steven R, 2009, Gastrointest Cancer Res, V3, pS2; Grando SA, 2008, J PHARMACOL SCI, V106, P174, DOI 10.1254/jphs.FM0070087; HALVORSEN RA, 1986, RADIOLOGY, V161, P147, DOI 10.1148/radiology.161.1.3763857; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; HECHT SS, 1986, CANCER RES, V46, P4162; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Hu YC, 2011, MODERN PATHOL, V24, P899, DOI 10.1038/modpathol.2011.47; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janes AC, 2012, DRUG ALCOHOL DEPEN, V120, P7, DOI 10.1016/j.drugalcdep.2011.06.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin G, 2012, J THORAC ONCOL, V7, P808, DOI 10.1097/JTO.0b013e31824c7d7c; Li MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012183; Li QQ, 2010, DIS ESOPHAGUS, V23, P253, DOI 10.1111/j.1442-2050.2009.01003.x; MOSS AA, 1981, AM J ROENTGENOL, V136, P1051, DOI 10.2214/ajr.136.6.1051; Nishino K, 2008, J OBSTET GYNAECOL RE, V34, P994, DOI 10.1111/j.1447-0756.2008.00798.x; Niu XM, 2010, J THORAC ONCOL, V5, P658, DOI 10.1097/JTO.0b013e3181d5e447; Russo P, 2012, LIFE SCI, V91, P1087, DOI 10.1016/j.lfs.2012.05.003; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Thunnissen FB, 2009, J THORAC ONCOL, V4, P943, DOI 10.1097/JTO.0b013e3181ad83fc; Wang DL, 2012, CANCER EPIDEMIOL, V36, P276, DOI 10.1016/j.canep.2011.10.008; Wang JB, 2008, JPN J CLIN ONCOL, V38, P87, DOI 10.1093/jjco/hym169; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Wu IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055834; Yang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046071; Yuan JM, 2011, CARCINOGENESIS, V32, P1366, DOI 10.1093/carcin/bgr125	39	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67664	10.1371/journal.pone.0067664	http://dx.doi.org/10.1371/journal.pone.0067664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844051	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000069
J	Sachan, N; Mishra, AK; Mutsuddi, M; Mukherjee, A				Sachan, Nalani; Mishra, Abhinava K.; Mutsuddi, Mousumi; Mukherjee, Ashim			The Drosophila Importin-alpha 3 Is Required for Nuclear Import of Notch In Vivo and It Displays Synergistic Effects with Notch Receptor on Cell Proliferation	PLOS ONE			English	Article							INTRACELLULAR DOMAIN; CLEAVAGE; LOCALIZATION; PRESENILIN; SEQUENCE; RELEASE; PATHWAY; TISSUES; PROTEIN; ACCESS	The Notch signaling pathway controls diverse cell-fate specification events throughout development. The versatility of this pathway to influence different aspects of development comes from its multiple levels of regulation. Upon ligand-induced Notch activation, the Notch intracellular domain (Notch-ICD) is released from the membrane and translocates to the nucleus, where it transduces Notch signals by regulating the transcription of downstream target genes. But the exact mechanism of translocation of Notch-ICD into the nucleus is not clear. Here, we implicate Importin-alpha 3 (also known as karyopherin-alpha 3) in the nuclear translocation of Notch-ICD in Drosophila. Our present analyses reveal that Importin-alpha 3 can directly bind to Notch-ICD and loss of Importin-alpha 3 function results in cytoplasmic accumulation of the Notch receptor. Using MARCM (Mosaic Analysis with a Repressible Cell Marker) technique, we demonstrate that Importin-alpha 3 is required for nuclear localization of Notch-ICD. These results reveal that the nuclear transport of Notch-ICD is mediated by the canonical Importin-alpha 3/Importin-beta transport pathway. In addition, co-expression of both Notch-ICD and Importin-alpha 3 displays synergistic effects on cell proliferation. Taken together, our results suggest that Importin-alpha 3 mediated nuclear import of Notch-ICD may play important role in regulation of Notch signaling.	[Sachan, Nalani; Mishra, Abhinava K.; Mutsuddi, Mousumi; Mukherjee, Ashim] Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Mukherjee, A (corresponding author), Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India.	amukherjee@bhu.ac.in	Mishra, Abhinava K./AAO-6303-2020	Mishra, Abhinava K./0000-0003-3733-3928	Indian Council of Medical Research and Council of Scientific and Industrial Research, India; Department of Science and Technology, India; Department of Biotechnology, India	Indian Council of Medical Research and Council of Scientific and Industrial Research, India; Department of Science and Technology, India(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	N.S. and A K.M. were supported by fellowships from Indian Council of Medical Research and Council of Scientific and Industrial Research, India, respectively. This work was supported by grants from Department of Science and Technology, India and Department of Biotechnology, India to A.M. and M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baron M, 2002, MOL MEMBR BIOL, V19, P27, DOI 10.1080/09687680110112929; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Chan CC, 2008, DEV BIOL, V318, P17, DOI 10.1016/j.ydbio.2008.02.050; Couturier L, 2012, NAT CELL BIOL, V14, P131, DOI 10.1038/ncb2419; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dockendorff TC, 1999, BIOL CHEM, V380, P1263, DOI 10.1515/BC.1999.161; Egan SE, 1998, CURR TOP MICROBIOL, V228, P273; Fang XD, 2001, DEVELOPMENT, V128, P3349; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Huenniger K, 2010, CELL MOL LIFE SCI, V67, P3187, DOI 10.1007/s00018-010-0378-7; Jeffries S, 2000, MOL CELL BIOL, V20, P3928, DOI 10.1128/MCB.20.11.3928-3941.2000; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Mason DA, 2009, SEMIN CELL DEV BIOL, V20, P582, DOI 10.1016/j.semcdb.2009.02.006; Mason DA, 2003, GENETICS, V165, P1943; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Quimby BB, 2001, CELL MOL LIFE SCI, V58, P1766, DOI 10.1007/PL00000816; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; XU T, 1993, DEVELOPMENT, V117, P1223; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yeurl PL, 2008, J CELL BIOCHEM, V103, P456, DOI 10.1002/jcb.21408	40	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68247	10.1371/journal.pone.0068247	http://dx.doi.org/10.1371/journal.pone.0068247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840889	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900028
J	Shantappa, S; Dhingra, S; Hernandez-Ortiz, P; Espeso, EA; Calvo, AM				Shantappa, Sourabha; Dhingra, Sourabh; Hernandez-Ortiz, Patricia; Espeso, Eduardo A.; Calvo, Ana M.			Role of the Zinc Finger Transcription Factor SltA in Morphogenesis and Sterigmatocystin Biosynthesis in the Fungus Aspergillus nidulans	PLOS ONE			English	Article							CALCIUM-INDUCED CONIDIATION; SECONDARY METABOLISM; ASEXUAL SPORULATION; SEXUAL DEVELOPMENT; SALT-TOLERANCE; EXPRESSION; PROTEIN; GENES; VEA; HOMEOSTASIS	Potassium, a widely accepted macronutrient, is vital for many physiological processes such as regulation of cell volume, maintenance of intracellular pH, synthesis of proteins and activation of enzymes in filamentous fungi. Another cation, calcium, plays an essential role in many signaling processes from lower to higher eukaryotes. Imbalance in the intracellular ionic levels of potassium or calcium causes adverse effects on cell growth, morphology and development, and eventually death. Previous studies on the adaptation of Aspergillus nidulans to salt and osmotic stress conditions have revealed the role of SltA, a C2H2 zinc finger transcription factor in cation homeostasis. SltA is highly conserved in the Ascomycota phylum with no identifiable homolog in S. cerevisiae and other yeast-like fungi, and prevents toxicity by the cations Na+, K+, Li+, Cs+ and Mg2+, but not by Ca2+. However its role in morphology and biosynthesis of natural products such as mycotoxins remained unknown. This study shows the first characterization of the role of calcium and SltA fungal homologs in morphogenesis using the model system A. nidulans. Addition of potassium to sltA deletion mutants resulted in decreased levels of sterigmatocystin production. A similar phenotype was observed for both types of mutants in veA1 and veA(+) genetic background. Expression of the sterigmatocystin genes aflR and stcU was strongly reduced in sltA deletion mutant when K+ was added. Additionally, increased concentrations of K+ drastically reduced sexual and asexual development, as well as radial growth in deletion sltA colonies. This reduction was accompanied by lower expression of the morphology related genes nsdD, steA and brlA. Interestingly, addition of calcium was able to stimulate asexual and sexual development and remediate the deletion sltA phenotype, including defects in morphology and toxin production.	[Shantappa, Sourabha; Dhingra, Sourabh; Calvo, Ana M.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Hernandez-Ortiz, Patricia; Espeso, Eduardo A.] CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Madrid, Spain	Northern Illinois University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Calvo, AM (corresponding author), No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	amcalvo@niu.edu	Espeso, Eduardo A/AAC-7238-2022; Espeso, Eduardo A/C-5259-2011	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Hernandez-Ortiz, Patricia/0000-0001-7683-0148	Northern Illinois University; Spanish Ministerio de Economia y Competitividad [BFU2009-08701, BFU2012-33142]	Northern Illinois University; Spanish Ministerio de Economia y Competitividad(Spanish Government)	This study was funded by Northern Illinois University. EAE thanks the support by the Spanish Ministerio de Economia y Competitividad, through grants BFU2009-08701(BMC) and BFU2012-33142. PH-O is a holder of a contract from the CSIC's JAE-Predoc program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, CURR OPIN MICROBIOL, V1, P674, DOI 10.1016/S1369-5274(98)80114-8; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Atoui A, 2010, FUNGAL GENET BIOL, V47, P962, DOI 10.1016/j.fgb.2010.08.007; Calcagno-Pizarelli AM, 2011, J CELL SCI, V124, P4064, DOI 10.1242/jcs.088344; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Chen SC, 2010, FUNGAL GENET BIOL, V47, P268, DOI 10.1016/j.fgb.2009.12.008; Chilton IJ, 2008, MYCOL RES, V112, P1435, DOI 10.1016/j.mycres.2008.06.028; Cole R.J., 1981, HDB TOXIC FUNGAL MET, P152, DOI [10.1016/B978-0-12-179760-7.50010-3, DOI 10.1016/B978-0-12-179760-7.50010-3]; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Espeso EA, 2005, GENETICS, V171, P835, DOI 10.1534/genetics.105.044578; Feng GH, 1998, APPL ENVIRON MICROB, V64, P2275; Findon H, 2010, FUNGAL GENET BIOL, V47, P647, DOI 10.1016/j.fgb.2010.04.002; Garzia A, 2010, MOL MICROBIOL, V75, P1314, DOI 10.1111/j.1365-2958.2010.07063.x; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Guzman-de-Pena D, 1998, ANTON LEEUW INT J G, V73, P199, DOI 10.1023/A:1000820221945; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; JACKSON SL, 1993, MICROBIOL REV, V57, P367, DOI 10.1128/MMBR.57.2.367-382.1993; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; KUES U, 2006, MYCOTA GROWTH DIFFER, P261; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; O'Mahony RJ, 2002, MYCOL RES, V106, P1480, DOI 10.1017/S0953756202006949; O'Neil JD, 2002, MYCOL RES, V106, P491, DOI 10.1017/S0953756202005701; Payne GA, 1998, ANNU REV PHYTOPATHOL, V36, P329, DOI 10.1146/annurev.phyto.36.1.329; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; PITT D, 1993, J GEN MICROBIOL, V139, P3053, DOI 10.1099/00221287-139-12-3053; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Ramamoorthy V, 2012, MOL MICROBIOL, V85, P795, DOI 10.1111/j.1365-2958.2012.08142.x; RONCAL T, 1993, J BACTERIOL, V175, P879, DOI 10.1128/JB.175.3.879-886.1993; SEKIGUCHI J, 1977, APPL ENVIRON MICROB, V33, P147, DOI 10.1128/AEM.33.1.147-158.1977; Shimizu K, 2003, GENETICS, V165, P1095; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spathas DH, 1978, ASPERGILLUS NEWSL, V46, P28; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Sweeney MJ, 1999, FEMS MICROBIOL LETT, V175, P149, DOI 10.1111/j.1574-6968.1999.tb13614.x; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Torralba S, 2001, CURR TOP DEV BIOL, V51, P135, DOI 10.1016/S0070-2153(01)51005-4; Vallim MA, 2000, MOL MICROBIOL, V36, P290, DOI 10.1046/j.1365-2958.2000.01874.x; YAGER LN, 1992, ASPERGILLUS BIOL IND, P19; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; YU JH, 1995, J BACTERIOL, V177, P4792, DOI 10.1128/jb.177.16.4792-4800.1995	48	16	16	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68492	10.1371/journal.pone.0068492	http://dx.doi.org/10.1371/journal.pone.0068492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840895	gold, Green Published			2022-12-27	WOS:000321271900034
J	Song, Y; Gao, J; Yang, FX; Kua, CS; Liu, JX; Cannon, CH				Song, Yu; Gao, Jie; Yang, Fengxi; Kua, Chai-Shian; Liu, Jingxin; Cannon, Charles H.			Molecular Evolutionary Analysis of the Alfin-Like Protein Family in Arabidopsis lyrata, Arabidopsis thaliana, and Thellungiella halophila	PLOS ONE			English	Article							WIDE COMPARATIVE-ANALYSIS; TRANSCRIPTION FACTORS; COMPARATIVE GENOMICS; NATURAL-SELECTION; STRESS TOLERANCE; SALT TOLERANCE; GENE FAMILY; PHD FINGER; OVEREXPRESSION; ALFALFA	In previous studies, the Alfin1 gene, a transcription factor, enhanced salt tolerance in alfalfa, primarily through altering gene expression levels in the root. Here, we examined the molecular evolution of the Alfin-like (AL) proteins in two Arabidopsis species (A. lyrata and A. thaliana) and a salt-tolerant close relative Thellungiella halophila. These AL-like proteins could be divided into four groups and the two known DUF3594 and PHD-finger domains had co-evolved within each group of genes, irrespective of species, due to gene duplication events in the common ancestor of all three species while gene loss was observed only in T. halophila. To detect whether natural selection acted in the evolution of AL genes, we calculated synonymous substitution ratios (dn/ds) and codon usage statistics, finding positive selection operated on four branches and significant differences in biased codon usage in the AL family between T. halophila and A. lyrata or A. thaliana. Distinctively, only the AL7 branch was under positive selection on the PHD-finger domain and the three members on the branch showed the smallest difference when codon bias was evaluated among the seven clusters. Functional analysis based on transgenic overexpression lines and T-DNA insertion mutants indicated that salt-stress-induced AtAL7 could play a negative role in salt tolerance of A. thaliana, suggesting that adaptive evolution occurred in the members of AL gene family.	[Song, Yu; Gao, Jie; Kua, Chai-Shian; Cannon, Charles H.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Menglun, Yunnan, Peoples R China; [Song, Yu; Kua, Chai-Shian] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Yang, Fengxi] Sichuan Univ, Minist Educ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China; [Liu, Jingxin] Univ Stuttgart Hohenheim, Agroecol Sect, Inst Plant Prod & Agroecol Trop & Subtrop 380, Stuttgart, Germany; [Cannon, Charles H.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan University; University Hohenheim; Texas Tech University System; Texas Tech University	Gao, J (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Menglun, Yunnan, Peoples R China.	gaojie@xtbg.org.cn	yu, song/L-7215-2019; Liu, Jing-Xin/G-5151-2016; Kua, Chai-Shian/AAP-8710-2021; Cannon, Charles/AAE-7715-2019; Cannon, Charles H/D-7186-2012	Liu, Jing-Xin/0000-0003-4127-7252; Cannon, Charles/0000-0003-1901-0420; Cannon, Charles H/0000-0003-1901-0420; Gao, Jie/0000-0002-2640-5116	Yunnan Provincial Government High Level Talent Introduction grant, through the Department of Science and Technology	Yunnan Provincial Government High Level Talent Introduction grant, through the Department of Science and Technology	This study was funded by the Yunnan Provincial Government High Level Talent Introduction grant, through the Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 2000, Methods Mol Biol, V132, P221; AKASHI H, 1994, GENETICS, V136, P927; AKASHI H, 1995, GENETICS, V139, P1067; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bancroft I, 2001, TRENDS GENET, V17, P89, DOI 10.1016/S0168-9525(00)02179-X; Bastola DR, 1998, PLANT MOL BIOL, V38, P1123, DOI 10.1023/A:1006081926699; Baum DA, 2005, MOL PHYLOGENET EVOL, V37, P1, DOI 10.1016/j.ympev.2005.07.002; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2005, DNA DIVERSITY MOL GE, pix; Chang SM, 2005, GENETICS, V170, P1967, DOI 10.1534/genetics.104.034975; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Inan G, 2004, PLANT PHYSIOL, V135, P1718, DOI 10.1104/pp.104.041723; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; KROCHKO JE, 1992, PLANT PHYSIOL, V99, P46, DOI 10.1104/pp.99.1.46; KROCHKO JE, 1988, ELECTROPHORESIS, V9, P751, DOI 10.1002/elps.1150091111; Lee WY, 2009, PLANT J, V58, P511, DOI 10.1111/j.1365-313X.2009.03795.x; Liu QP, 2007, J MOL EVOL, V64, P354, DOI 10.1007/s00239-006-0131-x; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Michael WP, 2001, NUCLEIC ACIDS RES, V29, pe45; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Preston JC, 2006, GENETICS, V174, P421, DOI 10.1534/genetics.106.057125; PURUGGANAN MD, 1994, GENETICS, V138, P849; PURUGGANAN MD, 1995, GENETICS, V140, P345; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Ramani AK, 2003, J MOL BIOL, V327, P273, DOI 10.1016/S0022-2836(03)00114-1; Remington DL, 2002, MOL BIOL EVOL, V19, P1563, DOI 10.1093/oxfordjournals.molbev.a004218; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; SCHINDLER U, 1993, PLANT J, V4, P137, DOI 10.1046/j.1365-313X.1993.04010137.x; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Song Y, 2010, J BIOSCIENCES, V35, P459, DOI 10.1007/s12038-010-0051-1; Song Y, 2009, CHINESE SCI BULL, V54, P4671, DOI 10.1007/s11434-009-0710-5; Stewart JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020083; Streisfeld MA, 2007, MOL BIOL EVOL, V24, P2816, DOI 10.1093/molbev/msm216; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Wang QS, 2011, GENETICA, V139, P973, DOI 10.1007/s10709-011-9599-4; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028150; Wei W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007209; Winicov I, 2004, PLANTA, V219, P925, DOI 10.1007/s00425-004-1296-4; Winicov I, 1999, PLANT PHYSIOL, V120, P473, DOI 10.1104/pp.120.2.473; WINICOV I, 1993, PLANT PHYSIOL, V102, P681, DOI 10.1104/pp.102.2.681; Winicov I, 2000, PLANTA, V210, P416, DOI 10.1007/PL00008150; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Yang ZF, 2008, GENOMICS, V92, P246, DOI 10.1016/j.ygeno.2008.06.001; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, P ROY SOC B-BIOL SCI, V267, P109, DOI 10.1098/rspb.2000.0974; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhang WH, 2008, MOL PHYLOGENET EVOL, V47, P175, DOI 10.1016/j.ympev.2007.12.022	62	14	20	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e66838	10.1371/journal.pone.0066838	http://dx.doi.org/10.1371/journal.pone.0066838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840867	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900006
J	Almeda, R; Wambaugh, Z; Wang, ZC; Hyatt, C; Liu, ZF; Buskey, EJ				Almeda, Rodrigo; Wambaugh, Zoe; Wang, Zucheng; Hyatt, Cammie; Liu, Zhanfei; Buskey, Edward J.			Interactions between Zooplankton and Crude Oil: Toxic Effects and Bioaccumulation of Polycyclic Aromatic Hydrocarbons	PLOS ONE			English	Article							WATER-SOLUBLE FRACTIONS; PETROLEUM-HYDROCARBONS; FECAL PELLETS; FUEL-OIL; MARINE COPEPODS; SUBLETHAL CONCENTRATIONS; ORGANIC CONTAMINANTS; RESTING EGGS; SPILL; DISPERSANT	We conducted ship-, shore- and laboratory-based crude oil exposure experiments to investigate (1) the effects of crude oil (Louisiana light sweet oil) on survival and bioaccumulation of polycyclic aromatic hydrocarbons (PAHs) in mesozooplankton communities, (2) the lethal effects of dispersant (Corexit 9500A) and dispersant-treated oil on mesozooplankton, (3) the influence of UVB radiation/sunlight exposure on the toxicity of dispersed crude oil to mesozooplankton, and (4) the role of marine protozoans on the sublethal effects of crude oil and in the bioaccumulation of PAHs in the copepod Acartia tonsa. Mortality of mesozooplankton increased with increasing oil concentration following a sigmoid model with a median lethal concentration of 32.4 mu l L-1 in 16 h. At the ratio of dispersant to oil commonly used in the treatment of oil spills (i.e. 1:20), dispersant (0.25 mu l L-1) and dispersant-treated oil were 2.3 and 3.4 times more toxic, respectively, than crude oil alone (5 mu l L-1) to mesozooplankton. UVB radiation increased the lethal effects of dispersed crude oil in mesozooplankton communities by 35%. We observed selective bioaccumulation of five PAHs, fluoranthene, phenanthrene, pyrene, chrysene and benzo[b]fluoranthene in both mesozooplankton communities and in the copepod A. tonsa. The presence of the protozoan Oxyrrhis marina reduced sublethal effects of oil on A. tonsa and was related to lower accumulations of PAHs in tissues and fecal pellets, suggesting that protozoa may be important in mitigating the harmful effects of crude oil exposure in copepods and the transfer of PAHs to higher trophic levels. Overall, our results indicate that the negative impact of oil spills on mesozooplankton may be increased by the use of chemical dispersant and UV radiation, but attenuated by crude oil-microbial food webs interactions, and that both mesozooplankton and protozoans may play an important role in fate of PAHs in marine environments.	[Almeda, Rodrigo; Wambaugh, Zoe; Wang, Zucheng; Hyatt, Cammie; Liu, Zhanfei; Buskey, Edward J.] Univ Texas Marine Sci Inst, Port Aransas, TX USA; [Wambaugh, Zoe] Humboldt State Univ, Arcata, CA 95521 USA; [Wang, Zucheng] E China Normal Univ, Shanghai 200062, Peoples R China	California State University System; California State Polytechnic University, Humboldt; East China Normal University	Almeda, R (corresponding author), Univ Texas Marine Sci Inst, Port Aransas, TX USA.	ralmeda@utexas.edu	Li, XH/B-2087-2010; ALMEDA, RODRIGO/R-1189-2016; Hyatt, Cammie/J-1100-2016; Kang, Sonia/L-4802-2016; Liu, Zhanfei/B-5613-2014; Buskey, Edward/L-8443-2017	ALMEDA, RODRIGO/0000-0002-0090-112X; Hyatt, Cammie/0000-0002-6397-8407; Kang, Sonia/0000-0002-0293-5323; Buskey, Edward/0000-0002-1729-6640	NOAA [NA07-NOS4780225]; National Science Foundation (NSF) Research Experiences for Undergraduates (REU) program [OCE-1062745]; BP/The Gulf of Mexico Research Initiative through the University of Texas Marine Science Institute (DROPPS consortium: 'Dispersion Research on Oil: Physics and Plankton Studies')	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation (NSF) Research Experiences for Undergraduates (REU) program(National Science Foundation (NSF)NSF - Office of the Director (OD)); BP/The Gulf of Mexico Research Initiative through the University of Texas Marine Science Institute (DROPPS consortium: 'Dispersion Research on Oil: Physics and Plankton Studies')	We thank the crew of the R/V Pelican for their assistance and Wayne S. Gardner for his great role as chief scientist (NOAA grant # NA07-NOS4780225). We also thank Rae Mooney for her help with the map elaboration.; Zoe Wambaugh was supported by the National Science Foundation (NSF) Research Experiences for Undergraduates (REU) program (grant OCE-1062745). This research was made possible by a grant from BP/The Gulf of Mexico Research Initiative through the University of Texas Marine Science Institute (DROPPS consortium: 'Dispersion Research on Oil: Physics and Plankton Studies'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbriano RM, 2011, OCEANOGRAPHY, V24, P294, DOI 10.5670/oceanog.2011.80; Alcaraz M, 2010, POLAR BIOL, V33, P1719, DOI 10.1007/s00300-010-0789-9; Allan SE, 2012, ENVIRON SCI TECHNOL, V46, P2033, DOI 10.1021/es202942q; Almeda R, 2011, LIMNOL OCEANOGR, V56, P415, DOI 10.4319/lo.2011.56.1.0415; ALYAMANI FY, 1993, MAR POLLUT BULL, V27, P239, DOI 10.1016/0025-326X(93)90030-N; ANDERSON JW, 1974, MAR BIOL, V27, P75, DOI 10.1007/BF00394763; ANDREWS AR, 1974, MAR BIOL, V25, P7, DOI 10.1007/BF00395102; Arfsten DP, 1996, ECOTOX ENVIRON SAFE, V33, P1, DOI 10.1006/eesa.1996.0001; Avila T.R., 2010, Journal of the Brazilian Society of Ecotoxicology, V5, P19; BANSE K, 1995, ICES J MAR SCI, V52, P265, DOI 10.1016/1054-3139(95)80043-3; Barata C, 2005, ENVIRON TOXICOL CHEM, V24, P2992, DOI 10.1897/05-189R.1; Barata C, 2002, MAR ECOL PROG SER, V230, P183, DOI 10.3354/meps230183; BARBIER M, 1973, DEEP-SEA RES, V20, P305, DOI 10.1016/0011-7471(73)90055-7; BARNETT CJ, 1975, ENVIRON POLLUT, V8, P45, DOI 10.1016/0013-9327(75)90071-3; Barron MG, 2003, ENVIRON TOXICOL CHEM, V22, P650, DOI 10.1002/etc.5620220326; Batten SD, 1998, MAR POLLUT BULL, V36, P764, DOI 10.1016/S0025-326X(98)00039-3; Bejarano AC, 2006, J EXP MAR BIOL ECOL, V332, P49, DOI 10.1016/j.jembe.2005.11.006; Bellas J, 2007, ECOTOXICOLOGY, V16, P465, DOI 10.1007/s10646-007-0152-2; BERDUGO V, 1977, Marine Pollution Bulletin, V8, P138, DOI 10.1016/0025-326X(77)90154-0; BERMAN MS, 1980, MAR BIOL, V56, P59, DOI 10.1007/BF00390594; Berrojalbiz N, 2009, ENVIRON SCI TECHNOL, V43, P2295, DOI 10.1021/es8018226; Bocard C., 1984, OIL SPILL CHEM DISPE; Boese BL, 1997, ARCH ENVIRON CON TOX, V32, P389, DOI 10.1007/s002449900201; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; Broglio E, 2004, AQUAT MICROB ECOL, V35, P65, DOI 10.3354/ame035065; BUSDOSH M, 1977, ARCTIC, V30, P85; Cailleaud K, 2009, ENVIRON TOXICOL CHEM, V28, P239, DOI 10.1897/07-664.1; Calbet A, 2008, ICES J MAR SCI, V65, P325, DOI 10.1093/icesjms/fsn013; Calbet A, 2007, MAR BIOL, V151, P195, DOI 10.1007/s00227-006-0468-0; CAPUZZO JM, 1984, MAR ENVIRON RES, V14, P201, DOI 10.1016/0141-1136(84)90079-5; Castonguay M, 2008, CAN J FISH AQUAT SCI, V65, P1528, DOI 10.1139/F08-126; CONOVER RJ, 1971, J FISH RES BOARD CAN, V28, P1327, DOI 10.1139/f71-202; Corner E.D.S., 1978, Advances in Marine Biology, V15, P289; CORNER EDS, 1976, J MAR BIOL ASSOC UK, V56, P121, DOI 10.1017/S0025315400020488; CORNER EDS, 1968, J MAR BIOL ASSOC UK, V48, P29, DOI 10.1017/S0025315400032409; COWLES TJ, 1983, MAR BIOL, V78, P45, DOI 10.1007/BF00392970; CUSHING DH, 1989, J PLANKTON RES, V11, P1, DOI 10.1093/plankt/11.1.1; DAVENPORT J, 1982, PHILOS T ROY SOC B, V297, P369, DOI 10.1098/rstb.1982.0048; De Flora S, 1991, TRENDS BIOL DOSIMETR, P69; DEFLORA S, 1991, MUTAT RES, V258, P285, DOI 10.1016/0165-1110(91)90013-L; DELPROO SAG, 1986, J PLANKTON RES, V8, P557; Delvigne G.A.L., 1988, OIL CHEM POLLUTION, V4, P281, DOI [10.1016/S0269-8579(88)80003-0, DOI 10.1016/S0269-8579(88)80003-0]; Duesterloh S, 2002, ENVIRON SCI TECHNOL, V36, P3953, DOI 10.1021/es020685y; Duesterloh S, 2002, THESIS U ALASKA FAIR; FISHER WS, 1993, MAR POLLUT BULL, V26, P385, DOI 10.1016/0025-326X(93)90186-N; Fisk AT, 2001, MAR POLLUT BULL, V43, P93, DOI 10.1016/S0025-326X(01)00038-8; French-McCay DP, 2002, ENVIRON TOXICOL CHEM, V21, P2080, DOI 10.1897/1551-5028(2002)021<2080:DAAOAO>2.0.CO;2; Fukami Kimio, 1996, Journal of Oceanography, V52, P399, DOI 10.1007/BF02239045; George-Ares A, 2000, CHEMOSPHERE, V40, P897, DOI 10.1016/S0045-6535(99)00498-1; Goodbody-Gringley G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045574; Graham WM, 2010, ENVIRON RES LETT; Gray JS, 2002, MAR POLLUT BULL, V45, P46, DOI 10.1016/S0025-326X(01)00323-X; Greer CD, 2012, ENVIRON TOXICOL CHEM, V31, P1324, DOI 10.1002/etc.1828; GYLLENBERG G, 1986, ANN ZOOL FENN, V23, P395; GYLLENBERG G, 1981, ANN ZOOL FENN, V18, P225; Gyllenberg G., 1976, ACTA ZOOL FENN, V148, P1; Harris R.P., 1977, FATE EFFECTS PETROLE, P286; HEBERT R, 1980, MAR ENVIRON RES, V4, P121, DOI 10.1016/0141-1136(80)90050-1; Hemmer MJ, 2011, ENVIRON TOXICOL CHEM, V30, P2244, DOI 10.1002/etc.619; Hemmer MJ, 2010, COMP TOXICITY EIGHT; Hylland K, 2006, J TOXICOL ENV HEAL A, V69, P109, DOI 10.1080/15287390500259327; Incardona JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030116; International Organization for Standardization ISO, 1999, DET AC LETH TOX MAR, V14669, P16; Jensen KJ, 2011, THESIS U TROMSO; Jensen LK, 2012, ECOTOX ENVIRON SAFE, V78, P225, DOI 10.1016/j.ecoenv.2011.11.029; Jensen LK, 2010, AQUAT BIOL, V10, P261, DOI 10.3354/ab00286; Jensen MH, 2008, AQUAT TOXICOL, V87, P99, DOI 10.1016/j.aquatox.2008.01.005; Jiang ZB, 2012, MAR ENVIRON RES, V81, P12, DOI 10.1016/j.marenvres.2012.08.003; Jiang Zhibing, 2010, Acta Ecologica Sinica, V30, P8; JOHANSSON S, 1980, MAR POLLUT BULL, V11, P284, DOI 10.1016/0025-326X(80)90166-6; Juhasz AL, 2000, INT BIODETER BIODEGR, V45, P57, DOI 10.1016/S0964-8305(00)00052-4; Jung SW, 2012, J HAZARD MATER, V217, P338, DOI 10.1016/j.jhazmat.2012.03.034; KAGAN J, 1990, CHEMOSPHERE, V20, P453, DOI 10.1016/0045-6535(90)90103-Z; KARINEN JF, 1974, MAR FISH REV, V36, P31; KATZ L M, 1973, Environmental Pollution, V5, P199, DOI 10.1016/0013-9327(73)90088-8; Kerr RA, 2010, SCIENCE, V329, P734, DOI 10.1126/science.329.5993.734; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; LAMPITT RS, 1990, MAR BIOL, V104, P15, DOI 10.1007/BF01313152; Law RJ, 1997, MAR POLLUT BULL, V34, P306, DOI 10.1016/S0025-326X(96)00096-3; Lee, 1975, P 1975 INT OIL SPILL, P549; Lee RF, 1977, OCEANS1997 C 4C, P1; Lee RF, 2012, J PLANKTON RES, V34, P1058, DOI 10.1093/plankt/fbs065; LEE WY, 1978, ENVIRON POLLUT, V15, P167, DOI 10.1016/0013-9327(78)90063-0; LEE WY, 1977, ENVIRON POLLUT, V12, P279, DOI 10.1016/0013-9327(77)90022-2; Lessard RR, 2000, SPILL SCI TECHNOL B, V6, P59, DOI 10.1016/S1353-2561(99)00061-4; Lewis A, 2001, OIL SPILL DISPERSANT; Lewis A, 1997, IOSC00423 AM PETR I; Lichtenthaler R.G., 1985, INT OIL SPILL C AM P, V1985, P471; LINDEN O, 1979, AMBIO, V8, P244; LINDEN O, 1987, ENVIRON SCI TECHNOL, V21, P374, DOI 10.1021/es00158a007; LINDEN O, 1976, Ambio, V5, P36; LIPIATOU E, 1993, MAR CHEM, V44, P43, DOI 10.1016/0304-4203(93)90005-9; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; LONGHURST AR, 1985, DEEP-SEA RES, V32, P1535, DOI 10.1016/0198-0149(85)90102-5; Lotufo GR, 1998, AQUAT TOXICOL, V44, P1, DOI 10.1016/S0166-445X(98)00072-1; MACKAY D, 1982, ENVIRON SCI TECHNOL, V16, P274, DOI 10.1021/es00099a008; MACKAY D, 1982, CAN J CHEM ENG, V60, P546, DOI 10.1002/cjce.5450600417; MACKIE PR, 1978, MAR POLLUT BULL, V9, P296, DOI 10.1016/0025-326X(78)90252-7; Marcus NH, 1996, HYDROBIOLOGIA, V320, P141, DOI 10.1007/BF00016815; McAuliffe CD, 1981, IOSC P, V1981, P269; McGeer JC, 2003, ENVIRON TOXICOL CHEM, V22, P1017, DOI [10.1897/1551-5028(2003)022&lt;1017:IRBBFA&gt;2.0.CO;2, 10.1002/etc.5620220509]; MCMANUS GB, 1983, ESTUAR COAST SHELF S, V17, P421, DOI 10.1016/0272-7714(83)90127-0; MEADOR JP, 1995, MAR ECOL PROG SER, V123, P107, DOI 10.3354/meps123107; MIRONOV OG, 1980, HELGOLANDER MEERESUN, V33, P292, DOI 10.1007/BF02414754; Mitra S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049505; MOORE SF, 1974, WATER RES, V8, P819, DOI 10.1016/0043-1354(74)90028-1; Mukherjee B, 2009, ENVIRON ENG SCI, V26, P1725, DOI 10.1089/ees.2009.0159; Muschenheim DK, 2002, SPILL SCI TECHNOL B, V8, P9, DOI 10.1016/S1353-2561(02)00129-9; NAGELL B, 1974, MAR BIOL, V28, P237, DOI 10.1007/BF00388490; National Commission on the BP Deep-water Horizon Oil Spill and Offshore Drilling, 2010, US SURF SUBS DISP BP; National Oceanic and Atmospheric Administration Coastal Response Research Center, 2012, FUT DISP OIL SPILL R; Neff JM, 1995, AM SOC TEST MATER, V1219, P141, DOI 10.1520/STP19863S; Nelson-Smith A, 1968, FLD STUD           S, V2, P73; Newman MC, 2003, FUNDAMENTALS ECOTOXI; NRC (National Research Council), 2003, OIL SEA; Offenheimer GH, 1977, INT 1997 OIL SPILL C, P593; OTT FS, 1978, MAR ENVIRON RES, V1, P49, DOI 10.1016/0141-1136(78)90013-2; PAFFENHO.GA, 1970, MAR BIOL, V5, P97, DOI 10.1007/BF00352591; Pavletic Z, 1975, JOURN ET POLL MAR 19; Pelletier E, 2006, PHOTOCHEM PHOTOBIOL, V82, P981, DOI 10.1562/2005-09-18-RA-688.1; Pelletier MC, 1997, ENVIRON TOXICOL CHEM, V16, P2190, DOI 10.1002/etc.5620161029; PRAHL FG, 1979, GEOCHIM COSMOCHIM AC, V43, P1959, DOI 10.1016/0016-7037(79)90008-5; Ramachandran SD, 2004, ECOTOX ENVIRON SAFE, V59, P300, DOI 10.1016/j.ecoenv.2003.08.018; Ramachandran SD, 2006, MAR POLLUT BULL, V52, P1182, DOI 10.1016/j.marpolbul.2006.02.009; Rico-Martinez R, 2013, ENVIRON POLLUT, V173, P5, DOI 10.1016/j.envpol.2012.09.024; Saiz E, 2009, ENVIRON POLLUT, V157, P1219, DOI 10.1016/j.envpol.2008.12.011; SAMAIN JF, 1980, HELGOLANDER MEERESUN, V33, P225, DOI 10.1007/BF02414748; Sanchez-Bayo F, 2006, ENVIRON POLLUT, V139, P385, DOI 10.1016/j.envpol.2005.06.016; Seuront L, 2010, MAR FRESHWATER RES, V61, P263, DOI 10.1071/MF09055; Seuront L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026283; Short J. W, 1993, EXX VALD OIL SPILL S, P57; SINGER MM, 1995, ECOTOX ENVIRON SAFE, V32, P81, DOI 10.1006/eesa.1995.1088; Singer MM, 1996, ECOTOX ENVIRON SAFE, V35, P183, DOI 10.1006/eesa.1996.0098; SINGER MM, 1990, ENVIRON TOXICOL CHEM, V9, P1387, DOI 10.1002/etc.5620091108; SINGER SC, 1977, BIOL BULL, V153, P377, DOI 10.2307/1540443; SLEETER TD, 1982, MAR POLLUT BULL, V13, P54, DOI 10.1016/0025-326X(82)90442-8; Spooner M. F., 1977, MAR POLLUT BULL, V8, P62; Stark JS, 2003, J EXP MAR BIOL ECOL, V283, P21, DOI 10.1016/S0022-0981(02)00449-5; STRAUGHAN D, 1972, J PETROL TECHNOL, V24, P250, DOI 10.2118/3204-PA; STRAUGHAN D, 1972, MARINE POLLUTION SEA, P00355; SUCHANEK TH, 1993, AM ZOOL, V33, P510; Suderman BL, 2002, ENVIRON POLLUT, V120, P787, DOI 10.1016/S0269-7491(02)00169-0; SWEDMARK M, 1973, WATER RES, V7, P1649, DOI 10.1016/0043-1354(73)90134-6; TURNER JT, 1979, BIOSCIENCE, V29, P670, DOI 10.2307/1307591; US Environmental Protection Agency EPA, 2010, QUEST ANSW DISP; US Environmental Protection Agency EPA, 1995, TECHN PROD B; USTACH JF, 1979, ESTUARIES, V2, P273, DOI 10.2307/1351575; VACA CE, 1988, MUTAT RES, V195, P137, DOI 10.1016/0165-1110(88)90022-X; Van Brummelen T., 1998, HDB ENV CHEM, V3, P203; VANDERMEULEN JH, 1986, B ENVIRON CONTAM TOX, V36, P260, DOI 10.1007/BF01623505; Varela M, 2006, MAR POLLUT BULL, V53, P272, DOI 10.1016/j.marpolbul.2005.10.005; Wade TL, 1975, MAR POLLUT B, V6, P54; Walsh G.E., 1978, PRINCIPLES ECOTOXICO, P257; Wells P.G., 1984, OIL SPILL CHEM DISPE, P177; WELLS PG, 1976, J FISH RES BOARD CAN, V33, P1604, DOI 10.1139/f76-200; WELLS PG, 1982, CHEMOSPHERE, V11, P1071, DOI 10.1016/0045-6535(82)90112-6; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Whitehead A, 2011, P NATL ACAD SCI USA; WILSON DP, 1968, J MAR BIOL ASSOC UK, V48, P177, DOI 10.1017/S0025315400032513; Wright DA, 1996, MSRC TECHNICAL REPOR, V95-013; Wu DM, 2012, ENVIRON TOXICOL CHEM, V31, P754, DOI 10.1002/etc.1739; Yu HT, 2002, J ENVIRON SCI HEAL C, V20, P149, DOI 10.1081/GNC-120016203; Zuijdgeest A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050549	163	114	117	0	457	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67212	10.1371/journal.pone.0067212	http://dx.doi.org/10.1371/journal.pone.0067212			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840628	Green Published, gold			2022-12-27	WOS:000321148400043
J	Cheng, F; Peng, XB; Zhao, P; Yuan, J; Zhong, CG; Cheng, YL; Cui, C; Zhang, SX				Cheng, Fei; Peng, Xiaobang; Zhao, Peng; Yuan, Jie; Zhong, Chonggao; Cheng, Yalong; Cui, Cui; Zhang, Shuoxin			Soil Microbial Biomass, Basal Respiration and Enzyme Activity of Main Forest Types in the Qinling Mountains	PLOS ONE			English	Article							ORGANIC-MATTER; PHOSPHATASE-ACTIVITIES; LITTER DECOMPOSITION; NITROGEN DEPOSITION; EXTRACTION METHOD; SECONDARY FOREST; SHORT-TERM; CARBON; NUTRIENTS; PHOSPHORUS	Different forest types exert essential impacts on soil physical-chemical characteristics by dominant tree species producing diverse litters and root exudates, thereby further regulating size and activity of soil microbial communities. However, the study accuracy is usually restricted by differences in climate, soil type and forest age. Our objective is to precisely quantify soil microbial biomass, basal respiration and enzyme activity of five natural secondary forest (NSF) types with the same stand age and soil type in a small climate region and to evaluate relationship between soil microbial and physical-chemical characters. We determined soil physical-chemical indices and used the chloroform fumigation-extraction method, alkali absorption method and titration or colorimetry to obtain the microbial data. Our results showed that soil physical-chemical characters remarkably differed among the NSFs. Microbial biomass carbon (Cmic) was the highest in wilson spruce soils, while microbial biomass nitrogen (Nmic) was the highest in sharptooth oak soils. Moreover, the highest basal respiration was found in the spruce soils, but mixed, Chinese pine and spruce stands exhibited a higher soil qCO(2). The spruce soils had the highest Cmic/Nmic ratio, the greatest Nmic/TN and Cmic/Corg ratios were found in the oak soils. Additionally, the spruce soils had the maximum invertase activity and the minimum urease and catalase activities, but the maximum urease and catalase activities were found in the mixed stand. The Pearson correlation and principle component analyses revealed that the soils of spruce and oak stands obviously discriminated from other NSFs, whereas the others were similar. This suggested that the forest types affected soil microbial properties significantly due to differences in soil physical-chemical features.	[Cheng, Fei; Peng, Xiaobang; Zhao, Peng; Yuan, Jie; Zhong, Chonggao; Cheng, Yalong; Cui, Cui; Zhang, Shuoxin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Zhang, Shuoxin] Northwest A&F Univ, Qinling Natl Forest Ecosyst Res Stn, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zhang, SX (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	sxzhang@nwsuaf.edu.cn			program "Technical management system for increasing the capacity of carbon sink and water regulation of mountain forests in the Qinling Mountains'' [201004036]	program "Technical management system for increasing the capacity of carbon sink and water regulation of mountain forests in the Qinling Mountains''	This work was funded by the program "Technical management system for increasing the capacity of carbon sink and water regulation of mountain forests in the Qinling Mountains'' (201004036), approved by the State Forestry Administration of China. http://www.forestry.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pietri JCA, 2009, SOIL BIOL BIOCHEM, V41, P1396, DOI 10.1016/j.soilbio.2009.03.017; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Arnold SS, 1999, BIOL FERT SOILS, V30, P239, DOI 10.1007/s003740050614; Ayres E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005964; Babujia LC, 2010, SOIL BIOL BIOCHEM, V42, P2174, DOI 10.1016/j.soilbio.2010.08.013; Banerjee MR, 1996, BIOL FERT SOILS, V22, P116, DOI 10.1007/BF00384442; Bauhus J, 1998, SOIL BIOL BIOCHEM, V30, P1077, DOI 10.1016/S0038-0717(97)00213-7; BROOKES PC, 1984, SOIL BIOL BIOCHEM, V16, P169, DOI 10.1016/0038-0717(84)90108-1; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Brumme R, 2009, ECOL STUD-ANAL SYNTH, V208, P1, DOI 10.1007/b82392; Carter MR, 1999, CAN J SOIL SCI, V79, P507, DOI 10.4141/S99-012; CERRI CC, 1981, J SOIL SCI, V32, P619, DOI 10.1111/j.1365-2389.1981.tb01734.x; Chen GC, 2004, BIOL FERT SOILS, V39, P446, DOI 10.1007/s00374-004-0734-6; Cheng WX, 1996, SOIL BIOL BIOCHEM, V28, P1283, DOI 10.1016/S0038-0717(96)00138-1; DANG K L, 1996, J NW FORESTRY COLL, V11, P127; Dang K-L, 1996, J NW FORESTRY U S, V11, P26; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; De Schrijver A, 2008, NATURE, V451, pE1, DOI 10.1038/nature06578; DIAZRAVINA M, 1993, BIOL FERT SOILS, V16, P205, DOI 10.1007/BF00361409; Ekschmitt K, 1999, PLANT SOIL, V212, P45, DOI 10.1023/A:1004682620283; Fall D, 2012, J ENVIRON MANAGE, V95, pS260, DOI 10.1016/j.jenvman.2011.03.038; FAUCI MF, 1994, SOIL SCI SOC AM J, V58, P801, DOI 10.2136/sssaj1994.03615995005800030023x; GALLARDO A, 1994, SOIL BIOL BIOCHEM, V26, P1409, DOI 10.1016/0038-0717(94)90225-9; Ge Xiao-gai, 2012, Yingyong Shengtai Xuebao, V23, P445; Gelsomino A, 2011, J PLANT NUTR SOIL SC, V174, P381, DOI 10.1002/jpln.200900267; Gianfreda L, 2005, SCI TOTAL ENVIRON, V341, P265, DOI 10.1016/j.scitotenv.2004.10.005; Gonzalez-Quinones V, 2011, SOIL RES, V49, P287, DOI 10.1071/SR10203; Griffiths B.S., 2012, ECOL PROCESS, V1, P1, DOI [10.1186/2192-1709-1-6, DOI 10.1186/2192-1709-1-6]; Harris MM, 1996, SOIL SCI, V161, P130, DOI 10.1097/00010694-199602000-00008; He, 1996, EXPT TECHNIQUE AGR M, P122; JACKSON LE, 1989, SOIL BIOL BIOCHEM, V21, P409, DOI 10.1016/0038-0717(89)90152-1; JENKINSON DS, 1977, SOIL SCI, V123, P298, DOI 10.1097/00010694-197705000-00005; Jia GM, 2005, FOREST ECOL MANAG, V217, P117, DOI 10.1016/j.foreco.2005.05.055; Kang Y.X., 1996, J NW FORESTRY COLL, V11, P1; Keenan RJ, 1996, CAN J BOT, V74, P1626, DOI 10.1139/b96-197; Lavahun MFE, 1996, BIOL FERT SOILS, V23, P38, DOI 10.1007/BF00335816; Lei R.D., 1996, J NW FORESTRY COLL, V11, P43; Lei R.D., 1996, J NW FORESTRY COLL, V11, P53; Li Z. G., 2008, SOIL ENV MICROBIAL M; Liu G., 1996, SOIL PHYS CHEM ANAL; Liu Jianjun, 2001, SHAANXI FOREST SCI T, V2, P7; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036434; Lorenz K, 2000, SOIL BIOL BIOCHEM, V32, P779, DOI 10.1016/S0038-0717(99)00201-1; Mahia J., 2006, Investigacion Agraria, Sistemas y Recursos Forestales, V15, P152; MARUMOTO T, 1982, SOIL BIOL BIOCHEM, V14, P469, DOI 10.1016/0038-0717(82)90106-7; MONTAGNINI F, 2005, TROP FOR, P1; Moscatelli MC, 2005, ECOL INDIC, V5, P171, DOI 10.1016/j.ecolind.2005.03.002; Nsabimana D, 2004, APPL SOIL ECOL, V26, P81, DOI 10.1016/j.apsoil.2003.12.005; RECOUS S, 1990, SOIL BIOL BIOCHEM, V22, P913, DOI 10.1016/0038-0717(90)90129-N; SAFFIGNA PG, 1989, SOIL BIOL BIOCHEM, V21, P759, DOI 10.1016/0038-0717(89)90167-3; Schneider K, 2000, COMMUN SOIL SCI PLAN, V31, P3077, DOI 10.1080/00103620009370651; SINGH JS, 1989, NATURE, V338, P499, DOI 10.1038/338499a0; SLAPOKAS T, 1991, BIOL FERT SOILS, V10, P241, DOI 10.1007/BF00337374; SPARLING GP, 1992, AUST J SOIL RES, V30, P195, DOI 10.1071/SR9920195; Stemmer M, 1998, SOIL BIOL BIOCHEM, V30, P9, DOI 10.1016/S0038-0717(97)00093-X; Thomas GA, 2007, SOIL TILL RES, V94, P295, DOI 10.1016/j.still.2006.08.005; Tian Y, 2008, J FOREST RES-JPN, V13, P205, DOI 10.1007/s10310-008-0073-9; Tietema A, 1998, FOREST ECOL MANAG, V101, P29, DOI 10.1016/S0378-1127(97)00122-9; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VANVEEN JA, 1984, PLANT SOIL, V76, P257, DOI 10.1007/BF02205585; Waldrop MP, 2004, SOIL BIOL BIOCHEM, V36, P1443, DOI 10.1016/j.soilbio.2004.04.023; Wang JB, 2011, PLANT SOIL ENVIRON, V57, P251, DOI 10.17221/437/2010-PSE; Xu XK, 2006, GEODERMA, V136, P310, DOI 10.1016/j.geoderma.2006.03.045; Yang K, 2010, J PLANT ECOL-UK, V3, P175, DOI 10.1093/jpe/rtq022; YAO KY, 2006, SOIL MICROBIAL ECOLO; Yu ZY, 2008, PEDOSPHERE, V18, P775, DOI 10.1016/S1002-0160(08)60073-9; Zechmeister-Boltenstern S, 2011, PLANT SOIL, V343, P37, DOI 10.1007/s11104-010-0528-6; [张崇邦 Zhang Chongbang], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P28; Zhang S. X., 1996, J NORTHWEST FOR UNIV, V11, P115	70	90	95	6	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67353	10.1371/journal.pone.0067353	http://dx.doi.org/10.1371/journal.pone.0067353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840671	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400062
J	Fahoum, F; Zelmann, R; Tyvaert, L; Dubeau, F; Gotman, J				Fahoum, Firas; Zelmann, Rina; Tyvaert, Louise; Dubeau, Francois; Gotman, Jean			Epileptic Discharges Affect the Default Mode Network fMRI and Intracerebral EEG Evidence	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; FUNCTIONAL MRI; GAMMA-OSCILLATIONS; INTRACRANIAL EEG; BOLD SIGNAL; 100-500 HZ; SEIZURES; CORTEX; BRAIN; STATE	Functional neuroimaging studies of epilepsy patients often show, at the time of epileptic activity, deactivation in default mode network (DMN) regions, which is hypothesized to reflect altered consciousness. We aimed to study the metabolic and electrophysiological correlates of these changes in the DMN regions. We studied six epilepsy patients that underwent scalp EEG-fMRI and later stereotaxic intracerebral EEG (SEEG) sampling regions of DMN (posterior cingulate cortex, Pre-cuneus, inferior parietal lobule, medial prefrontal cortex and dorsolateral frontal cortex) as well as non-DMN regions. SEEG recordings were subject to frequency analyses comparing sections with interictal epileptic discharges (IED) to IED-free baselines in the IED-generating region, DMN and non-DMN regions. EEG-fMRI and SEEG were obtained at rest. During IEDs, EEG-fMRI demonstrated deactivation in various DMN nodes in 5 of 6 patients, most frequently the pre-cuneus and inferior parietal lobule, and less frequently the other DMN nodes. SEEG analyses demonstrated decrease in gamma power (50150 Hz), and increase in the power of lower frequencies (<30 Hz) at times of IEDs, in at least one DMN node in all patients. These changes were not apparent in the non-DMN regions. We demonstrate that, at the time of IEDs, DMN regions decrease their metabolic demand and undergo an EEG change consisting of decreased gamma and increased lower frequencies. These findings, specific to DMN regions, confirm in a pathological condition a direct relationship between DMN BOLD activity and EEG activity. They indicate that epileptic activity affects the DMN, and therefore may momentarily reduce the consciousness level and cognitive reserve.	[Fahoum, Firas; Zelmann, Rina; Dubeau, Francois; Gotman, Jean] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Tyvaert, Louise] Univ Lille, Med Ctr, Roger Salengro Hosp, Dept Clin Neurophysiol, Lille, France	McGill University; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Fahoum, F (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	firas.fahoum@mcgill.ca	Tyvaert, Louise/AAL-5020-2021; Fahoum, Firas/AFJ-8624-2022	Fahoum, Firas/0000-0003-2262-5530; Zelmann, Rina/0000-0002-2142-7324	Canadian Institutes of Health Research [MOP-38079]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research [MOP-38079]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Bagshaw AP, 2009, EPILEPSIA, V50, P617, DOI 10.1111/j.1528-1167.2008.01784.x; Bagshaw AP, 2004, HUM BRAIN MAPP, V22, P179, DOI 10.1002/hbm.20024; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Benar CG, 2003, CLIN NEUROPHYSIOL, V114, P569, DOI 10.1016/S1388-2457(02)00383-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benuzzi F, 2012, EPILEPSIA, V53, P622, DOI 10.1111/j.1528-1167.2011.03385.x; Blumenfeld H, 2004, NEUROLOGY, V63, P1015, DOI 10.1212/01.WNL.0000141086.91077.CD; Blumenfeld H, 2003, NEUROSCIENTIST, V9, P301, DOI 10.1177/1073858403255624; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Englot DJ, 2010, BRAIN, V133, P3764, DOI 10.1093/brain/awq316; Fahoum F, 2012, EPILEPSIA; Gaona CM, 2011, J NEUROSCI, V31, P2091, DOI 10.1523/JNEUROSCI.4722-10.2011; Golomb JD, 2005, EPILEPSIA, V46, P315; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Jerbi K, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00027; Khursheed F, 2011, NEUROIMAGE, V56, P1773, DOI 10.1016/j.neuroimage.2011.02.062; Kobayashi E, 2009, EPILEPSIA, V50, P2549, DOI 10.1111/j.1528-1167.2009.02180.x; Koubeissi MZ, 2009, EPILEPSY BEHAV, V14, P108, DOI 10.1016/j.yebeh.2008.08.021; Lachaux JP, 2007, HUM BRAIN MAPP, V28, P1368, DOI 10.1002/hbm.20352; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Lee KH, 2002, NEUROLOGY, V59, P841, DOI 10.1212/WNL.59.6.841; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Miller KJ, 2009, P NATL ACAD SCI USA, V106, P12174, DOI 10.1073/pnas.0902071106; Moeller F, 2009, NEUROLOGY, V73, P2023, DOI 10.1212/WNL.0b013e3181c55d17; Morgan VL, 2007, EPILEPSY RES, V76, P22, DOI 10.1016/j.eplepsyres.2007.06.008; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; OLIVIER A, 1994, J NEUROSURG, V81, P629, DOI 10.3171/jns.1994.81.4.0629; Ossandon T, 2011, J NEUROSCI, V31, P14521, DOI 10.1523/JNEUROSCI.2483-11.2011; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Urrestarazu E, 2007, BRAIN, V130, P2354, DOI 10.1093/brain/awm149; Urrestarazu E, 2006, EPILEPSIA, V47, P1465, DOI 10.1111/j.1528-1167.2006.00618.x; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	47	65	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68038	10.1371/journal.pone.0068038	http://dx.doi.org/10.1371/journal.pone.0068038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840805	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400154
J	Gleim, S; Stitham, J; Tang, WH; Li, H; Douville, K; Chelikani, P; Rade, JJ; Martin, KA; Hwa, J				Gleim, Scott; Stitham, Jeremiah; Tang, Wai Ho; Li, Hong; Douville, Karen; Chelikani, Prashen; Rade, Jeffrey J.; Martin, Kathleen A.; Hwa, John			Human Thromboxane A(2) Receptor Genetic Variants: In Silico, In Vitro and "In Platelet" Analysis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; LIGAND-BINDING; POLYMORPHISMS; PROSTACYCLIN; MUTATION; AGONIST; A2; ANTAGONIST; ISOFORMS; ASPIRIN	Thromboxane and its receptor have emerged as key players in modulating vascular thrombotic events. Thus, a dysfunctional hTP genetic variant may protect against (hypoactivity) or promote (hyperactivity) vascular events, based upon its activity on platelets. After extensive in silico analysis, six hTP-alpha variants were selected ((CS)-S-68, (VE)-E-80, (EV)-V-94, A(160)T, (VE)-E-176, and (VI)-I-217) for detailed biochemical studies based on structural proximity to key regions involved in receptor function and in silico predictions. Variant biochemical profiles ranged from severe instability ((CS)-S-68) to normal ((VI)-I-217), with most variants demonstrating functional alteration in binding, expression or activation ((VE)-E-80, (EV)-V-94, A(160)T, and (VE)-E-176). In the absence of patient platelet samples, we developed and validated a novel megakaryocyte based system to evaluate human platelet function in the presence of detected dysfunctional genetic variants. Interestingly, variant V80E exhibited reduced platelet activation whereas A160T demonstrated platelet hyperactivity. This report provides the most comprehensive in silico, in vitro and "in platelet" evaluation of hTP variants to date and highlightscurrent inherent problems in evaluating genetic variants, with possible solutions. The study additionally provides clinical relevance to characterized dysfunctional hTP variants.	[Gleim, Scott; Stitham, Jeremiah; Tang, Wai Ho; Martin, Kathleen A.; Hwa, John] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Li, Hong; Douville, Karen; Hwa, John] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA; [Chelikani, Prashen] Univ Manitoba, Fac Dent, Dept Oral Biol, Winnipeg, MB, Canada; [Rade, Jeffrey J.] UMass Sch Med & Med Ctr, Internal Med Sect Cardiol, Worcester, MA USA	Yale University; Dartmouth College; University of Manitoba	Hwa, J (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	john.hwa@yale.edu		Chelikani, Prashen/0000-0003-1129-7957; Martin, Kathleen/0000-0002-1748-0034; Li, Hong/0000-0002-0458-0714	NHLBI [HL074190, HL115247, HL117798]; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798, R01HL091013, R01HL115247, R01HL074190] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI grants HL074190, HL115247, HL117798 to JH, and AHA grant to SG and WHT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arehart E, 2008, CIRC RES, V102, P986, DOI 10.1161/CIRCRESAHA.107.165936; Baek SJ, 1996, GENE, V173, P251, DOI 10.1016/0378-1119(95)00881-0; Binkley J, 2010, GENOME RES, V20, P142, DOI 10.1101/gr.097121.109; Bordeaux Bryan C, 2010, Prev Cardiol, V13, P56, DOI 10.1111/j.1751-7141.2009.00058.x; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Calapai G, 2009, INHAL TOXICOL, V21, P1138, DOI 10.3109/08958370902798455; Chakraborty R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029996; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Chevalier D, 2001, MUTAT RES-GENOMICS, V432, P61, DOI 10.1016/S1383-5726(00)00004-2; Chiang N, 1998, ARCH BIOCHEM BIOPHYS, V352, P207, DOI 10.1006/abbi.1998.0620; Chiang N, 1996, ARCH BIOCHEM BIOPHYS, V334, P9, DOI 10.1006/abbi.1996.0423; DAngelo DD, 1996, J BIOL CHEM, V271, P6233, DOI 10.1074/jbc.271.11.6233; DAVI G, 1990, NEW ENGL J MED, V322, P1769, DOI 10.1056/NEJM199006213222503; Ferroni P, 2004, J THROMB HAEMOST, V2, P1282, DOI 10.1111/j.1538-7836.2004.00836.x; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; FUNK CD, 1993, MOL PHARMACOL, V44, P934; Goodwill AG, 2008, AM J PHYSIOL-HEART C, V295, pH1522, DOI 10.1152/ajpheart.00596.2008; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; HIRATA T, 1994, J CLIN INVEST, V94, P1662, DOI 10.1172/JCI117510; Hirata T, 1996, J CLIN INVEST, V97, P949, DOI 10.1172/JCI118518; Hong SJ, 2005, J ALLERGY CLIN IMMUN, V115, P758, DOI 10.1016/j.jaci.2004.10.047; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Leung TF, 2002, PEDIAT ALLERG IMM-UK, V13, P10, DOI 10.1034/j.1399-3038.2002.01033.x; Mumford AD, 2010, BLOOD, V115, P363, DOI 10.1182/blood-2009-08-236976; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; NUNN B, 1981, THROMB HAEMOSTASIS, V45, P1; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Tanaka K, 2002, BIOCHEM BIOPH RES CO, V292, P776, DOI 10.1006/bbrc.2002.6713; Tang WH, 2011, J CLIN INVEST, V121, P4462, DOI 10.1172/JCI59291; Tsakiris DA, 1999, THROMB HAEMOSTASIS, V81, P177, DOI 10.1055/s-0037-1614439; TYMKEWYCZ PM, 1991, BRIT J PHARMACOL, V102, P607, DOI 10.1111/j.1476-5381.1991.tb12220.x; Ulrich Cornelia M, 2005, Hum Mutat, V26, P394, DOI 10.1002/humu.9371; Unoki M, 2000, HUM GENET, V106, P440, DOI 10.1007/s004390000267; Xie YH, 2010, BASIC CLIN PHARMACOL, V107, P803, DOI 10.1111/j.1742-7843.2010.00585.x; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67314	10.1371/journal.pone.0067314	http://dx.doi.org/10.1371/journal.pone.0067314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840660	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400057
J	Hudson, CM; Fu, JZ				Hudson, Cameron M.; Fu, Jinzhong			Male-Biased Sexual Size Dimorphism, Resource Defense Polygyny, and Multiple Paternity in the Emei Moustache Toad (Leptobrachium boringii)	PLOS ONE			English	Article							BEHAVIOR; VIBRISSAPHORA; EVOLUTION; PREFER; ENERGY; ANURA; CARE	We tested the hypotheses that the Emei moustache toad (Leptobrachium boringii) exhibits resource defense polygyny and that combat led to the evolution of male-biased sexual size dimorphism. Between February and March of 2011 and 2012, 26 female and 55 male L. boringii from Mount Emei UNESCO World Heritage Site, Sichuan, China, were observed throughout the breeding season. Prior to the breeding season, males grow 10-16 keratinized maxillary nuptial spines, which fall off once the season has ended. Throughout this time, males construct and defend aquatic nests where they produce advertisement calls to attract females. In a natural setting, we documented 14 cases involving a total of 22 males where males used their moustaches for aggressive interaction, and nest takeover was observed on seven occasions. Males were also observed to possess injuries resulting from combat. Genetic analysis using microsatellite DNA markers revealed several cases of multiple paternity, both within nest and within clutch. This observation indicated that some alternative male reproductive strategy, such as satellite behaviour, is occurring, which may have led to the multiple paternity. Larger males were observed to mate more frequently, and in multiple nests, suggesting that females are selecting for larger males, or that larger males are more capable of defending high quality territories.	[Hudson, Cameron M.; Fu, Jinzhong] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Hudson, CM (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	cam.hudson@gmail.com		Hudson, Cameron/0000-0003-3298-4510	National Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by the National Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Bi K, 2010, CONSERV GENET, V11, P1135, DOI 10.1007/s10592-009-9899-8; Cuc Tho Ho, 1999, Russian Journal of Herpetology, V6, P48; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fei L., 1984, CHIN J ZOOL, V19, P1; Han X, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-27; Hudson CM, 2011, ASIAN HERPETOL RES, V2, P142, DOI 10.3724/SP.J.1245.2011.00142; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Liu C. C, 1961, CHINESE TAILLESS AMP; MARTINS M, 1998, AMPHIBIA-REPTILIA, V9, P49; Ohler A, 2004, RAFFLES B ZOOL, V52, P695; Orlov Nikolai L., 2005, Russian Journal of Herpetology, V12, P17; RIDLEY M, 1981, BEHAVIOUR, V76, P152, DOI 10.1163/156853981X00059; Roldan M, 2011, BEHAV ECOL, V22, P679, DOI 10.1093/beheco/arr041; RYAN MJ, 1988, AM ZOOL, V28, P885; SCHOENER TW, 1987, AM ZOOL, V27, P259; SHINE R, 1979, COPEIA, P297, DOI 10.2307/1443418; SMITH JM, 1977, ANIM BEHAV, V25, P1, DOI 10.1016/0003-3472(77)90062-8; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; UNGER LM, 1988, BEHAV ECOL SOCIOBIOL, V23, P27, DOI 10.1007/BF00303054; Vieites DR, 2004, NATURE, V431, P305, DOI 10.1038/nature02879; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Ye CY., 1993, RARE EC AMPHIBIANS; Zheng YC, 2008, MOL PHYLOGENET EVOL, V46, P695, DOI 10.1016/j.ympev.2007.09.019; Zheng YC, 2007, AMPHIBIA-REPTILIA, V28, P309, DOI 10.1163/156853807780202404; Zheng YC, 2011, ASIAN HERPETOL RES, V2, P199, DOI 10.3724/SP.J.1245.2011.00199; Zheng YC, 2010, AMPHIBIA-REPTILIA, V31, P183, DOI 10.1163/156853810791069092	30	12	12	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67502	10.1371/journal.pone.0067502	http://dx.doi.org/10.1371/journal.pone.0067502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840725	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400094
J	Wang, J; Wagner-Britz, L; Bogdanova, A; Ruppenthal, S; Wiesen, K; Kaiser, E; Tian, QH; Krause, E; Bernhardt, I; Lipp, P; Philipp, SE; Kaestner, L				Wang, Jue; Wagner-Britz, Lisa; Bogdanova, Anna; Ruppenthal, Sandra; Wiesen, Kathrina; Kaiser, Elisabeth; Tian, Qinghai; Krause, Elmar; Bernhardt, Ingolf; Lipp, Peter; Philipp, Stephan E.; Kaestner, Lars			Morphologically Homogeneous Red Blood Cells Present a Heterogeneous Response to Hormonal Stimulation	PLOS ONE			English	Article							ACTIVATED CATION CHANNEL; LYSOPHOSPHATIDIC ACID; HUMAN-ERYTHROCYTES; PHOSPHATIDYLSERINE EXPOSURE; MEMBRANE-PROTEINS; CALCIUM-IONS; RECEPTORS; MOUSE; DEATH; ACETYLCHOLINESTERASE	Red blood cells (RBCs) are among the most intensively studied cells in natural history, elucidating numerous principles and ground-breaking knowledge in cell biology. Morphologically, RBCs are largely homogeneous, and most of the functional studies have been performed on large populations of cells, masking putative cellular variations. We studied human and mouse RBCs by live-cell video imaging, which allowed single cells to be followed over time. In particular we analysed functional responses to hormonal stimulation with lysophosphatidic acid (LPA), a signalling molecule occurring in blood plasma, with the Ca2+ sensor Fluo-4. Additionally, we developed an approach for analysing the Ca2+ responses of RBCs that allowed the quantitative characterization of single-cell signals. In RBCs, the LPA-induced Ca2+ influx showed substantial diversity in both kinetics and amplitude. Also the age-classification was determined for each particular RBC and consecutively analysed. While reticulocytes lack a Ca2+ response to LPA stimulation, old RBCs approaching clearance generated robust LPA-induced signals, which still displayed broad heterogeneity. Observing phospatidylserine exposure as an effector mechanism of intracellular Ca2+ revealed an even increased heterogeneity of RBC responses. The functional diversity of RBCs needs to be taken into account in future studies, which will increasingly require single-cell analysis approaches. The identified heterogeneity in RBC responses is important for the basic understanding of RBC signalling and their contribution to numerous diseases, especially with respect to Ca2+ influx and the associated pro-thrombotic activity.	[Wang, Jue; Ruppenthal, Sandra; Wiesen, Kathrina; Kaiser, Elisabeth; Tian, Qinghai; Lipp, Peter; Kaestner, Lars] Univ Saarland, Inst Mol Cell Biol, Homburg, Germany; [Wang, Jue; Ruppenthal, Sandra; Wiesen, Kathrina; Kaiser, Elisabeth; Tian, Qinghai; Lipp, Peter; Kaestner, Lars] Univ Saarland, Res Ctr Mol Imaging & Screening, Homburg, Germany; [Wagner-Britz, Lisa; Bernhardt, Ingolf] Univ Saarland, Biophys Lab, D-66123 Saarbrucken, Germany; [Bogdanova, Anna] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, Zurich, Switzerland; [Bogdanova, Anna] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Krause, Elmar; Philipp, Stephan E.] Univ Saarland, Homburg, Germany	Saarland University; Saarland University; Saarland University; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Saarland University	Kaestner, L (corresponding author), Univ Saarland, Inst Mol Cell Biol, Homburg, Germany.	lars_kaestner@me.com	Bogdanova, Anna Yu/M-1977-2017; Wang, Jue/J-5741-2019; Kaestner, Lars/P-6988-2016; Philipp, Stephan/AAR-7519-2020	Bogdanova, Anna Yu/0000-0003-0502-5381; Kaestner, Lars/0000-0001-6796-9535; Krause, Elmar/0000-0003-0891-2373; Philipp, Stephan/0000-0003-1959-9167				Andrews D A, 1999, Curr Opin Hematol, V6, P76, DOI 10.1097/00062752-199903000-00004; BEAUREGARD G, 1979, BIOCHIM BIOPHYS ACTA, V557, P102, DOI 10.1016/0005-2736(79)90093-2; BENGA G, 1986, BIOCHEMISTRY-US, V25, P1535, DOI 10.1021/bi00355a011; BENGA G, 1986, EUR J CELL BIOL, V41, P252; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bogdanova A, 2013, INT J MOL S IN PRESS; Bollensdorff C, 1998, THESIS HUMBOLDT U BE; BOOKCHIN RM, 1980, NATURE, V284, P561, DOI 10.1038/284561a0; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; CHRISTOPHERSEN P, 1991, BIOCHIM BIOPHYS ACTA, V1065, P103, DOI 10.1016/0005-2736(91)90017-3; Chung SM, 2007, ARTERIOSCL THROM VAS, V27, P414, DOI 10.1161/01.ATV.0000252898.48084.6a; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; Nguyen DB, 2011, CELL PHYSIOL BIOCHEM, V28, P847, DOI 10.1159/000335798; Dyrda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009447; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; FAROOQUI SM, 1987, BIOCHIM BIOPHYS ACTA, V904, P239, DOI 10.1016/0005-2736(87)90373-7; FLIKWEERT JP, 1975, BIOCHIMIE, V57, P677, DOI 10.1016/S0300-9084(75)80043-5; Foller M, 2008, CELL PHYSIOL BIOCHEM, V21, P183, DOI 10.1159/000113760; Franco RS, 1998, J CLIN INVEST, V101, P2730, DOI 10.1172/JCI2484; Fricke H, 1925, J GEN PHYSIOL, V9, P137, DOI 10.1085/jgp.9.2.137; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Gorter E, 1925, J EXP MED, V41, P439, DOI 10.1084/jem.41.4.439; GRYGORCZYK R, 1984, BIOPHYS J, V45, P693, DOI 10.1016/S0006-3495(84)84211-3; HALBHUBER KJ, 1982, ACTA HISTOCHEM, V70, P290, DOI 10.1016/S0065-1281(82)80079-2; HANKIN S, 1995, INT J BIOCHEM CELL B, V27, P201, DOI 10.1016/1357-2725(94)00076-N; Hebbel R P, 1981, Prog Clin Biol Res, V51, P321; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; HORKY J, 1978, PHYSIOL BOHEMOSLOV, V27, P209; Huber SM, 2001, PFLUG ARCH EUR J PHY, V441, P551, DOI 10.1007/s004240000456; JOINER CH, 1995, BLOOD, V86, P4307, DOI 10.1182/blood.V86.11.4307.bloodjournal86114307; Kaestner L, 2006, CELL CALCIUM, V39, P13, DOI 10.1016/j.ceca.2005.09.004; Kaestner L, 2004, THROMB HAEMOSTASIS, V92, P1269, DOI 10.1160/TH04-06-0338; Kaestner L., 2011, Open Biology Journal, V4, P27, DOI 10.2174/1874196701104010027; Kaestner L, 2000, BIOELECTROCHEMISTRY, V52, P117, DOI 10.1016/S0302-4598(00)00110-0; Kaestner L, 1999, BBA-BIOMEMBRANES, V1417, P9, DOI 10.1016/S0005-2736(98)00240-5; Kaestner L., 2013, Calcium signalling Approaches and Findings in the Heart and Blood; Kaestner L, 2012, BIOELECTROCHEMISTRY, V87, P89, DOI 10.1016/j.bioelechem.2011.08.004; Kempe DS, 2006, FASEB J, V20, P368, DOI 10.1096/fj.05-4872fje; Kenney Nicholas J., 2001, Journal of Biomedicine and Biotechnology, V1, P133, DOI 10.1155/S1110724301000304; Kiessling K, 1994, THESIS HUMBOLDT U BE; Kraft R, 1995, THESIS HUMBOLDT U BE; Krishnan A, 2004, J INFECTION, V48, P86, DOI 10.1016/S0163-4453(03)00130-0; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; Lang PA, 2006, J MOL MED, V84, P378, DOI 10.1007/s00109-006-0058-0; LARSEN FL, 1978, J MEMBRANE BIOL, V41, P361, DOI 10.1007/BF01872000; Lew VL, 2007, BLOOD, V110, P1334, DOI 10.1182/blood-2006-11-057232; Mahmud H, 2013, CARDIOVASC RES, V98, P37, DOI 10.1093/cvr/cvt010; Makhro A, 2010, AM J PHYSIOL-CELL PH, V298, pC1315, DOI 10.1152/ajpcell.00407.2009; Minetti G, 2001, BBA-GEN SUBJECTS, V1527, P149, DOI 10.1016/S0304-4165(01)00159-3; Minetti G, 2013, BLOOD REV, V27, P91, DOI 10.1016/j.blre.2013.02.002; Misiti F, 2008, BIOCHEM CELL BIOL, V86, P501, DOI 10.1139/O08-139; Noh JY, 2010, AM J PHYSIOL-HEART C, V299, pH347, DOI 10.1152/ajpheart.01144.2009; OFFRINGA M, 1992, POSTGRAD MED J, V68, P648, DOI 10.1136/pgmj.68.802.648; Prall YG, 1998, LIFE SCI, V63, P177, DOI 10.1016/S0024-3205(98)00258-6; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; ROBERTSON JD, 1960, PROG BIOPHYS MOL BIO, V10, P343; Schatz H., 1989, RETINA, P3; SCHATZMANN HJ, 1969, J PHYSIOL-LONDON, V201, P369, DOI 10.1113/jphysiol.1969.sp008761; SCHEIBEL LW, 1987, P NATL ACAD SCI USA, V84, P7310, DOI 10.1073/pnas.84.20.7310; SCHMIDT W, 1987, RESP PHYSIOL, V68, P215, DOI 10.1016/S0034-5687(87)80007-5; SHALEV O, 1984, BLOOD, V64, P564; Soldati L, 2002, BIOCHEM BIOPH RES CO, V293, P974, DOI 10.1016/S0006-291X(02)00327-3; Steffen P, 2011, CELL CALCIUM, V50, P54, DOI 10.1016/j.ceca.2011.05.002; STRUNECKA A, 1990, BIOMED BIOCHIM ACTA, V49, pS141; Taher AT, 2008, BLOOD REV, V22, P283, DOI 10.1016/j.blre.2008.04.001; Thomas SLY, 2001, FEBS LETT, V500, P45, DOI 10.1016/S0014-5793(01)02579-0; Tian QH, 2012, CIRC RES, V111, P17, DOI 10.1161/CIRCRESAHA.112.266403; Tziakas D, 2012, CLIN HEMORHEOL MICRO, V51, P243, DOI 10.3233/CH-2012-1530; Weiss E, 2011, ANEMIA, V2011, DOI 10.1155/2011/379894; WESTRICK JA, 1994, COMP BIOCHEM PHYS B, V109, P489, DOI 10.1016/0305-0491(94)90032-9; Woon LA, 1999, CELL CALCIUM, V25, P313, DOI 10.1054/ceca.1999.0029; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425; Zennadi R, 2012, BLOOD, V119, P1217, DOI 10.1182/blood-2011-03-344440	74	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67697	10.1371/journal.pone.0067697	http://dx.doi.org/10.1371/journal.pone.0067697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840765	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000321148400127
J	Fozzatti, L; Park, JW; Zhao, L; Willingham, MC; Cheng, SY				Fozzatti, Laura; Park, Jeong Won; Zhao, Li; Willingham, Mark C.; Cheng, Sheue-yann			Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; HORMONE-BETA-RECEPTOR; TUMOR-SUPPRESSOR P53; VALPROIC ACID; CO-REPRESSOR; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; BREAST-CANCER; CELL-LINES; GENE	Studies have suggested that the nuclear receptor corepressor 1 (NCOR1) could play an important role in human cancers. However, the detailed molecular mechanisms by which it functions in vivo to affect cancer progression are not clear. The present study elucidated the in vivo actions of NCOR1 in carcinogenesis using a mouse model (Thrb(PV/PV) mice) that spontaneously develops thyroid cancer. Thrb(PV/PV) mice harbor a dominantly negative thyroid hormone receptor beta (TR beta) mutant (denoted as PV). We adopted the loss-of-the function approach by crossing Thrb(PV) mice with mice that globally express an NCOR1 mutant protein (NCOR1 Delta ID) in which the receptor interaction domains have been modified so that it cannot interact with the TR beta, or PV, in mice. Remarkably, expression of NCOR1 Delta ID protein reduced thyroid tumor growth, markedly delayed tumor progression, and prolonged survival of Thrb(PV/PV) Ncor1(Delta ID/Delta ID) mice. Tumor cell proliferation was inhibited by increased expression of cyclin-dependent kinase inhibitor 1 (p21(waf1/cip1); Cdkn1A), and apoptosis was activated by elevated expression of pro-apoptotic BCL-Associated X (Bax). Further analyses showed that p53 was recruited to the p53-binding site on the proximal promoter of the Cdkn1A and the Bax gene as a co-repressor complex with PV/NCOR1/histone deacetylas-3 (HDAC-3), leading to repression of the Cdkn1A as well as the Bax gene in thyroids of Thrb(PV/PV) mice. In thyroids of Thrb(PV/PV) Ncor1(Delta ID/Delta ID) mice, the p53/PV complex could not recruit NCOR1 Delta ID and HDAC-3, leading to de-repression of both genes to inhibit cancer progression. The present studies provided direct evidence in vivo that NCOR1 could function as an oncogene via transcription regulation in a mouse model of thyroid cancer.	[Fozzatti, Laura; Park, Jeong Won; Zhao, Li; Willingham, Mark C.; Cheng, Sheue-yann] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cheng, SY (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	chengs@mail.nih.gov			Intramural Research Program at the Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC008752, ZIABC011191] Funding Source: NIH RePORTER	Intramural Research Program at the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present research was supported by the Intramural Research Program at the Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. A. Hollenberg (Harvard Medical School) for providing Ncor1 Delta ID mice. The present research was supported by the Intramural Research Program at the Center for Cancer Research, National Cancer Institute, National Institutes of Health.	Abedin SA, 2009, CARCINOGENESIS, V30, P449, DOI 10.1093/carcin/bgp005; Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Altmann A, 2010, EUR J NUCL MED MOL I, V37, P2286, DOI 10.1007/s00259-010-1573-3; Astapova I, 2013, BBA-GEN SUBJECTS, V1830, P3876, DOI 10.1016/j.bbagen.2012.07.001; Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Banwell CM, 2006, CLIN CANCER RES, V12, P2004, DOI 10.1158/1078-0432.CCR-05-1218; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Catalano MG, 2007, ENDOCR-RELAT CANCER, V14, P839, DOI 10.1677/ERC-07-0096; Catalano MG, 2006, J ENDOCRINOL, V191, P465, DOI 10.1677/joe.1.06970; Catalano MG, 2009, ONCOL REP, V21, P515, DOI 10.3892/or_00000252; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cheng S Y, 2000, Rev Endocr Metab Disord, V1, P9, DOI 10.1023/A:1010052101214; Cheng SY, 2005, STEROIDS, V70, P450, DOI 10.1016/j.steroids.2005.02.003; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Ferrara AM, 2012, J CLIN ENDOCR METAB, V97, P1328, DOI 10.1210/jc.2011-2642; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; Fozzatti L, 2011, P NATL ACAD SCI USA, V108, P17462, DOI 10.1073/pnas.1107474108; Fozzatti L, 2011, MOL ENDOCRINOL, V25, P908, DOI 10.1210/me.2010-0474; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2007, CARCINOGENESIS, V28, P2451, DOI 10.1093/carcin/bgm174; Furuya F, 2007, MOL CELL BIOL, V27, P6116, DOI 10.1128/MCB.00900-07; Girault I, 2003, CLIN CANCER RES, V9, P1259; Glass CK, 2000, GENE DEV, V14, P121; Guigon CJ, 2008, MOL CELL BIOL, V28, P4598, DOI 10.1128/MCB.02192-07; Hollenberg AN, 2008, CELL METAB, V8, P10, DOI 10.1016/j.cmet.2008.06.008; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Jepsen K, 2002, J CELL SCI, V115, P689; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Kim CS, 2007, CARCINOGENESIS, V28, P932, DOI 10.1093/carcin/bgl231; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Love JD, 2000, BIOCHEM SOC T, V28, P390, DOI 10.1042/0300-5127:0280390; Lu CX, 2010, ENDOCRINOLOGY, V151, P1929, DOI 10.1210/en.2009-1017; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Makowski A, 2003, MOL ENDOCRINOL, V17, P273, DOI 10.1210/me.2002-0310; MIYASHITA T, 1995, CELL, V80, P293; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; PARRILLA R, 1991, J CLIN INVEST, V88, P2123, DOI 10.1172/JCI115542; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Qi JS, 1997, MOL CELL BIOL, V17, P7195, DOI 10.1128/MCB.17.12.7195; Ringel MD, 2001, CANCER RES, V61, P6105; Russo D, 2011, J MOL ENDOCRINOL, V46, pR73, DOI 10.1530/JME-10-0150; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Weiss R E, 2000, Rev Endocr Metab Disord, V1, P97, DOI 10.1023/A:1010072605757; Yap N, 1996, P NATL ACAD SCI USA, V93, P4273, DOI 10.1073/pnas.93.9.4273; Ying H, 2003, CANCER RES, V63, P5274; Ying H, 2006, J CLIN INVEST, V116, P2972, DOI 10.1172/JCI28598; Yuan Geng-Biao, 2010, Chin J Cancer, V29, P379; Zhang ZH, 2006, CANCER LETT, V237, P123, DOI 10.1016/j.canlet.2005.05.046	52	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67954	10.1371/journal.pone.0067954	http://dx.doi.org/10.1371/journal.pone.0067954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840792	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400122
J	Hilton, KJ; Cunningham, C; Reynolds, RA; Perry, VH				Hilton, Kathryn J.; Cunningham, Colm; Reynolds, Richard A.; Perry, V. Hugh			Early Hippocampal Synaptic Loss Precedes Neuronal Loss and Associates with Early Behavioural Deficits in Three Distinct Strains of Prion Disease	PLOS ONE			English	Article							PROTEIN EXPRESSION; TRANSGENIC MICE; SCRAPIE; BRAIN; DEGENERATION; PATHOGENESIS; LESIONS; AGENT; MODEL; LOCALIZATION	Prion diseases are fatal neurodegenerative diseases of the CNS that are associated with the accumulation of misfolded cellular prion protein. There are several different strains of prion disease defined by different patterns of tissue vacuolation in the brain and disease time course, but features of neurodegeneration in these strains have not been extensively studied. Our previous studies using the prion strains ME7, 79A and 22L showed that infected mice developed behavioural deficits in the same sequence and temporal pattern despite divergent end-stage neuropathology. Here the objective was to address the hypothesis that synaptic loss would occur early in the disease in all three strains, would precede neuronal death and would be associated with the early behavioural deficits. C57BL/6 mice inoculated with ME7, 79A, or 22L-infected brain homogenates were behaviourally assessed on species typical behaviours previously shown to change during progression and euthanised when all three strains showed statistically significant impairment on these tasks. A decrease in labelling with the presynaptic marker synaptophysin was observed in the stratum radiatum of the hippocampus in all three strains, when compared to control animals. Negligible cell death was seen by TUNEL at this time point. Astrocyte and microglial activation and protease resistant prion protein (PrPSc) deposition were assessed in multiple brain regions and showed some strain specificity but also strongly overlapping patterns. This study shows that despite distinct pathology, multiple strains lead to early synaptic degeneration in the hippocampus, associated with similar behavioural deficits and supports the idea that the initiation of synaptic loss is a primary target of the misfolded prion agent.	[Hilton, Kathryn J.; Reynolds, Richard A.; Perry, V. Hugh] Southampton Gen Hosp, Sch Biol Sci, Southampton SO9 4XY, Hants, England; [Cunningham, Colm] Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland; [Cunningham, Colm] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland	University of Southampton; Trinity College Dublin; Trinity College Dublin	Cunningham, C (corresponding author), Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland.	colm.cunningham@tcd.ie	Perry, V. Hugh/Y-2935-2019; Cunningham, Colm/A-1743-2010	Cunningham, Colm/0000-0003-1423-5209	Medical Research Council [G0301136]; MRC [G0301136] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (http://www.mrc.ac.uk/index.htm), grant G0301136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betmouni S, 1999, NEUROPATH APPL NEURO, V25, P20, DOI 10.1046/j.1365-2990.1999.00153.x; Betmouni S, 1999, PSYCHOBIOLOGY, V27, P63; Bremer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007160; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Caleo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041182; Chiesa R, 2005, P NATL ACAD SCI USA, V102, P238, DOI 10.1073/pnas.0406173102; CLINTON J, 1993, NEUROREPORT, V4, P65, DOI 10.1097/00001756-199301000-00017; Coleman P, 2004, NEUROLOGY, V63, P1155, DOI 10.1212/01.WNL.0000140626.48118.0A; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Combrinck MI, 2001, J NEUROIMMUNOL, V118, P107; Cunningham C, 2005, NEUROBIOL DIS, V18, P258, DOI 10.1016/j.nbd.2004.08.015; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Deacon RMJ, 2001, NEUROREPORT, V12, P2053, DOI 10.1097/00001756-200107030-00052; Ferrer I, 1999, NEUROBIOL DIS, V6, P92, DOI 10.1006/nbdi.1998.0226; Ferrer I, 2000, NEUROSCIENCE, V97, P715, DOI 10.1016/S0306-4522(00)00045-2; Fournier JG, 2000, MICROSC RES TECHNIQ, V50, P76, DOI 10.1002/1097-0029(20000701)50:1<76::AID-JEMT11>3.0.CO;2-#; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Fuhrmann M, 2007, J NEUROSCI, V27, P6224, DOI 10.1523/JNEUROSCI.5062-06.2007; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; Haeberle AM, 2000, MICROSC RES TECHNIQ, V50, P66, DOI 10.1002/1097-0029(20000701)50:1<66::AID-JEMT10>3.0.CO;2-3; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hetherington AW, 1942, AM J PHYSIOL, V136, P609, DOI 10.1152/ajplegacy.1942.136.4.609; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; KIM YS, 1990, ACTA NEUROPATHOL, V80, P388, DOI 10.1007/BF00307692; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; KIMBERLIN RH, 1988, CIBA F SYMP, V135, P37; KITAMOTO T, 1992, AM J PATHOL, V140, P1285; Langevin C, 2011, NEUROBIOL DIS, V41, P219, DOI 10.1016/j.nbd.2010.09.010; Li JY, 2003, TRENDS MOL MED, V9, P414, DOI 10.1016/j.molmed.2003.08.006; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nagao M, 1998, J NEUROPATH EXP NEUR, V57, P329, DOI 10.1097/00005072-199804000-00004; OUTRAM GW, 1973, J COMP PATHOL, V83, P19, DOI 10.1016/0021-9975(73)90023-6; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; SASAKI S, 1994, ACTA NEUROPATHOL, V87, P125; Sikorska B, 2004, INT J BIOCHEM CELL B, V36, P2563, DOI 10.1016/j.biocel.2004.04.014; Sikova Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055004, DOI 10.1371/J0URNAL.P0NE.0055004.PUBMED:23383030]; Siskova Z, 2010, BIOCHEM SOC T, V38, P471, DOI 10.1042/BST0380471; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; Siso S, 2002, ACTA NEUROPATHOL, V103, P615, DOI 10.1007/s00401-001-0512-6; Solomon IH, 2010, CURR ISSUES MOL BIOL, V12, P51; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410	47	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e68062	10.1371/journal.pone.0068062	http://dx.doi.org/10.1371/journal.pone.0068062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840812	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400128
J	Uribe, KB; Etxebarria, A; Martin, C; Ostolaza, H				Uribe, Kepa B.; Etxebarria, Aitor; Martin, Cesar; Ostolaza, Helena			Calpain-Mediated Processing of Adenylate Cyclase Toxin Generates a Cytosolic Soluble Catalytically Active N-Terminal Domain	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; T-CELLS; MEMBRANE; IDENTIFICATION; TRANSLOCATION; CALMODULIN; HEMOLYSIN; CD11B/CD18; ACTIVATION; INHIBITOR	Bordetella pertussis, the whooping cough pathogen, secretes several virulence factors among which adenylate cyclase toxin (ACT) is essential for establishment of the disease in the respiratory tract. ACT weakens host defenses by suppressing important bactericidal activities of the phagocytic cells. Up to now, it was believed that cell intoxication by ACT was a consequence of the accumulation of abnormally high levels of cAMP, generated exclusively beneath the host plasma membrane by the toxin N-terminal catalytic adenylate cyclase (AC) domain, upon its direct translocation across the lipid bilayer. Here we show that host calpain, a calcium-dependent Cys-protease, is activated into the phagocytes by a toxin-triggered calcium rise, resulting in the proteolytic cleavage of the toxin N-terminal domain that releases a catalytically active "soluble AC''. The calpain-mediated ACT processing allows trafficking of the "soluble AC'' domain into subcellular organella. At least two strategic advantages arise from this singular toxin cleavage, enhancing the specificity of action, and simultaneously preventing an indiscriminate activation of cAMP effectors throughout the cell. The present study provides novel insights into the toxin mechanism of action, as the calpain-mediated toxin processing would confer ACT the capacity for a space- and time-coordinated production of different cAMP "pools'', which would play different roles in the cell pathophysiology.	[Ostolaza, Helena] Univ Basque Country, CSIC, Unidad Biofis, Bilbao, Spain; Univ Pais Vasco UPV EHU, Dept Bioquim, Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Ostolaza, H (corresponding author), Univ Basque Country, CSIC, Unidad Biofis, Bilbao, Spain.	gbzoseth@ehu.es	Uribe, Kepa B./AGZ-5717-2022; martin, cesar/L-1303-2014; Uribe, Kepa B./AAC-2163-2019	Uribe, Kepa B./0000-0002-4502-4853; martin, cesar/0000-0002-4087-8729; Uribe, Kepa B./0000-0002-4502-4853; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975	Spanish Ministry of Economy [BFU 2012-36241]; Basque Government (ETORTEK Program); University of Basque Country (UPV/EHU) [UE06/10]	Spanish Ministry of Economy(Spanish Government); Basque Government (ETORTEK Program)(Basque Government); University of Basque Country (UPV/EHU)	This study was supported by grants from the Spanish Ministry of Economy (BFU 2012-36241), the Basque Government (ETORTEK Program), and the University of Basque Country (UPV/EHU, Project UE06/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banoczi Z, 2008, BIOCONJUGATE CHEM, V19, P1375, DOI 10.1021/bc800021y; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; BENZ R, 1994, J BIOL CHEM, V269, P27231; Berkowitz S.A., 1980, ANN NY ACAD SCI, V1, P356, DOI DOI 10.1111/J.1749-6632.1980.TB29626.X6263154; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Eby JC, 2012, INFECT IMMUN, V80, P850, DOI 10.1128/IAI.05979-11; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; FOX JEB, 1991, J BIOL CHEM, V266, P13289; Fukiage C, 1997, BBA-MOL BASIS DIS, V1361, P304, DOI 10.1016/S0925-4439(97)00043-4; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; Gray MC, 2011, CELL MICROBIOL, V13, P123, DOI 10.1111/j.1462-5822.2010.01525.x; Grenfell B, 2011, P NATL ACAD SCI USA, V108, P7279, DOI 10.1073/pnas.1103408108; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; KHELEF N, 1995, FEMS MICROBIOL LETT, V134, P27, DOI 10.1016/0378-1097(95)00375-F; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1988, J BIOL CHEM, V263, P2612; Lee SJ, 1999, INFECT IMMUN, V67, P2090, DOI 10.1128/IAI.67.5.2090-2095.1999; Martin C, 2004, J BACTERIOL, V186, P3760, DOI 10.1128/JB.186.12.3760-3765.2004; Martin C, 2010, J BIOL CHEM, V285, P357, DOI 10.1074/jbc.M109.003491; MELLGREN RL, 1987, FASEB J, V1, P110, DOI 10.1096/fasebj.1.2.2886390; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; MURACHI T, 1989, BIOCHEM INT, V18, P263; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; Paccani SR, 2011, J EXP MED, V208, P1317, DOI 10.1084/jem.20101558; Paccani SR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000325; ROGEL A, 1992, J BIOL CHEM, V267, P22599; Ross PJ, 2004, INFECT IMMUN, V72, P1568, DOI 10.1128/IAI.72.3.1568-1579.2004; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Weingart CL, 2000, INFECT IMMUN, V68, P1735, DOI 10.1128/IAI.68.3.1735-1739.2000; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; YANO Y, 1993, THROMB RES, V71, P385, DOI 10.1016/0049-3848(93)90163-I; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	47	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67648	10.1371/journal.pone.0067648	http://dx.doi.org/10.1371/journal.pone.0067648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840759	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400113
J	Epp, N; Ungermann, C				Epp, Nadine; Ungermann, Christian			The N-Terminal Domains of Vps3 and Vps8 Are Critical for Localization and Function of the CORVET Tethering Complex on Endosomes	PLOS ONE			English	Article							MEMBRANE-FUSION; RAB; YEAST; PROTEINS; SNARE; ENDOCYTOSIS; BIOGENESIS; INTERACTS; HOMOLOG; GTPASE	Endosomal biogenesis depends on multiple fusion and fission events. For fusion, the heterohexameric CORVET complex as an effector of the endosomal Rab5/Vps21 GTPase has a central function in the initial tethering event. Here, we show that the CORVET-specific Vps3 and Vps8 subunits, which interact with Rab5/Vps21, require their N-terminal domains for localization and function. Surprisingly, CORVET may lack either one of the two N-terminal domains, but not both, to promote protein sorting via the endosome. The dually truncated complex mislocalizes to the cytosol and is impaired in endocytic protein sorting, but not in assembly. Furthermore, the endosomal localization can be rescued by overexpression of Vps21 or one of the truncated CORVET subunits, even though CORVET assembly is not impaired by loss of the N-terminal domains or in strains lacking all endosomal Rab5s and Ypt7. We thus conclude that CORVET requires only its C-terminal domains for assembly and has beyond its putative beta-propeller domains additional binding sites for endosomes, which could be important to bind Vps21 and other endosome-specific factors for efficient endosome tethering.	[Epp, Nadine; Ungermann, Christian] Univ Osnabruck, Dept Biol Chem, Biochem Sect, Osnabruck, Germany	University Osnabruck	Ungermann, C (corresponding author), Univ Osnabruck, Dept Biol Chem, Biochem Sect, Osnabruck, Germany.	cu@uos.de			Hans-Muhlenhoff foundation; Sonderforschungsbereich (Collaborative Research Center) 944 (project P11) of the Deutsche Forschungsgemeinschaft (German Research Council)	Hans-Muhlenhoff foundation; Sonderforschungsbereich (Collaborative Research Center) 944 (project P11) of the Deutsche Forschungsgemeinschaft (German Research Council)	This work was supported by the Sonderforschungsbereich (Collaborative Research Center) 944 (project P11) of the Deutsche Forschungsgemeinschaft (German Research Council), and by the Hans-Muhlenhoff foundation (to CU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2010, MOL BIOL CELL, V21, P2756, DOI 10.1091/mbc.E10-02-0119; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Cabrera M, 2013, J BIOL CHEM, V288, P5166, DOI 10.1074/jbc.M112.431536; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Epp N, 2011, EUR J CELL BIOL, V90, P779, DOI 10.1016/j.ejcb.2011.04.007; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James P, 1996, GENETICS, V144, P1425; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Pawelec A, 2010, EUKARYOT CELL, V9, P602, DOI 10.1128/EC.00286-09; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	35	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67307	10.1371/journal.pone.0067307	http://dx.doi.org/10.1371/journal.pone.0067307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840658	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800128
J	Wang, LB; Yuan, C; Lv, KZ; Xie, SD; Fu, PF; Liu, XJ; Chen, YX; Qin, C; Deng, WG; Hu, WX				Wang, Linbo; Yuan, Chao; Lv, Kezhen; Xie, Shuduo; Fu, Peifen; Liu, Xiaojiao; Chen, Yongxia; Qin, Chuan; Deng, Wuguo; Hu, Wenxian			Lin28 Mediates Radiation Resistance of Breast Cancer Cells via Regulation of Caspase, H2A.X and Let-7 Signaling	PLOS ONE			English	Article							STEM-CELLS; RADIORESISTANCE; ACTIVATION; PATHWAY	Resistance to radiation therapy is a major obstacle for the effective treatment of cancers. Lin28 has been shown to contribute to breast tumorigenesis; however, the relationship between Lin28 and radioresistance remains unknown. In this study, we investigated the association of Lin28 with radiation resistance and identified the underlying mechanisms of action of Lin28 in human breast cancer cell lines. The results showed that the expression level of Lin28 was closely associated with resistance to radiation treatment. The T47D cancer cell line, which highly expresses Lin28, is more resistant to radiation than MCF7, Bcap-37 or SK-BR-3 cancer cell lines, which have low-level Lin28 expression. Transfection with Lin28 siRNA significantly led to an increase of sensitivity to radiation. By contrast, stable expression of Lin28 in breast cancer cells effectively attenuated the sensitivity to radiation treatment. Stable expression of Lin28 also significantly inhibited radiation-induced apoptosis. Moreover, further studies have shown that caspases, H2A.X and Let-7 miRNA were the molecular targets of Lin28. Stable expression of Lin28 and treatment with radiation induced H2AX expression, while inhibited p21 and gamma-H2A.X. Overexpression of Let-7 enhanced the sensitivities to radiation in breast cancer cells. Taken together, these results indicate that Lin28 might be one mechanism underlying radiation resistance, and Lin28 could be a potential target for overcoming radiation resistance in breast cancer.	[Wang, Linbo; Yuan, Chao; Xie, Shuduo; Chen, Yongxia; Qin, Chuan; Hu, Wenxian] Zhejiang Univ, Key Lab Biotherapy Zhejiang Prov, Dept Surg Oncol, Sir Run Run Shaw Hosp,Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Lv, Kezhen; Fu, Peifen; Liu, Xiaojiao] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Breast Ctr, Hangzhou, Zhejiang, Peoples R China; [Deng, Wuguo] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Peoples R China; [Deng, Wuguo] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Zhejiang University; Zhejiang University; Dalian Medical University; State Key Lab Oncology South China; Sun Yat Sen University	Hu, WX (corresponding author), Zhejiang Univ, Key Lab Biotherapy Zhejiang Prov, Dept Surg Oncol, Sir Run Run Shaw Hosp,Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	dengwg@hotmail.com; hwx2206@hotmail.com	wang, lin/GSE-3040-2022		Zhejiang National Science Funding [Y2090345]; Qianjiang Talents Program Funding [2010R10065]; National Natural Science Fundation of China [81000996/H1610]; Science Technology Funding [2009C33157]	Zhejiang National Science Funding; Qianjiang Talents Program Funding; National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Funding	This study was supported by grants from the Zhejiang National Science Funding (Y2090345), the Qianjiang Talents Program Funding (2010R10065), the National Natural Science Fundation of China (81000996/H1610), and the Science Technology Funding (2009C33157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Besancon R, 2009, CURR MED CHEM, V16, P394, DOI 10.2174/092986709787315531; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Chakravarti A, 2004, INT J RADIAT ONCOL, V58, P927, DOI 10.1016/j.ijrobp.2003.09.092; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Duru N, 2012, CLIN CANC RES; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Fedrigo CA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-156; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Jiang P, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-100; Liu ZL, 2012, MOL CELL BIOCH; Lv KZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040008; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Pan L, 2011, MOL CELL BIOCHEM, V355, P257, DOI 10.1007/s11010-011-0862-x; Park SH, 2000, RADIAT RES, V154, P421, DOI 10.1667/0033-7587(2000)154[0421:HIRIAW]2.0.CO;2; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Whelan T, 2003, CAN MED ASSOC J, V168, P437; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Zhu Y, 2012, ONCOGENE, V223	21	29	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67373	10.1371/journal.pone.0067373	http://dx.doi.org/10.1371/journal.pone.0067373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840685	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800131
J	Peng, B; Zhu, DW; Ander, BP; Zhang, XS; Xue, FZ; Sharp, FR; Yang, XW				Peng, Bin; Zhu, Dianwen; Ander, Bradley P.; Zhang, Xiaoshuai; Xue, Fuzhong; Sharp, Frank R.; Yang, Xiaowei			An Integrative Framework for Bayesian Variable Selection with Informative Priors for Identifying Genes and Pathways	PLOS ONE			English	Article							CHAIN MONTE-CARLO; MODEL SELECTION; TUMOR CLASSIFICATION; PRIOR DISTRIBUTIONS; LINEAR-MODELS; EXPRESSION; COMPUTATION; PREDICTION; GENOME; CANCER	The discovery of genetic or genomic markers plays a central role in the development of personalized medicine. A notable challenge exists when dealing with the high dimensionality of the data sets, as thousands of genes or millions of genetic variants are collected on a relatively small number of subjects. Traditional gene-wise selection methods using univariate analyses face difficulty to incorporate correlational, structural, or functional structures amongst the molecular measures. For microarray gene expression data, we first summarize solutions in dealing with 'large p, small n' problems, and then propose an integrative Bayesian variable selection (iBVS) framework for simultaneously identifying causal or marker genes and regulatory pathways. A novel partial least squares (PLS) g-prior for iBVS is developed to allow the incorporation of prior knowledge on gene-gene interactions or functional relationships. From the point view of systems biology, iBVS enables user to directly target the joint effects of multiple genes and pathways in a hierarchical modeling diagram to predict disease status or phenotype. The estimated posterior selection probabilities offer probabilitic and biological interpretations. Both simulated data and a set of microarray data in predicting stroke status are used in validating the performance of iBVS in a Probit model with binary outcomes. iBVS offers a general framework for effective discovery of various molecular biomarkers by combining data-based statistics and knowledge-based priors. Guidelines on making posterior inferences, determining Bayesian significance levels, and improving computational efficiencies are also discussed.	[Peng, Bin] Chongqing Med Univ, Dept Hlth Stat, Chongqing, Peoples R China; [Peng, Bin; Yang, Xiaowei] Bayessoft Inc, Div Biostat, Davis, CA USA; [Zhu, Dianwen; Yang, Xiaowei] CUNY Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA; [Ander, Bradley P.; Sharp, Frank R.] Univ Calif Davis, Med Invest Neurodev Disorders MIND Inst, Sacramento, CA 95817 USA; [Zhang, Xiaoshuai; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China	Chongqing Medical University; City University of New York (CUNY) System; Hunter College (CUNY); University of California System; University of California Davis; Shandong University	Yang, XW (corresponding author), Bayessoft Inc, Div Biostat, Davis, CA USA.	dyang@bayessoft.com	Xue, Fuzhong/AAG-4808-2020; Zhang, Xiaoshuai/AAG-7019-2019	Xue, Fuzhong/0000-0003-0378-7956	Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH, USA [5R01HD061404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061404] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research is supported in part by a grant from Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH, USA (5R01HD061404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Annest A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-72; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bayarri MJ, 2012, ANN STAT, V40, P1550, DOI 10.1214/12-AOS1013; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Berger JO, 1996, J AM STAT ASSOC, V91, P109, DOI 10.2307/2291387; Berger JO., 2001, LECT NOTES MONOGRAPH, V38, P135; Brown C.E., 1998, APPL MULTIVARIATE ST, DOI [DOI 10.1007/978-3-642-80328-4_13, 10.1007/978-3-642-80328-4_13]; Cai B, 2008, LECT NOTES STAT, V192, P63; Cano JA, 2008, TEST, V17, P493, DOI 10.1007/s11749-006-0040-8; CASELLA G, 1985, AM STAT, V39, P83, DOI 10.2307/2682801; Chen MH, 2008, BAYESIAN ANAL, V3, P585, DOI 10.1214/08-BA323; Chen RB, 2011, STAT COMPUT, V21, P247, DOI 10.1007/s11222-009-9165-4; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dellaportas P, 1997, HSSS WORKSH VAR DIM; Dettling M, 2004, BIOINFORMATICS, V20, P3583, DOI 10.1093/bioinformatics/bth447; Do KA, 2005, J R STAT SOC C-APPL, V54, P627, DOI 10.1111/j.1467-9876.2005.05593.x; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; George EI, 1997, STAT SINICA, V7, P339; Geweke J., 1996, BAYESIAN STAT, V5, P609; Godsill SJ, 2001, J COMPUT GRAPH STAT, V10, P230, DOI 10.1198/10618600152627924; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Gupta M, 2007, J AM STAT ASSOC, V102, P867, DOI 10.1198/016214507000000068; Hastie T, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-2-RESEARCH0003; Hill SM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-94; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Hoti F, 2006, HEREDITY, V97, P4, DOI 10.1038/sj.hdy.6800817; Ibrahim JG, 2002, J AM STAT ASSOC, V97, P88, DOI 10.1198/016214502753479257; Ishwaran H, 2003, J AM STAT ASSOC, V98, P438, DOI 10.1198/016214503000224; Jain K. K., 2009, TXB PERSONALIZED MED; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kilpikari R, 2003, GENET EPIDEMIOL, V25, P122, DOI 10.1002/gepi.10257; Kitchen CMR, 2007, STAT MED, V26, P975, DOI 10.1002/sim.2595; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lee KE, 2003, BIOINFORMATICS, V19, P90, DOI 10.1093/bioinformatics/19.1.90; Li F, 2010, J AM STAT ASSOC, V105, P1202, DOI 10.1198/jasa.2010.tm08177; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Liang F, 2008, J AM STAT ASSOC, V103, P410, DOI 10.1198/016214507000001337; MADIGAN D, 1994, J AM STAT ASSOC, V89, P1535, DOI 10.2307/2291017; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Mallick B, 2009, BAYESIAN ANAL GENE E, V130; MCCuLLAGH P., 1989, GEN LINEAR MODELS, V37; McLachlan GJ, 2006, BIOINFORMATICS, V22, P1608, DOI 10.1093/bioinformatics/btl148; Meuwissen THE, 2004, GENET SEL EVOL, V36, P261, DOI 10.1051/gse:2004001; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Moreno E, 1998, J AM STAT ASSOC, V93, P1451, DOI 10.2307/2670059; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; NEWTON MA, 2003, ANAL GENE EXPRESSION, P254; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Nott DJ, 2004, J COMPUT GRAPH STAT, V13, P362, DOI 10.1198/1061860043425; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; OHagan A, 1997, TEST, V6, P101, DOI 10.1007/BF02564428; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pancioli AM, 2008, STROKE, V39, P3268, DOI 10.1161/STROKEAHA.108.517656; Perez JM, 2002, BIOMETRIKA, V89, P491, DOI 10.1093/biomet/89.3.491; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Romero P, 2005, GENOME BIOL, V6; Scott JG, 2006, J STAT PLAN INFER, V136, P2144, DOI 10.1016/j.jspi.2005.08.031; Shahbaba B, 2011, J R STAT SOC C-APPL, V60, P541, DOI 10.1111/j.1467-9876.2011.00765.x; Sillanpaa MJ, 2002, TRENDS GENET, V18, P301, DOI 10.1016/S0168-9525(02)02688-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Srivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003860; Stamova B, 2010, STROKE, V41, P2171, DOI 10.1161/STROKEAHA.110.588335; Stingo FC, 2011, ANN APPL STAT, V5, P1978, DOI 10.1214/11-AOAS463; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wei P, 2009, J ROYAL STAT SOC C, V59, P105; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Wong ML, 1997, P NATL ACAD SCI USA, V94, P227, DOI 10.1073/pnas.94.1.227; Wu XL, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-29; Yang AJ, 2010, BIOINFORMATICS, V26, P215, DOI 10.1093/bioinformatics/btp638; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589; Yi NJ, 2004, GENETICS, V167, P967, DOI 10.1534/genetics.104.026286; Yi NJ, 2003, GENETICS, V164, P1129; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zellner, 1986, BAYESIAN INFERENCE D, P233, DOI DOI 10.4236/OJS.2013.34031; Zellner A., 1980, BAYESIAN STAT, V31, P585, DOI [10.1007/BF02888369, DOI 10.1007/BF02888369]; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	91	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67672	10.1371/journal.pone.0067672	http://dx.doi.org/10.1371/journal.pone.0067672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844055	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000091
J	Lim, CH; Lim, W; Jeong, W; Lee, JY; Bae, SM; Kim, J; Han, JY; Bazer, FW; Song, G				Lim, Chul-Hong; Lim, Whasun; Jeong, Wooyoung; Lee, Jin-Young; Bae, Seung-Min; Kim, Jinyoung; Han, Jae Yong; Bazer, Fuller W.; Song, Gwonhwa			Avian WNT4 in the Female Reproductive Tracts: Potential Role of Oviduct Development and Ovarian Carcinogenesis	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; CHICK OVIDUCT; GONADAL DIFFERENTIATION; LAYING CYCLE; CANCER; ESTROGEN; TUMORS; MODEL; TISSUE	The wingless-type MMTV integration site family of proteins (WNTs) is highly conserved secreted lipid-modified signaling molecules that play a variety of pivotal roles in developmental events such as embryogenesis, tissue homeostasis and cell polarity. Although, of these proteins, WNT4 is known to be involved in genital development in fetuses of mammalian species, its role is unknown in avian species. Therefore, in this study, we investigated expression profiles, as well as hormonal and post-transcriptional regulation of WNT4 expression in the reproductive tract of female chickens. Results of this study demonstrated that WNT4 is most abundant in the stromal and luminal epithelial cells of the isthmus and shell gland of the oviduct, respectively. WNT4 is also most abundant in the glandular epithelium of the shell gland of the oviduct of laying hens at 3 h post-ovulation during the laying cycle. In addition, treatment of young chicks with diethylstilbestrol (DES, a synthetic estrogen agonist) stimulated WNT4 only in the glandular epithelial cells of the isthmus and shell gland of the oviduct. Moreover, results of our study demonstrated that miR-1786 influences WNT4 expression via specific binding sites in its 39-UTR. On the other hand, our results also indicate that WNT4 is expressed predominantly in the glandular epithelium of cancerous ovaries, but not in normal ovaries of hens. Collectively, these results indicate cell-specific expression of WNT4 in the reproductive tract of chickens and that it likely has crucial roles in development and function of oviduct as well as initiation of ovarian carcinogenesis in laying hens.	[Lim, Chul-Hong; Lim, Whasun; Jeong, Wooyoung; Lee, Jin-Young; Bae, Seung-Min; Kim, Jinyoung; Han, Jae Yong; Bazer, Fuller W.; Song, Gwonhwa] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Jinyoung] Dankook Univ, Dept Anim Resources Sci, Cheonan, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Song, Gwonhwa] Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea	Seoul National University (SNU); Dankook University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Korea University	Song, G (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	ghsong@korea.ac.kr	Lim, Whasun/AAP-3156-2020; gwonhwa, song/H-3208-2015; Song, Gwonhwa/H-3647-2015; Bazer, Fuller/AAF-4317-2021	Lim, Whasun/0000-0002-1328-0465; Bazer, Fuller/0000-0002-5823-5086	World Class University (WCU) program [R31-10056]; Basic Science Research Program through National Research Foundation of Korea (NRF) [2010-0013078]; Ministry of Education, Science, and Technology; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008142]	World Class University (WCU) program; Basic Science Research Program through National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was funded by the World Class University (WCU) program (R31-10056) and by Basic Science Research Program (2010-0013078) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, and also by a grant from the Next-Generation BioGreen 21 Program (No. PJ008142), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SE, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-100; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Bovicelli A, 2011, J CELL PHYSIOL, V226, P2500, DOI 10.1002/jcp.22662; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; De Menna M, 2013, ONCOGENE, V32, P4110, DOI 10.1038/onc.2012.419; Dougherty DC, 2005, TRENDS ENDOCRIN MET, V16, P414, DOI 10.1016/j.tem.2005.09.001; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; HUGUET EL, 1994, CANCER RES, V54, P2615; Jeong W, 2012, EXP BIOL MED, V237, P758, DOI 10.1258/ebm.2012.011433; Jeong W, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098186; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lavelin I, 2000, POULTRY SCI, V79, P1014, DOI 10.1093/ps/79.7.1014; LEACH RM, 1981, ARCH BIOCHEM BIOPHYS, V207, P353, DOI 10.1016/0003-9861(81)90042-4; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051592; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034215; Lee SI, 2009, POULTRY SCI, V88, P1003, DOI 10.3382/ps.2008-00197; Lim W, 2013, MOL CELL ENDOCRINOL, V366, P1, DOI 10.1016/j.mce.2012.10.031; Lim W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049869; Lim W, 2012, BIOCHEM BIOPH RES CO, V422, P494, DOI 10.1016/j.bbrc.2012.05.026; Lim W, 2012, EXP BIOL MED, V237, P150, DOI 10.1258/ebm.2011.011250; Lim W, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Vinas JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060937; Miyakoshi T, 2009, ACTA HISTOCHEM CYTOC, V42, P205, DOI 10.1267/ahc.09033; Nicol B, 2012, MOL REPROD DEV, V79, P51, DOI 10.1002/mrd.21404; PALMITER RD, 1971, J CELL BIOL, V50, P598, DOI 10.1083/jcb.50.3.598; PALMITER RD, 1972, J BIOL CHEM, V247, P6450; Peltoketo H, 2004, CANCER LETT, V213, P83, DOI 10.1016/j.canlet.2004.02.024; SANDERS MM, 1988, BIOCHEMISTRY-US, V27, P6550, DOI 10.1021/bi00417a053; Song G, 2007, REPRODUCTION, V133, P285, DOI 10.1530/REP-06-0092; Song G, 2011, BIOL REPROD, V85, P306, DOI 10.1095/biolreprod.110.089227; Stammer K, 2008, GYNECOL ONCOL, V109, P115, DOI 10.1016/j.ygyno.2007.12.030; Trevino Lindsey S., 2010, Hormones & Cancer, V1, P177, DOI 10.1007/s12672-010-0024-8; Volkomorov V., 2013, Experimental Oncology, V35, P2; Wang X, 2002, POULTRY SCI, V81, P805, DOI 10.1093/ps/81.6.805	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e65935	10.1371/journal.pone.0065935	http://dx.doi.org/10.1371/journal.pone.0065935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843947	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000008
J	Valencia, M; Artieda, J; Bolam, JP; Mena-Segovia, J				Valencia, Miguel; Artieda, Julio; Bolam, J. Paul; Mena-Segovia, Juan			Dynamic Interaction of Spindles and Gamma Activity during Cortical Slow Oscillations and Its Modulation by Subcortical Afferents	PLOS ONE			English	Article							WAVE SLEEP; CORTICOTHALAMIC FEEDBACK; PEDUNCULOPONTINE NEURONS; NEOCORTICAL NEURONS; CELLULAR MECHANISMS; IN-VITRO; STATES; CORTEX; MEMORY; COHERENCE	Slow oscillations are a hallmark of slow wave sleep. They provide a temporal framework for a variety of phasic events to occur and interact during sleep, including the expression of high-frequency oscillations and the discharge of neurons across the entire brain. Evidence shows that the emergence of distinct high-frequency oscillations during slow oscillations facilitates the communication among brain regions whose activity was correlated during the preceding waking period. While the frequencies of oscillations involved in such interactions have been identified, their dynamics and the correlations between them require further investigation. Here we analyzed the structure and dynamics of these signals in anesthetized rats. We show that spindles and gamma oscillations coexist but have distinct temporal dynamics across the slow oscillation cycle. Furthermore, we observed that spindles and gamma are functionally coupled to the slow oscillations and between each other. Following the activation of ascending pathways from the brainstem by means of a carbachol injection in the pedunculopontine nucleus, we were able to modify the gain in the gamma oscillations that are independent of the spindles while the spindle amplitude was reduced. Furthermore, carbachol produced a decoupling of the gamma oscillations that are dependent on the spindles but with no effect on their amplitude. None of the changes in the high-frequency oscillations affected the onset or shape of the slow oscillations, suggesting that slow oscillations occur independently of the phasic events that coexist with them. Our results provide novel insights into the regulation, dynamics and homeostasis of cortical slow oscillations.	[Valencia, Miguel; Artieda, Julio] Univ Navarra, Neurophysiol Lab, Neurosci Area, Ctr Invest Med Aplicada, E-31080 Pamplona, Spain; [Bolam, J. Paul; Mena-Segovia, Juan] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3QT, England	University of Navarra; University of Oxford	Mena-Segovia, J (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, S Parks Rd, Oxford OX1 3QT, England.	juan.mena-segovia@pharm.ox.ac.uk	Valencia, Miguel/C-3055-2009; Artieda, Julio/L-4704-2014	Valencia, Miguel/0000-0001-5617-5270; Artieda, Julio/0000-0003-0987-0873; Bolam, J Paul/0000-0002-5008-8405; Mena-Segovia, Juan/0000-0002-9991-8254	Medical Research Council United Kingdom; UTE Proyecto Centro de Investigacion Medica Aplicada; Gobierno de Navarra, Education Department, Jeronimo de Ayanz Programme; Spanish Ministry of Science and Innovation, Juan de la Cierva Programme [JCI-2010-07876]; MRC [MC_U138164490] Funding Source: UKRI; Medical Research Council [MC_U138164490] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UTE Proyecto Centro de Investigacion Medica Aplicada; Gobierno de Navarra, Education Department, Jeronimo de Ayanz Programme; Spanish Ministry of Science and Innovation, Juan de la Cierva Programme(Ministry of Science and Innovation, Spain (MICINN)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council United Kingdom and the UTE Proyecto Centro de Investigacion Medica Aplicada. MV and JM-S acknowledge financial support from the Gobierno de Navarra, Education Department, Jeronimo de Ayanz Programme. MV acknowledges financial support from the Spanish Ministry of Science and Innovation, Juan de la Cierva Programme Ref. JCI-2010-07876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub A, 2012, NEUROIMAGE, V59, P1491, DOI 10.1016/j.neuroimage.2011.08.023; Bonjean M, 2011, J NEUROSCI, V31, P9124, DOI 10.1523/JNEUROSCI.0077-11.2011; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Compte A, 2008, J NEUROSCI, V28, P13828, DOI 10.1523/JNEUROSCI.2684-08.2008; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Cox R, 2012, LEARN MEMORY, V19, P264, DOI 10.1101/lm.026252.112; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Eschenko O, 2012, CEREB CORTEX, V22, P426, DOI 10.1093/cercor/bhr121; Fuentealba P, 2004, P NATL ACAD SCI USA, V101, P9816, DOI 10.1073/pnas.0402761101; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; Le Van Quyen M, 2010, J NEUROSCI, V30, P7770, DOI 10.1523/JNEUROSCI.5049-09.2010; Magill PJ, 2000, J NEUROSCI, V20, P820, DOI 10.1523/JNEUROSCI.20-02-00820.2000; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mena-Segovia J, 2008, J PHYSIOL-LONDON, V586, P2947, DOI 10.1113/jphysiol.2008.153874; Mena-Segovia J, 2011, PROG BRAIN RES, V193, P85, DOI 10.1016/B978-0-444-53839-0.00006-5; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, P119; Poil SS, 2008, HUM BRAIN MAPP, V29, P770, DOI 10.1002/hbm.20590; Ros H, 2010, NEUROSCIENCE, V170, P78, DOI 10.1016/j.neuroscience.2010.06.068; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schweimer JV, 2011, NEUROSCIENCE, V196, P115, DOI 10.1016/j.neuroscience.2011.08.072; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 1996, P NATL ACAD SCI USA, V93, P2533, DOI 10.1073/pnas.93.6.2533; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; van Albada SJ, 2007, J NEUROSCI METH, V161, P205, DOI 10.1016/j.jneumeth.2006.11.004; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011	36	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67540	10.1371/journal.pone.0067540	http://dx.doi.org/10.1371/journal.pone.0067540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844020	Green Published, gold			2022-12-27	WOS:000321341000050
J	Wang, JG; Kuai, XC; Ren, BQ; Gong, GF; Zhou, XM				Wang, Jian-Gang; Kuai, Xing-Cheng; Ren, Bi-Qiao; Gong, Guang-Fu; Zhou, Xin-Min			Reduced Leaflet Stress in the Stentless Quadrileaflet Mitral Valve: A Finite Element Model	PLOS ONE			English	Article							FOLLOW-UP; PORCINE; HEART; CALCIFICATION; BOVINE; REPLACEMENT; BIOPROSTHESIS; DEGENERATION; EXPERIENCE; FATIGUE	Background: Failure of bioprosthetics is usually caused by calcification of the leaflets as a consequence of high tensile stresses. The stentless valve resembles native mitral valve anatomy, has a flexible leaflet attachment and a suspension at the papillary muscles, and preserves annuloventricular continuity. In this study, the effects of the stentless valve design on leaflet stress were investigated with a finite element model. Methods: Finite element models of the stentless quadrileaflet mitral valve were created in the close and open configurations. The geometry of the stented trileaflet mitral valve was also analyzed for comparative purposes. Under the designated pressures, the regional stresses were evaluated, and the distributions of stresses were assessed. Results: Regardless of whether the valve is in the open or close configuration, the maximum first principal stress was significantly lower in the stentless valve than in the stented valve. For the stentless valves, limited stress concentration was discretely distributed in the papillary flaps under both close and open conditions. In contrast, in the stented valve, increased stress concentration was evident at the central belly under the open condition and at the commissural attachment under close condition. In either configuration, the maximum second principal stress was markedly lower in the stentless valve than in the stented valve. Conclusions: The stentless valve was associated with a significant reduction in leaflet stress and a more homogeneous stress distribution compared to the stented valve. These findings are consistent with recent reports of the clinical effectiveness of the stentless quadrileaflet mitral valve.	[Wang, Jian-Gang] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Kuai, Xing-Cheng; Ren, Bi-Qiao] Hunan Univ, Dept Engn Mech, Changsha 410082, Hunan, Peoples R China; [Gong, Guang-Fu; Zhou, Xin-Min] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China	Capital Medical University; Hunan University; Central South University	Wang, JG (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	wangjiangang7545@126.com	wang, jian/GVS-0711-2022					Aldous IG, 2009, AM J PHYSIOL-HEART C, V296, pH1898, DOI 10.1152/ajpheart.01173.2008; Askeland D.R., 2006, SCI ENG MAT, V5th, P198; Aybek T, 2000, J HEART VALVE DIS, V9, P667; Bathe KJ, 1999, COMPUT STRUCT, V72, P1, DOI 10.1016/S0045-7949(99)00042-5; Bourguignon T, 2011, J HEART VALVE DIS, V20, P673; Cacciola G, 2000, J BIOMECH, V33, P521, DOI 10.1016/S0021-9290(99)00222-5; Conti CA, 2010, J THORAC CARDIOV SUR, V140, P890, DOI 10.1016/j.jtcvs.2010.01.016; Hofmann B, 2001, ANN THORAC SURG, V71, pS323, DOI 10.1016/S0003-4975(01)02544-9; Jamieson WRE, 2011, J THORAC CARDIOV SUR, V141, P1449, DOI 10.1016/j.jtcvs.2010.05.055; Jorge-Herrero E, 2010, ARTIF ORGANS, V34, pE168, DOI 10.1111/j.1525-1594.2009.00978.x; Lehmann S, 2004, J HEART VALVE DIS, V13, P410; Middlemost S J, 1999, Semin Thorac Cardiovasc Surg, V11, P183; Middlemost SJ, 2003, J HEART VALVE DIS, V12, P758; Middlemost SJ, 1999, J HEART VALVE DIS, V8, P180; MILANO A, 1984, AM J CARDIOL, V53, P1066, DOI 10.1016/0002-9149(84)90638-6; Mirnajafi A, 2010, J BIOMED MATER RES A, V94A, P205, DOI 10.1002/jbm.a.32659; Raghavan D, 2010, J BIOMED MATER RES B, V92B, P168, DOI 10.1002/jbm.b.31503; Simionescu DT, 2003, J HEART VALVE DIS, V12, P226; Sinha P, 2012, J THORAC CARDIOV SUR, V143, P224, DOI 10.1016/j.jtcvs.2011.09.043; Srivatsa SS, 1997, J CLIN INVEST, V99, P996, DOI 10.1172/JCI119265; Stevanella M, 2010, MED ENG PHYS, V32, P1213, DOI 10.1016/j.medengphy.2010.08.013; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Vrandecic M, 1997, EUR J CARDIO-THORAC, V12, P56, DOI 10.1016/S1010-7940(97)01221-9; Walther T, 1999, THORAC CARDIOV SURG, V47, P357, DOI 10.1055/s-2007-1013174; Whitlock RP, 2012, CHEST, V141, pE576S, DOI 10.1378/chest.11-2305; Xu C, 2012, ANN THORAC SURG, V93, P1141, DOI 10.1016/j.athoracsur.2012.01.069; Zuppiroli A, 1998, AM J CARDIOL, V82, P823, DOI 10.1016/S0002-9149(98)00454-8	27	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67683	10.1371/journal.pone.0067683	http://dx.doi.org/10.1371/journal.pone.0067683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844060	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000074
J	Xie, L; Zhu, D; Kang, YH; Liang, T; He, Y; Gaisano, HY				Xie, Li; Zhu, Dan; Kang, Youhou; Liang, Tao; He, Yu; Gaisano, Herbert Y.			Exocyst Sec5 Regulates Exocytosis of Newcomer Insulin Granules Underlying Biphasic Insulin Secretion	PLOS ONE			English	Article							CALCIUM-CHANNELS; RALA GTPASE; BETA-CELLS; SUBUNIT; COMPLEX; GLUCOSE; FUSION; STIMULATION; SYNCOLLIN; MUNC13-1	The exocyst complex subunit Sec5 is a downstream effector of RalA-GTPase which promotes RalA-exocyst interactions and exocyst assembly, serving to tether secretory granules to docking sites on the plasma membrane. We recently reported that RalA regulates biphasic insulin secretion in pancreatic islet beta cells in part by tethering insulin secretory granules to Ca2+ channels to assist excitosome assembly. Here, we assessed beta cell exocytosis by patch clamp membrane capacitance measurement and total internal reflection fluorescence microscopy to investigate the role of Sec5 in regulating insulin secretion. Sec5 is present in human and rodent islet beta cells, localized to insulin granules. Sec5 protein depletion in rat INS-1 cells inhibited depolarization-induced release of primed insulin granules from both readily-releasable pool and mobilization from the reserve pool. This reduction in insulin exocytosis was attributed mainly to reduction in recruitment and exocytosis of newcomer insulin granules that undergo minimal docking time at the plasma membrane, but which encompassed a larger portion of biphasic glucose stimulated insulin secretion. Sec5 protein knockdown had little effect on predocked granules, unless vigorously stimulated by KCl depolarization. Taken together, newcomer insulin granules in beta cells are more sensitive than predocked granules to Sec5 regulation.	[Xie, Li; Zhu, Dan; Kang, Youhou; Liang, Tao; He, Yu; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto	Gaisano, HY (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes for Health Research [MOP 86544]; Canadian Diabetes Association	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported by a grant from the Canadian Institutes for Health Research (MOP 86544) to Herbert Gaisano, and a postdoctoral fellowship from the Canadian Diabetes Association to Li Xie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Beronja S, 2005, J CELL BIOL, V169, P635, DOI 10.1083/jcb.200410081; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Fernandez NA, 2011, AM J PHYSIOL-CELL PH, V300, pC1513, DOI 10.1152/ajpcell.00433.2010; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Gaisano HY, 2012, DIABETOLOGIA, V55, P877, DOI 10.1007/s00125-012-2483-7; Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hays LB, 2005, J ENDOCRINOL, V185, P57, DOI 10.1677/joe.1.05934; Hazelett CC, 2011, MOL BIOL CELL, V22, P4787, DOI 10.1091/mbc.E11-07-0657; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; Kowluru A, 1996, J CLIN INVEST, V98, P540, DOI 10.1172/JCI118822; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lam P, 2013, DIABETES; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Ljubicic S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007770; Lopez JA, 2008, J BIOL CHEM, V283, P17939, DOI 10.1074/jbc.M800321200; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Proks P, 1996, J PHYSIOL-LONDON, V496, P255, DOI 10.1113/jphysiol.1996.sp021682; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tse FW, 2000, J PHYSIOL-LONDON, V526, P99, DOI 10.1111/j.1469-7793.2000.00099.x; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Whyte JRC, 2002, J CELL SCI, V115, P2627; Xie L, 2012, DIABETOLOGIA, V55, P2693, DOI 10.1007/s00125-012-2640-z; Xie L, 2013, TRAFFIC, V14, P428, DOI 10.1111/tra.12047; Zhu D, 2013, DIABETOLOGIA, V56, P359, DOI 10.1007/s00125-012-2757-0; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	44	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67561	10.1371/journal.pone.0067561	http://dx.doi.org/10.1371/journal.pone.0067561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844030	Green Submitted, gold, Green Published			2022-12-27	WOS:000321341000058
J	Cheadle, GA; Costantini, TW; Lopez, N; Bansal, V; Eliceiri, BP; Coimbra, R				Cheadle, Gerald A.; Costantini, Todd W.; Lopez, Nicole; Bansal, Vishal; Eliceiri, Brian P.; Coimbra, Raul			Enteric Glia Cells Attenuate Cytomix-Induced Intestinal Epithelial Barrier Breakdown	PLOS ONE			English	Article							NERVE-STIMULATION PROTECTS; TIGHT JUNCTION STRUCTURE; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; S-NITROSYLATION; BURN-INJURY; PERMEABILITY; GUT; KINASE; ACTIVATION	Background: Intestinal barrier failure may lead to systemic inflammation and distant organ injury in patients following severe injury. Enteric glia cells (EGCs) have been shown to play an important role in maintaining gut barrier integrity through secretion of S-Nitrosoglutathione (GSNO). We have recently shown than Vagal Nerve Stimulation (VNS) increases EGC activation, which was associated with improved gut barrier integrity. Thus, we sought to further study the mechanism by which EGCs prevent intestinal barrier breakdown utilizing an in vitro model. We postulated that EGCs, through the secretion of GSNO, would improve intestinal barrier function through improved expression and localization of intestinal tight junction proteins. Methods: Epithelial cells were co-cultured with EGCs or incubated with GSNO and exposed to Cytomix (TNF-alpha, INF-gamma, IL-1 beta) for 24 hours. Barrier function was assessed by permeability to 4kDa FITC-Dextran. Changes in tight junction proteins ZO-1, occludin, and phospho-MLC (P-MLC) were assessed by immunohistochemistry and immunoblot. Key Results: Co-culture of Cytomix-stimulated epithelial monolayers with EGCs prevented increases in permeability and improved expression and localization of occludin, ZO-1, and P-MLC. Further, treatment of epithelial monolayers with GSNO also prevented Cytomix-induced increases in permeability and exhibited a similar improvement in expression and localization of occludin, ZO-1, and P-MLC. Conclusions & Inferences: The addition of EGCs, or their secreted mediator GSNO, prevents epithelial barrier failure after injury and improved expression of tight junction proteins. Thus, therapies that increase EGC activation, such as VNS, may be a novel strategy to limit barrier failure in patients following severe injury.	[Cheadle, Gerald A.; Costantini, Todd W.; Lopez, Nicole; Bansal, Vishal; Eliceiri, Brian P.; Coimbra, Raul] Univ Calif San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA USA	University of California System; University of California San Diego	Coimbra, R (corresponding author), Univ Calif San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020; Lopez, Nicole/GZL-3059-2022	Coimbra, Raul/0000-0002-3759-6851; Lopez, Nicole/0000-0002-4807-7360; Eliceiri, Brian/0000-0003-1811-1916; Costantini, Todd/0000-0002-0215-5327	American Association for the Surgery of Trauma (AAST) Research and Education Foundation Scholarship	American Association for the Surgery of Trauma (AAST) Research and Education Foundation Scholarship	This work was supported by the American Association for the Surgery of Trauma (AAST) Research and Education Foundation Scholarship (TWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Boivin MA, 2007, AM J PHYSIOL-GASTR L, V292, pG590, DOI 10.1152/ajpgi.00252.2006; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chavez AM, 1999, CRIT CARE MED, V27, P2246, DOI 10.1097/00003246-199910000-00030; Conlin VS, 2009, AM J PHYSIOL-GASTR L, V297, pG735, DOI 10.1152/ajpgi.90551.2008; Costantini TW, 2012, AM J PATHOL, V181, P478, DOI 10.1016/j.ajpath.2012.04.005; Costantini TW, 2010, AM J PHYSIOL-GASTR L, V299, pG1308, DOI 10.1152/ajpgi.00156.2010; Costantini TW, 2010, J TRAUMA, V68, P1349, DOI 10.1097/TA.0b013e3181dccea0; Costantini TW, 2009, J TRAUMA, V67, P1162, DOI 10.1097/TA.0b013e3181ba3577; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Costantini TW, 2009, J TRAUMA, V66, P17, DOI 10.1097/TA.0b013e318191bb1f; Costantini TW, 2009, LIFE SCI, V84, P18, DOI 10.1016/j.lfs.2008.10.007; Deitch EA, 2004, CRIT CARE MED, V32, P533, DOI 10.1097/01.CCM.0000109773.00644.F4; Flamant M, 2011, GUT, V60, P473, DOI 10.1136/gut.2010.229237; Hollander D, 2003, J Physiol Pharmacol, V54 Suppl 4, P183; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Krzyzaniak M, 2011, J TRAUMA, V70, P1168, DOI 10.1097/TA.0b013e318216f754; Krzyzaniak MJ, 2011, SURGERY, V150, P379, DOI 10.1016/j.surg.2011.06.008; MacEachern SJ, 2011, J PHYSIOL-LONDON, V589, P3333, DOI 10.1113/jphysiol.2011.207902; MADARA JL, 1987, AM J PHYSIOL, V253, pC854, DOI 10.1152/ajpcell.1987.253.6.C854; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Musch MW, 2006, AM J PHYSIOL-GASTR L, V290, pG222, DOI 10.1152/ajpgi.00301.2005; Neunlist M, 2008, J INTERN MED, V263, P577, DOI 10.1111/j.1365-2796.2008.01963.x; Neunlist M, 2007, AM J PHYSIOL-GASTR L, V292, pG231, DOI 10.1152/ajpgi.00276.2005; Neunlist M, 2003, AM J PHYSIOL-GASTR L, V285, pG1028, DOI 10.1152/ajpgi.00066.2003; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Ruhl A, 2004, NEUROGASTROENT MOTIL, V16, P44, DOI 10.1111/j.1743-3150.2004.00474.x; Samonte VA, 2004, CRIT CARE MED, V32, P2267, DOI 10.1097/01.CCM.0000145579.66001.05; Savidge TC, 2007, LAB INVEST, V87, P731, DOI 10.1038/labinvest.3700600; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Van Landeghem L, 2011, AM J PHYSIOL-GASTR L, V300, pG976, DOI 10.1152/ajpgi.00427.2010; Van Landeghem L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-507; Wang Q, 2008, SHOCK, V29, P531, DOI 10.1097/SHK.0b013e318150737f	40	42	43	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e69042	10.1371/journal.pone.0069042	http://dx.doi.org/10.1371/journal.pone.0069042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840906	Green Submitted, Green Published, gold			2022-12-27	WOS:000321271900045
J	Shepard, BD; Natarajan, N; Protzko, RJ; Acres, OW; Pluznick, JL				Shepard, Blythe D.; Natarajan, Niranjana; Protzko, Ryan J.; Acres, Omar W.; Pluznick, Jennifer L.			A Cleavable N-Terminal Signal Peptide Promotes Widespread Olfactory Receptor Surface Expression in HEK293T Cells	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; ODORANT RECEPTORS; TRAFFICKING; IDENTIFICATION; DEGRADATION; ACTIVATION; LIGANDS; FAMILY; MOR23	Olfactory receptors (ORs) are G protein-coupled receptors that detect odorants in the olfactory epithelium, and comprise the largest gene family in the genome. Identification of OR ligands typically requires OR surface expression in heterologous cells; however, ORs rarely traffic to the cell surface when exogenously expressed. Therefore, most ORs are orphan receptors with no known ligands. To date, studies have utilized non-cleavable rhodopsin (Rho) tags and/or chaperones (i.e. Receptor Transporting Protein, RTP1S, Ric8b and G(aolf)) to improve surface expression. However, even with these tools, many ORs still fail to reach the cell surface. We used a test set of fifteen ORs to examine the effect of a cleavable leucine-rich signal peptide sequence (Lucy tag) on OR surface expression in HEK293T cells. We report here that the addition of the Lucy tag to the N-terminus increases the number of ORs reaching the cell surface to 7 of the 15 ORs (as compared to 3/15 without Rho or Lucy tags). Moreover, when ORs tagged with both Lucy and Rho were co-expressed with previously reported chaperones (RTP1S, Ric8b and Gaolf), we observed surface expression for all 15 receptors examined. In fact, two-thirds of Lucy-tagged ORs are able to reach the cell surface synergistically with chaperones even when the Rho tag is removed (10/15 ORs), allowing for the potential assessment of OR function with only an 8-amino acid Flag tag on the mature protein. As expected for a signal peptide, the Lucy tag was cleaved from the mature protein and did not alter OR-ligand binding and signaling. Our studies demonstrate that widespread surface expression of ORs can be achieved in HEK293T cells, providing promise for future large-scale deorphanization studies.	[Shepard, Blythe D.; Natarajan, Niranjana; Protzko, Ryan J.; Acres, Omar W.; Pluznick, Jennifer L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Pluznick, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	Jpluznick@jhmi.edu		Shepard, Blythe/0000-0001-6194-5268	National Institutes of Health [R00-DK081610, F32-DK096780]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK096780, R00DK081610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by grants from the National Institutes of Health (R00-DK081610 awarded to JLP and F32-DK096780 awarded to BDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alken M, 2009, MOL PHARMACOL, V75, P801, DOI 10.1124/mol.108.051581; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bush CF, 2008, CELL MOL LIFE SCI, V65, P2289, DOI 10.1007/s00018-008-8028-z; Chan DV, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-27; Chapin HC, 2009, METHOD CELL BIOL, V94, P223, DOI 10.1016/S0091-679X(08)94011-5; Dunham JH, 2009, TRENDS BIOTECHNOL, V27, P541, DOI 10.1016/j.tibtech.2009.06.005; Gaillard I, 2002, EUR J NEUROSCI, V15, P409, DOI 10.1046/j.0953-816x.2001.01871.x; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Hall RA, 2009, ANN NY ACAD SCI, V1170, P147, DOI 10.1111/j.1749-6632.2009.03879.x; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lu M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-34; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Matsunami H, 2009, ANN NY ACAD SCI, V1170, P153, DOI 10.1111/j.1749-6632.2009.03888.x; McClintock TS, 2003, NEUROREPORT, V14, P1547, DOI 10.1097/00001756-200308260-00001; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Pavlath GK, 2010, CELL ADHES MIGR, V4, P502, DOI 10.4161/cam.4.4.12291; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Schulein R, 2012, EUR J CELL BIOL, V91, P294, DOI 10.1016/j.ejcb.2011.02.006; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Spehr M, 2006, MOL CELL ENDOCRINOL, V250, P128, DOI 10.1016/j.mce.2005.12.035; Touhara K, 2007, NEUROCHEM INT, V51, P132, DOI 10.1016/j.neuint.2007.05.020; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wu LF, 2012, J BIOL CHEM, V287, P22287, DOI 10.1074/jbc.M112.345884; Zampatis DE, 2012, FEBS LETT, V586, P2351, DOI 10.1016/j.febslet.2012.05.042; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	43	49	53	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68758	10.1371/journal.pone.0068758	http://dx.doi.org/10.1371/journal.pone.0068758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840901	gold, Green Submitted, Green Published			2022-12-27	WOS:000321271900040
J	Lambeth, LS; Cummins, D; Doran, TJ; Sinclair, AH; Smith, CA				Lambeth, Luke S.; Cummins, DavidM.; Doran, Timothy J.; Sinclair, Andrew H.; Smith, Craig A.			Overexpression of Aromatase Alone is Sufficient for Ovarian Development in Genetically Male Chicken Embryos	PLOS ONE			English	Article							HENNY-FEATHERING TRAIT; SEX DETERMINATION; GONADAL DEVELOPMENT; ESTROGEN-RECEPTOR; INHIBITOR DEVELOPMENT; MESSENGER-RNA; EXPRESSION; GENE; SEBRIGHT; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE	Estrogens play a key role in sexual differentiation of both the gonads and external traits in birds. The production of estrogen occurs via a well-characterised steroidogenic pathway, which is a multi-step process involving several enzymes, including cytochrome P450 aromatase. In chicken embryos, the aromatase gene (CYP19A1) is expressed female-specifically from the time of gonadal sex differentiation. To further explore the role of aromatase in sex determination, we ectopically delivered this enzyme using the retroviral vector RCASBP in ovo. Aromatase overexpression in male chicken embryos induced gonadal sex-reversal characterised by an enlargement of the left gonad and development of ovarian structures such as a thickened outer cortex and medulla with lacunae. In addition, the expression of key male gonad developmental genes (DMRT1, SOX9 and Anti-Mullerian hormone (AMH)) was suppressed, and the distribution of germ cells in sex-reversed males followed the female pattern. The detection of SCP3 protein in late stage sex-reversed male embryonic gonads indicated that these genetically male germ cells had entered meiosis, a process that normally only occurs in female embryonic germ cells. This work shows for the first time that the addition of aromatase into a developing male embryo is sufficient to direct ovarian development, suggesting that male gonads have the complete capacity to develop as ovaries if provided with aromatase.	[Lambeth, Luke S.; Sinclair, Andrew H.; Smith, Craig A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Sinclair, Andrew H.; Smith, Craig A.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Lambeth, Luke S.; Cummins, DavidM.; Doran, Timothy J.; Sinclair, Andrew H.; Smith, Craig A.] Poultry Cooperat Res Ctr, Armidale, NSW, Australia; [Cummins, DavidM.; Doran, Timothy J.] CSIRO Anim Food & Hlth Sci, Australian Anim Hlth Lab, Geelong, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lambeth, LS (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	luke.lambeth@mcri.edu.au	Sinclair, Andrew H/A-3598-2010; Doran, Timothy J/B-3824-2011	Sinclair, Andrew H/0000-0003-2741-7992; Doran, Timothy J/0000-0002-9716-5148; Smith, Craig/0000-0002-1670-5545	Australian Research Council (ARC); Australian Government's Cooperative Research Centres Program	Australian Research Council (ARC)(Australian Research Council); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by an Australian Research Council (ARC) Future Fellowship awarded to CAS. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank collaborators Jim McKay, Scott Tyack, and Ton Schat for their input and guidance throughout this study. Also, the technical assistance and useful discussions with Kelly Roeszler, Thomas Ohnesorg, Yu Cao and Katie Ayers were greatly appreciated. This research was partly conducted within the Poultry CRC, established and supported under the Australian Government's Cooperative Research Centres Program.	Andrews JE, 1997, GEN COMP ENDOCR, V108, P182, DOI 10.1006/gcen.1997.6978; Ayers KL, 2013, GENOME BIOL IN PRESS; Bruggeman V, 2002, COMP BIOCHEM PHYS A, V131, P839, DOI 10.1016/S1095-6433(02)00022-3; Burke WH, 1999, POULTRY SCI, V78, P1019, DOI 10.1093/ps/78.7.1019; Chue J, 2011, FEBS J, V278, P1027, DOI 10.1111/j.1742-4658.2011.08032.x; Clinton M, 1998, J EXP ZOOL, V281, P457, DOI 10.1002/(SICI)1097-010X(19980801)281:5&lt;457::AID-JEZ10&gt;3.0.CO;2-6; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Etches RJ, 1997, PERSPECTIVES AVIAN E, P57; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; GEORGE FW, 1990, J HERED, V81, P107, DOI 10.1093/oxfordjournals.jhered.a110938; George MM, 2010, HORM RES PAEDIAT, V74, P229, DOI 10.1159/000318004; Govoroun MS, 2004, DEV DYNAM, V231, P859, DOI 10.1002/dvdy.20189; Hong YY, 2011, MOL CELL ENDOCRINOL, V340, P120, DOI 10.1016/j.mce.2010.09.012; Hudson QJ, 2005, DEV DYNAM, V233, P1052, DOI 10.1002/dvdy.20388; Kent J, 1996, DEVELOPMENT, V122, P2813; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Marchais-Oberwinkler S, 2011, J STEROID BIOCHEM, V125, P66, DOI 10.1016/j.jsbmb.2010.12.013; MATSUMINE H, 1990, MOL ENDOCRINOL, V4, P905, DOI 10.1210/mend-4-6-905; MATSUMINE H, 1991, J BIOL CHEM, V266, P19900; MCPHAUL MJ, 1988, J BIOL CHEM, V263, P16358; Nakabayashi O, 1998, J MOL ENDOCRINOL, V20, P193, DOI 10.1677/jme.0.0200193; Nomura O, 1999, J STEROID BIOCHEM, V71, P103, DOI 10.1016/S0960-0760(99)00127-2; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; SCHEIB D, 1983, DIFFERENTIATION, V23, pS87; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Smith CA, 2003, BIOL REPROD, V68, P560, DOI 10.1095/biolreprod.102.007294; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; Smith CA, 2009, DIFFERENTIATION, V77, P473, DOI 10.1016/j.diff.2009.02.001; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Vaillant S, 2001, J EXP ZOOL, V290, P727, DOI 10.1002/jez.1123; Wajima Y, 1999, GENE, V233, P75, DOI 10.1016/S0378-1119(99)00154-7	36	54	56	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68362	10.1371/journal.pone.0068362	http://dx.doi.org/10.1371/journal.pone.0068362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840850	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400192
J	Lui, LL; Bourne, JA; Rosa, MGP				Lui, Leo L.; Bourne, James A.; Rosa, Marcello G. P.			Relationship between Size Summation Properties, Contrast Sensitivity and Response Latency in the Dorsomedial and Middle Temporal Areas of the Primate Extrastriate Cortex	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; MONKEY STRIATE CORTEX; NEW-WORLD MONKEYS; LATERAL GENICULATE-NUCLEUS; MACAQUE V1 NEURONS; CALLITHRIX-JACCHUS; OWL MONKEY; SPATIAL SUMMATION; RECEPTIVE-FIELDS; ORIENTATION SELECTIVITY	Analysis of the physiological properties of single neurons in visual cortex has demonstrated that both the extent of their receptive fields and the latency of their responses depend on stimulus contrast. Here, we explore the question of whether there are also systematic relationships between these response properties across different cells in a neuronal population. Single unit recordings were obtained from the middle temporal (MT) and dorsomedial (DM) extrastriate areas of anaesthetized marmoset monkeys. For each cell, spatial integration properties (length and width summation, as well as the presence of end-and side-inhibition within 15 degrees of the receptive field centre) were determined using gratings of optimal direction of motion and spatial and temporal frequencies, at 60% contrast. Following this, contrast sensitivity was assessed using gratings of near-optimal length and width. In both areas, we found a relationship between spatial integration and contrast sensitivity properties: cells that summated over smaller areas of the visual field, and cells that displayed response inhibition at larger stimulus sizes, tended to show higher contrast sensitivity. In a sample of MT neurons, we found that cells showing longer latency responses also tended to summate over larger expanses of visual space in comparison with neurons that had shorter latencies. In addition, longer-latency neurons also tended to show less obvious surround inhibition. Interestingly, all of these effects were stronger and more consistent with respect to the selectivity for stimulus width and strength of side-inhibition than for length selectivity and end-inhibition. The results are partially consistent with a hierarchical model whereby more extensive receptive fields require convergence of information from larger pools of "feedforward'' afferent neurons to reach near-optimal responses. They also suggest that a common gain normalization mechanism within MT and DM is involved, the spatial extent of which is more evident along the cell's preferred axis of motion.	[Lui, Leo L.; Bourne, James A.; Rosa, Marcello G. P.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Lui, Leo L.; Rosa, Marcello G. P.] Monash Univ, Monash Vis Grp, Clayton, Vic, Australia; [Bourne, James A.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia	Monash University; Monash University; Australian Regenerative Medicine Institute; Monash University	Lui, LL (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.	Leo.Lui@monash.edu	Rosa, Marcello G/D-9278-2013; Bourne, James/B-5265-2018	Rosa, Marcello G/0000-0002-6620-6285; Bourne, James/0000-0002-0902-3108	Australian Research Council [DP0878965]; Bionic Vision Sciences and Technology Initiative [SR100006]; National Health and Medical Research Council [491022]; CJ Martin Biomedical Fellowship [490908]; National Health and Medical Council of Australia	Australian Research Council(Australian Research Council); Bionic Vision Sciences and Technology Initiative; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CJ Martin Biomedical Fellowship; National Health and Medical Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian Research Council, www.arc.gov.au, (Grant DP0878965); Bionic Vision Sciences and Technology Initiative (SR100006); and by the National Health and Medical Research Council, www.nhmrc.gov.au, (Grant 491022). LL was funded by CJ Martin Biomedical Fellowship (490908) awarded by the National Health and Medical Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLMAN JM, 1975, BRAIN RES, V100, P473, DOI 10.1016/0006-8993(75)90153-5; Anderson JS, 2001, J NEUROSCI, V21, P2104, DOI 10.1523/JNEUROSCI.21-06-02104.2001; Angelucci A, 2002, J NEUROSCI, V22, P8633; BAKER JF, 1981, J NEUROPHYSIOL, V45, P397, DOI 10.1152/jn.1981.45.3.397; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bourne JA, 2004, EUR J NEUROSCI, V19, P169, DOI 10.1111/j.1460-9568.2004.03082.x; Bourne JA, 2003, BRAIN RES PROTOC, V11, P168, DOI 10.1016/S1385-299X(03)00044-8; Bourne JA, 2002, CEREB CORTEX, V12, P1132, DOI 10.1093/cercor/12.11.1132; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; EDWARDS DP, 1995, VISION RES, V35, P1501, DOI 10.1016/0042-6989(94)00253-I; Elston GN, 1997, CEREB CORTEX, V7, P432, DOI 10.1093/cercor/7.5.432; Gallyas F, 1979, Neurol Res, V1, P203; HAWKEN MJ, 1984, EXP BRAIN RES, V54, P367; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; LEE BB, 1981, J NEUROPHYSIOL, V45, P807, DOI 10.1152/jn.1981.45.5.807; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Lui LL, 2007, EUR J NEUROSCI, V25, P1780, DOI 10.1111/j.1460-9568.2007.05453.x; Lui LL, 2007, J NEUROPHYSIOL, V97, P1135, DOI 10.1152/jn.01018.2006; Lui LL, 2012, EUR J NEUROSCI, V36, P2063, DOI 10.1111/j.1460-9568.2012.08121.x; Lui LL, 2006, CEREB CORTEX, V16, P162, DOI 10.1093/cercor/bhi094; Lui LL, 2005, EXP BRAIN RES, V162, P100, DOI 10.1007/s00221-004-2113-9; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; O'Keefe LP, 1998, J NEUROPHYSIOL, V80, P594, DOI 10.1152/jn.1998.80.2.594; Oram MW, 2010, J PHYSIOL-PARIS, V104, P167, DOI 10.1016/j.jphysparis.2009.11.021; Oram MW, 2002, PHILOS T ROY SOC B, V357, P987, DOI 10.1098/rstb.2002.1113; Pack CC, 2005, J NEUROPHYSIOL, V93, P1809, DOI 10.1152/jn.00629.2004; Palmer SM, 2006, CEREB CORTEX, V16, P1361, DOI 10.1093/cercor/bhj078; Priebe NJ, 2003, J NEUROSCI, V23, P5650; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Raiguel SE, 1999, J NEUROPHYSIOL, V82, P1944, DOI 10.1152/jn.1999.82.4.1944; Rosa MGP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1372; Rosa MGP, 2009, J NEUROSCI, V29, P4548, DOI 10.1523/JNEUROSCI.0529-09.2009; Rosa MGP, 1998, J COMP NEUROL, V393, P505; ROSA MGP, 1995, J COMP NEUROL, V359, P272, DOI 10.1002/cne.903590207; Rosa MGP, 2005, J COMP NEUROL, V483, P164, DOI 10.1002/cne.20412; Rosa MGP, 2001, EUR J NEUROSCI, V13, P421, DOI 10.1046/j.0953-816X.2000.01414.x; Rosa MGP, 2000, J NEUROSCI, V20, P5552, DOI 10.1523/JNEUROSCI.20-14-05552.2000; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shushruth S, 2009, J NEUROPHYSIOL, V102, P2069, DOI 10.1152/jn.00512.2009; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P293, DOI 10.1017/S0952523800011433; TOOTELL RBH, 1988, J NEUROSCI, V8, P1594; Tsui JMG, 2011, J NEUROPHYSIOL, V106, P1888, DOI 10.1152/jn.00165.2011; WEISENHORN DMV, 1995, J COMP NEUROL, V362, P233, DOI 10.1002/cne.903620207; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Yang Y, 2008, NEUROSCIENCE, V156, P748, DOI 10.1016/j.neuroscience.2008.08.007; Yu HH, 2010, J VISION, V10, DOI 10.1167/10.14.15; Zheng J, 2007, J NEUROPHYSIOL, V97, P3905, DOI 10.1152/jn.01320.2006	60	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68276	10.1371/journal.pone.0068276	http://dx.doi.org/10.1371/journal.pone.0068276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840842	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400184
J	Morota, S; Manolopoulos, T; Eyjolfsson, A; Kimblad, PO; Wierup, P; Metzsch, C; Blomquist, S; Hansson, MJ				Morota, Saori; Manolopoulos, Theodor; Eyjolfsson, Atli; Kimblad, Per-Ola; Wierup, Per; Metzsch, Carsten; Blomquist, Sten; Hansson, Magnus J.			Functional and Pharmacological Characteristics of Permeability Transition in Isolated Human Heart Mitochondria	PLOS ONE			English	Article							CA-2&-INDUCED MEMBRANE TRANSITION; CYCLOSPORINE-A; CYCLOPHILIN-D; BRAIN MITOCHONDRIA; CA-2+-DEPENDENT PORE; INORGANIC-PHOSPHATE; CELL-DEATH; INHIBITION; PROTECTION; TARGET	The objective of the present study was to validate the presence and explore the characteristics of mitochondrial permeability transition (mPT) in isolated mitochondria from human heart tissue in order to investigate if previous findings in animal models of cardiac disorders are translatable to human disease. Mitochondria were rapidly isolated from fresh atrial tissue samples obtained from 14 patients undergoing Maze surgery due to atrial fibrillation. Human heart mitochondria exhibited typical mPT characteristics upon calcium overload such as swelling, evaluated by changes in light scattering, inhibition of respiration and loss of respiratory coupling. Swelling was a morphologically reversible event following transient calcium challenge. Calcium retention capacity (CRC), a quantitative measure of mPT sensitivity assayed by following extramitochondrial [Ca2+] and changes in respiration during a continuous calcium infusion, was significantly increased by cyclophilin D (CypD) inhibitors. The thiol-reactive oxidant phenylarsine oxide sensitized mitochondria to calcium-induced mPT. Release of the pro-apoptotic intermembrane protein cytochrome c was increased after, but not before, calcium discharge and respiratory inhibition in the CRC assay. From the present study, we conclude that adult viable heart mitochondria have a CypD- and oxidant-regulated mPT. The findings support that inhibition of mPT may be a relevant pharmacological target in human cardiac disease and may underlie the beneficial effect of cyclosporin A in reperfusion injury.	[Morota, Saori; Hansson, Magnus J.] Skane Univ Hosp, Mitochondrial Pathophysiol Unit, Lund, Sweden; [Morota, Saori; Manolopoulos, Theodor; Eyjolfsson, Atli; Kimblad, Per-Ola; Wierup, Per; Metzsch, Carsten; Blomquist, Sten; Hansson, Magnus J.] Lund Univ, Lund, Sweden; [Manolopoulos, Theodor; Metzsch, Carsten; Blomquist, Sten] Skane Univ Hosp, Dept Cardiothorac Anesthesiol & Intens Care, Lund, Sweden; [Eyjolfsson, Atli; Kimblad, Per-Ola; Wierup, Per] Skane Univ Hosp, Dept Cardiothorac Surg, Lund, Sweden; [Hansson, Magnus J.] Skane Univ Hosp, Dept Clin Physiol, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Hansson, MJ (corresponding author), Skane Univ Hosp, Mitochondrial Pathophysiol Unit, Lund, Sweden.	magnus.hansson@med.lu.se	Hansson, Magnus/G-4486-2014	Hansson, Magnus/0000-0002-0201-0638	Swedish Research Council [2011-3470]; Royal Physiographic Society; Foundation of the Swedish National Board of Health and Welfare; Swedish Society of Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society; Foundation of the Swedish National Board of Health and Welfare; Swedish Society of Medicine	This work was supported by the Swedish Research Council (Reference number 2011-3470), the Royal Physiographic Society, the Foundation of the Swedish National Board of Health and Welfare and the Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2011, AM J PHYSIOL-HEART C, V300, pH118, DOI 10.1152/ajpheart.00932.2010; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; CROMPTON M, 1988, BIOCHEM J, V255, P357; Eliseev RA, 2007, NEUROBIOL AGING, V28, P1532, DOI 10.1016/j.neurobiolaging.2006.06.022; Feuerstein GZ, 2009, STROKE, V40, pS121, DOI 10.1161/STROKEAHA.108.535104; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HALESTRAP AP, 1987, BIOCHEM J, V244, P159, DOI 10.1042/bj2440159; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Hansson MJ, 2011, J NEUROTRAUM, V28, P143, DOI 10.1089/neu.2010.1613; Hansson MJ, 2010, J BIOL CHEM, V285, P741, DOI 10.1074/jbc.M109.017731; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hausenloy DJ, 2010, CARDIOVASC RES, V88, P67, DOI 10.1093/cvr/cvq113; Hausenloy DJ, 2004, AM J PHYSIOL-HEART C, V287, pH841, DOI 10.1152/ajpheart.00678.2003; Hausenloy DJ, 2002, CARDIOVASC RES, V55, P534, DOI 10.1016/S0008-6363(02)00455-8; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; HUNTER FE, 1955, J BIOL CHEM, V216, P357; Javadov SA, 2003, J PHYSIOL-LONDON, V549, P513, DOI 10.1113/jphysiol.2003.034231; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; LEDER O, 1969, PFLUG ARCH EUR J PHY, V312, pR9; LEHNINGER AL, 1949, J BIOL CHEM, V178, P625; Lim SY, 2011, J CELL MOL MED, V15, P2443, DOI 10.1111/j.1582-4934.2010.01235.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu RR, 2009, J BIOL CHEM, V284, P36109, DOI 10.1074/jbc.M109.055301; Liu YG, 1998, CIRCULATION, V97, P2463, DOI 10.1161/01.CIR.97.24.2463; Mansson R, 2007, NEUROBIOL DIS, V25, P198, DOI 10.1016/j.nbd.2006.09.008; Mansson R, 2010, HEPATOLOGY, V51, P347, DOI 10.1002/hep.23465; Mewton N, 2010, J AM COLL CARDIOL, V55, P1200, DOI 10.1016/j.jacc.2009.10.052; Morota S, 2007, J NEUROCHEM, V103, P2066, DOI 10.1111/j.1471-4159.2007.04912.x; Morota S, 2009, EXP NEUROL, V218, P353, DOI 10.1016/j.expneurol.2009.03.036; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; PANDE SV, 1971, J BIOL CHEM, V246, P402; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; Pemberton TJ, 2005, COMP FUNCT GENOM, V6, P277, DOI 10.1002/cfg.482; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Schneider A, 2003, ANN THORAC SURG, V76, P1240, DOI 10.1016/S0003-4975(03)00830-0; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; Shanmuganathan S, 2005, AM J PHYSIOL-HEART C, V289, pH237, DOI 10.1152/ajpheart.01192.2004; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	56	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67747	10.1371/journal.pone.0067747	http://dx.doi.org/10.1371/journal.pone.0067747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840770	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400131
J	Ramamoorthy, R; Phua, EEK; Lim, SH; Tan, HTW; Kumar, PP				Ramamoorthy, Rengasamy; Phua, Edwin Ek-Kian; Lim, Saw-Hoon; Tan, Hugh Tiang-Wah; Kumar, Prakash P.			Identification and Characterization of RcMADS1, an AGL24 Ortholog from the Holoparasitic Plant Rafflesia cantleyi Solms-Laubach (Rafflesiaceae)	PLOS ONE			English	Article							FLORAL MERISTEM IDENTITY; MADS-BOX GENES; FLOWERING TIME GENES; TRANSCRIPTION FACTORS; ARABIDOPSIS; EVOLUTION; SVP; FAMILY; PROTEINS; SIGNALS	Rafflesia, a holoparasitic genus that produces the largest flower in the world is characterized by the absence of leaves, stem and other macroscopic organs. To better understand the molecular regulation of flower development in this genus we isolated and characterized a floral MADS-box gene, namely, RcMADS1 from Rafflesia cantleyi. Heterologous expression analysis in Arabidopsis was chosen because Rafflesia is not amenable to genetic manipulations. RcMADS1 shares sequence similarity with AGAMOUS-LIKE 24 (AGL24) and SHORT VEGETATIVE PHASE (SVP) of Arabidopsis. Ectopic expression of RcMADS1 in Arabidopsis caused early flowering and conversion of sepals and petals into leaf-like structures, and carpels into inflorescences. In 35S::RcMADS1 plants SUPPRESSOR OF OVEREXPRESSION OF CONSTANS 1 (SOC1), a downstream target gene of AGL24, was upregulated. 35S::RcMADS1 plants exhibit early flowering and conversion of the floral meristem into inflorescence meristem, as in 35S::AGL24 plants. Similar to AGL24, RcMADS1 could rescue the late flowering phenotypes of agl24-1 and FRIGIDA, but not the early flowering of svp-41. Based on these results, we propose that RcMADS1 is a functional ortholog of Arabidopsis AGL24.	[Ramamoorthy, Rengasamy; Phua, Edwin Ek-Kian; Tan, Hugh Tiang-Wah; Kumar, Prakash P.] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore; [Lim, Saw-Hoon] Malaysia Univ Sci & Technol, Petaling Jaya, Selangor, Malaysia; [Lim, Saw-Hoon] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Kumar, Prakash P.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore; Monash University; National University of Singapore	Kumar, PP (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore.	dbskumar@nus.edu.sg	Ramamoorthy, Rengasamy/L-3982-2015; Tan, Hugh Tiang Wah/H-9802-2012; Kumar, Prakash P/A-6236-2009; Ramamoorthy, Rengasamy/C-2656-2011; Ramamoorthy, Rengasamy/AAW-8518-2020	Ramamoorthy, Rengasamy/0000-0003-1045-9109; Kumar, Prakash P/0000-0002-0963-1664; Ramamoorthy, Rengasamy/0000-0003-1045-9109; Lim, Saw Hoon/0000-0001-7629-2888; Tan, Hugh Tiang Wah/0000-0002-3056-4945	Lee Hiok Kwee Endowment funds [R-154-000-154-720]	Lee Hiok Kwee Endowment funds	This work was supported by a research grant from the Lee Hiok Kwee Endowment funds (R-154-000-154-720) to the Department of Biological Sciences, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; [Anonymous], 1969, BIOL PARASITIC FLOWE; Barcelona Julie F., 2002, Kew Bulletin, V57, P647, DOI 10.2307/4110994; Barcelona Julie F., 2006, Kew Bulletin, V61, P231; Barkman TJ, 2004, P NATL ACAD SCI USA, V101, P787, DOI 10.1073/pnas.0305562101; BEAMAN RS, 1988, AM J BOT, V75, P1148, DOI 10.2307/2444098; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis CC, 2007, SCIENCE, V315, P1812, DOI 10.1126/science.1135260; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doyle J. J., 1987, PHYTOCHEM B, P11; Fernando Edwino S., 2005, Asia Life Sciences, V14, P263; Fornara F, 2008, J EXP BOT, V59, P2181, DOI 10.1093/jxb/ern083; GALANG R, 2006, FOLIA MALAYSIANA, V7, P1, DOI DOI 10.2307/4110994; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; Gregis V, 2008, PLANT J, V56, P891, DOI 10.1111/j.1365-313X.2008.03648.x; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Khan Moazzam, 2012, MILCOM 2012 2012 IEE, P1; Kim ST, 2004, AM J BOT, V91, P2102, DOI 10.3732/ajb.91.12.2102; Lee JH, 2007, BBA-GENE STRUCT EXPR, V1769, P455, DOI 10.1016/j.bbaexp.2007.05.001; Lee JH, 2012, PLANT SCI, V185, P97, DOI 10.1016/j.plantsci.2011.09.003; Lee S, 2008, PLANT J, V54, P93, DOI 10.1111/j.1365-313X.2008.03406.x; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Liu L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001313; Madulid Domingo A., 2006, Philippine Scientist, V43, P43; Masiero S, 2004, DEVELOPMENT, V131, P5981, DOI 10.1242/dev.01517; Meijer W, 1997, FLORA MALESIANA 1, P1; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Michaels SD, 2000, PLANT CELL ENVIRON, V23, P1145, DOI 10.1046/j.1365-3040.2000.00643.x; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Mylne JS, 2011, NAT CHEM BIOL, V7, P665, DOI 10.1038/nchembio.666; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; NICKRENT DL, 1994, J MOL EVOL, V39, P62; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Thouet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031096; Trevaskis B, 2007, PLANT PHYSIOL, V143, P225, DOI 10.1104/pp.106.090860; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Yu Hao, 2002, Proceedings of the National Academy of Sciences of the United States of America, V99, P16336, DOI 10.1073/pnas.212624599; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141	51	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67243	10.1371/journal.pone.0067243	http://dx.doi.org/10.1371/journal.pone.0067243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840638	Green Published, gold			2022-12-27	WOS:000321148400049
J	Reinagel, P				Reinagel, Pamela			Speed and Accuracy of Visual Motion Discrimination by Rats	PLOS ONE			English	Article							PERCEPTUAL DECISION-MAKING; PARIETAL CORTEX; NEURAL BASIS; MACAQUE MT; NEURONS; TIME; RESPONSES; TASKS; PERFORMANCE; INTEGRATION	Animals must continuously evaluate sensory information to select the preferable among possible actions in a given context, including the option to wait for more information before committing to another course of action. In experimental sensory decision tasks that replicate these features, reaction time distributions can be informative about the implicit rules by which animals determine when to commit and what to do. We measured reaction times of Long-Evans rats discriminating the direction of motion in a coherent random dot motion stimulus, using a self-paced two-alternative forced-choice (2-AFC) reaction time task. Our main findings are: (1) When motion strength was constant across trials, the error trials had shorter reaction times than correct trials; in other words, accuracy increased with response latency. (2) When motion strength was varied in randomly interleaved trials, accuracy increased with motion strength, whereas reaction time decreased. (3) Accuracy increased with reaction time for each motion strength considered separately, and in the interleaved motion strength experiment overall. (4) When stimulus duration was limited, accuracy improved with stimulus duration, whereas reaction time decreased. (5) Accuracy decreased with response latency after stimulus offset. This was the case for each stimulus duration considered separately, and in the interleaved duration experiment overall. We conclude that rats integrate visual evidence over time, but in this task the time of their response is governed more by elapsed time than by a criterion for sufficient evidence.	Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Reinagel, P (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	preinagel@ucsd.edu	Reinagel, Pamela/ABI-7659-2020	Reinagel, Pamela/0000-0002-6338-2611	J.S. McDonnel Foundation Scholar Award; Kavli Institute for Brain and Mind at UCSD - Innovative Research Program grant	J.S. McDonnel Foundation Scholar Award; Kavli Institute for Brain and Mind at UCSD - Innovative Research Program grant	Supported by J.S. McDonnel Foundation Scholar Award and Kavli Institute for Brain and Mind at UCSD - Innovative Research Program grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Glimcher PW, 2003, DECISIONS UNCERTAINT, Vxx; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; Hastie R, 2001, RATIONAL CHOICE UNCE, Vxv; Huang Y., 2012, ADV NEURAL INFORM PR, V25, P1277; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kahneman D., 2011, THINKING FAST SLOW; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lavan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026863; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; Liu TS, 2011, J NEUROPHYSIOL, V106, P2383, DOI 10.1152/jn.00413.2011; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933	33	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68505	10.1371/journal.pone.0068505	http://dx.doi.org/10.1371/journal.pone.0068505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840856	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400196
J	Ren, HJ; Cui, J; Yang, W; Liu, RD; Wang, ZQ				Ren, Hui Jun; Cui, Jing; Yang, Wei; Liu, Ruo Dan; Wang, Zhong Quan			Identification of Differentially Expressed Genes of Trichinella spiralis Larvae after Exposure to Host Intestine Milieu	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; PROTEOMIC ANALYSIS; EPITHELIAL-CELLS; TRICHINOSIS; INVASION; ANTIGENS; INFECTION; PARASITE; CLONING	Although it has been known for many years that T. spiralis muscle larvae (ML) can not invade intestinal epithelial cells unless they are exposed to the intestinal milieu and activated into intestinal infective larvae (IIL), which genes in IIL are involved in the process of invasion is still unknown. In this study, suppression subtractive hybridization (SSH) was performed to identify differentially expressed genes between IIL and ML. SSH library was constructed using cDNA generated from IIL as the 'tester'. About 110 positive clones were randomly selected from the library and sequenced, of which 33 T. spiralis genes were identified. Thirty encoded proteins were annotated according to Gene Ontology Annotation in terms of molecular function, biological process, and cellular localization. Out of 30 annotated proteins, 16 proteins (53.3%) had binding activity and 12 proteins (40.0%) had catalytic activity. The results of real-time PCR showed that the expression of nine genes (Ts7, Ndr family protein; Ts8, serine/threonine-protein kinase polo; Ts11, proteasome subunit beta type-7; Ts17, nudix hydrolase; Ts19, ovochymase-1; Ts22, fibronectin type III domain protein; Ts23, muscle cell intermediate filament protein OV71; Ts26, neutral and basic amino acid transport protein rBAT and Ts33, FACT complex subunit SPT16) from 33 T. spiralis genes in IIL were up-regulated compared with that of ML. The present study provide a group of the potential invasion-related candidate genes and will be helpful for further studies of mechanisms by which T. spiralis infective larvae recognize and invade the intestinal epithelial cells.	[Ren, Hui Jun; Cui, Jing; Yang, Wei; Liu, Ruo Dan; Wang, Zhong Quan] Zhengzhou Univ, Dept Parasitol, Coll Med, Zhengzhou 450052, Peoples R China; [Ren, Hui Jun] Zhengzhou Univ, Dept Clin Lab, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China	Zhengzhou University; Zhengzhou University	Cui, J (corresponding author), Zhengzhou Univ, Dept Parasitol, Coll Med, Zhengzhou 450052, Peoples R China.	cuij@zzu.edu.cn; wangzq@zzu.edu.cn			National Natural Science Foundation of China [30972579, 81271860]; Doctoral Program Foundation of Institutions of Higher Education of China [20124101110005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No. 30972579 and 81271860). In addition, this study was also supported by and the Doctoral Program Foundation of Institutions of Higher Education of China (No. 20124101110005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger JL, 2000, MOL MICROBIOL, V36, P174, DOI 10.1046/j.1365-2958.2000.01840.x; Bolas-Fernandez F, 2006, RES VET SCI, V81, P297, DOI 10.1016/j.rvsc.2006.01.002; Chen AQ, 2009, ANIM REPROD SCI, V115, P39, DOI 10.1016/j.anireprosci.2008.10.022; Cui J, 2013, VACCINE, V31, P1171, DOI 10.1016/j.vaccine.2012.12.070; DEARMASSERRA C, 1995, PARASITOL RES, V81, P540, DOI 10.1007/BF00931800; Despommier D. D., 1983, TRICHINELLA TRICHINO; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dzik JM, 2006, ACTA BIOCHIM POL, V53, P33; Gamble HR, 2000, VET PARASITOL, V93, P393, DOI 10.1016/S0304-4017(00)00354-X; Gare D, 2004, MOL BIOCHEM PARASIT, V134, P257, DOI 10.1016/j.molbiopara.2004.01.001; Hale BG, 2007, BIOCHEM SOC T, V35, P186, DOI 10.1042/BST0350186; HARA E, 1991, NUCLEIC ACIDS RES, V19, P7097, DOI 10.1093/nar/19.25.7097; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Inaba T, 2003, PARASITOLOGY, V126, P591, DOI 10.1017/S003118200300310X; Kang SA, 2012, VET PARASITOL, V186, P319, DOI 10.1016/j.vetpar.2011.12.002; KHAN ZA, 1966, J PARASITOL, V52, P248, DOI 10.2307/3276480; KOZEK WJ, 1971, J PARASITOL, V57, P1015, DOI 10.2307/3277858; Li F, 2010, FOODBORNE PATHOG DIS, V7, P879, DOI 10.1089/fpd.2009.0445; Liu MY, 2007, PARASITOLOGY, V134, P1443, DOI 10.1017/S0031182007002855; Mak CH, 2001, PARASITOLOGY, V123, P293, DOI 10.1017/S0031182001008320; Manjunatha HB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20401; ManWarren T, 1997, INFECT IMMUN, V65, P4806, DOI 10.1128/IAI.65.11.4806-4812.1997; Martinez J, 2005, PARASITOL RES, V97, P213, DOI 10.1007/s00436-005-1420-9; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mulder Nicola, 2007, V396, P59; Murrell KD, 2011, EMERG INFECT DIS, V17, P2194, DOI 10.3201/eid1712.110896; Nishikawa M, 2008, INT J PHARM, V354, P23, DOI 10.1016/j.ijpharm.2007.09.030; Pozio E, 2009, INFECT GENET EVOL, V9, P606, DOI 10.1016/j.meegid.2009.03.003; Qin MH, 2003, ARTERIOSCL THROM VAS, V23, P425, DOI 10.1161/01.ATV.0000059303.94760.5C; Ren HJ, 2013, CHIN J ZOON IN PRESS, V29; Ren HJ, 2013, PARASITOL RES, V112, P1857, DOI 10.1007/s00436-013-3339-x; Renault T, 2011, DEV COMP IMMUNOL, V35, P725, DOI 10.1016/j.dci.2011.02.004; Reyes A, 2007, DEV COMP IMMUNOL, V31, P23, DOI 10.1016/j.dci.2006.05.003; Robinson MW, 2005, PROTEOMICS, V5, P4525, DOI 10.1002/pmic.200402057; Romaris F, 2002, MOL BIOCHEM PARASIT, V122, P149, DOI 10.1016/S0166-6851(02)00094-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Vayssier M, 1999, PARASITOLOGY, V119, P81, DOI 10.1017/S0031182099004461; Venkatachalam P, 2009, PLANT MOL BIOL, V69, P1, DOI 10.1007/s11103-008-9401-x; Wang L, 2010, J PATHOG BIOL, P901; Wang L, 2013, VET PARASITOL, V194, P160, DOI 10.1016/j.vetpar.2013.01.045; Wang SA, 2009, J MOL BIOL, V387, P1106, DOI 10.1016/j.jmb.2009.02.040; Wang ZQ, 2012, J PROTEOMICS, V75, P2375, DOI 10.1016/j.jprot.2012.02.005; Xu TS, 2012, MOL BIOL REP, V39, P7647, DOI 10.1007/s11033-012-1599-7; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuryev A, 2003, GENOMICS, V81, P112, DOI 10.1016/S0888-7543(02)00008-3	46	46	51	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67570	10.1371/journal.pone.0067570	http://dx.doi.org/10.1371/journal.pone.0067570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840742	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400108
J	Tsai, SH; Shen, GH; Lin, CH; Liau, JR; Lai, HC; Hu, ST				Tsai, Sheng-Hui; Shen, Gwan-Han; Lin, Chao-Hsiung; Liau, Jiue-Ru; Lai, Hsin-Chih; Hu, Shiau-Ting			Mab_3168c, a Putative Acetyltransferase, Enhances Adherence, Intracellular Survival and Antimicrobial Resistance of Mycobacterium abscessus	PLOS ONE			English	Article							RAPIDLY GROWING MYCOBACTERIA; BIOFILM FORMATION; IMMUNOCOMPETENT PATIENTS; PULMONARY-DISEASE; SLIDING MOTILITY; VIRULENCE GENES; CELL-SURFACE; LUNG-DISEASE; TUBERCULOSIS; SMEGMATIS	Mycobacterium abscessus is a non-tuberculous mycobacterium. It can cause diseases in both immunosuppressed and immunocompetent patients and is highly resistant to multiple antimicrobial agents. M. abscessus displays two different colony morphology types: smooth and rough morphotypes. Cells with a rough morphotype are more virulent. The purpose of this study was to identify genes responsible for M. abscessus morphotype switching. With transposon mutagenesis, a mutant with a Tn5 inserted into the promoter region of the mab_3168c gene was found to switch its colonies from a rough to a smooth morphotype. This mutant had a higher sliding motility but a lower ability to form biofilms, aggregate in culture, and survive inside macrophages. Results of bioinformatic analyses suggest that the putative Mab_3168c protein is a member of the GCN5-related N-acetyltransferase superfamily. This prediction was supported by the demonstration that the mab_3168c gene conferred M. abscessus and M. smegmatis cells resistance to amikacin. The multiple roles of mab_3168c suggest that it could be a potential target for development of therapeutic regimens to treat diseases caused by M. abscessus.	[Tsai, Sheng-Hui; Liau, Jiue-Ru; Hu, Shiau-Ting] Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Shen, Gwan-Han] Vet Gen Hosp, Dept Internal Med, Div Resp & Crit Care Med, Taichung, Taiwan; [Shen, Gwan-Han] China Med Univ, Inst Resp Therapy, Taichung, Taiwan; [Shen, Gwan-Han] Hungkuang Univ, Inst Nursing Care, Taichung, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Dept Life Sci, Sch Life Sci, Taipei 112, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Genome Sci, Sch Life Sci, Taipei 112, Taiwan; [Lai, Hsin-Chih] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan; [Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Lai, Hsin-Chih] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; Hungkuang University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung University; Chang Gung University; Chang Gung University	Hu, ST (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan.	tingnahu@ym.edu.tw		LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council, Taiwan, ROC [NSC 99-2320-B-006-MY3]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC 99-2320-B-006-MY3 from the National Science Council, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsa JA, 1997, MOL MICROBIOL, V24, P431, DOI 10.1046/j.1365-2958.1997.3471717.x; Arora K, 2008, J BACTERIOL, V190, P4291, DOI 10.1128/JB.00023-08; Balasubramanian V, 1996, J BACTERIOL, V178, P273, DOI 10.1128/jb.178.1.273-279.1996; Brown AC, 2010, J BACTERIOL, V192, P2424, DOI 10.1128/JB.01402-09; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036292; Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.188.2.633-641.2006; Colangeli R, 2007, PLOS PATHOG, V3, P780, DOI 10.1371/journal.ppat.0030087; Davidson LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029148; Esteban J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-184; Etienne G, 2002, MICROBIOL-SGM, V148, P3089, DOI 10.1099/00221287-148-10-3089; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Furuya EY, 2008, CLIN INFECT DIS, V46, P1181, DOI 10.1086/529191; GANGADHARAM PR, 1972, AM REV RESPIR DIS, V106, P275, DOI 10.1164/arrd.1972.106.2.275; Gordon BRG, 2008, J BACTERIOL, V190, P7052, DOI 10.1128/JB.00733-08; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Greendyke R, 2008, ANTIMICROB AGENTS CH, V52, P2019, DOI 10.1128/AAC.00986-07; Griffith DE, 2010, CURR OPIN INFECT DIS, V23, P185, DOI 10.1097/QCO.0b013e328336ead6; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; Gwan-Han S, 2007, MYCOBACTERIA DETECTI; Ho IIY, 2000, ANTIMICROB AGENTS CH, V44, P39, DOI 10.1128/AAC.44.1.39-42.2000; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Jana S, 2006, APPL MICROBIOL BIOT, V70, P140, DOI 10.1007/s00253-005-0279-0; Jarand J, 2011, CLIN INFECT DIS, V52, P565, DOI 10.1093/cid/ciq237; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Jeong YJ, 2004, RADIOLOGY, V231, P880, DOI 10.1148/radiol.2313030833; Martinez A, 1999, J BACTERIOL, V181, P7331; Naka T, 2011, J BACTERIOL, V193, P5766, DOI 10.1128/JB.05412-11; Nessar R, 2011, MICROBIOL-SGM, V157, P1187, DOI 10.1099/mic.0.046557-0; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Ozluer S M, 2001, Australas J Dermatol, V42, P26, DOI 10.1046/j.1440-0960.2001.00468.x; Pompilio A, 2008, FEMS MICROBIOL LETT, V287, P41, DOI 10.1111/j.1574-6968.2008.01292.x; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Ripoll F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-114; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; ROSENBERG M, 1981, APPL ENVIRON MICROB, V42, P375, DOI 10.1128/AEM.42.2.375-377.1981; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; van Ingen J, 2011, ARE PHYLOGENETIC POS; van Ingen J, 2012, DRUG RESIST UPDATE, V15, P149, DOI 10.1016/j.drup.2012.04.001; Varghese B, 2012, ANN SAUDI MED, V32, P312, DOI 10.5144/0256-4947.2012.312; Wright GD, 1997, ANTIMICROB AGENTS CH, V41, P956, DOI 10.1128/AAC.41.5.956; Zhang WL, 2008, INT J BIOCHEM CELL B, V40, P2560, DOI 10.1016/j.biocel.2008.05.003	45	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67563	10.1371/journal.pone.0067563	http://dx.doi.org/10.1371/journal.pone.0067563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840740	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400107
J	Dube, FS; Kaba, M; Whittaker, E; Zar, HJ; Nicol, MP				Dube, Felix S.; Kaba, Mamadou; Whittaker, Elizabeth; Zar, Heather J.; Nicol, Mark P.			Detection of Streptococcus pneumoniae from Different Types of Nasopharyngeal Swabs in Children	PLOS ONE			English	Article							FLOCKED NYLON SWABS; PNEUMOCOCCAL PNEUMONIA; STAPHYLOCOCCUS-AUREUS; RESPIRATORY VIRUSES; TRANSPORT-SYSTEMS; NASAL CARRIAGE; RAYON SWABS; COLLECTION; COLONIZATION; RECOVERY	Background: A better understanding of the epidemiology of nasopharyngeal carriage of Streptococcus pneumoniae is important to assess the impact of vaccination and the pathogenesis of pneumococcal disease. We compared the recovery of S. pneumoniae from nylon flocked, Dacron and rayon swabs. Methods: The recovery of S. pneumoniae from mocked specimens using flocked, Dacron and rayon swabs were compared by culture. The yield from paired nasopharyngeal (NP) samples obtained from healthy children sampled with flocked and Dacron swabs was also determined using culture and lytA-targeted real-time polymerase chain reaction (qPCR). Results: Using mock specimen, the percentage recovery of S. pneumoniae ATCC 49619 (serotype 19F) strain from the flocked swabs was 100%, while it was 41% from Dacron swabs and 7% from rayon swabs. Similar results were observed for S. pneumoniae serotypes 1 and 5. S. pneumoniae was cultured from 18 of 42 (43%) paired NP samples from the healthy children (median age 8 [interquartile range (IQR) 5-16] months). The median number of colony-forming units (CFU) recovered from flocked swabs was two-fold higher (8.8x10(4) CFU/mL [IQR, 2.0x10(2) - 4.0x10(5) CFU/mL]) than Dacron swabs (3.7x10(4) CFU/mL [IQR, 4.0x10(2)-3.2x10(5) CFU/mL], p = 0.17). Using lytA-targeted qPCR from paired NP samples, the median copy number of S. pneumoniae detected from flocked swabs was significantly higher than from Dacron swabs (3.0x10(5) genome copies/mL [IQR, 1.3x10(2)-1.8x10(6)] vs. 9.3x10(4) genome copies/mL [IQR, 7.0x10(1)-1.1x10(6)]; p = 0.005). Conclusion: Flocked swabs released more S. pneumoniae compared to both Dacron and rayon swabs from mock specimens. Similarly, higher bacterial loads were detected by qPCR from flocked swabs compared with Dacron swabs from healthy children.	[Dube, Felix S.; Kaba, Mamadou; Nicol, Mark P.] Univ Cape Town, Div Med Microbiol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Kaba, Mamadou; Nicol, Mark P.] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Whittaker, Elizabeth] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, Wright Fleming Inst, London, England; [Whittaker, Elizabeth; Zar, Heather J.] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa; [Whittaker, Elizabeth; Zar, Heather J.] Red Cross War Mem Childrens Hosp, Cape Town, South Africa; [Nicol, Mark P.] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; Imperial College London; University of Cape Town; University of Cape Town	Dube, FS (corresponding author), Univ Cape Town, Div Med Microbiol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	fdube82@gmail.com	Nicol, Mark/W-4149-2019; Zar, Heather/GZL-5350-2022	Nicol, Mark/0000-0002-1366-4805; Zar, Heather/0000-0002-9046-759X; Whittaker, Elizabeth/0000-0002-7944-8793; Dube, Felix Sizwe/0000-0003-2775-7786	National Institutes of Health, USA [1R01HD058971-01]; Medical Research Council of South Africa; Wellcome Trust; Bill and Mellinda Gates Foundation Global Health Grant [OPP1017641]; National Research Foundation of South Africa; Carnegie Corporation of New York (USA) fellowship; Wellcome Trust, UK; National Institute for Health Research [ACF-2006-21-031] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI110466] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council of South Africa(South African Medical Research Council); Wellcome Trust(Wellcome Trust); Bill and Mellinda Gates Foundation Global Health Grant; National Research Foundation of South Africa(National Research Foundation - South Africa); Carnegie Corporation of New York (USA) fellowship; Wellcome Trust, UK(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by grants from the National Institutes of Health, USA (1R01HD058971-01), the Medical Research Council of South Africa, the Wellcome Trust and the Bill and Mellinda Gates Foundation Global Health Grant (OPP1017641). Felix S. Dube is supported by the National Research Foundation of South Africa; Mamadou Kaba is a recipient of Carnegie Corporation of New York (USA) fellowship; Elizabeth Whittaker is supported by the Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Diab A, 2008, J CLIN MICROBIOL, V46, P2414, DOI 10.1128/JCM.00369-08; Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Antono M, 2008, BMC INFECT DIS, V10, P1; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brownlow RJ, 2012, J FORENSIC SCI, V57, P713, DOI 10.1111/j.1556-4029.2011.02022.x; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Coles CL, 2009, TROP MED INT HEALTH, V14, P1025, DOI 10.1111/j.1365-3156.2009.02331.x; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; Dalmaso Giblerto, 2008, PDA J Pharm Sci Technol, V62, P191; De Silva S, 2010, J CLIN MICROBIOL, V48, P2963, DOI 10.1128/JCM.01617-09; DeByle C, 2012, J VIROL METHODS, V185, P89, DOI 10.1016/j.jviromet.2012.06.009; Drake C, 2005, J CLIN MICROBIOL, P3; Esposito S, 2010, J MED MICROBIOL, V59, P96, DOI 10.1099/jmm.0.015305-0; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Gage JC, 2011, ACTA CYTOL, V55, P364, DOI 10.1159/000329488; Greve T, 2012, J MED MICROBIOL, V61, P478, DOI 10.1099/jmm.0.036574-0; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hedin G, 2010, J HOSP INFECT, V75, P314, DOI 10.1016/j.jhin.2010.02.027; Hernes SS, 2011, EUR J CLIN MICROBIOL, V30, P159, DOI 10.1007/s10096-010-1064-2; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Leung MH, 2012, J CLIN MICROBIOL, V50, P2419, DOI 10.1128/JCM.06384-11; Miernyk K, 2011, J CLIN MICROBIOL, V49, P3209, DOI 10.1128/JCM.00610-11; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Ohrmalm L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-340; Probst A, 2011, APPL ENVIRON MICROB, V77, P1628, DOI 10.1128/AEM.02037-10; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Rubin LG, 2008, J CLIN MICROBIOL, V46, P2635, DOI 10.1128/JCM.01903-07; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Sharma D, 2013, PEDIATR INFECT DIS J, V32, pE45, DOI 10.1097/INF.0b013e3182788fdd; Smieja M, 2010, J CLIN MICROBIOL, V48, P3340, DOI 10.1128/JCM.02235-09; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Turner P, 2011, J CLIN MICROBIOL, V49, P2311, DOI 10.1128/JCM.00224-11; van den Bergh MR, 2012, J CLIN MICROBIOL, V50, P4134, DOI 10.1128/JCM.02376-12; Van Horn KG, 2008, J CLIN MICROBIOL, V46, P1655, DOI 10.1128/JCM.02047-07; Van Horn KG, 2008, DIAGN MICR INFEC DIS, V62, P471, DOI 10.1016/j.diagmicrobio.2008.08.004; Verhoeven P, 2010, J CLIN MICROBIOL, V48, P4242, DOI 10.1128/JCM.01425-10; Werno AM, 2012, J MED MICROBIOL, V61, P1129, DOI 10.1099/jmm.0.044107-0	40	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e68097	10.1371/journal.pone.0068097	http://dx.doi.org/10.1371/journal.pone.0068097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840817	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400129
J	Lee, JT; Shao, PL; Chang, LY; Xia, NS; Chen, PJ; Lu, CY; Huang, LM				Lee, Jian-Te; Shao, Pei-Lan; Chang, Luan-Yin; Xia, Ning-Shao; Chen, Pei-Jer; Lu, Chun-Yi; Huang, Li-Min			Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan	PLOS ONE			English	Article							BLOOD-DONORS; ANTI-HEV; IGG SEROPREVALENCE; GENOTYPE 3; PREVALENCE; ANTIBODIES	Objectives: Hepatitis E virus (HEV) is an emerging pathogen. We evaluated the seroprevalence of HEV infection among swine farmers and the general population in Taiwan, a nonendemic country. Methods: We conducted a cross-sectional seroepidemiologic study in rural Taiwan in 2012 and 2013. The study included swine farmers, health examination attendees, pregnant women, and students. A commercial enzyme-linked immunosor-bent assay was used to detect immunoglobulin G (IgG) and IgM against HEV. Pertinent information was collected using a questionnaire. Results: In total, 660 participants were enrolled in the study, including 156 swine farmers, 314 health examination attendees, 100 pregnant women, and 90 students. IgG anti-HEV was detected in 29.5% of swine farmers, 11.5% of health examination attendees, 2% of pregnant women, and 1.1% of students. Two subjects were positive for IgM anti-HEV. Logistic regression analysis revealed that swine farmers had an approximately 3.5-fold increased risk (odds ratio [OR], 3.46; 95% confidence interval [CI], 1.91-6.27; p<0.0001) for being seropositive for IgG anti-HEV as compared to the general population. Age was positively associated with seropositive rate (OR, 1.07 per year; 95% CI, 1.05-1.09; p<0.0001). Conclusion: HEV infection is prevalent in Taiwan. The seroprevalence of HEV infection is high in swine farmers and in the elderly population.	[Lee, Jian-Te] Natl Taiwan Univ Hosp, Dept Pediat, Yun Lin Branch, Yunlin, Taiwan; [Shao, Pei-Lan; Chang, Luan-Yin; Lu, Chun-Yi; Huang, Li-Min] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Shao, Pei-Lan; Chang, Luan-Yin; Chen, Pei-Jer; Lu, Chun-Yi; Huang, Li-Min] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Xia, Ning-Shao] Xiamen Univ, Sch Publ Hlth, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Chen, Pei-Jer] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Xiamen University; National Taiwan University; National Taiwan University Hospital	Huang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	lmhuang@ntu.edu.tw	Lee, Jian-Te/HGA-7595-2022	CHANG, LUAN-YIN/0000-0003-2632-1956; Chen, Pei-Jer/0000-0001-8316-3785; HUANG, LI-MIN/0000-0002-9291-260X; LU, CHUN-YI/0000-0002-5240-2808; Lee, Jian-Te/0000-0002-2567-5501; Shao, Pei-Lan/0000-0003-3334-1330; Xia, Ningshao/0000-0003-0179-5266	National Taiwan University Hospital, Yun-Lin Branch [NTUHYL 99.S027]	National Taiwan University Hospital, Yun-Lin Branch	Funding was provided by National Taiwan University Hospital, Yun-Lin Branch (NTUHYL 99.S027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anty R, 2012, J CLIN VIROL, V54, P76, DOI 10.1016/j.jcv.2012.01.016; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Bouquet J, 2011, EMERG INFECT DIS, V17, P2018, DOI 10.3201/eid1711.110616; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chiu DMY, 2013, J MED VIROL, V85, P459, DOI 10.1002/jmv.23429; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Council of Agriculture, 2012, 22012 COUNC AGR; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Drobeniuc J, 2001, J INFECT DIS, V184, P1594, DOI 10.1086/324566; Engle RE, 2002, J CLIN MICROBIOL, V40, P4576, DOI 10.1128/JCM.40.12.4576-4580.2002; Guthmann JP, 2006, CLIN INFECT DIS, V42, P1685, DOI 10.1086/504321; Hinjoy S, 2012, ZOONOSES PU IN PRESS; Hsieh SY, 1999, J CLIN MICROBIOL, V37, P3828, DOI 10.1128/JCM.37.12.3828-3834.1999; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; LEE SD, 1994, HEPATOLOGY, V19, P866, DOI 10.1016/0270-9139(94)90284-4; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Meng XJ, 2011, VIRUS TAXONOMY; Miyamura T, 2011, VIRUS RES, V161, P40, DOI 10.1016/j.virusres.2011.03.006; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Park HK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-142; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Rutjes SA, 2009, EMERG INFECT DIS, V15, P381, DOI 10.3201/eid1503.071472; Su SB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-719; Taiwan Centers for Disease Control, 2013, NOT INF DIS STAT SYS; Tamura A, 2007, HEPATOL RES, V37, P113, DOI 10.1111/j.1872-034X.2007.00024.x; Tanaka E, 2005, J VIRAL HEPATITIS, V12, P439, DOI 10.1111/j.1365-2893.2005.00616.x; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Tseng YT, 2012, J FORMOS MED ASSOC, V111, P431, DOI 10.1016/j.jfma.2011.06.022; Zhao QJ, 2013, J GASTROENTEROL, V48, P159, DOI 10.1007/s00535-012-0701-1; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	35	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67180	10.1371/journal.pone.0067180	http://dx.doi.org/10.1371/journal.pone.0067180			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840620	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400081
J	Lee, SL; Chou, CC; Chuang, HC; Hsu, EC; Chiu, PC; Kulp, SK; Byrd, JC; Chen, CS				Lee, Su-Lin; Chou, Chih-Chien; Chuang, Hsiao-Ching; Hsu, En-Chi; Chiu, Po-Chen; Kulp, Samuel K.; Byrd, John C.; Chen, Ching-Shih			RETRACTED: Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines (Retracted article. See vol. 13, art. e0202299, 2018)	PLOS ONE			English	Article; Retracted Publication							EXPRESSION INCREASES; AKT PHOSPHORYLATION; THERAPEUTIC TARGET; TUMOR PROGRESSION; INHIBITOR QLT0267; E-CADHERIN; ILK; ACTIVATION; B/AKT; PATHWAY	Although the rictor-mTOR complex (mTORC2) has been shown to act as phosphoinositide-dependent kinase (PDK) 2 in many cell types, other kinases have also been implicated in mediating Ser473-Akt phosphorylation. Here, we demonstrated the cell line specificity of integrin-linked kinase (ILK) versus mTORC2 as PDK2 in LNCaP and PC-3 prostate and MDA-MB-468 breast cancer cells, of which the PTEN-negative status allowed the study of Ser473-Akt phosphorylation independent of external stimulation. PC-3 and MDA-MB-468 cells showed upregulated ILK expression relative to LNCaP cells, which expressed a high abundance of mTOR. Exposure to Ku-0063794, a second-generation mTOR inhibitor, decreased Ser473-Akt phosphorylation in LNCaP cells, but not in PC-3 or MDA-MB-468 cells. In contrast, treatment with T315, a novel ILK inhibitor, reduced the phosphorylation of Ser473-Akt in PC-3 and MDA-MB-468 cells without affecting that in LNCaP cells. This cell line specificity was verified by comparing Ser473-Akt phosphorylation status after genetic knockdown of rictor, ILK, and other putative Ser-473-Akt kinases. Genetic knockdown of rictor, but not ILK or the other kinases examined, inhibited Ser473-Akt phosphorylation in LNCaP cells. Conversely, PC-3 and MDA-MB-468 cells were susceptible to the effect of ILK silencing on Ser473-Akt phosphorylation, while knockdown of rictor or any of the other target kinases had no appreciable effect. Co-immunoprecipitation analysis demonstrated the physical interaction between ILK and Akt in PC-3 cells, and T315 blocked ILK-mediated Ser473 phosphorylation of bacterially expressed Akt. ILK also formed complexes with rictor in PC-3 and MDA-MB-468 cells that were disrupted by T315, but such complexes were not observed in LNCaP cells. In the PTEN-functional MDA-MB-231 cell line, both T315 and Ku-0063794 suppressed EGF-induced Ser473-Akt phosphorylation. Inhibition of ILK by T315 or siRNA-mediated knockdown suppressed epithelial-mesenchymal transition in MDA-MB-468 and PC-3 cells. Thus, we hypothesize that ILK might bestow growth advantage and metastatic potential in the course of tumor progression.	[Lee, Su-Lin; Chou, Chih-Chien; Chuang, Hsiao-Ching; Hsu, En-Chi; Chiu, Po-Chen; Kulp, Samuel K.; Byrd, John C.; Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA; [Byrd, John C.] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Chen, Ching-Shih] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Cheng Kung University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem, 500 W 12Th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu			Public Health Service Grants from the National Cancer Institute [R01CA112250]; Stefanie Spielman Fund for Breast Cancer Research; Specialized Center of Research grant from the Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	Public Health Service Grants from the National Cancer Institute; Stefanie Spielman Fund for Breast Cancer Research; Specialized Center of Research grant from the Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grants R01CA112250 from the National Cancer Institute, the Stefanie Spielman Fund for Breast Cancer Research to C. S. C, and a Specialized Center of Research grant from the Leukemia and Lymphoma Society to C. S. C. and J.C.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud ER, 2007, INT J ONCOL, V30, P113; Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Bravou V, 2006, J PATHOL, V208, P91, DOI 10.1002/path.1860; Chan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016984; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Edwards LA, 2005, ONCOGENE, V24, P3596, DOI 10.1038/sj.onc.1208427; Edwards LA, 2008, MOL CANCER THER, V7, P59, DOI 10.1158/1535-7163.MCT-07-0329; Eke I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006434; Esfandiarei Mitra, 2010, BMC Cell Biol, V11, P16, DOI 10.1186/1471-2121-11-16; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fan QW, 2011, AUTOPHAGY, V7, P536, DOI 10.4161/auto.7.5.14779; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang Y, 2000, J CELL BIOL, V150, P861, DOI 10.1083/jcb.150.4.861; Ishii T, 2001, J BIOL CHEM, V276, P42994, DOI 10.1074/jbc.M105198200; Ito R, 2003, VIRCHOWS ARCH, V442, P118, DOI 10.1007/s00428-002-0718-6; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Kalra J, 2010, ONCOGENE, V29, P6343, DOI 10.1038/onc.2010.366; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Kawakami Y, 2004, J BIOL CHEM, V279, P47720, DOI 10.1074/jbc.M408797200; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; Koul D, 2005, MOL CANCER THER, V4, P1681, DOI 10.1158/1535-7163.MCT-05-0258; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Lasham A, 2012, JNCI-J NATL CANCER I, V104, P133, DOI 10.1093/jnci/djr512; Lee SL, 2011, J MED CHEM, V54, P6364, DOI 10.1021/jm2007744; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lynch DK, 1999, ONCOGENE, V18, P8024, DOI 10.1038/sj.onc.1203258; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Muranyi AL, 2009, EXP HEMATOL, V37, P450, DOI 10.1016/j.exphem.2009.01.002; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pontier SM, 2010, ONCOGENE, V29, P3374, DOI 10.1038/onc.2010.86; Riaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032081; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sawai H, 2006, ONCOGENE, V25, P3237, DOI 10.1038/sj.onc.1209356; Schaeffer DF, 2010, VIRCHOWS ARCH, V456, P261, DOI 10.1007/s00428-009-0866-z; Serrano I, 2013, ONCOGENE, V32, P50, DOI 10.1038/onc.2012.30; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122; Tabe Y, 2007, CANCER RES, V67, P684, DOI 10.1158/0008-5472.CAN-06-3166; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wang HV, 2008, J CELL BIOL, V180, P1037, DOI 10.1083/jcb.200707175; Wang L, 2004, J BIOL CHEM, V279, P32444, DOI 10.1074/jbc.M313963200; White DE, 2001, ONCOGENE, V20, P7064, DOI 10.1038/sj.onc.1204910; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Younes MN, 2007, ARCH OTOLARYNGOL, V133, P15, DOI 10.1001/archotol.133.1.15; Younes MN, 2005, MOL CANCER THER, V4, P1146, DOI 10.1158/1535-7163.MCT-05-0078; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	67	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67149	10.1371/journal.pone.0067149	http://dx.doi.org/10.1371/journal.pone.0067149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840605	Green Published, gold			2022-12-27	WOS:000322361200121
J	Choi, IK; Li, Y; Oh, E; Kim, J; Yun, CO				Choi, Il-Kyu; Li, Yan; Oh, Eonju; Kim, Jaesung; Yun, Chae-Ok			Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-gamma- and TNF-alpha-Co-Producing T Cell-Mediated Antitumor Immunity	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INTERFERON-GAMMA; GM-CSF; MYCOBACTERIUM-TUBERCULOSIS; INTERLEUKIN (IL)-12; CANCER-THERAPY; GENE-TRANSFER; IL-12; TUMOR; CYTOKINES	Cytokine immunogene therapy is a promising strategy for cancer treatment. Interleukin (IL)-12 boosts potent antitumor immunity by inducing T helper 1 cell differentiation and stimulating cytotoxic T lymphocyte and natural killer cell cytotoxicity. IL-23 has been proposed to have similar but not overlapping functions with IL-12 in inducing Th1 cell differentiation and antitumor immunity. However, the therapeutic effects of intratumoral co-expression of IL-12 and IL-23 in a cancer model have yet to be investigated. Therefore, we investigated for the first time an effective cancer immunogene therapy of syngeneic tumors via intratumoral inoculation of oncolytic adenovirus co-expressing IL-23 and p35, RdB/IL23/p35. Intratumoral administration of RdB/IL23/p35 elicited strong antitumor effects and increased survival in a murine B16-F10 syngeneic tumor model. The levels of IL-12, IL-23, interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha) were elevated in RdB/IL23/p35-treated tumors. Moreover, the proportion of regulatory T cells was markedly decreased in mice treated with RdB/IL23/p35. Consistent with these data, mice injected with RdB/IL23/p35 showed massive infiltration of CD4(+) and CD8(+) T cells into the tumor as well as enhanced induction of tumor-specific immunity. Importantly, therapeutic mechanism of antitumor immunity mediated by RdB/IL23/p35 is associated with the generation and recruitment of IFN-gamma- and TNF-alpha-co-producing T cells in tumor microenvironment. These results provide a new insight into therapeutic mechanisms of IL-12 plus IL-23 and provide a potential clinical cancer immunotherapeutic agent for improved antitumor immunity.	[Choi, Il-Kyu; Oh, Eonju; Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea; [Li, Yan] Yonsei Univ, Grad Program Nanomed Sci, Seoul 120749, South Korea; [Kim, Jaesung] Univ Utah, Ctr Controlled Chem Delivery, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84108 USA	Hanyang University; Yonsei University; Utah System of Higher Education; University of Utah	Yun, CO (corresponding author), Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea.	chaeok@hanyang.ac.kr	Yun, Chae-Ok/P-3698-2015	Yun, Chae-Ok/0000-0002-9466-4531	Ministry of Knowledge Economy [10030051]; Korea Science and Engineering Foundation [R15-2004-024-02001-0, 2009K001644, 2010-0029220]; Korea Food and Drug Administration [KFDA-13172-306]; KOSEF through National Core Research Center for Nanomedical Technology, Seoul, Korea	Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); KOSEF through National Core Research Center for Nanomedical Technology, Seoul, Korea	This work was supported by grants from the Ministry of Knowledge Economy (10030051, Dr. CO Yun), the Korea Science and Engineering Foundation (R15-2004-024-02001-0, 2009K001644, 2010-0029220, Dr. CO Yun), and the Korea Food and Drug Administration (KFDA-13172-306 to Dr. CO Yun). Yan Li is a graduate student sponsored by KOSEF through National Core Research Center for Nanomedical Technology, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 1997, J IMMUNOL, V159, P2125; ASTEAMEZAGA M, 1994, CELL IMMUNOL, V156, P480, DOI 10.1006/cimm.1994.1192; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; BLOOM BR, 1994, IMMUNOBIOLOGY, V191, P526, DOI 10.1016/S0171-2985(11)80459-6; Cao XF, 2009, CANCER RES, V69, P8700, DOI 10.1158/0008-5472.CAN-09-1145; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Choi IK, 2011, GENE THER, V18, P898, DOI 10.1038/gt.2011.37; Choi KJ, 2006, GENE THER, V13, P1010, DOI 10.1038/sj.gt.3302759; Choi KJ, 2012, GENE THER, V19, P711, DOI 10.1038/gt.2011.125; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gadducci A, 2004, BIOMED PHARMACOTHER, V58, P24, DOI 10.1016/j.biopha.2003.11.003; Haicheur N, 2000, CLIN EXP IMMUNOL, V119, P28, DOI 10.1046/j.1365-2249.2000.01112.x; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Helms T, 2000, J IMMUNOL, V164, P3723, DOI 10.4049/jimmunol.164.7.3723; Huang JH, 2010, MOL THER, V18, P264, DOI 10.1038/mt.2009.205; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Kaiga T, 2007, J IMMUNOL, V178, P7571, DOI 10.4049/jimmunol.178.12.7571; Kim J, 2007, HUM GENE THER, V18, P773, DOI 10.1089/hum.2006.167; Lee YS, 2006, CLIN CANCER RES, V12, P5859, DOI 10.1158/1078-0432.CCR-06-0935; Li QX, 2008, INT J CANCER, V123, P493, DOI 10.1002/ijc.23692; LING P, 1995, J IMMUNOL, V154, P116; Ma XJ, 2001, MICROBES INFECT, V3, P121, DOI 10.1016/S1286-4579(00)01359-9; Malmberg KJ, 2004, CANCER IMMUNOL IMMUN, V53, P879, DOI 10.1007/s00262-004-0577-x; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Mizuguchi H, 2003, HUM GENE THER, V14, P1265, DOI 10.1089/104303403767740803; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pei DS, 2010, EXPERT OPIN BIOL TH, V10, P917, DOI 10.1517/14712598.2010.481668; Podhajcer OL, 2007, CYTOKINE GROWTH F R, V18, P183, DOI 10.1016/j.cytogfr.2007.01.014; Portielje JEA, 2003, CLIN CANCER RES, V9, P76; Prevost-Blondel A, 2000, J IMMUNOL, V164, P3645, DOI 10.4049/jimmunol.164.7.3645; Ramakrishna E, 2009, CANCER RES, V69, P1448, DOI 10.1158/0008-5472.CAN-08-1160; RANGES GE, 1987, J EXP MED, V166, P991, DOI 10.1084/jem.166.4.991; Reay J, 2009, CANCER GENE THER, V16, P776, DOI 10.1038/cgt.2009.27; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Stoop JN, 2007, HEPATOLOGY, V46, P699, DOI 10.1002/hep.21761; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zhang SN, 2011, MOL THER, V19, P1558, DOI 10.1038/mt.2011.29; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	53	37	41	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67512	10.1371/journal.pone.0067512	http://dx.doi.org/10.1371/journal.pone.0067512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844018	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000077
J	Huang, JL; Tang, TT; Hu, GC; Zheng, J; Wang, YY; Wang, Q; Su, J; Zou, YF; Peng, XW				Huang, Jiongli; Tang, Tiantong; Hu, Guocheng; Zheng, Jing; Wang, Yuyu; Wang, Qiang; Su, Jing; Zou, Yunfeng; Peng, Xiaowu			Association between Exposure to Electromagnetic Fields from High Voltage Transmission Lines and Neurobehavioral Function in Children	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MAGNETIC-FIELDS; POWER-LINES; OCCUPATIONAL-EXPOSURE; RESIDENTIAL EXPOSURE; COGNITIVE PERFORMANCE; NO INFLUENCE; RISK; EMF	Background: Evidence for a possible causal relationship between exposure to electromagnetic fields (EMF) emitted by high voltage transmission (HVT) lines and neurobehavioral dysfunction in children is insufficient. The present study aims to investigate the association between EMF exposure from HVT lines and neurobehavioral function in children. Methods: Two primary schools were chosen based on monitoring data of ambient electromagnetic radiation. A cross-sectional study with 437 children (9 to 13 years old) was conducted. Exposure to EMF from HVT lines was monitored at each school. Information was collected on possible confounders and relevant exposure predictors using standardized questionnaires. Neurobehavioral function in children was evaluated using established computerized neurobehavioral tests. Data was analyzed using multivariable regression models adjusted for relevant confounders. Results: After controlling for potential confounding factors, multivariable regression revealed that children attending a school near 500 kV HVT lines had poorer performance on the computerized neurobehavioral tests for Visual Retention and Pursuit Aiming compared to children attending a school that was not in close proximity to HVT lines. Conclusions: The results suggest long-term low-level exposure to EMF from HVT lines might have a negative impact on neurobehavioral function in children. However, because of differences in results only for two of four tests achieved statistical significance and potential limitations, more studies are needed to explore the effects of exposure to extremely low frequency EMF on neurobehavioral function and development in children.	[Huang, Jiongli; Hu, Guocheng; Zheng, Jing; Wang, Yuyu; Peng, Xiaowu] Minist Environm Protect, Ctr Environm Hlth Res, South China Inst Environm Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Jiongli; Su, Jing; Zou, Yunfeng] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China; [Tang, Tiantong] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Wang, Qiang] Chinese Ctr Dis Control & Prevent, Environm Hlth & Related Prod Safety, Beijing, Peoples R China	Guangxi Medical University; Southern Medical University - China; Chinese Center for Disease Control & Prevention	Zou, YF (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China.	email_zyf@163.com; pengxiaowu@scies.org			Public Sector Program of National Environmental Protection of the People's Republic of China [200909107]	Public Sector Program of National Environmental Protection of the People's Republic of China	This study was financially supported by the Public Sector Program of National Environmental Protection of the People's Republic of China (No. 200909107). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Allen SG, 1994, 16 ANN M BIOEL SOC C, P103; [Anonymous], 2002, C9532002 IEEE, P1, DOI [10.1109/IEEESTD.2002.94143, DOI 10.1109/IEEESTD.2002.94143]; Baldi I, 2011, INT J CANCER, V129, P1477, DOI 10.1002/ijc.25765; BEARER CF, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432337; Behrens T, 2004, J EXPO ANAL ENV EPID, V14, P144, DOI 10.1038/sj.jea.7500305; Coble JB, 2009, NEURO-ONCOLOGY, V11, P242, DOI 10.1215/15228517-2009-002; Crasson M, 1999, BIOELECTROMAGNETICS, V20, P474, DOI 10.1002/(SICI)1521-186X(199912)20:8<474::AID-BEM2>3.0.CO;2-M; Crasson M, 2003, RADIAT PROT DOSIM, V106, P333, DOI 10.1093/oxfordjournals.rpd.a006369; Dahl R, 1996, NEUROTOXICOL TERATOL, V18, P413, DOI 10.1016/0892-0362(96)00031-1; Davidson PW, 2000, NEUROTOXICOLOGY, V21, P957; Delhez M, 2004, BIOELECTROMAGNETICS, V25, P592, DOI 10.1002/bem.20040; Draper G, 2005, BRIT MED J, V330, P1290, DOI 10.1136/bmj.330.7503.1290; Feizi AAHP, 2007, ASIAN PAC J CANCER P, V8, P69; Forssen UM, 2002, BIOELECTROMAGNETICS, V23, P239, DOI 10.1002/bem.10013; Foster KR, 2003, RADIAT PROT DOSIM, V106, P301, DOI 10.1093/oxfordjournals.rpd.a006364; Frei P, 2010, ENVIRON INT, V36, P714, DOI 10.1016/j.envint.2010.05.005; GAUGER JR, 1985, IEEE T POWER AP SYST, V104, P2436, DOI 10.1109/TPAS.1985.318988; GOLDMAN LR, 1995, ENVIRON HEALTH PERSP, V103, P13, DOI 10.2307/3432338; Heida T, 2003, ADV ANAT EMBRYOL CEL, V173, P1; Hubal EAC, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454607; Iarc, 2002, IARC MONOGRAPHS EVAL, V80; ICNIRP-International Commission on Non-Ionizing Radiation Protection, 2003, 132003 ICNIRP; Johnsson A, 2000, CHILDREN RAD SELECTE, P53; Kabuto M, 2006, INT J CANCER, V119, P643, DOI 10.1002/ijc.21374; KAUNE WT, 1993, ENVIRON HEALTH PERSP, V101, P121, DOI 10.2307/3431668; Kheifets L, 2009, OCCUP ENVIRON MED, V66, P72, DOI 10.1136/oem.2007.037994; Kheifets L.I, 2001, J RISK RES, V4, P113, DOI DOI 10.1080/136698701750128042; King RWP, 1999, IEEE T BIO-MED ENG, V46, P1426, DOI 10.1109/10.804570; King RWP, 1998, IEEE ENG MED BIOL, V17, P67, DOI 10.1109/51.731324; Kurokawa Y, 2003, INT ARCH OCC ENV HEA, V76, P437, DOI 10.1007/s00420-003-0445-6; Landgrebe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005026; Leitgeb N, 2008, INT J HYG ENVIR HEAL, V211, P69, DOI 10.1016/j.ijheh.2007.03.005; Levallois P, 1998, ENV HLTH PERSPECT, V106, pA422; Li CY, 2003, AM J IND MED, V43, P212, DOI 10.1002/ajim.10148; Maslanyj MP, 2007, J RADIOL PROT, V27, P41, DOI 10.1088/0952-4746/27/1/002; McGuire V, 1997, AM J EPIDEMIOL, V145, P1076, DOI 10.1093/oxfordjournals.aje.a009070; Mezei G, 2001, J EXPO ANAL ENV EPID, V11, P41, DOI 10.1038/sj.jea.7500145; Miller AB, 2010, CHRONIC DIS CAN, V29, P69; Miller RD, 2000, IEEE ENG MED BIOL, V19, P131; Nevelsteen S, 2007, BIOELECTROMAGNETICS, V28, P53, DOI 10.1002/bem.20265; Nielsen U, 1998, Ugeskr Laeger, V160, P3557; Noonan CW, 2002, SCAND J WORK ENV HEA, V28, P42, DOI 10.5271/sjweh.645; Otto DA, 1996, NEUROTOXICOL TERATOL, V18, P421, DOI 10.1016/0892-0362(96)00036-0; People's Republic of China, 1998, HJT241998 PEOPL REP; People's Republic of China, 1996, HJT1296 PEOPL REP CH; Preece AW, 2000, PHYS MED BIOL, V45, pR139, DOI 10.1088/0031-9155/45/9/201; Prochnow N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019437; Qin JingXiang, 2010, Journal of Environmental & Occupational Medicine, V27, P590; Radiation and Environmental Health Department of Protection of the Human Environment World Health Organization, 2002, RAD ENV HLTH DEP PRO; ROGAN WJ, 1995, ENVIRON HEALTH PERSP, V103, P19, DOI 10.2307/3432339; Rohlman DS, 2008, NEUROTOXICOLOGY, V29, P143, DOI 10.1016/j.neuro.2007.10.006; Rohlman DS, 2007, NEUROTOXICOLOGY, V28, P240, DOI 10.1016/j.neuro.2006.03.021; Saunders RD, 2007, HEALTH PHYS, V92, P596, DOI 10.1097/01.HP.0000257856.83294.3e; Sobel E, 1996, NEUROLOGY, V47, P1594, DOI 10.1212/WNL.47.6.1594; Tamburlini G, 2002, CHILDRENS HLTH ENV R, V29, P172; Valjus J, 1995, BIOELECTROMAGNETICS, V16, P365, DOI 10.1002/bem.2250160604; Vistnes AI, 1997, BIOELECTROMAGNETICS, V18, P47, DOI 10.1002/(SICI)1521-186X(1997)18:1<47::AID-BEM8>3.0.CO;2-5; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; World Health Organization, 2007, EMF PUBL HLTH EXP EX; World Health Organization, 2007, ASS CONCL SUGG WHOS, P58; World Health Organization, 1998, INT EMF PROJ; World Health Organization, 2007, ENV HLTH CRIT, V238; [吴海磊 Wu Hailei], 2004, [环境与健康杂志, Journal of Environment and Health], V21, P186; Xu LM, 2001, J LABOUR MED, V18, P101; Zhou HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048354	66	23	23	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67284	10.1371/journal.pone.0067284	http://dx.doi.org/10.1371/journal.pone.0067284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843999	Green Published, gold, Green Submitted			2022-12-27	WOS:000321733000068
J	Saeki, M; Egusa, H; Kamano, Y; Kakihara, Y; Houry, WA; Yatani, H; Noguchi, S; Kamisaki, Y				Saeki, Makio; Egusa, Hiroshi; Kamano, Yuya; Kakihara, Yoshito; Houry, Walid A.; Yatani, Hirofumi; Noguchi, Shinzaburo; Kamisaki, Yoshinori			Exosome-Bound WD Repeat Protein Monad Inhibits Breast Cancer Cell Invasion by Degrading Amphiregulin mRNA	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; R2TP COMPLEX; BINDING-PROTEIN; DECAY; DEGRADATION; ACTIVATION; AUTOCRINE; INTERACTS; MULTIPLE; ELEMENTS	Increased stabilization of mRNA coding for key cancer genes can contribute to invasiveness. This is achieved by down-regulation of exosome cofactors, which bind to 3'-UTR in cancer-related genes. Here, we identified amphiregulin, an EGFR ligand, as a target of WD repeat protein Monad, a component of R2TP/prefoldin-like complex, in MDA-MB-231 breast cancer cells. Monad specifically interacted with both the 3'-UTR of amphiregulin mRNA and the RNA degrading exosome, and enhanced decay of amphiregulin transcripts. Knockdown of Monad increased invasion and this effect was abolished with anti-amphiregulin neutralizing antibody. These results suggest that Monad could prevent amphiregulin-mediated invasion by degrading amphiregulin mRNA.	[Saeki, Makio; Kamano, Yuya; Kamisaki, Yoshinori] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Suita, Osaka, Japan; [Egusa, Hiroshi; Kamano, Yuya; Yatani, Hirofumi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka, Japan; [Kakihara, Yoshito; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Noguchi, Shinzaburo] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Suita, Osaka, Japan	Osaka University; Osaka University; University of Toronto; Osaka University	Saeki, M (corresponding author), Osaka Univ, Grad Sch Dent, Dept Pharmacol, Suita, Osaka, Japan.	msaeki@dent.osaka-u.ac.jp	Egusa, Hiroshi/AFT-9694-2022	Egusa, Hiroshi/0000-0002-0200-8132	Japan Society for the Promotion of Science [C24592795]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (C24592795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Souhibani N, 2010, ONCOGENE, V29, P4205, DOI 10.1038/onc.2010.168; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Boulon S, 2012, RNA BIOL, V9, DOI 10.4161/rna.9.2.18494; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Garbett EA, 2000, J CLIN PATHOL-MOL PA, V53, P99, DOI 10.1136/mp.53.2.99; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Granneman S, 2002, J BIOL CHEM, V277, P48490, DOI 10.1074/jbc.M206631200; Grigoletto A, 2011, BBA-REV CANCER, V1815, P147, DOI 10.1016/j.bbcan.2010.11.002; Gururaj AE, 2006, CLIN CANCER RES, V12, p1001S, DOI 10.1158/1078-0432.CCR-05-2110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Inoue M, 2010, BIOCHEM BIOPH RES CO, V403, P340, DOI 10.1016/j.bbrc.2010.11.031; Itsuki Y, 2008, FEBS LETT, V582, P2365, DOI 10.1016/j.febslet.2008.05.041; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Johnston SRD, 2006, CLIN CANCER RES, V12, p1061S, DOI 10.1158/1078-0432.CCR-05-2125; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Latasa MU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052711; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; McKeegan KS, 2009, MOL CELL BIOL, V29, P4971, DOI 10.1128/MCB.00752-09; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Nakayama H, 2013, J BIOL CHEM, V288, P10338, DOI 10.1074/jbc.M112.417527; Ni L, 2009, J CELL BIOCHEM, V106, P920, DOI 10.1002/jcb.22073; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Saeki M, 2006, BIOCHEM BIOPH RES CO, V342, P568, DOI 10.1016/j.bbrc.2006.02.009; Saeki M, 2002, J CELL BIOCHEM, V84, P708, DOI 10.1002/jcb.10086; Saeki M, 2007, J BIOL CHEM, V282, P11786, DOI 10.1074/jbc.M609347200; Shen V, 2006, CELL, V127, P1093, DOI 10.1016/j.cell.2006.11.035; Shimada K, 2011, BIOCHEM BIOPH RES CO, V404, P910, DOI 10.1016/j.bbrc.2010.12.071; Silvy M, 2001, BRIT J CANCER, V84, P936, DOI 10.1054/bjoc.2000.1678; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Yoshida M, 2013, BIOCHEM BIOPH RES CO, V430, P320, DOI 10.1016/j.bbrc.2012.11.017; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	48	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67326	10.1371/journal.pone.0067326	http://dx.doi.org/10.1371/journal.pone.0067326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844004	gold, Green Published, Green Submitted			2022-12-27	WOS:000321733000069
J	Islam, MR; Khatun, R; Uddin, MKM; Khan, MSR; Rahman, MT; Ahmed, T; Banu, S				Islam, Mohammad R.; Khatun, Razia; Uddin, Mohammad Khaja Mafij; Khan, Md. Siddiqur Rahman; Rahman, Md. Toufiq; Ahmed, Tahmeed; Banu, Sayera			Yield of Two Consecutive Sputum Specimens for the Effective Diagnosis of Pulmonary Tuberculosis	PLOS ONE			English	Article							DECOMPRESSION-SICKNESS; AIR SATURATION; OXYGEN; ASCENT; ATA	Background: From long instances, it is debatable whether three sputum specimens are required for the diagnosis of pulmonary tuberculosis (TB) or TB can be diagnosed effectively using two consecutive sputum specimens. This study was set out to evaluate the significance of examining multiple sputum specimens in diagnosis of TB. Methods: We retrospectively reviewed the acid-fast bacillus (AFB) smear and culture results of three consecutive days' sputum specimens from 413 confirmed TB patients which were detected as part of a larger active case finding study in Dhaka Central Jail, the largest correctional facility in Bangladesh. Results: AFB was detected from 81% (n = 334) patients, of which 89% (n = 297) were diagnosed from the first and additional 9% (n = 30) were from the second sputum specimen. M. tuberculosis growth was observed for 406 patients and 85% (n = 343) were obtained from the first sputum and additional 10% (n = 42) were from the second one. The third specimen didn't show significant additional diagnostic value for the detection of AFB by microscopy or growth of the M. tuberculosis. Conclusions: We concluded from our study results that examining two consecutive sputum specimens is sufficient enough for the effective diagnosis of TB. It can also decrease the laboratory workload and hence improve the quality of work in settings with high TB burden like Bangladesh.	[Khatun, Razia; Uddin, Mohammad Khaja Mafij; Khan, Md. Siddiqur Rahman; Rahman, Md. Toufiq; Ahmed, Tahmeed; Banu, Sayera] Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, Dhaka 1000, Bangladesh; [Islam, Mohammad R.] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka 1000, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); University of Dhaka	Banu, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Communicable Dis, GPO Box 128, Dhaka 1000, Bangladesh.	sbanu@icddrb.org	Khan, Mohammad Siddiqur/J-3025-2018	Khan, Mohammad Siddiqur/0000-0003-2479-6405; Banu, Sayera/0000-0002-5121-1962	Government of Bangladesh through IHP-HNPRP; icddr,b;  [GR-00410]	Government of Bangladesh through IHP-HNPRP; icddr,b; 	This work was supported by grants from the Government of Bangladesh through IHP-HNPRP and icddr,b. The grant number is GR-00410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PD, 1984, UNDERSEA BIOMED RES, V11, P387; BERGHAGE T E, 1976, Undersea Biomedical Research, V3, P387; Blatteau JE, 2012, 1206 IRBA; Blatteau JE, 2012, EUR J APPL PHYSIOL, V112, P2257, DOI 10.1007/s00421-011-2195-6; Bregeon F, 2002, RESP PHYSIOL NEUROBI, V132, P191, DOI 10.1016/S1569-9048(02)00069-1; Bregeon F, 2010, J PHYSIOL-LONDON, V588, P1309, DOI 10.1113/jphysiol.2010.187658; Clark JM, 1999, J APPL PHYSIOL, V86, P243, DOI 10.1152/jappl.1999.86.1.243; Clark JM, 2003, BENNETT ELLIOTTS PHY, V5th, P358; Clarke Jr, 1999, LUNG BIOL HEALTH DIS, V132, P1; Degryse J, 2012, RESPIRATION, V83, P543, DOI 10.1159/000334907; Dromsky DM, 2000, J APPL PHYSIOL, V89, P791, DOI 10.1152/jappl.2000.89.2.791; ECKENHOFF RG, 1986, UNDERSEA BIOMED RES, V13, P305; ECKENHOFF RG, 1985, UNDERSEA BIOMED RES, V12, P41; ECKENHOFF RG, 1987, AVIAT SPACE ENVIR MD, V58, P658; Eftedal O, 2007, THESIS NORWEGIAN U S; GARDETTE B, 1979, UNDERSEA BIOMED RES, V6, P99; Hamilton R.W., 2003, BENNETT ELLIOTTS PHY, P455; Harvey C, 1989, SP891 NAV SUBM MED R; Hugon J, 2010, THESIS U MEDITERRANE; Jammes Y, 2006, PHYSL MED PLONGEE, P86; Lambersten CJ, 1973, AEROSPACE MED, V44, P703; Latson G, 2000, 1100 NEDU TR NAV SEA; Miller JW, 1979, NOAA DIVING MANUAL D, P1; Nishi R. Y., 2003, BENNETT ELLIOTTS PHY, P501; Risberg J, 2008, 1100 NEDU TR NAV SEA; Sawatzky KD, 1991, THESIS YORK U TORONT; Thalmann ED, 1989, UHMS PUBLICATION, V74(VAL)1-1-88, P33; THORSEN E, 1994, EUR RESPIR J, V7, P4, DOI 10.1183/09031936.94.07010004	28	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67678	10.1371/journal.pone.0067678	http://dx.doi.org/10.1371/journal.pone.0067678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844057	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000073
J	Liddelow, SA; Dziegielewska, KM; Ek, CJ; Habgood, MD; Bauer, H; Bauer, HC; Lindsay, H; Wakefield, MJ; Strazielle, N; Kratzer, I; Mollgard, K; Ghersi-Egea, JF; Saunders, NR				Liddelow, Shane A.; Dziegielewska, Katarzyna M.; Ek, C. Joakim; Habgood, Mark D.; Bauer, Hannelore; Bauer, Hans-Christian; Lindsay, Helen; Wakefield, Matthew J.; Strazielle, Nathalie; Kratzer, Ingrid; Mollgard, Kjeld; Ghersi-Egea, Jean-Francois; Saunders, Norman R.			Mechanisms That Determine the Internal Environment of the Developing Brain: A Transcriptomic, Functional and Ultrastructural Approach	PLOS ONE			English	Article							BASOLATERAL PLASMA-MEMBRANE; CHOROID-PLEXUS EPITHELIUM; CEREBROSPINAL-FLUID; BLOOD-BRAIN; TIGHT JUNCTIONS; FETAL SHEEP; DIFFERENTIAL EXPRESSION; METABOLIC-ACIDOSIS; GENE-EXPRESSION; BARRIER	We provide comprehensive identification of embryonic (E15) and adult rat lateral ventricular choroid plexus transcriptome, with focus on junction-associated proteins, ionic influx transporters and channels. Additionally, these data are related to new structural and previously published permeability studies. Results reveal that most genes associated with intercellular junctions are expressed at similar levels at both ages. In total, 32 molecules known to be associated with brain barrier interfaces were identified. Nine claudins showed unaltered expression, while two claudins (6 and 8) were expressed at higher levels in the embryo. Expression levels for most cytoplasmic/regulatory adaptors (10 of 12) were similar at the two ages. A few junctional genes displayed lower expression in embryos, including 5 claudins, occludin and one junctional adhesion molecule. Three gap junction genes were enriched in the embryo. The functional effectiveness of these junctions was assessed using blood-delivered water-soluble tracers at both the light and electron microscopic level: embryo and adult junctions halted movement of both 286Da and 3kDa molecules into the cerebrospinal fluid (CSF). The molecular identities of many ion channel and transporter genes previously reported as important for CSF formation and secretion in the adult were demonstrated in the embryonic choroid plexus (and validated with immunohistochemistry of protein products), but with some major age-related differences in expression. In addition, a large number of previously unidentified ion channel and transporter genes were identified for the first time in plexus epithelium. These results, in addition to data obtained from electron microscopical and physiological permeability experiments in immature brains, indicate that exchange between blood and CSF is mainly transcellular, as well-formed tight junctions restrict movement of small water-soluble molecules from early in development. These data strongly indicate the brain develops within a well-protected internal environment and the exchange between the blood, brain and CSF is transcellular and not through incomplete barriers.	[Liddelow, Shane A.; Dziegielewska, Katarzyna M.; Habgood, Mark D.; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Lindsay, Helen] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Wakefield, Matthew J.] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Liddelow, Shane A.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Ek, C. Joakim] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Bauer, Hannelore; Bauer, Hans-Christian; Kratzer, Ingrid] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria; [Bauer, Hans-Christian] Paracelsus Med Univ, Salzburg, Austria; [Lindsay, Helen; Wakefield, Matthew J.] Walter & Eliza Hall Inst Med Res, Melbourne, Australia; [Ghersi-Egea, Jean-Francois] INSERM, Lyon Neurosci Res Ctr, U1028, F-69008 Lyon, France; [Strazielle, Nathalie] Brain I, Lyon, France; [Mollgard, Kjeld] Univ Copenhagen, Inst Cellular & Mol Med, Copenhagen, Denmark	University of Melbourne; University of Melbourne; University of Melbourne; Stanford University; University of Gothenburg; Salzburg University; Paracelsus Private Medical University; Walter & Eliza Hall Institute; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Copenhagen	Liddelow, SA (corresponding author), Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia.	liddelow@stanford.edu	Wakefield, Matthew/X-7593-2019; Liddelow, Shane/ABE-6456-2020; Wakefield, Matthew J/A-7795-2008	Wakefield, Matthew/0000-0001-6624-4698; Liddelow, Shane/0000-0002-0840-1437; Wakefield, Matthew J/0000-0001-6624-4698; Lindsay, Helen/0000-0001-8614-1661; Ghersi-Egea, Jean-Francois/0000-0002-0181-4909; Saunders, Norman/0000-0001-6660-7639	National Health and Medical Research Council (Australia) [567205]; European Union Seventh Framework Program (FP7) Neurobid consortium [HEALTH-F2-2009-241778]; American-Australian Association	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); European Union Seventh Framework Program (FP7) Neurobid consortium; American-Australian Association	SAL, KMD and NRS are supported by the National Health and Medical Research Council (Australia) - Grant No. 567205. SAL, KMD, NRS, CJE, HB, H-CB, NS, J-FG-E are supported by the European Union Seventh Framework Program (FP7) Neurobid consortium - Agreement No. HEALTH-F2-2009-241778, KM was an advisor to the consortium. SAL was supported as a Neurological Fellow by the by the American-Australian Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; ADINOLFI M, 1985, DEV MED CHILD NEUROL, V27, P532; Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Alberts B, 2008, MOL BIOL CELL, P1151; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; AMTORP O, 1974, J PHYSIOL-LONDON, V243, P387, DOI 10.1113/jphysiol.1974.sp010759; Anders S., 2010, HTSEQ 0 4 7P4; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelidou A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-89; Arabzadeh A, 2006, MOL CELL BIOL, V26, P5876, DOI 10.1128/MCB.02342-05; Balslev Y, 1997, ANAT EMBRYOL, V195, P229, DOI 10.1007/s004290050042; BASS NH, 1973, BRAIN RES, V52, P323, DOI 10.1016/0006-8993(73)90668-9; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bauer HC, 2011, J NEURAL TRANSM, V118, P7, DOI 10.1007/s00702-010-0484-6; BITO LZ, 1970, J PHYSIOL-LONDON, V208, P153, DOI 10.1113/jphysiol.1970.sp009111; BRADBURY MW, 1972, J PHYSIOL-LONDON, V227, P591, DOI 10.1113/jphysiol.1972.sp010049; Brown PD, 2004, NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003; Chiba H, 2003, EXP CELL RES, V286, P288, DOI 10.1016/S0014-4827(03)00116-2; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Costa LG, 2004, ANNU REV PHARMACOL, V44, P87, DOI 10.1146/annurev.pharmtox.44.101802.121424; Costa LG, 2010, NEUROTOXICOLOGY, V31, P409, DOI 10.1016/j.neuro.2010.05.003; Dagnino L, 1997, MECH DEVELOP, V66, P13, DOI 10.1016/S0925-4773(97)00083-X; Damkier HH, 2010, PHYSIOLOGY, V25, P239, DOI 10.1152/physiol.00011.2010; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Damkier HH, 2010, J BIOL CHEM, V285, P26998, DOI 10.1074/jbc.M110.108712; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Davson H, 1996, PHYSL CSF BLOOD BRAI; DIAMOND JM, 1974, FED PROC, V33, P2220; Edwards JC, 2010, FEBS LETT, V584, P2102, DOI 10.1016/j.febslet.2010.01.037; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Ek CJ, 2003, J COMP NEUROL, V460, P451, DOI 10.1002/cne.10661; Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z; EVANS CAN, 1974, J PHYSIOL-LONDON, V238, P371, DOI 10.1113/jphysiol.1974.sp010530; FRIEND DS, 1972, J CELL BIOL, V53, P758, DOI 10.1083/jcb.53.3.758; Fromm M, 2011, ANN NY ACAD SCI, V1257, P1; FROMTER E, 1972, NATURE-NEW BIOL, V235, P9, DOI 10.1038/newbio235009a0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hubner CA, 2004, GENE EXPR PATTERNS, V5, P219, DOI 10.1016/j.modgep.2004.08.002; Hurskainen T, 2012, CELL TISSUE RES, V348, P579, DOI 10.1007/s00441-012-1368-x; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jo KD, 2013, ANAT CELL BIOL, V46, P68, DOI 10.5115/acb.2013.46.1.68; JOHANSON CE, 1976, LIFE SCI, V19, P691, DOI 10.1016/0024-3205(76)90166-1; Johanson CE, 1974, DRUGS DEV BRAIN, P281; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Johansson PA, 2006, EUR J NEUROSCI, V24, P65, DOI 10.1111/j.1460-9568.2006.04904.x; Johansson PA, 2005, CELL TISSUE RES, V322, P353, DOI 10.1007/s00441-005-1120-x; Johansson P, 2008, NEUROSCI LETT, V442, P77, DOI 10.1016/j.neulet.2008.06.068; Johansson PA, 2008, BIOESSAYS, V30, P237, DOI 10.1002/bies.20718; JONES HC, 1988, PHYSIOL BOHEMOSLOV, V37, P213; KEEP RF, 1990, DEV BRAIN RES, V56, P47, DOI 10.1016/0165-3806(90)90163-S; Knott GW, 1997, J PHYSIOL-LONDON, V499, P179, DOI 10.1113/jphysiol.1997.sp021919; Kratzer I, 2013, FLUIDS BARR IN PRESS; Kratzer I, 2012, HISTOCHEM CELL BIOL, V138, P861, DOI 10.1007/s00418-012-1001-9; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; Liang WB, 2012, PSYCHIAT RES, V200, P214, DOI 10.1016/j.psychres.2012.06.007; Liddelow SA, 2011, EUR J NEUROSCI, V34, P1062, DOI 10.1111/j.1460-9568.2011.07821.x; Liddelow SA, 2011, EUR J NEUROSCI, V33, P391, DOI 10.1111/j.1460-9568.2010.07509.x; Liddelow SA, 2013, MOL EXPRESSION UNPUB; Liddelow SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033554; Liddelow SA, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-16; Liddelow SA, 2009, EUR J NEUROSCI, V29, P253, DOI 10.1111/j.1460-9568.2008.06571.x; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Llop S, 2011, SCI TOTAL ENVIRON, V409, P2298, DOI 10.1016/j.scitotenv.2011.02.004; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; MARINPADILLA M, 1985, J COMP NEUROL, V241, P237, DOI 10.1002/cne.902410210; Marques F, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-10; Millar Ian D, 2007, Cerebrospinal Fluid Res, V4, P8, DOI 10.1186/1743-8454-4-8; MITCHELL W, 1982, NEUROSCI LETT, V31, P37, DOI 10.1016/0304-3940(82)90050-7; MOLLGARD K, 1979, J NEUROCYTOL, V8, P139, DOI 10.1007/BF01175557; MURPHY VA, 1989, J NEUROCHEM, V52, P1058, DOI 10.1111/j.1471-4159.1989.tb01847.x; MURPHY VA, 1990, AM J PHYSIOL, V258, pF1528, DOI 10.1152/ajprenal.1990.258.6.F1528; NATTIE EE, 1981, J APPL PHYSIOL, V50, P566, DOI 10.1152/jappl.1981.50.3.566; Nejsum LN, 2005, AM J PHYSIOL-CELL PH, V289, pC333, DOI 10.1152/ajpcell.00228.2004; Niehof M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-68; Nishikata M, 2007, MOL CARCINOGEN, V46, P208, DOI 10.1002/mc.20264; OOSTERWEGEL M, 1993, DEVELOPMENT, V118, P439; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Owler Brian K, 2010, Cerebrospinal Fluid Res, V7, P15, DOI 10.1186/1743-8454-7-15; Paris L, 2008, MOL BIOL CELL, V19, P5409, DOI 10.1091/mbc.E08-05-0477; Pfeiffer F, 2011, ACTA NEUROPATHOL, V122, P601, DOI 10.1007/s00401-011-0883-2; Picaud SS, 2009, PROTEINS, V76, P507, DOI 10.1002/prot.22411; POLLAY M, 1985, NEUROSURGERY, V17, P768, DOI 10.1227/00006123-198511000-00007; Praetorius J, 2004, AM J PHYSIOL-CELL PH, V286, pC601, DOI 10.1152/ajpcell.00240.2003; Praetorius J, 2007, PFLUG ARCH EUR J PHY, V454, P1, DOI 10.1007/s00424-006-0170-6; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Reed DJ, 1976, EXPT BRAIN RES, V3, P212; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROSSDALE PD, 1982, EQUINE VET J, V14, P134, DOI 10.1111/j.2042-3306.1982.tb02367.x; Salehi Z, 2009, J CLIN NEUROSCI, V16, P950, DOI 10.1016/j.jocn.2008.09.018; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Saunders NR, 1992, PHYSL PHARM BLOOD BR, P327, DOI DOI 10.1007/978-3-642-76894-1_14; Schmitt C, 2011, J NEUROCHEM, V117, P747, DOI 10.1111/j.1471-4159.2011.07246.x; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; STRONG LH, 1964, J COMP NEUROL, V123, P151, DOI 10.1002/cne.901230111; Sun M, 2010, NEUROSCIENCE, V169, P920, DOI 10.1016/j.neuroscience.2010.05.026; Swetloff A, 2005, INT J DEV BIOL, V49, P859, DOI 10.1387/ijdb.051996as; Theil T, 1999, DEVELOPMENT, V126, P3561; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; Turksen K, 2001, DEV DYNAM, V222, P292, DOI 10.1002/dvdy.1174; Vogelmann R, 2005, MOL BIOL CELL, V16, P701, DOI 10.1091/mbc.E04-09-0827; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wolburg H, 2001, NEUROSCI LETT, V307, P77, DOI 10.1016/S0304-3940(01)01927-9; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200	116	49	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e65629	10.1371/journal.pone.0065629	http://dx.doi.org/10.1371/journal.pone.0065629			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843944	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000007
J	Schabussova, I; Ul-Haq, O; Hoflehner, E; Akgun, J; Wagner, A; Loupal, G; Joachim, A; Ruttkowski, B; Maizels, RM; Wiedermann, U				Schabussova, Irma; Ul-Haq, Onisa; Hoflehner, Elisabeth; Akguen, Johnnie; Wagner, Angelika; Loupal, Gerhard; Joachim, Anja; Ruttkowski, Baerbel; Maizels, Rick M.; Wiedermann, Ursula			Oesophagostomum dentatum Extract Modulates T Cell-Dependent Immune Responses to Bystander Antigens and Prevents the Development of Allergy in Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLACEBO-CONTROLLED TRIAL; TRICHURIS-SUIS THERAPY; SKIN-TEST REACTIVITY; HELMINTH INFECTION; HUMORAL RESPONSES; HUMAN ONCHOCERCIASIS; AIRWAY INFLAMMATION; TETANUS VACCINATION; HOOKWORM INFECTION	One third of the human population is currently infected by one or more species of parasitic helminths. Certain helminths establish long-term chronic infections resulting in a modulation of the host's immune system with attenuated responsiveness to "bystander" antigens such as allergens or vaccines. In this study we investigated whether parasite-derived products suppress the development of allergic inflammation in a mouse model. We show that extract derived from adult male Oesophagostomum dentatum (eMOD) induced Th2 and regulatory responses in BALB/c mice. Stimulation of bone marrow-derived dendritic cells induced production of regulatory cytokines IL-10 and TGF-beta. In a mouse model of birch pollen allergy, co-administration of eMOD with sensitizing allergen Bet v 1 markedly reduced the production of allergen-specific antibodies in serum as well as IgE-dependent basophil degranulation. Furthermore, eMOD prevented the development of airway inflammation, as demonstrated by attenuation of bronchoalveolar lavages eosinophil influx, peribronchial inflammatory infiltrate, and mucus secretion in lungs and IL-4 and IL-5 levels in lung cell cultures. Reduced secretion of Th2-related cytokines by birch pollen-re-stimulated splenocytes and mesenteric lymph node cells was observed in eMOD-treated/sensitized and challenged mice in comparison to sensitized and challenged controls. The suppressive effects of eMOD were heat-stable. Immunization with model antigens in the presence of eMOD reduced production of antibodies to thymus-dependent but not to thymus-independent antigen, suggesting that suppression of the immune responses by eMOD was mediated by interference with antigen presenting cell or T helper cell function but did not directly suppress B cell function. In conclusion, we have shown that eMOD possesses immunomodulatory properties and that heat-stable factors in eMOD are responsible for the dramatic suppression of allergic responses in a mouse model of type I allergy. The identification and characterization of parasite-derived immune-modulating molecules might have potential for designing novel prophylactic/therapeutic strategies for immune-mediated diseases.	[Schabussova, Irma; Ul-Haq, Onisa; Hoflehner, Elisabeth; Akguen, Johnnie; Wagner, Angelika; Wiedermann, Ursula] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Loupal, Gerhard] Univ Vet Med, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria; [Joachim, Anja; Ruttkowski, Baerbel] Univ Vet Med, Inst Parasitol, Vienna, Austria; [Maizels, Rick M.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Edinburgh	Schabussova, I (corresponding author), Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	irma.schabussova@meduniwien.ac.at		Wagner, Angelika/0000-0002-5447-9534; Joachim, Anja/0000-0003-3082-6885; Wiedermann, Ursula/0000-0002-1302-3223; Schabussova, Irma/0000-0002-2109-2640	Austrian Science Fund [F46]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was financially supported by SFB grant "Towards prevention and therapy of allergy", F46 from Austrian Science Fund. The Austrian Science Fund had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara-Neves NM, 2012, J ALLERGY CLIN IMMUN, V129, P359, DOI 10.1016/j.jaci.2011.09.015; Bager P, 2012, J ALLERGY CLIN IMMUN, V125, pe121; Baumgart M, 2006, J IMMUNOL, V176, P5374, DOI 10.4049/jimmunol.176.9.5374; Boitelle A, 2005, INT J PARASITOL, V35, P765, DOI 10.1016/j.ijpara.2005.02.013; Bourke CD, 2012, CLIN EXP ALLERGY, V42, P1582, DOI 10.1111/j.1365-2222.2012.04063.x; Cardoso LS, 2010, CLIN EXP IMMUNOL, V160, P266, DOI 10.1111/j.1365-2249.2009.04084.x; Cooper PJ, 1999, INFECT IMMUN, V67, P5951, DOI 10.1128/IAI.67.11.5951-5957.1999; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; Doetze A, 2000, INT IMMUNOL, V12, P623, DOI 10.1093/intimm/12.5.623; Donnelly S, 2006, CHEM IMMUNOL ALLERGY, V90, P45, DOI 10.1159/000088880; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x; Esen M, 2012, VACCINE; Feary J, 2009, CLIN EXP ALLERGY, V39, P1060, DOI 10.1111/j.1365-2222.2009.03187.x; Feary JR, 2010, CLIN EXP ALLERGY, V40, P299, DOI 10.1111/j.1365-2222.2009.03433.x; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; Flohr C, 2010, CLIN EXP ALLERGY, V40, P131, DOI 10.1111/j.1365-2222.2009.03346.x; Flohr C, 2009, CLIN EXP ALLERGY, V39, P20, DOI 10.1111/j.1365-2222.2008.03134.x; Flohr C, 2006, J ALLERGY CLIN IMMUN, V118, P1305, DOI 10.1016/j.jaci.2006.08.035; Gasser RB, 2007, BIOTECHNOL ADV, V25, P281, DOI 10.1016/j.biotechadv.2007.01.008; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hartgers FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000227; Hartmann W, 2012, EXP PARASITOL; Hartmann W, 2011, J IMMUNOL, V187, P4088, DOI 10.4049/jimmunol.1004136; Hufnagl K, 2003, CLIN EXP IMMUNOL, V133, P170, DOI 10.1046/j.1365-2249.2003.02210.x; Ilic N, 2011, PARASITE IMMUNOL, V33, P572, DOI 10.1111/j.1365-3024.2011.01322.x; Joachim A, 2001, PARASITOL INT, V50, P41, DOI 10.1016/S1383-5769(00)00070-2; Joachim A, 1999, PARASITOLOGY, V119, P491, DOI 10.1017/S0031182099004965; Johnston MJG, 2010, INFECT IMMUN, V78, P1364, DOI 10.1128/IAI.01349-08; KILIAN HD, 1989, TROP MED PARASITOL, V40, P445; Kuijk LM, 2012, MOL IMMUNOL, V51, P210, DOI 10.1016/j.molimm.2012.03.020; Lack G, 1996, J IMMUNOL, V157, P1432; Lee KH, 2008, VET PARASITOL, V156, P216, DOI 10.1016/j.vetpar.2008.06.016; LYNCH NR, 1993, J ALLERGY CLIN IMMUN, V92, P404, DOI 10.1016/0091-6749(93)90119-Z; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; McSorley HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024092; McSorley HJ, 2012, EUR J IMMUNOL; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Noland GS, 2010, VACCINE, V28, P2917, DOI 10.1016/j.vaccine.2010.02.055; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Randolph DA, 1999, J IMMUNOL, V162, P2375; Rodrigues LC, 2008, CLIN EXP ALLERGY, V38, P1769, DOI 10.1111/j.1365-2222.2008.03027.x; ROUGEMONT A, 1977, LANCET, V1, P309; Schabussova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040271; Schabussova I, 2011, VACCINE, V29, P1981, DOI 10.1016/j.vaccine.2010.12.101; Schabussova I, 2008, CURR OPIN ALLERGY CL, V8, P557, DOI 10.1097/ACI.0b013e328317b88b; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Slotved HC, 1996, VET PARASITOL, V63, P237, DOI 10.1016/0304-4017(95)00916-7; Smits HH, 2010, CURR ALLERGY ASTHM R, V10, P3, DOI 10.1007/s11882-009-0085-3; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Taylor MD, 2009, EUR J IMMUNOL, V39, P192, DOI 10.1002/eji.200838727; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; van Riet E, 2007, J INFECT DIS, V196, P1671, DOI 10.1086/522010; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128; Zheng XP, 2008, J NEUROIMMUNOL, V194, P107, DOI 10.1016/j.jneuroim.2007.12.001	64	21	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67544	10.1371/journal.pone.0067544	http://dx.doi.org/10.1371/journal.pone.0067544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844022	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000052
J	Alvarez-Gonzalez, C; Duggleby, R; Vagaska, B; Querol, S; Gomez, SG; Ferretti, P; Madrigal, A				Alvarez-Gonzalez, Cesar; Duggleby, Richard; Vagaska, Barbora; Querol, Sergio; Gomez, Susana G.; Ferretti, Patrizia; Madrigal, Alejandro			Cord Blood Lin(-)CD45(-) Embryonic-Like Stem Cells Are a Heterogeneous Population That Lack Self-Renewal Capacity	PLOS ONE			English	Article							BONE-MARROW; PROGENITOR CELLS; IN-VITRO; DIFFERENTIATION; CULTURE; MURINE; BRAIN	Human umbilical cord blood (hUCB) has been proposed to contain not only haematopoietic stem cells, but also a rare pluripotent embryonic-like stem cell (ELSc) population that is negative for hematopoietic markers (Lin(-)CD45(-)) and expresses markers typical of pluripotent cells. The aim of this work was to isolate, characterise and expand this ELSc fraction from hUCB, as it may provide a valuable cell source for regenerative medicine applications. We found that we could indeed isolate a Lin(-)CD45(-) population of small cells (3-10 mu m diameter) with a high nucleus to cytoplasm ratio that expressed the stem cell markers CD34 and CXCR4. However, in contrast to some previous reports, this fraction was not positive for CD133. Furthermore, although these cells expressed transcripts typical of pluripotent cells, such as SOX2, OCT3/4, and NANOG, they were not able to proliferate in any of the culture media known to support stem cell growth that we tested. Further analysis of the Lin(-)CD45(-) population by flow cytometry showed the presence of a Lin(-)CD45(-)Nestin(+) population that were also positive for CD34 (20%) but negative for CXCR4. These data suggest that the Lin(-)CD45(-) stem cell fraction present in the cord blood represents a small heterogeneous population with phenotypic characteristics of stem cells, including a Lin(-)CD45(-)Nestin(+) population not previously described. This study also suggests that heterogeneity within the Lin(-)CD45(-) cell fraction is the likely explanation for differences in the hUCB cell populations described by different groups that were isolated using different methods. These populations have been widely called "embryonic-like stem cell" on the basis of their phenotypical similarity to embryonic stem cells. However, the fact they do not seem to be able to self-renew casts some doubt on their identity, and warns against defining them as "embryonic-like stem cell" at this stage.	[Alvarez-Gonzalez, Cesar; Duggleby, Richard; Querol, Sergio; Gomez, Susana G.; Madrigal, Alejandro] Anthony Nolan Res Inst, London, England; [Alvarez-Gonzalez, Cesar] UCL, Inst Canc, London, England; [Vagaska, Barbora; Ferretti, Patrizia] UCL, Inst Child Hlth, Dev Biol Unit, London, England; [Gomez, Susana G.] Anthony Nolan Cell Therapy Ctr, Nottingham, England; [Querol, Sergio] Banc Sang & Teixits, Barcelona, Spain	University of London; University College London; University of London; University College London	Madrigal, A (corresponding author), Anthony Nolan Res Inst, London, England.	a.madrigal@ucl.ac.uk	González, César Alvarez/I-7484-2019; Duggleby, Richard/AAE-7134-2021; Ferretti, Patrizia/E-9375-2010	González, César Alvarez/0000-0002-1644-3549; Ferretti, Patrizia/0000-0002-3590-6772; Madrigal, Alejandro/0000-0001-8359-9917; Vagaska, Barbora/0000-0001-7511-6428	Anthony Nolan; Great Ormond Street Hospital Charity; Cesar Alvarez-Gonzalez is a fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACyT); Instituto Jaliscience de la Juventud (IJJ) Mexico	Anthony Nolan; Great Ormond Street Hospital Charity; Cesar Alvarez-Gonzalez is a fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACyT); Instituto Jaliscience de la Juventud (IJJ) Mexico	The authors thank the Anthony Nolan and the Great Ormond Street Hospital Charity for financial support. Cesar Alvarez-Gonzalez is a fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACyT) and Instituto Jaliscience de la Juventud (IJJ); Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2012, STEM CELL REV; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bhartiya D, 2012, STEM CELLS DEV, V21, P1, DOI 10.1089/scd.2011.0311; Chua SJ, 2009, BIOCHEM BIOPH RES CO, V379, P217, DOI 10.1016/j.bbrc.2008.12.045; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Danova-Alt R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034899; Duggleby RC, 2012, TRANSFUSION, V52, P549, DOI 10.1111/j.1537-2995.2011.03305.x; Gonzalez S, 2009, CYTOTHERAPY, V11, P35, DOI 10.1080/14653240802499148; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guasti L, 2012, STEM CELL TRANSL MED, V1, P384, DOI 10.5966/sctm.2012-0009; Heider A, 2013, CYTOM PART A, V83A, P72, DOI 10.1002/cyto.a.22229; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Liu R, 2009, EUR J HAEMATOL, V83, P220, DOI 10.1111/j.1600-0609.2009.01271.x; McGuckin CP, 2008, CELL PROLIFERAT, V41, P31, DOI 10.1111/j.1365-2184.2008.00490.x; McGuckin C, 2008, NAT PROTOC, V3, P1046, DOI 10.1038/nprot.2008.69; McGuckin C, 2006, ACTA NEUROBIOL EXP, V66, P321; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Parte S, 2011, STEM CELLS DEV, V20, P1451, DOI 10.1089/scd.2010.0461; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Sauerzweig S, 2009, EXP CELL RES, V315, P50, DOI 10.1016/j.yexcr.2008.10.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Storms RW, 2000, BLOOD, V96, P2125; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Sutherland DR, 2009, CYTOTHERAPY, V11, P595, DOI 10.1080/14653240902923161; Vieyra DS, 2009, STEM CELLS DEV, V18, P1155, DOI 10.1089/scd.2008.0391; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Zuba-Surma EK, 2010, EUR J HAEMATOL, V84, P34, DOI 10.1111/j.1600-0609.2009.01352.x	32	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67968	10.1371/journal.pone.0067968	http://dx.doi.org/10.1371/journal.pone.0067968			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840798	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400149
J	Aprile, FA; Dhulesia, A; Stengel, F; Roodveldt, C; Benesch, JLP; Tortora, P; Robinson, CV; Salvatella, X; Dobson, CM; Cremades, N				Aprile, Francesco A.; Dhulesia, Anne; Stengel, Florian; Roodveldt, Cintia; Benesch, Justin L. P.; Tortora, Paolo; Robinson, Carol V.; Salvatella, Xavier; Dobson, Christopher M.; Cremades, Nunilo			Hsp70 Oligomerization Is Mediated by an Interaction between the Interdomain Linker and the Substrate-Binding Domain	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE DNAK; LEUCINE-RICH REPEAT; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ALLOSTERIC REGULATION; STRUCTURAL-ANALYSIS; UNFOLDED PROTEINS; MASS-SPECTROMETRY; SELF-ASSOCIATION	Oligomerization in the heat shock protein (Hsp) 70 family has been extensively documented both in vitro and in vivo, although the mechanism, the identity of the specific protein regions involved and the physiological relevance of this process are still unclear. We have studied the oligomeric properties of a series of human Hsp70 variants by means of nanoelectrospray ionization mass spectrometry, optical spectroscopy and quantitative size exclusion chromatography. Our results show that Hsp70 oligomerization takes place through a specific interaction between the interdomain linker of one molecule and the substrate-binding domain of a different molecule, generating dimers and higher-order oligomers. We have found that substrate binding shifts the oligomerization equilibrium towards the accumulation of functional monomeric protein, probably by sequestering the helical lid sub-domain needed to stabilize the chaperone: substrate complex. Taken together, these findings suggest a possible role of chaperone oligomerization as a mechanism for regulating the availability of the active monomeric form of the chaperone and for the control of substrate binding and release.	[Aprile, Francesco A.; Dhulesia, Anne; Dobson, Christopher M.; Cremades, Nunilo] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Aprile, Francesco A.; Tortora, Paolo] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Stengel, Florian; Benesch, Justin L. P.; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Roodveldt, Cintia] Univ Seville, CABIMER Andalusian Ctr Mol Biol & Regenerat Med, Consejo Super Invest Cient, UPO,Junta Andalucia, Seville, Spain; [Salvatella, Xavier] Inst Res Biomed IRB Barcelona, Joint BSC IRB Res Programme Computat Biol, Barcelona, Spain; [Salvatella, Xavier] ICREA, Barcelona, Spain	University of Cambridge; University of Milano-Bicocca; University of Oxford; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Cremades, N (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	nc347@cam.ac.uk	Roodveldt, Cintia/I-9118-2014; Salvatella, Xavier/C-7337-2008; Cremades, Nunilo/F-9634-2015	Roodveldt, Cintia/0000-0003-4124-8769; Salvatella, Xavier/0000-0002-8371-4185; Cremades, Nunilo/0000-0002-9138-6687; Aprile, Francesco Antonio/0000-0002-5040-4420; Tortora, Paolo/0000-0001-5234-601X; robinson, carol/0000-0001-7829-5505; Stengel, Florian/0000-0003-1447-4509; Benesch, Justin/0000-0002-1507-3742	Italian Ministry of Education, University and Research; Murray Edwards College, Cambridge, through a Junior Research Fellowship; Spanish Ministry of Health; FEDER [CP10/00527]; Regione Lombardia (NEDD and "Network Tecnologico integrato per lo studio proteomico e trascrittomico di malattie neurodegenerative correlate a deposizioni di amiloidi"); BBSRC [BB/E019927/1]; Wellcome Trust [094425/Z/10/Z]; European Commission [LSHM-CT-2006-037525]; Human Frontiers Science Program (HFSP) through a Long-term Fellowship [LT000795/2009]; BBSRC [BB/J018082/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J018082/1, BB/E019927/1] Funding Source: researchfish; ICREA Funding Source: Custom	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Murray Edwards College, Cambridge, through a Junior Research Fellowship; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission); Regione Lombardia (NEDD and "Network Tecnologico integrato per lo studio proteomico e trascrittomico di malattie neurodegenerative correlate a deposizioni di amiloidi"); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontiers Science Program (HFSP) through a Long-term Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ICREA(ICREA)	FAA was recipient of a graduate fellowship from the Italian Ministry of Education, University and Research. AD is grateful for support from Murray Edwards College, Cambridge, through a Junior Research Fellowship. FS is a Sir Henry Wellcome Fellow. CR acknowledges financial support by the Spanish Ministry of Health according to the 'Plan Nacional de I+D+I 2008-2011', through ISCIII with cofunding by FEDER (CP10/00527). JLPB is a Royal Society University Research Fellow. FAA and PT are grateful for support from Regione Lombardia (NEDD and "Network Tecnologico integrato per lo studio proteomico e trascrittomico di malattie neurodegenerative correlate a deposizioni di amiloidi"). CMD acknowledges support from BBSRC (BB/E019927/1), the Wellcome Trust (094425/Z/10/Z), the European Commission (project LSHM-CT-2006-037525). NC acknowledges support from Human Frontiers Science Program (HFSP) through a Long-term Fellowship (LT000795/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JV, 1994, PLANT PHYSIOL, V104, P1371, DOI 10.1104/pp.104.4.1371; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Angelidis CE, 1999, EUR J BIOCHEM, V259, P505, DOI 10.1046/j.1432-1327.1999.00078.x; Benaroudj N, 1996, J BIOL CHEM, V271, P18471, DOI 10.1074/jbc.271.31.18471; Benaroudj N, 1997, J BIOL CHEM, V272, P8744, DOI 10.1074/jbc.272.13.8744; Benesch JLP, 2011, CURR OPIN STRUC BIOL, V21, P641, DOI 10.1016/j.sbi.2011.08.002; Benesch JLP, 2009, NATURE, V462, P576, DOI 10.1038/462576a; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BLONDELGUINDI S, 1993, J BIOL CHEM, V268, P12730; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; CHEN RF, 1968, ANAL BIOCHEM, V25, P412, DOI 10.1016/0003-2697(68)90116-4; Chevalier M, 1998, J BIOL CHEM, V273, P26827, DOI 10.1074/jbc.273.41.26827; Chou CC, 2003, J BIOL CHEM, V278, P30311, DOI 10.1074/jbc.M304563200; Cremades N, 2008, BIOCHEMISTRY-US, V47, P627, DOI 10.1021/bi701365e; Ebong IO, 2011, P NATL ACAD SCI USA, V108, P17939, DOI 10.1073/pnas.1106261108; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fouchaq B, 1999, EUR J BIOCHEM, V259, P379, DOI 10.1046/j.1432-1327.1999.00053.x; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Gao BC, 1996, J BIOL CHEM, V271, P16792, DOI 10.1074/jbc.271.28.16792; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GUIDON PT, 1986, BIOCHEMISTRY-US, V25, P3231, DOI 10.1021/bi00359a023; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; KIM DH, 1992, J CELL PHYSIOL, V153, P353, DOI 10.1002/jcp.1041530215; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Konermann L, 2007, J PHYS CHEM B, V111, P6534, DOI 10.1021/jp070720t; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; MONTGOMERY D, 1993, J MOL BIOL, V232, P680, DOI 10.1006/jmbi.1993.1418; Moro F, 2004, J BIOL CHEM, V279, P19600, DOI 10.1074/jbc.M400921200; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Nemoto TK, 2006, J BIOCHEM, V139, P677, DOI 10.1093/jb/mvj071; Ohno M, 2004, FEBS LETT, V576, P381, DOI 10.1016/j.febslet.2004.09.044; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; Revington M, 2005, J MOL BIOL, V349, P163, DOI 10.1016/j.jmb.2005.03.033; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Stengel F, 2012, CHEM BIOL, V19, P599, DOI 10.1016/j.chembiol.2012.04.007; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Thompson AD, 2012, CELL STRESS CHAPERON, V17, P313, DOI 10.1007/s12192-011-0307-1; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Worrall LJ, 2007, BIOCHEM BIOPH RES CO, V357, P105, DOI 10.1016/j.bbrc.2007.03.107; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108	57	58	59	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67961	10.1371/journal.pone.0067961	http://dx.doi.org/10.1371/journal.pone.0067961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840795	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400147
J	Atkin, AJ; Corder, K; Ekelund, U; Wijndaele, K; Griffin, SJ; van Sluijs, EMF				Atkin, Andrew J.; Corder, Kirsten; Ekelund, Ulf; Wijndaele, Katrien; Griffin, Simon J.; van Sluijs, Esther M. F.			Determinants of Change in Children's Sedentary Time	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEALTH INDICATORS; YOUNG-PEOPLE; SCREEN TIME; BEHAVIOR; INTERVENTIONS; ASSOCIATIONS; ADOLESCENTS; FAMILY; REPEATABILITY	Background: Understanding the determinants of sedentary time during childhood contributes to the development of effective intervention programmes. Purpose: To examine family and home-environmental determinants of 1-year change in objectively measured sedentary time after-school and at the weekend. Methods: Participants wore accelerometers at baseline and 1 year later. Longitudinal data for after-school and weekend analyses were available for 854 (41.5% male, mean +/- SD age 10.2 +/- 0.3years) and 718 (41.8% male, age 10.2 +/- 0.3years) participants. Information on 26 candidate determinants, including socioeconomic status (SES), availability of electronic media and parental rules for sedentary behaviours was self-reported by children or their parents at baseline. Change in the proportion of registered time spent sedentary was used as the outcome variable in multi-level linear regression models, adjusted for age, sex, body mass index and baseline sedentary time. Simple and multiple models were run and interactions with sex explored. Results: Children from higher socioeconomic status families exhibited greater increases in after-school (beta; 95% CI for change in % time spent sedentary 1.02; 0.37, 1.66) and weekend (1.42; 0.65, 2.18) sedentary time. Smaller increases in after-school sedentary time were observed in children with more siblings (-1.00; -1.69, -0.30), greater availability of electronic media (-0.81; -1.29, -0.33) and, for boys, more frequent family visits to the park (-1.89; -3.28, -0.51) and family participation in sport (-1.28; -2.54, -0.02). Greater maternal weekend screen-time (0.45; 0.08, 0.83) and, in girls, greater parental restriction on playing outside (0.91; 0.08, 1.74) were associated with larger increases in weekend sedentary time. The analytical sample was younger, more likely to be female, had lower BMI and was of higher SES than the original baseline sample. Conclusions: Intervention strategies aimed at reducing parents' weekend screen-time, increasing family participation in sports or recreation (boys) and promoting freedom to play outside (girls) may contribute towards preventing the age-related increase in sedentary time.	[Atkin, Andrew J.; Griffin, Simon J.; van Sluijs, Esther M. F.] UKCRC Ctr Diet & Act Res CEDAR, Inst Publ Hlth, Cambridge, England; [Corder, Kirsten; Ekelund, Ulf; Wijndaele, Katrien; Griffin, Simon J.; van Sluijs, Esther M. F.] MRC, Epidemiol Unit, Cambridge, England; [Ekelund, Ulf] Norwegian Sch Sports Sci, Dept Sports Med, Oslo, Norway	University of Cambridge; Norwegian School of Sport Sciences	Atkin, AJ (corresponding author), UKCRC Ctr Diet & Act Res CEDAR, Inst Publ Hlth, Cambridge, England.	aa595@medschl.cam.ac.uk	Ekelund, Ulf/AAE-8471-2019; Griffin, Simon/K-3106-2013; Wijndaele, Katrien/H-5465-2013	Ekelund, Ulf/0000-0003-2115-9267; Griffin, Simon/0000-0002-2157-4797; Atkin, Andrew/0000-0002-3819-3448; Wijndaele, Katrien/0000-0003-2199-7981; van Sluijs, Esther/0000-0001-9141-9082	Centre for Diet and Activity Research (CEDAR); UK Clinical Research Collaboration Public Health Research Centre of Excellence [RES-590-28-0002]; British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust, under the auspices of the UK Clinical Research Collaboration; British Heart Foundation Intermediate Basic Science Research Fellowship [FS/12/58/29709]; Medical Research Council [MC_U106179474, MC_U106179473, MC_UP_1001/2]; National Prevention Research Initiative; Cancer Research United Kingdom; Department of Health; Diabetes United Kingdom; Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government; World Cancer Research Fund; British Heart Foundation [FS/12/58/29709] Funding Source: researchfish; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [G0501294, MC_UU_12015/4, MC_UU_12015/3, MC_UU_12015/7] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179474, MC_UU_12015/4, MC_U106179473, MC_UP_1001/2, MC_UU_12015/7, G0501294, MC_UU_12015/3] Funding Source: UKRI	Centre for Diet and Activity Research (CEDAR); UK Clinical Research Collaboration Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust, under the auspices of the UK Clinical Research Collaboration(Wellcome Trust); British Heart Foundation Intermediate Basic Science Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Prevention Research Initiative(Diabetes UK); Cancer Research United Kingdom(Cancer Research UK); Department of Health; Diabetes United Kingdom(Diabetes UK); Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work of Andrew J. Atkin, Kirsten Corder, Simon J. Griffin and Esther M. F. van Sluijs was supported, wholly or in part, by the Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration Public Health Research Centre of Excellence (RES-590-28-0002). Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The work of Katrien Wijndaele is supported by a British Heart Foundation Intermediate Basic Science Research Fellowship (FS/12/58/29709). The SPEEDY study was funded by the Medical Research Council (Unit Programme number MC_U106179474; MC_U106179473; MC_UP_1001/2) and the National Prevention Research Initiative, consisting of the following funding partners: British Heart Foundation; Cancer Research United Kingdom; Department of Health; Diabetes United Kingdom; Economic and Social Research Council; Medical Research Council; Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government; and World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin AJ, 2013, MED SCI SPORT EXER, V45, P1097, DOI 10.1249/MSS.0b013e318282190e; Ball K, 2009, J PHYS ACT HEALTH, V6, P289, DOI 10.1123/jpah.6.3.289; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Basterfield L, 2011, PEDIATRICS, V127, pE24, DOI 10.1542/peds.2010-1935; Bibby P., 2004, DEV NEW CLASSIFICATI; Biddle SJH, 2007, AM J PREV MED, V33, P502, DOI 10.1016/j.amepre.2007.08.002; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Biddle SJH, 2011, BRIT J SPORT MED, V45, P937, DOI 10.1136/bjsports-2011-090205; Biddle SJH, 2009, ANN BEHAV MED, V38, P147, DOI 10.1007/s12160-009-9136-1; Chinapaw MJM, 2011, OBES REV, V12, pE621, DOI 10.1111/j.1467-789X.2011.00865.x; Corder K, 2010, PEDIATRICS, V126, pE926, DOI 10.1542/peds.2010-0048; Davison KK, 2005, J PEDIATR-US, V147, P436, DOI 10.1016/j.jpeds.2005.05.002; Dolinsky DH, 2011, PREV CHRONIC DIS, V8; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Epstein L H, 2001, Exerc Sport Sci Rev, V29, P103, DOI 10.1097/00003677-200107000-00003; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fitzmaurice G, 2001, NUTRITION, V17, P360, DOI 10.1016/S0899-9007(00)00593-1; Gebremariam MK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-104; Gorely T, 2004, INT J BEHAV MED, V11, P152, DOI 10.1207/s15327558ijbm1103_4; Gorely T, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-33; Granich J, 2011, J PHYS ACT HEALTH, V8, P613, DOI 10.1123/jpah.8.5.613; Hardy LL, 2006, AUST NZ J PUBL HEAL, V30, P534, DOI 10.1111/j.1467-842X.2006.tb00782.x; Cillero IH, 2010, PREV MED, V51, P3, DOI 10.1016/j.ypmed.2010.04.012; Janz KF, 2005, AM J PREV MED, V29, P171, DOI 10.1016/j.amepre.2005.06.001; Jordan AB, 2006, PEDIATRICS, V118, pE1303, DOI 10.1542/peds.2006-0732; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Maniccia DM, 2011, PEDIATRICS, V128, pE193, DOI 10.1542/peds.2010-2353; Marshall SJ, 2011, AM J LIFESTYLE MED, V5, P518, DOI 10.1177/1559827610395487; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Mitchell JA, 2012, MED SCI SPORT EXER, V44, P1081, DOI 10.1249/MSS.0b013e3182446c65; Nilsson A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-322; Noble M, 2007, ENGLISH INDICES DEPR; Olds T, 2012, HEALTH EDUC BEHAV, V39, P732, DOI 10.1177/1090198111429822; Olds TS, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-92; Ommundsen Y, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-29; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; Saelens BE, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200206000-00001; Sallis J.F., 2002, HLTH BEHAV HLTH ED T, V3rd ed., P462; Sallis JF., 1999, PHYS ACTIVITY BEHAV, Vvol. 3; Salmon J, 2005, OBES RES, V13, P1939, DOI 10.1038/oby.2005.239; Salmon J., 2004, CHILDRENS LEISURE AC; Salmon J, 2011, AM J PREV MED, V41, P197, DOI 10.1016/j.amepre.2011.05.001; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Schmidt ME, 2012, OBESITY, DOI [10.1038/oby.2011.348, DOI 10.1038/0BY.2011.348]; Start Active Stay Active, 2011, REP PHYS ACT HLTH 4; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Uijtdewilligen L, 2011, BRIT J SPORT MED, V45, P896, DOI 10.1136/bjsports-2011-090197; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; van Sluijs EMF, 2010, BRIT J SPORT MED, V44, P747, DOI 10.1136/bjsm.2008.049783; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Verloigne M, 2012, PUBLIC HEALTH NUTR, V15, P1380, DOI 10.1017/S1368980011003168; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Wiecha JL, 2001, AMBUL PEDIATR, V1, P244, DOI 10.1367/1539-4409(2001)001<0244:HTAAWS>2.0.CO;2	59	50	52	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67627	10.1371/journal.pone.0067627	http://dx.doi.org/10.1371/journal.pone.0067627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840753	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400118
J	Bekhit, OEM; Yousef, RM				Bekhit, Osama E. M.; Yousef, Remon M.			Permanent and Transient Congenital Hypothyroidism in Fayoum, Egypt: A Descriptive Retrospective Study	PLOS ONE			English	Article							SCREENING-PROGRAM; DIAGNOSTIC REEVALUATION; HIGH PREVALENCE; CHILDREN; THYROTROPIN; POPULATION; DISORDERS; GLAND	Background: Congenital hypothyroidism (CH) is one of the most common preventable causes of mental retardation. One important challenge in understanding the epidemiology of CH is that some newborns will have transient CH, a temporary depression of thyroid hormone concentrations that can last from several days to several months. Studies from other countries have reported that 10 to 15% of children treated for CH ultimately prove not to need treatment past 3 years of age to maintain normal hormone concentrations, and thus have transient hypothyroidism. The purpose of this study was to determine the prevalence of permanent and transient congenital hypothyroidism in Fayoum, Egypt. Methods: Cases detected by Fayoum neonatal screening program (NSP) between January 2003 and December 2011, and followed up at health insurance center were included. Permanent or transient CH was determined using results of thyroid function tests. Results: Of the 248 patients diagnosed primarily with CH by NSP; 204 (82.3%) patients were diagnosed to have permanent CH (prevalence 1/3587 live birth), and 44 (17.7%) patients were diagnosed to have transient CH (prevalence 1/16667 live birth). Initial TSH levels were higher in permanent CH cases than transient cases (p<0.004). Female to male ratio was 0.8 and 0.7 in permanent and transient CH respectively. 161 (65%) patients had thyroid dysgenesis (107 ectopic thyroid gland, 28 athyreosis and 26 thyroid hypoplasia). 87 (35%) patients had intact gland in thyroid scan and were considered to have dyshormonogenesis. Of these 87 patients 44 proved to have transient CH and 43 had permanent CH. Conclusion: The preliminary data from our study revealed that the incidences of CH as well as the permanent form were similar to worldwide reports. Although the high incidence of transient CH in our study could be explained by iodine deficiency further studies are needed to confirm the etiology and plan the treatment strategies.	[Bekhit, Osama E. M.; Yousef, Remon M.] Fayoum Univ, Fayoum Fac Med, Dept Pediat 1, Al Fayoum, Egypt	Egyptian Knowledge Bank (EKB); Fayoum University	Bekhit, OEM (corresponding author), Fayoum Univ, Fayoum Fac Med, Dept Pediat 1, Al Fayoum, Egypt.	dr_elsayed71@yahoo.com						AlJurayyan NAM, 1996, J TROP PEDIATRICS, V42, P348, DOI 10.1093/tropej/42.6.348; ARISAKA O, 1986, AM J DIS CHILD, V140, P998, DOI 10.1001/archpedi.1986.02140240044023; Bhavani, 2011, INDIAN J ENDOCRINOL, V15, P117, DOI [10.4103/2230-8210.83345, DOI 10.4103/2230-8210.83345]; Brown RS, 1996, J CLIN ENDOCR METAB, V81, P1147, DOI 10.1210/jc.81.3.1147; BROWN RS, 2001, CLIN PEDIAT ENDOCRIN, P288; Castanet M, 2001, J CLIN ENDOCR METAB, V86, P2009, DOI 10.1210/jc.86.5.2009; Connelly JF, 2001, J PEDIATR ENDOCR MET, V14, P1597; DAVY T, 1985, AM J DIS CHILD, V139, P1028, DOI 10.1001/archpedi.1985.02140120074031; El-Mougi F A, 2004, East Mediterr Health J, V10, P863; FISHER DA, 1996, PEDIAT ENDOCRINOLOGY, P51; Gaudino R, 2005, CLIN ENDOCRINOL, V62, P444, DOI 10.1111/j.1365-2265.2005.02239.x; GRUTERS A, 1993, EUR J PEDIATR, V152, P974; Hashemipour M, 2009, J MED SCREEN, V16, P11, DOI 10.1258/jms.2009.008090; Jaruratanasirikul S, 2006, J PEDIATR ENDOCR MET, V19, P727; Kaiserman I, 1997, EUR J ENDOCRINOL, V137, P356, DOI 10.1530/eje.0.1370356; Kemper AR, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-9; Kempers MJE, 2006, J CLIN ENDOCR METAB, V91, P3370, DOI 10.1210/jc.2006-0058; Korzeniewski SJ, 2013, J PEDIATR-US, V162, P177, DOI 10.1016/j.jpeds.2012.06.050; Leger J, 2002, J CLIN ENDOCR METAB, V87, P575, DOI 10.1210/jc.87.2.575; Mitchell ML, 2011, CLIN ENDOCRINOL, V75, P806, DOI 10.1111/j.1365-2265.2011.04128.x; Nair PS, 2010, INDIAN PEDIATR, V47, P757, DOI 10.1007/s13312-010-0115-1; Ordookhani A, 2004, J PEDIATR ENDOCR MET, V17, P1201; Panoutsopoulos G, 2001, EUR J NUCL MED, V28, P529, DOI 10.1007/s002590100491; Parks JS, 2010, PEDIATRICS, V125, pS54, DOI 10.1542/peds.2009-1975F; Rose SR, 2006, PEDIATRICS, V117, P2290; Seeherunvong Tossaporn, 1998, Journal of the Medical Association of Thailand, V81, P653; Simpser Tamar, 2010, J Clin Res Pediatr Endocrinol, V2, P95, DOI 10.4274/jcrpe.v2i3.95; Skordis N, 2005, J PEDIATR ENDOCR MET, V18, P453; Tonacchera M, 2004, THYROID, V14, P584, DOI 10.1089/1050725041692864; VERMIGLIO F, 1995, CLIN ENDOCRINOL, V42, P409, DOI 10.1111/j.1365-2265.1995.tb02650.x; Weber G, 2005, J ENDOCRINOL INVEST, V28, P516, DOI 10.1007/BF03347239; Wu RP, 1995, PRACTICAL PAEDIAT, P1944	32	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68048	10.1371/journal.pone.0068048	http://dx.doi.org/10.1371/journal.pone.0068048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840807	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400156
J	Diers, AR; Vayalil, PK; Oliva, CR; Griguer, CE; Darley-Usmar, V; Hurst, DR; Welch, DR; Landar, A				Diers, Anne R.; Vayalil, Praveen K.; Oliva, Claudia R.; Griguer, Corinne E.; Darley-Usmar, Victor; Hurst, Douglas R.; Welch, Danny R.; Landar, Aimee			Mitochondrial Bioenergetics of Metastatic Breast Cancer Cells in Response to Dynamic Changes in Oxygen Tension: Effects of HIF-1 alpha	PLOS ONE			English	Article							CYTOCHROME-OXIDASE; GLUCOSE-METABOLISM; HYPOXIA; TUMOR; RESPIRATION; ADAPTATION; EXPRESSION; PHYSIOLOGY; GROWTH	Solid tumors are characterized by regions of low oxygen tension (OT), which play a central role in tumor progression and resistance to therapy. Low OT affects mitochondrial function and for the cells to survive, mitochondria must functionally adapt to low OT to maintain the cellular bioenergetics. In this study, a novel experimental approach was developed to examine the real-time bioenergetic changes in breast cancer cells (BCCs) during adaptation to OT (from 20% to <1% oxygen) using sensitive extracellular flux technology. Oxygen was gradually removed from the medium, and the bioenergetics of metastatic BCCs (MDA-MB-231 and MCF10CA clones) was compared with non-tumorigenic (MCF10A) cells. BCCs, but not MCF10A, rapidly responded to low OT by stabilizing HIF-1 alpha and increasing HIF-1 alpha responsive gene expression and glucose uptake. BCCs also increased extracellular acidification rate (ECAR), which was markedly lower in MCF10A. Interestingly, BCCs exhibited a biphasic response in basal respiration as the OT was reduced from 20% to <1%. The initial stimulation of oxygen consumption is found to be due to increased mitochondrial respiration. This effect was HIF-1 alpha dependent, as silencing HIF-1 alpha abolished the biphasic response. During hypoxia and reoxygenation, BCCs also maintained oxygen consumption rates at specific OT; however, HIF-1 alpha silenced BCC were less responsive to changes in OT. Our results suggest that HIF-1 alpha provides a high degree of bioenergetic flexibility under different OT which may confer an adaptive advantage for BCC survival in the tumor microenvironment and during invasion and metastasis. This study thus provides direct evidence for the cross-talk between HIF-1 alpha and mitochondria during adaptation to low OT by BCCs and may be useful in identifying novel therapeutic agents that target the bioenergetics of BCCs in response to low OT.	[Diers, Anne R.; Vayalil, Praveen K.; Darley-Usmar, Victor; Hurst, Douglas R.; Landar, Aimee] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Oliva, Claudia R.; Griguer, Corinne E.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Diers, Anne R.; Vayalil, Praveen K.; Oliva, Claudia R.; Griguer, Corinne E.; Darley-Usmar, Victor; Landar, Aimee] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL USA; [Oliva, Claudia R.; Griguer, Corinne E.; Hurst, Douglas R.; Landar, Aimee] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Welch, Danny R.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Kansas; University of Kansas Medical Center	Landar, A (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	landar@uab.edu	Welch, Danny R/B-7310-2009; Landar, Aimee/F-7269-2010	Welch, Danny R/0000-0002-1951-4947; Landar, Aimee/0000-0003-2306-9214; Oliva, Claudia/0000-0003-0624-5490; , Corinne/0000-0003-3877-5031; Hurst, Douglas/0000-0002-1296-2210; Darley-Usmar, Victor/0000-0001-8921-7086	UAB Department of Pathology Start-up funds; University of Alabama at Birmingham (UAB) CCC funding [T32 HL007918, R21 CA139290, R01 CA160821]; National Foundation for Cancer Research; Susan G. Komen for the Cure SAC [110037]; NATIONAL CANCER INSTITUTE [R01CA160821, R21CA139290] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	UAB Department of Pathology Start-up funds; University of Alabama at Birmingham (UAB) CCC funding; National Foundation for Cancer Research; Susan G. Komen for the Cure SAC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by UAB Department of Pathology Start-up funds to AL, University of Alabama at Birmingham (UAB) CCC funding to AL, T32 HL007918 to ARD, R21 CA139290 to CEG, and R01 CA160821 to CEG, National Foundation for Cancer Research to DRW, and Susan G. Komen for the Cure SAC 110037 to DRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; BROWN JM, 1979, BRIT J RADIOL, V52, P650, DOI 10.1259/0007-1285-52-620-650; Brown JM, 1998, CANCER RES, V58, P1408; Budinger GRS, 1996, AM J PHYSIOL-LUNG C, V270, pL44, DOI 10.1152/ajplung.1996.270.1.L44; Cairns RA, 2001, CANCER RES, V61, P8903; CHANDEL N, 1995, AM J PHYSIOL-LUNG C, V268, pL918, DOI 10.1152/ajplung.1995.268.6.L918; Chandel NS, 1997, J BIOL CHEM, V272, P18808, DOI 10.1074/jbc.272.30.18808; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Chiche J, 2009, J CELL MOL MED; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DEWHIRST MW, 1989, INT J RADIAT ONCOL, V17, P91, DOI 10.1016/0360-3016(89)90375-1; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gerencser A, 2009, ANAL CHEM; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hurst DR, 2009, CLIN EXP METASTAS, V26, P89, DOI 10.1007/s10585-008-9216-9; KALLINOWSKI F, 1989, CANCER RES, V49, P3759; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Li XF, 2008, CANCER LETT, V264, P172, DOI 10.1016/j.canlet.2008.02.037; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Rofstad EK, 2007, CLIN CANCER RES, V13, P1971, DOI 10.1158/1078-0432.CCR-06-1967; Rofstad EK, 2002, CANCER RES, V62, P1847; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Semenza G L, 2001, Novartis Found Symp, V240, P251; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Smolkova K, 2010, J BIOENERG BIOMEMBR, V42, P55, DOI 10.1007/s10863-009-9267-x; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; WARBURG O, 1956, SCIENCE, V124, P269; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WICK AN, 1957, J BIOL CHEM, V224, P963; Zelickson BR, 2011, BBA-BIOENERGETICS, V1807, P1573, DOI 10.1016/j.bbabio.2011.09.011	42	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68348	10.1371/journal.pone.0068348	http://dx.doi.org/10.1371/journal.pone.0068348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840849	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400191
J	Hosokawa, M; Kenmotsu, H; Koh, Y; Yoshino, T; Yoshikawa, T; Naito, T; Takahashi, T; Murakami, H; Nakamura, Y; Tsuya, A; Shukuya, T; Ono, A; Akamatsu, H; Watanabe, R; Ono, S; Mori, K; Kanbara, H; Yamaguchi, K; Tanaka, T; Matsunaga, T; Yamamoto, N				Hosokawa, Masahito; Kenmotsu, Hirotsugu; Koh, Yasuhiro; Yoshino, Tomoko; Yoshikawa, Takayuki; Naito, Tateaki; Takahashi, Toshiaki; Murakami, Haruyasu; Nakamura, Yukiko; Tsuya, Asuka; Shukuya, Takehito; Ono, Akira; Akamatsu, Hiroaki; Watanabe, Reiko; Ono, Sachiyo; Mori, Keita; Kanbara, Hisashige; Yamaguchi, Ken; Tanaka, Tsuyoshi; Matsunaga, Tadashi; Yamamoto, Nobuyuki			Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CLINICAL-SIGNIFICANCE; BREAST-CANCER; SURVIVAL; IMPACT; PROGRESSION	Background: Epithelial cell adhesion molecule (EpCAM)-based enumeration of circulating tumor cells (CTC) has prognostic value in patients with solid tumors, such as advanced breast, colon, and prostate cancer. However, poor sensitivity has been reported for non-small cell lung cancer (NSCLC). To address this problem, we developed a microcavity array (MCA) system integrated with a miniaturized device for CTC isolation without relying on EpCAM expression. Here, we report the results of a clinical study on CTCs of advanced lung cancer patients in which we compared the MCA system with the CellSearch system, which employs the conventional EpCAM-based method. Methods: Paired peripheral blood samples were collected from 43 metastatic lung cancer patients to enumerate CTCs using the CellSearch system according to the manufacturer's protocol and the MCA system by immunolabeling and cytomorphological analysis. The presence of CTCs was assessed blindly and independently by both systems. Results: CTCs were detected in 17 of 22 NSCLC patients using the MCA system versus 7 of 22 patients using the CellSearch system. On the other hand, CTCs were detected in 20 of 21 small cell lung cancer (SCLC) patients using the MCA system versus 12 of 21 patients using the CellSearch system. Significantly more CTCs in NSCLC patients were detected by the MCA system (median 13, range 0-291 cells/7.5 mL) than by the CellSearch system (median 0, range 0-37 cells/7.5 ml) demonstrating statistical superiority (p = 0.0015). Statistical significance was not reached in SCLC though the trend favoring the MCA system over the CellSearch system was observed (p = 0.2888). The MCA system also isolated CTC clusters from patients who had been identified as CTC negative using the CellSearch system. Conclusions: The MCA system has a potential to isolate significantly more CTCs and CTC clusters in advanced lung cancer patients compared to the CellSearch system.	[Hosokawa, Masahito; Yoshino, Tomoko; Yoshikawa, Takayuki; Tanaka, Tsuyoshi; Matsunaga, Tadashi] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Tokyo, Japan; [Hosokawa, Masahito; Koh, Yasuhiro; Yamaguchi, Ken] Shizuoka Canc Ctr, Res Inst, Drug Discovery & Dev Div, Shizuoka, Japan; [Kenmotsu, Hirotsugu; Naito, Tateaki; Takahashi, Toshiaki; Murakami, Haruyasu; Nakamura, Yukiko; Tsuya, Asuka; Shukuya, Takehito; Ono, Akira; Akamatsu, Hiroaki; Yamamoto, Nobuyuki] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; [Watanabe, Reiko; Ono, Sachiyo] Shizuoka Canc Ctr, Div Diagnost Pathol, Shizuoka, Japan; [Mori, Keita] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Shizuoka, Japan; [Kanbara, Hisashige] Hitachi Chem Co Ltd, Tokyo, Japan	Tokyo University of Agriculture & Technology; Shizuoka Cancer Center; Shizuoka Cancer Center; Shizuoka Cancer Center; Shizuoka Cancer Center; Hitachi Limited	Yamamoto, N (corresponding author), Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan.	n.yamamoto@scchr.jp	Tanaka, Tsuyoshi/B-9949-2013; Matsunaga, Tadashi/A-6293-2015; Naito, Tateaki/K-4703-2019; Yoshino, Tomoko/E-9066-2013	Tanaka, Tsuyoshi/0000-0003-2601-2256; Matsunaga, Tadashi/0000-0002-6216-3687; Naito, Tateaki/0000-0003-4047-2929; Yoshino, Tomoko/0000-0002-4505-2774; Hosokawa, Masahito/0000-0002-7070-4690	Ministry of Education, Culture, Sports, Science and Technology of Japan [11J11150]; Regional Innovation Cluster Program; Grants-in-Aid for Scientific Research [11J11150] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Regional Innovation Cluster Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Regional Innovation Cluster Program and a Grant-in-Aid for Research Fellowship for Young Scientists (11J11150) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Bhagat AAS, 2011, LAB CHIP, V11, P1870, DOI 10.1039/c0lc00633e; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brandt B, 1996, CANCER RES, V56, P4556; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Desitter I, 2011, ANTICANCER RES, V31, P427; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Hayata Y, 1975, JINGAN SAIBO NO BAIY; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Hosokawa M, 2013, ANAL CHEM IN PRESS, DOI [10.1021/ac400167x, DOI 10.1021/AC400167X:IN]; Hosokawa M, 2012, BIOTECHNOL BIOENG, V109, P2017, DOI 10.1002/bit.24471; Hosokawa M, 2010, ANAL CHEM, V82, P6629, DOI 10.1021/ac101222x; Hosokawa M, 2009, ANAL CHEM, V81, P5308, DOI 10.1021/ac900535h; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Hou JM, 2009, AM J PATHOL, V175, P808, DOI 10.2353/ajpath.2009.090078; Kats-Ugurlu G, 2009, J PATHOL, V219, P287, DOI 10.1002/path.2613; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kularatne BY, 2002, CYTOMETRY, V50, P160, DOI 10.1002/cyto.10071; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McFaul SM, 2012, LAB CHIP, V12, P2369, DOI 10.1039/c2lc21045b; Mikolajczyk SD, 2011, J ONCOL, V2011, DOI 10.1155/2011/252361; Naito T, 2012, J THORAC ONCOL, V7, P512, DOI 10.1097/JTO.0b013e31823f125d; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Pecot CV, 2011, CANCER DISCOV, V1, P580, DOI 10.1158/2159-8290.CD-11-0215; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Sieuwerts AM, 2009, J NATL CANCER I, V101, P61, DOI 10.1093/jnci/djn419; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; Vona G, 2004, HEPATOLOGY, V39, P792, DOI 10.1002/hep.20091; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wu C, 2009, J THORAC ONCOL, V4, P30, DOI 10.1097/JTO.0b013e3181914125; Zabaglo L, 2003, CYTOM PART A, V55A, P102, DOI 10.1002/cyto.a.10071; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3	42	136	143	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67466	10.1371/journal.pone.0067466	http://dx.doi.org/10.1371/journal.pone.0067466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840710	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400086
J	Wang, LY; Liu, YP; Chen, LG; Chen, YL; Tan, L; Liu, JJ; Jazag, A; Ren, JL; Guleng, B				Wang, Le-Yi; Liu, Yun-Peng; Chen, Li-Gang; Chen, Yan-Ling; Tan, Li; Liu, Jing-Jing; Jazag, Amarsanaa; Ren, Jian-Lin; Guleng, Bayasi			Pyruvate Kinase M2 Plays a Dual Role on Regulation of the EGF/EGFR Signaling via E-Cadherin-Dependent Manner in Gastric Cancer Cells	PLOS ONE			English	Article							ADHESION; EXPRESSION; MIGRATION; GROWTH; METABOLISM; TRANSITION; ISOFORM; BIOLOGY; PKM2	Background and Aims: EGFR activation and PKM2 expression are instrumental in tumorigenesis. EGFR activation regulates PKM2 functions in a subcellular compartment-dependent manner and promotes gene transcription and tumor growth. In addition, PKM2 is upregulated in EGFR-induced pathways in glioma malignancies. However, we found that PKM2 could also regulate the activity of the EGF/EGFR signaling pathway in gastric cancer cells. We aimed to define the biological mechanisms for PKM2 in regulating the cell motility and invasion. Methods: We employed stable transfection with short hairpin RNA to stably silence the expression of PKM2 in the BGC823, SGC7901 and AGS gastric cancer cell lines. The effects of PKM2 in vitro were determined by assessing cell migration and invasion. Immunohistochemical analysis was used to explore the relationship among PKM2 and other proteins. Results: Our results indicate that the knockdown of PKM2 decreased the activity of E-cadherin and enhanced the EGF/EGFR signaling pathway in the gastric cell lines BGC823 and SGC7901 that were positive for E-cadherin expression. However, in the undifferentiated gastric carcinoma cell line AGS, which lacks E-cadherin expression, PKM2 promoted cell migration and invasion. Immunohistochemical analyses showed that the levels of E-cadherin expression, ERK1/2 phosphorylation, and cytoplasmic PKM2 expression were correlated with each other. Conclusion: PKM2 may play different roles in differently differentiated gastric cancer cell types, and this finding would be consistent with the previous clinical research. The results of our study reveal an important link between PKM2 and Ecadherin during EGFR-stimulated gastric cancer cell motility and invasion.	[Wang, Le-Yi; Liu, Yun-Peng; Chen, Li-Gang; Chen, Yan-Ling; Tan, Li; Liu, Jing-Jing; Ren, Jian-Lin; Guleng, Bayasi] Xiamen Univ, Dept Gastroenterol, Zhongshan Hosp, Xiamen, Fujian Province, Peoples R China; [Guleng, Bayasi] Xiamen Univ, Coll Med, Xiamen, Fujian Province, Peoples R China; [Jazag, Amarsanaa] 3rd Gen Hosp, Natl Inst Med Res, Ulaanbaatar, Mongolia	Xiamen University; Xiamen University	Ren, JL (corresponding author), Xiamen Univ, Dept Gastroenterol, Zhongshan Hosp, Xiamen, Fujian Province, Peoples R China.	renjianl@xmu.edu.cn; bayasi8@gmail.com	chen, yanling/GRE-8287-2022		National Natural Science Foundation of China [30971362, 81072013, 91229201]; Fundamental Research Funds for the Central Universities in China [2010111082]; Ministry of Health Foundation for State Key Clinical Department	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China; Ministry of Health Foundation for State Key Clinical Department	This work was supported by National Natural Science Foundation of China (No. 30971362, 81072013 & 91229201), Fundamental Research Funds for the Central Universities in China (No. 2010111082) and Ministry of Health Foundation for State Key Clinical Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PD, 1996, J BIOL CHEM, V271, P20516, DOI 10.1074/jbc.271.34.20516; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; de Bruin J H, 2003, Ned Tijdschr Geneeskd, V147, P2474; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gabbert HE, 1996, INT J CANCER, V69, P184, DOI 10.1002/(SICI)1097-0215(19960621)69:3<184::AID-IJC6>3.0.CO;2-W; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Kim SM, 2005, EXP CELL RES, V308, P18, DOI 10.1016/j.yexcr.2005.04.002; Kitoh T, 2004, J GASTROENTEROL, V39, P434, DOI 10.1007/s00535-003-1316-3; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; MANSKE M, 1994, INT REV CYTOL, V155, P49, DOI 10.1016/S0074-7696(08)62096-3; Mastoraki A, 2011, SURG ONCOL, V20, pE223, DOI 10.1016/j.suronc.2011.08.001; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Wang JF, 2001, COMPARATIVE MED, V51, P341; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wroblewski LE, 2003, J CELL SCI, V116, P3017, DOI 10.1242/jcs.00518; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhou CF, 2012, IUBMB LIFE, V64, P775, DOI 10.1002/iub.1066	33	22	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67542	10.1371/journal.pone.0067542	http://dx.doi.org/10.1371/journal.pone.0067542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840737	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400104
J	Wyatt, MK; Tsai, JY; Mishra, S; Campos, M; Jaworski, C; Fariss, RN; Bernstein, SL; Wistow, G				Wyatt, M. Keith; Tsai, Jen-Yue; Mishra, Sanghamitra; Campos, Maria; Jaworski, Cynthia; Fariss, Robert N.; Bernstein, Steven L.; Wistow, Graeme			Interaction of Complement Factor H and Fibulin3 in Age-Related Macular Degeneration	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MALATTIA LEVENTINESE; OXIDATIVE STRESS; TISSUE INHIBITOR; VARIANT; DRUSEN; RISK; POLYMORPHISM; GENE; SUSCEPTIBILITY	Age-related macular degeneration (AMD) is a major cause of vision loss. It is associated with development of characteristic plaque-like deposits (soft drusen) in Bruch's membrane basal to the retinal pigment epithelium (RPE). A sequence variant (Y402H) in short consensus repeat domain 7 (SCR7) of complement factor H (CFH) is associated with risk for "dry'' AMD. We asked whether the eye-targeting of this disease might be related to specific interactions of CFH SCR7 with proteins expressed in the aging human RPE/choroid that could contribute to protein deposition in drusen. Yeast 2-hybrid (Y2H) screens of a retinal pigment epithelium/choroid library derived from aged donors using CFH SCR7 baits detected an interaction with EFEMP1/Fibulin 3 (Fib3), which is the locus for an inherited macular degeneration and also accumulates basal to macular RPE in AMD. The CFH/Fib3 interaction was validated by co-immunoprecipitation of native proteins. Quantitative Y2H and ELISA assays with different recombinant protein constructs both demonstrated higher affinity for Fib3 for the disease-related CFH 402H variant. Immuno-labeling revealed colocalization of CFH and Fib3 in globular deposits within cholesterol-rich domains in soft drusen in two AMD donors homozygous for CFH 402H (H/H). This pattern of labeling was quite distinct from those seen in examples of eyes with Y/Y and H/Y genotypes. The CFH 402H/Fib3 interaction could contribute to the development of pathological aggregates in soft drusen in some patients and as such might provide a target for therapeutic intervention in some forms of AMD.	[Wyatt, M. Keith; Mishra, Sanghamitra; Wistow, Graeme] NEI, Sect Mol Struct & Funct Genom, NIH, Bethesda, MD 20892 USA; [Tsai, Jen-Yue; Campos, Maria; Fariss, Robert N.] NEI, Biol Imaging Core, NIH, Bethesda, MD 20892 USA; [Jaworski, Cynthia] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Bernstein, Steven L.] Univ Maryland, Sch Med, Dept Ophthalmol, Baltimore, MD 21201 USA; [Bernstein, Steven L.] Univ Maryland, Sch Med, Dept Neurobiol & Genet, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wistow, G (corresponding author), NEI, Sect Mol Struct & Funct Genom, NIH, Bethesda, MD 20892 USA.	graeme@helix.nih.gov	Fariss, Robert/ABI-1771-2020	Fariss, Robert/0000-0003-3227-7170	NEI Intramural Research Program; NATIONAL EYE INSTITUTE [ZICEY000459, ZIAEY000444, ZIAEY000433] Funding Source: NIH RePORTER	NEI Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the NEI Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Bhutto IA, 2011, BRIT J OPHTHALMOL, V95, P1323, DOI 10.1136/bjo.2010.199216; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2007, HUM MUTAT, V28, P406, DOI 10.1002/humu.20464; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Fu L, 2007, HUM MOL GENET; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, OPHTHAL EPIDEMIOL, V14, P184, DOI 10.1080/09286580701344381; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Marmorstein LY, 2007, HUM MOL GENET; Meyer KJ, 2011, HUM GENET, V129, P91, DOI 10.1007/s00439-010-0904-6; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Sallo FB, 2009, BRIT J OPHTHALMOL, V93, P1345, DOI 10.1136/bjo.2008.150334; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Sparrow JR, 2010, ADV EXP MED BIOL, V703, P63, DOI 10.1007/978-1-4419-5635-4_5; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Uno K, 2010, BIOMARK MED, V4, P361, DOI [10.2217/bmm.10.57, 10.2217/BMM.10.57]; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	59	32	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68088	10.1371/journal.pone.0068088	http://dx.doi.org/10.1371/journal.pone.0068088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840815	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400162
J	Baker, RW; Jeffrey, PD; Hughson, FM				Baker, Richard W.; Jeffrey, Philip D.; Hughson, Frederick M.			Crystal Structures of the Sec1/Munc18 (SM) Protein Vps33, Alone and Bound to the Homotypic Fusion and Vacuolar Protein Sorting (HOPS) Subunit Vps16	PLOS ONE			English	Article							SYNTAXIN N-PEPTIDE; SNARE COMPLEX; MEMBRANE-FUSION; TETHERING COMPLEX; BINDING MODE; TERMINAL PEPTIDE; DOMAIN 3A; YEAST; MUNC18-1; SEC1	Intracellular membrane fusion requires the regulated assembly of SNARE (soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor) proteins anchored in the apposed membranes. To exert the force required to drive fusion between lipid bilayers, juxtamembrane SNARE motifs zipper into four-helix bundles. Importantly, SNARE function is regulated by additional factors, none more extensively studied than the SM (Sec1/Munc18-like) proteins. SM proteins interact with both individual SNAREs and SNARE complexes, likely chaperoning SNARE complex formation and protecting assembly intermediates from premature disassembly by NSF. Four families of SM proteins have been identified, and representative members of two of these families (Sec1/Munc18 and Sly1) have been structurally characterized. We report here the 2.6 angstrom resolution crystal structure of an SM protein from the third family, Vps33. Although Vps33 shares with the first two families the same basic three-domain architecture, domain 1 is displaced by 15 angstrom, accompanied by a 40 degrees rotation. A unique feature of the Vps33 family of SM proteins is that its members function as stable subunits within a multi-subunit tethering complex called HOPS (homotypic fusion and vacuolar protein sorting). Integration into the HOPS complex depends on the interaction between Vps33 and a second HOPS subunit, Vps16. The crystal structure of Vps33 bound to a C-terminal portion of Vps16, also at 2.6 angstrom resolution, reveals the structural basis for this interaction. Despite the extensive interface between the two HOPS subunits, the conformation of Vps33 is only subtly affected by binding to Vps16.	[Baker, Richard W.; Jeffrey, Philip D.; Hughson, Frederick M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu	Baker, Richard/N-1428-2016	Baker, Richard/0000-0003-1136-6000; Jeffrey, Philip/0000-0002-4351-5341	NIH [R01 GM071574]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071574, T32GM007388] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01 GM071574 (FMH) and a pre-doctoral fellowship from NSF (RWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Boyd A, 2008, GENETICS, V180, P165, DOI 10.1534/genetics.108.090423; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Bracher A, 2001, J MOL BIOL, V306, P7, DOI 10.1006/jmbi.2000.4347; Bracher A, 2000, STRUCTURE, V8, P685, DOI 10.1016/S0969-2126(00)00156-8; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Burkhardt P, 2011, P NATL ACAD SCI USA, V108, P15264, DOI 10.1073/pnas.1106189108; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Christie MP, 2012, P NATL ACAD SCI USA, V109, P9816, DOI 10.1073/pnas.1116975109; Diao JJ, 2010, ACS CHEM NEUROSCI, V1, P168, DOI 10.1021/cn900034p; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epp N, 2011, EUR J CELL BIOL, V90, P779, DOI 10.1016/j.ejcb.2011.04.007; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Hashizume K, 2009, MOL BIOL CELL, V20, P4673, DOI 10.1091/mbc.E09-02-0172; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Jones TA, 1992, MOL REPLACEMENT, P92; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Laufman O, 2009, EMBO J, V28, P2006, DOI 10.1038/emboj.2009.168; Li W, 2011, STRUCTURE, V19, P1443, DOI 10.1016/j.str.2011.07.012; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Morgera F, 2012, MOL BIOL CELL, V23, P337, DOI 10.1091/mbc.E11-08-0670; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Shi L, 2011, MOL BIOL CELL, V22, P4150, DOI 10.1091/mbc.E11-02-0150; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Togneri J, 2006, P NATL ACAD SCI USA, V103, P17730, DOI 10.1073/pnas.0605448103; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; VanRheenen SM, 2001, TRAFFIC, V2, P212, DOI 10.1034/j.1600-0854.2001.020307.x; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	68	40	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67409	10.1371/journal.pone.0067409	http://dx.doi.org/10.1371/journal.pone.0067409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840694	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400100
J	Huang, Y; Harrison, MR; Osorio, A; Kim, J; Baugh, A; Duan, CM; Sucov, HM; Lien, CL				Huang, Ying; Harrison, Michael R.; Osorio, Arthela; Kim, Jieun; Baugh, Aaron; Duan, Cunming; Sucov, Henry M.; Lien, Ching-Ling			Igf Signaling Is Required for Cardiomyocyte Proliferation during Zebrafish Heart Development and Regeneration	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC REGENERATION; EXPRESSION ANALYSIS; CONCENTRIC GROWTH; IN-VITRO; MYOCYTES; INHIBITOR; CAPACITY; DISEASE; KINASE	Unlike its mammalian counterpart, the adult zebrafish heart is able to fully regenerate after severe injury. One of the most important events during the regeneration process is cardiomyocyte proliferation, which results in the replacement of lost myocardium. Growth factors that induce cardiomyocyte proliferation during zebrafish heart regeneration remain to be identified. Signaling pathways important for heart development might be reutilized during heart regeneration. IGF2 was recently shown to be important for cardiomyocyte proliferation and heart growth during mid-gestation heart development in mice, although its role in heart regeneration is unknown. We found that expression of igf2b was upregulated during zebrafish heart regeneration. Following resection of the ventricle apex, igf2b expression was detected in the wound, endocardium and epicardium at a time that coincides with cardiomyocyte proliferation. Transgenic zebrafish embryos expressing a dominant negative form of Igf1 receptor (dn-Igf1r) had fewer cardiomyocytes and impaired heart development, as did embryos treated with an Igf1r inhibitor. Moreover, inhibition of Igf1r signaling blocked cardiomyocyte proliferation during heart development and regeneration. We found that Igf signaling is required for a subpopulation of cardiomyocytes marked by gata4:EGFP to contribute to the regenerating area. Our findings suggest that Igf signaling is important for heart development and myocardial regeneration in zebrafish.	[Huang, Ying; Harrison, Michael R.; Osorio, Arthela; Kim, Jieun; Baugh, Aaron; Lien, Ching-Ling] Childrens Hosp Los Angeles, Saban Res Inst, Inst Heart, Los Angeles, CA 90027 USA; [Huang, Ying; Harrison, Michael R.; Osorio, Arthela; Kim, Jieun; Baugh, Aaron; Lien, Ching-Ling] Childrens Hosp Los Angeles, Program Dev Biol & Regenerat Med, Saban Res Inst, Los Angeles, CA 90027 USA; [Huang, Ying] Univ So Calif, Ostrow Sch Dent, Craniofacial Biol Grad Program, Los Angeles, CA USA; [Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Sucov, Henry M.] Univ So Calif, Broad CIRM Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA USA; [Lien, Ching-Ling] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Sucov, Henry M.; Lien, Ching-Ling] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Michigan System; University of Michigan; University of Southern California; University of Southern California; University of Southern California	Lien, CL (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Inst Heart, Los Angeles, CA 90027 USA.	clien@chla.usc.edu	Harrison, Michael/F-5026-2015	Harrison, Michael/0000-0003-1703-9879; Sucov, Henry/0000-0002-3792-3795	National Heart, Lung and Blood Institute [HL096121, HL070123, R01HL096121]; Saban Research Institute; Pre-Doctoral Research Award; California Institute of Regenerative Medicine Postgraduate Training Grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070123, R01HL096121] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Saban Research Institute; Pre-Doctoral Research Award; California Institute of Regenerative Medicine Postgraduate Training Grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by National Heart, Lung and Blood Institute R01 grants (HL096121 to C-L.L., HL070123 to H.M.S.). This work was supported by National Heart, Lung and Blood Institute Grant (R01HL096121 to C.-L.L.), a Research Career Development Award from the Saban Research Institute (C.-L.L.); Pre-Doctoral Research Award (Y.H.) and Research Career Development Fellowship (J.K.) from the Saban Research Institute and California Institute of Regenerative Medicine Postgraduate Training Grants (M.H. and J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Brade T, 2011, DEVELOPMENT, V138, P139, DOI 10.1242/dev.054239; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Chablais F, 2012, DEVELOPMENT, V139, P1921, DOI 10.1242/dev.078543; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Choi WY, 2013, DEVELOPMENT, V140, P660, DOI 10.1242/dev.088526; Choi WY, 2012, CURR TOP DEV BIOL, V100, P319, DOI 10.1016/B978-0-12-387786-4.00010-5; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Hartnett L, 2010, INT J DEV BIOL, V54, P573, DOI 10.1387/ijdb.092922lh; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kamei H, 2011, DEVELOPMENT, V138, P777, DOI 10.1242/dev.056853; Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kim J, 2012, NAT PROTOC, V7, P247, DOI 10.1038/nprot.2011.440; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; LeRoith Derek, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P739; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li P, 2011, DEVELOPMENT, V138, P1795, DOI 10.1242/dev.054338; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Lien CL, 2012, WOUND REPAIR REGEN, V20, P638, DOI 10.1111/j.1524-475X.2012.00814.x; Liu QQ, 1996, CIRC RES, V79, P716, DOI 10.1161/01.RES.79.4.716; Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/j.cub.2003.11.055; Mably JD, 2006, DEVELOPMENT, V133, P3139, DOI 10.1242/dev.02469; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; Nusslein-Volhard CD, 2002, ZEBRATISH PRACTICAL; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Serluca FC, 2008, DEV BIOL, V315, P18, DOI 10.1016/j.ydbio.2007.10.007; Sucov HM, 2009, PEDIATR CARDIOL, V30, P617, DOI 10.1007/s00246-009-9391-8; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278	43	33	35	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67266	10.1371/journal.pone.0067266	http://dx.doi.org/10.1371/journal.pone.0067266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840646	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400088
J	Abramovitch, JB; Kamath, S; Varese, N; Zubrinich, C; Lopata, AL; O'Hehir, RE; Rolland, JM				Abramovitch, Jodie B.; Kamath, Sandip; Varese, Nirupama; Zubrinich, Celia; Lopata, Andreas L.; O'Hehir, Robyn E.; Rolland, Jennifer M.			IgE Reactivity of Blue Swimmer Crab (Portunus pelagicus) Tropomyosin, Por p 1, and Other Allergens; Cross-Reactivity with Black Tiger Prawn and Effects of Heating	PLOS ONE			English	Article							MAJOR SHRIMP ALLERGEN; FOOD ALLERGY; ARGININE KINASE; IDENTIFICATION; BINDING; ANTIBODIES; DIAGNOSIS; DIGESTION; PROTEINS; CLONING	Shellfish allergy is a major cause of food-induced anaphylaxis, but the allergens are not well characterized. This study examined the effects of heating on blue swimmer crab (Portunus pelagicus) allergens in comparison with those of black tiger prawn (Penaeus monodon) by testing reactivity with shellfish-allergic subjects' serum IgE. Cooked extracts of both species showed markedly increased IgE reactivity by ELISA and immunoblotting, and clinical relevance of IgE reactivity was confirmed by basophil activation tests. Inhibition IgE ELISA and immunoblotting demonstrated cross-reactivity between the crab and prawn extracts, predominantly due to tropomyosin, but crab-specific IgE-reactivity was also observed. The major blue swimmer crab allergen tropomyosin, Por p 1, was cloned and sequenced, showing strong homology with tropomyosin of other crustacean species but also sequence variation within known and predicted linear IgE epitopes. These findings will advance more reliable diagnosis and management of potentially severe food allergy due to crustaceans.	[Abramovitch, Jodie B.; Varese, Nirupama; O'Hehir, Robyn E.; Rolland, Jennifer M.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Abramovitch, Jodie B.; Varese, Nirupama; O'Hehir, Robyn E.; Rolland, Jennifer M.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [Abramovitch, Jodie B.; Varese, Nirupama; O'Hehir, Robyn E.; Rolland, Jennifer M.] Monash Univ, Melbourne, Vic 3004, Australia; [Kamath, Sandip; Zubrinich, Celia; Lopata, Andreas L.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; James Cook University	Rolland, JM (corresponding author), Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia.	jennifer.rolland@monash.edu	Lopata, Andreas L/O-2143-2017; O'Hehir, Robyn/H-3627-2011; Kamath, Sandip/H-9741-2012	Lopata, Andreas L/0000-0002-2940-9235; Varese, Nirupama/0000-0001-9074-3710; O'Hehir, Robyn/0000-0002-3489-7595; Kamath, Sandip/0000-0002-5956-8552	Alfred Research Trusts	Alfred Research Trusts	The Alfred Research Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Asero R, 2007, MOL NUTR FOOD RES, V51, P135, DOI 10.1002/mnfr.200600132; Ayuso R, 2002, INT ARCH ALLERGY IMM, V127, P27, DOI 10.1159/000048166; Ayuso R, 2008, J ALLERGY CLIN IMMUN, V122, P795, DOI 10.1016/j.jaci.2008.07.023; Bublin M, 2008, MOL NUTR FOOD RES, V52, P1130, DOI 10.1002/mnfr.200700167; Chung SY, 2001, J AGR FOOD CHEM, V49, P3911, DOI 10.1021/jf001186o; Crespo JF, 2003, ALLERGY, V58, P98, DOI 10.1034/j.1398-9995.2003.02170.x; Davis PJ, 2001, ALLERGY, V56, P56, DOI 10.1034/j.1398-9995.2001.00918.x; DeWitt AM, 2004, MOL NUTR FOOD RES, V48, P370, DOI 10.1002/mnfr.200400015; Drew AC, 2004, J IMMUNOL, V173, P5872, DOI 10.4049/jimmunol.173.9.5872; Emoto A, 2009, FOOD CHEM, V114, P634, DOI 10.1016/j.foodchem.2008.09.100; Gamez C, 2011, ALLERGY, V66, P1375, DOI 10.1111/j.1398-9995.2011.02663.x; Garcia-Orozco KD, 2007, INT ARCH ALLERGY IMM, V144, P23, DOI 10.1159/000102610; Gautrin D, 2010, OCCUP ENVIRON MED, V67, P17, DOI 10.1136/oem.2008.039578; Jeebhay MF, 2001, OCCUP ENVIRON MED, V58, P553, DOI 10.1136/oem.58.9.553; Jeebhay MF, 2008, AM J IND MED, V51, P899, DOI 10.1002/ajim.20635; Jirapongsananuruk O, 2008, CLIN EXP ALLERGY, V38, P1038, DOI 10.1111/j.1365-2222.2008.02979.x; Kalogeromitros D, 2006, ALLERGY ASTHMA PROC, V27, P399, DOI 10.2500/aap.2006.27.2882; Leung PSC, 1996, J ALLERGY CLIN IMMUN, V98, P954, DOI 10.1016/S0091-6749(96)80012-1; LEUNG PSC, 1994, J ALLERGY CLIN IMMUN, V94, P882, DOI 10.1016/0091-6749(94)90156-2; Lieberman P, 2010, J ALLERGY CLIN IMMUN, V126, P477, DOI 10.1016/j.jaci.2010.06.022; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Lopata AL, 2005, INT ARCH ALLERGY IMM, V138, P21, DOI 10.1159/000087354; Lopata AL, 2009, CHEM BIOL PROPERTIES, P233; Lopata AL, 2009, CURR OPIN ALLERGY CL, V9, P270, DOI 10.1097/ACI.0b013e32832b3e6f; Mandalari G, 2009, REGUL TOXICOL PHARM, V55, P372, DOI 10.1016/j.yrtph.2009.08.010; Mills ENC, 2009, MOL NUTR FOOD RES, V53, P963, DOI 10.1002/mnfr.200800236; MORGAN JE, 1989, J ALLERGY CLIN IMMUN, V83, P1112, DOI 10.1016/0091-6749(89)90454-5; Motoyama K, 2007, J AGR FOOD CHEM, V55, P985, DOI 10.1021/jf062798x; Rahman AMA, 2010, RAPID COMMUN MASS SP, V24, P2462, DOI 10.1002/rcm.4664; Reese G, 2005, J IMMUNOL, V175, P8354, DOI 10.4049/jimmunol.175.12.8354; Rosmilah M, 2012, TROP BIOMED, V29, P467; Ross MP, 2008, J ALLERGY CLIN IMMUN, V121, P166, DOI 10.1016/j.jaci.2007.10.012; Samson KTR, 2004, INT ARCH ALLERGY IMM, V133, P225, DOI 10.1159/000076828; SHANTI KN, 1993, J IMMUNOL, V151, P5354; Shiomi K, 2008, INT ARCH ALLERGY IMM, V146, P91, DOI 10.1159/000113512; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P881, DOI 10.1067/mai.2001.118515; Skypala I, 2011, J AM DIET ASSOC, V111, P1877, DOI 10.1016/j.jada.2011.09.001; Thomas K, 2007, FOOD CHEM TOXICOL, V45, P1116, DOI 10.1016/j.fct.2006.12.016; Vissers YM, 2011, CLIN EXP ALLERGY, V41, P1631, DOI 10.1111/j.1365-2222.2011.03830.x; Wickham M, 2009, MOL NUTR FOOD RES, V53, P952, DOI 10.1002/mnfr.200800193; Yang AC, 2010, J ALLERGY CLIN IMMUN, V125, P872, DOI 10.1016/j.jaci.2009.11.043; Zhang Y, 2006, J DERMATOL, V33, P174, DOI 10.1111/j.1346-8138.2006.00040.x; Zheng LN, 2011, FOOD CHEM TOXICOL, V49, P2954, DOI 10.1016/j.fct.2011.07.043	45	49	57	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67487	10.1371/journal.pone.0067487	http://dx.doi.org/10.1371/journal.pone.0067487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840718	gold, Green Accepted, Green Published			2022-12-27	WOS:000322361200137
J	Wehkalampi, K; Muurinen, M; Wirta, SB; Hannula-Jouppi, K; Hovi, P; Jarvenpaa, AL; Eriksson, JG; Andersson, S; Kere, J; Kajantie, E				Wehkalampi, Karoliina; Muurinen, Mari; Wirta, Sara Bruce; Hannula-Jouppi, Katariina; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Eriksson, Johan G.; Andersson, Sture; Kere, Juha; Kajantie, Eero			Altered Methylation of IGF2 Locus 20 Years after Preterm Birth at Very Low Birth Weight	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; DNA METHYLATION; RUSSELL-SILVER; BLOOD-PRESSURE; YOUNG-ADULTS; GROWTH; DISEASE; FETAL; RISK; AGE	Introduction: People born preterm at very low birth weight (VLBW, <= 1500g) have higher rates of risk factors for adult-onset diseases, including cardiovascular diseases and type 2 diabetes. These risks may be mediated through epigenetic modification of genes that are critical to normal growth and development. Methods: We measured the methylation level of an imprinted insulin-like-growth-factor 2 (IGF2) locus (IGF2/H19) in young adults born preterm at VLBW and in their peers born at term. We studied 158 VLBW and 161 control subjects aged 18 to 27 years from the Helsinki Study of Very Low Birth Weight Adults. Methylation fraction at two IGF2 differentially methylated regions (DMRs) - IGF2 antisense transcript (IGF2AS, also known as IGF2 DMR0) and last exon of IGF2 (IGF2_05, also known as IGF2 DMR2) - were measured with Sequenom Epityper. We used linear regression and adjustment for covariates to compare methylation fractions at these DMRs between VLBW and control subjects. Results: At one IGF2AS CpG site, methylation was significantly lower in VLBW than in control subjects, mean difference 20.017 (95% CI; -0.028, -0.005), P = 0.004. Methylation at IGF2_05 was not different between the groups. Conclusions: Methylation of IGF2AS is altered 20 years after preterm birth at VLBW. Altered methylation may be a mechanism of later increased disease risk but more data are needed to indicate causality.	[Wehkalampi, Karoliina; Hovi, Petteri; Eriksson, Johan G.; Kajantie, Eero] Natl Inst Hlth & Welf, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Wehkalampi, Karoliina; Hovi, Petteri; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Hannula-Jouppi, Katariina] Univ Helsinki, Cent Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Muurinen, Mari; Hannula-Jouppi, Katariina; Kere, Juha] Univ Helsinki, Res Programs Unit, Program Mol Med, Helsinki, Finland; [Muurinen, Mari; Hannula-Jouppi, Katariina; Kere, Juha] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Folkhalsan Res Ctr, Helsinki, Finland; [Wirta, Sara Bruce; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Stockholm, Sweden	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Karolinska Institutet	Wehkalampi, K (corresponding author), Natl Inst Hlth & Welf, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland.	wehkalampi@helsinki.fi	Hannula-Jouppi, Katariina SE/F-4476-2011; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Hannula-Jouppi, Katariina/0000-0003-3864-2853; Eriksson, Johan/0000-0002-2516-2060	Academy of Finland; Novo Nordisk Foundation; Finnish Foundation for Pediatric Research; Finnish Medical Foundation; Yrjo Jahnsson Foundation; Biomedicum Helsinki Foundation; Finnish Medical Society (Duodecim); Finnish Special Governmental Subsidiary for Health Sciences; Finnish National Graduate School of Clinical Investigation; Helsinki Biomedical Graduate Program; Swedish Research Council; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Waldemar von Frenckell Foundation; Vasa Nation; Wiipurilainen Osakunta at Helsinki University; Finnish Medical Society (Finska Lakaresallskapet); Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Academy of Finland(Academy of Finland); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Finnish Foundation for Pediatric Research; Finnish Medical Foundation; Yrjo Jahnsson Foundation; Biomedicum Helsinki Foundation; Finnish Medical Society (Duodecim); Finnish Special Governmental Subsidiary for Health Sciences; Finnish National Graduate School of Clinical Investigation; Helsinki Biomedical Graduate Program; Swedish Research Council(Swedish Research CouncilEuropean Commission); Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Waldemar von Frenckell Foundation; Vasa Nation; Wiipurilainen Osakunta at Helsinki University; Finnish Medical Society (Finska Lakaresallskapet); Novo Nordisk Fonden(Novo Nordisk Foundation)	The study has been supported by the Academy of Finland, the Novo Nordisk Foundation, the Finnish Foundation for Pediatric Research, the Finnish Medical Foundation, the Yrjo Jahnsson Foundation, the Biomedicum Helsinki Foundation, Finnish Medical Societies (Duodecim and Finska Lakaresallskapet), the Finnish Special Governmental Subsidiary for Health Sciences, the Finnish National Graduate School of Clinical Investigation, Helsinki Biomedical Graduate Program, Swedish Research Council, the Jalmari and Rauha Ahokas Foundation, the Juho Vainio Foundation, the Paivikki and Sakari Sohlberg Foundation, the Signe and Ane Gyllenberg Foundation, the Sigrid Juselius Foundation, the Waldemar von Frenckell Foundation, Vasa Nation and Wiipurilainen Osakunta at Helsinki University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2010, J PEDIATR-US, V156, P54, DOI 10.1016/j.jpeds.2009.07.022; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Hoyo C, 2012, CANCER CAUSE CONTROL, V23, P635, DOI 10.1007/s10552-012-9932-y; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Hoyo C, 2009, J EPIDEMIOL COMMUN H, V63, P683, DOI 10.1136/jech.2009.090803; Hult M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013582; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Koukoura O, 2011, INT J MOL MED, V28, P481, DOI 10.3892/ijmm.2011.754; Lee H, 2012, INT J EPIDEMIOL, V41, P188, DOI 10.1093/ije/dyr237; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Lumey LH, 2012, INT J EPIDEMIOL, V41, P116, DOI 10.1093/ije/dyr137; Murphy R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-42; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Netchine I, 2007, J CLIN ENDOCR METAB, V92, P3148, DOI 10.1210/jc.2007-0354; Pihkala J, 1989, Duodecim, V105, P1540; Pyhala R, 2009, PEDIATRICS, V123, P731, DOI 10.1542/peds.2008-0277; Reinius LE, 2012, DIFFERENTIAL DNA MET; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Schroeder JW, 2011, EPIGENETICS-US, V6, P1498, DOI 10.4161/epi.6.12.18296; Talens RP, 2012, INT J EPIDEMIOL, V41, P106, DOI 10.1093/ije/dyr153; Tobi EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037933; Tobi EW, 2011, EPIGENETICS-US, V6, P171, DOI 10.4161/epi.6.2.13516; Turan N, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-10; Turan N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001033; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011	40	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67379	10.1371/journal.pone.0067379	http://dx.doi.org/10.1371/journal.pone.0067379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840686	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200131
J	Kaushik, R; Battiston, S				Kaushik, Rahul; Battiston, Stefano			Credit Default Swaps Drawup Networks: Too Interconnected to Be Stable?	PLOS ONE			English	Article							LINKS; RISK	We analyse time series of CDS spreads for a set of major US and European institutions in a period overlapping the recent financial crisis. We extend the existing methodology of epsilon-drawdowns to the one of joint epsilon-drawups, in order to estimate the conditional probabilities of spike-like co-movements among pairs of spreads. After correcting for randomness and finite size effects, we find that, depending on the period of time, 50% of the pairs or more exhibit high probabilities of joint drawups and the majority of spread series are trend-reinforced, i.e. drawups tend to be followed by drawups in the same series. We then carry out a network analysis by taking the probability of joint drawups as a proxy of financial dependencies among institutions. We introduce two novel centrality-like measures that offer insights on how both the systemic impact of each node as well as its vulnerability to other nodes' shocks evolve in time.	[Kaushik, Rahul; Battiston, Stefano] ETH, Chair Syst Design, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kaushik, R (corresponding author), ETH, Chair Syst Design, Zurich, Switzerland.	rkaushik@alumni.ethz.ch	Kaushik, Rahul/ABG-9528-2021; /M-1612-2017	/0000-0002-0051-973X	Swiss National Science Foundation Grant [CR12I1-127000]; OTC Derivatives and Systemic Risk in Financial Networks; European Commission FET Open Project [FOC 255987]	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); OTC Derivatives and Systemic Risk in Financial Networks; European Commission FET Open Project	The authors acknowledge the finnancial support from the Swiss National Science Foundation Grant (CR12I1-127000), OTC Derivatives and Systemic Risk in Financial Networks and the European Commission FET Open Project FOC 255987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, TECHNICAL REPORT; Banks G, 2011, ASS METH ADD LOSS AB; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Battiston S, 2013, NAT PHYS, V9, P123, DOI 10.1038/nphys2575; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Battiston S, 2012, J FINANC STABIL, V8, P138, DOI 10.1016/j.jfs.2012.01.002; Bloomberg-News, 2011, BLOOMBERG NEWS; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Caldarelli G., 2007, SCALE FREE NETWORKS; Caldarelli G, 2013, NAT PHYS, V9, P125, DOI 10.1038/nphys2580; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Commission F.C.I., 2011, FIN CRIS INQ REP FIN; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; Garas A, 2008, EUR PHYS J B, V63, P265, DOI 10.1140/epjb/e2008-00237-3; Johansen A, 2003, PHYSICA A, V324, P157, DOI 10.1016/S0378-4371(02)01843-5; Kullmann L, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026125; Lorenz J, 2008, NETW HETEROG MEDIA, V3, P185, DOI 10.3934/nhm.2008.3.185; Markose S, 2012, J EC BEHAV ORG; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Sornette D, 2006, INT J FORECASTING, V22, P153, DOI 10.1016/j.ijforecast.2005.02.004; Stiglitz J, 2008, AM ECON REV, V100, P388	23	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e61815	10.1371/journal.pone.0061815	http://dx.doi.org/10.1371/journal.pone.0061815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182HT	23843931	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321733000037
J	Dubnovitsky, A; Sandberg, A; Rahman, MM; Benilova, I; Lendel, C; Hard, T				Dubnovitsky, Anatoly; Sandberg, Anders; Rahman, M. Mahafuzur; Benilova, Iryna; Lendel, Christofer; Hard, Torleif			Amyloid-beta Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; FIBRILLAR OLIGOMERS; PROTEIN; PEPTIDE; NEUROTOXICITY; COMMON; STABILIZATION; NUCLEATION; MUTATION	Structural and biochemical studies of the aggregation of the amyloid-beta peptide (A beta) are important to understand the mechanisms of Alzheimer's disease, but research is complicated by aggregate inhomogeneity and instability. We previously engineered a hairpin form of A beta called A beta cc, which forms stable protofibrils that do not convert into amyloid fibrils. Here we provide a detailed characterization of A beta(42)cc protofibrils. Like wild type A beta they appear as smooth rod-like particles with a diameter of 3.1 (+/- 0.2) nm and typical lengths in the range 60 to 220 nm when observed by atomic force microscopy. Non-perturbing analytical ultracentrifugation and nanoparticle tracking analyses are consistent with such rod-like protofibrils. A beta(42)cc protofibrils bind the ANS dye indicating that they, like other toxic protein aggregates, expose hydrophobic surface. Assays with the OC/A11 pair of oligomer specific antibodies put A beta(42)cc protofibrils into the same class of species as fibrillar oligomers of wild type A beta. A beta(42)cc protofibrils may be used to extract binding proteins in biological fluids and apolipoprotein E is readily detected as a binder in human serum. Finally, A beta(42)cc protofibrils act to attenuate spontaneous synaptic activity in mouse hippocampal neurons. The experiments indicate considerable structural and chemical similarities between protofibrils formed by A beta(42)cc and aggregates of wild type A beta(42). We suggest that A beta(42)cc protofibrils may be used in research and applications that require stable preparations of protofibrillar A beta.	[Dubnovitsky, Anatoly; Rahman, M. Mahafuzur; Lendel, Christofer; Hard, Torleif] Swedish Univ Agr Sci SLU, Dept Mol Biol, Uppsala, Sweden; [Sandberg, Anders] Alzinova AB, Gothenburg, Sweden; [Benilova, Iryna] Flanders Inst Biotechnol VIB, Dept Mol & Dev Genet, Louvain, Belgium; [Benilova, Iryna] KULeuven, Ctr Human Genet, Louvain, Belgium	Swedish University of Agricultural Sciences; Flanders Institute for Biotechnology (VIB); KU Leuven	Hard, T (corresponding author), Swedish Univ Agr Sci SLU, Dept Mol Biol, Uppsala, Sweden.	torleif.hard@slu.se	Lendel, Christofer/AAC-9439-2022; Benilova, Iryna/H-6533-2019; Rahman, M. Mahafuzur/N-4815-2015	Lendel, Christofer/0000-0001-9238-7246; Rahman, M. Mahafuzur/0000-0003-4247-7766; Dubnovitsky, Anatoly/0000-0002-5350-4531; Hard, Torleif/0000-0001-9813-9913	Swedish Research Council (VR); Science for Life Laboratory MS technology platform in Uppsala	Swedish Research Council (VR)(Swedish Research Council); Science for Life Laboratory MS technology platform in Uppsala	This work was supported by a grant to TH from the Swedish Research Council (VR) and by the Science for Life Laboratory MS technology platform in Uppsala. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Cantor C.R., 1980, BIOPHYS CHEM; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Filipe V, 2011, PHARM RES-DORDR, V28, P1112, DOI 10.1007/s11095-011-0374-0; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Hard T, 2011, FEBS J, V278, P3884, DOI 10.1111/j.1742-4658.2011.08295.x; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hoyer W, 2008, J MOL BIOL, V378, P398, DOI 10.1016/j.jmb.2008.02.040; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lam AR, 2008, J AM CHEM SOC, V130, P17413, DOI 10.1021/ja804984h; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Macao B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-82; MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253; Mitternacht S, 2010, PROTEINS, V78, P2600, DOI 10.1002/prot.22775; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	45	37	38	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66101	10.1371/journal.pone.0066101	http://dx.doi.org/10.1371/journal.pone.0066101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843949	gold, Green Submitted, Green Published			2022-12-27	WOS:000321341000010
J	Gu, SJ; Yang, HR; Qi, Y; Deng, X; Zhang, L; Guo, Y; Huang, Q; Li, J; Shi, XL; Song, Z; Deng, H				Gu, Shaojuan; Yang, Huarong; Qi, Yong; Deng, Xiong; Zhang, Le; Guo, Yi; Huang, Qing; Li, Jing; Shi, Xiaoliu; Song, Zhi; Deng, Hao			Novel ATPase Cu2+ Transporting Beta Polypeptide Mutations in Chinese Families with Wilson's Disease	PLOS ONE			English	Article							ATP7B GENE; IDENTIFICATION; METABOLISM; EXPRESSION; LEVEL	Wilson's disease (WD) is an autosomal recessive inherited disorder caused by mutations in the ATPase Cu2+ transporting beta polypeptide gene (ATP7B). The detailed metabolism of copper-induced pathology in WD is still unknown. Gene mutations as well as the possible pathways involved in the ATP7B deficiency were documented. The ATP7B gene was analyzed for mutations in 18 Chinese Han families with WD by direct sequencing. Cell viability and apoptosis analysis of ATP7B small interfering RNA (siRNA)-treated human liver carcinoma (HepG2) cells were measured by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay and Hoechst 33342 staining. Finally, the expression of B-cell CLL/lymphoma 2 (BCL2), BCL2-associated X protein (BAX), sterol regulatory element binding protein 1 (SREBP1), and minichromosome maintenance protein 7 (MCM7) of ATP7B siRNA-treated cells were tested by real-time polymerase chain reaction (real-time PCR) and Western blot analysis. Twenty different mutations including four novel mutations (p.Val145Phe, p.Glu388X, p.Thr498Ser and p.Gly837X) in the ATP7B gene were identified in our families. Haplotype analysis revealed that founder effects for four mutations (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val) existed in these families. Transfection of HepG2 cells with ATP7B siRNA resulted in decreased mRNA expression by 86.3%, 93.1% and 90.8%, and decreased protein levels by 58.5%, 85.5% and 82.1% at 24, 48 and 72 hours, respectively (All P<0.01). In vitro study revealed that the apoptotic, cell cycle and lipid metabolism pathway may be involved in the mechanism of WD. Our results revealed that the genetic cause of 18 Chinese families with WD and ATP7B deficiency-induce apoptosis may result from imbalance in cell cycle and lipid metabolism pathway.	[Gu, Shaojuan; Yang, Huarong; Qi, Yong; Deng, Xiong; Deng, Hao] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China; [Gu, Shaojuan; Yang, Huarong; Song, Zhi; Deng, Hao] Cent S Univ, Xiangya Hosp 3, Dept Neurol, Changsha, Hunan, Peoples R China; [Zhang, Le; Huang, Qing; Li, Jing] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Guo, Yi] Cent S Univ, Xiangya Med Sch, Dept Physiol, Changsha, Hunan, Peoples R China; [Shi, Xiaoliu] Cent S Univ, Xiangya Hosp 2, Dept Gastroenterol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University	Deng, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China.	hdeng008@yahoo.com	GUO, YI/AAW-2801-2021; Deng, Hao/O-6340-2017	Deng, Hao/0000-0003-3240-4352; Guo, Yi/0000-0003-2727-9809; Shi, Xiaoliu/0000-0002-9759-2254	National Natural Science Foundation of China [81101339, 81271921]; Research Fund for the Doctoral Program of Higher Education of China [20110162110026]; Fundamental Research Funds for the Central Universities [2011JQ014]; Fund of "125'' Project of The Third Xiangya Hospital of P.R. China; Sheng Hua Scholars Program of Central South University, China; Construction Fund for Key Subjects of the Third Xiangya Hospital; Central South University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fund of "125'' Project of The Third Xiangya Hospital of P.R. China; Sheng Hua Scholars Program of Central South University, China; Construction Fund for Key Subjects of the Third Xiangya Hospital; Central South University, China	This study was supported by National Natural Science Foundation of China (81101339 and 81271921 to HD), the Research Fund for the Doctoral Program of Higher Education of China (20110162110026 to HD), the Fundamental Research Funds for the Central Universities (2011JQ014 to HD), the Fund of "125'' Project of The Third Xiangya Hospital of P.R. China (to SG), Sheng Hua Scholars Program of Central South University, China (to HD), Construction Fund for Key Subjects of the Third Xiangya Hospital(to HD), Central South University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Barada K, 2010, J CLIN GASTROENTEROL, V44, P432, DOI 10.1097/MCG.0b013e3181ce5138; Deguti MM, 2004, HUM MUTAT, V23, P398, DOI 10.1002/humu.9227; Deng H, 2007, ARCH NEUROL-CHICAGO, V64, P421, DOI 10.1001/archneur.64.3.421; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Fujioka S, 2009, LUNG CANCER, V65, P223, DOI 10.1016/j.lungcan.2008.11.007; Gromadzka G, 2005, CLIN GENET, V68, P524, DOI 10.1111/j.1399-0004.2005.00528.x; Gromadzka G, 2011, J HEPATOL, V55, P913, DOI 10.1016/j.jhep.2011.01.030; He K, 2011, MAMM GENOME, V22, P703, DOI 10.1007/s00335-011-9359-x; Horslen S, 2010, J CLIN GASTROENTEROL, V44, P387, DOI 10.1097/MCG.0b013e3181d96ac4; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Kenney SM, 2007, HUM MUTAT, V28, P1171, DOI 10.1002/humu.20586; Linn FHH, 2009, HEPATOLOGY, V50, P1442, DOI 10.1002/hep.23182; Mak CM, 2008, J HUM GENET, V53, P55, DOI 10.1007/s10038-007-0218-2; Mangala LS, 2009, CLIN CANCER RES, V15, P3770, DOI 10.1158/1078-0432.CCR-08-2306; Margarit E, 2005, CLIN GENET, V68, P61, DOI 10.1111/j.1399-0004.2005.00439.x; Nanji MS, 1997, AM J HUM GENET, V60, P1423, DOI 10.1086/515459; Nicastro E, 2009, J HEPATOL, V50, P555, DOI 10.1016/j.jhep.2008.09.020; Ota T, 2011, MODERN PATHOL, V24, P277, DOI 10.1038/modpathol.2010.202; Ralle M, 2010, J BIOL CHEM, V285, P30875, DOI 10.1074/jbc.M110.114447; Rodo M, 2000, EUR J NEUROL, V7, P491; Saydam O, 2010, J PROTEOME RES, V9, P485, DOI 10.1021/pr900834h; Sayre LM, 2000, CELL MOL BIOL, V46, P731; Schilsky Michael L, 2010, Curr Gastroenterol Rep, V12, P57, DOI 10.1007/s11894-009-0084-5; Shigehara K, 2011, CANCER-AM CANCER SOC, V117, P2067, DOI 10.1002/cncr.25777; Tang ZR, 2000, J NUTR, V130, P2915, DOI 10.1093/jn/130.12.2915; Vrabelova S, 2005, MOL GENET METAB, V86, P277, DOI 10.1016/j.ymgme.2005.05.004; Yamaguchi A, 1998, HUM MUTAT, pS320	28	7	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66526	10.1371/journal.pone.0066526	http://dx.doi.org/10.1371/journal.pone.0066526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843956	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000015
J	Kumar, S; Prasad, S; Sitasawad, SL				Kumar, Santosh; Prasad, Sahdeo; Sitasawad, Sandhya L.			Multiple Antioxidants Improve Cardiac Complications and Inhibit Cardiac Cell Death in Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							NF-KAPPA-B; MEDIATED OXIDATIVE STRESS; LOW-DENSITY-LIPOPROTEIN; TRANSCRIPTION FACTORS; MONOAMINE-OXIDASE; ANGIOTENSIN-II; HEART-FAILURE; NADPH OXIDASE; MYOCARDIAL-INFARCTION; GENE-TRANSCRIPTION	Diabetic cardiomyopathy, a disorder of the heart muscle in diabetic patients, is one of the major causes of heart failure. Since diabetic cardiomyopathy is now known to have a high prevalence in the asymptomatic diabetic patient, prevention at the earliest stage of development by existing molecules would be appropriate in order to prevent the progression of heart failure. In this study, we investigated the protective role of multiple antioxidants (MA), on cardiac dysfunction and cardiac cell apoptosis in streptozotocin (STZ)-induced diabetic rat. Diabetic cardiomyopathy in STZ-treated animals was characterized by declined systolic, diastolic myocardial performance, oxidative stress and apoptosis in cardiac cells. Diabetic rats on supplementation with MA showed decreased oxidative stress evaluated by the content of reduced levels of lipid per-oxidation and decreased activity of catalase with down-regulation of heme-oxygenase-1 mRNA. Supplementation with MA also resulted in a normalized lipid profile and decreased levels of pro-inflammatory transcription factor NF-kappaB as well as cytokines such as TNF-alpha, IFN-gamma, TGF-beta, and IL-10. MA was found to decrease the expression of ROS-generating enzymes like xanthine oxidase, monoamine oxidase-A along with 5-Lipoxygenase mRNA and/or protein expression. Further, left ventricular function, measured by a microtip pressure transducer, was re-established as evidenced by increase in +/- dp/dtmax, heart rate, decreased blood pressure, systolic and diastolic pressure as well as decrease in the TUNEL positive cardiac cells with increased Bcl-2/Bax ratio. In addition, MA supplementation decreased cell death and activation of NF-kappaB in cardiac H9c2 cells. Based on our results, we conclude that MA supplementation significantly attenuated cardiac dysfunction in diabetic rats; hence MA supplementation may have important clinical implications in terms of prevention and management of diabetic cardiomyopathy.	[Kumar, Santosh; Prasad, Sahdeo; Sitasawad, Sandhya L.] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sitasawad, SL (corresponding author), Natl Ctr Cell Sci, NCCS Complex, Pune, Maharashtra, India.	ssitaswad@nccs.res.in			Department of Biotechnology, Government of India; Indian Council of Medical Research, New Delhi	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This work was supported by the Department of Biotechnology, Government of India, and the Indian Council of Medical Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bianchi P, 2005, CIRCULATION, V112, P3297, DOI 10.1161/CIRCULATIONAHA.104.528133; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Cai L, 2002, DIABETES, V51, P1938, DOI 10.2337/diabetes.51.6.1938; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Cai L, 2006, FREE RADICAL BIO MED, V41, P851, DOI 10.1016/j.freeradbiomed.2006.06.007; Cnop M, 2002, ENDOCRINOLOGY, V143, P3449, DOI 10.1210/en.2002-220273; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Feldman AM, 2000, J AM COLL CARDIOL, V35, P537, DOI 10.1016/S0735-1097(99)00600-2; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Grieve DJ, 2003, EUR HEART J, V24, P2161, DOI 10.1016/j.ehj.2003.10.015; Guo ZX, 2007, AM J PHYSIOL-HEART C, V292, pH1728, DOI 10.1152/ajpheart.01328.2005; JAFFE AS, 1984, AM HEART J, V108, P31, DOI 10.1016/0002-8703(84)90541-6; Jiang Q, 2011, MOL CELL ENDOCRINOL, V331, P34, DOI 10.1016/j.mce.2010.07.023; Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414; Kowluru RA, 2000, FREE RADICAL RES, V32, P67, DOI 10.1080/10715760000300071; Kwon SH, 2003, J MOL CELL CARDIOL, V35, P615, DOI 10.1016/S0022-2828(03)00084-1; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Li SY, 2006, DIABETOLOGIA, V49, P1434, DOI 10.1007/s00125-006-0229-0; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Maurel A, 2003, AM J PHYSIOL-HEART C, V284, pH1460, DOI 10.1152/ajpheart.00700.2002; Maziere C, 2009, FREE RADICAL BIO MED, V46, P127, DOI 10.1016/j.freeradbiomed.2008.10.024; McCord J M, 1985, Adv Myocardiol, V5, P183; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Min W, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-8; Modesti A, 2005, DIABETES, V54, P394, DOI 10.2337/diabetes.54.2.394; Mohamed AK, 1999, BIOFACTORS, V10, P157, DOI 10.1002/biof.5520100211; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Nishio Y, 1998, DIABETES, V47, P1318, DOI 10.2337/diabetes.47.8.1318; Privratsky JR, 2003, HYPERTENSION, V42, P206, DOI 10.1161/01.HYP.0000082814.62655.85; Rahman I, 2000, FREE RADICAL BIO MED, V28, P1405, DOI 10.1016/S0891-5849(00)00215-X; RAJAVASHISTH TB, 1995, ARTERIOSCL THROM VAS, V15, P1591, DOI 10.1161/01.ATV.15.10.1591; Riad A, 2007, EUR J PHARMACOL, V569, P204, DOI 10.1016/j.ejphar.2007.04.065; Saraiva RM, 2007, NITRIC OXIDE-BIOL CH, V16, P331, DOI 10.1016/j.niox.2006.12.001; Schrammel A, 2000, CARDIOVASC RES, V47, P602, DOI 10.1016/S0008-6363(00)00019-5; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Sun Y, 2004, J LAB CLIN MED, V143, P41, DOI 10.1016/j.lab.2003.07.004; Thakker GD, 2006, AM J PHYSIOL-HEART C, V291, pH2504, DOI 10.1152/ajpheart.00322.2006; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Tschope C, 2005, FASEB J, V19, P2057, DOI 10.1096/fj.05-4095fje; Turkseven S, 2005, AM J PHYSIOL-HEART C, V289, pH701, DOI 10.1152/ajpheart.00024.2005; Westermann D, 2007, DIABETES, V56, P1834, DOI 10.2337/db06-1662; Westermann D, 2007, DIABETES, V56, P641, DOI 10.2337/db06-1163; WEYLER W, 1990, PHARMACOL THERAPEUT, V47, P391, DOI 10.1016/0163-7258(90)90064-9; Wold LE, 2006, FREE RADIC BIOL MED, V40, P1419	52	48	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67009	10.1371/journal.pone.0067009	http://dx.doi.org/10.1371/journal.pone.0067009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843977	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000026
J	Zhang, JB; Yue, TL; Yuan, YH				Zhang, Jiangbo; Yue, Tianli; Yuan, Yahong			Alicyclobacillus Contamination in the Production Line of Kiwi Products in China	PLOS ONE			English	Article							FRUIT PROCESSING ENVIRONMENT; OFF-FLAVOR COMPOUNDS; BACILLUS-ACIDOTERRESTRIS; ORANGE JUICE; SP NOV.; IDENTIFICATION; ACIDOCALDARIUS; RESISTANCE; BACTERIA; SOIL	Alicyclobacillus are spoilage microbes of many juice products, but contamination of kiwi products by Alicyclobacillus is seldom reported. This study aims to investigate the whole production line of kiwi products in China to assess the potential risk of their contamination. A total of 401 samples from 18 commercial products, 1 processing plant and 16 raw material orchards were tested, and 76 samples were positive, from which 76 strains of microbes were isolated and identified as 4 species of Alicyclobacillus, including Alicyclobacillus acidoterrestris, Alicyclobacillus contaminans, Alicyclobacillus herbarius and Alicyclobacillus cycloheptanicus, and another 9 strains as 3 species of Bacillus by sequencing of their 16S rDNA. Through phylogenetic tree construction and RAPD-PCR amplification, it was found that there exist genotypic diversities to some extent among these isolates. Four test strains (each from one species of the 4 Alicyclobacillus species isolated in this study) could spoil pH adjusted kiwi fruit juice and some commercial kiwi fruit products with producing guaiacol (11-34 ppb).	[Zhang, Jiangbo; Yue, Tianli; Yuan, Yahong] Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China	Northwest A&F University - China	Yue, TL (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China.	yuetl@nwsuaf.edu.cn	yue, tianli/AEY-3384-2022	yue, tianli/0000-0002-4768-5831	China State "12th-Five-Year Plan" Scientific and Technological Schemes Support [2012BAK17B06]; National Natural Science Foundation of China [31071550, 31171721]	China State "12th-Five-Year Plan" Scientific and Technological Schemes Support; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the China State "12th-Five-Year Plan" Scientific and Technological Schemes Support (2012BAK17B06) (http://www.most.gov.cn/), and the National Natural Science Foundation of China (31071550, 31171721)(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart J., 2000, FRUIT PROCESS, V10, P251; BLOCHER JC, 1983, FOOD TECHNOL-CHICAGO, V37, P87; Borlinghaus A., 1997, Fruit Processing, V7, P262; CERNY G, 1984, Z LEBENSM UNTERS FOR, V179, P224, DOI 10.1007/BF01041898; Chang SS, 2004, CRIT REV MICROBIOL, V30, P55, DOI 10.1080/10408410490435089; Chen SQ, 2006, FOOD MICROBIOL, V23, P439, DOI 10.1016/j.fm.2005.07.005; Danyluk MD, 2011, FOOD MICROBIOL, V28, P472, DOI 10.1016/j.fm.2010.10.008; De Clerck E, 2004, RES MICROBIOL, V155, P483, DOI 10.1016/j.resmic.2004.02.007; DEINHARD G, 1987, SYST APPL MICROBIOL, V10, P47, DOI 10.1016/S0723-2020(87)80009-7; Durak MZ, 2010, INT J FOOD MICROBIOL, V142, P286, DOI 10.1016/j.ijfoodmicro.2010.07.003; Eiroa MNU, 1999, J FOOD PROTECT, V62, P883, DOI 10.4315/0362-028X-62.8.883; Eisele TA, 2005, J FOOD SCI, V70, pS267, DOI 10.1111/j.1365-2621.2005.tb07201.x; Gocmen D, 2005, LETT APPL MICROBIOL, V40, P172, DOI 10.1111/j.1472-765X.2004.01636.x; Goto K, 2008, LETT APPL MICROBIOL, V46, P289, DOI 10.1111/j.1472-765X.2007.02307.x; Goto K, 2002, EXTREMOPHILES, V6, P333, DOI 10.1007/s00792-001-0262-3; Goto K., 2006, MICROBIOL CULT COLLE, V22, P1; Gouws PA, 2005, INT J FOOD SCI TECH, V40, P789, DOI 10.1111/j.1365-2621.2005.01006.x; Groenewald WH, 2009, FOOD MICROBIOL, V26, P71, DOI 10.1016/j.fm.2008.07.008; Howard I, 2006, ACB WORKSH OCT 2005; Huang H, 2001, NEW ZEAL J CROP HORT, V29, P1, DOI 10.1080/01140671.2001.9514154; IFU (International Federation of Fruit Juice Producers), 2007, 12 IFU, P1; Jensen N, 2003, LETT APPL MICROBIOL, V36, P9, DOI 10.1046/j.1472-765X.2003.01251.x; Jiang CY, 2008, INT J SYST EVOL MICR, V58, P2898, DOI 10.1099/ijs.0.2008/000562-0; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Oteiza JM, 2011, INT J FOOD MICROBIOL, V151, P229, DOI 10.1016/j.ijfoodmicro.2011.09.004; Pettipher GL, 1997, LETT APPL MICROBIOL, V24, P185, DOI 10.1046/j.1472-765X.1997.00373.x; Pinhatti M. E. M. C., 1997, FRUIT PROCESS, V7, P350; Previdi M. P., 1999, Industria Conserve, V74, P231; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDOVAL AJ, 1992, J FOOD SCI, V57, P1369, DOI 10.1111/j.1365-2621.1992.tb06860.x; Siegmund B, 2006, J AGR FOOD CHEM, V54, P5984, DOI 10.1021/jf060602n; Smit Y, 2011, FOOD MICROBIOL, V28, P331, DOI 10.1016/j.fm.2010.11.008; SPLITTSTOESSER DF, 1994, J FOOD PROTECT, V57, P1080, DOI 10.4315/0362-028X-57.12.1080; Steyn CE, 2011, INT J FOOD MICROBIOL, V147, P1, DOI 10.1016/j.ijfoodmicro.2011.03.004; Ten LN, 2006, J MICROBIOL BIOTECHN, V16, P1554; UCHINO F, 1967, AGR BIOL CHEM TOKYO, V31, P817, DOI 10.1080/00021369.1967.10858890; Walker M, 2008, INT J FOOD SCI TECH, V43, P250, DOI 10.1111/j.1365-2621.2006.01427.x; Walls I, 2000, FOOD AUST, V52, P286; Walls I, 1998, DAIRY FOOD ENV SANIT, V18, P99; WISOTZKEY JD, 1992, INT J SYST BACTERIOL, V42, P263, DOI 10.1099/00207713-42-2-263; Wisse C.A., 1998, DIARY FOOD ENV SANIT, V18, P504; Zierler B, 2004, ANAL CHIM ACTA, V520, P3, DOI 10.1016/j.aca.2004.03.084	42	38	44	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67704	10.1371/journal.pone.0067704	http://dx.doi.org/10.1371/journal.pone.0067704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844069	Green Published, gold, Green Submitted			2022-12-27	WOS:000321341000080
J	Vandeghinste, B; Vandenberghe, S; Vanhove, C; Staelens, S; Van Holen, R				Vandeghinste, Bert; Vandenberghe, Stefaan; Vanhove, Chris; Staelens, Steven; Van Holen, Roel			Low-Dose Micro-CT Imaging for Vascular Segmentation and Analysis Using Sparse-View Acquisitions	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; MOUSE MODEL; RECONSTRUCTION; ALGORITHM; ALLOWS; IMAGES	The aim of this study is to investigate whether reliable and accurate 3D geometrical models of the murine aortic arch can be constructed from sparse-view data in vivo micro-CT acquisitions. This would considerably reduce acquisition time and X-ray dose. In vivo contrast-enhanced micro-CT datasets were reconstructed using a conventional filtered back projection algorithm (FDK), the image space reconstruction algorithm (ISRA) and total variation regularized ISRA (ISRA-TV). The reconstructed images were then semi-automatically segmented. Segmentations of high-and low-dose protocols were compared and evaluated based on voxel classification, 3D model diameters and centerline differences. FDK reconstruction does not lead to accurate segmentation in the case of low-view acquisitions. ISRA manages accurate segmentation with 1024 or more projection views. ISRA-TV needs a minimum of 256 views. These results indicate that accurate vascular models can be obtained from micro-CT scans with 8 times less X-ray dose and acquisition time, as long as regularized iterative reconstruction is used.	[Vandeghinste, Bert; Vandenberghe, Stefaan; Vanhove, Chris; Van Holen, Roel] Univ Ghent, iMinds, MEDISIP, Inst Biomed Technol, B-9000 Ghent, Belgium; [Staelens, Steven] Univ Antwerp, Mol Imaging Ctr Antwerp, Antwerp, Belgium	Ghent University; IMEC; University of Antwerp	Vandeghinste, B (corresponding author), Univ Ghent, iMinds, MEDISIP, Inst Biomed Technol, B-9000 Ghent, Belgium.	Bert.Vandeghinste@UGent.be	Van Holen, Roel/O-7147-2014; Staelens, Steven/D-8385-2017; Vanhove, Christian/I-2095-2019	Staelens, Steven/0000-0003-3376-0519; Vanhove, Christian/0000-0002-3988-5980	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Research Foundation Flanders (FWO); GROUP-ID consortium	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); GROUP-ID consortium	Bert Vandeghinste is supported by a grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). Roel van Holen is a postdoctoral fellow of the Research Foundation Flanders (FWO). Christian Vanhove is supported by GROUP-ID consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 2006, MOL IMAGING BIOL, V8, P76; ARCHER GEB, 1995, STAT SINICA, V5, P77; Badea CT, 2008, PHYS MED BIOL, V53, pR319, DOI 10.1088/0031-9155/53/19/R01; Beck A, 2009, IEEE T IMAGE PROCESS, V18, P2419, DOI 10.1109/TIP.2009.2028250; Bian JG, 2010, PHYS MED BIOL, V55, P6575, DOI 10.1088/0031-9155/55/22/001; Campbell GM, 2011, OSTEOPOROSIS INT, V22, P931, DOI 10.1007/s00198-010-1283-5; Carlson SK, 2007, MOL IMAGING BIOL, V9, P78, DOI 10.1007/s11307-007-0080-9; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Couffinhal T, 1998, AM J PATHOL, V152, P1667; DAUBEWITHERSPOON ME, 1986, IEEE T MED IMAGING, V5, P61, DOI 10.1109/TMI.1986.4307748; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Defrise M, 2010, P 1 INT C IM FORM XR, P82; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Freeman TA, 2009, J ORTHOP RES, V27, P673, DOI 10.1002/jor.20771; Gannon B. J., 1978, PRINCIPLES TECHNIQUE, V6, P170; GREEN PJ, 1990, IEEE T MED IMAGING, V9, P84, DOI 10.1109/42.52985; GULLBERG GT, 1985, PHYS MED BIOL, V30, P799, DOI 10.1088/0031-9155/30/8/004; Han X, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5245; Han XA, 2011, IEEE T MED IMAGING, V30, P606, DOI 10.1109/TMI.2010.2089695; Herman GT, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/4/045011; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Johnson LC, 2011, BONE, V48, P141, DOI 10.1016/j.bone.2010.05.033; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Kontaxakis G., 1998, 1998 IEEE Nuclear Science Symposium Conference Record. 1998 IEEE Nuclear Science Symposium and Medical Imaging Conference (Cat. No.98CH36255), P1347, DOI 10.1109/NSSMIC.1998.774403; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Laforest R, 2004, MOL IMAGING, V3, P288; LANGE K, 1990, IEEE T MED IMAGING, V9, P439, DOI 10.1109/42.61759; Lima BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014136; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Meyer Y, 2001, AM MATH SOC LEWIS ME, V22; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Morimoto M, 2002, STROKE, V33, P1911, DOI 10.1161/01.STR.0000021000.19637.3D; Oliveira JP, 2009, SIGNAL PROCESS, V89, P1683, DOI 10.1016/j.sigpro.2009.03.018; Pan XC, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123009; Persson M, 2001, NUCL INSTRUM METH A, V471, P98, DOI 10.1016/S0168-9002(01)00962-7; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Sidky EY, 2012, PHYS MED BIOL, V57, P3065, DOI 10.1088/0031-9155/57/10/3065; Sidky EY, 2009, MED PHYS, V36, P4920, DOI 10.1118/1.3232211; Trachet B, 2011, ANN BIOMED ENG, V39, P2430, DOI 10.1007/s10439-011-0330-5; Trachet B, 2009, COMPUT METHOD BIOMEC, V12, P491, DOI 10.1080/10255840802695445; Vandeghinste B, 2011, MOL IMAGING BIOL, V13, P78, DOI 10.1007/s11307-010-0335-8; Vanhove C, 2011, EUR J NUCL MED MOL I, V38, P153, DOI 10.1007/s00259-010-1627-6; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Yin W., 2005, TR200501 CORC COL U	46	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68449	10.1371/journal.pone.0068449	http://dx.doi.org/10.1371/journal.pone.0068449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840893	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900032
J	Burton, DGA; Giribaldi, MG; Munoz, A; Halvorsen, K; Patel, A; Jorda, M; Perez-Stable, C; Rai, P				Burton, Dominick G. A.; Giribaldi, Maria G.; Munoz, Anisleidys; Halvorsen, Katherine; Patel, Asmita; Jorda, Merce; Perez-Stable, Carlos; Rai, Priyamvada			Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; CELLULAR SENESCENCE; HUMAN FIBROBLASTS; PREMATURE SENESCENCE; STROMAL FIBROBLASTS; RECEPTOR ACTIVATION; INDEPENDENT GROWTH; INDUCED APOPTOSIS; P53	Androgen deprivation (AD) is an effective method for initially suppressing prostate cancer (PC) progression. However, androgen-refractory PC cells inevitably emerge from the androgen-responsive tumor, leading to incurable disease. Recent studies have shown AD induces cellular senescence, a phenomenon that is cell-autonomously tumor-suppressive but which confers tumor-promoting adaptations that can facilitate the advent of senescence-resistant malignant cell populations. Because androgen-refractory PC cells emerge clonally from the originally androgen-responsive tumor, we sought to investigate whether AD-induced senescence (ADIS) affects acquisition of androgen-refractory behavior in androgen-responsive LNCaP and LAPC4 prostate cancer cells. We find that repeated exposure of these androgen-responsive cells to senescence-inducing stimuli via cyclic AD leads to the rapid emergence of ADIS-resistant, androgen-refractory cells from the bulk senescent cell population. Our results show that the ADIS phenotype is associated with tumor-promoting traits, notably chemoresistance and enhanced pro-survival mechanisms such as inhibition of p53-mediated cell death, which encourage persistence of the senescent cells. We further find that pharmacologic enforcement of p53/Bax activation via Nutlin-3 prior to establishment of ADIS is required to overcome the associated pro-survival response and preferentially trigger pervasive cell death instead of senescence during AD. Thus our study demonstrates that ADIS promotes outgrowth of androgen-refractory PC cells and is consequently a suboptimal tumor-suppressor response to AD.	[Burton, Dominick G. A.; Giribaldi, Maria G.; Munoz, Anisleidys; Halvorsen, Katherine; Patel, Asmita; Perez-Stable, Carlos; Rai, Priyamvada] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Giribaldi, Maria G.; Munoz, Anisleidys] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Jorda, Merce] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Perez-Stable, Carlos] Bruce W Carter Vet Affairs Med Ctr, Miami, FL USA; [Perez-Stable, Carlos; Rai, Priyamvada] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Rai, P (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	prai@med.miami.edu	Burton, Dominick/C-5282-2013	Burton, Dominick/0000-0003-3631-6448; Rai, Priyamvada/0000-0001-7822-7553	University of Miami/Stanley Glaser Foundation award; Sylvester Comprehensive Cancer Center Summer Undergraduate Research Award; University of Miami/Sylvester Comprehensive Cancer Center Pap Corps Developmental Cancer Research Grant; Florida Biomed Bankhead Coley New Investigator Award	University of Miami/Stanley Glaser Foundation award; Sylvester Comprehensive Cancer Center Summer Undergraduate Research Award; University of Miami/Sylvester Comprehensive Cancer Center Pap Corps Developmental Cancer Research Grant; Florida Biomed Bankhead Coley New Investigator Award	This work was funded by a Florida Biomed Bankhead Coley New Investigator Award, a University of Miami/Sylvester Comprehensive Cancer Center Pap Corps Developmental Cancer Research Grant and a University of Miami/Stanley Glaser Foundation award (to PR). MGG was partially supported by a Sylvester Comprehensive Cancer Center Summer Undergraduate Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780; Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; APRIKIAN AG, 1994, J UROLOGY, V151, P1276, DOI 10.1016/S0022-5347(17)35231-X; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Burchardt M, 2001, PROSTATE, V48, P225, DOI 10.1002/pros.1101; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Chen JH, 2005, DNA REPAIR, V4, P1140, DOI 10.1016/j.dnarep.2005.06.003; Cheng L, 1999, CANCER, V85, P1293, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1293::AID-CNCR11>3.0.CO;2-O; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Craft N, 1999, CANCER RES, V59, P5030; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Dean JP, 2008, BRIT J CANCER, V98, P245, DOI 10.1038/sj.bjc.6604087; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Ewald JA, 2012, PROSTATE; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gingrich JR, 1996, CANCER RES, V56, P4096; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hampel B, 2004, EXP GERONTOL, V39, P1713, DOI 10.1016/j.exger.2004.05.010; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hsieh TC, 1997, INT J ONCOL, V10, P1109; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Khandrika L, 2009, ONCOGENE, V28, P1248, DOI 10.1038/onc.2008.476; Kishi H, 2004, J UROLOGY, V171, P1855, DOI 10.1097/01.ju.0000120317.88372.03; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Linja MJ, 2001, CANCER RES, V61, P3550; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Lu S, 1997, CANCER RES, V57, P4511; Lu S, 1999, ENDOCRINOLOGY, V140, P5054, DOI 10.1210/en.140.11.5054; Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007; Mirochnik Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031052; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Mu Z, 2008, PROSTATE, V68, P599, DOI 10.1002/pros.20731; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Pazolli E, 2009, CANCER RES, V69, P1230, DOI 10.1158/0008-5472.CAN-08-2970; Peacock SO, 2012, MOL ENDOCRINOL, V26, P1967, DOI 10.1210/me.2012-1165; Pernicova Z, 2011, NEOPLASIA, V13, P526, DOI 10.1593/neo.11182; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Rieber M, 2009, INT J CANCER, V125, P1604, DOI 10.1002/ijc.24512; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Seluanov A, 2001, MOL CELL BIOL, V21, P1552, DOI 10.1128/MCB.21.5.1552-1564.2001; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Tokar EJ, 2005, DIFFERENTIATION, V73, P463, DOI 10.1111/j.1432-0436.2005.00047.x; Toussaint O, 2002, INT J BIOCHEM CELL B, V34, P1415, DOI 10.1016/S1357-2725(02)00034-1; Tovar C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-49; Tsai KKC, 2009, RADIAT RES, V172, P306, DOI 10.1667/RR1764.1; Tso CL, 2000, CANCER J, V6, P220; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WANG E, 1995, CANCER RES, V55, P2284; Wen Y, 2000, CANCER RES, V60, P6841; Wilson C, 2008, MOL CANCER THER, V7, P2649, DOI 10.1158/1535-7163.MCT-08-0148; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yu EY, 2010, J CLIN ONCOL, V28, P2668, DOI 10.1200/JCO.2009.25.1330; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882; Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490	89	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68003	10.1371/journal.pone.0068003	http://dx.doi.org/10.1371/journal.pone.0068003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840802	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400152
J	Courtois, EA; Devillechabrolle, J; Dewynter, M; Pineau, K; Gaucher, P; Chave, J				Courtois, Elodie A.; Devillechabrolle, Jennifer; Dewynter, Mael; Pineau, Kevin; Gaucher, Philippe; Chave, Jerome			Monitoring Strategy for Eight Amphibian Species in French Guiana, South America	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; OCCUPANCY; ABUNDANCE; RICHNESS; FROGS; MODELS; SIZE; TIME	Although dramatic amphibian declines have been documented worldwide, only few of such events have been quantitatively documented for the tropical forests of South America. This is due partly to the fact that tropical amphibians are patchily distributed and difficult to detect. We tested three methods often used to monitor population trends in amphibian species in a remote lowland tropical forest of French Guiana. These methods are capture-mark-recapture (CMR), estimation of the number of calling males with repeated counts data and distance sampling, and rates of occupancy inferred by presence/absence data. We monitored eight diurnal, terrestrial amphibian species including five Dendrobatidae and three Bufonidae. We found that CMR, the most precise way of estimating population size, can be used only with two species in high density patches where the recapture rate is high enough. Only for one of the species (Dendrobates tinctorius), a low coefficient of variation (CV = 0.19) can be achieved with 15 to 20 capture events. For dendrobatid species with day-calling males, audio surveys yield a better probability of detection with only 8 audio surveys needed; quantitative estimates can be achieved by computing the number of calling males inferred from audio counts or distance sampling analysis. We therefore suggest that an efficient monitoring protocol for Neotropical amphibian species should include a combination of sighting and audio techniques, and we discuss the need of implementing a large-scale monitoring in order to provide a baseline for comparison with future changes.	[Courtois, Elodie A.; Gaucher, Philippe] CNRS Guyane USR 3456, Residence Le Relais, Cayenne, French Guiana; [Courtois, Elodie A.] Stn Ecol Expt CNRS Moulis, USR 2936, St Girons, France; [Devillechabrolle, Jennifer] Maison Assoc, AGEP, Bourg De Regina, Regina, French Guiana; [Dewynter, Mael; Pineau, Kevin] Biotope Guyane, Cayenne, French Guiana; [Chave, Jerome] Univ Toulouse 3, CNRS, Lab EDB UMR 5174, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Courtois, EA (corresponding author), CNRS Guyane USR 3456, Residence Le Relais, Cayenne, French Guiana.	courtoiselodie@gmail.com			CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work has been funded by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2002, AM NAT, V160, P293, DOI 10.1086/341521; Buckland S.T., 2001, pi; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Courtois Elodie A., 2012, PHYLLOMEDUSA, V11, P63; Driscoll DA, 1998, J HERPETOL, V32, P475, DOI 10.2307/1565200; Ficetola GF, 2008, BIODIVERS CONSERV, V17, P2185, DOI 10.1007/s10531-007-9280-5; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2007, ZOOTAXA, P17; Funk WC, 2003, J HERPETOL, V37, P245, DOI 10.1670/0022-1511(2003)037[0245:MPTOEF]2.0.CO;2; Gewin V, 2008, PLOS BIOL, V6, P18, DOI 10.1371/journal.pbio.0060024; Guillera-Arroita G, 2012, METHODS ECOL EVOL, V3, P860, DOI 10.1111/j.2041-210X.2012.00225.x; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hecnar SJ, 1997, BIOL CONSERV, V79, P123, DOI 10.1016/S0006-3207(96)00113-9; Heyer W.R., 1994, MEASURING MONITORING; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x; Kenyon N, 2009, HERPETOL CONSERV BIO, V4, P403; Laake J.L., 2009, PROGRAM MARK GENTLE, pC1; Lips KR, 2005, BIOTROPICA, V37, P163, DOI 10.1111/j.1744-7429.2005.00023.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; PEARMAN PB, 1995, HERPETOLOGICA, V51, P325; PETRANKA JW, 1993, CONSERV BIOL, V7, P363, DOI 10.1046/j.1523-1739.1993.07020363.x; Prohl H, 2002, BEHAV ECOL, V13, P175, DOI 10.1093/beheco/13.2.175; Ringler M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1281, DOI 10.1007/s00265-009-0793-7; ROITHMAIR ME, 1994, COPEIA, P107; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Spitzen-van der Sluijs A, 2011, AMPHIBIA-REPTILIA, V32, P419, DOI 10.1163/017353711X579830; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Tanadini LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028244; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wollenberg KC, 2008, BIOL J LINN SOC, V93, P433, DOI 10.1111/j.1095-8312.2007.00906.x; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	37	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67486	10.1371/journal.pone.0067486	http://dx.doi.org/10.1371/journal.pone.0067486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840717	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400090
J	Ge, HJ; Huang, X; Li, XC; Chen, SP; Zheng, J; Jiang, HJ; Zhang, CL; Pan, XY; Guo, J; Chen, F; Chen, N; Fang, Q; Jiang, H; Wang, W				Ge, Huijuan; Huang, Xuan; Li, Xuchao; Chen, Shengpei; Zheng, Jing; Jiang, Haojun; Zhang, Chunlei; Pan, Xiaoyu; Guo, Jing; Chen, Fang; Chen, Ning; Fang, Qun; Jiang, Hui; Wang, Wei			Noninvasive Prenatal Detection for Pathogenic CNVs: The Application in alpha-Thalassemia	PLOS ONE			English	Article							MATERNAL PLASMA; FETAL DNA; DIAGNOSIS	Background: The discovery of cell free fetal DNA (cff-DNA) in maternal plasma has brought new insight for noninvasive prenatal diagnosis. Combining with the rapidly developed massively parallel sequencing technology, noninvasive prenatal detection of chromosome aneuploidy and single base variation has been successfully validated. However, few studies discussed the possibility of noninvasive pathogenic CNVs detection. Methodology/Principal Findings: A novel algorithm for noninvasive prenatal detection of fetal pathogenic CNVs was firstly tested in 5 pairs of parents with heterozygote a-thalassemia of Southeast Asian (SEA) deletion using target region capture sequencing for maternal plasma. Capture probes were designed for alpha-globin (HBA) and beta-globin (HBB) gene, as well as 4,525 SNPs selected from 22 automatic chromosomes. Mixed adaptors with 384 different barcodes were employed to construct maternal plasma DNA library for massively parallel sequencing. The signal of fetal CNVs was calculated using the relative copy ratio (RCR) of maternal plasma combined with the analysis of R-score and L-score by comparing with normal control. With mean of 101.93xmaternal plasma sequencing depth for the target region, the RCR value combined with further R-score and L-score analysis showed a possible homozygous deletion in the HBA gene region for one fetus, heterozygous deletion for two fetus and normal for the other two fetus, which was consistent with that of invasive prenatal diagnosis. Conclusions/Significance: Our study showed the feasibility to detect pathogenic CNVs using target region capture sequencing, which might greatly extend the scope of noninvasive prenatal diagnosis.	[Ge, Huijuan; Huang, Xuan; Fang, Qun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Fetal Med Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Ge, Huijuan; Li, Xuchao; Chen, Shengpei; Zheng, Jing; Jiang, Haojun; Zhang, Chunlei; Pan, Xiaoyu; Guo, Jing; Chen, Fang; Chen, Ning; Jiang, Hui; Wang, Wei] BGI Shenzhen, Shenzhen, Peoples R China; [Wang, Wei] Shenzhen Clin Lab, Shenzhen, Peoples R China; [Chen, Shengpei; Jiang, Haojun; Guo, Jing] Southeast Univ, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China; [Pan, Xiaoyu] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Chen, Fang; Jiang, Hui] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Sun Yat Sen University; Beijing Genomics Institute (BGI); Southeast University - China; South China University of Technology; University of Copenhagen	Fang, Q (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Fetal Med Ctr, Guangzhou 510275, Guangdong, Peoples R China.	fang_qun@163.com; jianghui@genomics.org.cn; wangw@genomics.org.cn	Pan, Xiaoyu/AAT-9002-2021	Pan, Xiaoyu/0000-0002-0282-6047	Key Laboratory of Cooperation Project in Guangdong Province [2011A060906007]; Shenzhen Birth Defect Screening Project Lab (JZF) [[2011] 861]; Key Laboratory Project in Shenzhen [CXB200903110066A, CXB201108250096A]	Key Laboratory of Cooperation Project in Guangdong Province; Shenzhen Birth Defect Screening Project Lab (JZF); Key Laboratory Project in Shenzhen	The study was funded by Key Laboratory of Cooperation Project in Guangdong Province (2011A060906007), Shenzhen Birth Defect Screening Project Lab (JZF No. [2011] 861), and Key Laboratory Project in Shenzhen (CXB200903110066A and CXB201108250096A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Kozlowski P, 2008, ULTRASCHALL MED, V29, P165, DOI 10.1055/s-2007-963217; Lam KWG, 2012, CLIN CHEM, V58, P1467, DOI 10.1373/clinchem.2012.189589; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P1370, DOI 10.3109/14767058.2011.635730; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liao GJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038154; [林业辉 Lin Yehui], 2012, [中国当代儿科杂志, Chinese Journal of Contemporary Pediatrics], V14, P264; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Zheng CG, 2011, HEMOGLOBIN, V35, P28, DOI 10.3109/03630269.2010.547429	15	19	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67464	10.1371/journal.pone.0067464	http://dx.doi.org/10.1371/journal.pone.0067464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840709	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400085
J	Pezet-Valdez, M; Fernandez-Retana, J; Ospina-Villa, JD; Ramirez-Moreno, ME; Orozco, E; Charcas-Lopez, S; Soto-Sanchez, J; Mendoza-Hernandez, G; Lopez-Casamicha, M; Lopez-Camarillo, C; Marchat, LA				Pezet-Valdez, Marisol; Fernandez-Retana, Jorge; David Ospina-Villa, Juan; Esther Ramirez-Moreno, Maria; Orozco, Esther; Charcas-Lopez, Socorro; Soto-Sanchez, Jacqueline; Mendoza-Hernandez, Guillermo; Lopez-Casamicha, Mavil; Lopez-Camarillo, Cesar; Marchat, Laurence A.			The 25 kDa Subunit of Cleavage Factor Im Is a RNA-Binding Protein That Interacts with the Poly(A) Polymerase in Entamoeba histolytica	PLOS ONE			English	Article							CIS-REGULATORY ELEMENTS; CRYSTAL-STRUCTURE; ALTERNATIVE POLYADENYLATION; MECHANISM; EXPRESSION; REVEALS; INTERRELATIONSHIPS; DICTYOSTELIUM; ASSOCIATION; RESISTANCE	In eukaryotes, polyadenylation of pre-mRNA 3' end is essential for mRNA export, stability and translation. Taking advantage of the knowledge of genomic sequences of Entamoeba histolytica, the protozoan responsible for human amoebiasis, we previously reported the putative polyadenylation machinery of this parasite. Here, we focused on the predicted protein that has the molecular features of the 25 kDa subunit of the Cleavage Factor Im (CFIm25) from other organisms, including the Nudix (nucleoside diphosphate linked to another moiety X) domain, as well as the RNA binding domain and the PAP/PAB interacting region. The recombinant EhCFIm25 protein (rEhCFIm25) was expressed in bacteria and used to generate specific antibodies in rabbit. Subcellular localization assays showed the presence of the endogenous protein in nuclear and cytoplasmic fractions. In RNA electrophoretic mobility shift assays, rEhCFIm25 was able to form specific RNA-protein complexes with the EhPgp5 mRNA 3' UTR used as probe. In addition, Pull-Down and LC/ESI-MS/MS tandem mass spectrometry assays evidenced that the putative EhCFIm25 was able to interact with the poly(A) polymerase (EhPAP) that is responsible for the synthesis of the poly(A) tail in other eukaryotic cells. By Far-Western experiments, we confirmed the interaction between the putative EhCFIm25 and EhPAP in E. histolytica. Taken altogether, our results showed that the putative EhCFIm25 is a conserved RNA binding protein that interacts with the poly(A) polymerase, another member of the pre-mRNA 3' end processing machinery in this protozoan parasite.	[Pezet-Valdez, Marisol; Fernandez-Retana, Jorge; David Ospina-Villa, Juan; Esther Ramirez-Moreno, Maria; Charcas-Lopez, Socorro; Soto-Sanchez, Jacqueline; Marchat, Laurence A.] IPN, Escuela Nacl Med & Homeopatia, Programa Inst Biomed Mol, Mexico City 07738, DF, Mexico; [Esther Ramirez-Moreno, Maria; Marchat, Laurence A.] IPN, Escuela Nacl Med & Homeopatia, Biotecnol Red, Mexico City 07738, DF, Mexico; [Orozco, Esther] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Infect & Patogenesis Mol, Mexico City 07738, DF, Mexico; [Mendoza-Hernandez, Guillermo] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Lopez-Casamicha, Mavil; Lopez-Camarillo, Cesar] Univ Autonoma Ciudad Mexico, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Marchat, LA (corresponding author), IPN, Escuela Nacl Med & Homeopatia, Programa Inst Biomed Mol, Guillermo Massieu Helguera 239, Mexico City 07738, DF, Mexico.	lmarchat@gmail.com	Lopez-Camarillo, Cesar/I-1946-2019; Ospina-Villa, Juan D./AAD-8349-2020; Marchat, Laurence A./S-8418-2018; Soto-Sánchez, Jacqueline/AAI-6247-2020	Lopez-Camarillo, Cesar/0000-0002-9417-2609; Marchat, Laurence A./0000-0003-1615-8614; Soto-Sánchez, Jacqueline/0000-0002-1063-3130; Fernandez-Retana, Jorge/0000-0002-8282-3865; ospina villa, juan david/0000-0003-1679-3036	Consejo Nacional de Ciencia y Tecnologia; Instituto Politecnico Nacional and Universidad Autonoma de la Ciudad de Mexico, Mexico	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Politecnico Nacional and Universidad Autonoma de la Ciudad de Mexico, Mexico	This work was supported by Consejo Nacional de Ciencia y Tecnologia, Instituto Politecnico Nacional and Universidad Autonoma de la Ciudad de Mexico, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2003, RNA, V9, P1400, DOI 10.1261/rna.5104603; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Coseno M, 2008, NUCLEIC ACIDS RES, V36, P3474, DOI 10.1093/nar/gkn079; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Herrera-Aguirre ME, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/734898; Fonseca-Sanchez MA, 2012, INT J ONCOL, V41, P670, DOI 10.3892/ijo.2012.1478; Fukumitsu H, 2012, BIOCHEM BIOPH RES CO, V425, P848, DOI 10.1016/j.bbrc.2012.07.164; Garcia-Rivera G, 1999, MOL MICROBIOL, V33, P556, DOI 10.1046/j.1365-2958.1999.01500.x; Garcia-Vivas J, 2005, EXP PARASITOL, V110, P226, DOI 10.1016/j.exppara.2005.02.017; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Jackson T. F. H. G., 2000, Amebiasis., P47; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; KESSLER MM, 1995, BIOCHEMISTRY-US, V34, P1750, DOI 10.1021/bi00005a032; Kim H, 2001, BIOCHEM BIOPH RES CO, V289, P513, DOI 10.1006/bbrc.2001.5992; Kim S, 2010, GENES CELLS, V15, P1003, DOI 10.1111/j.1365-2443.2010.01436.x; Kubo T, 2006, NUCLEIC ACIDS RES, V34, P6264, DOI 10.1093/nar/gkl794; Li H, 2011, CELL RES, V21, P1039, DOI 10.1038/cr.2011.67; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin J, 2008, PROTEIN PEPTIDE LETT, V15, P108; Lopez-Camarillo C, 2005, EXP PARASITOL, V110, P184, DOI 10.1016/j.exppara.2005.02.024; Lopez-Camarillo C, 2003, J BIOL CHEM, V278, P11273, DOI 10.1074/jbc.M211757200; Lopez-Camarillo C, 2008, GENE, V414, P19, DOI 10.1016/j.gene.2008.01.024; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nei M., 2000, MOL EVOLUTION PHYLOG; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Ranatunga W, 2004, J MOL BIOL, V339, P103, DOI 10.1016/j.jmb.2004.01.065; Reyes-dal Valle J, 2004, J VIROL METHODS, V116, P95, DOI 10.1016/j.jviromet.2003.10.014; Ruegsegger U, 1996, J BIOL CHEM, V271, P6107; Ruegsegger U, 1998, MOL CELL, V1, P243, DOI 10.1016/S1097-2765(00)80025-8; Rush M, 2005, J VIROL, V79, P12002, DOI 10.1128/JVI.79.18.12002-12015.2005; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Shimazu T, 2007, J BIOL CHEM, V282, P4470, DOI 10.1074/jbc.M609745200; Switala J, 1999, BIOCHEMISTRY-US, V38, P3895, DOI 10.1021/bi982863z; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tresaugues L, 2008, PROTEINS, V73, P1047, DOI 10.1002/prot.22198; Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Yang Q, 2011, RNA BIOL, V8, P748, DOI 10.4161/rna.8.5.16040; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Zamorano A, 2008, COMPUT BIOL CHEM, V32, P256, DOI 10.1016/j.compbiolchem.2008.03.019; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	60	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67977	10.1371/journal.pone.0067977	http://dx.doi.org/10.1371/journal.pone.0067977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840799	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400150
J	Cao, JZ; Liu, WQ; He, JJ; Gu, H				Cao, Junzhe; Liu, Wenqi; He, Jianjun; Gu, Hong			Mining Proteins with Non-Experimental Annotations Based on an Active Sample Selection Strategy for Predicting Protein Subcellular Localization	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; ENSEMBLE; MPLOC	Subcellular localization of a protein is important to understand proteins' functions and interactions. There are many techniques based on computational methods to predict protein subcellular locations, but it has been shown that many prediction tasks have a training data shortage problem. This paper introduces a new method to mine proteins with non-experimental annotations, which are labeled by non-experimental evidences of protein databases to overcome the training data shortage problem. A novel active sample selection strategy is designed, taking advantage of active learning technology, to actively find useful samples from the entire data pool of candidate proteins with non-experimental annotations. This approach can adequately estimate the "value'' of each sample, automatically select the most valuable samples and add them into the original training set, to help to retrain the classifiers. Numerical experiments with for four popular multi-label classifiers on three benchmark datasets show that the proposed method can effectively select the valuable samples to supplement the original training set and significantly improve the performances of predicting classifiers.	[Cao, Junzhe; Liu, Wenqi; Gu, Hong] Dalian Univ Technol, Sch Control Sci & Engn, Dalian, Peoples R China; [He, Jianjun] Dalian Nationalities Univ, Coll Informat & Commun Engn, Dalian, Peoples R China	Dalian University of Technology; Dalian Minzu University	Liu, WQ (corresponding author), Dalian Univ Technol, Sch Control Sci & Engn, Dalian, Peoples R China.	wqliu@dlut.edu.cn			Specialized Research Fund for the Doctoral Program of Higher Education [20120041110008]; National Science and Technology Mega-Project Program of China [2011ZX09101-008-09]; National Natural Science Foundation of China [61174027]; Program for Liaoning Excellent Talents in University [LJQ2012005]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Science and Technology Mega-Project Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Excellent Talents in University	This work was supported by a Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20120041110008), National Science and Technology Mega-Project Program of China (Grant No. 2011ZX09101-008-09), National Natural Science Foundation of China (Grant No. 61174027), and the Program for Liaoning Excellent Talents in University (Grant No. LJQ2012005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutet Emmanuel, 2007, V406, P89; Briesemeister S, 2009, J PROTEOME RES, V8, P5363, DOI 10.1021/pr900665y; Bulashevska A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-298; Cao JZ, 2012, PROTEIN PEPTIDE LETT, V19, P1163, DOI 10.2174/092986612803216999; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; He JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037155; Hoi SCH, 2007, ACM T INFORM SYST, V27, P1; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang J, 2005, ACTA BIOTHEOR, V53, P39, DOI 10.1007/s10441-005-7002-5; Junker VL, 1999, BIOINFORMATICS, V15, P1066; Li B, 2008, IEEE T SYST MAN CY B, V38, P141, DOI 10.1109/TSMCB.2007.908363; Ma JW, 2010, INT J INNOV COMPUT I, V6, P5093; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Settles Burr, 2009, ACTIVE LEARNING LIT; Shatkay H, 2007, BIOINFORMATICS, V23, P1410, DOI 10.1093/bioinformatics/btm115; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2010, J BIOMOL STRUCT DYN, V28, P175, DOI 10.1080/07391102.2010.10507351; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Xu QA, 2011, IEEE ACM T COMPUT BI, V8, P748, DOI 10.1109/TCBB.2010.22; Zhang ML, 2009, NEURAL PROCESS LETT, V29, P61, DOI 10.1007/s11063-009-9095-3	27	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67343	10.1371/journal.pone.0067343	http://dx.doi.org/10.1371/journal.pone.0067343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840667	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400096
J	Christen, L; Lai, CT; Hartmann, B; Hartmann, PE; Geddes, DT				Christen, Lukas; Lai, Ching Tat; Hartmann, Ben; Hartmann, Peter E.; Geddes, Donna T.			Ultraviolet-C Irradiation: A Novel Pasteurization Method for Donor Human Milk	PLOS ONE			English	Article							FATTY-ACIDS; MICROORGANISMS; INACTIVATION; ABSORPTION; GROWTH; LIGHT; FOOD	Background: Holder pasteurization (milk held at 62.5 degrees C for 30 minutes) is the standard treatment method for donor human milk. Although this method of pasteurization is able to inactivate most bacteria, it also inactivates important bioactive components. Therefore, the objective of this study was to investigate ultraviolet irradiation as an alternative treatment method for donor human milk. Methods: Human milk samples were inoculated with five species of bacteria and then UV-C irradiated. Untreated and treated samples were analysed for bacterial content, bile salt stimulated lipase (BSSL) activity, alkaline phosphatase (ALP) activity, and fatty acid profile. Results: All five species of bacteria reacted similarly to UV-C irradiation, with higher dosages being required with increasing concentrations of total solids in the human milk sample. The decimal reduction dosage was 289 +/- 17 and 945 +/- 164 J/l for total solids of 107 and 146 g/l, respectively. No significant changes in the fatty acid profile, BSSL activity or ALP activity were observed up to the dosage required for a 5-log(10) reduction of the five species of bacteria. Conclusion: UV-C irradiation is capable of reducing vegetative bacteria in human milk to the requirements of milk bank guidelines with no loss of BSSL and ALP activity and no change of FA.	[Christen, Lukas; Lai, Ching Tat; Hartmann, Peter E.; Geddes, Donna T.] Univ Western Australia, Sch Chem & Biochem, Fac Sci, Crawley, WA, Australia; [Christen, Lukas] Carag AG, Baar, Switzerland; [Hartmann, Ben] King Edward Mem Hosp Women, Perron Rotary Express Milk Bank, Subiaco, WA 6008, Australia; [Hartmann, Ben] Univ Western Australia, Ctr Neonatal Res & Educ, Crawley, WA, Australia	University of Western Australia; King Edward Memorial Hospital; University of Western Australia; University of Western Australia	Christen, L (corresponding author), Univ Western Australia, Sch Chem & Biochem, Fac Sci, Crawley, WA, Australia.	lukas.christen@carag.com	Lai, ching tat/M-2452-2018; Geddes, Donna/H-9254-2014	Lai, ching tat/0000-0002-9025-4922; Hartmann, Peter/0000-0002-7709-0740; Geddes, Donna/0000-0002-0431-7078	Medela AG, Baar, Switzerland	Medela AG, Baar, Switzerland	Funding for this study was provided by an unrestricted research grant from Medela AG, Baar, Switzerland http://www.medela.com/IW/en/breastfeeding.html?force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Y, 2007, ACTA PAEDIATR, V96, P1445, DOI 10.1111/j.1651-2227.2007.00450.x; Arnold L, 1994, GUIDELINES ESTABLISH; Baumer JH, 2004, ARCH DIS CHILD-FETAL, V89, pEP27, DOI 10.1136/adc.2004.053330; Bintsis T, 2000, J SCI FOOD AGR, V80, P637, DOI 10.1002/(SICI)1097-0010(20000501)80:6<637::AID-JSFA603>3.0.CO;2-1; Casadio YS, 2010, J HUM LACT, V26, P376, DOI 10.1177/0890334410376948; CHANG JCH, 1985, APPL ENVIRON MICROB, V49, P1361, DOI 10.1128/AEM.49.6.1361-1365.1985; Choudhary R, 2011, J FOOD ENG, V107, P14, DOI 10.1016/j.jfoodeng.2011.06.009; Czank C, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-3; Czank C, 2009, PEDIATR RES, V66, P374, DOI 10.1203/PDR.0b013e3181b4554a; Falguera V, 2011, FOOD RES INT, V44, P1580, DOI 10.1016/j.foodres.2011.03.025; Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359; Hartmann BT, 2007, EARLY HUM DEV, V83, P667, DOI 10.1016/j.earlhumdev.2007.07.012; Health Protection Agency, 2004, D7 HLTH PROT AG, V7; Henderson TR, 1998, J PEDIATR-US, V132, P876, DOI 10.1016/S0022-3476(98)70323-3; HERNELL O, 1994, J PEDIATR-US, V125, pS56, DOI 10.1016/S0022-3476(06)80737-7; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Innis SM, 2007, P NUTR SOC, V66, P397, DOI 10.1017/S0029665107005666; Innis SM, 2004, ADV EXP MED BIOL, V554, P27; Jay J M, 2000, MODERN FOOD MICROBIO, V2nd; Keyser M, 2008, INNOV FOOD SCI EMERG, V9, P348, DOI 10.1016/j.ifset.2007.09.002; Koutchma T, 2008, OZONE-SCI ENG, V30, P93, DOI 10.1080/01919510701816346; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Mai Thu Thi Tran, 2004, Innovative Food Science & Emerging Technologies, V5, P495, DOI 10.1016/j.ifset.2004.08.002; Matak KE, 2007, J DAIRY SCI, V90, P3178, DOI 10.3168/jds.2006-642; Mitoulas LR, 2003, BRIT J NUTR, V90, P979, DOI 10.1079/BJN2003979; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; Ribeiro P, 2012, INT J FOOD SCI NUTR, V63, P36, DOI 10.3109/09637486.2011.593714; Rossitto PV, 2012, J FOOD PROTECT, V75, P2197, DOI 10.4315/0362-028X.JFP-12-036; Sarkar D., 2008, LATTICE LATTICE GRAP; Shama G., 1999, ULTRAVIOLET LIGHT EN; T. R. C. Team, 2008, R LANG ENV STAT COMP; Tully D B, 2001, J Hum Lact, V17, P152, DOI 10.1177/089033440101700212; Walter K, 1974, METHOD ENZYMAT AN, V2, P860; WARDELL JM, 1984, PEDIATR RES, V18, P382, DOI 10.1203/00006450-198404000-00017; Wight N E, 2001, J Perinatol, V21, P249, DOI 10.1038/sj.jp.7200533; WILLIAMSON S, 1978, ARCH DIS CHILD, V53, P555, DOI 10.1136/adc.53.7.555	38	46	50	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e68120	10.1371/journal.pone.0068120	http://dx.doi.org/10.1371/journal.pone.0068120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840820	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400131
J	Janssens, L; Stoks, R				Janssens, Lizanne; Stoks, Robby			Fitness Effects of Chlorpyrifos in the Damselfly Enallagma cyathigerum Strongly Depend upon Temperature and Food Level and Can Bridge Metamorphosis	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; DROSOPHILA-MELANOGASTER; MULTIPLE STRESSORS; NATURAL STRESSORS; HSP70 EXPRESSION; EXPOSURE; INSECTICIDE; ACCLIMATION; PERFORMANCE; ADAPTATION	Interactions between pollutants and suboptimal environmental conditions can have severe consequences for the toxicity of pollutants, yet are still poorly understood. To identify patterns across environmental conditions and across fitness-related variables we exposed Enallagma cyathigerum damselfly larvae to the pesticide chlorpyrifos at two food levels or at two temperatures and quantified four fitness-related variables (larval survival, development time, mass at emergence and adult cold resistance). Food level and temperature did not affect survival in the absence of the pesticide, yet the pesticide reduced survival only at the high temperature. Animals reacted to the pesticide by accelerating their development but only at the high food level and at the low temperature; at the low food level, however, pesticide exposure resulted in a slower development. Chlorpyrifos exposure resulted in smaller adults except in animals reared at the high food level. Animals reared at the low food level and at the low temperature had a higher cold resistance which was not affected by the pesticide. In summary our study highlight that combined effects of exposure to chlorpyrifos and the two environmental conditions (i) were mostly interactive and sometimes even reversed in comparison with the effect of the environmental condition in isolation, (ii) strongly differed depending on the fitness-related variable under study, (iii) were not always predictable based on the effect of the environmental condition in isolation, and (iv) bridged metamorphosis depending on which environmental condition was combined with the pesticide thereby potentially carrying over from aquatic to terrestrial ecosystems. These findings are relevant when extrapolating results of laboratory tests done under ideal environmental conditions to natural communities.	[Janssens, Lizanne; Stoks, Robby] Univ Louvain, Lab Aquat Ecol Evolut & Conservat, Louvain, Belgium		Janssens, L (corresponding author), Univ Louvain, Lab Aquat Ecol Evolut & Conservat, Louvain, Belgium.	lizanne.janssens@bio.kuleuven.be	Stoks, Robby/AAK-1227-2020	Stoks, Robby/0000-0003-4130-0459	KU Leuven Research Fund [PF/10/007]; FWO-Flanders [G.0185.09]	KU Leuven Research Fund(KU Leuven); FWO-Flanders(FWO)	This research was financially supported by research grants of the KU Leuven Research Fund (PF/10/007) and FWO-Flanders (G.0185.09) to R. Stoks. L. Janssens is a PhD fellow of the IWT, Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AC, 2008, FRESHWATER BIOL, V53, P171, DOI 10.1111/j.1365-2427.2007.01880.x; Allen JL, 2012, J INSECT PHYSIOL, V58, P669, DOI 10.1016/j.jinsphys.2012.01.016; Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Boone MD, 2003, ENVIRON TOXICOL CHEM, V22, P2695, DOI 10.1897/02-401; Boone MD, 2003, ECOL APPL, V13, P829, DOI 10.1890/1051-0761(2003)013[0829:IOAIHA]2.0.CO;2; Bubliy OA, 2012, FUNCT ECOL, V26, P245, DOI 10.1111/j.1365-2435.2011.01928.x; Campero M, 2008, FUNCT ECOL, V22, P271, DOI 10.1111/j.1365-2435.2007.01381.x; Campero M, 2008, J ANIM ECOL, V77, P66, DOI 10.1111/j.1365-2656.2007.01308.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; De Block M, 2003, J EVOLUTION BIOL, V16, P986, DOI 10.1046/j.1420-9101.2003.00581.x; De Block M, 2013, GLOBAL CHANGE BIOL, V19, P689, DOI 10.1111/gcb.12089; Distel CA, 2010, FUNCT ECOL, V24, P1342, DOI 10.1111/j.1365-2435.2010.01749.x; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Herring G, 2011, FUNCT ECOL, V25, P682, DOI 10.1111/j.1365-2435.2010.01792.x; Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Janssens L, 2013, ENVIRON POLLUT, V177, P143, DOI 10.1016/j.envpol.2013.02.016; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; Laskowski R, 2010, SCI TOTAL ENVIRON, V408, P3763, DOI 10.1016/j.scitotenv.2010.01.043; Lilley TM, 2012, ENVIRON SCI TECHNOL, V46, P7382, DOI 10.1021/es300536t; Lydy MJ, 1999, ARCH ENVIRON CON TOX, V37, P542, DOI 10.1007/s002449900550; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Mikolajewski DJ, 2005, OIKOS, V110, P91, DOI 10.1111/j.0030-1299.2005.13766.x; Modlmeier AP, 2012, NATURWISSENSCHAFTEN, V99, P811, DOI 10.1007/s00114-012-0963-8; MORAN NA, 1994, ANNU REV ECOL SYST, V25, P573, DOI 10.1146/annurev.es.25.110194.003041; Nazir A, 2001, ARCH ENVIRON CON TOX, V41, P443, DOI 10.1007/s002440010270; Noyes PD, 2009, ENVIRON INT, V35, P971, DOI 10.1016/j.envint.2009.02.006; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Polkki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038832; Raghavendra K, 2010, PARASITOL RES, V107, P1291, DOI 10.1007/s00436-010-2001-0; Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x; Rohr JR, 2011, GLOBAL CHANGE BIOL, V17, P657, DOI 10.1111/j.1365-2486.2010.02301.x; Rohr JR, 2006, ENVIRON HEALTH PERSP, V114, P46, DOI 10.1289/ehp.8405; Rohr JR, 2005, ENVIRON TOXICOL CHEM, V24, P1253, DOI 10.1897/04-448R.1; Rohr JR, 2004, ECOL APPL, V14, P1028, DOI 10.1890/03-5087; Rubach MN, 2012, ECOTOXICOLOGY, V21, P2088, DOI 10.1007/s10646-012-0962-8; Scheil V, 2010, ENVIRON TOXICOL, V25, P83, DOI 10.1002/tox.20477; Schulz R, 2004, J ENVIRON QUAL, V33, P419, DOI 10.2134/jeq2004.0419; Shama LNS, 2011, MOL ECOL, V20, P2929, DOI 10.1111/j.1365-294X.2011.05156.x; SIBLY RM, 1989, BIOL J LINN SOC, V37, P101, DOI 10.1111/j.1095-8312.1989.tb02007.x; Stenersen J., 2004, CHEM PESTICIDES MODE; Stoks R, 2001, OECOLOGIA, V127, P222, DOI 10.1007/s004420000595; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Stoks R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016935; Teplitsky C, 2005, ENVIRON SCI TECHNOL, V39, P6079, DOI 10.1021/es050127u; United Nations Environment Program (UNEP), 2004, SCREEN INF DAT IN AS; WEIS JS, 1976, ESTUAR COAST MAR SCI, V4, P461, DOI 10.1016/0302-3524(76)90020-7; Widder PD, 2008, AQUAT TOXICOL, V88, P9, DOI 10.1016/j.aquatox.2008.02.008; Yengkokpam S, 2008, AQUACULTURE, V285, P234, DOI 10.1016/j.aquaculture.2008.08.034	54	29	29	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e68107	10.1371/journal.pone.0068107	http://dx.doi.org/10.1371/journal.pone.0068107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840819	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400130
J	Matos, I; Mizenina, O; Lubkin, A; Steinman, RM; Idoyaga, J				Matos, Ines; Mizenina, Olga; Lubkin, Ashira; Steinman, Ralph M.; Idoyaga, Juliana			Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity	PLOS ONE			English	Article							CD4(+) T-CELLS; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; LANGERHANS CELLS; INTRACELLULAR PATHOGEN; POLYPROTEIN VACCINE; CYTOKINE PROFILE; BALB/C MICE; IFN-GAMMA; PROTEIN	Efficient vaccination against the parasite Leishmania major, the causative agent of human cutaneous leishmaniasis, requires development of type 1 T-helper (Th1) CD4(+) T cell immunity. Because of their unique capacity to initiate and modulate immune responses, dendritic cells (DCs) are attractive targets for development of novel vaccines. In this study, for the first time, we investigated the capacity of a DC-targeted vaccine to induce protective responses against L. major. To this end, we genetically engineered the N-terminal portion of the stress-inducible 1 protein of L. major (LmSTI1a) into anti-DEC205/CD205 (DEC) monoclonal antibody (mAb) and thereby delivered the conjugated protein to DEC+ DCs in situ in the intact animal. Delivery of LmSTI1a to adjuvant-matured DCs increased the frequency of antigen-specific CD4(+) T cells producing IFN-gamma(+), IL-2(+), and TNF-alpha(+) in two different strains of mice (C57BL/6 and Balb/c), while such responses were not observed with the same doses of a control Ig-LmSTI1a mAb without receptor affinity or with non-targeted LmSTI1a protein. Using a peptide library for LmSTI1a, we identified at least two distinct CD4(+) T cell mimetopes in each MHC class II haplotype, consistent with the induction of broad immunity. When we compared T cell immune responses generated after targeting DCs with LmSTI1a or other L. major antigens, including LACK (Leishmania receptor for activated C kinase) and LeIF (Leishmania eukaryotic ribosomal elongation and initiation factor 4a), we found that LmSTI1a was superior for generation of IFN-gamma-producing CD4(+) T cells, which correlated with higher protection of susceptible Balb/c mice to a challenge with L. major. For the first time, this study demonstrates the potential of a DC-targeted vaccine as a novel approach for cutaneous leishmaniasis, an increasing public health concern that has no currently available effective treatment.	[Idoyaga, Juliana] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Idoyaga, J (corresponding author), Rockefeller Univ, Lab Cellular Physiol & Immunol, 1230 York Ave, New York, NY 10021 USA.	ijuliana@rockefeller.edu		Lubkin, Ashira/0000-0002-0271-0562	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI013013, R01AI013013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR062595] Funding Source: NIH RePORTER; NIAID NIH HHS [AI13013] Funding Source: Medline; NIAMS NIH HHS [1K99AR062595, K99 AR062595] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Berberich C, 2003, J IMMUNOL, V170, P3171, DOI 10.4049/jimmunol.170.6.3171; Bertholet S, 2009, VACCINE, V27, P7036, DOI 10.1016/j.vaccine.2009.09.066; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Campos-Neto A, 2002, INFECT IMMUN, V70, P2828, DOI 10.1128/IAI.70.6.2828-2836.2002; Campos-Neto A, 2001, INFECT IMMUN, V69, P4103, DOI 10.1128/IAI.69.6.4103-4108.2001; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; CHAKKALATH HR, 1995, J INFECT DIS, V171, P1302, DOI 10.1093/infdis/171.5.1302; Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; Coler RN, 2002, INFECT IMMUN, V70, P4215, DOI 10.1128/IAI.70.8.4215-4225.2002; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Do Y, 2008, EUR J IMMUNOL, V38, P20, DOI 10.1002/eji.200737799; Do Y, 2012, VACCINE, V30, P6359, DOI 10.1016/j.vaccine.2012.08.051; Flohe SB, 1998, EUR J IMMUNOL, V28, P3800, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3800::AID-IMMU3800&gt;3.0.CO;2-0; Ghosh M, 2003, J IMMUNOL, V170, P5625, DOI 10.4049/jimmunol.170.11.5625; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hemmi H, 2012, J IMMUNOL, V188, P1147, DOI 10.4049/jimmunol.1102541; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Idoyaga J, 2011, P NATL ACAD SCI USA, V108, P2384, DOI 10.1073/pnas.1019547108; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kastenmuller K, 2013, INFECT IMMUN, V81, P789, DOI 10.1128/IAI.01108-12; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; Larregina AT, 2005, J INVEST DERMATOL, V124, P1, DOI 10.1111/j.1523-1747.2004.23554.x; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Launois P, 1997, PARASITOLOGY, V115, pS25, DOI 10.1017/S0031182097001777; Launois P, 2008, EXPERT REV VACCINES, V7, P1277, DOI 10.1586/14760584.7.8.1277; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Macedo ABB, 2012, CLIN EXP IMMUNOL, V167, P505, DOI 10.1111/j.1365-2249.2011.04536.x; MAUEL J, 1990, J LEUKOCYTE BIOL, V47, P187, DOI 10.1002/jlb.47.2.187; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nascimento E, 2010, VACCINE, V28, P6581, DOI 10.1016/j.vaccine.2010.07.063; OLOBO JO, 1995, VET PARASITOL, V60, P199, DOI 10.1016/0304-4017(95)00788-6; Ponte-Sucre A, 2001, IMMUNOLOGY, V104, P462, DOI 10.1046/j.1365-2567.2001.01333.x; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Rafati S, 2005, VACCINE, V23, P3716, DOI 10.1016/j.vaccine.2005.02.009; Ramirez-Pineda JR, 2004, J IMMUNOL, V172, P6281, DOI 10.4049/jimmunol.172.10.6281; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Remer KA, 2007, EUR J IMMUNOL, V37, P2463, DOI 10.1002/eji.200636780; Romani N, 2010, IMMUNOL CELL BIOL, V88, P424, DOI 10.1038/icb.2010.39; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SACKS DL, 1985, J IMMUNOL, V135, P564; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; Sjolander A, 1998, VACCINE, V16, P2077, DOI 10.1016/S0264-410X(98)00075-9; SKEIKY YAW, 1995, J EXP MED, V181, P1527, DOI 10.1084/jem.181.4.1527; Skeiky YAW, 1998, J IMMUNOL, V161, P6171; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Trumpfheller C, 2012, J INTERN MED, V271, P183, DOI 10.1111/j.1365-2796.2011.02496.x; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Wang B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3135; Webb JR, 1996, J IMMUNOL, V157, P5034; Webb JR, 1997, MOL BIOCHEM PARASIT, V89, P179, DOI 10.1016/S0166-6851(97)00115-1	64	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67453	10.1371/journal.pone.0067453	http://dx.doi.org/10.1371/journal.pone.0067453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840706	gold, Green Published			2022-12-27	WOS:000321424400103
J	Sklenarova, K; Chesters, D; Bocak, L				Sklenarova, Katerina; Chesters, Douglas; Bocak, Ladislav			Phylogeography of Poorly Dispersing Net-Winged Beetles: A Role of Drifting India in the Origin of Afrotropical and Oriental Fauna	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FAMILY LYCIDAE INSECTA; HISTORICAL BIOGEOGRAPHY; COLEOPTERA LYCIDAE; PLATE-TECTONICS; REVISION; GENUS; ASIA; METRIORRHYNCHUS; PHYLOGENY	Ancient dispersal history may be obscured by subsequent dispersal events. Therefore, we intend to investigate the biogeography of metriorrhynchine net-winged beetles, a group characterized by limited dispersal propensity. We used DNA data to construct phylogenies and the BayesTraits and RASP programs to identify putative ancestral areas. Further, we inferred ultrametric trees to estimate the ages of selected nodes. The time frame is inferred from tectonic calibrations and the general mutation rate of the mitochondrial genes. Metriorrhynchini consists of two lineages with Afro/Oriental and Australian distributions. The basal lineages originated in Eastern Gondwana after the split of Australia, India and Madagascar; the Afrotropical and Madagascar Metriorrhynchini separated from the Oriental clades 65 and 62 mya. Several already diversified lineages colonized continental Asia 55-35 mya. A few genera of the Australian clade dispersed to the Oriental region 5-15 mya and reached Eastern India and Southern China. Only Xylobanus crossed the Makassar Strait to Sulawesi and does not occur further to the east. The current distribution of Metriorrhynchini is a result of drifting on continental fragments and over-sea dispersal events limited to a few hundreds of kilometers. We conclude that: (1) Afrotropical and Madagascar lineages originated independently from dispersal events during India's drift to the north and the Mozambique Channel completely isolates the respective faunas since then; (2) Oriental fauna is a recently established mixture of the Indian and Australian lineages, with predominance of the older Indian clades; (3) The fauna of islands located north of Australia colonized Sulawesi after collision with the Sundaland margin and the species rich Australian lineages did not reach Western Wallacea or the Philippines. Our results suggest an impact of subtle differences in biological characteristics on biogeographic history of individual lineages, when mostly lowland and flower-visiting lineages were able to disperse across sea channels.	[Sklenarova, Katerina; Chesters, Douglas; Bocak, Ladislav] Palacky Univ, Dept Zool, Fac Sci, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Bocak, L (corresponding author), Palacky Univ, Dept Zool, Fac Sci, CR-77147 Olomouc, Czech Republic.	ladislav.bocak@upol.cz	Chesters, Douglas/AAF-7926-2019; Bocak, Ladislav/J-5989-2019		European Community Research Infrastructure Action under the FP7 "Structuring the European Research Area" Program; Czech Science Foundation [P506/11/1757]; Internal Grant Agency of the Palacky University [PrF2013-018]	European Community Research Infrastructure Action under the FP7 "Structuring the European Research Area" Program; Czech Science Foundation(Grant Agency of the Czech Republic); Internal Grant Agency of the Palacky University	Czech Science Foundation (P506/11/1757) http://www.gacr.cz/en/. Internal Grant Agency of the Palacky University PrF2013-018. SYNTHESYS Project http://www.synthesys.info/, financed by European Community Research Infrastructure Action under the FP7 "Structuring the European Research Area" Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Balke M, 2009, P ROY SOC B-BIOL SCI, V276, P2359, DOI 10.1098/rspb.2009.0015; Belshaw R, 2005, BIOINFORMATICS, V21, P122, DOI 10.1093/bioinformatics/bth459; BERNOR RL, 1987, GEOBIOS-LYON, V20, P431, DOI 10.1016/S0016-6995(87)80079-7; Bocak L, 2000, EUR J ENTOMOL, V97, P271, DOI 10.14411/eje.2000.043; Bocak L, 2006, EUR J ENTOMOL, V103, P115, DOI 10.14411/eje.2006.017; Bocak L, 2003, J NAT HIST, V37, P1463, DOI 10.1080/00222930210125362; Bocak L, 2002, EUR J ENTOMOL, V99, P315, DOI 10.14411/eje.2002.043; Bocak L., 2001, EUR J ENTOMOL, V49, P1; Bocak L, 2000, ANN ENTOMOLOGIQUE FR, V36, P71; Bocak L, 2010, EVOLUTION, V64, P39, DOI 10.1111/j.1558-5646.2009.00812.x; Bocak L, 2008, P ROY SOC B-BIOL SCI, V275, P2015, DOI 10.1098/rspb.2008.0476; Bocak L, 2008, ANN ZOOL, V58, P695, DOI 10.3161/000345408X396639; Briggs JC, 2003, J BIOGEOGR, V30, P381, DOI 10.1046/j.1365-2699.2003.00809.x; Carpenter RJ, 2010, J BIOGEOGR, V37, P1202, DOI 10.1111/j.1365-2699.2010.02279.x; Cruaud A, 2011, J BIOGEOGR, V38, P209, DOI 10.1111/j.1365-2699.2010.02429.x; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eagles G, 2006, EARTH PLANET SC LETT, V242, P343, DOI 10.1016/j.epsl.2005.11.060; Eagles G, 2008, GEOPHYS J INT, V173, P703, DOI [10.1111/j.1365-246X.2008.03753.x, 10.1111/J.1365-246X.2008.03753.X]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Goloboff PA, 2004, CLADISTICS, V20, P84; Hall Robert, 1998, P99; Hall R, 2011, GEOL SOC SPEC PUBL, V355, P75, DOI 10.1144/SP355.5; Huelsenbeck J. P., 2000, MRBAYES BAYESIAN INF; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kubecek V, 2011, ZOOL STUD, V50, P645; Malohlava V, 2010, MOL ECOL, V19, P4800, DOI 10.1111/j.1365-294X.2010.04850.x; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Morley RJ, 2003, PERSPECT PLANT ECOL, V6, P5, DOI 10.1078/1433-8319-00039; Najman Y, 2001, NATURE, V410, P194, DOI 10.1038/35065577; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pigram C. J., 1987, BMR Journal of Australian Geology & Geophysics, V10, P193; Plummer PS, 1996, TERRA NOVA, V8, P34, DOI 10.1111/j.1365-3121.1996.tb00723.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; SCOTESE CR, 1988, TECTONOPHYSICS, V155, P27, DOI 10.1016/0040-1951(88)90259-4; Sniderman JMK, 2011, J BIOGEOGR, V38, P1445, DOI 10.1111/j.1365-2699.2011.02519.x; Sota T, 2008, MOL PHYLOGENET EVOL, V46, P183, DOI 10.1016/j.ympev.2007.10.016; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239	47	41	41	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67957	10.1371/journal.pone.0067957	http://dx.doi.org/10.1371/journal.pone.0067957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840793	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400123
J	Poteete, AR				Poteete, Anthony R.			Involvement of Escherichia coli DNA Replication Proteins in Phage Lambda Red-Mediated Homologous Recombination	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; POLYMERASE-I; BACTERIOPHAGE-LAMBDA; GENE REPLACEMENT; POLA GENE; MUTANTS; SYSTEM; RECF; INITIATION; MUTATIONS	The Red recombination system of bacteriophage lambda is widely used for genetic engineering because of its ability to promote recombination between bacterial chromosomes or plasmids and linear DNA species introduced by electroporation. The process is known to be intimately tied to replication, but the cellular functions which participate with Red in this process are largely unknown. Here two such functions are identified: the GrpE-DnaK-DnaJ chaperone system, and DNA polymerase I. Mutations in either function are found to decrease the efficiency of Red recombination. grpE and dnaJ mutations which greatly decrease Red recombination with electroporated DNA species have only small effects on Red-mediated transduction. This recombination event specificity suggests that the involvement of GrpE-DnaJ-DnaK is not simply an effect on Red structure or stability.	Univ Massachusetts, Dept Microbiol & Physiol Syst, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Poteete, AR (corresponding author), Univ Massachusetts, Dept Microbiol & Physiol Syst, Sch Med, Worcester, MA 01605 USA.	anthony.poteete@umassmed.edu						ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; FOSTER PL, 1992, J BACTERIOL, V174, P7509, DOI 10.1128/JB.174.23.7509-7516.1992; FUNATSU G, 1972, J MOL BIOL, V68, P547, DOI 10.1016/0022-2836(72)90108-8; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HENDERSON D, 1975, GENETICS, V79, P143; JOYCE CM, 1983, P NATL ACAD SCI-BIOL, V80, P1830, DOI 10.1073/pnas.80.7.1830; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; JOYCE CM, 1982, J BIOL CHEM, V257, P1958; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Kornberg A., 1992, DNA REPLICATION; Lajoie MJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks751; LEHMAN IR, 1976, SCIENCE, V193, P963, DOI 10.1126/science.781842; Li XT, 2013, MOL MICROBIOL, V88, P906, DOI 10.1111/mmi.12231; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; MYERS RS, 1994, ANNU REV GENET, V28, P49, DOI 10.1146/annurev.ge.28.120194.000405; Niwa T, 2012, P NATL ACAD SCI USA, V109, P8937, DOI 10.1073/pnas.1201380109; Oppenheim AB, 2004, VIROLOGY, V319, P185, DOI 10.1016/j.virol.2003.11.007; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; Poteete AR, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-12; POTEETE AR, 1988, J BACTERIOL, V170, P4379, DOI 10.1128/jb.170.9.4379-4381.1988; Poteete AR, 2000, J BACTERIOL, V182, P2336, DOI 10.1128/JB.182.8.2336-2340.2000; Poteete AR, 1999, J BACTERIOL, V181, P5402, DOI 10.1128/JB.181.17.5402-5408.1999; SAITO H, 1977, J MOL BIOL, V113, P1, DOI 10.1016/0022-2836(77)90038-9; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; SAWITZKE JA, 1992, GENETICS, V130, P7; Sawitzke JA, 1997, GENETICS, V147, P357; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; SCHILDKRAUT CL, 1964, J MOL BIOL, V9, P24, DOI 10.1016/S0022-2836(64)80089-9; SKALKA AM, 1977, CURR TOP MICROBIOL, P201; Stahl FW, 1998, GENE, V223, P95, DOI 10.1016/S0378-1119(98)00246-7; STAHL FW, 1974, GENETICS, V77, P395; Stahl MM, 1997, GENETICS, V147, P961; THALER DS, 1989, GENOME, V31, P53, DOI 10.1139/g89-013; VOCKE C, 1983, P NATL ACAD SCI-BIOL, V80, P6557, DOI 10.1073/pnas.80.21.6557; WU B, 1994, J BACTERIOL, V176, P6965, DOI 10.1128/JB.176.22.6965-6973.1994; Xu Y, 1997, J MOL BIOL, V268, P284, DOI 10.1006/jmbi.1997.0967; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zissler J, 1971, BACTERIOPHAGE LAMBDA, P455; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x	51	10	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67440	10.1371/journal.pone.0067440	http://dx.doi.org/10.1371/journal.pone.0067440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840702	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200134
J	Gross, J; Wajid, S; Price, DC; Zelzion, E; Li, JY; Chan, CX; Bhattacharya, D				Gross, Jeferson; Wajid, Sana; Price, Dana C.; Zelzion, Ehud; Li, Junyi; Chan, Cheong Xin; Bhattacharya, Debashish			Evidence for Widespread Exonic Small RNAs in the Glaucophyte Alga Cyanophora paradoxa	PLOS ONE			English	Article							FUNGUS MUCOR-CIRCINELLOIDES; TRANS-ACTING SIRNAS; TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; MESSENGER-RNAS; IDENTIFICATION; MICRORNAS; GENOME; INTERFERENCE; BIOGENESIS	RNAi (RNA interference) relies on the production of small RNAs (sRNAs) from double-stranded RNA and comprises a major pathway in eukaryotes to restrict the propagation of selfish genetic elements. Amplification of the initial RNAi signal by generation of multiple secondary sRNAs from a targeted mRNA is catalyzed by RNA-dependent RNA polymerases (RdRPs). This phenomenon is known as transitivity and is particularly important in plants to limit the spread of viruses. Here we describe, using a genome-wide approach, the distribution of sRNAs in the glaucophyte alga Cyanophora paradoxa. C. paradoxa is a member of the supergroup Plantae (also known as Archaeplastida) that includes red algae, green algae, and plants. The ancient (>1 billion years ago) split of glaucophytes within Plantae suggests that C. paradoxa may be a useful model to learn about the early evolution of RNAi in the supergroup that ultimately gave rise to plants. Using next-generation sequencing and bioinformatic analyses we find that sRNAs in C. paradoxa are preferentially associated with mRNAs, including a large number of transcripts that encode proteins arising from different functional categories. This pattern of exonic sRNAs appears to be a general trend that affects a large fraction of mRNAs in the cell. In several cases we observe that sRNAs have a bias for a specific strand of the mRNA, including many instances of antisense predominance. The genome of C. paradoxa encodes four sequences that are homologous to RdRPs in Arabidopsis thaliana. We discuss the possibility that exonic sRNAs in the glaucophyte may be secondarily derived from mRNAs by the action of RdRPs. If this hypothesis is confirmed, then transitivity may have had an ancient origin in Plantae.	[Gross, Jeferson; Wajid, Sana; Price, Dana C.; Zelzion, Ehud; Li, Junyi; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Gross, Jeferson; Wajid, Sana; Price, Dana C.; Zelzion, Ehud; Li, Junyi; Bhattacharya, Debashish] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Chan, Cheong Xin] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Chan, Cheong Xin] ARC Ctr Excellence Bioinformat, Brisbane, Qld, Australia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Queensland	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	bhattacharya@aesop.rutgers.edu	Chan, Cheong Xin/A-7005-2008	Chan, Cheong Xin/0000-0002-3729-8176	National Science Foundation [MGSP 0625440, MCB 0946528]; Rutgers University, New Brunswick	National Science Foundation(National Science Foundation (NSF)); Rutgers University, New Brunswick	This research was made possible by grants from the National Science Foundation (MGSP 0625440, MCB 0946528) awarded to DB. Partial support was provided to DB by Rutgers University, New Brunswick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2010, SEMIN CELL DEV BIOL, V21, P798, DOI 10.1016/j.semcdb.2010.03.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arif MA, 2013, INT J MOL SCI, V14, P1516, DOI 10.3390/ijms14011516; Calo S, 2012, MOL MICROBIOL, V83, P379, DOI 10.1111/j.1365-2958.2011.07939.x; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gierga G, 2012, ISME J, V6, P1544, DOI 10.1038/ismej.2011.215; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Huang AY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-337; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kawasaki H, 2005, CURR OPIN MOL THER, V7, P125; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; Norden-Krichmar TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022870; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; Reyes-Prieto A, 2007, MOL BIOL EVOL, V24, P2358, DOI 10.1093/molbev/msm186; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Talmor-Neiman M, 2006, PLANT J, V48, P511, DOI 10.1111/j.1365-313X.2006.02895.x; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128	36	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67669	10.1371/journal.pone.0067669	http://dx.doi.org/10.1371/journal.pone.0067669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844054	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000090
J	Leibon, G; Rockmore, DN				Leibon, Gregory; Rockmore, Daniel N.			Orienteering in Knowledge Spaces: The Hyperbolic Geometry of Wikipedia Mathematics	PLOS ONE			English	Article							SEARCH; GRAPH	In this paper we show how the coupling of the notion of a network with directions with the adaptation of the four-point probe from materials testing gives rise to a natural geometry on such networks. This four-point probe geometry shares many of the properties of hyperbolic geometry wherein the network directions take the place of the sphere at infinity, enabling a navigation of the network in terms of pairs of directions: the geodesic through a pair of points is oriented from one direction to another direction, the pair of which are uniquely determined. We illustrate this in the interesting example of the pages of Wikipedia devoted to Mathematics, or "The MathWiki." The applicability of these ideas extends beyond Wikipedia to provide a natural framework for visual search and to prescribe a natural mode of navigation for any kind of "knowledge space" in which higher order concepts aggregate various instances of information. Other examples would include genre or author organization of cultural objects such as books, movies, documents or even merchandise in an online store.	[Leibon, Gregory; Rockmore, Daniel N.] Dartmouth Coll, Dept Math, Hanover, NH 03755 USA; [Rockmore, Daniel N.] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA; [Rockmore, Daniel N.] Dartmouth Coll, Neukom Inst Computat Sci, Hanover, NH 03755 USA; [Rockmore, Daniel N.] Santa Fe Inst, Santa Fe, NM 87501 USA	Dartmouth College; Dartmouth College; Dartmouth College; The Santa Fe Institute	Leibon, G (corresponding author), Dartmouth Coll, Dept Math, Hanover, NH 03755 USA.	gleibon@gmail.com			AFOSR Award [FA9550-11-1-0166]	AFOSR Award(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was partially supported by AFOSR Award FA9550-11-1-0166. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Ahlfors L, 1979, COMPLEX ANAL; Allesina S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000494; Blei DM, 2007, ANN APPL STAT, V1, P17, DOI 10.1214/07-AOAS114; Boguna Marian, 2010, Nat Commun, V1, P62, DOI 10.1038/ncomms1063; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Cannon J.W., 1997, FLAVORS GEOMETRY, P59; Chandra AK, 1997, COMPUT COMPLEX, V6, P312; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; Doyle J, 2011, COMMUTING TIME GEOME; Doyle PG., 1984, RANDOM WALKS ELECT N, Vvol 22; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; Grinstead C, 1997, RANDOM WALKS ELECT N; Hughes JM, 2012, P NATL ACAD SCI USA, V109, P7682, DOI 10.1073/pnas.1115407109; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Krasinski A, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.124016; Krioukov D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036106; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Pickard G, 2011, SCIENCE, V334, P509, DOI 10.1126/science.1205869; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; West R., 2012, P 6 INT AAAI C WEBL, P362; West R., 2012, WWW, P619, DOI DOI 10.1145/2187836.2187920; West R, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1598	25	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67508	10.1371/journal.pone.0067508	http://dx.doi.org/10.1371/journal.pone.0067508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844017	gold, Green Submitted, Green Published			2022-12-27	WOS:000321733000076
J	Weaver, EA; Nehete, PN; Nehete, BP; Yang, GJ; Buchl, SJ; Hanley, PW; Palmer, D; Montefiori, DC; Ferrari, G; Ng, P; Sastry, KJ; Barry, MA				Weaver, Eric A.; Nehete, Pramod N.; Nehete, Bharti P.; Yang, Guojun; Buchl, Stephanie J.; Hanley, Patrick W.; Palmer, Donna; Montefiori, David C.; Ferrari, Guido; Ng, Philip; Sastry, K. Jagannadha; Barry, Michael A.			Comparison of Systemic and Mucosal Immunization with Helper-Dependent Adenoviruses for Vaccination against Mucosal Challenge with SHIV	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS SHIVSF162P3; IMMUNE-RESPONSES; RHESUS MACAQUES; SIMIAN AIDS; T-CELLS; ANTI-AD5 IMMUNITY; VECTOR; HIV-1; IMMUNOGENICITY; PROTECTION	Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has been hypothesized that vaccines delivered at mucosal surfaces may mediate better protection against HIV-1 than vaccines that are delivered systemically. To test this, rhesus macaques were vaccinated by intramuscular (i.m.) or intravaginal (ivag.) routes with helper-dependent adenoviral (HD-Ad) vectors expressing HIV-1 envelope. Macaques were first immunized intranasally with species C Ad serotype 5 (Ad5) prior to serotype-switching with species C HD-Ad6, Ad1, Ad5, and Ad2 vectors expressing env followed by rectal challenge with CCR5-tropic SHIV-SF162P3. Vaccination by the systemic route generated stronger systemic CD8 T cell responses in PBMC, but weaker mucosal responses. Conversely, mucosal immunization generated stronger CD4 T cell central memory (Tcm) responses in the colon. Intramuscular immunization generated higher levels of env-binding antibodies, but neither produced neutralizing or cytotoxic antibodies. After mucosal SHIV challenge, both groups controlled SHIV better than control animals. However, more animals in the ivag. group had lower viral set points than in in the i.m. group. These data suggest mucosal vaccination may have improve protection against sexually-transmitted HIV. These data also demonstrate that helper-dependent Ad vaccines can mediate robust vaccine responses in the face of prior immunity to Ad5 and during four rounds of adenovirus vaccination.	[Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Dept Internal Med, Div Infect Dis, Translat Immunovirol Program,Dept Immunol, Rochester, MN 55905 USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Nehete, Pramod N.; Nehete, Bharti P.; Buchl, Stephanie J.; Hanley, Patrick W.; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Houston, TX 77030 USA; [Yang, Guojun; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Palmer, Donna; Ng, Philip] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Montefiori, David C.; Ferrari, Guido] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Duke University	Barry, MA (corresponding author), Mayo Clin, Dept Internal Med, Div Infect Dis, Translat Immunovirol Program,Dept Immunol, Rochester, MN 55905 USA.	mab@mayo.edu	Ferrari, Guido/A-6088-2015; Ferrari, Guido/Z-2137-2019	Ferrari, Guido/0000-0001-7747-3349; Sastry, Jagannadha/0000-0002-6987-4422; Nehete, Pramod/0000-0002-2815-2677; Hanley, Patrick/0000-0003-2300-1818	NIH/NIAID [HHSN27201100016C];  [AI096967];  [AI06795];  [AI065304];  [AI42694];  [AI46969];  [HL083047];  [DK067324]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI042694, R01AI096967, R01AI097241, R01AI046969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067324] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants AI096967, AI06795, and AI065304 to M.A.B., grants AI42694 and AI46969 to J.S., and grants HL083047 and DK067324 to P.N. This work was also supported by NIH/NIAID contract HHSN27201100016C to D.C.M and contract HHSN27201100016C to G.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfe P, 2004, VIROLOGY, V318, P267, DOI 10.1016/j.virol.2003.09.022; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Chen HH, 1997, P NATL ACAD SCI USA, V94, P1645, DOI 10.1073/pnas.94.5.1645; Cohen J, 2011, SCIENCE, P333; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; He H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019607; Hsu M, 2003, J MED PRIMATOL, V32, P211, DOI 10.1034/j.1600-0684.2003.00027.x; Hsu M, 2003, J VIROL, V77, P989, DOI 10.1128/JVI.77.2.989-998.2003; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Lehner T, 2002, AIDS, V16, pS125, DOI 10.1097/00002030-200216004-00017; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; McCoy K, 2007, J VIROL, V81, P6594, DOI 10.1128/JVI.02497-06; Mercier GT, 2007, VACCINE, V25, P8687, DOI 10.1016/j.vaccine.2007.10.030; Mitchell MF, 1996, AM J OBSTET GYNECOL, V174, P1094, DOI 10.1016/S0002-9378(96)70650-6; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Morral N, 1998, HUM GENE THER, V9, P2709, DOI 10.1089/hum.1998.9.18-2709; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Nehete PN, 2003, J MED PRIMATOL, V32, P67, DOI 10.1034/j.1600-0684.2003.00011.x; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Parks RJ, 1999, GENE THER, V6, P1565, DOI 10.1038/sj.gt.3300995; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Pinto AR, 2003, J IMMUNOL, V171, P6774, DOI 10.4049/jimmunol.171.12.6774; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Reyes RA, 2004, J VIROL, V78, P2121, DOI 10.1128/JVI.78.4.2121-2130.2004; Santra S, 2009, VACCINE, V27, P5837, DOI 10.1016/j.vaccine.2009.07.050; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Someya K, 2007, VIROLOGY; Weaver EA, 2009, VIRUSES-BASEL, V1, P920, DOI 10.3390/v1030920; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059	36	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67574	10.1371/journal.pone.0067574	http://dx.doi.org/10.1371/journal.pone.0067574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844034	Green Published, gold			2022-12-27	WOS:000321733000082
J	Bartolini, B; Thelin, MA; Svensson, L; Ghiselli, G; van Kuppevelt, TH; Malmstrom, A; Maccarana, M				Bartolini, Barbara; Thelin, Martin A.; Svensson, Lena; Ghiselli, Giancarlo; van Kuppevelt, Toin H.; Malmstrom, Anders; Maccarana, Marco			Iduronic Acid in Chondroitin/Dermatan Sulfate Affects Directional Migration of Aortic Smooth Muscle Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; DERMATAN SULFATE; GROWTH-FACTOR; HEPARAN-SULFATE; MONOCLONAL-ANTIBODIES; HYBRID CHAINS; BINDING; PROTEOGLYCAN; RECEPTOR; PROLIFERATION	Aortic smooth muscle cells produce chondroitin/dermatan sulfate (CS/DS) proteoglycans that regulate extracellular matrix organization and cell behavior in normal and pathological conditions. A unique feature of CS/DS proteoglycans is the presence of iduronic acid (IdoA), catalyzed by two DS epimerases. Functional ablation of DS-epi1, the main epimerase in these cells, resulted in a major reduction of IdoA both on cell surface and in secreted CS/DS proteoglycans. Downregulation of IdoA led to delayed ability to re-populate wounded areas due to loss of directional persistence of migration. DS-epi1-/- aortic smooth muscle cells, however, had not lost the general property of migration showing even increased speed of movement compared to wild type cells. Where the cell membrane adheres to the substratum, stress fibers were denser whereas focal adhesion sites were fewer. Total cellular expression of focal adhesion kinase (FAK) and phospho-FAK (pFAK) was decreased in mutant cells compared to control cells. As many pathological conditions are dependent on migration, modulation of IdoA content may point to therapeutic strategies for diseases such as cancer and atherosclerosis.	[Bartolini, Barbara; Thelin, Martin A.; Malmstrom, Anders; Maccarana, Marco] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Svensson, Lena] Lund Univ, Dept Expt Med Sci, Immunol Sect, Lund, Sweden; [Ghiselli, Giancarlo] Glyconova Srl, Turin, Italy; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands	Lund University; Lund University; Radboud University Nijmegen	Bartolini, B (corresponding author), Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy.	barbara.bartolini@uninsubria.it	maccarana, marco/AAB-4764-2021; van Kuppevelt, A.H.M.S.M./L-4463-2015; Thelin, Martin/R-6918-2016	Thelin, Martin/0000-0003-1815-7965; Thelin, Martin/0000-0002-2232-5514; Malmstrom, Anders/0000-0002-6691-146X; Maccarana, Marco/0000-0003-3549-8921	Vetenskapsradet; Lund University; Mizutani Foundation for Glycoscience; Alfred Osterlunds Stiftelse; Kockska Stifelserna; The Royal Swedish Academy of Sciences	Vetenskapsradet(Swedish Research Council); Lund University; Mizutani Foundation for Glycoscience; Alfred Osterlunds Stiftelse; Kockska Stifelserna; The Royal Swedish Academy of Sciences	This work as supported by Vetenskapsradet (http://www.vr.se/), Lund University (http://www.med.lu.se/English), Mizutani Foundation for Glycoscience (http://mizutanifdn.or.jp/[MM]), Alfred Osterlunds Stiftelse (http://www.alfredosterlundsstiftelse.se/), Kockska Stifelserna (http://www.kockskastiftelsen.se/), and The Royal Swedish Academy of Sciences (http://www.crafoordprize.se/2.6433d6e310d82ee289d800011119.html [to BB]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES JL, 1991, J BIOL CHEM, V266, P23282; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Bartolini B, 2012, GLYCOBIOLOGY, V22, P1007, DOI 10.1093/glycob/cws065; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cheng C, 2012, ARTERIOSCL THROM VAS, V32, P1289, DOI 10.1161/ATVBAHA.112.245530; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; FAGER G, 1995, J CELL PHYSIOL, V163, P380, DOI 10.1002/jcp.1041630218; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; Grako KA, 1999, J CELL SCI, V112, P905; Ilarraza Lomeli Hermes, 2009, ARCHIVOS DE CARDIOLOGIA DE MEXICO, V79, P63; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kop EN, 2005, ARTHRITIS RHEUM-US, V52, P442, DOI 10.1002/art.20788; Kozma EM, 2009, BIOCHIMIE, V91, P1394, DOI 10.1016/j.biochi.2009.07.010; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Li HP, 2012, AM J PHYSIOL-LUNG C, V302, pL569, DOI 10.1152/ajplung.00217.2011; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Merle B, 1999, J CELL BIOCHEM, V75, P538; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Multhaupt HA, 2012, INT J BIOCH CELL BIO; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Pacheco B, 2009, GLYCOBIOLOGY, V19, P1197, DOI 10.1093/glycob/cwp110; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Suwan K, 2009, J BIOL CHEM, V284, P8596, DOI 10.1074/jbc.M806927200; Suzuki K, 2008, GLYCOCONJUGATE J, V25, P703, DOI 10.1007/s10719-008-9130-z; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Thelin MA, 2012, CANCER RES, V72, P1943, DOI 10.1158/0008-5472.CAN-11-1351; Tufvesson E, 2002, EUR J BIOCHEM, V269, P3688, DOI 10.1046/j.1432-1033.2002.03058.x; Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Veiga SS, 1997, J BIOL CHEM, V272, P12529, DOI 10.1074/jbc.272.19.12529; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; WESTERGRENTHORSSON G, 1991, J CELL PHYSIOL, V147, P523, DOI 10.1002/jcp.1041470319; Woods A, 2000, J BIOL CHEM, V275, P24233, DOI 10.1074/jbc.R000001200; Rasente RY, 2012, CARBOHYD RES, V356, P233, DOI 10.1016/j.carres.2012.03.036; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	48	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66704	10.1371/journal.pone.0066704	http://dx.doi.org/10.1371/journal.pone.0066704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843960	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000017
J	Matsushita, H; Hijioka, M; Hisatsune, A; Isohama, Y; Iwamoto, S; Terasawa, H; Katsuki, H				Matsushita, Hideaki; Hijioka, Masanori; Hisatsune, Akinori; Isohama, Yoichiro; Iwamoto, Shigeto; Terasawa, Hiroaki; Katsuki, Hiroshi			MRI-Based Analysis of Intracerebral Hemorrhage in Mice Reveals Relationship between Hematoma Expansion and the Severity of Symptoms	PLOS ONE			English	Article							PREDICTOR; RECOVERY; MODELS; RATS	Intracerebral hemorrhage (ICH) is featured by poor prognosis such as high mortality rate and severe neurological dysfunction. In humans, several valuables including hematoma volume and ventricular expansion of hemorrhage are known to correlate with the extent of mortality and neurological dysfunction. However, relationship between hematoma conditions and the severity of symptoms in animal ICH models has not been clarified. Here we addressed this issue by using 7-tesla magnetic resonance imaging (MRI) on collagenase-induced ICH model in mice. We found that the mortality rate and the performance in behavioral tests did not correlate well with the volume of hematoma. In contrast, when hemorrhage invaded the internal capsule, mice exhibited high mortality and showed poor sensorimotor performance. High mortality rate and poor performance in behavioral tests were also observed when hemorrhage invaded the lateral ventricle, although worsened symptoms associated with ventricular hemorrhage were apparent only during early phase of the disease. These results clearly indicate that invasion of the internal capsule or the lateral ventricle by hematoma is a critical determinant of poor prognosis in experimental ICH model in mice as well as in human ICH patients. MRI assessment may be a powerful tool to refine investigations of pathogenic mechanisms and evaluations of drug effects in animal models of ICH.	[Matsushita, Hideaki; Hijioka, Masanori; Hisatsune, Akinori; Isohama, Yoichiro; Katsuki, Hiroshi] Kumamoto Univ, Dept Chemicopharmacol Sci, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Hisatsune, Akinori] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Japan; [Iwamoto, Shigeto; Terasawa, Hiroaki] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Struct Bioimaging, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Katsuki, H (corresponding author), Kumamoto Univ, Dept Chemicopharmacol Sci, Grad Sch Pharmaceut Sci, Kumamoto, Japan.	hkatsuki@gpo.kumamoto-u.ac.jp	HIJIOKA, Masanori/N-6665-2017; HIJIOKA, Masanori/AAL-3018-2020	HIJIOKA, Masanori/0000-0001-6912-3496; HIJIOKA, Masanori/0000-0001-6912-3496; Katsuki, Hiroshi/0000-0001-7595-3154	Smoking Research Foundation; Mitsubishi Pharma Research Foundation; MEXT KAKENHI [23117714]; JSPS KAKENHI [24659118]	Smoking Research Foundation; Mitsubishi Pharma Research Foundation; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Smoking Research Foundation, Mitsubishi Pharma Research Foundation, MEXT KAKENHI Grant Number 23117714, and JSPS KAKENHI Grant Number 24659118. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the funders (Mitsubishi Pharma Research Foundation) is based on commercial source, but this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors have no relation with this foundation concerning employment, consultancy, patents, products in development or marketed products etc.	Arboix A, 2002, ACTA NEUROL SCAND, V105, P282, DOI 10.1034/j.1600-0404.2002.1o170.x; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hijioka M, 2012, NEUROSCIENCE, V222, P10, DOI 10.1016/j.neuroscience.2012.07.024; Katsuki H, 2010, J PHARMACOL SCI, V114, P366, DOI 10.1254/jphs.10R05CR; Liliang PC, 2001, STROKE, V32, P1195, DOI 10.1161/01.STR.32.5.1195; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, J CEREBR BLOOD F MET, V26, P1031, DOI 10.1038/sj.jcbfm.9600255; MacLellan CL, 2010, STROKE, V41, pS95, DOI 10.1161/STROKEAHA.110.594457; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; Matsushita H, 2012, EUR J PHARMACOL, V683, P125, DOI 10.1016/j.ejphar.2012.03.023; Matsushita H, 2011, J CEREBR BLOOD F MET, V31, P222, DOI 10.1038/jcbfm.2010.80; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; MORI E, 1985, STROKE, V16, P454, DOI 10.1161/01.STR.16.3.454; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Shaya M, 2005, SURG NEUROL, V63, P343, DOI 10.1016/j.surneu.2004.06.019; TAPIA JF, 1983, STROKE, V14, P505, DOI 10.1161/01.STR.14.4.505; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0	19	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67691	10.1371/journal.pone.0067691	http://dx.doi.org/10.1371/journal.pone.0067691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844065	Green Published, Green Submitted, gold			2022-12-27	WOS:000321341000079
J	Namas, RA; Bartels, J; Hoffman, R; Barclay, D; Billiar, TR; Zamora, R; Vodovotz, Y				Namas, Rami A.; Bartels, John; Hoffman, Rosemary; Barclay, Derek; Billiar, Timothy R.; Zamora, Ruben; Vodovotz, Yoram			Combined In Silico, In Vivo, and In Vitro Studies Shed Insights into the Acute Inflammatory Response in Middle-Aged Mice	PLOS ONE			English	Article							INNATE IMMUNITY; NITRIC-OXIDE; ENDOTOXIN TOLERANCE; CYTOKINE PRODUCTION; SYSTEMS BIOLOGY; LIPOPOLYSACCHARIDE; IMMUNOSENESCENCE; HEMORRHAGE; COMPLEXITY; SECRETION	We combined in silico, in vivo, and in vitro studies to gain insights into age-dependent changes in acute inflammation in response to bacterial endotoxin (LPS). Time-course cytokine, chemokine, and NO2-/NO3- data from "middle-aged" (6-8 months old) C57BL/6 mice were used to re-parameterize a mechanistic mathematical model of acute inflammation originally calibrated for "young" (2-3 months old) mice. These studies suggested that macrophages from middle-aged mice are more susceptible to cell death, as well as producing higher levels of pro-inflammatory cytokines, vs. macrophages from young mice. In support of the in silico-derived hypotheses, resident peritoneal cells from endotoxemic middle-aged mice exhibited reduced viability and produced elevated levels of TNF-alpha, IL-6, IL-10, and KC/CXCL1 as compared to cells from young mice. Our studies demonstrate the utility of a combined in silico, in vivo, and in vitro approach to the study of acute inflammation in shock states, and suggest hypotheses with regard to the changes in the cytokine milieu that accompany aging.	[Namas, Rami A.; Hoffman, Rosemary; Barclay, Derek; Billiar, Timothy R.; Zamora, Ruben; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Bartels, John] Immunetrics Inc, Pittsburgh, PA USA; [Vodovotz, Yoram] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Namas, Rami A.; Barclay, Derek; Billiar, Timothy R.; Zamora, Ruben; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Modeling, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vodovotz, Y (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu	Namas, Rami/AAD-5793-2020; Namas, Rami/GZK-4999-2022; Namas, Rami/AAD-5796-2020	Namas, Rami/0000-0002-8582-5321; Namas, Rami/0000-0002-8582-5321	National Institutes of Health [P50-GM-53789]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant P50-GM-53789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Alvarez E, 1996, CELL IMMUNOL, V169, P152, DOI 10.1006/cimm.1996.0103; Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001; Aujard F, 2001, NEUROSCIENCE, V106, P255, DOI 10.1016/S0306-4522(01)00285-8; Bagci EZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002249; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Beharka AA, 2001, J GERONTOL A-BIOL, V56, pB81, DOI 10.1093/gerona/56.2.B81; BRADLEY SF, 1989, J LEUKOCYTE BIOL, V45, P510, DOI 10.1002/jlb.45.6.510; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cevenini E, 2010, CURR PHARM DESIGN, V16, P802, DOI 10.2174/138161210790883660; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Daun S, 2008, J THEOR BIOL, V253, P843, DOI 10.1016/j.jtbi.2008.04.033; EFFROS RB, 1991, LYMPHOKINE CYTOK RES, V10, P347; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Ferrucci L, 2004, AGING CLIN EXP RES, V16, P240, DOI 10.1007/BF03327390; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Greeneltch KM, 2004, BRAIN BEHAV IMMUN, V18, P476, DOI 10.1016/j.bbi.2003.12.001; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Hasegawa Y, 2000, GERONTOLOGY, V46, P185, DOI 10.1159/000022157; INAMIZU T, 1985, IMMUNOLOGY, V55, P447; Ito Y, 2003, EUR SURG RES, V35, P408, DOI 10.1159/000072174; Jeck WR, 2012, AGING CELL, DOI [10.1111/j.1474-9726, DOI 10.1111/J.1474-9726]; Kang SC, 2004, CYTOKINE, V26, P223, DOI 10.1016/j.cyto.2004.03.005; Kohman RA, 2010, BRAIN BEHAV IMMUN, V24, P486, DOI 10.1016/j.bbi.2009.12.004; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; L'Episcopo F, 2013, J NEUROSCI, V33, P1462, DOI 10.1523/JNEUROSCI.3206-12.2013; Lagoa CE, 2006, SHOCK, V26, P592, DOI 10.1097/01.shk.0000232272.03602.0a; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nieman G, 2012, CRIT CARE MED, V40, P1052, DOI 10.1097/CCM.0b013e31823e986a; Ocasio FM, 2004, J NEUROIMMUNOL, V149, P90, DOI 10.1016/j.jneuroim.2003.12.016; Ochi H, 1998, FEMS IMMUNOL MED MIC, V20, P181, DOI 10.1111/j.1574-695X.1998.tb01126.x; Ostan R, 2008, NEUROIMMUNOMODULAT, V15, P224, DOI 10.1159/000156466; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Schroder AK, 2003, MECH AGEING DEV, V124, P419, DOI 10.1016/S0047-6374(03)00017-4; Schumer W, 1988, Prog Clin Biol Res, V264, P223; Sinha-Hikim I, 2013, J GERONTOL A; Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996; Torres A, 2009, SHOCK, V32, P172, DOI 10.1097/SHK.0b013e318193cc2b; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Vodovotz Y, 2007, J CRIT CARE, V22, P77, DOI 10.1016/j.jcrc.2006.12.001; Vodovotz Yoram, 2004, Curr Opin Crit Care, V10, P383, DOI 10.1097/01.ccx.0000139360.30327.69; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wang HK, 2013, NEUROSCI BULL, V29, P251, DOI 10.1007/s12264-013-1323-1; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; WiktorJedrzejczak W, 1996, PHYSIOL REV, V76, P927, DOI 10.1152/physrev.1996.76.4.927; Yang MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059673; Yang Z, 2003, J GERONTOL B-PSYCHOL, V58, pS2, DOI 10.1093/geronb/58.1.S2; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x; Zhang RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048141, 10.1371/journal.pone.0050348]; Zykova SN, 2000, DIABETES, V49, P1451, DOI 10.2337/diabetes.49.9.1451	59	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67419	10.1371/journal.pone.0067419	http://dx.doi.org/10.1371/journal.pone.0067419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23844008	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000321341000044
J	Schmid, T; Bogdan, M; Gunzel, D				Schmid, Thomas; Bogdan, Martin; Guenzel, Dorothee			Discerning Apical and Basolateral Properties of HT-29/B6 and IPEC-J2 Cell Layers by Impedance Spectroscopy, Mathematical Modeling and Machine Learning	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; EPITHELIAL BARRIER; NOISE INJECTION; AC-IMPEDANCE; RESISTANCE; MONOLAYERS; SECRETION; TRANSPORT; CHANNELS; A6	Quantifying changes in partial resistances of epithelial barriers in vitro is a challenging and time-consuming task in physiology and pathophysiology. Here, we demonstrate that electrical properties of epithelial barriers can be estimated reliably by combining impedance spectroscopy measurements, mathematical modeling and machine learning algorithms. Conventional impedance spectroscopy is often used to estimate epithelial capacitance as well as epithelial and subepithelial resistance. Based on this, the more refined two-path impedance spectroscopy makes it possible to further distinguish transcellular and paracellular resistances. In a next step, transcellular properties may be further divided into their apical and basolateral components. The accuracy of these derived values, however, strongly depends on the accuracy of the initial estimates. To obtain adequate accuracy in estimating subepithelial and epithelial resistance, artificial neural networks were trained to estimate these parameters from model impedance spectra. Spectra that reflect behavior of either HT-29/B6 or IPEC-J2 cells as well as the data scatter intrinsic to the used experimental setup were created computationally. To prove the proposed approach, reliability of the estimations was assessed with both modeled and measured impedance spectra. Transcellular and paracellular resistances obtained by such neural network-enhanced two-path impedance spectroscopy are shown to be sufficiently reliable to derive the underlying apical and basolateral resistances and capacitances. As an exemplary perturbation of pathophysiological importance, the effect of forskolin on the apical resistance of HT-29/B6 cells was quantified.	[Schmid, Thomas; Bogdan, Martin] Univ Leipzig, Dept Math & Comp Sci, D-04109 Leipzig, Germany; [Guenzel, Dorothee] Charite, Inst Clin Physiol, D-13353 Berlin, Germany	Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gunzel, D (corresponding author), Charite, Inst Clin Physiol, D-13353 Berlin, Germany.	dorothee.guenzel@charite.de		Gunzel, Dorothee/0000-0002-7998-7164	German Research Association [DFG FOR 721]; FAZIT-Stiftung Gemeinnutzige Verlagsgesellschaft mbH (Frankfurt am Main); German-American Binational Fulbright Commission	German Research Association(German Research Foundation (DFG)); FAZIT-Stiftung Gemeinnutzige Verlagsgesellschaft mbH (Frankfurt am Main); German-American Binational Fulbright Commission	This study was supported by the German Research Association (DFG FOR 721), FAZIT-Stiftung Gemeinnutzige Verlagsgesellschaft mbH (Frankfurt am Main) and the German-American Binational Fulbright Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum EB, 1989, NEURAL COMPUT, V1, P151, DOI 10.1162/neco.1989.1.1.151; BELL CL, 1992, AM J PHYSIOL, V262, pC555, DOI 10.1152/ajpcell.1992.262.3.C555; Bellman R., 1961, ADAPTIVE CONTROL PRO; BERSCHNEIDER H M, 1989, Gastroenterology, V96, pA41; Bertrand CA, 1998, BIOPHYS J, V75, P2743, DOI 10.1016/S0006-3495(98)77718-5; CLAUSEN C, 1979, BIOPHYS J, V26, P291, DOI 10.1016/S0006-3495(79)85250-9; CLAUSEN C, 1983, BIOPHYS J, V41, P167, DOI 10.1016/S0006-3495(83)84417-8; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; FLOOD I, 1994, J COMPUT CIVIL ENG, V8, P131, DOI 10.1061/(ASCE)0887-3801(1994)8:2(131); Fricke H, 1925, PHYS REV, V26, P0682, DOI 10.1103/PhysRev.26.682; FROMM M, 1985, PFLUG ARCH EUR J PHY, V405, P400, DOI 10.1007/BF00595695; FROMM M, 1985, J MEMBRANE BIOL, V87, P141, DOI 10.1007/BF01870660; FROMTER E, 1972, J MEMBRANE BIOL, V8, P259, DOI 10.1007/BF01868106; Gitter AH, 1997, J BIOCHEM BIOPH METH, V35, P81, DOI 10.1016/S0165-022X(97)00028-6; Gitter AH, 2000, PFLUG ARCH EUR J PHY, V439, P477, DOI 10.1007/s004240050966; Gitter AH, 2000, ANN NY ACAD SCI, V915, P193; Grandvalet Y, 1997, NEURAL COMPUT, V9, P1093, DOI 10.1162/neco.1997.9.5.1093; Gunzel D, 2012, ANN NY ACAD SCI, V1257, P142, DOI 10.1111/j.1749-6632.2012.06540.x; Hering NA, 2011, LAB INVEST, V91, P310, DOI 10.1038/labinvest.2010.180; Hober R, 1910, PFLUG ARCH GES PHYS, V133, P237, DOI 10.1007/BF01680330; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; KOTTRA G, 1984, PFLUG ARCH EUR J PHY, V402, P421, DOI 10.1007/BF00583943; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Krogh A, 2008, NAT BIOTECHNOL, V26, P195, DOI 10.1038/nbt1386; Krug SM, 2012, CELL MOL LIFE SCI, V69, P2765, DOI 10.1007/s00018-012-0949-x; Krug SM, 2009, BIOPHYS J, V97, P2202, DOI 10.1016/j.bpj.2009.08.003; MARABINI R, 1994, BIOPHYS J, V66, P1804, DOI 10.1016/S0006-3495(94)80974-9; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Minns AW, 1996, HYDROLOG SCI J, V41, P399, DOI 10.1080/02626669609491511; MONTAGUE G, 1994, TRENDS BIOTECHNOL, V12, P312, DOI 10.1016/0167-7799(94)90048-5; Nguyen G.H., 2009, PATTERN RECOGN, P193; Nossol C, 2011, HISTOCHEM CELL BIOL, V136, P103, DOI 10.1007/s00418-011-0826-y; Paunescu TG, 2001, BIOPHYS J, V81, P852, DOI 10.1016/S0006-3495(01)75746-3; Prechelt L, 1998, LECT NOTES COMPUT SC, V1524, P55; Rosenthal R, 2012, BIOMATERIALS, V33, P2791, DOI 10.1016/j.biomaterials.2011.12.034; SCHIFFERDECKER E, 1978, PFLUG ARCH EUR J PHY, V377, P125, DOI 10.1007/BF00582842; SCHULTZ SG, 1972, J GEN PHYSIOL, V59, P794, DOI 10.1085/jgp.59.6.794; SCHULZKE JD, 1995, GUT, V37, P777, DOI 10.1136/gut.37.6.777; Schulzke JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018107; Seguritan V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002657; SUZUKI K, 1982, PFLUG ARCH EUR J PHY, V394, P302, DOI 10.1007/BF00583694; TETKO IV, 1995, J CHEM INF COMP SCI, V35, P826, DOI 10.1021/ci00027a006; Verleysen M, 2003, LECT NOTES COMPUT SC, V2687, P105; Weskamp PE, 1990, THESIS FU BERLIN; WILLS NK, 1992, J MEMBRANE BIOL, V125, P273; Zur RM, 2009, MED PHYS, V36, P4810, DOI 10.1118/1.3213517	48	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e62913	10.1371/journal.pone.0062913	http://dx.doi.org/10.1371/journal.pone.0062913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840862	Green Submitted, Green Published, gold			2022-12-27	WOS:000321271900001
J	Casalegno, S; Inger, R; DeSilvey, C; Gaston, KJ				Casalegno, Stefano; Inger, Richard; DeSilvey, Caitlin; Gaston, Kevin J.			Spatial Covariance between Aesthetic Value & Other Ecosystem Services	PLOS ONE			English	Article							CULTURAL SERVICES; AUTOCORRELATION; BENEFITS; MODELS	Mapping the spatial distribution of ecosystem goods and services represents a burgeoning field of research, although how different services covary with one another remains poorly understood. This is particularly true for the covariation of supporting, provisioning and regulating services with cultural services (the non-material benefits people gain from nature). This is largely because of challenges associated with the spatially specific quantification of cultural ecosystem services. We propose an innovative approach for evaluating a cultural service, the perceived aesthetic value of ecosystems, by quantifying geo-tagged digital photographs uploaded to social media resources. Our analysis proceeds from the premise that images will be captured by greater numbers of people in areas that are more highly valued for their aesthetic attributes. This approach was applied in Cornwall, UK, to carry out a spatial analysis of the covariation between ecosystem services: soil carbon stocks, agricultural production, and aesthetic value. Our findings suggest that online geo-tagged images provide an effective metric for mapping a key component of cultural ecosystem services. They also highlight the non-stationarity in the spatial relationships between patterns of ecosystem services.	[Casalegno, Stefano; Inger, Richard; DeSilvey, Caitlin; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Exeter	Casalegno, S (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	stefano@casalegno.net	; Inger, Richard/D-3445-2009	DeSilvey, Caitlin/0000-0003-1629-8414; Gaston, Kevin J./0000-0002-7235-7928; Inger, Richard/0000-0003-1660-3706	University of Exeter	University of Exeter	This work was supported by the University of Exeter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2005, FARM MAN HDB; [Anonymous], 2011, JRC SCI TECHNICAL RE, DOI DOI 10.2788/63557; Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brownstein CA, 2009, NAT BIOTECHNOL, V27, P888, DOI 10.1038/nbt1009-888; Carroll C, 1999, CONSERV BIOL, V13, P1344, DOI 10.1046/j.1523-1739.1999.98364.x; Casalegno S, 2011, EUR J FOREST RES, V130, P971, DOI 10.1007/s10342-011-0480-x; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024378; CLIFFORD P, 1989, BIOMETRICS, V45, P123, DOI 10.2307/2532039; Cornwall Council, 2009, EC EV REV APP 1 GREE; Cornwall Council website, 2012, OFF NAT STAT MID EST; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; Departement for Environment, 2012, JUN SURV AGR 2000; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Egoh B, 2009, BIOL CONSERV, V142, P553, DOI 10.1016/j.biocon.2008.11.009; Eigenbrod F, 2010, BIOL CONSERV, V143, P2487, DOI 10.1016/j.biocon.2010.06.015; Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528; European Commission Joint Research Centre website, 2012, MAP ORG CARB CONT TO; European Environment Agency website, 2012, COR LAND COV 2000 RA; Gimona A, 2007, LANDSCAPE ECOL, V22, P1255, DOI 10.1007/s10980-007-9105-7; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRASS development team, 2012, GEOGR RES AN SUPP SY; Hawkins BA, 2012, J BIOGEOGR, V39, P1, DOI 10.1111/j.1365-2699.2011.02637.x; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Hill GW, 2006, FORESTRY, V79, P185, DOI 10.1093/forestry/cpl005; Holland RA, 2011, BIODIVERS CONSERV, V20, P3285, DOI 10.1007/s10531-011-0113-1; International Telecommunications Unions website, 2012, PERC IND US INT 2000; International Telecommunications Unions website, 2012, KEY GLOB TEL IND WOR; Jones RJA, 2005, EUR J SOIL SCI, V56, P655, DOI 10.1111/j.1365-2389.2005.00728.x; Joyce K, 2009, APPL GEOGR, V29, P409, DOI 10.1016/j.apgeog.2008.11.006; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Malizia A, 2011, J VISUAL LANG COMPUT, V22, P150, DOI 10.1016/j.jvlc.2010.12.003; Martin-Lopez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038970; Miller JA, 2012, PROG PHYS GEOG, V36, P681, DOI 10.1177/0309133312442522; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Norton LR, 2012, LAND USE POLICY, V29, P449, DOI 10.1016/j.landusepol.2011.09.002; O'Farrell PJ, 2011, J ARID ENVIRON, V75, P612, DOI 10.1016/j.jaridenv.2011.01.005; Panoramio website, 2013, PAN ACC POL GOOGL EA; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; R Core Team, 2021, R LANGUAGE ENV STAT; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reid W.V, 2005, MILLENNIUM ECOSYSTEM; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Thomson JD, 1996, ECOLOGY, V77, P1698, DOI 10.2307/2265776; Zar J. H., 2007, BIOSTATISTICAL ANAL	50	84	84	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68437	10.1371/journal.pone.0068437	http://dx.doi.org/10.1371/journal.pone.0068437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840853	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400194
J	Dave, RK; Dinger, ME; Andrew, M; Askarian-Amiri, M; Hume, DA; Kellie, S				Dave, Richa K.; Dinger, Marcel E.; Andrew, Megan; Askarian-Amiri, Marjan; Hume, David A.; Kellie, Stuart			Regulated Expression of PTPRJ/CD148 and an Antisense Long Noncoding RNA in Macrophages by Proinflammatory Stimuli	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PLASMINOGEN-ACTIVATOR GENE; TRANSCRIPTION FACTORS; INTERFERON-GAMMA; CELL; RECEPTOR; CD148; CSF-1; CANCER; GROWTH	PTPRJ/CD148 is a tyrosine phosphatase that has tumour suppressor-like activity. Quantitative PCR of various cells and tissues revealed that it is preferentially expressed in macrophage-enriched tissues. Within lymphoid tissues immunohistochemistry revealed that PTPRJ/CD148 co-localised with F4/80, indicating that macrophages most strongly express the protein. Macrophages express the highest basal level of ptprj, and this is elevated further by treatment with LPS and other Toll-like receptor ligands. In contrast, CSF-1 treatment reduced basal and stimulated Ptprj expression in human and mouse cells, and interferon also repressed Ptprj expression. We identified a 1006 nucleotide long noncoding RNA species, Ptprj-as1 that is transcribed antisense to Ptprj. Ptprj-as1 was highly expressed in macrophage-enriched tissue and was transiently induced by Toll-like receptor ligands with a similar time course to Ptprj. Finally, putative transcription factor binding sites in the promoter region of Ptprj were identified.	[Dave, Richa K.; Askarian-Amiri, Marjan; Hume, David A.; Kellie, Stuart] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Dave, Richa K.; Hume, David A.; Kellie, Stuart] Univ Queensland, CRC CID, Brisbane, Qld, Australia; [Dave, Richa K.; Andrew, Megan; Kellie, Stuart] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Dinger, Marcel E.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Dinger, Marcel E.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Garvan Institute of Medical Research; St Vincents Hospital Sydney; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Kellie, S (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	s.kellie@uq.edu.au	Askarian-Amiri, Marjan E./F-7910-2010; Kellie, Stuart/A-6036-2010; Dinger, Marcel/N-1398-2019	Askarian-Amiri, Marjan E./0000-0003-3524-9626; Kellie, Stuart/0000-0002-8163-1474; Hume, David/0000-0002-2615-1478; Dinger, Marcel/0000-0003-4423-934X	CRC for Chronic Inflammatory Diseases; NHMRC Dora Lush scholarship; NHMRC Career Development Award	CRC for Chronic Inflammatory Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NHMRC Dora Lush scholarship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	Part of this work was funded by the CRC for Chronic Inflammatory Diseases. RKD was in receipt of an NHMRC Dora Lush scholarship. MED is in receipt of an NHMRC Career Development Award. The authors wish to acknowledge the ARC Special Research Centre for Functional and Applied Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Arimura Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000966; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Crowe ML, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-16; Dave RK, 2009, EXP CELL RES, V315, P1734, DOI 10.1016/j.yexcr.2009.02.023; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dinger ME, 2011, MOL THER, V19, P2109, DOI 10.1038/mt.2011.251; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; EICHBAUM QG, 1994, J EXP MED, V179, P1985, DOI 10.1084/jem.179.6.1985; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Fowles LF, 2000, BIOCHEM J, V347, P313, DOI 10.1042/0264-6021:3470313; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gaya A, 1999, LEUKEMIA LYMPHOMA, V35, P237, DOI 10.3109/10428199909145726; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2012, J INNATE IMMUN, V4, P409, DOI 10.1159/000339280; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hume DA, 2008, J IMMUNOL, V180, P6733, DOI 10.4049/jimmunol.180.10.6733; Irvine KM, 2006, FASEB J, V20, P1921, DOI 10.1096/fj.06-5848fje; Iuliano R, 2003, CANCER RES, V63, P882; Karagyozov L, 2008, NUCLEIC ACIDS RES, V36, P4443, DOI 10.1093/nar/gkn391; Keane MM, 1996, CANCER RES, V56, P4236; Kellie S, 2004, J CELL SCI, V117, P609, DOI 10.1242/jcs.00879; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Lin G, 2011, GENE DEV, V25, P1412, DOI 10.1101/gad.2018911; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Lunardi C, 2002, LANCET, V360, P915, DOI 10.1016/S0140-6736(02)11028-2; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Osborne JM, 1998, J LEUKOCYTE BIOL, V64, P692, DOI 10.1002/jlb.64.5.692; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Pang KC, 2009, J IMMUNOL, V182, P7738, DOI 10.4049/jimmunol.0900603; Pettit AR, 2006, RHEUMATOLOGY, V45, P1068, DOI 10.1093/rheumatology/kel045; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; PRODUCTION F, FASEB J, P20; Rehli M, 1999, GENOMICS, V56, P111, DOI 10.1006/geno.1998.5588; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rintala-Maki Nina D, 2009, Gene, V445, P7, DOI 10.1016/j.gene.2009.06.009; Ross IL, 1998, J BIOL CHEM, V273, P6662, DOI 10.1074/jbc.273.12.6662; Ruivenkamp C, 2003, ONCOGENE, V22, P3472, DOI 10.1038/sj.onc.1206246; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schottelius AJ, 2006, CANC TREAT, V130, P67; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Sester DP, 2005, IMMUNOBIOLOGY, V210, P97, DOI 10.1016/j.imbio.2005.05.004; Shanley TP, 2002, CRIT CARE MED, V30, pS80, DOI 10.1097/00003246-200201001-00011; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Smart CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040742; STACEY KJ, 1993, J LEUKOCYTE BIOL, P63; Stepanek O, 2011, J BIOL CHEM, V286, P22101, DOI 10.1074/jbc.M110.196733; Stoy N, 2001, PATHOBIOLOGY, V69, P179, DOI 10.1159/000055944; Sweet MJ, 1998, J INTERF CYTOK RES, V18, P263, DOI 10.1089/jir.1998.18.263; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tagliani E, 2011, J EXP MED, V208, P1901, DOI 10.1084/jem.20110866; Tangye SG, 1998, FASEB J, V12, pA941; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Tonks NK, 2012, FEBS J; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Vang T, 2007, AUTOIMMUNITY, V40, P453, DOI 10.1080/08916930701464897; Wang XQ, 2004, NUCLEIC ACIDS RES, V32, P1382, DOI 10.1093/nar/gkh305; Weiss A, 2009, IMMUNOL REV, V228, P5, DOI 10.1111/j.1600-065X.2009.00761.x; Woodhead VE, 2000, INT IMMUNOL, V12, P1051, DOI 10.1093/intimm/12.7.1051; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024; Zhu JW, 2011, IMMUNITY, V35, P757, DOI 10.1016/j.immuni.2011.09.011	84	34	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68306	10.1371/journal.pone.0068306	http://dx.doi.org/10.1371/journal.pone.0068306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840844	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400186
J	Ford, NA; Dunlap, SM; Wheatley, KE; Hursting, SD				Ford, Nikki A.; Dunlap, Sarah M.; Wheatley, Karrie E.; Hursting, Stephen D.			Obesity, Independent of p53 Gene Dosage, Promotes Mammary Tumor Progression and Upregulates the p53 Regulator MicroRNA-504	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; ESTROGEN-RECEPTOR-ALPHA; BODY-MASS INDEX; CALORIE RESTRICTION; ENERGY-BALANCE; MOUSE MODEL; TRANSGENIC MICE; SUPPRESSOR P53; GROWTH	Obesity, prevalent in >= 35% of US women, is an established risk and progression factor for postmenopausal breast cancer, and strategies to break the obesity-breast cancer link are urgently needed. Approximately 30% of breast cancers carry p53 tumor suppressor gene alterations; however, the effects of obesity on breast cancer progression in relation to p53 gene dosage are unclear. Using murine models of postmenopausal breast cancer, we characterized the interactive effects of diet-induced obesity (DIO) and p53 gene dosage on mammary tumor growth and associated p53-related regulatory mechanisms. Ovariectomized C57BL/6 mice were randomly assigned to receive a DIO or control diet, and (at 10 weeks) orthotopic injection of MMTV-Wnt-1 p53(+/-) or MMTV-Wnt-1 p53(+/+) mammary tumor cells (n = 20 mice per diet and genotype group). DIO and control diets produced distinct phenotypes (mean percent body fat at 10 weeks: 57% and 39%, respectively, P<0.001). Regardless of phenotype, time to first palpable tumor was 57% less for Wnt-1 p53(+/-) than Wnt-1 p53(+/+) tumors. Regardless of tumoral p53 genotype, DIO (relative to control) increased tumor burden, tumor cell proliferation (Ki-67), severity of tumor pathology, local tissue invasion, epithelial-to-mesenchymal transition (EMT) programming, and tumoral microRNA-504 (a negative regulator of p53) expression; and suppressed p53, p21, and estrogen receptor-alpha protein expression. These findings in murine models of postmenopausal breast cancer suggest that obesity may augment procancer effects related to p53 gene alterations. Furthermore, microRNA-504, an obesity-responsive negative regulator of p53 and putative EMT regulator, may represent a novel molecular target for breaking the obesity-breast cancer link.	[Ford, Nikki A.; Dunlap, Sarah M.; Wheatley, Karrie E.; Hursting, Stephen D.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Hursting, Stephen D.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Hursting, SD (corresponding author), Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA.	shursting@austin.utexas.edu			Breast Cancer Research Foundation grant; American Institute for Cancer Research Postdoctoral Fellowship; National Cancer Institute	Breast Cancer Research Foundation grant; American Institute for Cancer Research Postdoctoral Fellowship; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Breast Cancer Research Foundation grant to SDH; NAF was supported by an American Institute for Cancer Research Postdoctoral Fellowship and KEW was supported by a National Cancer Institute R25 Predoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen CC, 2006, BREAST CANCER RES TR, V98, P121, DOI 10.1007/s10549-005-9139-y; Colbert LH, 2009, MED SCI SPORT EXER, V41, P1597, DOI 10.1249/MSS.0b013e31819f1f05; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; D'Assoro AB, 2010, INT J ONCOL, V37, P1167, DOI 10.3892/ijo_00000768; De Angel RE, 2012, MOL CARCINOG; De Angel RE, 2010, NUTR CANCER, V62, P1074, DOI 10.1080/01635581.2010.492092; Deisenroth Chad, 2011, Genes Cancer, V2, P392, DOI 10.1177/1947601911409737; DeSantis C, 2011, CANCER EPIDEM BIOMAR, V20, P733, DOI 10.1158/1055-9965.EPI-11-0061; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Dumay A, 2013, INT J CANCER, V132, P1227, DOI 10.1002/ijc.27767; Dunlap SM, 2012, CANC PREV RES PHILA; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fuchs-Young R, 2011, BREAST CANC RES TREA; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; Hurd C, 1999, ONCOGENE, V18, P1067, DOI 10.1038/sj.onc.1202398; Hursting SD, 1997, CANCER RES, V57, P2843; HURSTING SD, 1994, P NATL ACAD SCI USA, V91, P7036, DOI 10.1073/pnas.91.15.7036; Hursting SD, 2011, IGF SYSTEM CANC, P231; Hursting SD, 2008, BEST PRACT RES CL EN, V22, P659, DOI 10.1016/j.beem.2008.08.009; Hursting SD, 2012, CANCER PREV RES, V5, P1260, DOI 10.1158/1940-6207.CAPR-12-0140; Hursting SD, 2010, J CLIN ONCOL, V28, P4058, DOI 10.1200/JCO.2010.27.9935; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Ishii N, 2011, J TOXICOL PATHOL, V24, P25, DOI 10.1293/tox.24.25; Kamineni A, 2012, CANC CAUSE CONTROL; Kim EJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2927; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Konduri SD, 2010, P NATL ACAD SCI USA, V107, P15081, DOI 10.1073/pnas.1009575107; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Liu GZ, 2000, CANCER RES, V60, P1810; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ma Cynthia X, 2010, Breast Dis, V32, P73, DOI 10.3233/BD-2010-0309; Ma XL, 2012, NEURO-ONCOLOGY, V14, P1153, DOI 10.1093/neuonc/nos145; Mistry T, 2008, BJU INT, V101, P1317, DOI 10.1111/j.1464-410X.2008.07512.x; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Nogueira LM, 2012, ENDOCR-RELAT CANCER, V19, P57, DOI 10.1530/ERC-11-0213; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; Park H, 2012, MOL CARCINOGEN, V51, P869, DOI 10.1002/mc.20856; Ray A, 2007, CANCER LETT, V253, P291, DOI 10.1016/j.canlet.2007.02.005; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; RUCKLIDGE GJ, 1994, BIOCHEM SOC T, V22, P63, DOI 10.1042/bst0220063; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Shanle EK, 2010, ADV DRUG DELIVER REV, V62, P1265, DOI 10.1016/j.addr.2010.08.001; Shirley SH, 2009, CANCER RES, V69, P3405, DOI 10.1158/0008-5472.CAN-08-3628; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spike Benjamin T, 2011, Genes Cancer, V2, P404, DOI 10.1177/1947601911410224; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Trentham-Dietz A, 2000, CANCER CAUSE CONTROL, V11, P533, DOI 10.1023/A:1008961931534; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Zhang XM, 2005, ONCOGENE, V24, P4220, DOI 10.1038/sj.onc.1208597	57	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68089	10.1371/journal.pone.0068089	http://dx.doi.org/10.1371/journal.pone.0068089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840816	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400163
J	Gau, RD; Merz, U; Falloon, RE; Brunner, PC				Gau, Rebecca D.; Merz, Ueli; Falloon, Richard E.; Brunner, Patrick C.			Global Genetics and Invasion History of the Potato Powdery Scab Pathogen, Spongospora subterranea f.sp subterranea	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS; POPULATION-GENETICS; SOLANUM-TUBEROSUM; DNA; EPIDEMIOLOGY; RESISTANCE; DIVERSITY; SEQUENCES; CULTIVAR; TOMATO	Spongospora subterranea f. sp. subterranea (Sss) causes two diseases on potato (Solanum tuberosum), lesions on tubers and galls on roots, which are economically important worldwide. Knowledge of global genetic diversity and population structure of pathogens is essential for disease management including resistance breeding. A combination of microsatellite and DNA sequence data was used to investigate the structure and invasion history of Sss. South American populations (four countries, 132 samples) were consistently more diverse than those from all other regions (15 countries, 566 samples), in agreement with the hypothesis that Sss originated in South America where potato was domesticated. A substantial genetic differenciation was found between root and tuber-derived samples from South America. Estimates of past and recent gene flow suggested that Sss was probably introduced from South America into Europe. Subsequently, Europe is likely to have been the recent source of migrants of the pathogen, acting as a "bridgehead" for further global dissemination. Quarantine measures must continue to be focussed on maintaining low global genetic diversity and avoiding exchange of genetic material between the native and introduced regions. Nevertheless, the current low global genetic diversity of Sss allows potato breeders to select for resistance, which is likely to be durable.	[Gau, Rebecca D.; Merz, Ueli; Brunner, Patrick C.] ETH, Zurich, Switzerland; [Falloon, Richard E.] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand; [Falloon, Richard E.] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand	Swiss Federal Institutes of Technology Domain; ETH Zurich; New Zealand Institute for Plant & Food Research Ltd; Lincoln University - New Zealand	Merz, U (corresponding author), ETH, Zurich, Switzerland.	ueli.merz@usys.ethz.ch			Horticulture Australia Ltd; ETH Zurich, Plant Pathology; United Kingdom Potato Council; New Zealand Ministry of Science and Innovation; Horticulture New Zealand; Swiss Federal Office of Agriculture	Horticulture Australia Ltd(Horticulture Australia Limited); ETH Zurich, Plant Pathology(ETH Zurich); United Kingdom Potato Council; New Zealand Ministry of Science and Innovation; Horticulture New Zealand; Swiss Federal Office of Agriculture	This work was supported by Horticulture Australia Ltd, http://www.horticulture.com.au/; ETH Zurich, Plant Pathology, http://www.path.ethz.ch/; United Kingdom Potato Council, http://www.potato.org.uk/; New Zealand Ministry of Science and Innovation, www.msi.govt.nz/; Horticulture New Zealand, http://www.hortnz.co.nz/; Swiss Federal Office of Agriculture, www.blw.admin.ch/index.html?lang = en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Blandon-Diaz JU, 2012, PHYTOPATHOLOGY, V102, P323, DOI 10.1094/PHYTO-02-11-0033; BRASELTON JP, 1995, CRIT REV MICROBIOL, V21, P263, DOI 10.3109/10408419509113543; Bulman SR, 1998, PLANT PATHOL, V47, P759, DOI 10.1111/ppa.1998.47.6.759; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CIP, 2008, OD POT LANG WEG KART; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; DIRIWACHTER G, 1991, MYCOL RES, V95, P762, DOI 10.1016/S0953-7562(09)80830-7; Down GJ, 2002, MYCOL RES, V106, P1060, DOI 10.1017/S0953756202006391; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; Fry WE, 1997, PLANT DIS, V81, P1349, DOI 10.1094/PDIS.1997.81.12.1349; FRY WE, 1993, PLANT DIS, V77, P653, DOI 10.1094/PD-77-0653; GENET RA, 1995, NEW ZEAL J CROP HORT, V23, P105, DOI 10.1080/01140671.1995.9513875; Gilchrist E, 2011, TROP PLANT PATHOL, V36, P350, DOI 10.1590/S1982-56762011000600002; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Gonzalez-Varela G, 2011, EUR J PLANT PATHOL, V131, P67, DOI 10.1007/s10658-011-9788-0; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Lashermes P, 1997, THEOR APPL GENET, V94, P947, DOI 10.1007/s001220050500; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Lyman GR, 1915, SCIENCE, V42, P940, DOI 10.1126/science.42.1096.940; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McDonald BA, 1997, PHYTOPATHOLOGY, V87, P448, DOI 10.1094/PHYTO.1997.87.4.448; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Merz U, 2009, POTATO RES, V52, P17, DOI 10.1007/s11540-008-9105-2; Merz U, 2012, PLANT PATHOL, V61, P29, DOI 10.1111/j.1365-3059.2011.02489.x; Merz U, 2008, AM J POTATO RES, V85, P241, DOI 10.1007/s12230-008-9019-1; Montarry J, 2010, MOL ECOL, V19, P1965, DOI 10.1111/j.1365-294X.2010.04619.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Qu XS, 2006, PHYTOPATHOLOGY, V96, P1157, DOI 10.1094/PHYTO-96-1157; Qu XS, 2004, AM J POTATO RES, V81, P385, DOI 10.1007/BF02870199; Rabobank, 2009, WORLD POT MAP; Rannala B, 2003, GENETICS, V164, P1645; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Rozen S, 2000, Methods Mol Biol, V132, P365; Schrader G., 2003, BIOL INVASIONS, V5, P357, DOI DOI 10.1023/B:BINV.0000005567.58234.B9; Schwarzel R., 2002, Revue Suisse d'Agriculture, V34, P261; Shah FA, 2010, AUSTRALAS PLANT PATH, V39, P492, DOI 10.1071/AP10059; SMITH JJ, 1995, APPL ENVIRON MICROB, V61, P4263, DOI 10.1128/AEM.61.12.4263-4268.1995; Smith JJ, 1998, BACTERIAL WILT DISEASE, P50; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valtuena FJ, 2011, MOL ECOL, V20, P4318, DOI 10.1111/j.1365-294X.2011.05273.x; Vizzini A, 2009, BIOL INVASIONS, V11, P417, DOI 10.1007/s10530-008-9259-5; Wallroth RW., 1842, J BOT IHREM GANZEN U, V16, P332; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407	57	24	24	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67944	10.1371/journal.pone.0067944	http://dx.doi.org/10.1371/journal.pone.0067944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840791	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400146
J	Yang, TT; Qiu, HF; Bao, W; Li, BL; Lu, C; Du, GQ; Luo, X; Wang, LH; Wan, XP				Yang, Tingting; Qiu, Haifeng; Bao, Wei; Li, Bilan; Lu, Cong; Du, Guiqiang; Luo, Xin; Wang, Lihua; Wan, Xiaoping			Epigenetic Inactivation of EFEMP1 Is Associated with Tumor Suppressive Function in Endometrial Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITION; PROMOTER METHYLATION; CANCER; GENE; EXPRESSION; MECHANISMS; INHIBITOR; FIBULINS; INVASION	Objective: EFEMP1, the epidermal growth factor-containing fibulin-like extracellular matrix protein 1, functions as an oncogene or a tumor suppressor depending on the cancer types. In this study, we aim to determine whether EFEMP1 affects the tumorigenesis and progression of endometrial carcinoma. Methods: The expression of EFEMP1 was investigated using immunohistochemistry in a panel of normal endometrium (n = 40), atypical hyperplasia (n = 10) and endometrial carcinoma tissues (n = 84). Methylation status of the EFEMP1 promoter was detected by methylation-specific PCR (MSP) and bisulphite genomic sequencing. Up-or down-regulation of EFEMP1 were achieved by stable or transient transfection with pCMV6/GFP/Neo-EFEMP1 or pGPU6/GFP/Neo-shEFEMP1 respectively. Effects of EFEMP1 on tumor proliferation, invasion and migration were evaluated by MTT, plate colony formation, Transwell and wound healing assay. The nude mouse tumor xenograft assay was used to investigate function of EFEMP1 in vivo. Results: Compared with normal endometrium (32/40) and atypical hyperplasia (7/10), EFEMP1 expression was much lower in endometrial carcinoma tissues (16/84) (P<0.001 and P = 0.02). EFEMP1 promoter was hypermethylated in endometrial carcinoma tissues (67%) as compared to normal tissue (10%) and down-regulation of EFEMP1 was associated with promoter hypermethylation. Treatment with 5-aza-2'-deoxycytidine (5-aza-dC) and/or trichostatin A (TSA) altered EFEMP1 methylation status, and restored EFEMP1 expression. Moreover, EFEMP1 decreased secretion of MMPs and inhibited tumor cell proliferation, metastasis and invasion in vitro and suppressed tumorigenesis in nude mice. Besides, EFEMP1 increased expression of E-cadherin and suppressed expression of vimentin in endometrial carcinoma. Conclusion: EFEMP1 is a new candidate tumor suppressor gene in endometrial carcinoma, and is frequently silenced by promoter hypermethylation. It could inhibit tumor growth and invasion both in vitro and in vivo. Our findings propose that targeting EFEMP1 might offer future clinical utility in endometrial carcinoma.	[Yang, Tingting; Lu, Cong; Du, Guiqiang; Wan, Xiaoping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Yang, Tingting; Qiu, Haifeng; Bao, Wei; Li, Bilan; Wang, Lihua] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Luo, Xin] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Ctr Res Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, LH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	wanglihua0244@163.com; wanxp@sjtu.edu.cn			National Natural Science Funds of China [81072139, 81172476, 81272885]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This study was supported by Grants from the National Natural Science Funds of China (Nos. 81072139, 81172476 and 81272885) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhakat KK, 2003, CARCINOGENESIS, V24, P1337, DOI 10.1093/carcin/bgg086; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Brown AC, 2013, J PATHOL, V229, P25, DOI 10.1002/path.4114; Cannuyer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058743; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Geho DH, 2005, PHYSIOLOGY, V20, P194, DOI 10.1152/physiol.00009.2005; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Ichinose M, 2013, INT J GYNECOL CANCER, V23, P288, DOI 10.1097/IGC.0b013e31827c18a1; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaemmerer D, 2012, INT J CLIN EXP PATHO, V5, P187; Kim YJ, 2011, CLIN CANCER RES, V17, P4523, DOI 10.1158/1078-0432.CCR-10-2817; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Kolbe DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032941; Montserrat N, 2012, HUM PATHOL, V43, P632, DOI 10.1016/j.humpath.2011.06.021; Nishimura M, 2003, CARCINOGENESIS, V24, P1615, DOI 10.1093/carcin/bgg121; Ou JN, 2007, BIOCHEM PHARMACOL, V73, P1297, DOI 10.1016/j.bcp.2006.12.032; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Salvesen HB, 2001, INT J CANCER, V91, P22, DOI 10.1002/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Seeliger H, 2009, MOL CANCER RES, V7, P189, DOI 10.1158/1541-7786.MCR-08-0132; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song EL, 2010, GYNECOL ONCOL, V117, P417, DOI 10.1016/j.ygyno.2009.12.016; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; van der Horst PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030840; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Whitcomb BP, 2003, CLIN CANCER RES, V9, P2277; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yeramian A, 2012, ONCOGENE; Yu XH, 2008, CANCER SCI, V99, P543, DOI 10.1111/j.1349-7006.2007.00722.x; Yue W, 2007, CLIN CANCER RES, V13, P4336, DOI 10.1158/1078-0432.CCR-07-0015; Zhan Y, 2013, INT J CANCER, V132, P411, DOI 10.1002/ijc.27622; Zhang Y, 2010, GYNECOL ONCOL, V117, P41, DOI 10.1016/j.ygyno.2009.12.029	39	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67458	10.1371/journal.pone.0067458	http://dx.doi.org/10.1371/journal.pone.0067458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840707	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400083
J	Bentley, K; Armesto, M; Britton, P				Bentley, Kirsten; Armesto, Maria; Britton, Paul			Infectious Bronchitis Virus as a Vector for the Expression of Heterologous Genes	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; IN-VITRO; REVERSE GENETICS; DEFECTIVE RNA; CORONAVIRUS GENOME; VACCINE VECTOR; REPLICATION; PROTEIN; TRANSCRIPTION; DETERMINANT	The avian coronavirus infectious bronchitis virus (IBV) is the causative agent of the respiratory disease infectious bronchitis of domestic fowl, and is controlled by routine vaccination. To explore the potential use of IBV as a vaccine vector a reverse genetics system was utilised to generate infectious recombinant IBVs (rIBVs) expressing the reporter genes enhanced green fluorescent protein (eGFP) or humanised Renilla luciferase (hRluc). Infectious rIBVs were obtained following the replacement of Gene 5 or the intergenic region (IR) with eGFP or hRluc, or the replacement of ORFs 3a and 3b with hRluc. The replacement of Gene 5 with an IBV codon-optimised version of the hRluc gene also resulted in successful rescue of infectious rIBV. Reporter gene expression was confirmed by fluorescence microscopy, or luciferase activity assays, for all successfully rescued rIBVs following infection of primary chick kidney (CK) cells. The genetic stability of rIBVs was analysed by serial passage on CK cells. Recombinant IBV stability varied depending on the genome region being replaced, with the reporter genes maintained up to at least passage 8 (P8) following replacement of Gene 5, P7 for replacement of the IR and P5 for replacement of ORFs 3a and 3b. Codon-optimisation of the hRluc gene, when replacing Gene 5, resulted in an increase in genome stability, with hRluc expression stable up to P10 compared to P8 for standard hRluc. Repeated passaging of rIBVs expressing hRluc at an MOI of 0.01 demonstrated an increase in stability, with hRluc expression stable up to at least P12 following the replacement of Gene 5. This study has demonstrated that heterologous genes can be incorporated into, and expressed from a range of IBV genome locations and that replacement of accessory Gene 5 offers a promising target for realising the potential of IBV as a vaccine vector for other avian pathogens.	[Bentley, Kirsten; Armesto, Maria; Britton, Paul] Pirbright Inst, Compton Lab, Avian Viral Dis, Newbury, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Britton, P (corresponding author), Pirbright Inst, Compton Lab, Avian Viral Dis, Newbury, Berks, England.	paul.britton@pirbright.ac.uk		Bentley, Kirsten/0000-0002-6619-2098	Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/H01425X/1, BBS/E/I/00001706, BBS/E/I/00001424] Funding Source: researchfish; BBSRC [BBS/E/I/00001706, BBS/E/I/00001424, BB/H01425X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Sciences Research Council (BBSRC). K. Bentley was the holder of a BBSRC Doctoral Training Grant Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516; Alonso S, 2002, J GEN VIROL, V83, P567, DOI 10.1099/0022-1317-83-3-567; Alonso S, 2002, J VIROL, V76, P1293, DOI 10.1128/JVI.76.3.1293-1308.2002; Armesto M., 2012, REVERSE GENETICS RNA, P25, DOI 10.1002/9781118405338.ch2; Armesto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024352; Armesto M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007384; Armesto Maria, 2008, V454, P255, DOI 10.1007/978-1-59745-181-9_19; Bentley K, 2013, J VIROL, V87, P2128, DOI 10.1128/JVI.02967-12; Bosch BJ, 2004, J VIROL, V78, P7369, DOI 10.1128/JVI.78.14.7369-7378.2004; Bradel-Tretheway BG, 2003, J VIROL METHODS, V111, P145, DOI 10.1016/S0166-0934(03)00173-3; Britton P, 2005, J VIROL METHODS, V123, P203, DOI 10.1016/j.jviromet.2004.09.017; Britton Paul, 2007, P161; Casais R, 2005, J VIROL, V79, P8065, DOI 10.1128/JVI.79.13.8065-8078.2005; Casais R, 2003, J VIROL, V77, P9084, DOI 10.1128/JVI.77.16.9084-9089.2003; Casais R, 2001, J VIROL, V75, P12359, DOI 10.1128/JVI.75.24.12359-12369.2001; Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682; Cavanagh D., 2008, DIS POULTRY, P117; Cavanagh D, 2007, VACCINE, V25, P5558, DOI 10.1016/j.vaccine.2007.02.046; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432; de Haan CAA, 2005, J VIROL, V79, P12742, DOI 10.1128/JVI.79.20.12742-12751.2005; de Haan CAM, 2003, J VIROL, V77, P11312, DOI 10.1128/JVI.77.21.11312-11323.2003; de Haan CAM, 2002, VIROLOGY, V296, P177, DOI 10.1006/viro.2002.1412; DiNapoli JM, 2007, P NATL ACAD SCI USA, V104, P9788, DOI 10.1073/pnas.0703584104; Donaldson EF, 2008, J VIROL, V82, P11948, DOI 10.1128/JVI.01804-08; Ge JY, 2011, J VIROL, V85, P8241, DOI 10.1128/JVI.00519-11; Hackney K, 2003, J VIROL, V77, P5694, DOI 10.1128/JVI.77.10.5694-5702.2003; Hodgson T, 2006, J VIROL, V80, P296, DOI 10.1128/JVI.80.1.296-305.2006; Izeta A, 1999, J VIROL, V73, P1535, DOI 10.1128/JVI.73.2.1535-1545.1999; Jones RC, 2010, BRIT POULTRY SCI, V51, P1, DOI 10.1080/00071660903541378; Kofman Alexander, 2003, Tsitologiia, V45, P86; LIAO CL, 1994, J VIROL, V68, P4727, DOI 10.1128/JVI.68.8.4727-4737.1994; Ribes JM, 2011, VIROLOGY, V410, P107, DOI 10.1016/j.virol.2010.10.036; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Nakaya T, 2001, J VIROL, V75, P11868, DOI 10.1128/JVI.75.23.11868-11873.2001; Ortego J, 2003, VIROLOGY, V308, P13, DOI 10.1016/S0042-6822(02)00096-X; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; PENZES Z, 1994, VIROLOGY, V203, P286, DOI 10.1006/viro.1994.1486; Penzes Z, 1996, J VIROL, V70, P8660; Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06; Shen HY, 2009, J VIROL METHODS, V160, P48, DOI 10.1016/j.jviromet.2009.04.023; Shi XM, 2011, VACCINE, V29, P1576, DOI 10.1016/j.vaccine.2010.12.102; Skinner MA, 2005, EXPERT REV VACCINES, V4, P63, DOI 10.1586/14760584.4.1.63; Sola I, 2005, J VIROL, V79, P2506, DOI 10.1128/JVI.79.4.2506-2516.2005; Sola I, 2003, J VIROL, V77, P4357, DOI 10.1128/JVI.77.7.4357-4369.2003; Sola I, 2011, J VIROL, V85, P5136, DOI 10.1128/JVI.00195-11; Stirrups K, 2000, J GEN VIROL, V81, P1687, DOI 10.1099/0022-1317-81-7-1687; Tekes G, 2008, J VIROL, V82, P1851, DOI 10.1128/JVI.02339-07; Thiel V, 2001, J GEN VIROL, V82, P1273, DOI 10.1099/0022-1317-82-6-1273; Tsang KY, 2005, CLIN CANCER RES, V11, P1597, DOI 10.1158/1078-0432.CCR-04-1609; van den Worm SHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032857; Weli SC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-49; Youn S, 2005, VIROLOGY, V332, P206, DOI 10.1016/j.virol.2004.10.045; Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Zhuang Y, 2001, PROMEGA NOTES, V79, P6	57	13	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67875	10.1371/journal.pone.0067875	http://dx.doi.org/10.1371/journal.pone.0067875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840781	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400120
J	Sayeed, A; Luciani-Torres, G; Meng, ZH; Bennington, JL; Moore, DH; Dairkee, SH				Sayeed, Aejaz; Luciani-Torres, Gloria; Meng, Zhenhang; Bennington, James L.; Moore, Dan H.; Dairkee, Shanaz H.			Aberrant Regulation of the BST2 (Tetherin) Promoter Enhances Cell Proliferation and Apoptosis Evasion in High Grade Breast Cancer Cells	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; HIV-1 RELEASE; EXPRESSION; PROTEIN; RESVERATROL; SURFACE; TRANSCRIPTION; ANTIGEN-2; PATHWAYS; AP-2	Normal cellular phenotypes that serve an oncogenic function during tumorigenesis are potential candidates for cancer targeting drugs. Within a subset of invasive primary breast carcinoma, we observed relatively abundant expression of Tetherin, a cell surface protein encoded by the Bone Marrow Stromal Cell Antigen (BST2) known to play an inhibitory role in viral release from infected immune cells of the host. Using breast cancer cell lines derived from low and intermediate histopathologic grade invasive primary tumors that maintain growth-suppressive TGF beta signaling, we demonstrate that BST2 is negatively regulated by the TGF beta axis in epithelial cells. Binding of the transcription factor AP2 to the BST2 promoter was attenuated by inhibition of the TGF beta pathway thereby increasing BST2 expression in tumor cells. In contrast, inherent TGF beta resistance characteristic of high grade breast tumors is a key factor underlying compromised BST2 regulation, and consequently its constitutive overexpression relative to non-malignant breast epithelium, and to most low and intermediate grade cancer cells. In both 2-dimensional and 3-dimensional growth conditions, BST2-silenced tumor cells displayed an enhancement in tamoxifen or staurosporine-induced apoptotic cell death together with a reduction in the S-phase fraction compared to BST2 overexpressing counterparts. In a subset of breast cancer patients treated with pro apoptotic hormonal therapy, BST2 expression correlated with a trend for poor clinical outcome, further supporting its role in conferring an anti apoptotic phenotype. Similar to the effects of gene manipulation, declining levels of endogenous BST2 induced by the phytoalexin - resveratrol, restored apoptotic function, and curbed cell proliferation. We provide evidence for a direct approach that diminishes aberrant BST2 expression in cancer cells as an early targeting strategy to assist in surmounting resistance to pro apoptotic therapies.	[Sayeed, Aejaz; Luciani-Torres, Gloria; Meng, Zhenhang; Bennington, James L.; Moore, Dan H.; Dairkee, Shanaz H.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	California Pacific Medical Center; California Pacific Medical Center Research Institute	Dairkee, SH (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA.	dairkes@cpmcri.org		Dairkee, Shanaz/0000-0002-2073-9684	National Institutes of Health (NIH) [CA109325]; NATIONAL CANCER INSTITUTE [R01CA109325] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (NIH) under grant CA109325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bego MG, 2012, J VIROL, V86, P3513, DOI 10.1128/JVI.06971-11; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Buck MB, 2004, MOL ENDOCRINOL, V18, P1643, DOI 10.1210/me.2003-0278; Cai DQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-102; Cao W, 2010, IMMUNOL REV, V234, P163, DOI 10.1111/j.0105-2896.2009.00867.x; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Dairkee SH, 2007, ONCOGENE, V26, P6269, DOI 10.1038/sj.onc.1210452; Dairkee SH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-47; Dairkee SH, 1997, CANCER RES, V57, P1590; Dairkee SH, 2009, CANCER RES, V69, P7826, DOI 10.1158/0008-5472.CAN-09-1564; Gee JMW, 1999, J PATHOL, V189, P514, DOI 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9; Gota C, 2003, AUTOIMMUNITY, V36, P511, DOI 10.1080/08916930310001605873; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jhumka Z, 2009, INT J BIOCHEM CELL B, V41, P945, DOI 10.1016/j.biocel.2008.09.028; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Luciani MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020016; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Perissi V, 2000, ONCOGENE, V19, P280, DOI 10.1038/sj.onc.1203303; Sayeed A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.30; Schild-Hay LJ, 2009, CANCER RES, V69, P1150, DOI 10.1158/0008-5472.CAN-08-2806; Schliemann C, 2010, BLOOD, V115, P736, DOI 10.1182/blood-2009-08-239004; Serrero G, 2001, ANTIOXID REDOX SIGN, V3, P969, DOI 10.1089/152308601317203512; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wang D, 2000, CANCER RES, V60, P4507; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	34	34	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67191	10.1371/journal.pone.0067191	http://dx.doi.org/10.1371/journal.pone.0067191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840623	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800123
J	Lin, TY; Lin, YW; Lu, CW; Huang, SK; Wang, SJ				Lin, Tzu-Yu; Lin, Yu-Wan; Lu, Cheng-Wei; Huang, Shu-Kuei; Wang, Su-Jane			Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex	PLOS ONE			English	Article							SYNAPSIN-I PHOSPHORYLATION; PROTEIN-KINASE-C; CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC MODULATION; ALZHEIMERS-DISEASE; NEURONAL DAMAGE; MAP KINASE; SYNAPTOSOMES; HIPPOCAMPUS	Berberine, an isoquinoline plant alkaloid, protects neurons against neurotoxicity. An excessive release of glutamate is considered to be one of the molecular mechanisms of neuronal damage in several neurological diseases. In this study, we investigated whether berberine could affect endogenous glutamate release in nerve terminals of rat cerebral cortex (synaptosomes) and explored the possible mechanism. Berberine inhibited the release of glutamate evoked by the K+ channel blocker 4-aminopyridine (4-AP), and this phenomenon was prevented by the chelating extracellular Ca2+ ions and the vesicular transporter inhibitor bafilomycin A1, but was insensitive to the glutamate transporter inhibitor DL-threo-beta-benzyl-oxyaspartate. Inhibition of glutamate release by berberine was not due to it decreasing synaptosomal excitability, because berberine did not alter 4-AP-mediated depolarization. The inhibitory effect of berberine on glutamate release was associated with a reduction in the depolarization-induced increase in cytosolic free Ca2+ concentration. Involvement of the Cav2.1 (P/Q-type) channels in the berberine action was confirmed by blockade of the berberine-mediated inhibition of glutamate release by the Cav2.1 (P/Q-type) channel blocker v-agatoxin IVA. In addition, the inhibitory effect of berberine on evoked glutamate release was prevented by the mitogen-activated/extracellular signal-regulated kinase kinase (MEK) inhibitors. Berberine decreased the 4-AP-induced phosphorylation of extracellular signal-regulated kinase 1 and 2 (ERK1/2) and synapsin I, the main presynaptic target of ERK; this decrease was also blocked by the MEK inhibition. Moreover, the inhibitory effect of berberine on evoked glutamate release was prevented in nerve terminals from mice lacking synapsin I. Together, these results indicated that berberine inhibits glutamate release from rats cortical synaptosomes, through the suppression of presynaptic Cav2.1 channels and ERK/synapsin I signaling cascade. This finding may provide further understanding of the mode of berberine action in the brain and highlights the therapeutic potential of this compound in the treatment of a wide range of neurological disorders.	[Lin, Tzu-Yu; Lu, Cheng-Wei; Huang, Shu-Kuei] Far Eastern Mem Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Lin, Yu-Wan; Wang, Su-Jane] Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan; [Lin, Tzu-Yu; Lu, Cheng-Wei] Yuan Ze Univ, Dept Mech Engn, New Taipei, Taiwan	Far Eastern Memorial Hospital; Fu Jen Catholic University	Wang, SJ (corresponding author), Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan.	med0003@mail.fju.edu.tw		huang, shu kuei/0000-0003-2842-2531; Wang, Su Jane/0000-0002-4675-0259; Lin, Tzu Yu/0000-0002-1374-5189	National Science Council, Taiwan [NSC 100-2320-B-030-006-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	work was supported by grant from the the National Science Council (NSC 100-2320-B-030-006-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN KEO, 1987, J NEUROCHEM, V48, P552, DOI 10.1111/j.1471-4159.1987.tb04128.x; BARRIE AP, 1991, J NEUROCHEM, V57, P1398, DOI 10.1111/j.1471-4159.1991.tb08306.x; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cui HS, 2009, BIOL PHARM BULL, V32, P79, DOI 10.1248/bpb.32.79; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; Fdez E, 2006, BRAIN CELL BIOL, V35, P107, DOI 10.1007/s11068-007-9013-4; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hong JS, 2012, J NEUROSCI RES, V90, P489, DOI 10.1002/jnr.22756; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; LI M, 1993, SCIENCE, V261, P1439, DOI 10.1126/science.8396273; Lin TY, 2013, J ETHNOPHARMACOL, V147, P488, DOI 10.1016/j.jep.2013.03.045; Lin TY, 2011, PROG NEURO-PSYCHOPH, V35, P1785, DOI 10.1016/j.pnpbp.2011.06.012; Lin TY, 2012, TOXICOL APPL PHARM, V263, P233, DOI 10.1016/j.taap.2012.06.015; Lin TY, 2009, NEUROCHEM INT, V54, P506, DOI 10.1016/j.neuint.2009.02.001; Lu CW, 2012, J PHARMACOL EXP THER, V341, P532, DOI 10.1124/jpet.111.191189; MCMAHON HT, 1991, BIOCHIM BIOPHYS ACTA, V1059, P243, DOI 10.1016/S0005-2728(05)80210-5; Mdzinarishvili A, 2012, J PHARM PHARM SCI, V15, P94, DOI 10.18433/J3PS37; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Millan C, 2002, NEUROSCI LETT, V330, P29, DOI 10.1016/S0304-3940(02)00719-X; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; Nicholls DG, 1998, PROG BRAIN RES, V116, P15, DOI 10.1016/S0079-6123(08)60427-6; Niebroj-Dobosz I, 2002, ACTA NEUROL SCAND, V106, P39, DOI 10.1034/j.1600-0404.2002.00206.x; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; Pereira DB, 2002, NEUROPHARMACOLOGY, V42, P9, DOI 10.1016/S0028-3908(01)00162-9; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REHM H, 1991, FASEB J, V5, P164, DOI 10.1096/fasebj.5.2.2004663; SIHRA TS, 1992, J BIOL CHEM, V267, P1983; TIBBS GR, 1989, J NEUROCHEM, V53, P1693, DOI 10.1111/j.1471-4159.1989.tb09232.x; Vazquez E, 1997, EUR J NEUROSCI, V9, P2009, DOI 10.1111/j.1460-9568.1997.tb01369.x; Wang F, 2004, BRAIN RES, V999, P91, DOI 10.1016/j.brainres.2003.11.036; Wang J, 2011, NEURAL REGEN RES, V6, P183, DOI 10.3969/j.issn.1673-5374.2011.03.004; Wang SJ, 2004, NEUROSCIENCE, V125, P191, DOI 10.1016/j.neuroscience.2004.01.019; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Yamagata Y, 2002, J NEUROCHEM, V80, P835, DOI 10.1046/j.0022-3042.2001.00753.x; Yang TT, 2009, J PHARMACOL EXP THER, V331, P244, DOI 10.1124/jpet.109.155176; Ye MZ, 2009, J PHARM PHARMACOL, V61, P831, DOI [10.1211/jpp.61.07.0001, 10.1211/jpp/61.07.0001]; Yi Chang Y, 2010, EUR J PHARMACOL, V634, P53; Yoo KY, 2006, BIOL PHARM BULL, V29, P623, DOI 10.1248/bpb.29.623; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78	51	20	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67215	10.1371/journal.pone.0067215	http://dx.doi.org/10.1371/journal.pone.0067215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840629	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200124
J	Mii, S; Uehara, F; Yano, S; Tran, B; Miwa, S; Hiroshima, Y; Amoh, Y; Katsuoka, K; Hoffman, RM				Mii, Sumiyuki; Uehara, Fuminari; Yano, Shuya; Tran, Benjamin; Miwa, Shinji; Hiroshima, Yukihiro; Amoh, Yasuyuki; Katsuoka, Kensei; Hoffman, Robert M.			Nestin-Expressing Stem Cells Promote Nerve Growth in Long-Term 3-Dimensional Gelfoam (R)-Supported Histoculture	PLOS ONE			English	Article							SPINAL-CORD EXPLANTS; GFP TRANSGENIC MICE; HAIR-FOLLICLE; PROGENITOR CELLS; SCHWANN-CELLS; IN-VITRO; CULTURE; MOUSE; EXTENSION; NEURITES	We have previously reported that hair follicles contain multipotent stem cells which express nestin. The nestin-expressing cells form the hair follicle sensory nerve. In vitro, the nestin-expressing hair follicle cells can differentiate into neurons, Schwann cells, and other cell types. In the present study, the sciatic nerve was excised from transgenic mice in which the nestin promoter drives green fluorescent protein (ND-GFP mice). The ND-GFP cells of the sciatic nerve were also found to be multipotent as the ND-GFP cells in the hair follicle. When the ND-GFP cells in the mouse sciatic nerve cultured on Gelfoam (R) and were imaged by confocal microscopy, they were observed forming fibers extending the nerve. The fibers consisted of ND-GFP-expressing spindle cells, which co-expressed the neuron marker beta-III tubulin, the immature Schwann-cell marker p75(NTR) and TrkB which is associated with neurons. The fibers also contain nestin-negative spherical cells expressing GFAP, a Schwann-cell marker. The beta-III tubulin-positive fibers had growth cones on their tips expressing F-actin, indicating they are growing axons. When the sciatic nerve from mice ubiquitously expressing red fluorescent protein (RFP) was co-cultured on Gelfoam (R) with the sciatic nerve from ND-GFP transgenic mice, the interaction of nerves was observed. Proliferating nestin-expressing cells in the injured sciatic nerve were also observed in vivo. Nestin-expressing cells were also observed in posterior nerves but not in the spinal cord itself, when placed in 3-D Gelfoam (R) culture. The results of the present report suggest a critical function of nestin-expressing cells in peripheral nerve growth and regeneration.	[Mii, Sumiyuki; Uehara, Fuminari; Yano, Shuya; Tran, Benjamin; Miwa, Shinji; Hiroshima, Yukihiro; Hoffman, Robert M.] AntiCanc Inc, San Diego, CA USA; [Mii, Sumiyuki; Uehara, Fuminari; Yano, Shuya; Miwa, Shinji; Hiroshima, Yukihiro; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Mii, Sumiyuki; Amoh, Yasuyuki; Katsuoka, Kensei] Kitasato Univ, Sch Med, Dept Dermatol, Kanagawa, Japan	AntiCancer, Inc.; University of California System; University of California San Diego; Kitasato University	Hoffman, RM (corresponding author), AntiCanc Inc, San Diego, CA USA.	all@anticancer.com	Miwa, Shinji/AAI-9309-2020; Yano, Shuya/AAL-8028-2020	Miwa, Shinji/0000-0002-5962-8287; UEHARA, FUMINARI/0000-0001-6567-2113				Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; BRAY D, 1980, EXP CELL RES, V130, P241, DOI 10.1016/0014-4827(80)90060-9; Cajal SRY, 1968, DEGENERATION REGENER, p[223, 414]; Duong J, 2012, IN VITRO CELL DEV-AN, V48, P301, DOI 10.1007/s11626-012-9514-z; HEATON MB, 1986, J COMP NEUROL, V243, P381, DOI 10.1002/cne.902430308; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KAPFHAMMER JP, 1986, J NEUROSCI, V6, P2527; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Matsumura S, 2010, NEUROSCIENCE, V170, P942, DOI 10.1016/j.neuroscience.2010.07.034; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mii S, 2013, J CELL BIOCHEM, V114, P1674, DOI 10.1002/jcb.24509; NURCOMBE V, 1984, BRAIN RES, V291, P19, DOI 10.1016/0006-8993(84)90646-2; Takagi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021497; Thomson CE, 2006, J NEUROSCI RES, V84, P1703, DOI 10.1002/jnr.21084; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Uchugonova A, 2011, CELL CYCLE, V10, P2017, DOI 10.4161/cc.10.12.15895; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wang L, 2012, NAT PROTOC, V7, P351, DOI 10.1038/nprot.2011.442; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Yang M, 2009, J CELL BIOCHEM, V106, P279, DOI 10.1002/jcb.21999	22	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67153	10.1371/journal.pone.0067153	http://dx.doi.org/10.1371/journal.pone.0067153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840607	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200122
J	Stolp, ZD; Stotland, A; Diaz, S; Hilton, BJ; Burford, W; Wolkowicz, R				Stolp, Zachary D.; Stotland, Aleksandr; Diaz, Samantha; Hilton, Brett J.; Burford, Wesley; Wolkowicz, Roland			A Novel Two-Tag System for Monitoring Transport and Cleavage through the Classical Secretory Pathway - Adaptation to HIV Envelope Processing	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-BASED ASSAY; ENDOPROTEOLYTIC CLEAVAGE; PROPROTEIN CONVERTASES; PROTEOLYTIC ACTIVITY; PROTEASE ACTIVITY; FURIN CLEAVAGE; GLYCOPROTEIN; SURFACE; GP160	The classical secretory pathway is essential for the transport of a host of proteins to the cell surface and/or extracellular matrix. While the pathway is well-established, many factors still remain to be elucidated. One of the most relevant biological processes that occur during transport involves the cleavage of pro-proteins by enzymes residing in the endoplasmic reticulum/Golgi/TransGolgi Network compartment. Teasing out the requirements involved in the classical secretory pathway and cleavage during transport would shed new light into mis-regulation leading to disease. Current methodologies fail to link transport and cleavage at the single cell level. Here, we describe a cell-based assay that relies on an engineered protein scaffold that can discriminate between transport to the cell surface, in the absence or presence of cleavage. Our novel two-tag system works in a robust and quantitative manner and distinguishes between cleaved and non-cleaved events based on cell surface expression of one or two epitope tags, respectively. Here, we have used the HIV-1 envelope as a substrate, which is cleaved during transport, as proof of principle. Importantly, this assay can be easily coupled to existing siRNA-based screens to identify novel regulators and effectors involved in transport and/or cleavage of cell surface proteins. In addition, unlike other in vivo based assays, the assay described here can also be easily adapted to drug discovery purposes.	[Stolp, Zachary D.; Stotland, Aleksandr; Diaz, Samantha; Hilton, Brett J.; Burford, Wesley; Wolkowicz, Roland] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Wolkowicz, R (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	roland@mail.sdsu.edu						Basak A, 2002, FEBS LETT, V514, P333, DOI 10.1016/S0014-5793(02)02394-3; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Coppola JM, 2007, ANAL BIOCHEM, V364, P19, DOI 10.1016/j.ab.2007.01.013; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; DALBEY RE, 1992, TRENDS BIOCHEM SCI, V17, P474, DOI 10.1016/0968-0004(92)90492-R; Davids BJ, 2011, MOL BIOCHEM PARASIT, V175, P169, DOI 10.1016/j.molbiopara.2010.11.008; Decroly E, 1997, FEBS LETT, V405, P68, DOI 10.1016/S0014-5793(97)00156-7; Didigu CA, 2012, VIRUSES-BASEL, V4, P309, DOI 10.3390/v4020309; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; FISHER JM, 1988, J BIOL CHEM, V263, P16515; Hilton BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010940; Hobson JP, 2006, NAT METHODS, V3, P259, DOI 10.1038/NMETH862; KANTANEN ML, 1995, ARCH VIROL, V140, P1441, DOI 10.1007/BF01322670; Klasse PJ, 2012, CELL MICROBIOL, V14, P1183, DOI 10.1111/j.1462-5822.2012.01812.x; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Pasquato A, 2007, FEBS LETT, V581, P5807, DOI 10.1016/j.febslet.2007.11.050; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; Rajakuberan C, 2012, METHODS MOL BIOL, V903, P393, DOI 10.1007/978-1-61779-937-2_27; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; SIMON SM, 1992, J BIOL CHEM, V267, P3922; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tian S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00261; Tian S, 2011, INT J MOL SCI, V12, P1060, DOI 10.3390/ijms12021060; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; Wang X, 2001, J BIOL CHEM, V276, P35953, DOI 10.1074/jbc.M103680200; Wolkowicz R, 2005, J BIOL CHEM, V280, P15195, DOI 10.1074/jbc.M500254200; Wolkowicz R, 2003, FRONT BIOSCI-LANDMRK, V8, pD603, DOI 10.2741/952; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e68835	10.1371/journal.pone.0068835	http://dx.doi.org/10.1371/journal.pone.0068835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840860	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200142
J	Anblagan, D; Jones, NW; Costigan, C; Parker, AJJ; Allcock, K; Aleong, R; Coyne, LH; Deshpande, R; Raine-Fenning, N; Bugg, G; Roberts, N; Pausova, Z; Paus, T; Gowland, PA				Anblagan, Devasuda; Jones, Nia W.; Costigan, Carolyn; Parker, Alexander J. J.; Allcock, Kirsty; Aleong, Rosanne; Coyne, Lucy H.; Deshpande, Ruta; Raine-Fenning, Nick; Bugg, George; Roberts, Neil; Pausova, Zdenka; Paus, Tomas; Gowland, Penny A.			Maternal Smoking during Pregnancy and Fetal Organ Growth: A Magnetic Resonance Imaging Study	PLOS ONE			English	Article							CIGARETTE-SMOKING; EXPOSURE; NICOTINE; PLACENTA; VOLUME; SMOKERS; WEIGHT	Objective: To study whether maternal cigarette smoking during pregnancy is associated with alterations in the growth of fetal lungs, kidneys, liver, brain, and placenta. Design: A case-control study, with operators performing the image analysis blinded. Setting: Study performed on a research-dedicated magnetic resonance imaging (MRI) scanner (1.5 T) with participants recruited from a large teaching hospital in the United Kingdom. Participants: A total of 26 pregnant women (13 current smokers, 13 non smokers) were recruited; 18 women (10 current smokers, 8 nonsmokers) returned for the second scan later in their pregnancy. Methods: Each fetus was scanned with MRI at 22-27 weeks and 33-38 weeks gestational age (GA). Main outcome measures: Images obtained with MRI were used to measure volumes of the fetal brain, kidneys, lungs, liver and overall fetal size, as well as placental volumes. Results: Exposed fetuses showed lower brain volumes, kidney volumes, and total fetal volumes, with this effect being greater at visit 2 than at visit 1 for brain and kidney volumes, and greater at visit 1 than at visit 2 for total fetal volume. Exposed fetuses also demonstrated lower lung volume and placental volume, and this effect was similar at both visits. No difference was found between the exposed and nonexposed fetuses with regards to liver volume. Conclusion: Magnetic resonance imaging has been used to show that maternal smoking is associated with reduced growth of fetal brain, lung and kidney; this effect persists even when the volumes are corrected for maternal education, gestational age, and fetal sex. As expected, the fetuses exposed to maternal smoking are smaller in size. Similarly, placental volumes are smaller in smoking versus nonsmoking pregnant women.	[Anblagan, Devasuda; Costigan, Carolyn; Allcock, Kirsty; Gowland, Penny A.] Univ Nottingham, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, Notts, England; [Jones, Nia W.; Coyne, Lucy H.; Deshpande, Ruta; Bugg, George] Nottingham Univ Hosp NHS Trust, Nottingham, Notts, England; [Parker, Alexander J. J.; Roberts, Neil] Queens Med Res Inst, Clin Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Aleong, Rosanne; Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Raine-Fenning, Nick] Univ Nottingham, Div Obstet & Gynaecol, Sch Clin Sci, Nottingham NG7 2RD, Notts, England; [Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Pausova, Zdenka] Univ Montreal, Montreal, PQ, Canada; [Paus, Tomas] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, Notts, England	University of Nottingham; Nottingham University Hospital NHS Trust; University of Edinburgh; University of Toronto; University Toronto Affiliates; Baycrest; University of Nottingham; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal; University of Nottingham	Gowland, PA (corresponding author), Univ Nottingham, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, Notts, England.	penny.gowland@nottingham.ac.uk	Gowland, Penny A./I-9016-2012; Raine-Fenning, Nicholas J/C-3005-2008	Gowland, Penny A./0000-0002-4900-4817; Raine-Fenning, Nicholas J/0000-0001-5521-9059; costigan, carolyn/0000-0001-5144-7142	University of Nottingham, United Kingdom; Medical Research Council [MR/K026992/1] Funding Source: researchfish	University of Nottingham, United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funding was provide by University of Nottingham, United Kingdom. The funding contributed towards the patient recruitment, data collection and maintenance of the MRI machine used in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1980, BRIT J OBSTET GYNAEC, V87, P81, DOI 10.1111/j.1471-0528.1980.tb04498.x; Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; BASSI JA, 1984, PEDIATR RES, V18, P127, DOI 10.1203/00006450-198402000-00002; BURTON GJ, 1989, BRIT J OBSTET GYNAEC, V96, P907, DOI 10.1111/j.1471-0528.1989.tb03344.x; CASTRO LC, 1993, OBSTET GYNECOL, V81, P551; Czekaj P, 2002, INT ARCH OCC ENV HEA, V75, pS27, DOI 10.1007/s00420-002-0343-3; Damodaram MS, 2012, EARLY HUM DEV, V88, pS35, DOI 10.1016/j.earlhumdev.2011.12.026; Garden AS, 1996, AM J OBSTET GYNECOL, V175, P442, DOI 10.1016/S0002-9378(96)70159-X; Gholipour A, 2011, INT J COMPUT ASS RAD, V6, P329, DOI 10.1007/s11548-010-0512-x; Gong QY, 1998, MAGN RESON IMAGING, V16, P235, DOI 10.1016/S0730-725X(97)00281-6; HAGLUND B, 1990, AM J PUBLIC HEALTH, V80, P29, DOI 10.2105/AJPH.80.1.29; Huijbregts SCJ, 2008, DEV PSYCHOPATHOL, V20, P437, DOI 10.1017/S0954579408000217; Kallen K, 1997, INT J EPIDEMIOL, V26, P571, DOI 10.1093/ije/26.3.571; Lambers DS, 1996, SEMIN PERINATOL, V20, P115, DOI 10.1016/S0146-0005(96)80079-6; LUCK W, 1985, DEV PHARMACOL THERAP, V8, P384, DOI 10.1159/000457063; MARITZ GS, 1995, CELL BIOL INT, V19, P323, DOI 10.1006/cbir.1995.1075; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Moore RJ, 2001, MAGNET RESON MED, V45, P247, DOI 10.1002/1522-2594(200102)45:2<247::AID-MRM1033>3.0.CO;2-M; Nelson E, 1999, HUM EXP TOXICOL, V18, P257, DOI 10.1191/096032799678840011; NIfHaC Excellence, 2010, EXCELLENCE NIFHAC; Orleans CT, 2000, TOB CONTROL, V9, P6; Paus T, 2008, NEUROIMAGE, V40, P435, DOI 10.1016/j.neuroimage.2007.10.066; Paus T, 2011, CEREBRAL CORTEX; Pausova Z, 2003, KIDNEY INT, V64, P829, DOI 10.1046/j.1523-1755.2003.00172.x; Persson P-H, 1978, ACTA OBSTET GYNECOL, V57, P33; QUIGLEY ME, 1979, AM J OBSTET GYNECOL, V133, P685, DOI 10.1016/0002-9378(79)90019-X; ROBERTS N, 1994, BRIT J RADIOL, V67, P1067, DOI 10.1259/0007-1285-67-803-1067; Roberts N, 2000, BRIT J RADIOL, V73, P679, DOI 10.1259/bjr.73.871.11089458; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Stick SM, 1996, LANCET, V348, P1060, DOI 10.1016/S0140-6736(96)04446-7; Syme C, 2010, OBESITY, V18, P1021, DOI 10.1038/oby.2009.354; Toro R, 2008, NEUROPSYCHOPHARMACOL, V33, P1019, DOI 10.1038/sj.npp.1301484; Toschke AM, 2002, EUR J PEDIATR, V161, P445, DOI 10.1007/s00431-002-0983-z; VANDERVELDE WJ, 1983, PLACENTA, V4, P231, DOI 10.1016/S0143-4004(83)80002-2; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003	35	58	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67223	10.1371/journal.pone.0067223	http://dx.doi.org/10.1371/journal.pone.0067223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843995	Green Published, Green Submitted, gold			2022-12-27	WOS:000321733000065
J	Di Febbraro, M; Lurz, PWW; Genovesi, P; Maiorano, L; Girardello, M; Bertolino, S				Di Febbraro, Mirko; Lurz, Peter W. W.; Genovesi, Piero; Maiorano, Luigi; Girardello, Marco; Bertolino, Sandro			The Use of Climatic Niches in Screening Procedures for Introduced Species to Evaluate Risk of Spread: A Case with the American Eastern Grey Squirrel	PLOS ONE			English	Article							SCIURUS-CAROLINENSIS; DISTRIBUTION MODELS; POPULATION; RED; EUROPE; ESTABLISHMENT; ERADICATION; PREDICTION; INVASION; FUTURE	Species introduction represents one of the most serious threats for biodiversity. The realized climatic niche of an invasive species can be used to predict its potential distribution in new areas, providing a basis for screening procedures in the compilation of black and white lists to prevent new introductions. We tested this assertion by modeling the realized climatic niche of the Eastern grey squirrel Sciurus carolinensis. Maxent was used to develop three models: one considering only records from the native range (NRM), a second including records from native and invasive range (NIRM), a third calibrated with invasive occurrences and projected in the native range (RCM). Niche conservatism was tested considering both a niche equivalency and a niche similarity test. NRM failed to predict suitable parts of the currently invaded range in Europe, while RCM underestimated the suitability in the native range. NIRM accurately predicted both the native and invasive range. The niche equivalency hypothesis was rejected due to a significant difference between the grey squirrel's niche in native and invasive ranges. The niche similarity test yielded no significant results. Our analyses support the hypothesis of a shift in the species' climatic niche in the area of introductions. Species Distribution Models (SDMs) appear to be a useful tool in the compilation of black lists, allowing identifying areas vulnerable to invasions. We advise caution in the use of SDMs based only on the native range of a species for the compilation of white lists for other geographic areas, due to the significant risk of underestimating its potential invasive range.	[Di Febbraro, Mirko] Univ Molise, Dept Biosci & Terr, Pesche, Isernia, Italy; [Genovesi, Piero] ISPRA Inst Environm Protect & Res, Rome, Italy; [Genovesi, Piero] Chair IUCN Invas Species Specialist Grp, Rome, Italy; [Maiorano, Luigi] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Girardello, Marco] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Bertolino, Sandro] Univ Turin, Dept Agr Forest & Food Sci, Turin, Italy	University of Molise; Italian Institute for Environmental Protection & Research (ISPRA); Sapienza University Rome; UK Centre for Ecology & Hydrology (UKCEH); University of Turin	Di Febbraro, M (corresponding author), Univ Molise, Dept Biosci & Terr, Pesche, Isernia, Italy.	mirkodifebbraro@gmail.com	Di Febbraro, Mirko/GQA-4462-2022; Lurz, Peter/O-5108-2019; Di Febbraro, Mirko/I-3167-2019; Genovesi, Piero/Z-1571-2019; Maiorano, Luigi/A-8637-2008; Bertolino, Sandro/V-5508-2019	Maiorano, Luigi/0000-0002-2957-8979; Genovesi, Piero/0000-0002-0262-1420; Di Febbraro, Mirko/0000-0001-8898-7046	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bertolino S, 2008, BIOL CONSERV, V141, P2564, DOI 10.1016/j.biocon.2008.07.017; Bertolino S, 2008, CURR SCI INDIA, V95, P903; Bertolino S, 2009, DIVERS DISTRIB, V15, P701, DOI 10.1111/j.1472-4642.2009.00574.x; BOMFORD M, 1995, WILDLIFE SOC B, V23, P249; Bomford M, 2009, WILDLIFE RES, V36, P192, DOI 10.1071/WR08055; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Dagnall J, 1998, SPECIAL PUBLICATION, P249; Dudilc M., 2008, ECOGRAPHY, V31, P2005, DOI DOI 10.1111/J.0906-7590.2008.5203.X/FULL.ACCESSED; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Essl F, 2011, J NAT CONSERV, V19, P339, DOI 10.1016/j.jnc.2011.08.005; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Ficetola GF, 2009, DIVERS DISTRIB, V15, P108, DOI 10.1111/j.1472-4642.2008.00516.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Franklin J, 1995, PROGR PHYS GEOGRAPHY; Freeman E., 2007, PRESENCEABSENCE R PA; Genovesi P, 2010, EARLY WARNING INFORM; Genovesi P., 2011, ISLAND INVASIVES ERA, P5; GENOVESI P., 2004, NATURE ENV, V137; Genovesi Piero, 2007, V193, P385; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; GURNELL J, 1993, MAMMAL REV, V23, P127, DOI 10.1111/j.1365-2907.1993.tb00424.x; Gurnell J, 2004, J ANIM ECOL, V73, P26, DOI 10.1111/j.1365-2656.2004.00791.x; Gurnell J, 1996, J APPL ECOL, V33, P325, DOI 10.2307/2404754; GURNELL J, 2008, MAMMALS BRIT ISLES H, P66; HAAGNER A, 1920, S AFRICAN MAMMALS; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IUCN, 2012, IUCN RED LIST THREAT; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Jeschke JM, 2006, GLOBAL CHANGE BIOL, V12, P1608, DOI 10.1111/j.1365-2486.2006.01213.x; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Kettunen M., 2008, TECHNICAL SUPPORT EU; Koprowski John L., 1994, Mammalian Species, V480, P1, DOI 10.2307/3504263; Lawton C, 2010, REV SCI TECH OIE, V29, P113; Lever C, 1985, NATURALIZED MAMMALS; LLOYD HG, 1983, MAMMAL REV, V13, P69, DOI 10.1111/j.1365-2907.1983.tb00269.x; Lurz PWW, 2001, LANDSCAPE ECOL, V16, P407, DOI 10.1023/A:1017508711713; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Martinoli A, 2010, HYSTRIX, V21, P127, DOI 10.4404/Hystrix-21.2-4463; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Middleton AD, 1932, J ANIM ECOL, V1, P166, DOI 10.2307/978; Newson SE, 2010, J ORNITHOL, V151, P211, DOI 10.1007/s10336-009-0445-8; NIXON CM, 1969, J WILDLIFE MANAGE, V33, P353, DOI 10.2307/3799835; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Panzacchi M, 2007, WILDLIFE BIOL, V13, P159, DOI 10.2981/0909-6396(2007)13[159:PCOCMC]2.0.CO;2; Peacock David E., 2009, Victorian Naturalist (Blackburn), V126, P150; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Rushton SP, 1997, J APPL ECOL, V34, P1137, DOI 10.2307/2405227; Sainsbury AW, 2000, ANIM CONSERV, V3, P229, DOI 10.1017/S1367943000000949; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Silverman B.W., 1986, DENSITY ESTIMATION S; Steele M. A., 2001, N AM TREE SQUIRRELS; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tattoni C, 2006, BIOL INVASIONS, V8, P1605, DOI 10.1007/s10530-005-3503-z; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Van Wilgen NJ, 2012, CONSERV BIOL, V26, P267, DOI 10.1111/j.1523-1739.2011.01804.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x	77	42	42	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66559	10.1371/journal.pone.0066559	http://dx.doi.org/10.1371/journal.pone.0066559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843957	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000321733000048
J	Malapi-Wight, M; Smith, J; Campbell, J; Bluhm, BH; Shim, WB				Malapi-Wight, Martha; Smith, Jonathon; Campbell, Jacquelyn; Bluhm, Burton H.; Shim, Won-Bo			Sda1, a Cys(2)-His(2) Zinc Finger Transcription Factor, Is Involved in Polyol Metabolism and Fumonisin B-1 Production in Fusarium verticillioides	PLOS ONE			English	Article							D-ARABITOL DEHYDROGENASE; L-XYLULOSE REDUCTASE; ASPERGILLUS-NIGER; SORBITOL DEHYDROGENASE; TRICHODERMA-REESEI; HYPOCREA-JECORINA; FILAMENTOUS FUNGI; L-ARABINOSE; MANNITOL DEHYDROGENASE; GIBBERELLA-FUJIKUROI	The ubiquitous ascomycete Fusarium verticillioides causes ear rot and stalk rot of maize, both of which reduce grain quality and yield. Additionally, F. verticillioides produces the mycotoxin fumonisin B-1 (FB1) during infection of maize kernels, and thus potentially compromises human and animal health. The current knowledge is fragmentary regarding the regulation of FB1 biosynthesis, particularly when considering interplay with environmental factors such as nutrient availability. In this study, SDA1 of F. verticillioides, predicted to encode a Cys-2 His-2 zinc finger transcription factor, was shown to play a key role in catabolizing select carbon sources. Growth of the SDA1 knock-out mutant (Delta sda1) was completely inhibited when sorbitol was the sole carbon source and was severely impaired when exclusively provided mannitol or glycerol. Deletion of SDA1 unexpectedly increased FB1 biosynthesis, but reduced arabitol and mannitol biosynthesis, as compared to the wild-type progenitor. Trichoderma reesei ACE1, a regulator of cellulase and xylanase expression, complemented the F. verticillioides Delta sda1 mutant, which indicates that Ace1 and Sda1 are functional orthologs. Taken together, the data indicate that Sda1 is a transcriptional regulator of carbon metabolism and toxin production in F. verticillioides.	[Malapi-Wight, Martha; Shim, Won-Bo] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Smith, Jonathon; Bluhm, Burton H.] Univ Arkansas, Dept Plant Pathol, Fayetteville, AR 72701 USA; [Campbell, Jacquelyn; Shim, Won-Bo] Texas A&M Univ, Dept Plant Pathol & Microbiol, Bioenvironm Sci Program, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University of Arkansas System; University of Arkansas Fayetteville; Texas A&M University System; Texas A&M University College Station	Shim, WB (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	wbshim@neo.tamu.edu		Malapi, Martha/0000-0003-2249-6257	National Research Initiative of the United States Department of Agriculture (USDA) Cooperative state Research, Education, and Service [2007-35319-18334]	National Research Initiative of the United States Department of Agriculture (USDA) Cooperative state Research, Education, and Service	This study was supported in part by the National Research Initiative of the United States Department of Agriculture (USDA) Cooperative state Research, Education, and Service (Grant 2007-35319-18334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Barrera LO, 2006, CURR OPIN CELL BIOL, V18, P291, DOI 10.1016/j.ceb.2006.04.002; Bluhm BH, 2005, MOL PLANT MICROBE IN, V18, P1333, DOI 10.1094/MPMI-18-1333; BRAHMACHARI SK, 1995, ELECTROPHORESIS, V16, P1705, DOI 10.1002/elps.11501601283; Brodhagen M, 2006, MOL PLANT PATHOL, V7, P285, DOI [10.1111/j.1364-3703.2006.00338.x, 10.1111/J.1364-3703.2006.00338.X]; Brown DW, 2007, EUKARYOT CELL, V6, P1210, DOI 10.1128/EC.00400-06; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; CHANLIAUD E, 1995, J CEREAL SCI, V21, P195, DOI 10.1016/0733-5210(95)90035-7; Clark AJ, 2003, PLANTA, V216, P614, DOI 10.1007/s00425-002-0833-2; David H, 2003, EUR J BIOCHEM, V270, P4243, DOI 10.1046/j.1432-1033.2003.03798.x; Desjardins AE, 2000, MICROBIOL-UK, V146, P2059, DOI 10.1099/00221287-146-8-2059; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; El-Kabbani O, 2004, CURR MED CHEM, V11, P465, DOI 10.2174/0929867043455927; Fairhead C, 1996, YEAST, V12, P1439; Fillinger S, 2001, MOL MICROBIOL, V39, P145, DOI 10.1046/j.1365-2958.2001.02223.x; Flaherty JE, 2004, APPL ENVIRON MICROB, V70, P2653, DOI 10.1128/AEM.70.5.2653-2659.2004; Flaherty JE, 2003, APPL ENVIRON MICROB, V69, P5222, DOI 10.1128/AEM.69.9.5222-5227.2003; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; Fu J, 2006, FUNGAL GENET BIOL, V43, P200, DOI 10.1016/j.fgb.2005.09.007; GELDERBLOM WCA, 1988, APPL ENVIRON MICROB, V54, P1806, DOI 10.1128/AEM.54.7.1806-1811.1988; Han S, 2001, MOL GENET GENOMICS, V266, P260, DOI 10.1007/s004380100552; Horer S, 2001, J BIOL CHEM, V276, P27555, DOI 10.1074/jbc.M102850200; Huisman MMH, 2000, CARBOHYD POLYM, V43, P269, DOI 10.1016/S0144-8617(00)00154-5; HULT K, 1978, EUR J BIOCHEM, V88, P607, DOI 10.1111/j.1432-1033.1978.tb12487.x; Hwang YYC, 2003, FASEB J, V17, P2331, DOI 10.1096/fj.03-0128fje; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; JENNINGS DH, 1984, ADV MICROB PHYSIOL, V25, P149; Kim H, 2008, FUNGAL GENET BIOL, V45, P947, DOI 10.1016/j.fgb.2008.03.007; Kim H, 2011, MICROBIOL-SGM, V157, P2658, DOI 10.1099/mic.0.052506-0; Koivistoinen OM, 2012, FEBS LETT, V586, P378, DOI 10.1016/j.febslet.2012.01.004; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; LARKINS RG, 1992, DIABETOLOGIA, V35, P499, DOI 10.1007/BF00400475; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; Link T, 2005, BIOCHEM J, V389, P289, DOI 10.1042/BJ20050301; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Marasas WFO, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.2307/3435014; Metz B, 2009, FEBS LETT, V583, P1309, DOI 10.1016/j.febslet.2009.03.027; Minorsky PV, 2002, PLANT PHYSIOL, V129, P929, DOI 10.1104/pp.900040; Missmer SA, 2006, ENVIRON HEALTH PERSP, V114, P237, DOI 10.1289/ehp.8221; Mojzita D, 2010, FEBS LETT, V584, P3540, DOI 10.1016/j.febslet.2010.06.037; Munkvold GP, 1997, PLANT DIS, V81, P556, DOI 10.1094/PDIS.1997.81.6.556; Myung K, 2009, J AGR FOOD CHEM, V57, P5089, DOI 10.1021/jf900783u; NYUNOYA H, 1984, CAN J MICROBIOL, V30, P45, DOI 10.1139/m84-008; Oates PJ, 2002, INT REV NEUROBIOL, V50, P325; Park DL, 2002, ADV EXP MED BIOL, V504, P277; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Portnoy T, 2011, EUKARYOT CELL, V10, P262, DOI 10.1128/EC.00208-10; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Proctor RH, 1999, FUNGAL GENET BIOL, V27, P100, DOI 10.1006/fgbi.1999.1141; Rauscher R, 2006, EUKARYOT CELL, V5, P447, DOI 10.1128/EC.5.3.447-456.2006; Richard P, 2002, BIOCHEMISTRY-US, V41, P6432, DOI 10.1021/bi025529i; RODRIGUES F, 2006, SUGAR METABOLISM YEA; Ruijter GJG, 2003, EUKARYOT CELL, V2, P690, DOI 10.1128/EC.2.4.690-698.2003; Rutten L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-166; Sagaram US, 2007, MICROBIOL-SGM, V153, P2850, DOI 10.1099/mic.0.2007/007708-0; Sagaram US, 2007, MOL PLANT PATHOL, V8, P375, DOI 10.1111/J.1364-3703.2007.00398.X; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Shelest E, 2008, FEMS MICROBIOL LETT, V286, P145, DOI 10.1111/j.1574-6968.2008.01293.x; Shim WB, 2001, APPL ENVIRON MICROB, V67, P1607, DOI 10.1128/AEM.67.4.1607-1612.2001; Shim WB, 1999, FEMS MICROBIOL LETT, V177, P109, DOI 10.1111/j.1574-6968.1999.tb13720.x; Smith JE, 2012, METABOLOMICS, V8, P376, DOI 10.1007/s11306-011-0322-3; Solomon PS, 2007, TRENDS MICROBIOL, V15, P257, DOI 10.1016/j.tim.2007.04.002; Solomon PS, 2005, MOL PLANT MICROBE IN, V18, P110, DOI 10.1094/MPMI-18-0110; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Trail F, 2002, PHYTOCHEMISTRY, V61, P791, DOI 10.1016/S0031-9422(02)00430-2; Velez H, 2007, FUNGAL GENET BIOL, V44, P258, DOI 10.1016/j.fgb.2006.09.008; Visentin I, 2012, EUKARYOT CELL, V11, P252, DOI 10.1128/EC.05159-11; WANG E, 1991, J BIOL CHEM, V266, P14486; Warfield CY, 1999, APPL ENVIRON MICROB, V65, P2853; White D.G., 1999, COMPENDIUM CORN DIS, P44; WITTEVEEN CFB, 1989, J GEN MICROBIOL, V135, P2163; WONG B, 1995, J BACTERIOL, V177, P2971, DOI 10.1128/jb.177.11.2971-2976.1995	76	10	13	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e67656	10.1371/journal.pone.0067656	http://dx.doi.org/10.1371/journal.pone.0067656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23844049	Green Submitted, Green Published, gold			2022-12-27	WOS:000321733000088
J	Veerappa, AM; Vishweswaraiah, S; Lingaiah, K; Murthy, M; Manjegowda, DS; Nayaka, R; Ramachandra, NB				Veerappa, Avinash M.; Vishweswaraiah, Sangeetha; Lingaiah, Kusuma; Murthy, Megha; Manjegowda, Dinesh S.; Nayaka, Radhika; Ramachandra, Nallur B.			Unravelling the Complexity of Human Olfactory Receptor Repertoire by Copy Number Analysis across Population Using High Resolution Arrays	PLOS ONE			English	Article							GENES; POLYMORPHISM; EVOLUTION; SEQUENCE; FAMILY	Olfactory receptors (OR), responsible for detection of odor molecules, belong to the largest family of genes and are highly polymorphic in nature having distinct polymorphisms associated with specific regions around the globe. Since there are no reports on the presence of copy number variations in OR repertoire of Indian population, the present investigation in 43 Indians along with 270 HapMap and 31 Tibetan samples was undertaken to study genome variability and evolution. Analysis was performed using Affymetrix Genome-Wide Human SNP Array 6.0 chip, Affymterix CytoScan (R) High-Density array, HD-CNV, and MAFFT program. We observed a total of 1527 OR genes in 503 CNV events from 81.3% of the study group, which includes 67.6% duplications and 32.4% deletions encompassing more of genes than pseudogenes. We report human genotypic variation in functional OR repertoire size across populations and it was found that the combinatorial effect of both "orthologous obtained from closely related species'' and "paralogous derived sequences'' provide the complexity to the continuously occurring OR CNVs.	[Veerappa, Avinash M.; Vishweswaraiah, Sangeetha; Lingaiah, Kusuma; Murthy, Megha; Nayaka, Radhika; Ramachandra, Nallur B.] Univ Mysore, Dept Studies Zool, Genom Lab, Mysore, Karnataka, India; [Manjegowda, Dinesh S.] Yenepoya Univ, Yenepoya Med Coll, Dept Anat, Mangalore, India	University of Mysore; Yenepoya (Deemed to be University)	Ramachandra, NB (corresponding author), Univ Mysore, Dept Studies Zool, Genom Lab, Mysore, Karnataka, India.	nallurbr@gmail.com			Department of Science and Technology-Health Science, Government of India, New Delhi [SR/SO/HS-103/2007]; Yenepoya University Seed grant, Mangalore [YU/Seed Grant/2011-011]	Department of Science and Technology-Health Science, Government of India, New Delhi; Yenepoya University Seed grant, Mangalore	The authors thank the funding agency, Department of Science and Technology-Health Science (SR/SO/HS-103/2007), Government of India, New Delhi; Yenepoya University Seed grant (YU/Seed Grant/2011-011), Mangalore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc, 2008, US MAN GEN CONS SOFT; Affymetrix Inc, 2005, TECHN NOT GUID PROB; Affymetrix Inc, 2009, DAT SHEET GEN WID HU; Affymetrix Inc, 2007, WHIT PAP BRLMM P GEN; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; [Anonymous], 2008, WHIT PAP AFF CAN ALG, P1; Bozeman M., SNP VARIATION SUITE; Butler J, 2012, BIOINFORMATICS; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fuchs T, 2001, HUM GENET, V108, P1, DOI 10.1007/s004390000436; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gilad Y, 2000, NAT GENET, V26, P221, DOI 10.1038/79957; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Go Y, 2008, MOL BIOL EVOL, V25, P1897, DOI 10.1093/molbev/msn135; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Hoppe R, 2003, GENOME RES, V13, P2674, DOI 10.1101/gr.1372203; Kambere MB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S2; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim Hie Lim, 2012, Int J Evol Biol, V2012, P917678, DOI 10.1155/2012/917678; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lekkerkerker C., 1962, FUND MATH, V51, P45, DOI DOI 10.4064/FM-51-1-45-64; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; Young JM, 2008, AM J HUM GENET, V83, P228, DOI 10.1016/j.ajhg.2008.07.005; Zhang D, 2011, PLOS ONE, V13, P6	45	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2013	8	7							e66843	10.1371/journal.pone.0066843	http://dx.doi.org/10.1371/journal.pone.0066843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182HT	23843967	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000321733000054
J	Dedieu, L; Serveau-Avesque, C; Canaan, S				Dedieu, Luc; Serveau-Avesque, Carole; Canaan, Stephane			Identification of Residues Involved in Substrate Specificity and Cytotoxicity of Two Closely Related Cutinases from Mycobacterium tuberculosis	PLOS ONE			English	Article							PHOSPHOLIPASE-A; CRYSTAL-STRUCTURE; I-TASSER; LIPASE; PROTEINS; ENZYMES; PURIFICATION; VIRULENCE; ENCODES	The enzymes belonging to the cutinase family are serine enzymes active on a large panel of substrates such as cutin, triacylglycerols, and phospholipids. In the M. tuberculosis H37Rv genome, seven genes coding for cutinase-like proteins have been identified with strong immunogenic properties suggesting a potential role as vaccine candidates. Two of these enzymes which are secreted and highly homologous, possess distinct substrates specificities. Cfp21 is a lipase and Cut4 is a phospholipase A2, which has cytotoxic effects on macrophages. Structural overlay of their three-dimensional models allowed us to identify three areas involved in the substrate binding process and to shed light on this substrate specificity. By site-directed mutagenesis, residues present in these Cfp21 areas were replaced by residues occurring in Cut4 at the same location. Three mutants acquired phospholipase A1 and A2 activities and the lipase activities of two mutants were 3 and 15 fold greater than the Cfp21 wild type enzyme. In addition, contrary to mutants with enhanced lipase activity, mutants that acquired phospholipase B activities induced macrophage lysis as efficiently as Cut4 which emphasizes the relationship between apparent phospholipase A2 activity and cytotoxicity. Modification of areas involved in substrate specificity, generate recombinant enzymes with higher activity, which may be more immunogenic than the wild type enzymes and could therefore constitute promising candidates for antituberculous vaccine production.	[Dedieu, Luc; Serveau-Avesque, Carole; Canaan, Stephane] Aix Marseille Univ, CNRS, Enzymol Interfaciale & Physiol Lipolyse UMR 7282, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Canaan, S (corresponding author), Aix Marseille Univ, CNRS, Enzymol Interfaciale & Physiol Lipolyse UMR 7282, Marseille, France.	canaan@imm.cnrs.fr			Agence Nationale de la Recherche in the framework of the ANR-Foamy-TuB grant [ANR MIEN 2009-00904]; LISA Carnot Institute (Convention ANR) [07-CARN-009-01]; CNRS; Aix-Marseille Universite	Agence Nationale de la Recherche in the framework of the ANR-Foamy-TuB grant(French National Research Agency (ANR)); LISA Carnot Institute (Convention ANR)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite	This work and the post-doctoral fellowship to L. Dedieu were funded by the Agence Nationale de la Recherche in the framework of the ANR-Foamy-TuB grant (ANR MIEN 2009-00904) to Stephane Canaan, by the LISA Carnot Institute (Convention ANR no07-CARN-009-01) and by the CNRS and the Aix-Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brust B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025078; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotes K, 2008, APPL MICROBIOL BIOT, V78, P741, DOI 10.1007/s00253-008-1397-2; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Crellin PK, 2010, J BIOL CHEM, V285, P30050, DOI 10.1074/jbc.M110.150094; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Darrow AL, 2011, J LIPID RES, V52, P374, DOI 10.1194/jlr.D007971; Delorme V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046493; Dhouib R, 2010, J BACTERIOL, V192, P4776, DOI 10.1128/JB.00261-10; Egmond MR, 2000, BIOCHIMIE, V82, P1015, DOI 10.1016/S0300-9084(00)01183-4; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Goldman Robert C., 2007, Infectious Disorders - Drug Targets, V7, P73; HADVARY P, 1991, J BIOL CHEM, V266, P2021; Helmy M, 1999, BIOCHEM BIOPH RES CO, V258, P252, DOI 10.1006/bbrc.1999.0618; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; LEE KS, 1994, J BIOL CHEM, V269, P19725; Longhi S, 1997, J MOL BIOL, V268, P779, DOI 10.1006/jmbi.1997.1000; MANNESSE MLM, 1995, BIOCHEMISTRY-US, V34, P6400, DOI 10.1021/bi00019a020; Meniche X, 2009, J BACTERIOL, V191, P7323, DOI 10.1128/JB.01042-09; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Muller-Santos M, 2009, BBA-MOL CELL BIOL L, V1791, P719, DOI 10.1016/j.bbalip.2009.03.006; N'Goma JCB, 2010, BBA-MOL CELL BIOL L, V1801, P1305, DOI 10.1016/j.bbalip.2010.08.007; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; NISHIJIMA M, 1977, EUR J BIOCHEM, V73, P115, DOI 10.1111/j.1432-1033.1977.tb11297.x; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Ransac S, 1997, METHOD ENZYMOL, V286, P190; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; SCANDELLA CJ, 1971, BIOCHEMISTRY-US, V10, P4447, DOI 10.1021/bi00800a015; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Singh G, 2010, CRIT REV MICROBIOL, V36, P259, DOI 10.3109/1040841X.2010.482923; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Titball RW, 1998, J APPL MICROBIOL, V84, p127S; Vincentelli R, 2004, PROTEIN SCI, V13, P2782, DOI 10.1110/ps.04806004; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; WithersMartinez C, 1996, STRUCTURE, V4, P1363, DOI 10.1016/S0969-2126(96)00143-8; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	46	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e66913	10.1371/journal.pone.0066913	http://dx.doi.org/10.1371/journal.pone.0066913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	23843969	Green Submitted, Green Published, gold			2022-12-27	WOS:000321341000021
J	Mishra, S; Chauhan, N; Singhvi, AK				Mishra, Sheila; Chauhan, Naveen; Singhvi, Ashok K.			Continuity of Microblade Technology in the Indian Subcontinent Since 45 ka: Implications for the Dispersal of Modern Humans	PLOS ONE			English	Article							PLEISTOCENE HOMO-SAPIENS; RAIN-FOREST FAUNA; SOUTHEAST-ASIA; BLADE PRODUCTION; HOWIESONS POORT; QESEM CAVE; STONE-AGE; MIDDLE; AFRICA; EAST	We extend the continuity of microblade technology in the Indian Subcontinent to 45 ka, on the basis of optical dating of microblade assemblages from the site of Mehtakheri, (22 degrees 13' 44 '' N Lat 76 degrees 01' 36 '' E Long) in Madhya Pradesh, India. Microblade technology in the Indian Subcontinent is continuously present from its first appearance until the Iron Age (similar to 3 ka), making its association with modern humans undisputed. It has been suggested that microblade technology in the Indian Subcontinent was developed locally by modern humans after 35 ka. The dates reported here from Mehtakheri show this inference to be untenable and suggest alternatively that this technology arrived in the Indian Subcontinent with the earliest modern humans. It also shows that modern humans in Indian Subcontinent and SE Asia were associated with differing technologies and this calls into question the "southern dispersal" route of modern humans from Africa through India to SE Asia and then to Australia. We suggest that modern humans dispersed from Africa in two stages coinciding with the warmer interglacial conditions of MIS 5 and MIS 3. Competitive interactions between African modern humans and Indian archaics who shared an adaptation to tropical environments differed from that between modern humans and archaics like Neanderthals and Denisovans, who were adapted to temperate environments. Thus, while modern humans expanded into temperate regions during warmer climates, their expansion into tropical regions, like the Indian Subcontinent, in competition with similarly adapted populations, occurred during arid climates. Thus modern humans probably entered the Indian Subcontinent during the arid climate of MIS 4 coinciding with their disappearance from the Middle East and Northern Africa. The out of phase expansion of modern humans into tropical versus temperate regions has been one of the factors affecting the dispersal of modern humans from Africa during the period 200-40 ka.	[Mishra, Sheila] Deemed Univ, Deccan Coll, Dept Archaeol, Pune, Maharashtra, India; [Chauhan, Naveen; Singhvi, Ashok K.] Phys Res Lab, Geosci Div, Ahmadabad 380009, Gujarat, India	Department of Space (DoS), Government of India; Physical Research Laboratory - India	Mishra, S (corresponding author), Deemed Univ, Deccan Coll, Dept Archaeol, Pune, Maharashtra, India.	sheila.mishra@gmail.com		Chauhan, Naveen/0000-0001-9184-0459	NSF grant [EAR-9104489]; Deccan college; Indira Gandhi Rashtriya Manav Sangaralaya, Bhopal	NSF grant(National Science Foundation (NSF)); Deccan college; Indira Gandhi Rashtriya Manav Sangaralaya, Bhopal	Funding was received from departmental research grants to Sheila Mishra and Ashok Singhvi. Radiocarbon dates were funded by NSF grant no EAR-9104489 to Victor Baker, Lisa Ely, and Yehouda Enzel. Indira Gandhi Rashtriya Manav Sangaralaya, Bhopal, and the Deccan college provided funding for excavations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller T, 2012, NATURE, V485, P24, DOI 10.1038/485024a; Armitage SJ, 2007, QUAT GEOCHRONOL, V2, P181, DOI 10.1016/j.quageo.2006.05.019; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bar-Yosef O, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P39; Bar-Yosef O, 2012, ANNU REV ANTHROPOL, V41, P319, DOI 10.1146/annurev-anthro-092611-145832; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Boivin N, QUAT INT IN PRESS; Braeuer Guenter, 2007, P1749; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Chandel H.N., 2006, ANCIENT TL, V24, P21; Chauhan PR, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P121, DOI 10.1007/978-0-387-76487-0_7; Ciochon RL, 2010, VERTEBR PALEOBIOL PA, P111, DOI 10.1007/978-90-481-9036-2_8; Clarkson C, 2009, ANTIQUITY, V83, P326, DOI 10.1017/S0003598X0009846X; Costa AG, 2012, QUATERN INT, V269, P22, DOI 10.1016/j.quaint.2011.01.044; Crassard R, 2010, EVOLUTION HUMAN POPU, P139; Delagnes A, QUAT INT IN PRESS; Delagnes A, 2012, J HUM EVOL, V63, P452, DOI 10.1016/j.jhevol.2012.03.008; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Dennell R, 2012, QUATERNARY SCI REV, V47, P15, DOI 10.1016/j.quascirev.2012.05.002; Etler D.A., 2001, Human Evolution, V16, P1, DOI 10.1007/BF02438918; Gaillard C., 2001, ORIGIN SETTLEMENTS C, P73; Gaillard C, 2010, QUATERN INT, V223, P234, DOI 10.1016/j.quaint.2009.08.021; Ghosh A, 1993, MAN ENV, V18, P11; Gliganic LA, 2012, J HUM EVOL, V62, P533, DOI 10.1016/j.jhevol.2012.02.004; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guerin G, 2013, J HUM EVOL, V64, P314, DOI 10.1016/j.jhevol.2013.01.006; Habgood PJ, 2008, J HUM EVOL, V55, P187, DOI 10.1016/j.jhevol.2007.11.006; Harvati Katerina, 2007, P1717, DOI 10.1007/978-3-540-33761-4_56; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Johnson CR, 2010, J HUM EVOL, V58, P193, DOI 10.1016/j.jhevol.2009.10.001; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mercier N, 2013, J ARCHAEOL SCI, V40, P3011, DOI 10.1016/j.jas.2013.03.002; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mishra S, 2008, MAN ENV, V33, P14; Mishra S, 1985, EARLY MAN ENV W MADH; Mishra S, 1993, B DECCAN COLL POSTGR, V53, P59; Movius H. L., 1948, T AM PHILOS SOC, V38, P330; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Oppenheimer S, 2009, QUATERN INT, V202, P2, DOI 10.1016/j.quaint.2008.05.015; Pappu S, 2011, SCIENCE, V331, P1596, DOI 10.1126/science.1200183; Petraglia M., 2009, EURASIAN PREHIST, V6, P119; PETRAGLIA MD, 2007, RETHINKING HUMAN REV, P383; Petraglia MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049840; Petraglia MD, 2011, QUATERNARY SCI REV, V30, P1555, DOI 10.1016/j.quascirev.2011.04.006; Petraglia MD, 2011, NATURE, V470, P50, DOI 10.1038/470050a; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Richter J, 2012, QUATERN INT, V274, P5, DOI 10.1016/j.quaint.2012.04.017; Rose J. I., 2007, MEDITERRANEAN BASIN, P57; Rose JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028239; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; Shea JJ, 2003, J WORLD PREHIST, V17, P313, DOI 10.1023/B:JOWO.0000020194.01496.fe; Shea JJ, 2009, VERTEBR PALEOBIOL PA, P189, DOI 10.1007/978-1-4020-9699-0_14; Shimelmitz R, 2011, J HUM EVOL, V61, P458, DOI 10.1016/j.jhevol.2011.06.003; Singhvi AK, 2010, QUATERNARY SCI REV, V29, P3095, DOI 10.1016/j.quascirev.2010.08.003; Sisk Matthew L, 2011, Int J Evol Biol, V2011, P968012, DOI 10.4061/2011/968012; Skinner AR, 2003, QUATERNARY SCI REV, V22, P1361, DOI 10.1016/S0277-3791(03)00015-5; Storey M, 2012, P NATL ACAD SCI USA, V109, P18684, DOI 10.1073/pnas.1208178109; Storm P, 2005, J HUM EVOL, V49, P536, DOI 10.1016/j.jhevol.2005.06.003; Tribolo C, 2009, J ARCHAEOL SCI, V36, P730, DOI 10.1016/j.jas.2008.10.018; Tribolo C, ARCHAEOL SC IN PRESS; Usik VI, QUAT INT IN PRESS; Van Peer P, 2000, STUDIES AFRICAN ARCH, V7, P47; Van Peer P., 2007, RETHINKING HUMAN REV, P187; Van Peer P, 2010, TARAMSA 1; Wall JD, GENETICS IN PRESS; Westaway KE, 2007, J HUM EVOL, V53, P709, DOI 10.1016/j.jhevol.2007.06.002; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wilkins J, 2012, J ARCHAEOL SCI, V39, P1883, DOI 10.1016/j.jas.2012.01.031; Willoughby Pamela R., 2007, EVOLUTION MODERN HUM; Zuraina M, 1988, J MALAYSIAN BRANCH R, V61, P123	76	35	36	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e69280	10.1371/journal.pone.0069280	http://dx.doi.org/10.1371/journal.pone.0069280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	175ZH	23840912	gold, Green Published, Green Submitted			2022-12-27	WOS:000321271900051
J	Oswald, ME; Singer, M; Robison, BD				Oswald, Mary E.; Singer, Mathew; Robison, Barrie D.			The Quantitative Genetic Architecture of the Bold-Shy Continuum in Zebrafish, Danio rerio	PLOS ONE			English	Article							STICKLEBACK GASTEROSTEUS-ACULEATUS; RISK-TAKING BEHAVIOR; DOMESTICATION; POPULATIONS; SELECTION; MODEL; WILD; EXPLORATION; EVOLUTION; CONTEXTS	In studies of consistent individual differences (personality) along the bold-shy continuum, a pattern of behavioral correlations frequently emerges: individuals towards the bold end of the continuum are more likely to utilize risky habitat, approach potential predators, and feed under risky conditions. Here, we address the hypothesis that observed phenotypic correlations among component behaviors of the bold-shy continuum are a result of underlying genetic correlations (quantitative genetic architecture). We used a replicated three-generation pedigree of zebrafish (Danio rerio) to study three putative components of the bold-shy continuum: horizontal position, swim level, and feeding latency. We detected significant narrow-sense heritabilities as well as significant genetic and phenotypic correlations among all three behaviors, such that fish selected for swimming at the front of the tank swam closer to the observer, swam higher in the water column, and fed more quickly than fish selected for swimming at the back of the tank. Further, the lines varied in their initial open field behavior (swim level and activity level). The quantitative genetic architecture of the bold-shy continuum indicates that the multivariate behavioral phenotype characteristic of a "bold" personality type may be a result of correlated evolution via underlying genetic correlations.	[Oswald, Mary E.; Singer, Mathew; Robison, Barrie D.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho	Robison, BD (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	brobison@uidaho.edu	Robison, Barrie/AGW-1927-2022		National Science Foundation (NSF) Idaho EPSCoR Program; NSF [EPS-0447689, IOS-0818904, IOS-0808551]; National Institutes of Health from the COBRE Program of the National Center for Research Resources [P20 RR016448]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER	National Science Foundation (NSF) Idaho EPSCoR Program; NSF(National Science Foundation (NSF)); National Institutes of Health from the COBRE Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by National Science Foundation (NSF) Idaho EPSCoR Program and NSF under EPS-0447689 and IOS-0818904 to BDR and an NSF doctoral dissertation improvement grant (IOS-0808551) to MEO and BDR. The zebrafish facility was constructed with funding from the National Institutes of Health grant no. P20 RR016448 from the COBRE Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyomo TO, 2012, ANIM BEHAV, V83, P41, DOI 10.1016/j.anbehav.2011.10.004; Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Benner MJ, 2010, COMP BIOCHEM PHYS A, V157, P310, DOI [10.1016/J.cbpa.2010.07.016, 10.1016/j.cbpa.2010.07.016]; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; Brown C, 2007, J FISH BIOL, V71, P1590, DOI 10.1111/j.1095-8649.2007.01627.x; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; Dochtermann NA, 2011, EVOLUTION, V65, P1814, DOI 10.1111/j.1558-5646.2011.01264.x; Dugatkin LA, 2005, ETHOL ECOL EVOL, V17, P77; Dzieweczynski TL, 2011, J FISH BIOL, V79, P776, DOI 10.1111/j.1095-8649.2011.03064.x; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2010, BEHAV BRAIN RES, V207, P223, DOI 10.1016/j.bbr.2009.10.008; Hamilton IM, 2002, CAN J ZOOL, V80, P2164, DOI 10.1139/Z02-199; Huntingford FA, 2004, J FISH BIOL, V65, P122, DOI 10.1111/j.0022-1112.2004.00562.x; Iwama G.K., 1997, FISH STRESS HLTH AQU; Janzen FJ, 1998, EVOLUTION, V52, P1564, DOI 10.1111/j.1558-5646.1998.tb02237.x; Kenttamies H, 2002, APPL ANIM BEHAV SCI, V78, P67, DOI 10.1016/S0168-1591(02)00078-3; Kirkpatrick M, 2009, GENETICA, V136, P271, DOI 10.1007/s10709-008-9302-6; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lynch M., 1998, GENETICS ANAL QUANTI; Magnhagen C, 2007, BEHAV ECOL SOCIOBIOL, V61, P525, DOI 10.1007/s00265-006-0280-3; Moretz JA, 2007, ENVIRON BIOL FISH, V80, P91, DOI 10.1007/s10641-006-9122-4; Oswald M, 2008, CAN J ZOOL, V86, P1085, DOI 10.1139/Z08-085; Oswald ME, 2012, PHYSIOL BIOCHEM ZOOL, V85, P718, DOI 10.1086/668203; Price E.O., 2002, ANIMAL DOMESTICATION; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reinhardt UG, 2001, T AM FISH SOC, V130, P155, DOI 10.1577/1548-8659(2001)130&lt;0155:SFSFIF&gt;2.0.CO;2; Robison BD, 2005, CAN J FISH AQUAT SCI, V62, P2046, DOI [10.1139/f05-118, 10.1139/F05-118]; Robison BD, 2012, ZEBRAFISH PROTOC NEU, P203; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sison M, 2006, LAB ANIMAL, V35, P33, DOI 10.1038/laban0506-33; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Weber ED, 2003, CAN J FISH AQUAT SCI, V60, P1018, DOI 10.1139/F03-087; Wilson ADM, 2010, BEHAV ECOL SOCIOBIOL, V64, P703, DOI 10.1007/s00265-009-0888-1; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wright D, 2003, NATURWISSENSCHAFTEN, V90, P374, DOI 10.1007/s00114-003-0443-2; Yamamoto T, 2003, FISHERIES SCI, V69, P88, DOI 10.1046/j.1444-2906.2003.00591.x	41	28	28	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68828	10.1371/journal.pone.0068828	http://dx.doi.org/10.1371/journal.pone.0068828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840902	Green Submitted, gold, Green Published			2022-12-27	WOS:000321271900041
J	Tu, KS; Zheng, X; Zhou, ZY; Li, C; Zhang, J; Gao, J; Yao, YM; Liu, QG				Tu, Kangsheng; Zheng, Xin; Zhou, Zhenyu; Li, Chao; Zhang, Jing; Gao, Jie; Yao, Yingmin; Liu, Qingguang			Recombinant Human Adenovirus-p53 Injection Induced Apoptosis in Hepatocellular Carcinoma Cell Lines Mediated by p53-Fbxw7 Pathway, Which Controls c-Myc and Cyclin E	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; FBXW7 EXPRESSION; P53 GENE; CANCER; MUTATION; FBW7; HCDC4	F-box and WD repeat domain-containing 7 (Fbxw7/hAgo/hCdc4/Fbw7) is a p53-dependent tumor suppressor and leads to ubiquitination-mediated suppression of several oncoproteins including c-Myc, cyclin E, Notch, c-Jun and others. Our previous study has indicated that low expression of Fbxw7 was negatively correlated with c-Myc, cyclin E and mutant-p53 in hepatocellular carcinoma (HCC) tissues. But the role and mechanisms of Fbxw7 in HCC are still unknown. Here, we investigated the function of Fbxw7 in HCC cell lines and the anti-tumor activity of recombinant human adenovirus-p53 injection (rAd-p53, Gendicine) administration in vitro and in vivo. Fbxw7-specific siRNA enhanced expression of c-Myc and cyclin E proteins and increased proliferation in cell culture. rAd-p53 inhibited tumor cell growth with Fbxw7 upregulation and c-Myc and cyclin E downregulation in vitro and a murine HCC model. This effect could be partially reverted using Fbxw7-specific siRNA. Here, we suggest that the activation of Fbxw7 by adenoviral delivery of p53 leads to increased proteasomal degradation of c-Myc and cyclin E enabling growth arrest and apoptosis. Addressing this pathway, we identified that rAd-p53 could be a potential therapeutic agent for HCC.	[Tu, Kangsheng; Zheng, Xin; Zhou, Zhenyu; Li, Chao; Zhang, Jing; Gao, Jie; Yao, Yingmin; Liu, Qingguang] Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Coll Med, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Liu, QG (corresponding author), Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Coll Med, Xian 710049, Shaanxi, Peoples R China.	liuqingguang@vip.sina.com	ZHENG, XIN/H-2342-2016; Tu, Kangsheng/N-1544-2019	ZHENG, XIN/0000-0002-6328-0834; Tu, Kangsheng/0000-0002-0032-1459	National Natural Science Foundation of China [81272645, 81071897]; Ministry of Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education	This study was supported by a grant from the National Natural Science Foundation of China (no. 81272645 and no. 81071897) and the Scholarship Award for Excellent Doctoral Student granted by Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Callens C, 2012, J CLIN ONCOL, V30, P1966, DOI 10.1200/JCO.2011.39.7661; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hayashi H, 1995, HEPATOLOGY, V22, P1702; Honda K, 1998, BRIT J CANCER, V77, P776, DOI 10.1038/bjc.1998.126; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Ibusuki M, 2011, CANCER SCI, V102, P439, DOI 10.1111/j.1349-7006.2010.01801.x; Iwatsuki M, 2010, INT J CANCER, V126, P1828, DOI 10.1002/ijc.24879; Kwak EL, 2005, GYNECOL ONCOL, V98, P124, DOI 10.1016/j.ygyno.2005.04.007; Li Y, 2009, CLIN CANCER RES, V15, P6724, DOI 10.1158/1078-0432.CCR-09-1296; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Peng ZH, 2005, HUM GENE THER, V16, P1016, DOI 10.1089/hum.2005.16.1016; Piao Z, 1997, CANCER-AM CANCER SOC, V80, P865; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tu KS, 2012, HEPATOL RES, V42, P904, DOI 10.1111/j.1872-034X.2012.01005.x; Tu KS, 2012, MOL MED REP, V6, P525, DOI 10.3892/mmr.2012.953; Wang ZW, 2011, BIOESSAYS, V33, P851, DOI 10.1002/bies.201100101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Xie Q, 2012, GENE, V499, P303, DOI 10.1016/j.gene.2012.02.007; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846	29	49	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68574	10.1371/journal.pone.0068574	http://dx.doi.org/10.1371/journal.pone.0068574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840897	gold, Green Published, Green Submitted			2022-12-27	WOS:000321271900036
J	Yi, M; Marathe, A				Yi, Ming; Marathe, Achla			Policy Trap and Optimal Subsidization Policy under Limited Supply of Vaccines	PLOS ONE			English	Article							HERD-IMMUNITY; VACCINATION; BEHAVIOR; DYNAMICS; NETWORKS	We adopt a susceptible-infected-susceptible (SIS) model on a Barabasi and Albert (BA) network to investigate the effects of different vaccine subsidization policies. The goal is to control the prevalence of the disease given a limited supply and voluntary uptake of vaccines. The results show a uniform subsidization policy is always harmful and increases the prevalence of the disease, because the lower degree individuals' demand for vaccine crowds out the higher degree individuals' demand. In the absence of an effective uniform policy, we explore a targeted subsidization policy which relies on a proxy variable instead of individuals' connectivity. Findings show a poor proxy-based targeted program can still increase the disease prevalence and become a policy trap. The results are robust to general scale-free networks.	[Yi, Ming; Marathe, Achla] Virginia Tech, VBI, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA; [Yi, Ming] Virginia Tech, Dept Econ, Blacksburg, VA USA; [Marathe, Achla] Virginia Tech, Dept Agr & Appl Econ, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Marathe, A (corresponding author), Virginia Tech, VBI, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA.	amarathe@vbi.vt.edu			Defense Threat Reduction Agency (DTRA) [HDTRA1-11-1-0016]; DTRA CNIMS [HDTRA1-11-D-0016-0001]; National Institutes of Health (NIH) Models of Infectious Disease Agent Study (MIDAS) [2U01GM070694-09]; NIH MIDAS [3U01FM070694-09S1]; National Science Foundation (NSF) ICES [CCF-1216000]; NSF NetSE [CNS-1011769]; Direct For Computer & Info Scie & Enginr [1216000] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); DTRA CNIMS; National Institutes of Health (NIH) Models of Infectious Disease Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) ICES(National Science Foundation (NSF)); NSF NetSE(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Defense Threat Reduction Agency (DTRA) Grant HDTRA1-11-1-0016 (http://www.dtra.mil/), DTRA CNIMS Contract HDTRA1-11-D-0016-0001 (http://www.dtra.mil/), National Institutes of Health (NIH) Models of Infectious Disease Agent Study (MIDAS) Grant 2U01GM070694-09 (http://www.nigms.nih.gov/Research/FeaturedPrograms/MIDAS/), NIH MIDAS Grant 3U01FM070694-09S1 (http://www.nigms.nih.gov/Research/FeaturedPrograms/MIDAS/), National Science Foundation (NSF) ICES Grant CCF-1216000 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503549), and NSF NetSE Grant CNS-1011769 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503325). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Beckman RJ, 1996, TRANSPORT RES A-POL, V30, P415, DOI 10.1016/0965-8564(96)00004-3; Bisset K., 2009, DOE SCIDAC MAG, V66, P36; Bisset KR, 2009, ICS'09: PROCEEDINGS OF THE 2009 ACM SIGARCH INTERNATIONAL CONFERENCE ON SUPERCOMPUTING, P430, DOI 10.1145/1542275.1542336; Canh DG, 2006, HEALTH POLICY PLANN, V21, P241, DOI 10.1093/heapol/czl009; Chen JZ, 2010, LECT NOTES COMPUT SC, V6007, P218, DOI 10.1007/978-3-642-12079-4_28; Diekmann O., 2000, MATH EPIDEMIOLOGY IN, V5; Erdos P., 1960, EVOLUTION RANDOM GRA; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67249	10.1371/journal.pone.0067249	http://dx.doi.org/10.1371/journal.pone.0067249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840869	Green Published, gold, Green Submitted			2022-12-27	WOS:000321271900008
J	Hung, PH; Tsai, HB; Lin, CH; Hung, KY				Hung, Peir-Haur; Tsai, Hung-Bin; Lin, Chien-Hung; Hung, Kuan-Yu			Abdominal Obesity Is Associated with Peripheral Artery Disease in Hemodialysis Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE INDEX; METABOLIC SYNDROME; CARDIOVASCULAR MORTALITY; INFLAMMATORY MARKERS; ADIPOSE-TISSUE; RISK-FACTORS; INSULIN-RESISTANCE	Background: Peripheral arterial disease (PAD) is a leading cause of morbidity in hemodialysis (HD) patients. Recent evidence suggests that abdominal obesity (AO) may play a role in PAD. However, the association between AO and PAD has not been thoroughly studied in HD patients. Methods: The present cross-sectional study aimed to examine the relationship between AO and PAD in a cohort of 204 chronic HD patients. The ankle brachial index (ABI) was used as an estimate of the presence of PAD. Plasma adiponectin levels, interleukin-6 (IL-6) levels, high sensitivity C-reactive protein (hs-CRP) levels, asymmetric dimethylarginine (ADMA) levels, and lipid profiles were measured. Logistic regression was used to estimate the association between the presence of PAD and AO as well as other potential risk factors. Results: The metabolic risk factors and all individual traits, including elevated ln-transformed hs-CRP, were found to be significant (P<0.05) more frequently in HD patients with AO than that in control subjects. Patients with AO had a higher prevalence of PAD than the control individuals, with a mean ABI of 0.96 +/- 0.23 and 1.08 +/- 0.16 (P<0.0001) and PAD prevalence of 26.9% and 10.8% (P=0.003), respectively. By multivariate analysis, AO (odds ratio [OR], 4.532; 95% CI, 1.765-11.639; P=0.002), elevated serum ln-transformed ADMA (OR, 5.535; 95% CI, 1.323-23.155; P=0.019), and ln-transformed IL-6 (OR, 1.567; 95% CI, 1.033-2.378; P=0.035) were independent predictors of the presence of PAD. Conclusions: HD patients with AO exhibited a cluster of metabolic risk factors and lower ABI. AO, elevated serum lntransformed ADMA, and ln-transformed IL-6 were independent predictors of the presence of PAD.	[Hung, Peir-Haur] Ditmanson Med Fdn Chia Yi Christian Hosp, Dept Internal Med, Chiayi, Taiwan; [Hung, Peir-Haur] Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth, Tainan, Taiwan; [Tsai, Hung-Bin] Natl Taiwan Univ Hosp, Dept Tramatol, Taipei, Taiwan; [Lin, Chien-Hung] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Chien-Hung] Taipei City Hosp, Zhongxing Branch, Dept Pediat, Taipei, Taiwan; [Hung, Kuan-Yu] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Chia Nan University of Pharmacy & Science; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; National Taiwan University; National Taiwan University Hospital	Hung, KY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	kyhung@ntu.edu.tw	Tsai, Hung-Bin/G-3761-2011	HUNG, KUAN-YU/0000-0003-3472-5512; Tsai, Hung-Bin/0000-0002-0689-8339	National Science Council [NSC 97-2314-B-002-053-MY3]; Mrs. Hsiu-Chin Lee Kidney Foundation	National Science Council(Ministry of Science and Technology, Taiwan); Mrs. Hsiu-Chin Lee Kidney Foundation	This study was supported by grants from the National Science Council (NSC 97-2314-B-002-053-MY3) and Mrs. Hsiu-Chin Lee Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardena MY, 2009, CURR PHARM DESIGN, V15, P1809, DOI 10.2174/138161209788186290; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Boger RH, 2000, J AM COLL CARDIOL, V36, P2287, DOI 10.1016/S0735-1097(00)01013-5; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; Burton JO, 2012, NEPHROL DIAL TRANSPL, V27, P1860, DOI 10.1093/ndt/gfr574; Carbayo JA, 2007, NUTR METAB CARDIOVAS, V17, P41, DOI 10.1016/j.numecd.2005.08.009; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooke JP, 2010, J AM COLL CARDIOL, V55, P2017, DOI 10.1016/j.jacc.2009.08.090; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; DAUGIRDAS JT, 2001, HDB DIALYSIS, P15; de Vinuesa SG, 2006, J AM SOC NEPHROL, V17, pS206, DOI 10.1681/ASN.2006080916; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; FISHBANE S, 1995, AM J KIDNEY DIS, V25, P34, DOI 10.1016/0272-6386(95)90622-3; Furuki K, 2007, ATHEROSCLEROSIS, V191, P206, DOI 10.1016/j.atherosclerosis.2006.03.022; Golledge J, 2007, J VASC SURG, V45, P40, DOI 10.1016/j.jvs.2006.09.006; Gorter PM, 2004, ATHEROSCLEROSIS, V173, P363, DOI 10.1016/j.atherosclerosis.2003.12.033; Haddy N, 2003, ATHEROSCLEROSIS, V170, P277, DOI 10.1016/S0021-9150(03)00287-9; Hozawa A, 2004, HYPERTENS RES, V27, P955, DOI 10.1291/hypres.27.955; Joviliano EE, 2011, ANN VASC SURG, V25, P846, DOI 10.1016/j.avsg.2011.02.026; Jurek A, 2008, CLIN BIOCHEM, V41, P1015, DOI 10.1016/j.clinbiochem.2008.04.019; Kals J, 2006, AM J HYPERTENS, V19, P902, DOI 10.1016/j.amjhyper.2006.02.003; Klouche M, 2000, CIRCULATION, V101, P1799, DOI 10.1161/01.CIR.101.15.1799; Komulainen P, 2007, AGE AGEING, V36, P443, DOI 10.1093/ageing/afm051; Libra M, 2006, J CLIN PATHOL, V59, P211, DOI 10.1136/jcp.2004.025452; McDermott MM, 2005, AM HEART J, V150, P276, DOI 10.1016/j.ahj.2004.09.032; Nylaende M, 2006, VASC MED, V11, P21, DOI 10.1191/1358863x06vm662oa; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; Olijhoek JK, 2004, EUR HEART J, V25, P342, DOI 10.1016/j.ehj.2003.12.007; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; Planas A, 2001, INT J OBESITY, V25, P1068, DOI 10.1038/sj.ijo.0801638; Postorino M, 2009, J AM COLL CARDIOL, V53, P1265, DOI 10.1016/j.jacc.2008.12.040; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Saetre T, 2011, ANGIOLOGY, V62, P301, DOI 10.1177/0003319710385338; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Sjostrom L, 1998, ACTA MED SCAND, V723, P169; Suda O, 2004, ARTERIOSCL THROM VAS, V24, P1682, DOI 10.1161/01.ATV.0000136656.26019.6e; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Tarkun I, 2005, EUR J ENDOCRINOL, V153, P115, DOI 10.1530/eje.1.01948; Toikka JO, 1999, ARTERIOSCL THROM VAS, V19, P436, DOI 10.1161/01.ATV.19.2.436; Tzoulaki I, 2005, CIRCULATION, V112, P976, DOI 10.1161/CIRCULATIONAHA.104.513085; Vaziri ND, 2009, KIDNEY INT, V76, P437, DOI 10.1038/ki.2009.177; VOGT MT, 1993, AM J EPIDEMIOL, V137, P559, DOI 10.1093/oxfordjournals.aje.a116709; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Witasp A, 2011, J INTERN MED, V269, P410, DOI 10.1111/j.1365-2796.2010.02293.x; Yang SY, 2007, BLOOD PURIFICAT, V25, P252, DOI 10.1159/000101698; Yu HI, 2004, DIABETIC MED, V21, P336, DOI 10.1111/j.1464-5491.2004.01144.x; Zeymer U, 2009, CLIN RES CARDIOL, V98, P249, DOI 10.1007/s00392-009-0754-1; Zoccali C, 2004, NEPHROL DIAL TRANSPL, V19, P67, DOI 10.1093/ndt/gfh1059	49	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67555	10.1371/journal.pone.0067555	http://dx.doi.org/10.1371/journal.pone.0067555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840739	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400106
J	Kamnev, A; Muhar, M; Preinreich, M; Ammer, H; Propst, F				Kamnev, Anton; Muhar, Matthias; Preinreich, Martina; Ammer, Hermann; Propst, Friedrich			Difficulties in Generating Specific Antibodies for Immunohistochemical Detection of Nitrosylated Tubulins	PLOS ONE			English	Article							PROTEIN S-NITROSYLATION; NITRIC-OXIDE; DENITROSYLATION; IDENTIFICATION; CYSTEINES	Protein S-nitrosylation, the covalent attachment of a nitroso moiety to thiol groups of specific cysteine residues, is one of the major pathways of nitric oxide signaling. Hundreds of proteins are subject to this transient post-translational modification and for some the functional consequences have been identified. Biochemical assays for the analysis of protein S-nitrosylation have been established and can be used to study if and under what conditions a given protein is S-nitrosylated. In contrast, the equally desirable subcellular localization of specific S-nitrosylated protein isoforms has not been achieved to date. In the current study we attempted to specifically localize S-nitrosylated a-and b-tubulin isoforms in primary neurons after fixation. The approach was based on in situ replacement of the labile cysteine nitroso modification with a stable tag and the subsequent use of antibodies which recognize the tag in the context of the tubulin polypeptide sequence flanking the cysteine residue of interest. We established a procedure for tagging S-nitrosylated proteins in cultured primary neurons and obtained polyclonal anti-tag antibodies capable of specifically detecting tagged proteins on immunoblots and in fixed cells. However, the antibodies were not specific for tubulin isoforms. We suggest that different tagging strategies or alternative methods such as fluorescence resonance energy transfer techniques might be more successful.	[Kamnev, Anton; Muhar, Matthias; Preinreich, Martina; Propst, Friedrich] Univ Vienna, Max F Perutz Labs, Dept Biochem & Cell Biol, Vienna, Austria; [Ammer, Hermann] Univ Munich, Inst Pharmacol Toxicol & Pharm, Munich, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Munich	Propst, F (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Biochem & Cell Biol, Vienna, Austria.	friedrich.propst@univie.ac.at	Kamnev, Anton/AAC-5794-2019	Kamnev, Anton/0000-0002-6279-3486; Muhar, Matthias/0000-0002-3018-9698; Ammer, Hermann/0000-0003-4935-0207	(Doktoratskolleg Molecular Mechanisms of Cell Signaling) from the Austrian Science Fund (FWF) [P20839-B09, W1220-B09]; Austrian Science Fund (FWF) [P 20839] Funding Source: researchfish	(Doktoratskolleg Molecular Mechanisms of Cell Signaling) from the Austrian Science Fund (FWF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants P20839-B09 and W1220-B09 (Doktoratskolleg Molecular Mechanisms of Cell Signaling) from the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camerini S, 2007, J PROTEOME RES, V6, P3224, DOI 10.1021/pr0701456; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Ckless K, 2004, NITRIC OXIDE-BIOL CH, V11, P216, DOI 10.1016/j.niox.2004.06.002; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Harris LK, 2008, EXP CELL RES, V314, P1765, DOI 10.1016/j.yexcr.2008.02.010; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; KashibaIwatsuki M, 1997, J BIOCHEM-TOKYO, V122, P1208; Landino LM, 2007, CHEM RES TOXICOL, V20, P1693, DOI 10.1021/tx7001492; Mallis RJ, 2001, BIOCHEM J, V355, P145, DOI 10.1042/bj3550145; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Selvakumar B, 2013, P NATL ACAD SCI USA, V110, P1077, DOI 10.1073/pnas.1221295110; Stroissnigg H, 2007, NAT CELL BIOL, V9, P1035, DOI 10.1038/ncb1625; Yang Y, 2005, P NATL ACAD SCI USA, V102, P117, DOI 10.1073/pnas.0405989102; Yun HY, 1997, MOL PSYCHIATR, V2, P300, DOI 10.1038/sj.mp.4000272; Zhelyaskov VR, 1998, PHOTOCHEM PHOTOBIOL, V67, P282, DOI 10.1111/j.1751-1097.1998.tb05200.x	27	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68168	10.1371/journal.pone.0068168	http://dx.doi.org/10.1371/journal.pone.0068168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840827	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400170
J	Martin, G; Baurens, FC; Cardi, C; Aury, JM; D'Hont, A				Martin, Guillaume; Baurens, Franc-Christophe; Cardi, Celine; Aury, Jean-Marc; D'Hont, Angelique			The Complete Chloroplast Genome of Banana (Musa acuminata, Zingiberales): Insight into Plastid Monocotyledon Evolution	PLOS ONE			English	Article							TRANSFER-RNA GENES; COMPLETE SEQUENCE; DNA; PLANTS; ORGANIZATION; ANGIOSPERMS; PHYLOGENY; MARKERS; RICE; IDENTIFICATION	Background: Banana (genus Musa) is a crop of major economic importance worldwide. It is a monocotyledonous member of the Zingiberales, a sister group of the widely studied Poales. Most cultivated bananas are natural Musa inter-(sub-)specific triploid hybrids. A Musa acuminata reference nuclear genome sequence was recently produced based on sequencing of genomic DNA enriched in nucleus. Methodology/Principal Findings: The Musa acuminata chloroplast genome was assembled with chloroplast reads extracted from whole-genome-shotgun sequence data. The Musa chloroplast genome is a circular molecule of 169,972 bp with a quadripartite structure containing two single copy regions, a Large Single Copy region (LSC, 88,338 bp) and a Small Single Copy region (SSC, 10,768 bp) separated by Inverted Repeat regions (IRs, 35,433 bp). Two forms of the chloroplast genome relative to the orientation of SSC versus LSC were found. The Musa chloroplast genome shows an extreme IR expansion at the IR/SSC boundary relative to the most common structures found in angiosperms. This expansion consists of the integration of three additional complete genes (rps15, ndhH and ycf1) and part of the ndhA gene. No such expansion has been observed in monocots so far. Simple Sequence Repeats were identified in the Musa chloroplast genome and a new set of Musa chloroplastic markers was designed. Conclusion: The complete sequence of M. acuminata ssp malaccensis chloroplast we reported here is the first one for the Zingiberales order. As such it provides new insight in the evolution of the chloroplast of monocotyledons. In particular, it reinforces that IR/SSC expansion has occurred independently several times within monocotyledons. The discovery of new polymorphic markers within Musa chloroplast opens new perspectives to better understand the origin of cultivated triploid bananas.	[Martin, Guillaume; Baurens, Franc-Christophe; Cardi, Celine; D'Hont, Angelique] UMR AGAP, CIRAD Ctr Cooperat Int Rech Agron Dev, Montpellier, France; [Aury, Jean-Marc] Genoscope, Evry, France	CIRAD; Universite de Montpellier	D'Hont, A (corresponding author), UMR AGAP, CIRAD Ctr Cooperat Int Rech Agron Dev, Montpellier, France.	angelique.d'hont@cirad.fr	Aury, Jean-Marc/N-1621-2019; BAURENS, Franc-Christophe/ABC-7226-2021; DHONT, Angélique/AAL-8074-2021	Aury, Jean-Marc/0000-0003-1718-3010; BAURENS, Franc-Christophe/0000-0002-5219-8771; Martin, Guillaume/0000-0002-1801-7500	Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD); French National Research Agency (ANR); Commissariat a l'Energie Atomique (CEA)	Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD); French National Research Agency (ANR)(French National Research Agency (ANR)); Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	Funding: Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD), French National Research Agency (ANR) and Commissariat a l'Energie Atomique (CEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1962, EVOLUTION BANANAS; Bendich AJ, 2004, PLANT CELL, V16, P1661, DOI 10.1105/tpc.160771; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Boonruangrod R, 2008, THEOR APPL GENET, V118, P43, DOI 10.1007/s00122-008-0875-3; Carreel F, 2002, GENOME, V45, P679, DOI [10.1139/g02-033, 10.1139/G02-033]; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Cullis CA, 2009, ANN BOT-LONDON, V103, P625, DOI 10.1093/aob/mcn173; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; De Langhe E, 2010, ANN BOT-LONDON, V106, P849, DOI 10.1093/aob/mcq187; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Downie S, 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; FAURE S, 1994, CURR GENET, V25, P265, DOI 10.1007/BF00357172; Givnish TJ, 2010, ANN MO BOT GARD, V97, P584, DOI 10.3417/2010023; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Grassi F, 2002, VITIS; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; HOWE CJ, 1988, CURR GENET, V13, P343, DOI 10.1007/BF00424430; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jheng CF, 2012, PLANT SCI, V190, P62, DOI 10.1016/j.plantsci.2012.04.001; KATAYAMA H, 1993, CURR GENET, V23, P160, DOI 10.1007/BF00352016; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim JS, 2006, PLANT CELL REP, V25, P334, DOI 10.1007/s00299-005-0097-y; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Lescot T., 2011, FRUITROP, V189, P58; Logacheva MD, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1324, DOI 10.1134/S0006297907120061; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Melotto-Passarin DM, 2011, GENET MOL RES, V10, P2024, DOI 10.4238/vol10-3gmr1019; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; PALMER JD, 1983, NATURE, V301, P92, DOI 10.1038/301092a0; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raboin LM, 2005, MOL BREEDING, V16, P333, DOI 10.1007/s11032-005-2452-7; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Renoult JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-248; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shahmuradov IA, 2003, PLANT MOL BIOL, V52, P923, DOI 10.1023/A:1025472709537; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Terrab A, 2006, AM J BOT, V93, P1274, DOI 10.3732/ajb.93.9.1274; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Uthaipaisanwong P, 2012, GENE, V500, P172, DOI 10.1016/j.gene.2012.03.061; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872	63	67	71	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67350	10.1371/journal.pone.0067350	http://dx.doi.org/10.1371/journal.pone.0067350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840670	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400061
J	Richardson, K; Allen, SP; Mortiboys, H; Grierson, AJ; Wharton, SB; Ince, PG; Shaw, PJ; Heath, PR				Richardson, Katie; Allen, Scott P.; Mortiboys, Heather; Grierson, Andrew J.; Wharton, Stephen B.; Ince, Paul G.; Shaw, Pamela J.; Heath, Paul R.			The Effect of SOD1 Mutation on Cellular Bioenergetic Profile and Viability in Response to Oxidative Stress and Influence of Mutation-Type	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE GENE; FAMILIAL ALS; MITOCHONDRIAL DYSFUNCTION; MOTOR-NEURONS; MUTANT SOD1; MOUSE MODEL; IN-VITRO; HYDROGEN-PEROXIDE; NITRIC-OXIDE	Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the progressive degeneration of motor neurons. Substantial evidence implicates oxidative stress and mitochondrial dysfunction as early events in disease progression. Our aim was to ascertain whether mutation of the SOD1 protein increases metabolic functional susceptibility to oxidative stress. Here we used a motor neuron-like cell line (NSC34) stably transfected with various human mutant SOD1 transgenes (G93A, G37R, H48Q) to investigate the impact of oxidative stress on cell viability and metabolic function within intact cells. NSC34 cells expressing mutant SOD1 showed a dose dependent reduction in cell viability when exposed to oxidative stress induced by hydrogen peroxide, with variation between mutations. The G93A transfectants showed greater cell death and LDH release compared to cells transfected with the other SOD1 mutations, and H48Q showed an accelerated decline at later time points. Differences in mitochondrial bioenergetics, including mitochondrial respiration, coupling efficiency and proton leak, were identified between the mutations, consistent with the differences observed in viability. NSC34 cells expressing G93A SOD1 displayed reduced coupled respiration and mitochondrial membrane potential compared to controls. Furthermore, the G93A mutation had significantly increased metabolic susceptibility to oxidative stress, with hydrogen peroxide increasing ROS production, reducing both cellular oxygen consumption and glycolytic flux in the cell. This study highlights bioenergetic defects within a cellular model of ALS and suggests that oxidative stress is not only detrimental to oxygen consumption but also glycolytic flux, which could lead to an energy deficit in the cell.	[Richardson, Katie; Allen, Scott P.; Mortiboys, Heather; Grierson, Andrew J.; Wharton, Stephen B.; Ince, Paul G.; Shaw, Pamela J.; Heath, Paul R.] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield, S Yorkshire, England	University of Sheffield	Allen, SP (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield, S Yorkshire, England.	s.p.allen@sheffield.ac.uk	Grierson, Andy/A-5067-2009; Mortiboys, Heather/E-8838-2010	Grierson, Andy/0000-0001-7039-6731; Mortiboys, Heather/0000-0001-6439-0579; Allen, Scott/0000-0003-4418-7375; Wharton, Stephen B/0000-0003-2785-333X; Shaw, Pamela/0000-0002-8925-2567	University of Sheffield; British Neuropathological Society (BNS) small project grant; European Union [HEALTH-F2-2008-223388]; Neurocare; National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish	University of Sheffield; British Neuropathological Society (BNS) small project grant; European Union(European Commission); Neurocare; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a PhD scholarship from The University of Sheffield, a Research and Innovation award from The University of Sheffield (http://www.shef.ac.uk/ris), a British Neuropathological Society (BNS) small project grant to SBW (http://www.bns.org.uk/), and by the European Union under the 7th Framework Program for RTD (SA, AJG and PJS) - Project MitoTarget - Grant Agreement HEALTH-F2-2008-223388 (http://ec.europa.eu/research/fp7/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Neurocare for funding the Seahorse XF24 analyzer and Dr Neil Cashman for his kind gift of the original NSC34 cell line.	Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Ainscow EK, 1999, EUR J BIOCHEM, V263, P671, DOI 10.1046/j.1432-1327.1999.00534.x; Andersen PM, 2006, CURR NEUROL NEUROSCI, V6, P37, DOI 10.1007/s11910-996-0008-9; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Arciello M, 2010, J NEUROCHEM, V112, P183, DOI 10.1111/j.1471-4159.2009.06441.x; Barber SC, 2009, FREE RADICAL BIO MED, V46, P1127, DOI 10.1016/j.freeradbiomed.2009.01.019; Battistini S, 2005, J NEUROL, V252, P782, DOI 10.1007/s00415-005-0742-y; Bendotti C, 2004, TRENDS MOL MED, V10, P393, DOI 10.1016/j.molmed.2004.06.009; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BROWN GC, 1990, EUR J BIOCHEM, V192, P355, DOI 10.1111/j.1432-1033.1990.tb19234.x; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Carri MT, 1997, FEBS LETT, V414, P365, DOI 10.1016/S0014-5793(97)01051-X; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Choi SW, 2011, J NEUROSCI, V31, P4524, DOI 10.1523/JNEUROSCI.5817-10.2011; Colussi C, 2000, FASEB J, V14, P2266, DOI 10.1096/fj.00-0074com; Cozzolino M, 2009, ANTIOXID REDOX SIGN, V11, P1547, DOI 10.1089/ARS.2009.2545; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Duffy LM, 2011, NEUROPATH APPL NEURO, V37, P336, DOI 10.1111/j.1365-2990.2011.01166.x; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Ferraiuolo L, 2011, BRAIN, V134, P2627, DOI 10.1093/brain/awr193; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Jung CW, 2002, J NEUROCHEM, V83, P535, DOI 10.1046/j.1471-4159.2002.01112.x; Jung CW, 2002, J NEUROSCI METH, V114, P165, DOI 10.1016/S0165-0270(01)00524-6; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; Magrane J, 2009, HUM MOL GENET, V18, P4552, DOI 10.1093/hmg/ddp421; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Mazzio EA, 2004, BRAIN RES, V1004, P29, DOI 10.1016/j.brainres.2003.12.034; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Murata T, 2008, J NEUROL SCI, V267, P66, DOI 10.1016/j.jns.2007.09.038; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Pan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033409; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Strom AL, 2008, J BIOL CHEM, V283, P22795, DOI 10.1074/jbc.M800276200; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Varghese M, 2011, TRANSL NEUROSCI, V2, P1, DOI 10.2478/s13380-011-0011-8; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	54	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e68256	10.1371/journal.pone.0068256	http://dx.doi.org/10.1371/journal.pone.0068256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840839	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000321148400181
J	Serna, E; Morales, JM; Mata, M; Gonzalez-Darder, J; Miguel, TS; Gil-Benso, R; Lopez-Gines, C; Cerda-Nicolas, M; Monleon, D				Serna, Eva; Manuel Morales, Jose; Mata, Manuel; Gonzalez-Darder, Jose; San Miguel, Teresa; Gil-Benso, Rosario; Lopez-Gines, Concha; Cerda-Nicolas, Miguel; Monleon, Daniel			Gene Expression Profiles of Metabolic Aggressiveness and Tumor Recurrence in Benign Meningioma	PLOS ONE			English	Article							GROWTH; CANCER; HALLMARKS; TAURINE; INSULIN; TISSUE	Around 20% of meningiomas histologically benign may be clinically aggressive and recur. This strongly affects management of meningioma patients. There is a need to evaluate the potential aggressiveness of an individual meningioma. Additional criteria for better classification of meningiomas will improve clinical decisions as well as patient follow up strategy after surgery. The aim of this study was to determine the relationship between gene expression profiles and new metabolic subgroups of benign meningioma with potential clinical relevance. Forty benign and fourteen atypical meningioma tissue samples were included in the study. We obtained metabolic profiles by NMR and recurrence after surgery information for all of them. We measured gene expression by oligonucleotide microarray measurements on 19 of them. To our knowledge, this is the first time that distinct gene expression profiles are reported for benign meningioma molecular subgroups with clinical correlation. Our results show that metabolic aggressiveness in otherwise histological benign meningioma proceeds mostly through alterations in the expression of genes involved in the regulation of transcription, mainly the LMO3 gene. Genes involved in tumor metabolism, like IGF1R, are also differentially expressed in those meningioma subgroups with higher rates of membrane turnover, higher energy demand and increased resistance to apoptosis. These new subgroups of benign meningiomas exhibit different rates of recurrence. This work shows that benign meningioma with metabolic aggressiveness constitute a subgroup of potentially recurrent tumors in which alterations in genes regulating critical features of aggressiveness, like increased angiogenesis or cell invasion, are still no predominant. The determination of these gene expression biosignatures may allow the early detection of clinically aggressive tumors.	[Serna, Eva; Manuel Morales, Jose; Mata, Manuel] Univ Valencia, Unidad Cent Invest Med, Valencia, Spain; [Gonzalez-Darder, Jose] Univ Valencia, Hosp Clin, Serv Neurocirugia, Valencia, Spain; [San Miguel, Teresa; Gil-Benso, Rosario; Lopez-Gines, Concha; Cerda-Nicolas, Miguel] Univ Valencia, Dept Patol, Valencia, Spain; [Cerda-Nicolas, Miguel] Ctr Invest Biomed Red Enfermedades Resp CIBER RES, Madrid, Spain; [Monleon, Daniel] Univ Valencia, Hosp Clin, Fdn Invest, Inst Invest Sanitaria Clin Valencia INCLIVA, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Valencia	Monleon, D (corresponding author), Univ Valencia, Hosp Clin, Fdn Invest, Inst Invest Sanitaria Clin Valencia INCLIVA, Valencia, Spain.	Daniel.Monleon@uv.es	tatay, jose manuel morales/L-7972-2014; Monleon, Daniel/GNP-4083-2022; serna, eva/Z-1433-2019; Morcillo, Esteban/I-1552-2015; Monleon, Daniel/A-5078-2010; Roig, Manuel Mata/G-4338-2015; San-Miguel, Teresa/D-7784-2018	tatay, jose manuel morales/0000-0002-4404-6735; Monleon, Daniel/0000-0002-4803-1573; serna, eva/0000-0002-2968-3349; Morcillo, Esteban/0000-0003-4373-9457; Monleon, Daniel/0000-0002-4803-1573; Roig, Manuel Mata/0000-0002-1506-7983; San-Miguel, Teresa/0000-0003-1892-6285	Conselleria de Sanidad [GV-AP119/10, GV-AP023/10]; Conselleria de Educacion de la Generalitat Valenciana [PROMETEO11/2011/083, FPA/2011/054, ACOMP2011-237]; Ministerio de Educacion y Ciencia del Gobierno de Espana [SAF2011-23029]; Ministerio de Educacion y Ciencia del Gobierno de Espana for a Ramon y Cajal Contract	Conselleria de Sanidad; Conselleria de Educacion de la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Ministerio de Educacion y Ciencia del Gobierno de Espana(Spanish Government); Ministerio de Educacion y Ciencia del Gobierno de Espana for a Ramon y Cajal Contract(German Research Foundation (DFG))	This study was partly financed by grants from the Conselleria de Sanidad (GV-AP119/10 and GV-AP023/10) and the Conselleria de Educacion (PROMETEO11/2011/083, FPA/2011/054, and ACOMP2011-237) de la Generalitat Valenciana, the Ministerio de Educacion y Ciencia del Gobierno de Espana (SAF2011-23029). DM gratefully acknowledges the Ministerio de Educacion y Ciencia del Gobierno de Espana for a Ramon y Cajal 2006 Contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarhus M, 2011, ACTA NEUROCHIR, V153, P447, DOI 10.1007/s00701-010-0906-0; Aarhus M, 2010, NEUROSURGERY, V67, P998, DOI 10.1227/NEU.0b013e3181ec7b71; Ambros PF, 2001, MED PEDIATR ONCOL, V37, P492, DOI 10.1002/mpo.1242; Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Collins IM, 2010, ACTA ONCOL, V49, P874, DOI 10.3109/02841861003752408; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUMANSKI JP, 1990, CANCER RES, V50, P5863; GREEN TR, 1991, BIOCHIM BIOPHYS ACTA, V1073, P91, DOI 10.1016/0304-4165(91)90187-L; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itahana Y, 2003, CANCER RES, V63, P7098; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Larsen S, 2010, BIOCHEM BIOPH RES CO, V392, P252, DOI 10.1016/j.bbrc.2009.12.010; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Leon R, 2009, J NEUROSCI RES, V87, P1185, DOI 10.1002/jnr.21926; Lopez-Gines C, 2004, CANCER GENET CYTOGEN, V148, P123, DOI 10.1016/S0165-4608(03)00279-6; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mitelman F, 2009, ISCN 1995 INT SYSTEM; Monleon D, 2010, CANCER RES, V70, P8426, DOI 10.1158/0008-5472.CAN-10-1498; Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704; Perry A, 2004, J NEURO-ONCOL, V70, P183, DOI 10.1007/s11060-004-2749-0; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Pfisterer WK, 2004, NEURO-ONCOLOGY, V6, P290, DOI 10.1215/S1152851704000158; Pfisterer WK, 2008, J NEURO-ONCOL, V87, P43, DOI 10.1007/s11060-007-9498-9; Pfisterer WK, 2007, NEUROSURGERY, V61, P1048, DOI 10.1227/01.neu.0000303201.62123.5c; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ragel BT, 2010, J NEURO-ONCOL, V99, P315, DOI 10.1007/s11060-010-0381-8; SANDBERGNORDQVIST AC, 1993, CANCER RES, V53, P2475; Stuart JE, 2010, J NEUROPATHOL EXP NE; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wrobel G, 2005, INT J CANCER, V114, P249, DOI 10.1002/ijc.20733	37	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67291	10.1371/journal.pone.0067291	http://dx.doi.org/10.1371/journal.pone.0067291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840654	Green Submitted, gold, Green Published			2022-12-27	WOS:000321148400054
J	Yokota, H; Imai, Y; Tsuboko, Y; Tokumaru, AM; Fujimoto, H; Harada, K				Yokota, Hajime; Imai, Yasuko; Tsuboko, Yusuke; Tokumaru, Aya M.; Fujimoto, Hajime; Harada, Kazumasa			Nocturnal Blood Pressure Pattern Affects Left Ventricular Remodeling and Late Gadolinium Enhancement in Patients with Hypertension and Left Ventricular Hypertrophy	PLOS ONE			English	Article							CARDIAC MAGNETIC-RESONANCE; NATRIURETIC PEPTIDE; MORTALITY; FIBROSIS; PREVALENCE	Background: Left ventricular hypertrophy (LVH) is an independent predictor of cardiac mortality, regardless of its etiology. Previous studies have shown that high nocturnal blood pressure (BP) affects LV geometry in hypertensive patients. It has been suggested that continuous pressure overload affects the development of LVH, but it is unknown whether persistent pressure influences myocardial fibrosis or whether the etiology of LVH is associated with myocardial fibrosis. Comprehensive cardiac magnetic resonance (CMR) including the late gadolinium enhancement (LGE) technique can evaluate both the severity of changes in LV geometry and myocardial fibrosis. We tested the hypothesis that the nocturnal non-dipper BP pattern causes LV remodeling and fibrosis in patients with hypertension and LVH. Methods: Forty-seven hypertensive patients with LVH evaluated by echocardiography (29 men, age 73.0 +/- 10.4 years) were examined by comprehensive CMR and 24-h ambulatory blood pressure monitoring (ABPM). Results and Conclusions: Among the 47 patients, twenty-four had nocturnal non-dipper BP patterns. Patients with nocturnal non-dipper BP patterns had larger LV masses and scar volumes independent of etiologies than those in patients with dipper BP patterns (p = 0.035 and p = 0.015, respectively). There was no significant difference in mean 24-h systolic BP between patients with and without nocturnal dipper BP patterns (p = 0.367). Among hypertensive patients with LVH, the nocturnal non-dipper blood pressure pattern is associated with both LV remodeling and myocardial fibrosis independent of LVH etiology.	[Yokota, Hajime; Imai, Yasuko; Tsuboko, Yusuke; Fujimoto, Hajime; Harada, Kazumasa] Tokyo Metropolitan Geriatr Hosp, Dept Cardiol, Itabashi Ku, Tokyo 173, Japan; [Tokumaru, Aya M.] Tokyo Metropolitan Geriatr Hosp, Dept Radiol, Itabashi Ku, Tokyo 173, Japan		Yokota, H (corresponding author), Tokyo Metropolitan Geriatr Hosp, Dept Cardiol, Itabashi Ku, Tokyo 173, Japan.	hy14861114@gmail.com	Yokota, Hajime/ABI-7913-2020					Ben-Dov IZ, 2007, HYPERTENSION, V49, P1235, DOI 10.1161/HYPERTENSIONAHA.107.087262; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Conen D, 2006, AM J CARDIOL, V97, P249, DOI 10.1016/j.amjcard.2005.08.028; Dweck MR, 2011, J AM COLL CARDIOL, V58, P1271, DOI 10.1016/j.jacc.2011.03.064; FROHLICH ED, 1992, NEW ENGL J MED, V327, P998, DOI 10.1056/NEJM199210013271406; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Hermida RC, 2011, J AM COLL CARDIOL, V58, P1165, DOI 10.1016/j.jacc.2011.04.043; KANNEL W B, 1970, Annals of Internal Medicine, V72, P813; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; Katholi RE, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/495349; Kwon DH, 2009, J AM COLL CARDIOL, V54, P242, DOI 10.1016/j.jacc.2009.04.026; Maceira AM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-28; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Nakatsu T, 2007, HYPERTENS RES, V30, P651, DOI 10.1291/hypres.30.651; O'Sullivan C, 2003, HYPERTENSION, V42, P130, DOI 10.1161/01.HYP.0000084050.73533.C5; Rudolph A, 2009, J AM COLL CARDIOL, V53, P284, DOI 10.1016/j.jacc.2008.08.064; Sundstrom J, 2001, CIRCULATION, V103, P2346; SUZUKI Y, 1992, J HYPERTENS, V10, P173, DOI 10.1097/00004872-199202000-00011; VERDECCHIA P, 1990, CIRCULATION, V81, P528, DOI 10.1161/01.CIR.81.2.528; Yokota H, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-17	21	17	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67825	10.1371/journal.pone.0067825	http://dx.doi.org/10.1371/journal.pone.0067825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840777	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400117
J	Blatteau, JE; Brubakk, AO; Gempp, E; Castagna, O; Risso, JJ; Vallee, N				Blatteau, Jean-Eric; Brubakk, Alf O.; Gempp, Emmanuel; Castagna, Olivier; Risso, Jean-Jacques; Vallee, Nicolas			Sidenafil Pre-Treatment Promotes Decompression Sickness in Rats	PLOS ONE			English	Article							BUBBLE FORMATION; NITRIC-OXIDE; SILDENAFIL; DIVE; PEROXYNITRITE; ACTIVATION; DAMAGE; PDE5	Vascular bubble formation after decompression contributes to endothelial injuries which form the basis for the development of decompression sickness (DCS). Nitric oxide (NO) is a powerful vasodilator that contributes to vessel homeostasis. It has been shown that NO-releasing agent may reduce bubble formation and prevent serious decompression sickness. The use of sildenafil, a well-known, phosphodiesterase-5 blocker, which act by potentiating the vasodilatory effect on smooth muscle relaxation, has never been studied in DCS. The purpose of the present study was to evaluate the clinical effects of sildenafil pre-treatment on DCS in a rat model. 67 rats were subjected to a simulated dive at 90 msw for 45 min before staged decompression. The experimental group received 10 mg/kg of sildenafil one hour before exposure (n = 35) while controls were not treated (n = 32). Clinical assessment took place over a period of 30 min after surfacing. At the end, blood samples were collected for blood cells counts and the level of circulating bubbles in the right cavities was quantified. There were significantly more manifestations of DCS in the sildenafil group than in the controls (34.3% vs 6.25%, respectively, p = 0.012). Platelet count was more reduced in treated rats than in controls (-21.7% vs -7%, respectively, p = 0.029), whereas bubble grades did not differ between groups. We concluded that pre-treatment with sildenafil promotes the onset and severity of neurological DCS. When considering the use of phosphodiesterase-5 blockers in the context of diving, careful discussion with physician should be recommended.	[Blatteau, Jean-Eric; Castagna, Olivier; Risso, Jean-Jacques; Vallee, Nicolas] Inst Rech Biomed Armees, Dept Environm Operat Environm Extremes, Equipe Residante Rech Subaquat Operat, Toulon, France; [Brubakk, Alf O.] Norwegian Univ Sci & Technol, Med Technol Ctr, Fac Med, Dept Physiol & Biomed Engn, N-7034 Trondheim, Norway; [Castagna, Olivier] Univ Toulon & Var, Lab Motricite Humaine Educ Sport & Sante, Equipe Accueil 6309, Toulon, France; [Gempp, Emmanuel] HIA St Anne, Serv Med Hyperbare & Expertise Plonge, Toulon, France	Norwegian University of Science & Technology (NTNU); Universite de Toulon; Hospital Instruction Of Armees Sainte-Anne	Blatteau, JE (corresponding author), Inst Rech Biomed Armees, Dept Environm Operat Environm Extremes, Equipe Residante Rech Subaquat Operat, Toulon, France.	je.blatteau@infonie.fr						AHN HS, 1991, ELECTRON LETT, V27, P191, DOI 10.1049/el:19910123; Barnett CF, 2006, VASC HEALTH RISK MAN, V2, P411, DOI 10.2147/vhrm.2006.2.4.411; BERGHAGE TE, 1979, UNDERSEA BIOMED RES, V6, P1; Bert P, 1878, BAROMETRIC PRESSURE; Blatteau JE, 2006, AVIAT SPACE ENVIR MD, V77, P1068; Blatteau JE, 2011, NEUROCRIT CARE, V15, P120, DOI 10.1007/s12028-010-9370-1; Blatteau JE, 2008, AVIAT SPACE ENVIR MD, V79, P1100, DOI 10.3357/ASEM.2377.2008; Byoun HS, 2010, J KOREAN NEUROSURG S, V47, P210, DOI 10.3340/jkns.2010.47.3.210; Demchenko IT, 2009, J APPL PHYSIOL, V106, P1234, DOI 10.1152/japplphysiol.91407.2008; Dujic Z, 2006, MED SCI SPORT EXER, V38, P1432, DOI 10.1249/01.mss.0000228936.78916.23; Francis T. J. R., 2003, BENNETT ELLIOTTS PHY, P530; Gempp E, 2010, RES SPORTS MED, V18, P205, DOI 10.1080/15438627.2010.490189; GIRY PBL, 1977, UNDERSEA BIOMED RES, V4, P147; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Gopal VK, 2001, EUR J BIOCHEM, V268, P3304, DOI 10.1046/j.1432-1327.2001.02233.x; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hurlimann D, 2002, EUR HEART J SUPPL, V4, pA1, DOI 10.1016/S1520-765X(02)90067-2; Kotera J, 2000, J HISTOCHEM CYTOCHEM, V48, P685, DOI 10.1177/002215540004800512; LABORIT. H., 1961, AGRESSOLOGIE, V2, P229; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Lin CS, 2006, CURR PHARM DESIGN, V12, P3439, DOI 10.2174/138161206778343064; Mollerlokken A, 2006, J APPL PHYSIOL, V101, P1541, DOI 10.1152/japplphysiol.01191.2005; Montcalm-Smith EA, 2008, AVIAT SPACE ENVIR MD, V79, P7, DOI 10.3357/ASEM.2071.2008; Nishi R. Y., 2003, BENNETT ELLIOTTS PHY, P501; Nossum V, 1999, UNDERSEA HYPERBAR M, V26, P1; Nyquist PA, 2004, AVIAT SPACE ENVIR MD, V 75, P211; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Padma-Nathan H, 1998, INT J CLIN PRACT, V52, P375; Phillips BG, 2000, CIRCULATION, V102, P3068; PHILP R B, 1974, Undersea Biomedical Research, V1, P117; Pontier JM, 2008, AVIAT SPACE ENVIR MD, V79, P1096, DOI 10.3357/ASEM.2352.2008; Sawatzky KD, 1991, THESIS YORK U TORONT; Takizawa Shunya, 2003, J Stroke Cerebrovasc Dis, V12, P196, DOI 10.1016/S1052-3057(03)00074-0; THORSEN T, 1987, UNDERSEA BIOMED RES, V14, P45; Wisloff U, 2004, J PHYSIOL-LONDON, V555, P825, DOI 10.1113/jphysiol.2003.055467; Wisloff U, 2003, J PHYSIOL-LONDON, V546, P577, DOI 10.1113/jphysiol.2002.030338; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73	37	20	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e60639	10.1371/journal.pone.0060639	http://dx.doi.org/10.1371/journal.pone.0060639			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	23580342	Green Published, Green Submitted, gold			2022-12-27	WOS:000317898000044
J	Singh, RR; Lankadeva, YR; Denton, KM; Moritz, KM				Singh, Reetu R.; Lankadeva, Yugeesh R.; Denton, Kate M.; Moritz, Karen M.			Improvement in Renal Hemodynamics following Combined Angiotensin II Infusion and AT1R Blockade in Aged Female Sheep following Fetal Unilateral Nephrectomy	PLOS ONE			English	Article							LOW-PROTEIN DIET; REDUCED NEPHRON NUMBER; LIVING KIDNEY DONORS; BLOOD-PRESSURE; ADULT SHEEP; PRENATAL EXPOSURE; GLUCOCORTICOID TREATMENT; ANTENATAL BETAMETHASONE; CARDIOVASCULAR-DISEASE; ARTERIAL-PRESSURE	Renin-angiotensin system (RAS) is a powerful modulator of renal hemodynamic and fluid homeostasis. Up-regulation in components of intra-renal RAS occurs with ageing. Recently we reported that 2 year old uninephrectomised (uni-x) female sheep have low renin hypertension and reduced renal function. By 5 years of age, these uni-x sheep had augmented decrease in renal blood flow (RBF) compared to sham. We hypothesised that this decrease in RBF in 5 year old uni-x sheep was due to an up-regulation in components of the intra-renal RAS. In this study, renal responses to angiotensin II (AngII) infusion and AngII type 1 receptor (AT1R) blockade were examined in the same 5 year old sheep. We also administered AngII in the presence of losartan to increase AngII bioavailability to the AT2R in order to understand AT2R contribution to renal function in this model. Uni-x animals had significantly lower renal cortical content of renin, AngII (similar to 40%) and Ang 1-7 (similar to 60%) and reduced cortical expression of AT1R gene than sham animals. In response to both AngII infusion and AT1R blockade via losartan, renal hemodynamic responses and tubular sodium excretion were significantly attenuated in uni-x animals compared to sham. However, AngII infusion in the presence of losartan caused similar to 33% increase in RBF in uni-x sheep compared to similar to 14% in sham (P<0.05). This was associated with a significant decrease in renal vascular resistance in the uni-x animals (22% vs 15%, P<0.05) without any changes in systemic blood pressure. The present study shows that majority of the intra-renal RAS components are suppressed in this model of low renin hypertension. However, increasing the availability of AngII to AT2R by AT1R blockade improved renal blood flow in uni-x sheep. This suggests that manipulation of the AT2R maybe a potential therapeutic target for treatment of renal dysfunction associated with a congenital nephron deficit.	[Singh, Reetu R.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Singh, Reetu R.; Lankadeva, Yugeesh R.; Denton, Kate M.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Singh, Reetu R.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Queensland; Monash University; Monash University	Singh, RR (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	Reetu.Singh@monash.edu	Moritz, Karen/G-2508-2015; Lankadeva, Yugeesh/R-9253-2019; Denton, Kate/AAG-2423-2019	Moritz, Karen/0000-0002-8085-0034; Lankadeva, Yugeesh/0000-0002-3589-9111; RAMAKRISHNA, RACHUMALLU/0000-0002-8112-2450; singh, RAJBIR/0000-0002-2307-2360; Denton, Kate/0000-0002-5929-4387	Monash University Bridging Post-Doctoral Fellowship; Faculty Scholarship, Monash University; NH&MRC Senior Research Fellowships; National Heart Foundation; Monash University Strategic Grant Scheme	Monash University Bridging Post-Doctoral Fellowship; Faculty Scholarship, Monash University; NH&MRC Senior Research Fellowships; National Heart Foundation(National Heart Foundation of Australia); Monash University Strategic Grant Scheme(Monash University)	R.R.S was supported by a Monash University Bridging Post-Doctoral Fellowship. Y.R.L was supported by a Faculty Scholarship, Monash University. K. M. M and K. M. D were supported by NH&MRC Senior Research Fellowships. The project was funded by the National Heart Foundation and Monash University Strategic Grant Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, AM J PHYSIOL-RENAL, V283, pF236, DOI 10.1152/ajprenal.00336.2001; Barker DJP, 2005, J AM SOC NEPHROL, V16, P2537, DOI 10.1681/ASN.2005020160; Brenner BM, 1997, KIDNEY INT, pS124; Bucher BS, 2012, THER UMSCH, V69, P295, DOI 10.1024/0040-5930/a000288; Dodic M, 2006, J PHYSIOL-LONDON, V571, P651, DOI 10.1113/jphysiol.2005.102186; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Dodic M, 1999, CLIN EXP PHARMACOL P, V26, P550, DOI 10.1046/j.1440-1681.1999.03076.x; Douglas-Denton R, 2002, J AM SOC NEPHROL, V13, P406, DOI 10.1681/ASN.V132406; Fehrman-Ekholm I, 2001, TRANSPLANTATION, V72, P444, DOI 10.1097/00007890-200108150-00015; Ferrario CM, 1998, AM J HYPERTENS, V11, P137, DOI 10.1016/S0895-7061(97)00400-7; Gossmann J, 2005, AM J TRANSPLANT, V5, P2417, DOI 10.1111/j.1600-6143.2005.01037.x; Herrera M, 2013, HYPERTENSION, V61; Hilliard LM, 2012, HYPERTENSION, V59, P409, DOI 10.1161/HYPERTENSIONAHA.111.184986; Hilliard LM, 2011, HYPERTENSION, V58, pE94; Hilliard LM, 2011, HYPERTENSION, V57, P275, DOI 10.1161/HYPERTENSIONAHA.110.166827; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006; Ibrahim HN, 1998, J AM SOC NEPHROL, V9, P72; Joly E, 2006, AM J PHYSIOL-REG I, V291, pR977, DOI 10.1152/ajpregu.00401.2005; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Lankadeva YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047528; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; McInnes GT, 1999, J CARDIOVASC PHARM, V33, pS29, DOI 10.1097/00005344-199900001-00006; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; Miller JA, 2006, J AM SOC NEPHROL, V17, P2554, DOI 10.1681/ASN.2005101095; Moritz KM, 2010, PLACENTA, V31, pS40, DOI 10.1016/j.placenta.2010.01.006; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Moritz KM, 2002, ENDOCRINOLOGY, V143, P4455, DOI 10.1210/en.2002-220534; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Moritz KM, 1999, PEDIATR NEPHROL, V13, P171, DOI 10.1007/s004670050587; Navar LG, 2004, KIDNEY INT, V65, P1522, DOI 10.1111/j.1523-1755.2004.00539.x; Sahajpal V, 2005, J PHYSIOL-LONDON, V563, P193, DOI 10.1113/jphysiol.2004.078642; Salazar F, 2008, HYPERTENSION, V51, P1184, DOI 10.1161/HYPERTENSIONAHA.107.100750; Sampson AK, 2008, HYPERTENSION, V52, P666, DOI 10.1161/HYPERTENSIONAHA.108.114058; Schreuder MF, 2008, J PAEDIATR CHILD H, V44, P363, DOI 10.1111/j.1440-1754.2008.01315.x; Schulman IH, 2010, AM J NEPHROL, V32, P249, DOI 10.1159/000318607; Shaltout HA, 2010, AM J PHYSIOL-HEART C, V299, pH541, DOI 10.1152/ajpheart.00100.2010; Singh RR, 2007, AM J PHYSIOL-RENAL, V293, pF548, DOI 10.1152/ajprenal.00156.2007; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Singh RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042400; Singh RR, 2012, AM J PHYSIOL-REG I, V302, pR868, DOI 10.1152/ajpregu.00579.2011; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF1168, DOI 10.1152/ajprenal.00463.2011; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF319, DOI 10.1152/ajprenal.00139.2011; Singh RR, 2009, J HYPERTENS, V27, P386, DOI 10.1097/HJH.0b013e32831bc778; Steckelings UM, 2012, CURR OPIN NEPHROL HY, V21, P142, DOI 10.1097/MNH.0b013e328350261b; Vize PD, 1997, DEV BIOL, V188, P189, DOI 10.1006/dbio.1997.8629; Westland R, PEDIATRICS, V131, pe478; Wintour EM, 2003, J PHYSIOL-LONDON, V549, P929, DOI 10.1113/jphysiol.2003.042408; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; Yanes LL, 2006, AM J PHYSIOL-REG I, V291, pR383, DOI 10.1152/ajpregu.00510.2005; Zhang J, 2010, REPROD SCI, V17, P186, DOI 10.1177/1933719109351098	53	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68036	10.1371/journal.pone.0068036	http://dx.doi.org/10.1371/journal.pone.0068036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840884	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900023
J	Cho, SI; Gao, SS; Xia, AP; Wang, R; Salles, FT; Raphael, PD; Abaya, H; Wachtel, J; Baek, J; Jacobs, D; Rasband, MN; Oghalai, JS				Cho, Sung-Il; Gao, Simon S.; Xia, Anping; Wang, Rosalie; Salles, Felipe T.; Raphael, Patrick D.; Abaya, Homer; Wachtel, Jacqueline; Baek, Jongmin; Jacobs, David; Rasband, Matthew N.; Oghalai, John S.			Mechanisms of Hearing Loss after Blast Injury to the Ear	PLOS ONE			English	Article							TYMPANIC-MEMBRANE PERFORATION; NERVE DEGENERATION; BRAIN-INJURY; OVERPRESSURE; EXPOSURE; MODEL; VULNERABILITY; SURVIVORS; RECOVERY; AFFERENT	Given the frequent use of improvised explosive devices (IEDs) around the world, the study of traumatic blast injuries is of increasing interest. The ear is the most common organ affected by blast injury because it is the body's most sensitive pressure transducer. We fabricated a blast chamber to re-create blast profiles similar to that of IEDs and used it to develop a reproducible mouse model to study blast-induced hearing loss. The tympanic membrane was perforated in all mice after blast exposure and found to heal spontaneously. Micro-computed tomography demonstrated no evidence for middle ear or otic capsule injuries; however, the healed tympanic membrane was thickened. Auditory brainstem response and distortion product otoacoustic emission threshold shifts were found to be correlated with blast intensity. As well, these threshold shifts were larger than those found in control mice that underwent surgical perforation of their tympanic membranes, indicating cochlear trauma. Histological studies one week and three months after the blast demonstrated no disruption or damage to the intra-cochlear membranes. However, there was loss of outer hair cells (OHCs) within the basal turn of the cochlea and decreased spiral ganglion neurons (SGNs) and afferent nerve synapses. Using our mouse model that recapitulates human IED exposure, our results identify that the mechanisms underlying blast-induced hearing loss does not include gross membranous rupture as is commonly believed. Instead, there is both OHC and SGN loss that produce auditory dysfunction.	[Cho, Sung-Il; Gao, Simon S.; Xia, Anping; Wang, Rosalie; Salles, Felipe T.; Raphael, Patrick D.; Abaya, Homer; Wachtel, Jacqueline; Oghalai, John S.] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Cho, Sung-Il] Chosun Univ, Dept Otolaryngol Head & Neck Surg, Kwangju, South Korea; [Gao, Simon S.] Rice Univ, Dept Bioengn, Houston, TX USA; [Baek, Jongmin; Jacobs, David] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Rasband, Matthew N.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Stanford University; Chosun University; Rice University; Stanford University; Baylor College of Medicine	Oghalai, JS (corresponding author), Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	joghalai@stanford.edu		Ryoo, Seung Mok/0000-0002-2436-3311; Rasband, Matthew/0000-0001-8184-2477; Gao, Simon/0000-0002-7020-037X	DoD [W81XWH-11-2-0004 (DM090212)]; NIH [K08 DC006671, P30 DC010363]; Chosun University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC006671, P30DC010363] Funding Source: NIH RePORTER	DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chosun University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support came from DoD W81XWH-11-2-0004 (DM090212) and NIH grants K08 DC006671 and P30 DC010363. Sungil Cho was supported by research funds from Chosun University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahroon WA, 1996, J ACOUST SOC AM, V100, P2247, DOI 10.1121/1.417934; Applegate BE, 2011, OPT LETT, V36, P4716, DOI 10.1364/OL.36.004716; Baalman KL, 2012, NEUROTRAUMA IN PRESS; Barden EK, 2012, J AM ACAD AUDIOL, V23, P332, DOI 10.3766/jaaa.23.5.4; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chen ZQ, 2010, J NEUROPHYSIOL, V103, P2581, DOI 10.1152/jn.00018.2010; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Gao SS, 2011, OPT EXPRESS, V19, P15415, DOI 10.1364/OE.19.015415; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; GOLDSTEIN LE, 2012, SCI TRANSL MED, V4; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gutierrez de Ceballos J Peral, 2005, Crit Care Med, V33, pS107, DOI 10.1097/01.CCM.0000151072.17826.72; HAMERNIK RP, 1988, J ACOUST SOC AM, V84, P941, DOI 10.1121/1.396663; HAMERNIK RP, 1984, HEARING RES, V16, P143, DOI 10.1016/0378-5955(84)90004-2; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; HAMERNIK RP, 1987, J ACOUST SOC AM, V81, P1118, DOI 10.1121/1.394632; Helfer Thomas M, 2005, Am J Audiol, V14, P161, DOI 10.1044/1059-0889(2005/018); Horrocks C L, 2001, J R Army Med Corps, V147, P28; Ibekwe T S, 2009, J Laryngol Otol, V123, pe2, DOI 10.1017/S0022215108003800; Jeong HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013756; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Lerut B, 2012, OTOL NEUROTOL, V33, P379, DOI 10.1097/MAO.0b013e318245cea5; LIBERMAN MC, 1990, J COMP NEUROL, V301, P443, DOI 10.1002/cne.903010309; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Liu CC, 2011, JARO-J ASSOC RES OTO, V12, P577, DOI 10.1007/s10162-011-0269-0; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Masel BS, 2012, J NEUROTRAUMA; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Ohlemiller KK, 2011, HEARING RES, V272, P13, DOI 10.1016/j.heares.2010.11.006; Ohlemiller KK, 2010, JARO-J ASSOC RES OTO, V11, P605, DOI 10.1007/s10162-010-0228-1; Ohlemiller KK, 2000, HEARING RES, V149, P239, DOI 10.1016/S0378-5955(00)00191-X; PATOW CA, 1994, OTOLARYNG HEAD NECK, V110, P211, DOI 10.1177/019459989411000211; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; PRICE GR, 1979, J ACOUST SOC AM, V66, P456, DOI 10.1121/1.383096; PRICE GR, 1986, J ACOUST SOC AM, V80, P1076, DOI 10.1121/1.393849; PRICE GR, 1989, J ACOUST SOC AM, V86, P2185, DOI 10.1121/1.398479; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; Radford P, 2011, OTOLARYNG HEAD NECK, V145, P806, DOI 10.1177/0194599811411143; Ritzel DV, 2011, HUM FACT MED PAN S H, P1; Roberto M, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P23; Saliba I, 2011, INT J PEDIATR OTORHI, V75, P527, DOI 10.1016/j.ijporl.2011.01.012; Schulz TY., 2004, HEALTH-LONDON, V20, P18; Sharpnack D.D., 1991, CONVENTIONAL WARFARE, V1, P271; Stuhmiller J. H., 1991, CONVENTIONAL WARFARE, P241; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; [VA Affairs DoV], 2011, VET BEN ADM ANN BEN; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; White CH, 2009, MAMM GENOME, V20, P207, DOI 10.1007/s00335-009-9178-5; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Xia AP, 2010, DIS MODEL MECH, V3, P209, DOI 10.1242/dmm.004135; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Zhang B, 2011, J TRAUMA, V71, P694, DOI 10.1097/TA.0b013e318224595f	59	107	112	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67618	10.1371/journal.pone.0067618	http://dx.doi.org/10.1371/journal.pone.0067618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	24339927	gold, Green Published			2022-12-27	WOS:000321271900013
J	Zhang, Y; Zhang, WN; Lu, K; Ji, RR; Wang, FL; Liu, T				Zhang, Yu; Zhang, Wei-Nan; Lu, Ke; Ji, Rongrong; Wang, Fanglin; Liu, Ting			Phrasal Paraphrase Based Question Reformulation for Archived Question Retrieval	PLOS ONE			English	Article								Lexical gap in cQA search, resulted by the variability of languages, has been recognized as an important and widespread phenomenon. To address the problem, this paper presents a question reformulation scheme to enhance the question retrieval model by fully exploring the intelligence of paraphrase in phrase-level. It compensates for the existing paraphrasing research in a suitable granularity, which either falls into fine-grained lexical-level or coarse-grained sentence-level. Given a question in natural language, our scheme first detects the involved key-phrases by jointly integrating the corpus-dependent knowledge and question-aware cues. Next, it automatically extracts the paraphrases for each identified key-phrase utilizing multiple online translation engines, and then selects the most relevant reformulations from a large group of question rewrites, which is formed by full permutation and combination of the generated paraphrases. Extensive evaluations on a real world data set demonstrate that our model is able to characterize the complex questions and achieves promising performance as compared to the state-of-the-art methods.	[Zhang, Yu; Zhang, Wei-Nan; Liu, Ting] Harbin Inst Technol, Res Ctr Social Comp & Informat Retrieval, Harbin, Heilongjiang, Peoples R China; [Lu, Ke] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ji, Rongrong] Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China; [Wang, Fanglin] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	Harbin Institute of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xiamen University; National University of Singapore	Ji, RR (corresponding author), Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China.	rrji@ee.columbia.edu; hardegg@gmail.com		zhang, longxian/0000-0002-5706-131X; ling, hong/0000-0002-1886-1242; Liu, Jun/0000-0002-0522-6733				[Anonymous], 2006, P LREC; [Anonymous], 2012, P 2012 JOINT C EMP M; Bannard Colin, 2005, P 43 ANN M ASS COMP, P597, DOI [10.3115/1219840.1219914, DOI 10.3115/1219840.1219914]; Barzilay R, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P16; Bendersky M, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P605; Bendersky M, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P941, DOI 10.1145/2348283.2348408; Bendersky Michael, 2010, P 3 ACM INT C WEB SE, P31, DOI [10.1145/1718487.1718492, DOI 10.1145/1718487.1718492]; Bendersky Michael, 2008, P 31 ANN INT ACM SIG, P491, DOI DOI 10.1145/1390334.1390419; Buscaldi D, 2005, CROSS LANG EV FOR CL; CALLAN JP, 1995, INFORM PROCESS MANAG, V31, P327, DOI 10.1016/0306-4573(94)00050-D; Callison-Burch Chris, 2008, P C EMP METH NAT LAN, P196; Chakrabarti D., 2011, P 5 INT AAAI C WEBL, V11, P66; Dinh D, 2011, LECT NOTES COMPUT SC, V6611, P375, DOI 10.1007/978-3-642-20161-5_38; Duclaye F, 2003, P EACL WORKSH NAT LA, P35; Gao Y., 2017, ACM MULTIMEDIA, P1517; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Gao Yue, 2010, P INT C MULT, P123; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Grineva Maria, 2009, P 18 INT C WORLD WID, P661, DOI DOI 10.1145/1526709.1526798; Harabagiu S, 2001, P TEXT RETR C QUEST; Harman D., 1988, 11th International Conference on Research and Development in Information Retrieval, P321; Hovy E., 2001, P 10 TEXT RETRIEVAL; Jianfeng Gao, 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P170; Jinxi Xu, 1996, SIGIR Forum, P4; Kai Wang, 2010, P 23 INT C COMP LING, P1155; Lam-Adesina A. M., 2001, SIGIR Forum, P1; Mihalcea R., 2004, P 2004 C EMP METH NA, P404, DOI DOI 10.3115/1219044.1219064; Ponte J. M., 1998, P 21 ANN INT ACM SIG, P275, DOI DOI 10.1145/290941.291008; Riezler S, 2007, P 45 ANN M ASS COMP, V45, P464; Robertson S, 2002, INFORM RETRIEVAL, V5, P239, DOI 10.1023/A:1015702129514; Robertson S. E., 1995, Text REtrieval Conference (TREC-3) (NIST SP 500-225), P109; Robertson SE, 1999, TREC 99, V8; Sang J., 2012, P 20 ACM INT C MULT, P19; Sang JT, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037687; Song F, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P279, DOI 10.1145/312624.312698; Srikanth M., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P425; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang K, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P187, DOI 10.1145/1571941.1571975; Xu J, 2011, P 20 INT C COMP WORL, P153, DOI [10.1145/1963192.1963270, DOI 10.1145/1963192.1963270]; Xue X., 2008, P 31 ANN INT ACM SIG, P475, DOI 10.1145/1390334.1390416; Yang H, 2005, PDCAT 2005: SIXTH INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED COMPUTING, APPLICATIONS AND TECHNOLOGIES, PROCEEDINGS, P40; Yonggang Qiu, 1993, SIGIR Forum, P160; Zhang ST, 2012, LECT NOTES COMPUT SC, V7573, P660, DOI 10.1007/978-3-642-33709-3_47; Zhang ST, 2012, IEEE T SYST MAN CY B, V42, P838, DOI 10.1109/TSMCB.2011.2179533; Zhao S, 2008, P ACL 08, P1021; Zhao SQ, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1795; Zhao Shiqi, 2010, P COL 2010, P1326; Zhao Shiqi, 2009, P JOINT C 47 ANN M A, V2, P834	48	100	109	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e64601	10.1371/journal.pone.0064601	http://dx.doi.org/10.1371/journal.pone.0064601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23977002	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500006
J	Wang, H; Chen, K; Pan, YF; Jing, FY; Liu, H				Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He			Associations and Impact Factors between Living Arrangements and Functional Disability among Older Chinese Adults	PLOS ONE			English	Article							SOCIAL SUPPORT; MARITAL-STATUS; DEPRESSIVE SYMPTOMS; HEALTH-STATUS; MORTALITY; GENDER; INTEGRATION; PREDICTORS; CANCER; STAGE	Objectives: To examine the association of living arrangements with functional disability among older persons and explore the mediation of impact factors on the relationship. Design: Cross-sectional analysis using data from Healthy Aging study in Zhejiang Province. Participants: Analyzed sample was drawn from a representative rural population of older persons in Wuyi County, Zhejiang Province, including 1542 participants aged 60 and over in the second wave of the study. Measurements: Living arrangements, background, functional disability, self-rated health, number of diseases, along with contemporaneous circumstances including income, social support (physical assistance and emotional support). Instrument was Activities of Daily Living (ADL) scale, including Basic Activities Daily Living (BADL) and Instrumental Activities of Daily Living (IADL). Results: Living arrangements were significantly associated with BADL, IADL and ADL disability. Married persons living with or without children were more advantaged on all three dimensions of functional disability. Unmarried older adults living with children only had the worst functional status, even after controlling for background, social support, income and health status variables (compared with the unmarried living alone, beta for BADL: -1.262, beta for IADL: -2.112, beta for ADL: -3.388; compared with the married living with children only, beta for BADL: -1.166, beta for IADL: -2.723, beta for ADL: -3.902). In addition, older adults without difficulty in receiving emotional support, in excellent health and with advanced age had significantly better BADL, IADL and ADL function. However, a statistically significant association between physical assistance and functional disability was not found. Conclusion: Functional disabilities vary by living arrangements with different patterns and other factors. Our results highlight the association of unmarried elders living with children only and functioning decline comparing with other types. Our study implies policy makers should pay closer attention to unmarried elders living with children in community. Community service especially emotional support such as psychological counseling is important social support and should be improved.	[Wang, Hui; Chen, Kun; Pan, Yifeng; Jing, Fangyuan; Liu, He] Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Chen, K (corresponding author), Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	ck@zju.edu.cn	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	YANG, CHIEN-MING/0000-0001-8144-8496; wang, huaizhou/0000-0002-4126-100X	Zhejiang Research Center on Aging	Zhejiang Research Center on Aging	The source of funding that has supported our research is from Zhejiang Research Center on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWIN DF, 1985, J MARRIAGE FAM, V47, P319, DOI 10.2307/352132; AUSLANDER GK, 1991, J AGING HEALTH, V3, P493, DOI [DOI 10.1177/089826439100300404, DOI 10.1177/089826439100.300404]; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Beydoun MA, 2005, SOC SCI MED, V60, P2045, DOI 10.1016/j.socscimed.2004.08.063; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; BROADHEAD WE, 1983, AM J EPIDEMIOL, V117, P521, DOI 10.1093/oxfordjournals.aje.a113575; Chen FN, 2008, J FAM ISSUES, V29, P1379, DOI 10.1177/0192513X07313602; Cheng Ching-Yu, 2006, J Gerontol Nurs, V32, P16, DOI 10.3928/00989134-20060901-05; Cheng CY, 2006, J GERONTOLOGICAL NUR, V9, P24; Chou KL, 2006, AGING MENT HEALTH, V10, P583, DOI 10.1080/13607860600641150; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Davis MA, 1997, AM J PUBLIC HEALTH, V87, P371, DOI 10.2105/AJPH.87.3.371; Denton M, 1999, SOC SCI MED, V48, P1221, DOI 10.1016/S0277-9536(98)00421-3; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; GRIMBY G, 1988, SCAND J REHABIL MED, V20, P93; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; House JS, 1981, WORK STRESS SOCIAL S; HUGHES M, 1981, AM J SOCIOL, V87, P48, DOI 10.1086/227419; Hughes ME, 2002, J SOCIOL, V87, P48; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Hupcey JE, 1998, J ADV NURS, V27, P1231, DOI 10.1046/j.1365-2648.1998.01231.x; Jefferson AL, 2008, AM J GERIAT PSYCHIAT, V16, P375, DOI 10.1097/JGP.0b013e318162f197; JOUNG IMA, 1994, INT J EPIDEMIOL, V23, P91, DOI 10.1093/ije/23.1.91; Kharicha K, 2007, BRIT J GEN PRACT, V57, P271; Knodel J, 2002, PATTERNS DETERMINANT, P143; Koskinen S, 2007, INT J EPIDEMIOL, V36, P1255, DOI 10.1093/ije/dym212; LAWTON MP, 1984, RES AGING, V6, P323, DOI 10.1177/0164027584006003002; Lawton MP, 1976, HDB PSYCHOL AGING; Lennartsson C, 1999, RES AGING, V21, P657, DOI 10.1177/0164027599215002; Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013; Litwin H, 2012, J AGING HEALTH, V24, P846, DOI 10.1177/0898264312436714; Lund R, 2002, SOC SCI MED, V55, P673, DOI 10.1016/S0277-9536(01)00219-2; Macran S, 1996, SOC SCI MED, V42, P1203, DOI 10.1016/0277-9536(95)00432-7; MOEN P, 1989, AM SOCIOL REV, V54, P635, DOI 10.2307/2095884; Mor-Barak M E, 1991, J Appl Gerontol, V10, P293, DOI 10.1177/073346489101000305; MORITZ DJ, 1993, J CLIN EPIDEMIOL, V46, P443, DOI 10.1016/0895-4356(93)90021-R; Russell D, 2009, J GERONTOL B-PSYCHOL, V64, P95, DOI 10.1093/geronb/gbn002; Sarwari AR, 1998, AM J EPIDEMIOL, V147, P370; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; Shin JK, 2008, PSYCHIAT INVEST, V5, P155, DOI 10.4306/pi.2008.5.3.155; Taylor MG, 2004, J GERONTOL B-PSYCHOL, V59, pS238, DOI 10.1093/geronb/59.4.S238; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Vanderhorst RK, 2005, AGING MENT HEALTH, V9, P517, DOI 10.1080/13607860500193062; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Waite LJ, 1999, J GERONTOL B-PSYCHOL, V54, pS136, DOI 10.1093/geronb/54B.3.S136; Wang JJ, 2001, INT J NURS STUD, V38, P339, DOI 10.1016/S0020-7489(00)00072-9; Wong YS, 2009, J CROSS-CULT GERONTO, V24, P209, DOI 10.1007/s10823-008-9081-7; Wu Z, 2008, SPRINGER SERIES DEMO, V20, P197; Yeh SCJ, 2004, SOC BEHAV PERSONAL, V32, P129, DOI 10.2224/sbp.2004.32.2.129; You KS, 2009, ARCH PSYCHIAT NURS, V23, P309, DOI 10.1016/j.apnu.2008.07.003; Zhang H, 2004, FILIAL PIETY PRACTIC, P63; Zunzunegui MV, 2001, INT J EPIDEMIOL, V30, P1090, DOI 10.1093/ije/30.5.1090; Zyzanski S J, 1989, Fam Med, V21, P199	54	90	99	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53879	10.1371/journal.pone.0053879	http://dx.doi.org/10.1371/journal.pone.0053879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087KE	23843989	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400094
